<SEC-DOCUMENT>0000764180-21-000127.txt : 20211028
<SEC-HEADER>0000764180-21-000127.hdr.sgml : 20211028
<ACCEPTANCE-DATETIME>20211028101006
ACCESSION NUMBER:		0000764180-21-000127
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		105
CONFORMED PERIOD OF REPORT:	20210930
FILED AS OF DATE:		20211028
DATE AS OF CHANGE:		20211028

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALTRIA GROUP, INC.
		CENTRAL INDEX KEY:			0000764180
		STANDARD INDUSTRIAL CLASSIFICATION:	CIGARETTES [2111]
		IRS NUMBER:				133260245
		STATE OF INCORPORATION:			VA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08940
		FILM NUMBER:		211355713

	BUSINESS ADDRESS:	
		STREET 1:		6601 WEST BROAD STREET
		CITY:			RICHMOND
		STATE:			VA
		ZIP:			23230
		BUSINESS PHONE:		(804) 274-2200

	MAIL ADDRESS:	
		STREET 1:		6601 WEST BROAD STREET
		CITY:			RICHMOND
		STATE:			VA
		ZIP:			23230

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ALTRIA GROUP INC
		DATE OF NAME CHANGE:	20030127

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHILIP MORRIS COMPANIES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>mo-20210930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:24c66990-7eda-4ddf-9c7a-8f1433627d2e,g:a0baef4b-24ba-4415-bfd0-6e9831a24e17,d:295e56fb16f94dae9eacc631c56d466c--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:mo="http://www.altria.com/20210930" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mo-20210930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y180L2ZyYWc6MjFmMTBlYzAyOTg3NGFiMWI0YTZlZjIwYjYzNTdkYjYvdGFibGU6YTlkODBhNWZiNWNhNDYyNjg4MzIzZTEwMzU3ZjU2YjAvdGFibGVyYW5nZTphOWQ4MGE1ZmI1Y2E0NjI2ODgzMjNlMTAzNTdmNTZiMF8xLTEtMS0xLTA_590a731b-f56f-4114-866b-766d086fd39b">false</ix:nonNumeric><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y180L2ZyYWc6MjFmMTBlYzAyOTg3NGFiMWI0YTZlZjIwYjYzNTdkYjYvdGFibGU6YTlkODBhNWZiNWNhNDYyNjg4MzIzZTEwMzU3ZjU2YjAvdGFibGVyYW5nZTphOWQ4MGE1ZmI1Y2E0NjI2ODgzMjNlMTAzNTdmNTZiMF8yLTEtMS0xLTA_d48820e2-92a6-4f80-bcf2-6abd99f48a95">2021</ix:nonNumeric><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y180L2ZyYWc6MjFmMTBlYzAyOTg3NGFiMWI0YTZlZjIwYjYzNTdkYjYvdGFibGU6YTlkODBhNWZiNWNhNDYyNjg4MzIzZTEwMzU3ZjU2YjAvdGFibGVyYW5nZTphOWQ4MGE1ZmI1Y2E0NjI2ODgzMjNlMTAzNTdmNTZiMF8zLTEtMS0xLTA_bd074e46-138a-4837-8503-1f5e7c8e6516">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y180L2ZyYWc6MjFmMTBlYzAyOTg3NGFiMWI0YTZlZjIwYjYzNTdkYjYvdGFibGU6YTlkODBhNWZiNWNhNDYyNjg4MzIzZTEwMzU3ZjU2YjAvdGFibGVyYW5nZTphOWQ4MGE1ZmI1Y2E0NjI2ODgzMjNlMTAzNTdmNTZiMF80LTEtMS0xLTA_1c475cb2-d44b-4a72-937a-54445d1091c2">0000764180</ix:nonNumeric><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" format="ixt:date-month-day" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y180L2ZyYWc6MjFmMTBlYzAyOTg3NGFiMWI0YTZlZjIwYjYzNTdkYjYvdGFibGU6YTlkODBhNWZiNWNhNDYyNjg4MzIzZTEwMzU3ZjU2YjAvdGFibGVyYW5nZTphOWQ4MGE1ZmI1Y2E0NjI2ODgzMjNlMTAzNTdmNTZiMF81LTEtMS0xLTA_69692a58-f418-4405-98c5-a1f4fcabd80b">12/31</ix:nonNumeric><ix:nonFraction unitRef="usdPerShare" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMy9mcmFnOmE5OTcyOGY5Y2NmNjQ4ZDA4OTY3MzY2NDg0Y2RkODUxL3RhYmxlOjM0OTY4ZjRlOTc0NzRhNjc4OGMzYjNlZGE0Y2JjZjE0L3RhYmxlcmFuZ2U6MzQ5NjhmNGU5NzQ3NGE2Nzg4YzNiM2VkYTRjYmNmMTRfMi0xLTEtMS0w_fac722f5-baa7-4b0e-951b-7f56e2c8089c">0.3333</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMy9mcmFnOmE5OTcyOGY5Y2NmNjQ4ZDA4OTY3MzY2NDg0Y2RkODUxL3RhYmxlOjM0OTY4ZjRlOTc0NzRhNjc4OGMzYjNlZGE0Y2JjZjE0L3RhYmxlcmFuZ2U6MzQ5NjhmNGU5NzQ3NGE2Nzg4YzNiM2VkYTRjYmNmMTRfMi0yLTEtMS0w_2e093059-de80-445e-b5f1-2f33dfe9b222">0.3333</ix:nonFraction><ix:nonNumeric contextRef="ife49fc973ca746f092aa4d83bca9d740_D20210101-20210930" name="mo:RestrictedSharesLockupPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzkwMzI2NjI3OTEyMjM_deac5b80-5cfb-43db-b6ef-127a6fca35e3">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="ic8c655e105f449fd919701efabc22bc1_D20210101-20210930" name="mo:LossContingencyNumberOfStatesNotSettledArbitrationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM1NjYx_a644eea3-4823-4d15-b961-96400803386e">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i9eb956b79e6c4406aa88f5877ca274ab_D20210101-20210930" name="mo:LossContingencyNumberOfStatesNotSettledArbitrationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM1NzEx_1f0bca57-bdd0-4faf-a0bb-bb958177008c">P1Y</ix:nonNumeric><ix:nonFraction unitRef="court" contextRef="id021cc782b074325a57d6e0da163d67c_I20211025" decimals="INF" name="mo:LossContingencyStateCourtsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDMvZnJhZzoxMGRjNWMzNTg5OTE0MWY2OTEwNGQyMzUwNjYzOWM4OS90ZXh0cmVnaW9uOjEwZGM1YzM1ODk5MTQxZjY5MTA0ZDIzNTA2NjM5Yzg5XzU_6947b49a-350b-40fd-a482-283aaf25af92">21</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mo-20210930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i083f183560914b169a2b47229664ba43_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45fa0eb8e2f44df1a1178d965055b18b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock0.3313ParValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f72e3af91ab46a8894e0b9546b1c4b4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock1.000NotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i637e2b2941ef4dd592b5c3c4d55bfa25_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock1.700NotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bf469c5379b4f2d88bdd9ee3efeecc8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock2.200NotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia576c3905ea64c98b404cc8e4f72a7d9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock3.125NotesDue2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="iea6b6e16a27d4008b94c6c65b72d6673_I20211021"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-10-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i503473da7ed148e2805b9efd533f401c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b7b05662cb744f89da910b211c223dc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe5793331b9d44488c81b7f716d22cbb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44e385b4040e4ead83a85c0957688fd6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48d419bfc78f4132b045cf4fa761d902_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3dbc9fb0ec734480b6f0af9d1b9ac7b9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fa834a6c7dd41229d83b9ffbdd1b664_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa3df180bbc24f8c80034b0bb74a30e9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53aea5f1004341c7abdb570f2d2eb5b4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13776c8fb39a40d9af4989bb9862e205_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd9b7b88141b400786601f5cd3fec33a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ca1deaa032a4cdd9c95cc8ea4e8b898_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6f34d72cb7945e9bf68e87fc2c12f53_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic487ab98208d404887e95b93923fab79_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8693290ed18e4d7f87c0282e3f727528_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i007a6b02e9c44466879605af235d8517_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6448179dc624c73a14533ac4f8492a2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8c26c7de7b3445bb7421e82ca7564b4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fd83e66c1ff4909a7a501481a11f766_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib231dbdd7b5c42a4892838893be458cb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c17c5569ff54cf28521a8e8625991d8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i715d5e9f7cbe440b8d3c2b5ed4aeae4e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i433dda944a934320af202e2f484eaa1c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a16f34256ad48b49ed8a50852fea048_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i954fc4945ffa4f8e8cdfabbaf3f7cb6f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bf636ab56ad4d7cb37b9d77019eed37_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e8e3bf6dc224a4aa974a22b40a91d8a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cb0ffd7d3ff4483920746a3ef17c36d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f1f1cd9567d4e048bfb64a6d6ee6bd0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8407362350ee44c99f4b71eae2816e16_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf1005329da74407b072e55e84c44f7f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87c1b1fef9414aef84749896871324f1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic81e63acf60f4e9c8c9e8e24c19afd4b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i337dce81edc54d6b886012952b0b9ade_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b2a0f8b0eb84d6e98048c9c107d0d60_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f4f34969f60495f8314b93ba8b0dce5_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaeb4c19649a6480d80da77904d536dee_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b11e531794f48868e8b9e32c403e904_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9137713c9da54ea7a9359074d78d444d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffa730c0799046999cf2e97fed548bb6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcdf82bc9a97456f9411c9f42374d3f6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ea0515263584ea09063bbf40ec274b1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i610ba96937d54033839c8aaabcec01b3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86447877e5b642e4a75424d1e386ce93_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3df7c108f2c5403c96f58e273f0dc0d1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if06993d5e1db4a3f9eda4a58697e58a1_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib37636bce9b94aaeb1cbaece44b60523_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i811d953ad6844425a1abf068a0bef5ea_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb6a68caffdb4a49a42f353a7047b68a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfa6672fba3e4b2380d43bce7cac51b6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04acd635c03342bf90bc79dd81caef6b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id142ac3234994ef79d1ee5f1de4d371d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83adb27c0e2746b595871ff0b3f2b7d8_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65d2cfacd8464cd8a25b7d8f01804516_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib54bea9ab2a541ef9a1b1495988aba10_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b48e147a93c4d159841fd5c68e5adba_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i967d1f95af3f41eda51eed3bfc8a12af_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d98dc6b3b424d3cb692eff540ce05d9_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9284f3c4288b4cd2b2c41662e054c3d2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iece3d64b93d440e3863844f51f91d57b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idba80b960aa444f9afc7b3189ec8d63e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9870fc1d39c94d9f81e1e50ced847ae2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ie227d61fadaa4ad894b027826871e831_D20201201-20210429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mo:HelixInnovationsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2021-04-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33693bcc9b6d47e48094cbb1bb3c5f74_D20201201-20210429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2021-04-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96dcc4ff54674f288ddfdd67f37a96ab_D20210801-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96ddae8ac4da494d95d13e4d56d378cc_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7921863f9b84211b6ab722289417409_I20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:July2019ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58b4cc5497fa437d9019b1914e39936e_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:July2019ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1160db7af33456abd28f3ff1afe8c43_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:July2019ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if027f1be3b8b4d97b39ef8c617dc8946_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i210e56c06a7e4442963844e819875e34_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4244523c3094b0a9521b3089395bca7_I20211028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c8666d14400451b9e82c0e7c854ebe9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66dae12b306e4c15a45bf2cedaae9792_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica91e72247354acf9f03bbc39e5c5f66_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d91b3c8886d4970bfefc99ee9bd77ec_I20211001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mo:SteMichelleTransactionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i800ea809d24a4ae99423280ab9ed1ce7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mo:SteMichelleTransactionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9321155464464f6abb0579cd48d53de2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mo:SteMichelleTransactionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:MarketingAdministrationAndResearchCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ae5a856a040414ea2c55c9313370362_D20211001-20211001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mo:SteMichelleTransactionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11c3f27b7191493b8194d2564e1cbc32_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mo:SteMichelleTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib20e8844a92447d0a46d19d86ed0f7f5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mo:SteMichelleTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6f738f3284745ba87d4ead6955d877d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8023b74faf63413a92633caf766ceda1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72200b393daa452fb6e8b503937f1675_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia53e50acb7e34afea6df1a5247e0b9d6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3134917de914447a308c3c06a9e6332_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5afb831a7af4995b73bda6b83b376f7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2d67aef385b4488b0e8489bde6ec505_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c1ec10071a549c494de909a6803c0bc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id27af0c56a0e4f2c91692075789f16f1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55353e2d6bb3468a8bb902e7ef81616b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7f2b6c32d774ec2b7a6087a9251d893_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie01a2991fc0c45cda4ae5f730f069b9b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife49fc973ca746f092aa4d83bca9d740_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i142e3b708e7c4513964bfdef3821842c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic62d4fc827d0412695035c4816dc2a17_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b92cf433a64434db9bce40cc2385d5e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f91523b32934656837eccb431840056_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16da5adef0b64404a908cb9d15134fb8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3a641fc878c4afe85e1c9467ee9853c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if07c963ba7314996a07680309ec4ce52_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a7ceafc35c8455aa006544f31dada24_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff7bce46de9948cfbbc1a3790debcee8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d7c9a004f294d309f5a0ddbff7f9c62_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26492b9b36f34d359befa59e3e1f285d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32e2dbe44f974df484f948ed2b86c221_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3b7793faa454c9499956ae3df8ea507_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b95bdcd547049af892afbaf8e444f3e_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i134145e8cb494481a64026d08e24f670_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">mo:EquityMethodInvestmentsFairValueOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fe43b6fc76f4ce480f73470bdcc7717_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">mo:EquityMethodInvestmentsFairValueOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i050fe6a531654ecd9ffb665ff8b70dce_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">mo:EquityMethodInvestmentsFairValueOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1881e260a3842d1bcc033077fcf431f_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia17ccdc17eaa43c2895a3756a03e1e51_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="cadPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="cad"><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unit><xbrli:context id="ia8e68dd2bdba4a9fb2cab39cdf6ff65a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i413418f0ee6d4970991e224cb3ef2b61_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c45d9f454c845349a17b5b89122518e_D20211025-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-25</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90625c50de644d79a497ab347321af26_D20211025-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-25</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2c7ce11a66f40d7b866ad7f5cf8a0d7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantAndEquityContractPreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30a456d16ad04abf8d2bbed9680d3088_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcf3cacc08db49a29687505d3387266b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87169f0e47aa46f581a3b1a6a073d849_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic10cda982ea5415199ad34d94e8b02ba_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f7d03ea00174970b1ec83dc2dac1886_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4d49e3b18b5423e972b0489f00c3c44_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97d4b0a3f973401ab8af04812ad88ab8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i299ff36535794f3da00e849d49232f7e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58618b2d87444fa1b1e248c65a98ccf7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="year"><xbrli:measure>mo:year</xbrli:measure></xbrli:unit><xbrli:context id="ife62efd21d3c4274a6d99ee48062bd72_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27b16784136a4ee1b08eab8d661c0473_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe8f6ff98f9b4b6ba0315bd2c6c328fe_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f3288737dff4923b723710d770b6bfe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d742841c5fe465985b241c6d5f4484c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if695dc35dec34537808c09ca053c1768_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie51acd28a242489eb93cb384c8145b12_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic441be4c36e54182a0d7529d2ecc38b4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14ff2002b85248c2a717760fa5447b57_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8230deeac7a042d782c7c2a1edc62727_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95ddf40ef20a463983f2f6637bdadb3a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4bf3c8921284849a8922aa21c6d0fba_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb4ecc1e346d4864b399340e003690e1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i729af67cdbe44560b187bc2a5355d961_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia84fe1dcb00d4c42946248812c92de20_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6074d0f496474bc6b259bb2df8d5b30c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ebb29f66c07461aa96dfc8433fac067_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mo:MeasurementInputWeightedAverageExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55362d8be9514c0cabf140dc7d6239f6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mo:MeasurementInputWeightedAverageExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48b89d0bd67646b288c756c93a850879_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mo:MeasurementInputWeightedAverageExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57543deaa7a640628f92b751104d9900_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mo:MeasurementInputWeightedAverageExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7a53ae7739f46c7b604110d4483c929_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic67976b0907f4b868fa3d035e132418d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18d875d64a0945bd8350d34786e8fc87_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28afb29902db4901b31c391429b1b607_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia80bd4793ddf4b2d915e5f5ea7d8ca62_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EquityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64ff63b34a204467b3064abd7fcc4a64_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EquityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i888b21f50f1241039283cfc1fe265126_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EquityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cdb57e3b67e4af08c71b8743251e9dc_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EquityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice62522e8f3e4793835443a9d9fd2cda_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EquityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2be07afbaf94c6fb3d9eeb024386d1a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a791d31299e4494b797ffdc1cac8f2b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bd27afbf2ce487ea8421adf4864eba8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mo:OtherAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23b6cc53678a4c949419f35fd13251a6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mo:OtherAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd824826dc2c4942a04c7d39edd256d5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib813ea19505f4d82aac201b8d7cb1729_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i420bac3921ce42bea9dfcd0aa2d91620_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2d4c37137a7441c8d333d4e72463e40_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i448255743e3c41a4859a9556d275d76c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddb651cf441648dbb1dff101d6d3d546_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia565cea6862d417c97c684e3d00ae39e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mo:InvestmentsInEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bbe0c1517c44ab49c07a8fd54a1eb3c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mo:InvestmentsInEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e277a3e43d44130afbf73dc7dde1b91_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mo:InvestmentsInEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddd36608a5eb4e55a57cc46e949da550_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mo:InvestmentsInEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48f32e9fb6254c8587a74bd98c7ba505_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EquityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8922561835d4c67b1663239e270549b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EquityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaabb1ac00dc4de9afa2e9b2a864fa5b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd5a3b6fb7e34bca9dea72a0c14da288_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c367050085a48a69fa712c3eceab7c0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60d37aaec4d1491e9ffbbf008424f75a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20b1e637093c48f4969fae7d410a2693_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16161f66e87a41ab993f192e9c451cf6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b30b55ee2ef446882c7477d8328c504_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84041ff1f2d1478e9462865044b54b4d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideb6d765d89e4b91aa1a4fbb97d5de55_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7def76adb3ad4f72a02323fce73fbe1a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b22d5f204d248aab1e00daf3b0d8153_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib358f1bbb75b41f3aaca506bf354a2c0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4ee47e867c246b8be587254b4a9a6cc_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i157a11cd19544cd68917916131342ac2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3eaa97db709e43d0b68539ebfc1f7fcd_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i801ea70096974921a9cc6afb7fabddb3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f6f91cba83e4cafb448b38e704724c2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75d11c60a1504c2a8018692b2fdb8592_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95c1f586ef4041dd8c67ab4c79e3718a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe0426ef79dd4e1b93e9f3b19953e12f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i641562cd01894f84aa15b3d08486a81e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i285fd763c7cb4c95a6689072055b09d4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92dcd11d5d934931ab51a35b59f2acd1_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cc174939f1e414593012b716f47f230_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65e5f978b5c84e8aa707cac5eb7382f1_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia30f1b1250de433dabcb2cbe9baabacf_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib46d19a7eb014c0d80e8454b5ba93ecc_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bb0ce68c3494d79abc790fd0561a2c9_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a9748c0c5a34059bb965420acaa9a71_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4b4f1114be54cf39186a491bbc07db4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5da59f9184554221a714ef4fa85eeff2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a5e492ac0384dd28bb0ad0497562294_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32402401a0f844239e2c32d640969c41_D20210531-20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-31</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2ad51d5efd34c6890d17e0c82b226b7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f3fa8b9977e4b429a89b213dd45435e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb1b7837d3fd4f8097b3317e18a83bbf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4320d8cfd0aa4682ac4fd8e97489f333_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib94d886e09a149778fc4b762edca1bc7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3b0235cbe654245a5397a036c1d3132_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie628688809594c33a0f517053cd1c98f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c08359b25be43c9b6378dcc5e5e3f52_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6cd59bba4c64d728580eef19f7136ca_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia60bc9c826684e3dbf0b2a03a36b0a67_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f37b78605b24016b376248d47913825_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64f0bf43c52c463298e2f9f2570fe3e3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbbd3f4ab1454dcfa39e110e53cca664_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfb335bd0af94b69b6dbeda93b2431f4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb267062b0c74a0a89cf1006daf242da_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaadcf1874ca04724982a8928b2ba0492_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ad5ab3a5d744eae96a566cd3203adfa_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa91dd46f82a4982882dee9eb8e7ef08_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie55982b4b8094afd8cbd3644050918a9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70e46b26b4fc462a81bca6b1ee77e04c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1b552df277f47bdac453b74353a2434_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieedc417e26a742608b043deb27b97448_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1b03165fb2c4b76807e0ccc90d962b2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5bf1a00e1e4420f9e82ccdfbc6a5434_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id14c8ad0e1114859a5ef9774b11273ab_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3dac29830b94be0b1b1d5af479d71b6_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i529da0d49b1b4fcda97c6cf43be5a0e6_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc3428a068464ada9a25e4ce62287f36_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9501d5a448d4b8fb83b9f4658086140_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1663f22cd4af448bb0eabf4a88a2c65f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i903649a4650d4581b810b87a8e7abece_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba009efde806409683cbc9e86246b4df_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1f84a88e08b4b88ac5ad7e5696842ef_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i386a65106eed4b8480296af72f76b88a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia911d34c10624a4caad11aaf671e57a2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00054ad5017c49e886588f8692292ab7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i148aed2cafc8405f9c753e10684af7ce_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c117e78f8df4689addea5ed534be7cc_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90237e5e67d24c74afa25e85687a853f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4234136b96446cc9cf8cb134f4533f0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cdea01ef93f447c96c7b2a20036eb30_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09764927c7ec46e49e7775b99fd97136_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i129971b2b9ec49abbe1afc97cb429284_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia80f603ac4c848f78a7bcaf6c95cb8a5_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibaa55d29a7cf455ca4bf8fe55b94e9c0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d50e83d51e04a2c81a2fb7b3d33bd41_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if41a4137b96044f2853f90bee854a5a1_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0c26c7c96cd4d82a4534ab1f5e26951_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e957d6659b146e1a8a2c22448c05e52_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3658d6662464166bd1a7d63193f62b6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c60e64bda5e406c906f14c501403dcf_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb73dd7e78c54dc0bb94170fd12ab8ab_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88fcf49918a84402902b9a4fd578a532_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e951f6b74194f1ea5354f9049777599_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3e0ae69ae05491a91e3fdb908e909db_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a2569691b65440c9038155bd4cf097b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8712c39f1b4b407d8d3f616cd0f6d0b2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf557385c26346d78697ab7216ad25aa_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cc47fbf28e740b583be5f01ebc5de9b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7773a1a4d8454a6f8b93d93dbf471801_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7294329e59b4737858f1c36f4d117a6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaecb6abc654940949c584c7bce9fa618_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf8f1c9e35d64a1f98b39384820c20cc_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82c1570001674d4a844a4bfcb4e16ca8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i867ac19dbb4643b59a94aeeec8a58fa8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41fcc7aaf3534c59ace9f381d20aac6a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie45eb514d8c24379a2d84b6fdadc5908_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i348527fc0572499b8b09c70427059222_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idda2d39340b64a38b25c3fbb87815b91_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id08e4c2d3cad43fea50a182ef5e4bd72_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45eb44ceb75d4820b3468fcd56c069bb_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic06d55ed183d403ea8fab3081dabed8d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib87ad1bdee774676a43d32c69faf494a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8113c4d3abd42a8a3d5dc65de3551ea_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23d680315a484e78bb04a83054b0bd2c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5750ad1593bf4f39a28a67676e4be777_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i901cc99ae1b84fcaa334b79a557b2716_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92ece1efc67e4955b20f6106bfa5b1bc_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbc3e1fdad35440a8019431504912e54_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NpmAdjustmentToCostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab4ebcb1e91f46c4be02c3ade89e7bd6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NpmAdjustmentToCostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a6c36dc62614c039382474701d62704_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:InterestAndOtherDebtExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NpmAdjustmentToCostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0bdf868958f46d39d41b03294b42969_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:InterestAndOtherDebtExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NpmAdjustmentToCostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b0b695b39e941948146139c5236ab09_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NpmAdjustmentToCostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01fb7d5238cf4de6af35e1b8ee70534b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NpmAdjustmentToCostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0da5bdcd164423ab6c5e7d2d4619255_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71a6552e683a45df8a80deb0ff141acc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8c00af2fa2a47a08ce2e121cec7fa1a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id86681b1496e4200ac6e85e6642cca96_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44c555d22e7b40b0b20993dec5333004_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13dbf73b19844cd8895f0cadcf052f90_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5717ce456bae4169a32dfcce88700f00_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e76683652f2470896a6eb26e4f4b7a2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e46fc85802e4a6291b8902ec7c022dc_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3e6860a06dc45078a5772ad589b6723_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17fc09b753d24ddfb9c43ac782832373_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6059c690166441149c61f26c7db17255_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if433ba93efde45f38a5688307f77c9c4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i876dc6b8472b4c2ea0c3ae119b771d02_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74d52c13d1e44d56853af2d044689b8c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib11d64a866fe4276882eac217af0ec5f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e1577fefc474a9b9a5a1b492deccd82_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mo:COVID19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i986e7568db0547edb5f58a6f3d032e05_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mo:COVID19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i509fd5cc79b84947a1ddc23a201ceee8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mo:COVID19Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if08ac6b396064588b67bc488b59ea368_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mo:COVID19Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4f93cb048684f5f81d4c6d87a4b0f83_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mo:COVID19Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i637d3a2f463a43b4ba0c2c56616e75d5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mo:COVID19Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf975d8c2d674ea3839f3277f75cf4f1_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mo:InventoryDisposalCostsandOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mo:WineBusinessStrategicResetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99a5d17aefbc4d5ca90136899d314788_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mo:InventoryWriteOffMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mo:WineBusinessStrategicResetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57818fd795f445829d1bf3dd90269c34_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:PurchaseCommitmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mo:WineBusinessStrategicResetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f700f27ee5b4dc0b6b7ca55099ab015_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8782aa269d064a7f878a2d5f0a778720_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d9e692ae91a4176bbb8ab4a42237fa6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic42084bb2e9740b8b51ae3feeb2862d5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i634fff1d9b644e8cb5c918e89bad5ae8_D20200301-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0080cbb283042c7ad61da99c612ad5a_D20210501-20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2620d02ad1494d46ab52a4c075ab2c6b_I20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i857205f0e0394b73ad424ddb571fbf8c_I20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesDue2032Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb779f48ef584729a5fa769c008b9ac8_I20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesDue2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72bc00d2c5e94db1be910ff08d7edb62_I20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesDue2051Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd06b0461cd94297b50a5616b6cabc08_I20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesDue2061Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc8423e2c5df46eea5b83d3f181cc413_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic85fd5bdf74f4f0091c93c498eb3cc11_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2224c863f13e437d85f29be315d3c712_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes2850PercentDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i808f87bc995d47d5a86a27d0ee9f22b4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes2950PercentDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2502deb2ffd14f39bc40df7e2d62056e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes4000PercentDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie52346405ce94721b9a8f4e6ccd91ef6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes3800PercentDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icab982db20034341aa05031441a073b1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes4400PercentDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d76ccb7e1a5434bb17c22937296a8ae_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes4800PercentDue2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffbca0a488934ac8a34f87b93f39560e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes9950PercentDue2038Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61833c0644204fbfbcc52b66fce61e91_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedDebt10200PercentDue2039Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i347f7da5d0054edbad9c6e2ea4a0651c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedDebt6200PercentDue2059Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1fd6ffda965426487b95b70a8b31910_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes3490PercentDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20e14cfe0c0d46339af63110c7811e34_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes3490PercentDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice0b95503da241eb84089a6759b1e50f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="state"><xbrli:measure>mo:state</xbrli:measure></xbrli:unit><xbrli:context id="i926660aafc7244e495754a8afa4f6531_D20041001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2004-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a75c3716f9f44f8b0a633a8086be1e4_D20041001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2004-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3400b8bfff76440f9313bb4f3fb62ca3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica387b7fecba4bfebc8ddf8f17f04ad8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied52ab66233a43c196b987b68bd00b86_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5ef8014d73d4900afc3092294d2ca38_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b3cc5d6b74f41e9aed08f62d1656e61_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2529fcd54b74ef2a31abcd12138bb42_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6645d5f78024731bf63efa024c27f2f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if53282b7834348a9a6ada854639fdbd1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ea29768db1440de8cdfdba1d0ddb39f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>mo:claim</xbrli:measure></xbrli:unit><xbrli:context id="i663ff20a0cf640f8ae7953fdba19634a_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5ed554a97e64e58a2f7dff3f260635e_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35aefdfd25a54a77a106cbf1a1685ab5_I20191028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20886114cad04457981190cedb862851_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf6d7d9ce89842c7976f502120165e8c_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2704bd9b49ac4bdc8fb4f82a270c44ef_I20191028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d4206f6a0024fed8cfaa7a66fcf85d9_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71b573459eca4bea97af58bf49c87201_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icaf8b745a94b42ccad21473588116847_I20191028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12bdefb971104deda60ea7c60dd43501_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherTabaccoRelatedCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3dbb26207114dcbb85df4982dbc5033_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherTabaccoRelatedCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b166612ac8e4f99b7ad03601c8126b7_I20191028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherTabaccoRelatedCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b18278bbd184abca4253784cfde6900_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i223b3b59e9644a15b7fe55e88c315de3_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if18a359a02814e81ac2e7da57ce8914e_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2722814648844259fc7fba910bcb8f0_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="case"><xbrli:measure>mo:case</xbrli:measure></xbrli:unit><xbrli:context id="i11bb0f709f4840c9a6ba836ea86e439b_D20211025-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:ETSSmokingandHealthCaseFlightAttendantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-25</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="lawsuit"><xbrli:measure>mo:lawsuit</xbrli:measure></xbrli:unit><xbrli:context id="i7e914a4a2b8344169accefce0c454834_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingIndividualLawsuitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaeab395fb605402fb5a6b9c5bdc4a711_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingLawsuitsFiledByStateOrLocalGovernmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d5084fb63864e7d87b275079786c20d_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:ClassActionLawsuitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i656d506fcc8a4b9ab2659e2676677a0a_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd987a82f3714a11b7e8c291d69672a9_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9e0a1f532ea4ebf81ee548bc37ef0cc_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAandAltriaGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61b4bd1b44014f77ba98ffaddac70a1c_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAandAltriaGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90226fb36aa64d6bacef37bf4db3884b_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90fcd7f5574440a5ab359cb20e1a04c8_D19990101-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idce33acf337c4fe9a1645ddb2e019e7f_D19990101-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:AK</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id289701c573b45cca1a140d0c73c998a_D19990101-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d46d835a2d24d1ebd56341154a639d8_D19990101-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CT</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f2e6b71ad0c495aa1c5d1de5f3d1b7f_D19990101-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3500d94f16d4d48be23dbcd39c4724d_D19990101-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:LA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68a963409b744c62ada96bbe606437d0_D19990101-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a74a591f616416a8beecae26d6b025a_D19990101-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MS</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i080e23384aca46ac97b6d8534dd6870f_D19990101-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MO</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if89eceae6818421ab7e71078e8640a23_D19990101-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3434a001edb4107b89f9f106fa2815e_D19990101-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dbfceaeded0450399ee40b258518a3e_D19990101-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5569874aeca64116b11922db9cb7839b_D19990101-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib231c8aea8fd44718baa2914cd6cba3f_D19990101-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:PA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i552ef3865e7d48829a38177ee62b4979_D19990101-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:RI</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id38fc93aeda6476b9dac24a91fd1cf6d_D19990101-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TN</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia00a1362eff94111880c5d8063950c56_D19990101-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WV</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i052ec416024f4823bef90cd01d8b4153_I20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingAndHealthCasePrincipeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i517f019e7c1743319a6e9441dc360c47_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGreeneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib96d34ed4ae34693801830017a4f6049_I20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGreeneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ea87da7184343c09f4ee1578cc648ee_I20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGreeneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa32d699351d4292af9042e00b380590_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseLaramieMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id38820dc93e04812843942939c4e6352_D20210901-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseLaramieMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9edffb5157944c1b92f53a2aa6e6ff0a_I20171031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGentileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e21fbb1029544a7bf549cf560acc7df_I20171031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGentileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5287e7b9447640e785f900c6e40cbb09_I20000731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2000-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a5d377b4b3f458eba4a9e7b517b8e16_I20000731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2000-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a03e98802a847ef9e56a147ecdc0b02_D20060701-20060731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2006-07-01</xbrli:startDate><xbrli:endDate>2006-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id970cacb82804a6dafd9bb28ce0e0227_I20080131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2008-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i781149ad13854355a035d0bcc92ce4e5_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="plantiff"><xbrli:measure>mo:plantiff</xbrli:measure></xbrli:unit><xbrli:context id="i0285dbb248214e6b82f1b1e1fca99520_D20211025-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-25</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if243dafacad643ca8a92639963f3f04f_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesFederalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85fafeeb94a94367a935be26dbab3f38_D20211025-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-25</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1eb0635e87454a0fa2b2eec4909179e5_D20211025-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-25</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfc1fdbaa928482089e8a85cb409cd50_D20211025-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesPearsonDCohenCollarChaconMemberMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-25</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie96b5489b60e4b18b201d51a8582e17d_D20211025-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesReiderandBanksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-25</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0be9670c3294c5380d9907c287d1387_D20211025-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesWeingartandHancockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-25</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc49a3c9173544c3ba44b82aea64b761_D20211025-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesPollariMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-25</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if13eaf2626b1498396e84993151f34c0_D20211025-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGlogerRintoulandDuignamMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-25</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifda6adf0b2d84253922e03c7982666d4_D20211025-20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesFreemanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-25</xbrli:startDate><xbrli:endDate>2021-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec72a8c6101f4a219bd73a2c63d2d869_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73ae2282abd0496a96c1fcd57396db0e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesLippMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i194fa22064b649108a6b18c631884f77_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesLippMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17b84f6260d04ad6961ed01a6a4643ab_I20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGarciaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44c6aea7f36842009497759eedcaee54_I20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesDuignanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecc7b1e7a5514f8d981e71849df19766_I20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesDuignanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98691888015f4b7f97a8a5c022078de5_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCuddiheeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0f67b4fed23474aa26757b30fb8314b_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCuddiheeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b6b72d00f4a4457b91e1936a8656c3b_I20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesRintoulMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id11f7d76781a495487c1eed6818fc118_I20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesRintoulMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ef26206b34a4ca08fa1661b761ff4d0_I20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGlogerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17f63ef63bb548338c974ec35dd2a170_I20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGlogerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i019a0fe5dd374adeb0d5245d94a4dfb5_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMcCallMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief9b76c5f9e7421797d6551c8f48d8b6_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMcCallMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fc0d1aced7b4e3090804c6395b59378_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesNeffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1103462b7784169b773bbbc0efd59f8_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesNeffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefe17f299cc745aea480c5200a6d62fe_I20190228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMahfuzMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cd3514504b94f14b23eac85e141bf5c_I20190228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMahfuzMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic644f159146c4bce8ae598030b7521b2_I20190228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesHollimanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffaa0265108c43ac903736f8d4f7d960_I20190228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesHollimanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i934ff2e5139b4f9b96a1effc5fb356ce_I20180930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesChadwellMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0494654648d4e449182d0811815a094_I20180930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesChadwellMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2aad4919d9504ddfb45b65695fb63cfe_I20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesKaplanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1eed45c1dca24b51910ffb82b58ab797_I20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesKaplanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i507aeabef70b43509c6b3bb411894994_I20171130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesR.DouglasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44733c669e7348d3b2b001c64d98bc3c_I20171130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesR.DouglasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib164100fedd24083b3c0a5073943dffd_I20170430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSommersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd484e32de2d4223bdc64a37b20f3802_I20170430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSommersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e2d19c2ad0043a29926ac4f687526be_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSommersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd834bc282ff4ab6bfccb6bf6f85c412_I20150930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCooperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7978ed075eb24ecab8ef0c666e380e86_I20150930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCooperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c9bd9d9e7904a7c88f369cfecb8bcff_I20150131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesD.BrownMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if28ca12f29db4c178b382557c7195523_I20150131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesD.BrownMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8dcabc9bf25458b893acc42347fba65_D20181001-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesBergerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5b096cd3d6d4418807bf4da87541ffb_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesBergerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i149fa1186f594219bfa987dbdd8108f6_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSantoroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56daa4d75b794bf798d94d227d29e58d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSantoroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b7112204f034a1d857b3dec087a6b72_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesNaugleGoreMBrownJordanTheisAndLandiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9786b102ec154400a94c47410abdf0d2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesNaugleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a270cd854f546eaa7d120809442f7ea_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGoreMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c3f1a744f0843eb886c976a94595df2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesM.BrownMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ea5715a75a04415a4cc1a94df208c7b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesJordanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice47fff653d74495b39ba1566ff6ab1b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesTheisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4bc3e6b7f3141d8ad1df8728d140283_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesLandiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb6a94b0655c424dbf083fa25f9e6807_D20210401-20210429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesM.BrownMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cdf509335c8425e86145370f35dab92_D20210501-20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesTheisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6ca88fb103d422eba56dd92aabfb961_D20210701-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesLandiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f8871aa42a34c93b07bdabe159afc9d_D20210701-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesRJReynoldsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91285291d0224d41a9f6b6f098c51c67_I20090630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2009-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e74537c0b4c4859a3f2089a42ce56ae_D19960501-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic64ffeb5c74f4dfb969778dccaadc1bf_D19960501-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:AR</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id40a29a6291543d78c372cbf264db1d9_D19960501-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i555c1554720a424d98f50f13e51eeb80_D19960501-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53e4eebb4a714524b636f0534865d23e_D19960501-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:DC</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i898cd371a7b3471d989e10fd1301c6c6_D19960501-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a99e02ce83d418b860435133fff2496_D19960501-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib09e7e21f8824054b044c6461611053c_D19960501-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icefa681020fe4e1cb4c5b70752a2483d_D19960501-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:KS</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddd4591b90d04ff19b36afa6fd9b9e7a_D19960501-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:LA</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58f52856b1ef4eaeb4ce8c5360ba8d3c_D19960501-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MD</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8cca8977ddf4dceb3cd11ee8f5468f3_D19960501-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MI</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e80e20cf6794e25b4bcef5d2425a2c0_D19960501-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01b20b669936475f993e104a31de5013_D19960501-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NV</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83fd76d8eb1c479c890d6dbefa8006e5_D19960501-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie80c16c4c2d34cf7b117c4db4d715bd7_D19960501-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3950ec60b64d43e79a255e2090017c76_D19960501-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ef55ce7cdbf4a49ab62450c92339999_D19960501-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OK</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0af01f3e38964466aabcb29ac90c169f_D19960501-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12033c228a91450cb06602a444123772_D19960501-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:PA</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e9ec11b5d7f4c02a0471f53510291d4_D19960501-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i438bd25e9e5b4fa5b786198ed333fea2_D19960501-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:SC</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15af965191ab4b03be2934d3ca487181_D19960501-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf606e5861bc4311aab5a4deb0ea2a7e_D19960501-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WI</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39795ebd6cb34fd9b722c425c1d7f1b5_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAandAltriaGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mo:BritishColumbiaSaskatchewanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="manufacture"><xbrli:measure>mo:manufacture</xbrli:measure></xbrli:unit><xbrli:context id="i4618babb55a643e08513e3f263b04127_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:CanadianTobaccoManufacturersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i275c1685fc084d30907f39c9ca35ef66_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:AltriaGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="ruling"><xbrli:measure>mo:ruling</xbrli:measure></xbrli:unit><xbrli:context id="i78204298c1714c59b1565b14ec68a768_D20190301-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:CanadianTobaccoManufacturersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4afafb6cc22d4bfc8634ef389a32cb14_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:ThreatenedLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3b522f7309f4c28bb7cdb2e6f309062_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:CanadianTobaccoManufacturersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94453f2294bb47798d15011e7260b27b_D19981101-19981130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1998-11-01</xbrli:startDate><xbrli:endDate>1998-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9116d2cabdcb49b38d8d90ace75f12d8_I19981130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>1998-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53eb33b5a5a54692bf19b84768b69b6f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0748deafef534cbdb4febc2a98913d94_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2672eb1f4624a6b91e6bd2e2ad0726e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica606fb15fa64e31a1db6c7bbbc4c3a8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9664ef4ada2b462a8ed748d49c2d084c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i906990683f674cd28e47cbcc0f1c3ce6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2005NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ee9df31ad2b4e4ba1a5db1f61706b48_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2006NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia38de3fc206c47ab8cac6dffc4614a4d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2007NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i641a64c3fd2249f69b0e9e1f3f788718_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2008NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2774e5040f8c4961ae53d545a9f37afe_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2009NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f745bd8bca441319b8ed301cc2bc4cc_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2010NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7e7f831dff6421d8eb531fa106546e6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2011NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ed22e918d4f48e8b808961d921a33f4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2012NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9721043231044bc9aeae35bc61c92e2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2013NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i315da09d5b6b446fb033c07698d6d7a5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2014NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65cffff74cb04e8ea2ecc68c77d2b4db_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2015NPMAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4720a28bdb104979ab2247511d0da7e2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65954542804549b295903e71ce88b5d9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2017NPMAdjustmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2c3b4aebf6646d9972246c1621e7c8a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2018NPMAdjustmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21f876e2b3cf44cdb355f679e4503b4c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2019NPMAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifebf0c01e22141d8beb01098ae7c84fd_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2020NPMAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c5082287da0495e8408464c2a0a26c2_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96af53950024460b8a4b3ff962001c7b_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33c7acc23f4a44fe8c2a26183ccd5df2_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d3472b2a91245dea8ecb3a70a055bbc_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ead92d842db4635b29251f1f090ed5f_D20150101-20151231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsTransitionYears20042020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-01-01</xbrli:startDate><xbrli:endDate>2015-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f1a36b47df14a2887897a88255928c0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MT</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i308a1982e0b2451ba03e43963d30bf8a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia16faf9bb3364629910ff901aa086762_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie82ddd3ae8a04ec1904fa44df200d11f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb250f9fcdf1428aa03ed81b876ddfae_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20052007NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8c655e105f449fd919701efabc22bc1_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mo:ArbitrationPeriodAxis">mo:PeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20052007NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9eb956b79e6c4406aa88f5877ca274ab_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mo:ArbitrationPeriodAxis">mo:PeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20052007NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52787a392f8143ad96b8a01791362efb_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherDisputesUndertheStateSettlementAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37765c8db4d14257a1db295453135743_D20060801-20060831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2006-08-01</xbrli:startDate><xbrli:endDate>2006-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac111175a4b94767b66b855e1ae095ae_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95495989d64f46e4884394df5ac52ea3_D20140101-20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-01-01</xbrli:startDate><xbrli:endDate>2014-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05574f14d9b74110b3542338d268b496_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:AltriaGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37604da1eb80482781b7544e25e04971_D20140101-20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:AltriaGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-01-01</xbrli:startDate><xbrli:endDate>2014-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43eda0d8e1cd4c80b86df99bd8127abd_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingLawsuitFiledBySchoolDistrictMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ac851e84d934c1fae22ee819de18e27_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34283e5fbf764b508c0c3b5d55b0c2d8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39fd421e674b4f2885bbdc2d844388dc_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05447dda5f5a4d59809fb46f46b15f92_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IQOSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i035c8420533b4cbbb71f640ebbdb0bc3_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93cb9eb992434b78b7e8af13960914e0_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="complaint"><xbrli:measure>mo:complaint</xbrli:measure></xbrli:unit><xbrli:context id="if859d02a78924c39895c8fe236aea331_I20201130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shareholder"><xbrli:measure>mo:shareholder</xbrli:measure></xbrli:unit><xbrli:context id="i8b76752f44e74819b436e49281d45ca0_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6840f559dfc14605ad93fc181579892b_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i199dd80736164b16bc4c33007d8b83f5_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20c19903e59744cda38126a75fe80854_D20210401-20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic61197cb6b06443dbfd08c5b6acfcd30_D20200901-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72c3cdb7c38d49a39f60eaafddfc2f55_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:LightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdad9497490d4094a88132d419cbfe76_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibadad7f290d443d29bbe99b6abd7399f_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingIndividualLawsuitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:USTLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b49abf1769f40eb98805158adeb07ff_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89787fa06a89496fbdd25f2aaa8f0fe7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="court"><xbrli:measure>mo:court</xbrli:measure></xbrli:unit><xbrli:context id="id021cc782b074325a57d6e0da163d67c_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:LightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMy0xNC0xLTEtMA_7bcd41f6-88a5-47e4-a622-337fa0cd6df4 id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMy0xMi0xLTEtMA_e60fc491-328c-4c42-ba33-ec78cf50126b id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMy0xNC0xLTEtMA_6d928a65-3130-4032-8eb4-26155a95136d id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMy02LTEtMS0w_cfd1eecd-b66e-4023-878c-717aa000efe8 id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMy02LTEtMS0w_800dee3e-6c08-48a8-94d5-7442ad98a88e id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMy0xMi0xLTEtMA_565cff0f-4a2a-4943-9896-5eb2823df608" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RleHRyZWdpb246NWU1N2I2YTdkOGRhNGRiMmFkODU2YTZjNmQ1ZDM4MDdfNzU1_5d6ab827-9b33-4104-8102-5ca28ce47467" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfOC0xMi0xLTEtMA_cb2717aa-46fe-493e-b582-bd2353400bd8 id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfOC0xNC0xLTEtMA_4025fc2c-2256-4c1c-ba8b-25d2714d062e id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfOC00LTEtMS0w_b1200d39-2bbc-446d-af4c-b59a2cb1072e" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RleHRyZWdpb246NWU1N2I2YTdkOGRhNGRiMmFkODU2YTZjNmQ1ZDM4MDdfNzUz_029f7e53-60c3-4781-8238-1125abf6da16" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjItNC0xLTEtMA_9bfb5284-a421-42b3-b286-66b16e575028 id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjItMi0xLTEtMA_2fc96a21-b96e-484d-ab85-979d3fdfa3e8" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RleHRyZWdpb246ZjAzZDVmZWVjYWVhNDVjMGFhYWRjZGQ1ZTk1NjUwNjNfMjE5OTAyMzI1NjU0Nw_9e1319d5-e512-426f-a31b-3024b0ef9ab9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjEtMi0xLTEtMA_d74cfa78-d346-4336-bc60-534c20b3ac98 id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjMtMi0xLTEtMTQxMTg_49279f22-b894-4fd8-9feb-815fc4242613 id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjEtNC0xLTEtMA_e6f646b8-5f2a-45f9-af1e-7b395ab83a46 id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjMtNC0xLTEtMTQxMzg_969296e8-ad90-4de3-a528-19eb8d7cd4f8" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RleHRyZWdpb246ZjAzZDVmZWVjYWVhNDVjMGFhYWRjZGQ1ZTk1NjUwNjNfMjE5OTAyMzI1NjU3MQ_fc493c6f-a147-49ed-9e73-6edc925006a1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMy0xNC0xLTEtMA_78df59c3-809f-49aa-9b5c-a0fa6132b6b1 id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMy0xMi0xLTEtMA_e299ff39-6891-4862-b4c3-befa6e4d3fde id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMy02LTEtMS0w_69b19076-2d5c-4d98-ad1d-f41bbaa4b111 id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMy0xMi0xLTEtMA_478e1bc5-b708-41bf-ae0f-dfcc7133747a id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMy0xNC0xLTEtMA_7a2b4fe7-191b-47fb-b8e9-4985f46e58f0 id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMy02LTEtMS0w_f78d8c97-44f4-4870-b445-718b17513598" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RleHRyZWdpb246MmEyMDFjMzQ1ZGJjNGI3ZmE5MWVkOTA3MDdiNTRlOTRfNzU2_99cbc242-6050-4e3b-83de-8963c8a2b245" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjItMi0xLTEtMA_426d9aea-ecde-453e-bb32-ce817786fe90 id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjItNC0xLTEtMA_bbf1361c-cd98-4785-bdd8-db7d1ceeb089" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RleHRyZWdpb246ZjAzZDVmZWVjYWVhNDVjMGFhYWRjZGQ1ZTk1NjUwNjNfMjE5OTAyMzI1NjU3Mg_0c8fe14e-af7d-47e8-a204-fc47447c14d4" order="1"></ix:relationship></ix:resources></ix:header></div><div id="i295e56fb16f94dae9eacc631c56d466c_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="margin-top:6pt;padding-left:7.87pt;padding-right:7.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGV4dHJlZ2lvbjpjYWE5NzIzNzRhOWM0MmJmYjlkODRmNmU5YjJhYTczMV8yMDg4_96aa91a5-a9f4-40e4-a5e4-62ce5a68ba8d">10-Q</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.392%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZmM5NjgzZDUwMjczNDUyOGFlNGVlNDg4ZTI1YmZhNGIvdGFibGVyYW5nZTpmYzk2ODNkNTAyNzM0NTI4YWU0ZWU0ODhlMjViZmE0Yl8wLTAtMS0xLTA_3e5ca9c7-b5e7-4e52-9aa4-ce2fbe733086">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGV4dHJlZ2lvbjpjYWE5NzIzNzRhOWM0MmJmYjlkODRmNmU5YjJhYTczMV8yNzQ4Nzc5MDcxNTU4_a8779482-c7de-436c-b2e0-30ba02ace769">September 30, 2021</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.392%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6N2E5ZTE0MjMyZDUwNDA0ZTg4NmM0YTg1ZDQ0ZGNjMmMvdGFibGVyYW5nZTo3YTllMTQyMzJkNTA0MDRlODg2YzRhODVkNDRkY2MyY18wLTAtMS0xLTA_53aceef9-7a30-43cc-8888-04663422e9df">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGV4dHJlZ2lvbjpjYWE5NzIzNzRhOWM0MmJmYjlkODRmNmU5YjJhYTczMV8yMDg1_668a1747-e062-4bf9-bdb8-07a52fbfe3f2">1-08940</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGV4dHJlZ2lvbjpjYWE5NzIzNzRhOWM0MmJmYjlkODRmNmU5YjJhYTczMV8yMDg5_f2cbdec7-4cc9-49a9-9e98-1dc730865fa9">Altria Group, Inc.</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.749%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWFmYjRmYWM1Y2Q0NDdmMjg3MDIwOTllYzNhMDJmYmIvdGFibGVyYW5nZTplYWZiNGZhYzVjZDQ0N2YyODcwMjA5OWVjM2EwMmZiYl8xLTAtMS0xLTA_5a1dedae-38f9-48fa-a72f-22155daf2a8c">Virginia</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWFmYjRmYWM1Y2Q0NDdmMjg3MDIwOTllYzNhMDJmYmIvdGFibGVyYW5nZTplYWZiNGZhYzVjZDQ0N2YyODcwMjA5OWVjM2EwMmZiYl8xLTMtMS0xLTA_1f813581-a44e-4f22-b453-a5eddb67b5c7">13-3260245</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWFmYjRmYWM1Y2Q0NDdmMjg3MDIwOTllYzNhMDJmYmIvdGFibGVyYW5nZTplYWZiNGZhYzVjZDQ0N2YyODcwMjA5OWVjM2EwMmZiYl80LTAtMS0xLTA_0c0e3fab-b351-4d5d-9fc2-08ea8c624477">6601 West Broad Street,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWFmYjRmYWM1Y2Q0NDdmMjg3MDIwOTllYzNhMDJmYmIvdGFibGVyYW5nZTplYWZiNGZhYzVjZDQ0N2YyODcwMjA5OWVjM2EwMmZiYl80LTEtMS0xLTA_f64654ee-62b7-4652-a103-f0dcd804a0f6">Richmond,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWFmYjRmYWM1Y2Q0NDdmMjg3MDIwOTllYzNhMDJmYmIvdGFibGVyYW5nZTplYWZiNGZhYzVjZDQ0N2YyODcwMjA5OWVjM2EwMmZiYl80LTItMS0xLTA_0650dcec-5f4d-441d-a830-c74dbaac9c1f">Virginia</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWFmYjRmYWM1Y2Q0NDdmMjg3MDIwOTllYzNhMDJmYmIvdGFibGVyYW5nZTplYWZiNGZhYzVjZDQ0N2YyODcwMjA5OWVjM2EwMmZiYl80LTMtMS0xLTA_454fce4d-0106-450d-bd8f-74ac04a35026">23230</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;(<ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGV4dHJlZ2lvbjpjYWE5NzIzNzRhOWM0MmJmYjlkODRmNmU5YjJhYTczMV8yMDg2_941a5958-acda-4552-b116-b362e013cff0">804</ix:nonNumeric>) <ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGV4dHJlZ2lvbjpjYWE5NzIzNzRhOWM0MmJmYjlkODRmNmU5YjJhYTczMV8yMDgx_f729b3ff-ef14-4de9-b1f7-fd60300a3117">274-2200</ix:nonNumeric>&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Former name, former address and former fiscal year, if changed since last report</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:33.599%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title of each class&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbols</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i45fa0eb8e2f44df1a1178d965055b18b_D20210101-20210930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl8xLTAtMS0xLTA_b25fa8f9-c11c-404d-9cd2-19ee03ecfa96">Common Stock, $0.33 1/3 par value</ix:nonNumeric></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i45fa0eb8e2f44df1a1178d965055b18b_D20210101-20210930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl8xLTEtMS0xLTA_fd51a1b7-c1ec-435b-8bf3-b6a5a1c05eac">MO</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i45fa0eb8e2f44df1a1178d965055b18b_D20210101-20210930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl8xLTItMS0xLTA_a0c0ae8d-b8ab-4428-85a9-9a0352db5d01">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5f72e3af91ab46a8894e0b9546b1c4b4_D20210101-20210930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl8yLTAtMS0xLTA_d8160d2c-8d2a-4cf6-b1f6-2044d25634a2">1.000% Notes due 2023</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5f72e3af91ab46a8894e0b9546b1c4b4_D20210101-20210930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl8yLTEtMS0xLTA_aac23a3c-59db-4660-94a4-3fbeae8c86b6">MO23A</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5f72e3af91ab46a8894e0b9546b1c4b4_D20210101-20210930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl8yLTItMS0xLTA_975723f8-b373-47c1-b8f3-01c77adb0406">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i637e2b2941ef4dd592b5c3c4d55bfa25_D20210101-20210930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl8zLTAtMS0xLTA_a0370fda-00eb-49f1-93e0-b85ecee120bd">1.700% Notes due 2025</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i637e2b2941ef4dd592b5c3c4d55bfa25_D20210101-20210930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl8zLTEtMS0xLTA_7577d81f-7256-4ec0-8941-0d73dec33773">MO25</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i637e2b2941ef4dd592b5c3c4d55bfa25_D20210101-20210930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl8zLTItMS0xLTA_85cdc9ef-2c46-45cf-b3cb-3c4deb074d8b">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1bf469c5379b4f2d88bdd9ee3efeecc8_D20210101-20210930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl80LTAtMS0xLTA_92f40670-6bb1-4599-9449-4d111cd52051">2.200% Notes due 2027</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1bf469c5379b4f2d88bdd9ee3efeecc8_D20210101-20210930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl80LTEtMS0xLTA_57283a7a-42bb-4daf-a9fa-13cf5f965a20">MO27</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1bf469c5379b4f2d88bdd9ee3efeecc8_D20210101-20210930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl80LTItMS0xLTA_f42f8c56-fb7b-4f57-acdb-fbb7779d60ba">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia576c3905ea64c98b404cc8e4f72a7d9_D20210101-20210930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl81LTAtMS0xLTA_5addb28e-1653-4762-be73-443bdde4e9f5">3.125% Notes due 2031</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia576c3905ea64c98b404cc8e4f72a7d9_D20210101-20210930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl81LTEtMS0xLTA_3ae3fff1-be29-467d-8ef8-1252f7a7910b">MO31</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia576c3905ea64c98b404cc8e4f72a7d9_D20210101-20210930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl81LTItMS0xLTA_40a40154-f260-418c-ab50-2531e40c4567">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:3pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160; <ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGV4dHJlZ2lvbjpjYWE5NzIzNzRhOWM0MmJmYjlkODRmNmU5YjJhYTczMV8yMDgy_446cd166-f85d-4db0-ad6c-89077542e7c6">Yes</ix:nonNumeric>&#160;&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; No&#160;&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160; <ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGV4dHJlZ2lvbjpjYWE5NzIzNzRhOWM0MmJmYjlkODRmNmU5YjJhYTczMV8yMDgz_7d893983-7c9e-440b-bcab-f94e182afd25">Yes</ix:nonNumeric>&#160;&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.567%"><tr><td style="width:1.0%"></td><td style="width:21.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.743%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.118%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.185%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6NTE0NTNmN2JkYjU3NDVmZDhkYmU3ZGE3MGExYTBkOGQvdGFibGVyYW5nZTo1MTQ1M2Y3YmRiNTc0NWZkOGRiZTdkYTcwYTFhMGQ4ZF8wLTAtMS0xLTA_98c72b49-ff22-4655-b109-8be61087bb83">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#254;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6NTE0NTNmN2JkYjU3NDVmZDhkYmU3ZGE3MGExYTBkOGQvdGFibGVyYW5nZTo1MTQ1M2Y3YmRiNTc0NWZkOGRiZTdkYTcwYTFhMGQ4ZF8yLTYtMS0xLTA_5a0f5bd8-18e3-4cda-9909-5f0401ec287f">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth&#160;company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6NTE0NTNmN2JkYjU3NDVmZDhkYmU3ZGE3MGExYTBkOGQvdGFibGVyYW5nZTo1MTQ1M2Y3YmRiNTc0NWZkOGRiZTdkYTcwYTFhMGQ4ZF8zLTYtMS0xLTA_36401ff1-c370-4c96-b375-4e4330843a7e">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160; Yes&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGV4dHJlZ2lvbjpjYWE5NzIzNzRhOWM0MmJmYjlkODRmNmU5YjJhYTczMV8yMDg3_734ceed0-831b-4beb-81e8-3965323751a1">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#254;</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At October 21, 2021, there were <ix:nonFraction unitRef="shares" contextRef="iea6b6e16a27d4008b94c6c65b72d6673_I20211021" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGV4dHJlZ2lvbjpjYWE5NzIzNzRhOWM0MmJmYjlkODRmNmU5YjJhYTczMV8yNzQ4Nzc5MDcxNzI5_8247cf70-3718-4a75-820c-5fe397e0d283">1,836,988,822</ix:nonFraction> shares outstanding of the registrant&#8217;s common stock, par value $0.33 1/3&#160;per share.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i295e56fb16f94dae9eacc631c56d466c_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ALTRIA GROUP, INC.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page&#160;No.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART&#160;I -</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:45pt;text-indent:-22.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_10">Condensed Consolidated Balance Sheets at </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_10"><br/></a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_10">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_10"> 30, 2021 and December 31, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_10">3</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:45pt;text-indent:-22.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_16">Condensed Consolidated Statements of Earnings (Losses) for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_16"><br/></a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_16">Nine and Three Months Ended September 30, 2021 and 2020 </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_16">5</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:45pt;text-indent:-22.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_19">Condensed Consolidated Statements of Comprehensive Earnings (Losses) for the Nine and Three Months Ended September 30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_19">6</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:45pt;text-indent:-22.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_22">Condensed Consolidated Statements of Stockholders&#8217; (Deficit) Equity for the Nine  Months Ended September 30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_22">7</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:45pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_25">Three Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_25">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_25"> 30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_25">8</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:45pt;text-indent:-22.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_28">Condensed Consolidated Statements of Cash Flows for the</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_28"><br/></a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_28">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_28"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_28">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_28"> 30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_28">9</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_34">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_31">11</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_112">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_112">41</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_157">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_157">76</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_160">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_160">77</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART&#160;II -</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_163">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_163">77</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_166">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_166">77</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_169">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_169">78</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_172">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_172">79</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_175">Signature</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_175">80</a></span></div></td></tr></table></div><div style="margin-top:9pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i295e56fb16f94dae9eacc631c56d466c_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 1.  Financial Statements</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(in millions of dollars) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________ </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.465%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.640%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.643%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMi0yLTEtMS0w_b3925cf1-7288-4656-8e5e-ed8341940cf3">2,957</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMi00LTEtMS0w_ead053f5-08d5-4aa6-b67c-74c1c34fb878">4,945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMy0yLTEtMS0w_ae491670-29eb-47c6-9b3f-8c03b64043ac">36</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMy00LTEtMS0w_40175702-e81f-40e7-8dff-94ae24bed899">137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leaf tobacco</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" name="mo:InventoryRawMaterialsPlantMaterialNetofReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfNS0yLTEtMS0w_68165030-ed14-4078-9877-42e8c7464a3a">644</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" name="mo:InventoryRawMaterialsPlantMaterialNetofReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfNS00LTEtMS0w_c9e80244-e16d-41a2-852e-0fb162488c4b">844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other raw materials</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" name="mo:OtherInventoryRawMaterialsNetofReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfNi0yLTEtMS0w_88791573-4f9d-4517-b5f1-bc2a136ff11a">159</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" name="mo:OtherInventoryRawMaterialsNetofReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfNi00LTEtMS0w_f2508475-73d3-4115-89b2-5788136c4ad7">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfNy0yLTEtMS0w_7980a32f-90db-4b2a-a8c2-80b1c3d941f8">30</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfNy00LTEtMS0w_02b06d16-69c5-4f89-b6bf-52e9ff99847b">502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished product</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfOC0yLTEtMS0w_88384d29-5177-4b8f-8551-717af8c23f68">300</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfOC00LTEtMS0w_c764833f-9169-4114-bdac-9975c75c7615">420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfOS0yLTEtMS0w_f7970a99-492a-4d81-9f39-28bd427ed527">1,133</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfOS00LTEtMS0w_d05b21b4-7575-4ee9-9594-bb45a2160a4c">1,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTItMi0xLTEtMzA5NA_3ceb1b71-a4c7-42a5-8c4b-5fb8d367884a">1,490</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTItNC0xLTEtMzEwMQ_d6ff4362-debe-4d60-8abf-ff877ad32c54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 19pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTMtMi0xLTEtMTA4MTE_383632a5-a756-4a7f-bffa-baa22f6dc855">404</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTMtNC0xLTEtMTA4MzU_b380f149-d55c-4b33-952f-6b46c2f31bd9">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTItMi0xLTEtMA_3fe6ab54-0eea-4214-af16-a069af40efa0">6,020</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTItNC0xLTEtMA_8be7b242-5665-411c-8eb9-d830faccc882">7,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTMtMi0xLTEtMA_ab3931bf-e7e2-4f02-ae9a-20c1af67a169">4,418</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTMtNC0xLTEtMA_4f23d399-ec9c-4036-b67d-0b21f3d62e50">5,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTQtMi0xLTEtMA_cedea25c-9221-4a72-83fe-acc08695d078">2,900</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTQtNC0xLTEtMA_d556cf51-bccc-42d4-91ab-43140c761016">3,138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTUtMi0xLTEtMA_ab05a8ab-4c3f-4746-8e80-c2809c13ec07">1,518</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTUtNC0xLTEtMA_22d45e5f-f874-4d40-bae5-ad30ccde4d14">2,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTYtMi0xLTEtMA_3672e313-96e7-4431-96cd-b64663714b43">5,177</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTYtNC0xLTEtMA_9cc27abd-33f6-4b9c-9847-f2db5d93ef3a">5,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTctMi0xLTEtMA_01472b53-f57f-4617-94dd-a3e32418811f">12,326</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTctNC0xLTEtMA_70ed52d4-e24c-4dc7-885b-bcd1e80cbdb4">12,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity securities ($<ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjdkM2VlZmIxNGZhNjQ4MjNiM2UyNGMyNDg4YThhOTEzXzM4_9e40f0bd-af09-4b96-a9ca-a4de6f3667ad">1,740</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjdkM2VlZmIxNGZhNjQ4MjNiM2UyNGMyNDg4YThhOTEzXzQ1_1013e5b4-9aa0-42b5-8cb8-774baf675082">1,868</ix:nonFraction> million at September 30, 2021 and December 31, 2020, respectively, measured at fair value)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTgtMi0xLTEtMA_bf0e1c79-77ec-47b0-aa87-db72cbaf0c31">13,874</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTgtNC0xLTEtMA_13cce1b5-69a9-4619-85a5-fb295b0cac05">19,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMjAtMi0xLTEtMA_3f65b438-79f6-45fb-a332-b6ecb7515285">649</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMjAtNC0xLTEtMA_83f169fd-2a62-4632-870d-dbb63034361a">964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMjEtMi0xLTEtMA_f102a95f-6cfa-4443-a560-9fac93dec1fc">39,564</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMjEtNC0xLTEtMA_23aa3564-e9c2-4e4a-bd35-e0f866fb06ff">47,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets (Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in millions of dollars, except share and per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">________________________________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.465%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.640%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.643%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMy0yLTEtMS0w_1313c593-f540-444a-ab1d-936fd6d60101">1,105</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMy00LTEtMS0w_8d7717a5-be5c-4767-94fc-3cd4a4308028">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfNC0yLTEtMS0w_885e8fd2-6f3b-4faf-84bf-005cb43fed69">266</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfNC00LTEtMS0w_f9eadbff-8787-4d24-a453-d31bd83a31c0">380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" name="us-gaap:AccruedMarketingCostsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfNi0yLTEtMS0w_017cb363-6c83-46cf-9987-9ff33b1149cf">680</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" name="us-gaap:AccruedMarketingCostsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfNi00LTEtMS0w_3e824ab3-46d0-4759-9b6d-a4ab5a19d4a4">523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:AccruedSettlementLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfOS0yLTEtMS0w_0f31f277-01b8-4598-b99b-82220b8a2993">2,996</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="mo:AccruedSettlementLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfOS00LTEtMS0w_fc57e11a-bbf5-4c16-a6a2-092c8a05422b">3,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTAtMi0xLTEtMA_d66755ab-3972-478e-a567-92c2c976dc06">1,109</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTAtNC0xLTEtMA_ce79c00b-0f1c-46d0-a3a3-fae6e17841b7">1,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTItMi0xLTEtMA_c2768128-07f9-4763-9709-2e624061b06e">1,661</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTItNC0xLTEtMA_ee802bd4-1ce8-422f-9c79-877aa63709de">1,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTMtMi0xLTEtMzExMg_9de928ff-e76c-44a8-9103-53f370778651">295</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTMtNC0xLTEtMzExNw_884c4a0d-c49b-430a-9379-b5fb70404982">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTMtMi0xLTEtMA_1d7dd156-d331-4478-bbbe-fbc4d752b9cd">8,112</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTMtNC0xLTEtMA_17c99142-f20b-4a00-89c8-4ee544fd25c8">9,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTQtMi0xLTEtMA_9b5ae7f8-a3a7-4197-b5e3-082a9bdb2300">27,022</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTQtNC0xLTEtMA_c2356510-8213-44b6-8e76-a942815eb1e7">27,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTUtMi0xLTEtMA_51545fbf-f85a-4f9f-a862-b5248fb73bf1">3,557</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTUtNC0xLTEtMA_7ecde68f-ae42-4bf5-b145-c554f3254206">4,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued pension costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTYtMi0xLTEtMA_7ca96f0f-9c6a-43cb-9917-968e153adefa">280</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTYtNC0xLTEtMA_f0c0b180-57c1-4eb5-8091-95081e6794b9">551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued postretirement health care costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTctMi0xLTEtMA_9bfc20db-cc42-417c-a615-bd20658460c3">1,512</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTctNC0xLTEtMA_ad43b7b0-be8f-46d7-9578-a5497fb7c39a">1,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTgtMi0xLTEtMA_54ab344e-f584-4fad-9c45-51ed23648e88">307</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTgtNC0xLTEtMA_76907112-542e-40aa-ad05-38aa5817cf4a">381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTktMi0xLTEtMA_3d7808e4-cba5-46bf-a59b-fda5ddbe2003">40,790</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTktNC0xLTEtMA_74579203-ec46-4fd5-b5b1-d7971b55a982">44,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingencies (Note 12)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjAtMi0xLTEtMA_57d6ff06-5d13-4e94-aa01-b7c48f45d0e6"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjAtNC0xLTEtMA_b0b83a90-227b-4a29-9d61-45a9e8b2cc5b"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjEtMi0xLTEtMA_f780172b-ef84-4444-80e3-e553ffc4c065">39</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjEtNC0xLTEtMA_55cb9e8c-685c-4664-9e7f-399eed26660e">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217; (Deficit) Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $0.33 1/3&#160;per share</span></div><div style="padding-left:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOjI3ODAxNTIwMjdiNzQ2NWNiZDU0NWFjZWVhZDJkYjcwXzUw_15e8a503-8625-40e0-ba01-62f78920f2ec"><ix:nonFraction unitRef="shares" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOjI3ODAxNTIwMjdiNzQ2NWNiZDU0NWFjZWVhZDJkYjcwXzUw_38a977f0-aadb-4203-8e3e-fd73f74c14f2">2,805,961,317</ix:nonFraction></ix:nonFraction> shares issued)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjMtMi0xLTEtMA_1be9f7d3-4cf8-4e31-85bb-72f68e807176">935</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjMtNC0xLTEtMA_d3dbf824-1775-4c65-8617-c8dc9b4534c9">935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjQtMi0xLTEtMA_574a73b0-5387-4767-9775-804abb79a62e">5,846</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjQtNC0xLTEtMA_6be716d0-1602-4a9b-a492-f2f6712fa262">5,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings reinvested in the business</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjUtMi0xLTEtMA_9d21af08-20a1-48c9-b104-91bfe289c4ac">30,685</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjUtNC0xLTEtMA_91e9c684-e493-41de-bf41-4301e0c2bbe9">34,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjYtMi0xLTEtMA_0921820e-375e-4fe6-883e-d0ef9f758c7f">3,430</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjYtNC0xLTEtMA_0525410f-48f6-40ab-a574-de95a405f51c">4,341</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of repurchased stock</span></div><div style="padding-left:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockCommonShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmRjNGZiZGNmYTQ2ZDQ4YzViZWM3Y2I3OGU2Yjk0YTYyXzMy_9a659a35-8eac-4b46-8e90-14dc4b3155df">967,321,022</ix:nonFraction> shares at September 30, 2021 and </span></div><div style="padding-left:22.5pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockCommonShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmRjNGZiZGNmYTQ2ZDQ4YzViZWM3Y2I3OGU2Yjk0YTYyXzY0_8f5ac817-feda-4dac-8a26-c35d654e032b">947,542,152</ix:nonFraction> shares at December 31, 2020)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjctMi0xLTEtMA_70000d5d-21b1-4fa3-9dc1-155d721ae82e">35,303</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjctNC0xLTEtMA_35389638-0329-46ab-8b9c-4bc65fa7e786">34,344</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 25.75pt;text-align:left;text-indent:13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; (deficit) equity attributable to Altria</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjgtMi0xLTEtMA_90ae2ed1-5a69-4341-955e-355dab70ef5d">1,267</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjgtNC0xLTEtMA_96263690-f657-48ee-a44f-c0de05871f35">2,839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjktMi0xLTEtMA_db5f5086-9347-4af3-b679-5a05b95ecd14">2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjktNC0xLTEtMA_f5a112c0-e105-4e8c-aa3c-c66c6af29f2e">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 25.75pt;text-align:left;text-indent:13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stockholders&#8217; (deficit) equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMzAtMi0xLTEtMA_1744a9f2-bd2b-4513-8ff7-b1f4562af871">1,265</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMzAtNC0xLTEtMA_a8e5d276-07e3-4c5f-98b6-9affbdc07b32">2,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 25.75pt;text-align:left;text-indent:49.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Liabilities and Stockholders&#8217; (Deficit) Equity</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMzEtMi0xLTEtMA_5c4e35ad-efd3-4beb-89c8-b4fa476c2a9d">39,564</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMzEtNC0xLTEtMA_1ef20625-4c1b-41ae-8775-c605771e9185">47,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i295e56fb16f94dae9eacc631c56d466c_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Earnings (Losses)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in millions of dollars, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_____________________________________</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.993%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMi0yLTEtMS0w_ac78efc5-e1a0-48e7-ac13-03d0908d2ea5">19,758</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMi00LTEtMS0w_ca21b028-e933-4107-8646-bcaeb6e0fb4d">19,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMi02LTEtMS0w_0eae1368-1812-42f1-bba2-a5c342f5766d">6,786</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMi04LTEtMS0w_69d1cc19-3e7b-44ff-a67f-d0790be964c7">7,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMy0yLTEtMS0w_efc5db53-5b5b-4169-b574-38fc9e2c8520">5,348</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMy00LTEtMS0w_5c9d76ce-22c3-4839-ad59-5e3502fbc19d">5,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMy02LTEtMS0w_a69c0b34-a04f-4ead-96ea-572cd916193a">1,858</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMy04LTEtMS0w_4ca21f10-697c-4e88-be69-c599fb3759e4">1,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise taxes on products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OtherCostOfOperatingRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfNC0yLTEtMS0w_5e4f634e-fb3d-454e-a1e2-5300960d3e2f">3,733</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OtherCostOfOperatingRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfNC00LTEtMS0w_e0e04f75-6250-4804-88fd-2a538889631a">4,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OtherCostOfOperatingRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfNC02LTEtMS0w_2dda625b-c2cb-491e-a8a2-8be48d68b9db">1,255</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OtherCostOfOperatingRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfNC04LTEtMS0w_f1cbf7d6-3db3-4e3c-860f-b237a3f38f6f">1,445</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfNS0yLTEtMS0w_2c5034a2-8cbe-41fa-a1c5-07e96e250b0d">10,677</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfNS00LTEtMS0w_dbbec6ae-1843-4670-b1a7-74c394ea4295">9,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfNS02LTEtMS0w_992857ad-c8c9-4874-90fa-56a3ff04fee9">3,673</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfNS04LTEtMS0w_a3b0438a-11f2-4a04-b27f-f17a487a67a2">3,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, administration and research costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:MarketingAdministrationandResearchCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfNi0yLTEtMS0w_3db6ec1b-707c-4bb1-9016-5c8d64040644">1,850</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="mo:MarketingAdministrationandResearchCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfNi00LTEtMS0w_72f1fa97-d354-48a5-9941-89d6423e3f96">1,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" name="mo:MarketingAdministrationandResearchCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfNi02LTEtMS0w_6e4582db-96e3-4e86-8b7a-d0ce9c0a4d73">722</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" name="mo:MarketingAdministrationandResearchCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfNi04LTEtMS0w_b9ec322d-5012-4d13-8cc8-c5c649b2bcb4">557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfOC0yLTEtMS0w_3cae308f-d4a0-4770-bd1d-827f0ed620d8">8,827</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfOC00LTEtMS0w_9f92c5cc-9ffb-4df9-90b4-a379d5923d91">8,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfOC02LTEtMS0w_2f4f6147-5564-443d-b465-ef09ac8d2bd2">2,951</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfOC04LTEtMS0w_c6e10aa1-25a6-4a83-850f-03a9a69da016">3,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfOS0yLTEtMS0w_e555f8d6-f71b-471a-a9a5-dc08ff8aef81">869</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfOS00LTEtMS0w_ec05b7e4-5d09-4971-80b4-7310bdacbbcf">893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfOS02LTEtMS0w_678cbf04-af0f-4f62-9c55-11409d1aa189">266</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfOS04LTEtMS0w_d938773d-d316-4b2e-9036-43563165b613">310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTAtMi0xLTEtMA_ce78fd5d-a89f-4718-ab63-1426ddd6634b">649</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTAtNC0xLTEtMA_2f5c9e81-4463-4b42-b90d-db449c7da1a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTAtNi0xLTEtMA_36ba1b00-daf4-4eaa-8de0-1d0514f942ec">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTAtOC0xLTEtMA_74adc56f-1d7a-4c44-b268-a31aef07ccab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit income, excluding service cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTEtMi0xLTEtMA_416da791-497c-46d0-a18a-ac2b46b4690c">152</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTEtNC0xLTEtMA_4629ead1-b522-4d9e-afde-9cf558e2ab62">58</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTEtNi0xLTEtMA_a50085ac-e4e3-4493-8b75-1e3204bdac64">63</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTEtOC0xLTEtMA_d0cb54a2-1386-47e8-bf27-7e32222a24b8">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="mo:IncomeLossFromEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTItMi0xLTEtMA_72e21590-3d5c-4029-9952-552af710f959">5,789</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTItNC0xLTEtMA_3b8b2f44-23f6-4db9-b78f-d79b618375d4">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="mo:IncomeLossFromEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTItNi0xLTEtMA_1d47c25d-aa9e-441f-af30-31f9685f8919">5,915</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTItOC0xLTEtMA_9a67a6e9-d17b-4147-a8f9-026d919aead1">472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of JUUL equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTMtMi0xLTEtMA_cde40c38-1b07-4d09-8d75-52a177e397b4">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTMtNC0xLTEtMA_9baff033-2513-42d1-a97e-ee2254aa3bbe">2,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTMtNi0xLTEtMA_623557cd-f273-4eb7-b2f2-2fa2ac984619">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTMtOC0xLTEtMA_d3b8babd-4722-4187-9a4d-6cb8eaedf2fb">2,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on Cronos-related financial instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTQtMi0xLTEtMA_57c72893-93ed-4e4a-acd9-007b27994880">128</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTQtNC0xLTEtMA_fab442dc-20d5-4898-a662-689b27f497b2">202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTQtNi0xLTEtMA_8b3afaea-9e45-4e2c-b9ef-5755de0da0c0">135</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTQtOC0xLTEtMA_c9632bd4-f06d-4565-862a-9cf353893c6d">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTYtMi0xLTEtMA_074ad156-5090-49f7-8342-dd0895d65a9d">1,544</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTYtNC0xLTEtMA_f1e49282-da8b-430a-b084-d4f2ebccc94d">4,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTYtNi0xLTEtMA_a67896e2-e7f9-4336-8e7c-640a3a659a21">3,302</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTYtOC0xLTEtMA_ca2633cb-287c-400a-9251-b9e614119470">324</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision (benefit) for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTctMi0xLTEtMA_34ce4104-ca53-4968-a0dd-7120b40423e6">693</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTctNC0xLTEtMA_14cb1b30-aa27-4a61-8f2b-a772ae57c815">1,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTctNi0xLTEtMA_3752c2ee-c992-4910-8ca6-fcda3e5ca0c9">582</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTctOC0xLTEtMA_ead4e7f4-36db-48ad-90f2-339ddc28a22e">632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTgtMi0xLTEtMA_c344639e-424f-4fa9-a1d4-e876f221f5bd">851</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTgtNC0xLTEtMA_80b57013-8813-4066-9a15-dd5959a8a805">2,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTgtNi0xLTEtMA_bcacd4c7-1c5f-4b36-a430-9c4bccd19bc6">2,720</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTgtOC0xLTEtMA_2db02dda-14b3-41e1-b479-89f4cd35273d">956</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (earnings) losses attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTktMi0xLTEtMA_01c5b5b6-0dda-48db-9202-313a75f6aa15">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTktNC0xLTEtMA_97714597-3d91-4ead-9dc0-01f7e71ce528">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTktNi0xLTEtMA_bb51fe09-36ac-465f-bc2a-33ecde754794">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTktOC0xLTEtMA_34cb588f-0893-488f-9d38-835c8c1db0e5">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses) attributable to Altria</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMjAtMi0xLTEtMA_38f362dc-e15c-436e-8124-580f3e4689d7">851</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMjAtNC0xLTEtMA_e46bb0ee-4b94-4add-8be8-e3219fa44f95">2,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMjAtNi0xLTEtMA_7dcd2cd7-96fa-4a40-9a1c-bc547979e282">2,722</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMjAtOC0xLTEtMA_052fe737-90fc-4f22-b119-7102dce6a1bb">952</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Per share data:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings (losses) per share attributable to Altria</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMjItMi0xLTEtMA_3ad84ac3-7eac-4b03-a48f-890953550101">0.46</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMjItNC0xLTEtMA_b825c939-f8ba-4a3e-95d7-04b616fae195">1.37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMjItNi0xLTEtMA_ec896b15-6191-4b75-a4f3-dcab4186faed">1.48</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMjItOC0xLTEtMA_a7e8d095-60f2-4f8d-b1c1-29e82f21b993">0.51</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (losses) per share attributable to Altria</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMjMtMi0xLTEtMA_5a7caacf-380b-4b46-88b7-bd76d8628bdb">0.46</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMjMtNC0xLTEtMA_c4dca33c-f319-4d07-ad36-b4f527966187">1.36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMjMtNi0xLTEtMA_b2e00d38-646e-477d-9046-6879ca5a6fa9">1.48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMjMtOC0xLTEtMA_55d70f77-a821-453d-a52b-53a207719c2a">0.51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i295e56fb16f94dae9eacc631c56d466c_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Earnings (Losses)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in millions of dollars)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_____________________</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.408%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.409%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfMi0yLTEtMS0w_771cb154-a4d5-4310-b9f7-4be61026d4f6">851</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfMi00LTEtMS0w_8415f675-2b3f-4360-b66f-a913282804da">2,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfMi02LTEtMS0w_5dce92b3-f91d-436d-af22-6c65e3f1a16a">2,720</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfMi04LTEtMS0w_345393f2-df85-4c50-a1ba-34ee22d9bf6c">956</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNC0yLTEtMS0w_a2fe7e2f-0221-41ae-a452-3dbfb247d0b0">383</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNC00LTEtMS0w_25c5b9aa-3ca9-4848-9818-32abca9e89d4">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNC02LTEtMS0w_339668e8-ba64-4f53-bb8b-9fd83bbe7226">6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNC04LTEtMS0w_c7e8e822-3f45-4195-8776-1c3fa9bfc077">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:OciEquityMethodInvestmentAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNS0yLTEtMS0w_30588ac8-c1cb-42b2-b771-feb272152bf5">495</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OciEquityMethodInvestmentAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNS00LTEtMS0w_ad415e10-0dea-47ba-81f8-5ecb103c70a7">928</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" name="us-gaap:OciEquityMethodInvestmentAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNS02LTEtMS0w_9689b52a-6168-4322-9cd8-19639ae477ec">161</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OciEquityMethodInvestmentAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNS04LTEtMS0w_de0ada17-3bd9-401c-ad49-0028873cec41">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNi0yLTEtMS0w_e36309e8-e882-4156-8f5c-26bd7172e2e8">33</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNi00LTEtMS0w_1d5d60ac-9627-451f-9ade-3ae1854f3d6f">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNi02LTEtMS0w_f22ff8a1-b540-496f-b81d-ef8e21a4890a">5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNi04LTEtMS0w_d40bab72-7849-4afd-a014-1053617d81ef">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred </span></div><div style="padding-left:51.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNy0yLTEtMS0w_048388cd-9348-47f9-9cf6-36013364bf82">911</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNy00LTEtMS0w_79715a2a-f5b4-4f8b-87e5-e5626289603d">917</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNy02LTEtMS0w_bc215c24-0921-492c-813f-69043435ca23">172</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNy04LTEtMS0w_316b2a5f-a049-45da-9f8b-aff6072eb07e">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive earnings (losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfOS0yLTEtMS0w_c7a3e2ed-9cae-41c2-919b-6ecd1f0bcfc3">1,762</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfOS00LTEtMS0w_854289c5-9d27-4475-834b-b9924cd6e6c9">1,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfOS02LTEtMS0w_768ca6cc-2391-4cbb-882c-61193ca4b945">2,548</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfOS04LTEtMS0w_1e924c98-b3a6-4d33-ac5b-0ef8c09e014f">963</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive (earnings) losses attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfMTAtMi0xLTEtMA_c8de2a2c-0f9d-445f-926c-2f24b5abf136">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfMTAtNC0xLTEtMA_9a0d15e9-5bd4-40cc-a1e7-610a23b891d1">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfMTAtNi0xLTEtMA_d6943aca-0c39-4ce4-8f65-c74016a69eb7">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfMTAtOC0xLTEtMA_764e4f4e-9389-4075-9195-aed8c4dacb0c">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive earnings (losses) attributable to Altria</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfMTEtMi0xLTEtMA_37d20655-ebe9-46c0-b357-17c570af7ef8">1,762</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfMTEtNC0xLTEtMA_4dea7290-cfd9-4132-b149-b9efde4592ed">1,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfMTEtNi0xLTEtMA_531a1fbf-e3d2-44f2-9834-5f10b5f62ba5">2,550</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfMTEtOC0xLTEtMA_60245580-69ab-43ce-b36e-07327235c0c1">959</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i295e56fb16f94dae9eacc631c56d466c_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Stockholders&#8217; (Deficit) Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">for the Nine Months Ended September 30, 2021 and 2020 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in millions of dollars, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.484%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Attributable to Altria</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings<br/>Reinvested<br/>in the<br/>Business</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of<br/>Repurchased<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>(Deficit) Equity </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe5793331b9d44488c81b7f716d22cbb_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMi0yLTEtMS0w_dbc1f0ec-38a7-4bbc-8bc3-48849d297e43">935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44e385b4040e4ead83a85c0957688fd6_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMi00LTEtMS0w_fd5a8be3-0b5c-4932-9319-17664cf7a818">5,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d419bfc78f4132b045cf4fa761d902_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMi02LTEtMS0w_44b5b960-5976-4217-b953-49adecfc6915">34,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dbc9fb0ec734480b6f0af9d1b9ac7b9_I20201231" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMi04LTEtMS0w_96213114-fa8a-4f6a-a2e0-4004e8bb8204">4,341</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fa834a6c7dd41229d83b9ffbdd1b664_I20201231" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMi0xMC0xLTEtMA_2d104714-8558-495c-a2d8-ec16cf7ab650">34,344</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa3df180bbc24f8c80034b0bb74a30e9_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMi0xMi0xLTEtMA_3d01a196-d5d9-4da3-928d-06206bcee8fb">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMi0xNC0xLTEtMA_389a2397-04c8-43d1-ba45-bd48ed017560">2,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings (losses) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53aea5f1004341c7abdb570f2d2eb5b4_D20210101-20210930" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMy02LTEtMS0w_800dee3e-6c08-48a8-94d5-7442ad98a88e">851</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13776c8fb39a40d9af4989bb9862e205_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMy0xMi0xLTEtMA_e60fc491-328c-4c42-ba33-ec78cf50126b">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMy0xNC0xLTEtMA_6d928a65-3130-4032-8eb4-26155a95136d">847</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd9b7b88141b400786601f5cd3fec33a_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfNC04LTEtMS0w_c3eb0343-2290-4590-82bc-1202f0422843">911</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfNC0xNC0xLTEtMA_aa0aa7fb-c655-475b-80e2-17011aea907d">911</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock award activity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ca1deaa032a4cdd9c95cc8ea4e8b898_D20210101-20210930" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfNS00LTEtMS0w_569196ee-6a5e-4eab-a5d4-4cdc01054da3">13</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f34d72cb7945e9bf68e87fc2c12f53_D20210101-20210930" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfNS0xMC0xLTEtMA_33c91c40-c0e4-427b-97ce-f1cedf06a0cb">13</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfNS0xNC0xLTEtMA_8677b951-eae4-48e1-a20c-978a20eaefaf">26</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfNi0wLTEtMS0wL3RleHRyZWdpb246MTBlNzJhYWQ1ODZjNGI5NDgwYTYzM2I4MTQ3NjJmZDRfMjc0ODc3OTA2OTQ4Mw_bbb36c31-88d2-48b8-b585-562be22678fa">2.62</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53aea5f1004341c7abdb570f2d2eb5b4_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfNi02LTEtMS0w_21f6b03b-a2f6-4c03-83ec-7ee45d7de8a1">4,845</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfNi0xNC0xLTEtMA_dd869e5d-d86c-4e88-990b-713f229dc1fb">4,845</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6f34d72cb7945e9bf68e87fc2c12f53_D20210101-20210930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfNy0xMC0xLTEtMA_b60c0781-0979-4827-b77f-9ca8fdcddc14">972</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfNy0xNC0xLTEtMA_4b653530-d375-4972-bb5b-0cdc21daab04">972</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ca1deaa032a4cdd9c95cc8ea4e8b898_D20210101-20210930" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfOC00LTEtMS0w_b1200d39-2bbc-446d-af4c-b59a2cb1072e">77</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13776c8fb39a40d9af4989bb9862e205_D20210101-20210930" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfOC0xMi0xLTEtMA_cb2717aa-46fe-493e-b582-bd2353400bd8">80</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfOC0xNC0xLTEtMA_4025fc2c-2256-4c1c-ba8b-25d2714d062e">157</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic487ab98208d404887e95b93923fab79_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMTAtMi0xLTEtMA_16027baf-5af8-478f-98dd-8f152a95e1a6">935</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8693290ed18e4d7f87c0282e3f727528_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMTAtNC0xLTEtMA_71c67a12-9b6b-487f-99e3-4db33ccabec6">5,846</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i007a6b02e9c44466879605af235d8517_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMTAtNi0xLTEtMA_0f442185-72ec-4265-9f2b-24fa54f78b70">30,685</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6448179dc624c73a14533ac4f8492a2_I20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMTAtOC0xLTEtMA_f753caa1-f6a2-4114-8549-baac88f83932">3,430</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8c26c7de7b3445bb7421e82ca7564b4_I20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMTAtMTAtMS0xLTA_1942656b-8df3-42f7-8589-f3fd8361d253">35,303</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fd83e66c1ff4909a7a501481a11f766_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMTAtMTItMS0xLTA_25357d8c-df83-4a6b-8d8b-ac61b55b8b2d">2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMTAtMTQtMS0xLTA_65558933-a183-4e00-9a21-f55b7852e5d2">1,265</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.484%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Attributable to Altria</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings<br/>Reinvested<br/>in the<br/>Business</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of<br/>Repurchased<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>(Deficit) Equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib231dbdd7b5c42a4892838893be458cb_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMi0yLTEtMS0w_7ed3a8e1-6023-45e3-bd3a-6ee9d6b1ece2">935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c17c5569ff54cf28521a8e8625991d8_I20191231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMi00LTEtMS0w_ae3ebed3-90c3-4bdc-b995-e9f8cc645b78">5,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i715d5e9f7cbe440b8d3c2b5ed4aeae4e_I20191231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMi02LTEtMS0w_4488fabb-f46b-4a80-8016-20a39d6eb071">36,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i433dda944a934320af202e2f484eaa1c_I20191231" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMi04LTEtMS0w_1b40da41-ce32-4883-8a8a-c5f9fb4952d8">2,864</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a16f34256ad48b49ed8a50852fea048_I20191231" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMi0xMC0xLTEtMA_12b84008-0cdc-453c-96ac-a1e12bd617da">34,358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i954fc4945ffa4f8e8cdfabbaf3f7cb6f_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMi0xMi0xLTEtMA_e31d6790-0503-4c92-a1ee-9ac1a579a6cb">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf636ab56ad4d7cb37b9d77019eed37_I20191231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMi0xNC0xLTEtMA_ef551cab-98ba-41c7-ba12-dcebdb645e42">6,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings (losses) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e8e3bf6dc224a4aa974a22b40a91d8a_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMy02LTEtMS0w_cfd1eecd-b66e-4023-878c-717aa000efe8">2,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb0ffd7d3ff4483920746a3ef17c36d_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMy0xMi0xLTEtMA_565cff0f-4a2a-4943-9896-5eb2823df608">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMy0xNC0xLTEtMA_7bcd41f6-88a5-47e4-a622-337fa0cd6df4">2,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f1f1cd9567d4e048bfb64a6d6ee6bd0_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfNC04LTEtMS0w_536de7a6-124f-4283-8f28-82d6f0fc2c5d">917</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfNC0xNC0xLTEtMA_a55a0bb2-7645-4ca2-820d-f0daec6d5a1d">917</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock award activity</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8407362350ee44c99f4b71eae2816e16_D20200101-20200930" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfNS00LTEtMS0w_df000f7b-7e87-48ed-9b5c-dd4fa3583b22">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf1005329da74407b072e55e84c44f7f_D20200101-20200930" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfNS0xMC0xLTEtMA_a8e5d496-c9be-48f8-b48e-746679f41016">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfNS0xNC0xLTEtMA_37ee7ea6-7994-48bd-8977-d7bf01cec57d">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfNi0wLTEtMS0wL3RleHRyZWdpb246YTBiMzQ5Zjc0ZDhiNDI3NmFhNDhhNWM2Y2EyYTNjN2RfMjc0ODc3OTA2OTQ4Mg_3749665f-a07e-4563-bb2e-77e09292c19b">2.54</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e8e3bf6dc224a4aa974a22b40a91d8a_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfNi02LTEtMS0w_d6f36aa3-2b60-4767-896e-70741263e99f">4,726</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfNi0xNC0xLTEtMA_b9514623-ffd2-4373-a4db-09ccb34d53bb">4,726</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb0ffd7d3ff4483920746a3ef17c36d_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfOS0xMi0xLTEtMA_ee7f961d-49ed-44d5-93d2-b13639b04171">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfOS0xNC0xLTEtMA_b9224981-32d0-4019-9906-ec55e10a080c">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c1b1fef9414aef84749896871324f1_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMTAtMi0xLTEtMA_49bd45e1-ab42-4a8d-bb53-eb9f366009e0">935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic81e63acf60f4e9c8c9e8e24c19afd4b_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMTAtNC0xLTEtMA_daa6cd4a-aa34-40d0-b926-63267e3562bd">5,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i337dce81edc54d6b886012952b0b9ade_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMTAtNi0xLTEtMA_8f85158c-d7de-46c9-b0e1-4a44608f4e7a">34,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b2a0f8b0eb84d6e98048c9c107d0d60_I20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMTAtOC0xLTEtMA_51eeb9b2-7b6d-4430-8def-469a2f07ce81">3,781</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f4f34969f60495f8314b93ba8b0dce5_I20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMTAtMTAtMS0xLTA_826b59b9-3761-458f-94e2-9d54197301f6">34,344</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeb4c19649a6480d80da77904d536dee_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMTAtMTItMS0xLTA_55d00b26-59a3-4b8f-b12b-5278cba73231">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b11e531794f48868e8b9e32c403e904_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMTAtMTQtMS0xLTA_ce04d473-0c70-4779-87da-9f69aba5a321">3,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RleHRyZWdpb246NWU1N2I2YTdkOGRhNGRiMmFkODU2YTZjNmQ1ZDM4MDdfNzU1_5d6ab827-9b33-4104-8102-5ca28ce47467" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">Amounts attributable to noncontrolling interests for the nine months ended September 30, 2021 and 2020 exclude net earnings of $<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RleHRyZWdpb246NWU1N2I2YTdkOGRhNGRiMmFkODU2YTZjNmQ1ZDM4MDdfMzI1_9792b5d7-e167-42a2-8c57-e042a1e953a2">4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RleHRyZWdpb246NWU1N2I2YTdkOGRhNGRiMmFkODU2YTZjNmQ1ZDM4MDdfMzMy_9e40e23a-308f-498b-b12b-44ce8007ef73">2</ix:nonFraction> million, respectively, due to the redeemable noncontrolling interest related to Stag&#8217;s Leap Wine Cellars</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> which is reported in the mezzanine equity section on the condensed consolidated balance sheets.</span></ix:footnote></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)  </span><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RleHRyZWdpb246NWU1N2I2YTdkOGRhNGRiMmFkODU2YTZjNmQ1ZDM4MDdfNzUz_029f7e53-60c3-4781-8238-1125abf6da16" continuedAt="ie74b77cbb28f4d388a9b96c1a6742350" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents the purchase of the remaining noncontrolling interests in Helix.  For additional information, see Note 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Background and Basis of Presentation</span></ix:footnote><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ie74b77cbb28f4d388a9b96c1a6742350">. </ix:continuation> </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i295e56fb16f94dae9eacc631c56d466c_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Stockholders&#8217; (Deficit) Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">for the Three Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">in millions of dollars, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.484%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Attributable to Altria</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings<br/>Reinvested<br/>in the<br/>Business</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of<br/>Repurchased<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>(Deficit) Equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9137713c9da54ea7a9359074d78d444d_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMi0yLTEtMS0w_02099726-2fb5-44af-82f5-393ceb82b91b">935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffa730c0799046999cf2e97fed548bb6_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMi00LTEtMS0w_b9ddc80b-a9ee-44bb-b3ab-b1803826b03f">5,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcdf82bc9a97456f9411c9f42374d3f6_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMi02LTEtMS0w_bd2ef235-12b6-4adb-908e-acb8064dab7d">35,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ea0515263584ea09063bbf40ec274b1_I20210630" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMi04LTEtMS0w_a0e74227-c4c5-4bd1-80b3-fd4747a397c8">3,602</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i610ba96937d54033839c8aaabcec01b3_I20210630" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMi0xMC0xLTEtMA_28631a5a-7eaf-4208-abdb-69a02e77523b">34,981</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86447877e5b642e4a75424d1e386ce93_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMi0xMi0xLTEtMA_14e559e9-ec24-4a82-b0ae-a71b46ed865a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3df7c108f2c5403c96f58e273f0dc0d1_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMi0xNC0xLTEtMA_bd619966-7695-4167-a8fd-e1356ce50427">3,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings (losses)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if06993d5e1db4a3f9eda4a58697e58a1_D20210701-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMy02LTEtMS0w_69b19076-2d5c-4d98-ad1d-f41bbaa4b111">2,722</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib37636bce9b94aaeb1cbaece44b60523_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMy0xMi0xLTEtMA_478e1bc5-b708-41bf-ae0f-dfcc7133747a">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMy0xNC0xLTEtMA_7a2b4fe7-191b-47fb-b8e9-4985f46e58f0">2,722</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i811d953ad6844425a1abf068a0bef5ea_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfNC04LTEtMS0w_96d542a5-30af-45ca-ba98-aaf27e11d973">172</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfNC0xNC0xLTEtMA_75c093cd-c16e-469b-9f9d-63827fb6b4f3">172</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock award activity</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6a68caffdb4a49a42f353a7047b68a_D20210701-20210930" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfNS00LTEtMS0w_1c6d2781-e6c8-4447-804e-ba3dbf0ba4c3">6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfa6672fba3e4b2380d43bce7cac51b6_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfNS0xMC0xLTEtMA_5050b2f8-52dc-4655-884f-dec243822ab6">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfNS0xNC0xLTEtMA_22dbfd18-aff8-49cd-aa5f-75e091e93953">6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends declared $<ix:nonFraction unitRef="usdPerShare" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfNi0wLTEtMS0wL3RleHRyZWdpb246MTg5ZDZkNzUwMDg2NGQ5MTg5ZjgwNTdmZTUxNWIyNmNfMjc0ODc3OTA2OTQ4Mg_eb91678b-c5ec-46d5-ac36-d1f47f0f80d9">0.90</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if06993d5e1db4a3f9eda4a58697e58a1_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfNi02LTEtMS0w_289c4bbd-fce9-4666-b243-36f4ded62437">1,658</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfNi0xNC0xLTEtMA_bb45a8be-01ad-47b5-91f0-a713db6ddddf">1,658</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idfa6672fba3e4b2380d43bce7cac51b6_D20210701-20210930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfNy0xMC0xLTEtMA_86a3eeeb-f9a8-4090-a7d3-ae7c494c2938">322</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfNy0xNC0xLTEtMA_e4df6a39-2927-43ec-a9e2-72e8e15eb4c5">322</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, September 30, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic487ab98208d404887e95b93923fab79_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfOS0yLTEtMS0w_ab24a533-0275-4355-b3a7-b20d687933b8">935</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8693290ed18e4d7f87c0282e3f727528_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfOS00LTEtMS0w_fffccbf5-7563-4ea7-95e3-e786ac6f4c3d">5,846</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i007a6b02e9c44466879605af235d8517_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfOS02LTEtMS0w_8ff6461e-b9f4-4037-8819-c5449c5821c6">30,685</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6448179dc624c73a14533ac4f8492a2_I20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfOS04LTEtMS0w_944e59e9-381c-4d7a-9c6c-6ce62378f075">3,430</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8c26c7de7b3445bb7421e82ca7564b4_I20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfOS0xMC0xLTEtMA_2addefc5-f862-4983-a4be-87f7e3e41277">35,303</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fd83e66c1ff4909a7a501481a11f766_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfOS0xMi0xLTEtMA_b0e12402-b6bf-4586-9282-167c57538868">2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfOS0xNC0xLTEtMA_18956863-9394-4822-b9c7-05dbeddede43">1,265</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.484%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Attributable to Altria</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings<br/>Reinvested<br/>in the<br/>Business</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of<br/>Repurchased<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>(Deficit) Equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04acd635c03342bf90bc79dd81caef6b_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMi0yLTEtMS0w_1cb820e6-a23c-43f7-a9c6-d82731f77f94">935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id142ac3234994ef79d1ee5f1de4d371d_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMi00LTEtMS0w_6cd3163d-b375-4504-ad1c-1bfae38ba777">5,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83adb27c0e2746b595871ff0b3f2b7d8_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMi02LTEtMS0w_b23e7051-003e-491e-b7c8-5aa3a7b01280">36,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65d2cfacd8464cd8a25b7d8f01804516_I20200630" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMi04LTEtMS0w_1b7188bd-265b-4ea1-89ee-0581539bc53b">3,774</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib54bea9ab2a541ef9a1b1495988aba10_I20200630" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMi0xMC0xLTEtMA_6fc07e1c-f6a5-4a43-b8e1-66bb110c31b5">34,345</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b48e147a93c4d159841fd5c68e5adba_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMi0xMi0xLTEtMA_72e0266c-a0dc-4dbf-ba32-fb76593ffe10">98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967d1f95af3f41eda51eed3bfc8a12af_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMi0xNC0xLTEtMA_3e4ac13f-c3c7-4d20-ba85-140dc18b64d5">5,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings (losses) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d98dc6b3b424d3cb692eff540ce05d9_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMy02LTEtMS0w_f78d8c97-44f4-4870-b445-718b17513598">952</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9284f3c4288b4cd2b2c41662e054c3d2_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMy0xMi0xLTEtMA_e299ff39-6891-4862-b4c3-befa6e4d3fde">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMy0xNC0xLTEtMA_78df59c3-809f-49aa-9b5c-a0fa6132b6b1">957</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iece3d64b93d440e3863844f51f91d57b_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfNC04LTEtMS0w_e8b55e7e-1148-49d1-92e0-9019fab2c7bf">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfNC0xNC0xLTEtMA_68c2b893-6d4b-453f-89a5-03609dc1f77f">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock award activity</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idba80b960aa444f9afc7b3189ec8d63e_D20200701-20200930" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfNS00LTEtMS0w_270d645d-0cca-4d77-8517-fc3c3e9de371">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9870fc1d39c94d9f81e1e50ced847ae2_D20200701-20200930" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfNS0xMC0xLTEtMA_b376419c-264d-4238-9255-7a712f92da69">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfNS0xNC0xLTEtMA_b809a789-8827-4f17-9bdd-b25b02df4b6c">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfNi0wLTEtMS0wL3RleHRyZWdpb246NTM5MGZiY2YyOThkNGQ0ZWIzMzE5ODcxMmIyNzliZWZfMjc0ODc3OTA2OTQ5NQ_0e56eeab-6c7e-4f81-aa7a-828286d2356f">0.86</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d98dc6b3b424d3cb692eff540ce05d9_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfNi02LTEtMS0w_f948b0d6-69c3-4923-8ec3-37870ee77698">1,600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfNi0xNC0xLTEtMA_965aac6e-72c1-4481-be39-b3f91cd594c9">1,600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c1b1fef9414aef84749896871324f1_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfOS0yLTEtMS0w_1a302e93-c3ff-445d-92c0-d4565834c8a8">935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic81e63acf60f4e9c8c9e8e24c19afd4b_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfOS00LTEtMS0w_b0d7257b-c4b5-4c7b-aedb-bf9079b062db">5,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i337dce81edc54d6b886012952b0b9ade_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfOS02LTEtMS0w_da0ae987-831a-4614-b965-5cadb25feecb">34,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b2a0f8b0eb84d6e98048c9c107d0d60_I20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfOS04LTEtMS0w_7e974c93-c590-44f1-85fd-2420b0ecf033">3,781</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f4f34969f60495f8314b93ba8b0dce5_I20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfOS0xMC0xLTEtMA_9b47dacc-e746-4af3-869c-21527d1f85fe">34,344</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeb4c19649a6480d80da77904d536dee_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfOS0xMi0xLTEtMA_a557d41a-fada-41d6-a23c-e27dd579992a">93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b11e531794f48868e8b9e32c403e904_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfOS0xNC0xLTEtMA_5fffdb1f-0194-4d1e-8db2-8a6cd131dd08">3,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)  </span><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RleHRyZWdpb246MmEyMDFjMzQ1ZGJjNGI3ZmE5MWVkOTA3MDdiNTRlOTRfNzU2_99cbc242-6050-4e3b-83de-8963c8a2b245" continuedAt="i3c47f3731dde40e7851230e0234c0ca2" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amounts attributable to noncontrolling interests for the three months ended September 30, 2021 and 2020 exclude net earnings of $<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RleHRyZWdpb246MmEyMDFjMzQ1ZGJjNGI3ZmE5MWVkOTA3MDdiNTRlOTRfMzUw_f4a38c9e-0fa2-40ed-af0e-14431f6a7499">2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RleHRyZWdpb246MmEyMDFjMzQ1ZGJjNGI3ZmE5MWVkOTA3MDdiNTRlOTRfMjc0ODc3OTA3MDc0NA_ecd687b2-bdd4-45b7-af58-9cfadca2b51d">1</ix:nonFraction> million, respectively, due to the redeemable noncontrolling interest related to Stag&#8217;s Leap Wine Cellars</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">,</span></ix:footnote><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i3c47f3731dde40e7851230e0234c0ca2"> which is reported in the mezzanine equity section on the condensed consolidated balance sheets.</ix:continuation><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RleHRyZWdpb246MmEyMDFjMzQ1ZGJjNGI3ZmE5MWVkOTA3MDdiNTRlOTRfNzU3_c16a8d73-2113-450a-b3d8-13a7467920b6" footnoteRole="http://www.xbrl.org/2003/role/footnote"> </ix:footnote></span></div><div><span><br/></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i295e56fb16f94dae9eacc631c56d466c_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in millions of dollars)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_____________________</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Provided by (Used in) Operating Activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMi0yLTEtMS0w_d7146f06-6e7f-4d1b-8a1b-df9902d49254">851</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMi00LTEtMS0w_65ad409d-44f7-4d62-a8b6-ad40e3a7e8dd">2,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings (losses) to operating cash flows:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfNC0yLTEtMS0w_984d5a8c-b5c3-46ad-b637-15e7e0626cb7">190</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfNC00LTEtMS0w_cfa135dd-d8f1-49cf-9643-b909b032c32b">192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax provision (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfNS0yLTEtMS0w_06fb0a8a-ff15-43bc-a541-32b5de18a41f">1,180</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfNS00LTEtMS0w_d43c9bd2-f148-4fc1-bdd2-13184a8f6a5f">111</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="mo:IncomeLossFromEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfNi0yLTEtMS0w_b3918efa-ba78-4f98-b08b-bb1dd5b53c69">5,789</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfNi00LTEtMS0w_2ebbddbc-242a-4b99-9b94-f50f98940467">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends from ABI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfNy0yLTEtMS0w_dff39cb4-b988-4aa8-ba3c-327b885ca271">119</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfNy00LTEtMS0w_489dbc03-2997-45c9-b275-4e3711948d94">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on Cronos-related financial instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfOS0yLTEtMS0w_687b7d82-9cc2-4717-8483-3ac60d5b3a7e">128</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfOS00LTEtMS0w_c4498872-1490-4b25-bfa4-c55014d958d9">202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of JUUL equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTAtMi0xLTEtMTM4MTE_7cf8430a-911d-4da5-a7d4-682a0d71cdb0"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTAtMi0xLTEtMTM4MTE_92da0c18-f8ac-4099-b1b8-427a925d27a7">&#8212;</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTAtNC0xLTEtOTgz_aa7a6a57-d2fe-4b49-936c-a26405cffc5e">2,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTItMi0xLTEtMA_761cac2a-0eb9-4aa6-9532-36498209d6fa">649</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTItNC0xLTEtMA_ddc0024a-a72c-4d90-bb39-bd64ea7cb621">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash effects of changes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTQtMi0xLTEtMA_c9bc1cab-9b90-497c-9943-616f633a3627">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTQtNC0xLTEtMA_6e5be5fe-d082-4dad-915f-1dfd6ffe2e03">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTUtMi0xLTEtMA_1a46d545-bd78-4ada-a99d-b30b6fb0a70f">118</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTUtNC0xLTEtMA_c346ab08-a6fb-45be-931b-72987654eefd">136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTYtMi0xLTEtMA_627c4a8d-7684-4031-b292-2af16980f9d0">3</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTYtNC0xLTEtMA_0480bfdc-24b4-417c-b43e-8ac0897ae1ee">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTctMi0xLTEtMA_2fd98c22-9c0e-401c-82a9-73f09cdf1c4a">200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTctNC0xLTEtMA_c47ed5a9-624e-4c39-a949-8388bf833c88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTgtMi0xLTEtMA_132cc766-ac7f-441f-ad4a-4a98b2f42382">104</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTgtNC0xLTEtMA_3e78207b-2326-42e7-89e8-efb27a0604e5">504</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued settlement charges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" name="mo:IncreaseDecreaseInSettlementPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTktMi0xLTEtMA_70cacccd-24c5-45e7-86d7-143e35433655">568</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="mo:IncreaseDecreaseInSettlementPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTktNC0xLTEtMA_ffb53b99-8737-4ef4-9af9-82df355c7769">140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan contributions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:PensionAndOtherPostretirementBenefitContributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjAtMi0xLTEtMA_925a71e5-bfcd-4d34-bfbc-c45523261391">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" name="us-gaap:PensionAndOtherPostretirementBenefitContributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjAtNC0xLTEtMA_330f4e49-e886-43f4-a6c1-24189dfa6165">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension provisions and postretirement, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjEtMi0xLTEtMA_bc56abd0-88b6-4213-a37c-ca54494ea2dd">127</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjEtNC0xLTEtMA_0c0e6682-e432-468c-8e75-f99063baa0e1">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjItMi0xLTEtMA_2fc96a21-b96e-484d-ab85-979d3fdfa3e8">104</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjItNC0xLTEtMA_9bfb5284-a421-42b3-b286-66b16e575028">549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjMtMi0xLTEtMA_b448e8ba-87f7-49c9-afa2-bb8a33f9361c">5,742</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjMtNC0xLTEtMA_9c11e16c-1beb-4692-9789-96e3058b7e2f">5,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Provided by (Used in) Investing Activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjUtMi0xLTEtMA_585d82dd-76a5-4d74-9dfd-e6ad0056b01c">102</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjUtNC0xLTEtMA_6e9ff6a5-3a17-4e2f-b8f6-871ca6050e39">162</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjktMi0xLTEtMA_68bd0cfa-8b10-4ea6-93ae-17073fa261ac">60</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjktNC0xLTEtMA_168fbbd2-ee1f-4114-8f6c-8932751b4feb">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMzAtMi0xLTEtMA_75c1800f-6a08-45b8-942e-e9ce0bb22de1">42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMzAtNC0xLTEtMA_47d730fb-0e99-4329-8d18-fe40b2b13252">107</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RleHRyZWdpb246ZjAzZDVmZWVjYWVhNDVjMGFhYWRjZGQ1ZTk1NjUwNjNfMjE5OTAyMzI1NjU0Nw_9e1319d5-e512-426f-a31b-3024b0ef9ab9" continuedAt="i92406a90e80549b3a091d1d12fb07b9f" footnoteRole="http://www.xbrl.org/2003/role/footnote">2020 primarily reflects inventory-related amounts associated with the wine business strategic reset.  For further discussion, see Note 9.</ix:footnote></span><ix:continuation id="i92406a90e80549b3a091d1d12fb07b9f"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting.</span></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows (Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in millions of dollars)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_____________________</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:55.268%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.814%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Provided by (Used in) Financing Activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from short-term borrowings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMi0yLTEtMS0w_a15f1802-f471-448c-8384-02226405ef58">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMi00LTEtMS0w_a1623f17-91f7-4242-b533-85b1444bc2d0">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of short-term borrowings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMy0yLTEtMS0w_1dd4a30b-dcfa-455a-a87e-e1a9c7b9cfac">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMy00LTEtMS0w_42b35a7a-6b79-456d-86bc-62cce394f831">3,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt issued</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfNC0yLTEtMS0w_379ed8e2-fc59-4c24-9878-cf602286290b">5,472</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfNC00LTEtMS0w_c9febc6e-27e5-4ca3-a634-2aa00cfce5c1">1,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt repaid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfNS0yLTEtMS0w_a5bc7478-7edd-4efb-a1fc-1e5a45715b5b">6,542</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfNS00LTEtMS0w_14352ccd-5a8f-4c64-8b8a-54f525879f3f">1,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfNi0yLTEtMS0w_f768a012-df4b-4302-921c-13e5e97a9240">972</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfNi00LTEtMS0w_bdfc8521-0140-46be-8658-459c7804afc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid on common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfNy0yLTEtMS0w_081add56-0677-4aaf-b0cb-3cf7b305bda8">4,787</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfNy00LTEtMS0w_b004ed9b-b52d-484b-851f-12f2ef931522">4,690</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums and fees related to early extinguishment of debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMTAtMi0xLTEtMA_b5fe2099-1f88-4b04-82c7-6dec15880a1a">623</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMTAtNC0xLTEtMA_e78e6a70-cb8c-4669-a0e0-475684fb520a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMTEtMi0xLTEtMA_955397fe-3f36-4923-a52f-a88cba79f17e">216</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMTEtNC0xLTEtMA_4a1d99a3-034b-404a-95ff-ac92b4bfd5ef">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMTItMi0xLTEtMA_301d666e-126f-4fb7-b05f-2cba6a811b28">7,668</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMTItNC0xLTEtMA_e37d808e-4ce0-4de4-b72e-088ab54982be">3,713</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMTQtMi0xLTEtMA_932d5894-c2eb-407b-baf5-c60cf8de7317">1,968</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMTQtNC0xLTEtMA_ae507599-1787-43fb-86ae-d2543506ef35">2,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMTUtMi0xLTEtMA_4d45006f-d58a-457c-b964-022719622bf4">5,006</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf636ab56ad4d7cb37b9d77019eed37_I20191231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMTUtNC0xLTEtMA_bb66c604-d5d9-4452-9340-74e50ed6872e">2,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMTYtMi0xLTEtMA_5e6d196f-cc1d-4a83-a4ba-000c6b08cb1a">3,038</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b11e531794f48868e8b9e32c403e904_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMTYtNC0xLTEtMA_f94c320a-0c08-4e5f-9c53-5db404b32fa5">4,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following table provides a reconciliation of cash, cash equivalents and restricted cash to the amounts reported on Altria&#8217;s condensed consolidated balance sheets:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">At September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">At December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjAtMi0xLTEtMA_4a02cd8b-7b05-4e2d-911e-a6caa4d44542">2,957</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjAtNC0xLTEtMA_663e4661-1316-492c-943b-e987908a5e04">4,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjEtMi0xLTEtMA_d74cfa78-d346-4336-bc60-534c20b3ac98">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjEtNC0xLTEtMA_e6f646b8-5f2a-45f9-af1e-7b395ab83a46">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjMtMi0xLTEtMTQxMTg_49279f22-b894-4fd8-9feb-815fc4242613">45</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjMtNC0xLTEtMTQxMzg_969296e8-ad90-4de3-a528-19eb8d7cd4f8">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash included in assets held for sale </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjItMi0xLTEtMA_426d9aea-ecde-453e-bb32-ce817786fe90">36</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjItNC0xLTEtMA_bbf1361c-cd98-4785-bdd8-db7d1ceeb089">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjMtMi0xLTEtMA_ac434255-3402-46f3-a7b0-dc2dfea210b1">3,038</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjMtNC0xLTEtMA_4e27126c-979a-4273-9e46-3d1cce7db2f5">5,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RleHRyZWdpb246ZjAzZDVmZWVjYWVhNDVjMGFhYWRjZGQ1ZTk1NjUwNjNfMjE5OTAyMzI1NjU3MQ_fc493c6f-a147-49ed-9e73-6edc925006a1" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals.  See Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></ix:footnote></div><div style="margin-bottom:5pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RleHRyZWdpb246ZjAzZDVmZWVjYWVhNDVjMGFhYWRjZGQ1ZTk1NjUwNjNfMjE5OTAyMzI1NjU3Mg_0c8fe14e-af7d-47e8-a204-fc47447c14d4" continuedAt="i2365a35151bf4290ac62dc7558fdf56d" footnoteRole="http://www.xbrl.org/2003/role/footnote">Cash included in assets held for sale at September 30, 2021 is related to the Ste. Michelle Transaction.  For further discussion, see Note 3. </ix:footnote></span><ix:continuation id="i2365a35151bf4290ac62dc7558fdf56d"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Assets Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i295e56fb16f94dae9eacc631c56d466c_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span><br/></span></div><div id="i295e56fb16f94dae9eacc631c56d466c_34"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 1. <ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfNTk2OA_58bf489e-79bc-49ca-b862-29b1c428b9ef" continuedAt="i0ceb266ce41f450fa834a05d22137687" escape="true">Background and Basis of Presentation</ix:nonNumeric></span></div><ix:continuation id="i0ceb266ce41f450fa834a05d22137687" continuedAt="i68c2dde296e246bca08411e6b7c5bd75"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">When used in these notes, the term </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Altria,&#8221; refers to Altria Group, Inc. and its subsidiaries, unless the context requires otherwise.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Background: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, Altria&#8217;s wholly owned subsidiaries included Philip Morris USA Inc. (&#8220;PM USA&#8221;), which is engaged in the manufacture and sale of cigarettes in the United States; John Middleton Co. (&#8220;Middleton&#8221;), which is engaged in the manufacture and sale of machine-made large cigars and pipe tobacco and is a wholly owned subsidiary of PM USA; UST LLC (&#8220;UST&#8221;), which through its wholly owned subsidiaries, including U.S. Smokeless Tobacco Company LLC (&#8220;USSTC&#8221;) and Ste. Michelle Wine Estates Ltd. (&#8220;Ste. Michelle&#8221;), is engaged in the manufacture and sale of moist smokeless tobacco products (&#8220;MST&#8221;), snus products and wine; Helix Innovations LLC (&#8220;Helix&#8221;), which operates in the United States and Canada, and Helix Innovations GmbH and its subsidiaries (&#8220;Helix ROW&#8221;), which operate internationally in the rest-of-world, are engaged in the manufacture and sale of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on! </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">oral nicotine pouches; and Philip Morris Capital Corporation (&#8220;PMCC&#8221;), which maintains a portfolio of finance assets, substantially all of which are leveraged leases.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 8, 2021, UST entered into a share purchase agreement pursuant to which it agreed to sell its subsidiary, International Wine &amp; Spirits Ltd. (&#8220;IWS&#8221;), which includes Ste. Michelle.  The sale was completed on October 1, 2021.  At September 30, 2021, the assets and liabilities associated with the pending sale of IWS were classified as assets held for sale on Altria&#8217;s condensed consolidated balance sheet.  For further discussion, see Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Altria owns <ix:nonFraction unitRef="number" contextRef="ie227d61fadaa4ad894b027826871e831_D20201201-20210429" decimals="INF" name="us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMTMzMg_225dc2ad-8f92-4ba7-826c-1445a0b0f2d7">100</ix:nonFraction>% of the global </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> business as a result of transactions in December 2020 and April 2021 to purchase the remaining <ix:nonFraction unitRef="number" contextRef="ie227d61fadaa4ad894b027826871e831_D20201201-20210429" decimals="2" name="mo:NoncontrollingInterestRemainingInterestPurchasedByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMTQ0OA_75584995-2e82-419e-8c22-8fcadd484594">20</ix:nonFraction>% interest in (i) Helix ROW and (ii) Helix, respectively</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  The total purchase price of the December 2020 and April 2021 transactions was approximately $<ix:nonFraction unitRef="usd" contextRef="i33693bcc9b6d47e48094cbb1bb3c5f74_D20201201-20210429" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMTYwMA_3b8763fb-aa59-4fcf-a707-7d0c63cd8d77">250</ix:nonFraction> million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Altria wholly owned subsidiaries included Altria Group Distribution Company, which provides sales and distribution services to certain Altria operating subsidiaries, and Altria Client Services LLC, which provides various support services in areas such as legal, regulatory, consumer engagement, finance, human resources and external affairs to Altria and its subsidiaries.  Altria&#8217;s access to the operating cash flows of its wholly owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans by its subsidiaries.  At September&#160;30, 2021, Altria&#8217;s significant wholly owned subsidiaries were not limited by contractual obligations in their ability to pay cash dividends or make other distributions with respect to their equity interests.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, Altria&#8217;s investments in equity securities consisted of Anheuser-Busch InBev SA/NV (&#8220;ABI&#8221;), Cronos Group Inc. (&#8220;Cronos&#8221;) and JUUL Labs, Inc. (&#8220;JUUL&#8221;).  <ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfNTk1NA_699fc204-96bc-466b-b816-ae31a18dca70" escape="true">Altria accounts for its investments in ABI and Cronos under the equity method of accounting using a one-quarter lag.  Altria accounts for its equity investment in JUUL under the fair value option.</ix:nonNumeric></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion of Altria&#8217;s investments in equity securities, see Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;padding-right:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Dividends and Share Repurchases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, Altria&#8217;s Board of Directors (the &#8220;Board of Directors&#8221; or &#8220;Board&#8221;) approved a <ix:nonFraction unitRef="number" contextRef="i96dcc4ff54674f288ddfdd67f37a96ab_D20210801-20210831" decimals="3" name="mo:CommonStockDividendIncreasePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMjc0ODc3OTA3OTE3MA_08db400c-2cd5-47ec-b850-81014cf81ced">4.7</ix:nonFraction>% increase in the quarterly dividend rate to $<ix:nonFraction unitRef="usdPerShare" contextRef="i96dcc4ff54674f288ddfdd67f37a96ab_D20210801-20210831" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMjc0ODc3OTA3OTE3Nw_707fafa9-9b3a-4348-84c1-a5cd49c7c746">0.90</ix:nonFraction> per share of Altria common stock versus the previous rate of $<ix:nonFraction unitRef="usdPerShare" contextRef="i96ddae8ac4da494d95d13e4d56d378cc_D20210401-20210630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMjc0ODc3OTA3OTE4NQ_222b2dc3-c042-4b4e-bd09-929cb398cb88">0.86</ix:nonFraction> per share.  The current annualized dividend rate is $<ix:nonFraction unitRef="usdPerShare" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="2" name="mo:CommonStockDividendRateAnnualPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMjc0ODc3OTA3OTE5Mw_a3cbf72c-737e-4d74-bc3e-44e3b0d315e6">3.60</ix:nonFraction>.  Future dividend payments remain subject to the discretion of the Board.</span></div><div style="margin-bottom:5pt;padding-right:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, the Board of Directors authorized a $<ix:nonFraction unitRef="usd" contextRef="ia7921863f9b84211b6ab722289417409_I20190731" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMzIyOQ_17b58755-ae31-4947-a8ba-aa797a911905">1.0</ix:nonFraction> billion share repurchase program.  In April 2020, the Board rescinded the $<ix:nonFraction unitRef="usd" contextRef="i58b4cc5497fa437d9019b1914e39936e_I20200430" decimals="-6" format="ixt:num-dot-decimal" name="mo:StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMzI5OA_2531b70b-bd95-47e9-be40-d2d2c2bea1d0">500</ix:nonFraction> million remaining in this program as part of Altria&#8217;s efforts to enhance its liquidity position in response to the COVID-19 pandemic.  Altria did <ix:nonFraction unitRef="shares" contextRef="ie1160db7af33456abd28f3ff1afe8c43_D20200101-20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMzQzOQ_7d8b77b8-393f-4a21-b1df-5bf3a3a22560">no</ix:nonFraction>t repurchase any shares in 2020.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Board authorized a new $<ix:nonFraction unitRef="usd" contextRef="if027f1be3b8b4d97b39ef8c617dc8946_I20210131" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMzUxOA_32674f34-6b5c-4222-8ba5-620477049a1d">2.0</ix:nonFraction> billion share repurchase program, of which  $<ix:nonFraction unitRef="usd" contextRef="i210e56c06a7e4442963844e819875e34_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMzU2Ng_186544bd-bd47-41a6-bbc1-1f78186a9f49">1,028</ix:nonFraction> million was remaining at September 30, 2021.  In October 2021, the Board authorized a $<ix:nonFraction unitRef="usd" contextRef="id4244523c3094b0a9521b3089395bca7_I20211028" decimals="INF" format="ixt:num-dot-decimal" name="mo:StockRepurchaseProgramIncreaseAuthorizedAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMjc0ODc3OTA3OTU1Mg_dfd38650-6bd1-4db6-9d7f-d5fa9f538e6b">1.5</ix:nonFraction> billion expansion of this program to $<ix:nonFraction unitRef="usd" contextRef="id4244523c3094b0a9521b3089395bca7_I20211028" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMjc0ODc3OTA3OTU5Mw_2454ad04-1584-4e15-a39e-299cc6b88179">3.5</ix:nonFraction> billion.  The timing of share repurchases under this program depends upon marketplace conditions and other factors, and the program remains subject to the discretion of the Board.</span></div><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfNTk3NQ_2e45b067-a2eb-4829-b353-eaa51df361b7" escape="true"><div style="padding-right:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Altria&#8217;s share repurchase activity for the nine and three months ended September&#160;30, 2021 was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of shares repurchased</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0c8666d14400451b9e82c0e7c854ebe9_D20210101-20210930" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RhYmxlOmFiZGVkMTg5N2Y5NTRmNjg5OWI1NDkwOTg1OWE4YzdkL3RhYmxlcmFuZ2U6YWJkZWQxODk3Zjk1NGY2ODk5YjU0OTA5ODU5YThjN2RfMS0xLTEtMS0w_2a0d90d5-7500-41ae-bc04-4e5cd8bdb951">20.2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i66dae12b306e4c15a45bf2cedaae9792_D20210701-20210930" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RhYmxlOmFiZGVkMTg5N2Y5NTRmNjg5OWI1NDkwOTg1OWE4YzdkL3RhYmxlcmFuZ2U6YWJkZWQxODk3Zjk1NGY2ODk5YjU0OTA5ODU5YThjN2RfMS0zLTEtMS0w_779f1517-6849-427a-8c18-ad0b13e57f79">6.7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate cost of shares repurchased</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c8666d14400451b9e82c0e7c854ebe9_D20210101-20210930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RhYmxlOmFiZGVkMTg5N2Y5NTRmNjg5OWI1NDkwOTg1OWE4YzdkL3RhYmxlcmFuZ2U6YWJkZWQxODk3Zjk1NGY2ODk5YjU0OTA5ODU5YThjN2RfMi0xLTEtMS0w_2a984507-b135-4339-bdec-832d0fc15d4d">972</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66dae12b306e4c15a45bf2cedaae9792_D20210701-20210930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RhYmxlOmFiZGVkMTg5N2Y5NTRmNjg5OWI1NDkwOTg1OWE4YzdkL3RhYmxlcmFuZ2U6YWJkZWQxODk3Zjk1NGY2ODk5YjU0OTA5ODU5YThjN2RfMi0zLTEtMS0w_c07d9c84-927a-4c01-817e-50cad85a8f20">322</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share of shares repurchased</span></div></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0c8666d14400451b9e82c0e7c854ebe9_D20210101-20210930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RhYmxlOmFiZGVkMTg5N2Y5NTRmNjg5OWI1NDkwOTg1OWE4YzdkL3RhYmxlcmFuZ2U6YWJkZWQxODk3Zjk1NGY2ODk5YjU0OTA5ODU5YThjN2RfMy0xLTEtMS0w_b72bc1ad-f078-4166-ae31-1991722afb1f">48.17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i66dae12b306e4c15a45bf2cedaae9792_D20210701-20210930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RhYmxlOmFiZGVkMTg5N2Y5NTRmNjg5OWI1NDkwOTg1OWE4YzdkL3RhYmxlcmFuZ2U6YWJkZWQxODk3Zjk1NGY2ODk5YjU0OTA5ODU5YThjN2RfMy0zLTEtMS0w_822d89c5-5419-4f7f-994f-5f78f890d8af">48.35</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="i68c2dde296e246bca08411e6b7c5bd75"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfNTk3NA_668e55f3-09c8-4071-9a51-4cf75400bfe7" escape="true">The interim condensed consolidated financial statements of Altria are unaudited.  It is the opinion of Altria&#8217;s management that all adjustments necessary for a fair statement of the interim results presented have been reflected in the interim condensed consolidated financial statements.  All such adjustments were of a normal recurring nature.  Net revenues and net earnings for any interim period are not necessarily indicative of results that may be expected for the entire year.</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain immaterial prior year amounts have been reclassified to conform with the current year&#8217;s presentation.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These statements should be read in conjunction with Altria&#8217;s audited consolidated financial statements and related notes, which appear in Altria&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020 (the &#8220;2020 Form 10-K&#8221;).</span></div><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfNTk2NQ_5d64768f-5b6b-427a-96e3-5310da8b79c4" continuedAt="ibb6f64f03893418ea0b976a2cd7a1dae" escape="true"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021, Altria adopted Accounting Standards Update (&#8220;ASU&#8221;) 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU No. 2019-12&#8221;).  This guidance removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes.  The adoption of ASU No. 2019-12 did not have a material impact on Altria&#8217;s condensed consolidated financial statements.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, on January 1, 2021, Altria adopted ASU No. 2020-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Clarifying the Interactions between Topic 321, Topic 323, and Topic 815</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU No. 2020-01&#8221;).  This guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities.  The adoption of ASU No. 2020-01 did not have a material impact on Altria&#8217;s condensed consolidated financial statements.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of issued accounting guidance applicable to, but not yet adopted by, Altria, see Note 13. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Accounting Guidance Not Yet Adopted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i295e56fb16f94dae9eacc631c56d466c_37"></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 2. <ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNy9mcmFnOmFlYmRlMzk4MGM1ZDQ0ODRhNDBmNDY4NjMyZDU5OWExL3RleHRyZWdpb246YWViZGUzOTgwYzVkNDQ4NGE0MGY0Njg2MzJkNTk5YTFfMzkxOQ_583c152f-29b8-4281-8aa9-ffb7fd413c57" continuedAt="ifecb3437df914486b6b529042ed62682" escape="true">Revenues from Contracts with Customers</ix:nonNumeric></span></div><ix:continuation id="ifecb3437df914486b6b529042ed62682" continuedAt="i1948e42340a0437f88e99640db638eff"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria disaggregates net revenues based on product type.  For further discussion, see Note 9. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="mo:CashDiscountsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNy9mcmFnOmFlYmRlMzk4MGM1ZDQ0ODRhNDBmNDY4NjMyZDU5OWExL3RleHRyZWdpb246YWViZGUzOTgwYzVkNDQ4NGE0MGY0Njg2MzJkNTk5YTFfMzkyMA_ad01b287-52aa-44ce-8506-e450bf0ff6bc" escape="true">In 2020, a majority of Altria&#8217;s businesses offered cash discounts to customers for prompt payment and calculated cash discounts as a percentage of the list price based on historical experience and agreed-upon payment terms.  Beginning in the first quarter of 2021 for USSTC and the third quarter of 2021 for PM USA, cash discounts were calculated as a flat rate per unit, based on agreed-upon payment terms.  Altria&#8217;s businesses record receivables net of the cash discounts on Altria&#8217;s condensed consolidated balance sheets.</ix:nonNumeric></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s businesses that receive payments in advance of product shipment record such payments as deferred revenue.  These payments are included in other accrued liabilities on Altria&#8217;s condensed consolidated balance sheets until control of such products is obtained by the customer.  Deferred revenue was $<ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNy9mcmFnOmFlYmRlMzk4MGM1ZDQ0ODRhNDBmNDY4NjMyZDU5OWExL3RleHRyZWdpb246YWViZGUzOTgwYzVkNDQ4NGE0MGY0Njg2MzJkNTk5YTFfOTMy_c77188ac-27d8-460d-b0ea-d3f5075e491e">260</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNy9mcmFnOmFlYmRlMzk4MGM1ZDQ0ODRhNDBmNDY4NjMyZDU5OWExL3RleHRyZWdpb246YWViZGUzOTgwYzVkNDQ4NGE0MGY0Njg2MzJkNTk5YTFfOTM5_5f258860-920c-4ee9-b645-b5c5fbe87809">301</ix:nonFraction> million at September&#160;30, 2021 and December&#160;31, 2020, respectively.  When cash is received in advance of product shipment, Altria&#8217;s businesses satisfy their performance obligations within <ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:RevenuePerformanceObligationDescriptionOfTiming" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNy9mcmFnOmFlYmRlMzk4MGM1ZDQ0ODRhNDBmNDY4NjMyZDU5OWExL3RleHRyZWdpb246YWViZGUzOTgwYzVkNDQ4NGE0MGY0Njg2MzJkNTk5YTFfMTA5MA_ec7a9961-33fb-42d4-bfc4-b9d7546aff0a">three days</ix:nonNumeric> of receiving payment.  At September&#160;30, 2021 and December&#160;31, 2020, there were no differences between amounts recorded as deferred revenue and amounts subsequently recognized as revenue.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables were $<ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:ReceivablesNetCurrentIncludingAssetsHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNy9mcmFnOmFlYmRlMzk4MGM1ZDQ0ODRhNDBmNDY4NjMyZDU5OWExL3RleHRyZWdpb246YWViZGUzOTgwYzVkNDQ4NGE0MGY0Njg2MzJkNTk5YTFfMTI2Ng_4dcf3d16-e7a9-4f0f-bb0e-99f7b5b07d56">144</ix:nonFraction> million (including $<ix:nonFraction unitRef="usd" contextRef="ica91e72247354acf9f03bbc39e5c5f66_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNy9mcmFnOmFlYmRlMzk4MGM1ZDQ0ODRhNDBmNDY4NjMyZDU5OWExL3RleHRyZWdpb246YWViZGUzOTgwYzVkNDQ4NGE0MGY0Njg2MzJkNTk5YTFfMjc0ODc3OTA3NDAyOQ_6cb30840-84ca-4b60-b61a-ea241aa223f5">108</ix:nonFraction> million in assets held for sale) and $<ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNy9mcmFnOmFlYmRlMzk4MGM1ZDQ0ODRhNDBmNDY4NjMyZDU5OWExL3RleHRyZWdpb246YWViZGUzOTgwYzVkNDQ4NGE0MGY0Njg2MzJkNTk5YTFfMTI3Mw_1df1001d-bbd1-4b70-b401-9bb2442f3ebf">137</ix:nonFraction> million at September&#160;30, 2021 and December&#160;31, 2020, respectively.  At September&#160;30, 2021 and December&#160;31, 2020, there were no expected differences between amounts recorded and subsequently received, and Altria&#8217;s businesses did <ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNy9mcmFnOmFlYmRlMzk4MGM1ZDQ0ODRhNDBmNDY4NjMyZDU5OWExL3RleHRyZWdpb246YWViZGUzOTgwYzVkNDQ4NGE0MGY0Njg2MzJkNTk5YTFfMjc0ODc3OTA3NDM2Ng_1a5471c0-c01f-4c78-866d-970dc5dee9a7"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNy9mcmFnOmFlYmRlMzk4MGM1ZDQ0ODRhNDBmNDY4NjMyZDU5OWExL3RleHRyZWdpb246YWViZGUzOTgwYzVkNDQ4NGE0MGY0Njg2MzJkNTk5YTFfMjc0ODc3OTA3NDM2Ng_68699ec7-af71-4f9e-965a-c2beea6db716">no</ix:nonFraction></ix:nonFraction>t record an allowance for doubtful accounts against these receivables.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNy9mcmFnOmFlYmRlMzk4MGM1ZDQ0ODRhNDBmNDY4NjMyZDU5OWExL3RleHRyZWdpb246YWViZGUzOTgwYzVkNDQ4NGE0MGY0Njg2MzJkNTk5YTFfMjE5OTAyMzI2MDQ4Nw_3654c7b5-964e-42a8-a759-8286d3e3d244" escape="true">Altria&#8217;s businesses record an allowance for returned goods, which is included in other accrued liabilities on Altria&#8217;s condensed consolidated balance sheets.  While all of Altria&#8217;s tobacco operating companies sell tobacco products with dates relative to freshness as printed on product packaging, it is USSTC&#8217;s policy to accept authorized sales returns from its customers for products that have passed such dates due to the limited shelf life of USSTC&#8217;s MST and snus products.  Altria&#8217;s businesses record estimated sales returns, which are based principally on historical volume and return rates, as a reduction to revenues.  Actual sales returns will differ from estimated sales returns to the extent actual results differ from estimated assumptions.  Altria&#8217;s businesses reflect differences between actual and estimated sales returns in the period in which the actual amounts become known.  These differences, if any, have not had a material impact on Altria&#8217;s condensed consolidated financial statements.  All returned goods are destroyed upon return and not included in inventory.  Consequently, Altria&#8217;s businesses do not record an asset for their right to recover goods from customers upon return.</ix:nonNumeric></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales incentives include variable payments related to goods sold by Altria&#8217;s businesses.  Altria&#8217;s businesses include estimates of variable consideration as a reduction to revenues upon shipment of goods to customers.  The sales incentives that require significant estimates and judgments are as follows:</span></div><div style="margin-bottom:5pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Price promotion payments- </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s businesses make price promotion payments, substantially all of which are made to their retail partners, to incent the promotion of certain product offerings in select geographic areas.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="i1948e42340a0437f88e99640db638eff"><div style="margin-bottom:5pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wholesale and retail participation payments-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Altria&#8217;s businesses make payments to their wholesale and retail partners to incent merchandising and sharing of sales data in accordance with each business&#8217;s trade agreements.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates primarily include estimated wholesale to retail sales volume and historical acceptance rates.  Actual payments will differ from estimated payments to the extent actual results differ from estimated assumptions.  Differences between actual and estimated payments are reflected in the period such information becomes available.  These differences, if any, have not had a material impact on Altria&#8217;s condensed consolidated financial statements.</span></div></ix:continuation><div><span><br/></span></div><div id="i295e56fb16f94dae9eacc631c56d466c_1432"></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 3. <ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGV4dHJlZ2lvbjoxYzgwNjM1NjdiMmY0NmM0YTNhZmEzNzAxMWI3NGJhZF8yMTk5MDIzMjU5NDk3_db87d8b9-b41c-44d6-91ff-2dbdabcbcd10" continuedAt="ifd7b628b387b4d86a93ed0924914556c" escape="true">Assets Held for Sale</ix:nonNumeric></span></div><ix:continuation id="ifd7b628b387b4d86a93ed0924914556c"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 8, 2021, UST entered into a share purchase agreement pursuant to which it agreed to sell its subsidiary, IWS, which includes Ste. Michelle, to an entity controlled by investment funds managed by Sycamore Partners Management, L.P. in an all-cash transaction with a purchase price of approximately $<ix:nonFraction unitRef="usd" contextRef="i4d91b3c8886d4970bfefc99ee9bd77ec_I20211001" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGV4dHJlZ2lvbjoxYzgwNjM1NjdiMmY0NmM0YTNhZmEzNzAxMWI3NGJhZF8yNzQ4Nzc5MDczMzkx_e1502bdc-b0b9-43c5-a7a8-9fd23abc23bd">1.2</ix:nonFraction> billion and the assumption of certain liabilities of IWS and its subsidiaries (the &#8220;Ste. Michelle Transaction&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, the assets and liabilities associated with the Ste. Michelle Transaction were classified as assets held for sale and were measured at their fair value less costs to sell, resulting in a pre-tax charge of $<ix:nonFraction unitRef="usd" contextRef="i800ea809d24a4ae99423280ab9ed1ce7_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGV4dHJlZ2lvbjoxYzgwNjM1NjdiMmY0NmM0YTNhZmEzNzAxMWI3NGJhZF8yNzQ4Nzc5MDczNDA3_7692919f-3674-4f48-a108-6be93ca7c214">41</ix:nonFraction> million.  A reserve (as shown below), representing the adjustment to record the assets and liabilities at their fair value less costs to sell, was included as a component of assets held for sale in Altria&#8217;s condensed consolidated balance sheets at September&#160;30, 2021.  Altria recorded an additional pre-tax charge of $<ix:nonFraction unitRef="usd" contextRef="i800ea809d24a4ae99423280ab9ed1ce7_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGV4dHJlZ2lvbjoxYzgwNjM1NjdiMmY0NmM0YTNhZmEzNzAxMWI3NGJhZF8yNzQ4Nzc5MDc0OTEy_207dd39d-5bfa-4702-8b18-1b1c3c3254e6">10</ix:nonFraction> million for disposition-related costs related to the Ste. Michelle Transaction.  The total pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="i9321155464464f6abb0579cd48d53de2_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGV4dHJlZ2lvbjoxYzgwNjM1NjdiMmY0NmM0YTNhZmEzNzAxMWI3NGJhZF8yNzQ4Nzc5MDc0ODk3_19f899e6-a34a-40a6-8bb9-08fa173e4b1c">51</ix:nonFraction> million were included in the wine segment and recorded in marketing, administration and research costs in Altria&#8217;s condensed consolidated statements of earnings (losses) for the nine and three months ended September 30, 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2021, UST completed the sale of IWS and received approximately $<ix:nonFraction unitRef="usd" contextRef="i2ae5a856a040414ea2c55c9313370362_D20211001-20211001" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGV4dHJlZ2lvbjoxYzgwNjM1NjdiMmY0NmM0YTNhZmEzNzAxMWI3NGJhZF8yNzQ4Nzc5MDczNDIz_f76c6f25-4f3b-4180-a833-37eb98a676b4">1.2</ix:nonFraction> billion in net cash proceeds.  Altria expects to record additional adjustments related to the Ste. Michelle Transaction in the fourth quarter of 2021 and does not expect these adjustments to be material.</span></div><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGV4dHJlZ2lvbjoxYzgwNjM1NjdiMmY0NmM0YTNhZmEzNzAxMWI3NGJhZF8yMTk5MDIzMjU5NTAx_ae064e29-8fa9-4abc-93a4-3fea17e30096" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The major classes of assets and liabilities of IWS classified as held for sale at September 30, 2021 were as follows:</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:80.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl8yLTItMS0xLTEyODEw_abbce3af-4f64-45e0-bd85-0974f0d35cf9">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl8zLTItMS0xLTU5NDY_aea5f779-aa99-475a-83de-b58e5bb51818">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl80LTItMS0xLTEyODEw_521ce51e-a476-4b5e-b601-80703df92993">715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net of accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl81LTItMS0xLTEyODEw_c891ea0a-ab35-48a5-b623-71dee127dc49">407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl82LTItMS0xLTEyODEw_2c54666d-1781-44c8-8847-fa46f6176cd7">236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl83LTItMS0xLTEyODEw_a1b65c1c-e0c8-411d-8fa4-eea3f57f9790">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl84LTItMS0xLTEyODEw_701b4e1b-9f12-48c9-99b7-973bf44d87cd">1,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930" decimals="-6" name="mo:DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl85LTItMS0xLTEyODEw_c1a88dfb-fcde-4d24-8873-13362b59e156">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl8xMC0yLTEtMS0xMjgxMA_7186c651-5295-4e9e-9c99-a862f8c31e39">1,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl8xMy0yLTEtMS0xMjgxMA_684a43ad-ac7b-444b-a4bb-b075bfeb2453">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl8xNC0yLTEtMS0xMjgxMA_baaa70d7-466f-4dcc-92d8-abb47793786e">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued pension costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl8xNS0yLTEtMS0xMjgxMA_0da2ae1f-e82e-4727-a5e0-717b31729c5d">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl8xNi0yLTEtMS0xMjgxMA_2d1904e3-a164-4f35-bd7a-f8520b4fd321">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl8xNy0yLTEtMS0xMjgxMA_0885d7f5-d3ae-40ff-b0a9-6e6bc5fe61fd">295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets and liabilities held for sale, net</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib20e8844a92447d0a46d19d86ed0f7f5_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl8xOS0yLTEtMS0xMjgxMA_e36d8702-9871-4087-a4c5-9a8bdbf8d37f">1,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i295e56fb16f94dae9eacc631c56d466c_49"></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i295e56fb16f94dae9eacc631c56d466c_52"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 4. <ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:InvestmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzU1OQ_4aa6b21a-e2a9-4acd-90a1-b3aa5fa076b2" continuedAt="i3231c04c0cef456e9175435ff7adee89" escape="true">Investments in Equity Securities</ix:nonNumeric></span></div><ix:continuation id="i3231c04c0cef456e9175435ff7adee89" continuedAt="iac184c9935c248c280e0f6f97a1c0a3f"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:InvestmentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzU1NA_918e02bf-2a22-4a9c-908c-055367c0afa5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of Altria&#8217;s investments consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.885%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f738f3284745ba87d4ead6955d877d_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOjRlMmZhMjUxOWU0NDRjY2I5ZDBkYjJkODkyYTBlMDFhL3RhYmxlcmFuZ2U6NGUyZmEyNTE5ZTQ0NGNjYjlkMGRiMmQ4OTJhMGUwMWFfMS0yLTEtMS0w_ee0e5ac5-96dd-46d7-a101-fdaab639dcb2">11,237</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8023b74faf63413a92633caf766ceda1_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOjRlMmZhMjUxOWU0NDRjY2I5ZDBkYjJkODkyYTBlMDFhL3RhYmxlcmFuZ2U6NGUyZmEyNTE5ZTQ0NGNjYjlkMGRiMmQ4OTJhMGUwMWFfMS00LTEtMS0w_0ce394a7-7dbc-4232-b6a6-43671b78e3cb">16,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72200b393daa452fb6e8b503937f1675_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:EquityInvestmentFairValueOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOjRlMmZhMjUxOWU0NDRjY2I5ZDBkYjJkODkyYTBlMDFhL3RhYmxlcmFuZ2U6NGUyZmEyNTE5ZTQ0NGNjYjlkMGRiMmQ4OTJhMGUwMWFfMi0yLTEtMS0w_fbaca8f5-1bc3-4fca-a41f-d2b63c1c3369">1,705</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53e50acb7e34afea6df1a5247e0b9d6_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="mo:EquityInvestmentFairValueOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOjRlMmZhMjUxOWU0NDRjY2I5ZDBkYjJkODkyYTBlMDFhL3RhYmxlcmFuZ2U6NGUyZmEyNTE5ZTQ0NGNjYjlkMGRiMmQ4OTJhMGUwMWFfMi00LTEtMS0w_c22f2d42-c072-42d6-8074-2d59a02d26bb">1,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3134917de914447a308c3c06a9e6332_I20210930" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOjRlMmZhMjUxOWU0NDRjY2I5ZDBkYjJkODkyYTBlMDFhL3RhYmxlcmFuZ2U6NGUyZmEyNTE5ZTQ0NGNjYjlkMGRiMmQ4OTJhMGUwMWFfMy0yLTEtMS0w_6d2db296-6eb2-47c9-b2fe-d6d90f3c23f7">932</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5afb831a7af4995b73bda6b83b376f7_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOjRlMmZhMjUxOWU0NDRjY2I5ZDBkYjJkODkyYTBlMDFhL3RhYmxlcmFuZ2U6NGUyZmEyNTE5ZTQ0NGNjYjlkMGRiMmQ4OTJhMGUwMWFfMy00LTEtMS0w_3b7b3779-2433-4f8f-8a42-d0ac5d4ad321">1,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOjRlMmZhMjUxOWU0NDRjY2I5ZDBkYjJkODkyYTBlMDFhL3RhYmxlcmFuZ2U6NGUyZmEyNTE5ZTQ0NGNjYjlkMGRiMmQ4OTJhMGUwMWFfNC0yLTEtMS0w_9c7c59b9-b0b3-4bb1-b729-f0fdc3e32ca1">13,874</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOjRlMmZhMjUxOWU0NDRjY2I5ZDBkYjJkODkyYTBlMDFhL3RhYmxlcmFuZ2U6NGUyZmEyNTE5ZTQ0NGNjYjlkMGRiMmQ4OTJhMGUwMWFfNC00LTEtMS0w_d5ef1d4c-36c0-48a8-b17d-5cb2f9501f09">19,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Atria&#8217;s investment in Cronos at September 30, 2021 consisted of Altria&#8217;s equity method investment in Cronos ($<ix:nonFraction unitRef="usd" contextRef="ie2d67aef385b4488b0e8489bde6ec505_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMTg5_0c266e1d-fbe0-4101-b5a9-495632844521">897</ix:nonFraction> million), the Cronos warrant ($<ix:nonFraction unitRef="usd" contextRef="i4c1ec10071a549c494de909a6803c0bc_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMjE0_66f552bc-8fdb-40cc-a1c2-08fb85fc96b8">32</ix:nonFraction> million) and the Fixed-price Preemptive Rights ($<ix:nonFraction unitRef="usd" contextRef="id27af0c56a0e4f2c91692075789f16f1_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMjU3_e7fec709-60cd-4c9d-89cb-def60575a9d0">3</ix:nonFraction> million), (collectively, &#8220;Investment in Cronos&#8221;).  The Investment in Cronos at December 31, 2020 consisted of Altria&#8217;s equity method investment in Cronos ($<ix:nonFraction unitRef="usd" contextRef="i55353e2d6bb3468a8bb902e7ef81616b_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfNDAz_4db853a4-feb1-41b1-b63e-747f7e7af605">1,010</ix:nonFraction> million), the Cronos warrant ($<ix:nonFraction unitRef="usd" contextRef="ia7f2b6c32d774ec2b7a6087a9251d893_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfNDI4_f03e1bd5-008a-4873-a263-6efd568b3f3a">139</ix:nonFraction> million) and the Fixed-price Preemptive Rights ($<ix:nonFraction unitRef="usd" contextRef="ie01a2991fc0c45cda4ae5f730f069b9b_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfNDcx_9a36291c-04f0-4f21-923d-4f59a8cb3152">24</ix:nonFraction> million).  See below for further discussion.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzU1Mw_290e3727-29ab-4742-973e-aef3a98cce1f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (losses) from equity investments accounted for under the equity method of accounting and fair value option consisted of the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.184%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife49fc973ca746f092aa4d83bca9d740_D20210101-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfMi0xLTEtMS0w_fd5b639f-fb50-482b-b439-86c2311bd160">5,644</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i142e3b708e7c4513964bfdef3821842c_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfMi0zLTEtMS0w_a3361718-78b6-4fbd-a2d2-56c5015a2c06">306</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic62d4fc827d0412695035c4816dc2a17_D20210701-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfMi01LTEtMS0w_ef4136d5-0274-4506-b639-d12e8072b9e0">6,036</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b92cf433a64434db9bce40cc2385d5e_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfMi03LTEtMS0w_9a17e577-d4b7-498e-ba0f-7cfb720e95a9">418</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f91523b32934656837eccb431840056_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfMy0xLTEtMS0w_c337c316-5111-47b0-a216-e22b375dd452">145</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16da5adef0b64404a908cb9d15134fb8_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfMy0zLTEtMS0w_126b6a3c-b5f9-4860-ac63-7ac560be9d3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3a641fc878c4afe85e1c9467ee9853c_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfMy01LTEtMS0w_63c1d1ba-2798-4bea-93c1-d5dc3323412a"><ix:nonFraction unitRef="usd" contextRef="if3a641fc878c4afe85e1c9467ee9853c_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfMy01LTEtMS0w_f35816df-b515-4b7b-b548-32599e8bbb2d">21</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if07c963ba7314996a07680309ec4ce52_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfMy03LTEtMS0w_62d20a20-1901-4c7d-9e59-825f8a0a619b">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (losses) from investments under equity method of accounting</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfNC0xLTEtMS0w_3b3ff5cc-478c-4dfa-896b-bdcbeade9bf0">5,789</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfNC0zLTEtMS0w_ab89b3fa-2fd9-4bd2-804c-740bd49a3005">306</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfNC01LTEtMS0w_a64ccf31-d7f6-4902-911d-ed812b11a3c5">6,015</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfNC03LTEtMS0w_5083ec23-0eac-49d0-a27e-ab4b68ae9e25">472</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a7ceafc35c8455aa006544f31dada24_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="mo:IncomeLossFromEquityInvestmentsFairValueOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfNS0xLTEtMS0w_16c357c5-b4ab-4c98-9bb3-5b9ce1ab92fb">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff7bce46de9948cfbbc1a3790debcee8_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="mo:IncomeLossFromEquityInvestmentsFairValueOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfNS0zLTEtMS0w_393f375f-73c8-4021-bddf-cdd8b2b7bf0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d7c9a004f294d309f5a0ddbff7f9c62_D20210701-20210930" decimals="-6" name="mo:IncomeLossFromEquityInvestmentsFairValueOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfNS01LTEtMS0w_937ff4b1-ce28-49ae-9da1-7c36e47d71fa">100</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26492b9b36f34d359befa59e3e1f285d_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="mo:IncomeLossFromEquityInvestmentsFairValueOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfNS03LTEtMS0w_c6e7b96f-f563-4570-ab75-950d650b6da3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (losses) from equity investments</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="mo:IncomeLossFromEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfNi0xLTEtMS0w_d45752fd-e53b-44f0-9f82-5019cb69eea0">5,789</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfNi0zLTEtMS0w_68d0be54-a6c5-4e27-8088-bfd5ae346549">306</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="mo:IncomeLossFromEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfNi01LTEtMS0w_6993e694-c297-4cdd-a40c-62248f76ff88">5,915</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfNi03LTEtMS0w_3804f3aa-8217-4720-87e1-7f74f10273d8">472</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the nine and three months ended September 30, 2021, Altria recorded a non-cash, pre-tax impairment charge of $<ix:nonFraction unitRef="usd" contextRef="ife49fc973ca746f092aa4d83bca9d740_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:EquityMethodInvestmentImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzI5ODUzNDkwMDI3Ng_6a37dd71-d6cf-4ce5-884a-7d2cc643850c"><ix:nonFraction unitRef="usd" contextRef="ic62d4fc827d0412695035c4816dc2a17_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:EquityMethodInvestmentImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzI5ODUzNDkwMDI3Ng_9903f87f-2c6c-44ff-9939-bcc8ccad5ace">6,157</ix:nonFraction></ix:nonFraction> million related to its equity investment in ABI. See below for further discussion.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in ABI</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, Altria had an approximate <ix:nonFraction unitRef="number" contextRef="ib6f738f3284745ba87d4ead6955d877d_I20210930" decimals="3" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfNjkz_6b508091-5219-4fcc-a5df-eea075ddc372">10</ix:nonFraction>% ownership interest in ABI, consisting of <ix:nonFraction unitRef="shares" contextRef="ib6f738f3284745ba87d4ead6955d877d_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:EquityMethodInvestmentNumberofSharesOwnedRestricted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfNzM3_58b8ba5d-048e-4b5c-9070-4955c118854b">185</ix:nonFraction> million restricted shares of ABI (the &#8220;Restricted Shares&#8221;) and <ix:nonFraction unitRef="shares" contextRef="ib6f738f3284745ba87d4ead6955d877d_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:EquityMethodInvestmentNumberofSharesOwnedCommon" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfNzk1_f466b0b5-83fb-41c2-b6d3-9ba25bd35bfe">12</ix:nonFraction> million ordinary shares of ABI.  The Restricted Shares:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">are unlisted and not admitted to trading on any stock exchange;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">are convertible by Altria into ordinary shares of ABI on a one-for-one basis;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">rank equally with ordinary shares of ABI with regards to dividends and voting rights; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">have director nomination rights with respect to ABI.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restricted Shares were subject to a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzkwMzI2NjI3OTEyMjM_deac5b80-5cfb-43db-b6ef-127a6fca35e3">five</span>-year lock-up period that ended October 10, 2021.  As of this filing, Altria has not elected to convert its Restricted Shares into ordinary shares of ABI.</span></div><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzU2Ng_bb3b631b-a1a2-4a93-aaa9-be03138f53f6" continuedAt="iaea1114049b74f88928718166d3e5cb7" escape="true"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria accounts for its investment in ABI under the equity method of accounting because Altria has the ability to exercise significant influence over the operating and financial policies of ABI, including having active representation on ABI&#8217;s board of directors and certain ABI board committees.  Through this representation, Altria participates in ABI policy making processes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria reports its share of ABI&#8217;s results using a one-quarter lag because ABI&#8217;s results are not available in time for Altria to record them in the concurrent period.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of Altria&#8217;s equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI&#8217;s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy.  Altria can convert its Restricted Shares to ordinary shares at its discretion.  Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2019, the fair value of Altria&#8217;s equity investment in ABI declined below its carrying value and has not recovered.   At December&#160;31, 2020, the fair value of Altria&#8217;s equity investment in ABI was $<ix:nonFraction unitRef="usd" contextRef="i32e2dbe44f974df484f948ed2b86c221_I20201231" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfNzY5NjU4MTQxMTk0NA_2d7851c7-9b06-4905-8a64-b0be382cb742">13.8</ix:nonFraction> billion (carrying value of $<ix:nonFraction unitRef="usd" contextRef="i8023b74faf63413a92633caf766ceda1_I20201231" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfNzY5NjU4MTQxMTk2Nw_d443dc89-adf7-4af2-b24a-c5a5cdf2b8e8">16.7</ix:nonFraction> billion), which was less than its carrying value by approximately <ix:nonFraction unitRef="number" contextRef="id3b7793faa454c9499956ae3df8ea507_D20200101-20201231" decimals="2" sign="-" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfNzY5NjU4MTQxMjAyOA_822c7fbf-4ab0-4470-ab65-8d933e35a5ef">17</ix:nonFraction>%. In preparing its financial statements for the period ended December&#160;31, 2020, Altria evaluated the factors related to the fair value decline, including the impact on the fair value of ABI&#8217;s shares during the COVID-19 pandemic, which has negatively impacted ABI&#8217;s business.  Altria evaluated the duration and magnitude of the fair value decline, ABI&#8217;s financial condition and near-term prospects and Altria&#8217;s intent and ability to hold its </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="iac184c9935c248c280e0f6f97a1c0a3f" continuedAt="i932a49f4db4443f38a28a7e70e92a864"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iaea1114049b74f88928718166d3e5cb7" continuedAt="ic093a7fa5e284ebf9a38c3331ec5ab72">investment in ABI until recovery.  Altria concluded that the decline in fair value of its investment in ABI at December 31, 2020 below its carrying value was temporary and, therefore, <ix:nonFraction unitRef="usd" contextRef="id3b7793faa454c9499956ae3df8ea507_D20200101-20201231" decimals="INF" format="ixt:fixed-zero" name="mo:EquityMethodInvestmentImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzI5ODUzNDkwMDIyMQ_7445f01c-5d8d-4a56-90fb-6b8ad7de4315">no</ix:nonFraction> impairment was recorded at that time.</ix:continuation></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic093a7fa5e284ebf9a38c3331ec5ab72" continuedAt="i597f869a0eed48f185430d85d9cfa7d5">Following the consideration of the same factors, Altria, in preparing its financial statements for the period ended September&#160;30, 2021, concluded that the decline in fair value of its investment in ABI at September&#160;30, 2021 was other than temporary. As a result, Altria recorded a non-cash, pre-tax impairment charge of $<ix:nonFraction unitRef="usd" contextRef="ife49fc973ca746f092aa4d83bca9d740_D20210101-20210930" decimals="-8" format="ixt:num-dot-decimal" name="mo:EquityMethodInvestmentImpairment" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzI5ODUzNDkwMDIzMA_61e782a2-9f07-4ec6-b309-f9cf56611226"><ix:nonFraction unitRef="usd" contextRef="ic62d4fc827d0412695035c4816dc2a17_D20210701-20210930" decimals="-8" format="ixt:num-dot-decimal" name="mo:EquityMethodInvestmentImpairment" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzI5ODUzNDkwMDIzMA_95df2bdb-1871-4e44-a2ff-9d57e0ce87a6">6.2</ix:nonFraction></ix:nonFraction> billion for the nine and three months ended September&#160;30, 2021, which was recorded to income (losses) from equity investments in its condensed consolidated statements of earnings (losses).  This impairment charge reflects the difference between the fair value of Altria&#8217;s investment in ABI using ABI&#8217;s share price at September&#160;30, 2021 and the carrying value of Altria&#8217;s equity investment in ABI at September&#160;30, 2021.  Altria continues to have confidence in ABI&#8217;s (i) long-term strategies, (ii) premium global brands, (iii) experienced management team and (iv) capability to successfully navigate its near-term challenges. Altria further expects that the impacts related to the COVID-19 pandemic that have negatively impacted ABI&#8217;s global business are transitory, but now also anticipates that the full recovery to carrying value will take longer than previously expected. This is evidenced by the resumption of declines in fair value during the third quarter of 2021, following positive share price momentum during the first half of 2021.  At September&#160;30, 2021, prior to recording the impairment charge, the fair value of Altria&#8217;s investment in ABI was below the carrying value by approximately <ix:nonFraction unitRef="number" contextRef="ife49fc973ca746f092aa4d83bca9d740_D20210101-20210930" decimals="2" sign="-" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfNzY5NjU4MTQxMDA5MA_0186c66c-46e0-41cc-a39c-1b07ad647b30">35</ix:nonFraction>%, which represents an additional <ix:nonFraction unitRef="number" contextRef="ib6f738f3284745ba87d4ead6955d877d_I20210930" decimals="2" name="mo:EquityMethodInvestmentReductionInSharePricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzI5ODUzNDkwMDI1MQ_d8bb450e-d1f5-469f-9aaf-8641bd8daeb9">18</ix:nonFraction>% reduction in ABI&#8217;s share price since December&#160;31, 2020.  </ix:continuation>After recording the impairment charge, the fair value and carrying value of Altria&#8217;s equity investment in ABI at September&#160;30, 2021 were $<ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMjY2Ng_e5de8afb-9a1f-402c-8352-9add88f37ac9"><ix:nonFraction unitRef="usd" contextRef="ib6f738f3284745ba87d4ead6955d877d_I20210930" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMjY2Ng_f5ede66c-013d-464b-bd88-f087eab807f9">11.2</ix:nonFraction></ix:nonFraction> billion.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, the carrying value of Altria&#8217;s equity investment in ABI exceeded its share of ABI&#8217;s net assets attributable to equity holders of ABI by approximately $<ix:nonFraction unitRef="usd" contextRef="ib6f738f3284745ba87d4ead6955d877d_I20210930" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzI5ODUzNDkwMDI1Nw_06a2a3ec-4c71-42a6-a608-1a4c25a6a60f">5.1</ix:nonFraction> billion.  Substantially all of this difference is comprised of goodwill and other indefinite-lived intangible assets (consisting primarily of trademarks).</span></div></ix:continuation><div id="i295e56fb16f94dae9eacc631c56d466c_55"></div><ix:continuation id="i932a49f4db4443f38a28a7e70e92a864" continuedAt="ic7b30161e56b454cba06c03542cf302f"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in JUUL</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2018, Altria made an investment in JUUL and received a <ix:nonFraction unitRef="number" contextRef="i7b95bdcd547049af892afbaf8e444f3e_I20181231" decimals="2" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RleHRyZWdpb246ZWQyNmE4YTUyYjU3NDE5OWJiMjg1Mzc0MzlhMzBhYTBfOTI_78908f0b-807a-4260-8e46-e0f67291d8f9">35</ix:nonFraction>% economic interest in JUUL through non-voting shares, which were convertible at Altria&#8217;s election into voting shares (&#8220;Share Conversion&#8221;), and a security convertible into additional non-voting or voting shares, as applicable, upon settlement or exercise of certain JUUL convertible securities (the &#8220;JUUL Transaction&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria received a broad preemptive right to purchase JUUL shares, exercisable each quarter upon dilution, to maintain its ownership percentage and is subject to a standstill restriction under which it may not acquire additional JUUL shares above its <ix:nonFraction unitRef="number" contextRef="i7b95bdcd547049af892afbaf8e444f3e_I20181231" decimals="2" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RleHRyZWdpb246ZWQyNmE4YTUyYjU3NDE5OWJiMjg1Mzc0MzlhMzBhYTBfNjYz_dc3b3f22-02dd-4464-b368-7db787187748">35</ix:nonFraction>% interest.  Furthermore, Altria agreed not to sell or transfer any of its JUUL shares until December 20, 2024.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2020, the U.S. Federal Trade Commission (&#8220;FTC&#8221;) issued an administrative complaint challenging Altria&#8217;s investment in JUUL.  For further discussion, see Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies -&#160;Antitrust Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, Altria exercised its rights to convert its non-voting JUUL shares into voting shares.  Altria does not currently intend to exercise its additional governance rights obtained upon Share Conversion, including the right to elect directors to JUUL&#8217;s board or to vote its JUUL shares other than as a passive investor, pending the outcome of the FTC administrative complaint.  At September&#160;30, 2021, Altria had a <ix:nonFraction unitRef="number" contextRef="i72200b393daa452fb6e8b503937f1675_I20210930" decimals="2" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RleHRyZWdpb246ZWQyNmE4YTUyYjU3NDE5OWJiMjg1Mzc0MzlhMzBhYTBfMTM5Mg_4b887ff9-f9b8-4bb0-9675-06abe39b2fa5">35</ix:nonFraction>% ownership interest in JUUL, consisting of <ix:nonFraction unitRef="shares" contextRef="i72200b393daa452fb6e8b503937f1675_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:EquityInvestmentsFairValueOptionVotingShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RleHRyZWdpb246ZWQyNmE4YTUyYjU3NDE5OWJiMjg1Mzc0MzlhMzBhYTBfMTQzNw_9c2267eb-2acf-4e66-8f1b-2b495a9f0964">42</ix:nonFraction> million voting shares.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following Share Conversion in the fourth quarter of 2020, Altria elected to account for its equity method investment in JUUL under the fair value option.  Under this option, Altria&#8217;s condensed consolidated statements of earnings (losses) include any cash dividends received from its investment in JUUL and any changes in the estimated fair value of its investment, which is calculated quarterly.  Altria believes the fair value option provides quarterly transparency to investors as to the fair market value of Altria&#8217;s investment in JUUL, given the changes and volatility in the e-vapor category since Altria&#8217;s initial investment, as well as the lack of publicly available information regarding JUUL&#8217;s business or a market-derived valuation.</span></div><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RleHRyZWdpb246ZWQyNmE4YTUyYjU3NDE5OWJiMjg1Mzc0MzlhMzBhYTBfMjE5OTAyMzI2NzQ3OA_e43d1331-0671-4416-a75b-57cc04f4dea3" escape="true"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balance of Altria&#8217;s investment in JUUL, which is classified in Level 3 of the fair value hierarchy:</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134145e8cb494481a64026d08e24f670_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RhYmxlOjU5NGIxMGNkMTVkMDQ4ODI5M2Y3M2YxYmFjODAwMDlhL3RhYmxlcmFuZ2U6NTk0YjEwY2QxNWQwNDg4MjkzZjczZjFiYWM4MDAwOWFfMi0yLTEtMS00OTY3OA_0ebfa021-cfcc-4834-a6c8-654f7139cf10">1,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) included in income (losses) from equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fe43b6fc76f4ce480f73470bdcc7717_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RhYmxlOjU5NGIxMGNkMTVkMDQ4ODI5M2Y3M2YxYmFjODAwMDlhL3RhYmxlcmFuZ2U6NTk0YjEwY2QxNWQwNDg4MjkzZjczZjFiYWM4MDAwOWFfMy0yLTEtMS00OTY3Mg_1073114d-068a-43c4-99c5-e180c1f6d0c8">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i050fe6a531654ecd9ffb665ff8b70dce_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RhYmxlOjU5NGIxMGNkMTVkMDQ4ODI5M2Y3M2YxYmFjODAwMDlhL3RhYmxlcmFuZ2U6NTk0YjEwY2QxNWQwNDg4MjkzZjczZjFiYWM4MDAwOWFfNC0yLTEtMS01MDk5NQ_22285a07-3a54-4919-ba8c-94b5a7419780">1,705</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:10pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2021, Altria recorded a non-cash, pre-tax unrealized gain of $<ix:nonFraction unitRef="usd" contextRef="i0d7c9a004f294d309f5a0ddbff7f9c62_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:IncomeLossFromEquityInvestmentsFairValueOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RleHRyZWdpb246ZWQyNmE4YTUyYjU3NDE5OWJiMjg1Mzc0MzlhMzBhYTBfMTQ4NDM0MDY5ODU5NDc_339d62f5-4d1f-468e-8d69-4bbb5608b3b3">100</ix:nonFraction> million, as a result of changes in the estimated fair value of its investment in JUUL.  At September 30, 2021, the estimated fair value of Altria&#8217;s JUUL investment was $<ix:nonFraction unitRef="usd" contextRef="i72200b393daa452fb6e8b503937f1675_I20210930" decimals="-8" format="ixt:num-dot-decimal" name="mo:EquityInvestmentFairValueOption" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RleHRyZWdpb246ZWQyNmE4YTUyYjU3NDE5OWJiMjg1Mzc0MzlhMzBhYTBfMzI5ODUzNDg5NjEzMg_e4b32d69-c033-4e77-be3a-22c2e07f55df">1.7</ix:nonFraction> billion, unchanged from its December 31, 2020 estimated fair value.  There were no material </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="ic7b30161e56b454cba06c03542cf302f" continuedAt="i17b872f3cfba41d8859fa3bd22ebf369"><div style="margin-bottom:10pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">changes to the significant assumptions used in the valuations, as described below, during the nine and three months ended September&#160;30, 2021.</span></div><div style="margin-bottom:10pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to Share Conversion, Altria accounted for its investment in JUUL as an investment in an equity security.  Since the JUUL shares do not have a readily determinable fair value, Altria elected to measure its investment in JUUL at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.  There were <ix:nonFraction unitRef="usd" contextRef="ia1881e260a3842d1bcc033077fcf431f_I20201031" decimals="INF" format="ixt:fixed-zero" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RleHRyZWdpb246ZWQyNmE4YTUyYjU3NDE5OWJiMjg1Mzc0MzlhMzBhYTBfMTg4Mw_db9140ed-38da-4524-96a3-c6b7b58b2782"><ix:nonFraction unitRef="usd" contextRef="ia17ccdc17eaa43c2895a3756a03e1e51_I20201031" decimals="INF" format="ixt:fixed-zero" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RleHRyZWdpb246ZWQyNmE4YTUyYjU3NDE5OWJiMjg1Mzc0MzlhMzBhYTBfMTg4Mw_e20fabc3-27e9-4646-8018-f8a4e1d38ae5">no</ix:nonFraction></ix:nonFraction> upward or downward adjustments to the carrying value of Altria&#8217;s investment in JUUL resulting from observable price changes in orderly transactions since the JUUL Transaction through the date of Share Conversion.  In addition, prior to Share Conversion, Altria reviewed its investment in JUUL for impairment by performing a qualitative assessment of impairment indicators on a quarterly basis in connection with the preparation of its financial statements.  If this qualitative assessment indicated that Altria&#8217;s investment in JUUL may be impaired, a quantitative assessment was performed.  If the quantitative assessment indicated the estimated fair value of the investment was less than its carrying value, the investment was written down to its fair value.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, JUUL announced a strategic update, which included its plans for a significant global workforce reduction, its evaluation of its resource allocation and the possibility of exiting various international markets.  As part of the preparation of Altria&#8217;s financial statements for the period ended September 30, 2020, Altria performed a qualitative assessment of impairment indicators for its investment in JUUL and determined that JUUL&#8217;s strategic update was an indicator of impairment at September 30, 2020, given the significant deterioration in JUUL&#8217;s business prospects.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the existence of this impairment indicator, Altria performed a quantitative valuation of its investment in JUUL during the third quarter of 2020 and recorded a non-cash, pre-tax charge of $<ix:nonFraction unitRef="usd" contextRef="i26492b9b36f34d359befa59e3e1f285d_D20200701-20200930" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RleHRyZWdpb246ZWQyNmE4YTUyYjU3NDE5OWJiMjg1Mzc0MzlhMzBhYTBfMjc0ODc3OTA3NzI2Ng_464fc599-469c-425b-b9e2-013ca4b080d0"><ix:nonFraction unitRef="usd" contextRef="iff7bce46de9948cfbbc1a3790debcee8_D20200101-20200930" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RleHRyZWdpb246ZWQyNmE4YTUyYjU3NDE5OWJiMjg1Mzc0MzlhMzBhYTBfMjc0ODc3OTA3NzI2Ng_4ff90847-68aa-454c-a680-9db96bd4a9d3">2.6</ix:nonFraction></ix:nonFraction> billion for the nine and three months ended September 30, 2020, reported as impairment of JUUL equity securities in its condensed consolidated statements of earnings (losses).  The impairment charge was driven by Altria&#8217;s projections of lower JUUL revenues over time due to lower pricing assumptions and delays in JUUL achieving previously forecasted operating margin performance.  These drivers were the result of (i) JUUL&#8217;s revised international expansion plans and (ii) the evolving U.S. e-vapor category and associated competitive dynamics.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria uses an income approach to estimate the fair value of its investment in JUUL.  The income approach reflects the discounting of future cash flows for the U.S. and international markets at a rate of return that incorporates the risk-free rate for the use of those funds, the expected rate of inflation and the risks associated with realizing future cash flows.  Future cash flows were based on a range of scenarios that consider various potential regulatory and market outcomes.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the estimated fair value of its investment in JUUL, as of September&#160;30, 2021 and December&#160;31, 2020, Altria made various judgments, estimates and assumptions, the most significant of which were sales volume, operating margins, discount rates and perpetual growth rates.  All significant inputs used in the valuation are classified in Level 3 of the fair value hierarchy.  Additionally, in determining these significant assumptions, Altria made judgments regarding the (i) likelihood and extent of various potential regulatory actions and the continued adverse public perception impacting the e-vapor category and specifically JUUL, (ii) risk created by the number and types of legal cases pending against JUUL and (iii) expectations for the future state of the e-vapor category, including competitive dynamics.</span></div></ix:continuation><div id="i295e56fb16f94dae9eacc631c56d466c_58"></div><ix:continuation id="i17b872f3cfba41d8859fa3bd22ebf369" continuedAt="i457cc38ab5264e2ca4cdad42a8be7691"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in Cronos</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, Altria had a <ix:nonFraction unitRef="number" contextRef="ia3134917de914447a308c3c06a9e6332_I20210930" decimals="3" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfNDY_08d5d906-3699-4b47-a55c-295d9b2144b0">41.9</ix:nonFraction>% ownership interest in Cronos, consisting of <ix:nonFraction unitRef="shares" contextRef="ia3134917de914447a308c3c06a9e6332_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="mo:EquityMethodInvestmentNumberofSharesOwnedCommon" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfOTM_894980f1-02ec-4a0f-9765-c5f6ad8e9cbc">156.6</ix:nonFraction>&#160;million shares, which Altria accounts for under the equity method of accounting.  Altria&#8217;s ownership percentage decreased from <ix:nonFraction unitRef="number" contextRef="ib5afb831a7af4995b73bda6b83b376f7_I20201231" decimals="3" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMjE1_ae309607-d6b0-411b-a960-cfd1dcd4f6e5">43.5</ix:nonFraction>% at December 31, 2020 due to the issuance of additional shares by Cronos.  Altria reports its share of Cronos&#8217;s results using a one-quarter lag because Cronos&#8217;s results are not available in time for Altria to record them in the concurrent period.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of its Investment in Cronos, at September&#160;30, 2021, Altria owned:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">anti-dilution protections to purchase Cronos common shares, exercisable each quarter upon dilution, to maintain its ownership percentage.  Certain of the anti-dilution protections provide Altria the ability to purchase additional Cronos common shares at a per share exercise price of Canadian dollar (&#8220;CAD&#8221;) $<ix:nonFraction unitRef="cadPerShare" contextRef="id27af0c56a0e4f2c91692075789f16f1_I20210930" decimals="INF" name="mo:EquityMethodInvestmentPricePerShareIfExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfODMx_c280a85d-af13-4dae-a471-2e2b039fedb5">16.25</ix:nonFraction> upon the occurrence of specified events (&#8220;Fixed-price Preemptive Rights&#8221;).  Based on Altria&#8217;s assumptions as of September 30, 2021, Altria estimates the Fixed-price Preemptive Rights allows Altria to purchase up to an additional approximately <ix:nonFraction unitRef="shares" contextRef="id27af0c56a0e4f2c91692075789f16f1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="mo:EquityMethodInvestmentNumberofSharesEligibleForPurchase" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMTA3Mg_31738973-b174-4c10-b57e-706114c35cf2">14</ix:nonFraction> million common shares of Cronos; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">a warrant providing Altria the ability to purchase an additional approximate <ix:nonFraction unitRef="number" contextRef="i4c1ec10071a549c494de909a6803c0bc_I20210930" decimals="INF" name="mo:EquityMethodInvestmentPercentageofSharesEligibleForPurchase" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMTE4MQ_8bd4b6b4-c1ab-4d71-8833-75a9ed83b631">10</ix:nonFraction>% of common shares of Cronos (approximately <ix:nonFraction unitRef="shares" contextRef="i4c1ec10071a549c494de909a6803c0bc_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:EquityMethodInvestmentNumberofSharesEligibleForPurchase" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMTIyNg_1d71990e-d224-4405-a923-16e77eec1571">83</ix:nonFraction> million common shares at September 30, 2021) at a per share exercise price of CAD $<ix:nonFraction unitRef="cadPerShare" contextRef="i4c1ec10071a549c494de909a6803c0bc_I20210930" decimals="INF" name="mo:EquityMethodInvestmentPricePerShareIfExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMTI5OA_8fadf37e-03df-455e-9e71-2f01ff5a7184">19.00</ix:nonFraction>, which expires on March 8, 2023.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If exercised in full, the exercise prices for the warrant and Fixed-price Preemptive Rights are approximately CAD $<ix:nonFraction unitRef="cad" contextRef="ia8e68dd2bdba4a9fb2cab39cdf6ff65a_D20210101-20210930" decimals="-8" format="ixt:num-dot-decimal" name="mo:EquityMethodInvestmentAggregateExercisePrice" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMTQ0OQ_4d66deda-7d12-4dac-8f2e-be9318a810a1">1.6</ix:nonFraction> billion and CAD $<ix:nonFraction unitRef="cad" contextRef="i413418f0ee6d4970991e224cb3ef2b61_D20210101-20210930" decimals="-8" format="ixt:num-dot-decimal" name="mo:EquityMethodInvestmentAggregateExercisePrice" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMTQ2MA_12f6d63f-8112-4498-a683-39ee27533bb2">0.2</ix:nonFraction> billion, respectively (approximately USD $<ix:nonFraction unitRef="usd" contextRef="i4c45d9f454c845349a17b5b89122518e_D20211025-20211025" decimals="-8" format="ixt:num-dot-decimal" name="mo:EquityMethodInvestmentAggregateExercisePrice" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMTQ5Nw_10e24711-d565-42d4-a7a2-cec55d1a2cd6">1.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i90625c50de644d79a497ab347321af26_D20211025-20211025" decimals="-8" format="ixt:num-dot-decimal" name="mo:EquityMethodInvestmentAggregateExercisePrice" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMTUwNA_705adff1-a465-4c1b-aadf-25a072fcbcfa">0.2</ix:nonFraction> billion, respectively, based on the CAD to USD exchange rate on October 25, 2021).  At September 30, 2021, upon full exercise of the Fixed-price Preemptive Rights, to the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="i457cc38ab5264e2ca4cdad42a8be7691"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">extent such rights become available, and the warrant, Altria would own approximately <ix:nonFraction unitRef="number" contextRef="ia2c7ce11a66f40d7b866ad7f5cf8a0d7_D20210101-20210930" decimals="2" name="mo:EquityMethodInvestmentWarrantExercisedOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMTc0Nw_6386f993-e827-4a6f-85d5-d1ed317969c1">53</ix:nonFraction>% of the outstanding common shares of Cronos.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of derivatives related to the Investment in Cronos, including Altria&#8217;s accounting for changes in the fair value of these derivatives, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i597f869a0eed48f185430d85d9cfa7d5">The fair value of Altria&#8217;s equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos&#8217;s common shares and was classified in Level 1 of the fair value hierarchy.  In September 2021, the fair value of Altria&#8217;s equity method investment in Cronos declined below its carrying value.</ix:continuation>  At September&#160;30, 2021, the fair value of Altria&#8217;s equity method investment in Cronos was less than its carrying value by $<ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMzc5MzMxNTExNjE3Mjg_8169507c-212b-41e5-bda6-65de62c82ddf">14</ix:nonFraction>&#160;million or approximately <ix:nonFraction unitRef="number" contextRef="i7f91523b32934656837eccb431840056_D20210101-20210930" decimals="2" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMjM4MQ_11e0efa3-58f2-4a75-b93d-94ff7a2e8c8d">2</ix:nonFraction>%.  The fair value of Altria&#8217;s equity method investment in Cronos exceeded its carrying value by $<ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMzc5MzMxNTExNjE3NDY_fc159456-7527-4156-958a-e765c92faff1">77</ix:nonFraction> million or approximately <ix:nonFraction unitRef="number" contextRef="i30a456d16ad04abf8d2bbed9680d3088_D20200101-20201231" decimals="2" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMjM4OA_bd678119-6a2e-474f-b4b6-a6a31dfe994e">8</ix:nonFraction>% at December&#160;31, 2020.  Based on Altria&#8217;s evaluation of the duration and magnitude of the fair value decline at September 30, 2021, Altria concluded that the decline in fair value of its equity method investment in Cronos below its carrying value is temporary and, therefore, no impairment was recorded.</span></div></ix:continuation><div><span><br/></span></div><div id="i295e56fb16f94dae9eacc631c56d466c_61"></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 5. <ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfNjE4NA_b97f96b0-c614-44ae-a23b-a99ab86f82db" continuedAt="i3f374951e2674b6fbdce6ac4c712d78d" escape="true">Financial Instruments</ix:nonNumeric></span></div><ix:continuation id="i3f374951e2674b6fbdce6ac4c712d78d" continuedAt="icabbeb6f88c548b69edd6ddde41fd097"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria enters into derivative financial instruments to mitigate the potential impact of certain market risks, including foreign currency exchange rate risk.  Altria uses various types of derivative financial instruments, including forward contracts, options and swaps.  Altria does not enter into or hold derivative financial instruments for trading or speculative purposes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s investment in ABI, whose functional currency is the Euro, exposes Altria to foreign currency exchange risk on the carrying value of its investment.  To manage this risk, Altria designates certain foreign exchange contracts, including cross-currency swap contracts and forward contracts (collectively, &#8220;foreign currency contracts&#8221;), and Euro denominated unsecured long-term notes (&#8220;foreign currency denominated debt&#8221;) as net investment hedges of Altria&#8217;s investment in ABI.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, all outstanding foreign currency contracts matured.  When Altria has foreign currency contracts in effect, counterparties are domestic and international financial institutions.  Under these contracts, Altria is exposed to potential losses due to non-performance by these counterparties.  Altria manages its credit risk by entering into transactions with counterparties with investment grade credit ratings, limiting the amount of exposure Altria has with each counterparty and monitoring the financial condition of each counterparty.  The counterparty agreements contain provisions that require Altria to maintain an investment grade credit rating.  In the event Altria&#8217;s credit rating falls below investment grade, counterparties to Altria&#8217;s foreign currency contracts can require Altria to post collateral.  No collateral was received or posted related to derivative assets and liabilities at December&#160;31, 2020.</span></div><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfNjE3MA_31c8b71f-5e73-4931-8bf2-829b096c9d63" continuedAt="ib4ca0b76672d4406a19e75c56fc67291" escape="true"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides (i) the aggregate notional amounts of foreign currency contracts and (ii) the aggregate carrying value and fair value of foreign currency denominated debt:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts (notional amounts)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf3cacc08db49a29687505d3387266b_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjBjZTdjMTNjYzFjZjQyNDVhYWY0ODc4YTkzMDUyYWRhL3RhYmxlcmFuZ2U6MGNlN2MxM2NjMWNmNDI0NWFhZjQ4NzhhOTMwNTJhZGFfMS0xLTEtMS0w_e83e1f82-aec8-4d63-9c05-1a88e3327a15">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87169f0e47aa46f581a3b1a6a073d849_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjBjZTdjMTNjYzFjZjQyNDVhYWY0ODc4YTkzMDUyYWRhL3RhYmxlcmFuZ2U6MGNlN2MxM2NjMWNmNDI0NWFhZjQ4NzhhOTMwNTJhZGFfMS0zLTEtMS0w_c4e36033-9a63-4b84-9083-73287a718abc">1,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic10cda982ea5415199ad34d94e8b02ba_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjBjZTdjMTNjYzFjZjQyNDVhYWY0ODc4YTkzMDUyYWRhL3RhYmxlcmFuZ2U6MGNlN2MxM2NjMWNmNDI0NWFhZjQ4NzhhOTMwNTJhZGFfMy0xLTEtMS0w_5af4e374-3d97-40a0-b8f2-d45032ca3078">4,905</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7d03ea00174970b1ec83dc2dac1886_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjBjZTdjMTNjYzFjZjQyNDVhYWY0ODc4YTkzMDUyYWRhL3RhYmxlcmFuZ2U6MGNlN2MxM2NjMWNmNDI0NWFhZjQ4NzhhOTMwNTJhZGFfMy0zLTEtMS0w_fd3ae30c-227e-4c1a-b8a5-a1ff2c1fb502">5,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic10cda982ea5415199ad34d94e8b02ba_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjBjZTdjMTNjYzFjZjQyNDVhYWY0ODc4YTkzMDUyYWRhL3RhYmxlcmFuZ2U6MGNlN2MxM2NjMWNmNDI0NWFhZjQ4NzhhOTMwNTJhZGFfNC0xLTEtMS0w_56fbdb53-ebb2-4103-b68f-0b9598489402">5,288</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7d03ea00174970b1ec83dc2dac1886_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjBjZTdjMTNjYzFjZjQyNDVhYWY0ODc4YTkzMDUyYWRhL3RhYmxlcmFuZ2U6MGNlN2MxM2NjMWNmNDI0NWFhZjQ4NzhhOTMwNTJhZGFfNC0zLTEtMS0w_e6aa1801-62b7-48eb-89b1-5760ce84afa0">5,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s estimates of the fair values of its foreign currency contracts are determined using valuation models with significant inputs that are readily available in public markets, or can be derived from observable market transactions, and therefore are classified in Level 2 of the fair value hierarchy.  An adjustment for credit risk and non-performance risk is included in the fair values of foreign currency contracts.</span></div><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfNjE3MQ_863d94b3-b289-48e4-8454-7e4ce4899e95" escape="true"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the aggregate carrying value and fair value of Altria&#8217;s total long-term debt:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmY0OThlZTM4MDI4MjRjYWFiOTVjZDI0MzI1ZGNiOTNjL3RhYmxlcmFuZ2U6ZjQ5OGVlMzgwMjgyNGNhYWI5NWNkMjQzMjVkY2I5M2NfMS0xLTEtMS0w_a98aae77-c3ef-4afd-9149-524585a5d893">28,127</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmY0OThlZTM4MDI4MjRjYWFiOTVjZDI0MzI1ZGNiOTNjL3RhYmxlcmFuZ2U6ZjQ5OGVlMzgwMjgyNGNhYWI5NWNkMjQzMjVkY2I5M2NfMS0zLTEtMS0w_db15a5a4-1d43-4a8d-81ff-7b774efeded2">29,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmY0OThlZTM4MDI4MjRjYWFiOTVjZDI0MzI1ZGNiOTNjL3RhYmxlcmFuZ2U6ZjQ5OGVlMzgwMjgyNGNhYWI5NWNkMjQzMjVkY2I5M2NfMi0xLTEtMS0w_7af65a5f-b33f-4cd6-85f0-4e06545cc819">31,037</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmY0OThlZTM4MDI4MjRjYWFiOTVjZDI0MzI1ZGNiOTNjL3RhYmxlcmFuZ2U6ZjQ5OGVlMzgwMjgyNGNhYWI5NWNkMjQzMjVkY2I5M2NfMi0zLTEtMS0w_3cc294c9-d349-4eca-bccb-037c166bc795">34,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s estimate of the fair value of its total long-term debt is based on observable market information derived from a third-party pricing source and is classified in Level 2 of the fair value hierarchy.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Fixed-price Preemptive Rights and Cronos warrant, which are further discussed in Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, are derivative financial instruments, which are required to be recorded at fair value.  <ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfNjE4MA_61f53d79-91be-426a-9f54-3d41ea61632e" continuedAt="ibe7b6627a5a848cf957185d3a479d81b" escape="true">The fair values of the Fixed-price Preemptive Rights and Cronos warrant are estimated using Black-Scholes option-pricing models, adjusted for observable inputs (which are classified in Level 1 of the fair value hierarchy), including share price, and unobservable inputs, including </ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="icabbeb6f88c548b69edd6ddde41fd097" continuedAt="ifd7dda9f0f03416c9ab908ba84e39ffb"><ix:continuation id="ibe7b6627a5a848cf957185d3a479d81b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">probability factors and weighting of expected life, volatility levels and risk-free interest rates (which are classified in Level 3 of the fair value hierarchy) based on the following assumptions at:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.448%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fixed-price Preemptive Rights</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Warrant</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">C$<ix:nonFraction unitRef="cadPerShare" contextRef="ia4d49e3b18b5423e972b0489f00c3c44_I20210930" decimals="2" name="us-gaap:DerivativeAssetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfMi0yLTEtMS0w_efecde8a-d961-493c-990b-48ac25a3af65">7.15</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$<ix:nonFraction unitRef="cadPerShare" contextRef="i97d4b0a3f973401ab8af04812ad88ab8_I20201231" decimals="2" name="us-gaap:DerivativeAssetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfMi00LTEtMS0w_f9307483-e578-4e3d-8baf-4c60bed4599a">8.84</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">C$<ix:nonFraction unitRef="cadPerShare" contextRef="i299ff36535794f3da00e849d49232f7e_I20210930" decimals="2" name="us-gaap:DerivativeAssetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfMi02LTEtMS0w_247a4985-0027-4353-8480-b0f7b7888bb1">7.15</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$<ix:nonFraction unitRef="cadPerShare" contextRef="i58618b2d87444fa1b1e248c65a98ccf7_I20201231" decimals="2" name="us-gaap:DerivativeAssetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfMi04LTEtMS0w_b5b8574d-b630-4333-b39b-971e93662c9c">8.84</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="year" contextRef="ife62efd21d3c4274a6d99ee48062bd72_I20210930" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeAssetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfMy0yLTEtMS0w_29554be8-0b61-42ec-9f08-723b43bbc4f4">0.81</ix:nonFraction> year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="year" contextRef="i27b16784136a4ee1b08eab8d661c0473_I20201231" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeAssetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfMy00LTEtMS0w_5feb2e5a-8c9b-4fbf-a835-cc0564d7a045">1.05</ix:nonFraction> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="year" contextRef="ibe8f6ff98f9b4b6ba0315bd2c6c328fe_I20210930" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeAssetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfMy02LTEtMS0w_93fafb7c-ca34-4402-8da3-b3d3aed0e8b4">1.43</ix:nonFraction> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="year" contextRef="i5f3288737dff4923b723710d770b6bfe_I20201231" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeAssetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfMy04LTEtMS0w_0c53accd-3a48-4ee3-b33a-1e7198f05b46">2.18</ix:nonFraction> years</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2d742841c5fe465985b241c6d5f4484c_I20210930" decimals="4" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfNC0yLTEtMS0w_efb6afb0-95a7-4732-a39a-36346908e415">67.32</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if695dc35dec34537808c09ca053c1768_I20201231" decimals="4" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfNC00LTEtMS0w_c6cf7460-4e3d-4bf6-949a-2c821ed9e88e">80.68</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie51acd28a242489eb93cb384c8145b12_I20210930" decimals="4" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfNC02LTEtMS0w_f43a8e48-44ef-4e8e-9ed1-cc2bb6dc37b4">67.32</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic441be4c36e54182a0d7529d2ecc38b4_I20201231" decimals="4" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfNC04LTEtMS0w_1a312c41-8b27-4313-8e60-8f74519b2af3">80.68</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i14ff2002b85248c2a717760fa5447b57_I20210930" decimals="4" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfNS0yLTEtMS0w_2456379b-ba19-48c9-8a0a-03075080cca0">0.24</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8230deeac7a042d782c7c2a1edc62727_I20201231" decimals="4" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfNS00LTEtMS0w_e8eff803-d751-4b6b-a8b8-441482e4e93f">0.13</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i95ddf40ef20a463983f2f6637bdadb3a_I20210930" decimals="4" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfNS02LTEtMS0w_9db206ab-00bd-4225-82fa-3f85f480cdfa">0.39</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia4bf3c8921284849a8922aa21c6d0fba_I20201231" decimals="4" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfNS04LTEtMS0w_9afce585-336e-40d4-9a3e-20a3a2c038db">0.21</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibb4ecc1e346d4864b399340e003690e1_I20210930" decimals="2" format="ixt:fixed-zero" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfNi0yLTEtMS0w_30b31c4c-5ed8-4b91-a733-8037cc28a779">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i729af67cdbe44560b187bc2a5355d961_I20201231" decimals="2" format="ixt:fixed-zero" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfNi00LTEtMS0w_087349bb-818c-4ccd-83d1-4ab50920ca88">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia84fe1dcb00d4c42946248812c92de20_I20210930" decimals="2" format="ixt:fixed-zero" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfNi02LTEtMS0w_e2ad6762-3dfa-4d11-9b0e-98e68c3f621d">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6074d0f496474bc6b259bb2df8d5b30c_I20201231" decimals="2" format="ixt:fixed-zero" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfNi04LTEtMS0w_7e8932f4-a5f0-49fb-b8fa-898f0e9a81fd">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Based on the closing market price for Cronos common stock on the Toronto Stock Exchange on the date indicated.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Based on the weighted-average expected life of the Fixed-price Preemptive Rights (with a range from approximately <ix:nonFraction unitRef="year" contextRef="i5ebb29f66c07461aa96dfc8433fac067_I20210930" decimals="2" name="us-gaap:DerivativeAssetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfMzY1MQ_f170b0eb-cb9e-4c46-9a76-863b46008168">0.25</ix:nonFraction> year to <ix:nonFraction unitRef="year" contextRef="i55362d8be9514c0cabf140dc7d6239f6_I20210930" decimals="2" name="us-gaap:DerivativeAssetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfMzY2Mg_82bff19d-f0fb-4a34-8303-e1a0b9080d46">4.00</ix:nonFraction> years at September&#160;30, 2021 and <ix:nonFraction unitRef="year" contextRef="i48b89d0bd67646b288c756c93a850879_I20201231" decimals="2" name="us-gaap:DerivativeAssetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfMzY4MQ_9e880125-c4eb-4e8f-ad74-f69d3a104a4a">0.25</ix:nonFraction> year to <ix:nonFraction unitRef="year" contextRef="i57543deaa7a640628f92b751104d9900_I20201231" decimals="1" name="us-gaap:DerivativeAssetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfMzY5Mg_524a2907-c142-493e-92a3-6ccac01409f8">5</ix:nonFraction> years at December&#160;31, 2020) and the March 8, 2023 expiration date of the Cronos warrant.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Based on a blend of historical volatility of the underlying equity security and implied volatility from traded options on the underlying equity security at September&#160;30, 2021.  Based on a blend of historical volatility levels of the underlying equity security and peer companies at December&#160;31, 2020.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Based on the implied yield currently available on Canadian Treasury zero coupon issues (with a range from approximately <ix:nonFraction unitRef="year" contextRef="ie7a53ae7739f46c7b604110d4483c929_I20210930" decimals="4" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfNDE2Nw_88ebafa5-6cff-4f29-875c-165ca11cf9e0">0.12</ix:nonFraction>% to <ix:nonFraction unitRef="year" contextRef="ic67976b0907f4b868fa3d035e132418d_I20210930" decimals="4" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfNDE3Mw_4bf25eca-a17e-4dc8-a8da-a5d8144495fa">0.89</ix:nonFraction>% at September&#160;30, 2021 and <ix:nonFraction unitRef="year" contextRef="i18d875d64a0945bd8350d34786e8fc87_I20201231" decimals="4" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfNDE4Ng_c844bcf1-613e-4eb0-8c8e-6c0fbbd61242">0.06</ix:nonFraction>% to <ix:nonFraction unitRef="year" contextRef="i28afb29902db4901b31c391429b1b607_I20201231" decimals="4" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfNDE5Mg_ed338a72-32dd-4ec2-b602-c22d52ce4c79">0.39</ix:nonFraction>% at December&#160;31, 2020) weighted for the remaining expected life of the Fixed-price Preemptive Rights.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Based on the implied yield currently available on Canadian Treasury zero coupon issues and the expected life of the Cronos warrant.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Based on Cronos&#8217;s expected dividend payments.</span></div></ix:continuation><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfNjE4MQ_f24bc7ea-33e9-4e0a-b790-53905e65d93e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balance of the Fixed-price Preemptive Rights and Cronos warrant, which are classified in Level 3 of the fair value hierarchy:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia80bd4793ddf4b2d915e5f5ea7d8ca62_I20191231" decimals="-6" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjBiYmJhMDcyMjFmMzQ3MGRiY2VhNjVkZTdhY2FhYWEyL3RhYmxlcmFuZ2U6MGJiYmEwNzIyMWYzNDcwZGJjZWE2NWRlN2FjYWFhYTJfMS0xLTEtMS0w_880ece5a-f36a-49ab-afb6-0d8ab4ee6884">303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax earnings (losses) recognized in net earnings (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64ff63b34a204467b3064abd7fcc4a64_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjBiYmJhMDcyMjFmMzQ3MGRiY2VhNjVkZTdhY2FhYWEyL3RhYmxlcmFuZ2U6MGJiYmEwNzIyMWYzNDcwZGJjZWE2NWRlN2FjYWFhYTJfMy0xLTEtMS0w_7b72c382-dd09-47fa-90c1-de348ee97fa0">140</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i888b21f50f1241039283cfc1fe265126_I20201231" decimals="-6" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjBiYmJhMDcyMjFmMzQ3MGRiY2VhNjVkZTdhY2FhYWEyL3RhYmxlcmFuZ2U6MGJiYmEwNzIyMWYzNDcwZGJjZWE2NWRlN2FjYWFhYTJfNC0xLTEtMS0w_b6b5a8a1-e2db-4af3-93db-759f9b0ade24">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax earnings (losses) recognized in net earnings (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2cdb57e3b67e4af08c71b8743251e9dc_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjBiYmJhMDcyMjFmMzQ3MGRiY2VhNjVkZTdhY2FhYWEyL3RhYmxlcmFuZ2U6MGJiYmEwNzIyMWYzNDcwZGJjZWE2NWRlN2FjYWFhYTJfNS0xLTEtMS0w_3929bb99-b870-4ae4-bd02-1503d44cd9ea">128</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice62522e8f3e4793835443a9d9fd2cda_I20210930" decimals="-6" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjBiYmJhMDcyMjFmMzQ3MGRiY2VhNjVkZTdhY2FhYWEyL3RhYmxlcmFuZ2U6MGJiYmEwNzIyMWYzNDcwZGJjZWE2NWRlN2FjYWFhYTJfNi0xLTEtMS0w_c16d1cdb-7230-4f62-b9f6-d7986e248d92">35</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria elects to record the gross assets and liabilities of derivative financial instruments executed with the same counterparty on its condensed consolidated balance sheets.  <ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfNjE2OA_7052b53b-463c-44d5-bec5-989dc88eb782" continuedAt="i4ae54bbd8ee444e78b17b67a23c53de2" escape="true">The fair values of Altria&#8217;s derivative financial instruments on a gross basis included on the condensed consolidated balance sheets were as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i4ae54bbd8ee444e78b17b67a23c53de2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.209%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></div></td><td colspan="30" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2be07afbaf94c6fb3d9eeb024386d1a_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfMy0zLTEtMS0w_961b2f5a-b2c4-4201-81fc-d770745d86cd">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a791d31299e4494b797ffdc1cac8f2b_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfMy01LTEtMS0w_38c83c50-806a-42d8-acf0-52dc1d92abb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bd27afbf2ce487ea8421adf4864eba8_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfMy04LTEtMS0w_b71ec57d-7cc6-49db-b731-c7fa0b0a40c3">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23b6cc53678a4c949419f35fd13251a6_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfMy0xMC0xLTEtMA_7126fd7b-94f3-43f3-ba24-de343438e632">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd824826dc2c4942a04c7d39edd256d5_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfNC0zLTEtMS0w_156833f7-52c3-4654-8e7e-c48f53f80245">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib813ea19505f4d82aac201b8d7cb1729_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfNC01LTEtMS0w_510f6873-7b68-41ed-ab23-4f0ba6678c05">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i420bac3921ce42bea9dfcd0aa2d91620_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfNC04LTEtMS0w_dc77d82f-637f-4386-ad16-73f0753ecfc8">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2d4c37137a7441c8d333d4e72463e40_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfNC0xMC0xLTEtMA_59e8b5ef-5148-4acf-b312-a796526080f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i448255743e3c41a4859a9556d275d76c_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfNi0zLTEtMS0w_ad195c73-698c-4f8b-b40d-db91aea7c23c">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddb651cf441648dbb1dff101d6d3d546_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfNi01LTEtMS0w_4632361d-fe4a-4afc-b3c9-61148e21b073">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i448255743e3c41a4859a9556d275d76c_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfNi04LTEtMS0w_8a338544-7005-4037-bcbc-da396d1e3747">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddb651cf441648dbb1dff101d6d3d546_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfNi0xMC0xLTEtMA_04f6111e-feab-4f29-9dc3-545457c45351">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cronos warrant</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia565cea6862d417c97c684e3d00ae39e_I20210930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfOS0zLTEtMS0w_f1dc930c-953e-43fc-a76a-e9b2275a11ab">32</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bbe0c1517c44ab49c07a8fd54a1eb3c_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfOS01LTEtMS0w_cbaf95ca-dd5a-4789-89d2-9de84585528a">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed-price Preemptive Rights</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e277a3e43d44130afbf73dc7dde1b91_I20210930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfMTAtMy0xLTEtMA_1eb61d93-86ce-4584-8bb2-5dd5abd528a1">3</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddd36608a5eb4e55a57cc46e949da550_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfMTAtNS0xLTEtMA_ab02982f-5a3a-44ee-b1ae-6117bc3485d2">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f32e9fb6254c8587a74bd98c7ba505_I20210930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfMTEtMy0xLTEtMA_e62c9bd5-6167-494a-8bd2-daff1b5f9327">35</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8922561835d4c67b1663239e270549b_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfMTEtNS0xLTEtMA_609018c4-1b33-41b8-8c93-4982d2cc747f">163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaabb1ac00dc4de9afa2e9b2a864fa5b_I20210930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfMTMtMy0xLTEtMA_5230eaa8-d2ba-45cb-9d02-f0f482f4a9a6">35</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd5a3b6fb7e34bca9dea72a0c14da288_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfMTMtNS0xLTEtMA_c9d8eec3-d2d1-4110-9efd-6709d2f34422">163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaabb1ac00dc4de9afa2e9b2a864fa5b_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfMTMtOC0xLTEtMA_7b6398b4-8091-4f6e-adc0-d7035b74313b">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd5a3b6fb7e34bca9dea72a0c14da288_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfMTMtMTAtMS0xLTA_411a015d-3dde-42e0-b022-8c95b1c06f11">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="ifd7dda9f0f03416c9ab908ba84e39ffb"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria records in its condensed consolidated statements of earnings (losses) any changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant as gains or losses on Cronos-related financial instruments in the periods in which the changes occur.  <ix:continuation id="ib4ca0b76672d4406a19e75c56fc67291" continuedAt="ic407d93ef9c74da680f0ca271dee3ca5">For the nine and three months ended September&#160;30, 2021 and 2020, Altria recorded non-cash, pre-tax unrealized gains (losses), representing the changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant, as follows:</ix:continuation></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="ic407d93ef9c74da680f0ca271dee3ca5" continuedAt="i2043e603a384453ab15df95a23cf9624"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.278%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-price Preemptive Rights</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c367050085a48a69fa712c3eceab7c0_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmM2OTk0N2RhYjk0YTQwM2U5MzEyYTIwZGJhYzFjNjVhL3RhYmxlcmFuZ2U6YzY5OTQ3ZGFiOTRhNDAzZTkzMTJhMjBkYmFjMWM2NWFfMi0xLTEtMS0w_e9b795fc-c033-4a5c-a890-0bb276fcc21c">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60d37aaec4d1491e9ffbbf008424f75a_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmM2OTk0N2RhYjk0YTQwM2U5MzEyYTIwZGJhYzFjNjVhL3RhYmxlcmFuZ2U6YzY5OTQ3ZGFiOTRhNDAzZTkzMTJhMjBkYmFjMWM2NWFfMi0zLTEtMS0w_aaba65a4-e4a5-47ea-a7bf-ff610dc05854">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20b1e637093c48f4969fae7d410a2693_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmM2OTk0N2RhYjk0YTQwM2U5MzEyYTIwZGJhYzFjNjVhL3RhYmxlcmFuZ2U6YzY5OTQ3ZGFiOTRhNDAzZTkzMTJhMjBkYmFjMWM2NWFfMi01LTEtMS0w_6b343191-4238-4612-b805-0614c6fb3c99">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16161f66e87a41ab993f192e9c451cf6_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmM2OTk0N2RhYjk0YTQwM2U5MzEyYTIwZGJhYzFjNjVhL3RhYmxlcmFuZ2U6YzY5OTQ3ZGFiOTRhNDAzZTkzMTJhMjBkYmFjMWM2NWFfMi03LTEtMS0w_c0b3c5c6-0c2c-4c5b-b59a-585cebd5d60f">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b30b55ee2ef446882c7477d8328c504_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmM2OTk0N2RhYjk0YTQwM2U5MzEyYTIwZGJhYzFjNjVhL3RhYmxlcmFuZ2U6YzY5OTQ3ZGFiOTRhNDAzZTkzMTJhMjBkYmFjMWM2NWFfMy0xLTEtMS0w_83418c22-50da-4891-a32e-b119322412cd">107</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84041ff1f2d1478e9462865044b54b4d_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmM2OTk0N2RhYjk0YTQwM2U5MzEyYTIwZGJhYzFjNjVhL3RhYmxlcmFuZ2U6YzY5OTQ3ZGFiOTRhNDAzZTkzMTJhMjBkYmFjMWM2NWFfMy0zLTEtMS0w_5b5a8beb-f06f-4558-804e-7d6008346ddb">148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideb6d765d89e4b91aa1a4fbb97d5de55_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmM2OTk0N2RhYjk0YTQwM2U5MzEyYTIwZGJhYzFjNjVhL3RhYmxlcmFuZ2U6YzY5OTQ3ZGFiOTRhNDAzZTkzMTJhMjBkYmFjMWM2NWFfMy01LTEtMS0w_e14339be-f1e7-43b7-a0fc-c77c9ad5141b">118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7def76adb3ad4f72a02323fce73fbe1a_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmM2OTk0N2RhYjk0YTQwM2U5MzEyYTIwZGJhYzFjNjVhL3RhYmxlcmFuZ2U6YzY5OTQ3ZGFiOTRhNDAzZTkzMTJhMjBkYmFjMWM2NWFfMy03LTEtMS0w_f5680ffe-ba7c-47bd-9358-b17337994d39">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmM2OTk0N2RhYjk0YTQwM2U5MzEyYTIwZGJhYzFjNjVhL3RhYmxlcmFuZ2U6YzY5OTQ3ZGFiOTRhNDAzZTkzMTJhMjBkYmFjMWM2NWFfNC0xLTEtMS0w_b05a0baf-66b9-4a29-b2f2-05604b2874da">128</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmM2OTk0N2RhYjk0YTQwM2U5MzEyYTIwZGJhYzFjNjVhL3RhYmxlcmFuZ2U6YzY5OTQ3ZGFiOTRhNDAzZTkzMTJhMjBkYmFjMWM2NWFfNC0zLTEtMS0w_8fc4f7f3-9a3a-46b6-8a17-f753e6c208ec">202</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmM2OTk0N2RhYjk0YTQwM2U5MzEyYTIwZGJhYzFjNjVhL3RhYmxlcmFuZ2U6YzY5OTQ3ZGFiOTRhNDAzZTkzMTJhMjBkYmFjMWM2NWFfNC01LTEtMS0w_7aab1e40-110a-438e-a5ac-4896ca1ef8da">135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmM2OTk0N2RhYjk0YTQwM2U5MzEyYTIwZGJhYzFjNjVhL3RhYmxlcmFuZ2U6YzY5OTQ3ZGFiOTRhNDAzZTkzMTJhMjBkYmFjMWM2NWFfNC03LTEtMS0w_ca04483f-ee62-4973-aaa1-5d10bc28ac7b">105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Investment Hedging</span></div><ix:continuation id="i2043e603a384453ab15df95a23cf9624"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pre-tax effects of Altria&#8217;s net investment hedges on accumulated other comprehensive losses and the condensed consolidated statements of earnings (losses) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.391%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in Accumulated Other Comprehensive Losses</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in <br/>Net Earnings (Losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in Accumulated Other Comprehensive Losses</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in <br/>Net Earnings (Losses)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b22d5f204d248aab1e00daf3b0d8153_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfMy0yLTEtMS0w_4c4bea0d-71ee-4193-b7f5-c46013600d9d">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib358f1bbb75b41f3aaca506bf354a2c0_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfMy00LTEtMS0w_7a3fea05-548d-46a3-845d-182108cfd53b">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b22d5f204d248aab1e00daf3b0d8153_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfMy02LTEtMS0w_59310655-e790-4f66-9c18-b77afc86adf9">7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib358f1bbb75b41f3aaca506bf354a2c0_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfMy04LTEtMS0w_be209ef8-1e10-4552-ac05-e450735e698c">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4ee47e867c246b8be587254b4a9a6cc_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfMy0xMC0xLTEtMA_c01ad271-06e0-4697-9f4b-e88b1a6972a6">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i157a11cd19544cd68917916131342ac2_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfMy0xMi0xLTEtMA_09eeabc1-21f1-4d9a-b6f6-087457924c80">66</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4ee47e867c246b8be587254b4a9a6cc_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfMy0xNC0xLTEtMA_c55b4900-18a2-4079-8954-0281ba83d53c">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i157a11cd19544cd68917916131342ac2_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfMy0xNi0xLTEtMA_340c7903-b75e-47f9-9fb1-ec6a75715020">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eaa97db709e43d0b68539ebfc1f7fcd_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNC0yLTEtMS0w_f4ebc078-cdae-4e61-b740-44ed4475ce56">270</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i801ea70096974921a9cc6afb7fabddb3_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNC00LTEtMS0w_c05531e3-f67b-4ff4-851f-5b65d5002ee4">215</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eaa97db709e43d0b68539ebfc1f7fcd_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNC02LTEtMS0w_b2c255d4-2831-4e2d-9dce-0d8bda57dc43">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i801ea70096974921a9cc6afb7fabddb3_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNC04LTEtMS0w_a3af6e0a-6f4b-4161-a3f7-9de42c26a9a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f6f91cba83e4cafb448b38e704724c2_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNC0xMC0xLTEtMA_18658f8e-da2c-4764-ad0a-255a81b586ae">118</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75d11c60a1504c2a8018692b2fdb8592_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNC0xMi0xLTEtMA_9ba1cb88-3fdd-403d-8172-5bd9387ec5a9">206</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f6f91cba83e4cafb448b38e704724c2_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNC0xNC0xLTEtMA_cadd9db1-42fa-420e-a69d-95afbf5ab7c0">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75d11c60a1504c2a8018692b2fdb8592_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNC0xNi0xLTEtMA_d517bef6-fc37-4cb1-9e02-b3ab13adccd2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95c1f586ef4041dd8c67ab4c79e3718a_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNS0yLTEtMS0w_55d063a1-584c-4110-90dd-9ca938f31b7b">286</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe0426ef79dd4e1b93e9f3b19953e12f_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNS00LTEtMS0w_06de61de-64c5-4fa7-8a10-7daed3683490">243</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95c1f586ef4041dd8c67ab4c79e3718a_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNS02LTEtMS0w_468d4a5b-866d-4936-947c-44cc8012f3ab">7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe0426ef79dd4e1b93e9f3b19953e12f_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNS04LTEtMS0w_5da920c5-bd25-472f-a4c5-4cccefd75630">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i641562cd01894f84aa15b3d08486a81e_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNS0xMC0xLTEtMA_0f6b6489-7b51-496e-8608-964b2aefcf81">118</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i285fd763c7cb4c95a6689072055b09d4_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNS0xMi0xLTEtMA_d277f97d-a1c4-4881-adb6-3227c6664e6e">272</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i641562cd01894f84aa15b3d08486a81e_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNS0xNC0xLTEtMA_b9c6034c-02c8-4521-b107-5bbfd1a92b7b">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i285fd763c7cb4c95a6689072055b09d4_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNS0xNi0xLTEtMA_4ff3a2fd-5b94-46f4-9b8b-8f8ab6901047">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the fair value of the foreign currency contracts and in the carrying value of the foreign currency denominated debt due to changes in the Euro to USD exchange rate were recognized in accumulated other comprehensive losses related to ABI.  Gains on the foreign currency contracts arising from components excluded from effectiveness testing were recognized in interest and other debt expense, net in the condensed consolidated statements of earnings (losses) based on an amortization approach.</span></div></ix:continuation><div style="margin-bottom:5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="i295e56fb16f94dae9eacc631c56d466c_67"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 6. <ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RleHRyZWdpb246Y2Q0NDc3ZDE2ZDE5NGE3Y2JhNjFjMTQxNDhlOTFiOTZfMTY3OA_1debc8c6-0e47-47dc-92a8-9cf574599166" continuedAt="i55501beadd424968b1e6261a1fbbd27b" escape="true">Benefit Plans</ix:nonNumeric></span></div><ix:continuation id="i55501beadd424968b1e6261a1fbbd27b"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Components of Net Periodic Benefit (Income) Cost</span></div><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RleHRyZWdpb246Y2Q0NDc3ZDE2ZDE5NGE3Y2JhNjFjMTQxNDhlOTFiOTZfMTY4Mw_03d28615-1254-46be-83b8-5a92601f64e7" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit (income) cost consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.094%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended <br/>September 30,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92dcd11d5d934931ab51a35b59f2acd1_D20210101-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMy0xLTEtMS0w_6098ce8a-1d68-4ef1-b2d0-880e6933519f">51</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cc174939f1e414593012b716f47f230_D20200101-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMy0zLTEtMS0w_b1d68765-b7da-403a-8f43-918063e98a35">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5f978b5c84e8aa707cac5eb7382f1_D20210101-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMy01LTEtMS0w_09934d2d-c389-4b86-ad79-e54f93f35545">15</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia30f1b1250de433dabcb2cbe9baabacf_D20200101-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMy03LTEtMS0w_4c95da18-43aa-463c-b9b7-6b7df239b781">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib46d19a7eb014c0d80e8454b5ba93ecc_D20210701-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMy05LTEtMS0w_4c758c81-7da0-4aa5-8cb2-93920b2abd4a">17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bb0ce68c3494d79abc790fd0561a2c9_D20200701-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMy0xMS0xLTEtMA_c33f6619-7aa6-47ad-b733-dde54b9ca53b">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a9748c0c5a34059bb965420acaa9a71_D20210701-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMy0xMy0xLTEtMA_46abc41a-c53f-4365-bef2-6e6cc2677109">5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b4f1114be54cf39186a491bbc07db4_D20200701-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMy0xNS0xLTEtMA_e6ad9857-d73e-4056-8f80-9c46d6434ac6">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92dcd11d5d934931ab51a35b59f2acd1_D20210101-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNC0xLTEtMS0w_17c36b5a-cf04-4669-9d08-9435bd7a7ce0">139</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cc174939f1e414593012b716f47f230_D20200101-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNC0zLTEtMS0w_0508b030-fef5-41d8-96b5-37a429a27799">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5f978b5c84e8aa707cac5eb7382f1_D20210101-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNC01LTEtMS0w_e143b6cd-eec6-464c-affb-aec63e649f41">29</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia30f1b1250de433dabcb2cbe9baabacf_D20200101-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNC03LTEtMS0w_d6ff2b6e-74c2-45eb-96cb-223dff6326f2">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib46d19a7eb014c0d80e8454b5ba93ecc_D20210701-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNC05LTEtMS0w_7b496da2-20f4-4ab8-88f2-bcdf392b8813">46</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bb0ce68c3494d79abc790fd0561a2c9_D20200701-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNC0xMS0xLTEtMA_72b80244-5deb-42b7-8f1f-c92688025c59">62</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a9748c0c5a34059bb965420acaa9a71_D20210701-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNC0xMy0xLTEtMA_996125ea-d550-4cf7-98fc-de18318fd4c1">8</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b4f1114be54cf39186a491bbc07db4_D20200701-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNC0xNS0xLTEtMA_4b012f8b-257f-4333-bde3-e33db5edabf0">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92dcd11d5d934931ab51a35b59f2acd1_D20210101-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNS0xLTEtMS0w_9244cd77-7e60-475c-8c38-bb164dc0a5fa">393</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8cc174939f1e414593012b716f47f230_D20200101-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNS0zLTEtMS0w_4b2a54a2-b5d2-4239-8c37-28f927df6a60">376</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5f978b5c84e8aa707cac5eb7382f1_D20210101-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNS01LTEtMS0w_e8514fc8-372d-49f0-9cfc-0ed6d0530825">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia30f1b1250de433dabcb2cbe9baabacf_D20200101-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNS03LTEtMS0w_8b3fc6cc-a39d-4f4c-9168-06a8204f12b2">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib46d19a7eb014c0d80e8454b5ba93ecc_D20210701-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNS05LTEtMS0w_b38b5927-8631-4ad5-be64-14919796bcc1">131</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bb0ce68c3494d79abc790fd0561a2c9_D20200701-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNS0xMS0xLTEtMA_9fcb221b-3d01-4105-a6e6-05e5215971fd">125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a9748c0c5a34059bb965420acaa9a71_D20210701-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNS0xMy0xLTEtMA_06280ee3-ddd3-4375-b31a-61d4c43020f1">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b4f1114be54cf39186a491bbc07db4_D20200701-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNS0xNS0xLTEtMA_995d4f85-e3eb-4266-bb06-d610f30dfeaa">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92dcd11d5d934931ab51a35b59f2acd1_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNy0xLTEtMS0w_3206eb18-2027-4cbb-a3b8-acca4bdca951">99</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cc174939f1e414593012b716f47f230_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNy0zLTEtMS0w_37e697c5-5f95-4fd5-825d-3b0fc1a0c59f">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5f978b5c84e8aa707cac5eb7382f1_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNy01LTEtMS0w_7ba999e1-0e0a-4956-9bbd-dc82c348e9ef">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia30f1b1250de433dabcb2cbe9baabacf_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNy03LTEtMS0w_d5add744-a0c9-433e-a42b-fe24a443846b">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib46d19a7eb014c0d80e8454b5ba93ecc_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNy05LTEtMS0w_66d1dbe3-c6c8-495f-8885-f40a1c4a448d">33</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bb0ce68c3494d79abc790fd0561a2c9_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNy0xMS0xLTEtMA_1b6245eb-c2d2-4bd1-a2c0-bbd395358112">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a9748c0c5a34059bb965420acaa9a71_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNy0xMy0xLTEtMA_2797922f-9a91-46d1-aa23-35b14ca4cf8d">2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b4f1114be54cf39186a491bbc07db4_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNy0xNS0xLTEtMA_82aae319-cf6b-4da3-a858-e08f2c7458f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92dcd11d5d934931ab51a35b59f2acd1_D20210101-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfOC0xLTEtMS0w_158f4a9d-ea22-435c-9662-ba9caca07b5e">3</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cc174939f1e414593012b716f47f230_D20200101-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfOC0zLTEtMS0w_910d3bb2-1f40-43a7-ba1e-16edb7f8a29a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e5f978b5c84e8aa707cac5eb7382f1_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfOC01LTEtMS0w_02c5f87c-d498-465f-9240-9fb2f01def2b">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia30f1b1250de433dabcb2cbe9baabacf_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfOC03LTEtMS0w_5072a529-5d1f-467f-add3-0e2054f7fd02">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib46d19a7eb014c0d80e8454b5ba93ecc_D20210701-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfOC05LTEtMS0w_cd71ed21-5b83-40f4-981c-2f12cc1d2022">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bb0ce68c3494d79abc790fd0561a2c9_D20200701-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfOC0xMS0xLTEtMA_359550d1-ac22-4214-9a5f-6d8aba5be145">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a9748c0c5a34059bb965420acaa9a71_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfOC0xMy0xLTEtMA_48b3dd90-4827-4cb7-955e-b38a662f9b54">20</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b4f1114be54cf39186a491bbc07db4_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfOC0xNS0xLTEtMA_b95f1ca5-b3bb-4a16-b9ff-54d807cfad74">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(income) cost</span></div></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92dcd11d5d934931ab51a35b59f2acd1_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMTAtMS0xLTEtMA_734f88ed-df22-4339-a4f4-1d8896e922df">101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8cc174939f1e414593012b716f47f230_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMTAtMy0xLTEtMA_0413cdc0-311d-4d07-a68a-4d7501555d64">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e5f978b5c84e8aa707cac5eb7382f1_D20210101-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMTAtNS0xLTEtMA_2d64084f-355f-4e63-a888-70a6a8bf1820">15</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia30f1b1250de433dabcb2cbe9baabacf_D20200101-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMTAtNy0xLTEtMA_ad18707d-eb8f-4cd3-90e5-84f0c2dd2123">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib46d19a7eb014c0d80e8454b5ba93ecc_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMTAtOS0xLTEtMA_52813db1-7a1e-4399-b85b-19dd15dc9c68">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bb0ce68c3494d79abc790fd0561a2c9_D20200701-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMTAtMTEtMS0xLTA_1ce6f7b4-078e-4aa1-9dd1-7de99ad8b5fa">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a9748c0c5a34059bb965420acaa9a71_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMTAtMTMtMS0xLTA_15b2c9c7-fcf8-4751-906d-69944dbdef41">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b4f1114be54cf39186a491bbc07db4_D20200701-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMTAtMTUtMS0xLTA_5a417344-aa29-48f6-a7a1-f84b01a9d378">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employer Contributions</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria makes contributions to the pension plans to the extent that the contributions are tax deductible and pays benefits that relate to plans for salaried employees that cannot be funded under Internal Revenue Service regulations.  Altria made employer contributions of $<ix:nonFraction unitRef="usd" contextRef="i92dcd11d5d934931ab51a35b59f2acd1_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RleHRyZWdpb246Y2Q0NDc3ZDE2ZDE5NGE3Y2JhNjFjMTQxNDhlOTFiOTZfNDMx_f5b90941-fcb9-4c3c-887a-65e003b85e59">23</ix:nonFraction> million to its pension plans and did <ix:nonFraction unitRef="usd" contextRef="i65e5f978b5c84e8aa707cac5eb7382f1_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RleHRyZWdpb246Y2Q0NDc3ZDE2ZDE5NGE3Y2JhNjFjMTQxNDhlOTFiOTZfNDYz_5e6931ba-d6b2-4b9c-9749-e59055c8ef40">no</ix:nonFraction>t make any contributions to its postretirement plans during the nine months ended September 30, 2021.  Currently, Altria anticipates making additional employer contributions to its pension plans of up to approximately $<ix:nonFraction unitRef="usd" contextRef="i5da59f9184554221a714ef4fa85eeff2_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RleHRyZWdpb246Y2Q0NDc3ZDE2ZDE5NGE3Y2JhNjFjMTQxNDhlOTFiOTZfNjY4_dfb16285-9c10-4077-b45f-5d19073b8b94">5</ix:nonFraction> million and <ix:nonFraction unitRef="usd" contextRef="i3a5e492ac0384dd28bb0ad0497562294_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RleHRyZWdpb246Y2Q0NDc3ZDE2ZDE5NGE3Y2JhNjFjMTQxNDhlOTFiOTZfMjc0ODc3OTA3MTM2MQ_af3fceec-8e0e-455b-824d-174c4fe6f9ba">no</ix:nonFraction>  additional contributions to its postretirement plans for the remainder of 2021. However, the foregoing estimates of 2021 contributions to the pension and postretirement plans are subject to change as a result of changes in tax and other benefit laws, changes in interest rates, as well as asset performance significantly above or below the assumed long-term rate of return for each respective plan.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, Altria announced several amendments to its salaried retiree healthcare plans, primarily changing its post-age 65 coverage to a private medicare marketplace.  These amendments triggered a plan remeasurement as of May 31, 2021 and resulted in Altria recording a reduction of $<ix:nonFraction unitRef="usd" contextRef="i32402401a0f844239e2c32d640969c41_D20210531-20210531" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RleHRyZWdpb246Y2Q0NDc3ZDE2ZDE5NGE3Y2JhNjFjMTQxNDhlOTFiOTZfMTMzMA_c6796350-2f61-4b12-8b51-580723bdcdfd">432</ix:nonFraction> million to its accrued postretirement health care costs liability and a corresponding reduction to its accumulated other comprehensive losses on its condensed consolidated balance sheet.  Ongoing amortization has been adjusted to reflect these changes as of June 1, 2021 and is reflected in the amounts shown above.</span></div></ix:continuation><div style="margin-bottom:5pt"><span><br/></span></div><div id="i295e56fb16f94dae9eacc631c56d466c_70"></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 7. <ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RleHRyZWdpb246Yjk3ZDU0ZGVkMTYwNDU5ODlmODk3NTk3MmI1NzM1MzNfMTE2_0da84f5c-a612-4a32-926a-3ac0f9238f1e" continuedAt="i0a99f9fa495b48f4b4584d940cacb137" escape="true">Earnings (Losses) per Share</ix:nonNumeric></span></div><ix:continuation id="i0a99f9fa495b48f4b4584d940cacb137"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RleHRyZWdpb246Yjk3ZDU0ZGVkMTYwNDU5ODlmODk3NTk3MmI1NzM1MzNfMTMy_ae67ce13-33e9-4755-ae5f-8432a7e255c6" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings (losses) per share (&#8220;EPS&#8221;) were calculated using the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses) attributable to Altria</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfMi0yLTEtMS0w_2d29d92f-47c1-43e1-abb6-41a3fa1f1f7a">851</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfMi00LTEtMS0w_ce67cd9f-95e1-405f-9a84-4967d8c5b58b">2,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfMi02LTEtMS0w_7fdbb055-a9ba-4e7d-ac7b-e88fa65c717a">2,722</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfMi04LTEtMS0w_ac355825-d652-426d-916c-184bdf4b4eca">952</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Distributed and undistributed earnings attributable to share-based awards</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfMy0yLTEtMS0w_c9c8c39d-8126-4a27-a1da-cb11787439e2">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" name="mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfMy00LTEtMS0w_3271436e-12e9-4643-8a31-b1953d42c76a">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" name="mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfMy02LTEtMS0w_97f69e87-58c6-4b75-93e6-e9e2853e4674">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" name="mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfMy04LTEtMS0w_e1141cd7-6ff7-444e-a689-78d361f36f6a">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) for basic and diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNC0yLTEtMS0w_7d8b6d63-8f0a-4ebd-ad6a-915f0c7105ef"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNC0yLTEtMS0w_a0c8c40a-fbec-43f7-a9fb-8bd9bd6e6f3e">843</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNC00LTEtMS0w_08de98b8-6380-4126-847e-289a33e08cf6"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNC00LTEtMS0w_fce68ec1-1882-4e8f-94e3-93b41d638c60">2,537</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNC02LTEtMS0w_4a154170-e462-4f47-994a-55e3356306f0"><ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNC02LTEtMS0w_4b168712-d962-4092-bf78-a7758a880e3e">2,724</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNC04LTEtMS0w_affdfcb2-2dfa-46b6-afac-a81ad4d0d261"><ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNC04LTEtMS0w_f7caaef6-698b-4ac7-83fd-cbd40bef645d">953</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares for basic EPS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNi0yLTEtMS0w_bef9acb7-7fcf-4af8-a96f-c5959082f924">1,849</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNi00LTEtMS0w_7975b9af-e48d-4b07-b4ee-97daa055254d">1,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNi02LTEtMS0w_bfde6240-5301-4ae8-8cb8-81719b10e9be">1,842</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNi04LTEtMS0w_357fe358-3da1-4b5f-aa64-104ca4fa37c4">1,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: contingently issuable performance stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNy0yLTEtMS0w_b17a7455-2150-47a0-8da0-3bb4dffe37c6">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNy00LTEtMS0w_06c27f38-0322-45ac-a9d1-32627dbdbcd5">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNy02LTEtMS0w_79c5e2d5-e1e4-4951-a44b-2c259d152027">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNy04LTEtMS0w_7861040f-e104-4418-9143-6c32288c6581">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares for diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfOC0yLTEtMS0w_1d5760f6-7f27-4580-be4b-15cde16f2d3d">1,849</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfOC00LTEtMS0w_373fb84a-7d8e-4d74-84c2-6a39c36e824c">1,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfOC02LTEtMS0w_c0b98b09-4f06-4007-a0eb-19d5500dec7e">1,842</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfOC04LTEtMS0w_8c0358f1-c495-4173-8293-98b7b1d09104">1,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i295e56fb16f94dae9eacc631c56d466c_73"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 8. <ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RleHRyZWdpb246NjIxYTZiY2Q3ZWE0NDg4NGIwOTVjZGFlYmQ2ZThhN2RfMjMx_0ea2d43e-c919-4878-8315-d5ce9a5ec7b2" continuedAt="i3f08f3b704a74128b697394888981afd" escape="true">Other Comprehensive Earnings/Losses</ix:nonNumeric></span></div><ix:continuation id="i3f08f3b704a74128b697394888981afd" continuedAt="i021f60c4538f45eb8301111411791e3b"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RleHRyZWdpb246NjIxYTZiY2Q3ZWE0NDg4NGIwOTVjZGFlYmQ2ZThhN2RfMjI4_ae430878-0533-4024-bbc7-6d7c1fdc815b" continuedAt="i8cfa98f9920d4859912d4832374d58e1" escape="true"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.377%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2ad51d5efd34c6890d17e0c82b226b7_I20201231" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMi0yLTEtMS0w_854ce322-3b10-49cd-8a03-ab3dd195c951">2,420</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f3fa8b9977e4b429a89b213dd45435e_I20201231" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMi00LTEtMS0w_7056b00a-733d-47c9-8493-284baff6fc6d">1,938</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb1b7837d3fd4f8097b3317e18a83bbf_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMi02LTEtMS0w_b008c498-f0b5-4215-9a38-71d0538c06a9">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dbc9fb0ec734480b6f0af9d1b9ac7b9_I20201231" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMi04LTEtMS0w_c7bb36fd-c883-4d38-8766-5c6a7fbcc10c">4,341</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4320d8cfd0aa4682ac4fd8e97489f333_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfNC0yLTEtMS0w_a9425a54-18b7-4c66-91ca-c499fa32706b">432</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94d886e09a149778fc4b762edca1bc7_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfNC00LTEtMS0w_9294b5c3-5b59-4531-86d1-514e0a67f89a">685</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3b0235cbe654245a5397a036c1d3132_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfNC02LTEtMS0w_a00e12b3-2e77-4949-847b-95c87290c731">35</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd9b7b88141b400786601f5cd3fec33a_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfNC04LTEtMS0w_b90be383-3024-47ea-b845-b5a671065b2a">1,152</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4320d8cfd0aa4682ac4fd8e97489f333_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfNS0yLTEtMS0w_1764feb9-7401-4554-b615-a8671f01d2e9">118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib94d886e09a149778fc4b762edca1bc7_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfNS00LTEtMS0w_e2e7a2c8-9f70-4607-9c37-88c71ff8bab7">151</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3b0235cbe654245a5397a036c1d3132_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfNS02LTEtMS0w_a34b8cbb-6ff3-4d86-99f8-5bb6d7be144c">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd9b7b88141b400786601f5cd3fec33a_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfNS04LTEtMS0w_6ee529fa-174b-4632-8ac0-ca0ecf83f29d">269</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4320d8cfd0aa4682ac4fd8e97489f333_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfNi0yLTEtMS0w_e1546fe6-44e5-43d8-9aaf-a0663d70c52f">314</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94d886e09a149778fc4b762edca1bc7_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfNi00LTEtMS0w_b1181c5d-9e0e-40b7-889e-4b5a1e29cba9">534</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3b0235cbe654245a5397a036c1d3132_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfNi02LTEtMS0w_b27a3527-861b-4f06-aaa3-7b4becfa0e35">35</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd9b7b88141b400786601f5cd3fec33a_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfNi04LTEtMS0w_354bb924-fc51-40be-bf9c-b080e1122779">883</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4320d8cfd0aa4682ac4fd8e97489f333_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfOC0yLTEtMS0w_14a59fc3-12de-421e-828a-172be42ae694">92</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib94d886e09a149778fc4b762edca1bc7_D20210101-20210930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfOC00LTEtMS0w_d3f39ad7-60f3-44f1-9146-5e4d23beebe9">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3b0235cbe654245a5397a036c1d3132_D20210101-20210930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfOC02LTEtMS0w_d102ed58-f531-4ec3-8d0b-0e6f4d101390">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd9b7b88141b400786601f5cd3fec33a_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfOC04LTEtMS0w_6f4ad506-baf4-41b0-a816-7802d48c7747">41</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4320d8cfd0aa4682ac4fd8e97489f333_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfOS0yLTEtMS0w_17dce605-0e41-498a-a950-d767b6736a40">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94d886e09a149778fc4b762edca1bc7_D20210101-20210930" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfOS00LTEtMS0w_e2e8a90f-1a7b-4d37-9f72-e2906e0bd2fa">10</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3b0235cbe654245a5397a036c1d3132_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfOS02LTEtMS0w_7221f7be-c58f-4f34-8d61-935b49d28e4e">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd9b7b88141b400786601f5cd3fec33a_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfOS04LTEtMS0w_506a6a8b-bb6d-44b9-b0b4-6401b70b627d">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4320d8cfd0aa4682ac4fd8e97489f333_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMTAtMi0xLTEtMA_0b4d8dfa-fe17-4c99-b22d-c7e03686b93e">69</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib94d886e09a149778fc4b762edca1bc7_D20210101-20210930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMTAtNC0xLTEtMA_09122b8a-d213-489d-a3ae-2a5c2fec6bde">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3b0235cbe654245a5397a036c1d3132_D20210101-20210930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMTAtNi0xLTEtMA_670ccbba-a695-415e-a70e-9099c98c36fa">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd9b7b88141b400786601f5cd3fec33a_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMTAtOC0xLTEtMA_af813e54-7427-43f7-8373-f70e1665b9c7">28</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4320d8cfd0aa4682ac4fd8e97489f333_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMTItMi0xLTEtMA_abee255f-a32c-4596-9fda-3a55f3afc4dd">383</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94d886e09a149778fc4b762edca1bc7_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMTItNC0xLTEtMA_ca26c7a6-89e3-4252-bb99-72ffd62da1b4">495</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3b0235cbe654245a5397a036c1d3132_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMTItNi0xLTEtMA_e0232d52-d116-4d6a-9d1a-e2a0871b5860">33</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd9b7b88141b400786601f5cd3fec33a_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMTItOC0xLTEtMA_8eb75c55-64b0-4726-bc95-0f24197025e2">911</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie628688809594c33a0f517053cd1c98f_I20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMTQtMi0xLTEtMA_fd339ba4-eb1a-4caf-b6c7-7119eeb6189e">2,037</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c08359b25be43c9b6378dcc5e5e3f52_I20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMTQtNC0xLTEtMA_5cfac3fa-0d5f-4c4b-b3e2-a90681dc4cba">1,443</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6cd59bba4c64d728580eef19f7136ca_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMTQtNi0xLTEtMA_fe346e41-36d4-45f0-8f34-83720c46fe79">50</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6448179dc624c73a14533ac4f8492a2_I20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMTQtOC0xLTEtMA_6df875b1-8f49-403d-a9a5-46834a47f5cf">3,430</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i295e56fb16f94dae9eacc631c56d466c_76"></div><div style="text-align:center"><ix:continuation id="i021f60c4538f45eb8301111411791e3b" continuedAt="i33100b707873492d8b1450e26d44c073"><ix:continuation id="i8cfa98f9920d4859912d4832374d58e1" continuedAt="i25760a7683a24f8f831fc598a6422b4c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.377%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia60bc9c826684e3dbf0b2a03a36b0a67_I20210630" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMi0yLTEtMS0w_573f0130-b0a3-449e-9ea6-2ad50ae66f57">2,043</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f37b78605b24016b376248d47913825_I20210630" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMi00LTEtMS0w_961a2a96-1ed0-4e04-bf4c-e357cd888f92">1,604</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64f0bf43c52c463298e2f9f2570fe3e3_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMi02LTEtMS0w_fca62af0-a42d-468a-9112-fea6c8bcb1e5">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ea0515263584ea09063bbf40ec274b1_I20210630" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMi04LTEtMS0w_aa7c1b14-85aa-43a9-9c93-bfffece3ab11">3,602</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbbd3f4ab1454dcfa39e110e53cca664_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfNC0yLTEtMS0w_93b82407-219c-466d-aadb-c6e028df1154">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfb335bd0af94b69b6dbeda93b2431f4_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfNC00LTEtMS0w_22e8b32c-3988-466b-b93c-4163aa1a512c">215</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb267062b0c74a0a89cf1006daf242da_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfNC02LTEtMS0w_3862937f-0f9a-448f-9275-924e1d4baa54">6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i811d953ad6844425a1abf068a0bef5ea_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfNC04LTEtMS0w_4061a215-e94b-444d-b47e-d54b1b365d1f">221</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbbd3f4ab1454dcfa39e110e53cca664_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfNS0yLTEtMS0w_316d4b3d-c2bb-40e2-984f-4a47288e96a6">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfb335bd0af94b69b6dbeda93b2431f4_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfNS00LTEtMS0w_14e1ef21-faa0-42fc-998e-18d4b6c38717">48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb267062b0c74a0a89cf1006daf242da_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfNS02LTEtMS0w_a16d47b3-5a4e-4a4b-b664-1d27b9f5b5ac">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i811d953ad6844425a1abf068a0bef5ea_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfNS04LTEtMS0w_75a31e60-c1d2-4347-929f-9f96c079ec55">57</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbbd3f4ab1454dcfa39e110e53cca664_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfNi0yLTEtMS0w_281d46aa-34b9-4f9b-b9e2-fc08f489fab5">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfb335bd0af94b69b6dbeda93b2431f4_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfNi00LTEtMS0w_71d9e5d0-f912-4450-9219-4f00a28e0ba1">167</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb267062b0c74a0a89cf1006daf242da_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfNi02LTEtMS0w_d9e4dd65-629a-4edd-9b80-ab3c8f675132">6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i811d953ad6844425a1abf068a0bef5ea_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfNi04LTEtMS0w_0b8f5dfc-609b-4112-b037-c18eba9daa00">164</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbbd3f4ab1454dcfa39e110e53cca664_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfOC0yLTEtMS0w_b3eb991d-f35f-426f-a5d8-5b14f692e50f">20</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfb335bd0af94b69b6dbeda93b2431f4_D20210701-20210930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfOC00LTEtMS0w_45c750ea-6f2c-4994-9256-16581840ee9b">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb267062b0c74a0a89cf1006daf242da_D20210701-20210930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfOC02LTEtMS0w_981e8e90-868e-4822-b7f3-6cc28ca9a971">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i811d953ad6844425a1abf068a0bef5ea_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfOC04LTEtMS0w_12a2b95d-d5be-4389-a140-2b2ecd63c6a3">12</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbbd3f4ab1454dcfa39e110e53cca664_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfOS0yLTEtMS0w_57e83fd1-9162-41f0-82d9-a38cb9edcded">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfb335bd0af94b69b6dbeda93b2431f4_D20210701-20210930" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfOS00LTEtMS0w_5fbbf552-1915-4ce0-aa7a-e863aea94177">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb267062b0c74a0a89cf1006daf242da_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfOS02LTEtMS0w_c34360d0-49c3-4dc6-9c0d-7cda687e2b56">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i811d953ad6844425a1abf068a0bef5ea_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfOS04LTEtMS0w_ff3f9b7a-e325-4347-9d6f-1524c1fccd9e">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbbd3f4ab1454dcfa39e110e53cca664_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMTAtMi0xLTEtMA_4988ddd3-4187-4c70-834f-72382e3fb51e">15</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfb335bd0af94b69b6dbeda93b2431f4_D20210701-20210930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMTAtNC0xLTEtMA_c0122198-1bcb-44ac-b833-cc5268397661">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb267062b0c74a0a89cf1006daf242da_D20210701-20210930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMTAtNi0xLTEtMA_1f4ce9d7-d3ce-4dac-a144-9dc70448259f">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i811d953ad6844425a1abf068a0bef5ea_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMTAtOC0xLTEtMA_b32ab6ce-4d64-411a-9872-25dbf31050fd">8</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbbd3f4ab1454dcfa39e110e53cca664_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMTItMi0xLTEtMA_01ab8000-fc2e-48d0-b096-0e08e2bceff2">6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfb335bd0af94b69b6dbeda93b2431f4_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMTItNC0xLTEtMA_8ccf29c2-ea41-48a3-8d00-b803c922762e">161</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb267062b0c74a0a89cf1006daf242da_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMTItNi0xLTEtMA_03a32b31-cc4c-49df-9233-101aee537892">5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i811d953ad6844425a1abf068a0bef5ea_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMTItOC0xLTEtMA_d25cec60-1c88-42f8-8146-c36f70d6c7a9">172</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie628688809594c33a0f517053cd1c98f_I20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMTQtMi0xLTEtMA_36e753d9-e5c6-4922-93a2-65f2f1be5dc5">2,037</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c08359b25be43c9b6378dcc5e5e3f52_I20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMTQtNC0xLTEtMA_2cb6ef58-96c4-4fea-8e24-6bc6600003b0">1,443</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6cd59bba4c64d728580eef19f7136ca_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMTQtNi0xLTEtMA_5c39ae5a-37c0-45e3-ba66-33cfb00ce7a2">50</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6448179dc624c73a14533ac4f8492a2_I20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMTQtOC0xLTEtMA_62a961aa-458e-4e35-b233-f6b5cb9daa64">3,430</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="i295e56fb16f94dae9eacc631c56d466c_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><div style="text-align:center"><ix:continuation id="i33100b707873492d8b1450e26d44c073" continuedAt="i48b85932631b4a2fa4b1ec7be4af7748"><ix:continuation id="i25760a7683a24f8f831fc598a6422b4c" continuedAt="i389106ccaf0c49a3bf223da3b819449c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.377%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaadcf1874ca04724982a8928b2ba0492_I20191231" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMi0yLTEtMS0w_00ad2a4c-ed81-4568-b4a3-8ae777a81d90">2,192</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ad5ab3a5d744eae96a566cd3203adfa_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMi00LTEtMS0w_afcf6955-e60e-4c43-832f-d3c436807f6a">693</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa91dd46f82a4982882dee9eb8e7ef08_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMi02LTEtMS0w_cd2cd5a9-3093-413a-bfd5-394fac9e25e3">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i433dda944a934320af202e2f484eaa1c_I20191231" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMi04LTEtMS0w_856edb8e-68b8-4bed-8fc8-e28baa836967">2,864</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie55982b4b8094afd8cbd3644050918a9_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfNC0yLTEtMS0w_88214d0b-6730-472d-b0ed-6ebf6450f5b1">75</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70e46b26b4fc462a81bca6b1ee77e04c_D20200101-20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfNC00LTEtMS0w_81239dcb-b930-4e02-87df-ce91ab85d5ef">1,211</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1b552df277f47bdac453b74353a2434_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfNC02LTEtMS0w_db3513d8-e53e-4049-ac94-7486edb63b56">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f1f1cd9567d4e048bfb64a6d6ee6bd0_D20200101-20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfNC04LTEtMS0w_e34b3fed-619d-4a5e-acc3-fb57cedcf98b">1,302</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie55982b4b8094afd8cbd3644050918a9_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfNS0yLTEtMS0w_2b641c24-e3de-49c0-b7cf-c90f49d530cb">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70e46b26b4fc462a81bca6b1ee77e04c_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfNS00LTEtMS0w_f10d31f2-6e9b-46e7-b855-083366b911cb">260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b552df277f47bdac453b74353a2434_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfNS02LTEtMS0w_d4a63db6-447f-4be9-a58e-58c1e9b488b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1f1cd9567d4e048bfb64a6d6ee6bd0_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfNS04LTEtMS0w_3beba0fb-acc2-4fc9-bd79-2b6d0f0e2b3a">279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie55982b4b8094afd8cbd3644050918a9_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfNi0yLTEtMS0w_b411d22b-bf1e-4b9b-a638-b556e9185f56">56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70e46b26b4fc462a81bca6b1ee77e04c_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfNi00LTEtMS0w_69449d50-e01a-4e98-9863-7b79116d4b86">951</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1b552df277f47bdac453b74353a2434_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfNi02LTEtMS0w_4ddda360-3d79-47e9-9bd1-573232a93c08">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f1f1cd9567d4e048bfb64a6d6ee6bd0_D20200101-20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfNi04LTEtMS0w_65dfdccd-d456-45d9-a39a-1812522660b6">1,023</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie55982b4b8094afd8cbd3644050918a9_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfOC0yLTEtMS0w_b78dc326-76aa-474f-8e97-e283a7a57fe7">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70e46b26b4fc462a81bca6b1ee77e04c_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfOC00LTEtMS0w_7cbab4a2-8d32-4223-a492-ab9db7c40c22">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b552df277f47bdac453b74353a2434_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfOC02LTEtMS0w_8b59733a-485e-413d-9b2a-296cf5ccb431">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1f1cd9567d4e048bfb64a6d6ee6bd0_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfOC04LTEtMS0w_db707d11-7710-443a-856a-a2574e63128f">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie55982b4b8094afd8cbd3644050918a9_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfOS0yLTEtMS0w_65d69c71-74f9-4d80-9b3f-e382edb23294">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70e46b26b4fc462a81bca6b1ee77e04c_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfOS00LTEtMS0w_0aa7eebc-802f-499c-a133-3116493583d7">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b552df277f47bdac453b74353a2434_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfOS02LTEtMS0w_9b4057f0-2562-4014-918c-b50b5235d2a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f1f1cd9567d4e048bfb64a6d6ee6bd0_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfOS04LTEtMS0w_fcf0af32-ba0a-4037-a710-0888db0b0c7d">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie55982b4b8094afd8cbd3644050918a9_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMTAtMi0xLTEtMA_857e7a9e-f31a-4c22-945a-b0ab829cde2e">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70e46b26b4fc462a81bca6b1ee77e04c_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMTAtNC0xLTEtMA_5ef4c146-c603-4114-bbb0-84a084a51100">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b552df277f47bdac453b74353a2434_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMTAtNi0xLTEtMA_63cdae92-1609-4dbf-84a2-2f5e35d8c4e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1f1cd9567d4e048bfb64a6d6ee6bd0_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMTAtOC0xLTEtMA_a185e205-3c21-4c1c-929f-28f13bfd6578">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie55982b4b8094afd8cbd3644050918a9_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMTItMi0xLTEtMA_a0033764-00e9-4c6f-ac76-628f0151030d">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70e46b26b4fc462a81bca6b1ee77e04c_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMTItNC0xLTEtMA_290930af-f91b-4d79-b3ed-700f9e15745c">928</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1b552df277f47bdac453b74353a2434_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMTItNi0xLTEtMA_3a2b9655-f203-4681-ac0a-2dbb65d085d6">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f1f1cd9567d4e048bfb64a6d6ee6bd0_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMTItOC0xLTEtMA_3bd26f0a-1aff-4fb8-bc24-83c07f0f8e7d">917</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieedc417e26a742608b043deb27b97448_I20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMTQtMi0xLTEtMA_cae1c2a5-5fc9-49a1-9720-aa0e1d1481a6">2,165</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1b03165fb2c4b76807e0ccc90d962b2_I20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMTQtNC0xLTEtMA_d2a5621e-2ff0-4160-b794-4cd0d6ad45b0">1,621</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5bf1a00e1e4420f9e82ccdfbc6a5434_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMTQtNi0xLTEtMA_a19f42f1-b1d1-4fe3-8ab6-4f687219c59d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b2a0f8b0eb84d6e98048c9c107d0d60_I20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMTQtOC0xLTEtMA_9080dd06-d13b-4f6d-8770-a1fec6a7b514">3,781</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span><br/></span></div><div><span><br/></span></div><div id="i295e56fb16f94dae9eacc631c56d466c_82"></div><ix:continuation id="i48b85932631b4a2fa4b1ec7be4af7748" continuedAt="icbad1f49a3794ef79e7d8b3e232f3663"><ix:continuation id="i389106ccaf0c49a3bf223da3b819449c"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.377%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id14c8ad0e1114859a5ef9774b11273ab_I20200630" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMi0yLTEtMS0w_e0e110cd-1a85-4553-b42d-ea5a6c7d4ef6">2,150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3dac29830b94be0b1b1d5af479d71b6_I20200630" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMi00LTEtMS0w_f7188f85-ea94-46fb-b459-806fbaf07556">1,606</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i529da0d49b1b4fcda97c6cf43be5a0e6_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMi02LTEtMS0w_b03a9a0c-7baa-4d8a-b21e-88c0d83c1de3">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65d2cfacd8464cd8a25b7d8f01804516_I20200630" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMi04LTEtMS0w_00cfd4c0-0a28-4774-a0e3-e1576211a5c7">3,774</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc3428a068464ada9a25e4ce62287f36_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfNC0yLTEtMS0w_80f52eb5-aa71-4b22-9d4c-bff74b3f2482">75</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9501d5a448d4b8fb83b9f4658086140_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfNC00LTEtMS0w_f7d67fb8-06ac-4d8e-8ddf-82e666f24c11">71</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1663f22cd4af448bb0eabf4a88a2c65f_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfNC02LTEtMS0w_9d1ff8f9-35b7-43e2-b116-d71f0fad93d1">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iece3d64b93d440e3863844f51f91d57b_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfNC04LTEtMS0w_2aba3531-09d0-489e-9ddd-597fb3cf43e7">123</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc3428a068464ada9a25e4ce62287f36_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfNS0yLTEtMS0w_ff89c2ae-0b15-436a-9beb-4ecddda228e1">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9501d5a448d4b8fb83b9f4658086140_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfNS00LTEtMS0w_4f959fd7-7973-4eed-bace-4e2047ace68a">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1663f22cd4af448bb0eabf4a88a2c65f_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfNS02LTEtMS0w_d5e908d1-ba6a-4a2d-9b5a-1b1f3d58ad64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iece3d64b93d440e3863844f51f91d57b_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfNS04LTEtMS0w_95e52d21-8147-4eed-a481-9095eeeae393">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc3428a068464ada9a25e4ce62287f36_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfNi0yLTEtMS0w_e7b27ee2-592f-4392-a0b4-716206626c67">56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9501d5a448d4b8fb83b9f4658086140_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfNi00LTEtMS0w_3fa9f4ea-dd34-4d67-9f1b-dc16f04882dc">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1663f22cd4af448bb0eabf4a88a2c65f_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfNi02LTEtMS0w_01e45ae0-1eaf-44ff-9f18-0f67e75f39c6">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iece3d64b93d440e3863844f51f91d57b_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfNi04LTEtMS0w_c5b92c59-cf51-4496-ab42-46358210c6a4">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc3428a068464ada9a25e4ce62287f36_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfOC0yLTEtMS0w_329dfa76-4107-4edb-9241-ba3ac9598830">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9501d5a448d4b8fb83b9f4658086140_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfOC00LTEtMS0w_c07819de-ca37-4f66-b16b-4eff57d29504">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1663f22cd4af448bb0eabf4a88a2c65f_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfOC02LTEtMS0w_9bc81f35-0b60-4714-b29f-6c0b56af4513">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iece3d64b93d440e3863844f51f91d57b_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfOC04LTEtMS0w_d02e8e36-46b1-4738-b086-26a4fdcbf918">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc3428a068464ada9a25e4ce62287f36_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfOS0yLTEtMS0w_689d8ea4-678e-4ea9-b423-29a32004f748">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9501d5a448d4b8fb83b9f4658086140_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfOS00LTEtMS0w_3e43e362-9ed6-4703-9be1-55881b4d72ed">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1663f22cd4af448bb0eabf4a88a2c65f_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfOS02LTEtMS0w_8d1a32e5-d18a-4172-9851-3f02d51e4944">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iece3d64b93d440e3863844f51f91d57b_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfOS04LTEtMS0w_4f0ddc5b-b930-498f-860e-0ba63c68b3e6">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc3428a068464ada9a25e4ce62287f36_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMTAtMi0xLTEtMA_23650dc3-2a93-4de6-a6f5-a7e64c77bc05">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9501d5a448d4b8fb83b9f4658086140_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMTAtNC0xLTEtMA_fdc67248-4b72-4898-9a38-fb4ee4f6e4a3">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1663f22cd4af448bb0eabf4a88a2c65f_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMTAtNi0xLTEtMA_afd8adc1-6241-47c1-82d4-4083bb5cdf3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iece3d64b93d440e3863844f51f91d57b_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMTAtOC0xLTEtMA_7ba1b225-639d-4081-82cd-dce1e7300ace">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc3428a068464ada9a25e4ce62287f36_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMTItMi0xLTEtMA_dd88d262-5234-4c81-abce-5a4f733bd6d5">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9501d5a448d4b8fb83b9f4658086140_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMTItNC0xLTEtMA_e2670ed3-3731-4947-9bef-871f43615a31">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1663f22cd4af448bb0eabf4a88a2c65f_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMTItNi0xLTEtMA_c5ee4c60-00a6-420f-a581-986cf7a37f7f">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iece3d64b93d440e3863844f51f91d57b_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMTItOC0xLTEtMA_40511a77-f2e8-4113-8ae5-4d03e645555a">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieedc417e26a742608b043deb27b97448_I20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMTQtMi0xLTEtMA_e199f29c-8657-469e-b592-5a892a85608a">2,165</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1b03165fb2c4b76807e0ccc90d962b2_I20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMTQtNC0xLTEtMA_8c63d1ee-31ef-4cec-8987-dae109275e98">1,621</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5bf1a00e1e4420f9e82ccdfbc6a5434_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMTQtNi0xLTEtMA_4eac24eb-c9c1-4d37-90c0-04422919f789">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b2a0f8b0eb84d6e98048c9c107d0d60_I20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMTQtOC0xLTEtMA_083aa4e4-23a3-436d-9780-9766c952871d">3,781</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Reflects the remeasurement impact of salaried retiree healthcare plan amendments.  For further discussion, see Note 6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans.</span></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Primarily reflects Altria&#8217;s share of ABI&#8217;s currency translation adjustments and the impact of Altria&#8217;s designated net investment hedges.  For further discussion of designated net investment hedges, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments.</span></div></ix:continuation></ix:continuation><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i295e56fb16f94dae9eacc631c56d466c_85"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="icbad1f49a3794ef79e7d8b3e232f3663"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RleHRyZWdpb246OTkyYjQ3YjI4OTRlNDNmMDgwMTFlYWZjZDgyYTgwZmRfNDU5_e750f64d-a61d-471d-bd93-0c3311a640d2" escape="true"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings (losses):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.806%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.037%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Plans: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i903649a4650d4581b810b87a8e7abece_D20210101-20210930" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfMy0yLTEtMS0w_dd3a2f23-bb59-4bd0-9470-a2cf102963b7">124</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba009efde806409683cbc9e86246b4df_D20200101-20200930" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfMy00LTEtMS0w_f30512e3-1d5d-4ed5-b8b9-f23915074090">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1f84a88e08b4b88ac5ad7e5696842ef_D20210701-20210930" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfMy02LTEtMS0w_37ed227e-8295-42b6-bc41-e73558b1983f">39</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386a65106eed4b8480296af72f76b88a_D20200701-20200930" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfMy04LTEtMS0w_d942e582-278f-4607-a0b1-99428f104b38">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia911d34c10624a4caad11aaf671e57a2_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNC0yLTEtMS0w_1bbe657a-06b0-4572-8e7c-2e16983d9836">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00054ad5017c49e886588f8692292ab7_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNC00LTEtMS0w_9f64518d-2330-4a99-8fb4-80443b533ade">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i148aed2cafc8405f9c753e10684af7ce_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNC02LTEtMS0w_73185224-afad-4dec-8ca9-4c7427fb6fcc">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c117e78f8df4689addea5ed534be7cc_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNC04LTEtMS0w_31272423-48d9-4a00-9736-f4ed2e854185">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90237e5e67d24c74afa25e85687a853f_D20210101-20210930" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNS0yLTEtMS0w_c0db3774-4f46-40aa-b379-f19d7fcb754a">92</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4234136b96446cc9cf8cb134f4533f0_D20200101-20200930" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNS00LTEtMS0w_ae04680f-04b2-4194-bff3-218e7a76e8ed">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cdea01ef93f447c96c7b2a20036eb30_D20210701-20210930" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNS02LTEtMS0w_8af72a3c-26c9-401d-a0eb-4c08b58ede03">20</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09764927c7ec46e49e7775b99fd97136_D20200701-20200930" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNS04LTEtMS0w_2995e01c-2b6e-4df0-9d50-b02f7d38e1db">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i129971b2b9ec49abbe1afc97cb429284_D20210101-20210930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNi0yLTEtMS0w_50e81ecf-83b8-4a85-8828-452dbf6f0e8b">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia80f603ac4c848f78a7bcaf6c95cb8a5_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNi00LTEtMS0w_8bbe1d32-287d-44a0-a85f-191409e412cf">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibaa55d29a7cf455ca4bf8fe55b94e9c0_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNi02LTEtMS0w_93e7e4a8-92f0-4d1a-a86f-e3945eff9a85">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d50e83d51e04a2c81a2fb7b3d33bd41_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNi04LTEtMS0w_68095f6f-7efb-4de4-88b0-0b9cb218fac6">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments and Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if41a4137b96044f2853f90bee854a5a1_D20210101-20210930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNy0yLTEtMS0w_96de2405-ea9e-42f6-aeb5-472a31a6004d">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0c26c7c96cd4d82a4534ab1f5e26951_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNy00LTEtMS0w_abb467e7-b349-4f66-bd99-ff9ea575f7c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e957d6659b146e1a8a2c22448c05e52_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNy02LTEtMS0w_61f3115c-89e2-45f9-90f9-774caee71c30">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3658d6662464166bd1a7d63193f62b6_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNy04LTEtMS0w_7c32a3fb-7151-4e1b-b800-331c9370bfd0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c60e64bda5e406c906f14c501403dcf_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfOC0yLTEtMS0w_c2a20cd7-7a6a-4c93-865e-e31646287ff4">41</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb73dd7e78c54dc0bb94170fd12ab8ab_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfOC00LTEtMS0w_3221b232-b7cc-41e7-b8f1-4733f44c4609">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88fcf49918a84402902b9a4fd578a532_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfOC02LTEtMS0w_79280ef2-efb0-4ee6-bb76-7d760a49efb4">12</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e951f6b74194f1ea5354f9049777599_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfOC04LTEtMS0w_a81862fd-37ef-4144-94d9-22eca94c5d52">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Amounts are included in net defined benefit plan costs.  For further information related to defined benefit plans, see Note 6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans.</span></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Amounts are included in (income) losses from equity investments.  For further information related to equity investments, see Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i295e56fb16f94dae9eacc631c56d466c_88"></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 9. <ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfNDYzNA_05bdd5ac-bd83-4e95-935c-b67b08b2d986" continuedAt="i102dd4e31e9549f79cb3c50b433b73de" escape="true">Segment Reporting</ix:nonNumeric></span></div><ix:continuation id="i102dd4e31e9549f79cb3c50b433b73de" continuedAt="i52074714141e45539560c7da89ec293e"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The products of Altria&#8217;s subsidiaries include smokeable tobacco products, consisting of combustible cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton; oral tobacco products, consisting of MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix; and wine produced and/or distributed by Ste. Michelle.  The products and services of these subsidiaries constitute Altria&#8217;s reportable segments of smokeable products, oral tobacco products and wine.  The financial services and the innovative tobacco products businesses, which include the heated tobacco business and Helix ROW, are included in all other.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s chief operating decision maker (the &#8220;CODM&#8221;) reviews operating companies income (loss) (&#8220;OCI&#8221;) to evaluate the performance of, and allocate resources to, the segments.  OCI for the segments is defined as operating income before general corporate expenses and amortization of intangibles.  Interest and other debt expense, net, along with net periodic benefit income/cost, excluding service cost, and provision (benefit) for income taxes are centrally managed at the corporate level and, accordingly, such items are not presented by segment since they are excluded from the measure of segment profitability reviewed by the CODM.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="i52074714141e45539560c7da89ec293e" continuedAt="if89ba45e0e4044f88ed0191ee7905021"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfNDY0Ng_49d09b17-794d-40ed-a406-df3484950ec9" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3e0ae69ae05491a91e3fdb908e909db_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMy0yLTEtMS0w_72bb635a-1aeb-4bbc-801e-d396e970609a">17,275</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2569691b65440c9038155bd4cf097b_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMy00LTEtMS0w_cb444576-8d14-46b0-9d13-489d8469b067">17,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8712c39f1b4b407d8d3f616cd0f6d0b2_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMy02LTEtMS0w_30c5c4ad-d36e-4026-bd54-7a6b9522e99e">5,975</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf557385c26346d78697ab7216ad25aa_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMy04LTEtMS0w_3437d29b-17eb-4e37-8918-ecb01d072a5d">6,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cc47fbf28e740b583be5f01ebc5de9b_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNC0yLTEtMS0w_c3c0dcf9-b1df-44d6-9d4f-98f3a6b3598b">1,945</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7773a1a4d8454a6f8b93d93dbf471801_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNC00LTEtMS0w_625f23df-943c-4204-b329-a2cfce91373f">1,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7294329e59b4737858f1c36f4d117a6_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNC02LTEtMS0w_9e061f37-60a9-4c79-9255-c784b170ff3a">626</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb6abc654940949c584c7bce9fa618_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNC04LTEtMS0w_4d94b35d-2787-46e4-bcc9-42f8908bc6f3">640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf8f1c9e35d64a1f98b39384820c20cc_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNS0yLTEtMS0w_398d0d71-fcd8-440c-996d-9408c196cf9f">494</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82c1570001674d4a844a4bfcb4e16ca8_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNS00LTEtMS0w_df772681-56ad-418d-9ed5-233280459d02">434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i867ac19dbb4643b59a94aeeec8a58fa8_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNS02LTEtMS0w_1cec1187-8d61-4be9-894e-6378422f0b98">177</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41fcc7aaf3534c59ace9f381d20aac6a_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNS04LTEtMS0w_deb425ea-3a97-4b09-a8cc-372aad114e91">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie45eb514d8c24379a2d84b6fdadc5908_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNi0yLTEtMS0w_0f64e4fe-a047-4e74-987a-461e491b8166">44</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i348527fc0572499b8b09c70427059222_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNi00LTEtMS0w_ae32a59c-c00a-4ab8-a602-2ddd3188f5a9">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idda2d39340b64a38b25c3fbb87815b91_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNi02LTEtMS0w_5ca0c688-46f1-4aaa-9f74-caa6086c5bd8">8</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id08e4c2d3cad43fea50a182ef5e4bd72_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNi04LTEtMS0w_1dbab2cd-da68-4698-a907-1cd8b16cc391">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNy0yLTEtMS0w_1586e0b0-aa86-418a-9baf-67bfa24012ee">19,758</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNy00LTEtMS0w_c593609e-3cf3-4852-bdf0-bcdacaa7e8c3">19,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNy02LTEtMS0w_4bf2e9e0-ffe0-4e72-8f67-26afad1b8d29">6,786</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNy04LTEtMS0w_71e4cf70-d894-4e39-8760-745f4bc8fc10">7,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings (losses) before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3e0ae69ae05491a91e3fdb908e909db_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTAtMi0xLTEtMA_232b7eb0-caba-4b7b-a051-90d5ae400244">7,901</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2569691b65440c9038155bd4cf097b_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTAtNC0xLTEtMA_093e32f3-f698-4ca1-977d-70a613c85755">7,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8712c39f1b4b407d8d3f616cd0f6d0b2_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTAtNi0xLTEtMA_4c91f919-be9a-405c-ad96-c69023530c31">2,753</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf557385c26346d78697ab7216ad25aa_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTAtOC0xLTEtMA_6048d3a2-fc86-4408-9945-07f2993d3da3">2,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cc47fbf28e740b583be5f01ebc5de9b_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTEtMi0xLTEtMA_68ce09ce-151b-437f-a013-5b6f5d973a6b">1,269</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7773a1a4d8454a6f8b93d93dbf471801_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTEtNC0xLTEtMA_449473ad-f5ed-4519-a871-8ff9278f1c57">1,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7294329e59b4737858f1c36f4d117a6_D20210701-20210930" decimals="-6" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTEtNi0xLTEtMA_86bce0a5-5275-433f-a115-ea717ce6f544">405</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb6abc654940949c584c7bce9fa618_D20200701-20200930" decimals="-6" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTEtOC0xLTEtMA_01f68864-a84f-4719-b8f9-5c6855277969">436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf8f1c9e35d64a1f98b39384820c20cc_D20210101-20210930" decimals="-6" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTItMi0xLTEtMA_69b82b81-de6f-4724-bf84-ec58a2d94676">21</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i82c1570001674d4a844a4bfcb4e16ca8_D20200101-20200930" decimals="-6" sign="-" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTItNC0xLTEtMA_d2f9f58c-5e21-4a71-9e65-7d338f587baa">347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i867ac19dbb4643b59a94aeeec8a58fa8_D20210701-20210930" decimals="-6" sign="-" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTItNi0xLTEtMA_1241df02-0eed-4003-8cfd-4f804f5baa46">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41fcc7aaf3534c59ace9f381d20aac6a_D20200701-20200930" decimals="-6" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTItOC0xLTEtMA_b453cd59-024c-4e4b-8a58-1d22ea8c3b6a">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie45eb514d8c24379a2d84b6fdadc5908_D20210101-20210930" decimals="-6" sign="-" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTMtMi0xLTEtMA_9fd89f26-a6bf-4654-9a99-b19790258721">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i348527fc0572499b8b09c70427059222_D20200101-20200930" decimals="-6" sign="-" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTMtNC0xLTEtMA_dbe3fef7-3005-44cb-bdc5-42775f7ed0b5">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idda2d39340b64a38b25c3fbb87815b91_D20210701-20210930" decimals="-6" sign="-" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTMtNi0xLTEtMA_9e3aab33-b680-498a-a3c8-9d855eababc1">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id08e4c2d3cad43fea50a182ef5e4bd72_D20200701-20200930" decimals="-6" sign="-" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTMtOC0xLTEtMA_1f8f44f3-5a30-439e-b0d7-211138e4c485">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45eb44ceb75d4820b3468fcd56c069bb_D20210101-20210930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTQtMi0xLTEtMA_e38c36a4-8f97-48ba-bdee-14c2589af227">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic06d55ed183d403ea8fab3081dabed8d_D20200101-20200930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTQtNC0xLTEtMA_cc93c7eb-4410-4066-ad6b-ac49b9703a88">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib87ad1bdee774676a43d32c69faf494a_D20210701-20210930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTQtNi0xLTEtMA_b24abb6e-adcc-454e-9433-93c89ecb9a40">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8113c4d3abd42a8a3d5dc65de3551ea_D20200701-20200930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTQtOC0xLTEtMA_69e50c2e-e735-4ff0-9332-7a7bde91c029">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23d680315a484e78bb04a83054b0bd2c_D20210101-20210930" decimals="-6" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTUtMi0xLTEtMA_e443b68e-5c60-436d-9f82-63518521b771">255</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5750ad1593bf4f39a28a67676e4be777_D20200101-20200930" decimals="-6" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTUtNC0xLTEtMA_e19c5b83-60df-4b58-ae6b-60558d365d50">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i901cc99ae1b84fcaa334b79a557b2716_D20210701-20210930" decimals="-6" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTUtNi0xLTEtMA_db6bdf87-cfac-4313-bcf6-bb1941aabbac">135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92ece1efc67e4955b20f6106bfa5b1bc_D20200701-20200930" decimals="-6" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTUtOC0xLTEtMA_e0e41923-3186-4ff3-9896-babe84191eda">60</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTctMi0xLTEtMA_0f1f91b3-3675-4f8b-923d-b451e159cebd">8,827</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTctNC0xLTEtMA_ac893f23-cfa5-4632-9782-6e7227f2ad04">8,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTctNi0xLTEtMA_77a6cbf3-7da4-44dd-9577-802522fcf08a">2,951</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTctOC0xLTEtMA_7c2b7651-47a7-4792-b471-cc33ac4993dc">3,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTgtMi0xLTEtMA_65b17fda-3ceb-41d3-b441-cf7c97d75441">869</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTgtNC0xLTEtMA_2c4c67db-dd81-4922-896b-8aa30925ec21">893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTgtNi0xLTEtMA_7c36f5bb-9b23-4476-a437-06c9afa4922c">266</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTgtOC0xLTEtMA_b18c614c-1423-4832-bbfb-648bb85c0b07">310</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTktMi0xLTEtMA_787d5e44-b80e-40be-9749-22ec272d28c0">649</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTktNC0xLTEtMA_3ed5c128-04ce-4a88-881b-2f6daa2b6809">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTktNi0xLTEtMA_2fb6d971-6a54-40a1-a441-4a1aff3af07c">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTktOC0xLTEtMA_b484a550-8fac-4d65-9e11-80ee24f95056">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit income, excluding </span></div><div style="padding-left:31.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">service cost</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjAtMi0xLTEtMA_b60e2142-8187-4bfd-bda5-9c3f16169272">152</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjAtNC0xLTEtMA_6f4c1592-0a08-47df-9de3-f3ab2dda04b3">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjAtNi0xLTEtMA_756b01d9-f58c-4f9d-821e-0f82f8f34f37">63</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjAtOC0xLTEtMA_cddb9eca-b118-4752-9cdf-28ad11156774">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (losses) from equity investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="mo:IncomeLossFromEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjEtMi0xLTEtMA_d6585ae6-b6b0-4019-a138-49aad873433d">5,789</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjEtNC0xLTEtMA_2c650870-f575-4c19-8662-768c062c4510">306</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="mo:IncomeLossFromEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjEtNi0xLTEtMA_e5a7d081-7886-4437-8069-c4a5d707b017">5,915</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjEtOC0xLTEtMA_d269cba1-0e4c-4419-b0fd-6de9286fa5c9">472</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of JUUL equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjItMi0xLTEtMTI2ODU_21844dd2-815e-4a3e-a69d-33a113d8933e">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjItNC0xLTEtMTMxMQ_1550427a-9f43-4c8c-b85e-33ab01179b36">2,600</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjItNi0xLTEtMTI2ODU_e1c0796a-4671-4e7c-acce-1a04994ac5cd">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjItOC0xLTEtMTMxNw_64d0d438-d796-4e64-920c-9b9221e83ffb">2,600</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on Cronos-related financial instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjMtMi0xLTEtMA_f0f254d1-68c3-4d4b-85b8-37cc308317fb">128</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjMtNC0xLTEtMA_7c019a27-91cb-4b16-891b-e4f70882a098">202</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjMtNi0xLTEtMA_2a6c1774-f36d-480f-b111-5e04e4f16896">135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjMtOC0xLTEtMA_62713641-33b0-49b1-b3c3-4ffbe9518707">105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) before income taxes</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjQtMi0xLTEtMA_d63eabbe-1b60-4a70-a4e6-ce81bd1d9c7c">1,544</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjQtNC0xLTEtMA_bf258827-f3f2-4998-bd20-38c3fa457ac4">4,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjQtNi0xLTEtMA_06c38aae-67b6-46e9-8aa4-1af775691a2f">3,302</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjQtOC0xLTEtMA_f0a0bf12-66ed-41e1-8475-cfd854a03933">324</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The comparability of OCI for the reportable segments was affected by the following:</span></div><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="mo:ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfMjE5OTAyMzI2NDI3MA_c76cd14c-1253-4172-a2f8-22d812dd724f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Non-Participating Manufacturer (&#8220;NPM&#8221;) Adjustment Items:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Pre-tax (income) for NPM adjustment items was recorded to Altria&#8217;s condensed consolidated statements of earnings (losses) as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.903%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products segment</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbc3e1fdad35440a8019431504912e54_D20210101-20210930" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmMyYmI1MjA5MjY4MzQwYjZhZmM2MWQ5MzYwNWQ3NzQ3L3RhYmxlcmFuZ2U6YzJiYjUyMDkyNjgzNDBiNmFmYzYxZDkzNjA1ZDc3NDdfMi0yLTEtMS04NTM5_c8f456eb-c173-4da7-b7f1-1edc105e8397">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab4ebcb1e91f46c4be02c3ade89e7bd6_D20210701-20210930" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmMyYmI1MjA5MjY4MzQwYjZhZmM2MWQ5MzYwNWQ3NzQ3L3RhYmxlcmFuZ2U6YzJiYjUyMDkyNjgzNDBiNmFmYzYxZDkzNjA1ZDc3NDdfMi00LTEtMS04NTM1_f4ed9fd6-52c9-4ca8-998f-e786d05a7af3">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a6c36dc62614c039382474701d62704_D20210101-20210930" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmMyYmI1MjA5MjY4MzQwYjZhZmM2MWQ5MzYwNWQ3NzQ3L3RhYmxlcmFuZ2U6YzJiYjUyMDkyNjgzNDBiNmFmYzYxZDkzNjA1ZDc3NDdfMy0yLTEtMS04NTg3_dbd5045b-f356-426c-8f2e-611d91743183">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0bdf868958f46d39d41b03294b42969_D20210701-20210930" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmMyYmI1MjA5MjY4MzQwYjZhZmM2MWQ5MzYwNWQ3NzQ3L3RhYmxlcmFuZ2U6YzJiYjUyMDkyNjgzNDBiNmFmYzYxZDkzNjA1ZDc3NDdfMy00LTEtMS04NjMw_3a5c1d03-b02d-4d37-980d-394e298588bc">23</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0b695b39e941948146139c5236ab09_D20210101-20210930" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmMyYmI1MjA5MjY4MzQwYjZhZmM2MWQ5MzYwNWQ3NzQ3L3RhYmxlcmFuZ2U6YzJiYjUyMDkyNjgzNDBiNmFmYzYxZDkzNjA1ZDc3NDdfNC0yLTEtMS0xMjYzNw_4268889d-8931-4ae6-b9ec-8fc8290d85a9">76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01fb7d5238cf4de6af35e1b8ee70534b_D20210701-20210930" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmMyYmI1MjA5MjY4MzQwYjZhZmM2MWQ5MzYwNWQ3NzQ3L3RhYmxlcmFuZ2U6YzJiYjUyMDkyNjgzNDBiNmFmYzYxZDkzNjA1ZDc3NDdfNC00LTEtMS0xMjY0OA_ca71714a-049b-4d1e-aed3-b6f85e6b2dd9">44</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NPM adjustment items result from the resolutions of certain disputes with states and territories related to the NPM adjustment provision under the 1998 Master Settlement Agreement (such dispute resolutions are referred to as &#8220;NPM Adjustment Items&#8221; and are more fully described in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).  The amounts shown in the table above for the smokeable products segment were recorded as reductions to cost of sales, which increased OCI in the smokeable products segment.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="if89ba45e0e4044f88ed0191ee7905021"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="mo:ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfNDYzMg_fe013eb3-140a-4c47-9d4f-4cf5a444211e" continuedAt="iede08cdcbf1d4e8abdda6badd0a24fa5" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Tobacco and Health and Certain Other Litigation Items:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax charges related to tobacco and health and certain other litigation items were recorded in Altria&#8217;s condensed consolidated statements of earnings (losses) as follows:</span></ix:nonNumeric></div><div style="margin-top:5pt"><ix:continuation id="iede08cdcbf1d4e8abdda6badd0a24fa5"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products segment</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0da5bdcd164423ab6c5e7d2d4619255_D20210101-20210930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfMi0yLTEtMS0w_a9ad46e0-b892-4e8c-abbf-d97ea0e6f8e7">72</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71a6552e683a45df8a80deb0ff141acc_D20200101-20200930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfMi00LTEtMS0w_8abdf419-d57f-40a1-a533-b393667f14e2">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c00af2fa2a47a08ce2e121cec7fa1a_D20210701-20210930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfMi02LTEtMS0w_173f1029-f19c-4c25-9ece-8d05e82261e4">29</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id86681b1496e4200ac6e85e6642cca96_D20200701-20200930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfMi04LTEtMS0w_24d64f29-50fd-4c1f-a013-0b635f9e84be">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44c555d22e7b40b0b20993dec5333004_D20210101-20210930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfMy0yLTEtMS01MzUzNw_bf48c05b-5702-45f8-8734-c46bf7e892f6">70</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13dbf73b19844cd8895f0cadcf052f90_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfMy00LTEtMS01MzUzNw_feb18ba7-c07e-452d-9e9a-2b3f206ccde9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5717ce456bae4169a32dfcce88700f00_D20210701-20210930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfMy02LTEtMS01MzI2MA_e89c234a-9a9c-45a2-81ee-82172e963805">70</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e76683652f2470896a6eb26e4f4b7a2_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfMy04LTEtMS01MzA5Mg_9296d139-4594-4ffc-ac81-4c6895d7cab1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e46fc85802e4a6291b8902ec7c022dc_D20210101-20210930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfMy0yLTEtMS0w_6f53f8f4-457e-42f5-9ba2-cb9f383acf1b">6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3e6860a06dc45078a5772ad589b6723_D20200101-20200930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfMy00LTEtMS0w_9d1703ce-2523-4902-96f1-afc961c30de3">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17fc09b753d24ddfb9c43ac782832373_D20210701-20210930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfMy02LTEtMS0w_e98571c1-2e42-4adf-83c6-33166d3e3743">6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6059c690166441149c61f26c7db17255_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfMy04LTEtMS0w_943e02fc-57b7-43af-9c81-2f0ea560aae5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if433ba93efde45f38a5688307f77c9c4_D20210101-20210930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfNC0yLTEtMS0w_b13edd0e-1fb4-4d87-8c47-4bdeb4ff300b">148</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i876dc6b8472b4c2ea0c3ae119b771d02_D20200101-20200930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfNC00LTEtMS0w_17a8797d-325d-42ad-b104-200d144f021b">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d52c13d1e44d56853af2d044689b8c_D20210701-20210930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfNC02LTEtMS0w_8ee9a9f1-9a4a-4ffd-ab2f-05b85cff6f2c">105</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib11d64a866fe4276882eac217af0ec5f_D20200701-20200930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfNC04LTEtMS0w_6a851f84-a706-4bbd-ac9b-3c2b68ea4938">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts shown in the table above for the smokeable products segment and general corporate were recorded in marketing, administration and research costs.  For further discussion, see Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">COVID-19 Special Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="i0e1577fefc474a9b9a5a1b492deccd82_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfMjQ2Mw_3f2502c8-cb3f-434d-ad15-8d9f28cfeab4"><ix:nonFraction unitRef="usd" contextRef="i986e7568db0547edb5f58a6f3d032e05_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfMjQ2Mw_f46b4975-dffa-47a6-800c-8702e16a768f">50</ix:nonFraction></ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="i509fd5cc79b84947a1ddc23a201ceee8_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfMjQ2Nw_05d10a78-525b-455a-8861-d76da33739f5"><ix:nonFraction unitRef="usd" contextRef="if08ac6b396064588b67bc488b59ea368_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfMjQ2Nw_611b402d-2644-4162-8931-1b9ef1c08a8b">41</ix:nonFraction></ix:nonFraction> million in the smokeable products segment and $<ix:nonFraction unitRef="usd" contextRef="ie4f93cb048684f5f81d4c6d87a4b0f83_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfMjUwOA_247b0811-64e2-4948-83b2-dfff830902bf"><ix:nonFraction unitRef="usd" contextRef="i637d3a2f463a43b4ba0c2c56616e75d5_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfMjUwOA_3beb5bf0-0716-40c1-8cef-d42416f388ff">9</ix:nonFraction></ix:nonFraction> million in the oral tobacco products segment) related to the COVID-19 pandemic were recorded in Altria&#8217;s condensed consolidated statements of earnings (losses) for the nine months ended September 30, 2020.  The net pre-tax charges, which were directly related to disruptions caused by or efforts to mitigate the impact of the COVID-19 pandemic, were all recorded in costs of sales and included premium pay, personal protective equipment and health screenings, which were partially offset by certain employment tax credits.  The COVID-19 special items do not include the inventory-related implementation costs associated with the wine business strategic reset discussed below.  These implementation costs were due to increased inventory levels, which were further negatively impacted by the COVID-19 pandemic, including economic uncertainty and government restrictions.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Implementation, Acquisition and Disposition-Related Costs:</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ste. Michelle Transaction:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine and three months ended September&#160;30, 2021, pre-tax disposition-related costs of $<ix:nonFraction unitRef="usd" contextRef="i9321155464464f6abb0579cd48d53de2_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfMjc0ODc3OTA3OTg3Nw_4f8ea03c-5c52-4ee1-95f7-5667989b2e73"><ix:nonFraction unitRef="usd" contextRef="i9321155464464f6abb0579cd48d53de2_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfMjc0ODc3OTA3OTg3Nw_ad7026a9-66a0-4328-a2db-fb38ab78ea7d">51</ix:nonFraction></ix:nonFraction> million were recorded in the wine segment, which consisted of a pre-tax charge of $<ix:nonFraction unitRef="usd" contextRef="i800ea809d24a4ae99423280ab9ed1ce7_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfNDk0NzgwMjMzNTcyNg_6bdb1251-2609-46b3-8e43-077277d76a84">41</ix:nonFraction> million to record the assets and liabilities associated with the Ste. Michelle Transaction at their fair value less costs to sell and  $<ix:nonFraction unitRef="usd" contextRef="i800ea809d24a4ae99423280ab9ed1ce7_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfNDk0NzgwMjMzNTczMg_c62635bf-cb7f-45c2-bc68-6f490b98c003">10</ix:nonFraction> million of other disposition-related costs.  For further discussion, see Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wine Business Strategic Reset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: During the nine months ended September 30, 2020, Ste. Michelle recorded pre-tax implementation costs of  $<ix:nonFraction unitRef="usd" contextRef="iaf975d8c2d674ea3839f3277f75cf4f1_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfMzU0NA_fdd14038-064b-4bc4-b1b2-d331e467177f">395</ix:nonFraction> million associated with a strategic reset initiated in the first quarter of 2020 to maximize Ste. Michelle&#8217;s profitability and achieve improved long-term cash flow generation.  Substantially all of the charges consisted of the following: (i) write-off of inventory ($<ix:nonFraction unitRef="usd" contextRef="i99a5d17aefbc4d5ca90136899d314788_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfMzgwNQ_07728b88-3d49-43f1-a20a-7e057cf8c4c9">292</ix:nonFraction> million) as Ste. Michelle no longer believed that the benefit of the blending and production plans for its inventory outweighed inventory carrying cost given the reduced product volume demand; and (ii) estimated losses on future non-cancelable grape purchase commitments that Ste. Michelle believed no longer had a future economic benefit ($<ix:nonFraction unitRef="usd" contextRef="i57818fd795f445829d1bf3dd90269c34_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfNDE0MA_bb5e3891-bf64-4d5f-b7a6-46d158e10af6">100</ix:nonFraction> million).  These charges were included in cost of sales in Altria&#8217;s condensed consolidated statements of earnings (losses).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-Related Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: For the nine months ended September 30, 2021, Altria recorded pre-tax acquisition-related costs of $<ix:nonFraction unitRef="usd" contextRef="i2cc47fbf28e740b583be5f01ebc5de9b_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfNDM3MQ_5b454d53-0110-499e-8eaf-00b41a315373">37</ix:nonFraction> million in the oral tobacco products segment primarily for the settlement of an arbitration related to the 2019 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> transaction.  These costs were included in marketing, administration and research costs in Altria&#8217;s condensed consolidated statements of earnings (losses).</span></div></ix:continuation><div style="margin-bottom:5pt"><span><br/></span></div><div id="i295e56fb16f94dae9eacc631c56d466c_94"></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 10. <ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNTI4OA_6c876eb1-972a-4e82-95b5-4f538aaa66b9" continuedAt="iee42e9b89f184b2f96ea039ef174f4f4" escape="true">Debt</ix:nonNumeric></span></div><ix:continuation id="iee42e9b89f184b2f96ea039ef174f4f4" continuedAt="i363270773bd74891b7b4ffccd9e61ddb"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Short-term Borrowings and Borrowing Arrangements</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021 and December&#160;31, 2020, Altria had <ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShortTermBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfODg_6e89f641-31b9-46b9-8d76-f6c66633ebc1"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShortTermBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfODg_f5c7315a-cdc9-4315-b87a-b141814f4740">no</ix:nonFraction></ix:nonFraction> short-term borrowings.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 18, 2021, Altria entered into an extension and amendment (the &#8220;Extension and Amendment&#8221;) to its $<ix:nonFraction unitRef="usd" contextRef="i0f700f27ee5b4dc0b6b7ca55099ab015_I20210930" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMjc0ODc3OTA3NzQyOQ_822a2179-2e1b-480f-b4d0-884a94a85dbb">3.0</ix:nonFraction> billion senior unsecured <ix:nonNumeric contextRef="i8782aa269d064a7f878a2d5f0a778720_D20210101-20210930" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMjE5OTAyMzI2MzY0MA_c92a75d3-9c23-41e7-ad3b-f55e178be964">5-year</ix:nonNumeric> revolving credit agreement (as amended, the &#8220;Credit Agreement&#8221;).  The Extension and Amendment extends the maturity date of the Credit Agreement from August 1, 2023 to August 1, 2024 and amends the Credit Agreement to update certain provisions regarding a successor interest rate to the London Interbank Offered Rate (&#8220;LIBOR&#8221;) and make certain other market updates.  All other terms and conditions of the Credit Agreement remain in full force and effect.  The Credit Agreement, which is used for general corporate purposes, includes an additional option, subject to certain conditions, for Altria to extend the expiration date for an additional <ix:nonNumeric contextRef="i8782aa269d064a7f878a2d5f0a778720_D20210101-20210930" format="ixt-sec:durwordsen" name="mo:DebtInstrumentExtensionTerm" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNTI5Mw_9d80b219-6007-4a7a-8e53-89446761570f">one-year</ix:nonNumeric> period.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, the Credit Agreement had available borrowings up to an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i0f700f27ee5b4dc0b6b7ca55099ab015_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNTQ5NzU1ODE0NTk4Nw_49a3ad5b-6333-4277-a65c-f190a0bc66f7">3.0</ix:nonFraction> billion.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="i363270773bd74891b7b4ffccd9e61ddb" continuedAt="ibd108e60df5141929cf8ccfbb221a613"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pricing for interest and fees under the Credit Agreement may be modified in the event of a change in the rating of Altria&#8217;s long-term senior unsecured debt.  Interest rates on borrowings under the Credit Agreement are expected to be based on LIBOR, or a fallback benchmark rate determined based on prevailing market convention, plus a percentage based on the higher of the ratings of Altria&#8217;s long-term senior unsecured debt from Moody&#8217;s Investors Service, Inc. (&#8220;Moody&#8217;s&#8221;) and Standard&#160;&amp; Poor&#8217;s Financial Services LLC (&#8220;S&amp;P&#8221;).  The applicable percentage based on Altria&#8217;s long-term senior unsecured debt ratings&#160;at September&#160;30, 2021 for borrowings under the Credit Agreement was <ix:nonFraction unitRef="number" contextRef="i4d9e692ae91a4176bbb8ab4a42237fa6_D20210101-20210930" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMTE5MQ_4c950843-bd6b-4d9d-8272-61d15b995e9d">1.0</ix:nonFraction>%.  The Credit Agreement does not include any other rating triggers, or any provisions that could require the posting of collateral.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement includes various covenants, one of which requires Altria to maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization (&#8220;EBITDA&#8221;) to Consolidated Interest Expense of not less than <ix:nonFraction unitRef="number" contextRef="ic42084bb2e9740b8b51ae3feeb2862d5_D20210101-20210930" decimals="INF" name="mo:DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMTU2Mw_ea149248-224f-4aec-8c71-32381bc4e416">4.0</ix:nonFraction> to 1.0, calculated as of the end of the applicable quarter on a rolling four quarters basis.  At September&#160;30, 2021, the ratio of consolidated EBITDA to Consolidated Interest Expense, calculated in accordance with the Credit Agreement, was <ix:nonFraction unitRef="number" contextRef="ic42084bb2e9740b8b51ae3feeb2862d5_D20210101-20210930" decimals="INF" name="mo:DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMTc5MA_fba01e2e-f829-478f-bc9b-efef4a12d88a">9.8</ix:nonFraction> to 1.0.  At September&#160;30, 2021, Altria was in compliance with its covenants in the Credit Agreement.  The terms &#8220;Consolidated EBITDA&#8221; and &#8220;Consolidated Interest Expense,&#8221; each as defined in the Credit Agreement, include certain adjustments.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, due to the uncertainty at that time in the global capital markets, including the commercial paper markets, resulting from the COVID-19 pandemic, Altria elected to borrow the full $<ix:nonFraction unitRef="usd" contextRef="i634fff1d9b644e8cb5c918e89bad5ae8_D20200301-20200331" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMjIxMg_a62e9d5a-702f-4c68-9ea4-39935d3744f2">3.0</ix:nonFraction> billion available under the Credit Agreement as a precautionary measure to increase its cash position and preserve financial flexibility.  In June 2020, Altria repaid the full amount outstanding under the Credit Agreement using the net proceeds from the issuance of long-term senior unsecured notes issued in May 2020 and available cash.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any commercial paper issued by Altria and borrowings under the Credit Agreement are guaranteed by PM&#160;USA.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Debt</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying value of Altria&#8217;s total long-term debt at September&#160;30, 2021 and December&#160;31, 2020 was $<ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMjc0NQ_a4d014f3-8b68-4c16-860c-a1cfd5b75668">28.1</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMjc1Mg_dbcab7ba-5fee-4954-9087-45c2765d7a3e">29.5</ix:nonFraction> billion, respectively.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, Altria repaid in full senior unsecured notes in the aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="ib0080cbb283042c7ad61da99c612ad5a_D20210501-20210531" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfUnsecuredDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMjg2NQ_5d3c5f49-031b-4c19-b5f9-df4a60c36e5d">1.5</ix:nonFraction> billion at maturity.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, Altria issued long-term senior unsecured notes in the aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i2620d02ad1494d46ab52a4c075ab2c6b_I20210228" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMjk4Mw_2093457f-5d90-4bb4-9897-3feb20756bd4">5.5</ix:nonFraction> billion (the &#8220;Notes&#8221;).  The net proceeds from the Notes were used (i) to fund the purchase and redemption of certain unsecured notes and payment of related fees and expenses, as described below, and (ii) for other general corporate purposes.  The Notes contain the following terms:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">$<ix:nonFraction unitRef="usd" contextRef="i857205f0e0394b73ad424ddb571fbf8c_I20210228" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMzI2MQ_e820f3c8-d09f-4d42-a1de-6aa7c759da7a">1.75</ix:nonFraction> billion at <ix:nonFraction unitRef="number" contextRef="i857205f0e0394b73ad424ddb571fbf8c_I20210228" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMzI2Nw_89fb41bf-7eb8-4081-9a78-a8031856eced">2.450</ix:nonFraction>%, due 2032, interest payable semiannually beginning August 4, 2021;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">$<ix:nonFraction unitRef="usd" contextRef="idb779f48ef584729a5fa769c008b9ac8_I20210228" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMzMzOA_2420a3d2-ba42-4751-bc28-1ea09795bb83">1.50</ix:nonFraction> billion at <ix:nonFraction unitRef="number" contextRef="idb779f48ef584729a5fa769c008b9ac8_I20210228" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMzM0NA_372077c2-3594-4bb3-a5fe-a5903e3aa5c7">3.400</ix:nonFraction>%, due 2041, interest payable semiannually beginning August 4, 2021;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">$<ix:nonFraction unitRef="usd" contextRef="i72bc00d2c5e94db1be910ff08d7edb62_I20210228" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMzQxNA_7f673136-62fb-4f51-9efb-e2cf2dc43a5d">1.25</ix:nonFraction> billion at <ix:nonFraction unitRef="number" contextRef="i72bc00d2c5e94db1be910ff08d7edb62_I20210228" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMzQyMA_a865f5f8-d292-4750-a208-97f076197217">3.700</ix:nonFraction>%, due 2051, interest payable semiannually beginning August 4, 2021; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">$<ix:nonFraction unitRef="usd" contextRef="idd06b0461cd94297b50a5616b6cabc08_I20210228" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMzQ5NA_3343bad2-72ae-422d-b6e5-6dbd69280960">1.00</ix:nonFraction> billion at <ix:nonFraction unitRef="number" contextRef="idd06b0461cd94297b50a5616b6cabc08_I20210228" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMzUwMA_4897a29c-d826-4100-935e-041b06fde0af">4.000</ix:nonFraction>%, due 2061, interest payable semiannually beginning August 4, 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Notes are Altria&#8217;s senior unsecured obligations and rank equally in right of payment with all of Altria&#8217;s existing and future senior unsecured indebtedness.  Upon the occurrence of both (i) a change of control of Altria and (ii) the Notes ceasing to be rated investment grade by each of Moody&#8217;s, S&amp;P and Fitch Ratings, Inc. within a specified time period, Altria will be required to make an offer to purchase the Notes at a price equal to <ix:nonFraction unitRef="number" contextRef="ifc8423e2c5df46eea5b83d3f181cc413_D20210201-20210228" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNDAxMw_edf97e65-6a2a-4168-9f4f-b0584586c9ad">101</ix:nonFraction>% of the aggregate principal amount of such Notes, plus accrued and unpaid interest to the date of repurchase as and to the extent set forth in the terms of the Notes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The obligations of Altria under the Notes are guaranteed by PM USA.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="ibd108e60df5141929cf8ccfbb221a613"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNTI4Ng_83059b90-df51-4d03-87cc-2d59b5a2653d" escape="true"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, Altria completed debt tender offers to purchase for cash certain of its long-term senior unsecured notes in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="ic85fd5bdf74f4f0091c93c498eb3cc11_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNDQyNQ_e1972a46-56a6-4dc4-aa39-3e0c16c8ebd5">4,042</ix:nonFraction> million.  Details of the debt tender offers are as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal Amount of Notes Purchased</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2224c863f13e437d85f29be315d3c712_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfMS0wLTEtMS0wL3RleHRyZWdpb246NDRhZGFmOWZjMDNjNDY0ZjhlZWJhZWRlMzBiOTI3NzJfNA_0cc56b75-6d8d-4acd-a02c-7624ec789f6d">2.850</ix:nonFraction>% Notes due 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2224c863f13e437d85f29be315d3c712_I20210930" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfMS0xLTEtMS0w_b424dabf-e779-417a-a551-9be375b20ae8">795</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i808f87bc995d47d5a86a27d0ee9f22b4_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfMi0wLTEtMS0wL3RleHRyZWdpb246NjgyYjJmNjdiZjdiNDUwOWI2ZTU5ZmQzZDJlNTAxYjVfNA_a1657f26-2984-4960-8ae0-681c183182ea">2.950</ix:nonFraction>% Notes due 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808f87bc995d47d5a86a27d0ee9f22b4_I20210930" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfMi0xLTEtMS0w_a6ea437b-e24c-4bf5-a90d-fbd63bd2a715">132</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2502deb2ffd14f39bc40df7e2d62056e_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfMy0wLTEtMS0wL3RleHRyZWdpb246YjFmMjQ1YTRiZWRkNDhiMGIyOWU3MDRkMjg5MjVkZjdfNA_c604834e-b86d-4d21-a971-3b2caad111f6">4.000</ix:nonFraction>% Notes due 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2502deb2ffd14f39bc40df7e2d62056e_I20210930" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfMy0xLTEtMS0w_fab747a0-640f-4059-b365-f75336835675">624</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie52346405ce94721b9a8f4e6ccd91ef6_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfNC0wLTEtMS0wL3RleHRyZWdpb246MDdlZWViZTNjZWY0NDM4MTk0MGQ0NWQyNjBhNzkyNGZfNA_df84b60e-e995-455b-ac41-401b32fc1876">3.800</ix:nonFraction>% Notes due 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie52346405ce94721b9a8f4e6ccd91ef6_I20210930" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfNC0xLTEtMS0w_0ef13555-f376-4526-b6f7-2d12eda46be1">655</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icab982db20034341aa05031441a073b1_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfNS0wLTEtMS0wL3RleHRyZWdpb246NGQ5YzUyNjUyMjliNGMwY2E0MzNhNWRmMmVmMTE2MTlfNA_5c81171c-5163-4573-8c58-123e014c9e8b">4.400</ix:nonFraction>% Notes due 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icab982db20034341aa05031441a073b1_I20210930" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfNS0xLTEtMS0w_25a3f13e-569a-4484-ae6f-002b9c8778d6">430</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5d76ccb7e1a5434bb17c22937296a8ae_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfNi0wLTEtMS0wL3RleHRyZWdpb246ZTM1NmNmOTAwZWFlNDZhMWI1Yzc1NzVkMzk0YmQyNjBfNA_7e72a0cc-7e5f-447e-8628-37d54638ff6d">4.800</ix:nonFraction>% Notes due 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d76ccb7e1a5434bb17c22937296a8ae_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfNi0xLTEtMS0w_17c78a9f-ea93-4f85-b573-7696a6295851">1,094</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iffbca0a488934ac8a34f87b93f39560e_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfNy0wLTEtMS0wL3RleHRyZWdpb246YzQzOWM4NjBjOWY2NGQ0ZDkxM2RjNjc1N2YwN2ExYzVfNA_1b23df55-26c9-4f6a-b9da-8ffb12c66f84">9.950</ix:nonFraction>% Notes due 2038</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffbca0a488934ac8a34f87b93f39560e_I20210930" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfNy0xLTEtMS0w_f6b8cd42-a5f4-488f-9ca7-76a247b1afdb">65</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i61833c0644204fbfbcc52b66fce61e91_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfOC0wLTEtMS0wL3RleHRyZWdpb246NGVjYjZlNzA0NWY3NGY0NGFmYTBiZDkxYWY5OGQxZGJfNA_d1bdf8ec-50cb-423b-8967-2c2fb7d2d3e8">10.200</ix:nonFraction>% Notes due 2039</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61833c0644204fbfbcc52b66fce61e91_I20210930" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfOC0xLTEtMS0w_3b80f4bb-1aa3-460d-a1f7-97dd946de1cb">18</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i347f7da5d0054edbad9c6e2ea4a0651c_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfOS0wLTEtMS0wL3RleHRyZWdpb246ZDdjZGVkOGRjMGExNDkzMWFiYzA2OWQ3NjY1ZDhiZGFfNA_d03ca73d-defe-48ba-b368-06d3e5770f0b">6.200</ix:nonFraction>% Notes due 2059</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i347f7da5d0054edbad9c6e2ea4a0651c_I20210930" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfOS0xLTEtMS0w_1a2035c5-1b61-48af-af97-3436c2ce10ff">229</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic85fd5bdf74f4f0091c93c498eb3cc11_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfMTAtMS0xLTEtMA_e1972a46-56a6-4dc4-aa39-3e0c16c8ebd5">4,042</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, Altria also redeemed all of its outstanding <ix:nonFraction unitRef="number" contextRef="ic1fd6ffda965426487b95b70a8b31910_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNDU2MA_ca1573db-780b-4727-9b5d-f9c69d5b765f">3.490</ix:nonFraction>% Notes due 2022 in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i20e14cfe0c0d46339af63110c7811e34_D20210101-20210331" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNDYxNA_4b1c9adb-bcf1-4f94-ab73-3a322a0b5bf8">1.0</ix:nonFraction> billion.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the debt tender offers and redemption, during the first quarter of 2021, Altria recorded pre-tax losses on early extinguishment of debt of $<ix:nonFraction unitRef="usd" contextRef="ice0b95503da241eb84089a6759b1e50f_D20210101-20210331" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNDc3Mg_4e1f77c4-e6c3-43ca-8fb0-4c204174c75c">649</ix:nonFraction> million, which included premiums and fees of $<ix:nonFraction unitRef="usd" contextRef="ice0b95503da241eb84089a6759b1e50f_D20210101-20210331" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNDgxMg_3f62df37-a1ec-473b-a55b-dbbb5b1a004d">623</ix:nonFraction> million and the write-off of related unamortized debt discounts and debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="ice0b95503da241eb84089a6759b1e50f_D20210101-20210331" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNDg5OA_d6174176-039c-49a2-b88f-61a6ea3289ff">26</ix:nonFraction> million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021 and December&#160;31, 2020, accrued interest on long-term debt of $<ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:InterestPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNDk1NA_606e84b7-3354-43b6-b485-96671b95d040">206</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:InterestPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNDk2MQ_51ccebe2-7704-492e-bcd5-75953729ee9e">458</ix:nonFraction> million, respectively, was included in other accrued liabilities on Altria&#8217;s condensed consolidated balance sheets.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of the fair value of Altria&#8217;s long-term debt and the designation of its Euro denominated senior unsecured notes as a net investment hedge of its investment in ABI, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div><span><br/></span></div><div id="i295e56fb16f94dae9eacc631c56d466c_97"></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 11. <ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RleHRyZWdpb246M2ViZTg4MDQzNGQ2NDUzYTk2MDIyOWQwYWJhZmJiNDRfMTIwMw_0c17ce46-8321-44da-a1fa-34780b225b90" continuedAt="i9584037531df45b8b4eac243577d5017" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="i9584037531df45b8b4eac243577d5017" continuedAt="i4903c111c18e46c9a0d4dff19c81823c"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="mo:SummaryOfIncomeTaxesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RleHRyZWdpb246M2ViZTg4MDQzNGQ2NDUzYTk2MDIyOWQwYWJhZmJiNDRfMjE5OTAyMzI3NzA4Mg_3f9a4a90-29c5-4ac6-9206-e836e76de121" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Earnings (losses) before income taxes, provision (benefit) for income taxes and income tax rates consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjBiZmYxZmFkMzBjODQwOTE4MWIyODFiN2Y5MGQ1MDU0L3RhYmxlcmFuZ2U6MGJmZjFmYWQzMGM4NDA5MTgxYjI4MWI3ZjkwZDUwNTRfMi0yLTEtMS00OTgwNQ_14729549-bae0-4437-9f55-f1ca207159c1">1,544</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjBiZmYxZmFkMzBjODQwOTE4MWIyODFiN2Y5MGQ1MDU0L3RhYmxlcmFuZ2U6MGJmZjFmYWQzMGM4NDA5MTgxYjI4MWI3ZjkwZDUwNTRfMi00LTEtMS00OTgwNQ_f5893501-75bc-4e2f-8cc1-253074215a5e">4,349</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjBiZmYxZmFkMzBjODQwOTE4MWIyODFiN2Y5MGQ1MDU0L3RhYmxlcmFuZ2U6MGJmZjFmYWQzMGM4NDA5MTgxYjI4MWI3ZjkwZDUwNTRfMi02LTEtMS00OTgwNQ_05e3c760-27af-4548-8120-d18b73b3f01e">3,302</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjBiZmYxZmFkMzBjODQwOTE4MWIyODFiN2Y5MGQ1MDU0L3RhYmxlcmFuZ2U6MGJmZjFmYWQzMGM4NDA5MTgxYjI4MWI3ZjkwZDUwNTRfMi04LTEtMS00OTgwNQ_3baf5292-fbc1-4016-be27-d481b021929e">324</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision (benefit) for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjBiZmYxZmFkMzBjODQwOTE4MWIyODFiN2Y5MGQ1MDU0L3RhYmxlcmFuZ2U6MGJmZjFmYWQzMGM4NDA5MTgxYjI4MWI3ZjkwZDUwNTRfMy0yLTEtMS00OTgwNQ_d1a4369f-9028-49f4-a75b-b2c99d21d136">693</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjBiZmYxZmFkMzBjODQwOTE4MWIyODFiN2Y5MGQ1MDU0L3RhYmxlcmFuZ2U6MGJmZjFmYWQzMGM4NDA5MTgxYjI4MWI3ZjkwZDUwNTRfMy00LTEtMS00OTgwNQ_4123e773-356a-4d15-8b2d-4de11690a07f">1,817</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjBiZmYxZmFkMzBjODQwOTE4MWIyODFiN2Y5MGQ1MDU0L3RhYmxlcmFuZ2U6MGJmZjFmYWQzMGM4NDA5MTgxYjI4MWI3ZjkwZDUwNTRfMy02LTEtMS00OTgwNQ_6400eadf-2d6a-4a52-b71f-a7a83951a741">582</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjBiZmYxZmFkMzBjODQwOTE4MWIyODFiN2Y5MGQ1MDU0L3RhYmxlcmFuZ2U6MGJmZjFmYWQzMGM4NDA5MTgxYjI4MWI3ZjkwZDUwNTRfMy04LTEtMS00OTgwNQ_8a6e71f3-10fc-4cf0-a915-ec8d25a6c049">632</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax rate</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjBiZmYxZmFkMzBjODQwOTE4MWIyODFiN2Y5MGQ1MDU0L3RhYmxlcmFuZ2U6MGJmZjFmYWQzMGM4NDA5MTgxYjI4MWI3ZjkwZDUwNTRfNC0yLTEtMS01MDA1OA_7dbb1270-470f-4f51-a1a4-0bec2ff89495">44.9</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjBiZmYxZmFkMzBjODQwOTE4MWIyODFiN2Y5MGQ1MDU0L3RhYmxlcmFuZ2U6MGJmZjFmYWQzMGM4NDA5MTgxYjI4MWI3ZjkwZDUwNTRfNC00LTEtMS01MDA2NA_36b4e49e-622a-4808-85dc-90d90e2a9115">41.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjBiZmYxZmFkMzBjODQwOTE4MWIyODFiN2Y5MGQ1MDU0L3RhYmxlcmFuZ2U6MGJmZjFmYWQzMGM4NDA5MTgxYjI4MWI3ZjkwZDUwNTRfNC02LTEtMS01MDA3Mg_17b74217-4fb1-4e33-8643-cb24b9c0d59c">17.6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjBiZmYxZmFkMzBjODQwOTE4MWIyODFiN2Y5MGQ1MDU0L3RhYmxlcmFuZ2U6MGJmZjFmYWQzMGM4NDA5MTgxYjI4MWI3ZjkwZDUwNTRfNC04LTEtMS01MDA5MQ_6c04d5ff-bd4d-48c6-b1e0-b0a35d2f1a97">195.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s income tax rates for the nine and three months ended September 30, 2021 and 2020 are not comparable in a meaningful way due to the following significant pre-tax charges and valuation allowances:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the $<ix:nonFraction unitRef="usd" contextRef="ife49fc973ca746f092aa4d83bca9d740_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:EquityMethodInvestmentImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RleHRyZWdpb246M2ViZTg4MDQzNGQ2NDUzYTk2MDIyOWQwYWJhZmJiNDRfMjc0ODc3OTA5MDU1Mg_43b69887-e836-4433-9d85-30be1704a462"><ix:nonFraction unitRef="usd" contextRef="ic62d4fc827d0412695035c4816dc2a17_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:EquityMethodInvestmentImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RleHRyZWdpb246M2ViZTg4MDQzNGQ2NDUzYTk2MDIyOWQwYWJhZmJiNDRfMjc0ODc3OTA5MDU1Mg_a3b5d996-7b94-4612-8e99-24de2166adfc">6,157</ix:nonFraction></ix:nonFraction> million impairment of Altria&#8217;s equity investment in ABI during the nine and three months ended September 30, 2021;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the $<ix:nonFraction unitRef="usd" contextRef="iff7bce46de9948cfbbc1a3790debcee8_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RleHRyZWdpb246M2ViZTg4MDQzNGQ2NDUzYTk2MDIyOWQwYWJhZmJiNDRfMjc0ODc3OTA5MDU2Mg_47fd4983-27fe-40d1-9652-1ccc27ccb763"><ix:nonFraction unitRef="usd" contextRef="i26492b9b36f34d359befa59e3e1f285d_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RleHRyZWdpb246M2ViZTg4MDQzNGQ2NDUzYTk2MDIyOWQwYWJhZmJiNDRfMjc0ODc3OTA5MDU2Mg_df27a969-3c31-4d60-bbfa-3bbd1cb63fc1">2,600</ix:nonFraction></ix:nonFraction> million impairment of Altria&#8217;s investment in JUUL during the nine and three months ended September 30, 2020 and valuation allowances associated with Altria&#8217;s investments in JUUL and Altria&#8217;s Investment in Cronos.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s income tax rates for the nine and three months ended September 30, 2021 differ from the U.S. federal statutory rate of 21%, due primarily to the state tax treatment of the impairment charge on Altria&#8217;s equity investment in ABI.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s income tax rates for the nine and three months ended September 30, 2020 differ from the U.S. federal statutory rate of 21%, due primarily to valuation allowances primarily attributable to deferred tax assets recorded in connection with the impairment of Altria&#8217;s investment in JUUL, and Altria&#8217;s Investment in Cronos.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further information on the impairments of Altria&#8217;s equity investment in ABI and investment in JUUL, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="i4903c111c18e46c9a0d4dff19c81823c"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:SummaryOfValuationAllowanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RleHRyZWdpb246M2ViZTg4MDQzNGQ2NDUzYTk2MDIyOWQwYWJhZmJiNDRfMTIwMg_dad3f485-9472-41fd-8f88-495c6d0034a3" escape="true"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following chart provides a reconciliation of the beginning and ending valuation allowances for the period ended September&#160;30, 2021:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.130%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjAyYjc0MjdjZTQxMTQ5MzhhYzllNDc5MWQ2MmM1MGY2L3RhYmxlcmFuZ2U6MDJiNzQyN2NlNDExNDkzOGFjOWU0NzkxZDYyYzUwZjZfMS0yLTEtMS0w_fe526642-f00c-4433-a94b-f4c3b8c1aca5">2,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to valuation allowance charged to income tax expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="mo:ValuationAllowanceDeferredTaxAssetIncreaseInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjAyYjc0MjdjZTQxMTQ5MzhhYzllNDc5MWQ2MmM1MGY2L3RhYmxlcmFuZ2U6MDJiNzQyN2NlNDExNDkzOGFjOWU0NzkxZDYyYzUwZjZfMi0yLTEtMS0w_9a086ff7-723e-465b-b93b-24f5110ca03d">264</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions to valuation allowance credited to income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="mo:ValuationAllowanceDeferredTaxAssetDecreaseInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjAyYjc0MjdjZTQxMTQ5MzhhYzllNDc5MWQ2MmM1MGY2L3RhYmxlcmFuZ2U6MDJiNzQyN2NlNDExNDkzOGFjOWU0NzkxZDYyYzUwZjZfMy0yLTEtMS0w_1b2f14d7-2c04-4d74-96bd-9026cb03c11d">73</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" sign="-" name="mo:ValuationAllowanceForeignCurrencyTranslationAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjAyYjc0MjdjZTQxMTQ5MzhhYzllNDc5MWQ2MmM1MGY2L3RhYmxlcmFuZ2U6MDJiNzQyN2NlNDExNDkzOGFjOWU0NzkxZDYyYzUwZjZfNC0yLTEtMS0w_5b264c7e-c681-4f28-a5d4-e5c16afab1f8">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjAyYjc0MjdjZTQxMTQ5MzhhYzllNDc5MWQ2MmM1MGY2L3RhYmxlcmFuZ2U6MDJiNzQyN2NlNDExNDkzOGFjOWU0NzkxZDYyYzUwZjZfNS0yLTEtMS0w_25c1dc25-24dc-4577-a24c-b5c1f87e841c">3,004</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria determines the realizability of deferred tax assets based on the weight of available evidence, that it is more-likely-than-not that the deferred tax asset will not be realized. In reaching this determination, Altria considers all available positive and negative evidence, including the character of the loss, carryback and carryforward considerations, future reversals of temporary differences and available tax planning strategies.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current changes in valuation allowances were due to deferred tax assets recorded in connection with Altria&#8217;s Investment in Cronos and changes in the estimated fair value of its investment in JUUL.  The valuation allowance at the end of the period is primarily attributable to deferred tax assets recorded in connection with Altria&#8217;s investment in JUUL and Investment in Cronos.</span></div></ix:continuation><div><span><br/></span></div><div id="i295e56fb16f94dae9eacc631c56d466c_100"></div><div style="margin-bottom:5pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 12. <ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:LegalMattersAndContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzYyNTk0_7abcdf57-0268-44ca-9d11-8de5bb7eb8b8" continuedAt="i2b01b0bcdfba4775ab85a0119eb8739e" escape="true">Contingencies</ix:nonNumeric></span></div><ix:continuation id="i2b01b0bcdfba4775ab85a0119eb8739e" continuedAt="i05f49780e0d548e7a2091d18f5705e03"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal proceedings covering a wide range of matters are pending or threatened in various U.S. and foreign jurisdictions against Altria and its subsidiaries, including PM USA and USSTC, as well as their respective indemnitees and Altria&#8217;s investees.  Various types of claims may be raised in these proceedings, including product liability, unfair trade practices, antitrust, tax, contraband shipments, patent infringement, employment matters, claims alleging violation of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), claims for contribution and claims of competitors, shareholders or distributors.  Legislative action, such as changes to tort law, also may expand the types of claims and remedies available to plaintiffs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation is subject to uncertainty and it is possible that there could be adverse developments in pending or future cases.  An unfavorable outcome or settlement of pending tobacco-related or other litigation could encourage the commencement of additional litigation.  Damages claimed in some tobacco-related and other litigation are or can be significant and, in certain cases, have ranged in the billions of dollars.  The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome.  In certain cases, plaintiffs claim that defendants&#8217; liability is joint and several.  In such cases, Altria or its subsidiaries may face the risk that one or more co-defendants decline or otherwise fail to participate in the bonding required for an appeal or to pay their proportionate or jury-allocated share of a judgment.  As a result, Altria or its subsidiaries under certain circumstances may have to pay more than their proportionate share of any bonding- or judgment-related amounts.  Furthermore, in those cases where plaintiffs are successful, Altria or its subsidiaries also may be required to pay interest and attorneys&#8217; fees.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although PM USA has historically been able to obtain required bonds or relief from bonding requirements in order to prevent plaintiffs from seeking to collect judgments while adverse verdicts have been appealed, there remains a risk that such relief may not be obtainable in all cases.  This risk has been substantially reduced given that <ix:nonFraction unitRef="state" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="INF" name="mo:LossContingencyNumberofStatesThatCapBondorRequireNoBond" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI0MDk_03b91ae2-d9f6-45ab-a125-3dbdb2d8f3fa">47</ix:nonFraction> states and Puerto Rico limit the dollar amount of bonds or require no bond at all.  As discussed below, however, tobacco litigation plaintiffs have challenged the constitutionality of Florida&#8217;s bond cap statute in several cases and plaintiffs may challenge state bond cap statutes in other jurisdictions as well.  Such challenges may include the applicability of state bond caps in federal court.  States, including Florida, also may seek to repeal or alter bond cap statutes through legislation.  Although Altria cannot predict the outcome of such challenges, it is possible that the consolidated results of operations, cash flows or financial position of Altria, or one or more of its subsidiaries, could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome of one or more such challenges.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and its subsidiaries record provisions in the condensed consolidated financial statements for pending litigation when they determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated.  At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, except to the extent discussed elsewhere in this Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: (i)&#160;management has concluded that it is not probable that a loss has been incurred in any of the pending cases; (ii)&#160;management is unable to estimate the possible loss or range of loss that could result from an unfavorable outcome in any of the pending cases; and (iii)&#160;accordingly, management has not provided any amounts in the condensed consolidated financial statements for unfavorable outcomes, if any.  Litigation defense costs are expensed as incurred.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="i05f49780e0d548e7a2091d18f5705e03" continuedAt="ic69e900562ce474098206d44717ed876"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and its subsidiaries have achieved substantial success in managing litigation.  Nevertheless, litigation is subject to uncertainty and significant challenges remain.  It is possible that the consolidated results of operations, cash flows or financial position of Altria, or one or more of its subsidiaries, could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation.  Altria and each of its subsidiaries named as a defendant believe, and each has been so advised by counsel handling the respective cases, that it has valid defenses to the litigation pending against it, as well as valid bases for appeal of adverse verdicts.  Each of the companies has defended, and will continue to defend, vigorously against litigation challenges.  However, Altria and its subsidiaries may enter into settlement discussions in particular cases if they believe it is in the best interests of Altria to do so.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Judgments Paid and Provisions for Tobacco and Health and Certain Other Litigation Items (Including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Progeny Litigation): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After exhausting all appeals in those cases resulting in adverse verdicts associated with tobacco-related litigation, since October 2004, PM USA has paid judgments and settlements (including related costs and fees) totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i926660aafc7244e495754a8afa4f6531_D20041001-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesPaidValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNTkxODY_23450641-4137-4b67-b5b6-8449cb083147">865</ix:nonFraction> million and interest totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i926660aafc7244e495754a8afa4f6531_D20041001-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LitigationSettlementInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNTkyMjY_ad591dc7-2ef8-4cd3-883b-af1a6155d2ae">218</ix:nonFraction> million as of September 30, 2021.  These amounts include payments for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny judgments (and related costs and fees) totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i9a75c3716f9f44f8b0a633a8086be1e4_D20041001-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesPaidValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNTkzNjg_0fcbff62-a5c6-40d7-a6d4-d35b34e2ef97">410</ix:nonFraction> million and related interest totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i9a75c3716f9f44f8b0a633a8086be1e4_D20041001-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LitigationSettlementInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNTk0MTY_88838f0c-d5e2-492c-86cf-a60865e3c573">56</ix:nonFraction> million.</span></div><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIxOTkwMjMzNDg1NzA_7d4643f6-0366-49fa-83a2-a14c119f60b0" continuedAt="i7f91678534a14e66bce265dde916544b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in Altria&#8217;s accrued liability for tobacco and health and certain other litigation items, including related interest costs, for the periods specified below are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liability for tobacco and health and certain other  litigation items at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzItMS0xLTEtNTMxODk_8fad86d5-57d6-45c2-8214-c7e8a4a73184">9</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf636ab56ad4d7cb37b9d77019eed37_I20191231" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzItMy0xLTEtNTMxODk_8f88470c-d704-489c-bb98-6b87eaa77410">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3df7c108f2c5403c96f58e273f0dc0d1_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzItNS0xLTEtNTMxOTM_6d73b746-eb0f-40f7-bb56-8d65b18951e8">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967d1f95af3f41eda51eed3bfc8a12af_I20200630" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzItNy0xLTEtNTMxODk_58dec502-09a0-4a23-a0fd-1ff11b7cc3d4">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax charges for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3400b8bfff76440f9313bb4f3fb62ca3_D20210101-20210930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzQtMS0xLTEtNTMxODk_ef29e80f-c040-4d90-b1e1-4991e9c5f3ee">142</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica387b7fecba4bfebc8ddf8f17f04ad8_D20200101-20200930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzQtMy0xLTEtNTMxODk_1af78dff-0d92-4a5b-8d73-e2acf7bffdc8">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied52ab66233a43c196b987b68bd00b86_D20210701-20210930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzQtNS0xLTEtNTMxOTM_e2275338-3699-412d-9595-1998ae17210a">99</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5ef8014d73d4900afc3092294d2ca38_D20200701-20200930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzQtNy0xLTEtNTMxODk_88379e7c-5127-4f27-a647-398b27b1052b">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related interest costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3cc5d6b74f41e9aed08f62d1656e61_D20210101-20210930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzUtMS0xLTEtNTMxODk_3df1559a-1bc9-4b55-b6cf-d6a6315d6283">6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2529fcd54b74ef2a31abcd12138bb42_D20200101-20200930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzUtMy0xLTEtNTMxODk_f61cce80-bac2-494c-a501-337afcab9d54">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6645d5f78024731bf63efa024c27f2f_D20210701-20210930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzUtNS0xLTEtNTMxOTM_6cf09437-f918-4681-9696-f20abd671cb5">6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if53282b7834348a9a6ada854639fdbd1_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzUtNy0xLTEtNTMxODk_bbe30cb4-210c-43da-8aa3-c26b2d775851">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" decimals="-6" name="us-gaap:LossContingencyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzktMS0xLTEtNTMxODk_6ae6d8ee-3659-464b-9e73-10a2489d1d45">60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930" decimals="-6" name="us-gaap:LossContingencyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzktMy0xLTEtNTMxODk_fc2331f6-6f9d-4ce7-8bab-45d9669f0d12">81</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="-6" name="us-gaap:LossContingencyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzktNS0xLTEtNTMxOTM_26aec93d-b85f-4320-b05f-47c57ce5734a">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930" decimals="-6" name="us-gaap:LossContingencyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzktNy0xLTEtNTMxODk_1b07673a-f751-46ce-984b-e1507760da55">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liability for tobacco and health and certain other  litigation items at end of period</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzEwLTEtMS0xLTUzMTkz_56d2f1fa-cd52-40ad-b621-f1400b6e3b85">97</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b11e531794f48868e8b9e32c403e904_I20200930" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzEwLTMtMS0xLTUzMTkz_81ef5710-a39c-4ddf-8173-5c36ee318108">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzEwLTUtMS0xLTUzMTkz_3fb9b7d6-8c1a-4ab2-a0ab-2f0c006690a6">97</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b11e531794f48868e8b9e32c403e904_I20200930" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzEwLTctMS0xLTUzMTg5_01c135c9-30ef-4634-ba49-2c9fff1b74bc">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes amounts related to certain other litigation and pre-trial resolution of certain tobacco and health cases.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accrued liability for tobacco and health and certain other litigation items, including related interest costs, was included in accrued liabilities on Altria&#8217;s condensed consolidated balance sheets.  Pre-tax charges for tobacco and health and certain other litigation were included in marketing, administration and research costs on Altria&#8217;s condensed consolidated statements of earnings (losses).  Pre-tax charges for related interest costs were included in interest and other debt expense, net on Altria&#8217;s condensed consolidated statements of earnings (losses).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Security for Judgments: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To obtain stays of judgments pending appeal, PM USA has posted various forms of security.  As of September 30, 2021, PM USA has posted appeal bonds totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i3ea29768db1440de8cdfdba1d0ddb39f_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LitigationEscrowDeposit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNjA0MDQ_cf92ca66-ee45-4415-9e6f-379f600e6910">45</ix:nonFraction> million, which have been collateralized with restricted cash that are included in assets on the condensed consolidated balance sheets.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Altria and/or PM USA Tobacco-Related Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Types and Number of U.S. Cases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Claims related to tobacco products generally fall within the following categories: (i)&#160;smoking and health cases alleging personal injury brought on behalf of individual plaintiffs; (ii)&#160;health care cost recovery cases brought by governmental (both domestic and foreign) plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and/or disgorgement of profits; (iii) e-vapor cases alleging violation of RICO, fraud, failure to warn, design defect, negligence, antitrust and unfair trade practices; and (iv)&#160;other tobacco-related litigation described below.  Plaintiffs&#8217; theories of recovery and the defenses raised in tobacco-related litigation are discussed below.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="ic69e900562ce474098206d44717ed876" continuedAt="idd1790de2ec5494fbae69790e2ad5b3f"><ix:continuation id="i7f91678534a14e66bce265dde916544b" continuedAt="i1f3039dce32a4c708e326bd1b54edc40"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below lists the number of certain tobacco-related cases pending in the U.S. against PM USA and/or Altria as of October 25, 2021, October 27, 2020 and October 28, 2019:</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">October 25, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">October 27, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">October 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Smoking and Health Cases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i663ff20a0cf640f8ae7953fdba19634a_I20211025" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTpmYzIzZmUxYmI5YzI0YjQzYThjMWFlYjc2ZTkyZWUxYS90YWJsZXJhbmdlOmZjMjNmZTFiYjljMjRiNDNhOGMxYWViNzZlOTJlZTFhXzEtMS0xLTEtMA_7a93d09d-b5ca-4243-9761-0d21b4c90d3d">179</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="ia5ed554a97e64e58a2f7dff3f260635e_I20201027" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTpmYzIzZmUxYmI5YzI0YjQzYThjMWFlYjc2ZTkyZWUxYS90YWJsZXJhbmdlOmZjMjNmZTFiYjljMjRiNDNhOGMxYWViNzZlOTJlZTFhXzEtMy0xLTEtMA_96d48a20-2510-4825-931a-1cd8018e8150">142</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i35aefdfd25a54a77a106cbf1a1685ab5_I20191028" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTpmYzIzZmUxYmI5YzI0YjQzYThjMWFlYjc2ZTkyZWUxYS90YWJsZXJhbmdlOmZjMjNmZTFiYjljMjRiNDNhOGMxYWViNzZlOTJlZTFhXzEtNS0xLTEtMA_4f2e3eb0-27e3-4183-9e5b-6e0a85a6fec2">95</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Cost Recovery Actions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i20886114cad04457981190cedb862851_I20211025" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTpmYzIzZmUxYmI5YzI0YjQzYThjMWFlYjc2ZTkyZWUxYS90YWJsZXJhbmdlOmZjMjNmZTFiYjljMjRiNDNhOGMxYWViNzZlOTJlZTFhXzItMS0xLTEtMA_7c401007-b113-46fd-a8f6-5f53414c9a44">1</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="ibf6d7d9ce89842c7976f502120165e8c_I20201027" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTpmYzIzZmUxYmI5YzI0YjQzYThjMWFlYjc2ZTkyZWUxYS90YWJsZXJhbmdlOmZjMjNmZTFiYjljMjRiNDNhOGMxYWViNzZlOTJlZTFhXzItMy0xLTEtMA_f895406d-84a6-4a48-b7f7-e192f9c126e6">1</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i2704bd9b49ac4bdc8fb4f82a270c44ef_I20191028" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTpmYzIzZmUxYmI5YzI0YjQzYThjMWFlYjc2ZTkyZWUxYS90YWJsZXJhbmdlOmZjMjNmZTFiYjljMjRiNDNhOGMxYWViNzZlOTJlZTFhXzItNS0xLTEtMA_b0dc73b1-d5cc-46d8-9826-6b32a5d86068">1</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-vapor Cases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i2d4206f6a0024fed8cfaa7a66fcf85d9_I20211025" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTpmYzIzZmUxYmI5YzI0YjQzYThjMWFlYjc2ZTkyZWUxYS90YWJsZXJhbmdlOmZjMjNmZTFiYjljMjRiNDNhOGMxYWViNzZlOTJlZTFhXzMtMS0xLTEtMA_ec2f2e04-cd7d-48e6-ab39-f4d5071b557b">2,951</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i71b573459eca4bea97af58bf49c87201_I20201027" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTpmYzIzZmUxYmI5YzI0YjQzYThjMWFlYjc2ZTkyZWUxYS90YWJsZXJhbmdlOmZjMjNmZTFiYjljMjRiNDNhOGMxYWViNzZlOTJlZTFhXzMtMy0xLTEtMA_84a8e95a-d667-442e-b1ac-413c1a6223fe">1,145</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="icaf8b745a94b42ccad21473588116847_I20191028" decimals="INF" format="ixt:fixed-zero" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTpmYzIzZmUxYmI5YzI0YjQzYThjMWFlYjc2ZTkyZWUxYS90YWJsZXJhbmdlOmZjMjNmZTFiYjljMjRiNDNhOGMxYWViNzZlOTJlZTFhXzMtNS0xLTEtMA_06f91d0b-1056-4cac-99a4-42579bd5349f">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Tobacco-Related Cases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i12bdefb971104deda60ea7c60dd43501_I20211025" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTpmYzIzZmUxYmI5YzI0YjQzYThjMWFlYjc2ZTkyZWUxYS90YWJsZXJhbmdlOmZjMjNmZTFiYjljMjRiNDNhOGMxYWViNzZlOTJlZTFhXzQtMS0xLTEtMA_dba9f0ae-e5ff-49fc-bbca-99c0223514c4">3</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="ib3dbb26207114dcbb85df4982dbc5033_I20201027" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTpmYzIzZmUxYmI5YzI0YjQzYThjMWFlYjc2ZTkyZWUxYS90YWJsZXJhbmdlOmZjMjNmZTFiYjljMjRiNDNhOGMxYWViNzZlOTJlZTFhXzQtMy0xLTEtMA_9b61eab7-c34e-434f-b4f7-5f1f32496ec2">4</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i2b166612ac8e4f99b7ad03601c8126b7_I20191028" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTpmYzIzZmUxYmI5YzI0YjQzYThjMWFlYjc2ZTkyZWUxYS90YWJsZXJhbmdlOmZjMjNmZTFiYjljMjRiNDNhOGMxYWViNzZlOTJlZTFhXzQtNS0xLTEtMA_23819de9-eb9e-4786-8489-964b4b7269d4">4</ix:nonFraction></span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes <ix:nonFraction unitRef="claim" contextRef="i1b18278bbd184abca4253784cfde6900_I20211025" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzYwODI_3f1b733c-9d1b-4d41-8949-601880690c28">18</ix:nonFraction> cases filed in Illinois, <ix:nonFraction unitRef="claim" contextRef="i223b3b59e9644a15b7fe55e88c315de3_I20211025" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzYxMTA_eaed9f6c-084f-4c66-b6eb-770ec50fd81c">17</ix:nonFraction> cases filed in New Mexico, <ix:nonFraction unitRef="claim" contextRef="if18a359a02814e81ac2e7da57ce8914e_I20211025" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzYxNDA_65741eb2-8a20-4f18-af45-cf1a61f78359">40</ix:nonFraction> cases filed in Massachusetts and <ix:nonFraction unitRef="claim" contextRef="ic2722814648844259fc7fba910bcb8f0_I20211025" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzYxNzY_b068119c-348e-4a7d-a78c-f9bc40bda403">70</ix:nonFraction> non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">cases filed in Florida.  Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">case (these </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> progeny cases are discussed below in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Engle Class Action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  Also does not include <ix:nonFraction unitRef="case" contextRef="i11bb0f709f4840c9a6ba836ea86e439b_D20211025-20211025" decimals="INF" format="ixt:num-dot-decimal" name="mo:LossContingencyNumberOfCases" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzY1MTU_ce6abc99-38ef-4427-99f0-7238c17e13ce">1,471</ix:nonFraction> cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (&#8220;ETS&#8221;).  The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Broin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages.  Class members were prohibited from filing individual lawsuits after 2000 under the court-approved settlement.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation - Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> below.</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes <ix:nonFraction unitRef="lawsuit" contextRef="i2d4206f6a0024fed8cfaa7a66fcf85d9_I20211025" decimals="INF" name="mo:LossContingencyClassActionLawsuit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzcyMDk_d14fd3fe-2231-4d69-9fbc-3111fe17fbc9">53</ix:nonFraction> class action lawsuits, <ix:nonFraction unitRef="claim" contextRef="i7e914a4a2b8344169accefce0c454834_I20211025" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzcyMzU_334aff9f-9a4e-4153-bd48-a602ddf4ea2a">2,548</ix:nonFraction> individual lawsuits and <ix:nonFraction unitRef="claim" contextRef="iaeab395fb605402fb5a6b9c5bdc4a711_I20211025" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzcyNjI_fd09b3bf-5ef4-4ce4-8289-8d4d22486689">350</ix:nonFraction> &#8220;third party&#8221; lawsuits relating to JUUL e-vapor products, which include school districts, state and local government, tribal and healthcare organization lawsuits.  JUUL is an additional named defendant in each of these lawsuits. The <ix:nonFraction unitRef="lawsuit" contextRef="i2d4206f6a0024fed8cfaa7a66fcf85d9_I20211025" decimals="INF" name="mo:LossContingencyClassActionLawsuit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzc0OTg_d14fd3fe-2231-4d69-9fbc-3111fe17fbc9">53</ix:nonFraction> class action lawsuits include <ix:nonFraction unitRef="claim" contextRef="i4d5084fb63864e7d87b275079786c20d_I20211025" decimals="INF" name="mo:LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzc1MzE_f63adaac-038f-4711-8c34-8460c3c026be">28</ix:nonFraction> cases in the Northern District of California (&#8220;Multidistrict Litigation&#8221; or &#8220;MDL&#8221;) involving plaintiffs whose claims were previously included in other class action complaints but were refiled as separate stand-alone class actions for procedural and other reasons.</span></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes <ix:nonFraction unitRef="case" contextRef="i12bdefb971104deda60ea7c60dd43501_I20211025" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberOfInactiveCases" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzc4MTM_c467c519-bc73-4e54-b72b-7db98c72d311">one</ix:nonFraction> inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and <ix:nonFraction unitRef="case" contextRef="i12bdefb971104deda60ea7c60dd43501_I20211025" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberOfInactiveClassActionLawsuits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzc5NTM_ddf612b1-b8f8-46e4-9a5b-462ea1ad53cb">two</ix:nonFraction> inactive class action lawsuits alleging that use of the terms &#8220;Lights&#8221; and &#8220;Ultra Lights&#8221; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.</span></div></ix:continuation><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">International Tobacco-Related Cases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 25, 2021, (i) Altria is named as a defendant in <ix:nonFraction unitRef="claim" contextRef="i656d506fcc8a4b9ab2659e2676677a0a_I20211025" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzgyODQ_4a7f70db-2672-432b-a744-2cce7203459b">three</ix:nonFraction> e-vapor class action lawsuits in Canada; (ii) PM USA is a named defendant in <ix:nonFraction unitRef="claim" contextRef="ibd987a82f3714a11b7e8c291d69672a9_I20211025" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzgzNjQ_57a9f6aa-150b-460e-bff2-1c31820bfe9b">10</ix:nonFraction> health care cost recovery actions in Canada, <ix:nonFraction unitRef="claim" contextRef="ia9e0a1f532ea4ebf81ee548bc37ef0cc_I20211025" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzg0MTI_07a3d2ad-2959-4ee9-8e0c-34ab6f1e7076">eight</ix:nonFraction> of which also name Altria as a defendant; and (iii) PM USA and Altria are named as defendants in <ix:nonFraction unitRef="claim" contextRef="i61b4bd1b44014f77ba98ffaddac70a1c_I20211025" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzg1MTI_e0bc12c8-b85f-493c-8b92-3069b5b85c98">seven</ix:nonFraction> smoking and health class actions filed in various Canadian provinces.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the Distribution Agreement between Altria and Philip Morris International Inc. (&#8220;PMI&#8221;) that provides for indemnities for certain liabilities concerning tobacco products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tobacco-Related Cases Set for Trial: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 25, 2021, <ix:nonFraction unitRef="case" contextRef="i90226fb36aa64d6bacef37bf4db3884b_I20211025" decimals="INF" format="ixt:fixed-zero" name="mo:LossContingencyNumberofCasesSetforTrial" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzg4ODE_7d987095-db43-479d-8b7e-ba7a97ae5874">no</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny or individual smoking and health cases against PM USA are set for trial through December 31, 2021.  Trial dates are subject to change and many of the trials were postponed due to the COVID-19 pandemic; however, the courts are reopening and additional trials may be scheduled for the remainder of 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trial Results: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 1999, excluding the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases (separately discussed below), verdicts have been returned in <ix:nonFraction unitRef="case" contextRef="i90fcd7f5574440a5ab359cb20e1a04c8_D19990101-20211025" decimals="INF" name="mo:LossContingencyClaimsDecided" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzkyODk_159facdd-0afd-4510-8951-81f119a450ae">69</ix:nonFraction> tobacco-related cases in which PM USA was a defendant. Verdicts in favor of PM USA and other defendants were returned in <ix:nonFraction unitRef="case" contextRef="i90fcd7f5574440a5ab359cb20e1a04c8_D19990101-20211025" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk0MTM_05be57d2-3a3a-439b-9c81-5a5091d9302d">44</ix:nonFraction> of the <ix:nonFraction unitRef="case" contextRef="i90fcd7f5574440a5ab359cb20e1a04c8_D19990101-20211025" decimals="INF" name="mo:LossContingencyClaimsDecided" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk0MjM_159facdd-0afd-4510-8951-81f119a450ae">69</ix:nonFraction> cases.  These <ix:nonFraction unitRef="case" contextRef="i90fcd7f5574440a5ab359cb20e1a04c8_D19990101-20211025" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk0NDA_05be57d2-3a3a-439b-9c81-5a5091d9302d">44</ix:nonFraction> cases were tried in Alaska (<ix:nonFraction unitRef="case" contextRef="idce33acf337c4fe9a1645ddb2e019e7f_D19990101-20211025" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk0NzE_4c8dbc2d-8e63-4f7b-90ff-af11dd9ad6c4">1</ix:nonFraction>), California (<ix:nonFraction unitRef="case" contextRef="id289701c573b45cca1a140d0c73c998a_D19990101-20211025" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk0ODg_22ba26e2-4181-4f70-a9dc-3dea6708d924">7</ix:nonFraction>), Connecticut (<ix:nonFraction unitRef="case" contextRef="i8d46d835a2d24d1ebd56341154a639d8_D19990101-20211025" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk1MDY_ac4e25af-9842-4d07-bef6-cd1b3503bbfd">1</ix:nonFraction>), Florida (<ix:nonFraction unitRef="case" contextRef="i6f2e6b71ad0c495aa1c5d1de5f3d1b7f_D19990101-20211025" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk1MjA_828ad3ff-6e54-4497-9449-a850e6f4b7a8">10</ix:nonFraction>), Louisiana (<ix:nonFraction unitRef="case" contextRef="ie3500d94f16d4d48be23dbcd39c4724d_D19990101-20211025" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk1MzY_dcf8c667-b9dd-47d9-98a0-b18076b850b7">1</ix:nonFraction>), Massachusetts (<ix:nonFraction unitRef="case" contextRef="i68a963409b744c62ada96bbe606437d0_D19990101-20211025" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk1NTY_670ce984-8756-4374-97da-04161375e730">4</ix:nonFraction>), Mississippi (<ix:nonFraction unitRef="case" contextRef="i5a74a591f616416a8beecae26d6b025a_D19990101-20211025" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk1NzQ_fedec37f-ab06-4234-8aa9-8ecaec3f23a9">1</ix:nonFraction>), Missouri (<ix:nonFraction unitRef="case" contextRef="i080e23384aca46ac97b6d8534dd6870f_D19990101-20211025" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk1ODk_5e3b239a-8ff2-415c-88e5-26f27445a502">4</ix:nonFraction>), New Hampshire (<ix:nonFraction unitRef="case" contextRef="if89eceae6818421ab7e71078e8640a23_D19990101-20211025" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk2MDk_d354be8b-0197-4aa0-9bbe-031363c9ec8c">1</ix:nonFraction>), New Jersey (<ix:nonFraction unitRef="case" contextRef="ia3434a001edb4107b89f9f106fa2815e_D19990101-20211025" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk2MjY_80ad797f-944d-45bd-b4a3-a8e4857559ee">1</ix:nonFraction>), New York (<ix:nonFraction unitRef="case" contextRef="i8dbfceaeded0450399ee40b258518a3e_D19990101-20211025" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk2NDE_af9c1c43-1ad6-46f4-a246-fd82290ff4ee">5</ix:nonFraction>), Ohio (<ix:nonFraction unitRef="case" contextRef="i5569874aeca64116b11922db9cb7839b_D19990101-20211025" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk2NTI_83d5f591-615c-4e18-91b1-c2998b9b27d1">2</ix:nonFraction>), Pennsylvania (<ix:nonFraction unitRef="case" contextRef="ib231c8aea8fd44718baa2914cd6cba3f_D19990101-20211025" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk2NzE_f607ab93-e7ca-4216-80b6-c54ab95252f7">1</ix:nonFraction>), Rhode Island (<ix:nonFraction unitRef="case" contextRef="i552ef3865e7d48829a38177ee62b4979_D19990101-20211025" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk2OTA_31b40851-4f85-42b2-ae5e-61ae07e46f06">1</ix:nonFraction>), Tennessee (<ix:nonFraction unitRef="case" contextRef="id38fc93aeda6476b9dac24a91fd1cf6d_D19990101-20211025" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk3MDY_d2d600be-6fd2-4ee9-a424-dcbf2d179719">2</ix:nonFraction>) and West Virginia (<ix:nonFraction unitRef="case" contextRef="ia00a1362eff94111880c5d8063950c56_D19990101-20211025" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk3Mjk_d8cafe08-cc63-45f8-8833-ee9935b1427a">2</ix:nonFraction>).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the <ix:nonFraction unitRef="case" contextRef="i90fcd7f5574440a5ab359cb20e1a04c8_D19990101-20211025" decimals="INF" name="mo:LossContingencyClaimsDecidedUnfavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk3NDE_08ef4441-8fb5-4ad4-87a4-3062cd5f4a41">25</ix:nonFraction> non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in which verdicts were returned in favor of plaintiffs, <ix:nonFraction unitRef="case" contextRef="i90fcd7f5574440a5ab359cb20e1a04c8_D19990101-20211025" decimals="INF" name="mo:LossContingencyClaimsResolvedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk4MjQ_06d4c3a0-b1ad-44ed-871f-4e221dbc661b">20</ix:nonFraction> have reached final resolution, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and <ix:nonFraction unitRef="case" contextRef="i90fcd7f5574440a5ab359cb20e1a04c8_D19990101-20211025" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyVerdictReversedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk4NjI_c5c48f28-a6e0-4225-bc6b-c53b6a727613">two</ix:nonFraction> cases (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gentile </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Principe</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) that were initially returned in favor of plaintiffs were reversed post-trial and remain pending.</span></div><div style="margin-bottom:5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Liti</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">gation - Engle Progeny Trial Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of verdicts in state and federal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases involving PM USA as of October 25, 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Smoking and Health Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plaintiffs&#8217; allegations of liability in smoking and health cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, nuisance, breach of express and implied warranties, breach of special duty, conspiracy, concert of action, violations of unfair trade practice laws and consumer protection statutes, and claims under the federal and state anti-racketeering statutes.  Plaintiffs in the smoking and health cases seek various forms of relief, including compensatory and punitive damages, treble/multiple damages and other statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and equitable relief.  Defenses raised in these cases include lack of proximate cause, assumption of the risk, comparative fault and/or contributory negligence, statutes of limitations and preemption by the Federal Cigarette Labeling and Advertising Act.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="idd1790de2ec5494fbae69790e2ad5b3f" continuedAt="i27e72f3d4e464fa8876747e1190c8bb0"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Progeny Litigation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny smoking and health cases pending during 2021 in which a verdict was returned in favor of plaintiff and against PM USA.  Charts listing certain verdicts for plaintiffs in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases can be found in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Engle Progeny Trial Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In February 2020, a jury in a Florida state court returned a verdict in favor of plaintiff and against PM USA, awarding approximately $<ix:nonFraction unitRef="usd" contextRef="i052ec416024f4823bef90cd01d8b4153_I20200229" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzEzMzYz_22ff336b-7f89-4096-abcd-3df0322b7130">11</ix:nonFraction> million in compensatory damages.  There was <ix:nonFraction unitRef="usd" contextRef="i052ec416024f4823bef90cd01d8b4153_I20200229" decimals="INF" format="ixt:fixed-zero" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzEzNDAy_898c8742-bc2e-4f2d-9054-ce9263eb1453">no</ix:nonFraction> claim for punitive damages.  PM USA appealed the trial court verdict to the Third District Court of Appeal and, in September 2021, the appellate court reversed the trial court&#8217;s decision and found in favor of PM USA.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Greene</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In September 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiffs and against PM USA, awarding approximately $<ix:nonFraction unitRef="usd" contextRef="i517f019e7c1743319a6e9441dc360c47_I20190930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzEzNjUw_96ed6e3b-f5f4-40fe-85ce-016f09d937e0">10</ix:nonFraction> million in compensatory damages.  In May 2020, the court ruled on plaintiffs&#8217; remaining claim and trebled the compensatory damages award to approximately $<ix:nonFraction unitRef="usd" contextRef="ib96d34ed4ae34693801830017a4f6049_I20200531" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzEzNzk5_b0c308c7-f611-4be8-9a86-50de289399ae">30</ix:nonFraction> million.  In February 2021, the trial court awarded plaintiffs attorneys&#8217; fees and costs in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="i7ea87da7184343c09f4ee1578cc648ee_I20210228" decimals="-5" format="ixt:num-dot-decimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzEzOTE0_9eb8e57e-a7b7-4f39-9cd4-1bf6ce4479a4">2.3</ix:nonFraction> million.  Also in February 2021, PM USA served its post-trial motions to reverse the judgment or for a new trial. The trial court denied the post-trial motions in June 2021.  In July 2021, PM USA appealed the judgment to the Appeals Court of Massachusetts.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Laramie</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In August 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiff and against PM USA, awarding $<ix:nonFraction unitRef="usd" contextRef="ifa32d699351d4292af9042e00b380590_I20190831" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE0Mjg5_9f28d4d9-c75a-4f7c-ad74-bcee2bcc09ec">11</ix:nonFraction> million in compensatory damages and $<ix:nonFraction unitRef="usd" contextRef="ifa32d699351d4292af9042e00b380590_I20190831" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE0MzIw_1362e064-5b71-4a42-ab4f-7affda1454f1">10</ix:nonFraction> million in punitive damages.  PM USA appealed and, in February 2021, the Massachusetts Supreme Judicial Court asserted jurisdiction over the appeal.  In September 2021, the Massachusetts Supreme Judicial Court affirmed the trial court award of $<ix:nonFraction unitRef="usd" contextRef="id38820dc93e04812843942939c4e6352_D20210901-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNDE2NzA_b3ae4e1d-5b4b-409b-a813-2675c68a3dda">21</ix:nonFraction> million in compensatory and punitive damages.  PM USA recorded a pre-tax provision of approximately $<ix:nonFraction unitRef="usd" contextRef="id38820dc93e04812843942939c4e6352_D20210901-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNDE2ODU_639258e4-74ef-4275-a849-1394b50842d9">27.1</ix:nonFraction> million for the judgment, including interest, in the third quarter of 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gentile</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In October 2017, a jury in a Florida state court returned a verdict in favor of plaintiff and against PM USA, awarding approximately $<ix:nonFraction unitRef="usd" contextRef="i9edffb5157944c1b92f53a2aa6e6ff0a_I20171031" decimals="-5" format="ixt:num-dot-decimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE0NjEy_9e22e498-b341-4e92-8e75-526b861a71b7">7.1</ix:nonFraction> million in compensatory damages and allocating <ix:nonFraction unitRef="number" contextRef="i7e21fbb1029544a7bf549cf560acc7df_I20171031" decimals="2" name="mo:LossContingencyCompensatoryDamagesAwardedAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE0NjU0_cefba787-b6ac-4bcd-8535-1bd32de35942">75</ix:nonFraction>% of the fault to PM USA.  PM USA appealed.  In September 2019, the Florida Fourth District Court of Appeal reversed the judgment entered by the trial court, granted PM USA judgment on certain claims and remanded for a new trial on the remaining claims.  Plaintiff petitioned the Florida Supreme Court for further review, which the court denied in January 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation - Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the verdict and post-trial developments in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> health care cost recovery case.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Class Action: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2000, in the second phase of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> smoking and health class action in Florida, a jury returned a verdict assessing punitive damages totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i5287e7b9447640e785f900c6e40cbb09_I20000731" decimals="-9" format="ixt:num-dot-decimal" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE1NDM3_27d16adb-9471-4fc1-a759-9b5dbe7fc198">145</ix:nonFraction> billion against various defendants, including $<ix:nonFraction unitRef="usd" contextRef="i3a5d377b4b3f458eba4a9e7b517b8e16_I20000731" decimals="-9" format="ixt:num-dot-decimal" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE1NDc4_772df556-6eff-4be7-a937-c646f65dea79">74</ix:nonFraction> billion against PM USA.  Following entry of judgment, PM USA appealed.  In May 2003, the Florida Third District Court of Appeal reversed the judgment entered by the trial court and instructed the trial court to order the decertification of the class.  Plaintiffs petitioned the Florida Supreme Court for further review.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2006, the Florida Supreme Court ordered that the punitive damages award be vacated, that the class approved by the trial court be decertified and that members of the decertified class could file individual actions against defendants within <ix:nonNumeric contextRef="i9a03e98802a847ef9e56a147ecdc0b02_D20060701-20060731" format="ixt-sec:durwordsen" name="mo:LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE2MDQx_4f411703-8d97-4694-be21-61b48a186b6f">one year</ix:nonNumeric> of issuance of the mandate.  The court further declared the following Phase I findings are entitled to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">res judicata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> effect in such individual actions brought within <ix:nonNumeric contextRef="i9a03e98802a847ef9e56a147ecdc0b02_D20060701-20060731" format="ixt-sec:durwordsen" name="mo:LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE2MjA5_88ae6915-870e-44da-8c98-f71cbe57091e">one year</ix:nonNumeric> of the issuance of the mandate: (i)&#160;that smoking causes various diseases; (ii)&#160;that nicotine in cigarettes is addictive; (iii)&#160;that defendants&#8217; cigarettes were defective and unreasonably dangerous; (iv)&#160;that defendants concealed or omitted material information not otherwise known or available knowing that the material was false or misleading or failed to disclose a material fact concerning the health effects or addictive nature of smoking; (v)&#160;that defendants agreed to misrepresent information regarding the health effects or addictive nature of cigarettes with the intention of causing the public to rely on this information to their detriment; (vi)&#160;that defendants agreed to conceal or omit information regarding the health effects of cigarettes or their addictive nature with the intention that smokers would rely on the information to their detriment; (vii)&#160;that all defendants sold or supplied cigarettes that were defective; and (viii)&#160;that defendants were negligent.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2006, PM USA and plaintiffs sought rehearing from the Florida Supreme Court on parts of its July 2006 opinion.  In December 2006, the Florida Supreme Court refused to revise its July 2006 ruling, except that it revised the set of Phase I findings entitled to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">res judicata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> effect by excluding finding (v)&#160;listed above (relating to agreement to misrepresent information), and added the finding that defendants sold or supplied cigarettes that, at the time of sale or supply, did not conform to the representations of fact made by defendants.  In February 2008, the trial court decertified the class.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pending </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">e Progeny Cases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The deadline for filing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases expired in January 2008, at which point a total of approximately <ix:nonFraction unitRef="claim" contextRef="id970cacb82804a6dafd9bb28ce0e0227_I20080131" decimals="-2" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE3OTM3_289d0c2c-e74a-411d-84b0-f29f76d04e1b">9,300</ix:nonFraction> federal and state claims were pending.  As of October 25, 2021, approximately <ix:nonFraction unitRef="claim" contextRef="i781149ad13854355a035d0bcc92ce4e5_I20211025" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE4MDE1_64f04954-83d3-4033-8cab-71b34f6a5bf5">1,026</ix:nonFraction> state court cases were pending against PM USA or Altria asserting individual claims by or on behalf of approximately <ix:nonFraction unitRef="plantiff" contextRef="i0285dbb248214e6b82f1b1e1fca99520_D20211025-20211025" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE4MTM1_ea293a7a-616c-4221-a433-e3c3689322e9">1,285</ix:nonFraction> state court plaintiffs.&#160; Because of a number of factors, including docketing delays, duplicated filings and overlapping dismissal orders, these numbers are estimates.  While the Federal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agreement (discussed below) resolved nearly all </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases pending in federal court, as of October 25, 2021, <ix:nonFraction unitRef="claim" contextRef="if243dafacad643ca8a92639963f3f04f_I20211025" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE4NDQ1_a46b418c-99ed-455d-a68c-fe0d07b830bd">two</ix:nonFraction> cases were pending against PM USA in federal court representing the cases excluded from that agreement.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="i27e72f3d4e464fa8876747e1190c8bb0" continuedAt="i59a8a0e1f88647948c94fbc4babfb655"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Progeny Trial Results: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 25, 2021, <ix:nonFraction unitRef="case" contextRef="i85fafeeb94a94367a935be26dbab3f38_D20211025-20211025" decimals="INF" name="mo:LossContingencyClaimsDecided" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE4NjAy_6f38b492-6f70-4af9-8a21-a9d3472c2a4b">137</ix:nonFraction> federal and state </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases involving PM USA have resulted in verdicts since the Florida Supreme Court </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decision.  <ix:nonFraction unitRef="case" contextRef="i85fafeeb94a94367a935be26dbab3f38_D20211025-20211025" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyClaimsDecidedUnfavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE4NzM1_2cde145a-67ac-438c-9d24-1b64767e479e">Seventy-six</ix:nonFraction> verdicts were returned in favor of plaintiffs and <ix:nonFraction unitRef="case" contextRef="i90226fb36aa64d6bacef37bf4db3884b_I20211025" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyUnfavorableVerdictsPendingReversed" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE4Nzg4_d41e5750-cbfe-409b-80cc-aa72fe83eb86">seven</ix:nonFraction> verdicts (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skolnick</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Calloway</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oshinsky-Blacker,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">McCoy, Mahfuz, Neff and Frogel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) that were initially returned in favor of plaintiffs were reversed post-trial or on appeal and remain pending.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="case" contextRef="i85fafeeb94a94367a935be26dbab3f38_D20211025-20211025" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE4OTgx_e334a32b-a844-432d-974e-eb01b4721b56">Fifty-four</ix:nonFraction> verdicts were returned in favor of PM USA, of which <ix:nonFraction unitRef="case" contextRef="i1eb0635e87454a0fa2b2eec4909179e5_D20211025-20211025" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE5MDM2_4050b6b9-9af1-46d2-9e54-957d8903f7b6">44</ix:nonFraction> were state cases.  In addition, there have been a number of mistrials, only some of which have resulted in new trials as of October 25, 2021.  The jury in one case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Garcia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, awarded plaintiff compensatory damages and found plaintiff was entitled to punitive damages; however, the court declared a mistrial in the second phase of the trial regarding punitive damages because the jury was unable to determine the amount of the punitive damages. <ix:nonFraction unitRef="case" contextRef="ibfc1fdbaa928482089e8a85cb409cd50_D20211025-20211025" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyVerdictReversedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE5NDc4_6144ea19-ed77-4f53-9892-cd08dfbe95ed">Four</ix:nonFraction> verdicts (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearson, D. Cohen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collar </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Chacon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) that were returned in favor of PM USA were subsequently reversed for new trials.  Juries in <ix:nonFraction unitRef="case" contextRef="ie96b5489b60e4b18b201d51a8582e17d_D20211025-20211025" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyZeroDamagesVerdicts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE5NjIx_d8d38cef-fcd5-4f97-af21-51f58a470982">two</ix:nonFraction> cases (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reider </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Banks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">returned <ix:nonFraction unitRef="usd" contextRef="ie96b5489b60e4b18b201d51a8582e17d_D20211025-20211025" decimals="INF" format="ixt:fixed-zero" name="us-gaap:LossContingencyDamagesAwardedValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE5NjU4_e1688240-192a-448a-b693-f527683059de">zero</ix:nonFraction> damages verdicts in favor of PM USA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Juries in <ix:nonFraction unitRef="case" contextRef="ie0be9670c3294c5380d9907c287d1387_D20211025-20211025" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyZeroDamagesVerdictModified" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE5NzA5_6d8a047f-6db9-41a5-acf7-50ba89dfc163">two</ix:nonFraction> other cases (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Weingart</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hancock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) returned verdicts against PM USA awarding <ix:nonFraction unitRef="usd" contextRef="ie0be9670c3294c5380d9907c287d1387_D20211025-20211025" decimals="INF" format="ixt:fixed-zero" name="us-gaap:LossContingencyDamagesAwardedValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE5Nzg5_2391ec49-0470-4b6b-bccd-9493592c8e95">no</ix:nonFraction> damages, but the trial court in each case decided to award plaintiffs damages.  <ix:nonFraction unitRef="case" contextRef="icc49a3c9173544c3ba44b82aea64b761_D20211025-20211025" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE5ODcy_c58c9f8b-a6c2-4d4d-bf46-47b129407793">One</ix:nonFraction> case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pollari, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resulted in a verdict in favor of PM USA following a retrial of an initial verdict returned in favor of plaintiff.  Plaintiff and defendants appealed the verdict and the appellate court affirmed the judgement in favor of the defendants.  <ix:nonFraction unitRef="case" contextRef="if13eaf2626b1498396e84993151f34c0_D20211025-20211025" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIwMTI4_626b7fa5-5b9d-4203-99cc-ed8ba769e4de">Three</ix:nonFraction> cases, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gloger,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rintoul </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Caprio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Duignan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, resulted in verdicts in favor of plaintiffs following retrial of initial verdicts returned in favor of plaintiffs.  Post-trial appeals are pending in those <ix:nonFraction unitRef="case" contextRef="if13eaf2626b1498396e84993151f34c0_D20211025-20211025" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIwMzMy_a0d1d270-6bb9-435b-9ef1-8b3611d660bd">three</ix:nonFraction> cases.  <ix:nonFraction unitRef="case" contextRef="ifda6adf0b2d84253922e03c7982666d4_D20211025-20211025" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIwMzQz_a927bee7-27a5-454b-b685-ac070aca9adf">Two</ix:nonFraction> cases, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Freeman </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Harris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, resulted in an appellate reversal of a jury verdict in favor of plaintiff, and a judgment in favor of PM USA.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The charts below list the verdicts and post-trial developments in certain </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in which verdicts were returned in favor of plaintiffs.  The first chart lists cases that are pending as of October 25, 2021 but where PM USA has determined an unfavorable outcome is not probable and the amount of loss cannot be reasonably estimated.  The second chart lists cases that have concluded within the previous 12 months.  Unless otherwise noted for a particular case, the jury&#8217;s award for compensatory damages will not be reduced by any finding of plaintiff&#8217;s comparative fault.  Further, the damages noted reflect adjustments based on post-trial or appellate rulings.  As of October 25, 2021, there are <ix:nonFraction unitRef="case" contextRef="iec72a8c6101f4a219bd73a2c63d2d869_I20211025" decimals="INF" format="ixt:fixed-zero" name="mo:ProvisionRecordedNumberOfCases" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIxMTg2_6e8c9921-6932-45e4-a89e-83ce5b8fb56f">no</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases where PM USA has recorded a provision in its condensed consolidated financial statements because PM USA has not determined for any currently pending case that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">References below to &#8220;R.J. Reynolds,&#8221; &#8220;Lorillard&#8221; and &#8220;Liggett Group&#8221; are to R.J. Reynolds Tobacco Company, Lorillard Tobacco Company and Liggett Group, LLC, respectively.</span></div><ix:continuation id="i1f3039dce32a4c708e326bd1b54edc40" continuedAt="i06bf386befa0487b9765b85b36586ee6"><div style="margin-bottom:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Currently Pending Engle Cases with Verdicts Against PM USA </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.488%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensatory Damages </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Punitive Damages <br/>(PM USA)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Appeal Status</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Lipp</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i73ae2282abd0496a96c1fcd57396db0e_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzEtNC0xLTEtMzc1MjgvdGV4dHJlZ2lvbjo0OGFhNTY0MmM5OTg0YjEzOTE2YzUxYjhhYjk5YmIwZl8yNzQ4Nzc5MDY5NDU1_47f69fe8-db5a-45b3-bb89-4ea95bba9547">15</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i194fa22064b649108a6b18c631884f77_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzEtNS0xLTEtMzc1MzQvdGV4dHJlZ2lvbjplZDllZWJhZDYxOTA0NzNhODgyNGNhNzFhMGY1N2Y4M18yNzQ4Nzc5MDY5NDU1_4d83a315-f77a-4a2b-a542-d2041b805162">28</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defendant&#8217;s post-trial motions denied.  Defendant plans to appeal.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Garcia</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2021</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i17b84f6260d04ad6961ed01a6a4643ab_I20210531" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzEtNC0xLTEtMC90ZXh0cmVnaW9uOmUwZmY5ZTk1MjkzZjRmZDU4MTc4OTM3NWRjMmNmN2ViXzQ_e3863474-2ed7-438a-9300-3b1cf13b892e">3</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mistrial</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendant to Third District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Duignan</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pinellas</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i44c6aea7f36842009497759eedcaee54_I20200229" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzItNC0xLTEtMC90ZXh0cmVnaW9uOjU4NGE4OTFiMDE4YzRjYjRiOTgyZTZhMGQwYjVhYjBhXzQ_ffe73d38-e2b9-49e5-a827-99aaa3d1be9f">3</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="iecc7b1e7a5514f8d981e71849df19766_I20200229" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzItNS0xLTEtMC90ZXh0cmVnaW9uOmM2ODQ0NzMxZTc4ZTQ4NmRiMjAxYjgyYjE2N2I1OGQ3XzQ_eec49789-485b-4d3c-bae1-627186fdfc43">12</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendants to Second District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cuddihee</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Duval</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i98691888015f4b7f97a8a5c022078de5_I20200131" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzMtNC0xLTEtMC90ZXh0cmVnaW9uOmJhMzY5ZWI4YTZlYzQ4OTVhMzNkNDU2NDZmM2Y3YjRkXzQ_3a2dd211-8e3c-4a09-97bb-8621114a2698">3</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="if0f67b4fed23474aa26757b30fb8314b_I20200131" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzMtNS0xLTEtMC90ZXh0cmVnaW9uOjM5YjA2OWI5NjJiMDRiMzRhMjM3Mjg3MzdiNDk1NjFjXzQ_3030c0bb-daff-4024-ba0b-4bc87e86613b">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendant to First District Court of Appeal pending. </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Rintoul </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Caprio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 2019 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i6b6b72d00f4a4457b91e1936a8656c3b_I20191130" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzQtNC0xLTEtMC90ZXh0cmVnaW9uOmUzNDViMTYwNDMzZTQ1MTY4ZGU4OGE2OGM3N2E2ZDM1XzQ_76cfdd0a-ec37-4de7-984c-662d700d0b05">9</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="id11f7d76781a495487c1eed6818fc118_I20191130" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzQtNS0xLTEtMC90ZXh0cmVnaW9uOjk1NDk0NDBhMzNjMzQwZjhiYWRhNmM5NzI1ZjcxNjE4XzQ_c22a1b0c-dc33-4eb1-a22b-2a577bd8b1f2">74</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by plaintiff and defendants to Fourth District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Gloger</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 2019 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i1ef26206b34a4ca08fa1661b761ff4d0_I20191130" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzUtNC0xLTEtMC90ZXh0cmVnaW9uOjFiOWUyZjBmNDA3NTRiNWZiNDNlYTBhZDg1NjUyYzZlXzQ_8a77e591-176d-49c2-a4a7-6a011874f62b">15</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i17f63ef63bb548338c974ec35dd2a170_I20191130" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzUtNS0xLTEtMC90ZXh0cmVnaW9uOjQ2MzRhZDYxNDJiNjQ3YWY4NDI3MzZkZWE4YWI1ZTZlXzQ_9fb21b04-942b-4548-9b72-49798ef997b7">11</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendants to Third District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">McCall</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$<ix:nonFraction unitRef="usd" contextRef="i019a0fe5dd374adeb0d5245d94a4dfb5_I20190331" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzYtNC0xLTEtMC90ZXh0cmVnaW9uOjkxYjc5YTU2OTQyMzQ3ODhhOTAwYzYyMWRiMzMxNmYyXzU_8c3dc018-8a18-4a6b-b285-f33fda9b5c38">1</ix:nonFraction>&#160;million (&lt;$<ix:nonFraction unitRef="usd" contextRef="ief9b76c5f9e7421797d6551c8f48d8b6_I20190331" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzYtNC0xLTEtMC90ZXh0cmVnaW9uOjkxYjc5YTU2OTQyMzQ3ODhhOTAwYzYyMWRiMzMxNmYyXzEw_95a1cd6c-2597-461f-abdf-a3b55b1252d7">1</ix:nonFraction>&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ief9b76c5f9e7421797d6551c8f48d8b6_I20190331" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzYtNS0xLTEtMC90ZXh0cmVnaW9uOjc3YzQyMjc1YTZkNzRiYTFiNGRhNDAyMWU1ZTI3ZGNhXzQ_548d8357-7633-45ce-98db-5bcf78438116">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New trial ordered on punitive damages.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Neff</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i6fc0d1aced7b4e3090804c6395b59378_I20190331" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzctNC0xLTEtMC90ZXh0cmVnaW9uOmQyMjBhMjBjYjllMzRiZDI5ODYwODZlYmQ0Y2ZjNzgxXzQ_ace5f99e-c5b6-4ffe-9293-fa2b03d1358b">4</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ia1103462b7784169b773bbbc0efd59f8_I20190331" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzctNS0xLTEtMC90ZXh0cmVnaW9uOjVmZTIzZTdlZmM1ZjRkYWNhNWU3YzVmYWExNGZiZDY4XzQ_d44f492a-f3a8-4c5c-adb8-8ede4319838c">2</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth District Court of Appeal reversed the judgment against defendants and remanded for a new trial. Plaintiff's motion for rehearing was denied.</span></td></tr></table></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="i59a8a0e1f88647948c94fbc4babfb655" continuedAt="i152d419e97d24801bce474a06efad777"><ix:continuation id="i06bf386befa0487b9765b85b36586ee6" continuedAt="if8360f74f2104e228c2084869ed2be67"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.488%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensatory Damages </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Punitive Damages <br/>(PM USA)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Appeal Status</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Mahfuz</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="iefe17f299cc745aea480c5200a6d62fe_I20190228" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzgtNC0xLTEtMC90ZXh0cmVnaW9uOmJkOTA4NDc3OGNhNjQ5NWFiNTcyMWM0ZWM5OTUzN2VkXzQ_cd723893-5670-4d52-a18d-ab7b5704ef5a">12</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i4cd3514504b94f14b23eac85e141bf5c_I20190228" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzgtNS0xLTEtMC90ZXh0cmVnaW9uOjExYmFlODE3NmIwZDQzOWZiZmM3ODYyYzRiN2M4Yzc4XzQ_2e192fd3-5a15-4c0d-aeff-55b85cb4c826">10</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth District Court of Appeal reversed the judgment against defendants and remanded for a new trial.   Plaintiff's motion for rehearing was denied.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Holliman</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ic644f159146c4bce8ae598030b7521b2_I20190228" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzktNC0xLTEtMC90ZXh0cmVnaW9uOjNjZjg0ODM0MjgyOTQ3NjE5NWU5MTZmMmFlNWJkODVlXzQ_d72296bf-8011-42e5-85ef-4a0827a56307">3</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="iffaa0265108c43ac903736f8d4f7d960_I20190228" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzktNS0xLTEtMC90ZXh0cmVnaW9uOmI5YWM3ZTk3YmZhZDQxN2Y4MTZiMGQzYjk4NWRhYWU3XzQ_261c6434-6b80-4fb0-a2a7-6f2295f34336">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defendant&#8217;s appeal to Third District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Chadwell</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i934ff2e5139b4f9b96a1effc5fb356ce_I20180930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzEwLTQtMS0xLTAvdGV4dHJlZ2lvbjphMTVkZjk4ODU3ZWY0MTY0OThjZmIwM2Q2ODcwNGM5MV80_91e61b1f-b63c-421d-8584-e9821129da6d">2</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ia0494654648d4e449182d0811815a094_I20180930" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzEwLTUtMS0xLTAvdGV4dHJlZ2lvbjpjZjQxOGU0M2ViNTU0ZTFiYWMyN2Q0ZjY3OTNjZTY0Yl80_613676ee-1ef2-44a5-afd0-8a5baf06bfb8">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third District Court of Appeal affirmed the compensatory damages award.  PM USA petitioned Florida Supreme Court for review.  Case stayed pending Florida Supreme Court decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Prentice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Kaplan</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2018</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i2aad4919d9504ddfb45b65695fb63cfe_I20180731" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzExLTQtMS0xLTAvdGV4dHJlZ2lvbjpkNjU3MGYxNjYxYzI0Y2M1YTdmN2Q5YjRmODY0MGU3ZV80_605fafce-1a4c-4cca-a33a-89f2d5f84f4a">2</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i1eed45c1dca24b51910ffb82b58ab797_I20180731" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzExLTUtMS0xLTAvdGV4dHJlZ2lvbjo5YzdlMDNiMzNjMzY0ZWU4YmIzMjIxOGFjZTA3NTY3Y180_828b006c-91c2-406c-92ad-34f3fce7531c">2</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Fourth District Court of Appeal affirmed the verdict and  reaffirmed the verdict on rehearing.  Defendants sought review of the decision before the Florida Supreme Court and the court stayed the case pending its decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Sheffield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">R. Douglas</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 2017</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Duval</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$<ix:nonFraction unitRef="usd" contextRef="i507aeabef70b43509c6b3bb411894994_I20171130" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzEyLTQtMS0xLTAvdGV4dHJlZ2lvbjo3ZjE1OWU4ZDk2NzI0OThmOWJhMDNkYjk4NDZiYWI0NV81_a8c17c5e-7fe9-41b7-ac14-74d88cff11af">1</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i44733c669e7348d3b2b001c64d98bc3c_I20171130" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzEyLTUtMS0xLTAvdGV4dHJlZ2lvbjo2NDA4YWZmMzFhZDQ0MjJlYmI1NTRmZDAyNzYwMTBkOV80_9b391973-a30e-477b-9dc7-6485fc5037ca">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Awaiting entry of final judgment by the trial court.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Sommers</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2017</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ib164100fedd24083b3c0a5073943dffd_I20170430" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzEzLTQtMS0xLTAvdGV4dHJlZ2lvbjpkYjA3OGVkMDBlZWU0MDc4YTYyNWZhZGI3OTY2OGRjMV80_2a132710-4797-4ecc-b061-f5e4aa79e61d">1</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="idd484e32de2d4223bdc64a37b20f3802_I20170430" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzEzLTUtMS0xLTAvdGV4dHJlZ2lvbjpmMmNhZTE2NWYwMmY0MzQyODhmMTExOTQxMmU4MTEzMl80_3e471682-5028-48aa-8c72-3f449b12358c">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third District Court of Appeal affirmed compensatory damages award and granted new trial on punitive damages.  Florida Supreme Court denied PM USA&#8217;s petition for review of the Third District Court of Appeal&#8217;s decision.  PM USA paid approximately $<ix:nonFraction unitRef="usd" contextRef="i3e2d19c2ad0043a29926ac4f687526be_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzEzLTYtMS0xLTAvdGV4dHJlZ2lvbjo1NmRlOTM2ZDg1M2Q0YWZiOWVhMDc5MDBmNjhiOGRhM18yNTA_b7b8c0b9-4e39-4eab-a94e-770c1cf3c116">1</ix:nonFraction> million for the compensatory damages award and awaits the new trial on punitive damages.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">  The trial court stayed the new trial on punitive damages pending Florida Supreme Court&#8217;s decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Sheffield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cooper (Blackwood)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="icd834bc282ff4ab6bfccb6bf6f85c412_I20150930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzE0LTQtMS0xLTAvdGV4dHJlZ2lvbjpmM2U4NGNhNmIxYmU0ZmYxOWJiNjhhMDJhY2IwOTg4Nl80_1314c30d-0d0d-4f5f-89fa-aa3983e39065">5</ix:nonFraction>&#160;million </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(&lt;$<ix:nonFraction unitRef="usd" contextRef="i7978ed075eb24ecab8ef0c666e380e86_I20150930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzE0LTQtMS0xLTAvdGV4dHJlZ2lvbjpmM2U4NGNhNmIxYmU0ZmYxOWJiNjhhMDJhY2IwOTg4Nl8xMA_4224fb2c-3488-45be-9895-a5cae1fdc7f2">1</ix:nonFraction>&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i7978ed075eb24ecab8ef0c666e380e86_I20150930" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzE0LTUtMS0xLTAvdGV4dHJlZ2lvbjo5MDVlYmE0NGY5ZjA0ZTJiOTIzM2U1OGMxZWVhNDM0MF80_f391caee-3cd7-4f32-bd14-f251976c4d4f">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth District Court of Appeal affirmed judgment and granted a new trial on punitive damages.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">D. Brown</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2015</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal Court - Middle District of Florida</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i7c9bd9d9e7904a7c88f369cfecb8bcff_I20150131" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzE1LTQtMS0xLTAvdGV4dHJlZ2lvbjoxZDdmMmNhNmExNTU0NWE3OWRmNjNhYTg0MDJhZGEwMV80_4fe64f2c-15c2-4dd8-a3ff-1baa26cc68ba">8</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="if28ca12f29db4c178b382557c7195523_I20150131" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzE1LTUtMS0xLTAvdGV4dHJlZ2lvbjo2OTY1OTJkMzQ2MGI0MjI3OWRjMWY2MWJlNDFhZTZkNF80_3c6a0ea0-1620-47da-ba92-49fc20edf08b">9</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendant to U.S. Court of Appeals for the Eleventh Circuit stayed pending Florida Supreme Court decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Prentice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PM USA&#8217;s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Plaintiff&#8217;s verdict following a retrial of an initial verdict in favor of plaintiff.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> PM USA is not a defendant in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Prentice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Sheffield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Prentice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Sheffield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">are discussed below in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle Progeny Appellate Issues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Plaintiff was granted an award of approximately $<ix:nonFraction unitRef="usd" contextRef="i3e2d19c2ad0043a29926ac4f687526be_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIyMDMy_e91b1683-ed72-40f9-aa9e-1383dde2d9bb">3</ix:nonFraction> million in fees, costs and interest that PM USA appealed.  The Florida Third District Court of Appeals affirmed the award and PM USA paid the award amount in March 2021.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="i152d419e97d24801bce474a06efad777" continuedAt="i03241b0d439449a8b1643d4157488ca8"><ix:continuation id="if8360f74f2104e228c2084869ed2be67"><div style="margin-bottom:3pt;margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle Cases Concluded Within Past 12 Months </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:14.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.437%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.850%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrual Date</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Amount<br/>(if any)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Berger (Cote)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2014</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal Court - Middle District of Florida</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth quarter of 2018 and first quarter of 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ie8dcabc9bf25458b893acc42347fba65_D20181001-20181231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5MjA2NjVjMjhlMTc0MTE3OTg4ZWVjNjc4Y2U1MWVkYi90YWJsZXJhbmdlOjkyMDY2NWMyOGUxNzQxMTc5ODhlZWM2NzhjZTUxZWRiXzEtNS0xLTEtMC90ZXh0cmVnaW9uOjIxMWI0MmY5OWRkMzRkM2Q5ZmI5MGYxYWNlYmZkOGU5XzQ_921248df-6ab5-4389-b737-1f9a1ad21b90"><ix:nonFraction unitRef="usd" contextRef="ic5b096cd3d6d4418807bf4da87541ffb_D20210101-20210331" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5MjA2NjVjMjhlMTc0MTE3OTg4ZWVjNjc4Y2U1MWVkYi90YWJsZXJhbmdlOjkyMDY2NWMyOGUxNzQxMTc5ODhlZWM2NzhjZTUxZWRiXzEtNS0xLTEtMC90ZXh0cmVnaW9uOjIxMWI0MmY5OWRkMzRkM2Q5ZmI5MGYxYWNlYmZkOGU5XzQ_ce3a13ab-9e61-4738-9d12-8279ed3a3bff">29</ix:nonFraction></ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Santoro</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2017</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA, R.J. Reynolds and Liggett Group</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Second quarter of 2020 and first quarter of 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i149fa1186f594219bfa987dbdd8108f6_D20200401-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5MjA2NjVjMjhlMTc0MTE3OTg4ZWVjNjc4Y2U1MWVkYi90YWJsZXJhbmdlOjkyMDY2NWMyOGUxNzQxMTc5ODhlZWM2NzhjZTUxZWRiXzItNS0xLTEtMC90ZXh0cmVnaW9uOjY0MWIxNmRiM2U1ZTRhZmFiMzYxN2VkOWM5NWU5YTFmXzQ_93065460-c3f9-455c-a721-84ff36365a0c"><ix:nonFraction unitRef="usd" contextRef="i56daa4d75b794bf798d94d227d29e58d_D20210101-20210331" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5MjA2NjVjMjhlMTc0MTE3OTg4ZWVjNjc4Y2U1MWVkYi90YWJsZXJhbmdlOjkyMDY2NWMyOGUxNzQxMTc5ODhlZWM2NzhjZTUxZWRiXzItNS0xLTEtMC90ZXh0cmVnaW9uOjY0MWIxNmRiM2U1ZTRhZmFiMzYxN2VkOWM5NWU5YTFmXzQ_f425f063-5e15-4731-a993-8e702009933b">1</ix:nonFraction></ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2021</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In <ix:nonFraction unitRef="case" contextRef="i8b7112204f034a1d857b3dec087a6b72_I20210930" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIyMjg1_d68296ea-a2de-4766-9a6f-d8e214c19588">six</ix:nonFraction> cases in which PM USA paid the judgments more than a year ago, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Naugle,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Gore</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">M. Brown,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Jordan,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Theis </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Landi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, plaintiffs were awarded approximately $<ix:nonFraction unitRef="usd" contextRef="i9786b102ec154400a94c47410abdf0d2_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIyNDMx_d003bf23-2136-4f54-955f-10744e640e2e">8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i1a270cd854f546eaa7d120809442f7ea_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIyNDM1_e5eb8967-06f8-484a-a70f-c48eedfa4acb">2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0c3f1a744f0843eb886c976a94595df2_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIyNDM5_59bf2169-99d7-42ce-b267-37f03727b538">8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2ea5715a75a04415a4cc1a94df208c7b_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIyNDQz_26cf4c49-3a30-4c0b-a55c-3ddd1ff65ad8">4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ice47fff653d74495b39ba1566ff6ab1b_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIyNDUw_f0e1d172-ddbd-4f5d-9806-e8fd9b2cf7cc">1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie4bc3e6b7f3141d8ad1df8728d140283_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNDE2OTY_5d6fb5e3-a597-44ee-98a2-c45ac718bfbf">3</ix:nonFraction> million in fees and costs, respectively.  PM USA has appealed in all of these cases, except </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Theis </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Landi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.  In</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> M. Brown</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, in March 2021 the Florida First District Court of Appeals affirmed the fee award and reversed the pre-judgment interest award and, in April 2021, PM USA paid $<ix:nonFraction unitRef="usd" contextRef="ifb6a94b0655c424dbf083fa25f9e6807_D20210401-20210429" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesPaidValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIyNzE2_a01bb02a-4d77-4947-b506-ca221fec6eec">8.2</ix:nonFraction> million in satisfaction of the fee award and post-judgment interest. In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Theis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, PM USA paid $<ix:nonFraction unitRef="usd" contextRef="i2cdf509335c8425e86145370f35dab92_D20210501-20210531" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesPaidValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIyODAy_cca1cd97-0b04-469a-90d2-7b05b45cc1b9">1</ix:nonFraction> million in satisfaction of fees and costs in May 2021 and, in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Landi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, PM USA paid approximately $<ix:nonFraction unitRef="usd" contextRef="ie6ca88fb103d422eba56dd92aabfb961_D20210701-20210731" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesPaidValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNDE3MTA_eee7a49f-05c5-44a5-8c87-0c447f6406d4">1.5</ix:nonFraction> million in satisfaction of fees, costs and interest in July 2021 (R.J. Reynolds paid approximately $<ix:nonFraction unitRef="usd" contextRef="i0f8871aa42a34c93b07bdabe159afc9d_D20210701-20210731" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesPaidValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNDE3NDA_a5bb4334-795e-4c64-8c19-d29f80e81005">1.5</ix:nonFraction> million of the approximately $<ix:nonFraction unitRef="usd" contextRef="i0f8871aa42a34c93b07bdabe159afc9d_D20210701-20210731" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMyOTg1MzQ5NjQ0OTU_d08269d7-f6fd-4e7f-9d43-078ca440aa14">3</ix:nonFraction> million award).</span></div></ix:continuation><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Progeny Appellate Issues: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Florida appellate courts are considering the following appeals which may have wide application to other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases:</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mary Sheffield v. R.J. Reynolds Tobacco Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny case against R.J. Reynolds only, the Florida Supreme Court has taken jurisdiction to resolve the conflict among Florida&#8217;s District Courts of Appeal over whether the 1999 amendments to Florida&#8217;s punitive damages statute (including its caps and bar on multiple punitive damages awards for the same course of conduct) apply in wrongful death cases where the decedent was injured prior to the October 1, 1999 effective date of the amendments but died from his or her injuries after such effective date.  Oral argument was held before the Florida Supreme Court in April 2021; a decision has not yet been issued.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Linda Prentice v. R.J. Reynolds Tobacco Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny case against R.J. Reynolds only, the Florida First District Court of Appeal in January 2020 reversed a judgment in favor of the plaintiff and remanded for a new trial. The court held that the trial court had erred by failing to instruct the jury that in order to prevail on her claim for conspiracy to commit fraudulent concealment, the plaintiff was required to prove that her decedent relied to his detriment on a statement that concealed or omitted material information about the health risks of smoking.  That holding conflicts with decisions from the Second, Third, and Fourth District Courts of Appeal, which have each held that </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">plaintiffs do not need to prove reliance on a statement, and instead can prevail by proving reliance on the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> defendants&#8217; concealment of information.  In August 2020, the Florida Supreme Court accepted jurisdiction in the case.  As an alternative ground to approve the First District Court of Appeal&#8217;s decision in its favor in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prentice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, R.J. Reynolds has asked the Florida Supreme Court to reconsider its prior decisions giving the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Phase I findings preclusive effect in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases, as described more fully in the section </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Class Action above.  Oral argument was held before the Florida Supreme Court in June 2021; a decision has not yet been issued.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Florida Bond Statute: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2009, Florida amended its existing bond cap statute by adding a $<ix:nonFraction unitRef="usd" contextRef="i91285291d0224d41a9f6b6f098c51c67_I20090630" decimals="INF" format="ixt:num-dot-decimal" name="mo:MaximumBondForAllDefendants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI1Mjk4_276f17db-9cef-4008-9ac3-c4fdab645201">200</ix:nonFraction> million bond cap that applies to all state </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny lawsuits in the aggregate and establishes individual bond caps for individual </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in amounts that vary depending on the number of judgments in effect at a given time.  Plaintiffs have been unsuccessful in various challenges to the bond cap statute in Florida state court.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No federal court has yet addressed the constitutionality of the bond cap statute or the applicability of the bond cap to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases tried in federal court.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, legislation has been presented to the Florida legislature that would repeal the bond cap statute; however to date, no legislation repealing the statute has passed.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Smoking and Health Class Actions: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the dismissal in May 1996 of a purported nationwide class action brought on behalf of allegedly addicted smokers, plaintiffs have filed numerous putative smoking and health class action suits in various state and federal courts.  In general, these cases purport to be brought on behalf of residents of a particular state or states (although a few cases purport to be nationwide in scope) and raise addiction claims and, in many cases, claims of physical injury as well.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Class certification has been denied or reversed by courts in <ix:nonFraction unitRef="case" contextRef="i5e74537c0b4c4859a3f2089a42ce56ae_D19960501-20210930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2NTYz_e6f24122-5c50-46e1-bb40-433889e46ce0">61</ix:nonFraction> smoking and health class actions involving PM USA in Arkansas (<ix:nonFraction unitRef="case" contextRef="ic64ffeb5c74f4dfb969778dccaadc1bf_D19960501-20210930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2NjI5_ae1404be-7126-4de8-9a29-442481a7895c">1</ix:nonFraction>), California (<ix:nonFraction unitRef="case" contextRef="id40a29a6291543d78c372cbf264db1d9_D19960501-20210930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2NjQ2_fec3ef40-5285-457e-8e91-6299c7ecd02a">1</ix:nonFraction>), Delaware (<ix:nonFraction unitRef="case" contextRef="i555c1554720a424d98f50f13e51eeb80_D19960501-20210930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2NjYx_c9604d6d-e089-4bb5-9676-8ba5d550ec18">1</ix:nonFraction>), the District of Columbia (<ix:nonFraction unitRef="case" contextRef="i53e4eebb4a714524b636f0534865d23e_D19960501-20210930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2Njky_1933198e-ae8e-4bb4-8817-f5f08788eeb6">2</ix:nonFraction>), Florida (<ix:nonFraction unitRef="case" contextRef="i898cd371a7b3471d989e10fd1301c6c6_D19960501-20210930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2NzA2_499b86aa-3d4c-48fd-88a2-c25395a19a3c">2</ix:nonFraction>), Illinois (<ix:nonFraction unitRef="case" contextRef="i4a99e02ce83d418b860435133fff2496_D19960501-20210930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2NzIx_159c1e5a-028e-4fe9-a72c-96b5f9a15f9b">3</ix:nonFraction>), Iowa (<ix:nonFraction unitRef="case" contextRef="ib09e7e21f8824054b044c6461611053c_D19960501-20210930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2NzMy_c8677192-5beb-49ac-a818-1afd44d809e5">1</ix:nonFraction>), Kansas (<ix:nonFraction unitRef="case" contextRef="icefa681020fe4e1cb4c5b70752a2483d_D19960501-20210930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2NzQ1_60025cad-ac7f-44d2-8f5c-d37417a2c9c7">1</ix:nonFraction>), Louisiana (<ix:nonFraction unitRef="case" contextRef="iddd4591b90d04ff19b36afa6fd9b9e7a_D19960501-20210930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2NzYx_8bcb524a-9a5a-40b0-a1ea-57ce1a7692d3">1</ix:nonFraction>), Maryland (<ix:nonFraction unitRef="case" contextRef="i58f52856b1ef4eaeb4ce8c5360ba8d3c_D19960501-20210930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2Nzc2_88daf73e-a7a1-4a75-b6b8-5f31f94ad2aa">1</ix:nonFraction>), Michigan (<ix:nonFraction unitRef="case" contextRef="ia8cca8977ddf4dceb3cd11ee8f5468f3_D19960501-20210930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2Nzkx_99f80655-f05e-4b81-a4f2-10ebb56fb8f1">1</ix:nonFraction>), Minnesota (<ix:nonFraction unitRef="case" contextRef="i3e80e20cf6794e25b4bcef5d2425a2c0_D19960501-20210930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2ODA3_f9300242-d746-4434-9461-e0a2ab57965d">1</ix:nonFraction>), Nevada (<ix:nonFraction unitRef="case" contextRef="i01b20b669936475f993e104a31de5013_D19960501-20210930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2ODIw_eb1cfa6c-62ef-4fd6-9412-ee93eb82ecb0">29</ix:nonFraction>), New Jersey (<ix:nonFraction unitRef="case" contextRef="i83fd76d8eb1c479c890d6dbefa8006e5_D19960501-20210930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2ODM3_b6ed2bd4-ec58-4d34-b3f3-7d392a1cbfd7">6</ix:nonFraction>), New York (<ix:nonFraction unitRef="case" contextRef="ie80c16c4c2d34cf7b117c4db4d715bd7_D19960501-20210930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2ODUy_0d3a2670-be3c-471b-afc2-1ea8ab8ec00c">2</ix:nonFraction>), Ohio (<ix:nonFraction unitRef="case" contextRef="i3950ec60b64d43e79a255e2090017c76_D19960501-20210930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2ODYz_8aface47-0603-4edb-9fe2-fbd85b540b55">1</ix:nonFraction>), Oklahoma (<ix:nonFraction unitRef="case" contextRef="i5ef55ce7cdbf4a49ab62450c92339999_D19960501-20210930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2ODc4_d0061840-c059-4b4e-9d2c-681a27354634">1</ix:nonFraction>), Oregon (<ix:nonFraction unitRef="case" contextRef="i0af01f3e38964466aabcb29ac90c169f_D19960501-20210930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2ODkx_fc3a1041-3dc7-4613-8242-42804f149ff8">1</ix:nonFraction>), Pennsylvania (<ix:nonFraction unitRef="case" contextRef="i12033c228a91450cb06602a444123772_D19960501-20210930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2OTEw_2bdd6681-871e-4e8e-b162-d62d87baec84">1</ix:nonFraction>), Puerto Rico (<ix:nonFraction unitRef="case" contextRef="i3e9ec11b5d7f4c02a0471f53510291d4_D19960501-20210930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2OTI4_8e65433e-30d0-4a51-b219-ecf62d1f31d8">1</ix:nonFraction>), South Carolina (<ix:nonFraction unitRef="case" contextRef="i438bd25e9e5b4fa5b786198ed333fea2_D19960501-20210930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2OTQ5_f3d9cbbc-a973-4155-84a8-00099f4e0b41">1</ix:nonFraction>), Texas (<ix:nonFraction unitRef="case" contextRef="i15af965191ab4b03be2934d3ca487181_D19960501-20210930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2OTYx_da8c262c-a91a-4f46-b2b4-1e29af20e6dc">1</ix:nonFraction>)&#160;and Wisconsin (<ix:nonFraction unitRef="case" contextRef="iaf606e5861bc4311aab5a4deb0ea2a7e_D19960501-20210930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2OTgw_f745d2b1-e976-4508-a526-adedc1f9f2c4">1</ix:nonFraction>).  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Other Tobacco-Related </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="i03241b0d439449a8b1643d4157488ca8" continuedAt="i7117157b236347d0ad26ce9824443774"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for a discussion of &#8220;Lights&#8221; and &#8220;Ultra Lights&#8221; class action cases and medical monitoring class action cases pending against PM USA.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 25, 2021, PM USA and Altria are named as defendants, along with other cigarette manufacturers, in <ix:nonFraction unitRef="claim" contextRef="i61b4bd1b44014f77ba98ffaddac70a1c_I20211025" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3Mjc5_e0bc12c8-b85f-493c-8b92-3069b5b85c98">seven</ix:nonFraction> class actions filed in the Canadian provinces of Alberta, Manitoba, Nova Scotia, Saskatchewan, British Columbia and Ontario.  In Saskatchewan, British Columbia (<ix:nonFraction unitRef="claim" contextRef="i39795ebd6cb34fd9b722c425c1d7f1b5_I20211025" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDQz_e0f997b3-aadd-4976-8191-846aa6657cad">two</ix:nonFraction> separate cases) and Ontario, plaintiffs seek class certification on behalf of individuals who suffer or have suffered from various diseases, including chronic obstructive pulmonary disease, emphysema, heart disease or cancer, after smoking defendants&#8217; cigarettes.  In the actions filed in Alberta, Manitoba and Nova Scotia, plaintiffs seek certification of classes of all individuals who smoked defendants&#8217; cigarettes.  In March 2019, all of these class actions were stayed as a result of <ix:nonFraction unitRef="manufacture" contextRef="i4618babb55a643e08513e3f263b04127_I20190331" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberofManufacturers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3OTM1_2f6c4c71-ad1d-4125-bd9c-8bab43d03500">three</ix:nonFraction> Canadian tobacco manufacturers (<ix:nonFraction unitRef="manufacture" contextRef="i275c1685fc084d30907f39c9ca35ef66_I20190331" decimals="INF" format="ixt:fixed-zero" name="mo:LossContingencyNumberofManufacturers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3OTcw_ef73232f-5049-40fc-81e7-943230aa324b">no</ix:nonFraction>ne of which is related to Altria or its subsidiaries) seeking protection under Canada&#8217;s Companies&#8217; Creditors Arrangement Act (which is similar to Chapter 11 bankruptcy in the U.S.).  The companies entered into these proceedings following a Canadian appellate court upholding <ix:nonFraction unitRef="ruling" contextRef="i4618babb55a643e08513e3f263b04127_I20190331" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyVerdictsUpheld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI4MjQ3_85acf636-e402-483e-a936-663a3230c396">two</ix:nonFraction> smoking and health class action verdicts against those companies totaling approximately CAD $<ix:nonFraction unitRef="cad" contextRef="i78204298c1714c59b1565b14ec68a768_D20190301-20190331" decimals="-9" format="ixt:num-dot-decimal" name="mo:AmountAwardedtoOtherParty" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI4MzQy_0d39102e-8ce6-4813-a906-785b70e51671">13</ix:nonFraction> billion.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the Distribution Agreement between Altria and PMI, which provides for indemnities for certain liabilities concerning tobacco products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Care Cost Recovery Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the health care cost recovery litigation, governmental entities seek reimbursement of health care cost expenditures allegedly caused by tobacco products and, in some cases, of future expenditures and damages.  Relief sought by some but not all plaintiffs includes punitive damages, multiple damages and other statutory damages and penalties, injunctions prohibiting alleged marketing and sales to minors, disclosure of research, disgorgement of profits, funding of anti-smoking programs, additional disclosure of nicotine yields, and payment of attorney and expert witness fees.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although there have been some decisions to the contrary, most judicial decisions in the U.S. have dismissed all or most health care cost recovery claims against cigarette manufacturers.  Nine federal circuit courts of appeals and eight state appellate courts, relying primarily on grounds that plaintiffs&#8217; claims were too remote, have ordered or affirmed dismissals of health care cost recovery actions.  The United States Supreme Court has refused to consider plaintiffs&#8217; appeals from the cases decided by five federal circuit courts of appeal.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the cases brought in the U.S., health care cost recovery actions have also been brought against tobacco industry participants, including PM USA and Altria, in Canada (<ix:nonFraction unitRef="claim" contextRef="i4afafb6cc22d4bfc8634ef389a32cb14_I20210930" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI5OTA2_8c6003c8-2893-445e-93d6-7a3dc847c286">10</ix:nonFraction> cases),&#160;and other entities have stated that they are considering filing such actions.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the beginning of 2008, the Canadian Provinces of British Columbia, New Brunswick, Ontario, Newfoundland and Labrador, Quebec, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia have brought health care reimbursement claims against cigarette manufacturers.  PM USA is named as a defendant in the British Columbia and Quebec cases, while both Altria and PM USA are named as defendants in the New Brunswick, Ontario, Newfoundland and Labrador, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia cases.  The Nunavut Territory and Northwest Territory have passed legislation permitting similar claims, but lawsuits based on this legislation have not been filed.  All of these cases have been stayed pending resolution of proceedings in Canada involving <ix:nonFraction unitRef="manufacture" contextRef="if3b522f7309f4c28bb7cdb2e6f309062_I20210930" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberofManufacturers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMwNzg3_8eacb306-dc09-4ec3-9d7f-ac0f7df479fa">three</ix:nonFraction> tobacco manufacturers (none of which are affiliated with Altria or its subsidiaries) under the Companies&#8217; Creditors Arrangement Act discussed above.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Other Smoking and Health Class Actions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above for a discussion of these proceedings.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the Distribution Agreement between Altria and PMI that provides for indemnities for certain liabilities concerning tobacco products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Settlements of Health Care Cost Recovery Litigation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 1998, PM USA and certain other tobacco product manufacturers entered into the 1998 Master Settlement Agreement (the &#8220;MSA&#8221;) with <ix:nonFraction unitRef="state" contextRef="i94453f2294bb47798d15011e7260b27b_D19981101-19981130" decimals="INF" name="mo:LossContingencyNumberofStateswithSettledLitigation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMxNDU1_d39813d1-ee16-48e5-b7d5-a16d4946fd60">46</ix:nonFraction> states, the District of Columbia and certain U.S. territories to settle asserted and unasserted health care cost recovery and other claims.  PM USA and certain other tobacco product manufacturers had previously entered into agreements to settle similar claims brought by Mississippi, Florida, Texas and Minnesota (together with the MSA, the &#8220;State Settlement Agreements&#8221;).  The State Settlement Agreements require that the original participating manufacturers or &#8220;OPMs&#8221; (now PM USA, R.J. Reynolds and, with respect to certain brands, ITG Brands, LLC (&#8220;ITG&#8221;)) make annual payments of approximately $<ix:nonFraction unitRef="usd" contextRef="i94453f2294bb47798d15011e7260b27b_D19981101-19981130" decimals="-8" format="ixt:num-dot-decimal" name="mo:LitigationSettlementAnnualPaymentAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMyMDU1_6e784d27-c920-4dc0-834d-2e13e0ff838a">9.4</ix:nonFraction> billion, subject to adjustments for several factors, including inflation, market share and industry volume.  In addition, the OPMs are required to pay settling plaintiffs&#8217; attorneys&#8217; fees, subject to an annual cap of $<ix:nonFraction unitRef="usd" contextRef="i9116d2cabdcb49b38d8d90ace75f12d8_I19981130" decimals="INF" format="ixt:num-dot-decimal" name="mo:LitigationSettlementAnnualLegalFeesPayableMaximum" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMyMjY3_4f628c77-f538-47bc-9791-5cf2202c5a04">500</ix:nonFraction> million.  For the three months ended September 30, 2021 and 2020, the aggregate amount recorded in cost of sales with respect to the State Settlement Agreements was approximately $<ix:nonFraction unitRef="usd" contextRef="i53eb33b5a5a54692bf19b84768b69b6f_D20210701-20210930" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNDMyMDY_477d226b-49d6-4251-b070-468961f48cfb">1.1</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i0748deafef534cbdb4febc2a98913d94_D20200701-20200930" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNDMxNTc_60204804-2442-481e-bed6-047b73563f52">1.2</ix:nonFraction> billion, respectively.  For the nine months ended September 30, 2021 and 2020, the aggregate amount recorded in cost of sales with respect to the State Settlement Agreements was approximately $<ix:nonFraction unitRef="usd" contextRef="ic2672eb1f4624a6b91e6bd2e2ad0726e_D20210101-20210930" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMyNjI0_627e3965-af10-4500-9f64-0b0931969da7">3.2</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ica606fb15fa64e31a1db6c7bbbc4c3a8_D20200101-20200930" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNDMxODc_9f22c676-ba0a-414a-87f8-250426bcec92">3.3</ix:nonFraction> billion, respectively. These amounts include PM USA&#8217;s estimate of amounts related to NPM Adjustments discussed below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NPM Adjustment Disputes: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The &#8220;NPM Adjustment&#8221; is a reduction in MSA payments made by the OPMs and those manufacturers that are subsequent signatories to the MSA (collectively, the &#8220;participating manufacturers&#8221; or &#8220;PMs&#8221;) that </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="i7117157b236347d0ad26ce9824443774" continuedAt="i736ad14a6e1c49cd8ce9cc8dee0c72b6"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applies if the PMs collectively lose at least a specified level of market share to non-participating manufacturers since 1997, subject to certain conditions and defenses.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The independent auditor (&#8220;IA&#8221;) appointed under the MSA has calculated that PM USA&#8217;s share of the maximum potential NPM Adjustments for 2004-2020 is (exclusive of interest or earnings):  $<ix:nonFraction unitRef="usd" contextRef="i9664ef4ada2b462a8ed748d49c2d084c_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzMzIx_58d0ab58-466a-4b73-9d27-82007bcfd572">388</ix:nonFraction> million for 2004; $<ix:nonFraction unitRef="usd" contextRef="i906990683f674cd28e47cbcc0f1c3ce6_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzMzM0_52f1df28-100e-478e-a9b8-aab64c805b06">181</ix:nonFraction> million for 2005; $<ix:nonFraction unitRef="usd" contextRef="i9ee9df31ad2b4e4ba1a5db1f61706b48_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzMzQ3_d45ed409-eae9-41e2-8a9f-f51338a248db">154</ix:nonFraction> million for 2006; $<ix:nonFraction unitRef="usd" contextRef="ia38de3fc206c47ab8cac6dffc4614a4d_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzMzYw_febb8c89-8f1d-42be-8672-9bcb837cc82b">185</ix:nonFraction> million for 2007; $<ix:nonFraction unitRef="usd" contextRef="i641a64c3fd2249f69b0e9e1f3f788718_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzMzcz_552eea22-dc52-4ca5-a15d-0f130452b782">250</ix:nonFraction> million for 2008; $<ix:nonFraction unitRef="usd" contextRef="i2774e5040f8c4961ae53d545a9f37afe_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzMzg2_2a58577a-fe86-4c87-ad2e-a289eb24b5b6">211</ix:nonFraction> million for 2009; $<ix:nonFraction unitRef="usd" contextRef="i0f745bd8bca441319b8ed301cc2bc4cc_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzMzk5_b048d878-a79e-453c-9afb-d002c26afccd">218</ix:nonFraction> million for 2010; $<ix:nonFraction unitRef="usd" contextRef="id7e7f831dff6421d8eb531fa106546e6_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzNDEy_a9cdc1d2-d6f9-4f44-b237-10d3fb7ea4c7">166</ix:nonFraction> million for 2011; $<ix:nonFraction unitRef="usd" contextRef="i5ed22e918d4f48e8b808961d921a33f4_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzNDI1_3bf376b4-bb17-4a44-814b-d8b3fb2e6d53">214</ix:nonFraction> million for 2012; $<ix:nonFraction unitRef="usd" contextRef="id9721043231044bc9aeae35bc61c92e2_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzNDM4_902ceb41-6e39-4ee1-b107-bfeed5cb35e6">224</ix:nonFraction> million for 2013; $<ix:nonFraction unitRef="usd" contextRef="i315da09d5b6b446fb033c07698d6d7a5_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzNDUx_f0f02146-0ddd-4411-9247-789c57a09b39">258</ix:nonFraction> million for 2014; $<ix:nonFraction unitRef="usd" contextRef="i65cffff74cb04e8ea2ecc68c77d2b4db_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzNDY0_171ee6d0-8cc0-41db-9048-a5389a5afe88">313</ix:nonFraction> million for 2015; $<ix:nonFraction unitRef="usd" contextRef="i4720a28bdb104979ab2247511d0da7e2_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzNDc3_38fbed96-bddf-42d1-80f6-02e3274c430c">292</ix:nonFraction> million for 2016; $<ix:nonFraction unitRef="usd" contextRef="i65954542804549b295903e71ce88b5d9_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzNDkw_35cc402f-5e11-44b9-a734-c53d04691974">302</ix:nonFraction> million for 2017; $<ix:nonFraction unitRef="usd" contextRef="id2c3b4aebf6646d9972246c1621e7c8a_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzNTAz_a158c3cf-190f-4323-9bc5-a46fab8df9fe">325</ix:nonFraction> million for 2018; $<ix:nonFraction unitRef="usd" contextRef="i21f876e2b3cf44cdb355f679e4503b4c_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzNTE2_56f5d4e1-5d04-4ec7-a521-5b31b84cddc5">444</ix:nonFraction> million for 2019; and $<ix:nonFraction unitRef="usd" contextRef="ifebf0c01e22141d8beb01098ae7c84fd_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzNTMz_063e1fe0-c7bf-4b3a-a3e3-d63cf1556a7f">572</ix:nonFraction> million for 2020.  These maximum amounts will be reduced, likely substantially, to reflect the NPM Adjustment settlements discussed below, and potentially for current and future calculation disputes and other developments.  In addition, PM USA&#8217;s recovery of these amounts, even as reduced, is dependent upon subsequent determinations regarding state-specific defenses and disputes with other PMs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Settlements of NPM Adjustment Disputes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Multi-State Settlement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> By the end of 2018, PM USA entered into a multi-state settlement of NPM Adjustment disputes with a total of <ix:nonFraction unitRef="state" contextRef="i0c5082287da0495e8408464c2a0a26c2_D20180101-20181231" decimals="INF" name="mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM0MDk4_00c4ec69-8efd-4473-ba9e-0bf125dce271">36</ix:nonFraction> MSA states and territories in which PM USA settled the NPM Adjustment disputes through 2022 with <ix:nonFraction unitRef="state" contextRef="i96af53950024460b8a4b3ff962001c7b_D20180101-20181231" decimals="INF" name="mo:LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM0MTk4_150d08e8-44d3-4bbf-97ab-4aec8836ca78">35</ix:nonFraction> of the <ix:nonFraction unitRef="state" contextRef="i0c5082287da0495e8408464c2a0a26c2_D20180101-20181231" decimals="INF" name="mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM0MjA4_104fb0d9-0637-47d5-8f54-6362b0149739">36</ix:nonFraction> states, and through 2024 with <ix:nonFraction unitRef="state" contextRef="i33c7acc23f4a44fe8c2a26183ccd5df2_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM0MjQx_50bcae92-5488-4e10-b438-9533a7d27bf0">one</ix:nonFraction> state.  Pursuant to the multi-state settlement, PM USA received $<ix:nonFraction unitRef="usd" contextRef="i0c5082287da0495e8408464c2a0a26c2_D20180101-20181231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LitigationSettlementAmountAwardedFromOtherParty" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM0MzA4_cb574794-aaf7-4e10-a496-665ba1421052">1.03</ix:nonFraction> billion and expects to receive approximately $<ix:nonFraction unitRef="usd" contextRef="i4d3472b2a91245dea8ecb3a70a055bbc_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM0MzQ4_c1395f7e-5eef-492c-bc83-3cf30c87233f">320</ix:nonFraction> million in credits to offset PM USA&#8217;s MSA payments through 2029.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">New York Settlement.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2015, PM USA entered into a separate NPM Adjustment settlement with New York in which PM USA settled the NPM Adjustment disputes with New York in perpetuity.  PM USA received $<ix:nonFraction unitRef="usd" contextRef="i1ead92d842db4635b29251f1f090ed5f_D20150101-20151231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM0NjA4_8ccc43e6-0b0d-4b8d-9047-ee627009a64f">373</ix:nonFraction> million pursuant to the New York settlement and expects to receive annual credits applied against the MSA payments due to New York going forward.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Montana Settlement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In 2020, PM USA entered into a separate NPM Adjustment settlement with Montana in which PM USA settled the NPM Adjustment disputes with Montana through 2030.  This settlement resulted in a payment by PM USA of $<ix:nonFraction unitRef="usd" contextRef="i5f1a36b47df14a2887897a88255928c0_D20200101-20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM0OTgw_e7997c07-4262-4cf3-a5d2-80a7b37bfaaf">4</ix:nonFraction> million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Continuing NPM Adjustment Disputes with States That Have Not Settled</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">2004 NPM Adjustment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The PMs and the <ix:nonFraction unitRef="state" contextRef="i308a1982e0b2451ba03e43963d30bf8a_D20210101-20210930" decimals="INF" name="mo:LossContingencyNumberOfStatesNotSettled" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM1MDky_4836df38-dd25-400c-845a-e94bd5e2c3b9">10</ix:nonFraction> states that have not settled the NPM Adjustment disputes are currently arbitrating NPM Adjustment disputes for 2004 in a multi-state arbitration.  Hearings for <ix:nonFraction unitRef="state" contextRef="i308a1982e0b2451ba03e43963d30bf8a_D20210101-20210930" decimals="INF" name="mo:LossContingencyNumberOfStatesWithConcludedHearings" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM1MjU1_7da925a1-70cb-4233-a343-762c9d35d085">9</ix:nonFraction> of the <ix:nonFraction unitRef="state" contextRef="i308a1982e0b2451ba03e43963d30bf8a_D20210101-20210930" decimals="INF" name="mo:LossContingencyNumberOfStatesNotSettled" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM1MjY1_b8e5f161-edb9-42cd-afd5-423b90e6af02">10</ix:nonFraction> states have concluded.  In September 2021, the arbitration panels issued decisions finding that <ix:nonFraction unitRef="state" contextRef="i308a1982e0b2451ba03e43963d30bf8a_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMyOTg1MzQ5NjQ0ODg_0f332de6-1752-40f9-8cf7-f66359350a9d">two</ix:nonFraction> states, Missouri and Washington, were not diligent in their enforcement of their escrow statutes in 2004 and, therefore, are subject to the NPM adjustment for 2004. The arbitration panels further found that the remaining <ix:nonFraction unitRef="state" contextRef="i308a1982e0b2451ba03e43963d30bf8a_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberOfStatesInComplianceWithEscrowStatues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQ5NDc4MDI0MTgwMjg_d706a46c-a8c4-428a-a5c4-8b9e8f07b072">seven</ix:nonFraction> states were diligent in their enforcement and, therefore, are not subject to the NPM adjustment for 2004.  The hearing for one remaining state is currently scheduled for February 2022.  Several issues remain to be resolved by the arbitration panels that will affect the final amount of the 2004 NPM adjustment PM USA and other PMs will receive. PM USA recorded $<ix:nonFraction unitRef="usd" contextRef="ia16faf9bb3364629910ff901aa086762_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="mo:LossContingencyReductionToCostOfSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMyOTg1MzQ5NjgwNTI_da2ddb02-f808-4748-82b7-4d156b7851cd">21</ix:nonFraction> million as a reduction to cost of sales in the third quarter of 2021 for its estimate of the minimum amount of the 2004 NPM adjustment it will receive.  PM USA estimates it is entitled to interest of approximately $<ix:nonFraction unitRef="usd" contextRef="ie82ddd3ae8a04ec1904fa44df200d11f_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesSoughtValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMyOTg1MzQ5NjgwNjk_0ffbed8c-462b-48ab-8ca5-3cbd21e58dbc">23</ix:nonFraction> million in connection with the 2004 NPM adjustment, which it recorded as interest income in the third quarter of 2021.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">2005-2007 NPM Adjustments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The PMs and the <ix:nonFraction unitRef="state" contextRef="icb250f9fcdf1428aa03ed81b876ddfae_D20210101-20210930" decimals="INF" name="mo:LossContingencyNumberOfStatesNotSettled" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM1NDg3_720f17e9-5157-433b-a913-062a2daff373">10</ix:nonFraction> states that have not settled the NPM Adjustment disputes are currently arbitrating NPM Adjustment disputes before a single arbitration panel.  The arbitration encompasses <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM1NjYx_a644eea3-4823-4d15-b961-96400803386e">three</span> years, 2005-2007, for <ix:nonFraction unitRef="state" contextRef="ic8c655e105f449fd919701efabc22bc1_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberOfStatesNotSettled" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM1Njg2_b09ecdc2-c6de-422e-b994-8fd7aec0556f">nine</ix:nonFraction> of the <ix:nonFraction unitRef="state" contextRef="icb250f9fcdf1428aa03ed81b876ddfae_D20210101-20210930" decimals="INF" name="mo:LossContingencyNumberOfStatesNotSettled" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM1Njk2_59713fd2-102c-426d-8da1-6c46e5c8a11b">10</ix:nonFraction> states, and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM1NzEx_1f0bca57-bdd0-4faf-a0bb-bb958177008c">one</span> year, 2005, for <ix:nonFraction unitRef="state" contextRef="i9eb956b79e6c4406aa88f5877ca274ab_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberOfStatesNotSettled" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM1NzMw_b3892aa2-95e5-485d-8555-2fd8ae092bbf">one</ix:nonFraction> state.  As of October 25, 2021, no decisions have resulted from the arbitration.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Subsequent Years.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No assurance can be given as to when proceedings for 2008 and subsequent years will be scheduled or the precise form those proceedings will take.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Disputes Under the State Settlement Agreements: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The payment obligations of the tobacco product manufacturers that are parties to the State Settlement Agreements, as well as the allocations of any NPM Adjustments and related settlements, have been and may continue to be affected by R.J. Reynolds&#8217;s acquisition of Lorillard in 2015 and its related sale of certain cigarette brands to ITG (the &#8220;ITG transferred brands&#8221;).  PM USA filed motions to enforce the state settlement agreements in Florida, Minnesota, Texas and Mississippi in connection with various positions that R.J. Reynolds and ITG took with regard to the ITG transferred brands.  After various court decisions in each of those states that were favorable to PM USA, those motions to enforce have now been resolved either through settlement or exhaustion of appeals.  Despite these resolutions, PM USA continues to dispute the accuracy of certain submissions made by R.J. Reynolds and ITG concerning the calculation of certain payments relating to the ITG transferred brands and may pursue such claims.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the State of Mississippi filed a motion in Mississippi state court seeking to enforce the Mississippi State Settlement Agreement against PM USA, R.J. Reynolds and ITG concerning the tax rates used in the annual calculation of the net operating profit adjustment payments starting in 2018. The Mississippi state court held a hearing in October 2021 and has not yet issued a decision.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="i736ad14a6e1c49cd8ce9cc8dee0c72b6" continuedAt="ia27cd4319de74fefa83a0f7aa89a6aae"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, PM USA and other PMs reached an agreement with several MSA states to waive the PMs&#8217; claim under the most favored nation provision of the MSA in connection with a settlement between those MSA states and a non-participating manufacturer, S&amp;M Brands, Inc. (&#8220;S&amp;M Brands&#8221;), under which the states released certain claims against S&amp;M Brands in exchange for receiving a portion of the funds S&amp;M Brands deposited into escrow accounts in those states pursuant to the states&#8217; escrow statutes.  In consideration for waiving its most favored nation claim, PM USA received approximately $<ix:nonFraction unitRef="usd" contextRef="i52787a392f8143ad96b8a01791362efb_D20210101-20210131" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LitigationSettlementAmountAwardedFromOtherParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMyOTg1MzQ5NjgwOTA_8de37841-3e88-4794-9041-e25edb82e595">32</ix:nonFraction> million from the escrow funds paid to those MSA states under their settlement with S&amp;M Brands.  These funds were received in January 2021 and were recorded in Altria&#8217;s condensed consolidated statement of earnings for the first quarter of 2021 as a reduction to cost of sales.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Federal Government&#8217;s Lawsuit: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 1999, the United States government filed a lawsuit in the U.S. District Court for the District of Columbia against various cigarette manufacturers, including PM USA, and others, including Altria, asserting claims under three federal statutes.  The case ultimately proceeded only under the civil provisions of RICO.  In August 2006, the district court held that certain defendants, including Altria and PM USA, violated RICO and engaged in seven of the eight &#8220;sub-schemes&#8221; to defraud that the government had alleged.  Specifically, the court found that:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely denied, distorted and minimized the significant adverse health consequences of smoking;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants hid from the public that cigarette smoking and nicotine are addictive;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely denied that they control the level of nicotine delivered to create and sustain addiction;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely marketed and promoted &#8220;low tar/light&#8221; cigarettes as less harmful than full-flavor cigarettes;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely denied that they intentionally marketed to youth;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants publicly and falsely denied that ETS is hazardous to non-smokers; and </span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants suppressed scientific research.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The court did not impose monetary penalties on defendants, but ordered the following relief: (i)&#160;an injunction against &#8220;committing any act of racketeering&#8221; relating to the manufacturing, marketing, promotion, health consequences or sale of cigarettes in the United States; (ii)&#160;an injunction against participating directly or indirectly in the management or control of the Council for Tobacco Research, the Tobacco Institute, or the Center for Indoor Air Research, or any successor or affiliated entities of each; (iii)&#160;an injunction against &#8220;making, or causing to be made in any way, any material false, misleading, or deceptive statement or representation or engaging in any public relations or marketing endeavor that is disseminated to the United States public and that misrepresents or suppresses information concerning cigarettes;&#8221; (iv)&#160;an injunction against conveying any express or implied health message or health descriptors on cigarette packaging or in cigarette advertising or promotional material, including &#8220;lights,&#8221; &#8220;ultra lights&#8221; and &#8220;low tar,&#8221; which the court found could cause consumers to believe one cigarette brand is less hazardous than another brand; (v)&#160;the issuance of &#8220;corrective statements&#8221; in various media regarding the adverse health effects of smoking, the addictiveness of smoking and nicotine, the lack of any significant health benefit from smoking &#8220;low tar&#8221; or &#8220;light&#8221; cigarettes, defendants&#8217; manipulation of cigarette design to ensure optimum nicotine delivery and the adverse health effects of exposure to ETS; (vi)&#160;the disclosure on defendants&#8217; public document websites and in the Minnesota document repository of all documents produced to the government in the lawsuit or produced in any future court or administrative action concerning smoking and health until the third quarter of 2021, with certain additional requirements as to documents withheld from production under a claim of privilege or confidentiality; (vii)&#160;the disclosure of disaggregated marketing data to the government in the same form and on the same schedule as defendants now follow in disclosing such data to the FTC for a period of <ix:nonNumeric contextRef="i37765c8db4d14257a1db295453135743_D20060801-20060831" format="ixt-sec:duryear" name="mo:FederalTradeCommissionDisclosurePeriod" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQwNzIx_f4b842d5-304c-4571-9795-594f10a9b6f3">10</ix:nonNumeric> years; (viii)&#160;certain restrictions on the sale or transfer by defendants of any cigarette brands, brand names, formulas or cigarette businesses within the U.S.; and (ix)&#160;payment of the government&#8217;s costs in bringing the action.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following several years of appeals relating to the content of the corrective statements remedy described above, in October 2017, the district court approved the parties&#8217; proposed consent order implementing corrective statements in newspapers and on television.  The corrective statements began appearing in newspapers and on television in the fourth quarter of 2017.  In April 2018, the parties reached agreement on the implementation details of the corrective statements on websites and onserts.  The corrective statements began appearing on websites in the second quarter of 2018 and the onserts began appearing in the fourth quarter of 2018.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014 and 2019, Altria and PM USA recorded provisions totaling approximately $<ix:nonFraction unitRef="usd" contextRef="iac111175a4b94767b66b855e1ae095ae_D20190101-20191231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQxNjc2_1ba37c19-3568-4904-988f-b41c5223076e"><ix:nonFraction unitRef="usd" contextRef="i95495989d64f46e4884394df5ac52ea3_D20140101-20141231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQxNjc2_4c9ee1cb-7d0e-4e20-8b52-e8a891c6c4f0"><ix:nonFraction unitRef="usd" contextRef="i05574f14d9b74110b3542338d268b496_D20190101-20191231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQxNjc2_988333cb-6bb0-4c79-a898-3378ca1aaeb2"><ix:nonFraction unitRef="usd" contextRef="i37604da1eb80482781b7544e25e04971_D20140101-20141231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQxNjc2_c795d270-05c5-41a9-9d06-d4106ba86c0a">36</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> million for the estimated costs of implementing the corrective communications remedy.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The requirements related to corrective statements at point-of-sale remain outstanding.  In May 2014, the district court ordered further briefing on the issue, which was completed in June 2014.  In May 2018, the parties submitted a joint status report and additional briefing on point-of-sale signage to the district court.  In May 2019, the district court ordered a hearing on the point-of-sale signage issue.  The hearing is currently scheduled for June 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, the United States government filed a motion with the district court asking for clarification as to whether the court-ordered injunction that applies to cigarettes also applies to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> a heated tobacco product used with the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device.  In August 2020, Altria and PM USA filed an opposition to the government&#8217;s motion and, in the alternative, a motion to </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="ia27cd4319de74fefa83a0f7aa89a6aae" continuedAt="ia91e501cc4794061b01584e25ab57c31"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">modify the injunction to make clear it does not apply to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Regardless of the district court&#8217;s decisions on the pending motions, the government has indicated it will not oppose a modification to the injunction that permits PM USA to use the Modified Risk Tobacco Product claim authorized by the United States Food and Drug Administration for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">E-vapor Product Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 25, 2021, Altria and/or its subsidiaries, including PM USA, were named as defendants in <ix:nonFraction unitRef="claim" contextRef="i4d5084fb63864e7d87b275079786c20d_I20211025" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQzMDk1_5e95cdd6-aa09-4df1-9e23-2c3be1e56996">53</ix:nonFraction> class action lawsuits relating to JUUL e-vapor products.  JUUL is an additional named defendant in each of these lawsuits.  The theories of recovery include violation of RICO, fraud, failure to warn, design defect, negligence and unfair trade practices.  Plaintiffs seek various remedies, including compensatory and punitive damages and an injunction prohibiting product sales.  The <ix:nonFraction unitRef="claim" contextRef="i4d5084fb63864e7d87b275079786c20d_I20211025" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQzNDgx_fef19941-ac4e-4677-8af9-fd07b03ef33f">53</ix:nonFraction> class action lawsuits include <ix:nonFraction unitRef="claim" contextRef="i4d5084fb63864e7d87b275079786c20d_I20211025" decimals="INF" name="mo:LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQzNTE0_f63adaac-038f-4711-8c34-8460c3c026be">28</ix:nonFraction> cases involving plaintiffs whose claims were previously included in other class action complaints but were refiled as separate stand-alone class actions for procedural and other reasons</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and/or its subsidiaries, including PM USA, also have been named as defendants in other lawsuits involving JUUL e-vapor products, including <ix:nonFraction unitRef="claim" contextRef="i7e914a4a2b8344169accefce0c454834_I20211025" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQzODUw_aadac51d-f0f9-46e3-856c-3819e4c6bca6">2,548</ix:nonFraction> individual lawsuits, <ix:nonFraction unitRef="claim" contextRef="i43eda0d8e1cd4c80b86df99bd8127abd_I20211025" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQzODc0_07c79ceb-78ab-42ec-943e-ca4a2a3eacb4">350</ix:nonFraction> &#8220;third party&#8221; lawsuits, which include school districts, state and local governments and tribal and healthcare organization lawsuits.  JUUL is an additional named defendant in each of these lawsuits.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the individual and class action lawsuits mentioned above were filed in federal court.  In October 2019, the United States Judicial Panel on Multidistrict Litigation ordered the coordination or consolidation of these lawsuits in the U.S. District Court for the Northern District of California for pretrial purposes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and its subsidiaries filed motions to dismiss certain claims in the class action and school district cases, including the federal RICO claim.  In October 2020, the U.S. District Court for the Northern District of California granted the motion to dismiss the RICO class action claim without prejudice.  Although it otherwise denied the motion, the court found that plaintiffs had not sufficiently alleged standing or causation with respect to their claim under California law.  The court also granted the motion to dismiss the RICO claim in the cases filed by various school districts, but denied the motion in all other respects.  The court gave plaintiffs the opportunity to amend their complaints to attempt to cure the deficiencies the court identified and plaintiffs filed their amended complaints in November 2020.  In January 2021, Altria and its subsidiaries filed a renewed motion to dismiss the RICO claim, which the court denied in April 2021.  In December 2020, the U.S. District Court for the Northern District of California and the parties selected <ix:nonFraction unitRef="plantiff" contextRef="i8ac851e84d934c1fae22ee819de18e27_D20201201-20201231" decimals="INF" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQ1NDYw_a4d99f15-5973-434b-9f57-292a091769f1">20</ix:nonFraction> personal injury plaintiffs to be adjudicated as bellwether cases and in July 2021, the court set dates for the first <ix:nonFraction unitRef="case" contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberOfCasesWithCourtDatesSet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQ1NTgw_2e6324ed-6c68-40bb-941f-018a411ad690">four</ix:nonFraction> of such cases to commence in 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An additional group of cases is pending in California state courts.  In January 2020, the Judicial Council of California determined that this group of cases was appropriate for coordination and assigned the group to the Superior Court of California, Los Angeles County, for pretrial purposes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">JUUL also is named in a significant number of additional individual and class action lawsuits to which neither Altria nor any of its subsidiaries is currently named.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="lawsuit" contextRef="i34283e5fbf764b508c0c3b5d55b0c2d8_I20210930" decimals="INF" format="ixt-sec:numwordsen" name="mo:NumberOfThirdPartyLawsuits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQ2MDc3_a04c3f31-4fe7-4861-b2d0-c35d42b8029f">Three</ix:nonFraction> of the &#8220;third party&#8221; lawsuits noted above against Altria and/or its subsidiaries and JUUL, as an additional named defendant, were initiated, individually, by the attorneys general of Alaska, Hawaii and Minnesota alleging violations of state consumer protection and other similar laws.  JUUL is also named in other attorneys general lawsuits to which neither Altria nor any of its subsidiaries is currently named.  JUUL settled <ix:nonFraction unitRef="claim" contextRef="i39fd421e674b4f2885bbdc2d844388dc_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyClaimsSettledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQ2NTA3_5f1ad8d7-138e-4d2e-bd59-72cd5d383292">one</ix:nonFraction> such lawsuit by agreeing to (i) pay approximately $<ix:nonFraction unitRef="usd" contextRef="i39fd421e674b4f2885bbdc2d844388dc_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQ2NTYw_e7781e2e-3133-4177-8971-2e77c6d050c2">40</ix:nonFraction> million and (ii) certain restrictions on its sales and marketing activities.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, RAI Strategic Holdings, Inc. and R.J. Reynolds Vapor Co., which are affiliates of R.J. Reynolds, filed a lawsuit against Altria, PM USA, Altria Client Services LLC, PMI and its affiliate, Philip Morris Products S.A., in the United States District Court for the Eastern District of Virginia.  The lawsuit asserts claims of patent infringement based on the sale of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the United States.  Plaintiffs seek various remedies, including preliminary and permanent injunctive relief, treble damages and attorneys&#8217; fees.  Altria and PMI have been dismissed from the lawsuit.  In June 2020, the remaining defendants filed a motion to dismiss certain of plaintiffs&#8217; claims and also filed counterclaims against the plaintiffs for infringement of various patents owned by the remaining defendants. The case was stayed in December 2020 due to the COVID-19 pandemic; however, the stay was lifted with respect to defendants&#8217; counterclaims in February 2021 and a trial is currently scheduled for April 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also in April 2020, a related action was filed against the same defendants by the same plaintiffs, as well as R.J. Reynolds, with the United States International Trade Commission (&#8220;ITC&#8221;).  There, the plaintiffs also allege patent infringement, but the remedies sought include a prohibition on the importation of the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and component parts into the United States and on the sale of any such products previously imported into the United States.  <ix:nonFraction unitRef="usd" contextRef="i05447dda5f5a4d59809fb46f46b15f92_D20200401-20200430" decimals="INF" format="ixt:fixed-zero" name="mo:LossContingencyDamagesRecoverableValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQ4MTIx_1ea1b56e-4562-4293-a31c-3c870b834a63">No</ix:nonFraction> damages are recoverable in the proceedings before the ITC.  In May 2021, an administrative law judge found that the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infringe plaintiffs&#8217; patents and recommended to the ITC a ban on the importation of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the infringing components into the United States.  In September 2021, the ITC affirmed the administrative law judge&#8217;s initial determination and issued a limited exclusion order barring the importation of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">electronic device,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="ia91e501cc4794061b01584e25ab57c31" continuedAt="ib795f73dcbdf45989effbdd97ebf8e29"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the infringing components into the United States and a cease and desist order barring domestic sales, marketing and distribution of these imported products.  The orders will become effective on November 29, 2021 unless rejected by the Biden Administration prior to that date.  Defendants may appeal the orders to the United States Court of Appeals for the Federal Circuit; however, any ban on importation or on the sale, marketing and distribution of previously imported product is unlikely to be stayed pending the conclusion of the appeal.  Due to this litigation, in October 2021, PM USA announced plans to begin removing the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">electronic device and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> from the marketplace as it awaits the outcome of administrative review.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An additional unrelated patent infringement case regarding the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device was filed in November 2020 in the United States District Court for the Northern District of Georgia against PM USA and Philip Morris Products S.A. seeking damages and equitable relief.  In February 2021, defendants filed a motion to dismiss the lawsuit, which the court granted in July 2021.  In August 2021, plaintiff filed a motion to amend the complaint.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Antitrust Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the FTC issued an administrative complaint against Altria and JUUL alleging that Altria&#8217;s <ix:nonFraction unitRef="number" contextRef="i035c8420533b4cbbb71f640ebbdb0bc3_I20200430" decimals="2" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQ5ODIw_d996d4ad-f708-4f63-a8ba-aec34fb9e250">35</ix:nonFraction>% investment in JUUL and the associated agreements constitute an unreasonable restraint of trade in violation of Section 1 of the Sherman Antitrust Act of 1890 (&#8220;Sherman Act&#8221;) and Section 5 of the Federal Trade Commission Act of 1914, and substantially lessened competition in violation of Section 7 of the Clayton Antitrust Act (&#8220;Clayton Act&#8221;).  If the FTC&#8217;s challenge is successful, the FTC may order a broad range of remedies, including divestiture of Altria&#8217;s minority investment in JUUL, rescission of the transaction and all associated agreements, a requirement of FTC approval of future agreements related to the development, manufacture, distribution or sale of e-vapor products and prohibition against any officer or director of either Altria or JUUL serving on the other party&#8217;s board of directors or attending meetings of the other party&#8217;s board of directors.  The administrative trial was held before an FTC administrative law judge in June 2021.  The post-trial briefing was completed in October 2021.  The administrative law judge&#8217;s decision is subject to review by the FTC on its own motion or at the request of any party.  The FTC then issues its ruling, which may be appealed to any United States Court of Appeals.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also as of October 25, 2021, <ix:nonFraction unitRef="lawsuit" contextRef="i93cb9eb992434b78b7e8af13960914e0_I20211025" decimals="INF" name="mo:LossContingencyClassActionLawsuit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzUwOTYx_de8e3d0b-8966-4a51-9b95-beb08f8c2932">16</ix:nonFraction> putative class action lawsuits have been filed against Altria and JUUL in the United States District Court for the Northern District of California.  The lawsuits initially named, in addition to the two companies, certain senior executives and certain members of the board of directors of both companies as defendants; however, those individuals currently or formerly affiliated with Altria were later dismissed. In November 2020 these lawsuits were consolidated into <ix:nonFraction unitRef="complaint" contextRef="if859d02a78924c39895c8fe236aea331_I20201130" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberOfComplaints" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzUxNDMw_f6ba889e-9d29-459e-b6fc-a03bb002aca2">three</ix:nonFraction> complaints (one on behalf of direct purchasers, one on behalf of indirect purchasers and one on behalf of indirect resellers).  The consolidated lawsuits, as amended, cite the FTC administrative complaint and allege that Altria and JUUL violated Sections 1, 2 and/or 3 of the Sherman Act and Section 7 of the Clayton Act and various state antitrust, consumer protection and unjust enrichment laws by restraining trade and/or substantially lessening competition in the U.S. closed-system electronic cigarette market.  Plaintiffs seek various remedies, including treble damages, attorneys&#8217; fees, a declaration that the agreements between Altria and JUUL are invalid, divestiture of Altria&#8217;s minority investment in JUUL and rescission of the transaction.  Altria filed a motion to dismiss these lawsuits in January 2021.  In August 2021, the United States District Court for the Northern District of California denied Altria&#8217;s motion to dismiss except with respect to plaintiffs&#8217; claims for injunctive and equitable relief.  However, plaintiffs were granted the opportunity to replead such claims by the trial court, which plaintiffs did in September 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, Altria exercised its rights to convert its non-voting JUUL shares to voting shares.  However, pending the outcome of the FTC administrative complaint, Altria currently does not intend to exercise its additional governance rights obtained upon the conversion, including the right to elect directors to JUUL&#8217;s board or to vote its JUUL shares other than as a passive investor.  For further discussion of Altria&#8217;s rights in the event of share conversion, see Note 4.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities - Investment in JUUL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shareholder Class Action and Shareholder Derivative Lawsuits</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholder Class Action:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  In October and December 2019, <ix:nonFraction unitRef="shareholder" contextRef="i8b76752f44e74819b436e49281d45ca0_D20191001-20191231" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzUyODc2_b2a2146f-4500-4ad7-b042-282782167736">two</ix:nonFraction> purported Altria shareholders filed putative class action lawsuits against Altria, Howard A. Willard III, Altria&#8217;s former Chairman and Chief Executive Officer, and William F. Gifford, Jr., Altria&#8217;s former Vice Chairman and Chief Financial Officer and current Chief Executive Officer, in the United States District Court for the Eastern District of New York.  In December 2019, the court consolidated the <ix:nonFraction unitRef="shareholder" contextRef="i8b76752f44e74819b436e49281d45ca0_D20191001-20191231" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzUzMjgz_b2a2146f-4500-4ad7-b042-282782167736">two</ix:nonFraction> lawsuits into a single proceeding.  The consolidated lawsuit was subsequently transferred to the United States District Court for the Eastern District of Virginia.  The lawsuit asserts claims under Sections 10(b) and 20(a) and under Rule 10b-5 of the Exchange Act.  In April 2020, JUUL, its founders and some of its current and former executives were added to the lawsuit.  The claims allege false and misleading statements and omissions relating to Altria&#8217;s investment in JUUL.  Plaintiffs seek various remedies, including damages and attorneys&#8217; fees.  In July 2020, the defendants filed motions to dismiss plaintiffs&#8217; claims, which the district court denied in March 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal Shareholder Derivative Lawsuits: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In August 2020, <ix:nonFraction unitRef="shareholder" contextRef="i6840f559dfc14605ad93fc181579892b_D20200801-20200831" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzUzOTc3_e05b161a-b907-47a3-bcd4-481b5e1e5951">two</ix:nonFraction> purported Altria shareholders filed separate derivative lawsuits in the United States District Court for the Northern District of California on behalf of themselves and Altria, against Mr. Willard, Mr. Gifford, JUUL and certain of its executives and officers.  These derivative lawsuits relate to Altria&#8217;s </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="ib795f73dcbdf45989effbdd97ebf8e29" continuedAt="i82a7aa822518426aba78290b5bbe43b9"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investment in JUUL, and assert claims of breach of fiduciary duty by the Altria defendants and aiding and abetting in that alleged breach of fiduciary duty by the remaining defendants.  In March 2021, the United States District Court for the Northern District of California granted defendants&#8217; motion to transfer both lawsuits to the United States District Court for the Eastern District of Virginia.  <ix:nonFraction unitRef="shareholder" contextRef="i199dd80736164b16bc4c33007d8b83f5_D20201001-20210331" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMyOTg1MzQ5NjgxMDg_e9ec859f-63f1-4d62-abec-6f0ed36f5005">Three</ix:nonFraction> additional federal derivative lawsuits were filed in October 2020, January 2021 and March 2021, respectively, in the United States District Court for the Eastern District of Virginia against Mr. Willard, Mr. Gifford, Mr. Crosthwaite, certain members of Altria&#8217;s Board of Directors, JUUL, its founders and some of its current and former executives.  These suits assert various claims, including breach of fiduciary duty, unjust enrichment, waste of corporate assets and violations of certain federal securities laws.  The remedies sought in these lawsuits include damages, disgorgement of profits, reformation of Altria&#8217;s corporate governance and internal procedures, and attorneys&#8217; fees.  In April 2021, the court consolidated the <ix:nonFraction unitRef="claim" contextRef="i20c19903e59744cda38126a75fe80854_D20210401-20210430" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberOfPendingCasesConsolidated" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzU1ODcy_cd334336-65c0-4a6a-a065-4333a66b9823">five</ix:nonFraction> cases pending in the Eastern District of Virginia into a single action.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State Shareholder Derivative Lawsuits:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  <ix:nonFraction unitRef="shareholder" contextRef="ic61197cb6b06443dbfd08c5b6acfcd30_D20200901-20210831" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMyOTg1MzQ5NjgxMjE_fae947c9-ef99-41bc-85dd-fd819c589761">Six</ix:nonFraction> derivative lawsuits have been filed in Virginia state courts against Mr. Willard, Mr. Gifford, Mr. Crosthwaite (Altria&#8217;s former Chief Growth Officer and JUUL&#8217;s current Chief Executive Officer), certain members of Altria&#8217;s Board of Directors, JUUL, its founders and some of its current and former executives.  The lawsuits were filed in September 2020, May 2021, June 2021, July 2021, August 2021 and August 2021, respectively.  The lawsuits assert various claims, including breach of fiduciary duty, and seek remedies similar to those sought by plaintiffs in the cases pending in federal court in the Eastern District of Virginia.  In July 2021 and September 2021, the court consolidated the first <ix:nonFraction unitRef="claim" contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberOfConsolidatedDerivativeLawsuits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNjI3NzM_000c0dbc-991b-4975-b5e2-64cfa1b81b69">four</ix:nonFraction> of these state derivative cases into a single action.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Other Tobacco-Related Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lights/Ultra Lights&#8221; Cases and Other Smoking and Health Class Actions: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plaintiffs have sought certification of their cases as class actions, alleging among other things, that the uses of the terms &#8220;Lights&#8221; and/or &#8220;Ultra Lights&#8221; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment or breach of warranty, and have sought injunctive and equitable relief, including restitution and, in certain cases, punitive damages.  These class actions have been brought against PM USA and, in certain instances, Altria or its other subsidiaries, on behalf of individuals who purchased and consumed various brands of cigarettes.  Defenses raised in these cases include lack of misrepresentation, lack of causation, injury and damages, the statute of limitations, non-liability under state statutory provisions exempting conduct that complies with federal regulatory directives, and the First Amendment. Twenty-one state courts in <ix:nonFraction unitRef="case" contextRef="i72c3cdb7c38d49a39f60eaafddfc2f55_I20211025" decimals="INF" name="mo:LossContingencyClaimsNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzU3NTA1_541fd7b2-eb33-41f4-bfbb-9b5bf815343e">23</ix:nonFraction> &#8220;Lights&#8221; cases have refused to certify class actions, dismissed class action allegations, reversed prior class certification decisions or have entered judgment in favor of PM USA.  As of October 25, 2021, <ix:nonFraction unitRef="claim" contextRef="i72c3cdb7c38d49a39f60eaafddfc2f55_I20211025" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzU3NzEw_c381d466-24cb-4125-b5b1-9817c09078c4">two</ix:nonFraction> &#8220;Lights/Ultra Lights&#8221; class actions are pending in U.S. state court.  Neither case is active.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 25, 2021, <ix:nonFraction unitRef="claim" contextRef="icdad9497490d4094a88132d419cbfe76_I20211025" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzU3ODI4_af94c4c0-1ef5-4599-8c02-863a2ee0b8b2">one</ix:nonFraction> smoking and health case alleging personal injury or seeking court-supervised programs or ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, is pending in a U.S. state court.  The case is currently inactive.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UST Litigation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UST and/or its tobacco subsidiaries have been named in a number of individual tobacco and health lawsuits over time.  Plaintiffs&#8217; allegations of liability in these cases have been based on various theories of recovery, such as negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of implied warranty, addiction and breach of consumer protection statutes.  Plaintiffs have typically sought various forms of relief, including compensatory and punitive damages, and certain equitable relief, including but not limited to disgorgement.  Defenses raised in these cases include lack of causation, assumption of the risk, comparative fault and/or contributory negligence, and statutes of limitations.  As of October 25, 2021, there is <ix:nonFraction unitRef="claim" contextRef="ibadad7f290d443d29bbe99b6abd7399f_I20211025" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzU4ODcz_f1752908-a064-4642-b4b7-7d4039ddf3ad">one</ix:nonFraction> case pending against USSTC.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental Regulation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:EnvironmentalCostsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzYyNTk2_3260e495-b01e-46b3-a905-67973f4b18e9" continuedAt="i7402ac6d48d147bf9817e90c8675d3bd" escape="true">Altria and its subsidiaries (and former subsidiaries) are subject to various federal, state and local laws and regulations concerning the discharge of materials into the environment, or otherwise related to environmental protection, including, in the U.S.: the Clean Air Act, the Clean Water Act, the Resource Conservation and Recovery Act and the Comprehensive Environmental Response, Compensation and Liability Act (commonly known as &#8220;Superfund&#8221;), which can impose joint and several liability on each responsible party.  Subsidiaries (and former subsidiaries) of Altria are involved in several matters subjecting them to potential costs of remediation and natural resource damages under Superfund or other laws and regulations.  Altria&#8217;s subsidiaries expect to continue to make capital and other expenditures in connection with environmental laws and regulations.</ix:nonNumeric></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7402ac6d48d147bf9817e90c8675d3bd">Altria provides for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are probable and can be reasonably estimated.  Such accruals are adjusted as new information develops or circumstances change.</ix:continuation>  Other than those amounts, it is not possible to reasonably estimate the cost of any environmental remediation and compliance efforts that subsidiaries of Altria may undertake in the future.  In the opinion of management, however, compliance with environmental laws and regulations, including the payment of any remediation costs or damages and the making of related expenditures, has not had, and is not expected to have, a material adverse effect on Altria&#8217;s consolidated results of operations, capital expenditures, financial position or cash flows.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span></div></div><ix:continuation id="i82a7aa822518426aba78290b5bbe43b9"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees and Other Similar Matters</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, certain subsidiaries of Altria have agreed to indemnify a limited number of third parties in the event of future litigation.  At September&#160;30, 2021, Altria and certain of its subsidiaries (i) had $<ix:nonFraction unitRef="usd" contextRef="i8b49abf1769f40eb98805158adeb07ff_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzYwODU0_ae4c75e8-33bf-4cbc-9b0f-758052dec1b3">48</ix:nonFraction> million of unused letters of credit obtained in the ordinary course of business; (ii) were contingently liable for guarantees related to their own performance, including $<ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:GuaranteeObligationsMaximumExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzYxMDE5_f8ab490f-94d6-41c0-b7e1-f3e063b4653d">24</ix:nonFraction> million for surety bonds;  and (iii) had a redeemable noncontrolling interest of $<ix:nonFraction unitRef="usd" contextRef="i503473da7ed148e2805b9efd533f401c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNDI5NDc_f780172b-ef84-4444-80e3-e553ffc4c065">39</ix:nonFraction> million recorded on its condensed consolidated balance sheet.  In addition, from time to time, subsidiaries of Altria issue lines of credit to affiliated entities.  These items have not had, and are not expected to have, a significant impact on Altria&#8217;s liquidity.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of a distribution agreement between Altria and PMI (the &#8220;Distribution Agreement&#8221;), entered into as a result of Altria&#8217;s 2008 spin-off of its former subsidiary PMI, liabilities concerning tobacco products will be allocated based in substantial part on the manufacturer.  PMI will indemnify Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for liabilities related to tobacco products manufactured by PM USA, excluding tobacco products contract manufactured for PMI.  Altria does not have a related liability recorded on its condensed consolidated balance sheet at September&#160;30, 2021 as the fair value of this indemnification is insignificant.  PMI has agreed not to seek indemnification with respect to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patent litigation discussed above under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Other Tobacco-Related Litigation - IQOS Litigation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">excluding the patent infringement case filed with the United States District Court for the Northern District of Georgia.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA has issued guarantees relating to Altria&#8217;s obligations under its outstanding debt securities, borrowings under its $<ix:nonFraction unitRef="usd" contextRef="i89787fa06a89496fbdd25f2aaa8f0fe7_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzYyNTE0_1cae6826-fc40-43f0-9ad7-324b0c00859a">3.0</ix:nonFraction> billion Credit Agreement and amounts outstanding under its commercial paper program.</span></div></ix:continuation><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div id="i295e56fb16f94dae9eacc631c56d466c_106"></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 13. <ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDYvZnJhZzo0NWUxMDBlY2RkMDE0NWY1YjgxZjg0ZjQ4ZDkzNzk4Ni90ZXh0cmVnaW9uOjQ1ZTEwMGVjZGQwMTQ1ZjViODFmODRmNDhkOTM3OTg2XzE3Nw_dfeb17b7-1dcb-46ac-ae1a-bcd24fdd8a1a" continuedAt="i6c7f7dff7a294a09872f7e4adef082ce" escape="true">New Accounting Guidance Not Yet Adopted</ix:nonNumeric></span></div><ix:continuation id="i6c7f7dff7a294a09872f7e4adef082ce"><ix:nonNumeric contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930" name="us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDYvZnJhZzo0NWUxMDBlY2RkMDE0NWY1YjgxZjg0ZjQ4ZDkzNzk4Ni90ZXh0cmVnaW9uOjQ1ZTEwMGVjZGQwMTQ1ZjViODFmODRmNDhkOTM3OTg2XzE3NQ_0987f967-3941-424c-ad15-470e5b6d2e9f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, Altria:</span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="ibb6f64f03893418ea0b976a2cd7a1dae"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:16.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.232%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Standards</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective Date for Public Entity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect on Financial Statements </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2020-06 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Accounting for Convertible Instruments and Contracts in an Entity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">s Own Equity</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#8217;s own equity.&#160; Key provisions of the guidance include reducing the number of accounting models, simplifying the earnings per share calculations and expanding the disclosures related to convertible instruments.</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021.  </span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Altria&#8217;s adoption of this guidance is not expected to have a material impact on its consolidated financial statements and related  disclosures. </span></td></tr></table></ix:continuation></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i295e56fb16f94dae9eacc631c56d466c_112"></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 2.  Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div id="i295e56fb16f94dae9eacc631c56d466c_115"></div><div style="margin-bottom:5pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Description of the Company</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">When used in this Quarterly Report on Form 10-Q (&#8220;Form 10-Q&#8221;), the terms </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Altria,&#8221; &#8220;we&#8221; and &#8220;our&#8221; refer to Altria Group, Inc. and its subsidiaries, unless the context requires otherwise.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s Vision by 2030 is to responsibly lead the transition of adult smokers to a smoke-free future (&#8220;Vision&#8221;).  Altria is focused on moving adult smokers away from cigarettes by taking action to transition adult smokers to potentially less harmful choices.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of Altria, see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Background</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Note 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background and Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the condensed consolidated financial statements in Part I, Item 1. Financial Statements of this Form 10-Q (&#8220;Item 1&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a detailed description of Altria&#8217;s reportable segments, see Note 9. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the condensed consolidated financial statements in Item 1 (&#8220;Note 9&#8221;).</span></div><div id="i295e56fb16f94dae9eacc631c56d466c_118"></div><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Executive Summary</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations section, Altria refers to the following &#8220;adjusted&#8221; financial measures: adjusted operating companies income (loss) (&#8220;OCI&#8221;); adjusted OCI margins; adjusted net earnings attributable to Altria; adjusted diluted earnings per share attributable to Altria; and adjusted effective tax rates.  These adjusted financial measures are not required by, or calculated in accordance with, United States generally accepted accounting principles (&#8220;GAAP&#8221;) and may not be calculated the same as similarly titled measures used by other companies.  These adjusted financial measures should thus be considered as supplemental in nature and not considered in isolation or as a </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">substitute for the related financial information prepared in accordance with GAAP.  Except as noted in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Forecasted Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below, when Altria provides a non-GAAP measure in this Form 10-Q, it also provides a reconciliation of that non-GAAP financial measure to the most directly comparable GAAP financial measure.  OCI for the segments is defined as operating income before general corporate expenses and amortization of intangibles.  For a further description of these non-GAAP financial measures, see the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-GAAP Financial Measures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ste. Michelle Transaction</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 8, 2021, UST LLC (&#8220;UST&#8221;) entered into a share purchase agreement pursuant to which it agreed to sell its subsidiary, International Wine &amp; Spirits Ltd. (&#8220;IWS&#8221;), which includes Ste. Michelle Wine Estates Ltd. (&#8220;Ste. Michelle&#8221;), to an entity controlled by investment funds managed by Sycamore Partners Management, L.P. in an all-cash transaction with a purchase price of approximately $1.2 billion and the assumption of certain liabilities of IWS and its subsidiaries (the &#8220;Ste. Michelle Transaction&#8221;).  UST completed the sale of IWS on October 1, 2021.  For further discussion, see Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Held for Sale </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the condensed consolidated financial statements in Item 1 (&#8220;Note 3&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 Pandemic</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has led to adverse impacts on the U.S. and global economies and continues to create economic uncertainty even as COVID-19 vaccines have been and continue to be administered in 2021 and the U.S. and global economies have begun to operate with reduced restrictions on consumer movements and business operations.  Although much uncertainty still surrounds the pandemic (including its duration, the impact of COVID-19 variants and ultimate overall impact on U.S and global economies, Altria and its subsidiaries&#8217; operations and those of its investees), Altria continues to monitor the macroeconomic risks of the COVID-19 pandemic (including labor shortages and inflation) and continues to carefully evaluate potential outcomes and work to mitigate risks.  Specifically, Altria remains focused on any potential impact to its liquidity, operations, supply and distribution chains and on economic conditions.  In terms of Altria&#8217;s liquidity, despite some volatility in commercial paper markets in 2020, Altria has not experienced a material adverse impact to its liquidity.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As with so many other companies throughout the U.S. and globally, Altria&#8217;s operations have been affected by the COVID-19 pandemic.  To date, Altria believes its tobacco businesses have not experienced any material adverse effects associated with governmental actions to restrict consumer movement or business operations, but continues to monitor these factors.  Altria has implemented remote working for many employees and aligned with the social distancing protocols recommended by public health authorities for employees working at Altria facilities.  Altria continues to believe that remote working due to the COVID-19 pandemic has had minimal impact on productivity.  Also, Altria&#8217;s critical information technology systems have remained operational.  Although Altria&#8217;s tobacco businesses previously suspended operations temporarily at several of their manufacturing facilities in March 2020, the businesses resumed operations at those facilities under enhanced safety protocols in April 2020 and all manufacturing facilities are currently operational under enhanced safety protocols. Altria continues to monitor the risks associated with facility disruptions and workforce availability as a result of uncertainty related to the COVID-19 pandemic.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s suppliers and those within its distribution chain continue to be subject to potential facility closures, remote working protocols and labor shortages.  To date, Altria has not experienced any material disruptions to its supply chains or distribution systems, but is continuing to monitor these factors.  Altria continues to monitor the risk that the business of one or more suppliers, distributors or any other entities within its supply and distribution chains may be disrupted.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the President of the United States issued an Executive Order charging the Occupational Safety and Health Administration (&#8220;OSHA&#8221;) with developing an emergency temporary standard requiring almost all employers mandate certain COVID-19 vaccination and testing requirements in the workplace.  This mandate could have an adverse impact on worker availability at Altria&#8217;s subsidiaries&#8217; or investees&#8217; manufacturing, salesforce and administrative operations, or in their distribution and supply chains.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria believes that the COVID-19 pandemic altered adult tobacco consumer behaviors and purchasing patterns, particularly in the earlier stages of the pandemic.  While the number of adult tobacco consumer trips to the store remain below pre-pandemic levels and tobacco expenditures per trip remain elevated, the environment continues to evolve as the effects of government stimulus have lessened and consumer mobility returns to more normal levels.  Although Altria&#8217;s tobacco businesses have not experienced a material adverse impact to date by the COVID-19 pandemic, there is continued uncertainty as to how the COVID-19 pandemic (including changes in COVID-19-related restrictions and guidelines) may impact adult tobacco consumers in the future.  Altria continues to monitor the macroeconomic risks of the COVID-19 pandemic (including risks associated with the timing and extent of vaccine administration and the impact of COVID-19 variants), and their effect on adult tobacco consumers, including stay-at-home practices and disposable income, which may be further impacted by unemployment rates and inflation.  Altria also continues to monitor adult tobacco consumers&#8217; purchasing behaviors, including overall tobacco product expenditures, mix between premium and discount brand purchases and adoption of smoke-free products.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anheuser-Busch InBev SA/NV (&#8220;ABI&#8221;) continued to be impacted by the COVID-19 pandemic, including the effects of COVID-19 variants, supply-chain constraints across certain markets, transactional foreign exchange and commodity cost headwinds.  During the first nine months of 2021, ABI&#8217;s share price continued to fluctuate, ultimately resulting in a lower share price at September 30, 2021 compared to December 31, 2020. As discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. Investment in Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the condensed consolidated financial statements in Item 1 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), in preparing Altria&#8217;s financial statements for the period ended September 30, 2021, Altria concluded that the full recovery to the carrying value will take longer than previously expected, therefore, the decline in fair value of its investment in ABI at September 30, 2021 was other than temporary. In determining that the decline in fair value was other than temporary, Altria considered the continued impact of the COVID-19 pandemic on ABI&#8217;s global business along with several other factors. As a result, Altria recorded to income (losses) from equity investments in its condensed consolidated statements of earnings (losses) a non-cash, pre-tax impairment charge of $6.2 billion for the nine and three months ended September 30, 2021. Altria will continue to monitor its investment in ABI, including the impact of the COVID-19 pandemic on ABI&#8217;s business and market valuation.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria has considered the impact of the COVID-19 pandemic on the business of JUUL Labs, Inc. (&#8220;JUUL&#8221;), including its sales, distribution, operations, supply chain and liquidity, in conducting its periodic impairment assessment and quantitative valuations.  JUUL&#8217;s operations were negatively impacted in 2020 by the COVID-19 pandemic due to stay-at-home practices and government-mandated restrictions.  While the impact was considered in Altria&#8217;s quantitative valuations conducted in connection with the preparation of its financial statements for the nine months ended September 30, 2021 and during 2020, Altria does not believe the COVID-19 pandemic was a primary driver of the non-cash, pre-tax impairment charge recorded during 2020 or any quarterly changes in fair value recorded since the fourth quarter of 2020.  Altria will continue to monitor the impact of the COVID-19 pandemic on JUUL&#8217;s business, including near-term supply chain constraints and component part shortages, in Altria&#8217;s quarterly quantitative valuations of JUUL.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria has considered the impact of the COVID-19 pandemic on the business of Cronos Group Inc. (&#8220;Cronos&#8221;), including its sales, distribution, operations, supply chain and liquidity. During 2020 and the first nine months of 2021, Cronos has been adversely impacted by the COVID-19 pandemic, due in part to government actions limiting access to retail stores in the United States and Canada, including the recording in 2020 of an impairment charge on certain goodwill and intangible assets. However, the continued rollout of vaccines in the United States and Canada has resulted in the easing of COVID-19 related restrictions in most of the United States and Canada during the third quarter of 2021.  Altria will continue to monitor the impact of COVID-19 pandemic on Cronos&#8217; business, including near-term supply chain challenges, and market valuation.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Results of Operations for the Nine Months Ended September 30, 2021</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in net earnings (losses) attributable to Altria and diluted earnings (losses) per share (&#8220;EPS&#8221;) attributable to Altria for the nine months ended September 30, 2021, from the nine months ended September 30, 2020, were due primarily to the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.710%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Earnings (Losses)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the nine months ended September 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Implementation and acquisition-related costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Tobacco and health and certain other litigation items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Impairment of JUUL equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 ABI-related special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Cronos-related special items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 COVID-19 special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Tax items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal 2020 special items</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,733&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.01&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 NPM Adjustment Items</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">57</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.03</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Implementation, acquisition and disposition-related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(95)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.05)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Tobacco and health and certain other litigation items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.06)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 ABI-related special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,828)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2.60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Cronos-related special items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(205)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(496)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Tax items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal 2021 special items</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,675)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3.06)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fewer shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.02</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.01)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">268</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the nine months ended September 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">851</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.46</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Reported Net Earnings (Losses)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">851</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.46</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Reported Net Earnings (Losses)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(66.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(66.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Adjusted Net Earnings and Adjusted Diluted EPS</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,526</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.52</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Adjusted Net Earnings and Adjusted Diluted EPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">For a discussion of special items and other business drivers affecting the comparability of statements of earnings (losses) amounts and reconciliations of adjusted earnings attributable to Altria and adjusted diluted EPS attributable to Altria, see the Consolidated Operating Results section below.</span></div><div style="margin-bottom:5pt;padding-left:18pt;padding-right:9pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Fewer Shares Outstanding:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fewer shares outstanding were due primarily to shares repurchased by Altria under its share repurchase program in 2021.</span></div><div style="margin-bottom:5pt;padding-left:18pt;padding-right:9pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Change in Tax Rate:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The change in the tax rate (which excludes the impact of special items shown in the table above) was driven primarily by higher state tax expense and foreign tax rate differential.</span></div><div style="margin-bottom:5pt;padding-left:18pt;padding-right:9pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Operations: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase of $268 million in operations (which excludes the impact of special items shown in the table above) was due primarily to the following:</span></div><div style="margin-bottom:5pt;padding-left:54pt;padding-right:9pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">higher OCI from the smokeable products segment;</span></div><div style="margin-bottom:5pt;padding-left:54pt;padding-right:9pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">favorable net periodic benefit income, excluding service cost; and</span></div><div style="margin-bottom:5pt;padding-left:54pt;padding-right:9pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">higher income from Altria&#8217;s equity investment in ABI.</span></div><div style="margin-bottom:5pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">For further details, see the Consolidated Operating Results and Operating Results by Business Segment sections below.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Results of Operations for the Three Months Ended September 30, 2021</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in net earnings (losses) attributable to Altria and diluted EPS attributable to Altria for the three months ended September 30, 2021, from the three months ended September 30, 2020, were due primarily to the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.710%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Earnings (Losses)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the three months ended September 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(952)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.51)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Implementation and acquisition-related costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Tobacco and health and certain other litigation items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Impairment of JUUL equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 ABI-related special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Cronos-related special items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Tax items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal 2020 special items</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,167&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.70&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 NPM Adjustment Items</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.02</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Implementation, acquisition and disposition-related costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Tobacco and health and certain other litigation items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(80)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 JUUL changes in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.05</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 ABI-related special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,899)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2.65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Cronos-related special items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(89)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.05)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Tax items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal 2021 special items</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,979)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2.70)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fewer shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.01</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.01</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.01</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the three months ended September 30, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,722)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.48)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Reported Net Earnings (Losses)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,722)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Reported Net Earnings (Losses)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(952)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(100)%+</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(100)%+</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Adjusted Net Earnings and Adjusted Diluted EPS</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,257</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.22</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Adjusted Net Earnings and Adjusted Diluted EPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">For a discussion of special items and other business drivers affecting the comparability of statements of earnings (losses) amounts and reconciliations of adjusted earnings attributable to Altria and adjusted diluted EPS attributable to Altria, see the Consolidated Operating Results section below.</span></div><div style="margin-bottom:5pt;padding-left:18pt;padding-right:9pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.81pt">Fewer Shares Outstanding:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fewer shares outstanding were due primarily to shares repurchased by Altria under its share repurchase program in 2021.</span></div><div style="margin-bottom:5pt;padding-left:18pt;padding-right:9pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Change in Tax Rate:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The change in the tax rate (which excludes the impact of special items shown in the table above) was driven primarily by dividends associated with Altria&#8217;s equity investment in ABI.</span></div><div style="margin-bottom:5pt;padding-left:18pt;padding-right:9pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Operations: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase of $16 million in operations (which excludes the impact of special items shown in the table above) was due primarily to the following:</span></div><div style="margin-bottom:3pt;padding-left:54pt;padding-right:9pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">higher income from Altria&#8217;s equity investment in ABI;</span></div><div style="margin-bottom:3pt;padding-left:54pt;padding-right:9pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">favorable net periodic benefit income, excluding service cost; and </span></div><div style="margin-bottom:5pt;padding-left:54pt;padding-right:9pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lower interest and other debt expense, net;</span></div><div style="margin-bottom:5pt;padding-left:18pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">partially offset by:</span></div><div style="margin-bottom:5pt;padding-left:54pt;padding-right:9pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">lower OCI.</span></div><div style="margin-bottom:5pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">For further details, see the Consolidated Operating Results and Operating Results by Business Segment sections below.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021 Forecasted Results</span></div><div style="margin-bottom:5pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria narrows its guidance for 2021 full-year adjusted diluted EPS to be in a range of $4.58 to $4.62, representing a growth rate of 5% to 6% over its 2020 full-year adjusted diluted EPS base of $4.36, as shown in the first table below.  While the 2021 full-year adjusted diluted EPS guidance accounts for a range of scenarios, the external environment remains dynamic. Altria will continue to monitor conditions related to (i) the economy (including unemployment rates and the impact of increased inflation), (ii) adult tobacco consumer dynamics, including stay-at-home practices, disposable income, purchasing patterns and adoption of smoke-free products, (iii) regulatory and legislative (including excise tax) developments and (iv) the timing and extent of COVID-19 vaccine administration and the impact of COVID-19 variants.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s 2021 full-year adjusted diluted EPS guidance range includes planned investments in support of its Vision to responsibly lead the transition of adult smokers to a smoke-free future, such as (i) marketplace investments to expand the availability and awareness of Altria&#8217;s smoke-free products, (ii) costs associated with building an industry-leading consumer engagement platform that enhances data collection and insights in support of adult tobacco consumer transition to smoke-free products and (iii) increased smoke-free product research and development expense.  This forecasted growth rate excludes the (income) expense items in the second table below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria continues to expect its 2021 full-year adjusted effective tax rate will be in a range of 24.5% to 25.5%.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.667%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of 2020 Reported Diluted EPS to 2020 Adjusted Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Reported diluted EPS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment, exit, implementation and acquisition-related costs </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other litigation items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of JUUL equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL changes in fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.05)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI-related special items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos-related special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 special items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax items </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Adjusted diluted EPS</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.36&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;padding-left:9pt;padding-right:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following (income) expense items are excluded from Altria&#8217;s 2021 forecasted adjusted diluted EPS growth rate:</span></div><div style="margin-bottom:5pt;margin-top:3pt;padding-right:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.667%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Income) Expense Excluded from 2021 Forecasted Adjusted Diluted EPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NPM Adjustment Items</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Implementation, acquisition and disposition-related costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.05</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other litigation items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.06</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI-related special items </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.60</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos-related special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.27</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.06</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">For a discussion of certain income and expense items excluded from the forecasted results above, see the Consolidated Operating Results section below.</span></div><div style="margin-bottom:5pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s full-year adjusted diluted EPS guidance and full-year forecast for its adjusted effective tax rate exclude the impact of certain income and expense items, including those items noted in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-GAAP Financial Measures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below, that management believes are not part of underlying operations.  Altria&#8217;s management cannot estimate on a forward-looking basis the impact of these items on its reported diluted EPS or its reported effective tax rate because these items, which could be significant, may be unusual or infrequent, are difficult to predict and may be highly variable.  As a result, Altria does not provide a corresponding GAAP measure for, or reconciliation to, its adjusted diluted EPS guidance or its adjusted effective tax rate forecast.</span></div><div id="i295e56fb16f94dae9eacc631c56d466c_121"></div><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While Altria reports its financial results in accordance with GAAP, its management also reviews certain financial results, including OCI, OCI margins, net earnings (losses) attributable to Altria and diluted EPS, on an adjusted basis, which excludes certain income and expense items that management believes are not part of underlying operations.  These items may include, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for example, loss on early extinguishment of debt, restructuring charges, asset impairment charges, acquisition-related and disposition-related costs, COVID-19 special items, equity investment-related special items (including any changes in fair value of the equity investment and any related warrants and preemptive rights), certain tax items, charges associated with tobacco and health and certain other litigation items, and resolutions of certain non-participating manufacturer (&#8220;NPM&#8221;) adjustment disputes under the 1998 Master Settlement Agreement (such dispute resolutions are referred to as &#8220;NPM Adjustment Items&#8221;).  Altria&#8217;s management does not view any of these special items to be part of Altria&#8217;s underlying results as they may be highly variable, may be unusual or infrequent, are difficult to predict and can distort underlying business trends and results.  Altria&#8217;s management also reviews income tax rates on an adjusted basis.  Altria&#8217;s adjusted effective tax rate may exclude certain tax items from its reported effective tax rate.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s management believes that adjusted financial measures provide useful additional insight into underlying business trends and results, and provide a more meaningful comparison of year-over-year results.  Adjusted financial measures are used by management and regularly provided to Altria&#8217;s chief operating decision maker (the &#8220;CODM&#8221;) for planning, forecasting and evaluating business and financial performance, including allocating resources and evaluating results relative to employee compensation targets.  These adjusted financial measures are not required by, or calculated in accordance with GAAP and may not be calculated the same as similarly titled measures used by other companies.  These adjusted financial measures should thus be considered as supplemental in nature and not considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.</span></div><div id="i295e56fb16f94dae9eacc631c56d466c_124"></div><div style="margin-bottom:5pt;margin-top:10pt;padding-right:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Discussion and Analysis</span></div><div style="margin-bottom:5pt;padding-right:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-bottom:5pt;padding-right:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s critical accounting policies and estimates are discussed in its Annual Report on Form 10-K for the year ended December 31, 2020 (the &#8220;2020 Form 10-K&#8221;); there have been no material changes to these critical accounting policies and estimates, except as noted below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in ABI</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021, Altria&#8217;s investment in ABI consisted of 185 million restricted shares (the &#8220;Restricted Shares&#8221;) and 12 million ordinary shares of ABI.  The fair value of Altria&#8217;s equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI&#8217;s ordinary shares and, at September 30, 2021, was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets, for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2019, the fair value of Altria&#8217;s equity investment in ABI declined below its carrying value and at September 30, 2021 had not recovered. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing its financial statements for the period ended September 30, 2021, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria evaluated the factors related to the fair value decline, including the impact on the fair value of ABI&#8217;s shares during the COVID-19 pandemic, which has negatively impacted ABI&#8217;s business.  Altria evaluated the duration and magnitude of the fair value decline at September 30, 2021, ABI&#8217;s financial condition and near-term prospects, and Altria&#8217;s intent and ability to hold its investment in ABI until recovery</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing its financial statements for the period ended September&#160;30, 2021, Altria concluded that the decline in fair value of its investment in ABI at September&#160;30, 2021 was other than temporary.  As a result, Altria recorded a non-cash, pre-tax impairment charge of $6.2 billion for the nine and three months ended September 30, 2021 to income (losses) from equity investments in its condensed consolidated statements of earnings (losses).  This impairment charge reflected the difference between the fair value using ABI&#8217;s share price at September 30, 2021 and the carrying value of Altria&#8217;s equity investment in ABI at September 30, 2021, prior to recording the impairment charge. This conclusion was based on the following factors:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the fair value of Altria&#8217;s investment in ABI had been below its carrying value since October 2019 and had not fully recovered. At its lowest point in March 2020, the fair value of Altria&#8217;s investment in ABI was below its carrying value by approximately 52% and at December 31, 2020 had recovered to approximately 17%.  During the first nine months of 2021, ABI&#8217;s share price continued to fluctuate, ultimately resulting in a share price decline of 18% since December 31, 2020.  At September 30, 2021, prior to recording the impairment charge, the fair value of Altria&#8217;s investment in ABI was below its carrying value by approximately 35%;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the fair value of Altria&#8217;s investment in ABI historically exceeded its carrying value since October 2016 (when Altria obtained its ownership interest in ABI) with the exception of certain periods starting in September 2018 and since October 2019. Altria was optimistic about a near-term recovery because ABI&#8217;s share price demonstrated significant recovery, including during 2019, the second half of 2020 and the first half of 2021.  However, during the third quarter of 2021, the decline in ABI&#8217;s share price resumed and, at September 30, 2021, the share price was lower than at December 31, 2020, erasing much of the recovery experienced in the second half of 2020 and first half of 2021;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">ABI&#8217;s share price continued to decline following the release of ABI&#8217;s second quarter of 2021 earnings report in which ABI&#8217;s performance in the first half of 2021 improved meaningfully versus the same period in 2020.  Despite ABI&#8217;s </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:3pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">second quarter of 2021 results, which also included top-line growth ahead of the pre-pandemic levels from the second quarter of 2019 as well as the reaffirmation of its 2021 outlook, ABI&#8217;s income growth was impacted by, among other things, transactional foreign exchange and commodity cost headwinds; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the industry disruption and volatility associated with the COVID-19 pandemic, including the impact of COVID-19 variants and related cost headwinds, have continued.  While Altria continues to believe that ABI&#8217;s share price performance is not reflective of its underlying long-term equity value, and ABI&#8217;s share price will recover, Altria now believes that it will take longer than previously expected as Altria believes that COVID-19 variants, supply-chain constraints across certain markets, transactional foreign exchange and commodity cost headwinds may continue to impact ABI&#8217;s near-term financial results and share price performance.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although Altria recorded an impairment charge on its investment in ABI during the nine and three months ended September 30, 2021, Altria continues to have confidence in ABI&#8217;s (i) long-term strategies, (ii) premium global brands, (iii) experienced management team and (iv) capability to successfully navigate its near-term challenges.  Altria further expects that the adverse impacts related to the COVID-19 pandemic that have negatively impacted ABI&#8217;s global business are transitory, but now also anticipates that the full recovery to the carrying value will take longer than previously expected.  During October 2021, ABI&#8217;s share price continued to fluctuate and at October 25, 2021, the fair value of Altria&#8217;s investment in ABI approximated its carrying value.  Altria will continue to monitor its investment in ABI, including the impact of the COVID-19 pandemic and subsequent recovery on ABI&#8217;s business and market valuation.  For further discussion of Altria&#8217;s investment in ABI, see Note 4.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in Cronos</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of Altria&#8217;s equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos&#8217;s common shares and was classified in Level 1 of the fair value hierarchy.  In September 2021, the fair value of Altria&#8217;s equity method investment in Cronos declined below its carrying value.  At September 30 2021, the fair value of Altria&#8217;s equity method investment in Cronos was below its carrying value by $14 million or approximately 2%.  Altria has evaluated the factors related to the fair value decline.  Based on Altria&#8217;s evaluation of the duration and magnitude of the fair value decline at September 30, 2021, Altria concluded that the decline in fair value of its equity method investment in Cronos below its carrying value is temporary and, therefore, no impairment was recorded.  At October 25, 2021, the fair value of Altria&#8217;s equity method investment in Cronos was below its carrying value by $26 million or approximately 3%.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria will continue to monitor its equity method investment in Cronos, including the impact of the COVID-19 pandemic on Cronos&#8217;s business and market valuation. If Altria were to conclude that the decline in fair value is other than temporary, Altria would determine and recognize, in the period identified, the impairment of its equity method investment, which could result in a material adverse effect on Altria&#8217;s consolidated financial position or earnings. For further discussion of Altria&#8217;s investment in Cronos, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Excise Taxes</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Congress is currently considering legislation that would significantly increase the federal excise tax for all tobacco products and create a new tax for e-vapor products and other products containing nicotine that are not currently subject to a tobacco federal excise tax.  Additionally, e-vapor products and oral nicotine products not currently taxed would be subject to a federal excise tax that would vary based on the nicotine content.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria uses an income approach to estimate (i) the fair values of its goodwill and intangible assets when conducting its annual review of goodwill and indefinite-lived intangible assets for potential impairment (more frequently if events occur that would require an interim review) and (ii) the fair value of its investment in JUUL, when accounting for its equity method investment in JUUL under the fair value option. Altria believes that an excise tax on cigars, moist smokeless tobacco products (&#8220;MST&#8221;), e-vapor products and oral nicotine pouches at the current proposed rates could have a material adverse impact on the significant assumptions used in performing these valuations, including volume, operating margins and income.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At this time, it is unclear (i) whether proposed tobacco and nicotine taxes will be included in any final legislation and (ii) what the amounts of any such taxes that would be included, if enacted.  If the proposed tobacco and nicotine federal excise taxes on cigars, MST and e-vapor products are included in any final legislation at the rates that are currently proposed, it could result in a material non-cash impairment of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> trademark and a material decrease in the fair value of its investment in JUUL, either of which would have a material adverse effect on Altria&#8217;s consolidated financial position or earnings.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Consolidated Operating Results</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.184%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,275</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,975</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,945</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">626</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">494</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">177</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,758</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,849&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,786</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,123&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Excise taxes on products:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,620</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,218</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">98</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise taxes on products</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,733</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,063&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,255</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,445&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,901</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,753</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,269</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">405</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(255)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,827</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,292&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,951</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,160&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;padding-right:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed further in Note 9, the CODM reviews OCI to evaluate the performance of, and allocate resources to, the segments.  Management believes it is appropriate to disclose this measure to help investors analyze the business performance and trends of the various business segments.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of adjusted net earnings (losses) attributable to Altria and adjusted diluted EPS attributable to Altria for the nine months ended September 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.958%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.452%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions of dollars, except per share data)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings (Losses) before Income Taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Provision (Benefit) for Income Taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Earnings (Losses)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Earnings (Losses) Attributable <br/>to Altria</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted EPS</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Reported</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,544</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">693</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">851</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">851</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.46</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NPM Adjustment Items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Implementation, acquisition and disposition-related costs </span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">117</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">95</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">95</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.05</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">litigation items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">148</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.06</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI-related special items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,111</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,283</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,828</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,828</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.60</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos-related special items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">205</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">205</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">649</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">153</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">496</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">496</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.27</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Adjusted for Special Items</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,693</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,167</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,526</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,526</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.52</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Reported</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,817&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Implementation and acquisition-related costs </span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">litigation items </span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of JUUL equity securities</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI-related special items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos-related special items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 special items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Adjusted for Special Items</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,323&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,058&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,265&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,276&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.37&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of adjusted net earnings (losses) attributable to Altria and adjusted diluted EPS attributable to Altria for the three months ended September 30:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:39.017%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.469%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions of dollars, except per share data)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings (Losses) before Income Taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Provision (Benefit) for Income Taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Earnings (Losses)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Earnings (Losses) Attributable <br/>to Altria</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted EPS</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Reported</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,302)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(582)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,720)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,722)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.48)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NPM Adjustment Items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Implementation, acquisition and disposition-related costs </span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">61</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">52</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">52</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.03</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">litigation items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">105</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">80</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">80</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.04</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL changes in fair value</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.05)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI-related special items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,301</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,899</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,899</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.65</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos-related special items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.05</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Adjusted for Special Items</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,009</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">750</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,259</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,257</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.22</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Reported</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(956)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(952)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Implementation and acquisition-related costs </span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">litigation items </span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of JUUL equity securities</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI-related special items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos-related special items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Adjusted for Special Items</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,978&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,215&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.19&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following special items affected the comparability of statements of earnings (losses) amounts for the nine and three months ended September 30, 2021 and 2020:</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">NPM Adjustment Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of NPM Adjustment Items and a breakdown of these items by segment, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Note 12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Contingencies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the condensed consolidated financial statements in Item 1 (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 12&#8221;) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">NPM Adjustment Items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Note 9, respectively.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Implementation, Acquisition and Disposition-Related Costs: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax implementation, acquisition and disposition-related charges were $117 million and $61 million for the nine and three months ended September 30, 2021, respectively.  Pre-tax implementation and acquisition-related costs were $415 million and $12 million for the nine and three months ended September 30, 2020, respectively.  For a discussion of implementation, acquisition and disposition-related costs, see Note 9.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Tobacco and Health and Certain Other Litigation Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of tobacco and health and certain other litigation items and a breakdown of these costs by segment, see Note 12 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tobacco and Health and Certain Other Litigation Items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Note 9, respectively.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Impairment of JUUL Equity Securities: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine and three months ended September 30, 2020, Altria recorded a non-cash, pre-tax impairment charge of $2,600 million, reported as impairment of JUUL equity securities in its condensed consolidated statements of earnings (losses).  A full tax valuation allowance was recorded in 2020 attributable to the tax benefit associated with the impairment charge.  For further discussion, see Note 4 and Note 11. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the condensed consolidated financial statements in Item 1 (&#8220;Note 11&#8221;).</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">JUUL Changes in Fair Value: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2021, Altria recorded a non-cash, pre-tax unrealized gain of  $100 million, reported as (income) losses from equity investments in its condensed consolidated statements of earnings (losses) as a result of changes in the estimated fair value of Altria&#8217;s investment in JUUL.  A corresponding adjustment was made to the JUUL tax valuation allowance.  At September 30, 2021, the estimated fair value of Altria&#8217;s investment in JUUL was $1,705 million, unchanged from its December 31, 2020 estimated fair value.  For further discussion, see Note 4.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">ABI-Related Special Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s losses from its equity investment in ABI for the nine and three months ended September 30, 2021 included net pre-tax charges  of $6,111&#160;million and $6,200&#160;million, respectively, substantially all of which related to an impairment of Altria&#8217;s equity investment in ABI.  For further discussion, see Note 4.</span></div><div style="margin-bottom:5pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s losses from its equity investment in ABI for the nine months ended September 30, 2020 included net pre-tax charges of $689 million, consisting primarily of  (i) mark-to-market losses on certain ABI financial instruments associated with its share commitments, (ii) completion of the sale of its Australia subsidiary and (iii) goodwill impairment charges associated with its Africa businesses.</span></div><div style="margin-bottom:5pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s losses from its equity investment in ABI for the three months ended September 30, 2020 included net pre-tax charges of $513 million, consisting primarily of ABI&#8217;s completion of the sale of its Australia subsidiary and goodwill impairment charges associated with its Africa businesses.</span></div><div style="margin-bottom:5pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These amounts include Altria&#8217;s respective share of amounts recorded by ABI and may also include additional adjustments related to (i) conversion from international financial reporting standards to GAAP and (ii) adjustments to Altria&#8217;s investment required under the equity method of accounting.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Cronos-Related Special Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine and three months ended September 30, 2021 and 2020, Altria recorded net pre-tax (income) expense consisting of the following:</span></div><div style="margin-top:5pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.076%"><tr><td style="width:1.0%"></td><td style="width:43.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.153%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.153%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.153%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.154%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on Cronos-related financial instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">128</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">135</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from equity investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Cronos-related special items - (income) expense</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:5pt;padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">Amounts are related to the non-cash change in the fair value of the warrant and certain anti-dilution protections (the &#8220;Fixed-price Preemptive Rights&#8221;) acquired in the Cronos transaction.</span></div><div style="margin-bottom:5pt;margin-top:3pt;padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">Amounts include Altria&#8217;s share of special items recorded by Cronos and may also include adjustments to Altria&#8217;s investment required under the equity method of accounting.</span></div><div style="margin-bottom:5pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion, see Note 4 and Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the condensed consolidated financial statements in Item 1.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Loss on Early Extinguishment of Debt: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, Altria recorded pre-tax losses of $649 million as a result of the completed debt tender offers and redemption of certain long-term senior unsecured notes.  For further discussion, see Note 10. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the condensed consolidated financial statements in Item 1 (&#8220;Note 10&#8221;).</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">COVID-19 Special Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2020, Altria recorded net pre-tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">charges totaling $50 million directly related to disruptions caused by or efforts to mitigate the impact of the COVID-19 pandemic.  For further discussion and a breakdown of these costs by segment, see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> COVID-19 Special Items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Note 9.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Tax Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax items for the nine months ended September 30, 2020 included net tax expense of $38 million, due primarily to tax expense of $17 million for a tax basis adjustment to Altria&#8217;s investment in ABI and net tax expense of $12 million for adjustments resulting from amended returns and audit adjustments related to prior years.  Tax items for the three months ended September 30, 2020 included tax benefits of $13 million, due primarily to tax benefits of $17 million for a tax basis adjustment of Altria&#8217;s investment in ABI.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended September&#160;30, 2021 Compared with Nine Months Ended September&#160;30, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues, which include excise taxes billed to customers, decreased $91 million (0.5%), due primarily to lower net revenues in the smokeable products segment, partially offset by higher net revenues in the wine and oral tobacco products segments and the financial services business.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales decreased $561 million (9.5.%), due primarily to the inventory-related charges in the wine segment in 2020 (as discussed in Note 9), lower shipment volume in the smokeable products segment, NPM Adjustment Items in 2021 and COVID-19 special items in 2020, partially offset by higher per unit settlement charges, higher manufacturing costs and higher shipment volume in the wine segment.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excise taxes on products decreased $330 million (8.1%), due primarily to lower shipment volume in the smokeable products segment.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing, administration and research costs increased $265 million (16.7%), due primarily to higher general corporate expenses, higher spending in the oral tobacco products (including higher acquisition-related costs - as discussed in Note 9) and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">smokeable products segments, the charge associated with the Ste. Michelle Transaction and higher spending associated with the retail expansion of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income increased $535 million (6.5%), due primarily to higher operating results in the wine and smokeable products segments, partially offset by higher general corporate expenses and lower operating results in the oral tobacco products segment.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit income, excluding service cost, increased by $94 million (100.0%+), due primarily to lower interest cost resulting from a decrease in discount rates and amendments to its salaried retiree healthcare plans during the second quarter of 2021.  For further discussion, see Note 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Benefit Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the condensed consolidated financial statements in Item 1 (&#8220;Note 6&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (losses) from equity investments, which decreased $5,483 million (100.0%+), were negatively impacted by unfavorable special items from Altria&#8217;s equity investments in ABI (primarily due to the impairment of Altria&#8217;s equity investment in ABI in 2021) and Cronos (as shown above).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s income tax rate increased 3.1 percentage points to 44.9%.  For further discussion, see Note 11.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reported net earnings (losses) attributable to Altria of $851 million decreased $1,692 million (66.5%), due primarily to higher losses from equity investments and the loss on early extinguishment of debt, partially offset by the 2020 impairment of JUUL equity securities, higher operating income, lower loss on Cronos-related financial instruments and favorable net periodic benefit income, excluding service cost.  Reported basic and diluted EPS attributable to Altria of $0.46, decreased by 66.4% and 66.2%, respectively, due to lower reported net earnings (losses) attributable to Altria, partially offset by fewer shares outstanding.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted net earnings attributable to Altria of $6,526 million increased $250 million (4.0%), due primarily to higher smokeable products segment OCI, favorable net periodic benefit income, excluding service cost, and higher income from Altria&#8217;s investment in ABI, partially offset by a higher income tax rate.  Adjusted diluted EPS attributable to Altria of $3.52 increased by 4.5%, due to higher adjusted net earnings attributable to Altria and fewer shares outstanding.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended September&#160;30, 2021 Compared with Three Months Ended September&#160;30, 2020</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues, which include excise taxes billed to customers, decreased $337 million (4.7%), due primarily to lower net revenues in the smokeable products segment.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales decreased $103 million (5.3%), due primarily to lower shipment volume in the smokeable products segment and NPM Adjustment Items in 2021, partially offset by higher per unit settlement charges and higher manufacturing costs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excise taxes on products decreased $190 million (13.1%), due primarily to lower shipment volume in the smokeable products segment.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing, administration and research costs increased $165 million (29.6%), due primarily to higher general corporate expenses, the charge associated with the Ste. Michelle Transaction, higher spending associated with the retail expansion of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro HeatSticks </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and higher spending in the oral tobacco products segment.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income decreased $209 million (6.6%), due primarily to lower operating results in all reportable segments and higher general corporate expenses.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other debt expense, net decreased $44 million (14.2%), due primarily to lower interest costs in 2021 as a result of debt refinancing activities and interest income associated with NPM Adjustment Items in 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit income, excluding service cost, increased by $60 million (100.0%+), due primarily to lower interest cost resulting from a decrease in discount rates and amendments to its salaried retiree healthcare plans during the second quarter of 2021.  For further discussion, see Note 6.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (losses) from equity investments, which decreased $5,443 million (100.0%+), were negatively impacted by unfavorable special items from Altria&#8217;s equity investment in ABI (primarily due to the impairment of Altria&#8217;s equity investment in ABI in 2021), partially offset by an increase in the estimated fair value of Altria&#8217;s investment in JUUL and Cronos&#8217;s special items (as shown above).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s income tax rate increased 212.7 percentage points to 17.6%.  For further discussion, see Note 11.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reported net earnings (losses) attributable to Altria of $(2,722) million decreased $1,770 million (100.0%+), due primarily to higher losses from equity investments and lower operating income, partially offset by the 2020 impairment of JUUL equity securities, favorable net periodic benefit income, excluding service cost, and lower interest and other debt expense, net.  Reported basic and diluted EPS attributable to Altria of $(1.48), each decreased by 100.0%+, due to lower reported net earnings (losses) attributable to Altria, partially offset by fewer shares outstanding.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted net earnings attributable to Altria of $2,257 million increased $42 million (1.9%), due primarily to higher income from Altria&#8217;s equity investment in ABI, favorable net periodic income, excluding service cost, a lower income tax rate and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lower interest and other debt expense, net, partially offset by lower OCI.  Adjusted diluted EPS attributable to Altria of $1.22 increased by 2.5%, due to higher adjusted net earnings attributable to Altria and fewer shares outstanding.</span></div><div><span><br/></span></div><div id="i295e56fb16f94dae9eacc631c56d466c_127"></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Operating Results by Business Segment</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tobacco Space</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Environment</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. tobacco industry faces a number of business and legal challenges that have adversely affected and may adversely affect the business and sales volume of Altria&#8217;s tobacco subsidiaries and investees and Altria&#8217;s consolidated results of operations, cash flows or financial position.  These challenges, some of which are discussed in more detail in Note 12, in Part I, Item 1A. Risk Factors of our 2020 Form 10-K, in Part II, Item 1A. Risk Factors of our Quarterly Report on Form 10-Q for the period ended June 30, 2021 (&#8220;Second Quarter 2021 Form 10-Q&#8221;) and in Part II, Item 1A. Risk Factors of this Form 10-Q, include:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">pending and threatened litigation and bonding requirements;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">restrictions and requirements imposed by the Family Smoking Prevention and Tobacco Control Act (the &#8220;FSPTCA&#8221;), and restrictions and requirements (and related enforcement actions) that have been, and in the future will be, imposed by the United States Food and Drug Administration (the &#8220;FDA&#8221;);</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">actual and proposed excise tax increases, as well as changes in tax structures and tax stamping requirements;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">bans and restrictions on tobacco use imposed by governmental entities and private establishments and employers;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">other federal, state and local government actions, including:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">restrictions on the sale of certain tobacco products, the sale of tobacco products by certain retail establishments, the sale of tobacco products with characterizing flavors and the sale of tobacco products in certain package sizes;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">additional restrictions on the advertising and promotion of tobacco products;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">other actual and proposed tobacco-related legislation and regulation; and</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">governmental investigations;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">reductions in cigarette and MST consumption levels due to growth of innovative tobacco products;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">increased efforts by tobacco control advocates and other private sector entities (including retail establishments) to further restrict the availability and use of tobacco products;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">changes in adult tobacco consumer purchase behavior, which is influenced by various factors such as economic conditions, excise taxes and price gap relationships, may result in adult tobacco consumers switching to discount products or other lower-priced tobacco products;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the highly competitive nature of all tobacco categories, including, without limitation, competitive disadvantages related to cigarette price increases attributable to the settlement of certain litigation and the proliferation of innovative tobacco products, including e-vapor and oral nicotine pouch products;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">illicit trade in tobacco products;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">potential adverse changes in prices, availability and quality of tobacco, other raw materials and components; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the COVID-19 pandemic.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to and in connection with the foregoing, evolving adult tobacco consumer preferences are continuing to impact the tobacco industry.  Altria&#8217;s tobacco subsidiaries believe that a significant number of adult tobacco consumers switch among tobacco categories, use multiple forms of tobacco products and try innovative tobacco products, such as e-vapor products and oral nicotine pouches. Adult smokers continue to transition from cigarettes to exclusive use of smoke-free tobacco product alternatives, which aligns with Altria&#8217;s Vision.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until the second half of 2019, the e-vapor category experienced significant growth, and the number of adults who exclusively used e-vapor products also increased during that time, which, along with growth in oral nicotine pouches, negatively impacted consumption levels and sales volume of cigarettes and MST.  Over the past two years, the legislative and regulatory activities discussed below negatively impacted growth in the e-vapor category.  While these activities continue to impact the e-vapor category, the category has recently been experiencing a moderate rate of growth and has become increasingly competitive.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Oral nicotine pouch retail share of the total oral tobacco category has grown significantly over the past year from 7.7% year to date as of September 30, 2020 to 14.5% year to date as of September 30, 2021.  The oral nicotine pouch category is also becoming increasingly competitive.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are monitoring the introduction of unregulated synthetic nicotine products, which may lead to further competition for regulated tobacco products, including oral nicotine pouches and e-vapor products, and may result in underage use of these unregulated products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and its tobacco subsidiaries believe the innovative tobacco products categories (in particular, e-vapor) will continue to be dynamic due to adult tobacco consumer exploration of a variety of tobacco product options, adult consumer perceptions of the relative risks of smoke-free products compared to cigarettes, FDA determinations on product applications and legislative actions.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the nine months ended September 30, 2021, we estimate that, when adjusted for trade inventory movements, calendar differences and other factors, domestic cigarette industry volume declined by 5%.  Altria expects 2021 cigarette industry volume trends to continue to be most influenced by (i) changes to adult smoker stay-at-home practices, disposable income, purchasing patterns and adoption of smoke-free products, (ii) the economy (including unemployment rates, the impact of increased inflation and gasoline prices), (iii) fiscal stimulus, (iv) cross-category movement, (v) the timing and extent of COVID-19 vaccine administration and the impact of COVID-19 variants, (vi) adult smoker purchasing behavior of those who receive the vaccine and (vii) regulatory and legislative (including excise tax) developments.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Economic conditions also impact adult tobacco consumer purchase behavior.  Prior economic downturns have resulted in adult tobacco consumers choosing discount products and other lower-priced tobacco products.  Although the economic impact resulting from the COVID-19 pandemic has not meaningfully increased the growth of discount and lower priced tobacco products, in part due to stimulus payments, adult tobacco consumers may increasingly choose these products if economic conditions do not continue to improve. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Summary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in Item 7 above for further discussion.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and its tobacco subsidiaries work to meet these evolving adult tobacco consumer preferences over time by developing, manufacturing, marketing and distributing products both within and outside the U.S. through innovation and adjacency growth strategies (including, where appropriate, arrangements with, or investments in, third parties).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FSPTCA and FDA Regulation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">The Regulatory Framework:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FSPTCA, its implementing regulations and its 2016 deeming regulations establish broad FDA regulatory authority over all tobacco products and, among other provisions:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">impose restrictions on the advertising, promotion, sale and distribution of tobacco products (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Final Tobacco Marketing Rule</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below);</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">establish pre-market review pathways for new and modified tobacco products (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pre-Market Review Pathways for Tobacco Products and Market Authorization Enforcement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below);</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">prohibit any express or implied claims that a tobacco product is or may be less harmful than other tobacco products without FDA authorization;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">authorize the FDA to impose tobacco product standards that are appropriate for the protection of the public health; and</span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">equip the FDA with a variety of investigatory and enforcement tools, including the authority to inspect product manufacturing and other facilities.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FSPTCA also bans descriptors such as &#8220;light,&#8221; &#8220;low&#8221; or &#8220;mild&#8221; when used as descriptors of modified risk, unless expressly authorized by the FDA.  In connection with a 2016 lawsuit initiated by John Middleton Co. (&#8220;Middleton&#8221;), the Department of Justice, on behalf of the FDA, informed Middleton that the FDA does not intend to bring an enforcement action against Middleton for the use of the term &#8220;mild&#8221; in the trademark &#8220;Black &amp; Mild.&#8221;  Consequently, Middleton dismissed its lawsuit without prejudice.  If the FDA were to change its position at some later date, Middleton would have the opportunity to bring another lawsuit.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Final Tobacco Marketing Rule: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by the FSPTCA, in March 2010 the FDA promulgated a wide range of advertising and promotion restrictions for cigarettes and smokeless tobacco</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products (the &#8220;Final Tobacco Marketing Rule&#8221;).  The May 2016 deeming regulations amended the Final Tobacco Marketing Rule to expand specific provisions to all tobacco products, including cigars, pipe tobacco and e-vapor and oral nicotine products containing tobacco-derived nicotine or other tobacco derivatives, but do not include any component or part that is not made or derived from tobacco.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Final Tobacco Marketing Rule, as amended, among other things:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">restricts the use of non-tobacco trade and brand names on cigarettes and smokeless tobacco products;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">prohibits sampling of all tobacco products except that sampling of smokeless tobacco products is permitted in qualified adult-only facilities;</span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Smokeless tobacco,&#8221; as used in this section of this Form 10-Q, refers to smokeless tobacco products first regulated by the FDA in 2009, including MST.  It excludes oral nicotine pouches, which were first regulated by the FDA in 2016.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">prohibits the sale or distribution of items such as hats and tee shirts with cigarette or smokeless tobacco brands or logos;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">prohibits cigarettes and smokeless tobacco brand name sponsorship of any athletic, musical, artistic or other social or cultural event, or any entry or team in any event; and</span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">requires the development by the FDA of graphic warnings for cigarettes, establishes warning requirements for other tobacco products, and gives the FDA the authority to require new warnings for any type of tobacco product (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">FDA Regulatory Actions - Graphic Warnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to certain limitations arising from legal challenges, the Final Tobacco Marketing Rule took effect in June 2010 for cigarettes and smokeless tobacco products and in August 2016 for all other tobacco products, including e-vapor and oral nicotine pouch products containing tobacco-derived nicotine.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Rulemaking and Guidance: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the FDA issues proposed regulations and guidance, which may be issued in draft or final form, generally involve public comment and may include scientific review.  The FDA also may request comments on broad topics through an Advanced Notice of Proposed Rulemaking (&#8220;ANPRM&#8221;).  Altria&#8217;s tobacco subsidiaries actively engage with the FDA to develop and implement the FSPTCA&#8217;s regulatory framework, including submission of comments to various FDA policies and proposals and participation in public hearings and engagement sessions.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA&#8217;s implementation of the FSPTCA and related regulations and guidance also may have an impact on enforcement efforts by U.S. states, territories and localities of their laws and regulations as well as of the State Settlement Agreements discussed below (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State Settlement Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below).&#160; Such enforcement efforts may adversely affect the ability of Altria&#8217;s tobacco subsidiaries and investees to market and sell regulated tobacco products in those states, territories and localities.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">FDA&#8217;s Comprehensive Plan for Tobacco and Nicotine Regulation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, the FDA announced a &#8220;Comprehensive Plan for Tobacco and Nicotine Regulation&#8221; (&#8220;Comprehensive Plan&#8221;) designed to strike a balance between regulation and encouraging the development of innovative tobacco products that may be less risky than cigarettes.  Since then, the FDA has issued additional information about its Comprehensive Plan in response to concerns associated with the rise in the use of e-vapor products by youth and the potential youth appeal of flavored tobacco products (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Underage Access and Use of Certain Tobacco Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below).  As part of the Comprehensive Plan, the FDA:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">issued ANPRMs relating to potential product standards for nicotine in cigarettes, flavors in all tobacco products (including menthol in cigarettes and characterizing flavors in all cigars); and, for e-vapor products, to protect against known public health risks such as concerns about youth exposure to liquid nicotine;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">took actions to restrict youth access to e-vapor products;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">reconsidered the processes used by the FDA to review certain reports and new product applications; and</span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">revisited the timelines (previously extended by the FDA) to submit applications for tobacco products first regulated by the FDA in 2016.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Pre-Market Review Pathways for Tobacco Products and Market Authorization Enforcement: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FSPTCA permits the sale of tobacco products commercially marketed as of February 15, 2007 and not subsequently modified (&#8220;Grandfathered Products&#8221;) and new or modified products authorized through the pre-market tobacco product application (&#8220;PMTA&#8221;), Substantial Equivalence (&#8220;SE&#8221;) or SE Exemption pathways. Subsequent FDA rules also provide a Supplemental PMTA pathway designed to increase the efficiency of submission and review for modified versions of previously authorized products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA pre-market authorization enforcement policy varies based on product type and date of availability in the market, specifically:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">all tobacco products on the market as of February 15, 2007, and not subsequently modified, are Grandfathered Products and exempt from the pre-market authorization requirement;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">cigarette and smokeless tobacco products that were modified or first introduced into the market between February 15, 2007 and March 22, 2011 are generally considered &#8220;Provisional Products&#8221; for which SE reports were required to be filed by March 22, 2011.  These reports must demonstrate that the product has the same characteristics as a product on the market as of February 15, 2007 or to a product previously determined to be substantially equivalent, or has different characteristics but does not raise different questions of public health; and</span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">tobacco products that were first regulated by the FDA in 2016, including cigars, e-vapor products and oral nicotine pouches that are not Grandfathered Products, are generally products for which either an SE report or PMTA needed to be filed by September 9, 2020.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Modifications to currently marketed products, including modifications that result from, for example, changes to the quantity of tobacco product(s) in a package, a manufacturer being unable to acquire ingredients or a supplier being unable to maintain the consistency required in ingredients, could trigger the FDA&#8217;s pre-market or SE review processes.  Through these processes, a </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">manufacturer could receive (i) a &#8220;not substantially equivalent&#8221; determination, (ii) a denial of a PMTA or (iii) a marketing order withdrawal by the FDA on one or more products, which would require the removal of the product or products from the market.  Such actions could have a material adverse impact on the business and consolidated results of operations of our tobacco subsidiaries and investees, and the cash flows or financial position of Altria and its tobacco subsidiaries, including adversely affecting the value of Altria&#8217;s investment in JUUL.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Provisional Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most cigarette and smokeless tobacco products currently marketed by Philip Morris USA Inc. (&#8220;PM USA&#8221;) and U.S. Smokeless Tobacco Company LLC (&#8220;USSTC&#8221;) are &#8220;Provisional Products&#8221;.  Altria&#8217;s subsidiaries timely submitted SE reports for these Provisional Products.  PM USA and USSTC have received SE determinations on certain Provisional Products. Those products that were found by the FDA to be not substantially equivalent (certain smokeless tobacco products) had been discontinued for business reasons prior to the FDA&#8217;s determinations; therefore, those determinations did not impact business results.  PM USA and USSTC have other Provisional Products that continue to be subject to the FDA&#8217;s pre-market review process.  In the meantime, they can continue marketing these products unless the FDA determines that a specific Provisional Product is not substantially equivalent.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the FDA has communicated that it will not review a certain subset of Provisional Product SE reports and that the products that are the subject of those reports can continue to be legally marketed without further FDA review.  PM USA and USSTC have Provisional Products included in this subset of products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While Altria&#8217;s cigarette and smokeless tobacco subsidiaries believe their current Provisional Products meet the statutory requirements of the FSPTCA, they cannot predict how the FDA will ultimately apply law, regulation and guidance to their various SE reports. Should Altria&#8217;s cigarette and smokeless tobacco subsidiaries receive unfavorable determinations on any SE reports currently pending with the FDA, they believe they can replace the vast majority of their respective product volumes with other FDA authorized products or with Grandfathered Products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Provisional Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Cigarette and smokeless tobacco products introduced into the market or modified after March 22, 2011 are &#8220;Non-Provisional Products&#8221; and must receive a marketing order from the FDA prior to being offered for sale.  Marketing orders for Non-Provisional Products may be obtained by filing an SE report, PMTA or using another pre-market pathway established by the FDA.  Altria&#8217;s cigarette and smokeless tobacco subsidiaries may not be able to obtain a marketing order for non-provisional products because the FDA may determine that any such product does not meet the statutory requirements for approval.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Products Regulated in 2016</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Manufacturers of products first regulated by the FDA in 2016, including cigars, oral nicotine pouches and e-vapor products, that were on the market as of August 8, 2016 and not subsequently modified must have filed an SE report or PMTA by the filing deadline of September 9, 2020 in order for their products to remain on the market.  These products can remain on the market during FDA review through court-allowed, case-by-case discretion, so long as the report or application was timely filed with the FDA.  Due to the large number of applications received by September 9, 2020, the FDA did not complete its review of all submitted applications by September 9, 2021; although it has issued various marketing denial orders on over 90% of the applications and issued marketing granted orders on a few applications for tobacco flavor e-vapor products.  For those products still under FDA review, it is uncertain when and for how long the FDA may permit continued marketing and sale of those products pursuant to its case-by-case discretion.  For products (new or modified) not on the market as of August 8, 2016, manufacturers must file an SE report or PMTA and receive FDA authorization prior to marketing and selling the product.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helix Innovations LLC (&#8220;Helix&#8221;) submitted PMTAs for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;on!&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">oral nicotine pouches in May 2020.  JUUL submitted PMTAs to the FDA for its e-vapor device and the related tobacco and menthol flavors in July 2020.  As of October 25, 2021, the FDA has not issued marketing order decisions for any </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or JUUL products. In addition, as of October 25, 2021, Middleton has received market orders or exemptions that cover over 98% of its cigar product volume and has pending timely filed SE reports for its remaining cigar product volume.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2013, Altria&#8217;s subsidiaries entered into a series of agreements with Philip Morris International Inc. (&#8220;PMI&#8221;), including an agreement that grants Altria an exclusive right to commercialize certain of PMI&#8217;s heated tobacco products in the United States, subject to FDA authorization of the applicable products.  PMI submitted a PMTA and a modified risk tobacco product application with the FDA for its electronically heated tobacco products comprising the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS Tobacco Heating System</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In April 2019, the FDA authorized the PMTA for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS Tobacco Heating System </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and in July 2020, the FDA authorized the marketing of this system as a modified risk tobacco product (&#8220;MRTP&#8221;) with a reduced exposure claim.  The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device heats but does not burn tobacco. In December 2020, the FDA authorized the PMTA for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3, an updated version of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">electronic device.  The MRTP authorization for the original </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device currently does not apply to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">device.  PMI submitted an MRTP application for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 electronic device in March 2021, which is currently under review by the FDA.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, in connection with a patent dispute, the United States International Trade Commission (&#8220;ITC&#8221;) issued a cease and desist order banning (i) the importation of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and infringing components into the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States and (ii) the sale, marketing and distribution of such imported products in the United States.  As a result, PM USA announced plans to begin removing the product from the marketplace. For a further discussion of the ITC decision, see Note 12.</span></div><div style="margin-bottom:5pt"><span style="background-color:#ffffff;color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October 2021, the FDA authorized the marketing and sale of four of USSTC&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Verve</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> oral nicotine products, including Green Mint and Blue Mint varieties, representing the first flavored product authorizations issued by the FDA for newly deemed products.  These products are not currently marketed or sold.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Post-Market Surveillance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  Manufacturers that receive product authorizations through the PMTA process must submit to the FDA post-market records and reports, as detailed in market orders.  This includes notification of all marketing activities.  The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS Tobacco Heating System</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is subject to this post-market surveillance requirement.  The FDA may amend requirements of a market order or withdraw the market order based on this information if, among other reasons, it determines that the continued marketing of the products is no longer appropriate for the protection of the public health.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Effect of Adverse FDA Determinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: FDA review time frames have varied.  It is therefore difficult to predict the duration of FDA reviews of SE reports or PMTAs.  Failure of manufacturers to submit applications by the applicable deadline, an unfavorable determination on an application or the withdrawal by the FDA of a prior marketing order could result in the removal of products from the market.  These manufacturers would have the option of marketing products that have received FDA pre-market authorization or Grandfathered Products.  A &#8220;not substantially equivalent&#8221; determination, a denial of a PMTA or a marketing order withdrawal by the FDA on one or more products (which would require the removal of the product or products from the market) could have a material adverse impact on the business and consolidated results of operations of our tobacco subsidiaries and investees, and the cash flows or financial position of Altria and its tobacco subsidiaries, including adversely affecting the value of Altria&#8217;s investment in JUUL.  Also, an adverse FDA determination on one or more innovative tobacco products could impede our ability to achieve our Vision.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">FDA Regulatory Actions</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.46pt">Graphic Warnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FDA issued a final rule requiring 11 textual warnings accompanied by color graphics depicting certain negative health consequences of smoking on cigarette packaging and advertising.  As a result of a March 2021 court order related to the COVID-19 pandemic and subsequent court orders resulting from a lawsuit brought by R.J. Reynolds Tobacco Company and others against the FDA, the final rule will be effective October 11, 2022.  PM USA and other cigarette manufacturers have filed lawsuits challenging the final rule on substantive and procedural grounds.</span></div><div style="margin-bottom:5pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the preamble to the final rule, the FDA stated that it would not exempt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a heated tobacco product</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">used with the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device, as part of the rulemaking, but would consider the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> marketing order, and other marketing orders, on a case-by-case basis.  To date, the FDA has not taken any action to exempt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">from the graphic health warnings requirements.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.46pt">Underage Access and Use of Certain Tobacco Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA announced regulatory actions in September 2018 to address underage access and use of e-vapor products.  Altria has engaged with the FDA on this topic and has reaffirmed to the FDA its ongoing and long-standing commitment to preventing underage use.  For example, during 2019, Altria advocated raising the minimum legal age to purchase all tobacco products to 21 at the federal and state levels to further address underage use, which is now federal law.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal, State and Local Legislation to Increase the Legal Age to Purchase Tobacco Products </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for further discussion.</span></div><div style="margin-bottom:5pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in March 2019, the FDA issued draft guidance further proposing restrictions to address underage e-vapor use.  This guidance, which the FDA finalized in January 2020 and then revised in April 2020, states that the FDA intends to prioritize enforcement action against certain product categories, including cartridge-based, flavored e-vapor products and products targeted to minors.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.46pt">Flavored Electronic Nicotine Delivery System (&#8220;ENDS&#8221;) Products:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Some e-vapor product manufacturers filed PMTAs for flavored tobacco products.  As of October 25, 2021, many of these manufacturers received marketing denial orders for failure to provide sufficiently strong product-specific scientific evidence to demonstrate that the benefit of their products to adult smokers overcomes the risk that their products pose to youth.  FDA has communicated in these marketing denial orders that vapor products with non-tobacco flavors present unique questions relevant to the FDA&#8217;s &#8220;Appropriate for the Protection of Public Health&#8221; standard and that successful applications will require strong, product-specific evidence.  A number of manufacturers are appealing the marketing denial orders for their products.  If the FDA does not ultimately allow for the reintroduction of flavors other than tobacco, it could adversely affect the value of Altria&#8217;s investment in JUUL.</span></div><div style="margin-bottom:5pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some ENDS manufacturers, including some that have received marketing denial orders, have indicated their intention to market ENDS products containing synthetically-derived nicotine, which is not currently FDA-regulated. If these products are sold in higher volumes, and marketed outside of FDA oversight, it could adversely affect the value of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s investment in JUUL, have a material adverse effect on Altria&#8217;s consolidated financial position or earnings and impede our ability to achieve our Vision.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Potential Product Standards</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.46pt">Nicotine in Cigarettes and Other Combustible Tobacco Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2018, the FDA issued an ANPRM seeking comments on the potential public health benefits and any possible adverse effects of lowering nicotine in combustible cigarettes to non-addictive or minimally addictive levels.  Among other issues, the FDA sought comments on (i) whether smokers would compensate by smoking more cigarettes to obtain the same level of nicotine as with their current product and (ii) whether the proposed rule would create an illicit trade of cigarettes containing nicotine at levels higher than a non-addictive threshold that may be established by the FDA.  The FDA also sought comments on whether a nicotine product standard should apply to other combustible tobacco products, including cigars.  Were the FDA to develop and finalize a product standard for nicotine in combustible products, and if the standard was appealed and upheld in the courts, it could have a material adverse effect on the business, consolidated results of operations, cash flows or financial position of Altria and its tobacco subsidiaries.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.46pt">Flavors in Tobacco Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed above under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">FDA&#8217;s Comprehensive Plan for Tobacco and Nicotine Regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the FDA indicated that it is considering proposing rulemaking for a product standard that would seek to ban menthol in combustible tobacco products, including cigarettes and cigars, and that it intends to propose a product standard that would ban characterizing flavors in all cigars, including Grandfathered Products and those that have received SE determinations from the FDA - an intention reiterated in the FDA&#8217;s January 2020 guidance.  In March 2018, the FDA issued an ANPRM seeking comments on the role, if any, that flavors (including menthol) in tobacco products may play in attracting youth and in helping some smokers switch to potentially less harmful forms of nicotine delivery.  In the context of litigation, in April 2021, the FDA issued a response to a 2013 citizen petition requesting that the FDA prohibit menthol as a characterizing flavor in cigarettes. In the response, the FDA announced it intends to develop and propose two product standards within one year that would (i) ban menthol as a characterizing flavor in cigarettes and (ii) ban all characterizing flavors (including menthol) in cigars.  While the FDA has yet to define &#8220;characterizing flavors&#8221; with respect to cigars, most of Middleton&#8217;s cigar products contain added flavors and may be subject to any action by the FDA to ban flavors in cigars.</span></div><div style="margin-bottom:5pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any such product standards become final and are appealed and upheld in the courts, it could have a material adverse effect on the business of our tobacco subsidiaries and investees, and the consolidated results of operations, cash flows or financial position of Altria and its tobacco subsidiaries, including adversely affecting the value of Altria&#8217;s investment in JUUL.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.46pt">NNN in Smokeless Tobacco</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, the FDA proposed a product standard for N-nitrosonornicotine (&#8220;NNN&#8221;) levels in finished smokeless tobacco products.&#160; If the proposed rule, in present form, were to become final and was appealed and upheld in the courts, it could have a material adverse effect on the business, consolidated results of operations, cash flows or financial position of Altria and USSTC.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Good Manufacturing Practices: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FSPTCA requires that the FDA promulgate good manufacturing practice regulations (referred to by the FDA as &#8220;Requirements for Tobacco Product Manufacturing Practice&#8221;) for tobacco product manufacturers, but does not specify a timeframe for such regulations.  Compliance with any such regulations could result in increased costs, which could have a material adverse effect on the financial position of Altria, its tobacco subsidiaries and its investees, including adversely affecting the value of Altria&#8217;s investment in JUUL.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Impact on Our Business; Compliance Costs and User Fees: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FDA regulatory actions under the FSPTCA could have a material adverse effect on the business, consolidated results of operations, cash flows or financial position of Altria and its tobacco subsidiaries in various ways.  For example, actions by the FDA could:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">impact the consumer acceptability of tobacco products;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">delay, discontinue or prevent the sale or distribution of existing, new or modified tobacco products;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">limit adult tobacco consumer choices;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">impose restrictions on communications with adult tobacco consumers;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">create a competitive advantage or disadvantage for certain tobacco companies;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">impose additional manufacturing, labeling or packaging requirements;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">impose additional restrictions at retail;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">result in increased illicit trade in tobacco products; and/or</span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">otherwise significantly increase the cost of doing business.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The failure to comply with FDA regulatory requirements, even inadvertently, and FDA enforcement actions also could have a material adverse effect on the business of our tobacco subsidiaries and investees, and the consolidated results of operations, cash flows or financial position of Altria and its tobacco subsidiaries, including adversely affecting the value of Altria&#8217;s investment in JUUL.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FSPTCA imposes user fees on cigarette, cigarette tobacco, smokeless tobacco, cigar and pipe tobacco manufacturers and importers to pay for the cost of regulation and other matters.  The FSPTCA does not impose user fees on e-vapor or oral nicotine pouch manufacturers.  The cost of the FDA user fee is allocated&#160;first among tobacco product categories subject to FDA user fees and then among manufacturers and importers within each respective category based on their relative market shares, all as prescribed by the FSPTCA and FDA regulations.  Payments for user fees are adjusted for several factors, including market share and industry volume.  For a discussion of the impact of the FDA user fee payments on Altria, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt and Liquidity - Payments Under State Settlement Agreements and FDA Regulation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below.  In addition, compliance with the FSPTCA&#8217;s regulatory requirements has resulted, and will continue to result, in additional costs for Altria&#8217;s tobacco businesses.  The amount of additional compliance and related costs has not been material in any given quarter or year to date period but could become material, either individually or in the aggregate, to one or more of Altria&#8217;s tobacco subsidiaries.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Investigation and Enforcement: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has a number of investigatory and enforcement tools available to it, including document requests and other required information submissions, facility inspections, examinations and investigations, injunction proceedings, monetary penalties, product withdrawal and recall orders, and product seizures.  Investigations or enforcement actions could result in significant costs or otherwise have a material adverse effect on the business of our tobacco subsidiaries and investees, and the consolidated results of operations, cash flows or financial position of Altria and its tobacco subsidiaries, including adversely affecting the value of Altria&#8217;s investment in JUUL.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Excise Taxes</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tobacco products are subject to substantial excise taxes in the U.S.  Significant increases in tobacco-related taxes or fees have been proposed or enacted (including with respect to e-vapor products) and are likely to continue to be proposed or enacted at the federal, state and local levels within the U.S.  The frequency and magnitude of excise tax increases can be influenced by various factors, including the composition of executive and legislative bodies.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Congress is currently considering legislation that would significantly increase the federal excise tax for all tobacco products and create a new tax for e-vapor products and other products containing nicotine that are not currently subject to a tobacco federal excise tax.  Additionally, e-vapor products and oral nicotine products not currently taxed would be subject to a federal excise tax that would vary based on the nicotine content.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal, state and local cigarette excise taxes have increased substantially over the past two decades, far outpacing the rate of inflation.  Between the end of 1998 and October 25, 2021, the weighted-average state cigarette excise tax increased from $0.36 to $1.89 per pack.  As of October 25, 2021, one state, Maryland, has enacted new legislation increasing cigarette excise taxes in 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A majority of states currently tax MST using an ad valorem method, which is calculated as a percentage of the price of the product, typically the wholesale price. This ad valorem method results in more tax being paid on premium products than is paid on lower-priced products of equal weight.  Altria&#8217;s subsidiaries support legislation to convert ad valorem taxes on MST to a weight-based methodology because, unlike the ad valorem tax, a weight-based tax subjects cans of equal weight to the same tax.  As of October 25, 2021, the federal government, 23 states, Puerto Rico, Philadelphia, Pennsylvania and Cook County, Illinois have adopted a weight-based tax methodology for MST.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An increasing number of states and localities also are imposing excise taxes on e-vapor and oral nicotine pouches.  As of October 25, 2021, 30 states, the District of Columbia, Puerto Rico and a number of cities and counties have enacted legislation to tax e-vapor products.  These taxes are calculated in varying ways and may differ based on the e-vapor product form.  Similarly, 11 states and the District of Columbia have enacted legislation to tax oral nicotine pouches.  Tax increases could have an adverse impact on the sales of these products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax increases are expected to continue to have an adverse impact on product sales of Altria&#8217;s tobacco subsidiaries and JUUL through lower consumption levels and the potential shift in adult consumer purchases from the premium to the non-premium or discount segments, or to counterfeit and contraband products.  Lower sales volume and reported share performance of Altria&#8217;s tobacco subsidiaries&#8217; products could have a material adverse effect on Altria&#8217;s consolidated financial position or earnings.  In addition, excise taxes on e-vapor and oral nicotine products may negatively impact adult smokers&#8217; transition to these products, which could impede our ability to achieve our Vision.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">International Treaty on Tobacco Control</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The World Health Organization&#8217;s Framework Convention on Tobacco Control (the &#8220;FCTC&#8221;) entered into force in February&#160;2005.  As of October 25, 2021, 181 countries, as well as the European Community, have become parties to the FCTC.  While the U.S. is a signatory of the FCTC, it is not currently a party to the agreement, as the agreement has not been submitted to, or ratified by, the United States Senate.  The FCTC is the first international public health treaty and its objective is to establish a global agenda for tobacco regulation with the purpose of reducing initiation of tobacco use and encouraging cessation.  The treaty recommends (and in certain instances, requires) signatory nations to enact legislation that would address various tobacco-related issues.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of proposals currently under consideration by the governing body of the FCTC, some of which call for substantial restrictions on the manufacture, marketing, distribution and sale of tobacco products.  It is not possible to predict the outcome of these proposals or the impact of any FCTC actions on legislation or regulation in the U.S., either indirectly or as a result of the U.S. becoming a party to the FCTC, or whether or how these actions might indirectly influence FDA regulation and enforcement.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">State Settlement Agreements</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 12, during 1997 and 1998, PM USA and other major domestic cigarette manufacturers entered into the State Settlement Agreements.  These settlements require participating manufacturers to make substantial annual payments, which are adjusted for several factors, including inflation, operating income, market share and industry volume.  Increases in inflation can increase our financial liability under the State Settlement Agreements.  The State Settlement Agreements&#8217; inflation calculations require us to apply the higher of 3% or the United States Bureau of Labor Statistics&#8217; Consumer Price Index for All Urban Consumers (&#8220;CPI-U&#8221;) percentage rate as published in January of each year.  For 2021, based on the latest CPI-U data, the inflation calculation may be above 3%, but Altria does not believe the increase would result in a material financial impact.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of the impact of the State Settlement Agreements on Altria, see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Debt and Liquidity - Payments Under State Settlement Agreements and FDA Regulation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below and Note 12.  The State Settlement Agreements also place numerous requirements and restrictions on participating manufacturers&#8217; business operations, including prohibitions and restrictions on the advertising and marketing of cigarettes and smokeless tobacco products.  Among these are prohibitions of outdoor and transit brand advertising, payments for product placement and free sampling (except in adult-only facilities).  The State Settlement Agreements also place restrictions on the use of brand name sponsorships and brand name non-tobacco products and prohibitions on targeting youth and the use of cartoon characters.  In addition, the State Settlement Agreements require companies to affirm corporate principles directed at reducing underage use of cigarettes; impose requirements regarding lobbying activities; mandate public disclosure of certain industry documents; limit the industry&#8217;s ability to challenge certain tobacco control and underage use laws; and provide for the dissolution of certain tobacco-related organizations and place restrictions on the establishment of any replacement organizations.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 1998,&#160;USSTC entered into the Smokeless Tobacco Master Settlement Agreement (the &#8220;STMSA&#8221;) with the attorneys general of various states and U.S. territories to resolve the remaining health care cost reimbursement cases initiated against&#160;USSTC.  The STMSA required USSTC to adopt various marketing and advertising restrictions.  USSTC is the only smokeless tobacco manufacturer to sign the STMSA.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other International, Federal, State and Local Regulation and Governmental and Private Activity</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">International, Federal, State and Local Regulation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of states and localities have enacted or proposed legislation that imposes restrictions on tobacco products (including cigarettes, smokeless tobacco, cigars, e-vapor products and oral nicotine pouches), such as legislation that (i) prohibits the sale of all tobacco products or certain tobacco categories, such as e-vapor, (ii) prohibits the sale of tobacco products with characterizing flavors, such as menthol cigarettes and flavored e-vapor products, (iii) requires the disclosure of health information separate from or in addition to federally mandated health warnings and (iv) restricts commercial speech or imposes additional restrictions on the marketing or sale of tobacco products.  The legislation varies in terms of the type of tobacco products, the conditions under which such products are or would be restricted or prohibited, and exceptions to the restrictions or prohibitions.  For example, a number of proposals involving characterizing flavors would prohibit smokeless tobacco products with characterizing flavors without providing an exception for mint- or wintergreen-flavored products.  As of October 25, 2021, three states are considering legislation to ban flavors in one or more tobacco products, and six states (California, Massachusetts, New Jersey, Utah, New York and Illinois) and the District of Columbia have passed such legislation.  Some of these states, such as New York, Utah and Illinois, exempt certain products that have received FDA market authorization through the PMTA pathway.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The legislation in California bans the sale of most tobacco products with characterizing flavors, including menthol, mint and wintergreen.  Following enactment of the flavor ban in August 2020, several registered California voters filed a referendum against the legislation.  In January 2021 the requisite number of registered California voters signed a petition to place the question of whether the legislation should be affirmed or overturned on the next statewide general election ballot, which will </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">likely take place in 2022, unless a special statewide election is called earlier.  As a result, the implementation of the legislation is delayed until after a vote on the referendum occurs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Massachusetts passed legislation capping the amount of nicotine in e-vapor products.  Similar legislation is pending in one other state.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restrictions on e-vapor products also have been instituted or proposed internationally.  For example, India and Singapore have instituted bans on e-vapor products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s tobacco subsidiaries have challenged and will continue to challenge certain federal, state and local legislation and other governmental action, including through litigation.  It is possible, however, that legislation, regulation or other governmental action could be enacted or implemented that could have a material adverse impact on the business and volume of our tobacco subsidiaries and investees, and the consolidated results of operations, cash flows or financial position of Altria and its tobacco subsidiaries, including adversely affecting the value of Altria&#8217;s investment in JUUL.  Such action also could negatively impact adult smokers&#8217; transition to these products, which could adversely affect our ability to achieve our Vision.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Federal, State and Local Legislation to Increase the Legal Age to Purchase Tobacco Products: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a number of states and localities proposed and enacted legislation to increase the minimum age to purchase all tobacco products, including e-vapor products, in December 2019, the federal government passed legislation increasing the minimum age to purchase all tobacco products, including e-vapor products, to 21 nationwide.  As of October 25, 2021, 39 states, the District of Columbia and Puerto Rico have enacted laws increasing the legal age to purchase tobacco products to 21.  Although an increase in the minimum age to purchase tobacco products may have a negative impact on sales volume of our tobacco businesses, as discussed above under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Underage Access and Use of Certain Tobacco Products,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Altria supported raising the minimum legal age to purchase all tobacco products to 21 at the federal and state levels, reflecting its longstanding commitment to combat underage tobacco use.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Health Effects of Tobacco Products, Including E-vapor Products: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reports with respect to the health effects of smoking have been publicized for many years, including various reports by the U.S. Surgeon General.  In 2019, there were public health advisories concerning vaping-related lung injuries and deaths and, more recently, there have been health concerns raised about potential increased risks associated with COVID-19 among smokers and vapers.  Altria and its tobacco subsidiaries believe that the public should be guided by the messages of the U.S. Surgeon General and public health authorities worldwide in making decisions concerning the use of tobacco products, including e-vapor products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most jurisdictions within the U.S. have restricted smoking in public places and some have restricted vaping in public places.  Some public health groups have called for, and various jurisdictions have adopted or proposed, bans on smoking and vaping in outdoor places, in private apartments and in cars transporting children.  It is not possible to predict the results of ongoing scientific research or the types of future scientific research into the health risks of tobacco exposure and the impact of such research on legislation and regulation.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Other Legislation or Governmental Initiatives: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the actions discussed above, other regulatory initiatives affecting the tobacco industry have been adopted or are being considered at the federal level and in a number of state and local jurisdictions.  For example, during the COVID-19 pandemic, state and local governments required additional health and safety requirements of all businesses, including tobacco manufacturing and other facilities.  State and local governments also mandated the temporary closure of some businesses.  While many restrictions have eased, it is possible that tobacco manufacturing and other facilities and the facilities of our suppliers, our suppliers&#8217; suppliers and our trade partners could be subject to additional government-mandated temporary closures and restrictions.  In September 2021, the President of the United States issued an Executive Order charging OSHA with developing an emergency temporary standard requiring almost all employers to mandate certain COVID-19 vaccination and testing requirements in the workplace.  This mandate could have an adverse impact on worker availability at Altria&#8217;s subsidiaries&#8217; or investees&#8217; manufacturing, salesforce and administrative operations, or in their distribution and supply chains.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in recent years, legislation has been introduced or enacted at the state or local level to subject tobacco products to various reporting requirements and performance standards; establish educational campaigns relating to tobacco consumption or tobacco control programs or provide additional funding for governmental tobacco control activities; restrict the sale of tobacco products in certain retail establishments and the sale of tobacco products in certain package sizes; require tax stamping of smokeless tobacco products; require the use of state tax stamps using data encryption technology; and further restrict the sale, marketing and advertising of cigarettes and other tobacco products.  Such legislation may be subject to constitutional or other challenges on various grounds, which may or may not be successful.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is not possible to predict what, if any, additional legislation, regulation or other governmental action will be enacted or implemented (and, if challenged, upheld) relating to the manufacturing, design, packaging, marketing, advertising, sale or use of tobacco products, or the tobacco industry generally.  It is possible, however, that legislation, regulation or other governmental action could be enacted or implemented that could have a material adverse impact on the business and volume of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our tobacco subsidiaries and investees, and the consolidated results of operations, cash flows or financial position of Altria and its tobacco subsidiaries, including adversely affecting the value of Altria&#8217;s investment in JUUL.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Governmental Investigations: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, Altria, its subsidiaries and investees are subject to governmental investigations on a range of matters.&#160; For example: (i) the U.S. Federal Trade Commission (the &#8220;FTC&#8221;)  issued a Civil Investigative Demand (&#8220;CID&#8221;) to Altria while conducting its antitrust review of Altria&#8217;s investment in JUUL seeking information regarding, among other things, Altria&#8217;s role in the resignation of JUUL&#8217;s former chief executive officer and the hiring by JUUL of any current or former Altria director, executive or employee (see Note 12 for a description of the FTC&#8217;s administrative complaint against Altria and JUUL); (ii) the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) commenced an investigation relating to Altria&#8217;s acquisition, disclosures and accounting</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">controls in connection with the JUUL investment; and (iii) the New York State Office of the Attorney General issued a subpoena to Altria seeking documents relating to Altria&#8217;s investment in and provision of services to JUUL.  Additionally, JUUL is currently under investigation by various federal and state agencies, including the SEC, the FDA and the FTC, and state attorneys general.&#160; Such investigations vary in scope but at least some appear to include JUUL&#8217;s marketing practices, particularly as such practices relate to youth, and Altria may be asked in the context of those investigations to provide information concerning its investment in JUUL or relating to its marketing of Nu Mark LLC e-vapor products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Private Sector Activity on E-Vapor</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of retailers, including national chains, have discontinued the sale of e-vapor products.  Reasons for the discontinuation include reported illnesses related to e-vapor product use and the uncertain regulatory environment.  It is possible that this private sector activity could adversely affect the value of Altria&#8217;s investment in JUUL and have a material adverse effect on Altria&#8217;s consolidated financial position or earnings.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Illicit Trade in Tobacco Products</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Illicit trade in tobacco products can have an adverse impact on the businesses of Altria, its tobacco subsidiaries and investees.  Illicit trade can take many forms, including the sale of counterfeit tobacco products; the sale of tobacco products in the U.S. that are intended for sale outside the country; the sale of untaxed tobacco products over the Internet and by other means designed to avoid the collection of applicable taxes; and diversion into one taxing jurisdiction of tobacco products intended for sale in another.  Counterfeit tobacco products, for example, are manufactured by unknown third parties in unregulated environments.  Counterfeit versions of our tobacco subsidiaries&#8217; and investees&#8217; products can negatively affect adult tobacco consumer experiences with and opinions of those brands.  Illicit trade in tobacco products also harms law-abiding wholesalers and retailers by depriving them of lawful sales and undermines the significant investment Altria&#8217;s tobacco subsidiaries and investees have made in legitimate distribution channels.  Moreover, illicit trade in tobacco products results in federal, state and local governments losing tax revenues.  Losses in tax revenues can cause such governments to take various actions, including increasing excise taxes; imposing legislative or regulatory requirements that may adversely impact Altria&#8217;s consolidated results of operations and cash flows, including adversely affecting the value of Altria&#8217;s investment in JUUL, and the businesses of its tobacco subsidiaries and investees; or asserting claims against manufacturers of tobacco products or members of the trade channels through which such tobacco products are distributed and sold.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s tobacco subsidiaries communicate with wholesale and retail trade members regarding illicit trade in tobacco products and how they can help prevent such activities, enforce wholesale and retail trade programs and policies that address illicit trade in tobacco products and, when necessary, litigate to protect their trademarks.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Price, Availability and Quality of Tobacco, Other Raw Materials, Ingredients and Component Parts</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shifts in crops (such as those driven by economic conditions and adverse weather patterns), government restrictions and mandated prices, production control programs, economic trade sanctions, import duties and tariffs, international trade disruptions, inflation, geopolitical instability, climate and environmental changes and disruptions due to man-made or natural disasters may increase the cost or reduce the supply or quality&#160;of tobacco or other raw materials or ingredients or component parts used to manufacture our companies&#8217; and our investees&#8217; products.  Any significant change in the price, availability or quality of tobacco, other raw materials, ingredients or component parts used to manufacture our products and those of our investees could restrict our subsidiaries&#8217; and investees&#8217; ability to continue manufacturing and marketing existing products or impact adult consumer product acceptability and adversely affect our&#160;subsidiaries&#8217; and investees&#8217; profitability and businesses.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to tobacco, as with other agricultural commodities, crop quality&#160;and availability can be influenced by variations in weather patterns, including those caused by climate change.  Additionally, the price and availability of tobacco leaf can be influenced by&#160;economic conditions and imbalances in supply and demand.  Economic conditions, including the economic effects of the COVID-19 pandemic, are unpredictable, which, among other factors, may result in changes in the patterns of demand for agricultural products&#160;and the cost of tobacco production which could impact tobacco leaf prices and tobacco supply.  In addition, as consumer demand increases for smoke-free products and decreases for combustible products, the volume of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tobacco leaf required for production may decrease.  The reduced demand for tobacco leaf may result in the reduced supply and availability of domestic tobacco as growers divert resources to other crops.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tobacco production in certain countries also is subject to a variety of controls, including government-mandated prices and production control programs.&#160; Moreover, certain types of tobacco are only available in limited geographies, including geographies experiencing political instability or government prohibitions on the import or export of tobacco, and loss of their availability could impair our subsidiaries&#8217; ability to continue marketing existing products or impact adult tobacco consumer product acceptability.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic also may limit access to and increase the cost of raw materials, component parts and personal protective equipment as U.S. and global suppliers may temporarily shut down facilities or use different production schedules with lower productivity in order to address exposure to the virus or as a result of a government mandate.  In addition, current labor market dynamics indicate labor shortages, with employers in a number of industries having difficulty employing workers.  These shortages have led to certain increases in raw material, ingredient and component part prices and may lead to disruptions in the supply chain; however, to date, the impact has been immaterial.  The effects of the COVID-19 pandemic and labor market dynamics outlined above may continue after the pandemic wanes as a result of the developing commercial and economic environment, including increased government spending.  This environment has led to an increased rate of inflation that, to date, has not had a material impact on our businesses, revenues or profitability.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Timing of Sales</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, our tobacco subsidiaries are subject to many influences that can impact the timing of sales to customers, including the timing of holidays and other annual or special events, the timing of promotions, customer incentive programs and customer inventory programs, as well as the actual or speculated timing of pricing actions and tax-driven price increases.</span></div><div id="i295e56fb16f94dae9eacc631c56d466c_130"></div><div style="padding-right:9pt;text-align:justify"><span><br/></span></div><div id="i295e56fb16f94dae9eacc631c56d466c_133"></div><div style="margin-bottom:5pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Operating Results</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Smokeable Products Segment</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Results</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes operating results, includes reported and adjusted OCI margins, and provides a reconciliation of reported OCI to adjusted OCI for the smokeable products segment:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Results</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,275</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,522&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,975</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,313&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,620)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,950)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,218)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues net of excise taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,655</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,757</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,906&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported OCI</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,901</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,753</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NPM Adjustment Items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other litigation items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 special items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted OCI</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,920</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,723&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,761</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,823&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported OCI margins </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">57.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 pp</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">57.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 pp</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted OCI margins </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">58.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 pp</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">58.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 pp</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Reported and adjusted OCI margins are calculated as reported and adjusted OCI, respectively, divided by revenues net of excise taxes.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nine Months Ended September&#160;30, 2021 Compared with Nine Months Ended September&#160;30, 2020</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues, which include excise taxes billed to customers, decreased $247 million (1.4%), due primarily to lower shipment volume ($1,539 million), partially offset by higher pricing ($1,284 million).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reported OCI increased $292 million (3.8%), due primarily to higher pricing ($1,273 million), NPM Adjustment Items in 2021 ($53 million) and COVID-19 special items in 2020 ($41 million), partially offset by lower shipment volume ($923 million), higher per unit settlement charges and higher marketing, administration and research costs ($27 million).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted OCI increased $197 million (2.6%), due primarily to higher pricing, partially offset by lower shipment volume, higher per unit settlement charges and higher marketing, administration and research costs.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Three Months Ended September&#160;30, 2021 Compared with Three Months Ended September&#160;30, 2020</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues, which include excise taxes billed to customers, decreased $338 million (5.4%), due primarily to lower shipment volume ($925 million), partially offset by higher pricing ($570 million), which includes lower promotional investments.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reported OCI decreased $36 million (1.3%), due primarily to lower shipment volume ($546 million) and higher per unit settlement charges, partially offset by higher pricing ($567 million), which includes lower promotional investments and NPM Adjustment Items in 2021 ($21 million).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted OCI decreased $62 million (2.2%), due primarily to lower shipment volume and higher per unit settlement charges, partially offset by higher pricing, which includes lower promotional investments.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shipment Volume and Retail Share Results</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the smokeable products segment shipment volume performance:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shipment Volume</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(sticks in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cigarettes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Marlboro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">63,122</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,368</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other premium</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,180</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,042</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,068</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,640</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cigarettes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">71,370</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,050</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,619&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cigars:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Black &amp; Mild</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,356</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">424</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cigars</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,361</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">425</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total smokeable products</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72,731</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,916&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,475</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,090&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.9)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note: Cigarettes shipment volume includes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Marlboro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">; Other premium brands, such as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Virginia Slims</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Parliament, Benson &amp; Hedges and Nat&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">; and Discount brands, which include </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">L&amp;M, Basic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Chesterfield.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cigarettes volume includes units sold as well as promotional units, but excludes units sold for distribution to Puerto Rico, and units sold in U.S. Territories, to overseas military and by Philip Morris Duty Free Inc., none of which, individually or in the aggregate, is material to the smokeable products segment.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes cigarettes retail share performance:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Retail Share</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage Point Change</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage Point Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cigarettes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Marlboro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">43.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">43.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other premium</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cigarettes</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">49.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note: Retail share results for cigarettes are based on data from IRI/Management Science Associates, Inc., a tracking service that uses a sample of stores and certain wholesale shipments to project market share and depict share trends.  This service tracks sales in the food, drug, mass merchandisers, convenience, military, dollar store and club trade classes.  For other trade classes selling cigarettes, retail share is based on shipments from wholesalers to retailers through the Store Tracking Analytical Reporting System (&#8220;STARS&#8221;).  This service is not designed to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">capture sales through other channels, including the internet, direct mail and some illicitly tax-advantaged outlets. It is IRI&#8217;s standard practice to periodically refresh its services, which could restate retail share results that were previously released in this service.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of volume trends and factors that impact volume and retail share performance, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tobacco Space - Business Environment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nine Months Ended September&#160;30, 2021 Compared with the Nine Months Ended September&#160;30, 2020</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The smokeable products segment&#8217;s reported domestic cigarettes shipment volume decreased 8.0%, driven primarily by the industry&#8217;s rate of decline, trade inventory movements, calendar differences and other factors.  When adjusted for trade inventory movements, calendar differences and other factors, the smokeable products segment&#8217;s reported domestic cigarettes shipment volume decreased by an estimated 5%.  When adjusted for trade inventory movements, calendar differences and other factors, total estimated domestic cigarette industry volume decreased by an estimated 5%.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipments of premium cigarettes accounted for 92.9% and 92.0% of the smokeable products segment&#8217;s reported domestic cigarettes shipment volume for the nine months ended September&#160;30, 2021 and 2020, respectively.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cigarettes industry discount category retail share increased 0.3 share points to 25.2%.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Three Months Ended September&#160;30, 2021 Compared with the Three Months Ended September&#160;30, 2020</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The smokeable products segment&#8217;s reported domestic cigarettes shipment volume decreased 12.9%, driven primarily by the industry&#8217;s rate of decline and trade inventory movements.  When adjusted for trade inventory movements, the smokeable products segment&#8217;s reported domestic cigarettes shipment volume decreased by an estimated 7%.  When adjusted for trade inventory movements and other factors, total estimated domestic cigarette industry volume decreased by an estimated 6.5%.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipments of premium cigarettes accounted for 93.2% and 92.3% of the smokeable products segment&#8217;s reported domestic cigarettes shipment volume for the three months ended September&#160;30, 2021 and 2020, respectively.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cigarettes industry discount category retail share increased 0.6 share points sequentially to 25.3%.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pricing Actions</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA and Middleton executed the following pricing and promotional allowance actions during 2021 and 2020:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective August 15, 2021, PM USA increased the list price of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro, L&amp;M </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Chesterfield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> by $0.14 per pack.  In addition, PM USA increased the list price of all of its other cigarette brands by $0.17 per pack.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective January 24, 2021, PM USA increased the list price on all of its cigarette brands by $0.14 per pack.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective January 10, 2021, Middleton increased various list prices across substantially all of its cigar brands resulting in a weighted-average increase of approximately $0.07 per five-pack.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective November 1, 2020, PM USA increased the list price on all of its cigarette brands by $0.13 per pack.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective June 21, 2020, PM USA increased the list price on all of its cigarette brands by $0.11 per pack.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective February 16, 2020, PM USA increased the list price on all of its cigarette brands by $0.08 per pack.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective January 12, 2020, Middleton increased various list prices across substantially all of its cigar brands resulting in a weighted-average increase of approximately $0.08 per five-pack.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><div id="i295e56fb16f94dae9eacc631c56d466c_136"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Oral Tobacco Products Segment</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Results</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes operating results, includes reported and adjusted OCI margins, and provides a reconciliation of reported OCI to adjusted OCI for the oral tobacco products segment:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Results</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,945</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">626</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(98)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues net of excise taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,847</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,803&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">594</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported OCI</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,269</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">405</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted OCI</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,306</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,312&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">405</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported OCI margins </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2) pp</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6) pp</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted OCI margins </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1) pp</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3) pp</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Reported and adjusted OCI margins are calculated as reported and adjusted OCI, respectively, divided by revenues net of excise taxes.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nine Months Ended September&#160;30, 2021 Compared with Nine Months Ended September&#160;30, 2020</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues, which include excise taxes billed to customers, increased $44 million (2.3%), due primarily to higher pricing ($72 million), which includes higher promotional investments in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, partially offset by lower shipment volume ($29 million), including unfavorable shipment volume mix between the segment&#8217;s MST and oral nicotine pouch products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reported OCI decreased $28 million (2.2%) due primarily to higher costs ($51 million), which includes higher acquisition-related costs and COVID-19 special items in 2020, and lower shipment volume ($45 million), including unfavorable shipment volume mix), partially offset by higher pricing ($72 million), which includes higher promotional investments in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted OCI was essentially unchanged as lower volume, including unfavorable shipment volume mix, and higher costs were mostly offset by higher pricing, which includes higher promotional investments in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Adjusted OCI margins declined by 2.1 percentage point to 70.7%, due to changes in shipment volume mix between the segment&#8217;s MST and oral nicotine pouch products.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Three Months Ended September&#160;30, 2021 Compared with Three Months Ended September&#160;30, 2020</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues, which include excise taxes billed to customers, decreased $14 million (2.2%), due primarily to lower shipment volume ($33 million), including unfavorable shipment volume mix, partially offset by higher pricing ($20 million), which includes higher promotional investments in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reported OCI decreased $31 million (7.1%), due primarily to lower shipment volume ($35 million), including unfavorable shipment volume mix and higher costs ($13 million), including lower acquisition-related costs, partially offset by higher pricing, which includes higher promotional investments in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted OCI decreased $35 million (8.0%), due primarily to lower shipment volume, including unfavorable shipment volume mix, and higher costs, partially offset by higher pricing, which includes higher promotional investments in o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">n!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Adjusted OCI margins declined by 4.3 percentage points to 68.2%, due to changes in shipment volume mix between the segment&#8217;s MST and oral nicotine pouch products.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shipment Volume and Retail Share Results</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes oral tobacco products segment shipment volume performance:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shipment Volume</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(cans and packs in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Copenhagen</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">378.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">121.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Skoal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">148.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (includes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Red Seal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total oral tobacco products</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">614.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">198.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note: Oral tobacco products shipment volume includes cans and packs sold, as well as promotional units, but excludes international volume, which is currently not material to the oral tobacco products segment.  New types of oral tobacco products, as well as new packaging configurations of existing oral tobacco products, may or may not be equivalent to existing MST products on a can-for-can basis.  To calculate volumes of cans and packs shipped, one pack of snus or one can of oral nicotine pouches, irrespective of the number of pouches in the pack or can, is assumed to be equivalent to one can of MST.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes oral tobacco products segment retail share performance (excluding international volume):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Retail Share</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage Point Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage Point Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Copenhagen</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Skoal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (includes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Red Seal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total oral tobacco products</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note: Retail share results for oral tobacco products are based on data from IRI InfoScan, a tracking service that uses a sample of stores to project market share and depict share trends.&#160; This service tracks sales in the food, drug, mass merchandisers, convenience, military, dollar store and club trade classes on the number of cans and packs sold.&#160; Oral tobacco products is defined by IRI as MST, snus and oral nicotine pouches.  New types of oral tobacco products, as well as new packaging configurations of existing oral tobacco products, may or may not be equivalent to existing MST products on a can-for-can basis.  For example, one pack of snus or one can of oral nicotine pouches, irrespective of the number of pouches in the pack or can, is assumed to be equivalent to one can of MST.  Because this service represents retail share performance only in key trade channels, it should not be considered a precise measurement of actual retail share.&#160; It is IRI&#8217;s standard practice to periodically refresh its InfoScan services, which could restate retail share results that were previously released in this service.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of volume trends and factors that impact volume and retail share performance, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tobacco Space - Business Environment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nine Months Ended September&#160;30, 2021 Compared with the Nine Months Ended September&#160;30, 2020</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The oral tobacco products segment&#8217;s reported domestic shipment volume decreased 0.5%, driven primarily by retail share losses (primarily due to the growth of oral nicotine pouches) and calendar differences, partially offset by industry growth and trade inventory movements.  When adjusted for trade inventory movements and calendar differences, the oral tobacco products segment&#8217;s reported domestic shipment volume decreased by an estimated 0.5%.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total oral tobacco products category industry volume increased by an estimated 3% over the six months ended September&#160;30, 2021, driven by growth in oral nicotine pouches.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retail share losses in the oral tobacco products segment, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n, were due to the growth of oral nicotine pouches.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Three Months Ended September&#160;30, 2021 Compared with the Three Months Ended September&#160;30, 2020</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The oral tobacco products segment&#8217;s reported domestic shipment volume decreased 3.8%, driven primarily by retail share losses (primarily due to the growth of oral nicotine pouches) and trade inventory movements, partially offset by industry growth, calendar differences and other factors.  When adjusted for trade inventory movements and calendar differences, the oral tobacco products segment&#8217;s reported domestic shipment volume decreased by an estimated 2.5%.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The oral tobacco products segment&#8217;s retail share was 47.8% and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> continued to be the leading oral tobacco brand with retail share of 29.2%.  Share losses in the oral tobacco products segment, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n, were due to the growth of oral nicotine pouches.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total U.S. oral tobacco category share for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was 3.0% in the third quarter, an increase of 1.0 percentage point sequentially and an increase of 1.9 percentage points from the end of 2020.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, Helix had broadened the U.S. distribution of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to over 110,000 stores.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pricing Actions</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USSTC executed the following pricing actions during 2021 and 2020:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective October 26, 2021, USSTC increased the list price on its</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Copenhagen </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands by $0.08 per can.  USSTC also increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Husky</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand by $0.12 per can.  In addition, USSTC decreased the price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Red Seal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand by $0.17 per can.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective June 29, 2021, USSTC increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Blend products by $0.46 per can.  USSTC also increased the list price on its</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Red Seal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands and the balance of its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products by $0.05 per can. In addition, USSTC decreased the price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Husky</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand by $1.65 per can.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective March 2, 2021, USSTC increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Blend products by $0.16 per can.  USSTC also increased the list price on its</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Husky</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Red Seal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands and the balance of its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products by $0.08 per can.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective October 20, 2020, USSTC increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blend products by $0.15 per can.  USSTC also increased the list price on its</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Husky</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Red Seal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">brands and its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> popular price products by $0.08 per can.  In addition, USSTC increased the list price on the balance of its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products by $0.07 per can.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective July 21, 2020, USSTC increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Blend products by $0.15 per can.&#160; USSTC also increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Husky</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Red Seal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands and the balance of its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products by $0.07 per can.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective February 18, 2020, USSTC increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X-TRA products by $0.56 per can.  USSTC also increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Blend products by $0.16 cents per can and increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Husky</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Red Seal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands and the balance of its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products by $0.07 per can.</span></div><div id="i295e56fb16f94dae9eacc631c56d466c_139"></div><div style="padding-right:9pt;text-align:justify"><span><br/></span></div><div id="i295e56fb16f94dae9eacc631c56d466c_145"></div><div style="margin-bottom:5pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Wine Segment</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Results</span></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Results and Shipment Volume</span></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes operating results, includes reported and adjusted OCI margins, and provides a reconciliation of reported OCI to adjusted OCI for the wine segment:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Results</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">494</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">177</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues net of excise taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">480</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">172</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported OCI (Loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0%+</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)%+</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Implementation and disposition-related costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">52</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted OCI</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported OCI margins</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.0 pp</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(14.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.5) pp</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted OCI margins</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 pp</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 pp</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Reported and adjusted OCI margins are calculated as reported and adjusted OCI, respectively, divided by revenues net of excise taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nine Months Ended September&#160;30, 2021 Compared with Nine Months Ended September&#160;30, 2020</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues, which include excise taxes billed to customers, increased $60 million (13.8%), due to higher shipment volume, improved mix and higher pricing.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reported OCI increased $368 million (100%+), due primarily to 2020 inventory-related charges discussed in Note 9 (included in implementation costs and charged to cost of sales), higher shipment volume, improved mix and higher pricing, partially offset by disposition-related charges recorded in the third quarter of 2021 related to the Ste. Michelle Transaction.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted OCI increased $25 million (52.1%), due primarily to higher shipment volume, improved mix and higher pricing.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September&#160;30, 2021, Ste. Michelle&#8217;s reported wine shipment volume increased 5.1% to 5,446 thousand cases.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Three Months Ended September&#160;30, 2021 Compared with Three Months Ended September&#160;30, 2020</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues, which include excise taxes billed to customers, increased $20 million (12.7%), due primarily to improved mix and higher pricing. </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reported OCI decreased $43 million (100.0%+), due primarily to disposition-related charges related to the Ste. Michelle Transaction, partially offset by higher pricing and improved mix.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted OCI increased $7 million (35.0%), due primarily to higher pricing and improved mix.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2021, Ste. Michelle&#8217;s reported wine shipment volume decreased 2.6% to 1,836 thousand cases.</span></div><div style="margin-bottom:5pt"><span><br/></span></div><div id="i295e56fb16f94dae9eacc631c56d466c_148"></div><div style="margin-bottom:5pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Financial Review</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Provided by/Used in Operating Activities</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first nine months of 2021, net cash provided by operating activities was $5,742 million compared with $5,844 million during the first nine months of 2020.  This decrease was due primarily to higher settlement and income tax payments, partially offset by lower excise tax payments due to lower volume.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria had a working capital deficit at September&#160;30, 2021 and December&#160;31, 2020.  Altria&#8217;s management believes that Altria has the ability to fund working capital deficits with cash provided by operating activities and borrowings through its access to credit and capital markets, as discussed in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt and Liquidity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Provided by/Used in Investing Activities</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first nine months of 2021, net cash used in investing activities was $42 million compared with $107 million during the first nine months of 2020.  This decrease was due primarily to lower capital expenditures.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital expenditures for 2021 are expected to be in the range of $150 million to $200 million, a reduction from the previous range of $200 million to $250 million, and are expected to be funded from operating cash flows.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Provided by/Used in Financing Activities</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first nine months of 2021, net cash used in financing activities was $7,668 million compared with $3,713 million during the first nine months of 2020.  This change was due primarily to the following:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">repayment of $5.0 billion of Altria senior unsecured notes in connection with the 2021 debt tender offers and redemption and the premiums and fees in connection with the debt tender offers described below and in Note 10;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">proceeds of $2.0 billion from the issuance of long-term senior unsecured notes in 2020;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">repayment of $1.5 billion in full of Altria senior unsecured notes at scheduled maturity in May 2021;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">repurchases of common stock in 2021;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">higher dividends paid in 2021; and</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">purchase of the remaining 20% interest in Helix;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">partially offset by:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">proceeds of $5.5 billion from the issuance of long-term senior unsecured notes used to repurchase and redeem senior unsecured notes in connection with the 2021 debt tender offers and redemption; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">repayment of $1.0 billion in full of Altria senior unsecured notes at scheduled maturity in January 2020.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt and Liquidity</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Source of Funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Altria is a holding company.  As a result, its access to the operating cash flows of its wholly owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans by its subsidiaries.  In addition, Altria receives cash dividends on its interest in ABI and will continue to do so as long as ABI pays dividends.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Ratings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Altria&#8217;s cost and terms of financing and its access to commercial paper markets may be impacted by applicable credit ratings.  The impact of credit ratings on the cost of borrowings under the Credit Agreement (as defined below) is discussed in Note 10.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, the credit ratings and outlook for Altria&#8217;s indebtedness by major credit rating agencies were:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term Debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term Debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outlook</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moody&#8217;s Investors Service, Inc. (&#8220;Moody&#8217;s&#8221;)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;P-2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;A3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;Stable</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard &amp; Poor&#8217;s Financial Services LLC (&#8220;S&amp;P&#8221;)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;A-2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BBB</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;Stable</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fitch Ratings Inc.</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;F2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BBB</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;Stable</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Lines </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- From time to time, Altria has short-term borrowing needs to meet its working capital requirements and generally uses its commercial paper program to meet those needs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August  2021, Altria entered into an extension and amendment to its $3.0 billion senior unsecured 5-year revolving credit agreement (as amended, the &#8220;Credit Agreement&#8221;).  For further discussion, see Note 10.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any commercial paper issued by Altria and borrowings under the Credit Agreement are guaranteed by PM USA.  For further discussion, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplemental Guarantor Financial Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below and Note 10.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Market Environment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Altria believes it has adequate liquidity and access to financial resources to meet its anticipated obligations and ongoing business needs in the foreseeable future.  Altria monitors the credit quality of its bank group and is not aware of any potential non-performing credit provider in that group.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ste. Michelle Transaction </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- On October 1, 2021, UST received net cash proceeds of approximately $1.2 billion from the sale of its wine business.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - At September&#160;30, 2021 and December&#160;31, 2020, Altria&#8217;s total debt was $28.1 billion and $29.5 billion, respectively.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, Altria repaid in full senior unsecured notes in the aggregate principal amount of $1.5 billion at maturity.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, Altria issued long-term senior unsecured notes in the aggregate principal amount of $5.5 billion (the &#8220;Notes&#8221;).  The net proceeds from the Notes were used (i) to fund the purchase and redemption of certain unsecured notes and payment of related fees and expenses, as described below, and (ii) for other general corporate purposes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, Altria (i) completed debt tender offers to purchase for cash certain of its long-term senior unsecured notes in the aggregate principal amount of $4,042 million and (ii) redeemed all of its outstanding 3.490% Notes due 2022 in an aggregate principal amount of $1.0 billion.  As a result, for the nine months ended September&#160;30, 2021, Altria recorded pre-tax losses on early extinguishment of debt of $649 million, which included premiums and fees of $623 million and the write-off of related unamortized debt discounts and debt issuance costs of $26 million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the first quarter debt transactions, Altria reduced its near-term maturity towers and extended the weighted-average maturity of its debt.  In addition, the weighted-average coupon interest rate on total long-term debt decreased to 4.0% at September&#160;30, 2021 from 4.1% at December&#160;31, 2020.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further details on long-term debt, including the terms of the Notes, the debt tender offers and the redemption, see Note 10.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- As discussed in Note 12, Altria and certain of its subsidiaries had unused letters of credit obtained in the ordinary course of business, guarantees (including third-party guarantees) and a redeemable noncontrolling interest outstanding at September 30, 2021.  From time to time, subsidiaries of Altria also issue lines of credit to affiliated entities.  In addition, as discussed below in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplemental Guarantor Financial Information </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and in Note 10, PM USA has issued guarantees relating to Altria&#8217;s obligations under its outstanding debt securities, borrowings under the Credit Agreement and amounts outstanding under the commercial paper program.  These items have not had, and are not expected to have, a significant impact on Altria&#8217;s liquidity.  For further discussion regarding Altria&#8217;s liquidity, see the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Debt and Liquidity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">section above.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payments Under State Settlement Agreements and FDA Regulation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- As discussed previously and in Note 12, PM USA has entered into State Settlement Agreements with the states and territories of the United States that call for certain payments.  In addition, PM USA, Middleton and USSTC are subject to quarterly user fees imposed by the FDA as a result of the FSPTCA.  Altria&#8217;s subsidiaries recorded $3.4 billion and $3.6 billion of charges to cost of sales for the nine months ended September&#160;30, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 and 2020, respectively, and $1.2 billion and $1.3 billion of charges to cost of sales for the three months ended September&#160;30, 2021 and 2020, in connection with the State Settlement Agreements and FDA user fees.  For further discussion of the resolutions of certain disputes with states and territories related to the NPM adjustment provision under the 1998 Master Settlement Agreement, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation - NPM Adjustment Disputes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Note 12.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on current agreements, 2020 market share and estimated annual industry volume decline rates, the estimated amounts that Altria&#8217;s subsidiaries may charge to cost of sales for payments related to State Settlement Agreements and FDA user fees are $4.5 billion on average for the next three years.  These amounts exclude the potential impact of any NPM Adjustment Items.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated amounts due under the State Settlement Agreements charged to cost of sales in each year would generally be paid in the following year.  The amounts charged to cost of sales for FDA user fees are generally paid in the quarter in which the fees are incurred.  As previously stated, the payments due under the terms of the State Settlement Agreements and FDA user fees are subject to adjustment for several factors, including volume, operating income, inflation and certain contingent events and, in general, are allocated based on each manufacturer&#8217;s market share.  The future payment amounts discussed above are estimates, and actual payment amounts will differ to the extent underlying assumptions differ from actual future results.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-Related Deposits and Payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - With respect to certain adverse verdicts currently on appeal, to obtain stays of judgments pending appeals, as of September&#160;30, 2021, PM USA had posted appeal bonds totaling $45 million, which have been collateralized with restricted cash that is included in assets on the condensed consolidated balance sheet.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although litigation is subject to uncertainty and an adverse outcome or settlement of litigation could have a material adverse effect on the financial position, cash flows or results of operations of PM USA, UST or Altria in a particular fiscal quarter or fiscal year, as more fully disclosed in Note 12, management expects cash flow from operations, together with Altria&#8217;s access to capital markets, to provide sufficient liquidity to meet ongoing business needs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity and Dividends</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends paid during the first nine months of 2021 and 2020 were $4,787 million and $4,690 million, respectively, an increase of 2.1%, reflecting a higher dividend rate, partially offset by fewer shares outstanding as a result of shares repurchased by Altria in 2021 under its share repurchase program.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Board of Directors (the &#8220;Board of Directors&#8221; or &#8220;Board&#8221;) declared a 4.7% increase in the quarterly dividend rate to $0.90 per share of Altria common stock versus the previous rate of $0.86 per share.  The current annualized dividend rate is $3.60 per share.  Altria maintains its long-term objective of a dividend payout ratio target of approximately 80% of its adjusted diluted EPS.  Future dividend payments remain subject to the discretion of the Board.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the Board authorized a $1.5 billion expansion of Altria&#8217;s existing share repurchase program from $2.0 billion to $3.5 billion, partially funded by the net cash proceeds from the Ste. Michelle Transaction.  Altria expects to complete the expanded program by December 31, 2022.  The timing of share repurchases under this program depends upon marketplace conditions and other factors, and the program remains subject to the discretion of the Board.  For a discussion of Altria&#8217;s share repurchase programs, see Note 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background and Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the condensed consolidated financial statements in Item 1 and Part II, Item 2. Unregistered Sales of Equity Securities and Use of Proceeds of this Form 10-Q.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Guidance Not Yet Adopted</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 13. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Accounting Guidance Not Yet Adopted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the condensed consolidated financial statements in Item 1 for a discussion of issued accounting guidance applicable to, but not yet adopted by, Altria.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 12 for a discussion of contingencies.</span></div><div id="i295e56fb16f94dae9eacc631c56d466c_151"></div><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental Guarantor Financial Information</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA (the &#8220;Guarantor&#8221;), which is a 100% owned subsidiary of Altria Group, Inc. (the &#8220;Parent&#8221;), has guaranteed the Parent&#8217;s obligations under its outstanding debt securities, borrowings under its Credit Agreement and amounts outstanding under its&#160;commercial paper program (the &#8220;Guarantees&#8221;).  Pursuant to&#160;the Guarantees, the Guarantor fully and unconditionally guarantees, as primary obligor, the payment and performance of the Parent&#8217;s obligations under the guaranteed debt instruments (the &#8220;Obligations&#8221;), subject to release under certain customary circumstances as noted below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Guarantees provide that the Guarantor guarantees the punctual payment when due, whether at stated maturity, by acceleration or otherwise, of the Obligations.  The liability of the Guarantor under the Guarantees is absolute and unconditional irrespective of: any lack of validity, enforceability or genuineness of any provision of any agreement or instrument relating thereto; any change in the time, manner or place of payment of, or in any other term of, all or any of the Obligations, or any other amendment or waiver of or any consent to departure from any agreement or instrument relating thereto; any exchange, release or non-perfection of any collateral, or any release or amendment or waiver of or consent to departure from any other guarantee, for all or any of the Obligations; or any other circumstance that might otherwise constitute a defense available to, or </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a discharge of, the Parent or the Guarantor.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under applicable provisions of federal bankruptcy law or comparable provisions of state fraudulent transfer law, the Guarantees could be voided, or claims in respect of the Guarantees could be subordinated to the debts of the Guarantor, if, among other things, the Guarantor, at the time it incurred the Obligations evidenced by the Guarantees:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">received less than reasonably equivalent value or fair consideration therefor; and</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">either:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">was insolvent or rendered insolvent by reason of such occurrence;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">was engaged in a business or transaction for which the assets of the Guarantor constituted unreasonably small capital; or</span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">intended to incur, or believed that it would incur, debts beyond its ability to pay such debts as they mature.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, under such circumstances, the payment of amounts by the Guarantor pursuant to the Guarantees could be voided and required to be returned to the Guarantor, or to a fund for the benefit of the Guarantor, as the case may be.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The measures of insolvency for purposes of the foregoing considerations will vary depending upon the law applied in any proceeding with respect to the foregoing. Generally, however, the Guarantor would be considered insolvent if:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the sum of its debts, including contingent liabilities, was greater than the saleable value of its assets, all at a fair valuation;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the present fair saleable value of its assets was less than the amount that would be required to pay its probable liability on its existing debts, including contingent liabilities, as they become absolute and mature; or</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">it could not pay its debts as they become due.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent the Guarantees are voided as a fraudulent conveyance or held unenforceable for any other reason, the holders of the guaranteed debt obligations would not have any claim against the Guarantor and would be creditors solely of the Parent.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The obligations of the Guarantor under the Guarantees are limited to the maximum amount as will not result in the Guarantor&#8217;s obligations under the Guarantees constituting a fraudulent transfer or conveyance, after giving effect to such maximum amount and all other contingent and fixed liabilities of the Guarantor that are relevant under Bankruptcy Law, the Uniform Fraudulent Conveyance Act, the Uniform Fraudulent Transfer Act or any similar federal or state law to the extent applicable to the Guarantees.  For this purpose, &#8220;Bankruptcy Law&#8221; means Title 11, U.S. Code, or any similar federal or state law for the relief of debtors.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Guarantor will be unconditionally released and discharged from the Obligations upon the earliest to occur of:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the date, if any, on which the Guarantor consolidates with or merges into the Parent or any successor;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the date, if any, on which the Parent or any successor consolidates with or merges into the Guarantor;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the payment in full of the Obligations pertaining to such Guarantees; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the rating of the Parent&#8217;s long-term senior unsecured debt by S&amp;P of A or higher.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Parent is a holding company; therefore, its access to the operating cash flows of its wholly owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans by its subsidiaries.  Neither the Guarantor nor other 100% owned subsidiaries of the Parent that are not guarantors of the debt (&#8220;Non-Guarantor Subsidiaries&#8221;) are limited by contractual obligations on their ability to pay cash dividends or make other distributions with respect to their equity interests.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables include summarized financial information for the Parent and the Guarantor.  Transactions between the Parent and the Guarantor (including investment and intercompany balances as well as equity earnings) have been eliminated.  The Parent&#8217;s and the Guarantor&#8217;s intercompany balances with Non-Guarantor Subsidiaries have been presented separately.  This summarized financial information is not intended to present the financial position or results of operations of the Parent or the Guarantor in accordance with GAAP.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summarized Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions of dollars)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.823%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.158%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Parent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Guarantor</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due from Non-Guarantor Subsidiaries</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">81</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">199</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,076</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">962</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,157</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,008&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,161</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due from Non-Guarantor Subsidiaries</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,790</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,292</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,850</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,082</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,673&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,850</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,983&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to Non-Guarantor Subsidiaries</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,232</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">756</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,123</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,071</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,355</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,857&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,827</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28,923</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,958&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,052</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,268&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summarized Statements of Earnings (Losses)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions of dollars)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.347%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended <br/>September 30, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Parent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Guarantor</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,517</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,425</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,611)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,514</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the nine months ended September&#160;30, 2021, net earnings (losses)  include $174 million of intercompany interest income from non-guarantor subsidiaries.</span></div><div id="i295e56fb16f94dae9eacc631c56d466c_154"></div><div style="margin-bottom:5pt;margin-top:10pt;padding-right:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Factors That May Affect Future Results</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward-Looking and Cautionary Statements</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may from time to time make written or oral forward-looking statements, including earnings guidance and other statements contained in filings with the SEC, reports to security holders, press releases and investor webcasts.  You can identify these forward-looking statements by use of words such as &#8220;strategy,&#8221; &#8220;expects,&#8221; &#8220;continues,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;will,&#8221; &#8220;estimates,&#8221; &#8220;forecasts,&#8221; &#8220;intends,&#8221; &#8220;projects,&#8221; &#8220;goals,&#8221; &#8220;objectives,&#8221; &#8220;guidance,&#8221; &#8220;targets&#8221; and other words of similar meaning.  You can also identify them by the fact that they do not relate strictly to historical or current facts.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot guarantee that any forward-looking statement will be realized, although we believe we have been prudent in our plans, estimates and assumptions.  Achievement of future results is subject to risks, uncertainties and assumptions that may prove to be inaccurate.  Should known or unknown risks or uncertainties materialize, or should underlying estimates or assumptions prove inaccurate, actual results could differ materially from those anticipated, estimated or projected.  You should bear this in mind as you consider forward-looking statements and whether to invest in or remain invested in Altria&#8217;s securities. In connection with the &#8220;safe harbor&#8221; provisions of the Private Securities Litigation Reform Act of 1995, we are identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in, or implied by, any forward-looking statements made by Altria; any such statement is qualified by reference to the following cautionary statements.  We elaborate on these important factors and the risks we face throughout this Form 10-Q, particularly in Item 1A and the &#8220;Business Environment&#8221; section preceding our discussion of the operating results of our </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">segments, and in our publicly filed reports, including our 2020 Form 10-K and our Second Quarter 2021 Form 10-Q.  These factors include the following:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">unfavorable litigation outcomes, including risks associated with adverse jury and judicial determinations, courts and arbitrators reaching conclusions at variance with our, our subsidiaries&#8217; or our investees&#8217; understanding of applicable law, bonding requirements in the jurisdictions that do not limit the dollar amount of appeal bonds, and certain challenges to bond cap statutes;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">government (including the FDA) and private sector actions that impact adult tobacco consumer acceptability of, or access to, tobacco products;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">tobacco product taxation, including lower tobacco product consumption levels and potential shifts in adult consumer purchases as a result of federal, state and local excise tax increases;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">unfavorable outcomes of any government investigations of Altria, our subsidiaries or investees;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">a successful challenge to our tax positions, an increase to the corporate income tax rate or other changes to federal or state tax laws;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the risks related to our and our investees&#8217; international business operations, including failure to prevent violations of various U.S. and foreign laws and regulations such as foreign privacy laws and laws prohibiting bribery and corruption;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the risks associated with health epidemics and pandemics, including the COVID-19 pandemic and similar outbreaks, such as their impact on our financial performance and financial condition and on our subsidiaries&#8217; and investees&#8217; ability to continue manufacturing and distributing products, including as a result of labor shortages, and the impact of health epidemics and pandemics on general economic conditions (including any resulting recession or other economic crisis) and, in turn, adult consumer purchasing behavior, which may be further adversely impacted by any reductions in, or eliminations of, government stimulus or unemployment payments;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the failure of our tobacco subsidiaries and our investees to compete effectively in their respective markets;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the growth of the e-vapor category and other innovative tobacco products, including oral nicotine pouches, contributing to reductions in cigarette and MST consumption levels and sales volume;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">our tobacco subsidiaries&#8217; and our investees&#8217; continued ability to promote brand equity successfully; to anticipate and respond to evolving adult consumer preferences; to develop, manufacture, market and distribute products that appeal to adult consumers (including, where appropriate, through arrangements with, and investments in third parties); to improve productivity; and to protect or enhance margins through cost savings and price increases;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">changes, including in economic conditions (due to the COVID-19 pandemic or otherwise), that result in adult consumers choosing lower-priced brands, including discount brands;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the unsuccessful commercialization of adjacent products or processes by our tobacco subsidiaries and investees, including innovative tobacco products that may reduce the health risks associated with cigarettes and other traditional tobacco products, and that appeal to adult tobacco consumers;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">significant changes in price, availability or quality of tobacco, other raw materials or component parts, including as a result of the COVID-19 pandemic;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the risks related to the reliance by our tobacco subsidiaries on a few significant facilities and a small number of key suppliers, distributors and distribution chain service providers, and the risk of an extended disruption at a facility of, or of service by, a supplier, distributor or distribution chain service provider of our tobacco subsidiaries or investees, including as a result of the COVID-19 pandemic;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">required or voluntary product recalls as a result of various circumstances such as product contamination or FDA or other regulatory action;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the failure of our information systems or service providers&#8217; information systems to function as intended, or cyber attacks or security breaches;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">our inability to attract and retain the best talent due to the impact of decreasing social acceptance of tobacco usage, tobacco control actions and other factors;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">impairment losses as a result of the write down of intangible assets, including goodwill;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the adverse effect of acquisitions, investments, dispositions or other events on our credit rating;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">our inability to acquire attractive businesses or make attractive investments on favorable terms, or at all, or to realize the anticipated benefits from an acquisition or investment and our inability to dispose of businesses or investments on favorable terms or at all;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the risks related to disruption and uncertainty in the credit and capital markets, including risk of access to these markets both generally and at current prevailing rates, which may adversely affect our earnings or dividend rate or both;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">our inability to attract and retain investors due to the impact of decreasing social acceptance of tobacco usage or unfavorable environmental, social and governance ratings; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the risk that any challenge to our investment in JUUL, if successful, could result in a broad range of resolutions, including divestiture of the investment or rescission of the transaction;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the risks generally related to our investments in JUUL and Cronos, including our inability to realize the expected benefits of our investments in the expected time frames, or at all, due to the risks encountered by our investees in their businesses, such as operational, competitive, compliance, legislative and regulatory risks at the international, federal, state and local levels, including actions by the FDA, and adverse publicity; potential disruptions to our investees&#8217; management or current or future plans and operations; domestic or international litigation developments, government investigations, tax disputes or otherwise; and impairment of our investment in Cronos and changes in the fair value of our investment in JUUL;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the risks related to our inability to acquire a controlling interest in JUUL as a result of standstill restrictions or to control the material decisions of JUUL, restrictions on our ability to sell or otherwise transfer our shares of JUUL until December 20, 2024, and non-competition restrictions for the same time period subject to certain exceptions;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the adverse effects of risks encountered by ABI in its business, including effects of the COVID-19 pandemic, foreign currency exchange rates and the impact of movements in ABI&#8217;s stock price on our equity investment in ABI, including on our reported earnings from and carrying value of our investment in ABI, which could result in additional impairments of our investment, and the dividends paid by ABI on the shares we own;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the risks related to our ownership percentage in ABI decreasing below certain levels, including additional tax liabilities, a reduction in the number of directors that we have the right to have appointed to the ABI board of directors and our potential inability to use the equity method of accounting for our investment in ABI;  </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the risk of challenges to the tax treatment of the consideration we received in the ABI/SABMiller business combination and the tax treatment of our equity investment; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the risks, including criminal, civil or tax liability for Altria, related to Altria&#8217;s or Cronos&#8217;s failure to comply with applicable laws, including cannabis laws.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should understand that it is not possible to predict or identify all factors and risks.  Consequently, you should not consider the foregoing list to be complete.  We do not undertake to update any forward-looking statement that we may make from time to time except as required by applicable law.</span></div><div><span><br/></span></div><div id="i295e56fb16f94dae9eacc631c56d466c_157"></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 3.  Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of Altria&#8217;s long-term debt, all of which is fixed-rate debt, is subject to fluctuations resulting from changes in market interest rates.  The following table provides the fair value of Altria&#8217;s long-term debt and the change in fair value based on a 1% increase or decrease in market interest rates at September&#160;30, 2021 and December&#160;31, 2020:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in billions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in fair value from a 1% increase in market interest rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in fair value from a 1% decrease in market interest rates</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rates on borrowings under the Credit Agreement are expected to be based on the London Interbank Offered Rate, or a fallback benchmark rate determined based on prevailing market convention, plus a percentage based on the higher of the ratings of Altria&#8217;s long-term senior unsecured debt from Moody&#8217;s and S&amp;P.  The applicable percentage based on Altria&#8217;s long-term senior unsecured debt ratings&#160;at September&#160;30, 2021 borrowings under the Credit Agreement was 1.0%.  At September&#160;30, 2021 and December&#160;31, 2020, Altria had no borrowings under the Credit Agreement.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Price Risk</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair values of the Fixed-price Preemptive Rights and the Cronos warrant are subject to equity price risk.  The Fixed-price Preemptive Rights and warrant are recorded at fair value, which is estimated using Black-Scholes option-pricing models.  The fair values of the Fixed-price Preemptive Rights and Cronos warrant are subject to fluctuations resulting from changes in the quoted market price of Cronos shares, the underlying equity security.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides (i) fair values of the Fixed-price Preemptive Rights and Cronos warrants and (ii) the change in fair value based on a 10% increase or decrease in the quoted market price of Cronos shares at September&#160;30, 2021 and December&#160;31, 2020:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.451%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fixed-price Preemptive Rights</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Warrant</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair values</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value based on a 10% increase/decrease in the quoted market price of Cronos shares</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div id="i295e56fb16f94dae9eacc631c56d466c_160"></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 4.  Controls and Procedures</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria carried out an evaluation, with the participation of Altria&#8217;s management, including its Chief Executive Officer and Chief Financial Officer, of the effectiveness of its disclosure controls and procedures (as defined in Rule 13a-15(e)) under the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this Form 10-Q.  Based upon that evaluation, Altria&#8217;s Chief Executive Officer and Chief Financial Officer concluded that Altria&#8217;s disclosure controls and procedures are effective.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in Altria&#8217;s internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.</span></div><div><span><br/></span></div><div id="i295e56fb16f94dae9eacc631c56d466c_163"></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Part II &#8211; OTHER INFORMATION</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 1.  Legal Proceedings</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 12 for a discussion of legal proceedings pending against Altria and its subsidiaries.  See also Exhibits 99.1 and 99.2 to this Form 10-Q.</span></div><div><span><br/></span></div><div id="i295e56fb16f94dae9eacc631c56d466c_166"></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 1A.  Risk Factors</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding Risk Factors appears in Part I, Item 1A. Risk Factors of our 2020 Form 10-K and in Part II, Item 1A. Risk Factors of our Second Quarter 2021 Form 10-Q.  Except as set forth below, there have been no material changes to the risk factors previously disclosed in our 2020 Form 10-K and in our Second Quarter 2021 Form 10-Q.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Risks Related to Litigation, Legislative or Regulatory Action</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A challenge to our tax positions, an increase in the income tax rate or other changes to federal or state tax laws could adversely affect our earnings or cash flow</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax laws and regulations, such as the 2017 Tax Cuts and Jobs Act, are complex and subject to varying interpretations. A successful challenge to one or more of Altria&#8217;s tax positions (which could give rise to additional liabilities, including interest and potential penalties), an increase in the corporate income tax rate or other changes to federal or state tax laws, including changes in how foreign investments are taxed, could adversely affect our earnings or cash flow.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Risks Related to Our Investments</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Altria recorded an impairment charge of $6.2 billion on its investment in ABI for the nine and three months ended September 30, 2021. If the carrying value of our investment in ABI exceeds its fair value and the loss in value is other than temporary, the investment is considered impaired, which would result in additional impairment losses.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, since October 2019, the carrying value of our investment in ABI has exceeded the fair value of our equity investment in ABI. In preparing our financial statements for the period ended September 30, 2021, we concluded that the decline in fair value of our investment in ABI below its carrying value was other than temporary at September 30, 2021. As a result, we recorded a non-cash, pre-tax impairment charge of $6.2 billion for the nine and three months ended September 30, 2021 to income (losses) from equity investments in Altria&#8217;s condensed consolidated statements of earnings (losses). This impairment charge reflects the difference between the fair value of our investment in ABI using ABI&#8217;s share price at September 30, 2021 and the carrying value of Altria&#8217;s equity investment in ABI at September 30, 2021.  Additionally, if ABI is unable to successfully execute its business plans and strategies and the fair value of our investment in ABI continues to decrease, it could result in additional impairment losses, which could have a material adverse effect on our consolidated financial position or earnings.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><div id="i295e56fb16f94dae9eacc631c56d466c_169"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Board of Directors authorized a new $2.0 billion share repurchase program, which it expanded to $3.5 billion in October 2021.  Altria expects to complete the expanded program by December 31, 2022.  The timing of share repurchases under this program depends upon marketplace conditions and other factors, and the program remains subject to the discretion of the Board.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s share repurchase activity for each of the three months in the period ended September 30, was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.057%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.255%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Number of Shares Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average Price Paid Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Approximate Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1-31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,088,922</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47.30</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,088,922</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,251,200,508</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1-31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,381,498</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48.20</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,373,425</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,136,801,113</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1-30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,206,667</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">49.51</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,205,774</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,027,601,765</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,677,087</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48.35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,668,121</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The total number of shares purchased includes (a) shares purchased under the January 2021 share repurchase program (which totaled 2,088,922 shares in July, 2,373,425 shares in August and 2,205,774 shares in September) and (b) shares withheld by Altria in an amount equal to the statutory withholding taxes for vested stock-based awards previously granted to eligible employees (which totaled 8,073 shares in August and 893 shares in September).</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> This chart provides information for each of the three months in the period ended September 30. 2021; therefore, it does not reflect the October 2021 expansion of Altria&#8217;s share repurchase program discussed above.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><div id="i295e56fb16f94dae9eacc631c56d466c_172"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i295e56fb16f94dae9eacc631c56d466c_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 6.  Exhibits</span></div><div style="padding-left:45pt;padding-right:15.75pt;text-align:justify;text-indent:-42.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.182%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/764180/000119312521250405/d178833d8k.htm">Extension and Amendment No. 2 to the Credit Agreement, effective August 18, 2021, among Altria Group, Inc., the lenders party thereto and JPMorgan Chase Bank, N.A. and Citibank, N.A., as administrative agents.  Incorporated by reference to Altria Group, Inc.&#8217;s Current Report on Form 8-K filed on August 18, 2021 (File No. 1-08940). </a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:15.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000076418020000074/exhibit221q22020.htm">Guarantor Subsidiary of the Registrant.  Incorporated by reference to Altria Group, Inc.&#8217;s Quarterly Report on Form 10-Q for the period ended June 30, 2020 (File No. 1-08940).</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:15.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311q32021.htm">Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:15.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312q32021.htm">Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:15.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321q32021.htm">Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:15.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322q32021.htm">Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:15.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991q32021.htm">Certain Litigation Matters.</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:15.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit992q32021.htm">Trial Schedule for Certain Cases.</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:9pt;padding-left:40.5pt;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt;padding-right:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt;padding-right:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxonomy Extension Presentation Linkbase.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).</span></div></td></tr></table></div><div style="padding-left:45pt;padding-right:15.75pt;text-align:justify;text-indent:-42.75pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><div id="i295e56fb16f94dae9eacc631c56d466c_175"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Signature</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALTRIA GROUP, INC.</span></div><div style="margin-top:9pt"><span><br/></span></div><div style="padding-right:24.75pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">/s/ SALVATORE MANCUSO</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Salvatore Mancuso</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive Vice President and</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October 28, 2021</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exhibit311q32021.htm
<DESCRIPTION>CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A)
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i56a9121cc59b4f6a98a0b3f9843d9ff7_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:right"><font><br></font></div><div style="padding-left:32.62pt;padding-right:32.62pt;text-align:center;text-indent:-29.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certifications</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-right:15.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, William F. Gifford, Jr., certify that&#58;</font></div><div style="padding-left:18pt;padding-right:15.75pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Altria Group, Inc.&#59;</font></div><div style="padding-left:54pt;padding-right:15.75pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:54pt;padding-right:15.75pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:36pt;padding-right:15.75pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:36pt;padding-right:15.75pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and </font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:40.5pt;padding-right:15.75pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting. </font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58;  October 28, 2021</font></div><div style="margin-top:5pt;padding-left:7.87pt;padding-right:7.87pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:64.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.742%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; WILLIAM F. GIFFORD, JR.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William F. Gifford, Jr.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:15.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer </font></div></td></tr></table></div><div style="padding-right:15.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exhibit312q32021.htm
<DESCRIPTION>CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A)
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="iea180c7253fe48e0b25f93158c9e4993_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:right"><font><br></font></div><div style="padding-left:16.87pt;padding-right:16.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certifications</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-right:15.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Salvatore Mancuso, certify that&#58;</font></div><div style="padding-left:18pt;padding-right:15.75pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Altria Group, Inc.&#59;</font></div><div style="padding-left:15.75pt;padding-right:15.75pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:15.75pt;padding-right:15.75pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:15.75pt;padding-right:15.75pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:36pt;padding-right:15.75pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:36pt;padding-right:15.75pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and </font></div><div style="padding-left:58.5pt;padding-right:15.75pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:40.5pt;padding-right:15.75pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting. </font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58;  October 28, 2021</font></div><div style="margin-top:5pt;padding-left:7.87pt;padding-right:7.87pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:64.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.742%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:24.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; SALVATORE MANCUSO</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:24.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salvatore Mancuso</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and </font></div><div style="padding-right:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td></tr></table></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:24.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exhibit321q32021.htm
<DESCRIPTION>CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. 1350
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i267eb1fbbfd24227994971cddf55c49f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font><br></font></div><div style="padding-right:15.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Altria Group, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ended September&#160;30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, William F. Gifford, Jr., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(1)&#160;&#160;&#160;&#160;the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(2)&#160;&#160;&#160;&#160;the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; WILLIAM F. GIFFORD, JR.</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">William F. Gifford, Jr.</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Chief Executive Officer</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">October 28, 2021</font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-left:16.87pt;padding-right:16.87pt;text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>exhibit322q32021.htm
<DESCRIPTION>CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ie60900a3849e434fb29304d60d8b69dc_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO </font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font><br></font></div><div style="padding-right:15.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Altria Group, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ended September&#160;30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Salvatore Mancuso, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(1)&#160;&#160;&#160;&#160;the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(2)&#160;&#160;&#160;&#160;the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; SALVATORE MANCUSO</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Salvatore Mancuso</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Executive Vice President and</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Chief Financial Officer</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">October 28, 2021</font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>exhibit991q32021.htm
<DESCRIPTION>CERTAIN LITIGATION MATTERS
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i19e335229a1d49c881d0f018f7f29689_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTAIN LITIGATION MATTERS</font></div><div><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 12. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to Altria Group, Inc.&#8217;s (&#8220;Altria&#8221;) condensed consolidated financial statements in Part 1, Item 1 of the Quarterly Report on Form 10-Q to which this Exhibit 99.1 is attached (&#8220;Note 12&#8221;), there are legal proceedings covering a wide range of matters pending or threatened in various United States and foreign jurisdictions against Altria, its subsidiaries, including Philip Morris USA Inc. (&#8220;PM USA&#8221;), and their respective indemnitees.  Various types of claims may be raised in these proceedings, including product liability, unfair trade practices, antitrust, tax, contraband shipments, patent infringement, employment matters, claims alleging violation of the Racketeer Influenced and Corrupt Organizations Act, claims for contribution and claims of competitors, shareholders or distributors.  Claims related to tobacco products generally fall within the following categories&#58; (i) smoking and health cases alleging personal injury brought on behalf of individual plaintiffs, (ii) smoking and health cases primarily alleging personal injury or seeking court-supervised programs for ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, including cases in which the aggregated claims of a number of individual plaintiffs are to be tried in a single proceeding, (iii) health care cost recovery cases brought by governmental (both domestic and foreign) plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and&#47;or disgorgement of profits, (iv) class action suits alleging that the use of the terms &#8220;Lights&#8221; and &#8220;Ultra Lights&#8221; constitute deceptive and unfair trade practices, common law fraud or statutory fraud, unjust enrichment, breach of warranty, or violations of the Racketeer Influenced and Corrupt Organizations Act, (v) class action suits involving e-vapor products and (vi) international cases.  The following lists certain of the pending claims against Altria and PM USA included in these and other categories.</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SMOKING AND HEALTH LITIGATION</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following lists the consolidated individual smoking and health cases as well as smoking and health class actions pending against PM USA and, in some cases, Altria and&#47;or its other subsidiaries and affiliates, as of October 25, 2021.  See </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Cases </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for a list of smoking and health class actions pending in Canada.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Flight Attendant Litigation</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The settlement agreement entered into in 1997 in the case of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Broin, et al. v. Philip Morris Companies Inc., et al.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which was brought by flight attendants seeking damages for personal injuries allegedly caused by environmental tobacco smoke, allowed members of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Broin </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">class to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages.  See Note 12 for a discussion of this litigation.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Domestic Class Actions</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle, et al. v. R.J. Reynolds Tobacco Co., et al., Circuit Court, Eleventh Judicial Circuit, Dade County, Florida, filed May 5, 1994.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 12 for a discussion of this case (which has concluded) and the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny litigation.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Young, et al. v. The American Tobacco Company, et al., Civil District Court, Orleans Parish, Louisiana, filed November 12, 1997.</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HEALTH CARE COST RECOVERY LITIGATION</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following lists a health care cost recovery action pending against PM USA and Altria as of October 25, 2021.  See </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Cases </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for a list of international health care cost recovery actions.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Department of Justice Case</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The United States of America v. Philip Morris Incorporated, et al., United States District Court, District of Columbia, filed September 22, 1999</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  See Note 12 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;LIGHTS&#47;ULTRA LIGHTS&#8221; CASES</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following lists the &#8220;Lights&#47;Ultra Lights&#8221; class actions pending against Altria and&#47;or its various subsidiaries and others as of October 25, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Moore, et al. v. Philip Morris Incorporated, et al., Circuit Court, Marshall County, West Virginia, filed September 17, 2001.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Virden v. Altria Group, Inc., et al., Circuit Court, Hancock County, West Virginia, filed March 28, 2003.</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CLASS ACTION LAWSUITS INVOLVING E-VAPOR PRODUCTS</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following lists class action lawsuits relating to e-vapor products that are pending against Altria and&#47;or its various subsidiaries and others as of October 25, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">NesSmith, et al. v. JUUL Labs Inc., et al., United States District Court, Middle District of Florida, filed April 15, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Peavy (formerly Swearingen), et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of Alabama, filed May 31, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">R.E., et al. v. JUUL Labs, Inc., et al., United States District Court, Southern District of West Virginia, filed August 13, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">M.D., et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of Mississippi, filed August 15, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oberhauser, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed September 12, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hochhauser, et al. v. JUUL Labs, Inc., et al., United States District Court, Eastern District of New York, filed October 1, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Emidy et al. v. JUUL Labs, Inc., et al., United States District Court, Western District of Tennessee, filed October 2, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Montgomery County, Maryland, et al. v. JUUL Labs, Inc., et al., United States District Court, District of Maryland, filed October 11, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">King County, Washington, et al. v. JUUL Labs, Inc., et al., United States District Court, Western District of Washington, filed October 16, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Rochester, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed November 6, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jefferson County School District, et al. v. JUUL Labs, Inc., et al., United States District Court, Southern District of Mississippi, filed December 5, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ledbetter, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of Alabama, filed December 12, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Escambia County School District, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of Florida, filed December 18, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unified School District No. 320, Pottawatomie County, KS, individually and On Behalf Of Others Similarly Situated, v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed December 18, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">School Board of Miami-Dade County, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed December 19, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The School Board of Broward County, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed December 19, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Frederick County, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed December 19, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Imani, et al. v. JUUL Labs, Inc., et al., United States District Court, District of Oregon, filed December 20, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cooper, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of Texas, filed January 9, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">O&#8217;Reilly, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed January 13, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gabbard, et al. v. JUUL Labs, Inc., et al., United States District Court, Eastern District of Kentucky, filed February 21, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Peoria Public Schools v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed May 15, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Montgomery County Public Schools, MD. v. JUUL Labs, Inc. et al., United States District Court, Northern District of California, filed December 21, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ann Parker, On Behalf Of Her Daughter, S.P., Individually And On Behalf Of Others Similarly Situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 29, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adam Jenkins, Individually And On Behalf Of Others Similarly Situated, On Behalf Of D.L.J. v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 30, 2021.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Charleen Richey, On Behalf Of Her Son, T.Y., Individually And On Behalf Of Others Similarly Situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shayla Aceti, individually and on behalf of others similarly situated v. Juul Labs Inc et al., United States District Court, Northern District of California, filed March 30, 2021. </font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Timothy Critzer, individually and on behalf of others similarly situated v. Juul Labs Inc.., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Robert Dyer, On Behalf Of His Son, B.D., individually and on behalf of others similarly situated v. Juul Labs Inc., United States District Court, Northern District of California, filed March 30, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Joan Eubanks, individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bruce Gibson, on behalf of his son, K.G., individually and others similarly situated v.  Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jenika Ingram, individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shirley Moses on behalf of her daughter, K.S.C., individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Katherine Dentler, individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vickie Perry, On Behalf Of Her Daughter LP, individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jessica Pierre, individually and on behalf of others similarly situated v. Juul Labs Inc.&#59; Altria Group Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lacretia Pulce, On Behalf Of Her Daughter, K.P., individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Charles Tippe, individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Janece Wilhelm, individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Janece Wilhelm, on behalf of her son. D.L., individually and on behalf of others similarly situated v. Juul Labs Inc.&#59; et al., United States District Court, Northern District of California, filed April 1, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tonya Williams-Walker, On Behalf Of Her Son, M.W., and on behalf of others similarly situated v. Juul Labs Inc.et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Randi Lines, individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adam Jenkins, On Behalf Of His Son, M.R.J., Individually And On Behalf Of Others Similarly Situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 30, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ann Parker, On Behalf Of Her Daughter, S.P., Individually And On Behalf Of Others Similarly Situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 29, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Erin Puente, individually and On Behalf Of Others Similarly Situated, v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 30, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shannon Kinnard, individually and On Behalf Of Others Similarly Situated, v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 30, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">John Hollis, individually and On Behalf Of Others Similarly Situated, v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 30, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Coleman Holniker, individually and On Behalf of Others Similarly Situated, v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Addison Altizer, individually and On Behalf Of Others Similarly Situated, v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Charleen Richey, On Behalf Of Her Son, T.Y., Individually And On Behalf Of Others Similarly Situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 12 for a discussion of these cases.</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IQOS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> LITIGATION</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RAI Strategic Holdings, Inc., et al. v. Altria Client Services, LLC, et al., United States District Court, Eastern District of Virginia, filed April 9, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Tobacco Heating Articles and Components Thereof, United States International Trade Commission, filed April 9, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthier Choices Management Corp. v. Philip Morris USA Inc., et al., United States District Court, Northern District of Georgia, filed December 4, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 12 for a discussion of these cases.</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANTITRUST LITIGATION</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re Altria Group, Inc., et al., United States of America Before the Federal Trade Commission, filed April 1, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reece, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 7, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Blomquist, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 13, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Martinez, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 14, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deadwyler, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 20, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Licari, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 21, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flannery, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 27, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Walsh, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed May 8, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redfield, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed May 15, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Carlson, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed May 21, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">B&#38;C Retail, Inc., et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed June 11, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sofijon, Inc., et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed June 11, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noor Baig, Inc., et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed June 11, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Somerset Party Store, Inc., et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed June 18, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jackson, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed June 25, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">McGhee, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed July 1, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Irwindale Fuel Station, Inc. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed July 15, 2020.</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SHAREHOLDER CLASS ACTION</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Klein, et al. v. Altria Group, Inc., et al., United States District Court, Eastern District of Virginia, filed October 2, 2019.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 12 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SHAREHOLDER DERIVATIVE LAWSUITS</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sandys, et al. v. Willard, et al., United States District Court, Northern District of California, filed August 7, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lorca, et al. v. Gifford, et al., United States District Court, Northern District of California, filed August 27, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cohen, et al. v. Willard, et al., Circuit Court for Henrico County, Virginia, filed September 14, 2020.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gilbert, et al. v. Gifford et al., United States District Court, Eastern District of Virginia, filed October 1, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hamilton et al. v. Gifford et al., United States District Court, Eastern District of Virginia, filed January 25, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Randolph et al. v. Gifford et al., United States District Court, Eastern District of Virginia, filed March 28, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Braunstein et al. v. Gifford et al., Circuit Court for Henrico County, Virginia, filed May 18, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lopez et al. v. Casteen et al., Circuit Court for Henrico County, Virginia, filed June 16, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Merritts et al. v. Casteen et al., Circuit Court for Albemarle County, Virginia, filed July 30, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dalton et al. v. W. Hildebrandt Surgner et al., Circuit Court for Henrico County, Virginia, filed August 17, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">McCollum et al. v. Gifford et al., Circuit Court for Henrico County, Virginia, filed August 26, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See  Note 12 for a discussion of these cases.</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTERNATIONAL CASES</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following lists cases pending against Altria and&#47;or its subsidiaries in foreign jurisdictions as of October 25, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Canada</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">O&#8217;Donnell, et. al. v. JUUL Labs, Canada, Ltd., et al., Ontario, Ontario Superior Court, filed April 17, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  E-vapor class action.  See Note 12 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Salvatore, et al. v. JUUL Labs Canada, Ltd., et al., Quebec, District of Montreal Superior Court, filed June 12, 2019.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">E-vapor class action.  See Note 12 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stephens, et al. v. JUUL Labs, Inc., et al., British Columbia, Canada Supreme Court, filed October 1, 2019.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">E-vapor class action.  See Note 12 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of British Columbia v. Imperial Tobacco Limited, et al., Supreme Court, British Columbia, Vancouver Registry, Canada, filed January 24, 2001.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action.  See Note 12 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of the Province of New Brunswick v. Rothmans, Inc., et al., Court of Queen&#8217;s Bench of New Brunswick Judicial District of Fredericton, Canada, filed March 13, 2008.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action.  See Note 12 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dorion v. Canadian Tobacco Manufacturers&#8217; Council, et al., Court of Queen&#8217;s Bench of Alberta, Judicial District of Calgary, Canada, filed on or about June 17, 2009</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Smoking and health class action.  See Note 12 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Semple v. Canadian Tobacco Manufacturers&#8217; Council, et al., Supreme Court of Nova Scotia, Canada, filed on or about June 18, 2009.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smoking and health class action.  See Note 12 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kunta v. Canadian Tobacco Manufacturers&#8217; Council, et al., Court of Queen&#8217;s Bench of Manitoba, Winnipeg Judicial Centre, Canada, filed on an unknown date in June 2009</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Smoking and health class action.  See Note 12 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adams v. Canadian Tobacco Manufacturers&#8217; Council, et al., Court of Queen&#8217;s Bench for Saskatchewan, Judicial Centre of Regina, Canada, filed on or about July 10, 2009.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smoking and health class action.  See Note 12 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of Ontario v. Rothmans Inc., et al., Superior Court of Justice of Ontario, Canada, filed on or about September 30, 2009.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action.  See Note 12 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bourassa v. Imperial Tobacco Canada Limited, et al., Supreme Court of British Columbia, Victoria Registry, Canada, filed on or about June 25, 2010.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smoking and health class action.  See Note 12 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">McDermid v. Imperial Tobacco Canada Limited, et al., Supreme Court of British Columbia, Victoria Registry, Canada, filed on or about June 25, 2010.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smoking and health class action.  See Note 12 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Attorney General of Newfoundland and Labrador v. Rothmans Inc., et al., Supreme Court of Newfoundland and Labrador, Trial Division, Canada, filed February 8, 2011</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Health care cost recovery action.  See Note 12 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Attorney General of Quebec v. Imperial Tobacco Canada Limited, et al., Superior Court of Quebec, Montreal District, Canada, filed June 8, 2012</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Health care cost recovery action.  See Note 12 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty in Right of Alberta v. Altria Group, Inc., et al., Court of Queen&#8217;s Bench of Alberta, Judicial District of Calgary, Canada, filed June 8, 2012</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Health care cost recovery action.  See Note 12 for a discussion of this case.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in the Right of Manitoba v. Rothmans, Benson &#38; Hedges Inc., et al., Court of Queen&#8217;s Bench of Manitoba, Winnipeg Judicial Centre, Canada, filed May 31, 2012.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action.  See Note 12 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of Saskatchewan v. Rothmans, Benson &#38; Hedges Inc., et al., Court of Queen&#8217;s Bench of Saskatchewan, Judicial Centre of Saskatoon, Canada, filed on June 8, 2012.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action.  See Note 12 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty in the Right of the Province of Prince Edward Island v. Rothmans, Benson &#38; Hedges, Inc., et al., Supreme Court of Prince Edward Island, filed on September 10, 2012.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> See Note 12 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of the Province of Nova Scotia v. Benson &#38; Hedges, Inc., et al., Supreme Court of Nova Scotia, filed on January 2, 2015.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action.  See Note 12 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jacklin v. Canadian Tobacco Manufacturers&#8217; Council et al., Ontario Superior Court of Justice, Case No. 5379412, Ontario, Canada, filed on or about June 27, 2012.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smoking and health class action.  See Note 12 for a discussion of this case.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>7
<FILENAME>exhibit992q32021.htm
<DESCRIPTION>TRIAL SCHEDULE FOR CERTAIN CASES
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i8c2222f9db6045b1b8bfb00f8d872c36_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.2</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:9pt;text-align:center"><font><br></font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRIAL SCHEDULE FOR CERTAIN CASES </font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a schedule, as of October 25, 2021, setting forth by month the number of individual smoking and health cases against Philip Morris USA Inc. that are scheduled for but not in trial through December 31, 2021. </font></div><div style="margin-bottom:5pt;margin-top:4.5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021</font></div><div style="margin-bottom:5pt;margin-top:4.5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:5pt;margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.146%"><tr><td style="width:1.0%"></td><td style="width:76.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td></tr></table></div><div style="margin-bottom:4.4pt"><font><br></font></div><div style="margin-bottom:4.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 25, 2021, there are no </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in trial.</font></div><div style="margin-bottom:5pt;margin-top:4.5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Individual Smoking&#160;&#38; Health </font></div><div style="margin-bottom:5pt;margin-top:9.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.146%"><tr><td style="width:1.0%"></td><td style="width:76.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td></tr></table></div><div style="margin-bottom:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:4.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 25, 2021, there is one non-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny case in trial.</font></div><div style="margin-bottom:4.4pt"><font><br></font></div><div style="margin-bottom:4.4pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:4.5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>mo-20210930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:24c66990-7eda-4ddf-9c7a-8f1433627d2e,g:a0baef4b-24ba-4415-bfd0-6e9831a24e17-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mo="http://www.altria.com/20210930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.altria.com/20210930">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mo-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mo-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mo-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mo-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.altria.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.altria.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofEarningsLosses" roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Earnings (Losses)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveEarningsLosses" roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsLosses">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Earnings (Losses)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersDeficitEquity" roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersDeficitEquityParenthetical" roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquityParenthetical">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>1007008 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundandBasisofPresentation" roleURI="http://www.altria.com/role/BackgroundandBasisofPresentation">
        <link:definition>2101101 - Disclosure - Background and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundandBasisofPresentationPolicies" roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationPolicies">
        <link:definition>2202201 - Disclosure - Background and Basis of Presentation (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundandBasisofPresentationTables" roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationTables">
        <link:definition>2303301 - Disclosure - Background and Basis of Presentation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundandBasisofPresentationNarrativeDetails" roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails">
        <link:definition>2404401 - Disclosure - Background and Basis of Presentation (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundandBasisofPresentationShareRepurchaseTableDetails" roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails">
        <link:definition>2405402 - Disclosure - Background and Basis of Presentation (Share Repurchase Table) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesfromContractswithCustomers" roleURI="http://www.altria.com/role/RevenuesfromContractswithCustomers">
        <link:definition>2106102 - Disclosure - Revenues from Contracts with Customers</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesfromContractswithCustomersNarrativeDetails" roleURI="http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails">
        <link:definition>2407403 - Disclosure - Revenues from Contracts with Customers (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuefromContractwithCustomerPolicies" roleURI="http://www.altria.com/role/RevenuefromContractwithCustomerPolicies">
        <link:definition>2208202 - Disclosure - Revenue from Contract with Customer (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetsHeldforSale" roleURI="http://www.altria.com/role/AssetsHeldforSale">
        <link:definition>2109103 - Disclosure - Assets Held for Sale</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetsHeldforSaleTables" roleURI="http://www.altria.com/role/AssetsHeldforSaleTables">
        <link:definition>2310302 - Disclosure - Assets Held for Sale (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetsHeldforSaleNarrativeDetails" roleURI="http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails">
        <link:definition>2411404 - Disclosure - Assets Held for Sale (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails" roleURI="http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails">
        <link:definition>2412405 - Disclosure - Assets Held for Sale (Summary of Major Classes of Assets and Liabilities Classified as Held for Sale) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecurities" roleURI="http://www.altria.com/role/InvestmentsinEquitySecurities">
        <link:definition>2113104 - Disclosure - Investments in Equity Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesTables" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesTables">
        <link:definition>2314303 - Disclosure - Investments in Equity Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails">
        <link:definition>2415406 - Disclosure - Investments in Equity Securities (Summary of Investments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails">
        <link:definition>2416407 - Disclosure - Investments in Equity Securities (Earnings in Equity Securities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails">
        <link:definition>2417408 - Disclosure - Investments in Equity Securities (Investment in ABI Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails">
        <link:definition>2418409 - Disclosure - Investments in Equity Securities (Investment in JUUL Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details">
        <link:definition>2419410 - Disclosure - Investments in Equity Securities (JUUL Investment Classified as Level 3) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails">
        <link:definition>2420411 - Disclosure - Investments in Equity Securities (Investment in Cronos Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstruments" roleURI="http://www.altria.com/role/FinancialInstruments">
        <link:definition>2121105 - Disclosure - Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsTables" roleURI="http://www.altria.com/role/FinancialInstrumentsTables">
        <link:definition>2322304 - Disclosure - Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsAggregateNotionalAmountsAggregateFairValuesandCarryingValuesDetails" roleURI="http://www.altria.com/role/FinancialInstrumentsAggregateNotionalAmountsAggregateFairValuesandCarryingValuesDetails">
        <link:definition>2423412 - Disclosure - Financial Instruments (Aggregate Notional Amounts, Aggregate Fair Values and Carrying Values) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsAggregateFairValueandCarryingValueDetails" roleURI="http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails">
        <link:definition>2424413 - Disclosure - Financial Instruments (Aggregate Fair Value and Carrying Value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails" roleURI="http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails">
        <link:definition>2425414 - Disclosure - Financial Instruments (Fair Value Using Black-Scholes Option-Pricing Model) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails" roleURI="http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails">
        <link:definition>2426415 - Disclosure - Financial Instruments (Beginning and Ending Balances of Fixed-price Preemptive Rights and Warrants) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails" roleURI="http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails">
        <link:definition>2427416 - Disclosure - Financial Instruments (Fair Value Derivative Financial Instruments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsPretaxUnrealizedGainsLossesDetails" roleURI="http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails">
        <link:definition>2428417 - Disclosure - Financial Instruments (Pre-tax Unrealized Gains (Losses)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails" roleURI="http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails">
        <link:definition>2429418 - Disclosure - Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlans" roleURI="http://www.altria.com/role/BenefitPlans">
        <link:definition>2130106 - Disclosure - Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansTables" roleURI="http://www.altria.com/role/BenefitPlansTables">
        <link:definition>2331305 - Disclosure - Benefit Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" roleURI="http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails">
        <link:definition>2432419 - Disclosure - Benefit Plans (Schedule Of Components Of Net Periodic Benefit Cost (Income)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansNarrativeDetails" roleURI="http://www.altria.com/role/BenefitPlansNarrativeDetails">
        <link:definition>2433420 - Disclosure - Benefit Plans (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossesperShare" roleURI="http://www.altria.com/role/EarningsLossesperShare">
        <link:definition>2134107 - Disclosure - Earnings (Losses) per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossesperShareTables" roleURI="http://www.altria.com/role/EarningsLossesperShareTables">
        <link:definition>2335306 - Disclosure - Earnings (Losses) per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossesperShareBasicandDilutedEarningsPerShareDetails" roleURI="http://www.altria.com/role/EarningsLossesperShareBasicandDilutedEarningsPerShareDetails">
        <link:definition>2436421 - Disclosure - Earnings (Losses) per Share (Basic and Diluted Earnings Per Share) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveEarningsLosses" roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLosses">
        <link:definition>2137108 - Disclosure - Other Comprehensive Earnings/Losses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveEarningsLossesTables" roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesTables">
        <link:definition>2338307 - Disclosure - Other Comprehensive Earnings/Losses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails">
        <link:definition>2439422 - Disclosure - Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveEarningsLossesReclassificationsDetails" roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails">
        <link:definition>2440423 - Disclosure - Other Comprehensive Earnings/Losses (Reclassifications) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.altria.com/role/SegmentReporting">
        <link:definition>2141109 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.altria.com/role/SegmentReportingTables">
        <link:definition>2342308 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingSegmentDataScheduleDetails" roleURI="http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails">
        <link:definition>2443424 - Disclosure - Segment Reporting (Segment Data Schedule) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails" roleURI="http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails">
        <link:definition>2444425 - Disclosure - Segment Reporting (Non-Participating Manufacturer Adjustment Items) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails" roleURI="http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails">
        <link:definition>2445426 - Disclosure - Segment Reporting (Schedule of Tobacco and Health and Certain Other Litigation Items) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingNarrativeDetails" roleURI="http://www.altria.com/role/SegmentReportingNarrativeDetails">
        <link:definition>2446427 - Disclosure - Segment Reporting (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.altria.com/role/Debt">
        <link:definition>2147110 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.altria.com/role/DebtTables">
        <link:definition>2348309 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtNarrativeDetails" roleURI="http://www.altria.com/role/DebtNarrativeDetails">
        <link:definition>2449428 - Disclosure - Debt (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTenderOffersDetails" roleURI="http://www.altria.com/role/DebtTenderOffersDetails">
        <link:definition>2450429 - Disclosure - Debt (Tender Offers) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.altria.com/role/IncomeTaxes">
        <link:definition>2151111 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesupdateTables" roleURI="http://www.altria.com/role/IncomeTaxesupdateTables">
        <link:definition>2352310 - Disclosure - Income Taxes update (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesSummaryofIncomeTaxesDetails" roleURI="http://www.altria.com/role/IncomeTaxesSummaryofIncomeTaxesDetails">
        <link:definition>2453430 - Disclosure - Income Taxes - Summary of Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.altria.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>2454431 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.altria.com/role/IncomeTaxesDetails">
        <link:definition>2455432 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingencies" roleURI="http://www.altria.com/role/Contingencies">
        <link:definition>2156112 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesTables" roleURI="http://www.altria.com/role/ContingenciesTables">
        <link:definition>2357311 - Disclosure - Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesGeneralInformationDetails" roleURI="http://www.altria.com/role/ContingenciesGeneralInformationDetails">
        <link:definition>2458433 - Disclosure - Contingencies (General Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails" roleURI="http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails">
        <link:definition>2459434 - Disclosure - Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesScheduleofPendingCasesDetails" roleURI="http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails">
        <link:definition>2460435 - Disclosure - Contingencies (Schedule of Pending Cases) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails" roleURI="http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails">
        <link:definition>2461436 - Disclosure - Contingencies (Overview of Altria and/or PM USA Tobacco-Related Litigation Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesNonEngleProgenyLitigationDetails" roleURI="http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails">
        <link:definition>2462437 - Disclosure - Contingencies (Non-Engle Progeny Litigation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" roleURI="http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails">
        <link:definition>2463438 - Disclosure - Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails" roleURI="http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails">
        <link:definition>2464439 - Disclosure - Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesFloridaBondStatuteDetails" roleURI="http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails">
        <link:definition>2465440 - Disclosure - Contingencies (Florida Bond Statute) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesOtherSmokingandHealthClassActionsDetails" roleURI="http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails">
        <link:definition>2466441 - Disclosure - Contingencies (Other Smoking and Health Class Actions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesHealthCareCostRecoveryLitigationDetails" roleURI="http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails">
        <link:definition>2467442 - Disclosure - Contingencies (Health Care Cost Recovery Litigation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesNPMAdjustmentDisputesDetails" roleURI="http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails">
        <link:definition>2468443 - Disclosure - Contingencies (NPM Adjustment Disputes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails" roleURI="http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails">
        <link:definition>2469444 - Disclosure - Contingencies (Other Disputes Under the State Settlement Agreements) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesFederalGovernmentsLawsuitDetails" roleURI="http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails">
        <link:definition>2470445 - Disclosure - Contingencies (Federal Government's Lawsuit) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesEvaporProductLitigationandIQOSLitigationDetails" roleURI="http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails">
        <link:definition>2471446 - Disclosure - Contingencies (E-vapor Product Litigation and IQOS Litigation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails" roleURI="http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails">
        <link:definition>2472447 - Disclosure - Contingencies (Antitrust Litigation and Shareholder Class Action and Shareholder Derivative Lawsuits) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesLightsUltraLightsCasesDetails" roleURI="http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails">
        <link:definition>2473448 - Disclosure - Contingencies (Lights/Ultra Lights Cases) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesUSTLitigationsNarrativeDetails" roleURI="http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails">
        <link:definition>2474449 - Disclosure - Contingencies (UST Litigations Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails" roleURI="http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails">
        <link:definition>2475450 - Disclosure - Contingencies (Guarantees and Other Similar Matters Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingGuidanceNotYetAdopted" roleURI="http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted">
        <link:definition>2176113 - Disclosure - New Accounting Guidance Not Yet Adopted</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingGuidanceNotYetAdoptedTables" roleURI="http://www.altria.com/role/NewAccountingGuidanceNotYetAdoptedTables">
        <link:definition>2377312 - Disclosure - New Accounting Guidance Not Yet Adopted (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" abstract="false" name="EquityMethodInvestmentPercentageofSharesEligibleForPurchase" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock" abstract="false" name="ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mo_NpmAdjustmentToCostOfSalesMember" abstract="true" name="NpmAdjustmentToCostOfSalesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2009NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2006NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_SummaryOfIncomeTaxesTableTextBlock" abstract="false" name="SummaryOfIncomeTaxesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mo_LossContingencyNumberOfPendingCasesConsolidated" abstract="false" name="LossContingencyNumberOfPendingCasesConsolidated" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_NonParticipatingManufacturerArbitrationPanelDecisionMember" abstract="true" name="NonParticipatingManufacturerArbitrationPanelDecisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" abstract="false" name="OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_CommonStock0.3313ParValueMember" abstract="true" name="CommonStock0.3313ParValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyClassActionLawsuit" abstract="false" name="LossContingencyClassActionLawsuit" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_CommonStock2.200NotesDue2027Member" abstract="true" name="CommonStock2.200NotesDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyVerdictsUpheld" abstract="false" name="LossContingencyVerdictsUpheld" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" abstract="false" name="EquityMethodInvestmentNumberofSharesEligibleForPurchase" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mo_EngleProgenyCasesR.DouglasMember" abstract="true" name="EngleProgenyCasesR.DouglasMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_RestrictedSharesLockupPeriod" abstract="false" name="RestrictedSharesLockupPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mo_USDDenominatedNotesDue2061Member" abstract="true" name="USDDenominatedNotesDue2061Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_MeasurementInputWeightedAverageExpectedTermMember" abstract="true" name="MeasurementInputWeightedAverageExpectedTermMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityInvestmentFairValueOption" abstract="false" name="EquityInvestmentFairValueOption" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_InvestmentsTable" abstract="true" name="InvestmentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="mo_IncomeLossFromEquityInvestmentsFairValueOption" abstract="false" name="IncomeLossFromEquityInvestmentsFairValueOption" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EquityContractWarrantMember" abstract="true" name="EquityContractWarrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_USDDenominatedDebt10200PercentDue2039Member" abstract="true" name="USDDenominatedDebt10200PercentDue2039Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HelixInnovationsLLCMember" abstract="true" name="HelixInnovationsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberOfStatesWithConcludedHearings" abstract="false" name="LossContingencyNumberOfStatesWithConcludedHearings" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_FederalGovernmentsLawsuitMember" abstract="true" name="FederalGovernmentsLawsuitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_NoncontrollingInterestRemainingInterestPurchasedByParent" abstract="false" name="NoncontrollingInterestRemainingInterestPurchasedByParent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_InterestAndOtherDebtExpenseNetMember" abstract="true" name="InterestAndOtherDebtExpenseNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LitigationSettlementEstimateofPossibleGain" abstract="false" name="LitigationSettlementEstimateofPossibleGain" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_DebtInstrumentExtensionTerm" abstract="false" name="DebtInstrumentExtensionTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" abstract="false" name="AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2005NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount" abstract="false" name="ValuationAllowanceDeferredTaxAssetDecreaseInAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_SmokeableProductsSegmentMember" abstract="true" name="SmokeableProductsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberOfCasesWithCourtDatesSet" abstract="false" name="LossContingencyNumberOfCasesWithCourtDatesSet" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_NonEngleProgenyCasesMember" abstract="true" name="NonEngleProgenyCasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2011NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ABInBevMember" abstract="true" name="ABInBevMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_PendingLawsuitFiledBySchoolDistrictMember" abstract="true" name="PendingLawsuitFiledBySchoolDistrictMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberOfCases" abstract="false" name="LossContingencyNumberOfCases" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EngleProgenyCasesRJReynoldsMember" abstract="true" name="EngleProgenyCasesRJReynoldsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_CommonStock3.125NotesDue2031Member" abstract="true" name="CommonStock3.125NotesDue2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_USDDenominatedNotesDue2032Member" abstract="true" name="USDDenominatedNotesDue2032Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_July2019ShareRepurchaseProgramMember" abstract="true" name="July2019ShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberOfConsolidatedDerivativeLawsuits" abstract="false" name="LossContingencyNumberOfConsolidatedDerivativeLawsuits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_CreditAgreementMember" abstract="true" name="CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_COVID19Member" abstract="true" name="COVID19Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LitigationSettlementAnnualLegalFeesPayableMaximum" abstract="false" name="LitigationSettlementAnnualLegalFeesPayableMaximum" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" abstract="false" name="LossContingencyNumberofStatesThatCapBondorRequireNoBond" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_January2021ShareRepurchaseProgramMember" abstract="true" name="January2021ShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityInvestmentsFairValueOptionVotingShares" abstract="false" name="EquityInvestmentsFairValueOptionVotingShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mo_USDDenominatedNotes4400PercentDue2026Member" abstract="true" name="USDDenominatedNotes4400PercentDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_OtherInventoryRawMaterialsNetofReserves" abstract="false" name="OtherInventoryRawMaterialsNetofReserves" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_PeriodOneMember" abstract="true" name="PeriodOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_IncreaseDecreaseInSettlementPayable" abstract="false" name="IncreaseDecreaseInSettlementPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_IQOSMember" abstract="true" name="IQOSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ReceivablesNetCurrentIncludingAssetsHeldForSale" abstract="false" name="ReceivablesNetCurrentIncludingAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EquityMethodInvestmentAggregateExercisePrice" abstract="false" name="EquityMethodInvestmentAggregateExercisePrice" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EngleProgenyCasesSantoroMember" abstract="true" name="EngleProgenyCasesSantoroMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2004NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock" abstract="false" name="ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mo_InventoryDisposalCostsandOtherMember" abstract="true" name="InventoryDisposalCostsandOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesCooperMember" abstract="true" name="EngleProgenyCasesCooperMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_USDDenominatedNotesDue2041Member" abstract="true" name="USDDenominatedNotesDue2041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberofCasesSetforTrial" abstract="false" name="LossContingencyNumberofCasesSetforTrial" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod" abstract="false" name="LossContingencyNumberOfStatesNotSettledArbitrationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mo_LossContingencyClaimsNotCertifiedNumber" abstract="false" name="LossContingencyClaimsNotCertifiedNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_AccruedSettlementLiabilityCurrent" abstract="false" name="AccruedSettlementLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EngleProgenyCasesMahfuzMember" abstract="true" name="EngleProgenyCasesMahfuzMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_InventoryWriteOffMember" abstract="true" name="InventoryWriteOffMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesReiderandBanksMember" abstract="true" name="EngleProgenyCasesReiderandBanksMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" abstract="true" name="NonEngleProgenySmokingAndHealthCasePrincipeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyClaimsDecided" abstract="false" name="LossContingencyClaimsDecided" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_CanadianTobaccoManufacturersMember" abstract="true" name="CanadianTobaccoManufacturersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesGarciaMember" abstract="true" name="EngleProgenyCasesGarciaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesMember" abstract="true" name="EngleProgenyCasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LitigationEscrowDeposit" abstract="false" name="LitigationEscrowDeposit" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2013NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentPricePerShareIfExercised" abstract="false" name="EquityMethodInvestmentPricePerShareIfExercised" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mo_USDDenominatedNotesDue2051Member" abstract="true" name="USDDenominatedNotesDue2051Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_AmountAwardedtoOtherParty" abstract="false" name="AmountAwardedtoOtherParty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_TobaccoandHealthLitigationCasesMember" abstract="true" name="TobaccoandHealthLitigationCasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_USDDenominatedNotes3490PercentDue2022Member" abstract="true" name="USDDenominatedNotes3490PercentDue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesNaugleGoreMBrownJordanTheisAndLandiMember" abstract="true" name="EngleProgenyCasesNaugleGoreMBrownJordanTheisAndLandiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions20052007NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" abstract="true" name="ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" abstract="false" name="LossContingencyNumberOfShareholdersFilingClassActionLawsuits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_CronosGroupInc.Member" abstract="true" name="CronosGroupInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_InvestmentsLineItems" abstract="true" name="InvestmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mo_LossContingencyUnfavorableVerdictsPendingReversed" abstract="false" name="LossContingencyUnfavorableVerdictsPendingReversed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_FederalTradeCommissionDisclosurePeriod" abstract="false" name="FederalTradeCommissionDisclosurePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage" abstract="false" name="EquityMethodInvestmentWarrantExercisedOwnershipPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_NonEngleProgenySmokingandHealthCaseLaramieMember" abstract="true" name="NonEngleProgenySmokingandHealthCaseLaramieMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember" abstract="true" name="EngleProgenyCasesPearsonDCohenCollarChaconMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" abstract="true" name="ScheduleofPretaxTobaccoandHealthLitigationChargesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="mo_EngleProgenyCasesPollariMember" abstract="true" name="EngleProgenyCasesPollariMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount" abstract="false" name="ValuationAllowanceDeferredTaxAssetIncreaseInAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_USDDenominatedNotes3800PercentDue2024Member" abstract="true" name="USDDenominatedNotes3800PercentDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ProvisionRecordedNumberOfCases" abstract="false" name="ProvisionRecordedNumberOfCases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyDamagesRecoverableValue" abstract="false" name="LossContingencyDamagesRecoverableValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" abstract="false" name="EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_EngleProgenyCasesSommersMember" abstract="true" name="EngleProgenyCasesSommersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2008NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo" abstract="false" name="LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LitigationCasesResultsMember" abstract="true" name="LitigationCasesResultsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesTheisMember" abstract="true" name="EngleProgenyCasesTheisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberofStateswithSettledLitigation" abstract="false" name="LossContingencyNumberofStateswithSettledLitigation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_ForeignCurrencyDenominatedDebtMember" abstract="true" name="ForeignCurrencyDenominatedDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_USTLitigationMember" abstract="true" name="USTLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyZeroDamagesVerdictModified" abstract="false" name="LossContingencyZeroDamagesVerdictModified" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2007NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberOfInactiveClassActionLawsuits" abstract="false" name="LossContingencyNumberOfInactiveClassActionLawsuits" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EngleProgenyCasesCuddiheeMember" abstract="true" name="EngleProgenyCasesCuddiheeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" abstract="true" name="HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" abstract="true" name="HealthCareCostRecoveryActions2017NPMAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" abstract="false" name="EquityMethodInvestmentNumberofSharesOwnedRestricted" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" abstract="false" name="LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" abstract="false" name="LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mo_SmokingAndHealthClassActionsMember" abstract="true" name="SmokingAndHealthClassActionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ArbitrationPeriodAxis" abstract="true" name="ArbitrationPeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="mo_EngleProgenyCasesGoreMember" abstract="true" name="EngleProgenyCasesGoreMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyClaimsDecidedUnfavorableNumber" abstract="false" name="LossContingencyClaimsDecidedUnfavorableNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2014NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesChadwellMember" abstract="true" name="EngleProgenyCasesChadwellMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyPunitiveDamagesAwardedValue" abstract="false" name="LossContingencyPunitiveDamagesAwardedValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" abstract="false" name="DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="mo_OralTobaccoSegmentMember" abstract="true" name="OralTobaccoSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ValuationAllowanceRollforwardRollForward" abstract="true" name="ValuationAllowanceRollforwardRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mo_LossContingencyZeroDamagesVerdicts" abstract="false" name="LossContingencyZeroDamagesVerdicts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_CommonStockDividendIncreasePercentage" abstract="false" name="CommonStockDividendIncreasePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_MaximumBondForAllDefendants" abstract="false" name="MaximumBondForAllDefendants" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" abstract="false" name="ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_TobaccoandHealthJudgmentMember" abstract="true" name="TobaccoandHealthJudgmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_SteMichelleTransactionMember" abstract="true" name="SteMichelleTransactionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesHollimanMember" abstract="true" name="EngleProgenyCasesHollimanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_RevolvingCreditFacilityDueAugust2024Member" abstract="true" name="RevolvingCreditFacilityDueAugust2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesKaplanMember" abstract="true" name="EngleProgenyCasesKaplanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_WineBusinessStrategicResetMember" abstract="true" name="WineBusinessStrategicResetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesDuignanMember" abstract="true" name="EngleProgenyCasesDuignanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberOfComplaints" abstract="false" name="LossContingencyNumberOfComplaints" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_MarketingAdministrationAndResearchCostsMember" abstract="true" name="MarketingAdministrationAndResearchCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesD.BrownMember" abstract="true" name="EngleProgenyCasesD.BrownMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_PendingIndividualLawsuitsMember" abstract="true" name="PendingIndividualLawsuitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EngleProgenyCasesJordanMember" abstract="true" name="EngleProgenyCasesJordanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesFreemanMember" abstract="true" name="EngleProgenyCasesFreemanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_PhilipMorrisUSAandAltriaGroupMember" abstract="true" name="PhilipMorrisUSAandAltriaGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesLippMember" abstract="true" name="EngleProgenyCasesLippMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" abstract="true" name="HealthCareCostRecoveryActions2019NPMAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesMcCallMember" abstract="true" name="EngleProgenyCasesMcCallMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues" abstract="false" name="LossContingencyNumberOfStatesInComplianceWithEscrowStatues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EquityMethodInvestmentsFairValueOptionMember" abstract="true" name="EquityMethodInvestmentsFairValueOptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_JUULMember" abstract="true" name="JUULMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_StockRepurchaseProgramIncreaseAuthorizedAmount" abstract="false" name="StockRepurchaseProgramIncreaseAuthorizedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_NonEngleProgenySmokingandHealthCaseGreeneMember" abstract="true" name="NonEngleProgenySmokingandHealthCaseGreeneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LitigationSettlementAnnualPaymentAmount" abstract="false" name="LitigationSettlementAnnualPaymentAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EngleProgenyCasesGlogerMember" abstract="true" name="EngleProgenyCasesGlogerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyClassNotCertifiedNumber" abstract="false" name="LossContingencyClassNotCertifiedNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_OtherDisputesUndertheStateSettlementAgreementsMember" abstract="true" name="OtherDisputesUndertheStateSettlementAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesRintoulMember" abstract="true" name="EngleProgenyCasesRintoulMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_NumberOfThirdPartyLawsuits" abstract="false" name="NumberOfThirdPartyLawsuits" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_USDDenominatedNotes2850PercentDue2022Member" abstract="true" name="USDDenominatedNotes2850PercentDue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_USDDenominatedNotes2950PercentDue2023Member" abstract="true" name="USDDenominatedNotes2950PercentDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesNaugleMember" abstract="true" name="EngleProgenyCasesNaugleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesGlogerRintoulandDuignamMember" abstract="true" name="EngleProgenyCasesGlogerRintoulandDuignamMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EvaporLitigationMember" abstract="true" name="EvaporLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyStateCourtsNumber" abstract="false" name="LossContingencyStateCourtsNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_InterestExpenseRelatedToLitigationMember" abstract="true" name="InterestExpenseRelatedToLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesM.BrownMember" abstract="true" name="EngleProgenyCasesM.BrownMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" abstract="true" name="HealthCareCostRecoveryActions2018NPMAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_AltriaGroupMember" abstract="true" name="AltriaGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember" abstract="true" name="EquityContractWarrantAndEquityContractPreemptiveRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ValuationAllowanceForeignCurrencyTranslationAdjustment" abstract="false" name="ValuationAllowanceForeignCurrencyTranslationAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EquityMethodInvestmentNumberofSharesOwnedCommon" abstract="false" name="EquityMethodInvestmentNumberofSharesOwnedCommon" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mo_ETSSmokingandHealthCaseFlightAttendantsMember" abstract="true" name="ETSSmokingandHealthCaseFlightAttendantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_PeriodTwoMember" abstract="true" name="PeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentReductionInSharePricePercentage" abstract="false" name="EquityMethodInvestmentReductionInSharePricePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_USDDenominatedNotes4000PercentDue2024Member" abstract="true" name="USDDenominatedNotes4000PercentDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_CashDiscountsPolicyTextBlock" abstract="false" name="CashDiscountsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_USDDenominatedDebt6200PercentDue2059Member" abstract="true" name="USDDenominatedDebt6200PercentDue2059Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_PhilipMorrisUSAMember" abstract="true" name="PhilipMorrisUSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" abstract="false" name="DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="mo_EngleProgenyCasesStateMember" abstract="true" name="EngleProgenyCasesStateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyClaimsDecidedFavorableNumber" abstract="false" name="LossContingencyClaimsDecidedFavorableNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" abstract="true" name="AccumulatedEquityMethodInvestmentsAttributableToParentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_BritishColumbiaSaskatchewanMember" abstract="true" name="BritishColumbiaSaskatchewanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount" abstract="false" name="StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_InvestmentsInEquitySecuritiesMember" abstract="true" name="InvestmentsInEquitySecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesNeffMember" abstract="true" name="EngleProgenyCasesNeffMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" abstract="false" name="LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_IncomeLossFromEquityInvestments" abstract="false" name="IncomeLossFromEquityInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" abstract="false" name="LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_IndividualSmokingAndHealthCasesMember" abstract="true" name="IndividualSmokingAndHealthCasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyCompensatoryDamagesAwardedValue" abstract="false" name="LossContingencyCompensatoryDamagesAwardedValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EngleProgenyCasesLandiMember" abstract="true" name="EngleProgenyCasesLandiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyVerdictReversedNumber" abstract="false" name="LossContingencyVerdictReversedNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_WineSegmentMember" abstract="true" name="WineSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActionsMember" abstract="true" name="HealthCareCostRecoveryActionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_OtherAccruedLiabilitiesMember" abstract="true" name="OtherAccruedLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_OtherTabaccoRelatedCasesMember" abstract="true" name="OtherTabaccoRelatedCasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2012NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentImpairment" abstract="false" name="EquityMethodInvestmentImpairment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2010NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesFederalMember" abstract="true" name="EngleProgenyCasesFederalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_CommonStock1.000NotesDue2023Member" abstract="true" name="CommonStock1.000NotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" abstract="true" name="HealthCareCostRecoveryActions2015NPMAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LightsMember" abstract="true" name="LightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ArbitrationPeriodDomain" abstract="true" name="ArbitrationPeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyClaimsResolvedNumber" abstract="false" name="LossContingencyClaimsResolvedNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyNumberOfInactiveCases" abstract="false" name="LossContingencyNumberOfInactiveCases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EngleProgenyCasesWeingartandHancockMember" abstract="true" name="EngleProgenyCasesWeingartandHancockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember" abstract="true" name="HealthCareCostRecoveryActions2020NPMAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_SteMichelleTransactionsMember" abstract="true" name="SteMichelleTransactionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_NonEngleProgenySmokingandHealthCaseGentileMember" abstract="true" name="NonEngleProgenySmokingandHealthCaseGentileMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage" abstract="false" name="LossContingencyCompensatoryDamagesAwardedAllocationPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" abstract="true" name="PendingLawsuitsFiledByStateOrLocalGovernmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" abstract="false" name="LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_CommonStock1.700NotesDue2025Member" abstract="true" name="CommonStock1.700NotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ClassActionLawsuitMember" abstract="true" name="ClassActionLawsuitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberofManufacturers" abstract="false" name="LossContingencyNumberofManufacturers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EngleProgenyCasesBergerMember" abstract="true" name="EngleProgenyCasesBergerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_CommonStockDividendRateAnnualPerShare" abstract="false" name="CommonStockDividendRateAnnualPerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_USDDenominatedNotesMember" abstract="true" name="USDDenominatedNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyReductionToCostOfSales" abstract="false" name="LossContingencyReductionToCostOfSales" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_InventoryRawMaterialsPlantMaterialNetofReserves" abstract="false" name="InventoryRawMaterialsPlantMaterialNetofReserves" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EquityContractPreemptiveRIghtsMember" abstract="true" name="EquityContractPreemptiveRIghtsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberOfStatesNotSettled" abstract="false" name="LossContingencyNumberOfStatesNotSettled" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_USDDenominatedNotes9950PercentDue2038Member" abstract="true" name="USDDenominatedNotes9950PercentDue2038Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_MarketingAdministrationandResearchCosts" abstract="false" name="MarketingAdministrationandResearchCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_USDDenominatedNotes4800PercentDue2029Member" abstract="true" name="USDDenominatedNotes4800PercentDue2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ImplementationofCorrectiveCommunicationsMember" abstract="true" name="ImplementationofCorrectiveCommunicationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" abstract="false" name="LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActionsTransitionYears20042020Member" abstract="true" name="HealthCareCostRecoveryActionsTransitionYears20042020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" abstract="false" name="LossContingencyNumberofStateswithSettledLitigationSettlementOne" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>mo-20210930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:24c66990-7eda-4ddf-9c7a-8f1433627d2e,g:a0baef4b-24ba-4415-bfd0-6e9831a24e17-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="mo-20210930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_372b215d-1e88-4ac7-b338-c8cc73d10bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_93506b01-266f-412f-8717-4b0f252a0bad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_372b215d-1e88-4ac7-b338-c8cc73d10bb6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_93506b01-266f-412f-8717-4b0f252a0bad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7b294470-9f54-4079-bd4a-528eee91715f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_372b215d-1e88-4ac7-b338-c8cc73d10bb6" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7b294470-9f54-4079-bd4a-528eee91715f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0daf8062-cf47-4617-b057-ad8fd9e3d135" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f3b113ca-72c9-48de-8842-1ac52b601dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0daf8062-cf47-4617-b057-ad8fd9e3d135" xlink:to="loc_us-gaap_CommonStockValue_f3b113ca-72c9-48de-8842-1ac52b601dd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_29b4728b-1e45-47f5-8e29-0d12b4f57d67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0daf8062-cf47-4617-b057-ad8fd9e3d135" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_29b4728b-1e45-47f5-8e29-0d12b4f57d67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ff2f7897-4854-4bcb-85a5-0cc10780164c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0daf8062-cf47-4617-b057-ad8fd9e3d135" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ff2f7897-4854-4bcb-85a5-0cc10780164c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1b6ca1a6-2ae3-4519-96f9-900e51e3094b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0daf8062-cf47-4617-b057-ad8fd9e3d135" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1b6ca1a6-2ae3-4519-96f9-900e51e3094b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_24d6f814-528a-454a-b9b1-eb97f3fa8365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0daf8062-cf47-4617-b057-ad8fd9e3d135" xlink:to="loc_us-gaap_TreasuryStockValue_24d6f814-528a-454a-b9b1-eb97f3fa8365" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f9eac325-a7a7-4f43-9888-ec7f584cfe93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a9eb5d96-20ee-48d8-ba08-dfdc70e56482" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f9eac325-a7a7-4f43-9888-ec7f584cfe93" xlink:to="loc_us-gaap_LiabilitiesCurrent_a9eb5d96-20ee-48d8-ba08-dfdc70e56482" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_0ea9a770-11b1-4f9c-96af-623fb492bbe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f9eac325-a7a7-4f43-9888-ec7f584cfe93" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_0ea9a770-11b1-4f9c-96af-623fb492bbe2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3316b3e8-8d30-4ce2-9e07-f9c2c9dada9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f9eac325-a7a7-4f43-9888-ec7f584cfe93" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3316b3e8-8d30-4ce2-9e07-f9c2c9dada9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_0f9ef742-c4b6-4c18-8bbe-e5cf0bc9a8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f9eac325-a7a7-4f43-9888-ec7f584cfe93" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_0f9ef742-c4b6-4c18-8bbe-e5cf0bc9a8bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_2b31a2ba-09f6-461b-819e-f37aa791c771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f9eac325-a7a7-4f43-9888-ec7f584cfe93" xlink:to="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_2b31a2ba-09f6-461b-819e-f37aa791c771" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_b03d4ea8-4e7f-4d58-8206-fd57e7fd813a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f9eac325-a7a7-4f43-9888-ec7f584cfe93" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_b03d4ea8-4e7f-4d58-8206-fd57e7fd813a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f38dc2e8-267a-4505-9cff-0b024b7bc7de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1e2d78ff-80fa-47c4-8755-b44ffb62136b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f38dc2e8-267a-4505-9cff-0b024b7bc7de" xlink:to="loc_us-gaap_InventoryNet_1e2d78ff-80fa-47c4-8755-b44ffb62136b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_1ee5faf3-519c-4b89-812d-bb4af5f01a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f38dc2e8-267a-4505-9cff-0b024b7bc7de" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_1ee5faf3-519c-4b89-812d-bb4af5f01a9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7a921b78-7d09-40ab-ad0d-2a91eee0b10d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f38dc2e8-267a-4505-9cff-0b024b7bc7de" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7a921b78-7d09-40ab-ad0d-2a91eee0b10d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_8253bab7-3296-4651-88df-b4be9e9729d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f38dc2e8-267a-4505-9cff-0b024b7bc7de" xlink:to="loc_us-gaap_OtherAssetsCurrent_8253bab7-3296-4651-88df-b4be9e9729d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_3dbcdad2-6328-404e-9d59-647d3412abd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f38dc2e8-267a-4505-9cff-0b024b7bc7de" xlink:to="loc_us-gaap_ReceivablesNetCurrent_3dbcdad2-6328-404e-9d59-647d3412abd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e3f42701-b4c1-4793-be1a-ad5c53d54b90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InventoryRawMaterialsPlantMaterialNetofReserves_b6eeac73-c0c1-48c5-9abd-cc224209d104" xlink:href="mo-20210930.xsd#mo_InventoryRawMaterialsPlantMaterialNetofReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e3f42701-b4c1-4793-be1a-ad5c53d54b90" xlink:to="loc_mo_InventoryRawMaterialsPlantMaterialNetofReserves_b6eeac73-c0c1-48c5-9abd-cc224209d104" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherInventoryRawMaterialsNetofReserves_85a20e16-c5b2-4e7d-bf3e-23934c0172fa" xlink:href="mo-20210930.xsd#mo_OtherInventoryRawMaterialsNetofReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e3f42701-b4c1-4793-be1a-ad5c53d54b90" xlink:to="loc_mo_OtherInventoryRawMaterialsNetofReserves_85a20e16-c5b2-4e7d-bf3e-23934c0172fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_2fc102b5-0449-4ba3-95da-99306a8d09a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e3f42701-b4c1-4793-be1a-ad5c53d54b90" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_2fc102b5-0449-4ba3-95da-99306a8d09a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_4e88bbdf-f91f-45da-8430-2157ae3f2371" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e3f42701-b4c1-4793-be1a-ad5c53d54b90" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_4e88bbdf-f91f-45da-8430-2157ae3f2371" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_94163150-cc65-4586-a13b-6a078cd2f4d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_43211df0-0fe8-474e-9369-3d866049e426" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94163150-cc65-4586-a13b-6a078cd2f4d8" xlink:to="loc_us-gaap_AssetsCurrent_43211df0-0fe8-474e-9369-3d866049e426" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0fb4c6eb-8168-4646-add4-7f003f01aa86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94163150-cc65-4586-a13b-6a078cd2f4d8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0fb4c6eb-8168-4646-add4-7f003f01aa86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_eeed31ac-a8b2-423b-ae71-31139387ee9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94163150-cc65-4586-a13b-6a078cd2f4d8" xlink:to="loc_us-gaap_Goodwill_eeed31ac-a8b2-423b-ae71-31139387ee9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f7d4ce1f-1cf5-4782-af6c-d2b39f9fdd08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94163150-cc65-4586-a13b-6a078cd2f4d8" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f7d4ce1f-1cf5-4782-af6c-d2b39f9fdd08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_e1192a58-b54a-42bc-a631-680aaba0ad4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94163150-cc65-4586-a13b-6a078cd2f4d8" xlink:to="loc_us-gaap_Investments_e1192a58-b54a-42bc-a631-680aaba0ad4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_49f8e68d-8f64-433f-b162-e61e50deeece" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94163150-cc65-4586-a13b-6a078cd2f4d8" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_49f8e68d-8f64-433f-b162-e61e50deeece" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_87d4d9b1-7562-4e71-973b-4f93fa240483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ee1d7025-a02c-4d5c-92dd-fa200477dfe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_87d4d9b1-7562-4e71-973b-4f93fa240483" xlink:to="loc_us-gaap_StockholdersEquity_ee1d7025-a02c-4d5c-92dd-fa200477dfe4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_40f35a65-9562-4f72-b79b-f27f02c786ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_87d4d9b1-7562-4e71-973b-4f93fa240483" xlink:to="loc_us-gaap_MinorityInterest_40f35a65-9562-4f72-b79b-f27f02c786ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_dd28f686-581d-43ec-b9c0-e9e08ba71e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_884515c9-a16d-4f23-b8ae-444eb447a326" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_dd28f686-581d-43ec-b9c0-e9e08ba71e36" xlink:to="loc_us-gaap_LongTermDebtCurrent_884515c9-a16d-4f23-b8ae-444eb447a326" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_e7375ddd-7e2c-473d-9ed2-5500140fb0f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_dd28f686-581d-43ec-b9c0-e9e08ba71e36" xlink:to="loc_us-gaap_AccountsPayableCurrent_e7375ddd-7e2c-473d-9ed2-5500140fb0f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_a913032a-d492-49cf-82c1-9320289144e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_dd28f686-581d-43ec-b9c0-e9e08ba71e36" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_a913032a-d492-49cf-82c1-9320289144e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccruedSettlementLiabilityCurrent_90ef47d3-545e-4d22-897e-4ab053d8c381" xlink:href="mo-20210930.xsd#mo_AccruedSettlementLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_dd28f686-581d-43ec-b9c0-e9e08ba71e36" xlink:to="loc_mo_AccruedSettlementLiabilityCurrent_90ef47d3-545e-4d22-897e-4ab053d8c381" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_ac6f871b-f391-4be4-8d39-006bdb26c5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_dd28f686-581d-43ec-b9c0-e9e08ba71e36" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_ac6f871b-f391-4be4-8d39-006bdb26c5ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_9f555773-40c1-42d4-a64e-cf7ad319b8ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_dd28f686-581d-43ec-b9c0-e9e08ba71e36" xlink:to="loc_us-gaap_DividendsPayableCurrent_9f555773-40c1-42d4-a64e-cf7ad319b8ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_2ef95767-da3a-498d-847c-e8b4b5829196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_dd28f686-581d-43ec-b9c0-e9e08ba71e36" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_2ef95767-da3a-498d-847c-e8b4b5829196" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_27224969-e890-41dc-aa92-5ed29c59e87e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_fa53aa8e-fa21-4c6b-bf40-82eaa6fbdbaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_27224969-e890-41dc-aa92-5ed29c59e87e" xlink:to="loc_us-gaap_Liabilities_fa53aa8e-fa21-4c6b-bf40-82eaa6fbdbaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_3fb1585c-1fe5-4392-85e1-0b7075991a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_27224969-e890-41dc-aa92-5ed29c59e87e" xlink:to="loc_us-gaap_CommitmentsAndContingencies_3fb1585c-1fe5-4392-85e1-0b7075991a3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_21366dbd-869c-46db-bff9-0b384d917b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_27224969-e890-41dc-aa92-5ed29c59e87e" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_21366dbd-869c-46db-bff9-0b384d917b6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_eacb84be-6346-4297-89c4-af3b6b635905" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_27224969-e890-41dc-aa92-5ed29c59e87e" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_eacb84be-6346-4297-89c4-af3b6b635905" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses" xlink:type="simple" xlink:href="mo-20210930.xsd#CondensedConsolidatedStatementsofEarningsLosses"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c3892952-81c8-4fa5-9754-454a9a8f0d26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e2958474-fd2f-407c-bfc6-23131cdcf5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c3892952-81c8-4fa5-9754-454a9a8f0d26" xlink:to="loc_us-gaap_ProfitLoss_e2958474-fd2f-407c-bfc6-23131cdcf5c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4ef94a14-1781-4f03-aead-69479b816150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c3892952-81c8-4fa5-9754-454a9a8f0d26" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4ef94a14-1781-4f03-aead-69479b816150" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_15934bce-fb48-4a46-9228-426bd5260a21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_2209620d-5ade-4123-87ee-b22dd8a5a9da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_15934bce-fb48-4a46-9228-426bd5260a21" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_2209620d-5ade-4123-87ee-b22dd8a5a9da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_8ed6d3fc-922f-432b-9e74-ca7c32e91402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_15934bce-fb48-4a46-9228-426bd5260a21" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_8ed6d3fc-922f-432b-9e74-ca7c32e91402" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_694c1e81-380a-4cdb-8974-bd27e113d4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_15934bce-fb48-4a46-9228-426bd5260a21" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_694c1e81-380a-4cdb-8974-bd27e113d4cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c5f88f9f-6080-4b64-8bba-30bf8048b4ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_15934bce-fb48-4a46-9228-426bd5260a21" xlink:to="loc_us-gaap_OperatingIncomeLoss_c5f88f9f-6080-4b64-8bba-30bf8048b4ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_bb854c7c-b5b1-4071-9812-4d87ddf71a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_15934bce-fb48-4a46-9228-426bd5260a21" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_bb854c7c-b5b1-4071-9812-4d87ddf71a2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_cfc203ed-13d0-47a6-9494-e86cfc42f712" xlink:href="mo-20210930.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_15934bce-fb48-4a46-9228-426bd5260a21" xlink:to="loc_mo_IncomeLossFromEquityInvestments_cfc203ed-13d0-47a6-9494-e86cfc42f712" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_406d6aed-74d9-4020-b9fa-99fb6e362b14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_15934bce-fb48-4a46-9228-426bd5260a21" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_406d6aed-74d9-4020-b9fa-99fb6e362b14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_ba3cadbe-269d-4249-b5ea-e92039f170cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_04eaa6a6-ccf9-4689-ab91-ece2fae25eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_ba3cadbe-269d-4249-b5ea-e92039f170cd" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_04eaa6a6-ccf9-4689-ab91-ece2fae25eb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_801d24f5-47fc-4a90-92d7-49af7bcd3a31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_ba3cadbe-269d-4249-b5ea-e92039f170cd" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_801d24f5-47fc-4a90-92d7-49af7bcd3a31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostOfOperatingRevenue_b2f30be8-5045-4637-8e1e-d399873620fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCostOfOperatingRevenue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_ba3cadbe-269d-4249-b5ea-e92039f170cd" xlink:to="loc_us-gaap_OtherCostOfOperatingRevenue_b2f30be8-5045-4637-8e1e-d399873620fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c257228a-e687-48e1-af84-46ebe465ccdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_910e310b-0ac3-41ee-9ca8-6a826eb06d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_c257228a-e687-48e1-af84-46ebe465ccdd" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_910e310b-0ac3-41ee-9ca8-6a826eb06d5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4d2fc5e2-e865-4261-ae1d-ab5d88985793" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_c257228a-e687-48e1-af84-46ebe465ccdd" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_4d2fc5e2-e865-4261-ae1d-ab5d88985793" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_fb43fd31-c531-44da-ab39-b5ff8cb5b440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_24ee79d6-8f32-4172-bf02-722ec684f9bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_fb43fd31-c531-44da-ab39-b5ff8cb5b440" xlink:to="loc_us-gaap_GrossProfit_24ee79d6-8f32-4172-bf02-722ec684f9bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarketingAdministrationandResearchCosts_bac0e48f-ca15-4928-af1f-449397a698e5" xlink:href="mo-20210930.xsd#mo_MarketingAdministrationandResearchCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_fb43fd31-c531-44da-ab39-b5ff8cb5b440" xlink:to="loc_mo_MarketingAdministrationandResearchCosts_bac0e48f-ca15-4928-af1f-449397a698e5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsLosses" xlink:type="simple" xlink:href="mo-20210930.xsd#CondensedConsolidatedStatementsofComprehensiveEarningsLosses"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsLosses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c6c3ac53-b05f-464d-a143-4452e32ce82c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_099eae16-40c2-45ee-9bc5-444ad183d736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c6c3ac53-b05f-464d-a143-4452e32ce82c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_099eae16-40c2-45ee-9bc5-444ad183d736" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciEquityMethodInvestmentAfterTax_261a5606-e507-495c-aa0d-c82d10842350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciEquityMethodInvestmentAfterTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c6c3ac53-b05f-464d-a143-4452e32ce82c" xlink:to="loc_us-gaap_OciEquityMethodInvestmentAfterTax_261a5606-e507-495c-aa0d-c82d10842350" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_9959493a-de90-4b48-b369-5dba7b2ba412" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c6c3ac53-b05f-464d-a143-4452e32ce82c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_9959493a-de90-4b48-b369-5dba7b2ba412" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_88c538e0-981e-44c4-a9fe-3038cef28df2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_60f22d55-1713-4ac8-990b-c0939b88be47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_88c538e0-981e-44c4-a9fe-3038cef28df2" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_60f22d55-1713-4ac8-990b-c0939b88be47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_8e7082d6-bf2b-483e-b0bf-269e43ba8bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_88c538e0-981e-44c4-a9fe-3038cef28df2" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_8e7082d6-bf2b-483e-b0bf-269e43ba8bcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7f676ac0-7fbc-424a-bea7-aca27eb88f35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_86862d32-b1c6-4240-b2cd-dcb3dc965a85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7f676ac0-7fbc-424a-bea7-aca27eb88f35" xlink:to="loc_us-gaap_ProfitLoss_86862d32-b1c6-4240-b2cd-dcb3dc965a85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4938b808-425b-4e22-b0bc-66017007fc40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7f676ac0-7fbc-424a-bea7-aca27eb88f35" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4938b808-425b-4e22-b0bc-66017007fc40" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="mo-20210930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_70d129fc-42f6-4be9-b9b8-30758cd74077" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a9555d6-918c-4196-a252-4e45e43e5d30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_70d129fc-42f6-4be9-b9b8-30758cd74077" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a9555d6-918c-4196-a252-4e45e43e5d30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4338d018-c7b2-40e2-abb8-32dec629366f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_70d129fc-42f6-4be9-b9b8-30758cd74077" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4338d018-c7b2-40e2-abb8-32dec629366f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_98f52de1-560f-4453-bf1b-3c37444e3985" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_70d129fc-42f6-4be9-b9b8-30758cd74077" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_98f52de1-560f-4453-bf1b-3c37444e3985" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f1349151-f801-4c84-8010-9514074fe4ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_88f7ff20-2f65-475a-a6dc-d65f7a57cdf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f1349151-f801-4c84-8010-9514074fe4ca" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_88f7ff20-2f65-475a-a6dc-d65f7a57cdf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_e379bd1c-ee95-4109-a765-beb37661241c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f1349151-f801-4c84-8010-9514074fe4ca" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_e379bd1c-ee95-4109-a765-beb37661241c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_96990d33-23eb-4165-b501-80bdc263e630" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f1349151-f801-4c84-8010-9514074fe4ca" xlink:to="loc_us-gaap_RestrictedCashCurrent_96990d33-23eb-4165-b501-80bdc263e630" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_452ef033-cfc0-4a45-9aa4-a7b4e273ad6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f1349151-f801-4c84-8010-9514074fe4ca" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_452ef033-cfc0-4a45-9aa4-a7b4e273ad6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8abe72e7-53f6-4384-b7c4-447a5c9ce286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_23143cd4-a7e2-432d-94ed-3a3ae2c18585" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8abe72e7-53f6-4384-b7c4-447a5c9ce286" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_23143cd4-a7e2-432d-94ed-3a3ae2c18585" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f80aff1b-640a-45c1-b9fe-6e27a5022096" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8abe72e7-53f6-4384-b7c4-447a5c9ce286" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f80aff1b-640a-45c1-b9fe-6e27a5022096" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_874a606e-f071-4d84-9fee-6495cace1ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_ed55bd7d-1c24-4536-9e10-bad235e00783" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_874a606e-f071-4d84-9fee-6495cace1ee8" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_ed55bd7d-1c24-4536-9e10-bad235e00783" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_07149c2b-05c2-4fad-a890-fe03282810cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_874a606e-f071-4d84-9fee-6495cace1ee8" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_07149c2b-05c2-4fad-a890-fe03282810cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_f28ebedf-1ba4-4821-813e-1f8ec635f335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_874a606e-f071-4d84-9fee-6495cace1ee8" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_f28ebedf-1ba4-4821-813e-1f8ec635f335" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_5650e547-3434-474c-b127-24e7f84b6523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_874a606e-f071-4d84-9fee-6495cace1ee8" xlink:to="loc_us-gaap_ProfitLoss_5650e547-3434-474c-b127-24e7f84b6523" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_938601a5-52c4-4f62-b508-852bf651fce4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_874a606e-f071-4d84-9fee-6495cace1ee8" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_938601a5-52c4-4f62-b508-852bf651fce4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_9f8b0161-fda9-4669-8799-dc723729db3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_874a606e-f071-4d84-9fee-6495cace1ee8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_9f8b0161-fda9-4669-8799-dc723729db3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_537acede-1e15-4bf0-8eb9-bede43f99384" xlink:href="mo-20210930.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_874a606e-f071-4d84-9fee-6495cace1ee8" xlink:to="loc_mo_IncomeLossFromEquityInvestments_537acede-1e15-4bf0-8eb9-bede43f99384" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitContributions_496ef44c-5cc9-4d6c-a08c-0edb9ea56ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitContributions"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_874a606e-f071-4d84-9fee-6495cace1ee8" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitContributions_496ef44c-5cc9-4d6c-a08c-0edb9ea56ae7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_20c2343f-22b2-4d00-a2c7-706eef6cc43d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_874a606e-f071-4d84-9fee-6495cace1ee8" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_20c2343f-22b2-4d00-a2c7-706eef6cc43d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_89ba0d25-5339-43b8-933d-c264634dc333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_874a606e-f071-4d84-9fee-6495cace1ee8" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_89ba0d25-5339-43b8-933d-c264634dc333" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_0a6ac12b-0b77-4949-8578-38d9ab1b610e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_874a606e-f071-4d84-9fee-6495cace1ee8" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_0a6ac12b-0b77-4949-8578-38d9ab1b610e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fa0bacd1-e76b-4f65-a07f-39b751a08ced" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_874a606e-f071-4d84-9fee-6495cace1ee8" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fa0bacd1-e76b-4f65-a07f-39b751a08ced" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncreaseDecreaseInSettlementPayable_fafe0b19-a79d-45ec-9777-a57ac972dfa5" xlink:href="mo-20210930.xsd#mo_IncreaseDecreaseInSettlementPayable"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_874a606e-f071-4d84-9fee-6495cace1ee8" xlink:to="loc_mo_IncreaseDecreaseInSettlementPayable_fafe0b19-a79d-45ec-9777-a57ac972dfa5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_f154db43-bfcb-4f1e-9fd4-207ca1b0963d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_874a606e-f071-4d84-9fee-6495cace1ee8" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_f154db43-bfcb-4f1e-9fd4-207ca1b0963d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_29e677c0-cbfe-4e62-8f09-510ecd898600" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_874a606e-f071-4d84-9fee-6495cace1ee8" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_29e677c0-cbfe-4e62-8f09-510ecd898600" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_901190f1-58d9-4c80-9b6f-8a95f365f370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_874a606e-f071-4d84-9fee-6495cace1ee8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_901190f1-58d9-4c80-9b6f-8a95f365f370" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_85fb6110-ed6b-415b-9e44-147d24cc420a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_874a606e-f071-4d84-9fee-6495cace1ee8" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_85fb6110-ed6b-415b-9e44-147d24cc420a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_918daee4-5af7-41ae-b05f-c68c2359f92e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_0c060048-e0d8-47e2-a409-c70286ca569f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_918daee4-5af7-41ae-b05f-c68c2359f92e" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_0c060048-e0d8-47e2-a409-c70286ca569f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_9232f8df-4afa-4859-b9fc-84f064439685" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_918daee4-5af7-41ae-b05f-c68c2359f92e" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_9232f8df-4afa-4859-b9fc-84f064439685" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_7f2b5cc8-87bd-4f41-b350-23f08da175c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_918daee4-5af7-41ae-b05f-c68c2359f92e" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_7f2b5cc8-87bd-4f41-b350-23f08da175c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_8ce89b4a-de4d-471d-8bec-1bbdef992099" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_918daee4-5af7-41ae-b05f-c68c2359f92e" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_8ce89b4a-de4d-471d-8bec-1bbdef992099" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_714ddbd1-e7ad-4f05-8894-0b5e8e6c61dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_918daee4-5af7-41ae-b05f-c68c2359f92e" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_714ddbd1-e7ad-4f05-8894-0b5e8e6c61dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_e4d68b04-aa25-4e4d-b89b-13178a096dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_918daee4-5af7-41ae-b05f-c68c2359f92e" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_e4d68b04-aa25-4e4d-b89b-13178a096dbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_cc4934fb-4bd9-4e1d-b5e9-7700e8b82081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_918daee4-5af7-41ae-b05f-c68c2359f92e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_cc4934fb-4bd9-4e1d-b5e9-7700e8b82081" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_49c94617-d3c2-45ce-9ac6-3280cf850540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_918daee4-5af7-41ae-b05f-c68c2359f92e" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_49c94617-d3c2-45ce-9ac6-3280cf850540" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_c19f8f2c-7612-455a-b338-34d9b0b4d001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_0b552b9a-5c16-4036-858e-09ace2e22dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_c19f8f2c-7612-455a-b338-34d9b0b4d001" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_0b552b9a-5c16-4036-858e-09ace2e22dc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_a05fe5a5-51e9-45de-bc80-8374f3aae9f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_c19f8f2c-7612-455a-b338-34d9b0b4d001" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_a05fe5a5-51e9-45de-bc80-8374f3aae9f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationCurrent_69b6991c-84df-4e4d-a312-a088427aee8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_c19f8f2c-7612-455a-b338-34d9b0b4d001" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationCurrent_69b6991c-84df-4e4d-a312-a088427aee8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_f198da63-1f5c-4631-97e0-461c360fb7ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_c19f8f2c-7612-455a-b338-34d9b0b4d001" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_f198da63-1f5c-4631-97e0-461c360fb7ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross_9bc333e6-6c07-4a6a-9742-386cfe5d7651" xlink:href="mo-20210930.xsd#mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_8c4f533a-285c-4f2e-83ea-efa848d0b3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross_9bc333e6-6c07-4a6a-9742-386cfe5d7651" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_8c4f533a-285c-4f2e-83ea-efa848d0b3e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_8102a1d5-cb9e-4c27-b820-d9a3c9a1cffd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross_9bc333e6-6c07-4a6a-9742-386cfe5d7651" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_8102a1d5-cb9e-4c27-b820-d9a3c9a1cffd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_1000241d-e070-4c1b-a8a0-c2056d98a79d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross_9bc333e6-6c07-4a6a-9742-386cfe5d7651" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_1000241d-e070-4c1b-a8a0-c2056d98a79d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_dc941084-8957-4cc1-bcb8-999fdf713510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross_9bc333e6-6c07-4a6a-9742-386cfe5d7651" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_dc941084-8957-4cc1-bcb8-999fdf713510" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_5af31cd0-85da-402f-92b1-f659353d5b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross_9bc333e6-6c07-4a6a-9742-386cfe5d7651" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_5af31cd0-85da-402f-92b1-f659353d5b6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_0f72b9df-0430-4beb-bfff-94c525297efa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross_9bc333e6-6c07-4a6a-9742-386cfe5d7651" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_0f72b9df-0430-4beb-bfff-94c525297efa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_580aa63a-44e8-4065-bd6f-046a774dda20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve_b7071c35-ccc2-404f-b06e-639594d1c827" xlink:href="mo-20210930.xsd#mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_580aa63a-44e8-4065-bd6f-046a774dda20" xlink:to="loc_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve_b7071c35-ccc2-404f-b06e-639594d1c827" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross_311b76c3-1645-4e95-9ea6-cdd496d327ca" xlink:href="mo-20210930.xsd#mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_580aa63a-44e8-4065-bd6f-046a774dda20" xlink:to="loc_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross_311b76c3-1645-4e95-9ea6-cdd496d327ca" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_bba88c2e-7d6f-44ec-87b6-d4c8022b1bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_55b0ee9e-5d76-4ef3-8776-63b10a2439a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_bba88c2e-7d6f-44ec-87b6-d4c8022b1bc0" xlink:to="loc_us-gaap_EquityMethodInvestments_55b0ee9e-5d76-4ef3-8776-63b10a2439a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityInvestmentFairValueOption_b3b4dd26-6774-4016-b73b-0c22c5fbd9a9" xlink:href="mo-20210930.xsd#mo_EquityInvestmentFairValueOption"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_bba88c2e-7d6f-44ec-87b6-d4c8022b1bc0" xlink:to="loc_mo_EquityInvestmentFairValueOption_b3b4dd26-6774-4016-b73b-0c22c5fbd9a9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_2ba8b61e-4a5d-478e-bceb-e61ac08afda8" xlink:href="mo-20210930.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7be81146-9617-489c-b6cb-a55396758e17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mo_IncomeLossFromEquityInvestments_2ba8b61e-4a5d-478e-bceb-e61ac08afda8" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7be81146-9617-489c-b6cb-a55396758e17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestmentsFairValueOption_3df32449-cd90-444b-aa58-d36352adc62a" xlink:href="mo-20210930.xsd#mo_IncomeLossFromEquityInvestmentsFairValueOption"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mo_IncomeLossFromEquityInvestments_2ba8b61e-4a5d-478e-bceb-e61ac08afda8" xlink:to="loc_mo_IncomeLossFromEquityInvestmentsFairValueOption_3df32449-cd90-444b-aa58-d36352adc62a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_bb61d301-1e4e-49de-95fe-fa42b8dce732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_ba3aa752-3a98-4217-9040-a70a2379587f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_bb61d301-1e4e-49de-95fe-fa42b8dce732" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_ba3aa752-3a98-4217-9040-a70a2379587f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_865508e6-db32-44d2-b72b-ead0174d023a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_bb61d301-1e4e-49de-95fe-fa42b8dce732" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_865508e6-db32-44d2-b72b-ead0174d023a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_59b36df5-cb68-44fb-9595-377f8b3521b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_bb61d301-1e4e-49de-95fe-fa42b8dce732" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_59b36df5-cb68-44fb-9595-377f8b3521b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_1f8b2cd0-870d-414d-9ad1-66232b41813b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_bb61d301-1e4e-49de-95fe-fa42b8dce732" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_1f8b2cd0-870d-414d-9ad1-66232b41813b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_d61d320d-f35b-416c-aedd-0c9c0cf338ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_bb61d301-1e4e-49de-95fe-fa42b8dce732" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_d61d320d-f35b-416c-aedd-0c9c0cf338ea" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/EarningsLossesperShareBasicandDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#EarningsLossesperShareBasicandDilutedEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/EarningsLossesperShareBasicandDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_3589d9ef-5d9c-4141-beef-a4fff7ccc9b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_1e934950-0cac-4b7b-983f-a9c65e6fee73" xlink:href="mo-20210930.xsd#mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_3589d9ef-5d9c-4141-beef-a4fff7ccc9b4" xlink:to="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_1e934950-0cac-4b7b-983f-a9c65e6fee73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fd667840-de35-45ff-9271-67ba777bd5fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_3589d9ef-5d9c-4141-beef-a4fff7ccc9b4" xlink:to="loc_us-gaap_NetIncomeLoss_fd667840-de35-45ff-9271-67ba777bd5fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_77134b03-70f4-420e-b2c6-5c817b7080ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_17b298e6-a589-45f1-99f5-6e8868700da0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_77134b03-70f4-420e-b2c6-5c817b7080ff" xlink:to="loc_us-gaap_NetIncomeLoss_17b298e6-a589-45f1-99f5-6e8868700da0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_49d3d88e-097e-4fc2-a40f-f53aa6995dc7" xlink:href="mo-20210930.xsd#mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_77134b03-70f4-420e-b2c6-5c817b7080ff" xlink:to="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_49d3d88e-097e-4fc2-a40f-f53aa6995dc7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_14ddab91-c45c-4dfa-9a20-e3464a29d007" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_36c09980-cee4-408d-bbc8-7ca4c18ca6af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_14ddab91-c45c-4dfa-9a20-e3464a29d007" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_36c09980-cee4-408d-bbc8-7ca4c18ca6af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_6a9e3c07-877a-4143-8b79-a57f70c17067" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_14ddab91-c45c-4dfa-9a20-e3464a29d007" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_6a9e3c07-877a-4143-8b79-a57f70c17067" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_efd8a769-5408-45a2-bc7c-d4ad3bc3e008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c136ace9-9741-4bfa-a51f-5b257817deb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_efd8a769-5408-45a2-bc7c-d4ad3bc3e008" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c136ace9-9741-4bfa-a51f-5b257817deb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_00c6017a-36a3-4198-9abf-e991ac646d62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_efd8a769-5408-45a2-bc7c-d4ad3bc3e008" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_00c6017a-36a3-4198-9abf-e991ac646d62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_0132efe1-af9e-4c8b-8da8-ab18ce6f03f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_07185944-3fb0-4f40-8d63-e4199b800ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_0132efe1-af9e-4c8b-8da8-ab18ce6f03f1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_07185944-3fb0-4f40-8d63-e4199b800ed8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_3b6a354b-963b-4559-99bf-b9ebcfbded67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_0132efe1-af9e-4c8b-8da8-ab18ce6f03f1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_3b6a354b-963b-4559-99bf-b9ebcfbded67" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#DebtNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6373b01f-cb3a-4ed9-a467-e4f05e4ab7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_e58094f4-3d20-40df-8c36-4b7d89296fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6373b01f-cb3a-4ed9-a467-e4f05e4ab7d3" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_e58094f4-3d20-40df-8c36-4b7d89296fb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_e9ff2c6e-7a29-4ada-89de-6a28288fb509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6373b01f-cb3a-4ed9-a467-e4f05e4ab7d3" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_e9ff2c6e-7a29-4ada-89de-6a28288fb509" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>mo-20210930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:24c66990-7eda-4ddf-9c7a-8f1433627d2e,g:a0baef4b-24ba-4415-bfd0-6e9831a24e17-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.altria.com/role/CoverPage" xlink:type="simple" xlink:href="mo-20210930.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/CoverPage" xlink:type="extended" id="iee48378b76fb478ebf441409dea156ca_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_329f7129-1c86-45cf-a7c5-bcdc10e50685" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_DocumentType_329f7129-1c86-45cf-a7c5-bcdc10e50685" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_1b5a2c85-ff8b-4741-bae5-65b35df020df" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_DocumentQuarterlyReport_1b5a2c85-ff8b-4741-bae5-65b35df020df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_05a56d7c-f1d0-49d3-9a80-b72ac09ab6b2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_DocumentPeriodEndDate_05a56d7c-f1d0-49d3-9a80-b72ac09ab6b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_a9efb436-647c-4788-9bcc-7b57e16cc01a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_DocumentTransitionReport_a9efb436-647c-4788-9bcc-7b57e16cc01a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_38a825b1-9d10-4495-9797-0c40d48b5028" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityFileNumber_38a825b1-9d10-4495-9797-0c40d48b5028" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_d9317cbb-5922-48d9-bf99-59813c16275b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityRegistrantName_d9317cbb-5922-48d9-bf99-59813c16275b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_22fe9762-c736-4645-bbd0-63b86b133297" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_22fe9762-c736-4645-bbd0-63b86b133297" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_9796d6ed-8a68-4cc8-841c-823c99e24cac" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityTaxIdentificationNumber_9796d6ed-8a68-4cc8-841c-823c99e24cac" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_c1753fe8-b9a9-401b-a6e6-926c2093c65a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityAddressAddressLine1_c1753fe8-b9a9-401b-a6e6-926c2093c65a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_6086fc12-5415-45b1-9d99-e679f1d824b0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityAddressCityOrTown_6086fc12-5415-45b1-9d99-e679f1d824b0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_0f942521-2034-4398-b259-cd7a9d32b5fa" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityAddressStateOrProvince_0f942521-2034-4398-b259-cd7a9d32b5fa" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c41ac495-3264-4b26-b93b-afadde11a1a9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityAddressPostalZipCode_c41ac495-3264-4b26-b93b-afadde11a1a9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_d77710e4-c7d7-4a6d-958c-6603c1b289a2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_CityAreaCode_d77710e4-c7d7-4a6d-958c-6603c1b289a2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_e764f40b-96d3-4d78-a3c1-26762b84777a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_LocalPhoneNumber_e764f40b-96d3-4d78-a3c1-26762b84777a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b1c1f43b-85bf-4132-845b-685bc2eb2e67" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_Security12bTitle_b1c1f43b-85bf-4132-845b-685bc2eb2e67" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_db95b271-88c9-4054-b189-60a37310ff95" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_TradingSymbol_db95b271-88c9-4054-b189-60a37310ff95" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_12c39b78-122f-410e-9563-b2a410f90548" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_SecurityExchangeName_12c39b78-122f-410e-9563-b2a410f90548" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_aeb65d7c-d839-43c4-abf3-f58f5366adb7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityCurrentReportingStatus_aeb65d7c-d839-43c4-abf3-f58f5366adb7" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_0adf6968-4e86-4ece-8d9d-17ba8ae8793b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityInteractiveDataCurrent_0adf6968-4e86-4ece-8d9d-17ba8ae8793b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_242542eb-bc4d-4578-85c0-1502c2dae31c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityFilerCategory_242542eb-bc4d-4578-85c0-1502c2dae31c" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_2e50dfe1-f03a-4796-8d69-f132fc001acb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntitySmallBusiness_2e50dfe1-f03a-4796-8d69-f132fc001acb" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_9a8fbede-c7c6-4e21-b16f-369a918e7057" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityEmergingGrowthCompany_9a8fbede-c7c6-4e21-b16f-369a918e7057" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_e9f0fd74-e091-4723-a0e1-66aa4ebfbc1d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityShellCompany_e9f0fd74-e091-4723-a0e1-66aa4ebfbc1d" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_15b265c3-d0b3-4696-b9e7-26bb8d7e9a35" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_15b265c3-d0b3-4696-b9e7-26bb8d7e9a35" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_53162efe-aa9f-4cf1-a2b0-e88f9d73303b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_AmendmentFlag_53162efe-aa9f-4cf1-a2b0-e88f9d73303b" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_86390ed0-9a4e-4cf9-a909-5d809ac72e54" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_DocumentFiscalYearFocus_86390ed0-9a4e-4cf9-a909-5d809ac72e54" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_72f79eed-c88c-4b73-8139-b105ce2ac7fd" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_DocumentFiscalPeriodFocus_72f79eed-c88c-4b73-8139-b105ce2ac7fd" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_6699deb0-77ec-4ce4-ba87-6782150d02db" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityCentralIndexKey_6699deb0-77ec-4ce4-ba87-6782150d02db" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_95bb43c7-f4fb-44aa-abe4-5a367f79eb2e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_CurrentFiscalYearEndDate_95bb43c7-f4fb-44aa-abe4-5a367f79eb2e" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_4fd7e37f-2ca5-4908-a4fc-b0dd5873560e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntitiesTable_4fd7e37f-2ca5-4908-a4fc-b0dd5873560e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_9ac55477-eacc-4f08-8b2e-fbafe7147709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_4fd7e37f-2ca5-4908-a4fc-b0dd5873560e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_9ac55477-eacc-4f08-8b2e-fbafe7147709" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9ac55477-eacc-4f08-8b2e-fbafe7147709_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9ac55477-eacc-4f08-8b2e-fbafe7147709" xlink:to="loc_us-gaap_ClassOfStockDomain_9ac55477-eacc-4f08-8b2e-fbafe7147709_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9944ce23-d0c8-43a9-a39d-24e040aeeaac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9ac55477-eacc-4f08-8b2e-fbafe7147709" xlink:to="loc_us-gaap_ClassOfStockDomain_9944ce23-d0c8-43a9-a39d-24e040aeeaac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock0.3313ParValueMember_a296706e-7129-4d4c-9683-6c2cac996ee0" xlink:href="mo-20210930.xsd#mo_CommonStock0.3313ParValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9944ce23-d0c8-43a9-a39d-24e040aeeaac" xlink:to="loc_mo_CommonStock0.3313ParValueMember_a296706e-7129-4d4c-9683-6c2cac996ee0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock1.000NotesDue2023Member_51236545-3cdb-4ad0-a5d5-b46ad2471523" xlink:href="mo-20210930.xsd#mo_CommonStock1.000NotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9944ce23-d0c8-43a9-a39d-24e040aeeaac" xlink:to="loc_mo_CommonStock1.000NotesDue2023Member_51236545-3cdb-4ad0-a5d5-b46ad2471523" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock1.700NotesDue2025Member_d214c695-75f3-4d5b-b34d-a21bc51054a7" xlink:href="mo-20210930.xsd#mo_CommonStock1.700NotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9944ce23-d0c8-43a9-a39d-24e040aeeaac" xlink:to="loc_mo_CommonStock1.700NotesDue2025Member_d214c695-75f3-4d5b-b34d-a21bc51054a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock2.200NotesDue2027Member_f45cf0f9-92c9-4ed2-a5f5-43ca26c1c56a" xlink:href="mo-20210930.xsd#mo_CommonStock2.200NotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9944ce23-d0c8-43a9-a39d-24e040aeeaac" xlink:to="loc_mo_CommonStock2.200NotesDue2027Member_f45cf0f9-92c9-4ed2-a5f5-43ca26c1c56a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock3.125NotesDue2031Member_8940cec7-53e2-42ef-897d-dc96e9ac1e68" xlink:href="mo-20210930.xsd#mo_CommonStock3.125NotesDue2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9944ce23-d0c8-43a9-a39d-24e040aeeaac" xlink:to="loc_mo_CommonStock3.125NotesDue2031Member_8940cec7-53e2-42ef-897d-dc96e9ac1e68" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity" xlink:type="simple" xlink:href="mo-20210930.xsd#CondensedConsolidatedStatementsofStockholdersDeficitEquity"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity" xlink:type="extended" id="ide4517d06ccb49c0974a3cd903b6e32d_CondensedConsolidatedStatementsofStockholdersDeficitEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f68a7e75-65b3-4d85-b22e-a97678ccee23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_64146132-2af0-4a47-942f-0fa81eb29f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f68a7e75-65b3-4d85-b22e-a97678ccee23" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_64146132-2af0-4a47-942f-0fa81eb29f7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9cfacc31-0c76-4602-952b-49a6571856f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_64146132-2af0-4a47-942f-0fa81eb29f7a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9cfacc31-0c76-4602-952b-49a6571856f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_22708bc5-f109-4609-84e7-2d67ad52c9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_64146132-2af0-4a47-942f-0fa81eb29f7a" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_22708bc5-f109-4609-84e7-2d67ad52c9b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d1fe4340-9a6e-42e5-81b0-c4192ae983b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_64146132-2af0-4a47-942f-0fa81eb29f7a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d1fe4340-9a6e-42e5-81b0-c4192ae983b4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_f5fc20d5-403d-49ca-9b00-d024166833b1" xlink:href="mo-20210930.xsd#mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_64146132-2af0-4a47-942f-0fa81eb29f7a" xlink:to="loc_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_f5fc20d5-403d-49ca-9b00-d024166833b1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_892cb0bf-af5e-4138-b93f-36526e820b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_64146132-2af0-4a47-942f-0fa81eb29f7a" xlink:to="loc_us-gaap_DividendsCommonStockCash_892cb0bf-af5e-4138-b93f-36526e820b0b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_39281094-acde-4ed1-9764-bf6471d940b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_64146132-2af0-4a47-942f-0fa81eb29f7a" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_39281094-acde-4ed1-9764-bf6471d940b7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_d4095ad5-82cf-4da7-b603-132033cbce24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_64146132-2af0-4a47-942f-0fa81eb29f7a" xlink:to="loc_us-gaap_StockholdersEquityOther_d4095ad5-82cf-4da7-b603-132033cbce24" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_98b6526e-77e1-4c48-8e6e-fd3c100b88fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ce180e61-84db-4c38-a6db-6426f648fbce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f68a7e75-65b3-4d85-b22e-a97678ccee23" xlink:to="loc_us-gaap_StatementTable_ce180e61-84db-4c38-a6db-6426f648fbce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_627d7184-d9fc-49b5-a606-253b8f051ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ce180e61-84db-4c38-a6db-6426f648fbce" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_627d7184-d9fc-49b5-a606-253b8f051ce8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_627d7184-d9fc-49b5-a606-253b8f051ce8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_627d7184-d9fc-49b5-a606-253b8f051ce8" xlink:to="loc_us-gaap_EquityComponentDomain_627d7184-d9fc-49b5-a606-253b8f051ce8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_917ba78b-78a9-4612-a62c-070278e399d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_627d7184-d9fc-49b5-a606-253b8f051ce8" xlink:to="loc_us-gaap_EquityComponentDomain_917ba78b-78a9-4612-a62c-070278e399d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b2758cae-24de-4b5f-b528-80d39486049d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_917ba78b-78a9-4612-a62c-070278e399d4" xlink:to="loc_us-gaap_CommonStockMember_b2758cae-24de-4b5f-b528-80d39486049d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_84550931-c878-4924-a181-648733f92476" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_917ba78b-78a9-4612-a62c-070278e399d4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_84550931-c878-4924-a181-648733f92476" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_1f0b94b9-b081-4227-928e-404622a1a7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_917ba78b-78a9-4612-a62c-070278e399d4" xlink:to="loc_us-gaap_RetainedEarningsMember_1f0b94b9-b081-4227-928e-404622a1a7cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d3dc5212-167c-4257-881f-2d070d36198d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_917ba78b-78a9-4612-a62c-070278e399d4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d3dc5212-167c-4257-881f-2d070d36198d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_0fb1e486-18b4-49c0-84f3-8a9ec1d56d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_917ba78b-78a9-4612-a62c-070278e399d4" xlink:to="loc_us-gaap_TreasuryStockMember_0fb1e486-18b4-49c0-84f3-8a9ec1d56d8e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_03c7b67f-d271-4949-8f2d-c5b3a9667ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_917ba78b-78a9-4612-a62c-070278e399d4" xlink:to="loc_us-gaap_NoncontrollingInterestMember_03c7b67f-d271-4949-8f2d-c5b3a9667ed7" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#BackgroundandBasisofPresentationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails" xlink:type="extended" id="i684483cc9ebc4035bb98363a2d942544_BackgroundandBasisofPresentationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_4c5c7582-894a-4a1d-b61f-3a2377f4a65f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_4c5c7582-894a-4a1d-b61f-3a2377f4a65f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NoncontrollingInterestRemainingInterestPurchasedByParent_0b52f924-c974-4818-a1a8-19c9b4335d6d" xlink:href="mo-20210930.xsd#mo_NoncontrollingInterestRemainingInterestPurchasedByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:to="loc_mo_NoncontrollingInterestRemainingInterestPurchasedByParent_0b52f924-c974-4818-a1a8-19c9b4335d6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_f1e3f565-1618-4a21-a213-3a8fc906e52c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:to="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_f1e3f565-1618-4a21-a213-3a8fc906e52c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStockDividendIncreasePercentage_e463d01f-5e32-4e66-aaad-e63a9eddcdc5" xlink:href="mo-20210930.xsd#mo_CommonStockDividendIncreasePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:to="loc_mo_CommonStockDividendIncreasePercentage_e463d01f-5e32-4e66-aaad-e63a9eddcdc5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_1ff344b5-8a09-404a-b7b6-a67024665a51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_1ff344b5-8a09-404a-b7b6-a67024665a51" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStockDividendRateAnnualPerShare_4c384652-581b-419c-b074-6ffec4c22067" xlink:href="mo-20210930.xsd#mo_CommonStockDividendRateAnnualPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:to="loc_mo_CommonStockDividendRateAnnualPerShare_4c384652-581b-419c-b074-6ffec4c22067" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_8d1fff13-0bfe-46a0-a35c-4aca7e39e16d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_8d1fff13-0bfe-46a0-a35c-4aca7e39e16d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount_0700b317-2b73-45f2-8f7d-5ead00b0b700" xlink:href="mo-20210930.xsd#mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:to="loc_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount_0700b317-2b73-45f2-8f7d-5ead00b0b700" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_1bebefd1-3441-49aa-8f88-cd9f22b47050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_1bebefd1-3441-49aa-8f88-cd9f22b47050" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_6034101d-700e-4be5-84e2-b61e1bc8612a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_6034101d-700e-4be5-84e2-b61e1bc8612a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_StockRepurchaseProgramIncreaseAuthorizedAmount_ece58050-b9a7-4f24-bf41-cabea0d9967d" xlink:href="mo-20210930.xsd#mo_StockRepurchaseProgramIncreaseAuthorizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:to="loc_mo_StockRepurchaseProgramIncreaseAuthorizedAmount_ece58050-b9a7-4f24-bf41-cabea0d9967d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_d6f159ec-6216-47b7-8a26-cfc65e00c3f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_d6f159ec-6216-47b7-8a26-cfc65e00c3f0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_220e78b1-2677-4502-8b7e-a9c29afef675" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_d6f159ec-6216-47b7-8a26-cfc65e00c3f0" xlink:to="loc_srt_OwnershipAxis_220e78b1-2677-4502-8b7e-a9c29afef675" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_220e78b1-2677-4502-8b7e-a9c29afef675_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_220e78b1-2677-4502-8b7e-a9c29afef675" xlink:to="loc_srt_OwnershipDomain_220e78b1-2677-4502-8b7e-a9c29afef675_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_f527d43c-f6eb-4fa7-aeba-804253bdda3f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_220e78b1-2677-4502-8b7e-a9c29afef675" xlink:to="loc_srt_OwnershipDomain_f527d43c-f6eb-4fa7-aeba-804253bdda3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HelixInnovationsLLCMember_8af49b99-1f9a-4b6b-9042-9166258d9065" xlink:href="mo-20210930.xsd#mo_HelixInnovationsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_f527d43c-f6eb-4fa7-aeba-804253bdda3f" xlink:to="loc_mo_HelixInnovationsLLCMember_8af49b99-1f9a-4b6b-9042-9166258d9065" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_fb39038e-1d3d-4565-9c18-80e18d81537b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_d6f159ec-6216-47b7-8a26-cfc65e00c3f0" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_fb39038e-1d3d-4565-9c18-80e18d81537b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_fb39038e-1d3d-4565-9c18-80e18d81537b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_fb39038e-1d3d-4565-9c18-80e18d81537b" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_fb39038e-1d3d-4565-9c18-80e18d81537b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_5aaa2b2f-0a25-4ec0-ba79-05624a4fc8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_fb39038e-1d3d-4565-9c18-80e18d81537b" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_5aaa2b2f-0a25-4ec0-ba79-05624a4fc8e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_July2019ShareRepurchaseProgramMember_4f560f62-a2f2-4702-b4a6-8f5328c8f9d0" xlink:href="mo-20210930.xsd#mo_July2019ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_5aaa2b2f-0a25-4ec0-ba79-05624a4fc8e6" xlink:to="loc_mo_July2019ShareRepurchaseProgramMember_4f560f62-a2f2-4702-b4a6-8f5328c8f9d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_January2021ShareRepurchaseProgramMember_a00f9dd3-a32f-45d7-858e-98dc18ee9979" xlink:href="mo-20210930.xsd#mo_January2021ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_5aaa2b2f-0a25-4ec0-ba79-05624a4fc8e6" xlink:to="loc_mo_January2021ShareRepurchaseProgramMember_a00f9dd3-a32f-45d7-858e-98dc18ee9979" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_97cb1f9c-2730-42cc-ab89-6421eea474ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_d6f159ec-6216-47b7-8a26-cfc65e00c3f0" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_97cb1f9c-2730-42cc-ab89-6421eea474ef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_97cb1f9c-2730-42cc-ab89-6421eea474ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_97cb1f9c-2730-42cc-ab89-6421eea474ef" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_97cb1f9c-2730-42cc-ab89-6421eea474ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_cfb6e950-34a3-46bb-97c1-08cf6457428e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_97cb1f9c-2730-42cc-ab89-6421eea474ef" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_cfb6e950-34a3-46bb-97c1-08cf6457428e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d89da509-e86c-459f-b669-ca8d66107db5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_cfb6e950-34a3-46bb-97c1-08cf6457428e" xlink:to="loc_us-gaap_SubsequentEventMember_d89da509-e86c-459f-b669-ca8d66107db5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#BackgroundandBasisofPresentationShareRepurchaseTableDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails" xlink:type="extended" id="ieaacac09eb88472094dc437cfdb14a1a_BackgroundandBasisofPresentationShareRepurchaseTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ee44fb1b-fb24-40b0-bed0-f8c93821f699" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_dd8a683c-4c90-4560-a317-6cafe356ce39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ee44fb1b-fb24-40b0-bed0-f8c93821f699" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_dd8a683c-4c90-4560-a317-6cafe356ce39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_0a2eca23-745d-4cbc-9333-5c078ea0cd07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ee44fb1b-fb24-40b0-bed0-f8c93821f699" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_0a2eca23-745d-4cbc-9333-5c078ea0cd07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_f36d52a4-665c-4127-9934-f17332de2865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ee44fb1b-fb24-40b0-bed0-f8c93821f699" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_f36d52a4-665c-4127-9934-f17332de2865" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_e5b50307-2a00-4b28-9af8-8e959d2bfd7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ee44fb1b-fb24-40b0-bed0-f8c93821f699" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_e5b50307-2a00-4b28-9af8-8e959d2bfd7f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_f25a676f-a474-4191-b27a-7df9638fa6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_e5b50307-2a00-4b28-9af8-8e959d2bfd7f" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_f25a676f-a474-4191-b27a-7df9638fa6c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_f25a676f-a474-4191-b27a-7df9638fa6c9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_f25a676f-a474-4191-b27a-7df9638fa6c9" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_f25a676f-a474-4191-b27a-7df9638fa6c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_6577aa09-32b7-4d54-87b3-b4d3a1328b41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_f25a676f-a474-4191-b27a-7df9638fa6c9" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_6577aa09-32b7-4d54-87b3-b4d3a1328b41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_January2021ShareRepurchaseProgramMember_09c610db-f08f-45ff-9300-3d959e12f379" xlink:href="mo-20210930.xsd#mo_January2021ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_6577aa09-32b7-4d54-87b3-b4d3a1328b41" xlink:to="loc_mo_January2021ShareRepurchaseProgramMember_09c610db-f08f-45ff-9300-3d959e12f379" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#RevenuesfromContractswithCustomersNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails" xlink:type="extended" id="ia135efafac1540f1b4ae49d1675e10bb_RevenuesfromContractswithCustomersNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cf994d57-d51a-49c6-ba38-793bdbc9bce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_165cce3e-8a43-4abd-8cba-632934242dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cf994d57-d51a-49c6-ba38-793bdbc9bce7" xlink:to="loc_us-gaap_ContractWithCustomerLiability_165cce3e-8a43-4abd-8cba-632934242dc9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_c618d85c-9f98-4fd5-a8a9-42aed672bbd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfTiming"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cf994d57-d51a-49c6-ba38-793bdbc9bce7" xlink:to="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_c618d85c-9f98-4fd5-a8a9-42aed672bbd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ReceivablesNetCurrentIncludingAssetsHeldForSale_4499c44d-9c49-4830-8672-769a4090c971" xlink:href="mo-20210930.xsd#mo_ReceivablesNetCurrentIncludingAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cf994d57-d51a-49c6-ba38-793bdbc9bce7" xlink:to="loc_mo_ReceivablesNetCurrentIncludingAssetsHeldForSale_4499c44d-9c49-4830-8672-769a4090c971" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_736d020e-391c-4863-8d32-f6db7705e6a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cf994d57-d51a-49c6-ba38-793bdbc9bce7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_736d020e-391c-4863-8d32-f6db7705e6a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_9b8d7555-a8d3-4fc2-a36c-1c203d0865e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cf994d57-d51a-49c6-ba38-793bdbc9bce7" xlink:to="loc_us-gaap_ReceivablesNetCurrent_9b8d7555-a8d3-4fc2-a36c-1c203d0865e4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_983eb87f-6be5-44e5-9cdc-7e8aa4ab6d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cf994d57-d51a-49c6-ba38-793bdbc9bce7" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_983eb87f-6be5-44e5-9cdc-7e8aa4ab6d2c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_4f7c937a-a43e-482f-9291-d235a412d4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cf994d57-d51a-49c6-ba38-793bdbc9bce7" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_4f7c937a-a43e-482f-9291-d235a412d4a9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_ea58c2ed-1690-49af-b540-d6cc78539b05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_4f7c937a-a43e-482f-9291-d235a412d4a9" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_ea58c2ed-1690-49af-b540-d6cc78539b05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_ea58c2ed-1690-49af-b540-d6cc78539b05_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_ea58c2ed-1690-49af-b540-d6cc78539b05" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_ea58c2ed-1690-49af-b540-d6cc78539b05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_cc472085-beb9-487d-8ef6-eb273363c304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_ea58c2ed-1690-49af-b540-d6cc78539b05" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_cc472085-beb9-487d-8ef6-eb273363c304" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_57c02cfb-bca8-4ce0-9216-9af66776b1c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_cc472085-beb9-487d-8ef6-eb273363c304" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_57c02cfb-bca8-4ce0-9216-9af66776b1c9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#AssetsHeldforSaleNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails" xlink:type="extended" id="iaff92a724b364ec1b068489a2ba4b254_AssetsHeldforSaleNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a13ca168-430c-4d31-8b0c-13bafeb857c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_ea617b4c-7a2b-47c3-b696-ee8e4c311556" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a13ca168-430c-4d31-8b0c-13bafeb857c4" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_ea617b4c-7a2b-47c3-b696-ee8e4c311556" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_1118f9fd-5781-418f-9ddc-0c841a3ee56b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a13ca168-430c-4d31-8b0c-13bafeb857c4" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_1118f9fd-5781-418f-9ddc-0c841a3ee56b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts_6b8d48c7-4f3f-4439-b492-8a61b226d98d" xlink:href="mo-20210930.xsd#mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a13ca168-430c-4d31-8b0c-13bafeb857c4" xlink:to="loc_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts_6b8d48c7-4f3f-4439-b492-8a61b226d98d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts_eef90762-2c67-4611-8224-5c670dadb5e1" xlink:href="mo-20210930.xsd#mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a13ca168-430c-4d31-8b0c-13bafeb857c4" xlink:to="loc_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts_eef90762-2c67-4611-8224-5c670dadb5e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_4e9a77dc-433a-43d7-beab-5ad995df1e97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a13ca168-430c-4d31-8b0c-13bafeb857c4" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_4e9a77dc-433a-43d7-beab-5ad995df1e97" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_aed127bc-402e-4028-b684-5169d1049043" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a13ca168-430c-4d31-8b0c-13bafeb857c4" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_aed127bc-402e-4028-b684-5169d1049043" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c97a7442-48ba-4fa2-b8bb-72f4c4415b69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_aed127bc-402e-4028-b684-5169d1049043" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c97a7442-48ba-4fa2-b8bb-72f4c4415b69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c97a7442-48ba-4fa2-b8bb-72f4c4415b69_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c97a7442-48ba-4fa2-b8bb-72f4c4415b69" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c97a7442-48ba-4fa2-b8bb-72f4c4415b69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d99d3968-b907-4474-9bc7-3ded533e2b43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c97a7442-48ba-4fa2-b8bb-72f4c4415b69" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d99d3968-b907-4474-9bc7-3ded533e2b43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SteMichelleTransactionsMember_a711b2f2-1762-44e9-a3b0-f4cebd760dac" xlink:href="mo-20210930.xsd#mo_SteMichelleTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d99d3968-b907-4474-9bc7-3ded533e2b43" xlink:to="loc_mo_SteMichelleTransactionsMember_a711b2f2-1762-44e9-a3b0-f4cebd760dac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SteMichelleTransactionMember_10d10528-92d5-4baa-ae50-48d6f08e203a" xlink:href="mo-20210930.xsd#mo_SteMichelleTransactionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d99d3968-b907-4474-9bc7-3ded533e2b43" xlink:to="loc_mo_SteMichelleTransactionMember_10d10528-92d5-4baa-ae50-48d6f08e203a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_f42a1433-5529-4ad8-a0ce-4c9f595924f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_aed127bc-402e-4028-b684-5169d1049043" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_f42a1433-5529-4ad8-a0ce-4c9f595924f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_f42a1433-5529-4ad8-a0ce-4c9f595924f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_f42a1433-5529-4ad8-a0ce-4c9f595924f6" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_f42a1433-5529-4ad8-a0ce-4c9f595924f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e2c839a5-75b7-454f-86b6-7e95d9ce6382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_f42a1433-5529-4ad8-a0ce-4c9f595924f6" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e2c839a5-75b7-454f-86b6-7e95d9ce6382" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_78a269d8-1ebb-444a-8109-f3b2b89e8527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_e2c839a5-75b7-454f-86b6-7e95d9ce6382" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_78a269d8-1ebb-444a-8109-f3b2b89e8527" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_db3d3f7a-3200-44f3-870c-ab1868241853" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_aed127bc-402e-4028-b684-5169d1049043" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_db3d3f7a-3200-44f3-870c-ab1868241853" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_db3d3f7a-3200-44f3-870c-ab1868241853_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_db3d3f7a-3200-44f3-870c-ab1868241853" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_db3d3f7a-3200-44f3-870c-ab1868241853_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_25b82337-442d-4508-bc82-8be962b268d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_db3d3f7a-3200-44f3-870c-ab1868241853" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_25b82337-442d-4508-bc82-8be962b268d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SteMichelleTransactionsMember_49b24401-91a6-467d-9c06-7459042321c2" xlink:href="mo-20210930.xsd#mo_SteMichelleTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_25b82337-442d-4508-bc82-8be962b268d5" xlink:to="loc_mo_SteMichelleTransactionsMember_49b24401-91a6-467d-9c06-7459042321c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SteMichelleTransactionMember_07d5c7b5-2068-4189-9e14-89c6bbed1457" xlink:href="mo-20210930.xsd#mo_SteMichelleTransactionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_25b82337-442d-4508-bc82-8be962b268d5" xlink:to="loc_mo_SteMichelleTransactionMember_07d5c7b5-2068-4189-9e14-89c6bbed1457" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_8d89dbbc-da73-48bb-9611-707cc85d7a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_aed127bc-402e-4028-b684-5169d1049043" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_8d89dbbc-da73-48bb-9611-707cc85d7a1e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8d89dbbc-da73-48bb-9611-707cc85d7a1e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8d89dbbc-da73-48bb-9611-707cc85d7a1e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8d89dbbc-da73-48bb-9611-707cc85d7a1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e52ebe95-4016-4679-91f4-f888bfd69b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8d89dbbc-da73-48bb-9611-707cc85d7a1e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e52ebe95-4016-4679-91f4-f888bfd69b5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_55724be9-6967-47a0-9678-f3e8f0936cde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_e52ebe95-4016-4679-91f4-f888bfd69b5d" xlink:to="loc_us-gaap_SubsequentEventMember_55724be9-6967-47a0-9678-f3e8f0936cde" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ab23d828-6bb5-4d37-b73b-4fb4c36eb959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_aed127bc-402e-4028-b684-5169d1049043" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ab23d828-6bb5-4d37-b73b-4fb4c36eb959" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ab23d828-6bb5-4d37-b73b-4fb4c36eb959_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ab23d828-6bb5-4d37-b73b-4fb4c36eb959" xlink:to="loc_us-gaap_SegmentDomain_ab23d828-6bb5-4d37-b73b-4fb4c36eb959_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9d8f66c5-6277-4a67-8c5e-89d64f665984" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ab23d828-6bb5-4d37-b73b-4fb4c36eb959" xlink:to="loc_us-gaap_SegmentDomain_9d8f66c5-6277-4a67-8c5e-89d64f665984" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineSegmentMember_4658df3a-3a19-4854-b5f0-637922b757e5" xlink:href="mo-20210930.xsd#mo_WineSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9d8f66c5-6277-4a67-8c5e-89d64f665984" xlink:to="loc_mo_WineSegmentMember_4658df3a-3a19-4854-b5f0-637922b757e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_813e1059-3931-4bee-a849-80f053e3da94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_aed127bc-402e-4028-b684-5169d1049043" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_813e1059-3931-4bee-a849-80f053e3da94" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_813e1059-3931-4bee-a849-80f053e3da94_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_813e1059-3931-4bee-a849-80f053e3da94" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_813e1059-3931-4bee-a849-80f053e3da94_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_53c59d25-3f71-44a7-81e3-6eba51fcf6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_813e1059-3931-4bee-a849-80f053e3da94" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_53c59d25-3f71-44a7-81e3-6eba51fcf6d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarketingAdministrationAndResearchCostsMember_95a73736-35e4-4a4c-b2f8-1e99868d097a" xlink:href="mo-20210930.xsd#mo_MarketingAdministrationAndResearchCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_53c59d25-3f71-44a7-81e3-6eba51fcf6d3" xlink:to="loc_mo_MarketingAdministrationAndResearchCostsMember_95a73736-35e4-4a4c-b2f8-1e99868d097a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails" xlink:type="extended" id="i78d52ff5061b475487a7d8b612e310bb_AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_975bb01a-61b5-4456-984b-e15dad97cd88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bae6a33d-71b5-45d5-b2a2-a58437597e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_975bb01a-61b5-4456-984b-e15dad97cd88" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bae6a33d-71b5-45d5-b2a2-a58437597e3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_baafed3c-1b56-4c23-9262-06573c7b1ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bae6a33d-71b5-45d5-b2a2-a58437597e3d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_baafed3c-1b56-4c23-9262-06573c7b1ccf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_0a970775-379d-4df4-8ab3-0012e5113fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bae6a33d-71b5-45d5-b2a2-a58437597e3d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_0a970775-379d-4df4-8ab3-0012e5113fa3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_e7888b49-e53b-48ac-bf9b-0dbc5e0cd7ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bae6a33d-71b5-45d5-b2a2-a58437597e3d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_e7888b49-e53b-48ac-bf9b-0dbc5e0cd7ff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_54d065a6-c2fa-4f01-a0a9-4f36b1249ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bae6a33d-71b5-45d5-b2a2-a58437597e3d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_54d065a6-c2fa-4f01-a0a9-4f36b1249ad3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_21918bab-ad7f-4f89-92cc-7eb5c4597557" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bae6a33d-71b5-45d5-b2a2-a58437597e3d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_21918bab-ad7f-4f89-92cc-7eb5c4597557" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_55e400ce-8319-4c71-8268-c5f9273283cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bae6a33d-71b5-45d5-b2a2-a58437597e3d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_55e400ce-8319-4c71-8268-c5f9273283cd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross_f8f771ea-9ec5-4e04-9d72-e6041ab46fae" xlink:href="mo-20210930.xsd#mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bae6a33d-71b5-45d5-b2a2-a58437597e3d" xlink:to="loc_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross_f8f771ea-9ec5-4e04-9d72-e6041ab46fae" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve_81d1775f-7355-43a7-8b88-1d66010e5b25" xlink:href="mo-20210930.xsd#mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bae6a33d-71b5-45d5-b2a2-a58437597e3d" xlink:to="loc_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve_81d1775f-7355-43a7-8b88-1d66010e5b25" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_89db3df4-6f53-4e26-a3b8-7d22938d318c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bae6a33d-71b5-45d5-b2a2-a58437597e3d" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_89db3df4-6f53-4e26-a3b8-7d22938d318c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_43a965ec-4559-4da0-9adc-0bbf6aa5225e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_975bb01a-61b5-4456-984b-e15dad97cd88" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_43a965ec-4559-4da0-9adc-0bbf6aa5225e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_4ecb1c14-0e07-49a8-87cb-c3ca0e1506e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_43a965ec-4559-4da0-9adc-0bbf6aa5225e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_4ecb1c14-0e07-49a8-87cb-c3ca0e1506e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_79ef9404-4ccb-4e69-9866-978aa6e66619" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_43a965ec-4559-4da0-9adc-0bbf6aa5225e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_79ef9404-4ccb-4e69-9866-978aa6e66619" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationCurrent_0b619a0e-0e35-43c0-a571-a8406d5c7140" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_43a965ec-4559-4da0-9adc-0bbf6aa5225e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationCurrent_0b619a0e-0e35-43c0-a571-a8406d5c7140" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_0ea78b15-88c7-4793-88db-060a46faa66a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_43a965ec-4559-4da0-9adc-0bbf6aa5225e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_0ea78b15-88c7-4793-88db-060a46faa66a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_44d46e0d-690b-439c-92b0-eeee6da21775" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_43a965ec-4559-4da0-9adc-0bbf6aa5225e" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_44d46e0d-690b-439c-92b0-eeee6da21775" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_c2f2762a-7c88-424f-bc3a-93ef9fd94047" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_975bb01a-61b5-4456-984b-e15dad97cd88" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_c2f2762a-7c88-424f-bc3a-93ef9fd94047" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6ff82903-0042-4367-bd0c-3c0e8256a38a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_975bb01a-61b5-4456-984b-e15dad97cd88" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6ff82903-0042-4367-bd0c-3c0e8256a38a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_35b474e3-0917-4696-9775-696e4c7d90a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6ff82903-0042-4367-bd0c-3c0e8256a38a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_35b474e3-0917-4696-9775-696e4c7d90a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_35b474e3-0917-4696-9775-696e4c7d90a4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_35b474e3-0917-4696-9775-696e4c7d90a4" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_35b474e3-0917-4696-9775-696e4c7d90a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c8620948-f52b-4181-9510-fcfd27905b25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_35b474e3-0917-4696-9775-696e4c7d90a4" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c8620948-f52b-4181-9510-fcfd27905b25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SteMichelleTransactionsMember_bc483a45-6bac-41c7-8d47-864b44364d7d" xlink:href="mo-20210930.xsd#mo_SteMichelleTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c8620948-f52b-4181-9510-fcfd27905b25" xlink:to="loc_mo_SteMichelleTransactionsMember_bc483a45-6bac-41c7-8d47-864b44364d7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_1f799b03-afaf-4779-9fc8-bb25c31ec21d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6ff82903-0042-4367-bd0c-3c0e8256a38a" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_1f799b03-afaf-4779-9fc8-bb25c31ec21d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_1f799b03-afaf-4779-9fc8-bb25c31ec21d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1f799b03-afaf-4779-9fc8-bb25c31ec21d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_1f799b03-afaf-4779-9fc8-bb25c31ec21d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_553b8385-9060-4a14-87b5-e840acb818ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1f799b03-afaf-4779-9fc8-bb25c31ec21d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_553b8385-9060-4a14-87b5-e840acb818ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_c0a7bb59-4304-4df3-a451-9d580948ae4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_553b8385-9060-4a14-87b5-e840acb818ad" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_c0a7bb59-4304-4df3-a451-9d580948ae4a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" xlink:type="extended" id="i1e3369c532a845e697dbdced58bcb2b0_InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_eb559e1c-ff3d-4cf8-9314-9ecfb1b34b52" xlink:href="mo-20210930.xsd#mo_InvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_ab22b25c-6230-46f2-922e-aaf1389fe9de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_eb559e1c-ff3d-4cf8-9314-9ecfb1b34b52" xlink:to="loc_us-gaap_EquityMethodInvestments_ab22b25c-6230-46f2-922e-aaf1389fe9de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityInvestmentFairValueOption_f69efb34-6474-4ca8-871a-20dcf9fc3f1f" xlink:href="mo-20210930.xsd#mo_EquityInvestmentFairValueOption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_eb559e1c-ff3d-4cf8-9314-9ecfb1b34b52" xlink:to="loc_mo_EquityInvestmentFairValueOption_f69efb34-6474-4ca8-871a-20dcf9fc3f1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_2beb2bea-2146-4bc6-84c6-c61a7fa9399b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_eb559e1c-ff3d-4cf8-9314-9ecfb1b34b52" xlink:to="loc_us-gaap_Investments_2beb2bea-2146-4bc6-84c6-c61a7fa9399b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_47229f50-337f-4f04-a05b-34f84973df7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_eb559e1c-ff3d-4cf8-9314-9ecfb1b34b52" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_47229f50-337f-4f04-a05b-34f84973df7c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_a5ec62f8-090c-41fb-90b1-0189bfa1fec4" xlink:href="mo-20210930.xsd#mo_InvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mo_InvestmentsLineItems_eb559e1c-ff3d-4cf8-9314-9ecfb1b34b52" xlink:to="loc_mo_InvestmentsTable_a5ec62f8-090c-41fb-90b1-0189bfa1fec4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_96997db7-5434-464b-969c-3861ee994535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_a5ec62f8-090c-41fb-90b1-0189bfa1fec4" xlink:to="loc_us-gaap_FinancialInstrumentAxis_96997db7-5434-464b-969c-3861ee994535" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_96997db7-5434-464b-969c-3861ee994535_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_96997db7-5434-464b-969c-3861ee994535" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_96997db7-5434-464b-969c-3861ee994535_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2b995ea6-2ddf-4d43-adc5-0d133b6e5e24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_96997db7-5434-464b-969c-3861ee994535" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2b995ea6-2ddf-4d43-adc5-0d133b6e5e24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_28c68789-26bf-410d-8f31-efd8db905a30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2b995ea6-2ddf-4d43-adc5-0d133b6e5e24" xlink:to="loc_us-gaap_CommonStockMember_28c68789-26bf-410d-8f31-efd8db905a30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_44ab6406-dcdf-4b6b-819c-ca8f217580be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_a5ec62f8-090c-41fb-90b1-0189bfa1fec4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_44ab6406-dcdf-4b6b-819c-ca8f217580be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_44ab6406-dcdf-4b6b-819c-ca8f217580be_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_44ab6406-dcdf-4b6b-819c-ca8f217580be" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_44ab6406-dcdf-4b6b-819c-ca8f217580be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3893af27-ed23-4665-801d-56d97a00fe86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_44ab6406-dcdf-4b6b-819c-ca8f217580be" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3893af27-ed23-4665-801d-56d97a00fe86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_68093dcd-ba5b-466b-934a-a47fa3b3fa1d" xlink:href="mo-20210930.xsd#mo_EquityContractWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3893af27-ed23-4665-801d-56d97a00fe86" xlink:to="loc_mo_EquityContractWarrantMember_68093dcd-ba5b-466b-934a-a47fa3b3fa1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_76e94f36-f8db-464e-ab81-45f812f16496" xlink:href="mo-20210930.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3893af27-ed23-4665-801d-56d97a00fe86" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_76e94f36-f8db-464e-ab81-45f812f16496" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f5a134a5-0080-4516-b7c3-28885030a204" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_a5ec62f8-090c-41fb-90b1-0189bfa1fec4" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f5a134a5-0080-4516-b7c3-28885030a204" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_f5a134a5-0080-4516-b7c3-28885030a204_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f5a134a5-0080-4516-b7c3-28885030a204" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_f5a134a5-0080-4516-b7c3-28885030a204_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a2092297-da2e-42df-9104-654942e4aacb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f5a134a5-0080-4516-b7c3-28885030a204" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a2092297-da2e-42df-9104-654942e4aacb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_d93507d7-92f3-4c5e-87b4-b36b2cc8dbab" xlink:href="mo-20210930.xsd#mo_ABInBevMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a2092297-da2e-42df-9104-654942e4aacb" xlink:to="loc_mo_ABInBevMember_d93507d7-92f3-4c5e-87b4-b36b2cc8dbab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_403287f2-2720-43c6-b514-0e1bf11a9539" xlink:href="mo-20210930.xsd#mo_JUULMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a2092297-da2e-42df-9104-654942e4aacb" xlink:to="loc_mo_JUULMember_403287f2-2720-43c6-b514-0e1bf11a9539" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_41e1b926-1bb6-485d-99ef-b1fb8bec3a59" xlink:href="mo-20210930.xsd#mo_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a2092297-da2e-42df-9104-654942e4aacb" xlink:to="loc_mo_CronosGroupInc.Member_41e1b926-1bb6-485d-99ef-b1fb8bec3a59" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails" xlink:type="extended" id="i0f5bd80ae53440a0a69ef29f969975ca_InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a30d86bb-d483-4693-80f6-90e14e391964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_4bd952ce-8f3e-473d-9c1c-ad9bc681bb20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a30d86bb-d483-4693-80f6-90e14e391964" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_4bd952ce-8f3e-473d-9c1c-ad9bc681bb20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestmentsFairValueOption_7fc97eec-08bb-413c-8431-608e8786a18f" xlink:href="mo-20210930.xsd#mo_IncomeLossFromEquityInvestmentsFairValueOption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a30d86bb-d483-4693-80f6-90e14e391964" xlink:to="loc_mo_IncomeLossFromEquityInvestmentsFairValueOption_7fc97eec-08bb-413c-8431-608e8786a18f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_8bbaa270-1ec3-4a4d-8475-cc999a2e077f" xlink:href="mo-20210930.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a30d86bb-d483-4693-80f6-90e14e391964" xlink:to="loc_mo_IncomeLossFromEquityInvestments_8bbaa270-1ec3-4a4d-8475-cc999a2e077f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentImpairment_5ec97257-ef7e-4646-b0ff-cd1aa42bbc43" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a30d86bb-d483-4693-80f6-90e14e391964" xlink:to="loc_mo_EquityMethodInvestmentImpairment_5ec97257-ef7e-4646-b0ff-cd1aa42bbc43" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_bd6aa09a-3889-45ae-a25d-942da1eb739a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a30d86bb-d483-4693-80f6-90e14e391964" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_bd6aa09a-3889-45ae-a25d-942da1eb739a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b80e33f1-9d50-41f5-a98e-89c85f33f7d1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_bd6aa09a-3889-45ae-a25d-942da1eb739a" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b80e33f1-9d50-41f5-a98e-89c85f33f7d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_b80e33f1-9d50-41f5-a98e-89c85f33f7d1_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b80e33f1-9d50-41f5-a98e-89c85f33f7d1" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_b80e33f1-9d50-41f5-a98e-89c85f33f7d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_c533190a-791b-4b86-9087-16053f024e99" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b80e33f1-9d50-41f5-a98e-89c85f33f7d1" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_c533190a-791b-4b86-9087-16053f024e99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_ed596870-705a-4ad3-8a7c-1472846e97a9" xlink:href="mo-20210930.xsd#mo_ABInBevMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_c533190a-791b-4b86-9087-16053f024e99" xlink:to="loc_mo_ABInBevMember_ed596870-705a-4ad3-8a7c-1472846e97a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_b2c1116a-1767-44ac-8810-71f220af9ddb" xlink:href="mo-20210930.xsd#mo_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_c533190a-791b-4b86-9087-16053f024e99" xlink:to="loc_mo_CronosGroupInc.Member_b2c1116a-1767-44ac-8810-71f220af9ddb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_3763673d-12c6-4e4c-9c53-b5f2ba198c73" xlink:href="mo-20210930.xsd#mo_JUULMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_c533190a-791b-4b86-9087-16053f024e99" xlink:to="loc_mo_JUULMember_3763673d-12c6-4e4c-9c53-b5f2ba198c73" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails" xlink:type="extended" id="i1eb6e3f3579b4dbaab1694a1eb5f2b54_InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_894040ef-9e01-4e5f-bf09-5c78930ddcfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_fddab318-282f-4781-918e-0a058f65ccf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_894040ef-9e01-4e5f-bf09-5c78930ddcfd" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_fddab318-282f-4781-918e-0a058f65ccf3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_2449a74e-f4a4-452c-a7e8-5bf9e9f92d05" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedRestricted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_894040ef-9e01-4e5f-bf09-5c78930ddcfd" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_2449a74e-f4a4-452c-a7e8-5bf9e9f92d05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_47b1ae2a-d02c-444a-bac9-de9a9b3756bf" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedCommon"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_894040ef-9e01-4e5f-bf09-5c78930ddcfd" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_47b1ae2a-d02c-444a-bac9-de9a9b3756bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RestrictedSharesLockupPeriod_b9bb6c81-4ee9-4769-92d0-9a657efe6655" xlink:href="mo-20210930.xsd#mo_RestrictedSharesLockupPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_894040ef-9e01-4e5f-bf09-5c78930ddcfd" xlink:to="loc_mo_RestrictedSharesLockupPeriod_b9bb6c81-4ee9-4769-92d0-9a657efe6655" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_98643c03-a2d1-42d9-8b3f-1f97a9705bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_894040ef-9e01-4e5f-bf09-5c78930ddcfd" xlink:to="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_98643c03-a2d1-42d9-8b3f-1f97a9705bd3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_f53ffeb2-b18e-468d-a48b-d06e2a8456f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_894040ef-9e01-4e5f-bf09-5c78930ddcfd" xlink:to="loc_us-gaap_EquityMethodInvestments_f53ffeb2-b18e-468d-a48b-d06e2a8456f0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_e5c9610d-05ee-4d5a-b75b-d57367ccedb3" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_894040ef-9e01-4e5f-bf09-5c78930ddcfd" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_e5c9610d-05ee-4d5a-b75b-d57367ccedb3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentImpairment_bfdf3b75-bb92-4064-9d95-04f5c4a61114" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_894040ef-9e01-4e5f-bf09-5c78930ddcfd" xlink:to="loc_mo_EquityMethodInvestmentImpairment_bfdf3b75-bb92-4064-9d95-04f5c4a61114" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentReductionInSharePricePercentage_e6f25a29-a9d1-4a3a-8380-7b6fa7e06978" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentReductionInSharePricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_894040ef-9e01-4e5f-bf09-5c78930ddcfd" xlink:to="loc_mo_EquityMethodInvestmentReductionInSharePricePercentage_e6f25a29-a9d1-4a3a-8380-7b6fa7e06978" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_f636fce8-8d54-4f8f-9e55-f0da818ad9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_894040ef-9e01-4e5f-bf09-5c78930ddcfd" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_f636fce8-8d54-4f8f-9e55-f0da818ad9b8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1b021b59-66ae-4d82-a829-fcc1741b037e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_894040ef-9e01-4e5f-bf09-5c78930ddcfd" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1b021b59-66ae-4d82-a829-fcc1741b037e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fcd01b19-5e4b-4174-a563-ff0acca6e385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1b021b59-66ae-4d82-a829-fcc1741b037e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fcd01b19-5e4b-4174-a563-ff0acca6e385" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fcd01b19-5e4b-4174-a563-ff0acca6e385_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fcd01b19-5e4b-4174-a563-ff0acca6e385" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fcd01b19-5e4b-4174-a563-ff0acca6e385_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f3b60c8-9974-46ed-939c-da108ade0668" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fcd01b19-5e4b-4174-a563-ff0acca6e385" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f3b60c8-9974-46ed-939c-da108ade0668" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d8187a23-0052-42cd-b505-7cef27beb277" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f3b60c8-9974-46ed-939c-da108ade0668" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d8187a23-0052-42cd-b505-7cef27beb277" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_88c20301-f575-433c-a77b-7ddb3506e5f6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1b021b59-66ae-4d82-a829-fcc1741b037e" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_88c20301-f575-433c-a77b-7ddb3506e5f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_88c20301-f575-433c-a77b-7ddb3506e5f6_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_88c20301-f575-433c-a77b-7ddb3506e5f6" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_88c20301-f575-433c-a77b-7ddb3506e5f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_7ce5c70d-5da0-4536-b4e4-0c68d19a9403" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_88c20301-f575-433c-a77b-7ddb3506e5f6" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_7ce5c70d-5da0-4536-b4e4-0c68d19a9403" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_603a4b96-2b88-47cd-89ab-cb00b88664a3" xlink:href="mo-20210930.xsd#mo_ABInBevMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_7ce5c70d-5da0-4536-b4e4-0c68d19a9403" xlink:to="loc_mo_ABInBevMember_603a4b96-2b88-47cd-89ab-cb00b88664a3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails" xlink:type="extended" id="i4579480aa60849078f568e0dfaeab330_InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_da3375e4-fd36-46a2-8fbf-7ba8c4e567b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_b70dea20-8832-4a56-a71b-a5fa644faa89" xlink:href="mo-20210930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_da3375e4-fd36-46a2-8fbf-7ba8c4e567b4" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_b70dea20-8832-4a56-a71b-a5fa644faa89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityInvestmentsFairValueOptionVotingShares_a5af2c37-974b-4bf9-a296-0415e420d515" xlink:href="mo-20210930.xsd#mo_EquityInvestmentsFairValueOptionVotingShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_da3375e4-fd36-46a2-8fbf-7ba8c4e567b4" xlink:to="loc_mo_EquityInvestmentsFairValueOptionVotingShares_a5af2c37-974b-4bf9-a296-0415e420d515" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_b3ca2316-ae0a-49a5-93a4-c24803dbf4bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_da3375e4-fd36-46a2-8fbf-7ba8c4e567b4" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_b3ca2316-ae0a-49a5-93a4-c24803dbf4bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_e6e3ae66-eaae-4fe2-a2aa-c933693c1c29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_da3375e4-fd36-46a2-8fbf-7ba8c4e567b4" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_e6e3ae66-eaae-4fe2-a2aa-c933693c1c29" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_1f8267c1-828b-4603-ba8d-f240aeb04e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_da3375e4-fd36-46a2-8fbf-7ba8c4e567b4" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_1f8267c1-828b-4603-ba8d-f240aeb04e1b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestmentsFairValueOption_167c87f9-bf31-4183-b5f8-ffe70aaf8315" xlink:href="mo-20210930.xsd#mo_IncomeLossFromEquityInvestmentsFairValueOption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_da3375e4-fd36-46a2-8fbf-7ba8c4e567b4" xlink:to="loc_mo_IncomeLossFromEquityInvestmentsFairValueOption_167c87f9-bf31-4183-b5f8-ffe70aaf8315" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_abfc9dea-a5b8-4482-9884-641a239af337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_da3375e4-fd36-46a2-8fbf-7ba8c4e567b4" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_abfc9dea-a5b8-4482-9884-641a239af337" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c98c528c-a68f-4eb9-8fac-9062cad26897" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_abfc9dea-a5b8-4482-9884-641a239af337" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c98c528c-a68f-4eb9-8fac-9062cad26897" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_c98c528c-a68f-4eb9-8fac-9062cad26897_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c98c528c-a68f-4eb9-8fac-9062cad26897" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_c98c528c-a68f-4eb9-8fac-9062cad26897_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3b715ff5-fdc9-4df3-be53-849720b6e27b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c98c528c-a68f-4eb9-8fac-9062cad26897" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3b715ff5-fdc9-4df3-be53-849720b6e27b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_a9756dde-655e-43ba-a829-1c5b138e1f38" xlink:href="mo-20210930.xsd#mo_JUULMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_3b715ff5-fdc9-4df3-be53-849720b6e27b" xlink:to="loc_mo_JUULMember_a9756dde-655e-43ba-a829-1c5b138e1f38" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details" xlink:type="simple" xlink:href="mo-20210930.xsd#InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details" xlink:type="extended" id="ie4bcf1781dd84428ba0b7df9708ba8d3_InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details">
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_9a19a767-00e0-482d-a87d-ce2d442f076e" xlink:href="mo-20210930.xsd#mo_InvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4a0916c2-17ad-467d-9e8f-e57eb8a5322a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_9a19a767-00e0-482d-a87d-ce2d442f076e" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4a0916c2-17ad-467d-9e8f-e57eb8a5322a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_37375182-47ae-47e5-8251-f1eeff5792d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4a0916c2-17ad-467d-9e8f-e57eb8a5322a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_37375182-47ae-47e5-8251-f1eeff5792d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_483b3973-862f-4149-b8e0-7043b7544406" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4a0916c2-17ad-467d-9e8f-e57eb8a5322a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_483b3973-862f-4149-b8e0-7043b7544406" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_15e47065-a170-4ec2-8e04-60b26c1986ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_aa4248c6-2a2f-4556-a8e7-4ff6afee8eec" xlink:href="mo-20210930.xsd#mo_InvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mo_InvestmentsLineItems_9a19a767-00e0-482d-a87d-ce2d442f076e" xlink:to="loc_mo_InvestmentsTable_aa4248c6-2a2f-4556-a8e7-4ff6afee8eec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_92c8eb3a-31c7-4025-ae4f-601abfe164f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_aa4248c6-2a2f-4556-a8e7-4ff6afee8eec" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_92c8eb3a-31c7-4025-ae4f-601abfe164f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_92c8eb3a-31c7-4025-ae4f-601abfe164f4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_92c8eb3a-31c7-4025-ae4f-601abfe164f4" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_92c8eb3a-31c7-4025-ae4f-601abfe164f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_141227c1-fa39-45da-aa70-f09f2186e548" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_92c8eb3a-31c7-4025-ae4f-601abfe164f4" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_141227c1-fa39-45da-aa70-f09f2186e548" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentsFairValueOptionMember_ae37fad3-526f-4078-871d-5902bb9d584c" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentsFairValueOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_141227c1-fa39-45da-aa70-f09f2186e548" xlink:to="loc_mo_EquityMethodInvestmentsFairValueOptionMember_ae37fad3-526f-4078-871d-5902bb9d584c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bfe092ae-95b9-4561-9d0a-2b197d2217eb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_aa4248c6-2a2f-4556-a8e7-4ff6afee8eec" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bfe092ae-95b9-4561-9d0a-2b197d2217eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_bfe092ae-95b9-4561-9d0a-2b197d2217eb_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bfe092ae-95b9-4561-9d0a-2b197d2217eb" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_bfe092ae-95b9-4561-9d0a-2b197d2217eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_0e636f93-3b2c-4089-b1b1-da1a6fcf1efc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bfe092ae-95b9-4561-9d0a-2b197d2217eb" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_0e636f93-3b2c-4089-b1b1-da1a6fcf1efc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_540a44bc-8124-478c-89b3-b2ceb0d6e6e1" xlink:href="mo-20210930.xsd#mo_JUULMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_0e636f93-3b2c-4089-b1b1-da1a6fcf1efc" xlink:to="loc_mo_JUULMember_540a44bc-8124-478c-89b3-b2ceb0d6e6e1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails" xlink:type="extended" id="iac38dea3ee2e4a6e9a9c8f9a4d8793b7_InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_07b80d9b-f618-4f9d-9fb4-dc92f77580d0" xlink:href="mo-20210930.xsd#mo_InvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_09ae85a1-17ee-47a9-ba55-6c6c1ee0a04f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_07b80d9b-f618-4f9d-9fb4-dc92f77580d0" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_09ae85a1-17ee-47a9-ba55-6c6c1ee0a04f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_6a415588-095b-4411-8d68-5069a31969b5" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedCommon"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_07b80d9b-f618-4f9d-9fb4-dc92f77580d0" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_6a415588-095b-4411-8d68-5069a31969b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentPricePerShareIfExercised_a8661c2b-49b2-48be-818b-53ab026d4b2f" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentPricePerShareIfExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_07b80d9b-f618-4f9d-9fb4-dc92f77580d0" xlink:to="loc_mo_EquityMethodInvestmentPricePerShareIfExercised_a8661c2b-49b2-48be-818b-53ab026d4b2f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_795fde3c-a0bb-4a34-824f-181e78e78cb3" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_07b80d9b-f618-4f9d-9fb4-dc92f77580d0" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_795fde3c-a0bb-4a34-824f-181e78e78cb3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_bccaf364-36a8-4868-8b75-6b2690649581" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_07b80d9b-f618-4f9d-9fb4-dc92f77580d0" xlink:to="loc_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_bccaf364-36a8-4868-8b75-6b2690649581" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentAggregateExercisePrice_195c7fe8-425f-4e6c-a51a-810a21612382" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentAggregateExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_07b80d9b-f618-4f9d-9fb4-dc92f77580d0" xlink:to="loc_mo_EquityMethodInvestmentAggregateExercisePrice_195c7fe8-425f-4e6c-a51a-810a21612382" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage_42e53e2a-7939-4496-9ef1-14cd8900f653" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_07b80d9b-f618-4f9d-9fb4-dc92f77580d0" xlink:to="loc_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage_42e53e2a-7939-4496-9ef1-14cd8900f653" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_da7baf8a-aee2-4160-886e-d5fda77e347e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_07b80d9b-f618-4f9d-9fb4-dc92f77580d0" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_da7baf8a-aee2-4160-886e-d5fda77e347e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_59c24dd5-9985-4d41-829f-2bcb9223dc21" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_07b80d9b-f618-4f9d-9fb4-dc92f77580d0" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_59c24dd5-9985-4d41-829f-2bcb9223dc21" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_0afa9f8a-6c5b-43cb-9ade-0779dde987c8" xlink:href="mo-20210930.xsd#mo_InvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mo_InvestmentsLineItems_07b80d9b-f618-4f9d-9fb4-dc92f77580d0" xlink:to="loc_mo_InvestmentsTable_0afa9f8a-6c5b-43cb-9ade-0779dde987c8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fe6f8865-537e-45e0-ac30-02c90a0c1ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_0afa9f8a-6c5b-43cb-9ade-0779dde987c8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fe6f8865-537e-45e0-ac30-02c90a0c1ee6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fe6f8865-537e-45e0-ac30-02c90a0c1ee6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fe6f8865-537e-45e0-ac30-02c90a0c1ee6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fe6f8865-537e-45e0-ac30-02c90a0c1ee6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7bcb9621-a15a-45b8-ac8c-4c99321b4d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fe6f8865-537e-45e0-ac30-02c90a0c1ee6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7bcb9621-a15a-45b8-ac8c-4c99321b4d5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1194c23e-808b-4278-881a-454949223603" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7bcb9621-a15a-45b8-ac8c-4c99321b4d5b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1194c23e-808b-4278-881a-454949223603" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_7a806d44-79b3-4fec-8c42-1482ae3bee32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_0afa9f8a-6c5b-43cb-9ade-0779dde987c8" xlink:to="loc_us-gaap_FinancialInstrumentAxis_7a806d44-79b3-4fec-8c42-1482ae3bee32" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7a806d44-79b3-4fec-8c42-1482ae3bee32_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7a806d44-79b3-4fec-8c42-1482ae3bee32" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7a806d44-79b3-4fec-8c42-1482ae3bee32_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8742cdfe-233a-4a34-aeee-d616183863ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7a806d44-79b3-4fec-8c42-1482ae3bee32" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8742cdfe-233a-4a34-aeee-d616183863ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_1ccead25-d9d6-4caf-9fc7-74dc7871e0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8742cdfe-233a-4a34-aeee-d616183863ea" xlink:to="loc_us-gaap_CommonStockMember_1ccead25-d9d6-4caf-9fc7-74dc7871e0aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8b8a119e-de08-44b7-9651-482a44d8be8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_0afa9f8a-6c5b-43cb-9ade-0779dde987c8" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8b8a119e-de08-44b7-9651-482a44d8be8a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8b8a119e-de08-44b7-9651-482a44d8be8a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8b8a119e-de08-44b7-9651-482a44d8be8a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8b8a119e-de08-44b7-9651-482a44d8be8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_22054e86-a951-4e34-9229-0eabd185bdd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8b8a119e-de08-44b7-9651-482a44d8be8a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_22054e86-a951-4e34-9229-0eabd185bdd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_1283f1f5-2300-4909-9395-a33ec1950e38" xlink:href="mo-20210930.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_22054e86-a951-4e34-9229-0eabd185bdd7" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_1283f1f5-2300-4909-9395-a33ec1950e38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_a0e057d8-572e-412b-987b-ae5d9b76520d" xlink:href="mo-20210930.xsd#mo_EquityContractWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_22054e86-a951-4e34-9229-0eabd185bdd7" xlink:to="loc_mo_EquityContractWarrantMember_a0e057d8-572e-412b-987b-ae5d9b76520d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember_b02772c3-6f75-4999-8bf8-1d8e63db9afd" xlink:href="mo-20210930.xsd#mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_22054e86-a951-4e34-9229-0eabd185bdd7" xlink:to="loc_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember_b02772c3-6f75-4999-8bf8-1d8e63db9afd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_74f32a1c-bfdf-4cf0-949f-d3ab91f59ee0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_0afa9f8a-6c5b-43cb-9ade-0779dde987c8" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_74f32a1c-bfdf-4cf0-949f-d3ab91f59ee0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_74f32a1c-bfdf-4cf0-949f-d3ab91f59ee0_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_74f32a1c-bfdf-4cf0-949f-d3ab91f59ee0" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_74f32a1c-bfdf-4cf0-949f-d3ab91f59ee0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_bfbc15bc-93bf-4f6f-b4a6-dbef016fc831" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_74f32a1c-bfdf-4cf0-949f-d3ab91f59ee0" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_bfbc15bc-93bf-4f6f-b4a6-dbef016fc831" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_043befd2-29df-424c-93d3-73f87937d23a" xlink:href="mo-20210930.xsd#mo_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_bfbc15bc-93bf-4f6f-b4a6-dbef016fc831" xlink:to="loc_mo_CronosGroupInc.Member_043befd2-29df-424c-93d3-73f87937d23a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_0ad973f2-3820-4107-a890-2a793e8d12bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_0afa9f8a-6c5b-43cb-9ade-0779dde987c8" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_0ad973f2-3820-4107-a890-2a793e8d12bd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0ad973f2-3820-4107-a890-2a793e8d12bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_0ad973f2-3820-4107-a890-2a793e8d12bd" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0ad973f2-3820-4107-a890-2a793e8d12bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3d2efd2a-84a9-451c-a50e-e75f65aca29c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_0ad973f2-3820-4107-a890-2a793e8d12bd" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3d2efd2a-84a9-451c-a50e-e75f65aca29c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_3aeb7d9c-d3d9-42c6-a72f-45384e236b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3d2efd2a-84a9-451c-a50e-e75f65aca29c" xlink:to="loc_us-gaap_SubsequentEventMember_3aeb7d9c-d3d9-42c6-a72f-45384e236b9f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsAggregateNotionalAmountsAggregateFairValuesandCarryingValuesDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#FinancialInstrumentsAggregateNotionalAmountsAggregateFairValuesandCarryingValuesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/FinancialInstrumentsAggregateNotionalAmountsAggregateFairValuesandCarryingValuesDetails" xlink:type="extended" id="i8ca5313cf5e5409cbdd7035beb9efac2_FinancialInstrumentsAggregateNotionalAmountsAggregateFairValuesandCarryingValuesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_378b813f-d698-454e-a7ba-9d5ccf19b65b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_4d0d6124-ccf9-4c56-a07c-b472463867e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_378b813f-d698-454e-a7ba-9d5ccf19b65b" xlink:to="loc_us-gaap_DerivativeNotionalAmount_4d0d6124-ccf9-4c56-a07c-b472463867e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_8201de99-b986-4237-8e64-7ca0685e0c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_378b813f-d698-454e-a7ba-9d5ccf19b65b" xlink:to="loc_us-gaap_LongTermDebt_8201de99-b986-4237-8e64-7ca0685e0c8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_cb26c3ca-f6ea-4f5b-b0d9-5961bbc5dac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_378b813f-d698-454e-a7ba-9d5ccf19b65b" xlink:to="loc_us-gaap_DebtInstrumentFairValue_cb26c3ca-f6ea-4f5b-b0d9-5961bbc5dac8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_3dc4abe4-a374-4e89-84e6-a4491c06a2b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_378b813f-d698-454e-a7ba-9d5ccf19b65b" xlink:to="loc_us-gaap_DerivativeTable_3dc4abe4-a374-4e89-84e6-a4491c06a2b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_30ae8e54-78ff-4806-8aee-22493490be2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3dc4abe4-a374-4e89-84e6-a4491c06a2b0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_30ae8e54-78ff-4806-8aee-22493490be2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_30ae8e54-78ff-4806-8aee-22493490be2e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_30ae8e54-78ff-4806-8aee-22493490be2e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_30ae8e54-78ff-4806-8aee-22493490be2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_29eb1d03-fcf5-4e3b-8e28-85f60f2b9879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_30ae8e54-78ff-4806-8aee-22493490be2e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_29eb1d03-fcf5-4e3b-8e28-85f60f2b9879" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_2a8d6981-6bd8-49ee-9582-f864ece97d18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_29eb1d03-fcf5-4e3b-8e28-85f60f2b9879" xlink:to="loc_us-gaap_ForeignExchangeContractMember_2a8d6981-6bd8-49ee-9582-f864ece97d18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_56c4fb3b-98e0-4b49-9e39-093800384183" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3dc4abe4-a374-4e89-84e6-a4491c06a2b0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_56c4fb3b-98e0-4b49-9e39-093800384183" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_56c4fb3b-98e0-4b49-9e39-093800384183_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_56c4fb3b-98e0-4b49-9e39-093800384183" xlink:to="loc_us-gaap_HedgingRelationshipDomain_56c4fb3b-98e0-4b49-9e39-093800384183_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_73b2c5d2-c6ed-4d01-af58-b895d4fe7acf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_56c4fb3b-98e0-4b49-9e39-093800384183" xlink:to="loc_us-gaap_HedgingRelationshipDomain_73b2c5d2-c6ed-4d01-af58-b895d4fe7acf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_ca21cf1c-aafe-4a5a-a4c3-a208e6706a25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_73b2c5d2-c6ed-4d01-af58-b895d4fe7acf" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_ca21cf1c-aafe-4a5a-a4c3-a208e6706a25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b411ebe3-0832-4fd6-9fa6-24a862264a60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3dc4abe4-a374-4e89-84e6-a4491c06a2b0" xlink:to="loc_us-gaap_DebtInstrumentAxis_b411ebe3-0832-4fd6-9fa6-24a862264a60" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b411ebe3-0832-4fd6-9fa6-24a862264a60_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b411ebe3-0832-4fd6-9fa6-24a862264a60" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b411ebe3-0832-4fd6-9fa6-24a862264a60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8f35c9f9-8b35-44f9-9548-f973617fa107" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b411ebe3-0832-4fd6-9fa6-24a862264a60" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8f35c9f9-8b35-44f9-9548-f973617fa107" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtMember_9b1bb34e-ffe5-4b75-b9e0-b92472401f1c" xlink:href="mo-20210930.xsd#mo_ForeignCurrencyDenominatedDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f35c9f9-8b35-44f9-9548-f973617fa107" xlink:to="loc_mo_ForeignCurrencyDenominatedDebtMember_9b1bb34e-ffe5-4b75-b9e0-b92472401f1c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails" xlink:type="extended" id="i5115905d9d7a4e03a4a0cba4b348d950_FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_ba0506db-2d80-4c0f-93d4-c20667e7a0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetMeasurementInput_3810d7f2-1301-4c82-b32b-28701d20f0da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ba0506db-2d80-4c0f-93d4-c20667e7a0d5" xlink:to="loc_us-gaap_DerivativeAssetMeasurementInput_3810d7f2-1301-4c82-b32b-28701d20f0da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_0ffeca72-c83e-44b6-ab5c-51b5f977ff8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_ba0506db-2d80-4c0f-93d4-c20667e7a0d5" xlink:to="loc_us-gaap_DerivativeTable_0ffeca72-c83e-44b6-ab5c-51b5f977ff8b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_189825f7-8716-495b-aa51-871a4369f7fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_0ffeca72-c83e-44b6-ab5c-51b5f977ff8b" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_189825f7-8716-495b-aa51-871a4369f7fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_189825f7-8716-495b-aa51-871a4369f7fb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_189825f7-8716-495b-aa51-871a4369f7fb" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_189825f7-8716-495b-aa51-871a4369f7fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_8d68b3d0-59bb-4079-8359-97d0d2856a55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_189825f7-8716-495b-aa51-871a4369f7fb" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_8d68b3d0-59bb-4079-8359-97d0d2856a55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_44c49fae-6dc9-4f14-a683-c53373493b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_8d68b3d0-59bb-4079-8359-97d0d2856a55" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_44c49fae-6dc9-4f14-a683-c53373493b3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_e8b7d4bb-f0d3-43d6-a14c-1d7521681241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_8d68b3d0-59bb-4079-8359-97d0d2856a55" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_e8b7d4bb-f0d3-43d6-a14c-1d7521681241" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_265821ca-bccd-4a1b-ba48-01453f0f9122" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_8d68b3d0-59bb-4079-8359-97d0d2856a55" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_265821ca-bccd-4a1b-ba48-01453f0f9122" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_ea74a8f1-33a0-4843-b70a-0934f26dc900" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_8d68b3d0-59bb-4079-8359-97d0d2856a55" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_ea74a8f1-33a0-4843-b70a-0934f26dc900" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_9faf584d-e4f0-4087-a5fa-1ef256946597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_8d68b3d0-59bb-4079-8359-97d0d2856a55" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_9faf584d-e4f0-4087-a5fa-1ef256946597" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MeasurementInputWeightedAverageExpectedTermMember_a57e89f2-ce04-4298-bf51-630746ba9ff8" xlink:href="mo-20210930.xsd#mo_MeasurementInputWeightedAverageExpectedTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_8d68b3d0-59bb-4079-8359-97d0d2856a55" xlink:to="loc_mo_MeasurementInputWeightedAverageExpectedTermMember_a57e89f2-ce04-4298-bf51-630746ba9ff8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ee9a5343-7c16-4f93-b1ed-39cff609a3d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_0ffeca72-c83e-44b6-ab5c-51b5f977ff8b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ee9a5343-7c16-4f93-b1ed-39cff609a3d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ee9a5343-7c16-4f93-b1ed-39cff609a3d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ee9a5343-7c16-4f93-b1ed-39cff609a3d7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ee9a5343-7c16-4f93-b1ed-39cff609a3d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3dbf07f6-5dad-4b88-839a-b270599349c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ee9a5343-7c16-4f93-b1ed-39cff609a3d7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3dbf07f6-5dad-4b88-839a-b270599349c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_91b53942-a2a2-40b7-9dd3-4c4fbdf7b08c" xlink:href="mo-20210930.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3dbf07f6-5dad-4b88-839a-b270599349c1" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_91b53942-a2a2-40b7-9dd3-4c4fbdf7b08c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_9f8b5386-06cb-4824-a1a4-121664be9fcc" xlink:href="mo-20210930.xsd#mo_EquityContractWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3dbf07f6-5dad-4b88-839a-b270599349c1" xlink:to="loc_mo_EquityContractWarrantMember_9f8b5386-06cb-4824-a1a4-121664be9fcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_208d7dd2-cbbc-4210-a182-acb32cad8bed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_0ffeca72-c83e-44b6-ab5c-51b5f977ff8b" xlink:to="loc_srt_RangeAxis_208d7dd2-cbbc-4210-a182-acb32cad8bed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_208d7dd2-cbbc-4210-a182-acb32cad8bed_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_208d7dd2-cbbc-4210-a182-acb32cad8bed" xlink:to="loc_srt_RangeMember_208d7dd2-cbbc-4210-a182-acb32cad8bed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_99e6a053-571f-405c-9c67-0c935af05428" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_208d7dd2-cbbc-4210-a182-acb32cad8bed" xlink:to="loc_srt_RangeMember_99e6a053-571f-405c-9c67-0c935af05428" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_fed4319f-cff2-4988-9336-f8be1cbde9a7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_99e6a053-571f-405c-9c67-0c935af05428" xlink:to="loc_srt_MinimumMember_fed4319f-cff2-4988-9336-f8be1cbde9a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bd0bf37a-6c10-4987-a070-050403decdf4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_99e6a053-571f-405c-9c67-0c935af05428" xlink:to="loc_srt_MaximumMember_bd0bf37a-6c10-4987-a070-050403decdf4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails" xlink:type="extended" id="ibaf85fe94f7e40088a14384118c1f826_FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_5893e6af-8f05-4314-86d2-10e4e98915fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_b293a688-f01c-4397-b649-6d688d8dbd59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5893e6af-8f05-4314-86d2-10e4e98915fa" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_b293a688-f01c-4397-b649-6d688d8dbd59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_2be9b660-e34a-4f81-bdbf-39a947019757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_b293a688-f01c-4397-b649-6d688d8dbd59" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_2be9b660-e34a-4f81-bdbf-39a947019757" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_3aff3b57-7e9a-4bf0-b38f-36b694ae1d04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_b293a688-f01c-4397-b649-6d688d8dbd59" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_3aff3b57-7e9a-4bf0-b38f-36b694ae1d04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_a3b7732a-5eb6-48c1-9de4-bc41ddede7d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_445c8114-1f5c-40e8-a12e-ac66cb27168f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_5893e6af-8f05-4314-86d2-10e4e98915fa" xlink:to="loc_us-gaap_DerivativeTable_445c8114-1f5c-40e8-a12e-ac66cb27168f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9ecc2314-5c99-4de4-a39a-fcd81291861e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_445c8114-1f5c-40e8-a12e-ac66cb27168f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9ecc2314-5c99-4de4-a39a-fcd81291861e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9ecc2314-5c99-4de4-a39a-fcd81291861e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9ecc2314-5c99-4de4-a39a-fcd81291861e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9ecc2314-5c99-4de4-a39a-fcd81291861e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fc884e11-e617-4668-8174-edd16de102a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9ecc2314-5c99-4de4-a39a-fcd81291861e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fc884e11-e617-4668-8174-edd16de102a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_969c207d-30fb-4495-a2b7-b0c49d99189a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fc884e11-e617-4668-8174-edd16de102a9" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_969c207d-30fb-4495-a2b7-b0c49d99189a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_af47906a-2341-4c48-8984-e74e2686e2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_445c8114-1f5c-40e8-a12e-ac66cb27168f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_af47906a-2341-4c48-8984-e74e2686e2dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_af47906a-2341-4c48-8984-e74e2686e2dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_af47906a-2341-4c48-8984-e74e2686e2dc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_af47906a-2341-4c48-8984-e74e2686e2dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3dc7d1d1-7f78-4892-91e9-39b1cc2fab35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_af47906a-2341-4c48-8984-e74e2686e2dc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3dc7d1d1-7f78-4892-91e9-39b1cc2fab35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityContractMember_c0679410-5b83-4b5e-a88e-dce0d5e449ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3dc7d1d1-7f78-4892-91e9-39b1cc2fab35" xlink:to="loc_us-gaap_EquityContractMember_c0679410-5b83-4b5e-a88e-dce0d5e449ef" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails" xlink:type="extended" id="i5b43fccbb24545f6b9ea9e206072e6de_FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_e63fb47d-c9dc-4d4d-a22f-395e216682c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0da22170-2952-418e-8092-1425ef3e4b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e63fb47d-c9dc-4d4d-a22f-395e216682c0" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0da22170-2952-418e-8092-1425ef3e4b5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_83ba0d72-5292-4010-934a-db766b8d9726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e63fb47d-c9dc-4d4d-a22f-395e216682c0" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_83ba0d72-5292-4010-934a-db766b8d9726" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d127c4bf-6297-45e5-a3e5-0ec0322764fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e63fb47d-c9dc-4d4d-a22f-395e216682c0" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d127c4bf-6297-45e5-a3e5-0ec0322764fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_09b55c22-a2d0-451e-9bf0-ac58f72d9817" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d127c4bf-6297-45e5-a3e5-0ec0322764fd" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_09b55c22-a2d0-451e-9bf0-ac58f72d9817" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_09b55c22-a2d0-451e-9bf0-ac58f72d9817_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_09b55c22-a2d0-451e-9bf0-ac58f72d9817" xlink:to="loc_us-gaap_HedgingRelationshipDomain_09b55c22-a2d0-451e-9bf0-ac58f72d9817_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_eba4ef40-fa6c-4290-8ae1-6002ee6c73e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_09b55c22-a2d0-451e-9bf0-ac58f72d9817" xlink:to="loc_us-gaap_HedgingRelationshipDomain_eba4ef40-fa6c-4290-8ae1-6002ee6c73e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_62b8d1e6-128c-4f19-a027-cec45b4b8b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_eba4ef40-fa6c-4290-8ae1-6002ee6c73e9" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_62b8d1e6-128c-4f19-a027-cec45b4b8b7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4a94f37b-603b-479c-baee-ae1dbccbee74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d127c4bf-6297-45e5-a3e5-0ec0322764fd" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4a94f37b-603b-479c-baee-ae1dbccbee74" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4a94f37b-603b-479c-baee-ae1dbccbee74_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4a94f37b-603b-479c-baee-ae1dbccbee74" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4a94f37b-603b-479c-baee-ae1dbccbee74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6f26f0b0-54a9-45a8-92fa-a92d51e6a5af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4a94f37b-603b-479c-baee-ae1dbccbee74" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6f26f0b0-54a9-45a8-92fa-a92d51e6a5af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_22fa410e-1197-48ae-82ca-2b248a3fa3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6f26f0b0-54a9-45a8-92fa-a92d51e6a5af" xlink:to="loc_us-gaap_ForeignExchangeContractMember_22fa410e-1197-48ae-82ca-2b248a3fa3f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityContractMember_c82d06ed-2192-4e24-95e8-9c555477b1ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6f26f0b0-54a9-45a8-92fa-a92d51e6a5af" xlink:to="loc_us-gaap_EquityContractMember_c82d06ed-2192-4e24-95e8-9c555477b1ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_e75efe8d-6a95-4901-89d8-9e833f386999" xlink:href="mo-20210930.xsd#mo_EquityContractWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityContractMember_c82d06ed-2192-4e24-95e8-9c555477b1ea" xlink:to="loc_mo_EquityContractWarrantMember_e75efe8d-6a95-4901-89d8-9e833f386999" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_34eae739-dca5-413e-bce5-11f7cffaedb3" xlink:href="mo-20210930.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityContractMember_c82d06ed-2192-4e24-95e8-9c555477b1ea" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_34eae739-dca5-413e-bce5-11f7cffaedb3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_09d87299-4baf-4c94-a79d-c324d8dd34f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d127c4bf-6297-45e5-a3e5-0ec0322764fd" xlink:to="loc_us-gaap_HedgingDesignationAxis_09d87299-4baf-4c94-a79d-c324d8dd34f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_09d87299-4baf-4c94-a79d-c324d8dd34f5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_09d87299-4baf-4c94-a79d-c324d8dd34f5" xlink:to="loc_us-gaap_HedgingDesignationDomain_09d87299-4baf-4c94-a79d-c324d8dd34f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_68e8e776-e70e-434b-a6c4-f2ef23c8829f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_09d87299-4baf-4c94-a79d-c324d8dd34f5" xlink:to="loc_us-gaap_HedgingDesignationDomain_68e8e776-e70e-434b-a6c4-f2ef23c8829f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_369723b8-aa1f-4466-a698-3401e4e9098e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_68e8e776-e70e-434b-a6c4-f2ef23c8829f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_369723b8-aa1f-4466-a698-3401e4e9098e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_d87c1276-3189-46a9-adfb-9ffec85cff6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_68e8e776-e70e-434b-a6c4-f2ef23c8829f" xlink:to="loc_us-gaap_NondesignatedMember_d87c1276-3189-46a9-adfb-9ffec85cff6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_60b7093a-8e87-4b3a-bff9-13f448c8f77b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d127c4bf-6297-45e5-a3e5-0ec0322764fd" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_60b7093a-8e87-4b3a-bff9-13f448c8f77b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_60b7093a-8e87-4b3a-bff9-13f448c8f77b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_60b7093a-8e87-4b3a-bff9-13f448c8f77b" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_60b7093a-8e87-4b3a-bff9-13f448c8f77b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1945f429-883b-402d-bde5-14907337b113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_60b7093a-8e87-4b3a-bff9-13f448c8f77b" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1945f429-883b-402d-bde5-14907337b113" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_cf75b7ce-a081-4886-9f78-ea8649c2512f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1945f429-883b-402d-bde5-14907337b113" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_cf75b7ce-a081-4886-9f78-ea8649c2512f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_36c1ab29-b428-45d0-afcd-4df1d854070c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1945f429-883b-402d-bde5-14907337b113" xlink:to="loc_us-gaap_OtherAssetsMember_36c1ab29-b428-45d0-afcd-4df1d854070c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherAccruedLiabilitiesMember_0838e66b-8104-4200-9b22-381c3d21650a" xlink:href="mo-20210930.xsd#mo_OtherAccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1945f429-883b-402d-bde5-14907337b113" xlink:to="loc_mo_OtherAccruedLiabilitiesMember_0838e66b-8104-4200-9b22-381c3d21650a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_e1e698f1-ff9a-4818-a44c-c13c489b8d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1945f429-883b-402d-bde5-14907337b113" xlink:to="loc_us-gaap_OtherLiabilitiesMember_e1e698f1-ff9a-4818-a44c-c13c489b8d3d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsInEquitySecuritiesMember_e99d1a98-a0d7-48bd-a198-f6fc1ce1e9ca" xlink:href="mo-20210930.xsd#mo_InvestmentsInEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1945f429-883b-402d-bde5-14907337b113" xlink:to="loc_mo_InvestmentsInEquitySecuritiesMember_e99d1a98-a0d7-48bd-a198-f6fc1ce1e9ca" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#FinancialInstrumentsPretaxUnrealizedGainsLossesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails" xlink:type="extended" id="iaccd50a107a54c21b7a3f287f717b954_FinancialInstrumentsPretaxUnrealizedGainsLossesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_3ffceb95-4c04-46c2-a739-62e075d9e8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_354f2df2-9e76-4603-b84c-bc6242fa5907" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3ffceb95-4c04-46c2-a739-62e075d9e8a0" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_354f2df2-9e76-4603-b84c-bc6242fa5907" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_0e94a736-2801-44f7-9ee9-a54147ac6762" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_3ffceb95-4c04-46c2-a739-62e075d9e8a0" xlink:to="loc_us-gaap_DerivativeTable_0e94a736-2801-44f7-9ee9-a54147ac6762" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5b034d34-14fc-4579-b1e6-8129ac5175e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_0e94a736-2801-44f7-9ee9-a54147ac6762" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5b034d34-14fc-4579-b1e6-8129ac5175e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5b034d34-14fc-4579-b1e6-8129ac5175e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5b034d34-14fc-4579-b1e6-8129ac5175e0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5b034d34-14fc-4579-b1e6-8129ac5175e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_68fa8c86-a076-4645-a7c6-02ed6949a2af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5b034d34-14fc-4579-b1e6-8129ac5175e0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_68fa8c86-a076-4645-a7c6-02ed6949a2af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_69dc3bae-faeb-4ad9-ae5e-5f9e5b03aa65" xlink:href="mo-20210930.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_68fa8c86-a076-4645-a7c6-02ed6949a2af" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_69dc3bae-faeb-4ad9-ae5e-5f9e5b03aa65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_c8cac1bb-f5c7-459b-9fa4-b35bc20e026d" xlink:href="mo-20210930.xsd#mo_EquityContractWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_68fa8c86-a076-4645-a7c6-02ed6949a2af" xlink:to="loc_mo_EquityContractWarrantMember_c8cac1bb-f5c7-459b-9fa4-b35bc20e026d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails" xlink:type="extended" id="i5fb31ed6e6a74540b67350854d2317c5_FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_f7873af7-0aad-4b09-b90c-31b726d650fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_6d2b4384-41fb-467a-ad4f-8848e2c37189" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_f7873af7-0aad-4b09-b90c-31b726d650fd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_6d2b4384-41fb-467a-ad4f-8848e2c37189" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_ec06edfd-c10c-4c45-9ec6-51a21fb180d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_f7873af7-0aad-4b09-b90c-31b726d650fd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_ec06edfd-c10c-4c45-9ec6-51a21fb180d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1b6f32d6-d527-409a-aca5-6c2b0ae611c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_f7873af7-0aad-4b09-b90c-31b726d650fd" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1b6f32d6-d527-409a-aca5-6c2b0ae611c2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_d980062f-5ccd-49f4-afc6-c9ac46c5d543" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1b6f32d6-d527-409a-aca5-6c2b0ae611c2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_d980062f-5ccd-49f4-afc6-c9ac46c5d543" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d980062f-5ccd-49f4-afc6-c9ac46c5d543_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d980062f-5ccd-49f4-afc6-c9ac46c5d543" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d980062f-5ccd-49f4-afc6-c9ac46c5d543_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3fac800f-ba8b-44fe-8db7-1a73d3d5911d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d980062f-5ccd-49f4-afc6-c9ac46c5d543" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3fac800f-ba8b-44fe-8db7-1a73d3d5911d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_ea3482fa-3043-4d56-bcdc-30ea1c114a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3fac800f-ba8b-44fe-8db7-1a73d3d5911d" xlink:to="loc_us-gaap_ForeignExchangeContractMember_ea3482fa-3043-4d56-bcdc-30ea1c114a2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtMember_e4e13d55-827c-451c-9f3b-c59cdb4ddeb7" xlink:href="mo-20210930.xsd#mo_ForeignCurrencyDenominatedDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3fac800f-ba8b-44fe-8db7-1a73d3d5911d" xlink:to="loc_mo_ForeignCurrencyDenominatedDebtMember_e4e13d55-827c-451c-9f3b-c59cdb4ddeb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_57c39543-4123-454b-a896-bc116492db42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1b6f32d6-d527-409a-aca5-6c2b0ae611c2" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_57c39543-4123-454b-a896-bc116492db42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_57c39543-4123-454b-a896-bc116492db42_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_57c39543-4123-454b-a896-bc116492db42" xlink:to="loc_us-gaap_HedgingRelationshipDomain_57c39543-4123-454b-a896-bc116492db42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c909e012-8a1e-4c57-82b0-5050562a65b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_57c39543-4123-454b-a896-bc116492db42" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c909e012-8a1e-4c57-82b0-5050562a65b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_c1c8d60a-3e6d-4a77-bfac-74bc8ba64879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c909e012-8a1e-4c57-82b0-5050562a65b4" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_c1c8d60a-3e6d-4a77-bfac-74bc8ba64879" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" xlink:type="extended" id="i4e924d18ae114343a2ae0625613da51b_BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d4146963-ead1-4e03-a54a-bbbd1f5a7e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_35b666a8-196a-4f2c-9245-9f7604da7e35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d4146963-ead1-4e03-a54a-bbbd1f5a7e4a" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_35b666a8-196a-4f2c-9245-9f7604da7e35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_fb078433-9de5-4471-b398-654cc0820d85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d4146963-ead1-4e03-a54a-bbbd1f5a7e4a" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_fb078433-9de5-4471-b398-654cc0820d85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_99e26f4d-0a68-4e93-a5fa-44cf6652c5fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d4146963-ead1-4e03-a54a-bbbd1f5a7e4a" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_99e26f4d-0a68-4e93-a5fa-44cf6652c5fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_01c119f1-4fee-464c-b63b-1a3463693818" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d4146963-ead1-4e03-a54a-bbbd1f5a7e4a" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_01c119f1-4fee-464c-b63b-1a3463693818" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_8931260f-7b06-4050-ae74-9554ddeda220" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_01c119f1-4fee-464c-b63b-1a3463693818" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_8931260f-7b06-4050-ae74-9554ddeda220" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_279891b8-d1a1-4507-9e7c-4b310c0670c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_01c119f1-4fee-464c-b63b-1a3463693818" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_279891b8-d1a1-4507-9e7c-4b310c0670c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3c3547b0-56f4-4083-9d2c-ab8fcbfe73f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d4146963-ead1-4e03-a54a-bbbd1f5a7e4a" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3c3547b0-56f4-4083-9d2c-ab8fcbfe73f6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f6f47e47-8ecc-46ba-be5c-4a7b8f4f8b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d4146963-ead1-4e03-a54a-bbbd1f5a7e4a" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f6f47e47-8ecc-46ba-be5c-4a7b8f4f8b9c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_c0ab9a3c-f5e8-4f2d-82d4-78a51f59af58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f6f47e47-8ecc-46ba-be5c-4a7b8f4f8b9c" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_c0ab9a3c-f5e8-4f2d-82d4-78a51f59af58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_c0ab9a3c-f5e8-4f2d-82d4-78a51f59af58_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c0ab9a3c-f5e8-4f2d-82d4-78a51f59af58" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_c0ab9a3c-f5e8-4f2d-82d4-78a51f59af58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_acaa5819-e2be-4fd6-a376-dc615471422e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c0ab9a3c-f5e8-4f2d-82d4-78a51f59af58" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_acaa5819-e2be-4fd6-a376-dc615471422e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_ff6eb56a-9d95-4d80-93ad-5f419b463c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_acaa5819-e2be-4fd6-a376-dc615471422e" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_ff6eb56a-9d95-4d80-93ad-5f419b463c3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_d5a9665c-9177-4134-ba19-4ab8037a53bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_acaa5819-e2be-4fd6-a376-dc615471422e" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_d5a9665c-9177-4134-ba19-4ab8037a53bc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansNarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#BenefitPlansNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BenefitPlansNarrativeDetails" xlink:type="extended" id="i3ee82aba4c454abab6d0aec8c22d91c2_BenefitPlansNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6a943a44-5326-4d9d-8862-76395fe710d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_7415046d-4dba-47ee-9e23-e2d21feca407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6a943a44-5326-4d9d-8862-76395fe710d2" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_7415046d-4dba-47ee-9e23-e2d21feca407" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_008efa91-4fd7-47ad-a62a-7d6222d48808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6a943a44-5326-4d9d-8862-76395fe710d2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_008efa91-4fd7-47ad-a62a-7d6222d48808" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_96b06a1a-8ff8-48a0-b346-b92f3c43f556" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6a943a44-5326-4d9d-8862-76395fe710d2" xlink:to="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_96b06a1a-8ff8-48a0-b346-b92f3c43f556" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3709025f-88e5-462c-93c2-e186bfd3bfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6a943a44-5326-4d9d-8862-76395fe710d2" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3709025f-88e5-462c-93c2-e186bfd3bfd4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_de339186-4f2b-413d-82f7-dbd10d5f4aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3709025f-88e5-462c-93c2-e186bfd3bfd4" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_de339186-4f2b-413d-82f7-dbd10d5f4aaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_de339186-4f2b-413d-82f7-dbd10d5f4aaf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_de339186-4f2b-413d-82f7-dbd10d5f4aaf" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_de339186-4f2b-413d-82f7-dbd10d5f4aaf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_4ca1766c-f1c0-4899-ab2f-48fcc5375716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_de339186-4f2b-413d-82f7-dbd10d5f4aaf" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_4ca1766c-f1c0-4899-ab2f-48fcc5375716" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_9ae65500-3a17-461e-aa4a-411c970f950b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_4ca1766c-f1c0-4899-ab2f-48fcc5375716" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_9ae65500-3a17-461e-aa4a-411c970f950b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_09e41336-908d-45f8-af3d-856c7ce9ddb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_4ca1766c-f1c0-4899-ab2f-48fcc5375716" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_09e41336-908d-45f8-af3d-856c7ce9ddb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2e2a93de-c73b-4eff-9962-04194235780a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3709025f-88e5-462c-93c2-e186bfd3bfd4" xlink:to="loc_srt_RangeAxis_2e2a93de-c73b-4eff-9962-04194235780a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2e2a93de-c73b-4eff-9962-04194235780a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2e2a93de-c73b-4eff-9962-04194235780a" xlink:to="loc_srt_RangeMember_2e2a93de-c73b-4eff-9962-04194235780a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dd8c6b74-ebbc-4d01-bab4-1e9207493f54" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2e2a93de-c73b-4eff-9962-04194235780a" xlink:to="loc_srt_RangeMember_dd8c6b74-ebbc-4d01-bab4-1e9207493f54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_82b83f5b-c547-4622-a43a-d3f69d962d3b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_dd8c6b74-ebbc-4d01-bab4-1e9207493f54" xlink:to="loc_srt_MaximumMember_82b83f5b-c547-4622-a43a-d3f69d962d3b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" xlink:type="extended" id="i4fabd0e19d664c5aac99fa0238f86f49_OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a444221b-7f81-482f-ab95-34f90aba2592" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0eb894bc-c697-4da0-afd0-fe4b5e20093c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a444221b-7f81-482f-ab95-34f90aba2592" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0eb894bc-c697-4da0-afd0-fe4b5e20093c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5109d6c8-d734-4449-8070-ab6be2468146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0eb894bc-c697-4da0-afd0-fe4b5e20093c" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5109d6c8-d734-4449-8070-ab6be2468146" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_486f9821-ef42-40eb-b36a-cb9fd74de20f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0eb894bc-c697-4da0-afd0-fe4b5e20093c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_486f9821-ef42-40eb-b36a-cb9fd74de20f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_a2e3ddd5-07e3-48dc-b11b-f5b0bf24eb25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0eb894bc-c697-4da0-afd0-fe4b5e20093c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_a2e3ddd5-07e3-48dc-b11b-f5b0bf24eb25" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_bf9e1eee-f83e-4ed0-89d2-dd4b9bc52563" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0eb894bc-c697-4da0-afd0-fe4b5e20093c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_bf9e1eee-f83e-4ed0-89d2-dd4b9bc52563" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_64c1d7a5-b894-4d9a-ae80-f06cff991ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0eb894bc-c697-4da0-afd0-fe4b5e20093c" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_64c1d7a5-b894-4d9a-ae80-f06cff991ffe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_c4a4583e-becd-406e-a82f-f724876650d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0eb894bc-c697-4da0-afd0-fe4b5e20093c" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_c4a4583e-becd-406e-a82f-f724876650d3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e9420724-c113-4361-a6a3-49aacdfb670e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0eb894bc-c697-4da0-afd0-fe4b5e20093c" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e9420724-c113-4361-a6a3-49aacdfb670e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9794fa44-e1f1-419a-bf97-bcb4e4207d19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0eb894bc-c697-4da0-afd0-fe4b5e20093c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9794fa44-e1f1-419a-bf97-bcb4e4207d19" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ab8b9be8-dc48-415f-b981-68978e05cef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a263a9f4-72f6-4019-8ad2-0085e8e92aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a444221b-7f81-482f-ab95-34f90aba2592" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a263a9f4-72f6-4019-8ad2-0085e8e92aa0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_cd9ca4d7-568f-4f38-9dbb-6eec55f78d36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a263a9f4-72f6-4019-8ad2-0085e8e92aa0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_cd9ca4d7-568f-4f38-9dbb-6eec55f78d36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cd9ca4d7-568f-4f38-9dbb-6eec55f78d36_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cd9ca4d7-568f-4f38-9dbb-6eec55f78d36" xlink:to="loc_us-gaap_EquityComponentDomain_cd9ca4d7-568f-4f38-9dbb-6eec55f78d36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d78cb71d-3c5a-4e29-b345-676f23c98606" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cd9ca4d7-568f-4f38-9dbb-6eec55f78d36" xlink:to="loc_us-gaap_EquityComponentDomain_d78cb71d-3c5a-4e29-b345-676f23c98606" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_33d712f5-a9c6-424f-89ac-061698a2b068" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d78cb71d-3c5a-4e29-b345-676f23c98606" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_33d712f5-a9c6-424f-89ac-061698a2b068" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_df20c61c-5491-464c-b6ef-f9ce60703366" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_33d712f5-a9c6-424f-89ac-061698a2b068" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_df20c61c-5491-464c-b6ef-f9ce60703366" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_19b2d833-468f-4b6b-a17c-e13ea778066d" xlink:href="mo-20210930.xsd#mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_33d712f5-a9c6-424f-89ac-061698a2b068" xlink:to="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_19b2d833-468f-4b6b-a17c-e13ea778066d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_f020ebc8-bf02-4b12-864a-84ac8102ab6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_33d712f5-a9c6-424f-89ac-061698a2b068" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_f020ebc8-bf02-4b12-864a-84ac8102ab6b" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#OtherComprehensiveEarningsLossesReclassificationsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" xlink:type="extended" id="i5216121fee9c4bf3b97d4d609edc0d7b_OtherComprehensiveEarningsLossesReclassificationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_20b21350-6a32-45e4-8102-17e1a4ed754c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_b75c45b2-235d-4c4e-bd8e-b5ec32e5334d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_20b21350-6a32-45e4-8102-17e1a4ed754c" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_b75c45b2-235d-4c4e-bd8e-b5ec32e5334d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_85e42601-3293-4f2b-a9c6-0698f169e4bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_20b21350-6a32-45e4-8102-17e1a4ed754c" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_85e42601-3293-4f2b-a9c6-0698f169e4bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_03a7002b-bc09-48b9-9073-8c072da529bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_20b21350-6a32-45e4-8102-17e1a4ed754c" xlink:to="loc_us-gaap_ProfitLoss_03a7002b-bc09-48b9-9073-8c072da529bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_c1fe3717-51fe-4acb-9dfb-7347f14d7729" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_20b21350-6a32-45e4-8102-17e1a4ed754c" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_c1fe3717-51fe-4acb-9dfb-7347f14d7729" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_610d70b2-f27c-4b18-9497-2a3e70ef370d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_c1fe3717-51fe-4acb-9dfb-7347f14d7729" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_610d70b2-f27c-4b18-9497-2a3e70ef370d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_610d70b2-f27c-4b18-9497-2a3e70ef370d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_610d70b2-f27c-4b18-9497-2a3e70ef370d" xlink:to="loc_us-gaap_EquityComponentDomain_610d70b2-f27c-4b18-9497-2a3e70ef370d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7a1ddb40-9dc4-4569-a726-253013437e19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_610d70b2-f27c-4b18-9497-2a3e70ef370d" xlink:to="loc_us-gaap_EquityComponentDomain_7a1ddb40-9dc4-4569-a726-253013437e19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f67ee744-ab70-458a-9a32-0f36c4d3c027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7a1ddb40-9dc4-4569-a726-253013437e19" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f67ee744-ab70-458a-9a32-0f36c4d3c027" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_4c0393b4-7a66-474f-8c99-e5750aaf084e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f67ee744-ab70-458a-9a32-0f36c4d3c027" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_4c0393b4-7a66-474f-8c99-e5750aaf084e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_5863802e-81ab-41c1-8fc3-934656a2a461" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f67ee744-ab70-458a-9a32-0f36c4d3c027" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_5863802e-81ab-41c1-8fc3-934656a2a461" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_27327f9f-f0ab-4849-9d63-26ba45c0aa73" xlink:href="mo-20210930.xsd#mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f67ee744-ab70-458a-9a32-0f36c4d3c027" xlink:to="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_27327f9f-f0ab-4849-9d63-26ba45c0aa73" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_b11f6832-9248-4a06-b750-6ce58f58ac61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f67ee744-ab70-458a-9a32-0f36c4d3c027" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_b11f6832-9248-4a06-b750-6ce58f58ac61" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_9c9c7a7a-4164-48da-9165-aced70e4db56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_c1fe3717-51fe-4acb-9dfb-7347f14d7729" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_9c9c7a7a-4164-48da-9165-aced70e4db56" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_9c9c7a7a-4164-48da-9165-aced70e4db56_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_9c9c7a7a-4164-48da-9165-aced70e4db56" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_9c9c7a7a-4164-48da-9165-aced70e4db56_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_1e50b097-af7d-45c3-8f99-a13cdcc8517a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_9c9c7a7a-4164-48da-9165-aced70e4db56" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_1e50b097-af7d-45c3-8f99-a13cdcc8517a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_3c25830b-2e5a-4675-b270-b9a2fa4ef3b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_1e50b097-af7d-45c3-8f99-a13cdcc8517a" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_3c25830b-2e5a-4675-b270-b9a2fa4ef3b6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#SegmentReportingSegmentDataScheduleDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" xlink:type="extended" id="ic37498686e5e426d8b484728348cadd2_SegmentReportingSegmentDataScheduleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6c75b465-c90f-476b-9003-6a8f6369e2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6c75b465-c90f-476b-9003-6a8f6369e2ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles_ff0b08ec-cc4a-4868-839b-ebf96f36b78c" xlink:href="mo-20210930.xsd#mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:to="loc_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles_ff0b08ec-cc4a-4868-839b-ebf96f36b78c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_80e3e34e-ac47-4490-8ca3-ad3a37195b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_80e3e34e-ac47-4490-8ca3-ad3a37195b3b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_91945b87-3313-4124-84cd-ff2398a9bd39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_91945b87-3313-4124-84cd-ff2398a9bd39" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a6ac7cf9-d431-4779-9959-c549d4ddf718" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:to="loc_us-gaap_OperatingIncomeLoss_a6ac7cf9-d431-4779-9959-c549d4ddf718" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_a4794b4e-55c7-46f4-b8ef-17d0249e7b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_a4794b4e-55c7-46f4-b8ef-17d0249e7b3e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_42c3790c-0d65-4120-bed3-801b4ad87ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_42c3790c-0d65-4120-bed3-801b4ad87ee4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_d0250e4e-a8d4-4e18-a1a4-bdf5d1b32824" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_d0250e4e-a8d4-4e18-a1a4-bdf5d1b32824" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_b43dc144-6a1a-4968-bd9a-f6f2bacbadf5" xlink:href="mo-20210930.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:to="loc_mo_IncomeLossFromEquityInvestments_b43dc144-6a1a-4968-bd9a-f6f2bacbadf5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_3e958591-1f50-4376-8b30-880a22d7809e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_3e958591-1f50-4376-8b30-880a22d7809e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6ae85386-e6d3-452e-8b6e-59410d680424" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6ae85386-e6d3-452e-8b6e-59410d680424" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a360e7ca-fd39-49c7-b6be-51e4f6e81f44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a360e7ca-fd39-49c7-b6be-51e4f6e81f44" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_48b0384d-fbd2-479d-823b-d60d4dfb89eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_48b0384d-fbd2-479d-823b-d60d4dfb89eb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_3174b10d-6e9a-410f-a68b-f9cd09f37a85" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_48b0384d-fbd2-479d-823b-d60d4dfb89eb" xlink:to="loc_srt_ConsolidationItemsAxis_3174b10d-6e9a-410f-a68b-f9cd09f37a85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3174b10d-6e9a-410f-a68b-f9cd09f37a85_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_3174b10d-6e9a-410f-a68b-f9cd09f37a85" xlink:to="loc_srt_ConsolidationItemsDomain_3174b10d-6e9a-410f-a68b-f9cd09f37a85_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_489240ee-0dd7-4a33-a823-f05f4b9c1030" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_3174b10d-6e9a-410f-a68b-f9cd09f37a85" xlink:to="loc_srt_ConsolidationItemsDomain_489240ee-0dd7-4a33-a823-f05f4b9c1030" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_193d6144-5fa3-448c-807e-ac3d68106e57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_489240ee-0dd7-4a33-a823-f05f4b9c1030" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_193d6144-5fa3-448c-807e-ac3d68106e57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_72ca46f8-8be9-4554-a64b-86d3a239eea1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_489240ee-0dd7-4a33-a823-f05f4b9c1030" xlink:to="loc_us-gaap_CorporateNonSegmentMember_72ca46f8-8be9-4554-a64b-86d3a239eea1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c0d74fd0-4a9a-47db-a709-320af3686be9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_48b0384d-fbd2-479d-823b-d60d4dfb89eb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c0d74fd0-4a9a-47db-a709-320af3686be9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c0d74fd0-4a9a-47db-a709-320af3686be9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c0d74fd0-4a9a-47db-a709-320af3686be9" xlink:to="loc_us-gaap_SegmentDomain_c0d74fd0-4a9a-47db-a709-320af3686be9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_14c1ce0e-1d3f-4ce8-b3ed-d651b901660c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c0d74fd0-4a9a-47db-a709-320af3686be9" xlink:to="loc_us-gaap_SegmentDomain_14c1ce0e-1d3f-4ce8-b3ed-d651b901660c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_eb8ed13f-7717-4667-ba6e-3857aaf9b13e" xlink:href="mo-20210930.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_14c1ce0e-1d3f-4ce8-b3ed-d651b901660c" xlink:to="loc_mo_SmokeableProductsSegmentMember_eb8ed13f-7717-4667-ba6e-3857aaf9b13e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember_217284c1-efc1-4fa0-9151-9c7754b0c5d9" xlink:href="mo-20210930.xsd#mo_OralTobaccoSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_14c1ce0e-1d3f-4ce8-b3ed-d651b901660c" xlink:to="loc_mo_OralTobaccoSegmentMember_217284c1-efc1-4fa0-9151-9c7754b0c5d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineSegmentMember_ffa53fe0-3499-41fe-a77b-418f3a794689" xlink:href="mo-20210930.xsd#mo_WineSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_14c1ce0e-1d3f-4ce8-b3ed-d651b901660c" xlink:to="loc_mo_WineSegmentMember_ffa53fe0-3499-41fe-a77b-418f3a794689" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_40af2bc9-2129-4a71-92ee-29c17d1b12f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_14c1ce0e-1d3f-4ce8-b3ed-d651b901660c" xlink:to="loc_us-gaap_AllOtherSegmentsMember_40af2bc9-2129-4a71-92ee-29c17d1b12f1" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails" xlink:type="extended" id="i21b211cf683749bb9b89b69a271476fa_SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_d0175c11-6cce-4f0d-9ad2-abdd5faca36b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_9117fc8a-e0e6-4049-8c9a-1a72ecb6e5d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d0175c11-6cce-4f0d-9ad2-abdd5faca36b" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_9117fc8a-e0e6-4049-8c9a-1a72ecb6e5d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_846bc5c3-687e-4aef-8047-c0c03a8a02cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d0175c11-6cce-4f0d-9ad2-abdd5faca36b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_846bc5c3-687e-4aef-8047-c0c03a8a02cb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_1bde0c53-3e35-4b7b-8979-c9363843d8da" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_846bc5c3-687e-4aef-8047-c0c03a8a02cb" xlink:to="loc_srt_LitigationCaseAxis_1bde0c53-3e35-4b7b-8979-c9363843d8da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_1bde0c53-3e35-4b7b-8979-c9363843d8da_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_1bde0c53-3e35-4b7b-8979-c9363843d8da" xlink:to="loc_srt_LitigationCaseTypeDomain_1bde0c53-3e35-4b7b-8979-c9363843d8da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_a04c1d4b-064d-45b0-9923-e1b5541af6ae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_1bde0c53-3e35-4b7b-8979-c9363843d8da" xlink:to="loc_srt_LitigationCaseTypeDomain_a04c1d4b-064d-45b0-9923-e1b5541af6ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember_f37efd5d-2c18-485e-85a0-12f12f216a88" xlink:href="mo-20210930.xsd#mo_NonParticipatingManufacturerArbitrationPanelDecisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_a04c1d4b-064d-45b0-9923-e1b5541af6ae" xlink:to="loc_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember_f37efd5d-2c18-485e-85a0-12f12f216a88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_be11c5cf-e186-4ff5-8e82-c61d8731a708" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_846bc5c3-687e-4aef-8047-c0c03a8a02cb" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_be11c5cf-e186-4ff5-8e82-c61d8731a708" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_be11c5cf-e186-4ff5-8e82-c61d8731a708_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_be11c5cf-e186-4ff5-8e82-c61d8731a708" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_be11c5cf-e186-4ff5-8e82-c61d8731a708_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ce6e874f-dad9-4efb-a152-02794f9df8c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_be11c5cf-e186-4ff5-8e82-c61d8731a708" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ce6e874f-dad9-4efb-a152-02794f9df8c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossMember_e546da35-2202-4a1c-bea4-7a8d30d0c9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ce6e874f-dad9-4efb-a152-02794f9df8c2" xlink:to="loc_us-gaap_OperatingIncomeLossMember_e546da35-2202-4a1c-bea4-7a8d30d0c9c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InterestAndOtherDebtExpenseNetMember_b019bdd8-d04a-4451-977d-bcd3728098c4" xlink:href="mo-20210930.xsd#mo_InterestAndOtherDebtExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ce6e874f-dad9-4efb-a152-02794f9df8c2" xlink:to="loc_mo_InterestAndOtherDebtExpenseNetMember_b019bdd8-d04a-4451-977d-bcd3728098c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_57eb9492-d386-41ef-8de1-b4e50073215c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_846bc5c3-687e-4aef-8047-c0c03a8a02cb" xlink:to="loc_us-gaap_NatureOfExpenseAxis_57eb9492-d386-41ef-8de1-b4e50073215c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_57eb9492-d386-41ef-8de1-b4e50073215c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NatureOfExpenseAxis_57eb9492-d386-41ef-8de1-b4e50073215c" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_57eb9492-d386-41ef-8de1-b4e50073215c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_2fa7eb25-7ea6-4231-b097-13672c6082c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NatureOfExpenseAxis_57eb9492-d386-41ef-8de1-b4e50073215c" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_2fa7eb25-7ea6-4231-b097-13672c6082c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NpmAdjustmentToCostOfSalesMember_cdc52f9a-46d6-473d-839e-c178ab57c512" xlink:href="mo-20210930.xsd#mo_NpmAdjustmentToCostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_2fa7eb25-7ea6-4231-b097-13672c6082c9" xlink:to="loc_mo_NpmAdjustmentToCostOfSalesMember_cdc52f9a-46d6-473d-839e-c178ab57c512" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_895f8cf6-5725-49a6-bb80-f7dc4ddacbc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_846bc5c3-687e-4aef-8047-c0c03a8a02cb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_895f8cf6-5725-49a6-bb80-f7dc4ddacbc2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_895f8cf6-5725-49a6-bb80-f7dc4ddacbc2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_895f8cf6-5725-49a6-bb80-f7dc4ddacbc2" xlink:to="loc_us-gaap_SegmentDomain_895f8cf6-5725-49a6-bb80-f7dc4ddacbc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c7fcf5ec-e783-4a41-acde-3094d3e86e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_895f8cf6-5725-49a6-bb80-f7dc4ddacbc2" xlink:to="loc_us-gaap_SegmentDomain_c7fcf5ec-e783-4a41-acde-3094d3e86e9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_6c0d0bb9-a2a2-4c8b-80e7-4d711c0f8bb8" xlink:href="mo-20210930.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c7fcf5ec-e783-4a41-acde-3094d3e86e9d" xlink:to="loc_mo_SmokeableProductsSegmentMember_6c0d0bb9-a2a2-4c8b-80e7-4d711c0f8bb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_506cff7d-92a1-4409-b875-1e5db13e0979" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_846bc5c3-687e-4aef-8047-c0c03a8a02cb" xlink:to="loc_dei_LegalEntityAxis_506cff7d-92a1-4409-b875-1e5db13e0979" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_506cff7d-92a1-4409-b875-1e5db13e0979_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_506cff7d-92a1-4409-b875-1e5db13e0979" xlink:to="loc_dei_EntityDomain_506cff7d-92a1-4409-b875-1e5db13e0979_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_68c4513b-4441-4db9-b99a-b154636f5c76" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_506cff7d-92a1-4409-b875-1e5db13e0979" xlink:to="loc_dei_EntityDomain_68c4513b-4441-4db9-b99a-b154636f5c76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_c6440f37-ebac-403a-b32a-4d370eb0216c" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_68c4513b-4441-4db9-b99a-b154636f5c76" xlink:to="loc_mo_PhilipMorrisUSAMember_c6440f37-ebac-403a-b32a-4d370eb0216c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_eef8a4e4-2c93-43bd-a35c-4c8176cfd6e1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_846bc5c3-687e-4aef-8047-c0c03a8a02cb" xlink:to="loc_srt_ConsolidationItemsAxis_eef8a4e4-2c93-43bd-a35c-4c8176cfd6e1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_eef8a4e4-2c93-43bd-a35c-4c8176cfd6e1_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_eef8a4e4-2c93-43bd-a35c-4c8176cfd6e1" xlink:to="loc_srt_ConsolidationItemsDomain_eef8a4e4-2c93-43bd-a35c-4c8176cfd6e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3c499ce5-fa3e-469d-ba09-22de5d69bd65" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_eef8a4e4-2c93-43bd-a35c-4c8176cfd6e1" xlink:to="loc_srt_ConsolidationItemsDomain_3c499ce5-fa3e-469d-ba09-22de5d69bd65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_58c0ca2c-6605-46dc-9016-ab6dfd73f041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_3c499ce5-fa3e-469d-ba09-22de5d69bd65" xlink:to="loc_us-gaap_OperatingSegmentsMember_58c0ca2c-6605-46dc-9016-ab6dfd73f041" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_328c0cbb-e576-4904-8072-36180f011e86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_3c499ce5-fa3e-469d-ba09-22de5d69bd65" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_328c0cbb-e576-4904-8072-36180f011e86" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails" xlink:type="extended" id="i11d9db3a6d854b59975aff94e7148db4_SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_bf6c86c8-7a28-4bf9-bf07-03fb03665722" xlink:href="mo-20210930.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_3b572ffc-61f7-45fd-a782-4d89ebc71793" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_bf6c86c8-7a28-4bf9-bf07-03fb03665722" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_3b572ffc-61f7-45fd-a782-4d89ebc71793" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ce1e009a-b1fb-4176-89be-17e79c032ea3" xlink:href="mo-20210930.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_bf6c86c8-7a28-4bf9-bf07-03fb03665722" xlink:to="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ce1e009a-b1fb-4176-89be-17e79c032ea3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b18a46b3-e4e3-44ec-a44b-f05e2c275b76" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ce1e009a-b1fb-4176-89be-17e79c032ea3" xlink:to="loc_dei_LegalEntityAxis_b18a46b3-e4e3-44ec-a44b-f05e2c275b76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b18a46b3-e4e3-44ec-a44b-f05e2c275b76_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_b18a46b3-e4e3-44ec-a44b-f05e2c275b76" xlink:to="loc_dei_EntityDomain_b18a46b3-e4e3-44ec-a44b-f05e2c275b76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ad7d98a7-4bc3-40f2-824f-b57909623d76" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_b18a46b3-e4e3-44ec-a44b-f05e2c275b76" xlink:to="loc_dei_EntityDomain_ad7d98a7-4bc3-40f2-824f-b57909623d76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_248f85e6-7aea-4dd3-a0ab-a6d7b813e3da" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_ad7d98a7-4bc3-40f2-824f-b57909623d76" xlink:to="loc_mo_PhilipMorrisUSAMember_248f85e6-7aea-4dd3-a0ab-a6d7b813e3da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_aeda89f1-9fce-4e6e-902f-cb7dbad641df" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ce1e009a-b1fb-4176-89be-17e79c032ea3" xlink:to="loc_srt_LitigationCaseAxis_aeda89f1-9fce-4e6e-902f-cb7dbad641df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_aeda89f1-9fce-4e6e-902f-cb7dbad641df_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_aeda89f1-9fce-4e6e-902f-cb7dbad641df" xlink:to="loc_srt_LitigationCaseTypeDomain_aeda89f1-9fce-4e6e-902f-cb7dbad641df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_48c247c6-5c25-4489-acdc-0b3c1c9660ce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_aeda89f1-9fce-4e6e-902f-cb7dbad641df" xlink:to="loc_srt_LitigationCaseTypeDomain_48c247c6-5c25-4489-acdc-0b3c1c9660ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthLitigationCasesMember_ec81e235-357d-4b63-8f80-c7ced6c0cce8" xlink:href="mo-20210930.xsd#mo_TobaccoandHealthLitigationCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_48c247c6-5c25-4489-acdc-0b3c1c9660ce" xlink:to="loc_mo_TobaccoandHealthLitigationCasesMember_ec81e235-357d-4b63-8f80-c7ced6c0cce8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_1efb1bf7-72fe-40eb-941c-f2f359a86065" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ce1e009a-b1fb-4176-89be-17e79c032ea3" xlink:to="loc_srt_ConsolidationItemsAxis_1efb1bf7-72fe-40eb-941c-f2f359a86065" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_1efb1bf7-72fe-40eb-941c-f2f359a86065_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_1efb1bf7-72fe-40eb-941c-f2f359a86065" xlink:to="loc_srt_ConsolidationItemsDomain_1efb1bf7-72fe-40eb-941c-f2f359a86065_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_40f47a4b-32f4-4d8d-95d6-629718f0d502" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_1efb1bf7-72fe-40eb-941c-f2f359a86065" xlink:to="loc_srt_ConsolidationItemsDomain_40f47a4b-32f4-4d8d-95d6-629718f0d502" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_2a03fa5d-60c1-4302-8fdb-f8b0c61fb7df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_40f47a4b-32f4-4d8d-95d6-629718f0d502" xlink:to="loc_us-gaap_OperatingSegmentsMember_2a03fa5d-60c1-4302-8fdb-f8b0c61fb7df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_c075ab95-b7d3-47ac-9270-2d46441640bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_40f47a4b-32f4-4d8d-95d6-629718f0d502" xlink:to="loc_us-gaap_CorporateNonSegmentMember_c075ab95-b7d3-47ac-9270-2d46441640bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_171cd108-0bdd-4653-9d55-9a208e4e41a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_40f47a4b-32f4-4d8d-95d6-629718f0d502" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_171cd108-0bdd-4653-9d55-9a208e4e41a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6c7f45f9-a12e-4fa9-8af1-f94390b573a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ce1e009a-b1fb-4176-89be-17e79c032ea3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6c7f45f9-a12e-4fa9-8af1-f94390b573a0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6c7f45f9-a12e-4fa9-8af1-f94390b573a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6c7f45f9-a12e-4fa9-8af1-f94390b573a0" xlink:to="loc_us-gaap_SegmentDomain_6c7f45f9-a12e-4fa9-8af1-f94390b573a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2c84f674-ba8e-4368-979f-4035bd4801d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6c7f45f9-a12e-4fa9-8af1-f94390b573a0" xlink:to="loc_us-gaap_SegmentDomain_2c84f674-ba8e-4368-979f-4035bd4801d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_2cda2532-82fd-4111-92c5-939eee47b7b8" xlink:href="mo-20210930.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2c84f674-ba8e-4368-979f-4035bd4801d9" xlink:to="loc_mo_SmokeableProductsSegmentMember_2cda2532-82fd-4111-92c5-939eee47b7b8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#SegmentReportingNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/SegmentReportingNarrativeDetails" xlink:type="extended" id="i5c903eda8500440195ef7e707174357f_SegmentReportingNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_8c723e2c-9706-457c-bfdf-b688e26f1f08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_54ee3bda-313a-48b4-8dcd-f9f9558ea996" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c723e2c-9706-457c-bfdf-b688e26f1f08" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_54ee3bda-313a-48b4-8dcd-f9f9558ea996" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts_c10f3701-369e-4b7b-9e5a-3dd28f993c88" xlink:href="mo-20210930.xsd#mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c723e2c-9706-457c-bfdf-b688e26f1f08" xlink:to="loc_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts_c10f3701-369e-4b7b-9e5a-3dd28f993c88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts_781b6fab-8b5b-44e9-923d-14367fe02a91" xlink:href="mo-20210930.xsd#mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c723e2c-9706-457c-bfdf-b688e26f1f08" xlink:to="loc_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts_781b6fab-8b5b-44e9-923d-14367fe02a91" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_cb15a621-58ba-42b5-998d-32ad868d8ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c723e2c-9706-457c-bfdf-b688e26f1f08" xlink:to="loc_us-gaap_RestructuringCharges_cb15a621-58ba-42b5-998d-32ad868d8ec0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_4b079bb4-af98-46bb-bf4b-eee1d52696de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c723e2c-9706-457c-bfdf-b688e26f1f08" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_4b079bb4-af98-46bb-bf4b-eee1d52696de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d4b07cff-10f7-4f0d-a8b9-2b561e378447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c723e2c-9706-457c-bfdf-b688e26f1f08" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d4b07cff-10f7-4f0d-a8b9-2b561e378447" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_b24e8ff6-a660-4d23-ba6d-d2da66ae87d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d4b07cff-10f7-4f0d-a8b9-2b561e378447" xlink:to="loc_us-gaap_RestructuringPlanAxis_b24e8ff6-a660-4d23-ba6d-d2da66ae87d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_b24e8ff6-a660-4d23-ba6d-d2da66ae87d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_b24e8ff6-a660-4d23-ba6d-d2da66ae87d7" xlink:to="loc_us-gaap_RestructuringPlanDomain_b24e8ff6-a660-4d23-ba6d-d2da66ae87d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_89991efe-1c24-4e97-9860-ae1f72dd4b00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_b24e8ff6-a660-4d23-ba6d-d2da66ae87d7" xlink:to="loc_us-gaap_RestructuringPlanDomain_89991efe-1c24-4e97-9860-ae1f72dd4b00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineBusinessStrategicResetMember_dea0aec3-d4b1-4986-bff4-d60ddbda8153" xlink:href="mo-20210930.xsd#mo_WineBusinessStrategicResetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_89991efe-1c24-4e97-9860-ae1f72dd4b00" xlink:to="loc_mo_WineBusinessStrategicResetMember_dea0aec3-d4b1-4986-bff4-d60ddbda8153" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_399db37a-da3a-455d-aa5e-4fd842c15138" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d4b07cff-10f7-4f0d-a8b9-2b561e378447" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_399db37a-da3a-455d-aa5e-4fd842c15138" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_399db37a-da3a-455d-aa5e-4fd842c15138_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_399db37a-da3a-455d-aa5e-4fd842c15138" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_399db37a-da3a-455d-aa5e-4fd842c15138_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_f3d52e1d-f553-428b-bfa9-3835b62319f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_399db37a-da3a-455d-aa5e-4fd842c15138" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_f3d52e1d-f553-428b-bfa9-3835b62319f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InventoryDisposalCostsandOtherMember_b72555ab-4ba4-42bc-9d93-aca48f06074c" xlink:href="mo-20210930.xsd#mo_InventoryDisposalCostsandOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_f3d52e1d-f553-428b-bfa9-3835b62319f9" xlink:to="loc_mo_InventoryDisposalCostsandOtherMember_b72555ab-4ba4-42bc-9d93-aca48f06074c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InventoryWriteOffMember_d9ff67bb-9638-4a08-a305-41c80e020200" xlink:href="mo-20210930.xsd#mo_InventoryWriteOffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_f3d52e1d-f553-428b-bfa9-3835b62319f9" xlink:to="loc_mo_InventoryWriteOffMember_d9ff67bb-9638-4a08-a305-41c80e020200" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentMember_14b1ef7a-9970-4276-a8a7-83d821e262bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseCommitmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_f3d52e1d-f553-428b-bfa9-3835b62319f9" xlink:to="loc_us-gaap_PurchaseCommitmentMember_14b1ef7a-9970-4276-a8a7-83d821e262bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9fd4157b-228a-479b-b72e-953074a86764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d4b07cff-10f7-4f0d-a8b9-2b561e378447" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9fd4157b-228a-479b-b72e-953074a86764" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9fd4157b-228a-479b-b72e-953074a86764_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9fd4157b-228a-479b-b72e-953074a86764" xlink:to="loc_us-gaap_SegmentDomain_9fd4157b-228a-479b-b72e-953074a86764_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d5b83406-1ad2-437f-ac22-51ba1cd40ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9fd4157b-228a-479b-b72e-953074a86764" xlink:to="loc_us-gaap_SegmentDomain_d5b83406-1ad2-437f-ac22-51ba1cd40ea7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember_a7c94484-d5fc-4c44-9088-b63c4b33de1e" xlink:href="mo-20210930.xsd#mo_OralTobaccoSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d5b83406-1ad2-437f-ac22-51ba1cd40ea7" xlink:to="loc_mo_OralTobaccoSegmentMember_a7c94484-d5fc-4c44-9088-b63c4b33de1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_e2558053-1e3d-4c50-ab77-b5472787b9de" xlink:href="mo-20210930.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d5b83406-1ad2-437f-ac22-51ba1cd40ea7" xlink:to="loc_mo_SmokeableProductsSegmentMember_e2558053-1e3d-4c50-ab77-b5472787b9de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineSegmentMember_95e69473-8b89-462c-ac53-a45e36ea03f3" xlink:href="mo-20210930.xsd#mo_WineSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d5b83406-1ad2-437f-ac22-51ba1cd40ea7" xlink:to="loc_mo_WineSegmentMember_95e69473-8b89-462c-ac53-a45e36ea03f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_589af2e8-fbad-4d02-a261-6b53cfcae039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d4b07cff-10f7-4f0d-a8b9-2b561e378447" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_589af2e8-fbad-4d02-a261-6b53cfcae039" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_589af2e8-fbad-4d02-a261-6b53cfcae039_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_589af2e8-fbad-4d02-a261-6b53cfcae039" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_589af2e8-fbad-4d02-a261-6b53cfcae039_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_29bc20c7-10e4-4496-a741-dfda7d8cc2a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_589af2e8-fbad-4d02-a261-6b53cfcae039" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_29bc20c7-10e4-4496-a741-dfda7d8cc2a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_COVID19Member_bb9fbb51-4287-4377-a5cb-6efd2923f324" xlink:href="mo-20210930.xsd#mo_COVID19Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_29bc20c7-10e4-4496-a741-dfda7d8cc2a1" xlink:to="loc_mo_COVID19Member_bb9fbb51-4287-4377-a5cb-6efd2923f324" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d04a50bd-a23b-4f41-8fef-3dbe3c59063d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d4b07cff-10f7-4f0d-a8b9-2b561e378447" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d04a50bd-a23b-4f41-8fef-3dbe3c59063d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d04a50bd-a23b-4f41-8fef-3dbe3c59063d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d04a50bd-a23b-4f41-8fef-3dbe3c59063d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d04a50bd-a23b-4f41-8fef-3dbe3c59063d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b35f1dd1-d9ae-47f9-9da3-d26d4f44526b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d04a50bd-a23b-4f41-8fef-3dbe3c59063d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b35f1dd1-d9ae-47f9-9da3-d26d4f44526b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_7478773e-397a-4a8b-9cb8-affe7b6566fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_b35f1dd1-d9ae-47f9-9da3-d26d4f44526b" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_7478773e-397a-4a8b-9cb8-affe7b6566fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5636acb5-153f-4fd8-ac3c-71951b293036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d4b07cff-10f7-4f0d-a8b9-2b561e378447" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5636acb5-153f-4fd8-ac3c-71951b293036" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5636acb5-153f-4fd8-ac3c-71951b293036_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5636acb5-153f-4fd8-ac3c-71951b293036" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5636acb5-153f-4fd8-ac3c-71951b293036_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_db654491-c47d-4b8f-96c9-efbfcd3d415a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5636acb5-153f-4fd8-ac3c-71951b293036" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_db654491-c47d-4b8f-96c9-efbfcd3d415a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SteMichelleTransactionMember_268a48c7-c9b3-4dfd-bfc3-938f3cdb099d" xlink:href="mo-20210930.xsd#mo_SteMichelleTransactionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_db654491-c47d-4b8f-96c9-efbfcd3d415a" xlink:to="loc_mo_SteMichelleTransactionMember_268a48c7-c9b3-4dfd-bfc3-938f3cdb099d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_889c84c1-45e5-40b0-812e-bb68292730a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d4b07cff-10f7-4f0d-a8b9-2b561e378447" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_889c84c1-45e5-40b0-812e-bb68292730a7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_889c84c1-45e5-40b0-812e-bb68292730a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_889c84c1-45e5-40b0-812e-bb68292730a7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_889c84c1-45e5-40b0-812e-bb68292730a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c5690152-26e7-45de-8f5a-454c32b803ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_889c84c1-45e5-40b0-812e-bb68292730a7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c5690152-26e7-45de-8f5a-454c32b803ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarketingAdministrationAndResearchCostsMember_98f62c92-6550-45a5-99d7-708e3f25b105" xlink:href="mo-20210930.xsd#mo_MarketingAdministrationAndResearchCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c5690152-26e7-45de-8f5a-454c32b803ea" xlink:to="loc_mo_MarketingAdministrationAndResearchCostsMember_98f62c92-6550-45a5-99d7-708e3f25b105" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#DebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/DebtNarrativeDetails" xlink:type="extended" id="i9e4023cc88044243980a709cc01e716b_DebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_827b4dba-bfec-472b-a0b3-061f606d71ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_ShortTermBorrowings_827b4dba-bfec-472b-a0b3-061f606d71ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_90486ede-6074-4878-8c82-e6469828c1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_90486ede-6074-4878-8c82-e6469828c1c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_9250404f-7bc2-4444-b172-6bedd065a257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_DebtInstrumentTerm_9250404f-7bc2-4444-b172-6bedd065a257" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentExtensionTerm_8937f46b-e612-402c-9c59-bf0e1246d5db" xlink:href="mo-20210930.xsd#mo_DebtInstrumentExtensionTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_mo_DebtInstrumentExtensionTerm_8937f46b-e612-402c-9c59-bf0e1246d5db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_611adfb2-0efa-4157-83e1-70c00df5a05b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_611adfb2-0efa-4157-83e1-70c00df5a05b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_5e1806c1-82ea-4ae5-a011-551f60b606fd" xlink:href="mo-20210930.xsd#mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_5e1806c1-82ea-4ae5-a011-551f60b606fd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_bb3109f3-0805-4afc-8067-63ebf76a2dc7" xlink:href="mo-20210930.xsd#mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_bb3109f3-0805-4afc-8067-63ebf76a2dc7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_83ca4831-6e5f-4b63-9b44-54eb51bc264e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_83ca4831-6e5f-4b63-9b44-54eb51bc264e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e3f9d908-6134-48de-93be-2ff456ae81a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_LongTermDebt_e3f9d908-6134-48de-93be-2ff456ae81a6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfUnsecuredDebt_1a9f0828-5a35-4489-8fdc-abafab0e7f44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfUnsecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_RepaymentsOfUnsecuredDebt_1a9f0828-5a35-4489-8fdc-abafab0e7f44" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_dcc35ae5-7d01-4ceb-a5e7-45ae178c6f85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_dcc35ae5-7d01-4ceb-a5e7-45ae178c6f85" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_b9e1e39e-a658-49ea-9eb5-9211e92c20c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_b9e1e39e-a658-49ea-9eb5-9211e92c20c1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_529c4af8-d620-4bbe-a925-0fa3e1602735" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_529c4af8-d620-4bbe-a925-0fa3e1602735" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_536289ae-c023-4da3-9bde-7bb174651efc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_536289ae-c023-4da3-9bde-7bb174651efc" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_07437ceb-8ac6-4987-b377-f21c57122076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_07437ceb-8ac6-4987-b377-f21c57122076" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_c75fc5d3-b11d-4fd9-b93e-c195b4f70c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_c75fc5d3-b11d-4fd9-b93e-c195b4f70c6e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_e76cb5b1-b9aa-479d-a2e1-6ae6206cf15c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_e76cb5b1-b9aa-479d-a2e1-6ae6206cf15c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a9620b17-3ff1-471d-b849-b4e551baf235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_DebtInstrumentTable_a9620b17-3ff1-471d-b849-b4e551baf235" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_4c4ab7be-f79b-42e2-a967-8532c1e4d222" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a9620b17-3ff1-471d-b849-b4e551baf235" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_4c4ab7be-f79b-42e2-a967-8532c1e4d222" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4c4ab7be-f79b-42e2-a967-8532c1e4d222_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_4c4ab7be-f79b-42e2-a967-8532c1e4d222" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4c4ab7be-f79b-42e2-a967-8532c1e4d222_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fed7dace-01bd-4e5f-87ad-8633a97afeb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_4c4ab7be-f79b-42e2-a967-8532c1e4d222" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fed7dace-01bd-4e5f-87ad-8633a97afeb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_2c861a53-bf9a-41af-b097-4286c5e968e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fed7dace-01bd-4e5f-87ad-8633a97afeb9" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_2c861a53-bf9a-41af-b097-4286c5e968e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_9ec5f406-07f2-4b28-88e2-9a0346f401a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a9620b17-3ff1-471d-b849-b4e551baf235" xlink:to="loc_us-gaap_VariableRateAxis_9ec5f406-07f2-4b28-88e2-9a0346f401a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9ec5f406-07f2-4b28-88e2-9a0346f401a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_9ec5f406-07f2-4b28-88e2-9a0346f401a1" xlink:to="loc_us-gaap_VariableRateDomain_9ec5f406-07f2-4b28-88e2-9a0346f401a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_6695bd11-5c40-44c0-af91-92ca3baa4c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_9ec5f406-07f2-4b28-88e2-9a0346f401a1" xlink:to="loc_us-gaap_VariableRateDomain_6695bd11-5c40-44c0-af91-92ca3baa4c46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_5ac9a13c-0b6e-435b-ba24-ef98c774faa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_6695bd11-5c40-44c0-af91-92ca3baa4c46" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_5ac9a13c-0b6e-435b-ba24-ef98c774faa5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_853adb2f-172d-4776-959e-27fb72aa5cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a9620b17-3ff1-471d-b849-b4e551baf235" xlink:to="loc_us-gaap_CreditFacilityAxis_853adb2f-172d-4776-959e-27fb72aa5cc1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_853adb2f-172d-4776-959e-27fb72aa5cc1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_853adb2f-172d-4776-959e-27fb72aa5cc1" xlink:to="loc_us-gaap_CreditFacilityDomain_853adb2f-172d-4776-959e-27fb72aa5cc1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f7f547f6-97e1-49e7-bf67-bd553f5b0c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_853adb2f-172d-4776-959e-27fb72aa5cc1" xlink:to="loc_us-gaap_CreditFacilityDomain_f7f547f6-97e1-49e7-bf67-bd553f5b0c2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_56665061-e2da-48fd-b4c7-6fcbb311d00f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f7f547f6-97e1-49e7-bf67-bd553f5b0c2f" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_56665061-e2da-48fd-b4c7-6fcbb311d00f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5120bb37-d679-4f9e-8d87-9ca6d4042114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a9620b17-3ff1-471d-b849-b4e551baf235" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5120bb37-d679-4f9e-8d87-9ca6d4042114" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5120bb37-d679-4f9e-8d87-9ca6d4042114_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5120bb37-d679-4f9e-8d87-9ca6d4042114" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5120bb37-d679-4f9e-8d87-9ca6d4042114_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_465a60af-ebf2-4e82-9050-2d48ccede1be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5120bb37-d679-4f9e-8d87-9ca6d4042114" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_465a60af-ebf2-4e82-9050-2d48ccede1be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_03c118d6-c1a5-4037-8b7d-9a06031c6539" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_465a60af-ebf2-4e82-9050-2d48ccede1be" xlink:to="loc_us-gaap_LineOfCreditMember_03c118d6-c1a5-4037-8b7d-9a06031c6539" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_86ae3818-cf74-4b7f-b43d-dec20154eb92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_465a60af-ebf2-4e82-9050-2d48ccede1be" xlink:to="loc_us-gaap_SeniorNotesMember_86ae3818-cf74-4b7f-b43d-dec20154eb92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c97b003b-2610-4f86-a37a-3d84e4bdfd30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a9620b17-3ff1-471d-b849-b4e551baf235" xlink:to="loc_us-gaap_DebtInstrumentAxis_c97b003b-2610-4f86-a37a-3d84e4bdfd30" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c97b003b-2610-4f86-a37a-3d84e4bdfd30_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c97b003b-2610-4f86-a37a-3d84e4bdfd30" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c97b003b-2610-4f86-a37a-3d84e4bdfd30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ad390ebc-d6a0-46c6-8294-ca97eca80b01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c97b003b-2610-4f86-a37a-3d84e4bdfd30" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ad390ebc-d6a0-46c6-8294-ca97eca80b01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RevolvingCreditFacilityDueAugust2024Member_014dd6cc-b9ea-446e-abd9-e1f5d99b20b6" xlink:href="mo-20210930.xsd#mo_RevolvingCreditFacilityDueAugust2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ad390ebc-d6a0-46c6-8294-ca97eca80b01" xlink:to="loc_mo_RevolvingCreditFacilityDueAugust2024Member_014dd6cc-b9ea-446e-abd9-e1f5d99b20b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesMember_b07620d9-248b-4410-886d-5d87388140f6" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ad390ebc-d6a0-46c6-8294-ca97eca80b01" xlink:to="loc_mo_USDDenominatedNotesMember_b07620d9-248b-4410-886d-5d87388140f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesDue2032Member_b0093bc3-907e-4429-9ecd-81f58cb8c7a6" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotesDue2032Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ad390ebc-d6a0-46c6-8294-ca97eca80b01" xlink:to="loc_mo_USDDenominatedNotesDue2032Member_b0093bc3-907e-4429-9ecd-81f58cb8c7a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesDue2041Member_3a97c7c0-8a70-4040-8fd7-7d9a45afc1db" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotesDue2041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ad390ebc-d6a0-46c6-8294-ca97eca80b01" xlink:to="loc_mo_USDDenominatedNotesDue2041Member_3a97c7c0-8a70-4040-8fd7-7d9a45afc1db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesDue2051Member_87e2e830-c5fc-45dc-b924-94c30227857e" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotesDue2051Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ad390ebc-d6a0-46c6-8294-ca97eca80b01" xlink:to="loc_mo_USDDenominatedNotesDue2051Member_87e2e830-c5fc-45dc-b924-94c30227857e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesDue2061Member_76b74dd7-c466-40e9-995b-8c89d1ff0320" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotesDue2061Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ad390ebc-d6a0-46c6-8294-ca97eca80b01" xlink:to="loc_mo_USDDenominatedNotesDue2061Member_76b74dd7-c466-40e9-995b-8c89d1ff0320" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes3490PercentDue2022Member_620bf90d-9cc7-4888-9e7b-7fb4bf08c4c7" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotes3490PercentDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ad390ebc-d6a0-46c6-8294-ca97eca80b01" xlink:to="loc_mo_USDDenominatedNotes3490PercentDue2022Member_620bf90d-9cc7-4888-9e7b-7fb4bf08c4c7" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/DebtTenderOffersDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#DebtTenderOffersDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/DebtTenderOffersDetails" xlink:type="extended" id="i23b2dafe251448e2b87c808e2e3d48c9_DebtTenderOffersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_596121dc-01b8-43bb-ba46-f1f077e371d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_edef35cb-40d6-498b-96d5-69406a46bd3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_596121dc-01b8-43bb-ba46-f1f077e371d4" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_edef35cb-40d6-498b-96d5-69406a46bd3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_afa9e5cb-5fba-4b1d-b1c1-2e9d150d55e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_596121dc-01b8-43bb-ba46-f1f077e371d4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_afa9e5cb-5fba-4b1d-b1c1-2e9d150d55e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_94f51414-84bf-416f-a277-78307ae9bd84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_596121dc-01b8-43bb-ba46-f1f077e371d4" xlink:to="loc_us-gaap_DebtInstrumentTable_94f51414-84bf-416f-a277-78307ae9bd84" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_18e39b19-34e8-49bf-a509-c7f3e1de4545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_94f51414-84bf-416f-a277-78307ae9bd84" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_18e39b19-34e8-49bf-a509-c7f3e1de4545" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_18e39b19-34e8-49bf-a509-c7f3e1de4545_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_18e39b19-34e8-49bf-a509-c7f3e1de4545" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_18e39b19-34e8-49bf-a509-c7f3e1de4545_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_538c54be-8474-45c7-b50b-99885becfb8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_18e39b19-34e8-49bf-a509-c7f3e1de4545" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_538c54be-8474-45c7-b50b-99885becfb8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_81b32488-49bf-4754-8dd1-c64692f4e3c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_538c54be-8474-45c7-b50b-99885becfb8e" xlink:to="loc_us-gaap_SeniorNotesMember_81b32488-49bf-4754-8dd1-c64692f4e3c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_44811bf0-bf4d-42e0-a6e5-d6fcc5a32e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_94f51414-84bf-416f-a277-78307ae9bd84" xlink:to="loc_us-gaap_DebtInstrumentAxis_44811bf0-bf4d-42e0-a6e5-d6fcc5a32e36" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_44811bf0-bf4d-42e0-a6e5-d6fcc5a32e36_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_44811bf0-bf4d-42e0-a6e5-d6fcc5a32e36" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_44811bf0-bf4d-42e0-a6e5-d6fcc5a32e36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d4745393-7ce8-4bb1-a462-5425bb77110f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_44811bf0-bf4d-42e0-a6e5-d6fcc5a32e36" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d4745393-7ce8-4bb1-a462-5425bb77110f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes2850PercentDue2022Member_04f89ff9-93f8-47be-b492-b1965f998dbd" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotes2850PercentDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4745393-7ce8-4bb1-a462-5425bb77110f" xlink:to="loc_mo_USDDenominatedNotes2850PercentDue2022Member_04f89ff9-93f8-47be-b492-b1965f998dbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes2950PercentDue2023Member_f7e2d178-abf2-4152-bef5-e1b183f7f686" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotes2950PercentDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4745393-7ce8-4bb1-a462-5425bb77110f" xlink:to="loc_mo_USDDenominatedNotes2950PercentDue2023Member_f7e2d178-abf2-4152-bef5-e1b183f7f686" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes4000PercentDue2024Member_76fe33e8-fbe1-4c87-a351-bf4fccd1b2f3" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotes4000PercentDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4745393-7ce8-4bb1-a462-5425bb77110f" xlink:to="loc_mo_USDDenominatedNotes4000PercentDue2024Member_76fe33e8-fbe1-4c87-a351-bf4fccd1b2f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes3800PercentDue2024Member_a0281d1f-c0a1-4a77-8f35-fd6b4867d58b" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotes3800PercentDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4745393-7ce8-4bb1-a462-5425bb77110f" xlink:to="loc_mo_USDDenominatedNotes3800PercentDue2024Member_a0281d1f-c0a1-4a77-8f35-fd6b4867d58b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes4400PercentDue2026Member_ea21af31-fee7-4d9b-96c4-d548dc40ba81" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotes4400PercentDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4745393-7ce8-4bb1-a462-5425bb77110f" xlink:to="loc_mo_USDDenominatedNotes4400PercentDue2026Member_ea21af31-fee7-4d9b-96c4-d548dc40ba81" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes4800PercentDue2029Member_259ab169-8d55-4c77-9285-85340f6565a5" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotes4800PercentDue2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4745393-7ce8-4bb1-a462-5425bb77110f" xlink:to="loc_mo_USDDenominatedNotes4800PercentDue2029Member_259ab169-8d55-4c77-9285-85340f6565a5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes9950PercentDue2038Member_5b531519-325e-470c-9c39-4d2033425e4a" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotes9950PercentDue2038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4745393-7ce8-4bb1-a462-5425bb77110f" xlink:to="loc_mo_USDDenominatedNotes9950PercentDue2038Member_5b531519-325e-470c-9c39-4d2033425e4a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedDebt10200PercentDue2039Member_450fe370-0645-475b-992a-37ae2b1eab44" xlink:href="mo-20210930.xsd#mo_USDDenominatedDebt10200PercentDue2039Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4745393-7ce8-4bb1-a462-5425bb77110f" xlink:to="loc_mo_USDDenominatedDebt10200PercentDue2039Member_450fe370-0645-475b-992a-37ae2b1eab44" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedDebt6200PercentDue2059Member_b10db195-48db-43e4-8627-d75f9f78be54" xlink:href="mo-20210930.xsd#mo_USDDenominatedDebt6200PercentDue2059Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4745393-7ce8-4bb1-a462-5425bb77110f" xlink:to="loc_mo_USDDenominatedDebt6200PercentDue2059Member_b10db195-48db-43e4-8627-d75f9f78be54" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="ic7ec48f124914b87b3a10b7a5899eeda_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_25e4f917-aa2d-49e3-8859-2478b094c826" xlink:href="mo-20210930.xsd#mo_InvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentImpairment_0ea64db7-3e0a-499c-b762-4d522d9a816d" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_25e4f917-aa2d-49e3-8859-2478b094c826" xlink:to="loc_mo_EquityMethodInvestmentImpairment_0ea64db7-3e0a-499c-b762-4d522d9a816d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_a5b88313-5cf4-4e19-b91f-27d5fcab352c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_25e4f917-aa2d-49e3-8859-2478b094c826" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_a5b88313-5cf4-4e19-b91f-27d5fcab352c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_276cb6fa-d3ea-419a-ab69-fee877e34f46" xlink:href="mo-20210930.xsd#mo_InvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mo_InvestmentsLineItems_25e4f917-aa2d-49e3-8859-2478b094c826" xlink:to="loc_mo_InvestmentsTable_276cb6fa-d3ea-419a-ab69-fee877e34f46" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_504a3413-ad0d-4633-80e4-f7d8434bf75e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_276cb6fa-d3ea-419a-ab69-fee877e34f46" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_504a3413-ad0d-4633-80e4-f7d8434bf75e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_504a3413-ad0d-4633-80e4-f7d8434bf75e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_504a3413-ad0d-4633-80e4-f7d8434bf75e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_504a3413-ad0d-4633-80e4-f7d8434bf75e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_8b24e247-b477-4b76-b6f1-a61cc61d703e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_504a3413-ad0d-4633-80e4-f7d8434bf75e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_8b24e247-b477-4b76-b6f1-a61cc61d703e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_4eb2703c-7e7f-44a9-b0e9-98cd8c251d98" xlink:href="mo-20210930.xsd#mo_ABInBevMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8b24e247-b477-4b76-b6f1-a61cc61d703e" xlink:to="loc_mo_ABInBevMember_4eb2703c-7e7f-44a9-b0e9-98cd8c251d98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_d9a356ea-4162-45ce-9108-16b13db0be97" xlink:href="mo-20210930.xsd#mo_JUULMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8b24e247-b477-4b76-b6f1-a61cc61d703e" xlink:to="loc_mo_JUULMember_d9a356ea-4162-45ce-9108-16b13db0be97" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails" xlink:type="extended" id="i4c2feb5be5fe42d58394a86b5778cf2b_ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_112caaea-c49a-4256-96fa-ffba3d737d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_2a7e9a40-0076-4e9a-86b4-6e7cf99d34b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_112caaea-c49a-4256-96fa-ffba3d737d7e" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_2a7e9a40-0076-4e9a-86b4-6e7cf99d34b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementInterest_d1e63136-b1dd-4490-84b9-6f0eb17375d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_112caaea-c49a-4256-96fa-ffba3d737d7e" xlink:to="loc_us-gaap_LitigationSettlementInterest_d1e63136-b1dd-4490-84b9-6f0eb17375d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualRollForward_ea0512ab-c833-4821-af92-d636b8be868c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_112caaea-c49a-4256-96fa-ffba3d737d7e" xlink:to="loc_us-gaap_LossContingencyAccrualRollForward_ea0512ab-c833-4821-af92-d636b8be868c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_14ade3a1-b0ef-4d55-98e7-2fba307aa2da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_ea0512ab-c833-4821-af92-d636b8be868c" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_14ade3a1-b0ef-4d55-98e7-2fba307aa2da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_f78a5117-9e21-49be-8931-00fa21a97153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_ea0512ab-c833-4821-af92-d636b8be868c" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_f78a5117-9e21-49be-8931-00fa21a97153" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_f2b6ff55-3666-401f-a520-fcf58f7b4723" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_ea0512ab-c833-4821-af92-d636b8be868c" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_f2b6ff55-3666-401f-a520-fcf58f7b4723" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_0547bcba-bc12-461f-86d1-4e8eaaa33820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationEscrowDeposit_37f382dd-d3b6-4c29-aa21-5acc9fcf8bbc" xlink:href="mo-20210930.xsd#mo_LitigationEscrowDeposit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_112caaea-c49a-4256-96fa-ffba3d737d7e" xlink:to="loc_mo_LitigationEscrowDeposit_37f382dd-d3b6-4c29-aa21-5acc9fcf8bbc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_d5972877-7b97-4be9-a4e5-9d9b3fa01c54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_112caaea-c49a-4256-96fa-ffba3d737d7e" xlink:to="loc_us-gaap_LossContingenciesTable_d5972877-7b97-4be9-a4e5-9d9b3fa01c54" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_fd821da9-2e70-4948-acdd-94a8014b1f04" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_d5972877-7b97-4be9-a4e5-9d9b3fa01c54" xlink:to="loc_srt_LitigationCaseAxis_fd821da9-2e70-4948-acdd-94a8014b1f04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_fd821da9-2e70-4948-acdd-94a8014b1f04_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_fd821da9-2e70-4948-acdd-94a8014b1f04" xlink:to="loc_srt_LitigationCaseTypeDomain_fd821da9-2e70-4948-acdd-94a8014b1f04_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_1706b05a-9d54-4f54-8f30-bde72357d516" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_fd821da9-2e70-4948-acdd-94a8014b1f04" xlink:to="loc_srt_LitigationCaseTypeDomain_1706b05a-9d54-4f54-8f30-bde72357d516" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthJudgmentMember_e6033b26-cc02-47af-8a28-150e6ac00c42" xlink:href="mo-20210930.xsd#mo_TobaccoandHealthJudgmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_1706b05a-9d54-4f54-8f30-bde72357d516" xlink:to="loc_mo_TobaccoandHealthJudgmentMember_e6033b26-cc02-47af-8a28-150e6ac00c42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember_531ee8a2-3f84-4b1d-a300-d3f60ea93656" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_1706b05a-9d54-4f54-8f30-bde72357d516" xlink:to="loc_mo_EngleProgenyCasesMember_531ee8a2-3f84-4b1d-a300-d3f60ea93656" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_a9e26e5c-2254-4ba1-80ac-b31dc9aa2e24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_d5972877-7b97-4be9-a4e5-9d9b3fa01c54" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_a9e26e5c-2254-4ba1-80ac-b31dc9aa2e24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a9e26e5c-2254-4ba1-80ac-b31dc9aa2e24_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a9e26e5c-2254-4ba1-80ac-b31dc9aa2e24" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a9e26e5c-2254-4ba1-80ac-b31dc9aa2e24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_16568566-064e-4f93-901f-1cf639d702d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a9e26e5c-2254-4ba1-80ac-b31dc9aa2e24" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_16568566-064e-4f93-901f-1cf639d702d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_dc7014da-7475-49ca-b6a3-3b6352f08b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_16568566-064e-4f93-901f-1cf639d702d0" xlink:to="loc_us-gaap_AssetsMember_dc7014da-7475-49ca-b6a3-3b6352f08b9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_a226bd37-01fa-4284-8341-f8e9d68f4929" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_d5972877-7b97-4be9-a4e5-9d9b3fa01c54" xlink:to="loc_us-gaap_LitigationStatusAxis_a226bd37-01fa-4284-8341-f8e9d68f4929" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_a226bd37-01fa-4284-8341-f8e9d68f4929_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_a226bd37-01fa-4284-8341-f8e9d68f4929" xlink:to="loc_us-gaap_LitigationStatusDomain_a226bd37-01fa-4284-8341-f8e9d68f4929_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_d6ca7835-c384-44d1-b246-6428bf5e02c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_a226bd37-01fa-4284-8341-f8e9d68f4929" xlink:to="loc_us-gaap_LitigationStatusDomain_d6ca7835-c384-44d1-b246-6428bf5e02c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_c5dbbc44-7b17-4999-bc5a-b72250ba1747" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_d6ca7835-c384-44d1-b246-6428bf5e02c9" xlink:to="loc_us-gaap_PendingLitigationMember_c5dbbc44-7b17-4999-bc5a-b72250ba1747" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_277ee8fb-ad6e-49d4-be2d-920ce82a22ed" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_d5972877-7b97-4be9-a4e5-9d9b3fa01c54" xlink:to="loc_dei_LegalEntityAxis_277ee8fb-ad6e-49d4-be2d-920ce82a22ed" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_277ee8fb-ad6e-49d4-be2d-920ce82a22ed_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_277ee8fb-ad6e-49d4-be2d-920ce82a22ed" xlink:to="loc_dei_EntityDomain_277ee8fb-ad6e-49d4-be2d-920ce82a22ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_63100925-b37f-4ba5-b8f2-8f0fc4c710e4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_277ee8fb-ad6e-49d4-be2d-920ce82a22ed" xlink:to="loc_dei_EntityDomain_63100925-b37f-4ba5-b8f2-8f0fc4c710e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_a7964e53-e316-4e84-910b-18c77638e5ca" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_63100925-b37f-4ba5-b8f2-8f0fc4c710e4" xlink:to="loc_mo_PhilipMorrisUSAMember_a7964e53-e316-4e84-910b-18c77638e5ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d3aebb6e-a582-45eb-a847-50e889b2c808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_d5972877-7b97-4be9-a4e5-9d9b3fa01c54" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d3aebb6e-a582-45eb-a847-50e889b2c808" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_d3aebb6e-a582-45eb-a847-50e889b2c808_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d3aebb6e-a582-45eb-a847-50e889b2c808" xlink:to="loc_us-gaap_LossContingencyNatureDomain_d3aebb6e-a582-45eb-a847-50e889b2c808_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_8ef7c930-c208-4afc-b56b-d62b8866ae13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d3aebb6e-a582-45eb-a847-50e889b2c808" xlink:to="loc_us-gaap_LossContingencyNatureDomain_8ef7c930-c208-4afc-b56b-d62b8866ae13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationCasesResultsMember_fa81bfed-39fe-4791-8b27-c8118ec5dd0c" xlink:href="mo-20210930.xsd#mo_LitigationCasesResultsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_8ef7c930-c208-4afc-b56b-d62b8866ae13" xlink:to="loc_mo_LitigationCasesResultsMember_fa81bfed-39fe-4791-8b27-c8118ec5dd0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InterestExpenseRelatedToLitigationMember_9b03e382-0308-4de5-ac1a-8611335cc3c4" xlink:href="mo-20210930.xsd#mo_InterestExpenseRelatedToLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_8ef7c930-c208-4afc-b56b-d62b8866ae13" xlink:to="loc_mo_InterestExpenseRelatedToLitigationMember_9b03e382-0308-4de5-ac1a-8611335cc3c4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesScheduleofPendingCasesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails" xlink:type="extended" id="i9fb3ff4fbbf84d2ca87e1f50e61c26f8_ContingenciesScheduleofPendingCasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_b967d7a5-a5b4-446f-b5b6-bfbaee2266aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_9832ced3-f685-4d38-a4d8-29246430b82a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b967d7a5-a5b4-446f-b5b6-bfbaee2266aa" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_9832ced3-f685-4d38-a4d8-29246430b82a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCases_79ba1e47-bc3b-48f3-b7d6-e407ff1f41b7" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfCases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b967d7a5-a5b4-446f-b5b6-bfbaee2266aa" xlink:to="loc_mo_LossContingencyNumberOfCases_79ba1e47-bc3b-48f3-b7d6-e407ff1f41b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassActionLawsuit_2ef83d98-e8af-450d-afb1-f3376d2bf1e6" xlink:href="mo-20210930.xsd#mo_LossContingencyClassActionLawsuit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b967d7a5-a5b4-446f-b5b6-bfbaee2266aa" xlink:to="loc_mo_LossContingencyClassActionLawsuit_2ef83d98-e8af-450d-afb1-f3376d2bf1e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfInactiveCases_8665fe5d-c7f1-464d-a02c-e4531220e6ec" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfInactiveCases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b967d7a5-a5b4-446f-b5b6-bfbaee2266aa" xlink:to="loc_mo_LossContingencyNumberOfInactiveCases_8665fe5d-c7f1-464d-a02c-e4531220e6ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfInactiveClassActionLawsuits_5ab6e774-47b1-49bd-9135-17af30192a90" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfInactiveClassActionLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b967d7a5-a5b4-446f-b5b6-bfbaee2266aa" xlink:to="loc_mo_LossContingencyNumberOfInactiveClassActionLawsuits_5ab6e774-47b1-49bd-9135-17af30192a90" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_9e008ed4-7caf-4391-bcf7-1c644d5d5111" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_b967d7a5-a5b4-446f-b5b6-bfbaee2266aa" xlink:to="loc_us-gaap_LossContingenciesTable_9e008ed4-7caf-4391-bcf7-1c644d5d5111" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_72bba7aa-2ed9-4c10-8e92-e34bf80f58bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_9e008ed4-7caf-4391-bcf7-1c644d5d5111" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_72bba7aa-2ed9-4c10-8e92-e34bf80f58bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_72bba7aa-2ed9-4c10-8e92-e34bf80f58bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_72bba7aa-2ed9-4c10-8e92-e34bf80f58bc" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_72bba7aa-2ed9-4c10-8e92-e34bf80f58bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_92715f03-7cda-4e71-811d-241172cb0054" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_72bba7aa-2ed9-4c10-8e92-e34bf80f58bc" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_92715f03-7cda-4e71-811d-241172cb0054" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_2f49d9e5-1582-4282-a06b-cd3a1b4d9956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_92715f03-7cda-4e71-811d-241172cb0054" xlink:to="loc_us-gaap_SubsequentEventMember_2f49d9e5-1582-4282-a06b-cd3a1b4d9956" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_71c31864-ae0a-4e7e-8b6c-a3dfec4f983b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_9e008ed4-7caf-4391-bcf7-1c644d5d5111" xlink:to="loc_srt_LitigationCaseAxis_71c31864-ae0a-4e7e-8b6c-a3dfec4f983b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_71c31864-ae0a-4e7e-8b6c-a3dfec4f983b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_71c31864-ae0a-4e7e-8b6c-a3dfec4f983b" xlink:to="loc_srt_LitigationCaseTypeDomain_71c31864-ae0a-4e7e-8b6c-a3dfec4f983b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_69e1a00c-1fc1-4e84-9a82-3e243add7b88" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_71c31864-ae0a-4e7e-8b6c-a3dfec4f983b" xlink:to="loc_srt_LitigationCaseTypeDomain_69e1a00c-1fc1-4e84-9a82-3e243add7b88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IndividualSmokingAndHealthCasesMember_97cce8c4-c970-40ac-a1b3-b87f50cfb865" xlink:href="mo-20210930.xsd#mo_IndividualSmokingAndHealthCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_69e1a00c-1fc1-4e84-9a82-3e243add7b88" xlink:to="loc_mo_IndividualSmokingAndHealthCasesMember_97cce8c4-c970-40ac-a1b3-b87f50cfb865" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ETSSmokingandHealthCaseFlightAttendantsMember_859b6bb8-606c-4041-ba2c-7500d25a8ad9" xlink:href="mo-20210930.xsd#mo_ETSSmokingandHealthCaseFlightAttendantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_IndividualSmokingAndHealthCasesMember_97cce8c4-c970-40ac-a1b3-b87f50cfb865" xlink:to="loc_mo_ETSSmokingandHealthCaseFlightAttendantsMember_859b6bb8-606c-4041-ba2c-7500d25a8ad9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_c37e0651-b5ed-4a57-a29c-97812221125b" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_69e1a00c-1fc1-4e84-9a82-3e243add7b88" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_c37e0651-b5ed-4a57-a29c-97812221125b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EvaporLitigationMember_942a50ef-b412-4881-b099-68e4e66ce818" xlink:href="mo-20210930.xsd#mo_EvaporLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_69e1a00c-1fc1-4e84-9a82-3e243add7b88" xlink:to="loc_mo_EvaporLitigationMember_942a50ef-b412-4881-b099-68e4e66ce818" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherTabaccoRelatedCasesMember_b9d7e270-3f79-4be5-9c6a-b9695afce854" xlink:href="mo-20210930.xsd#mo_OtherTabaccoRelatedCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_69e1a00c-1fc1-4e84-9a82-3e243add7b88" xlink:to="loc_mo_OtherTabaccoRelatedCasesMember_b9d7e270-3f79-4be5-9c6a-b9695afce854" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_2ac35e57-58e5-4955-aef9-ce742738555c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_9e008ed4-7caf-4391-bcf7-1c644d5d5111" xlink:to="loc_us-gaap_LitigationStatusAxis_2ac35e57-58e5-4955-aef9-ce742738555c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_2ac35e57-58e5-4955-aef9-ce742738555c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_2ac35e57-58e5-4955-aef9-ce742738555c" xlink:to="loc_us-gaap_LitigationStatusDomain_2ac35e57-58e5-4955-aef9-ce742738555c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_cc86d01d-aebf-45d7-8905-67ab5bef10ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_2ac35e57-58e5-4955-aef9-ce742738555c" xlink:to="loc_us-gaap_LitigationStatusDomain_cc86d01d-aebf-45d7-8905-67ab5bef10ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_db701bdc-21c2-4955-b7b6-eac04aa24463" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_cc86d01d-aebf-45d7-8905-67ab5bef10ea" xlink:to="loc_us-gaap_PendingLitigationMember_db701bdc-21c2-4955-b7b6-eac04aa24463" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember_e2b4c9b9-633a-49c8-9b78-fb954eef0796" xlink:href="mo-20210930.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_cc86d01d-aebf-45d7-8905-67ab5bef10ea" xlink:to="loc_mo_PendingIndividualLawsuitsMember_e2b4c9b9-633a-49c8-9b78-fb954eef0796" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_4cef902f-18e8-4e5b-b337-b1f4cbe6633a" xlink:href="mo-20210930.xsd#mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_cc86d01d-aebf-45d7-8905-67ab5bef10ea" xlink:to="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_4cef902f-18e8-4e5b-b337-b1f4cbe6633a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ccf10894-7e5b-423f-b109-865b69dad772" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_9e008ed4-7caf-4391-bcf7-1c644d5d5111" xlink:to="loc_srt_StatementGeographicalAxis_ccf10894-7e5b-423f-b109-865b69dad772" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ccf10894-7e5b-423f-b109-865b69dad772_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_ccf10894-7e5b-423f-b109-865b69dad772" xlink:to="loc_srt_SegmentGeographicalDomain_ccf10894-7e5b-423f-b109-865b69dad772_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_36538957-fd2a-4237-9d57-eff7cb43e886" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_ccf10894-7e5b-423f-b109-865b69dad772" xlink:to="loc_srt_SegmentGeographicalDomain_36538957-fd2a-4237-9d57-eff7cb43e886" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IL_b5ae7657-282a-4c5c-b0f4-ac6000b1a84c" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_IL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_36538957-fd2a-4237-9d57-eff7cb43e886" xlink:to="loc_stpr_IL_b5ae7657-282a-4c5c-b0f4-ac6000b1a84c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NM_c8b90a95-69c9-45c9-b992-18c5ebbeba26" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_NM"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_36538957-fd2a-4237-9d57-eff7cb43e886" xlink:to="loc_stpr_NM_c8b90a95-69c9-45c9-b992-18c5ebbeba26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA_9a51f085-5da2-44e9-9174-e09c1f860151" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_36538957-fd2a-4237-9d57-eff7cb43e886" xlink:to="loc_stpr_MA_9a51f085-5da2-44e9-9174-e09c1f860151" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_caef1c67-4c18-46d7-9c5c-f5abe9d04d99" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_FL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_36538957-fd2a-4237-9d57-eff7cb43e886" xlink:to="loc_stpr_FL_caef1c67-4c18-46d7-9c5c-f5abe9d04d99" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails" xlink:type="extended" id="i5727cae3257646d695b7c125379cd817_ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_980f6691-1bd5-481e-8ed7-903e72eb01f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_c6842b7f-e815-4daf-9a66-f3ff530b78a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_980f6691-1bd5-481e-8ed7-903e72eb01f3" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_c6842b7f-e815-4daf-9a66-f3ff530b78a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofCasesSetforTrial_f8e8835f-9830-4ce6-ab53-8dc7ca5272d4" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberofCasesSetforTrial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_980f6691-1bd5-481e-8ed7-903e72eb01f3" xlink:to="loc_mo_LossContingencyNumberofCasesSetforTrial_f8e8835f-9830-4ce6-ab53-8dc7ca5272d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecided_2bb4c651-1068-439f-9833-ee3c0f8daf79" xlink:href="mo-20210930.xsd#mo_LossContingencyClaimsDecided"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_980f6691-1bd5-481e-8ed7-903e72eb01f3" xlink:to="loc_mo_LossContingencyClaimsDecided_2bb4c651-1068-439f-9833-ee3c0f8daf79" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedFavorableNumber_8244fd8f-8edc-4a7e-bdc8-581ae3986519" xlink:href="mo-20210930.xsd#mo_LossContingencyClaimsDecidedFavorableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_980f6691-1bd5-481e-8ed7-903e72eb01f3" xlink:to="loc_mo_LossContingencyClaimsDecidedFavorableNumber_8244fd8f-8edc-4a7e-bdc8-581ae3986519" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_256b6e70-abf9-4f33-b07a-2a675ca14b9d" xlink:href="mo-20210930.xsd#mo_LossContingencyClaimsDecidedUnfavorableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_980f6691-1bd5-481e-8ed7-903e72eb01f3" xlink:to="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_256b6e70-abf9-4f33-b07a-2a675ca14b9d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsResolvedNumber_6052bb46-e076-4811-9987-a123678735d6" xlink:href="mo-20210930.xsd#mo_LossContingencyClaimsResolvedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_980f6691-1bd5-481e-8ed7-903e72eb01f3" xlink:to="loc_mo_LossContingencyClaimsResolvedNumber_6052bb46-e076-4811-9987-a123678735d6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictReversedNumber_0afb98df-5ef5-4e92-920e-c06430d7a628" xlink:href="mo-20210930.xsd#mo_LossContingencyVerdictReversedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_980f6691-1bd5-481e-8ed7-903e72eb01f3" xlink:to="loc_mo_LossContingencyVerdictReversedNumber_0afb98df-5ef5-4e92-920e-c06430d7a628" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_7ab8a735-1d16-4885-a0b5-bf2d8ae4334c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_980f6691-1bd5-481e-8ed7-903e72eb01f3" xlink:to="loc_us-gaap_LossContingenciesTable_7ab8a735-1d16-4885-a0b5-bf2d8ae4334c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_e94cbc5d-1598-4b10-be5d-72b0a12777b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_7ab8a735-1d16-4885-a0b5-bf2d8ae4334c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_e94cbc5d-1598-4b10-be5d-72b0a12777b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e94cbc5d-1598-4b10-be5d-72b0a12777b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e94cbc5d-1598-4b10-be5d-72b0a12777b9" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e94cbc5d-1598-4b10-be5d-72b0a12777b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c1741265-d3db-4d48-9ae9-1a07b36d468b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e94cbc5d-1598-4b10-be5d-72b0a12777b9" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c1741265-d3db-4d48-9ae9-1a07b36d468b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ec86c8a0-e3a6-47b7-9ed0-a22cd4c1efc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c1741265-d3db-4d48-9ae9-1a07b36d468b" xlink:to="loc_us-gaap_SubsequentEventMember_ec86c8a0-e3a6-47b7-9ed0-a22cd4c1efc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c8198218-c0b2-4b3a-84ab-3ebe49bc5f5b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_7ab8a735-1d16-4885-a0b5-bf2d8ae4334c" xlink:to="loc_dei_LegalEntityAxis_c8198218-c0b2-4b3a-84ab-3ebe49bc5f5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c8198218-c0b2-4b3a-84ab-3ebe49bc5f5b_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_c8198218-c0b2-4b3a-84ab-3ebe49bc5f5b" xlink:to="loc_dei_EntityDomain_c8198218-c0b2-4b3a-84ab-3ebe49bc5f5b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8756ea8d-2ddb-4bb0-b35d-4707812b2944" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_c8198218-c0b2-4b3a-84ab-3ebe49bc5f5b" xlink:to="loc_dei_EntityDomain_8756ea8d-2ddb-4bb0-b35d-4707812b2944" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_d48d76f6-af74-4289-aadf-2036b0b8b9c0" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_8756ea8d-2ddb-4bb0-b35d-4707812b2944" xlink:to="loc_mo_PhilipMorrisUSAMember_d48d76f6-af74-4289-aadf-2036b0b8b9c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAandAltriaGroupMember_ac2affa7-a766-4323-8932-74776778397c" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAandAltriaGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_8756ea8d-2ddb-4bb0-b35d-4707812b2944" xlink:to="loc_mo_PhilipMorrisUSAandAltriaGroupMember_ac2affa7-a766-4323-8932-74776778397c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_ecd53c42-1c42-41dc-9d9f-3e7091ad1ce0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_7ab8a735-1d16-4885-a0b5-bf2d8ae4334c" xlink:to="loc_srt_LitigationCaseAxis_ecd53c42-1c42-41dc-9d9f-3e7091ad1ce0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_ecd53c42-1c42-41dc-9d9f-3e7091ad1ce0_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_ecd53c42-1c42-41dc-9d9f-3e7091ad1ce0" xlink:to="loc_srt_LitigationCaseTypeDomain_ecd53c42-1c42-41dc-9d9f-3e7091ad1ce0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_210c2ea5-bc20-465f-8b82-0aea583dd8e0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_ecd53c42-1c42-41dc-9d9f-3e7091ad1ce0" xlink:to="loc_srt_LitigationCaseTypeDomain_210c2ea5-bc20-465f-8b82-0aea583dd8e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_9238578f-2fa4-4051-9686-222113b2f8e9" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_210c2ea5-bc20-465f-8b82-0aea583dd8e0" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_9238578f-2fa4-4051-9686-222113b2f8e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsMember_3edd605f-d33f-4422-acbe-0fbdeb5cec20" xlink:href="mo-20210930.xsd#mo_SmokingAndHealthClassActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_210c2ea5-bc20-465f-8b82-0aea583dd8e0" xlink:to="loc_mo_SmokingAndHealthClassActionsMember_3edd605f-d33f-4422-acbe-0fbdeb5cec20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember_d879a601-a347-4505-bd77-4d25a6211a4a" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_210c2ea5-bc20-465f-8b82-0aea583dd8e0" xlink:to="loc_mo_EngleProgenyCasesMember_d879a601-a347-4505-bd77-4d25a6211a4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenyCasesMember_44472cab-4d52-48da-81d8-311785418091" xlink:href="mo-20210930.xsd#mo_NonEngleProgenyCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_210c2ea5-bc20-465f-8b82-0aea583dd8e0" xlink:to="loc_mo_NonEngleProgenyCasesMember_44472cab-4d52-48da-81d8-311785418091" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_2038c36c-94c8-475e-9aac-3e6c3a59c6a6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_7ab8a735-1d16-4885-a0b5-bf2d8ae4334c" xlink:to="loc_srt_StatementGeographicalAxis_2038c36c-94c8-475e-9aac-3e6c3a59c6a6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2038c36c-94c8-475e-9aac-3e6c3a59c6a6_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_2038c36c-94c8-475e-9aac-3e6c3a59c6a6" xlink:to="loc_srt_SegmentGeographicalDomain_2038c36c-94c8-475e-9aac-3e6c3a59c6a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_2038c36c-94c8-475e-9aac-3e6c3a59c6a6" xlink:to="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_932eb677-a43f-4171-b1f9-753477cbfe9e" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_country_CA_932eb677-a43f-4171-b1f9-753477cbfe9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AK_8a46f621-8815-45d7-9b0b-a6d956c9809e" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_AK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_AK_8a46f621-8815-45d7-9b0b-a6d956c9809e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_c29b2233-24af-490d-9991-0dbcd2a5a7d1" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_CA_c29b2233-24af-490d-9991-0dbcd2a5a7d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CT_2fb2479b-8c12-43cc-a4f0-36141d9755be" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_CT"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_CT_2fb2479b-8c12-43cc-a4f0-36141d9755be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_6a31e7c5-2143-4e28-a168-de80a9b4cb29" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_FL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_FL_6a31e7c5-2143-4e28-a168-de80a9b4cb29" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_LA_af5343a4-6860-4d77-8330-11d55aa9b11a" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_LA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_LA_af5343a4-6860-4d77-8330-11d55aa9b11a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA_134d457e-effd-40ee-8a8d-74237d9b6766" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_MA_134d457e-effd-40ee-8a8d-74237d9b6766" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MS_28189467-f34f-42cb-842c-bd0be1e6b3c1" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_MS_28189467-f34f-42cb-842c-bd0be1e6b3c1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MO_777c2ac1-9d65-42f1-b925-e5034d515a40" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MO"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_MO_777c2ac1-9d65-42f1-b925-e5034d515a40" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NH_cf47b1e6-d6e6-406b-a4a7-88dc26b2b157" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_NH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_NH_cf47b1e6-d6e6-406b-a4a7-88dc26b2b157" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ_9f5a7796-c906-4326-b557-6c90d003dd28" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_NJ"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_NJ_9f5a7796-c906-4326-b557-6c90d003dd28" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_4dcc6d2e-249a-4bc2-b064-02aa75578404" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_NY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_NY_4dcc6d2e-249a-4bc2-b064-02aa75578404" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OH_a4738ee9-dcee-4fc0-80bd-770af08c06ed" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_OH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_OH_a4738ee9-dcee-4fc0-80bd-770af08c06ed" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_PA_89ffca6a-fffa-40ba-874b-eaf4b1c01c15" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_PA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_PA_89ffca6a-fffa-40ba-874b-eaf4b1c01c15" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_RI_0b1ec4f9-ed66-4d69-8fbb-2b30e55624e2" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_RI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_RI_0b1ec4f9-ed66-4d69-8fbb-2b30e55624e2" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TN_48258349-8bdf-4ee3-8b74-2ac363e55ecf" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_TN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_TN_48258349-8bdf-4ee3-8b74-2ac363e55ecf" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WV_1da325e7-e270-4697-94f9-30847b3a1c55" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_WV"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_WV_1da325e7-e270-4697-94f9-30847b3a1c55" xlink:type="arc" order="16"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesNonEngleProgenyLitigationDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails" xlink:type="extended" id="i95d2859989f7452cbef4dc1bb45289d4_ContingenciesNonEngleProgenyLitigationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_29eefeaf-e9c3-47d4-838d-16983575a5ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_a0b58bb5-ea0e-4d06-9ed7-fc02e88938ad" xlink:href="mo-20210930.xsd#mo_LossContingencyCompensatoryDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_29eefeaf-e9c3-47d4-838d-16983575a5ec" xlink:to="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_a0b58bb5-ea0e-4d06-9ed7-fc02e88938ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue_8a5af126-1236-4091-af93-8929a9c95819" xlink:href="mo-20210930.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_29eefeaf-e9c3-47d4-838d-16983575a5ec" xlink:to="loc_mo_LossContingencyPunitiveDamagesAwardedValue_8a5af126-1236-4091-af93-8929a9c95819" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_d4bb98d5-c1ca-491a-bfe0-3defaf1ee3dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_29eefeaf-e9c3-47d4-838d-16983575a5ec" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_d4bb98d5-c1ca-491a-bfe0-3defaf1ee3dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_4757dae9-9382-49ea-ad8d-2b87b584b298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_29eefeaf-e9c3-47d4-838d-16983575a5ec" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_4757dae9-9382-49ea-ad8d-2b87b584b298" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage_4082991a-82d9-413e-8f2a-f42f4c382ec5" xlink:href="mo-20210930.xsd#mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_29eefeaf-e9c3-47d4-838d-16983575a5ec" xlink:to="loc_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage_4082991a-82d9-413e-8f2a-f42f4c382ec5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_1ed700d3-2ed0-4ad5-96c8-9a5a7b491dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_29eefeaf-e9c3-47d4-838d-16983575a5ec" xlink:to="loc_us-gaap_LossContingenciesTable_1ed700d3-2ed0-4ad5-96c8-9a5a7b491dcc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_db623ad5-cdec-4695-8a33-20c625ea084b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_1ed700d3-2ed0-4ad5-96c8-9a5a7b491dcc" xlink:to="loc_srt_LitigationCaseAxis_db623ad5-cdec-4695-8a33-20c625ea084b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_db623ad5-cdec-4695-8a33-20c625ea084b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_db623ad5-cdec-4695-8a33-20c625ea084b" xlink:to="loc_srt_LitigationCaseTypeDomain_db623ad5-cdec-4695-8a33-20c625ea084b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_80b8670c-c4ff-46e5-8e9b-339d302c699c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_db623ad5-cdec-4695-8a33-20c625ea084b" xlink:to="loc_srt_LitigationCaseTypeDomain_80b8670c-c4ff-46e5-8e9b-339d302c699c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_30148588-6250-43c7-bb82-fe54f9b72c4c" xlink:href="mo-20210930.xsd#mo_NonEngleProgenySmokingAndHealthCasePrincipeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_80b8670c-c4ff-46e5-8e9b-339d302c699c" xlink:to="loc_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_30148588-6250-43c7-bb82-fe54f9b72c4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_0c62a4b8-741f-4494-9991-a9cf2b2f0168" xlink:href="mo-20210930.xsd#mo_NonEngleProgenySmokingandHealthCaseGreeneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_80b8670c-c4ff-46e5-8e9b-339d302c699c" xlink:to="loc_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_0c62a4b8-741f-4494-9991-a9cf2b2f0168" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseLaramieMember_eb48b133-322b-4dec-b0cd-14a71fb01711" xlink:href="mo-20210930.xsd#mo_NonEngleProgenySmokingandHealthCaseLaramieMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_80b8670c-c4ff-46e5-8e9b-339d302c699c" xlink:to="loc_mo_NonEngleProgenySmokingandHealthCaseLaramieMember_eb48b133-322b-4dec-b0cd-14a71fb01711" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseGentileMember_b30813f3-1010-43ae-85f1-103987179349" xlink:href="mo-20210930.xsd#mo_NonEngleProgenySmokingandHealthCaseGentileMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_80b8670c-c4ff-46e5-8e9b-339d302c699c" xlink:to="loc_mo_NonEngleProgenySmokingandHealthCaseGentileMember_b30813f3-1010-43ae-85f1-103987179349" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_f3efefa6-a022-466c-82ef-d6dfe02e1db0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_1ed700d3-2ed0-4ad5-96c8-9a5a7b491dcc" xlink:to="loc_dei_LegalEntityAxis_f3efefa6-a022-466c-82ef-d6dfe02e1db0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f3efefa6-a022-466c-82ef-d6dfe02e1db0_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_f3efefa6-a022-466c-82ef-d6dfe02e1db0" xlink:to="loc_dei_EntityDomain_f3efefa6-a022-466c-82ef-d6dfe02e1db0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a1584237-cb30-4b72-95b3-8b6a884e3041" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_f3efefa6-a022-466c-82ef-d6dfe02e1db0" xlink:to="loc_dei_EntityDomain_a1584237-cb30-4b72-95b3-8b6a884e3041" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_17aa819e-1e3f-4550-be11-bf74436d0ae9" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_a1584237-cb30-4b72-95b3-8b6a884e3041" xlink:to="loc_mo_PhilipMorrisUSAMember_17aa819e-1e3f-4550-be11-bf74436d0ae9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" xlink:type="extended" id="i9a00f54096594578b315c05681291b90_ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue_0dae4df4-9575-42e7-aeec-6b4466ae6e4a" xlink:href="mo-20210930.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_mo_LossContingencyPunitiveDamagesAwardedValue_0dae4df4-9575-42e7-aeec-6b4466ae6e4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_c7b22675-b945-4848-bb40-177706189e7f" xlink:href="mo-20210930.xsd#mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_c7b22675-b945-4848-bb40-177706189e7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_7303dedc-0c4a-4dbd-99e0-a4c0491e4298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_7303dedc-0c4a-4dbd-99e0-a4c0491e4298" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_dbfbb90f-df1c-4097-b2d6-e7d0783f30ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_dbfbb90f-df1c-4097-b2d6-e7d0783f30ba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecided_beff213a-fb8d-43c8-b00d-ded6c860e8ae" xlink:href="mo-20210930.xsd#mo_LossContingencyClaimsDecided"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_mo_LossContingencyClaimsDecided_beff213a-fb8d-43c8-b00d-ded6c860e8ae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_fb4e2260-9908-4683-a0f9-2561492a7ee5" xlink:href="mo-20210930.xsd#mo_LossContingencyClaimsDecidedUnfavorableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_fb4e2260-9908-4683-a0f9-2561492a7ee5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyUnfavorableVerdictsPendingReversed_72aa19c3-009a-4198-9130-5cb767f2a6a9" xlink:href="mo-20210930.xsd#mo_LossContingencyUnfavorableVerdictsPendingReversed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_mo_LossContingencyUnfavorableVerdictsPendingReversed_72aa19c3-009a-4198-9130-5cb767f2a6a9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedFavorableNumber_997b894b-8962-48e8-8b72-06f47095f60b" xlink:href="mo-20210930.xsd#mo_LossContingencyClaimsDecidedFavorableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_mo_LossContingencyClaimsDecidedFavorableNumber_997b894b-8962-48e8-8b72-06f47095f60b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictReversedNumber_b32427f3-9534-4d15-838e-0f11e283231c" xlink:href="mo-20210930.xsd#mo_LossContingencyVerdictReversedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_mo_LossContingencyVerdictReversedNumber_b32427f3-9534-4d15-838e-0f11e283231c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyZeroDamagesVerdicts_57d70c0f-1285-459b-b36a-f3fab0c11045" xlink:href="mo-20210930.xsd#mo_LossContingencyZeroDamagesVerdicts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_mo_LossContingencyZeroDamagesVerdicts_57d70c0f-1285-459b-b36a-f3fab0c11045" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_56d52c69-dd4c-400b-a9ae-71dbc3259a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_56d52c69-dd4c-400b-a9ae-71dbc3259a6d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyZeroDamagesVerdictModified_6b5598d8-1f91-4669-9549-8f6ceaf3a3e4" xlink:href="mo-20210930.xsd#mo_LossContingencyZeroDamagesVerdictModified"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_mo_LossContingencyZeroDamagesVerdictModified_6b5598d8-1f91-4669-9549-8f6ceaf3a3e4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ProvisionRecordedNumberOfCases_27512f54-a880-46c4-b906-afa34b748e08" xlink:href="mo-20210930.xsd#mo_ProvisionRecordedNumberOfCases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_mo_ProvisionRecordedNumberOfCases_27512f54-a880-46c4-b906-afa34b748e08" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_80827a3d-fd5f-43aa-bfab-8501a0fc183e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_us-gaap_LossContingenciesTable_80827a3d-fd5f-43aa-bfab-8501a0fc183e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_8ba10dd5-5717-40c8-a6a1-7c42794c7fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_80827a3d-fd5f-43aa-bfab-8501a0fc183e" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_8ba10dd5-5717-40c8-a6a1-7c42794c7fc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8ba10dd5-5717-40c8-a6a1-7c42794c7fc7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8ba10dd5-5717-40c8-a6a1-7c42794c7fc7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8ba10dd5-5717-40c8-a6a1-7c42794c7fc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_37e0b3d5-9684-428c-a88b-2243d302fc7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8ba10dd5-5717-40c8-a6a1-7c42794c7fc7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_37e0b3d5-9684-428c-a88b-2243d302fc7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e6b776de-172e-44a6-a59e-bd9573884cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_37e0b3d5-9684-428c-a88b-2243d302fc7c" xlink:to="loc_us-gaap_SubsequentEventMember_e6b776de-172e-44a6-a59e-bd9573884cd0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_22e7d3fa-d7b8-43fa-b7b4-b359b1a1825d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_80827a3d-fd5f-43aa-bfab-8501a0fc183e" xlink:to="loc_srt_LitigationCaseAxis_22e7d3fa-d7b8-43fa-b7b4-b359b1a1825d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_22e7d3fa-d7b8-43fa-b7b4-b359b1a1825d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_22e7d3fa-d7b8-43fa-b7b4-b359b1a1825d" xlink:to="loc_srt_LitigationCaseTypeDomain_22e7d3fa-d7b8-43fa-b7b4-b359b1a1825d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_828753a4-5937-4d33-9485-104b16597927" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_22e7d3fa-d7b8-43fa-b7b4-b359b1a1825d" xlink:to="loc_srt_LitigationCaseTypeDomain_828753a4-5937-4d33-9485-104b16597927" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember_113008d1-11d1-40dd-940a-3dfd9ca70c51" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_828753a4-5937-4d33-9485-104b16597927" xlink:to="loc_mo_EngleProgenyCasesMember_113008d1-11d1-40dd-940a-3dfd9ca70c51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesStateMember_13c0ea17-f993-431a-912f-f6908eb4f641" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesStateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_EngleProgenyCasesMember_113008d1-11d1-40dd-940a-3dfd9ca70c51" xlink:to="loc_mo_EngleProgenyCasesStateMember_13c0ea17-f993-431a-912f-f6908eb4f641" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesFederalMember_83b2a3a3-3868-452c-9298-ba28dae10079" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesFederalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_EngleProgenyCasesMember_113008d1-11d1-40dd-940a-3dfd9ca70c51" xlink:to="loc_mo_EngleProgenyCasesFederalMember_83b2a3a3-3868-452c-9298-ba28dae10079" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember_b5532b16-c537-4754-96e8-468501218cb5" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_828753a4-5937-4d33-9485-104b16597927" xlink:to="loc_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember_b5532b16-c537-4754-96e8-468501218cb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesReiderandBanksMember_7ab60fd3-c36f-4d73-a2d1-55ecae48c6db" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesReiderandBanksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_828753a4-5937-4d33-9485-104b16597927" xlink:to="loc_mo_EngleProgenyCasesReiderandBanksMember_7ab60fd3-c36f-4d73-a2d1-55ecae48c6db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesWeingartandHancockMember_8b8abdcf-2bec-4c71-957c-e58f7048c325" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesWeingartandHancockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_828753a4-5937-4d33-9485-104b16597927" xlink:to="loc_mo_EngleProgenyCasesWeingartandHancockMember_8b8abdcf-2bec-4c71-957c-e58f7048c325" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesPollariMember_f160369d-c172-445f-a1f1-f16564a2d0fb" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesPollariMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_828753a4-5937-4d33-9485-104b16597927" xlink:to="loc_mo_EngleProgenyCasesPollariMember_f160369d-c172-445f-a1f1-f16564a2d0fb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_e56027f8-e902-4f5d-829a-e970e3659ebe" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesGlogerRintoulandDuignamMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_828753a4-5937-4d33-9485-104b16597927" xlink:to="loc_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_e56027f8-e902-4f5d-829a-e970e3659ebe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesFreemanMember_ed3bb2d8-7b3d-4ac6-9e7e-60d1d3801dde" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesFreemanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_828753a4-5937-4d33-9485-104b16597927" xlink:to="loc_mo_EngleProgenyCasesFreemanMember_ed3bb2d8-7b3d-4ac6-9e7e-60d1d3801dde" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_1cce1991-b1dc-4bdb-85bf-b5c69ade0475" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_80827a3d-fd5f-43aa-bfab-8501a0fc183e" xlink:to="loc_dei_LegalEntityAxis_1cce1991-b1dc-4bdb-85bf-b5c69ade0475" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1cce1991-b1dc-4bdb-85bf-b5c69ade0475_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1cce1991-b1dc-4bdb-85bf-b5c69ade0475" xlink:to="loc_dei_EntityDomain_1cce1991-b1dc-4bdb-85bf-b5c69ade0475_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_02a0981b-6518-4808-b04b-5cb5a484010a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1cce1991-b1dc-4bdb-85bf-b5c69ade0475" xlink:to="loc_dei_EntityDomain_02a0981b-6518-4808-b04b-5cb5a484010a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_02914997-9b71-4f7b-9e9a-b99da6be7191" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_02a0981b-6518-4808-b04b-5cb5a484010a" xlink:to="loc_mo_PhilipMorrisUSAMember_02914997-9b71-4f7b-9e9a-b99da6be7191" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails" xlink:type="extended" id="i8cedba9f927440ccaa7377168aa3f0ec_ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c10c7e64-2959-46b0-ab53-d60f96e17403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo_a829c85a-649a-485a-9fd4-4af6b477747d" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c10c7e64-2959-46b0-ab53-d60f96e17403" xlink:to="loc_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo_a829c85a-649a-485a-9fd4-4af6b477747d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_9f755107-063b-4d32-97ce-f1a8f688dbd9" xlink:href="mo-20210930.xsd#mo_LossContingencyCompensatoryDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c10c7e64-2959-46b0-ab53-d60f96e17403" xlink:to="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_9f755107-063b-4d32-97ce-f1a8f688dbd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue_52c5af01-fd55-44b9-a911-5786994cd8a1" xlink:href="mo-20210930.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c10c7e64-2959-46b0-ab53-d60f96e17403" xlink:to="loc_mo_LossContingencyPunitiveDamagesAwardedValue_52c5af01-fd55-44b9-a911-5786994cd8a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_f53cf924-d5c2-4662-9da4-6296f7284797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c10c7e64-2959-46b0-ab53-d60f96e17403" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_f53cf924-d5c2-4662-9da4-6296f7284797" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_bf8af5d5-08e1-41d5-aa4e-6453a63b05f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c10c7e64-2959-46b0-ab53-d60f96e17403" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_bf8af5d5-08e1-41d5-aa4e-6453a63b05f4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_667f1923-e496-4be5-ac00-3fdb8fd33f53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c10c7e64-2959-46b0-ab53-d60f96e17403" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_667f1923-e496-4be5-ac00-3fdb8fd33f53" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_b0eafcd2-fadb-413d-bbec-7ae549d2c0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_c10c7e64-2959-46b0-ab53-d60f96e17403" xlink:to="loc_us-gaap_LossContingenciesTable_b0eafcd2-fadb-413d-bbec-7ae549d2c0f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_d9a006ea-5627-4d78-b687-e44ef5791a3a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b0eafcd2-fadb-413d-bbec-7ae549d2c0f6" xlink:to="loc_srt_LitigationCaseAxis_d9a006ea-5627-4d78-b687-e44ef5791a3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_d9a006ea-5627-4d78-b687-e44ef5791a3a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_d9a006ea-5627-4d78-b687-e44ef5791a3a" xlink:to="loc_srt_LitigationCaseTypeDomain_d9a006ea-5627-4d78-b687-e44ef5791a3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_d9a006ea-5627-4d78-b687-e44ef5791a3a" xlink:to="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesLippMember_e2f75e8a-78e4-46cf-a003-cca6b817d1f1" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesLippMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesLippMember_e2f75e8a-78e4-46cf-a003-cca6b817d1f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGarciaMember_df562140-7be2-4444-bfb4-bdac5a8af53b" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesGarciaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesGarciaMember_df562140-7be2-4444-bfb4-bdac5a8af53b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesDuignanMember_5104be37-c735-44b4-bb8b-3f6ba1f69379" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesDuignanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesDuignanMember_5104be37-c735-44b4-bb8b-3f6ba1f69379" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesCuddiheeMember_1970f5f4-4d81-4c29-a94d-62047dff0bbf" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesCuddiheeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesCuddiheeMember_1970f5f4-4d81-4c29-a94d-62047dff0bbf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesRintoulMember_e4092066-a62a-4e95-8a26-d0ea2480f374" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesRintoulMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesRintoulMember_e4092066-a62a-4e95-8a26-d0ea2480f374" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGlogerMember_052598a7-fb1e-4fb9-8110-3656e70c662f" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesGlogerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesGlogerMember_052598a7-fb1e-4fb9-8110-3656e70c662f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMcCallMember_a87bfed7-18fe-41b7-bdd8-5a99c4e59f42" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesMcCallMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesMcCallMember_a87bfed7-18fe-41b7-bdd8-5a99c4e59f42" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesNeffMember_6dc65d2c-91ab-47e1-ad9c-86e3c401a7ca" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesNeffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesNeffMember_6dc65d2c-91ab-47e1-ad9c-86e3c401a7ca" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMahfuzMember_e027328f-a1ae-4894-8c71-9c12a85edd71" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesMahfuzMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesMahfuzMember_e027328f-a1ae-4894-8c71-9c12a85edd71" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesHollimanMember_8eb0fb9c-2aae-4238-87e0-d8feb2e3cfcc" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesHollimanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesHollimanMember_8eb0fb9c-2aae-4238-87e0-d8feb2e3cfcc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesChadwellMember_962d6ece-a326-4668-bfb4-3abd901bcf9f" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesChadwellMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesChadwellMember_962d6ece-a326-4668-bfb4-3abd901bcf9f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesKaplanMember_f826e25f-0e38-4740-ba50-00da09a27b7f" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesKaplanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesKaplanMember_f826e25f-0e38-4740-ba50-00da09a27b7f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesR.DouglasMember_3e04023f-0938-4da4-8ea9-014ee0e0313e" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesR.DouglasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesR.DouglasMember_3e04023f-0938-4da4-8ea9-014ee0e0313e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesSommersMember_d3c13510-166a-4ffc-99ae-c11f19dfa6d1" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesSommersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesSommersMember_d3c13510-166a-4ffc-99ae-c11f19dfa6d1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesCooperMember_c4cb32b1-cde9-4ffe-9ca9-a37de053b332" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesCooperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesCooperMember_c4cb32b1-cde9-4ffe-9ca9-a37de053b332" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesD.BrownMember_347503db-630a-493f-aad8-0296203f259b" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesD.BrownMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesD.BrownMember_347503db-630a-493f-aad8-0296203f259b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesBergerMember_803e9101-3072-4818-a560-618859294e56" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesBergerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesBergerMember_803e9101-3072-4818-a560-618859294e56" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesSantoroMember_fc9db265-56d6-472a-a189-a4805e7acf85" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesSantoroMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesSantoroMember_fc9db265-56d6-472a-a189-a4805e7acf85" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesNaugleGoreMBrownJordanTheisAndLandiMember_c89eca3e-1430-47d0-b1b0-16d9d1f7f962" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesNaugleGoreMBrownJordanTheisAndLandiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesNaugleGoreMBrownJordanTheisAndLandiMember_c89eca3e-1430-47d0-b1b0-16d9d1f7f962" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesNaugleMember_1049b7b1-9060-48b7-b88d-b53237d018d7" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesNaugleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesNaugleMember_1049b7b1-9060-48b7-b88d-b53237d018d7" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGoreMember_363d8a30-e48e-4b9e-b1b0-2f51e6e32179" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesGoreMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesGoreMember_363d8a30-e48e-4b9e-b1b0-2f51e6e32179" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesM.BrownMember_3d6bb322-e1fe-4b99-9b94-cab1f2e712ce" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesM.BrownMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesM.BrownMember_3d6bb322-e1fe-4b99-9b94-cab1f2e712ce" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesJordanMember_2adac8ed-fbe9-40fa-8e26-9c72daf97cfa" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesJordanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesJordanMember_2adac8ed-fbe9-40fa-8e26-9c72daf97cfa" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesTheisMember_19223226-5e4b-496e-b189-c32da93aa889" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesTheisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesTheisMember_19223226-5e4b-496e-b189-c32da93aa889" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesLandiMember_ecf967cd-62ea-4411-b89f-b825763d964a" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesLandiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesLandiMember_ecf967cd-62ea-4411-b89f-b825763d964a" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesRJReynoldsMember_276ac9b2-4870-4f7b-a1ed-916870f4eaf8" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesRJReynoldsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesRJReynoldsMember_276ac9b2-4870-4f7b-a1ed-916870f4eaf8" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_ab1c644f-e788-476f-b45e-a89055145f87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b0eafcd2-fadb-413d-bbec-7ae549d2c0f6" xlink:to="loc_us-gaap_LitigationStatusAxis_ab1c644f-e788-476f-b45e-a89055145f87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_ab1c644f-e788-476f-b45e-a89055145f87_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_ab1c644f-e788-476f-b45e-a89055145f87" xlink:to="loc_us-gaap_LitigationStatusDomain_ab1c644f-e788-476f-b45e-a89055145f87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_b8428b74-15ec-4741-95aa-1e91b7728898" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_ab1c644f-e788-476f-b45e-a89055145f87" xlink:to="loc_us-gaap_LitigationStatusDomain_b8428b74-15ec-4741-95aa-1e91b7728898" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_31368484-2bea-47a7-869a-6b5f4b0b7f94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_b8428b74-15ec-4741-95aa-1e91b7728898" xlink:to="loc_us-gaap_PendingLitigationMember_31368484-2bea-47a7-869a-6b5f4b0b7f94" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_857f2250-5696-4163-bd63-6d73acccda09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_b8428b74-15ec-4741-95aa-1e91b7728898" xlink:to="loc_us-gaap_SettledLitigationMember_857f2250-5696-4163-bd63-6d73acccda09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_d34178d0-f213-4104-bd48-3d4aba31704d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b0eafcd2-fadb-413d-bbec-7ae549d2c0f6" xlink:to="loc_dei_LegalEntityAxis_d34178d0-f213-4104-bd48-3d4aba31704d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d34178d0-f213-4104-bd48-3d4aba31704d_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_d34178d0-f213-4104-bd48-3d4aba31704d" xlink:to="loc_dei_EntityDomain_d34178d0-f213-4104-bd48-3d4aba31704d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a6ceceb5-019f-4a25-93dc-dd0998a7fb9a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_d34178d0-f213-4104-bd48-3d4aba31704d" xlink:to="loc_dei_EntityDomain_a6ceceb5-019f-4a25-93dc-dd0998a7fb9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_c27a4c91-a440-4ac8-bb4e-5f7831129740" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_a6ceceb5-019f-4a25-93dc-dd0998a7fb9a" xlink:to="loc_mo_PhilipMorrisUSAMember_c27a4c91-a440-4ac8-bb4e-5f7831129740" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_628f7272-1693-4e51-a35d-2afd2fbe211f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b0eafcd2-fadb-413d-bbec-7ae549d2c0f6" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_628f7272-1693-4e51-a35d-2afd2fbe211f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_628f7272-1693-4e51-a35d-2afd2fbe211f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_628f7272-1693-4e51-a35d-2afd2fbe211f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_628f7272-1693-4e51-a35d-2afd2fbe211f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_86dd8111-3ac9-434b-bd7e-24a8b12e7156" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_628f7272-1693-4e51-a35d-2afd2fbe211f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_86dd8111-3ac9-434b-bd7e-24a8b12e7156" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_bc7f946d-e303-4a93-abf1-960b5e06e51a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_86dd8111-3ac9-434b-bd7e-24a8b12e7156" xlink:to="loc_us-gaap_SubsequentEventMember_bc7f946d-e303-4a93-abf1-960b5e06e51a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesFloridaBondStatuteDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails" xlink:type="extended" id="i9be82e3142f94194bb9f67dff29e5976_ContingenciesFloridaBondStatuteDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ec293dfc-b4cd-4dc6-8ca0-e6acabafb4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MaximumBondForAllDefendants_e268aaf7-8534-47d8-996a-bcd8b1780a7e" xlink:href="mo-20210930.xsd#mo_MaximumBondForAllDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ec293dfc-b4cd-4dc6-8ca0-e6acabafb4f1" xlink:to="loc_mo_MaximumBondForAllDefendants_e268aaf7-8534-47d8-996a-bcd8b1780a7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_55fa7fae-64bd-475e-8ec7-0d8b6cb6cc1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_ec293dfc-b4cd-4dc6-8ca0-e6acabafb4f1" xlink:to="loc_us-gaap_LossContingenciesTable_55fa7fae-64bd-475e-8ec7-0d8b6cb6cc1d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_fa37241a-dc56-4e1a-8411-0ad55f467141" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_55fa7fae-64bd-475e-8ec7-0d8b6cb6cc1d" xlink:to="loc_srt_StatementGeographicalAxis_fa37241a-dc56-4e1a-8411-0ad55f467141" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_fa37241a-dc56-4e1a-8411-0ad55f467141_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_fa37241a-dc56-4e1a-8411-0ad55f467141" xlink:to="loc_srt_SegmentGeographicalDomain_fa37241a-dc56-4e1a-8411-0ad55f467141_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8de8a097-6d2f-437e-849f-b742225c9b18" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_fa37241a-dc56-4e1a-8411-0ad55f467141" xlink:to="loc_srt_SegmentGeographicalDomain_8de8a097-6d2f-437e-849f-b742225c9b18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_dd4f8284-aa0e-4308-a9ed-7a9ae12d3c57" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_FL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8de8a097-6d2f-437e-849f-b742225c9b18" xlink:to="loc_stpr_FL_dd4f8284-aa0e-4308-a9ed-7a9ae12d3c57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_7502628f-a095-4f8b-8267-2d08e617d023" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_55fa7fae-64bd-475e-8ec7-0d8b6cb6cc1d" xlink:to="loc_srt_LitigationCaseAxis_7502628f-a095-4f8b-8267-2d08e617d023" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7502628f-a095-4f8b-8267-2d08e617d023_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_7502628f-a095-4f8b-8267-2d08e617d023" xlink:to="loc_srt_LitigationCaseTypeDomain_7502628f-a095-4f8b-8267-2d08e617d023_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_94719271-5f3c-4121-b547-e0a8f29f1fe7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_7502628f-a095-4f8b-8267-2d08e617d023" xlink:to="loc_srt_LitigationCaseTypeDomain_94719271-5f3c-4121-b547-e0a8f29f1fe7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesStateMember_23aa80f9-1f29-40b2-8ef5-e8275970bc6e" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesStateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_94719271-5f3c-4121-b547-e0a8f29f1fe7" xlink:to="loc_mo_EngleProgenyCasesStateMember_23aa80f9-1f29-40b2-8ef5-e8275970bc6e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesOtherSmokingandHealthClassActionsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails" xlink:type="extended" id="ifff6042d9c1048d698c524f18e76b2a3_ContingenciesOtherSmokingandHealthClassActionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_a8ee4d5e-6b78-469d-8185-b3bb347ac0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassNotCertifiedNumber_d7e844c7-9f5e-46c0-b106-280ad09a736b" xlink:href="mo-20210930.xsd#mo_LossContingencyClassNotCertifiedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a8ee4d5e-6b78-469d-8185-b3bb347ac0c4" xlink:to="loc_mo_LossContingencyClassNotCertifiedNumber_d7e844c7-9f5e-46c0-b106-280ad09a736b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_0b115b35-790f-4b30-833f-ec989e770c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a8ee4d5e-6b78-469d-8185-b3bb347ac0c4" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_0b115b35-790f-4b30-833f-ec989e770c7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofManufacturers_2ee12b3c-145f-4260-a9c7-22b2040a4eb3" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberofManufacturers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a8ee4d5e-6b78-469d-8185-b3bb347ac0c4" xlink:to="loc_mo_LossContingencyNumberofManufacturers_2ee12b3c-145f-4260-a9c7-22b2040a4eb3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictsUpheld_001ef8ff-4728-498a-bac6-b9f5b9becde5" xlink:href="mo-20210930.xsd#mo_LossContingencyVerdictsUpheld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a8ee4d5e-6b78-469d-8185-b3bb347ac0c4" xlink:to="loc_mo_LossContingencyVerdictsUpheld_001ef8ff-4728-498a-bac6-b9f5b9becde5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AmountAwardedtoOtherParty_3d03b503-6407-436c-a2ab-a73fc45f8056" xlink:href="mo-20210930.xsd#mo_AmountAwardedtoOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a8ee4d5e-6b78-469d-8185-b3bb347ac0c4" xlink:to="loc_mo_AmountAwardedtoOtherParty_3d03b503-6407-436c-a2ab-a73fc45f8056" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_954d3b4e-9ac0-44f4-8df3-e26c4f3fb8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_a8ee4d5e-6b78-469d-8185-b3bb347ac0c4" xlink:to="loc_us-gaap_LossContingenciesTable_954d3b4e-9ac0-44f4-8df3-e26c4f3fb8f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a86e77b5-786d-4324-97bb-4198c64f9e8b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_954d3b4e-9ac0-44f4-8df3-e26c4f3fb8f6" xlink:to="loc_srt_StatementGeographicalAxis_a86e77b5-786d-4324-97bb-4198c64f9e8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a86e77b5-786d-4324-97bb-4198c64f9e8b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_a86e77b5-786d-4324-97bb-4198c64f9e8b" xlink:to="loc_srt_SegmentGeographicalDomain_a86e77b5-786d-4324-97bb-4198c64f9e8b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_a86e77b5-786d-4324-97bb-4198c64f9e8b" xlink:to="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AR_b052de5c-762b-43fc-b32f-7c0422d0a27a" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_AR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_AR_b052de5c-762b-43fc-b32f-7c0422d0a27a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_73b146e8-9ffc-4a34-b4c1-79ae6e1e9bdf" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_CA_73b146e8-9ffc-4a34-b4c1-79ae6e1e9bdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DE_2878c2b1-fcce-416d-bf4f-b0e87ec4ccab" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_DE_2878c2b1-fcce-416d-bf4f-b0e87ec4ccab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DC_48b8710a-9f2b-4880-b5d6-625ed06367fd" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_DC"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_DC_48b8710a-9f2b-4880-b5d6-625ed06367fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_7a0134ac-c705-4f13-8b1a-4890e32d52e3" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_FL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_FL_7a0134ac-c705-4f13-8b1a-4890e32d52e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IL_61131b94-83b8-48d6-91d4-f04a04b3135d" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_IL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_IL_61131b94-83b8-48d6-91d4-f04a04b3135d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IA_91bec151-deba-4a64-8971-70d5716ba970" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_IA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_IA_91bec151-deba-4a64-8971-70d5716ba970" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_KS_17b230fd-9e69-465c-a8c6-b2572ec097b5" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_KS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_KS_17b230fd-9e69-465c-a8c6-b2572ec097b5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_LA_9bc24e4b-230e-4fad-853c-840e0a51a380" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_LA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_LA_9bc24e4b-230e-4fad-853c-840e0a51a380" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MD_da9ad02c-545f-4485-a4e1-b21cbd646195" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_MD_da9ad02c-545f-4485-a4e1-b21cbd646195" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MI_811b7d50-58f8-4fc5-b825-c2498b113b35" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_MI_811b7d50-58f8-4fc5-b825-c2498b113b35" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MN_a730c63b-dd20-4547-9dda-411577a84e20" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_MN_a730c63b-dd20-4547-9dda-411577a84e20" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NV_3b658d89-28f3-4fee-954f-3ec3b588e0b9" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_NV"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_NV_3b658d89-28f3-4fee-954f-3ec3b588e0b9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ_8d6b1f6d-e1e8-4101-ba72-03babaf7a2af" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_NJ"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_NJ_8d6b1f6d-e1e8-4101-ba72-03babaf7a2af" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_eb0abe00-8731-4a50-8d9e-9affd7f2ea9f" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_NY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_NY_eb0abe00-8731-4a50-8d9e-9affd7f2ea9f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OH_f809755b-30db-4717-ab51-ceabe3fd6822" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_OH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_OH_f809755b-30db-4717-ab51-ceabe3fd6822" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OK_2bc3b729-4371-4eb3-a58d-133e9e239112" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_OK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_OK_2bc3b729-4371-4eb3-a58d-133e9e239112" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OR_32c31469-5a94-4c15-87ab-d402694180d4" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_OR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_OR_32c31469-5a94-4c15-87ab-d402694180d4" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_PA_2d3729cb-8bc9-4169-9605-bffceee59285" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_PA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_PA_2d3729cb-8bc9-4169-9605-bffceee59285" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_PR_a9f1abee-d3af-4b8b-b552-83cf5f5a9345" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_PR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_country_PR_a9f1abee-d3af-4b8b-b552-83cf5f5a9345" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_SC_127ba1be-f93c-4089-af43-713229df7e9c" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_SC"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_SC_127ba1be-f93c-4089-af43-713229df7e9c" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_ea528225-86e7-4e9d-b673-5221f99b39d8" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_TX"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_TX_ea528225-86e7-4e9d-b673-5221f99b39d8" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WI_21d20026-033e-4c5b-99cf-f1c84004cc19" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_WI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_WI_21d20026-033e-4c5b-99cf-f1c84004cc19" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_14b6f60a-a290-443d-9fa0-77561b7ab213" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_country_CA_14b6f60a-a290-443d-9fa0-77561b7ab213" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_BritishColumbiaSaskatchewanMember_8a0ade4c-b03b-4e5f-a013-52aec4184bc6" xlink:href="mo-20210930.xsd#mo_BritishColumbiaSaskatchewanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_mo_BritishColumbiaSaskatchewanMember_8a0ade4c-b03b-4e5f-a013-52aec4184bc6" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c2fd9f97-c22c-40bb-890d-6c6560ec4b16" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_954d3b4e-9ac0-44f4-8df3-e26c4f3fb8f6" xlink:to="loc_dei_LegalEntityAxis_c2fd9f97-c22c-40bb-890d-6c6560ec4b16" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c2fd9f97-c22c-40bb-890d-6c6560ec4b16_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_c2fd9f97-c22c-40bb-890d-6c6560ec4b16" xlink:to="loc_dei_EntityDomain_c2fd9f97-c22c-40bb-890d-6c6560ec4b16_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_01543eba-562c-43a1-8c03-eb1f5e202ef9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_c2fd9f97-c22c-40bb-890d-6c6560ec4b16" xlink:to="loc_dei_EntityDomain_01543eba-562c-43a1-8c03-eb1f5e202ef9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_a9381b32-eef3-4de1-9fb8-6fec0df64b5b" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_01543eba-562c-43a1-8c03-eb1f5e202ef9" xlink:to="loc_mo_PhilipMorrisUSAMember_a9381b32-eef3-4de1-9fb8-6fec0df64b5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAandAltriaGroupMember_e78dfe01-6e26-4455-bc06-c1418cc09250" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAandAltriaGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_01543eba-562c-43a1-8c03-eb1f5e202ef9" xlink:to="loc_mo_PhilipMorrisUSAandAltriaGroupMember_e78dfe01-6e26-4455-bc06-c1418cc09250" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CanadianTobaccoManufacturersMember_1cd6bcb3-9f99-4333-83d7-0947cd31e391" xlink:href="mo-20210930.xsd#mo_CanadianTobaccoManufacturersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_01543eba-562c-43a1-8c03-eb1f5e202ef9" xlink:to="loc_mo_CanadianTobaccoManufacturersMember_1cd6bcb3-9f99-4333-83d7-0947cd31e391" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AltriaGroupMember_67494553-d246-4c29-937a-f7daf3510676" xlink:href="mo-20210930.xsd#mo_AltriaGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_01543eba-562c-43a1-8c03-eb1f5e202ef9" xlink:to="loc_mo_AltriaGroupMember_67494553-d246-4c29-937a-f7daf3510676" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_8b84a230-d179-4193-b95a-6bc1683d526b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_954d3b4e-9ac0-44f4-8df3-e26c4f3fb8f6" xlink:to="loc_srt_LitigationCaseAxis_8b84a230-d179-4193-b95a-6bc1683d526b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_8b84a230-d179-4193-b95a-6bc1683d526b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_8b84a230-d179-4193-b95a-6bc1683d526b" xlink:to="loc_srt_LitigationCaseTypeDomain_8b84a230-d179-4193-b95a-6bc1683d526b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7cfa08a5-316b-4ead-bd62-c1494cf3ec65" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_8b84a230-d179-4193-b95a-6bc1683d526b" xlink:to="loc_srt_LitigationCaseTypeDomain_7cfa08a5-316b-4ead-bd62-c1494cf3ec65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsMember_49fc184e-3d66-445d-80f6-ea3236b84e4a" xlink:href="mo-20210930.xsd#mo_SmokingAndHealthClassActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cfa08a5-316b-4ead-bd62-c1494cf3ec65" xlink:to="loc_mo_SmokingAndHealthClassActionsMember_49fc184e-3d66-445d-80f6-ea3236b84e4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_56833547-12c0-4dda-ae06-21bac709f4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_954d3b4e-9ac0-44f4-8df3-e26c4f3fb8f6" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_56833547-12c0-4dda-ae06-21bac709f4e9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_56833547-12c0-4dda-ae06-21bac709f4e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_56833547-12c0-4dda-ae06-21bac709f4e9" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_56833547-12c0-4dda-ae06-21bac709f4e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_16ed109a-a764-4c6a-9e46-744a42e78025" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_56833547-12c0-4dda-ae06-21bac709f4e9" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_16ed109a-a764-4c6a-9e46-744a42e78025" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e33752c7-fdb0-4a52-93b2-267d448d118b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_16ed109a-a764-4c6a-9e46-744a42e78025" xlink:to="loc_us-gaap_SubsequentEventMember_e33752c7-fdb0-4a52-93b2-267d448d118b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesHealthCareCostRecoveryLitigationDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" xlink:type="extended" id="icfd67818f2d3418ea7de72c675f8bc5d_ContingenciesHealthCareCostRecoveryLitigationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_9958f2cf-c769-41f4-9cbd-6bcd4d727b09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_09d8c480-cf65-4533-8534-2585d33809f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9958f2cf-c769-41f4-9cbd-6bcd4d727b09" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_09d8c480-cf65-4533-8534-2585d33809f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofManufacturers_d930fa06-b1fe-458a-a885-cf1b7483b2f5" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberofManufacturers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9958f2cf-c769-41f4-9cbd-6bcd4d727b09" xlink:to="loc_mo_LossContingencyNumberofManufacturers_d930fa06-b1fe-458a-a885-cf1b7483b2f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigation_8b2f3a92-2c7b-4d6b-9422-e41321be3723" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberofStateswithSettledLitigation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9958f2cf-c769-41f4-9cbd-6bcd4d727b09" xlink:to="loc_mo_LossContingencyNumberofStateswithSettledLitigation_8b2f3a92-2c7b-4d6b-9422-e41321be3723" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAnnualPaymentAmount_dab75431-efce-48ad-b9b0-e1dd2738dc00" xlink:href="mo-20210930.xsd#mo_LitigationSettlementAnnualPaymentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9958f2cf-c769-41f4-9cbd-6bcd4d727b09" xlink:to="loc_mo_LitigationSettlementAnnualPaymentAmount_dab75431-efce-48ad-b9b0-e1dd2738dc00" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_73e7625b-49dc-4542-82e6-a9ee96c850af" xlink:href="mo-20210930.xsd#mo_LitigationSettlementAnnualLegalFeesPayableMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9958f2cf-c769-41f4-9cbd-6bcd4d727b09" xlink:to="loc_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_73e7625b-49dc-4542-82e6-a9ee96c850af" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_8e9de2d8-90b4-4c9d-abdf-d68887fe1174" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9958f2cf-c769-41f4-9cbd-6bcd4d727b09" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_8e9de2d8-90b4-4c9d-abdf-d68887fe1174" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_99e4a3d3-43ee-4ce8-9be6-aec45ee67fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_9958f2cf-c769-41f4-9cbd-6bcd4d727b09" xlink:to="loc_us-gaap_LossContingenciesTable_99e4a3d3-43ee-4ce8-9be6-aec45ee67fe0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_898362c4-a809-4d9a-81eb-aef337eeb197" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_99e4a3d3-43ee-4ce8-9be6-aec45ee67fe0" xlink:to="loc_dei_LegalEntityAxis_898362c4-a809-4d9a-81eb-aef337eeb197" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_898362c4-a809-4d9a-81eb-aef337eeb197_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_898362c4-a809-4d9a-81eb-aef337eeb197" xlink:to="loc_dei_EntityDomain_898362c4-a809-4d9a-81eb-aef337eeb197_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c23dc1cb-b685-4406-8166-8ee265e4d0c3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_898362c4-a809-4d9a-81eb-aef337eeb197" xlink:to="loc_dei_EntityDomain_c23dc1cb-b685-4406-8166-8ee265e4d0c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CanadianTobaccoManufacturersMember_78dd0c81-c124-4780-a8bc-000caf754ac3" xlink:href="mo-20210930.xsd#mo_CanadianTobaccoManufacturersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_c23dc1cb-b685-4406-8166-8ee265e4d0c3" xlink:to="loc_mo_CanadianTobaccoManufacturersMember_78dd0c81-c124-4780-a8bc-000caf754ac3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_d14488ef-304f-4ef7-83d7-82f18d5c9a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_99e4a3d3-43ee-4ce8-9be6-aec45ee67fe0" xlink:to="loc_us-gaap_LitigationStatusAxis_d14488ef-304f-4ef7-83d7-82f18d5c9a4e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_d14488ef-304f-4ef7-83d7-82f18d5c9a4e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_d14488ef-304f-4ef7-83d7-82f18d5c9a4e" xlink:to="loc_us-gaap_LitigationStatusDomain_d14488ef-304f-4ef7-83d7-82f18d5c9a4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_effe74aa-97ea-460e-a930-ae268fd0d389" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_d14488ef-304f-4ef7-83d7-82f18d5c9a4e" xlink:to="loc_us-gaap_LitigationStatusDomain_effe74aa-97ea-460e-a930-ae268fd0d389" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ThreatenedLitigationMember_cc233d80-d873-4345-8939-a46b1a2f505a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ThreatenedLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_effe74aa-97ea-460e-a930-ae268fd0d389" xlink:to="loc_us-gaap_ThreatenedLitigationMember_cc233d80-d873-4345-8939-a46b1a2f505a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_768e97fe-d0e1-4281-9bb6-cc5169c4ec02" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_99e4a3d3-43ee-4ce8-9be6-aec45ee67fe0" xlink:to="loc_srt_StatementGeographicalAxis_768e97fe-d0e1-4281-9bb6-cc5169c4ec02" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_768e97fe-d0e1-4281-9bb6-cc5169c4ec02_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_768e97fe-d0e1-4281-9bb6-cc5169c4ec02" xlink:to="loc_srt_SegmentGeographicalDomain_768e97fe-d0e1-4281-9bb6-cc5169c4ec02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_cce5be4b-fc64-4f2a-a05a-ee877d031c6f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_768e97fe-d0e1-4281-9bb6-cc5169c4ec02" xlink:to="loc_srt_SegmentGeographicalDomain_cce5be4b-fc64-4f2a-a05a-ee877d031c6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_d4c49157-e4e3-4993-a449-f7346da252c3" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cce5be4b-fc64-4f2a-a05a-ee877d031c6f" xlink:to="loc_country_CA_d4c49157-e4e3-4993-a449-f7346da252c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_8d467970-b3cb-4d16-bff1-922f6d2dc64a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_99e4a3d3-43ee-4ce8-9be6-aec45ee67fe0" xlink:to="loc_srt_LitigationCaseAxis_8d467970-b3cb-4d16-bff1-922f6d2dc64a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_8d467970-b3cb-4d16-bff1-922f6d2dc64a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_8d467970-b3cb-4d16-bff1-922f6d2dc64a" xlink:to="loc_srt_LitigationCaseTypeDomain_8d467970-b3cb-4d16-bff1-922f6d2dc64a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_78822751-c15d-4cc3-b64d-bda78249bd7f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_8d467970-b3cb-4d16-bff1-922f6d2dc64a" xlink:to="loc_srt_LitigationCaseTypeDomain_78822751-c15d-4cc3-b64d-bda78249bd7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_b7188c5d-723d-4c14-a710-e8d4dc36af9f" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_78822751-c15d-4cc3-b64d-bda78249bd7f" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_b7188c5d-723d-4c14-a710-e8d4dc36af9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsMember_13e4371b-7c10-4f73-af52-28dfe20225f8" xlink:href="mo-20210930.xsd#mo_SmokingAndHealthClassActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_78822751-c15d-4cc3-b64d-bda78249bd7f" xlink:to="loc_mo_SmokingAndHealthClassActionsMember_13e4371b-7c10-4f73-af52-28dfe20225f8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesNPMAdjustmentDisputesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails" xlink:type="extended" id="i99260c04fafb4488988e49c138fa7996_ContingenciesNPMAdjustmentDisputesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementEstimateofPossibleGain_088e58c2-0b01-4632-a837-4c14f34fa12e" xlink:href="mo-20210930.xsd#mo_LitigationSettlementEstimateofPossibleGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_mo_LitigationSettlementEstimateofPossibleGain_088e58c2-0b01-4632-a837-4c14f34fa12e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_3a5c361f-18ae-4a79-a474-d190590f7ca6" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_3a5c361f-18ae-4a79-a474-d190590f7ca6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_6bc1497f-943e-4739-945e-a119b43c9b8d" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_6bc1497f-943e-4739-945e-a119b43c9b8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_89e95247-0ab2-4677-93b6-eacd7c60eb02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_89e95247-0ab2-4677-93b6-eacd7c60eb02" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty_a34b39d4-4f8b-414e-a0ae-ee1dd7dd4fd4" xlink:href="mo-20210930.xsd#mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty_a34b39d4-4f8b-414e-a0ae-ee1dd7dd4fd4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_50af5aa5-2f89-4db5-8dc7-a56cc766b4a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_50af5aa5-2f89-4db5-8dc7-a56cc766b4a4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotSettled_aef18c85-3da4-4063-b959-984d6c1e3f21" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfStatesNotSettled"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_mo_LossContingencyNumberOfStatesNotSettled_aef18c85-3da4-4063-b959-984d6c1e3f21" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesWithConcludedHearings_85e6be36-d81e-413c-bfc5-9b6286e80948" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfStatesWithConcludedHearings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_mo_LossContingencyNumberOfStatesWithConcludedHearings_85e6be36-d81e-413c-bfc5-9b6286e80948" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues_a52aa95a-711d-4bde-9dcb-d88b0cf4fa79" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues_a52aa95a-711d-4bde-9dcb-d88b0cf4fa79" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues_7ca3b4ba-d3d8-4a67-9c47-f27de1919371" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues_7ca3b4ba-d3d8-4a67-9c47-f27de1919371" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyReductionToCostOfSales_1a84bf4f-81e0-431f-afc5-a6de539c6d80" xlink:href="mo-20210930.xsd#mo_LossContingencyReductionToCostOfSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_mo_LossContingencyReductionToCostOfSales_1a84bf4f-81e0-431f-afc5-a6de539c6d80" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_a2c335c8-8f50-47ef-a72f-589d2054a879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_a2c335c8-8f50-47ef-a72f-589d2054a879" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod_38d39b6a-36a8-4741-8d77-26e22afcf5af" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod_38d39b6a-36a8-4741-8d77-26e22afcf5af" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_2ab54e45-f6e5-4b65-b2d4-f2b910dcaf29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_us-gaap_LossContingenciesTable_2ab54e45-f6e5-4b65-b2d4-f2b910dcaf29" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d68b2efa-a92e-4172-8af8-723b74aa47a5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_2ab54e45-f6e5-4b65-b2d4-f2b910dcaf29" xlink:to="loc_srt_StatementGeographicalAxis_d68b2efa-a92e-4172-8af8-723b74aa47a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d68b2efa-a92e-4172-8af8-723b74aa47a5_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_d68b2efa-a92e-4172-8af8-723b74aa47a5" xlink:to="loc_srt_SegmentGeographicalDomain_d68b2efa-a92e-4172-8af8-723b74aa47a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3121253d-9e29-4dbf-b0cf-08c6198f7937" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_d68b2efa-a92e-4172-8af8-723b74aa47a5" xlink:to="loc_srt_SegmentGeographicalDomain_3121253d-9e29-4dbf-b0cf-08c6198f7937" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_7ca85ee2-0db4-4083-b6fd-47e0ec540650" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_NY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3121253d-9e29-4dbf-b0cf-08c6198f7937" xlink:to="loc_stpr_NY_7ca85ee2-0db4-4083-b6fd-47e0ec540650" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MT_4597f340-d001-4df6-a146-9b6fe86aeffd" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MT"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3121253d-9e29-4dbf-b0cf-08c6198f7937" xlink:to="loc_stpr_MT_4597f340-d001-4df6-a146-9b6fe86aeffd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_68b95236-dfeb-4bb8-ac8c-39e1f07284d7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_2ab54e45-f6e5-4b65-b2d4-f2b910dcaf29" xlink:to="loc_dei_LegalEntityAxis_68b95236-dfeb-4bb8-ac8c-39e1f07284d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_68b95236-dfeb-4bb8-ac8c-39e1f07284d7_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_68b95236-dfeb-4bb8-ac8c-39e1f07284d7" xlink:to="loc_dei_EntityDomain_68b95236-dfeb-4bb8-ac8c-39e1f07284d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9879bb41-e35f-4971-94e1-a91515098167" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_68b95236-dfeb-4bb8-ac8c-39e1f07284d7" xlink:to="loc_dei_EntityDomain_9879bb41-e35f-4971-94e1-a91515098167" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_60720c06-65e7-4a5f-81c5-3057f693c625" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_9879bb41-e35f-4971-94e1-a91515098167" xlink:to="loc_mo_PhilipMorrisUSAMember_60720c06-65e7-4a5f-81c5-3057f693c625" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_0d8d5b4f-a64d-4bda-bbda-3a14f395c06d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_2ab54e45-f6e5-4b65-b2d4-f2b910dcaf29" xlink:to="loc_srt_LitigationCaseAxis_0d8d5b4f-a64d-4bda-bbda-3a14f395c06d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_0d8d5b4f-a64d-4bda-bbda-3a14f395c06d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_0d8d5b4f-a64d-4bda-bbda-3a14f395c06d" xlink:to="loc_srt_LitigationCaseTypeDomain_0d8d5b4f-a64d-4bda-bbda-3a14f395c06d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_11df2369-cdda-436a-91be-523ebd7e923d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_0d8d5b4f-a64d-4bda-bbda-3a14f395c06d" xlink:to="loc_srt_LitigationCaseTypeDomain_11df2369-cdda-436a-91be-523ebd7e923d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_11df2369-cdda-436a-91be-523ebd7e923d" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_9642b7ac-f3ec-414c-ac2f-a2fbb2b72eab" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_9642b7ac-f3ec-414c-ac2f-a2fbb2b72eab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_7e93a069-82b3-4979-b6f1-99193c71da76" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_7e93a069-82b3-4979-b6f1-99193c71da76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_947a85f8-966d-4549-a503-cb8420ac7f54" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_947a85f8-966d-4549-a503-cb8420ac7f54" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_dba01c3d-1809-4780-baae-fdcd9f6d90ff" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_dba01c3d-1809-4780-baae-fdcd9f6d90ff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_b92811cb-9bad-4500-98b5-4b9605200cad" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_b92811cb-9bad-4500-98b5-4b9605200cad" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_d49bd932-24c3-4508-b0c4-a626615a8833" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_d49bd932-24c3-4508-b0c4-a626615a8833" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_c0cf662d-b56d-4f86-959d-18fedcbc1fc5" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_c0cf662d-b56d-4f86-959d-18fedcbc1fc5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_2c902dad-7bd9-4eaf-8c8d-c0be06e0d2e3" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_2c902dad-7bd9-4eaf-8c8d-c0be06e0d2e3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_d6d49442-ca13-4f3a-832b-6c1338dcc1ac" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_d6d49442-ca13-4f3a-832b-6c1338dcc1ac" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_ebce2ac3-882b-436c-abd6-582845294573" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_ebce2ac3-882b-436c-abd6-582845294573" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_63dc7288-4a24-454d-8d8c-54e557b06c17" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_63dc7288-4a24-454d-8d8c-54e557b06c17" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_6ee29c26-80a8-4105-b386-5a74e882a84f" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_6ee29c26-80a8-4105-b386-5a74e882a84f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_266aefac-5e9e-465c-afb9-4404535baa33" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_266aefac-5e9e-465c-afb9-4404535baa33" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_12ca49e7-20f2-406f-8960-85207dc7c3b2" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_12ca49e7-20f2-406f-8960-85207dc7c3b2" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_83c49271-132a-45a9-aec5-3f1e2cc806d5" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_83c49271-132a-45a9-aec5-3f1e2cc806d5" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_d21381bb-1639-4f36-83dc-d4de41fe60e1" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_d21381bb-1639-4f36-83dc-d4de41fe60e1" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember_ba332393-6f8c-422e-9cb8-73f49114fb70" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember_ba332393-6f8c-422e-9cb8-73f49114fb70" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member_2998063f-6261-4d2f-9539-942d95b77385" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActionsTransitionYears20042020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member_2998063f-6261-4d2f-9539-942d95b77385" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember_c0dacca5-8463-4084-a3b0-92b37a39cf52" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember_c0dacca5-8463-4084-a3b0-92b37a39cf52" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_30608a65-46c2-44db-a286-9deaa3d9f16f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_2ab54e45-f6e5-4b65-b2d4-f2b910dcaf29" xlink:to="loc_us-gaap_LitigationStatusAxis_30608a65-46c2-44db-a286-9deaa3d9f16f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_30608a65-46c2-44db-a286-9deaa3d9f16f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_30608a65-46c2-44db-a286-9deaa3d9f16f" xlink:to="loc_us-gaap_LitigationStatusDomain_30608a65-46c2-44db-a286-9deaa3d9f16f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_9a18ce78-4110-4651-b20e-40e537d7c606" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_30608a65-46c2-44db-a286-9deaa3d9f16f" xlink:to="loc_us-gaap_LitigationStatusDomain_9a18ce78-4110-4651-b20e-40e537d7c606" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_3159a5ad-c9d9-4f39-a571-634c4a4cfe9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_9a18ce78-4110-4651-b20e-40e537d7c606" xlink:to="loc_us-gaap_SettledLitigationMember_3159a5ad-c9d9-4f39-a571-634c4a4cfe9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_ad1b2efe-9f43-49b7-ac5b-3e21e419fe25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_9a18ce78-4110-4651-b20e-40e537d7c606" xlink:to="loc_us-gaap_PendingLitigationMember_ad1b2efe-9f43-49b7-ac5b-3e21e419fe25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ArbitrationPeriodAxis_4077fa45-bdf4-450f-8fa2-762e8c887c4f" xlink:href="mo-20210930.xsd#mo_ArbitrationPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_2ab54e45-f6e5-4b65-b2d4-f2b910dcaf29" xlink:to="loc_mo_ArbitrationPeriodAxis_4077fa45-bdf4-450f-8fa2-762e8c887c4f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ArbitrationPeriodDomain_4077fa45-bdf4-450f-8fa2-762e8c887c4f_default" xlink:href="mo-20210930.xsd#mo_ArbitrationPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_mo_ArbitrationPeriodAxis_4077fa45-bdf4-450f-8fa2-762e8c887c4f" xlink:to="loc_mo_ArbitrationPeriodDomain_4077fa45-bdf4-450f-8fa2-762e8c887c4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ArbitrationPeriodDomain_4fb7df8c-391e-4942-8014-9c37712cea17" xlink:href="mo-20210930.xsd#mo_ArbitrationPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_mo_ArbitrationPeriodAxis_4077fa45-bdf4-450f-8fa2-762e8c887c4f" xlink:to="loc_mo_ArbitrationPeriodDomain_4fb7df8c-391e-4942-8014-9c37712cea17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PeriodOneMember_f9bdd316-79c1-4539-864a-8afb663c4042" xlink:href="mo-20210930.xsd#mo_PeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_ArbitrationPeriodDomain_4fb7df8c-391e-4942-8014-9c37712cea17" xlink:to="loc_mo_PeriodOneMember_f9bdd316-79c1-4539-864a-8afb663c4042" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PeriodTwoMember_512056a7-ee76-45e2-9141-30a5d638dfb4" xlink:href="mo-20210930.xsd#mo_PeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_ArbitrationPeriodDomain_4fb7df8c-391e-4942-8014-9c37712cea17" xlink:to="loc_mo_PeriodTwoMember_512056a7-ee76-45e2-9141-30a5d638dfb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2b329aef-c539-47ad-ad78-a545b67545ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_2ab54e45-f6e5-4b65-b2d4-f2b910dcaf29" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2b329aef-c539-47ad-ad78-a545b67545ec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2b329aef-c539-47ad-ad78-a545b67545ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2b329aef-c539-47ad-ad78-a545b67545ec" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2b329aef-c539-47ad-ad78-a545b67545ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2ed7b6ad-4042-49b9-81b7-37846af49da5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2b329aef-c539-47ad-ad78-a545b67545ec" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2ed7b6ad-4042-49b9-81b7-37846af49da5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_19e7fb05-33d9-4762-bc9a-7f8f37ec816d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2ed7b6ad-4042-49b9-81b7-37846af49da5" xlink:to="loc_us-gaap_CostOfSalesMember_19e7fb05-33d9-4762-bc9a-7f8f37ec816d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails" xlink:type="extended" id="ic8708b72a991478cab3a1df6e74436f9_ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_912caf8d-d49f-47cf-a05c-5d0b41550dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_697f7e33-c1e1-4762-a63e-4e5d60f91037" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_912caf8d-d49f-47cf-a05c-5d0b41550dc9" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_697f7e33-c1e1-4762-a63e-4e5d60f91037" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_efce0d71-5c3f-4484-a454-ae2b4072de7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_912caf8d-d49f-47cf-a05c-5d0b41550dc9" xlink:to="loc_us-gaap_LossContingenciesTable_efce0d71-5c3f-4484-a454-ae2b4072de7e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_f53db878-5aed-49e8-9793-c2fe20179af7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_efce0d71-5c3f-4484-a454-ae2b4072de7e" xlink:to="loc_dei_LegalEntityAxis_f53db878-5aed-49e8-9793-c2fe20179af7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f53db878-5aed-49e8-9793-c2fe20179af7_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_f53db878-5aed-49e8-9793-c2fe20179af7" xlink:to="loc_dei_EntityDomain_f53db878-5aed-49e8-9793-c2fe20179af7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ff2f0219-50b0-4358-a442-be1f2cd4e576" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_f53db878-5aed-49e8-9793-c2fe20179af7" xlink:to="loc_dei_EntityDomain_ff2f0219-50b0-4358-a442-be1f2cd4e576" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_0c0ec754-e413-4332-b692-56083fdfc222" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_ff2f0219-50b0-4358-a442-be1f2cd4e576" xlink:to="loc_mo_PhilipMorrisUSAMember_0c0ec754-e413-4332-b692-56083fdfc222" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_2cd1fd0c-0aae-402d-80d6-85e6f333d35a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_efce0d71-5c3f-4484-a454-ae2b4072de7e" xlink:to="loc_srt_LitigationCaseAxis_2cd1fd0c-0aae-402d-80d6-85e6f333d35a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_2cd1fd0c-0aae-402d-80d6-85e6f333d35a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_2cd1fd0c-0aae-402d-80d6-85e6f333d35a" xlink:to="loc_srt_LitigationCaseTypeDomain_2cd1fd0c-0aae-402d-80d6-85e6f333d35a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_2aefdc4b-054e-4448-9af6-da5f49feda4e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_2cd1fd0c-0aae-402d-80d6-85e6f333d35a" xlink:to="loc_srt_LitigationCaseTypeDomain_2aefdc4b-054e-4448-9af6-da5f49feda4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherDisputesUndertheStateSettlementAgreementsMember_5ff2a3b8-81a8-43d6-b4b1-437ff91bec52" xlink:href="mo-20210930.xsd#mo_OtherDisputesUndertheStateSettlementAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_2aefdc4b-054e-4448-9af6-da5f49feda4e" xlink:to="loc_mo_OtherDisputesUndertheStateSettlementAgreementsMember_5ff2a3b8-81a8-43d6-b4b1-437ff91bec52" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesFederalGovernmentsLawsuitDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails" xlink:type="extended" id="i212c08381a4e45cbacb4cc0a9a0c8e87_ContingenciesFederalGovernmentsLawsuitDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_bc16a862-c5f0-469c-9480-976e884f3cef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalTradeCommissionDisclosurePeriod_08033c3a-3ed0-47ac-a9df-2fe4d37b1513" xlink:href="mo-20210930.xsd#mo_FederalTradeCommissionDisclosurePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_bc16a862-c5f0-469c-9480-976e884f3cef" xlink:to="loc_mo_FederalTradeCommissionDisclosurePeriod_08033c3a-3ed0-47ac-a9df-2fe4d37b1513" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_7aef2868-b268-4647-b03c-003747000596" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_bc16a862-c5f0-469c-9480-976e884f3cef" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_7aef2868-b268-4647-b03c-003747000596" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_6e74f327-9d4c-41b6-a2a0-0577417c50b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_bc16a862-c5f0-469c-9480-976e884f3cef" xlink:to="loc_us-gaap_LossContingenciesTable_6e74f327-9d4c-41b6-a2a0-0577417c50b5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_302e70c6-fb0c-498c-b0aa-29b28075993c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_6e74f327-9d4c-41b6-a2a0-0577417c50b5" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_302e70c6-fb0c-498c-b0aa-29b28075993c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_302e70c6-fb0c-498c-b0aa-29b28075993c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_302e70c6-fb0c-498c-b0aa-29b28075993c" xlink:to="loc_us-gaap_LossContingencyNatureDomain_302e70c6-fb0c-498c-b0aa-29b28075993c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_e74710ea-9d92-493f-9c76-55d1b650bbdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_302e70c6-fb0c-498c-b0aa-29b28075993c" xlink:to="loc_us-gaap_LossContingencyNatureDomain_e74710ea-9d92-493f-9c76-55d1b650bbdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ImplementationofCorrectiveCommunicationsMember_10e98063-a251-46b9-9d09-90dc8afbc789" xlink:href="mo-20210930.xsd#mo_ImplementationofCorrectiveCommunicationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_e74710ea-9d92-493f-9c76-55d1b650bbdc" xlink:to="loc_mo_ImplementationofCorrectiveCommunicationsMember_10e98063-a251-46b9-9d09-90dc8afbc789" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_5b6b1dc7-33e2-4da8-831a-afe16cea3e5c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_6e74f327-9d4c-41b6-a2a0-0577417c50b5" xlink:to="loc_srt_LitigationCaseAxis_5b6b1dc7-33e2-4da8-831a-afe16cea3e5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_5b6b1dc7-33e2-4da8-831a-afe16cea3e5c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_5b6b1dc7-33e2-4da8-831a-afe16cea3e5c" xlink:to="loc_srt_LitigationCaseTypeDomain_5b6b1dc7-33e2-4da8-831a-afe16cea3e5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_914bfc05-e77d-48b6-8a91-3e7704919fc5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_5b6b1dc7-33e2-4da8-831a-afe16cea3e5c" xlink:to="loc_srt_LitigationCaseTypeDomain_914bfc05-e77d-48b6-8a91-3e7704919fc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalGovernmentsLawsuitMember_35970922-7857-406e-aa68-c993673dd145" xlink:href="mo-20210930.xsd#mo_FederalGovernmentsLawsuitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_914bfc05-e77d-48b6-8a91-3e7704919fc5" xlink:to="loc_mo_FederalGovernmentsLawsuitMember_35970922-7857-406e-aa68-c993673dd145" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b2b4f4d1-51a7-4e18-9a8d-dc781bd5f0b3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_6e74f327-9d4c-41b6-a2a0-0577417c50b5" xlink:to="loc_dei_LegalEntityAxis_b2b4f4d1-51a7-4e18-9a8d-dc781bd5f0b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b2b4f4d1-51a7-4e18-9a8d-dc781bd5f0b3_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_b2b4f4d1-51a7-4e18-9a8d-dc781bd5f0b3" xlink:to="loc_dei_EntityDomain_b2b4f4d1-51a7-4e18-9a8d-dc781bd5f0b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_12ffe043-9eca-4feb-bccd-547e5cca731b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_b2b4f4d1-51a7-4e18-9a8d-dc781bd5f0b3" xlink:to="loc_dei_EntityDomain_12ffe043-9eca-4feb-bccd-547e5cca731b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_ed6d454d-8d51-4a48-b3da-32a6bce02555" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_12ffe043-9eca-4feb-bccd-547e5cca731b" xlink:to="loc_mo_PhilipMorrisUSAMember_ed6d454d-8d51-4a48-b3da-32a6bce02555" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AltriaGroupMember_7d4ecff8-ff2c-4038-be14-4e2e17bba84c" xlink:href="mo-20210930.xsd#mo_AltriaGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_12ffe043-9eca-4feb-bccd-547e5cca731b" xlink:to="loc_mo_AltriaGroupMember_7d4ecff8-ff2c-4038-be14-4e2e17bba84c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesEvaporProductLitigationandIQOSLitigationDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails" xlink:type="extended" id="i488307650ae34a0b9d2c1ab333d2f9dd_ContingenciesEvaporProductLitigationandIQOSLitigationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_b82e93e2-c2de-4711-805e-e5e8fa00efc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_6fcba97b-e775-4842-8cab-dd2c7ba48c72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b82e93e2-c2de-4711-805e-e5e8fa00efc6" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_6fcba97b-e775-4842-8cab-dd2c7ba48c72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber_1bad2a14-6327-4255-9ec4-697479acd179" xlink:href="mo-20210930.xsd#mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b82e93e2-c2de-4711-805e-e5e8fa00efc6" xlink:to="loc_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber_1bad2a14-6327-4255-9ec4-697479acd179" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_10de25d5-ad06-4f35-a24b-70cbf3f9947f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b82e93e2-c2de-4711-805e-e5e8fa00efc6" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_10de25d5-ad06-4f35-a24b-70cbf3f9947f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCasesWithCourtDatesSet_35f79f18-0e85-4627-9e11-e8d9bdaa03e4" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfCasesWithCourtDatesSet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b82e93e2-c2de-4711-805e-e5e8fa00efc6" xlink:to="loc_mo_LossContingencyNumberOfCasesWithCourtDatesSet_35f79f18-0e85-4627-9e11-e8d9bdaa03e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NumberOfThirdPartyLawsuits_e558f55f-fa78-45fa-bd87-7d0952ed94dd" xlink:href="mo-20210930.xsd#mo_NumberOfThirdPartyLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b82e93e2-c2de-4711-805e-e5e8fa00efc6" xlink:to="loc_mo_NumberOfThirdPartyLawsuits_e558f55f-fa78-45fa-bd87-7d0952ed94dd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsSettledNumber_b7d82714-4489-466c-bf09-8a862cf74231" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyClaimsSettledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b82e93e2-c2de-4711-805e-e5e8fa00efc6" xlink:to="loc_us-gaap_LossContingencyClaimsSettledNumber_b7d82714-4489-466c-bf09-8a862cf74231" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_0bac835c-7004-43c5-8fa4-e30446fcbf29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b82e93e2-c2de-4711-805e-e5e8fa00efc6" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_0bac835c-7004-43c5-8fa4-e30446fcbf29" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyDamagesRecoverableValue_727d4221-d8b8-4118-bb9d-7414645f3e4e" xlink:href="mo-20210930.xsd#mo_LossContingencyDamagesRecoverableValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b82e93e2-c2de-4711-805e-e5e8fa00efc6" xlink:to="loc_mo_LossContingencyDamagesRecoverableValue_727d4221-d8b8-4118-bb9d-7414645f3e4e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_4ce82723-66fa-4534-aba9-03cd1c27dfa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_b82e93e2-c2de-4711-805e-e5e8fa00efc6" xlink:to="loc_us-gaap_LossContingenciesTable_4ce82723-66fa-4534-aba9-03cd1c27dfa8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_8905bf5c-eee6-4809-9247-100bbc8fbfbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_4ce82723-66fa-4534-aba9-03cd1c27dfa8" xlink:to="loc_us-gaap_LitigationStatusAxis_8905bf5c-eee6-4809-9247-100bbc8fbfbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_8905bf5c-eee6-4809-9247-100bbc8fbfbf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_8905bf5c-eee6-4809-9247-100bbc8fbfbf" xlink:to="loc_us-gaap_LitigationStatusDomain_8905bf5c-eee6-4809-9247-100bbc8fbfbf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_739dc935-dbf7-4ff1-b00a-d64403f5f180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_8905bf5c-eee6-4809-9247-100bbc8fbfbf" xlink:to="loc_us-gaap_LitigationStatusDomain_739dc935-dbf7-4ff1-b00a-d64403f5f180" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ClassActionLawsuitMember_573fb75d-6394-4b33-a482-45e5e544cda1" xlink:href="mo-20210930.xsd#mo_ClassActionLawsuitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_739dc935-dbf7-4ff1-b00a-d64403f5f180" xlink:to="loc_mo_ClassActionLawsuitMember_573fb75d-6394-4b33-a482-45e5e544cda1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember_5bf0256d-05b3-486f-af5b-433e60f8802f" xlink:href="mo-20210930.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_739dc935-dbf7-4ff1-b00a-d64403f5f180" xlink:to="loc_mo_PendingIndividualLawsuitsMember_5bf0256d-05b3-486f-af5b-433e60f8802f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingLawsuitFiledBySchoolDistrictMember_998c09e5-ceb6-4f74-95a4-d3311dba5d79" xlink:href="mo-20210930.xsd#mo_PendingLawsuitFiledBySchoolDistrictMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_739dc935-dbf7-4ff1-b00a-d64403f5f180" xlink:to="loc_mo_PendingLawsuitFiledBySchoolDistrictMember_998c09e5-ceb6-4f74-95a4-d3311dba5d79" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_b31294ad-93fb-4812-a015-28eff05a10ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_739dc935-dbf7-4ff1-b00a-d64403f5f180" xlink:to="loc_us-gaap_SettledLitigationMember_b31294ad-93fb-4812-a015-28eff05a10ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1754a22e-2167-4153-beec-85cae2e5aeb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_4ce82723-66fa-4534-aba9-03cd1c27dfa8" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1754a22e-2167-4153-beec-85cae2e5aeb0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1754a22e-2167-4153-beec-85cae2e5aeb0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1754a22e-2167-4153-beec-85cae2e5aeb0" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1754a22e-2167-4153-beec-85cae2e5aeb0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_260e6e0a-b94a-4fe7-8d3f-cbe3f2eff846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1754a22e-2167-4153-beec-85cae2e5aeb0" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_260e6e0a-b94a-4fe7-8d3f-cbe3f2eff846" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_632747f5-da1c-4ddf-a28b-e15a0b58b610" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_260e6e0a-b94a-4fe7-8d3f-cbe3f2eff846" xlink:to="loc_us-gaap_SubsequentEventMember_632747f5-da1c-4ddf-a28b-e15a0b58b610" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_6e520aae-c628-412b-b358-45fcf094c8a0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_4ce82723-66fa-4534-aba9-03cd1c27dfa8" xlink:to="loc_srt_LitigationCaseAxis_6e520aae-c628-412b-b358-45fcf094c8a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_6e520aae-c628-412b-b358-45fcf094c8a0_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_6e520aae-c628-412b-b358-45fcf094c8a0" xlink:to="loc_srt_LitigationCaseTypeDomain_6e520aae-c628-412b-b358-45fcf094c8a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_fbabf2fa-4785-4499-ab4d-8036eb667e80" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_6e520aae-c628-412b-b358-45fcf094c8a0" xlink:to="loc_srt_LitigationCaseTypeDomain_fbabf2fa-4785-4499-ab4d-8036eb667e80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EvaporLitigationMember_3bf10c08-4461-453e-9234-df84a1966f47" xlink:href="mo-20210930.xsd#mo_EvaporLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_fbabf2fa-4785-4499-ab4d-8036eb667e80" xlink:to="loc_mo_EvaporLitigationMember_3bf10c08-4461-453e-9234-df84a1966f47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IQOSMember_8b679928-fa53-4b51-8c86-87b51a9b97b8" xlink:href="mo-20210930.xsd#mo_IQOSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_fbabf2fa-4785-4499-ab4d-8036eb667e80" xlink:to="loc_mo_IQOSMember_8b679928-fa53-4b51-8c86-87b51a9b97b8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails" xlink:type="extended" id="ia01243d45a144613a0f768776a9a3d98_ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_8fd42053-e7be-4aef-a834-605f7ca4b232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_48813b83-a8e0-4b52-8ba3-ada0732851b2" xlink:href="mo-20210930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8fd42053-e7be-4aef-a834-605f7ca4b232" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_48813b83-a8e0-4b52-8ba3-ada0732851b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassActionLawsuit_5c9a4b30-64d1-4bd3-aaaa-48d6da72dd2e" xlink:href="mo-20210930.xsd#mo_LossContingencyClassActionLawsuit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8fd42053-e7be-4aef-a834-605f7ca4b232" xlink:to="loc_mo_LossContingencyClassActionLawsuit_5c9a4b30-64d1-4bd3-aaaa-48d6da72dd2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfComplaints_73a47f6e-295a-4e18-a5c6-7234365553a6" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfComplaints"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8fd42053-e7be-4aef-a834-605f7ca4b232" xlink:to="loc_mo_LossContingencyNumberOfComplaints_73a47f6e-295a-4e18-a5c6-7234365553a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_f651ec17-6626-4cf6-b4b0-3e247e74d16a" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8fd42053-e7be-4aef-a834-605f7ca4b232" xlink:to="loc_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_f651ec17-6626-4cf6-b4b0-3e247e74d16a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_d6e73e7b-41dd-408d-9507-8386878aeec5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8fd42053-e7be-4aef-a834-605f7ca4b232" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_d6e73e7b-41dd-408d-9507-8386878aeec5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfPendingCasesConsolidated_2064ebd9-2e37-48c8-8256-f3a2ca4ed443" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfPendingCasesConsolidated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8fd42053-e7be-4aef-a834-605f7ca4b232" xlink:to="loc_mo_LossContingencyNumberOfPendingCasesConsolidated_2064ebd9-2e37-48c8-8256-f3a2ca4ed443" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits_7b2b51ce-d2dd-4ffe-bcba-f2b4a85ee9bb" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8fd42053-e7be-4aef-a834-605f7ca4b232" xlink:to="loc_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits_7b2b51ce-d2dd-4ffe-bcba-f2b4a85ee9bb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfConsolidatedDerivativeLawsuits_caee3232-c5f2-4f24-b716-ec38c77001ea" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfConsolidatedDerivativeLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8fd42053-e7be-4aef-a834-605f7ca4b232" xlink:to="loc_mo_LossContingencyNumberOfConsolidatedDerivativeLawsuits_caee3232-c5f2-4f24-b716-ec38c77001ea" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_3333aa94-a03d-457b-a366-387c5c54beaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_8fd42053-e7be-4aef-a834-605f7ca4b232" xlink:to="loc_us-gaap_LossContingenciesTable_3333aa94-a03d-457b-a366-387c5c54beaa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_a0fa34ed-f714-480b-8d05-4876317adc16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3333aa94-a03d-457b-a366-387c5c54beaa" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_a0fa34ed-f714-480b-8d05-4876317adc16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a0fa34ed-f714-480b-8d05-4876317adc16_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a0fa34ed-f714-480b-8d05-4876317adc16" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a0fa34ed-f714-480b-8d05-4876317adc16_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_78068c3a-0573-41b3-9aba-a651d83ae540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a0fa34ed-f714-480b-8d05-4876317adc16" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_78068c3a-0573-41b3-9aba-a651d83ae540" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_25a592fb-108d-4744-9513-2e01886cb862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_78068c3a-0573-41b3-9aba-a651d83ae540" xlink:to="loc_us-gaap_SubsequentEventMember_25a592fb-108d-4744-9513-2e01886cb862" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_edd1647d-edeb-4870-9754-8d485b613ab3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3333aa94-a03d-457b-a366-387c5c54beaa" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_edd1647d-edeb-4870-9754-8d485b613ab3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_edd1647d-edeb-4870-9754-8d485b613ab3_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_edd1647d-edeb-4870-9754-8d485b613ab3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_edd1647d-edeb-4870-9754-8d485b613ab3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_153aa7bd-f038-45ca-bab1-d10332ef2bdf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_edd1647d-edeb-4870-9754-8d485b613ab3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_153aa7bd-f038-45ca-bab1-d10332ef2bdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_1d7395c7-49b5-4da1-9631-7cf4e4311bc2" xlink:href="mo-20210930.xsd#mo_JUULMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_153aa7bd-f038-45ca-bab1-d10332ef2bdf" xlink:to="loc_mo_JUULMember_1d7395c7-49b5-4da1-9631-7cf4e4311bc2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesLightsUltraLightsCasesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails" xlink:type="extended" id="iebb403857d5b4d5eaa424a2b0d13220c_ContingenciesLightsUltraLightsCasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c0330409-1363-4c08-965e-307669c21f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyStateCourtsNumber_c837f544-909b-4944-8689-f3b6f313f92e" xlink:href="mo-20210930.xsd#mo_LossContingencyStateCourtsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c0330409-1363-4c08-965e-307669c21f1f" xlink:to="loc_mo_LossContingencyStateCourtsNumber_c837f544-909b-4944-8689-f3b6f313f92e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsNotCertifiedNumber_c63c8816-dee6-43ea-babe-816a01801835" xlink:href="mo-20210930.xsd#mo_LossContingencyClaimsNotCertifiedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c0330409-1363-4c08-965e-307669c21f1f" xlink:to="loc_mo_LossContingencyClaimsNotCertifiedNumber_c63c8816-dee6-43ea-babe-816a01801835" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_276dcdb2-1ad5-467e-90dc-88d65ee8a8a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c0330409-1363-4c08-965e-307669c21f1f" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_276dcdb2-1ad5-467e-90dc-88d65ee8a8a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_5ca101a9-4349-4616-a3f4-fa65b451e3be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_c0330409-1363-4c08-965e-307669c21f1f" xlink:to="loc_us-gaap_LossContingenciesTable_5ca101a9-4349-4616-a3f4-fa65b451e3be" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_53a319ad-87b6-46c5-a29f-a8efef045434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5ca101a9-4349-4616-a3f4-fa65b451e3be" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_53a319ad-87b6-46c5-a29f-a8efef045434" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_53a319ad-87b6-46c5-a29f-a8efef045434_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_53a319ad-87b6-46c5-a29f-a8efef045434" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_53a319ad-87b6-46c5-a29f-a8efef045434_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a29bc6d1-c7c0-42d5-8460-8d36dfe66651" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_53a319ad-87b6-46c5-a29f-a8efef045434" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a29bc6d1-c7c0-42d5-8460-8d36dfe66651" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_83540f7a-32d3-442e-9b17-5fe1e244ab5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a29bc6d1-c7c0-42d5-8460-8d36dfe66651" xlink:to="loc_us-gaap_SubsequentEventMember_83540f7a-32d3-442e-9b17-5fe1e244ab5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_2d8ccbb4-7696-441a-9c81-c1be8c747ced" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5ca101a9-4349-4616-a3f4-fa65b451e3be" xlink:to="loc_srt_LitigationCaseAxis_2d8ccbb4-7696-441a-9c81-c1be8c747ced" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_2d8ccbb4-7696-441a-9c81-c1be8c747ced_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_2d8ccbb4-7696-441a-9c81-c1be8c747ced" xlink:to="loc_srt_LitigationCaseTypeDomain_2d8ccbb4-7696-441a-9c81-c1be8c747ced_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_71034b3d-3151-4408-8004-28b9a85e8b06" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_2d8ccbb4-7696-441a-9c81-c1be8c747ced" xlink:to="loc_srt_LitigationCaseTypeDomain_71034b3d-3151-4408-8004-28b9a85e8b06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LightsMember_381c39cd-3f56-48d7-bd1c-327b60d7aa5e" xlink:href="mo-20210930.xsd#mo_LightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_71034b3d-3151-4408-8004-28b9a85e8b06" xlink:to="loc_mo_LightsMember_381c39cd-3f56-48d7-bd1c-327b60d7aa5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsMember_42d7cc3f-9bb9-4bed-a480-62c9a5297ff0" xlink:href="mo-20210930.xsd#mo_SmokingAndHealthClassActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_71034b3d-3151-4408-8004-28b9a85e8b06" xlink:to="loc_mo_SmokingAndHealthClassActionsMember_42d7cc3f-9bb9-4bed-a480-62c9a5297ff0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USTLitigationMember_ff5bac63-282a-47d4-89c4-f7e00335916a" xlink:href="mo-20210930.xsd#mo_USTLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_71034b3d-3151-4408-8004-28b9a85e8b06" xlink:to="loc_mo_USTLitigationMember_ff5bac63-282a-47d4-89c4-f7e00335916a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a338e49b-05ce-4245-8110-4396b1e0bae5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5ca101a9-4349-4616-a3f4-fa65b451e3be" xlink:to="loc_dei_LegalEntityAxis_a338e49b-05ce-4245-8110-4396b1e0bae5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a338e49b-05ce-4245-8110-4396b1e0bae5_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_a338e49b-05ce-4245-8110-4396b1e0bae5" xlink:to="loc_dei_EntityDomain_a338e49b-05ce-4245-8110-4396b1e0bae5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_88ebb2bd-5cd0-4663-b1da-0e2f0a8dfb10" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_a338e49b-05ce-4245-8110-4396b1e0bae5" xlink:to="loc_dei_EntityDomain_88ebb2bd-5cd0-4663-b1da-0e2f0a8dfb10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_f6906f9d-d9bd-4d43-9481-6e294480be7f" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_88ebb2bd-5cd0-4663-b1da-0e2f0a8dfb10" xlink:to="loc_mo_PhilipMorrisUSAMember_f6906f9d-d9bd-4d43-9481-6e294480be7f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesUSTLitigationsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails" xlink:type="extended" id="iaebdf08d0e74479c8a011faa8fffa3ec_ContingenciesUSTLitigationsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_dfa44b12-e229-4eb1-8764-e6d259009dba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_87e8905a-afc5-4a7e-a387-16747ae4ff32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_dfa44b12-e229-4eb1-8764-e6d259009dba" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_87e8905a-afc5-4a7e-a387-16747ae4ff32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_d160e90a-ce20-4c46-bd3f-c05669d8f000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_dfa44b12-e229-4eb1-8764-e6d259009dba" xlink:to="loc_us-gaap_LossContingenciesTable_d160e90a-ce20-4c46-bd3f-c05669d8f000" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_3f6875ea-8662-4080-a66d-4ee210b907be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_d160e90a-ce20-4c46-bd3f-c05669d8f000" xlink:to="loc_us-gaap_LitigationStatusAxis_3f6875ea-8662-4080-a66d-4ee210b907be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_3f6875ea-8662-4080-a66d-4ee210b907be_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_3f6875ea-8662-4080-a66d-4ee210b907be" xlink:to="loc_us-gaap_LitigationStatusDomain_3f6875ea-8662-4080-a66d-4ee210b907be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_f3bec1f8-ef8e-4372-8fd8-16a4d545863e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_3f6875ea-8662-4080-a66d-4ee210b907be" xlink:to="loc_us-gaap_LitigationStatusDomain_f3bec1f8-ef8e-4372-8fd8-16a4d545863e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember_571c1a20-3866-480d-9296-2a0865dee073" xlink:href="mo-20210930.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_f3bec1f8-ef8e-4372-8fd8-16a4d545863e" xlink:to="loc_mo_PendingIndividualLawsuitsMember_571c1a20-3866-480d-9296-2a0865dee073" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_277d9feb-b936-4c1f-82af-f8441f54e212" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_d160e90a-ce20-4c46-bd3f-c05669d8f000" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_277d9feb-b936-4c1f-82af-f8441f54e212" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_277d9feb-b936-4c1f-82af-f8441f54e212_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_277d9feb-b936-4c1f-82af-f8441f54e212" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_277d9feb-b936-4c1f-82af-f8441f54e212_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_bc616a08-cf1b-4830-87d3-fa9cb00e32f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_277d9feb-b936-4c1f-82af-f8441f54e212" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_bc616a08-cf1b-4830-87d3-fa9cb00e32f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_aa1e14d7-9351-45a5-aabe-7bce4f2029ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_bc616a08-cf1b-4830-87d3-fa9cb00e32f0" xlink:to="loc_us-gaap_SubsequentEventMember_aa1e14d7-9351-45a5-aabe-7bce4f2029ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_a192e4dc-ede8-4c51-a240-976fe4a31144" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_d160e90a-ce20-4c46-bd3f-c05669d8f000" xlink:to="loc_srt_LitigationCaseAxis_a192e4dc-ede8-4c51-a240-976fe4a31144" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_a192e4dc-ede8-4c51-a240-976fe4a31144_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_a192e4dc-ede8-4c51-a240-976fe4a31144" xlink:to="loc_srt_LitigationCaseTypeDomain_a192e4dc-ede8-4c51-a240-976fe4a31144_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_24b11bc2-1ca1-4181-9e18-295e1bb073fb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_a192e4dc-ede8-4c51-a240-976fe4a31144" xlink:to="loc_srt_LitigationCaseTypeDomain_24b11bc2-1ca1-4181-9e18-295e1bb073fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USTLitigationMember_da9e128c-5cca-4ca3-a6bc-80008e530d8d" xlink:href="mo-20210930.xsd#mo_USTLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_24b11bc2-1ca1-4181-9e18-295e1bb073fb" xlink:to="loc_mo_USTLitigationMember_da9e128c-5cca-4ca3-a6bc-80008e530d8d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails" xlink:type="extended" id="i80e014b9af794b7abe242a433b32a8a7_ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_35643434-57a2-4366-ab1f-5649491d2ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_81d46857-a3f4-4cb2-9286-87b3d7b4e057" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_35643434-57a2-4366-ab1f-5649491d2ec9" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_81d46857-a3f4-4cb2-9286-87b3d7b4e057" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_e2d9bd91-30af-40f3-9fa0-ad74c58763db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_35643434-57a2-4366-ab1f-5649491d2ec9" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_e2d9bd91-30af-40f3-9fa0-ad74c58763db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_3460661e-d315-4df5-a615-c4c7a28a4637" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_35643434-57a2-4366-ab1f-5649491d2ec9" xlink:to="loc_us-gaap_LossContingenciesTable_3460661e-d315-4df5-a615-c4c7a28a4637" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fc831220-ada8-42b7-ba4d-bfb438ad9ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3460661e-d315-4df5-a615-c4c7a28a4637" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fc831220-ada8-42b7-ba4d-bfb438ad9ce8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fc831220-ada8-42b7-ba4d-bfb438ad9ce8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fc831220-ada8-42b7-ba4d-bfb438ad9ce8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fc831220-ada8-42b7-ba4d-bfb438ad9ce8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_76aa53f6-d9c8-4167-85ab-c8a4250ad29b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fc831220-ada8-42b7-ba4d-bfb438ad9ce8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_76aa53f6-d9c8-4167-85ab-c8a4250ad29b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_35b90949-4705-45d9-b513-e807355cc601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_76aa53f6-d9c8-4167-85ab-c8a4250ad29b" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_35b90949-4705-45d9-b513-e807355cc601" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_dde63912-abec-4ca6-8d77-0f923ba2c991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3460661e-d315-4df5-a615-c4c7a28a4637" xlink:to="loc_us-gaap_DebtInstrumentAxis_dde63912-abec-4ca6-8d77-0f923ba2c991" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dde63912-abec-4ca6-8d77-0f923ba2c991_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_dde63912-abec-4ca6-8d77-0f923ba2c991" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dde63912-abec-4ca6-8d77-0f923ba2c991_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1e58580e-74b0-484d-b279-03e2571e41aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_dde63912-abec-4ca6-8d77-0f923ba2c991" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1e58580e-74b0-484d-b279-03e2571e41aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CreditAgreementMember_8490b0a4-1dff-459d-9c13-b981bc7d95fc" xlink:href="mo-20210930.xsd#mo_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e58580e-74b0-484d-b279-03e2571e41aa" xlink:to="loc_mo_CreditAgreementMember_8490b0a4-1dff-459d-9c13-b981bc7d95fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_4d3cf179-e71e-419b-b427-6a503249a74f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3460661e-d315-4df5-a615-c4c7a28a4637" xlink:to="loc_us-gaap_CreditFacilityAxis_4d3cf179-e71e-419b-b427-6a503249a74f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_4d3cf179-e71e-419b-b427-6a503249a74f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_4d3cf179-e71e-419b-b427-6a503249a74f" xlink:to="loc_us-gaap_CreditFacilityDomain_4d3cf179-e71e-419b-b427-6a503249a74f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0e7b574b-09b8-4b27-aeb6-06659e805a10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_4d3cf179-e71e-419b-b427-6a503249a74f" xlink:to="loc_us-gaap_CreditFacilityDomain_0e7b574b-09b8-4b27-aeb6-06659e805a10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_ca2d5834-c9ad-43ab-8fb7-fd74a32b8445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_0e7b574b-09b8-4b27-aeb6-06659e805a10" xlink:to="loc_us-gaap_LetterOfCreditMember_ca2d5834-c9ad-43ab-8fb7-fd74a32b8445" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>mo-20210930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:24c66990-7eda-4ddf-9c7a-8f1433627d2e,g:a0baef4b-24ba-4415-bfd0-6e9831a24e17-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_mo_InvestmentsLineItems_2e2f057b-d230-43ff-b859-ddead660b547_terseLabel_en-US" xlink:label="lab_mo_InvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Line Items]</link:label>
    <link:label id="lab_mo_InvestmentsLineItems_label_en-US" xlink:label="lab_mo_InvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Line Items]</link:label>
    <link:label id="lab_mo_InvestmentsLineItems_documentation_en-US" xlink:label="lab_mo_InvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems" xlink:href="mo-20210930.xsd#mo_InvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InvestmentsLineItems" xlink:to="lab_mo_InvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_67611d34-f114-40d7-9737-5adf76e178b2_terseLabel_en-US" xlink:label="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, consolidated EBITDA to interest expense ratio</link:label>
    <link:label id="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_label_en-US" xlink:label="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Consolidated EBITDA to Interest Expense Ratio</link:label>
    <link:label id="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_documentation_en-US" xlink:label="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Consolidated EBITDA to Interest Expense Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" xlink:href="mo-20210930.xsd#mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" xlink:to="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_4f8e0765-1690-4ea2-98de-bd5460253c57_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualPayments_e13507de-965b-4a49-ad77-90d7018d47a2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualPayments" xlink:to="lab_us-gaap_LossContingencyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_f8cd3006-f3cf-4dfd-8483-ca0555f4349a_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_6612d957-2ff1-47d9-b56b-b81359a280a3_verboseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Planned share repurchase program</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CashDiscountsPolicyTextBlock_8571f22b-988a-463f-91c0-9dfda9a431b8_terseLabel_en-US" xlink:label="lab_mo_CashDiscountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Discounts</link:label>
    <link:label id="lab_mo_CashDiscountsPolicyTextBlock_label_en-US" xlink:label="lab_mo_CashDiscountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Discounts [Policy Text Block]</link:label>
    <link:label id="lab_mo_CashDiscountsPolicyTextBlock_documentation_en-US" xlink:label="lab_mo_CashDiscountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CashDiscountsPolicyTextBlock" xlink:href="mo-20210930.xsd#mo_CashDiscountsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CashDiscountsPolicyTextBlock" xlink:to="lab_mo_CashDiscountsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_51b1f930-4090-4802-be02-dc6be8292e17_terseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_9740fbd2-8943-4c53-9627-a3bf54aca884_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_a5e5161b-48ad-4ae3-a929-86a1c0a7a2ae_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified to net earnings (losses)</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_da0ae3ce-a661-4e20-a6ab-c871f776bc27_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share Repurchase Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock_e0487d68-8e43-4a8e-92ad-d208b62d7b7f_terseLabel_en-US" xlink:label="lab_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Non-Participating Manufacturer Adjustment Items</link:label>
    <link:label id="lab_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock_label_en-US" xlink:label="lab_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Non-Participating Manufacturer Adjustment Items [Table Text Block]</link:label>
    <link:label id="lab_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock_documentation_en-US" xlink:label="lab_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Non-Participating Manufacturer Adjustment Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock" xlink:href="mo-20210930.xsd#mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock" xlink:to="lab_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_fc22578d-b249-4b06-b314-41ace963a516_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal group, including discontinued operation, accounts, notes and loans receivable, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_2cfcccd3-5608-47fc-b6c5-f77590affb5b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember_e982bab0-52c2-4cc5-88f5-700e1f5db765_terseLabel_en-US" xlink:label="lab_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Participating Manufacturer Arbitration Panel Decision</link:label>
    <link:label id="lab_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember_label_en-US" xlink:label="lab_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Participating Manufacturer Arbitration Panel Decision [Member]</link:label>
    <link:label id="lab_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember_documentation_en-US" xlink:label="lab_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Participating Manufacturer Arbitration Panel Decision [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember" xlink:href="mo-20210930.xsd#mo_NonParticipatingManufacturerArbitrationPanelDecisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember" xlink:to="lab_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_July2019ShareRepurchaseProgramMember_0e4b6cf6-6d32-49a5-bc2c-96f652171d54_terseLabel_en-US" xlink:label="lab_mo_July2019ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">July 2019 Share Repurchase Program [Member]</link:label>
    <link:label id="lab_mo_July2019ShareRepurchaseProgramMember_label_en-US" xlink:label="lab_mo_July2019ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">July 2019 Share Repurchase Program [Member]</link:label>
    <link:label id="lab_mo_July2019ShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_mo_July2019ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">July 2019 Share Repurchase Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_July2019ShareRepurchaseProgramMember" xlink:href="mo-20210930.xsd#mo_July2019ShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_July2019ShareRepurchaseProgramMember" xlink:to="lab_mo_July2019ShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab494374-f4d0-4f26-978e-443309e804cb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_caa64623-9718-4972-b2e1-bd3bbf17fc33_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (losses) attributable to Altria</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_fcac1535-2d24-486f-9d7e-5cf52fa8f796_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (losses) attributable to Altria</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_4a5b43e5-31ef-44dc-a71b-ab78af852579_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_1e11b377-b718-42e8-b65a-815a8bf0ce4f_negatedTerseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Difference between carrying amount and fair value, percentage (approximately)</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_113ddabf-760a-468d-94da-8d933d7c0e6d_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, difference between carrying amount and fair value, percentage (approximately)</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" xlink:to="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_1155b725-c7ce-4f3f-bda7-2b2133339865_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_a0121930-e3de-4ef6-971e-7b8651fb2fcb_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of ordinary shares owned (in shares)</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_107249de-095e-4bb4-a1ff-ab499b9417d9_verboseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of ordinary shares owned (approximately) (in shares)</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Shares Owned, Common</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Shares Owned, Common</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedCommon"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:to="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_241c4c22-41ea-4804-89a7-2efd8aaf4183_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_b1c17b1b-4ed2-44a5-9b6c-8072846ac73f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, acquisition related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_8e9c620e-7c9b-4113-a5be-8086b7fa638d_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_49016da1-122b-4d89-be97-b489e508f326_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts_370b69b8-9436-4e3e-9e34-557e443d515e_terseLabel_en-US" xlink:label="lab_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal group disposition related costs</link:label>
    <link:label id="lab_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts_label_en-US" xlink:label="lab_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Disposition Related Costs</link:label>
    <link:label id="lab_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts_documentation_en-US" xlink:label="lab_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Disposition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts" xlink:href="mo-20210930.xsd#mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts" xlink:to="lab_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_StockRepurchaseProgramIncreaseAuthorizedAmount_bc8e8778-6b5c-405a-ab7f-01299a16c7bd_terseLabel_en-US" xlink:label="lab_mo_StockRepurchaseProgramIncreaseAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, increase authorized amount</link:label>
    <link:label id="lab_mo_StockRepurchaseProgramIncreaseAuthorizedAmount_label_en-US" xlink:label="lab_mo_StockRepurchaseProgramIncreaseAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Increase Authorized Amount</link:label>
    <link:label id="lab_mo_StockRepurchaseProgramIncreaseAuthorizedAmount_documentation_en-US" xlink:label="lab_mo_StockRepurchaseProgramIncreaseAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Increase Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_StockRepurchaseProgramIncreaseAuthorizedAmount" xlink:href="mo-20210930.xsd#mo_StockRepurchaseProgramIncreaseAuthorizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_StockRepurchaseProgramIncreaseAuthorizedAmount" xlink:to="lab_mo_StockRepurchaseProgramIncreaseAuthorizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_ae014e08-2f3e-400c-a3a0-cd804a2f163d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_e07c2055-5e8d-4a61-a2e8-2ed14153bd04_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_dc1f0264-e51c-4afe-9d19-197893fe6c18_terseLabel_en-US" xlink:label="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, consolidated EBITDA to interest expense ratio, minimum</link:label>
    <link:label id="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_label_en-US" xlink:label="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Consolidated EBITDA to Interest Expense Ratio, Minimum</link:label>
    <link:label id="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_documentation_en-US" xlink:label="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Consolidated EBITDA to Interest Expense Ratio, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" xlink:href="mo-20210930.xsd#mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" xlink:to="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_b77eb347-ab6c-4acc-8025-603f18c41716_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal group, including discontinued operation, consideration</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure_3b3b03e4-d7bb-4e35-a0e8-c464448a9238_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of equity investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsMember_969920c7-7f25-49dd-a131-0862714f6467_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember" xlink:to="lab_mo_HealthCareCostRecoveryActionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_43054c22-3c9d-4252-8e5a-dceb75299d6f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_13f4b981-52a4-47f1-9a08-4fe1256caa5a_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_1edd9624-e25f-4f29-bed9-4be158c0c4fc_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_a4f631ff-760a-4a12-9a63-82b6a65a4699_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_6d5e1b5d-2022-4cda-b91f-188b7268698b_terseLabel_en-US" xlink:label="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABI [Member]</link:label>
    <link:label id="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_label_en-US" xlink:label="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Equity Method Investments Attributable To Parent [Member]</link:label>
    <link:label id="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_documentation_en-US" xlink:label="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Equity Method Investments Attributable To Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" xlink:href="mo-20210930.xsd#mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" xlink:to="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_7d966577-b9d0-4e78-989c-c5e2129e0efa_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClaimsDecidedFavorableNumber_7acb9a01-d36e-4a37-b9e0-a08f60ce0b7a_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClaimsDecidedFavorableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of favorable verdicts</link:label>
    <link:label id="lab_mo_LossContingencyClaimsDecidedFavorableNumber_label_en-US" xlink:label="lab_mo_LossContingencyClaimsDecidedFavorableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Decided Favorable, Number</link:label>
    <link:label id="lab_mo_LossContingencyClaimsDecidedFavorableNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyClaimsDecidedFavorableNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Decided Favorable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedFavorableNumber" xlink:href="mo-20210930.xsd#mo_LossContingencyClaimsDecidedFavorableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClaimsDecidedFavorableNumber" xlink:to="lab_mo_LossContingencyClaimsDecidedFavorableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9673c2bf-d692-4a85-8949-0165a29042eb_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_21fdb620-b8f4-4112-b768-ca17f94f6f5b_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of JUUL equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_55234b67-7064-47cb-8de6-806566767811_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of JUUL equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_46ee6450-0de7-46c7-bfd1-82a1fd1d25a7_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_590ba14e-4090-44d6-9898-6d0deedb5ad9_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_d1554217-d393-435e-a73a-41d4562b7b2c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount_acf5fcac-b71e-430c-a778-bb24e9fbfab0_terseLabel_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to valuation allowance charged to income tax expense</link:label>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount_label_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase In Amount</link:label>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount_documentation_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase In Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount" xlink:href="mo-20210930.xsd#mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount" xlink:to="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_8db75d8c-0927-49d1-84f4-b69723901df8_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_af18ce35-b8d2-4e68-8cac-3840632c70d9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_563b95c5-6857-4a55-af48-f80f54709dc1_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease)</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits_d83869f1-8440-45f7-8e0b-d4c3bf61f613_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of inactive class action lawsuits</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Inactive Class Action Lawsuits</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Inactive Class Action Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfInactiveClassActionLawsuits" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfInactiveClassActionLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfInactiveClassActionLawsuits" xlink:to="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_17e91731-d2d9-4d07-94f9-9ea91c1c2074_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, redemption price, percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_694f653d-6ee4-4c00-81c6-01486b4fab39_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_4f33dabc-85ef-4d7b-b6c5-66a4f96f5fa5_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_c1b486c2-23ec-45e3-97c4-7bebc5bc7852_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held for Sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_73a59b2d-73af-4bcd-823d-0fb72f63cb65_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax charge for adjustment to record the assets and liabilities at fair value less costs to sell</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_afc961d0-86be-4692-90c6-f304d4e868c8_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LitigationSettlementEstimateofPossibleGain_3cfd7db5-47d9-40f4-b17e-581ed4ddfb19_terseLabel_en-US" xlink:label="lab_mo_LitigationSettlementEstimateofPossibleGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of possible gain</link:label>
    <link:label id="lab_mo_LitigationSettlementEstimateofPossibleGain_label_en-US" xlink:label="lab_mo_LitigationSettlementEstimateofPossibleGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Estimate of Possible Gain</link:label>
    <link:label id="lab_mo_LitigationSettlementEstimateofPossibleGain_documentation_en-US" xlink:label="lab_mo_LitigationSettlementEstimateofPossibleGain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Estimate of Possible Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementEstimateofPossibleGain" xlink:href="mo-20210930.xsd#mo_LitigationSettlementEstimateofPossibleGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LitigationSettlementEstimateofPossibleGain" xlink:to="lab_mo_LitigationSettlementEstimateofPossibleGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_a7430cb6-ad90-4000-a93e-486c2e1859f7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b56aa6bc-e76a-408d-8153-c0e017312e9c_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_6de20f7a-a6ac-44c9-aa5c-e615f0226233_negatedLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross_c8a5a5b0-b02f-4bfc-ab23-f7bb1c579be6_totalLabel_en-US" xlink:label="lab_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross_label_en-US" xlink:label="lab_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current, Gross</link:label>
    <link:label id="lab_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross_documentation_en-US" xlink:label="lab_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross" xlink:href="mo-20210930.xsd#mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross" xlink:to="lab_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesSommersMember_e023c369-c609-4f6e-9a2e-da5742d12c22_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesSommersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Sommers [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesSommersMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesSommersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Sommers [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesSommersMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesSommersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Sommers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesSommersMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesSommersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesSommersMember" xlink:to="lab_mo_EngleProgenyCasesSommersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_902f82dd-1256-4ec7-a061-6d299e04b77e_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_248c8170-6c77-44b5-b46b-2b2cf0a85ea3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsMember" xlink:to="lab_us-gaap_OtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AltriaGroupMember_a4b6a75f-675e-4e6f-a7f3-e5ad1ecfef44_terseLabel_en-US" xlink:label="lab_mo_AltriaGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Group [Member]</link:label>
    <link:label id="lab_mo_AltriaGroupMember_label_en-US" xlink:label="lab_mo_AltriaGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Group [Member]</link:label>
    <link:label id="lab_mo_AltriaGroupMember_documentation_en-US" xlink:label="lab_mo_AltriaGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Group</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AltriaGroupMember" xlink:href="mo-20210930.xsd#mo_AltriaGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AltriaGroupMember" xlink:to="lab_mo_AltriaGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_adbf918e-24ea-49c8-9f92-b41f785c46c3_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, percentage of shares eligible for purchase (approximately)</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Percentage of Shares Eligible For Purchase</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Percentage of Shares Eligible For Purchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" xlink:to="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfComplaints_19daf89d-6005-40f5-863e-cd97b97e83e7_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfComplaints" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of complaints</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfComplaints_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfComplaints" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Complaints</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfComplaints_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfComplaints" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Complaints</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfComplaints" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfComplaints"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfComplaints" xlink:to="lab_mo_LossContingencyNumberOfComplaints" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_1e4c25c5-15e9-463a-a4bb-58ee8066aa9b_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrent" xlink:to="lab_us-gaap_DividendsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member_516894c0-c87c-4554-9b8c-2ce6b5f29a4f_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, Transition Years 2004-2018 [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, Transition Years 2004-2020 [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, Transition Years 2004-2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActionsTransitionYears20042020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member" xlink:to="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_d365a3a3-81bb-40ef-8fb2-7f34d9d361ec_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesChadwellMember_cd818a26-7a17-4438-8df7-ec7c3d07da86_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesChadwellMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Chadwell [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesChadwellMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesChadwellMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Chadwell [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesChadwellMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesChadwellMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Chadwell [Member] [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesChadwellMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesChadwellMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesChadwellMember" xlink:to="lab_mo_EngleProgenyCasesChadwellMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_32fbf0f6-c333-450c-9f90-1b9531e9d629_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_ef904544-6149-4858-a832-a3dc7fcf0a63_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses) included in income (losses) from equity investments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDDenominatedNotes2850PercentDue2022Member_6a5605cf-25ff-4f25-bfaf-d74b7c5fd622_terseLabel_en-US" xlink:label="lab_mo_USDDenominatedNotes2850PercentDue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.850%, Notes Due 2022 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotes2850PercentDue2022Member_label_en-US" xlink:label="lab_mo_USDDenominatedNotes2850PercentDue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes, 2.850 Percent, Due 2022 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotes2850PercentDue2022Member_documentation_en-US" xlink:label="lab_mo_USDDenominatedNotes2850PercentDue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes, 2.850 Percent, Due 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes2850PercentDue2022Member" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotes2850PercentDue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDDenominatedNotes2850PercentDue2022Member" xlink:to="lab_mo_USDDenominatedNotes2850PercentDue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_a07ba4be-a059-4694-bedf-cf3e87c51d4d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_f8823407-8976-4c9d-af13-d1abb854f9f7_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_322f5bc8-6c2d-4110-8b84-8e144ad65ac3_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues_4af91d87-603c-495e-aae7-2565924f7690_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of states in compliance with escrow statues</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States In Compliance With Escrow Statues</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States In Compliance With Escrow Statues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues" xlink:to="lab_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesHollimanMember_d44eebd1-1a1b-45d8-abe0-7f765cc907cc_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesHollimanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Holliman [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesHollimanMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesHollimanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Holliman [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesHollimanMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesHollimanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Holliman [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesHollimanMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesHollimanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesHollimanMember" xlink:to="lab_mo_EngleProgenyCasesHollimanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_5565f0fb-3adf-41d7-88ad-68a580d11dd1_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_afeb5c20-c61a-498c-91d2-1bded01c9723_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterimPeriodCostsNotAllocableDomain_330a286d-4fe5-4f6b-967d-c651fd87c052_terseLabel_en-US" xlink:label="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interim Period, Costs Not Allocable [Domain]</link:label>
    <link:label id="lab_us-gaap_InterimPeriodCostsNotAllocableDomain_label_en-US" xlink:label="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interim Period, Costs Not Allocable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:to="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityInvestmentsFairValueOptionVotingShares_19c0002f-a907-4548-aeb6-cb14b1b819dc_terseLabel_en-US" xlink:label="lab_mo_EquityInvestmentsFairValueOptionVotingShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments, fair value option, voting shares (in shares)</link:label>
    <link:label id="lab_mo_EquityInvestmentsFairValueOptionVotingShares_label_en-US" xlink:label="lab_mo_EquityInvestmentsFairValueOptionVotingShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments, Fair Value Option, Voting Shares</link:label>
    <link:label id="lab_mo_EquityInvestmentsFairValueOptionVotingShares_documentation_en-US" xlink:label="lab_mo_EquityInvestmentsFairValueOptionVotingShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments, Fair Value Option, Voting Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityInvestmentsFairValueOptionVotingShares" xlink:href="mo-20210930.xsd#mo_EquityInvestmentsFairValueOptionVotingShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityInvestmentsFairValueOptionVotingShares" xlink:to="lab_mo_EquityInvestmentsFairValueOptionVotingShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_1bc390a3-4c78-482d-9177-e267072ea7cd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_27b48685-3cbd-447f-9433-ff94ea7b7e88_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofCasesSetforTrial_354038fa-35d1-44b9-912c-a5f99308149f_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofCasesSetforTrial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases set for trial</link:label>
    <link:label id="lab_mo_LossContingencyNumberofCasesSetforTrial_label_en-US" xlink:label="lab_mo_LossContingencyNumberofCasesSetforTrial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cases Set for Trial</link:label>
    <link:label id="lab_mo_LossContingencyNumberofCasesSetforTrial_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofCasesSetforTrial" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cases Set for Trial</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofCasesSetforTrial" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberofCasesSetforTrial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofCasesSetforTrial" xlink:to="lab_mo_LossContingencyNumberofCasesSetforTrial" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyStateCourtsNumber_d60cff32-d061-4947-a0f3-11c30e27fd2b_terseLabel_en-US" xlink:label="lab_mo_LossContingencyStateCourtsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of state courts</link:label>
    <link:label id="lab_mo_LossContingencyStateCourtsNumber_label_en-US" xlink:label="lab_mo_LossContingencyStateCourtsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, State Courts, Number</link:label>
    <link:label id="lab_mo_LossContingencyStateCourtsNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyStateCourtsNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, State Courts, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyStateCourtsNumber" xlink:href="mo-20210930.xsd#mo_LossContingencyStateCourtsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyStateCourtsNumber" xlink:to="lab_mo_LossContingencyStateCourtsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LitigationCasesResultsMember_9e5de17e-ddb9-434e-9372-f85096c60690_terseLabel_en-US" xlink:label="lab_mo_LitigationCasesResultsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health and Certain Other Litigation [Member]</link:label>
    <link:label id="lab_mo_LitigationCasesResultsMember_label_en-US" xlink:label="lab_mo_LitigationCasesResultsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Cases Results [Member]</link:label>
    <link:label id="lab_mo_LitigationCasesResultsMember_documentation_en-US" xlink:label="lab_mo_LitigationCasesResultsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Cases Results [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationCasesResultsMember" xlink:href="mo-20210930.xsd#mo_LitigationCasesResultsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LitigationCasesResultsMember" xlink:to="lab_mo_LitigationCasesResultsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PeriodOneMember_cbfbd795-2215-4385-ba76-98f7c3709890_terseLabel_en-US" xlink:label="lab_mo_PeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period One</link:label>
    <link:label id="lab_mo_PeriodOneMember_label_en-US" xlink:label="lab_mo_PeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period One [Member]</link:label>
    <link:label id="lab_mo_PeriodOneMember_documentation_en-US" xlink:label="lab_mo_PeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PeriodOneMember" xlink:href="mo-20210930.xsd#mo_PeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PeriodOneMember" xlink:to="lab_mo_PeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_d7c56534-d38d-4f7b-8634-171779601e29_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_084de869-c55e-43e0-8640-b1219dbb374e_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages awarded, value</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:to="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_2839333a-ec59-4a0a-8386-b052f683772b_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_26b10afc-b237-4ccc-9798-b727691cdf22_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Reinvested in the Business [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_25b782b6-44ef-4e36-8910-da8b29b4623c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_853000ce-af60-49d0-bb1c-b8e9106f9095_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ForeignCurrencyDenominatedDebtMember_1eb28218-6ecb-4a78-bf20-dfe1f2bde560_terseLabel_en-US" xlink:label="lab_mo_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Denominated Debt [Member]</link:label>
    <link:label id="lab_mo_ForeignCurrencyDenominatedDebtMember_787b2687-4e0f-4e18-9b4e-847abdb0469a_verboseLabel_en-US" xlink:label="lab_mo_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency denominated debt [Member]</link:label>
    <link:label id="lab_mo_ForeignCurrencyDenominatedDebtMember_label_en-US" xlink:label="lab_mo_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Denominated Debt [Member]</link:label>
    <link:label id="lab_mo_ForeignCurrencyDenominatedDebtMember_documentation_en-US" xlink:label="lab_mo_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Denominated Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtMember" xlink:href="mo-20210930.xsd#mo_ForeignCurrencyDenominatedDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ForeignCurrencyDenominatedDebtMember" xlink:to="lab_mo_ForeignCurrencyDenominatedDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AmountAwardedtoOtherParty_7ac2f8d1-5386-41bf-8f0b-d954cf640f0f_terseLabel_en-US" xlink:label="lab_mo_AmountAwardedtoOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount awarded to other party</link:label>
    <link:label id="lab_mo_AmountAwardedtoOtherParty_label_en-US" xlink:label="lab_mo_AmountAwardedtoOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Awarded to Other Party</link:label>
    <link:label id="lab_mo_AmountAwardedtoOtherParty_documentation_en-US" xlink:label="lab_mo_AmountAwardedtoOtherParty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AmountAwardedtoOtherParty" xlink:href="mo-20210930.xsd#mo_AmountAwardedtoOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AmountAwardedtoOtherParty" xlink:to="lab_mo_AmountAwardedtoOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber_46563713-4450-4806-8cd5-34683681908b_terseLabel_en-US" xlink:label="lab_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of pending claims, consolidated for pre-trial purposes</link:label>
    <link:label id="lab_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber_label_en-US" xlink:label="lab_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Consolidated For Pre-Trial Purposes, Number</link:label>
    <link:label id="lab_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Consolidated For Pre-Trial Purposes, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" xlink:href="mo-20210930.xsd#mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" xlink:to="lab_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotSettled_3c369778-ac88-41c5-b25a-20b09554a27c_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotSettled" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of states not settled</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotSettled_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotSettled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States Not Settled</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotSettled_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotSettled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States Not Settled</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotSettled" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfStatesNotSettled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfStatesNotSettled" xlink:to="lab_mo_LossContingencyNumberOfStatesNotSettled" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfPendingCasesConsolidated_5def333a-bc14-4d92-98fe-bcb3891e0f74_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfPendingCasesConsolidated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of pending cases consolidated</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfPendingCasesConsolidated_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfPendingCasesConsolidated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Pending Cases Consolidated</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfPendingCasesConsolidated_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfPendingCasesConsolidated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Pending Cases Consolidated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfPendingCasesConsolidated" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfPendingCasesConsolidated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfPendingCasesConsolidated" xlink:to="lab_mo_LossContingencyNumberOfPendingCasesConsolidated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_df820221-5561-42c6-8f41-d413b6e50d8a_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost (credit)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_5f660f38-40a8-4ccc-b209-6eec36beb85f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends from ABI</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:to="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve_85c756f3-bdd7-47a3-8bda-a2529f17c8b3_negatedTerseLabel_en-US" xlink:label="lab_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve</link:label>
    <link:label id="lab_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve_label_en-US" xlink:label="lab_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current, Reserve</link:label>
    <link:label id="lab_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve_documentation_en-US" xlink:label="lab_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current, Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve" xlink:href="mo-20210930.xsd#mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve" xlink:to="lab_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ValuationAllowanceRollforwardRollForward_091ca9e4-d58b-453d-a589-7f22c13e0441_terseLabel_en-US" xlink:label="lab_mo_ValuationAllowanceRollforwardRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance Rollforward [Roll Forward]</link:label>
    <link:label id="lab_mo_ValuationAllowanceRollforwardRollForward_label_en-US" xlink:label="lab_mo_ValuationAllowanceRollforwardRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance Rollforward [Roll Forward]</link:label>
    <link:label id="lab_mo_ValuationAllowanceRollforwardRollForward_documentation_en-US" xlink:label="lab_mo_ValuationAllowanceRollforwardRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance Rollforward [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceRollforwardRollForward" xlink:href="mo-20210930.xsd#mo_ValuationAllowanceRollforwardRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ValuationAllowanceRollforwardRollForward" xlink:to="lab_mo_ValuationAllowanceRollforwardRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_60d983cc-14d6-4a0c-8aef-9f10a98e09ab_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, repurchased face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2068f28e-a689-4970-91ce-d3333b06f4b2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1b825f39-61f4-46a7-baa5-a1c46e14dfcb_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a5696f95-d7e5-42a0-a25d-db45bb2ff178_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive earnings (losses)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesD.BrownMember_39100b64-10d2-4785-b467-ab07c92fe5b6_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesD.BrownMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, D. Brown [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesD.BrownMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesD.BrownMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, D. Brown [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesD.BrownMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesD.BrownMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, D. Brown [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesD.BrownMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesD.BrownMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesD.BrownMember" xlink:to="lab_mo_EngleProgenyCasesD.BrownMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond_2d7a4c0f-a3a2-4e54-be99-7c4f62136bf4_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states that cap bond or require no bond</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond_label_en-US" xlink:label="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States That Cap Bond or Require No Bond</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States That Cap Bond or Require No Bond</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" xlink:to="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_IQOSMember_4ae18a14-bed0-48a0-9e9c-b61ef88708b2_terseLabel_en-US" xlink:label="lab_mo_IQOSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IQOS</link:label>
    <link:label id="lab_mo_IQOSMember_label_en-US" xlink:label="lab_mo_IQOSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IQOS [Member]</link:label>
    <link:label id="lab_mo_IQOSMember_documentation_en-US" xlink:label="lab_mo_IQOSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IQOS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IQOSMember" xlink:href="mo-20210930.xsd#mo_IQOSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_IQOSMember" xlink:to="lab_mo_IQOSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_53dc09a4-a3c2-47f2-b933-b6240170c5e6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_134d8e54-faec-480f-acc3-b10721bec836_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_d45088a7-c0af-40bc-84fd-722841fd4e1e_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of additional states extended with settled litigation</link:label>
    <link:label id="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_label_en-US" xlink:label="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Additional States Extended with Settled Litigation</link:label>
    <link:label id="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Additional States Extended with Settled Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" xlink:to="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_74c118b1-0c93-401e-93ca-cb78c60c13bc_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of short-term borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_a4f8c48f-7444-4911-b597-dee6d96741d4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings (losses) per share attributable to Altria (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_aa145e64-d7d0-43fa-8956-d7fa0cde9bb7_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases pending</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_1b42558a-fcb1-44fa-932e-b72992126f97_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims filed, number</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_18188d6f-b995-4911-8998-72a203607b25_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_AR_0c84b37b-f588-4200-bd40-5de89fa4eb27_terseLabel_en-US" xlink:label="lab_stpr_AR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arkansas [Member]</link:label>
    <link:label id="lab_stpr_AR_label_en-US" xlink:label="lab_stpr_AR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ARKANSAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AR" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_AR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_AR" xlink:to="lab_stpr_AR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_ab8838fa-987d-4b50-8630-01bc5021bccf_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from Contracts with Customers</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDDenominatedDebt6200PercentDue2059Member_3d7c0fe8-27f1-48f6-b653-f60aad6d055a_terseLabel_en-US" xlink:label="lab_mo_USDDenominatedDebt6200PercentDue2059Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.200%, Notes Due 2059 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedDebt6200PercentDue2059Member_label_en-US" xlink:label="lab_mo_USDDenominatedDebt6200PercentDue2059Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Debt, 6.200 Percent, Due 2059 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedDebt6200PercentDue2059Member_documentation_en-US" xlink:label="lab_mo_USDDenominatedDebt6200PercentDue2059Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Debt, 6.200 Percent, Due 2059</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedDebt6200PercentDue2059Member" xlink:href="mo-20210930.xsd#mo_USDDenominatedDebt6200PercentDue2059Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDDenominatedDebt6200PercentDue2059Member" xlink:to="lab_mo_USDDenominatedDebt6200PercentDue2059Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_ad993ba4-50bf-45b2-aee8-43eae993e939_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_AK_fcdda2b0-cd7d-4795-8dee-263b78b123ee_terseLabel_en-US" xlink:label="lab_stpr_AK" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alaska [Member]</link:label>
    <link:label id="lab_stpr_AK_label_en-US" xlink:label="lab_stpr_AK" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ALASKA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AK" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_AK"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_AK" xlink:to="lab_stpr_AK" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_6f54ad4d-9e33-4562-a143-2b594c6a4bed_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada [Member]</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_8ef3f794-d132-4c4c-af3d-3ba12fa276c8_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on derivatives</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualRollForward_6fbdd687-1184-43b1-989a-b1dc56e6e4cd_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualRollForward_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward" xlink:to="lab_us-gaap_LossContingencyAccrualRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_RevolvingCreditFacilityDueAugust2024Member_6795fe39-1dfd-415c-9a2e-0108e8f9d7bd_terseLabel_en-US" xlink:label="lab_mo_RevolvingCreditFacilityDueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Due August 2024 [Member]</link:label>
    <link:label id="lab_mo_RevolvingCreditFacilityDueAugust2024Member_label_en-US" xlink:label="lab_mo_RevolvingCreditFacilityDueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Due August 2024 [Member]</link:label>
    <link:label id="lab_mo_RevolvingCreditFacilityDueAugust2024Member_documentation_en-US" xlink:label="lab_mo_RevolvingCreditFacilityDueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Due August 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RevolvingCreditFacilityDueAugust2024Member" xlink:href="mo-20210930.xsd#mo_RevolvingCreditFacilityDueAugust2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_RevolvingCreditFacilityDueAugust2024Member" xlink:to="lab_mo_RevolvingCreditFacilityDueAugust2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_a82e134a-8a99-4533-a5e2-a9ce9879d797_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesStateMember_d8b8f7e3-ebc3-4be0-9c13-8041862a0b75_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesStateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, State [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesStateMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesStateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, State [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesStateMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesStateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, State [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesStateMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesStateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesStateMember" xlink:to="lab_mo_EngleProgenyCasesStateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_dcc44fdc-27ec-479b-9d75-95a76672317d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued pension costs</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Pension Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofManufacturers_3f591e24-144b-4a08-b295-a3473245c10b_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofManufacturers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of manufacturers</link:label>
    <link:label id="lab_mo_LossContingencyNumberofManufacturers_label_en-US" xlink:label="lab_mo_LossContingencyNumberofManufacturers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Manufacturers</link:label>
    <link:label id="lab_mo_LossContingencyNumberofManufacturers_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofManufacturers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Manufacturers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofManufacturers" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberofManufacturers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofManufacturers" xlink:to="lab_mo_LossContingencyNumberofManufacturers" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CreditAgreementMember_a5cd6772-53ff-4ab6-9b41-be13be6b7202_terseLabel_en-US" xlink:label="lab_mo_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_mo_CreditAgreementMember_label_en-US" xlink:label="lab_mo_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_mo_CreditAgreementMember_documentation_en-US" xlink:label="lab_mo_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CreditAgreementMember" xlink:href="mo-20210930.xsd#mo_CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CreditAgreementMember" xlink:to="lab_mo_CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_fdde9812-1ba1-4331-b44d-d746dabfd280_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset, fair value, gross asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_8d11ae8a-17da-43fb-8cf8-67f0f33723cb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_228bc09d-3b32-4dff-b77c-b93d36cd37ac_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plaintiffs</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStock3.125NotesDue2031Member_99610416-a2f5-4def-bc90-a6fb27953623_terseLabel_en-US" xlink:label="lab_mo_CommonStock3.125NotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes due 2031 [Member]</link:label>
    <link:label id="lab_mo_CommonStock3.125NotesDue2031Member_label_en-US" xlink:label="lab_mo_CommonStock3.125NotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 3.125% Notes Due 2031 [Member]</link:label>
    <link:label id="lab_mo_CommonStock3.125NotesDue2031Member_documentation_en-US" xlink:label="lab_mo_CommonStock3.125NotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 3.125% Notes Due 2031 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock3.125NotesDue2031Member" xlink:href="mo-20210930.xsd#mo_CommonStock3.125NotesDue2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStock3.125NotesDue2031Member" xlink:to="lab_mo_CommonStock3.125NotesDue2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_20be700d-f1ca-40df-b4a5-ae90f9181aa5_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_1f2039a8-ac2c-4fd1-bd6e-c10e39bc96f0_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_a0690a1a-33c0-44bc-b50e-65a1bb707056_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_bd73a1de-3195-4213-b1c0-e700b0a7cbdb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_97c96c54-0d60-4ae7-be05-b9316d99c444_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_3ab4869d-9ace-4256-97dc-efe35abbe832_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember_2ab88750-8594-4f47-94e5-b6032be81049_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2020 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2020 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2020 NPM Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_6309e656-0b17-4fdd-8471-fef62af04878_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bfbea4c1-3741-4b84-abcd-a018777c6692_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_JUULMember_e8f1f6b9-b061-49a7-80dd-19e2b94f4330_terseLabel_en-US" xlink:label="lab_mo_JUULMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JUUL [Member]</link:label>
    <link:label id="lab_mo_JUULMember_label_en-US" xlink:label="lab_mo_JUULMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JUUL [Member]</link:label>
    <link:label id="lab_mo_JUULMember_documentation_en-US" xlink:label="lab_mo_JUULMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JUUL [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember" xlink:href="mo-20210930.xsd#mo_JUULMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_JUULMember" xlink:to="lab_mo_JUULMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_61a8253b-d90e-4535-b7e0-c54a1866d662_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_e19cee46-614b-4242-a98e-0b06ae064c8e_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClassNotCertifiedNumber_83d17414-3e92-403c-bf93-b313f070d669_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClassNotCertifiedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class not certified</link:label>
    <link:label id="lab_mo_LossContingencyClassNotCertifiedNumber_label_en-US" xlink:label="lab_mo_LossContingencyClassNotCertifiedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Not Certified, Number</link:label>
    <link:label id="lab_mo_LossContingencyClassNotCertifiedNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyClassNotCertifiedNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Not Certified, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassNotCertifiedNumber" xlink:href="mo-20210930.xsd#mo_LossContingencyClassNotCertifiedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClassNotCertifiedNumber" xlink:to="lab_mo_LossContingencyClassNotCertifiedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_4c101be0-8503-4e02-bbdf-fa926b5d1194_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_71bc4b3e-57e9-420d-ad74-ffc5f3c302a2_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Stockholders&#8217; (Deficit) Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_f63a82ec-0096-4afa-959c-0b06059f3912_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_3242e631-5e70-4025-9a80-08a8a9f512c5_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CanadianTobaccoManufacturersMember_0e1bf431-4315-4878-8e01-89c4b8303437_terseLabel_en-US" xlink:label="lab_mo_CanadianTobaccoManufacturersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Tobacco Manufacturers [Member]</link:label>
    <link:label id="lab_mo_CanadianTobaccoManufacturersMember_label_en-US" xlink:label="lab_mo_CanadianTobaccoManufacturersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Tobacco Manufacturers [Member]</link:label>
    <link:label id="lab_mo_CanadianTobaccoManufacturersMember_documentation_en-US" xlink:label="lab_mo_CanadianTobaccoManufacturersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Tobacco Manufacturers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CanadianTobaccoManufacturersMember" xlink:href="mo-20210930.xsd#mo_CanadianTobaccoManufacturersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CanadianTobaccoManufacturersMember" xlink:to="lab_mo_CanadianTobaccoManufacturersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ArbitrationPeriodDomain_feb96f7a-082e-47c9-903d-447b1894d483_terseLabel_en-US" xlink:label="lab_mo_ArbitrationPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arbitration Period [Domain]</link:label>
    <link:label id="lab_mo_ArbitrationPeriodDomain_label_en-US" xlink:label="lab_mo_ArbitrationPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arbitration Period [Domain]</link:label>
    <link:label id="lab_mo_ArbitrationPeriodDomain_documentation_en-US" xlink:label="lab_mo_ArbitrationPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arbitration Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ArbitrationPeriodDomain" xlink:href="mo-20210930.xsd#mo_ArbitrationPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ArbitrationPeriodDomain" xlink:to="lab_mo_ArbitrationPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_dfc9bbb6-b28c-46a6-951c-ea479d3399a4_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plus: contingently issuable performance stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares, Contingently Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_InvestmentsTable_588931b2-da35-4fc2-99f5-6a8c06b2b37b_terseLabel_en-US" xlink:label="lab_mo_InvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Table]</link:label>
    <link:label id="lab_mo_InvestmentsTable_label_en-US" xlink:label="lab_mo_InvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Table]</link:label>
    <link:label id="lab_mo_InvestmentsTable_documentation_en-US" xlink:label="lab_mo_InvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable" xlink:href="mo-20210930.xsd#mo_InvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InvestmentsTable" xlink:to="lab_mo_InvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember_2d2c57fa-60ae-44d5-ae7a-7176d53ac788_terseLabel_en-US" xlink:label="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Disputes Under the State Settlement Agreements [Member]</link:label>
    <link:label id="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember_label_en-US" xlink:label="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Disputes Under the State Settlement Agreements [Member]</link:label>
    <link:label id="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember_documentation_en-US" xlink:label="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Disputes Under the State Settlement Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherDisputesUndertheStateSettlementAgreementsMember" xlink:href="mo-20210930.xsd#mo_OtherDisputesUndertheStateSettlementAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OtherDisputesUndertheStateSettlementAgreementsMember" xlink:to="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentImpairment_fca332fa-3ca7-4ba1-a4c6-c76619f835a2_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, impairment</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentImpairment_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Impairment</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentImpairment_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentImpairment" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentImpairment" xlink:to="lab_mo_EquityMethodInvestmentImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_86cadc3a-86de-459a-b78f-32f80d1da020_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesLandiMember_aea00d94-85d3-4c2f-9f0b-269078ad9eeb_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesLandiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Landi [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesLandiMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesLandiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Landi [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesLandiMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesLandiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Landi [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesLandiMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesLandiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesLandiMember" xlink:to="lab_mo_EngleProgenyCasesLandiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_83fd3c4a-7395-4631-b700-67d3f1d09b88_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_11d6b1b3-9dd5-4b9c-baf0-21b177f15f79_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_ce529c03-022b-41ad-9553-ae68c54c2409_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member] [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_98d60ccd-d4a0-492d-9b14-de1b8415abb8_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_32ed7ae6-28b8-494a-91fa-f3a4a222db34_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (Losses) per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_804ce7a9-34f4-4eb0-8efb-9ae27ea35a8f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases of common stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_4223881a-a4c0-48f4-a085-003509f566bd_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate cost of shares repurchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_f8b538b6-8784-41fc-a97b-1b6eaeaa40a0_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_8a5bc1f0-2d6e-4fd8-b637-d7de64ea7d52_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_fbd55b03-4ddd-44ac-a484-aaab8a2d5b4d_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_6e48f2c1-6769-402c-af64-c0c0ef14129e_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average price per share of shares repurchased (usd per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage_3b587b82-23c8-4c61-bb1c-236d7992b310_terseLabel_en-US" xlink:label="lab_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensatory damages award, allocation percentage</link:label>
    <link:label id="lab_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage_label_en-US" xlink:label="lab_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Compensatory Damages Awarded, Allocation Percentage</link:label>
    <link:label id="lab_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage_documentation_en-US" xlink:label="lab_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Compensatory Damages Awarded, Allocation Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage" xlink:href="mo-20210930.xsd#mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage" xlink:to="lab_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_5fa6b320-2345-4e26-8a25-261015a7c966_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember_ad74309f-9675-4e74-b913-87b2f26a514d_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member] [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member] [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember" xlink:to="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_eefacbad-147f-4173-882f-34397c579890_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Background and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDDenominatedNotes2950PercentDue2023Member_e71a34d7-8f3e-44a7-9eb0-be631a269be1_terseLabel_en-US" xlink:label="lab_mo_USDDenominatedNotes2950PercentDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.950%, Notes Due 2023 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotes2950PercentDue2023Member_label_en-US" xlink:label="lab_mo_USDDenominatedNotes2950PercentDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes, 2.950 Percent, Due 2023 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotes2950PercentDue2023Member_documentation_en-US" xlink:label="lab_mo_USDDenominatedNotes2950PercentDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes, 2.950 Percent, Due 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes2950PercentDue2023Member" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotes2950PercentDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDDenominatedNotes2950PercentDue2023Member" xlink:to="lab_mo_USDDenominatedNotes2950PercentDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDDenominatedNotesDue2032Member_a68edb0f-48a6-446f-9849-048701dfb004_terseLabel_en-US" xlink:label="lab_mo_USDDenominatedNotesDue2032Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes Due 2032 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotesDue2032Member_label_en-US" xlink:label="lab_mo_USDDenominatedNotesDue2032Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes Due 2032 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotesDue2032Member_documentation_en-US" xlink:label="lab_mo_USDDenominatedNotesDue2032Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes Due 2032</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesDue2032Member" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotesDue2032Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDDenominatedNotesDue2032Member" xlink:to="lab_mo_USDDenominatedNotesDue2032Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_cebe7b82-5693-4ff8-b096-b76f8b57dac1_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_DC_83581e7a-5969-4d91-b332-7b0ddbaad864_terseLabel_en-US" xlink:label="lab_stpr_DC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">District of Columbia [Member]</link:label>
    <link:label id="lab_stpr_DC_label_en-US" xlink:label="lab_stpr_DC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DISTRICT OF COLUMBIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DC" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_DC"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_DC" xlink:to="lab_stpr_DC" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_a66596a6-12eb-4894-946c-08236813acc5_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_6b04d5c1-2f9d-479e-b987-4ee5deeefa87_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive (earnings) losses attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_DE_30ecbaec-374f-491a-8506-0cd6fa4afc21_terseLabel_en-US" xlink:label="lab_stpr_DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delaware [Member]</link:label>
    <link:label id="lab_stpr_DE_label_en-US" xlink:label="lab_stpr_DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DELAWARE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DE" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_DE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_DE" xlink:to="lab_stpr_DE" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyVerdictsUpheld_adf8d288-9c9e-4a39-9dbf-23af72ef0ca5_terseLabel_en-US" xlink:label="lab_mo_LossContingencyVerdictsUpheld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of verdicts upheld</link:label>
    <link:label id="lab_mo_LossContingencyVerdictsUpheld_label_en-US" xlink:label="lab_mo_LossContingencyVerdictsUpheld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Verdicts Upheld</link:label>
    <link:label id="lab_mo_LossContingencyVerdictsUpheld_documentation_en-US" xlink:label="lab_mo_LossContingencyVerdictsUpheld" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Verdicts Upheld</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictsUpheld" xlink:href="mo-20210930.xsd#mo_LossContingencyVerdictsUpheld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyVerdictsUpheld" xlink:to="lab_mo_LossContingencyVerdictsUpheld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_7313c8ce-8d45-48dc-8c19-7f40138ad720_terseLabel_en-US" xlink:label="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit income, excluding service cost</link:label>
    <link:label id="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_ac82eea6-4dc1-45d1-847f-102e9f11588c_negatedLabel_en-US" xlink:label="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit income, excluding service cost</link:label>
    <link:label id="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_label_en-US" xlink:label="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:to="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LightsMember_c0eea83b-cc2e-42c5-ab3b-a841293f23f0_terseLabel_en-US" xlink:label="lab_mo_LightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lights [Member]</link:label>
    <link:label id="lab_mo_LightsMember_label_en-US" xlink:label="lab_mo_LightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lights [Member]</link:label>
    <link:label id="lab_mo_LightsMember_documentation_en-US" xlink:label="lab_mo_LightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LightsMember" xlink:href="mo-20210930.xsd#mo_LightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LightsMember" xlink:to="lab_mo_LightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EnvironmentalCostsPolicy_c59d20ff-93dc-494a-8b92-acc081df6392_terseLabel_en-US" xlink:label="lab_us-gaap_EnvironmentalCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Regulation</link:label>
    <link:label id="lab_us-gaap_EnvironmentalCostsPolicy_label_en-US" xlink:label="lab_us-gaap_EnvironmentalCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalCostsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EnvironmentalCostsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EnvironmentalCostsPolicy" xlink:to="lab_us-gaap_EnvironmentalCostsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage_36f6c313-abd5-47ab-9df1-ba7a8b8a7ca0_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, warrant exercised, ownership percentage</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Warrant Exercised, Ownership Percentage</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Warrant Exercised, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage" xlink:to="lab_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_2c255856-ed21-4492-a28e-26091d043348_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (losses) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_5070d255-e4e3-4d35-b251-e0ed51c4ee38_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_c286fba6-e7f7-48c3-ac57-676db35ac5fd_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, damages sought, value</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_6c14e070-09d1-43d9-b2c1-47761c1ace66_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing</link:label>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Marketing Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:to="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_6897196a-8e72-4652-8ea5-254a09eef9ac_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash:</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_c7c21f16-827f-4617-98ea-58ce17db028d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General corporate expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_IncreaseDecreaseInSettlementPayable_fc718c34-970f-4904-8f79-18ff364765da_terseLabel_en-US" xlink:label="lab_mo_IncreaseDecreaseInSettlementPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued settlement charges</link:label>
    <link:label id="lab_mo_IncreaseDecreaseInSettlementPayable_label_en-US" xlink:label="lab_mo_IncreaseDecreaseInSettlementPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Settlement Payable</link:label>
    <link:label id="lab_mo_IncreaseDecreaseInSettlementPayable_documentation_en-US" xlink:label="lab_mo_IncreaseDecreaseInSettlementPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net change during the period in Settlement payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncreaseDecreaseInSettlementPayable" xlink:href="mo-20210930.xsd#mo_IncreaseDecreaseInSettlementPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_IncreaseDecreaseInSettlementPayable" xlink:to="lab_mo_IncreaseDecreaseInSettlementPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_74842ec2-fb1d-4655-a706-7de89c46cb58_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_e1fd4683-881f-427c-a94e-4516fff7148c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_95b4475c-abc4-49e0-bc42-9ec7bece934c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Translation Adjustments and Other [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesNeffMember_4741e5ae-4375-4b9f-ac78-4025899d8479_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesNeffMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Neff [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesNeffMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesNeffMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Neff [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesNeffMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesNeffMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Neff [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesNeffMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesNeffMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesNeffMember" xlink:to="lab_mo_EngleProgenyCasesNeffMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_6405d6b9-43d2-45f3-9bbc-b5f895d508ef_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesCooperMember_6090e3ae-5509-4bd3-a178-719f2aae3d55_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesCooperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Cooper [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesCooperMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesCooperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Cooper [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesCooperMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesCooperMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Cooper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesCooperMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesCooperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesCooperMember" xlink:to="lab_mo_EngleProgenyCasesCooperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_73ab7584-1b1b-4b29-98f3-c4a2cfb65a56_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_InterestAndOtherDebtExpenseNetMember_5c4938b0-c217-4993-bfa0-a7b65ba20fa3_terseLabel_en-US" xlink:label="lab_mo_InterestAndOtherDebtExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other debt expense, net [Member]</link:label>
    <link:label id="lab_mo_InterestAndOtherDebtExpenseNetMember_label_en-US" xlink:label="lab_mo_InterestAndOtherDebtExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest And Other Debt Expense, Net [Member]</link:label>
    <link:label id="lab_mo_InterestAndOtherDebtExpenseNetMember_documentation_en-US" xlink:label="lab_mo_InterestAndOtherDebtExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest And Other Debt Expense, Net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InterestAndOtherDebtExpenseNetMember" xlink:href="mo-20210930.xsd#mo_InterestAndOtherDebtExpenseNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InterestAndOtherDebtExpenseNetMember" xlink:to="lab_mo_InterestAndOtherDebtExpenseNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_5f333092-964f-43c4-a4b9-126c4e18f951_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_600a5a0d-7f11-4469-977b-370722a3f180_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, number of shares eligible for purchase (approximately) (in shares)</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Shares Eligible For Purchase</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Shares Eligible For Purchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" xlink:to="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_20f6116d-79b9-49d8-879d-f9fbc2c0daf5_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid on common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_39524b14-1e3a-4afd-8ef4-a623976725b5_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, difference between carrying amount and underlying equity</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Underlying Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:to="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ImplementationofCorrectiveCommunicationsMember_8e5011f3-9070-47dc-925c-b5e0bba0a065_terseLabel_en-US" xlink:label="lab_mo_ImplementationofCorrectiveCommunicationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Implementation of Corrective Communications [Member]</link:label>
    <link:label id="lab_mo_ImplementationofCorrectiveCommunicationsMember_label_en-US" xlink:label="lab_mo_ImplementationofCorrectiveCommunicationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Implementation of Corrective Communications [Member]</link:label>
    <link:label id="lab_mo_ImplementationofCorrectiveCommunicationsMember_documentation_en-US" xlink:label="lab_mo_ImplementationofCorrectiveCommunicationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Implementation of Corrective Communications [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ImplementationofCorrectiveCommunicationsMember" xlink:href="mo-20210930.xsd#mo_ImplementationofCorrectiveCommunicationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ImplementationofCorrectiveCommunicationsMember" xlink:to="lab_mo_ImplementationofCorrectiveCommunicationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_768d3fc0-1897-4f85-88b9-a2521841783f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_FederalTradeCommissionDisclosurePeriod_6a515ef1-d190-4321-963e-0d9ffa7db37e_terseLabel_en-US" xlink:label="lab_mo_FederalTradeCommissionDisclosurePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure period</link:label>
    <link:label id="lab_mo_FederalTradeCommissionDisclosurePeriod_label_en-US" xlink:label="lab_mo_FederalTradeCommissionDisclosurePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Trade Commission, Disclosure Period</link:label>
    <link:label id="lab_mo_FederalTradeCommissionDisclosurePeriod_documentation_en-US" xlink:label="lab_mo_FederalTradeCommissionDisclosurePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Trade Commission, Disclosure Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalTradeCommissionDisclosurePeriod" xlink:href="mo-20210930.xsd#mo_FederalTradeCommissionDisclosurePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_FederalTradeCommissionDisclosurePeriod" xlink:to="lab_mo_FederalTradeCommissionDisclosurePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DebtInstrumentExtensionTerm_15e8e6d7-938f-41e2-898c-068f04e184c8_terseLabel_en-US" xlink:label="lab_mo_DebtInstrumentExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, extension term</link:label>
    <link:label id="lab_mo_DebtInstrumentExtensionTerm_label_en-US" xlink:label="lab_mo_DebtInstrumentExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Term</link:label>
    <link:label id="lab_mo_DebtInstrumentExtensionTerm_documentation_en-US" xlink:label="lab_mo_DebtInstrumentExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentExtensionTerm" xlink:href="mo-20210930.xsd#mo_DebtInstrumentExtensionTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DebtInstrumentExtensionTerm" xlink:to="lab_mo_DebtInstrumentExtensionTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyPunitiveDamagesAwardedValue_5194016b-2358-4af9-b226-833fe524a6c4_terseLabel_en-US" xlink:label="lab_mo_LossContingencyPunitiveDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Punitive damages awarded</link:label>
    <link:label id="lab_mo_LossContingencyPunitiveDamagesAwardedValue_label_en-US" xlink:label="lab_mo_LossContingencyPunitiveDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Punitive Damages Awarded, Value</link:label>
    <link:label id="lab_mo_LossContingencyPunitiveDamagesAwardedValue_documentation_en-US" xlink:label="lab_mo_LossContingencyPunitiveDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Punitive Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue" xlink:href="mo-20210930.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyPunitiveDamagesAwardedValue" xlink:to="lab_mo_LossContingencyPunitiveDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_0965ea84-b2d7-4274-9fd2-920eb26ca6f9_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NumberOfThirdPartyLawsuits_8a38cd2a-5a05-4632-9de3-8b9fe2cbbee9_terseLabel_en-US" xlink:label="lab_mo_NumberOfThirdPartyLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of third party lawsuits</link:label>
    <link:label id="lab_mo_NumberOfThirdPartyLawsuits_label_en-US" xlink:label="lab_mo_NumberOfThirdPartyLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Third Party Lawsuits</link:label>
    <link:label id="lab_mo_NumberOfThirdPartyLawsuits_documentation_en-US" xlink:label="lab_mo_NumberOfThirdPartyLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Third Party Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NumberOfThirdPartyLawsuits" xlink:href="mo-20210930.xsd#mo_NumberOfThirdPartyLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NumberOfThirdPartyLawsuits" xlink:to="lab_mo_NumberOfThirdPartyLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_4bc5a809-1450-4f34-afa5-eeaad99633f7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.33 1/3&#160;per share (2,805,961,317 shares issued)</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_8baee69b-d354-48fe-b1e4-3446211b6652_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories:</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityContractPreemptiveRIghtsMember_2b41341c-585b-4922-94dc-01a1c4b653fa_verboseLabel_en-US" xlink:label="lab_mo_EquityContractPreemptiveRIghtsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Preemptive Rights [Member]</link:label>
    <link:label id="lab_mo_EquityContractPreemptiveRIghtsMember_da65c69c-0582-4fca-8c20-8938a1e41cb1_terseLabel_en-US" xlink:label="lab_mo_EquityContractPreemptiveRIghtsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed-price Preemptive Rights [Member]</link:label>
    <link:label id="lab_mo_EquityContractPreemptiveRIghtsMember_label_en-US" xlink:label="lab_mo_EquityContractPreemptiveRIghtsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Preemptive RIghts [Member]</link:label>
    <link:label id="lab_mo_EquityContractPreemptiveRIghtsMember_documentation_en-US" xlink:label="lab_mo_EquityContractPreemptiveRIghtsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Preemptive RIghts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember" xlink:href="mo-20210930.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityContractPreemptiveRIghtsMember" xlink:to="lab_mo_EquityContractPreemptiveRIghtsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty_4688634b-2740-41c4-a105-83057cf6e7ac_terseLabel_en-US" xlink:label="lab_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement, amount expected to be awarded from other party</link:label>
    <link:label id="lab_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty_label_en-US" xlink:label="lab_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Expected To Be Awarded from Other Party</link:label>
    <link:label id="lab_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty_documentation_en-US" xlink:label="lab_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Expected To Be Awarded from Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" xlink:href="mo-20210930.xsd#mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" xlink:to="lab_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_IndividualSmokingAndHealthCasesMember_bc7de1ac-3661-4c9e-808b-31f548d06c24_terseLabel_en-US" xlink:label="lab_mo_IndividualSmokingAndHealthCasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Smoking and Health Cases [Member]</link:label>
    <link:label id="lab_mo_IndividualSmokingAndHealthCasesMember_label_en-US" xlink:label="lab_mo_IndividualSmokingAndHealthCasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Smoking And Health Cases [Member]</link:label>
    <link:label id="lab_mo_IndividualSmokingAndHealthCasesMember_documentation_en-US" xlink:label="lab_mo_IndividualSmokingAndHealthCasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Smoking and Health Cases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IndividualSmokingAndHealthCasesMember" xlink:href="mo-20210930.xsd#mo_IndividualSmokingAndHealthCasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_IndividualSmokingAndHealthCasesMember" xlink:to="lab_mo_IndividualSmokingAndHealthCasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_34581eb7-a754-43f0-bd34-fc17d813c303_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGlogerRintoulandDuignamMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesGlogerRintoulandDuignamMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesGlogerRintoulandDuignamMember" xlink:to="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_c7aeb56b-eff6-4583-9361-0d495f43c28a_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation, Policy</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_60bbdd8b-99d9-4555-bd08-92ca6ecb1eef_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postretirement [Member]</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OtherAccruedLiabilitiesMember_35be4cf1-1fc4-4356-897f-a056d23e368f_terseLabel_en-US" xlink:label="lab_mo_OtherAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities [Member]</link:label>
    <link:label id="lab_mo_OtherAccruedLiabilitiesMember_label_en-US" xlink:label="lab_mo_OtherAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities [Member]</link:label>
    <link:label id="lab_mo_OtherAccruedLiabilitiesMember_documentation_en-US" xlink:label="lab_mo_OtherAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherAccruedLiabilitiesMember" xlink:href="mo-20210930.xsd#mo_OtherAccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OtherAccruedLiabilitiesMember" xlink:to="lab_mo_OtherAccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_fe4472dc-9bfc-4051-9f2b-a535024a48ce_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies (Note 12)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ea89f52c-89ea-439a-9d69-f00dbbcd3277_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive losses</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_e25a8087-b460-47a3-8916-e813584945a7_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of restricted shares owned (in shares)</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Shares Owned, Restricted</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Shares Owned, Restricted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedRestricted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" xlink:to="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_68b024c4-52eb-4ed0-a1de-b90f449f87c6_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_bfb51e4a-c025-4604-ae7a-7b0f82fd3cc8_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at begging of period</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_8c98b040-90b0-4431-96b6-4d84cfb67ab2_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_137fca6a-c244-4b4c-be7a-f88fed4af4dc_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision related to litigation recorded</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualProvision" xlink:to="lab_us-gaap_LossContingencyAccrualProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_fcabc5a1-b4e7-45e6-bedf-3cb63483b2ac_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_1010ec67-4738-494b-91ae-382afbb39d61_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_InventoryDisposalCostsandOtherMember_be2c0f87-73b0-4236-8154-ff95fb24bcf2_terseLabel_en-US" xlink:label="lab_mo_InventoryDisposalCostsandOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disposal Costs and Other [Member]</link:label>
    <link:label id="lab_mo_InventoryDisposalCostsandOtherMember_label_en-US" xlink:label="lab_mo_InventoryDisposalCostsandOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disposal Costs and Other [Member]</link:label>
    <link:label id="lab_mo_InventoryDisposalCostsandOtherMember_documentation_en-US" xlink:label="lab_mo_InventoryDisposalCostsandOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disposal Costs and Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InventoryDisposalCostsandOtherMember" xlink:href="mo-20210930.xsd#mo_InventoryDisposalCostsandOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InventoryDisposalCostsandOtherMember" xlink:to="lab_mo_InventoryDisposalCostsandOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CT_9d06a85d-9bef-49d7-a271-3617516af3e0_terseLabel_en-US" xlink:label="lab_stpr_CT" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Connecticut [Member]</link:label>
    <link:label id="lab_stpr_CT_label_en-US" xlink:label="lab_stpr_CT" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONNECTICUT</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CT" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_CT"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CT" xlink:to="lab_stpr_CT" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLossMember_db47feb0-db3d-40d7-a6c2-0858c70ca848_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) [Member]</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLossMember_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLossMember" xlink:to="lab_us-gaap_OperatingIncomeLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_889dc6e4-71eb-40d8-9e8e-b9b2d59c25ab_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_02b6fe6c-306e-46d6-8437-6c1dfd344f34_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_3e10cd8c-c712-46de-a74f-3a59573f03a6_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitContributions_be4ed24a-ac0f-4828-a70f-73e02bd783a6_negatedLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitContributions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension plan contributions</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitContributions_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Pension and Other Postretirement Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitContributions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitContributions" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyClaimsSettledNumber_c0f3481f-d410-4db4-9417-f23e17ce62df_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsSettledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, claims settled, number</link:label>
    <link:label id="lab_us-gaap_LossContingencyClaimsSettledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsSettledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Settled, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsSettledNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyClaimsSettledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyClaimsSettledNumber" xlink:to="lab_us-gaap_LossContingencyClaimsSettledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClaimsNotCertifiedNumber_d06bd454-3fc0-423e-afa7-553b8fcfd762_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClaimsNotCertifiedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims not certified, number</link:label>
    <link:label id="lab_mo_LossContingencyClaimsNotCertifiedNumber_label_en-US" xlink:label="lab_mo_LossContingencyClaimsNotCertifiedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Not Certified, Number</link:label>
    <link:label id="lab_mo_LossContingencyClaimsNotCertifiedNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyClaimsNotCertifiedNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Not Certified, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsNotCertifiedNumber" xlink:href="mo-20210930.xsd#mo_LossContingencyClaimsNotCertifiedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClaimsNotCertifiedNumber" xlink:to="lab_mo_LossContingencyClaimsNotCertifiedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_e8b56727-2d58-49c8-92d9-ec3b4a9e2c6b_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_813fbf0a-6ca5-4478-a130-2b29a636576a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_f53b925a-b8e0-4c07-acfb-3e79d1bc0c1c_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_0c122406-efcc-4fdd-b5d2-d6c4ec90bf34_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other debt expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_f8e59912-a22a-4b0f-8b10-15da75c05591_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other debt expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CA_9eecdad9-4a20-4508-b9e2-ba97570220ed_terseLabel_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California [Member]</link:label>
    <link:label id="lab_stpr_CA_label_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CALIFORNIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CA" xlink:to="lab_stpr_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_51bce6d0-524c-4288-a387-a6452fffb132_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_IA_ee8b9ff4-3506-4ed4-a119-a7cc2a5665bf_terseLabel_en-US" xlink:label="lab_stpr_IA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Iowa [Member]</link:label>
    <link:label id="lab_stpr_IA_label_en-US" xlink:label="lab_stpr_IA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IOWA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IA" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_IA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_IA" xlink:to="lab_stpr_IA" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_eaa021ce-5197-4bcb-8437-8a64c403ceac_negatedLabel_en-US" xlink:label="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Distributed and undistributed earnings attributable to share-based awards</link:label>
    <link:label id="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_label_en-US" xlink:label="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed and Undistributed Earnings (Loss), Basic and Diluted</link:label>
    <link:label id="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_documentation_en-US" xlink:label="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed and Undistributed Earnings (Loss), Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" xlink:href="mo-20210930.xsd#mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" xlink:to="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_2993d96d-ccbf-407f-896b-d148498e79cd_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_de4942c0-2f6a-405b-968d-c889221bcdd2_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary ownership percentage</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_January2021ShareRepurchaseProgramMember_9541da59-5bf2-477d-88a2-946b934f0c95_terseLabel_en-US" xlink:label="lab_mo_January2021ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2021 Share Repurchase Program [Member]</link:label>
    <link:label id="lab_mo_January2021ShareRepurchaseProgramMember_label_en-US" xlink:label="lab_mo_January2021ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2021 Share Repurchase Program [Member]</link:label>
    <link:label id="lab_mo_January2021ShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_mo_January2021ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2021 Share Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_January2021ShareRepurchaseProgramMember" xlink:href="mo-20210930.xsd#mo_January2021ShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_January2021ShareRepurchaseProgramMember" xlink:to="lab_mo_January2021ShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesGarciaMember_3aea27fc-e72b-420e-80c0-dd54ae7412c0_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesGarciaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Garcia [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesGarciaMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesGarciaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Garcia [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesGarciaMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesGarciaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Garcia</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGarciaMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesGarciaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesGarciaMember" xlink:to="lab_mo_EngleProgenyCasesGarciaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_31625015-a64c-4098-8589-8e8c0fa5fd5e_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_2ce7fc1c-050f-48c8-8303-8eea8ae45400_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax earnings (losses) recognized in net earnings (losses)</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_36f8f469-f387-455b-bd84-957ba3c105a0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_296c7486-eefe-411d-a915-5e95e5957c36_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDDenominatedNotesDue2051Member_9ea014a2-edd7-4178-abd9-5a03a0efaad0_terseLabel_en-US" xlink:label="lab_mo_USDDenominatedNotesDue2051Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes Due 2051 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotesDue2051Member_label_en-US" xlink:label="lab_mo_USDDenominatedNotesDue2051Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes Due 2051 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotesDue2051Member_documentation_en-US" xlink:label="lab_mo_USDDenominatedNotesDue2051Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes Due 2051</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesDue2051Member" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotesDue2051Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDDenominatedNotesDue2051Member" xlink:to="lab_mo_USDDenominatedNotesDue2051Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_32af5bfd-f6ba-4151-b519-ccff70b1813e_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared (usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fe386396-f3ee-4e28-8a12-b8b0d7e3b933_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDDenominatedNotesDue2041Member_b0f10467-c5f0-4e1d-bd9c-5be8f3228f24_terseLabel_en-US" xlink:label="lab_mo_USDDenominatedNotesDue2041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes Due 2041 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotesDue2041Member_label_en-US" xlink:label="lab_mo_USDDenominatedNotesDue2041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes Due 2041 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotesDue2041Member_documentation_en-US" xlink:label="lab_mo_USDDenominatedNotesDue2041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes Due 2041</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesDue2041Member" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotesDue2041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDDenominatedNotesDue2041Member" xlink:to="lab_mo_USDDenominatedNotesDue2041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesMcCallMember_ffe36de4-dce7-408e-89b2-62aec35fa872_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesMcCallMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, McCall [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesMcCallMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesMcCallMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, McCall [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesMcCallMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesMcCallMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, McCall [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMcCallMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesMcCallMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesMcCallMember" xlink:to="lab_mo_EngleProgenyCasesMcCallMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OtherInventoryRawMaterialsNetofReserves_8fefdf72-2257-443e-aeec-40966c080cb5_terseLabel_en-US" xlink:label="lab_mo_OtherInventoryRawMaterialsNetofReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other raw materials</link:label>
    <link:label id="lab_mo_OtherInventoryRawMaterialsNetofReserves_label_en-US" xlink:label="lab_mo_OtherInventoryRawMaterialsNetofReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Inventory, Raw Materials, Net of Reserves</link:label>
    <link:label id="lab_mo_OtherInventoryRawMaterialsNetofReserves_documentation_en-US" xlink:label="lab_mo_OtherInventoryRawMaterialsNetofReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherInventoryRawMaterialsNetofReserves" xlink:href="mo-20210930.xsd#mo_OtherInventoryRawMaterialsNetofReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OtherInventoryRawMaterialsNetofReserves" xlink:to="lab_mo_OtherInventoryRawMaterialsNetofReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ArbitrationPeriodAxis_a34ccabd-94be-4a66-a8d3-0202b32db667_terseLabel_en-US" xlink:label="lab_mo_ArbitrationPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arbitration Period [Axis]</link:label>
    <link:label id="lab_mo_ArbitrationPeriodAxis_label_en-US" xlink:label="lab_mo_ArbitrationPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arbitration Period [Axis]</link:label>
    <link:label id="lab_mo_ArbitrationPeriodAxis_documentation_en-US" xlink:label="lab_mo_ArbitrationPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arbitration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ArbitrationPeriodAxis" xlink:href="mo-20210930.xsd#mo_ArbitrationPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ArbitrationPeriodAxis" xlink:to="lab_mo_ArbitrationPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStockDividendIncreasePercentage_15d50e36-e00e-49ff-9f53-f57d71e65cb3_terseLabel_en-US" xlink:label="lab_mo_CommonStockDividendIncreasePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, dividend increase, percentage</link:label>
    <link:label id="lab_mo_CommonStockDividendIncreasePercentage_label_en-US" xlink:label="lab_mo_CommonStockDividendIncreasePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividend Increase, Percentage</link:label>
    <link:label id="lab_mo_CommonStockDividendIncreasePercentage_documentation_en-US" xlink:label="lab_mo_CommonStockDividendIncreasePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividend Increase, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStockDividendIncreasePercentage" xlink:href="mo-20210930.xsd#mo_CommonStockDividendIncreasePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStockDividendIncreasePercentage" xlink:to="lab_mo_CommonStockDividendIncreasePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed_0763bccc-9dcc-4035-a670-509920aff167_terseLabel_en-US" xlink:label="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of claims with unfavorable verdicts pending/reversed</link:label>
    <link:label id="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed_label_en-US" xlink:label="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Unfavorable Verdicts Pending/Reversed</link:label>
    <link:label id="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed_documentation_en-US" xlink:label="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Unfavorable Verdicts Pending/Reversed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyUnfavorableVerdictsPendingReversed" xlink:href="mo-20210930.xsd#mo_LossContingencyUnfavorableVerdictsPendingReversed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyUnfavorableVerdictsPendingReversed" xlink:to="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_d099d8a7-bc8a-41a1-9251-f01be6a5618f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished product</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfCases_f8f1a85a-f2a0-4570-af44-2edfc268f4ff_verboseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfCases" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfCases_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfCases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Cases</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfCases_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfCases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Cases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCases" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfCases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfCases" xlink:to="lab_mo_LossContingencyNumberOfCases" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfCasesWithCourtDatesSet_a2506825-7a21-4f8e-8c16-4e9b4bf2b0d8_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfCasesWithCourtDatesSet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of cases with set court dates</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfCasesWithCourtDatesSet_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfCasesWithCourtDatesSet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cases With Court Dates Set</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfCasesWithCourtDatesSet_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfCasesWithCourtDatesSet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cases With Court Dates Set</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCasesWithCourtDatesSet" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfCasesWithCourtDatesSet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfCasesWithCourtDatesSet" xlink:to="lab_mo_LossContingencyNumberOfCasesWithCourtDatesSet" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_InvestmentsInEquitySecuritiesMember_33bb2afa-3810-455f-98b4-3097c2a75ec5_terseLabel_en-US" xlink:label="lab_mo_InvestmentsInEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In Equity Securities [Member]</link:label>
    <link:label id="lab_mo_InvestmentsInEquitySecuritiesMember_label_en-US" xlink:label="lab_mo_InvestmentsInEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In Equity Securities [Member]</link:label>
    <link:label id="lab_mo_InvestmentsInEquitySecuritiesMember_documentation_en-US" xlink:label="lab_mo_InvestmentsInEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsInEquitySecuritiesMember" xlink:href="mo-20210930.xsd#mo_InvestmentsInEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InvestmentsInEquitySecuritiesMember" xlink:to="lab_mo_InvestmentsInEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_27ea8342-4b9a-42b1-aa37-2623ea36d1e8_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_b6279ea9-c3a0-4728-8fcc-ff419328812b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_44d5b0ae-65fb-4dc4-a34c-641a4895ecd5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesGlogerMember_1c5436d9-52f9-4467-8df5-ccce12c477ba_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesGlogerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Gloger [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesGlogerMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesGlogerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Gloger [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesGlogerMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesGlogerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Gloger [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGlogerMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesGlogerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesGlogerMember" xlink:to="lab_mo_EngleProgenyCasesGlogerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_3fb151a9-be58-49be-aee3-77b33ef41612_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesFreemanMember_6c971c4f-856d-4a68-a4fb-434d2501ac8d_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesFreemanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Freeman [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesFreemanMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesFreemanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Freeman [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesFreemanMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesFreemanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Freeman [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesFreemanMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesFreemanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesFreemanMember" xlink:to="lab_mo_EngleProgenyCasesFreemanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo_e59d53bd-4c2f-472e-b97d-37f36fcc8934_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of cases with payments a year or more ago</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Cases With Payments A Year Or More Ago</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Cases With Payments A Year Or More Ago</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo" xlink:to="lab_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_9aefb562-fbaf-4405-9600-c797d4561c9f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Recognized in Accumulated Other Comprehensive Losses</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_f40edfba-5434-409e-aee8-05268c7ce192_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_4c9fe75c-365a-40e7-a01d-123235e21ef1_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_ca25d885-edad-4cb1-ad8b-a20dc166fee7_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_aae3d207-1fff-4a3a-8884-b3ae4823f3fd_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_fa4a1c24-07e2-447c-ac74-0017cac82389_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_52480135-2a61-4bdb-8ddf-967db4b788b3_terseLabel_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Greene [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_label_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Greene [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_documentation_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Greene [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseGreeneMember" xlink:href="mo-20210930.xsd#mo_NonEngleProgenySmokingandHealthCaseGreeneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NonEngleProgenySmokingandHealthCaseGreeneMember" xlink:to="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_f2115494-a7b6-4219-a38b-29997802c2a9_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves_79d4abf8-faed-4ef2-8f66-b94001591614_terseLabel_en-US" xlink:label="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leaf tobacco</link:label>
    <link:label id="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves_label_en-US" xlink:label="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Plant Material, Net of Reserves</link:label>
    <link:label id="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves_documentation_en-US" xlink:label="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount as of the balance sheet date of products consisting of plant matter that is not used in the growth of plant goods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InventoryRawMaterialsPlantMaterialNetofReserves" xlink:href="mo-20210930.xsd#mo_InventoryRawMaterialsPlantMaterialNetofReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InventoryRawMaterialsPlantMaterialNetofReserves" xlink:to="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_b8959ad3-32ea-434a-9997-f5717870d5a7_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9ee4122-46f7-4d47-8e9e-0d1d8807ca5e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_46cee5b9-a8db-4a46-a33e-f5a9b462cdbb_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b4a4a687-f14e-4b11-af3b-657fe06e6cf2_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_09c8171e-8ee2-46e8-af9c-8418eb8917b8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_bc3c69fd-015b-48ac-9a43-45263349f571_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_ba9fa865-1586-4890-96a7-11899f4ef6f2_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_b57bcfd2-5be1-4027-b35d-2d1dc1112c8a_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_cf6dedf4-7372-48eb-897a-0df6c2357f51_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of states with settled litigation including New York, subsequent expansion</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_label_en-US" xlink:label="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States with Settled Litigation, Settlement One</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States with Settled Litigation, Settlement One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" xlink:to="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_IL_2da1ec52-3e4c-4e71-b0e4-42bc5caa546c_terseLabel_en-US" xlink:label="lab_stpr_IL" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Illinois [Member]</link:label>
    <link:label id="lab_stpr_IL_label_en-US" xlink:label="lab_stpr_IL" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ILLINOIS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IL" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_IL"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_IL" xlink:to="lab_stpr_IL" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyVerdictReversedNumber_4796a872-421f-4afa-8a23-2ebb8aa04e85_terseLabel_en-US" xlink:label="lab_mo_LossContingencyVerdictReversedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of verdicts reversed</link:label>
    <link:label id="lab_mo_LossContingencyVerdictReversedNumber_label_en-US" xlink:label="lab_mo_LossContingencyVerdictReversedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Verdict Reversed, Number</link:label>
    <link:label id="lab_mo_LossContingencyVerdictReversedNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyVerdictReversedNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Verdict Reversed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictReversedNumber" xlink:href="mo-20210930.xsd#mo_LossContingencyVerdictReversedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyVerdictReversedNumber" xlink:to="lab_mo_LossContingencyVerdictReversedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_86493fc1-fac9-4105-8d38-6f414bc3521b_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, credits to offset payments</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_f71ed39a-2cc9-4b99-b5e5-eea268078139_verboseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount ordered to be paid from other party</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded from Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_a13345e6-f61f-4a00-802a-a64ead39daf0_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_342b8640-64d4-4c39-9ad4-8784a3cf2cce_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Repurchased Stock [Member]</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_d654a1e4-ccc2-4ba3-b880-6af6fb6b6473_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest on long-term debt</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_f2fab8e6-e3f9-4f4a-9682-5f363ba47c1b_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of shareholders filing class action lawsuits</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Shareholders Filing Class Action Lawsuits</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Shareholders Filing Class Action Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" xlink:to="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_4ff62776-63cc-4f5e-8c69-664ff4562751_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_00388239-6d72-447c-bb9c-74e70d4da4c7_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_f63bf70f-b3f4-4d72-8150-b09a5ce98c6b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Guidance Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_c0eb7c9b-b311-4504-9521-ba66caea9ee1_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_fe3dcd64-9a7f-4517-8328-6ebe13d2fce7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency contracts (notional amounts)</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_a7f459d2-d572-41af-87e5-49b4127e49bd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_ac64b04a-def1-406b-b599-ccff91e4ab4b_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_abbe2d15-2bad-4599-a453-e4c42d004aa2_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_49c04b34-b9d2-40d1-b930-095f85974eb1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c0ebce10-b7da-4b08-a662-df91700de1ca_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_e06d5fcf-a232-4bd0-b839-040cfeaa3707_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan, plan assets, contributions by employer</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_928ef372-a083-4ad3-9fa6-85eb86ab8815_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_d261152e-059f-4029-8a69-430622b2071f_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_45f289f1-7123-4e2a-92e6-fa7be342d706_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_FL_a5feacad-938c-41e0-a89e-8dfe93aa13c5_terseLabel_en-US" xlink:label="lab_stpr_FL" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Florida [Member]</link:label>
    <link:label id="lab_stpr_FL_label_en-US" xlink:label="lab_stpr_FL" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FLORIDA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_FL"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_FL" xlink:to="lab_stpr_FL" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_e8021572-cc8f-45c0-af0e-ac025f39422c_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OtherTabaccoRelatedCasesMember_2f8f2811-8e2c-4c78-8cea-8d8348d8267a_terseLabel_en-US" xlink:label="lab_mo_OtherTabaccoRelatedCasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tabacco-Related Cases [Member]</link:label>
    <link:label id="lab_mo_OtherTabaccoRelatedCasesMember_label_en-US" xlink:label="lab_mo_OtherTabaccoRelatedCasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tabacco-Related Cases [Member]</link:label>
    <link:label id="lab_mo_OtherTabaccoRelatedCasesMember_documentation_en-US" xlink:label="lab_mo_OtherTabaccoRelatedCasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tabacco-Related Cases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherTabaccoRelatedCasesMember" xlink:href="mo-20210930.xsd#mo_OtherTabaccoRelatedCasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OtherTabaccoRelatedCasesMember" xlink:to="lab_mo_OtherTabaccoRelatedCasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_b609f155-d42f-4a01-8360-907cb4d87efd_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_cf714545-85a8-48f7-9fb9-9e88893c3153_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums and fees related to early extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_197b7c5e-24ff-4fc6-9cff-8061e4144d96_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_RestrictedSharesLockupPeriod_8061f6a2-686b-4477-ba2f-c738ae4de77c_terseLabel_en-US" xlink:label="lab_mo_RestrictedSharesLockupPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted shares, lock-up period</link:label>
    <link:label id="lab_mo_RestrictedSharesLockupPeriod_label_en-US" xlink:label="lab_mo_RestrictedSharesLockupPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Shares, Lock-up Period</link:label>
    <link:label id="lab_mo_RestrictedSharesLockupPeriod_documentation_en-US" xlink:label="lab_mo_RestrictedSharesLockupPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Shares, Lock-up Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RestrictedSharesLockupPeriod" xlink:href="mo-20210930.xsd#mo_RestrictedSharesLockupPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_RestrictedSharesLockupPeriod" xlink:to="lab_mo_RestrictedSharesLockupPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2a791e20-f4b9-4be7-96a9-ccc4df87bcd8_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_60a2ae49-f9aa-44e9-8388-90fde6158e10_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_1b56b7b8-205f-407c-8e6b-9306c81b3a65_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_b1ab3e53-22da-4d74-82e2-6f215506f029_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; (deficit) equity attributable to Altria</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SettledLitigationMember_42f2bd14-0896-460e-846e-7ad4155d6f41_terseLabel_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:label id="lab_us-gaap_SettledLitigationMember_label_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SettledLitigationMember" xlink:to="lab_us-gaap_SettledLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount_0b62db36-8bc6-414f-a4bb-edbc6fe43881_negatedTerseLabel_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions to valuation allowance credited to income tax benefit</link:label>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount_label_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Decrease In Amount</link:label>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount_documentation_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Decrease In Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount" xlink:href="mo-20210930.xsd#mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount" xlink:to="lab_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_ef4264eb-b3a7-4674-ad39-2b0572267a58_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_24550752-82ca-4b25-b750-5fead8810175_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_e06205af-a904-4ad3-b672-0223171c1865_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_584712a5-e822-4080-abb5-efd9e38ff881_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Life [Member]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Term [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:to="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_f700b531-f81c-4b46-8fd7-040d399390e4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on early extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_d73fcf28-c80d-4042-a5c4-ef5426f1571f_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on early extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_7b9dca2a-9379-4339-a3af-3ed10221e7fa_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on early extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_18e4f336-0991-4098-b547-7c2a213ab179_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AccruedSettlementLiabilityCurrent_e9afb5cb-b483-40d8-bf1a-92ad5d52113e_terseLabel_en-US" xlink:label="lab_mo_AccruedSettlementLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement charges</link:label>
    <link:label id="lab_mo_AccruedSettlementLiabilityCurrent_label_en-US" xlink:label="lab_mo_AccruedSettlementLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Settlement Liability, Current</link:label>
    <link:label id="lab_mo_AccruedSettlementLiabilityCurrent_documentation_en-US" xlink:label="lab_mo_AccruedSettlementLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Settlement Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccruedSettlementLiabilityCurrent" xlink:href="mo-20210930.xsd#mo_AccruedSettlementLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AccruedSettlementLiabilityCurrent" xlink:to="lab_mo_AccruedSettlementLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_7e803c1c-2379-4d01-a880-fa1bdf2ef44b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesM.BrownMember_a8045a6d-83c8-41a3-840c-a523d5e329bb_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesM.BrownMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, M. Brown [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesM.BrownMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesM.BrownMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, M. Brown [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesM.BrownMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesM.BrownMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, M. Brown [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesM.BrownMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesM.BrownMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesM.BrownMember" xlink:to="lab_mo_EngleProgenyCasesM.BrownMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8f2c0478-afd9-4ecf-b924-4885c5732328_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_ceea16df-788f-4efb-a382-9d830d4e41ca_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_796a24cf-1f57-4093-829c-b980b2fd5112_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities, ownership percentage</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Ownership Percentage</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:href="mo-20210930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesR.DouglasMember_4f69af34-b3ec-416a-bd87-9630b28d09b7_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesR.DouglasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, R. Douglas [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesR.DouglasMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesR.DouglasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, R. Douglas [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesR.DouglasMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesR.DouglasMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, R. Douglas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesR.DouglasMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesR.DouglasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesR.DouglasMember" xlink:to="lab_mo_EngleProgenyCasesR.DouglasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_d04d5460-4800-4e43-8625-fcd34ffda511_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and liabilities held for sale, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_f1ae78bf-de9c-4328-9e7a-6531137c588f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_472e7b88-ffef-4ae9-bc13-28d5f66aa8b7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued postretirement health care costs</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Other Postretirement Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MD_5c07ab06-fa84-494f-a3bd-72669928feae_terseLabel_en-US" xlink:label="lab_stpr_MD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maryland [Member]</link:label>
    <link:label id="lab_stpr_MD_label_en-US" xlink:label="lab_stpr_MD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MARYLAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MD" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MD" xlink:to="lab_stpr_MD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_ed904638-abe7-4399-8a34-6fcebb80f4c5_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_fe52a232-c8bb-48bf-a46e-1658a4c8e1cf_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Earnings/Losses</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MA_3d6d4437-7941-45c0-9dfe-079699fcf09d_verboseLabel_en-US" xlink:label="lab_stpr_MA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Massachusetts [Member]</link:label>
    <link:label id="lab_stpr_MA_label_en-US" xlink:label="lab_stpr_MA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MASSACHUSETTS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MA" xlink:to="lab_stpr_MA" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_MeasurementInputWeightedAverageExpectedTermMember_0c312184-f3a2-4eeb-ad94-d4d141c40597_terseLabel_en-US" xlink:label="lab_mo_MeasurementInputWeightedAverageExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Expected Term [Member]</link:label>
    <link:label id="lab_mo_MeasurementInputWeightedAverageExpectedTermMember_label_en-US" xlink:label="lab_mo_MeasurementInputWeightedAverageExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Weighted Average Expected Term [Member]</link:label>
    <link:label id="lab_mo_MeasurementInputWeightedAverageExpectedTermMember_documentation_en-US" xlink:label="lab_mo_MeasurementInputWeightedAverageExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Weighted Average Expected Term [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MeasurementInputWeightedAverageExpectedTermMember" xlink:href="mo-20210930.xsd#mo_MeasurementInputWeightedAverageExpectedTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_MeasurementInputWeightedAverageExpectedTermMember" xlink:to="lab_mo_MeasurementInputWeightedAverageExpectedTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_40b596b6-20ed-4cce-a368-21b4ae8096c9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStock1.700NotesDue2025Member_96ff64c2-0533-49ae-907f-2ea765d328c6_terseLabel_en-US" xlink:label="lab_mo_CommonStock1.700NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.700% Notes due 2025 [Member]</link:label>
    <link:label id="lab_mo_CommonStock1.700NotesDue2025Member_label_en-US" xlink:label="lab_mo_CommonStock1.700NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 1.700% Notes Due 2025 [Member]</link:label>
    <link:label id="lab_mo_CommonStock1.700NotesDue2025Member_documentation_en-US" xlink:label="lab_mo_CommonStock1.700NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 1.700% Notes Due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock1.700NotesDue2025Member" xlink:href="mo-20210930.xsd#mo_CommonStock1.700NotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStock1.700NotesDue2025Member" xlink:to="lab_mo_CommonStock1.700NotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_932ac115-c260-4065-bb06-e011b910a4cf_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit (income) cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_7ddce700-4a7e-4803-b5d3-f4b9c4d51320_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesGoreMember_6229e66f-ef35-4383-b036-ef24d995be03_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesGoreMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Gore [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesGoreMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesGoreMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Gore [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesGoreMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesGoreMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Gore [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGoreMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesGoreMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesGoreMember" xlink:to="lab_mo_EngleProgenyCasesGoreMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesRJReynoldsMember_83a6183f-54bf-4eea-9cd5-b4025e39695b_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesRJReynoldsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, R.J. Reynolds [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesRJReynoldsMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesRJReynoldsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, R.J. Reynolds [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesRJReynoldsMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesRJReynoldsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, R.J. Reynolds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesRJReynoldsMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesRJReynoldsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesRJReynoldsMember" xlink:to="lab_mo_EngleProgenyCasesRJReynoldsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_fc6761ac-57a2-45a4-bc45-83c3e38f884a_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NoncontrollingInterestRemainingInterestPurchasedByParent_d61d3b3b-95c1-4478-8ebd-0561beebe98d_terseLabel_en-US" xlink:label="lab_mo_NoncontrollingInterestRemainingInterestPurchasedByParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, remaining interest purchased by parent</link:label>
    <link:label id="lab_mo_NoncontrollingInterestRemainingInterestPurchasedByParent_label_en-US" xlink:label="lab_mo_NoncontrollingInterestRemainingInterestPurchasedByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Remaining Interest Purchased By Parent</link:label>
    <link:label id="lab_mo_NoncontrollingInterestRemainingInterestPurchasedByParent_documentation_en-US" xlink:label="lab_mo_NoncontrollingInterestRemainingInterestPurchasedByParent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Remaining Interest Purchased By Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NoncontrollingInterestRemainingInterestPurchasedByParent" xlink:href="mo-20210930.xsd#mo_NoncontrollingInterestRemainingInterestPurchasedByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NoncontrollingInterestRemainingInterestPurchasedByParent" xlink:to="lab_mo_NoncontrollingInterestRemainingInterestPurchasedByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClaimsResolvedNumber_e62aa4b3-64be-4cbc-b805-f7366a59ed18_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClaimsResolvedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of claims resolved</link:label>
    <link:label id="lab_mo_LossContingencyClaimsResolvedNumber_label_en-US" xlink:label="lab_mo_LossContingencyClaimsResolvedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Resolved, Number</link:label>
    <link:label id="lab_mo_LossContingencyClaimsResolvedNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyClaimsResolvedNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Resolved, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsResolvedNumber" xlink:href="mo-20210930.xsd#mo_LossContingencyClaimsResolvedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClaimsResolvedNumber" xlink:to="lab_mo_LossContingencyClaimsResolvedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_07f68072-7812-4d55-a872-201c5e286dff_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_028d75e2-499e-457f-b5bb-20026072bda7_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings reinvested in the business</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_1bf509e2-d1b1-4092-aa5c-45f8bf181523_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_14d43f5b-ac91-4777-bb2f-3967450788b5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PeriodTwoMember_d9b5a573-400e-41d1-b015-54046577263d_terseLabel_en-US" xlink:label="lab_mo_PeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period Two</link:label>
    <link:label id="lab_mo_PeriodTwoMember_label_en-US" xlink:label="lab_mo_PeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period Two [Member]</link:label>
    <link:label id="lab_mo_PeriodTwoMember_documentation_en-US" xlink:label="lab_mo_PeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PeriodTwoMember" xlink:href="mo-20210930.xsd#mo_PeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PeriodTwoMember" xlink:to="lab_mo_PeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_PR_5c42dc27-2beb-4862-8c5c-480058ca5216_terseLabel_en-US" xlink:label="lab_country_PR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Puerto Rico [Member]</link:label>
    <link:label id="lab_country_PR_label_en-US" xlink:label="lab_country_PR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PUERTO RICO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_PR" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_PR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_PR" xlink:to="lab_country_PR" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_924b069c-b3e0-457b-aa72-480acc3f6298_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_382d0849-9689-4487-bab7-600fea4fe001_verboseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_ec5c1e99-ab3c-443b-9193-18bdaca137fd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationCurrent_054672b0-98ec-482c-8b10-593e2416c672_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued pension costs</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_0333c272-bf5c-42b9-b325-7acf0ac04e17_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_SmokeableProductsSegmentMember_92f1c87a-713a-4366-ab68-0029481dc4ad_terseLabel_en-US" xlink:label="lab_mo_SmokeableProductsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smokeable Products Segment [Member]</link:label>
    <link:label id="lab_mo_SmokeableProductsSegmentMember_label_en-US" xlink:label="lab_mo_SmokeableProductsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smokeable Products Segment [Member]</link:label>
    <link:label id="lab_mo_SmokeableProductsSegmentMember_documentation_en-US" xlink:label="lab_mo_SmokeableProductsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smokeable Products Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember" xlink:href="mo-20210930.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_SmokeableProductsSegmentMember" xlink:to="lab_mo_SmokeableProductsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_40c9c9f7-245c-4d48-bfe2-b2b268b08e09_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NpmAdjustmentToCostOfSalesMember_bcccbc1e-1f0a-479f-be4b-9602ac58efd4_terseLabel_en-US" xlink:label="lab_mo_NpmAdjustmentToCostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NPM Adjustment to Cost Of Sales [Member]</link:label>
    <link:label id="lab_mo_NpmAdjustmentToCostOfSalesMember_label_en-US" xlink:label="lab_mo_NpmAdjustmentToCostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NPM Adjustment to Cost Of Sales [Member]</link:label>
    <link:label id="lab_mo_NpmAdjustmentToCostOfSalesMember_documentation_en-US" xlink:label="lab_mo_NpmAdjustmentToCostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NPM Adjustment to Cost Of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NpmAdjustmentToCostOfSalesMember" xlink:href="mo-20210930.xsd#mo_NpmAdjustmentToCostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NpmAdjustmentToCostOfSalesMember" xlink:to="lab_mo_NpmAdjustmentToCostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDDenominatedNotes4400PercentDue2026Member_4718c72b-377f-4faf-948c-f1cae373a252_terseLabel_en-US" xlink:label="lab_mo_USDDenominatedNotes4400PercentDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.400%, Notes Due 2026 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotes4400PercentDue2026Member_label_en-US" xlink:label="lab_mo_USDDenominatedNotes4400PercentDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes, 4.400 Percent, Due 2026 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotes4400PercentDue2026Member_documentation_en-US" xlink:label="lab_mo_USDDenominatedNotes4400PercentDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes, 4.400 Percent, Due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes4400PercentDue2026Member" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotes4400PercentDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDDenominatedNotes4400PercentDue2026Member" xlink:to="lab_mo_USDDenominatedNotes4400PercentDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesSantoroMember_cc5d04b2-1d8d-4fb4-8b28-a896eb344755_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesSantoroMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Santoro [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesSantoroMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesSantoroMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Santoro [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesSantoroMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesSantoroMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Santoro [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesSantoroMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesSantoroMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesSantoroMember" xlink:to="lab_mo_EngleProgenyCasesSantoroMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_11c337f0-3e5b-40c8-9366-8a4acd03710d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_ad717f85-9241-49a1-8a58-a15fdda20baf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesCuddiheeMember_a364a495-ca33-4a2a-a66d-0862cdcfc812_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesCuddiheeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Cuddihee [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesCuddiheeMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesCuddiheeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Cuddihee [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesCuddiheeMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesCuddiheeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Cuddihee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesCuddiheeMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesCuddiheeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesCuddiheeMember" xlink:to="lab_mo_EngleProgenyCasesCuddiheeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_956a2451-e070-405b-b5ab-e5a0ce7558af_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_dae8047b-5784-4221-b963-086e66fd469a_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity securities</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_3d75bf41-12e6-4b53-b23c-3c5ad1a759c6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_e918c6a2-d8da-4705-802f-a1b79e48ad1d_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NH_a4b6f4f7-8629-4676-a64b-e266f25892e7_terseLabel_en-US" xlink:label="lab_stpr_NH" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Hampshire [Member]</link:label>
    <link:label id="lab_stpr_NH_label_en-US" xlink:label="lab_stpr_NH" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW HAMPSHIRE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NH" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_NH"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NH" xlink:to="lab_stpr_NH" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDDenominatedNotes9950PercentDue2038Member_f4f3237d-5d9e-408a-80ca-7b4e578a6420_terseLabel_en-US" xlink:label="lab_mo_USDDenominatedNotes9950PercentDue2038Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">9.950%, Notes Due 2038 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotes9950PercentDue2038Member_label_en-US" xlink:label="lab_mo_USDDenominatedNotes9950PercentDue2038Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes, 9.950 Percent, Due 2038 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotes9950PercentDue2038Member_documentation_en-US" xlink:label="lab_mo_USDDenominatedNotes9950PercentDue2038Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes, 9.950 Percent, Due 2038</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes9950PercentDue2038Member" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotes9950PercentDue2038Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDDenominatedNotes9950PercentDue2038Member" xlink:to="lab_mo_USDDenominatedNotes9950PercentDue2038Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OralTobaccoSegmentMember_d3262ea5-27a9-41a5-9a11-ae3b9e93bc6a_verboseLabel_en-US" xlink:label="lab_mo_OralTobaccoSegmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Tobacco Segment [Member]</link:label>
    <link:label id="lab_mo_OralTobaccoSegmentMember_38e236a2-e737-4778-bfd2-1ee4a362a73e_terseLabel_en-US" xlink:label="lab_mo_OralTobaccoSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Tobacco Segment [Member]</link:label>
    <link:label id="lab_mo_OralTobaccoSegmentMember_label_en-US" xlink:label="lab_mo_OralTobaccoSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Tobacco Segment [Member]</link:label>
    <link:label id="lab_mo_OralTobaccoSegmentMember_documentation_en-US" xlink:label="lab_mo_OralTobaccoSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Tobacco Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember" xlink:href="mo-20210930.xsd#mo_OralTobaccoSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OralTobaccoSegmentMember" xlink:to="lab_mo_OralTobaccoSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_50cf1182-a25a-4922-876d-60acb3bfc86b_terseLabel_en-US" xlink:label="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking And Health Case, Principe [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_label_en-US" xlink:label="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking And Health Case, Principe [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_documentation_en-US" xlink:label="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking And Health Case, Principe</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" xlink:href="mo-20210930.xsd#mo_NonEngleProgenySmokingAndHealthCasePrincipeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" xlink:to="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod_4d324fea-64ea-49c3-badb-20f6c92f9bf5_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of states not settled, arbitration period</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States Not Settled, Arbitration Period</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States Not Settled, Arbitration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod" xlink:to="lab_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_383f8e67-93ca-4c35-a4a4-fb5cd3984275_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesNaugleMember_bb81d542-3a4a-4008-b7da-d4647e80e936_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesNaugleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Naugle [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesNaugleMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesNaugleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Naugle [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesNaugleMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesNaugleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Naugle [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesNaugleMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesNaugleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesNaugleMember" xlink:to="lab_mo_EngleProgenyCasesNaugleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_87ec4606-db46-437c-af3f-cd3865ba26c5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_45d19bea-a2c1-4d4e-84dd-785a9f8aaaea_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Guidance Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesFederalMember_aabf9b50-b499-4ec1-be69-1527b1cba666_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesFederalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Federal [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesFederalMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesFederalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Federal [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesFederalMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesFederalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Federal [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesFederalMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesFederalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesFederalMember" xlink:to="lab_mo_EngleProgenyCasesFederalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_1b1228ae-1a30-437f-a9be-724a4fc6d7b2_terseLabel_en-US" xlink:label="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, period for decertified class members to file individual actions against defendants</link:label>
    <link:label id="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_label_en-US" xlink:label="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Period for Decertified Class Members to File Individual Actions Against Defendants</link:label>
    <link:label id="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_documentation_en-US" xlink:label="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Period for Decertified Class Members to File Individual Actions Against Defendants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" xlink:href="mo-20210930.xsd#mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" xlink:to="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MT_f5dd36d7-e845-461f-b10e-88908a7c40d8_terseLabel_en-US" xlink:label="lab_stpr_MT" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MONTANA</link:label>
    <link:label id="lab_stpr_MT_label_en-US" xlink:label="lab_stpr_MT" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MONTANA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MT" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MT"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MT" xlink:to="lab_stpr_MT" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_MarketingAdministrationandResearchCosts_bb85da48-a48a-4645-b067-818fa9361e93_terseLabel_en-US" xlink:label="lab_mo_MarketingAdministrationandResearchCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing, administration and research costs</link:label>
    <link:label id="lab_mo_MarketingAdministrationandResearchCosts_label_en-US" xlink:label="lab_mo_MarketingAdministrationandResearchCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing, Administration and Research Costs</link:label>
    <link:label id="lab_mo_MarketingAdministrationandResearchCosts_documentation_en-US" xlink:label="lab_mo_MarketingAdministrationandResearchCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The aggregate total costs related to selling a firm's product and services, as well as research and development costs and all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. Research and development costs represent the aggregate costs incurred during an accounting period to research and develop new products/technologies when the technological feasibility has not been reached. General and administrative expenses include salaries of nonsales personnel, rent, utilities, communication, etc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarketingAdministrationandResearchCosts" xlink:href="mo-20210930.xsd#mo_MarketingAdministrationandResearchCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_MarketingAdministrationandResearchCosts" xlink:to="lab_mo_MarketingAdministrationandResearchCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDDenominatedNotesMember_5e54fb8a-866a-43d0-b727-71b878c83dfe_terseLabel_en-US" xlink:label="lab_mo_USDDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotesMember_label_en-US" xlink:label="lab_mo_USDDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotesMember_documentation_en-US" xlink:label="lab_mo_USDDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesMember" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDDenominatedNotesMember" xlink:to="lab_mo_USDDenominatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_1a6b8fbc-035b-4fb1-bf00-750816bf51dd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision (benefit) for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b446c37a-65e3-43dc-b22c-a3e7eba2ac64_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; (deficit) equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_11010089-e6d2-4857-9955-7b4f7fa88004_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_05ea1360-e47b-46b0-9b86-560afe1a0381_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseCommitmentMember_d13920a6-0d90-417b-83c3-d295168d4a4e_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment [Member]</link:label>
    <link:label id="lab_us-gaap_PurchaseCommitmentMember_label_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseCommitmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseCommitmentMember" xlink:to="lab_us-gaap_PurchaseCommitmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MS_64871e1c-de5a-4f71-9aea-c9e3e3af14c9_terseLabel_en-US" xlink:label="lab_stpr_MS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mississippi [Member]</link:label>
    <link:label id="lab_stpr_MS_label_en-US" xlink:label="lab_stpr_MS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MISSISSIPPI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MS" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MS" xlink:to="lab_stpr_MS" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember_128df30b-533f-4aaa-873f-6707eda52c43_terseLabel_en-US" xlink:label="lab_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Warrant And Equity Contract, Preemptive Rights [Member]</link:label>
    <link:label id="lab_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember_label_en-US" xlink:label="lab_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Warrant And Equity Contract, Preemptive Rights [Member]</link:label>
    <link:label id="lab_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember_documentation_en-US" xlink:label="lab_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Warrant And Equity Contract, Preemptive Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember" xlink:href="mo-20210930.xsd#mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember" xlink:to="lab_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_8158b75c-5914-4b84-bc84-159ef4368434_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt issued</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_4261c9c1-68d7-4c2b-828e-39e0ea30bad4_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_7f21f003-c000-44fe-af34-cde670ebc95a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfConsolidatedDerivativeLawsuits_cb02895a-16c2-4353-bc49-2fbde264a22a_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfConsolidatedDerivativeLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of consolidated derivative lawsuits</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfConsolidatedDerivativeLawsuits_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfConsolidatedDerivativeLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Consolidated Derivative Lawsuits</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfConsolidatedDerivativeLawsuits_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfConsolidatedDerivativeLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Consolidated Derivative Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfConsolidatedDerivativeLawsuits" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfConsolidatedDerivativeLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfConsolidatedDerivativeLawsuits" xlink:to="lab_mo_LossContingencyNumberOfConsolidatedDerivativeLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MO_6cc2e757-fd84-47ed-8608-f4380693bf29_terseLabel_en-US" xlink:label="lab_stpr_MO" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Missouri [Member]</link:label>
    <link:label id="lab_stpr_MO_label_en-US" xlink:label="lab_stpr_MO" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MISSOURI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MO" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MO"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MO" xlink:to="lab_stpr_MO" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ba8b0608-25d1-4895-9e71-ea7bdf6b5fc4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount_cae0fe79-9d14-4141-9601-fdcc701ed79b_terseLabel_en-US" xlink:label="lab_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, rescinded authorized repurchase amount</link:label>
    <link:label id="lab_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount_label_en-US" xlink:label="lab_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Rescinded Authorized Repurchase Amount</link:label>
    <link:label id="lab_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount_documentation_en-US" xlink:label="lab_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Rescinded Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount" xlink:href="mo-20210930.xsd#mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount" xlink:to="lab_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MN_7e7fed25-7bf6-427a-8160-ae76e7cd8046_terseLabel_en-US" xlink:label="lab_stpr_MN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minnesota [Member]</link:label>
    <link:label id="lab_stpr_MN_label_en-US" xlink:label="lab_stpr_MN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MINNESOTA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MN" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MN" xlink:to="lab_stpr_MN" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles_071858ab-bc5a-4b4c-b15b-807c191e85ef_terseLabel_en-US" xlink:label="lab_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI</link:label>
    <link:label id="lab_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles_label_en-US" xlink:label="lab_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Before General Corporate Expenses and Amortization Of Intangibles</link:label>
    <link:label id="lab_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles_documentation_en-US" xlink:label="lab_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Before General Corporate Expenses and Amortization Of Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" xlink:href="mo-20210930.xsd#mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" xlink:to="lab_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MI_9cc22806-376f-49e6-859a-c97cda937cab_terseLabel_en-US" xlink:label="lab_stpr_MI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Michigan [Member]</link:label>
    <link:label id="lab_stpr_MI_label_en-US" xlink:label="lab_stpr_MI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MICHIGAN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MI" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MI" xlink:to="lab_stpr_MI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_1059f7c9-cdf0-4468-bc47-3ecf69f089a3_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_1d989bb1-3b08-4b76-86d7-793ec9ac7d02_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt, premiums and fees</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CronosGroupInc.Member_ba044bf8-72c4-44b3-9d3d-b33cb6d8b142_verboseLabel_en-US" xlink:label="lab_mo_CronosGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos [Member]</link:label>
    <link:label id="lab_mo_CronosGroupInc.Member_label_en-US" xlink:label="lab_mo_CronosGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Group Inc. [Member]</link:label>
    <link:label id="lab_mo_CronosGroupInc.Member_documentation_en-US" xlink:label="lab_mo_CronosGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Group Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member" xlink:href="mo-20210930.xsd#mo_CronosGroupInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CronosGroupInc.Member" xlink:to="lab_mo_CronosGroupInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_ec4d4075-72ec-4bd4-adbd-edb99ee9ecdf_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_cac9a053-37bd-4c57-ab2e-9c5fcdca4e8d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_fdaabe95-e752-473d-8053-79a85775122f_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_TobaccoandHealthLitigationCasesMember_e91e3199-5006-4800-bca9-7cbd5d20409d_terseLabel_en-US" xlink:label="lab_mo_TobaccoandHealthLitigationCasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health Litigation Cases [Member]</link:label>
    <link:label id="lab_mo_TobaccoandHealthLitigationCasesMember_label_en-US" xlink:label="lab_mo_TobaccoandHealthLitigationCasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health Litigation Cases [Member]</link:label>
    <link:label id="lab_mo_TobaccoandHealthLitigationCasesMember_documentation_en-US" xlink:label="lab_mo_TobaccoandHealthLitigationCasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health Litigation Cases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthLitigationCasesMember" xlink:href="mo-20210930.xsd#mo_TobaccoandHealthLitigationCasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_TobaccoandHealthLitigationCasesMember" xlink:to="lab_mo_TobaccoandHealthLitigationCasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_77ac8dab-00a4-45cd-ab32-eeae6b73286c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesLippMember_5c4ea04b-5c4a-4ec5-8609-2a53a4cc6974_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesLippMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Lipp [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesLippMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesLippMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Lipp [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesLippMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesLippMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Lipp</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesLippMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesLippMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesLippMember" xlink:to="lab_mo_EngleProgenyCasesLippMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_MarketingAdministrationAndResearchCostsMember_a721f1e4-07a9-451c-9828-b523bac971e3_terseLabel_en-US" xlink:label="lab_mo_MarketingAdministrationAndResearchCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing Administration And Research Costs [Member]</link:label>
    <link:label id="lab_mo_MarketingAdministrationAndResearchCostsMember_label_en-US" xlink:label="lab_mo_MarketingAdministrationAndResearchCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing Administration And Research Costs [Member]</link:label>
    <link:label id="lab_mo_MarketingAdministrationAndResearchCostsMember_documentation_en-US" xlink:label="lab_mo_MarketingAdministrationAndResearchCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing Administration And Research Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarketingAdministrationAndResearchCostsMember" xlink:href="mo-20210930.xsd#mo_MarketingAdministrationAndResearchCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_MarketingAdministrationAndResearchCostsMember" xlink:to="lab_mo_MarketingAdministrationAndResearchCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_38d5fbeb-7416-4b9a-81a7-b7998321cee5_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStockDividendRateAnnualPerShare_583c48e6-e90f-42bb-93d1-e780405f259b_terseLabel_en-US" xlink:label="lab_mo_CommonStockDividendRateAnnualPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, dividend rate, annual (in usd per share)</link:label>
    <link:label id="lab_mo_CommonStockDividendRateAnnualPerShare_label_en-US" xlink:label="lab_mo_CommonStockDividendRateAnnualPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividend Rate, Annual, Per Share</link:label>
    <link:label id="lab_mo_CommonStockDividendRateAnnualPerShare_documentation_en-US" xlink:label="lab_mo_CommonStockDividendRateAnnualPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividend Rate, Annual, Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStockDividendRateAnnualPerShare" xlink:href="mo-20210930.xsd#mo_CommonStockDividendRateAnnualPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStockDividendRateAnnualPerShare" xlink:to="lab_mo_CommonStockDividendRateAnnualPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_fd524053-9af5-408f-889a-aba1537c4a68_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_99a3d56c-7287-4b91-bce2-75d262636b32_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_c794a2ee-0e11-4226-8a18-40791cac381c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_f94b1ced-6ccc-4c95-94e5-5244be895601_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_85fc4aa2-8a74-4adc-aef1-9d51a9d8bbb3_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_240a94e6-691c-4fdd-930c-958d7c5a3fad_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_FederalGovernmentsLawsuitMember_442d9429-ded8-4961-875f-09216cca5606_terseLabel_en-US" xlink:label="lab_mo_FederalGovernmentsLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Governments Lawsuit [Member]</link:label>
    <link:label id="lab_mo_FederalGovernmentsLawsuitMember_label_en-US" xlink:label="lab_mo_FederalGovernmentsLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Governments Lawsuit [Member]</link:label>
    <link:label id="lab_mo_FederalGovernmentsLawsuitMember_documentation_en-US" xlink:label="lab_mo_FederalGovernmentsLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Government's Lawsuit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalGovernmentsLawsuitMember" xlink:href="mo-20210930.xsd#mo_FederalGovernmentsLawsuitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_FederalGovernmentsLawsuitMember" xlink:to="lab_mo_FederalGovernmentsLawsuitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofStateswithSettledLitigation_5d34ac65-d629-42b0-8b84-75f3667faa73_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofStateswithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states with settled litigation</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStateswithSettledLitigation_label_en-US" xlink:label="lab_mo_LossContingencyNumberofStateswithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States with Settled Litigation</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStateswithSettledLitigation_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofStateswithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States with Settled Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigation" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberofStateswithSettledLitigation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofStateswithSettledLitigation" xlink:to="lab_mo_LossContingencyNumberofStateswithSettledLitigation" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ProvisionRecordedNumberOfCases_49ad8522-39fd-4ed7-b11b-75b224f390d8_terseLabel_en-US" xlink:label="lab_mo_ProvisionRecordedNumberOfCases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision recorded, number of cases</link:label>
    <link:label id="lab_mo_ProvisionRecordedNumberOfCases_label_en-US" xlink:label="lab_mo_ProvisionRecordedNumberOfCases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision Recorded, Number Of Cases</link:label>
    <link:label id="lab_mo_ProvisionRecordedNumberOfCases_documentation_en-US" xlink:label="lab_mo_ProvisionRecordedNumberOfCases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision Recorded, Number Of Cases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ProvisionRecordedNumberOfCases" xlink:href="mo-20210930.xsd#mo_ProvisionRecordedNumberOfCases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ProvisionRecordedNumberOfCases" xlink:to="lab_mo_ProvisionRecordedNumberOfCases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_6892fa66-f358-41ce-8fe1-0eaec2a06d61_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts_11566c9c-e9b1-4f04-8053-c4888f2845ff_terseLabel_en-US" xlink:label="lab_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal group, total pre-tax charges</link:label>
    <link:label id="lab_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts_label_en-US" xlink:label="lab_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Marketing, Administration And Research Costs</link:label>
    <link:label id="lab_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts_documentation_en-US" xlink:label="lab_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Marketing, Administration And Research Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts" xlink:href="mo-20210930.xsd#mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts" xlink:to="lab_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EvaporLitigationMember_03c6864e-b7ad-4025-8805-aff2a1bf12cb_terseLabel_en-US" xlink:label="lab_mo_EvaporLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E-vapor Litigation [Member]</link:label>
    <link:label id="lab_mo_EvaporLitigationMember_label_en-US" xlink:label="lab_mo_EvaporLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E-vapor Litigation [Member]</link:label>
    <link:label id="lab_mo_EvaporLitigationMember_documentation_en-US" xlink:label="lab_mo_EvaporLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E-vapor Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EvaporLitigationMember" xlink:href="mo-20210930.xsd#mo_EvaporLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EvaporLitigationMember" xlink:to="lab_mo_EvaporLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_1cc3040e-93e0-4d91-8ae6-22818c6a103e_negatedLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment_d89038b9-43ce-4116-bf54-2a1a7e6343a9_terseLabel_en-US" xlink:label="lab_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment_label_en-US" xlink:label="lab_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Foreign Currency Translation Adjustment</link:label>
    <link:label id="lab_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment_documentation_en-US" xlink:label="lab_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Foreign Currency Translation Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment" xlink:href="mo-20210930.xsd#mo_ValuationAllowanceForeignCurrencyTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment" xlink:to="lab_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e72e10b6-1be4-4256-b4b5-b4fbac5f0ec9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustments and other</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ee87de67-8fa3-4ec5-9773-b84e0328c755_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_56285fe2-2c7e-4ea0-a4a9-0ed79cd3d1ce_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_LA_9a6d6a64-e7cb-40c1-be30-2e43b8e49803_terseLabel_en-US" xlink:label="lab_stpr_LA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Louisiana [Member]</link:label>
    <link:label id="lab_stpr_LA_label_en-US" xlink:label="lab_stpr_LA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LOUISIANA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_LA" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_LA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_LA" xlink:to="lab_stpr_LA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_40ad8061-0466-411b-ab87-339e7862cc8e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClaimsDecided_1472785c-0b8b-46c6-8ad5-249c28ed4d41_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClaimsDecided" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of verdicts returned</link:label>
    <link:label id="lab_mo_LossContingencyClaimsDecided_label_en-US" xlink:label="lab_mo_LossContingencyClaimsDecided" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Decided</link:label>
    <link:label id="lab_mo_LossContingencyClaimsDecided_documentation_en-US" xlink:label="lab_mo_LossContingencyClaimsDecided" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Decided</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecided" xlink:href="mo-20210930.xsd#mo_LossContingencyClaimsDecided"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClaimsDecided" xlink:to="lab_mo_LossContingencyClaimsDecided" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityInvestmentFairValueOption_68e097fd-a88b-4ac5-aa92-c108758dc577_terseLabel_en-US" xlink:label="lab_mo_EquityInvestmentFairValueOption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JUUL</link:label>
    <link:label id="lab_mo_EquityInvestmentFairValueOption_label_en-US" xlink:label="lab_mo_EquityInvestmentFairValueOption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investment, Fair Value Option</link:label>
    <link:label id="lab_mo_EquityInvestmentFairValueOption_documentation_en-US" xlink:label="lab_mo_EquityInvestmentFairValueOption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investment, Fair Value Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityInvestmentFairValueOption" xlink:href="mo-20210930.xsd#mo_EquityInvestmentFairValueOption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityInvestmentFairValueOption" xlink:to="lab_mo_EquityInvestmentFairValueOption" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_5d5d3a6e-b2d0-4651-a37a-f56e871d8fb1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_f203eaaa-21a9-435a-99c6-42d900de1279_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_KS_f3b857d0-a62e-494f-aee6-6ec506f969f3_terseLabel_en-US" xlink:label="lab_stpr_KS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kansas [Member]</link:label>
    <link:label id="lab_stpr_KS_label_en-US" xlink:label="lab_stpr_KS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">KANSAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_KS" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_KS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_KS" xlink:to="lab_stpr_KS" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_0675054b-7033-4c67-8a58-ec5ff91de55a_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_0ebabc3a-063f-4613-9353-d9367c3c46d8_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash included in other assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PendingLawsuitFiledBySchoolDistrictMember_305fa71e-20dc-455c-b661-2aea380aa0cc_terseLabel_en-US" xlink:label="lab_mo_PendingLawsuitFiledBySchoolDistrictMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Lawsuit Filed By School District [Member]</link:label>
    <link:label id="lab_mo_PendingLawsuitFiledBySchoolDistrictMember_label_en-US" xlink:label="lab_mo_PendingLawsuitFiledBySchoolDistrictMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Lawsuit Filed By School District [Member]</link:label>
    <link:label id="lab_mo_PendingLawsuitFiledBySchoolDistrictMember_documentation_en-US" xlink:label="lab_mo_PendingLawsuitFiledBySchoolDistrictMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Lawsuit Filed By School District [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingLawsuitFiledBySchoolDistrictMember" xlink:href="mo-20210930.xsd#mo_PendingLawsuitFiledBySchoolDistrictMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PendingLawsuitFiledBySchoolDistrictMember" xlink:to="lab_mo_PendingLawsuitFiledBySchoolDistrictMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsMember_2f07fc00-4ea6-4c9f-801e-107f1c1aeb69_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Member]</link:label>
    <link:label id="lab_us-gaap_AssetsMember_label_en-US" xlink:label="lab_us-gaap_AssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsMember" xlink:to="lab_us-gaap_AssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_7259a47a-1313-4f48-88c1-a2a5f55bb074_verboseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity securities ($1,740 million and $1,868 million at September 30, 2021 and December 31, 2020, respectively, measured at fair value)</link:label>
    <link:label id="lab_us-gaap_Investments_a52b418a-9773-4791-b393-1ce9a5cb2de3_totalLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_COVID19Member_7aba08e4-89b9-494d-b0be-0b65e5021e81_terseLabel_en-US" xlink:label="lab_mo_COVID19Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 [Member]</link:label>
    <link:label id="lab_mo_COVID19Member_label_en-US" xlink:label="lab_mo_COVID19Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 [Member]</link:label>
    <link:label id="lab_mo_COVID19Member_documentation_en-US" xlink:label="lab_mo_COVID19Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_COVID19Member" xlink:href="mo-20210930.xsd#mo_COVID19Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_COVID19Member" xlink:to="lab_mo_COVID19Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_2e8a00aa-f3c2-439d-a42e-a8162fc612cb_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_IncomeLossFromEquityInvestmentsFairValueOption_27d2ac73-9d51-40dd-bc70-5ecdc23af7cc_terseLabel_en-US" xlink:label="lab_mo_IncomeLossFromEquityInvestmentsFairValueOption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JUUL</link:label>
    <link:label id="lab_mo_IncomeLossFromEquityInvestmentsFairValueOption_e7384ddb-7ac8-41b7-8efe-f4ee6f9dcca1_verboseLabel_en-US" xlink:label="lab_mo_IncomeLossFromEquityInvestmentsFairValueOption" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from equity investments, fair value option</link:label>
    <link:label id="lab_mo_IncomeLossFromEquityInvestmentsFairValueOption_label_en-US" xlink:label="lab_mo_IncomeLossFromEquityInvestmentsFairValueOption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Investments, Fair Value Option</link:label>
    <link:label id="lab_mo_IncomeLossFromEquityInvestmentsFairValueOption_documentation_en-US" xlink:label="lab_mo_IncomeLossFromEquityInvestmentsFairValueOption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Investments, Fair Value Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestmentsFairValueOption" xlink:href="mo-20210930.xsd#mo_IncomeLossFromEquityInvestmentsFairValueOption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_IncomeLossFromEquityInvestmentsFairValueOption" xlink:to="lab_mo_IncomeLossFromEquityInvestmentsFairValueOption" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_44b82f48-aa71-4ae8-9678-122b40c39e94_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected period for satisfaction of performance obligation</link:label>
    <link:label id="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_label_en-US" xlink:label="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation, Description of Timing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfTiming"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:to="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_4d91187c-48fb-4c52-bcf2-5ef9a899d289_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfStatesWithConcludedHearings_9e170f94-38be-4ad8-994a-b8af49937f8d_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesWithConcludedHearings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of states with concluded hearings</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesWithConcludedHearings_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesWithConcludedHearings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States With Concluded Hearings</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesWithConcludedHearings_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesWithConcludedHearings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States With Concluded Hearings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesWithConcludedHearings" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfStatesWithConcludedHearings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfStatesWithConcludedHearings" xlink:to="lab_mo_LossContingencyNumberOfStatesWithConcludedHearings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_7208d0ff-8383-4caa-b7d1-fdd2000acb7a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in accrued postretirement health care cost liability</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Obligation, Pension and Other Postretirement Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:to="lab_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesTheisMember_4feec344-6b0f-4120-96ff-852e46fc1b3d_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesTheisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Theis [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesTheisMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesTheisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Theis [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesTheisMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesTheisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Theis [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesTheisMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesTheisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesTheisMember" xlink:to="lab_mo_EngleProgenyCasesTheisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_e7440b75-7c70-443c-abd0-1903be0fdadf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyReductionToCostOfSales_00db83f3-d2a1-47b9-9099-7e69e3171f54_terseLabel_en-US" xlink:label="lab_mo_LossContingencyReductionToCostOfSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, reduction to cost of sales</link:label>
    <link:label id="lab_mo_LossContingencyReductionToCostOfSales_label_en-US" xlink:label="lab_mo_LossContingencyReductionToCostOfSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Reduction To Cost Of Sales</link:label>
    <link:label id="lab_mo_LossContingencyReductionToCostOfSales_documentation_en-US" xlink:label="lab_mo_LossContingencyReductionToCostOfSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Reduction To Cost Of Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyReductionToCostOfSales" xlink:href="mo-20210930.xsd#mo_LossContingencyReductionToCostOfSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyReductionToCostOfSales" xlink:to="lab_mo_LossContingencyReductionToCostOfSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_f3cbe339-c118-4b85-9409-226cd3f51f39_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities:</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_7a5f7b9a-f2e1-4056-af80-398548ed619f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesDuignanMember_43444d35-193c-4252-b17a-165fe677f6cb_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesDuignanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Duignan [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesDuignanMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesDuignanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Duignan [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesDuignanMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesDuignanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Duignan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesDuignanMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesDuignanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesDuignanMember" xlink:to="lab_mo_EngleProgenyCasesDuignanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7e38c8c6-4691-4781-a7df-f1e4589b0e90_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (losses) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c3bab6b9-b54f-414a-b977-99cf9e618f8b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (losses) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementInterest_a0c488f5-02c6-411e-b442-6cbd1c25dc3c_netLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementInterest" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement interest expense (income)</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementInterest_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementInterest" xlink:to="lab_us-gaap_LitigationSettlementInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_69ea48fa-2e5f-4ee1-adba-3be8c66ee578_terseLabel_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]</link:label>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_label_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]</link:label>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_documentation_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" xlink:href="mo-20210930.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" xlink:to="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentReductionInSharePricePercentage_ffc32d61-7a72-410c-b6a6-abe2a83e5213_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentReductionInSharePricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, reduction in share price, percentage</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentReductionInSharePricePercentage_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentReductionInSharePricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Reduction In Share Price, Percentage</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentReductionInSharePricePercentage_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentReductionInSharePricePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Reduction In Share Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentReductionInSharePricePercentage" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentReductionInSharePricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentReductionInSharePricePercentage" xlink:to="lab_mo_EquityMethodInvestmentReductionInSharePricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_0a85a569-9c25-4fb3-a4bd-5d2b640266d8_periodStartLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_fb0125fe-8216-4b86-b6cc-2f1fb3484d15_periodEndLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDDenominatedNotesDue2061Member_dba073e4-a7a6-480e-acee-a9da631d9a63_terseLabel_en-US" xlink:label="lab_mo_USDDenominatedNotesDue2061Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes Due 2061 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotesDue2061Member_label_en-US" xlink:label="lab_mo_USDDenominatedNotesDue2061Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes Due 2061 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotesDue2061Member_documentation_en-US" xlink:label="lab_mo_USDDenominatedNotesDue2061Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes Due 2061</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesDue2061Member" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotesDue2061Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDDenominatedNotesDue2061Member" xlink:to="lab_mo_USDDenominatedNotesDue2061Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_8bf8069a-d095-417a-8cfd-5708b7fe74f9_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Dividend Yield [Member]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStock0.3313ParValueMember_13e88586-57fd-42c4-b3a4-a4e1d2af42ed_terseLabel_en-US" xlink:label="lab_mo_CommonStock0.3313ParValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, $0.33 1/3 par value [Member]</link:label>
    <link:label id="lab_mo_CommonStock0.3313ParValueMember_label_en-US" xlink:label="lab_mo_CommonStock0.3313ParValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 0.33 1/3 Par Value [Member]</link:label>
    <link:label id="lab_mo_CommonStock0.3313ParValueMember_documentation_en-US" xlink:label="lab_mo_CommonStock0.3313ParValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 0.33 1/3 Par Value [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock0.3313ParValueMember" xlink:href="mo-20210930.xsd#mo_CommonStock0.3313ParValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStock0.3313ParValueMember" xlink:to="lab_mo_CommonStock0.3313ParValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDDenominatedDebt10200PercentDue2039Member_98fc399f-6543-4fb1-9970-f127a9f947f2_terseLabel_en-US" xlink:label="lab_mo_USDDenominatedDebt10200PercentDue2039Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">10.200%, Notes Due 2039 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedDebt10200PercentDue2039Member_label_en-US" xlink:label="lab_mo_USDDenominatedDebt10200PercentDue2039Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Debt, 10.200 Percent, Due 2039 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedDebt10200PercentDue2039Member_documentation_en-US" xlink:label="lab_mo_USDDenominatedDebt10200PercentDue2039Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Debt, 10.200 Percent, Due 2039</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedDebt10200PercentDue2039Member" xlink:href="mo-20210930.xsd#mo_USDDenominatedDebt10200PercentDue2039Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDDenominatedDebt10200PercentDue2039Member" xlink:to="lab_mo_USDDenominatedDebt10200PercentDue2039Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_9b73f2e8-933e-4f4d-a511-32d97361d609_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_39770b09-895b-4168-88d0-aa0b93ad1183_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_b979bce9-73a9-4a80-b895-8a7c1d0bfac2_verboseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General corporate [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_8077b43f-6000-413e-821a-960028bf4375_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_8a84b822-f465-434b-a5f4-8afd8909d836_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) loss on Cronos-related financial instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_b7695626-f71c-452d-8364-51ca0efecd20_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on Cronos-related financial instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_f2b0eb70-c228-425a-bb39-8a0b59a5293d_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_86ff59aa-017a-4b28-bd05-bb65727bf775_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_55ac630d-e8c8-4ea9-9bdf-483a43e4873e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_b07ed4f8-af46-4a91-b6aa-db53cd249afd_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_74ca5065-000c-4dc0-bb59-3dddf9650ed6_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_66d1f3fd-b946-4430-af0e-f92120cace3e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_SteMichelleTransactionsMember_150f8d7f-7587-4819-86a4-3e5502804de0_terseLabel_en-US" xlink:label="lab_mo_SteMichelleTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ste. Michelle Transaction [Member]</link:label>
    <link:label id="lab_mo_SteMichelleTransactionsMember_label_en-US" xlink:label="lab_mo_SteMichelleTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ste. Michelle Transactions [Member]</link:label>
    <link:label id="lab_mo_SteMichelleTransactionsMember_documentation_en-US" xlink:label="lab_mo_SteMichelleTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ste. Michelle Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SteMichelleTransactionsMember" xlink:href="mo-20210930.xsd#mo_SteMichelleTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_SteMichelleTransactionsMember" xlink:to="lab_mo_SteMichelleTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_d91da385-0887-4bb7-8e0a-a54d91d5d953_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_45195a06-b838-4e4b-83a4-f20d157ba1fd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_c0c40e91-168c-44a4-a157-031ecc6a6c33_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_RI_c98606a4-6b02-4b23-8c0a-c6e0c509750c_terseLabel_en-US" xlink:label="lab_stpr_RI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rhode Island [Member]</link:label>
    <link:label id="lab_stpr_RI_label_en-US" xlink:label="lab_stpr_RI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RHODE ISLAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_RI" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_RI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_RI" xlink:to="lab_stpr_RI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_5a4b70a4-11b3-43bc-bd0e-e3c723715daa_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_ca19310c-999c-4051-a02a-36dd9ccf5302_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) related to litigation settlement</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_f43dadc2-b85b-4407-9e6b-92426f7fd727_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_0562cd1b-7362-4bf7-a4e5-d4d1017c54e5_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, downward price adjustment, cumulative amount</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesPollariMember_03993281-b039-4b26-8146-ca4820a18701_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesPollariMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Pollari [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesPollariMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesPollariMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Pollari [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesPollariMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesPollariMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Pollari [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesPollariMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesPollariMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesPollariMember" xlink:to="lab_mo_EngleProgenyCasesPollariMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_78a5f02c-0099-4a0d-b99d-8d9ff7c8ea51_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_230fde51-0d56-4734-9d52-bcb57cd79574_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (losses) for diluted EPS</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PhilipMorrisUSAMember_5ba6d359-21df-4036-8d15-87808f9c41d1_terseLabel_en-US" xlink:label="lab_mo_PhilipMorrisUSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PM USA [Member]</link:label>
    <link:label id="lab_mo_PhilipMorrisUSAMember_label_en-US" xlink:label="lab_mo_PhilipMorrisUSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris USA [Member]</link:label>
    <link:label id="lab_mo_PhilipMorrisUSAMember_documentation_en-US" xlink:label="lab_mo_PhilipMorrisUSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris USA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PhilipMorrisUSAMember" xlink:to="lab_mo_PhilipMorrisUSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputSharePriceMember_c9238c73-b6f4-4802-8d6d-607ba25044d8_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price [Member]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputSharePriceMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Share Price [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputSharePriceMember" xlink:to="lab_us-gaap_MeasurementInputSharePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ClassActionLawsuitMember_9663abad-474b-498f-b3ea-85cbb77a424a_terseLabel_en-US" xlink:label="lab_mo_ClassActionLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Action Lawsuit [Member]</link:label>
    <link:label id="lab_mo_ClassActionLawsuitMember_label_en-US" xlink:label="lab_mo_ClassActionLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Action Lawsuit [Member]</link:label>
    <link:label id="lab_mo_ClassActionLawsuitMember_documentation_en-US" xlink:label="lab_mo_ClassActionLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Action Lawsuit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ClassActionLawsuitMember" xlink:href="mo-20210930.xsd#mo_ClassActionLawsuitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ClassActionLawsuitMember" xlink:to="lab_mo_ClassActionLawsuitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_956d2793-e409-49d2-bef4-77f0fad88f1d_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (losses) for basic EPS</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_1143c7ba-3251-4238-9923-4c238ef75d9e_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling Interests [Member]</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_ebcc57ba-3900-46bc-903c-1ed7d7d13bb2_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NonEngleProgenyCasesMember_b515def7-7cf1-4c31-a78c-28f773471ed3_terseLabel_en-US" xlink:label="lab_mo_NonEngleProgenyCasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Engle Progeny Cases [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenyCasesMember_label_en-US" xlink:label="lab_mo_NonEngleProgenyCasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Engle Progeny Cases [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenyCasesMember_documentation_en-US" xlink:label="lab_mo_NonEngleProgenyCasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Engle Progeny Cases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenyCasesMember" xlink:href="mo-20210930.xsd#mo_NonEngleProgenyCasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NonEngleProgenyCasesMember" xlink:to="lab_mo_NonEngleProgenyCasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_f263c37d-f7b5-4112-991a-f2df5880897e_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_2eceef7c-4782-45d1-9da1-fd7e29e091bc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, interest rate, stated percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_ba025c2f-100c-4ce8-890b-e35fce9736fe_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ReceivablesNetCurrentIncludingAssetsHeldForSale_8556c74f-1112-4403-be34-826537226966_terseLabel_en-US" xlink:label="lab_mo_ReceivablesNetCurrentIncludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net Current, Including Assets Held For Sale</link:label>
    <link:label id="lab_mo_ReceivablesNetCurrentIncludingAssetsHeldForSale_label_en-US" xlink:label="lab_mo_ReceivablesNetCurrentIncludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net Current, Including Assets Held For Sale</link:label>
    <link:label id="lab_mo_ReceivablesNetCurrentIncludingAssetsHeldForSale_documentation_en-US" xlink:label="lab_mo_ReceivablesNetCurrentIncludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net Current, Including Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ReceivablesNetCurrentIncludingAssetsHeldForSale" xlink:href="mo-20210930.xsd#mo_ReceivablesNetCurrentIncludingAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ReceivablesNetCurrentIncludingAssetsHeldForSale" xlink:to="lab_mo_ReceivablesNetCurrentIncludingAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciEquityMethodInvestmentAfterTax_186a23ef-a2bc-47ee-9e27-ae97fdae0a94_terseLabel_en-US" xlink:label="lab_us-gaap_OciEquityMethodInvestmentAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABI</link:label>
    <link:label id="lab_us-gaap_OciEquityMethodInvestmentAfterTax_label_en-US" xlink:label="lab_us-gaap_OciEquityMethodInvestmentAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Equity Method Investment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciEquityMethodInvestmentAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciEquityMethodInvestmentAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciEquityMethodInvestmentAfterTax" xlink:to="lab_us-gaap_OciEquityMethodInvestmentAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USTLitigationMember_00c5f8f2-945c-46a9-a501-355765c201ca_terseLabel_en-US" xlink:label="lab_mo_USTLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UST Litigation [Member]</link:label>
    <link:label id="lab_mo_USTLitigationMember_label_en-US" xlink:label="lab_mo_USTLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UST Litigation [Member]</link:label>
    <link:label id="lab_mo_USTLitigationMember_documentation_en-US" xlink:label="lab_mo_USTLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UST Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USTLitigationMember" xlink:href="mo-20210930.xsd#mo_USTLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USTLitigationMember" xlink:to="lab_mo_USTLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_07617d37-72e9-41e8-895c-4d62d533fa20_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (earnings) losses attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentPricePerShareIfExercised_fa0fba85-fd4d-459a-bfe4-dc5cba8deb60_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentPricePerShareIfExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, shares purchased, (CAD per share)</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentPricePerShareIfExercised_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentPricePerShareIfExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Price Per Share If Exercised</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentPricePerShareIfExercised_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentPricePerShareIfExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Price Per Share If Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentPricePerShareIfExercised" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentPricePerShareIfExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentPricePerShareIfExercised" xlink:to="lab_mo_EquityMethodInvestmentPricePerShareIfExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_a0f021d9-517a-4496-88c9-e052906b6e8a_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_47259c3a-59e5-4d64-823d-505dd5fd246f_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_7f3cd0ae-530b-4dff-8235-4fc87fd4dda9_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_e68e5ee4-a234-4903-befd-e9316dafd2b6_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other [Member]</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_be7b6e77-aefe-4273-880b-84c2c352de29_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_OH_1617c877-f7dd-44ec-bb21-0f70c2d1c3ef_terseLabel_en-US" xlink:label="lab_stpr_OH" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ohio [Member]</link:label>
    <link:label id="lab_stpr_OH_label_en-US" xlink:label="lab_stpr_OH" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OHIO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OH" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_OH"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_OH" xlink:to="lab_stpr_OH" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_f6325b4c-bcea-4244-8085-9b7f70456aa2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStock2.200NotesDue2027Member_2eefdae0-1a0f-409f-922f-2d2caf8af888_terseLabel_en-US" xlink:label="lab_mo_CommonStock2.200NotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.200% Notes due 2027 [Member]</link:label>
    <link:label id="lab_mo_CommonStock2.200NotesDue2027Member_label_en-US" xlink:label="lab_mo_CommonStock2.200NotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 2.200% Notes Due 2027 [Member]</link:label>
    <link:label id="lab_mo_CommonStock2.200NotesDue2027Member_documentation_en-US" xlink:label="lab_mo_CommonStock2.200NotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 2.200% Notes Due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock2.200NotesDue2027Member" xlink:href="mo-20210930.xsd#mo_CommonStock2.200NotesDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStock2.200NotesDue2027Member" xlink:to="lab_mo_CommonStock2.200NotesDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_69a96707-08af-462e-911d-94d82b04d9f4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_aa29771a-5cbd-40e6-aa99-db1fcab79589_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PendingIndividualLawsuitsMember_aa8e3f33-37df-4493-ac1b-c868a23d7608_terseLabel_en-US" xlink:label="lab_mo_PendingIndividualLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Individual Lawsuits [Member]</link:label>
    <link:label id="lab_mo_PendingIndividualLawsuitsMember_label_en-US" xlink:label="lab_mo_PendingIndividualLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Individual Lawsuits [Member]</link:label>
    <link:label id="lab_mo_PendingIndividualLawsuitsMember_documentation_en-US" xlink:label="lab_mo_PendingIndividualLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Individual Lawsuits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember" xlink:href="mo-20210930.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PendingIndividualLawsuitsMember" xlink:to="lab_mo_PendingIndividualLawsuitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_3f92787a-54e8-47bd-bb43-d7588d605d6c_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b370fb81-48e3-48ec-a594-4b3cd977867b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_35ea6d4e-085c-4a21-8bd0-af89cf9e6abc_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares for basic EPS (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_66aa5044-bf4f-4646-83fd-6bd6dc274226_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings (losses) per share attributable to Altria (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NY_f65bea6c-4b70-4361-aacb-8a5110bda445_terseLabel_en-US" xlink:label="lab_stpr_NY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York [Member]</link:label>
    <link:label id="lab_stpr_NY_label_en-US" xlink:label="lab_stpr_NY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW YORK</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_NY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NY" xlink:to="lab_stpr_NY" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_fb9aa02d-8155-43c7-a31f-1640a1f306d6_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_389562b0-c5f1-4bf1-bf3c-d5e57cd8f442_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Segment [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_a9829703-72ba-4ea7-be5a-ecc3c1277612_terseLabel_en-US" xlink:label="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Lawsuits Filed By State Or Local Governments [Member]</link:label>
    <link:label id="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_label_en-US" xlink:label="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Lawsuits Filed By State Or Local Governments [Member]</link:label>
    <link:label id="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_documentation_en-US" xlink:label="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Lawsuits Filed By State Or Local Governments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" xlink:href="mo-20210930.xsd#mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" xlink:to="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NV_97e9a2b6-4cdc-42ff-9040-ca9aa6916883_terseLabel_en-US" xlink:label="lab_stpr_NV" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nevada [Member]</link:label>
    <link:label id="lab_stpr_NV_label_en-US" xlink:label="lab_stpr_NV" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEVADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NV" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_NV"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NV" xlink:to="lab_stpr_NV" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfInactiveCases_3be68ca1-3921-4756-9f6b-086dc32e2dce_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfInactiveCases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of inactive cases</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfInactiveCases_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfInactiveCases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Inactive Cases</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfInactiveCases_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfInactiveCases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Inactive Cases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfInactiveCases" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfInactiveCases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfInactiveCases" xlink:to="lab_mo_LossContingencyNumberOfInactiveCases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_b2d7dc7b-4137-4620-bd9c-6980ddd0fbd3_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_3badfaf5-88b3-4009-befa-95b2ab20cbcd_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_4a3157ad-10c7-4186-bc6f-c3870ceeb7f4_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judgments paid (approximately)</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Paid, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:to="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_e2525542-225d-4fde-9546-6c83ca69de84_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Recognized in Net Earnings (Losses)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_391c9fcd-d9b3-4062-b015-8bf77132b0f1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_194a5ffa-5e8f-47c2-bc1c-861699815917_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NM_78629b0b-b0d8-4fa1-bbc7-64d5ac82b399_terseLabel_en-US" xlink:label="lab_stpr_NM" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Mexico [Member]</link:label>
    <link:label id="lab_stpr_NM_label_en-US" xlink:label="lab_stpr_NM" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW MEXICO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NM" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_NM"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NM" xlink:to="lab_stpr_NM" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NJ_15e478e6-6dbb-433a-bcc6-b945d0696c1d_terseLabel_en-US" xlink:label="lab_stpr_NJ" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Jersey [Member]</link:label>
    <link:label id="lab_stpr_NJ_label_en-US" xlink:label="lab_stpr_NJ" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW JERSEY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_NJ"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NJ" xlink:to="lab_stpr_NJ" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_18fe029d-59f7-476d-ab74-aaabaab0bbe7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_bf4c3b28-5a60-498d-a611-8f59096052ef_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive earnings (losses) attributable to Altria</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_43524066-9f1e-4636-b633-998e102872ca_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_SummaryOfIncomeTaxesTableTextBlock_f7ae1789-3727-4e30-86df-5a557dfc76cb_terseLabel_en-US" xlink:label="lab_mo_SummaryOfIncomeTaxesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Taxes</link:label>
    <link:label id="lab_mo_SummaryOfIncomeTaxesTableTextBlock_label_en-US" xlink:label="lab_mo_SummaryOfIncomeTaxesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Taxes [Table Text Block]</link:label>
    <link:label id="lab_mo_SummaryOfIncomeTaxesTableTextBlock_documentation_en-US" xlink:label="lab_mo_SummaryOfIncomeTaxesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SummaryOfIncomeTaxesTableTextBlock" xlink:href="mo-20210930.xsd#mo_SummaryOfIncomeTaxesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_SummaryOfIncomeTaxesTableTextBlock" xlink:to="lab_mo_SummaryOfIncomeTaxesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_167311ab-67e7-4fd3-89e5-28d9d2baef59_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_21752261-6706-4cc6-a312-0bcbcb7f1036_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_0051c554-597f-493d-81e3-c37a54fdf12a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost/credit [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesMember_6da9b248-e0a4-4e7c-bd3f-7bbf197dedf4_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesMember" xlink:to="lab_mo_EngleProgenyCasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_027be921-62f1-4892-913d-968237a5fb0c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ca6cb8cb-d0fe-4860-a2d0-2f3cda0250e5_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (losses), net of deferred income taxes:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_b9623818-6260-4727-9686-a8669b6c81a4_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of repurchased stock (967,321,022 shares at September 30, 2021 and 947,542,152 shares at December 31, 2020)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_5e9250b6-c178-4f7f-a753-0792708befbf_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesNaugleGoreMBrownJordanTheisAndLandiMember_89e9af3d-15cd-44c8-bc15-dc250e156bab_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesNaugleGoreMBrownJordanTheisAndLandiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Naugle, Gore, M. Brown, Jordan, Theis and Landi [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesNaugleGoreMBrownJordanTheisAndLandiMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesNaugleGoreMBrownJordanTheisAndLandiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Naugle, Gore, M. Brown, Jordan, Theis, and Landi [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesNaugleGoreMBrownJordanTheisAndLandiMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesNaugleGoreMBrownJordanTheisAndLandiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Naugle, Gore, M. Brown, Jordan, Theis, and Landi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesNaugleGoreMBrownJordanTheisAndLandiMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesNaugleGoreMBrownJordanTheisAndLandiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesNaugleGoreMBrownJordanTheisAndLandiMember" xlink:to="lab_mo_EngleProgenyCasesNaugleGoreMBrownJordanTheisAndLandiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_62280b73-af1c-4097-ae55-441abb0dc469_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (losses) from investments under equity method of accounting</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_7db0cab9-50d6-4e7e-b17e-0a6f93de7842_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Income) losses from equity investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_PA_cd0dc6eb-f5b4-4274-950a-6771f5e98904_terseLabel_en-US" xlink:label="lab_stpr_PA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pennsylvania [Member]</link:label>
    <link:label id="lab_stpr_PA_label_en-US" xlink:label="lab_stpr_PA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PENNSYLVANIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_PA" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_PA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_PA" xlink:to="lab_stpr_PA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_4ab9b54d-2f21-4f1b-9d65-a6059fe1967d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_1d248902-de68-4362-930f-38dae60fee13_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_ab713166-baa6-4c35-b1e9-2413d0aa6ce9_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_OR_6983d514-cf7d-4ca1-ae0e-c2d9803cb20f_terseLabel_en-US" xlink:label="lab_stpr_OR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oregon [Member]</link:label>
    <link:label id="lab_stpr_OR_label_en-US" xlink:label="lab_stpr_OR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OREGON</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OR" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_OR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_OR" xlink:to="lab_stpr_OR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_c124d65d-20a7-4e44-bd36-13ec1fea9fe4_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ThreatenedLitigationMember_ad271c7a-02d2-401b-809d-767606805b5f_terseLabel_en-US" xlink:label="lab_us-gaap_ThreatenedLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threatened Litigation [Member]</link:label>
    <link:label id="lab_us-gaap_ThreatenedLitigationMember_label_en-US" xlink:label="lab_us-gaap_ThreatenedLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threatened Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ThreatenedLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ThreatenedLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ThreatenedLitigationMember" xlink:to="lab_us-gaap_ThreatenedLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesWeingartandHancockMember_88ce7ac2-2b32-4cd9-adf7-52fafe9949bc_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesWeingartandHancockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Weingart and Hancock [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesWeingartandHancockMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesWeingartandHancockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Weingart and Hancock [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesWeingartandHancockMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesWeingartandHancockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Weingart and Hancock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesWeingartandHancockMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesWeingartandHancockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesWeingartandHancockMember" xlink:to="lab_mo_EngleProgenyCasesWeingartandHancockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_OK_25950169-f045-406f-9fc9-5d6c6edb080c_terseLabel_en-US" xlink:label="lab_stpr_OK" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oklahoma [Member]</link:label>
    <link:label id="lab_stpr_OK_label_en-US" xlink:label="lab_stpr_OK" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OKLAHOMA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OK" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_OK"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_OK" xlink:to="lab_stpr_OK" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_f09f64ed-43f2-4460-b806-041a23ae7cb2_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_BritishColumbiaSaskatchewanMember_f512dfa8-e9aa-4fc0-9fe5-b57210bf2ec1_terseLabel_en-US" xlink:label="lab_mo_BritishColumbiaSaskatchewanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Columbia and Saskatchewan [Member]</link:label>
    <link:label id="lab_mo_BritishColumbiaSaskatchewanMember_label_en-US" xlink:label="lab_mo_BritishColumbiaSaskatchewanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Columbia, Saskatchewan [Member]</link:label>
    <link:label id="lab_mo_BritishColumbiaSaskatchewanMember_documentation_en-US" xlink:label="lab_mo_BritishColumbiaSaskatchewanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Columbia, Saskatchewan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_BritishColumbiaSaskatchewanMember" xlink:href="mo-20210930.xsd#mo_BritishColumbiaSaskatchewanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_BritishColumbiaSaskatchewanMember" xlink:to="lab_mo_BritishColumbiaSaskatchewanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HelixInnovationsLLCMember_23cf4461-0985-47e6-8cae-5f50bed38743_terseLabel_en-US" xlink:label="lab_mo_HelixInnovationsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Helix Innovations LLC [Member]</link:label>
    <link:label id="lab_mo_HelixInnovationsLLCMember_label_en-US" xlink:label="lab_mo_HelixInnovationsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Helix Innovations LLC [Member]</link:label>
    <link:label id="lab_mo_HelixInnovationsLLCMember_documentation_en-US" xlink:label="lab_mo_HelixInnovationsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Helix Innovations LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HelixInnovationsLLCMember" xlink:href="mo-20210930.xsd#mo_HelixInnovationsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HelixInnovationsLLCMember" xlink:to="lab_mo_HelixInnovationsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyZeroDamagesVerdicts_c961d7be-dec8-414b-8669-afc92b1aea65_terseLabel_en-US" xlink:label="lab_mo_LossContingencyZeroDamagesVerdicts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero damages verdicts</link:label>
    <link:label id="lab_mo_LossContingencyZeroDamagesVerdicts_label_en-US" xlink:label="lab_mo_LossContingencyZeroDamagesVerdicts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Zero Damages Verdicts</link:label>
    <link:label id="lab_mo_LossContingencyZeroDamagesVerdicts_documentation_en-US" xlink:label="lab_mo_LossContingencyZeroDamagesVerdicts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Zero Damages Verdicts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyZeroDamagesVerdicts" xlink:href="mo-20210930.xsd#mo_LossContingencyZeroDamagesVerdicts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyZeroDamagesVerdicts" xlink:to="lab_mo_LossContingencyZeroDamagesVerdicts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_acb2bff1-aa3d-452c-88b8-23c84e300338_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Losses [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesJordanMember_5a299bb2-3060-42e4-8376-d976f285a746_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesJordanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Jordan [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesJordanMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesJordanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Jordan [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesJordanMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesJordanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Jordan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesJordanMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesJordanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesJordanMember" xlink:to="lab_mo_EngleProgenyCasesJordanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_31d0c30d-5778-42ee-9258-9414adb102c9_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_0b707c67-5426-4788-863d-ddda67ef4bee_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6dee996f-731f-42c7-b504-86f68f281c67_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_bb518929-4818-4638-b649-b45029bf34d6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_c9bbf3f2-b5b3-41bd-a74d-6aa98001ac7e_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_df580861-39b5-40d0-a822-8a605fab7ce0_terseLabel_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]</link:label>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_label_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]</link:label>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_documentation_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" xlink:href="mo-20210930.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" xlink:to="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_0b3d2c0c-937c-4764-ad1c-979b06785ac8_terseLabel_en-US" xlink:label="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State settlement agreements attorney fees annual cap</link:label>
    <link:label id="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_label_en-US" xlink:label="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Annual Legal Fees Payable, Maximum</link:label>
    <link:label id="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_documentation_en-US" xlink:label="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Annual Legal Fees Payable, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAnnualLegalFeesPayableMaximum" xlink:href="mo-20210930.xsd#mo_LitigationSettlementAnnualLegalFeesPayableMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LitigationSettlementAnnualLegalFeesPayableMaximum" xlink:to="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_16724227-17b1-4753-bc93-01eac34e796d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticipated additional employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_380fee55-079c-446e-98a6-1d97a92d5ff6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Liabilities at Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Hedges, Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCostOfOperatingRevenue_26cf96c6-8706-421e-85b3-e3209b4268a6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCostOfOperatingRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excise taxes on products</link:label>
    <link:label id="lab_us-gaap_OtherCostOfOperatingRevenue_label_en-US" xlink:label="lab_us-gaap_OtherCostOfOperatingRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Cost of Operating Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostOfOperatingRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCostOfOperatingRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCostOfOperatingRevenue" xlink:to="lab_us-gaap_OtherCostOfOperatingRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_00a05905-ac1d-4395-ac6f-fedce81c414c_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:to="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_89655dc6-5957-4d35-90c2-fcf89aac7900_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from divestiture of businesses</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_9c4647f3-ca1f-4f38-b8f0-94a3d1d06102_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire additional interest in subsidiaries</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Additional Interest in Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:to="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_TX_91c64926-198e-4176-8823-651e4d19aa94_terseLabel_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Texas [Member]</link:label>
    <link:label id="lab_stpr_TX_label_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TEXAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_TX"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_TX" xlink:to="lab_stpr_TX" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_673cac8e-c9ca-4880-bea2-6a9743b02371_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contingencies</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Loss Contingencies by Contingency [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:to="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStock1.000NotesDue2023Member_8ca0b816-e178-49a8-9243-9d19bdccf550_terseLabel_en-US" xlink:label="lab_mo_CommonStock1.000NotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.000% Notes due 2023 [Member]</link:label>
    <link:label id="lab_mo_CommonStock1.000NotesDue2023Member_label_en-US" xlink:label="lab_mo_CommonStock1.000NotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 1.000% Notes Due 2023 [Member]</link:label>
    <link:label id="lab_mo_CommonStock1.000NotesDue2023Member_documentation_en-US" xlink:label="lab_mo_CommonStock1.000NotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 1.000% Notes Due 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock1.000NotesDue2023Member" xlink:href="mo-20210930.xsd#mo_CommonStock1.000NotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStock1.000NotesDue2023Member" xlink:to="lab_mo_CommonStock1.000NotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues_18baafcc-55c2-4fe6-9717-b91646cc6b32_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of states not in compliance with escrow statues</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States Not In Compliance With Escrow Statues</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States Not In Compliance With Escrow Statues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" xlink:to="lab_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTextBlock_e4838cbd-43a5-4bc2-bc1b-e9b373f452cd_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Equity Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTextBlock" xlink:to="lab_us-gaap_InvestmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember_16e39001-2454-492b-966f-3f395baf0473_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b6939d1c-0554-4733-9504-544cf98306e1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentsFairValueOptionMember_d52e941a-73df-4169-aba4-6888e9925358_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentsFairValueOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Fair Value Option [Member]</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentsFairValueOptionMember_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentsFairValueOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Fair Value Option [Member]</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentsFairValueOptionMember_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentsFairValueOptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Fair Value Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentsFairValueOptionMember" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentsFairValueOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentsFairValueOptionMember" xlink:to="lab_mo_EquityMethodInvestmentsFairValueOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_20808af5-03c2-42ca-8271-0e4b0dd5e707_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_d0966033-6491-4b37-8cd9-ed1a6d75ec96_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_28e71c11-3b06-4b3b-8c37-d78e58019dc0_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; (Deficit) Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_20a67d74-1adc-4cfa-847a-06a54a734f67_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, fair value disclosure</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_8cb92cb8-d6ba-48f9-9210-0f9c8b287677_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations [Member]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfUnsecuredDebt_c0224dcb-659d-4877-8386-f78ec1673d80_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfUnsecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of senior unsecured debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfUnsecuredDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfUnsecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Unsecured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfUnsecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfUnsecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfUnsecuredDebt" xlink:to="lab_us-gaap_RepaymentsOfUnsecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PhilipMorrisUSAandAltriaGroupMember_883250ad-74d3-410a-b1be-389350f523ee_terseLabel_en-US" xlink:label="lab_mo_PhilipMorrisUSAandAltriaGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris USA and Altria Group [Member]</link:label>
    <link:label id="lab_mo_PhilipMorrisUSAandAltriaGroupMember_label_en-US" xlink:label="lab_mo_PhilipMorrisUSAandAltriaGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris USA and Altria Group [Member]</link:label>
    <link:label id="lab_mo_PhilipMorrisUSAandAltriaGroupMember_documentation_en-US" xlink:label="lab_mo_PhilipMorrisUSAandAltriaGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris USA and Altria Group [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAandAltriaGroupMember" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAandAltriaGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PhilipMorrisUSAandAltriaGroupMember" xlink:to="lab_mo_PhilipMorrisUSAandAltriaGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_5cad2065-9b94-4730-9698-027be3b10fc3_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_a360a1e4-3cb7-4221-b393-05b7c8a5930c_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_d8ad9266-8f59-4b6f-a6a0-5d917f364234_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_f4df1a00-6659-4e86-b969-6119d5803a57_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_971ea973-3ae0-4ee7-b261-c3e9ac5416f1_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_109b2343-e078-46c7-8512-cd0239503d7a_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total number of shares repurchased (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_b23ca3f2-26fc-4c7f-be03-e6b4ff01a504_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_b860a33a-3b6b-4a66-ab5c-2fbd36bbc7e6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt repaid</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_4098bc11-2420-4bea-84f6-3b29175f04a1_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt repaid</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDDenominatedNotes4000PercentDue2024Member_cd7a66b9-f0b8-43bf-86e1-5eda4451b65f_terseLabel_en-US" xlink:label="lab_mo_USDDenominatedNotes4000PercentDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.000%, Notes Due 2024 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotes4000PercentDue2024Member_label_en-US" xlink:label="lab_mo_USDDenominatedNotes4000PercentDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes, 4.000 Percent, Due 2024 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotes4000PercentDue2024Member_documentation_en-US" xlink:label="lab_mo_USDDenominatedNotes4000PercentDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes, 4.000 Percent, Due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes4000PercentDue2024Member" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotes4000PercentDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDDenominatedNotes4000PercentDue2024Member" xlink:to="lab_mo_USDDenominatedNotes4000PercentDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_3ef3d332-9f33-4de4-8817-2565e82b5f59_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_d307e93c-1447-4040-9ec6-b8d5dddfc0b1_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts, receivables</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Doubtful Accounts, Premiums and Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_bb4f2a27-6ca0-4627-83f4-c91ca21fb8ff_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Per share data:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_WineSegmentMember_328c5822-e9dd-4be2-a5d1-ba64a6773a5f_terseLabel_en-US" xlink:label="lab_mo_WineSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wine Segment [Member]</link:label>
    <link:label id="lab_mo_WineSegmentMember_label_en-US" xlink:label="lab_mo_WineSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wine Segment [Member]</link:label>
    <link:label id="lab_mo_WineSegmentMember_documentation_en-US" xlink:label="lab_mo_WineSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wine Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineSegmentMember" xlink:href="mo-20210930.xsd#mo_WineSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_WineSegmentMember" xlink:to="lab_mo_WineSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_513aeedf-ff1a-4585-b715-3d0cc2305f38_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, at cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_ebba4b25-e20f-4a19-ba6b-d626b5fde2b2_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c1e286cc-5969-4cd4-bfe9-15555f6cec56_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified to net earnings (losses), net of deferred income taxes</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_SC_b635fbc4-a9a4-4e48-bd55-b0e8fc3915dd_terseLabel_en-US" xlink:label="lab_stpr_SC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">South Carolina [Member]</link:label>
    <link:label id="lab_stpr_SC_label_en-US" xlink:label="lab_stpr_SC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOUTH CAROLINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_SC" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_SC"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_SC" xlink:to="lab_stpr_SC" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesRintoulMember_21dbcb4d-323b-4ed3-9f9a-512932634a22_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesRintoulMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Rintoul [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesRintoulMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesRintoulMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Rintoul [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesRintoulMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesRintoulMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Rintoul</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesRintoulMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesRintoulMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesRintoulMember" xlink:to="lab_mo_EngleProgenyCasesRintoulMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_7fa3d6a0-8c93-42d2-a930-a385cf249aee_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_bb1b9aa7-59f1-43b3-9147-e9a84fb6af71_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency contracts [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_d70ad3d2-b283-4430-a06c-6455a41bfec3_periodStartLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liability for tobacco and health litigation items at beginning of period</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_3884d44e-d9f8-4628-85a3-372bcf51d78c_periodEndLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liability for tobacco and health litigation items at end of period</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetMeasurementInput_29db329f-f47a-416e-8f96-ff25978c43d2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset, measurement input</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetMeasurementInput_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetMeasurementInput" xlink:to="lab_us-gaap_DerivativeAssetMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_cbc2c40f-f44f-4eb3-97df-2f3847a1beb5_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseLaramieMember_47ab85d5-a9a4-4eb0-9688-af6eca9a9de4_terseLabel_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseLaramieMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Laramie [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseLaramieMember_label_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseLaramieMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Laramie [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseLaramieMember_documentation_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseLaramieMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Laramie [Member] [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseLaramieMember" xlink:href="mo-20210930.xsd#mo_NonEngleProgenySmokingandHealthCaseLaramieMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NonEngleProgenySmokingandHealthCaseLaramieMember" xlink:to="lab_mo_NonEngleProgenySmokingandHealthCaseLaramieMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_f8b2e705-edcd-4f58-bb45-0cf8d1bc9b13_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyDamagesRecoverableValue_bca18e22-7cf4-4942-acd3-01600836a5de_terseLabel_en-US" xlink:label="lab_mo_LossContingencyDamagesRecoverableValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, damages recoverable, value</link:label>
    <link:label id="lab_mo_LossContingencyDamagesRecoverableValue_label_en-US" xlink:label="lab_mo_LossContingencyDamagesRecoverableValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Recoverable, Value</link:label>
    <link:label id="lab_mo_LossContingencyDamagesRecoverableValue_documentation_en-US" xlink:label="lab_mo_LossContingencyDamagesRecoverableValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Recoverable, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyDamagesRecoverableValue" xlink:href="mo-20210930.xsd#mo_LossContingencyDamagesRecoverableValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyDamagesRecoverableValue" xlink:to="lab_mo_LossContingencyDamagesRecoverableValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_71a0e688-4c6b-4eec-8a51-10f761559d35_terseLabel_en-US" xlink:label="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award activity</link:label>
    <link:label id="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_label_en-US" xlink:label="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition and Income Tax Effect, Net</link:label>
    <link:label id="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_documentation_en-US" xlink:label="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To Additional Paid In Capital, Share Based Compensation, Restricted And Deferred Stock Awards and the tax benefits associated with vestings of prior period restricted and deferred stock awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" xlink:href="mo-20210930.xsd#mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" xlink:to="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_6c01500f-4e83-4a9f-814e-b6ebed6cb06f_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_d50b65f1-bab9-47ce-9148-585f92e65826_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:to="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentAggregateExercisePrice_4e071da7-db9b-4f3c-b95c-9e57049a9131_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentAggregateExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, aggregate exercise price</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentAggregateExercisePrice_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentAggregateExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Exercise Price</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentAggregateExercisePrice_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentAggregateExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentAggregateExercisePrice" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentAggregateExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentAggregateExercisePrice" xlink:to="lab_mo_EquityMethodInvestmentAggregateExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5edf4562-e19f-4fb2-9f42-3452fec2177a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDDenominatedNotes4800PercentDue2029Member_1e6e3a2a-fc15-4941-979a-f33214ef9608_terseLabel_en-US" xlink:label="lab_mo_USDDenominatedNotes4800PercentDue2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.800%, Notes Due 2029 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotes4800PercentDue2029Member_label_en-US" xlink:label="lab_mo_USDDenominatedNotes4800PercentDue2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes, 4.800 Percent, Due 2029 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotes4800PercentDue2029Member_documentation_en-US" xlink:label="lab_mo_USDDenominatedNotes4800PercentDue2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes, 4.800 Percent, Due 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes4800PercentDue2029Member" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotes4800PercentDue2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDDenominatedNotes4800PercentDue2029Member" xlink:to="lab_mo_USDDenominatedNotes4800PercentDue2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_84dd988f-0e09-4d39-8e64-08be4f49f2bc_verboseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk Free Interest Rate [Member]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_ae17eaef-008e-4751-9e7f-e746d6cf1bbd_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_TN_ef362dcd-2a02-447f-9320-0a4882abc349_terseLabel_en-US" xlink:label="lab_stpr_TN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tennessee [Member]</link:label>
    <link:label id="lab_stpr_TN_label_en-US" xlink:label="lab_stpr_TN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TENNESSEE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TN" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_TN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_TN" xlink:to="lab_stpr_TN" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_355e09eb-d4a3-4d20-ab98-803b9f5ad919_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesKaplanMember_ce0d3a40-97a0-4e21-bd39-ce60706b8ba6_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesKaplanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Kaplan [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesKaplanMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesKaplanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Kaplan [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesKaplanMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesKaplanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Kaplan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesKaplanMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesKaplanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesKaplanMember" xlink:to="lab_mo_EngleProgenyCasesKaplanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_SmokingAndHealthClassActionsMember_88ceabae-fdc7-40cb-ba05-aa7b9f84b4ad_terseLabel_en-US" xlink:label="lab_mo_SmokingAndHealthClassActionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smoking and Health Class Actions and Aggregated Claims Litigation [Member]</link:label>
    <link:label id="lab_mo_SmokingAndHealthClassActionsMember_label_en-US" xlink:label="lab_mo_SmokingAndHealthClassActionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smoking And Health Class Actions [Member]</link:label>
    <link:label id="lab_mo_SmokingAndHealthClassActionsMember_documentation_en-US" xlink:label="lab_mo_SmokingAndHealthClassActionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smoking and Health Class Actions and Aggregated Claims Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsMember" xlink:href="mo-20210930.xsd#mo_SmokingAndHealthClassActionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_SmokingAndHealthClassActionsMember" xlink:to="lab_mo_SmokingAndHealthClassActionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_d4733fe3-2513-4765-949b-b6deebdad823_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_2d56e2f3-9549-40fc-a7f2-2e7696ca412d_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (losses)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_ecfc185c-d196-42cc-a73c-468330c3d304_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (losses)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_e620e616-5dd4-4869-82ba-8100e08e51f0_negatedLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings (losses)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_InterestExpenseRelatedToLitigationMember_3542a002-a488-4ab5-91d3-e06ce7d55418_terseLabel_en-US" xlink:label="lab_mo_InterestExpenseRelatedToLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Interest Costs [Member]</link:label>
    <link:label id="lab_mo_InterestExpenseRelatedToLitigationMember_label_en-US" xlink:label="lab_mo_InterestExpenseRelatedToLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense Related To Litigation [Member]</link:label>
    <link:label id="lab_mo_InterestExpenseRelatedToLitigationMember_documentation_en-US" xlink:label="lab_mo_InterestExpenseRelatedToLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense Related To Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InterestExpenseRelatedToLitigationMember" xlink:href="mo-20210930.xsd#mo_InterestExpenseRelatedToLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InterestExpenseRelatedToLitigationMember" xlink:to="lab_mo_InterestExpenseRelatedToLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_d047a388-4b25-49b9-84e5-dbd5f3d5863b_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash included in other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits_52c8061b-06e8-4b1c-aca0-4b0bb0fe1b39_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of shareholders filing derivative lawsuits</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Shareholders Filing Derivative Lawsuits</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Shareholders Filing Derivative Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" xlink:to="lab_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5a7888cb-9696-4a78-8249-49ce39bf7bcf_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_937034a7-5912-4676-b718-808878228d8f_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_85e440d9-b8a7-4a83-a020-8668892c939a_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_c5f3929f-4656-4e14-a1ea-9ab265711098_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_e8340cef-22b2-4083-817e-ad887c1067ba_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liability related to performance surety bonds</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Maximum Exposure, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:to="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_ddce8506-60cb-4613-a8ad-0e7b56afa5ec_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_29ac19a6-7a45-4a25-a9c7-5622a25d9959_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_dc9e54df-ee2a-4a3c-8969-163b720ff746_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyZeroDamagesVerdictModified_dda15313-96d6-4b2a-b222-3228d6740e70_terseLabel_en-US" xlink:label="lab_mo_LossContingencyZeroDamagesVerdictModified" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero damages verdict modified</link:label>
    <link:label id="lab_mo_LossContingencyZeroDamagesVerdictModified_label_en-US" xlink:label="lab_mo_LossContingencyZeroDamagesVerdictModified" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Zero Damages Verdict Modified</link:label>
    <link:label id="lab_mo_LossContingencyZeroDamagesVerdictModified_documentation_en-US" xlink:label="lab_mo_LossContingencyZeroDamagesVerdictModified" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Zero Damages Verdict Modified</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyZeroDamagesVerdictModified" xlink:href="mo-20210930.xsd#mo_LossContingencyZeroDamagesVerdictModified"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyZeroDamagesVerdictModified" xlink:to="lab_mo_LossContingencyZeroDamagesVerdictModified" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesReiderandBanksMember_0faa3669-1425-475a-a0ac-2cdd404de8a1_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesReiderandBanksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Reider and Banks [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesReiderandBanksMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesReiderandBanksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Reider and Banks [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesReiderandBanksMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesReiderandBanksMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Reider and Banks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesReiderandBanksMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesReiderandBanksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesReiderandBanksMember" xlink:to="lab_mo_EngleProgenyCasesReiderandBanksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_cbd72cc4-6eeb-485e-8615-8b2d5883bf4c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesBergerMember_2d445683-1ee3-41b7-b0c6-f66f3d5a2005_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesBergerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Berger [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesBergerMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesBergerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Berger [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesBergerMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesBergerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Berger [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesBergerMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesBergerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesBergerMember" xlink:to="lab_mo_EngleProgenyCasesBergerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LitigationSettlementAnnualPaymentAmount_b6894c2c-b164-4a88-96c3-062649b9e85f_terseLabel_en-US" xlink:label="lab_mo_LitigationSettlementAnnualPaymentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State settlement agreements annual payments</link:label>
    <link:label id="lab_mo_LitigationSettlementAnnualPaymentAmount_label_en-US" xlink:label="lab_mo_LitigationSettlementAnnualPaymentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Annual Payment Amount</link:label>
    <link:label id="lab_mo_LitigationSettlementAnnualPaymentAmount_documentation_en-US" xlink:label="lab_mo_LitigationSettlementAnnualPaymentAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Annual Payment Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAnnualPaymentAmount" xlink:href="mo-20210930.xsd#mo_LitigationSettlementAnnualPaymentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LitigationSettlementAnnualPaymentAmount" xlink:to="lab_mo_LitigationSettlementAnnualPaymentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_3b4876f0-33f6-49a2-b04a-452840357f6e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_a1b68db8-2265-4a6c-87f3-039251226db0_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesMahfuzMember_a7cc844e-bf74-40d0-a2ba-5dc78e98120b_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesMahfuzMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Mahfuz [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesMahfuzMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesMahfuzMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Mahfuz [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesMahfuzMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesMahfuzMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Mahfuz [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMahfuzMember" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesMahfuzMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesMahfuzMember" xlink:to="lab_mo_EngleProgenyCasesMahfuzMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_3dc47e5e-ee83-4afa-9f88-25e694ef3895_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_526386dc-fd34-4387-9a9b-bbd87a6d1c4c_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseGentileMember_ae9d1a62-c990-4054-9fb9-99da577523b4_terseLabel_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseGentileMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Gentile [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseGentileMember_label_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseGentileMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Gentile [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseGentileMember_documentation_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseGentileMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Gentile</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseGentileMember" xlink:href="mo-20210930.xsd#mo_NonEngleProgenySmokingandHealthCaseGentileMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NonEngleProgenySmokingandHealthCaseGentileMember" xlink:to="lab_mo_NonEngleProgenySmokingandHealthCaseGentileMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ff29d3eb-e30e-4efd-bc3e-64f1c5ebe668_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_23f97b51-19ad-4cfa-be4f-2012224eda3b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_f9803710-de23-4b5b-973b-a36e54a8d5d3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_084ab0f9-c9d2-4e8d-84b4-f7617e136ecf_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares for diluted EPS (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_3e55d37f-44d6-4794-9bc8-2f9764a7c2a5_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_783f7d65-e150-4e9e-8a6a-188cb6af2609_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fa10a489-f9f5-4b7e-99cc-fb9b63c9e49c_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (losses), net of deferred income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_28cbd1cc-866b-4ef5-94de-682a45cdc811_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (losses), net of deferred income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_6836545f-7599-4124-a0ae-1de9e19881f9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_f0835828-13eb-4eb4-a590-ead9844c338d_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_cbaeb9be-b1a0-4aa0-9e19-779248fc2056_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1b32504f-e2fe-4bf2-87fc-ba684c603f68_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_da2901a8-bf4d-4d4c-8ecc-5a11545effbb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Periodic Benefit (Income) Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_37df3489-fa35-473d-90f4-9af4b927396a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_1e5ec939-c798-4319-9a2f-93bf396d9372_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock_40cb18f9-3ff8-46ee-bfe4-0e4c4f7dac81_terseLabel_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Tobacco and Health and Certain Other Litigation Items</link:label>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock_label_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Charges [Table Text Block]</link:label>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock_documentation_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Table Text Block] for Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock" xlink:href="mo-20210930.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock" xlink:to="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_ca8cb71b-7196-4d84-b6e3-e4f324842ce5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_b085d3a9-f340-4491-a41d-33b20dc80ed2_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_708295c7-b182-4627-8a7a-f235c4f60ec7_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_d9249106-8ca2-45a5-8b2d-d6a7f8981b58_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_47ff274d-2596-48df-aaac-ff7d9f2f615a_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash effects of changes:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_IncomeLossFromEquityInvestments_c5d8499f-fdb9-41c8-be64-7f373fda3b03_negatedTerseLabel_en-US" xlink:label="lab_mo_IncomeLossFromEquityInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Income) losses from equity investments</link:label>
    <link:label id="lab_mo_IncomeLossFromEquityInvestments_733b03fb-8109-4825-8467-ca2a35de85dc_totalLabel_en-US" xlink:label="lab_mo_IncomeLossFromEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (losses) from equity investments</link:label>
    <link:label id="lab_mo_IncomeLossFromEquityInvestments_a2855fb7-e8e7-4a15-b95f-1d097146ddbd_terseLabel_en-US" xlink:label="lab_mo_IncomeLossFromEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (losses) from equity investments</link:label>
    <link:label id="lab_mo_IncomeLossFromEquityInvestments_label_en-US" xlink:label="lab_mo_IncomeLossFromEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Investments</link:label>
    <link:label id="lab_mo_IncomeLossFromEquityInvestments_documentation_en-US" xlink:label="lab_mo_IncomeLossFromEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments" xlink:href="mo-20210930.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_IncomeLossFromEquityInvestments" xlink:to="lab_mo_IncomeLossFromEquityInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d1540f42-53d7-4b88-b96c-b6e904b955e8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityContractWarrantMember_efff2b12-1d37-43ef-81ed-b2ee00a121c5_terseLabel_en-US" xlink:label="lab_mo_EquityContractWarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Warrant [Member]</link:label>
    <link:label id="lab_mo_EquityContractWarrantMember_0fb499fb-4b76-4acb-b290-31c9aa72a351_verboseLabel_en-US" xlink:label="lab_mo_EquityContractWarrantMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Warrant [Member]</link:label>
    <link:label id="lab_mo_EquityContractWarrantMember_label_en-US" xlink:label="lab_mo_EquityContractWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Warrant [Member]</link:label>
    <link:label id="lab_mo_EquityContractWarrantMember_documentation_en-US" xlink:label="lab_mo_EquityContractWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember" xlink:href="mo-20210930.xsd#mo_EquityContractWarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityContractWarrantMember" xlink:to="lab_mo_EquityContractWarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_aae64792-fb0a-4eb0-b8a5-df514a8759d0_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyCompensatoryDamagesAwardedValue_7f98b528-c9ab-4c5b-8768-c81b2e8ed059_terseLabel_en-US" xlink:label="lab_mo_LossContingencyCompensatoryDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensatory damages awarded</link:label>
    <link:label id="lab_mo_LossContingencyCompensatoryDamagesAwardedValue_label_en-US" xlink:label="lab_mo_LossContingencyCompensatoryDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Compensatory Damages Awarded, Value</link:label>
    <link:label id="lab_mo_LossContingencyCompensatoryDamagesAwardedValue_documentation_en-US" xlink:label="lab_mo_LossContingencyCompensatoryDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Compensatory Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedValue" xlink:href="mo-20210930.xsd#mo_LossContingencyCompensatoryDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyCompensatoryDamagesAwardedValue" xlink:to="lab_mo_LossContingencyCompensatoryDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDDenominatedNotes3490PercentDue2022Member_b2c2a07c-2f7c-4f5a-b8ba-d008f3e6f66d_terseLabel_en-US" xlink:label="lab_mo_USDDenominatedNotes3490PercentDue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes, 3.490 Percent, Due 2022 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotes3490PercentDue2022Member_label_en-US" xlink:label="lab_mo_USDDenominatedNotes3490PercentDue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes, 3.490 Percent, Due 2022 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotes3490PercentDue2022Member_documentation_en-US" xlink:label="lab_mo_USDDenominatedNotes3490PercentDue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes, 3.490 Percent, Due 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes3490PercentDue2022Member" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotes3490PercentDue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDDenominatedNotes3490PercentDue2022Member" xlink:to="lab_mo_USDDenominatedNotes3490PercentDue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_9c6a91f6-ed02-4ac3-a0fc-fec403294cc3_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_InventoryWriteOffMember_7a9a9eba-5394-4e9e-8ecb-74dc41b53b2a_terseLabel_en-US" xlink:label="lab_mo_InventoryWriteOffMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-Off [Member]</link:label>
    <link:label id="lab_mo_InventoryWriteOffMember_label_en-US" xlink:label="lab_mo_InventoryWriteOffMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-Off [Member]</link:label>
    <link:label id="lab_mo_InventoryWriteOffMember_documentation_en-US" xlink:label="lab_mo_InventoryWriteOffMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-Off [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InventoryWriteOffMember" xlink:href="mo-20210930.xsd#mo_InventoryWriteOffMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InventoryWriteOffMember" xlink:to="lab_mo_InventoryWriteOffMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_58a68f8a-6cda-48b5-b52d-e98a92146b44_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber_692c243b-c002-45d1-bd6b-08f6a0f07718_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of unfavorable verdicts</link:label>
    <link:label id="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber_label_en-US" xlink:label="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Decided Unfavorable, Number</link:label>
    <link:label id="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Decided Unfavorable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber" xlink:href="mo-20210930.xsd#mo_LossContingencyClaimsDecidedUnfavorableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber" xlink:to="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_MaximumBondForAllDefendants_fba73063-1514-473c-91a9-321a6c158e51_terseLabel_en-US" xlink:label="lab_mo_MaximumBondForAllDefendants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum bond for all defendants</link:label>
    <link:label id="lab_mo_MaximumBondForAllDefendants_label_en-US" xlink:label="lab_mo_MaximumBondForAllDefendants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Bond For All Defendants</link:label>
    <link:label id="lab_mo_MaximumBondForAllDefendants_documentation_en-US" xlink:label="lab_mo_MaximumBondForAllDefendants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Bond For All Defendants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MaximumBondForAllDefendants" xlink:href="mo-20210930.xsd#mo_MaximumBondForAllDefendants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_MaximumBondForAllDefendants" xlink:to="lab_mo_MaximumBondForAllDefendants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_5bee4d08-aad5-43f5-b04d-0d426e9518d6_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_036dbff3-4dbd-44df-b945-6e0cf45c88ed_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2e52d1ec-6ef1-4cf0-bbe1-6216be7127bf_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit line available under the agreement</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_107df483-d44c-40b8-8479-587f4ab6711f_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Valuation Allowance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_78aaf41d-ea78-4366-a943-de935c799c92_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_c8e6fb7b-86a1-4484-904f-ee7d74ddeab4_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_5c5cf5df-7992-4e2d-8ab7-0cc34f1e6c6e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_07bd9fc4-4acd-49a6-9412-d9b26a3252c4_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_25312d09-a67b-46c0-b181-a755ae111fc7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_21a2bc2b-d61f-4391-ab23-818eba0d7051_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash included in assets held for sale</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_WineBusinessStrategicResetMember_570722cb-2e3e-4863-8698-e6cb2d5fe6a0_terseLabel_en-US" xlink:label="lab_mo_WineBusinessStrategicResetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wine Business Strategic Reset [Member]</link:label>
    <link:label id="lab_mo_WineBusinessStrategicResetMember_label_en-US" xlink:label="lab_mo_WineBusinessStrategicResetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wine Business Strategic Reset [Member]</link:label>
    <link:label id="lab_mo_WineBusinessStrategicResetMember_documentation_en-US" xlink:label="lab_mo_WineBusinessStrategicResetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wine Business Strategic Reset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineBusinessStrategicResetMember" xlink:href="mo-20210930.xsd#mo_WineBusinessStrategicResetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_WineBusinessStrategicResetMember" xlink:to="lab_mo_WineBusinessStrategicResetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d8438955-58d3-4c23-9f04-c3103ebdc641_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_e43fa462-4b01-4b14-9d55-255acf208e20_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClassActionLawsuit_5032a123-d442-47a6-8119-1c8a16d517e3_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClassActionLawsuit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, class action lawsuit</link:label>
    <link:label id="lab_mo_LossContingencyClassActionLawsuit_label_en-US" xlink:label="lab_mo_LossContingencyClassActionLawsuit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action Lawsuit</link:label>
    <link:label id="lab_mo_LossContingencyClassActionLawsuit_documentation_en-US" xlink:label="lab_mo_LossContingencyClassActionLawsuit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action Lawsuit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassActionLawsuit" xlink:href="mo-20210930.xsd#mo_LossContingencyClassActionLawsuit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClassActionLawsuit" xlink:to="lab_mo_LossContingencyClassActionLawsuit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_ca7e54b1-15d2-42ff-a0c2-859ba5da4bd3_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (losses)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_42678697-7f6c-434a-9d87-411bf7092fab_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_a3ad0d48-7891-4ab9-8407-25979f6e1005_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_4a2fb2b3-8294-4fe8-b8f8-d0ccf0137f29_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_2aab0591-c179-4675-9ca5-6dfa83a8a6a4_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_a20d0072-aee5-4189-8b0e-8bb39bfe2675_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_e8deb16d-81df-4b78-b15b-491da84f6f15_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_WI_3058e0ac-a4f1-41b3-b35f-276681a1885a_terseLabel_en-US" xlink:label="lab_stpr_WI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wisconsin [Member]</link:label>
    <link:label id="lab_stpr_WI_label_en-US" xlink:label="lab_stpr_WI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WISCONSIN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WI" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_WI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_WI" xlink:to="lab_stpr_WI" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_326dea23-f3ed-4ca1-937c-ce67db2b19cc_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTableTextBlock_396194fd-c499-4a99-b77b-074f0a0f433a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment</link:label>
    <link:label id="lab_us-gaap_InvestmentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTableTextBlock" xlink:to="lab_us-gaap_InvestmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_97a5caf3-e018-4f99-b4bc-62d0f4b3f0d2_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_b29317ae-db66-457c-b0a0-3555bbee987e_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_f665cbcd-4db0-4e81-a60d-808ddb1cef2c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_4744c679-1b58-4331-8efb-bc3a2bf2561c_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ABInBevMember_d1e6a9d2-4445-4d33-8a94-e9a48610bfec_terseLabel_en-US" xlink:label="lab_mo_ABInBevMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABI [Member]</link:label>
    <link:label id="lab_mo_ABInBevMember_label_en-US" xlink:label="lab_mo_ABInBevMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AB InBev [Member]</link:label>
    <link:label id="lab_mo_ABInBevMember_documentation_en-US" xlink:label="lab_mo_ABInBevMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AB InBev [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember" xlink:href="mo-20210930.xsd#mo_ABInBevMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ABInBevMember" xlink:to="lab_mo_ABInBevMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember_758bbeb6-afab-4399-a7ed-836d43d7dedb_terseLabel_en-US" xlink:label="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ETS Smoking and Health Case, Flight Attendants [Member]</link:label>
    <link:label id="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember_label_en-US" xlink:label="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ETS Smoking and Health Case, Flight Attendants [Member]</link:label>
    <link:label id="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember_documentation_en-US" xlink:label="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ETS Smoking and Health Case, Flight Attendants [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ETSSmokingandHealthCaseFlightAttendantsMember" xlink:href="mo-20210930.xsd#mo_ETSSmokingandHealthCaseFlightAttendantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ETSSmokingandHealthCaseFlightAttendantsMember" xlink:to="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_091af8ea-52cd-484d-bbb9-fab68bca2059_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net of accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_e3a6f25d-7af9-44fa-b906-da34963232cc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_ca251265-d8d6-48d4-a8a9-40a1e81d3575_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_bb6069c2-11e4-4231-b96d-7bb4ba9b4e23_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_a5b92f6e-aa5f-40b4-a0a1-29e3553b4aa1_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_TobaccoandHealthJudgmentMember_95cb1d1b-bdbe-40dc-baf7-edfccec0072a_terseLabel_en-US" xlink:label="lab_mo_TobaccoandHealthJudgmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health Judgment [Member]</link:label>
    <link:label id="lab_mo_TobaccoandHealthJudgmentMember_label_en-US" xlink:label="lab_mo_TobaccoandHealthJudgmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health Judgment [Member]</link:label>
    <link:label id="lab_mo_TobaccoandHealthJudgmentMember_documentation_en-US" xlink:label="lab_mo_TobaccoandHealthJudgmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health Judgment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthJudgmentMember" xlink:href="mo-20210930.xsd#mo_TobaccoandHealthJudgmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_TobaccoandHealthJudgmentMember" xlink:to="lab_mo_TobaccoandHealthJudgmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_c505e8ac-2dfd-43a5-8f9f-9352f8de98dd_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2bedc6b8-b925-449e-9b1f-d7536447cd82_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_24487a13-8930-4e72-bb20-eb92855fff0a_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Volatility [Member]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_e4c2e8ad-d729-4588-a7c0-be7b48807b30_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_315f0f49-e6a1-4d2c-b8d1-980a7c035f82_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityContractMember_2d47a983-0d40-43ed-a95c-492bbd474d44_terseLabel_en-US" xlink:label="lab_us-gaap_EquityContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract [Member]</link:label>
    <link:label id="lab_us-gaap_EquityContractMember_label_en-US" xlink:label="lab_us-gaap_EquityContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityContractMember" xlink:to="lab_us-gaap_EquityContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_9d697cae-d40c-443f-8c46-87d0f8080124_terseLabel_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-off of amortized debt discounts and issuance costs, debt extinguishment</link:label>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of Deferred Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LitigationEscrowDeposit_7a80c411-2286-4a2e-be00-aeb3aa7c2f25_terseLabel_en-US" xlink:label="lab_mo_LitigationEscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security posted for appeal of judgments</link:label>
    <link:label id="lab_mo_LitigationEscrowDeposit_label_en-US" xlink:label="lab_mo_LitigationEscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Escrow Deposit</link:label>
    <link:label id="lab_mo_LitigationEscrowDeposit_documentation_en-US" xlink:label="lab_mo_LitigationEscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Escrow Deposit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationEscrowDeposit" xlink:href="mo-20210930.xsd#mo_LitigationEscrowDeposit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LitigationEscrowDeposit" xlink:to="lab_mo_LitigationEscrowDeposit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_58391b58-86ab-445a-bbb2-a7ce3c389743_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net earnings (losses) to operating cash flows:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_23669e09-a1ed-47a5-8be8-df751f972f02_verboseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension [Member]</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_407f4593-ed9a-4549-9898-94c3e3e21eaf_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension [Member]</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_48f1cd3a-3037-411d-bfcc-f14449aca413_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_00ae3abc-662c-4b96-ade5-60fbb6f4e8a3_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension provisions and postretirement, net</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_942c12fd-29ef-4972-b765-b50d4262d1f6_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, upward price adjustment, cumulative amount</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_6ff303eb-90ff-4ae8-b54b-72e7f66a3452_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_7917b108-acf0-4414-8cb7-8154438c5a9d_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_7dc97cfc-8af8-4f51-a791-9f9ca79fe502_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit Plans [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfExpenseAxis_72a22de4-2c9f-4c2e-97ed-ec16f3a2de7c_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfExpenseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Expense [Axis]</link:label>
    <link:label id="lab_us-gaap_NatureOfExpenseAxis_label_en-US" xlink:label="lab_us-gaap_NatureOfExpenseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Expense [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfExpenseAxis" xlink:to="lab_us-gaap_NatureOfExpenseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_WV_c152ff89-69e8-4a01-82c9-89620d0677a2_terseLabel_en-US" xlink:label="lab_stpr_WV" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">West Virginia [Member]</link:label>
    <link:label id="lab_stpr_WV_label_en-US" xlink:label="lab_stpr_WV" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WEST VIRGINIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WV" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_WV"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_WV" xlink:to="lab_stpr_WV" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDDenominatedNotes3800PercentDue2024Member_b161c31e-839a-4e0b-b3eb-4863c0d094d4_terseLabel_en-US" xlink:label="lab_mo_USDDenominatedNotes3800PercentDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.800%, Notes Due 2024 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotes3800PercentDue2024Member_label_en-US" xlink:label="lab_mo_USDDenominatedNotes3800PercentDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes, 3.800 Percent, Due 2024 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotes3800PercentDue2024Member_documentation_en-US" xlink:label="lab_mo_USDDenominatedNotes3800PercentDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes, 3.800 Percent, Due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes3800PercentDue2024Member" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotes3800PercentDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDDenominatedNotes3800PercentDue2024Member" xlink:to="lab_mo_USDDenominatedNotes3800PercentDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_3910a70a-96c5-4e8b-ae4b-05aabda02254_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax provision (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_SteMichelleTransactionMember_917b4a7f-102b-4d00-8669-8e6f762813a1_terseLabel_en-US" xlink:label="lab_mo_SteMichelleTransactionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ste. Michelle Transaction [Member]</link:label>
    <link:label id="lab_mo_SteMichelleTransactionMember_label_en-US" xlink:label="lab_mo_SteMichelleTransactionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ste. Michelle Transaction [Member]</link:label>
    <link:label id="lab_mo_SteMichelleTransactionMember_documentation_en-US" xlink:label="lab_mo_SteMichelleTransactionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ste. Michelle Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SteMichelleTransactionMember" xlink:href="mo-20210930.xsd#mo_SteMichelleTransactionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_SteMichelleTransactionMember" xlink:to="lab_mo_SteMichelleTransactionMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>mo-20210930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:24c66990-7eda-4ddf-9c7a-8f1433627d2e,g:a0baef4b-24ba-4415-bfd0-6e9831a24e17-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.altria.com/role/CoverPage" xlink:type="simple" xlink:href="mo-20210930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_deefb2b1-1e66-4ca6-9099-1a68212e9bd8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_4fd7e37f-2ca5-4908-a4fc-b0dd5873560e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_deefb2b1-1e66-4ca6-9099-1a68212e9bd8" xlink:to="loc_dei_EntitiesTable_4fd7e37f-2ca5-4908-a4fc-b0dd5873560e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_9ac55477-eacc-4f08-8b2e-fbafe7147709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_4fd7e37f-2ca5-4908-a4fc-b0dd5873560e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_9ac55477-eacc-4f08-8b2e-fbafe7147709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9944ce23-d0c8-43a9-a39d-24e040aeeaac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9ac55477-eacc-4f08-8b2e-fbafe7147709" xlink:to="loc_us-gaap_ClassOfStockDomain_9944ce23-d0c8-43a9-a39d-24e040aeeaac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock0.3313ParValueMember_a296706e-7129-4d4c-9683-6c2cac996ee0" xlink:href="mo-20210930.xsd#mo_CommonStock0.3313ParValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9944ce23-d0c8-43a9-a39d-24e040aeeaac" xlink:to="loc_mo_CommonStock0.3313ParValueMember_a296706e-7129-4d4c-9683-6c2cac996ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock1.000NotesDue2023Member_51236545-3cdb-4ad0-a5d5-b46ad2471523" xlink:href="mo-20210930.xsd#mo_CommonStock1.000NotesDue2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9944ce23-d0c8-43a9-a39d-24e040aeeaac" xlink:to="loc_mo_CommonStock1.000NotesDue2023Member_51236545-3cdb-4ad0-a5d5-b46ad2471523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock1.700NotesDue2025Member_d214c695-75f3-4d5b-b34d-a21bc51054a7" xlink:href="mo-20210930.xsd#mo_CommonStock1.700NotesDue2025Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9944ce23-d0c8-43a9-a39d-24e040aeeaac" xlink:to="loc_mo_CommonStock1.700NotesDue2025Member_d214c695-75f3-4d5b-b34d-a21bc51054a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock2.200NotesDue2027Member_f45cf0f9-92c9-4ed2-a5f5-43ca26c1c56a" xlink:href="mo-20210930.xsd#mo_CommonStock2.200NotesDue2027Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9944ce23-d0c8-43a9-a39d-24e040aeeaac" xlink:to="loc_mo_CommonStock2.200NotesDue2027Member_f45cf0f9-92c9-4ed2-a5f5-43ca26c1c56a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock3.125NotesDue2031Member_8940cec7-53e2-42ef-897d-dc96e9ac1e68" xlink:href="mo-20210930.xsd#mo_CommonStock3.125NotesDue2031Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9944ce23-d0c8-43a9-a39d-24e040aeeaac" xlink:to="loc_mo_CommonStock3.125NotesDue2031Member_8940cec7-53e2-42ef-897d-dc96e9ac1e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_4fd7e37f-2ca5-4908-a4fc-b0dd5873560e" xlink:to="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_329f7129-1c86-45cf-a7c5-bcdc10e50685" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_DocumentType_329f7129-1c86-45cf-a7c5-bcdc10e50685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_1b5a2c85-ff8b-4741-bae5-65b35df020df" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_DocumentQuarterlyReport_1b5a2c85-ff8b-4741-bae5-65b35df020df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_05a56d7c-f1d0-49d3-9a80-b72ac09ab6b2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_DocumentPeriodEndDate_05a56d7c-f1d0-49d3-9a80-b72ac09ab6b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_a9efb436-647c-4788-9bcc-7b57e16cc01a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_DocumentTransitionReport_a9efb436-647c-4788-9bcc-7b57e16cc01a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_38a825b1-9d10-4495-9797-0c40d48b5028" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityFileNumber_38a825b1-9d10-4495-9797-0c40d48b5028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_d9317cbb-5922-48d9-bf99-59813c16275b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityRegistrantName_d9317cbb-5922-48d9-bf99-59813c16275b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_22fe9762-c736-4645-bbd0-63b86b133297" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_22fe9762-c736-4645-bbd0-63b86b133297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_9796d6ed-8a68-4cc8-841c-823c99e24cac" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityTaxIdentificationNumber_9796d6ed-8a68-4cc8-841c-823c99e24cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_c1753fe8-b9a9-401b-a6e6-926c2093c65a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityAddressAddressLine1_c1753fe8-b9a9-401b-a6e6-926c2093c65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_6086fc12-5415-45b1-9d99-e679f1d824b0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityAddressCityOrTown_6086fc12-5415-45b1-9d99-e679f1d824b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_0f942521-2034-4398-b259-cd7a9d32b5fa" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityAddressStateOrProvince_0f942521-2034-4398-b259-cd7a9d32b5fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c41ac495-3264-4b26-b93b-afadde11a1a9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityAddressPostalZipCode_c41ac495-3264-4b26-b93b-afadde11a1a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_d77710e4-c7d7-4a6d-958c-6603c1b289a2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_CityAreaCode_d77710e4-c7d7-4a6d-958c-6603c1b289a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_e764f40b-96d3-4d78-a3c1-26762b84777a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_LocalPhoneNumber_e764f40b-96d3-4d78-a3c1-26762b84777a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b1c1f43b-85bf-4132-845b-685bc2eb2e67" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_Security12bTitle_b1c1f43b-85bf-4132-845b-685bc2eb2e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_db95b271-88c9-4054-b189-60a37310ff95" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_TradingSymbol_db95b271-88c9-4054-b189-60a37310ff95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_12c39b78-122f-410e-9563-b2a410f90548" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_SecurityExchangeName_12c39b78-122f-410e-9563-b2a410f90548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_aeb65d7c-d839-43c4-abf3-f58f5366adb7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityCurrentReportingStatus_aeb65d7c-d839-43c4-abf3-f58f5366adb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_0adf6968-4e86-4ece-8d9d-17ba8ae8793b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityInteractiveDataCurrent_0adf6968-4e86-4ece-8d9d-17ba8ae8793b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_242542eb-bc4d-4578-85c0-1502c2dae31c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityFilerCategory_242542eb-bc4d-4578-85c0-1502c2dae31c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_2e50dfe1-f03a-4796-8d69-f132fc001acb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntitySmallBusiness_2e50dfe1-f03a-4796-8d69-f132fc001acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_9a8fbede-c7c6-4e21-b16f-369a918e7057" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityEmergingGrowthCompany_9a8fbede-c7c6-4e21-b16f-369a918e7057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_e9f0fd74-e091-4723-a0e1-66aa4ebfbc1d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityShellCompany_e9f0fd74-e091-4723-a0e1-66aa4ebfbc1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_15b265c3-d0b3-4696-b9e7-26bb8d7e9a35" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_15b265c3-d0b3-4696-b9e7-26bb8d7e9a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_53162efe-aa9f-4cf1-a2b0-e88f9d73303b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_AmendmentFlag_53162efe-aa9f-4cf1-a2b0-e88f9d73303b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_86390ed0-9a4e-4cf9-a909-5d809ac72e54" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_DocumentFiscalYearFocus_86390ed0-9a4e-4cf9-a909-5d809ac72e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_72f79eed-c88c-4b73-8139-b105ce2ac7fd" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_DocumentFiscalPeriodFocus_72f79eed-c88c-4b73-8139-b105ce2ac7fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_6699deb0-77ec-4ce4-ba87-6782150d02db" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_EntityCentralIndexKey_6699deb0-77ec-4ce4-ba87-6782150d02db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_95bb43c7-f4fb-44aa-abe4-5a367f79eb2e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_910f769e-613a-4876-b866-c8075e8e9b3c" xlink:to="loc_dei_CurrentFiscalYearEndDate_95bb43c7-f4fb-44aa-abe4-5a367f79eb2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="mo-20210930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_9cde7b6a-5d98-41c2-9e43-d2dc3f64dc1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_45a85872-2c10-41de-a6a3-8b2c823843b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9cde7b6a-5d98-41c2-9e43-d2dc3f64dc1b" xlink:to="loc_us-gaap_AssetsAbstract_45a85872-2c10-41de-a6a3-8b2c823843b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_af990e3b-1361-4299-96f0-58e69da871f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_45a85872-2c10-41de-a6a3-8b2c823843b0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_af990e3b-1361-4299-96f0-58e69da871f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_53810956-bfbe-4808-aedc-a03c30562afc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_45a85872-2c10-41de-a6a3-8b2c823843b0" xlink:to="loc_us-gaap_ReceivablesNetCurrent_53810956-bfbe-4808-aedc-a03c30562afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_afe8f71b-28cf-4273-a2f1-1353616871db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_45a85872-2c10-41de-a6a3-8b2c823843b0" xlink:to="loc_us-gaap_InventoryNetAbstract_afe8f71b-28cf-4273-a2f1-1353616871db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InventoryRawMaterialsPlantMaterialNetofReserves_1cd39948-429e-4b69-86de-22e9a1a1ae17" xlink:href="mo-20210930.xsd#mo_InventoryRawMaterialsPlantMaterialNetofReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_afe8f71b-28cf-4273-a2f1-1353616871db" xlink:to="loc_mo_InventoryRawMaterialsPlantMaterialNetofReserves_1cd39948-429e-4b69-86de-22e9a1a1ae17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherInventoryRawMaterialsNetofReserves_bae4835a-bd99-4950-9d44-5a90455078b8" xlink:href="mo-20210930.xsd#mo_OtherInventoryRawMaterialsNetofReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_afe8f71b-28cf-4273-a2f1-1353616871db" xlink:to="loc_mo_OtherInventoryRawMaterialsNetofReserves_bae4835a-bd99-4950-9d44-5a90455078b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_52219c42-9dd4-41c2-ae99-b9e8247c6cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_afe8f71b-28cf-4273-a2f1-1353616871db" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_52219c42-9dd4-41c2-ae99-b9e8247c6cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_c756215c-da17-4727-b826-47eaddbc445c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_afe8f71b-28cf-4273-a2f1-1353616871db" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_c756215c-da17-4727-b826-47eaddbc445c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_99b2a385-45d1-4f07-95b9-48750870b966" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_afe8f71b-28cf-4273-a2f1-1353616871db" xlink:to="loc_us-gaap_InventoryNet_99b2a385-45d1-4f07-95b9-48750870b966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_38aad6e0-7da6-45d8-83e5-5b571eac94f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_45a85872-2c10-41de-a6a3-8b2c823843b0" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_38aad6e0-7da6-45d8-83e5-5b571eac94f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_c63bb8a3-7823-4510-b26e-d7e63b479393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_45a85872-2c10-41de-a6a3-8b2c823843b0" xlink:to="loc_us-gaap_OtherAssetsCurrent_c63bb8a3-7823-4510-b26e-d7e63b479393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1056fa4e-4cdf-4c99-ae3d-3cf349264bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_45a85872-2c10-41de-a6a3-8b2c823843b0" xlink:to="loc_us-gaap_AssetsCurrent_1056fa4e-4cdf-4c99-ae3d-3cf349264bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_f8bf95a0-7504-4d39-960d-337e38d5e9e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_45a85872-2c10-41de-a6a3-8b2c823843b0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_f8bf95a0-7504-4d39-960d-337e38d5e9e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e46e514f-fd13-41c4-a36b-0a6b3a554224" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_45a85872-2c10-41de-a6a3-8b2c823843b0" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e46e514f-fd13-41c4-a36b-0a6b3a554224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6a81b6d2-8dd8-43a6-a22d-03eb76dc3bee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_45a85872-2c10-41de-a6a3-8b2c823843b0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6a81b6d2-8dd8-43a6-a22d-03eb76dc3bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a4545b61-90a7-4356-bf42-0517f58bf74f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_45a85872-2c10-41de-a6a3-8b2c823843b0" xlink:to="loc_us-gaap_Goodwill_a4545b61-90a7-4356-bf42-0517f58bf74f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_05591394-9437-47dd-a016-1573339f4831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_45a85872-2c10-41de-a6a3-8b2c823843b0" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_05591394-9437-47dd-a016-1573339f4831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_23d6f1de-96dd-4f16-9cde-90da47c1c580" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_45a85872-2c10-41de-a6a3-8b2c823843b0" xlink:to="loc_us-gaap_Investments_23d6f1de-96dd-4f16-9cde-90da47c1c580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_3b1120d3-e668-4ca6-b9c0-95171656b0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_45a85872-2c10-41de-a6a3-8b2c823843b0" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_3b1120d3-e668-4ca6-b9c0-95171656b0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_089bc7ad-46d8-4a27-aeac-9ada51e94297" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_45a85872-2c10-41de-a6a3-8b2c823843b0" xlink:to="loc_us-gaap_Assets_089bc7ad-46d8-4a27-aeac-9ada51e94297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_d658df18-d9e2-418a-b19b-ce75f49e18b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9cde7b6a-5d98-41c2-9e43-d2dc3f64dc1b" xlink:to="loc_us-gaap_LiabilitiesAbstract_d658df18-d9e2-418a-b19b-ce75f49e18b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_5c1b95ba-2097-43bd-8701-29af39126780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_d658df18-d9e2-418a-b19b-ce75f49e18b2" xlink:to="loc_us-gaap_LongTermDebtCurrent_5c1b95ba-2097-43bd-8701-29af39126780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_90e9b467-bf2b-4244-8597-d9a972b9a66e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_d658df18-d9e2-418a-b19b-ce75f49e18b2" xlink:to="loc_us-gaap_AccountsPayableCurrent_90e9b467-bf2b-4244-8597-d9a972b9a66e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_cd936dd7-1e33-4227-bec9-049604bcd29a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_d658df18-d9e2-418a-b19b-ce75f49e18b2" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_cd936dd7-1e33-4227-bec9-049604bcd29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_c22811aa-ce34-493e-9961-eb90da6d4487" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_cd936dd7-1e33-4227-bec9-049604bcd29a" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_c22811aa-ce34-493e-9961-eb90da6d4487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccruedSettlementLiabilityCurrent_2e950d27-a496-4a39-8985-3dbca2eb4bf4" xlink:href="mo-20210930.xsd#mo_AccruedSettlementLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_cd936dd7-1e33-4227-bec9-049604bcd29a" xlink:to="loc_mo_AccruedSettlementLiabilityCurrent_2e950d27-a496-4a39-8985-3dbca2eb4bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_4814632f-a2ee-4768-9bd5-c3b962c4f82a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_cd936dd7-1e33-4227-bec9-049604bcd29a" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_4814632f-a2ee-4768-9bd5-c3b962c4f82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_15a06c72-105a-4dfd-9e8a-e449dd5684b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_d658df18-d9e2-418a-b19b-ce75f49e18b2" xlink:to="loc_us-gaap_DividendsPayableCurrent_15a06c72-105a-4dfd-9e8a-e449dd5684b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_6d23c79d-fc76-4eae-ac6a-6c3e1e7b7141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_d658df18-d9e2-418a-b19b-ce75f49e18b2" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_6d23c79d-fc76-4eae-ac6a-6c3e1e7b7141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5cca155b-f28f-440b-8031-e246758aa3e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_d658df18-d9e2-418a-b19b-ce75f49e18b2" xlink:to="loc_us-gaap_LiabilitiesCurrent_5cca155b-f28f-440b-8031-e246758aa3e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_5ba88a54-651c-45a7-ae43-fc89d3bef9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_d658df18-d9e2-418a-b19b-ce75f49e18b2" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_5ba88a54-651c-45a7-ae43-fc89d3bef9c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_57729180-8102-4bb5-a99a-60c2c8784f57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_d658df18-d9e2-418a-b19b-ce75f49e18b2" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_57729180-8102-4bb5-a99a-60c2c8784f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_dadb7c2c-f4ea-4e5d-9533-2f6812bceb06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_d658df18-d9e2-418a-b19b-ce75f49e18b2" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_dadb7c2c-f4ea-4e5d-9533-2f6812bceb06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_3125d4b8-f6e7-42ea-a1f3-aeb6c7b0bcda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_d658df18-d9e2-418a-b19b-ce75f49e18b2" xlink:to="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_3125d4b8-f6e7-42ea-a1f3-aeb6c7b0bcda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_800aaf32-9f5d-4333-a8e3-54feac30757e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_d658df18-d9e2-418a-b19b-ce75f49e18b2" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_800aaf32-9f5d-4333-a8e3-54feac30757e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4ddf1f0a-567b-4c61-b737-031e3c8c64f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_d658df18-d9e2-418a-b19b-ce75f49e18b2" xlink:to="loc_us-gaap_Liabilities_4ddf1f0a-567b-4c61-b737-031e3c8c64f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_124e6649-a9be-450c-8507-2e66e8598654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9cde7b6a-5d98-41c2-9e43-d2dc3f64dc1b" xlink:to="loc_us-gaap_CommitmentsAndContingencies_124e6649-a9be-450c-8507-2e66e8598654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_5a76b5b0-17be-4957-b785-36a3523f4691" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9cde7b6a-5d98-41c2-9e43-d2dc3f64dc1b" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_5a76b5b0-17be-4957-b785-36a3523f4691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_c34507b9-f489-448a-8a48-8c4b80f3e497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9cde7b6a-5d98-41c2-9e43-d2dc3f64dc1b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_c34507b9-f489-448a-8a48-8c4b80f3e497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_07df13f7-64ae-4cd3-97f8-59f24f617a55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_c34507b9-f489-448a-8a48-8c4b80f3e497" xlink:to="loc_us-gaap_CommonStockValue_07df13f7-64ae-4cd3-97f8-59f24f617a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_e57e441c-d2e0-4e90-93b8-489bc4172a08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_c34507b9-f489-448a-8a48-8c4b80f3e497" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_e57e441c-d2e0-4e90-93b8-489bc4172a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c26e0107-a521-4c09-9f9d-ac40ab957e68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_c34507b9-f489-448a-8a48-8c4b80f3e497" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c26e0107-a521-4c09-9f9d-ac40ab957e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_68ec4d10-fe3e-4289-b4f4-3c21e58e6969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_c34507b9-f489-448a-8a48-8c4b80f3e497" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_68ec4d10-fe3e-4289-b4f4-3c21e58e6969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_697f3570-33a7-402a-ab33-2b19a52c750d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_c34507b9-f489-448a-8a48-8c4b80f3e497" xlink:to="loc_us-gaap_TreasuryStockValue_697f3570-33a7-402a-ab33-2b19a52c750d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b2c1f893-c1be-4318-96cf-5e928dff4144" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_c34507b9-f489-448a-8a48-8c4b80f3e497" xlink:to="loc_us-gaap_StockholdersEquity_b2c1f893-c1be-4318-96cf-5e928dff4144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_df6f44d2-ae06-49c1-98fb-75acfd53a7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_c34507b9-f489-448a-8a48-8c4b80f3e497" xlink:to="loc_us-gaap_MinorityInterest_df6f44d2-ae06-49c1-98fb-75acfd53a7b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4a786584-33d2-4c4a-95c8-0beda02c4f14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_c34507b9-f489-448a-8a48-8c4b80f3e497" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4a786584-33d2-4c4a-95c8-0beda02c4f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e5f40673-8215-4a6c-beda-a940126399de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9cde7b6a-5d98-41c2-9e43-d2dc3f64dc1b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_e5f40673-8215-4a6c-beda-a940126399de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="mo-20210930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d62c237b-c595-462a-9d15-dd40d8d344f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d4236a36-6adb-4830-b40d-0169d176d252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d62c237b-c595-462a-9d15-dd40d8d344f0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d4236a36-6adb-4830-b40d-0169d176d252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_24678f3f-d003-4407-a937-3c32115e79dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d4236a36-6adb-4830-b40d-0169d176d252" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_24678f3f-d003-4407-a937-3c32115e79dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_120e5942-a2bf-4f35-aa71-bcb740ef41d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d4236a36-6adb-4830-b40d-0169d176d252" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_120e5942-a2bf-4f35-aa71-bcb740ef41d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_f8b054c0-09ee-494b-a857-24e768a9259a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d4236a36-6adb-4830-b40d-0169d176d252" xlink:to="loc_us-gaap_CommonStockSharesIssued_f8b054c0-09ee-494b-a857-24e768a9259a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_02295d52-17f1-41f8-b932-05c13b80f922" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d4236a36-6adb-4830-b40d-0169d176d252" xlink:to="loc_us-gaap_TreasuryStockCommonShares_02295d52-17f1-41f8-b932-05c13b80f922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses" xlink:type="simple" xlink:href="mo-20210930.xsd#CondensedConsolidatedStatementsofEarningsLosses"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_19f186f5-f821-4bd2-8875-0144affd662d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_df173cc7-9cd9-43ae-a4fc-ccebeb6c1e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_19f186f5-f821-4bd2-8875-0144affd662d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_df173cc7-9cd9-43ae-a4fc-ccebeb6c1e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_d1871962-d8b8-4a56-8730-ced0280d40a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_19f186f5-f821-4bd2-8875-0144affd662d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_d1871962-d8b8-4a56-8730-ced0280d40a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostOfOperatingRevenue_b17f020b-977a-4679-b435-dc980a9bf497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCostOfOperatingRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_19f186f5-f821-4bd2-8875-0144affd662d" xlink:to="loc_us-gaap_OtherCostOfOperatingRevenue_b17f020b-977a-4679-b435-dc980a9bf497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_1c1ba588-d07e-4af9-913d-0d23f7800830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_19f186f5-f821-4bd2-8875-0144affd662d" xlink:to="loc_us-gaap_GrossProfit_1c1ba588-d07e-4af9-913d-0d23f7800830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarketingAdministrationandResearchCosts_3328522c-e71a-4c6b-b2fa-be972e68e670" xlink:href="mo-20210930.xsd#mo_MarketingAdministrationandResearchCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_19f186f5-f821-4bd2-8875-0144affd662d" xlink:to="loc_mo_MarketingAdministrationandResearchCosts_3328522c-e71a-4c6b-b2fa-be972e68e670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_94d99215-6b3d-4f4f-9132-476523c9d84c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_19f186f5-f821-4bd2-8875-0144affd662d" xlink:to="loc_us-gaap_OperatingIncomeLoss_94d99215-6b3d-4f4f-9132-476523c9d84c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_f36d8af7-b332-4104-b128-479d2fa44fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_19f186f5-f821-4bd2-8875-0144affd662d" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_f36d8af7-b332-4104-b128-479d2fa44fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3c45d192-4de2-4064-8165-83842a8ad5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_19f186f5-f821-4bd2-8875-0144affd662d" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3c45d192-4de2-4064-8165-83842a8ad5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_86260a91-4afc-4597-ae7f-91a0aa5dbb55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_19f186f5-f821-4bd2-8875-0144affd662d" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_86260a91-4afc-4597-ae7f-91a0aa5dbb55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_1a69c3a4-b3a1-4ca0-a9a7-84f3ccefc1ea" xlink:href="mo-20210930.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_19f186f5-f821-4bd2-8875-0144affd662d" xlink:to="loc_mo_IncomeLossFromEquityInvestments_1a69c3a4-b3a1-4ca0-a9a7-84f3ccefc1ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_2081c481-9e57-443e-8808-f79bc3a462cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_19f186f5-f821-4bd2-8875-0144affd662d" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_2081c481-9e57-443e-8808-f79bc3a462cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_43513d39-788e-4391-ae66-f1600fc2e9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_19f186f5-f821-4bd2-8875-0144affd662d" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_43513d39-788e-4391-ae66-f1600fc2e9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_355b3567-6a77-44ff-b226-fe5750a5422c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_19f186f5-f821-4bd2-8875-0144affd662d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_355b3567-6a77-44ff-b226-fe5750a5422c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e2ec22a1-dbe7-4114-83e4-e4bb711d16ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_19f186f5-f821-4bd2-8875-0144affd662d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e2ec22a1-dbe7-4114-83e4-e4bb711d16ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_5bbfc8e4-bab9-4b19-825c-5f9eed2c8842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_19f186f5-f821-4bd2-8875-0144affd662d" xlink:to="loc_us-gaap_ProfitLoss_5bbfc8e4-bab9-4b19-825c-5f9eed2c8842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6839c250-91d5-440a-ac70-56aeca5fd1a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_19f186f5-f821-4bd2-8875-0144affd662d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6839c250-91d5-440a-ac70-56aeca5fd1a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ca78d587-971c-4bb6-90aa-158060961c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_19f186f5-f821-4bd2-8875-0144affd662d" xlink:to="loc_us-gaap_NetIncomeLoss_ca78d587-971c-4bb6-90aa-158060961c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c6f884b5-619a-4b08-bd14-18562d95cb10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_19f186f5-f821-4bd2-8875-0144affd662d" xlink:to="loc_us-gaap_EarningsPerShareAbstract_c6f884b5-619a-4b08-bd14-18562d95cb10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_e6edb7ea-fab7-46e4-bed5-67f2bc19b156" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c6f884b5-619a-4b08-bd14-18562d95cb10" xlink:to="loc_us-gaap_EarningsPerShareBasic_e6edb7ea-fab7-46e4-bed5-67f2bc19b156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_1184ea39-7b8d-4b49-8663-e51d6c81ee7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c6f884b5-619a-4b08-bd14-18562d95cb10" xlink:to="loc_us-gaap_EarningsPerShareDiluted_1184ea39-7b8d-4b49-8663-e51d6c81ee7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsLosses" xlink:type="simple" xlink:href="mo-20210930.xsd#CondensedConsolidatedStatementsofComprehensiveEarningsLosses"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsLosses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_23c6a7e0-f863-44d4-bff9-07022fa7f4db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ec5d47cd-20ee-46dc-8426-9bcbbc7176b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_23c6a7e0-f863-44d4-bff9-07022fa7f4db" xlink:to="loc_us-gaap_ProfitLoss_ec5d47cd-20ee-46dc-8426-9bcbbc7176b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_fb8f5e04-e36d-49e2-b4f1-49fd96384986" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_23c6a7e0-f863-44d4-bff9-07022fa7f4db" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_fb8f5e04-e36d-49e2-b4f1-49fd96384986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_48b63724-1968-434a-bb1c-f69e5c04b0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_fb8f5e04-e36d-49e2-b4f1-49fd96384986" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_48b63724-1968-434a-bb1c-f69e5c04b0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciEquityMethodInvestmentAfterTax_c5975a07-f06e-4685-8ad9-1164a60c4ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciEquityMethodInvestmentAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_fb8f5e04-e36d-49e2-b4f1-49fd96384986" xlink:to="loc_us-gaap_OciEquityMethodInvestmentAfterTax_c5975a07-f06e-4685-8ad9-1164a60c4ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_36ea1c7e-2cc3-497b-90d4-fdf7a89059cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_fb8f5e04-e36d-49e2-b4f1-49fd96384986" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_36ea1c7e-2cc3-497b-90d4-fdf7a89059cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e7f1fe98-a012-4826-bdd8-871c2ba64afc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_fb8f5e04-e36d-49e2-b4f1-49fd96384986" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e7f1fe98-a012-4826-bdd8-871c2ba64afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_bcb83ddb-3b83-4348-a31b-24c7392be2e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_23c6a7e0-f863-44d4-bff9-07022fa7f4db" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_bcb83ddb-3b83-4348-a31b-24c7392be2e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_9842fc73-f3d0-4851-b619-a328f74d99a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_23c6a7e0-f863-44d4-bff9-07022fa7f4db" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_9842fc73-f3d0-4851-b619-a328f74d99a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_3c086ac6-f192-4966-b0a9-757ec73d91f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_23c6a7e0-f863-44d4-bff9-07022fa7f4db" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_3c086ac6-f192-4966-b0a9-757ec73d91f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity" xlink:type="simple" xlink:href="mo-20210930.xsd#CondensedConsolidatedStatementsofStockholdersDeficitEquity"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_1e31de0c-5081-46d1-a81c-404742269ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ce180e61-84db-4c38-a6db-6426f648fbce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_1e31de0c-5081-46d1-a81c-404742269ad5" xlink:to="loc_us-gaap_StatementTable_ce180e61-84db-4c38-a6db-6426f648fbce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_627d7184-d9fc-49b5-a606-253b8f051ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ce180e61-84db-4c38-a6db-6426f648fbce" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_627d7184-d9fc-49b5-a606-253b8f051ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_917ba78b-78a9-4612-a62c-070278e399d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_627d7184-d9fc-49b5-a606-253b8f051ce8" xlink:to="loc_us-gaap_EquityComponentDomain_917ba78b-78a9-4612-a62c-070278e399d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b2758cae-24de-4b5f-b528-80d39486049d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_917ba78b-78a9-4612-a62c-070278e399d4" xlink:to="loc_us-gaap_CommonStockMember_b2758cae-24de-4b5f-b528-80d39486049d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_84550931-c878-4924-a181-648733f92476" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_917ba78b-78a9-4612-a62c-070278e399d4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_84550931-c878-4924-a181-648733f92476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_1f0b94b9-b081-4227-928e-404622a1a7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_917ba78b-78a9-4612-a62c-070278e399d4" xlink:to="loc_us-gaap_RetainedEarningsMember_1f0b94b9-b081-4227-928e-404622a1a7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d3dc5212-167c-4257-881f-2d070d36198d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_917ba78b-78a9-4612-a62c-070278e399d4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d3dc5212-167c-4257-881f-2d070d36198d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_0fb1e486-18b4-49c0-84f3-8a9ec1d56d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_917ba78b-78a9-4612-a62c-070278e399d4" xlink:to="loc_us-gaap_TreasuryStockMember_0fb1e486-18b4-49c0-84f3-8a9ec1d56d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_03c7b67f-d271-4949-8f2d-c5b3a9667ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_917ba78b-78a9-4612-a62c-070278e399d4" xlink:to="loc_us-gaap_NoncontrollingInterestMember_03c7b67f-d271-4949-8f2d-c5b3a9667ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f68a7e75-65b3-4d85-b22e-a97678ccee23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ce180e61-84db-4c38-a6db-6426f648fbce" xlink:to="loc_us-gaap_StatementLineItems_f68a7e75-65b3-4d85-b22e-a97678ccee23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_64146132-2af0-4a47-942f-0fa81eb29f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f68a7e75-65b3-4d85-b22e-a97678ccee23" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_64146132-2af0-4a47-942f-0fa81eb29f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9cfacc31-0c76-4602-952b-49a6571856f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_64146132-2af0-4a47-942f-0fa81eb29f7a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9cfacc31-0c76-4602-952b-49a6571856f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_22708bc5-f109-4609-84e7-2d67ad52c9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_64146132-2af0-4a47-942f-0fa81eb29f7a" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_22708bc5-f109-4609-84e7-2d67ad52c9b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d1fe4340-9a6e-42e5-81b0-c4192ae983b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_64146132-2af0-4a47-942f-0fa81eb29f7a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d1fe4340-9a6e-42e5-81b0-c4192ae983b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_f5fc20d5-403d-49ca-9b00-d024166833b1" xlink:href="mo-20210930.xsd#mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_64146132-2af0-4a47-942f-0fa81eb29f7a" xlink:to="loc_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_f5fc20d5-403d-49ca-9b00-d024166833b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_892cb0bf-af5e-4138-b93f-36526e820b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_64146132-2af0-4a47-942f-0fa81eb29f7a" xlink:to="loc_us-gaap_DividendsCommonStockCash_892cb0bf-af5e-4138-b93f-36526e820b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_39281094-acde-4ed1-9764-bf6471d940b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_64146132-2af0-4a47-942f-0fa81eb29f7a" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_39281094-acde-4ed1-9764-bf6471d940b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_d4095ad5-82cf-4da7-b603-132033cbce24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_64146132-2af0-4a47-942f-0fa81eb29f7a" xlink:to="loc_us-gaap_StockholdersEquityOther_d4095ad5-82cf-4da7-b603-132033cbce24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_98b6526e-77e1-4c48-8e6e-fd3c100b88fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_64146132-2af0-4a47-942f-0fa81eb29f7a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_98b6526e-77e1-4c48-8e6e-fd3c100b88fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquityParenthetical" xlink:type="simple" xlink:href="mo-20210930.xsd#CondensedConsolidatedStatementsofStockholdersDeficitEquityParenthetical"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_ab337b05-a539-4fd2-b83f-3ba39e8cb604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_cce35e9b-f078-4610-ac61-0c88e9dec842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_ab337b05-a539-4fd2-b83f-3ba39e8cb604" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_cce35e9b-f078-4610-ac61-0c88e9dec842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_f02837a0-ccb6-46ab-ad74-07c7059fe84b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_ab337b05-a539-4fd2-b83f-3ba39e8cb604" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_f02837a0-ccb6-46ab-ad74-07c7059fe84b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="mo-20210930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_121bc8bf-a229-44bd-b1e2-094bcc2c8983" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_576c86ab-1901-49be-980a-6ac099a8b16c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_121bc8bf-a229-44bd-b1e2-094bcc2c8983" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_576c86ab-1901-49be-980a-6ac099a8b16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_23158f30-3838-4dd2-8fc6-a82e493f7121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_576c86ab-1901-49be-980a-6ac099a8b16c" xlink:to="loc_us-gaap_ProfitLoss_23158f30-3838-4dd2-8fc6-a82e493f7121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43a7ebe2-f17a-449c-8453-7b45b0a978eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_576c86ab-1901-49be-980a-6ac099a8b16c" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43a7ebe2-f17a-449c-8453-7b45b0a978eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_540158b1-427c-47dd-b48b-b5e5a5437c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43a7ebe2-f17a-449c-8453-7b45b0a978eb" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_540158b1-427c-47dd-b48b-b5e5a5437c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ff4881e3-8e14-40c3-8a38-5ae76e7b3102" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43a7ebe2-f17a-449c-8453-7b45b0a978eb" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ff4881e3-8e14-40c3-8a38-5ae76e7b3102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_788ac035-57f9-479b-80ea-4708d9f6da16" xlink:href="mo-20210930.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43a7ebe2-f17a-449c-8453-7b45b0a978eb" xlink:to="loc_mo_IncomeLossFromEquityInvestments_788ac035-57f9-479b-80ea-4708d9f6da16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_11231ed4-c1e0-4fc4-9a55-47cf655da385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43a7ebe2-f17a-449c-8453-7b45b0a978eb" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_11231ed4-c1e0-4fc4-9a55-47cf655da385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_255f4a50-a299-4d79-92d9-1964c3fb85e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43a7ebe2-f17a-449c-8453-7b45b0a978eb" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_255f4a50-a299-4d79-92d9-1964c3fb85e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_8cd9a245-e893-4d83-b299-dc96da26a3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43a7ebe2-f17a-449c-8453-7b45b0a978eb" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_8cd9a245-e893-4d83-b299-dc96da26a3d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f496548d-7fd6-4f33-83e8-791f56bc9966" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43a7ebe2-f17a-449c-8453-7b45b0a978eb" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f496548d-7fd6-4f33-83e8-791f56bc9966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a09b8526-87ac-4235-a834-12555079022c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43a7ebe2-f17a-449c-8453-7b45b0a978eb" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a09b8526-87ac-4235-a834-12555079022c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_99a424a2-790f-448f-849b-572f67dd683e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a09b8526-87ac-4235-a834-12555079022c" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_99a424a2-790f-448f-849b-572f67dd683e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_f342e17c-8f2f-40c9-ad52-c92fe1078e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a09b8526-87ac-4235-a834-12555079022c" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_f342e17c-8f2f-40c9-ad52-c92fe1078e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_6f9c4ce5-8ae7-4756-89cd-cbeba228e514" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a09b8526-87ac-4235-a834-12555079022c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_6f9c4ce5-8ae7-4756-89cd-cbeba228e514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_cfe502c7-69ff-4d2e-a090-07f74e11da8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a09b8526-87ac-4235-a834-12555079022c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_cfe502c7-69ff-4d2e-a090-07f74e11da8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_f6c201bd-4190-414d-b3d3-ccf921455db0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a09b8526-87ac-4235-a834-12555079022c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_f6c201bd-4190-414d-b3d3-ccf921455db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncreaseDecreaseInSettlementPayable_8aac4616-8203-4654-905b-1c0bc79df306" xlink:href="mo-20210930.xsd#mo_IncreaseDecreaseInSettlementPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a09b8526-87ac-4235-a834-12555079022c" xlink:to="loc_mo_IncreaseDecreaseInSettlementPayable_8aac4616-8203-4654-905b-1c0bc79df306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitContributions_cc41485c-28ea-443f-8764-fefdedb67e21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitContributions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43a7ebe2-f17a-449c-8453-7b45b0a978eb" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitContributions_cc41485c-28ea-443f-8764-fefdedb67e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_7fb450cf-d317-4730-bf41-4bd9a3da7562" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43a7ebe2-f17a-449c-8453-7b45b0a978eb" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_7fb450cf-d317-4730-bf41-4bd9a3da7562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_35cba05b-58d5-424a-8688-788b7187535a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43a7ebe2-f17a-449c-8453-7b45b0a978eb" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_35cba05b-58d5-424a-8688-788b7187535a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ad8848fd-835f-4621-9544-59ae5ee7bc38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_576c86ab-1901-49be-980a-6ac099a8b16c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ad8848fd-835f-4621-9544-59ae5ee7bc38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5d69ff72-b16c-4a60-92ff-3db8904871f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_121bc8bf-a229-44bd-b1e2-094bcc2c8983" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5d69ff72-b16c-4a60-92ff-3db8904871f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_715cc637-6f2f-4ea0-8558-ac59b783e6df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5d69ff72-b16c-4a60-92ff-3db8904871f4" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_715cc637-6f2f-4ea0-8558-ac59b783e6df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1dcda4da-489d-4916-a736-803a0c76568e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5d69ff72-b16c-4a60-92ff-3db8904871f4" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1dcda4da-489d-4916-a736-803a0c76568e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28478469-12f8-433a-9666-36ee36ad0881" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5d69ff72-b16c-4a60-92ff-3db8904871f4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28478469-12f8-433a-9666-36ee36ad0881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_727286a8-3e15-4b49-acd6-a38d2e07a7fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_121bc8bf-a229-44bd-b1e2-094bcc2c8983" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_727286a8-3e15-4b49-acd6-a38d2e07a7fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_c6f82bb4-1fe6-493d-b07f-0d27f77db497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_727286a8-3e15-4b49-acd6-a38d2e07a7fe" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_c6f82bb4-1fe6-493d-b07f-0d27f77db497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_0ae2032d-9a54-4bf5-a06f-25b2d36334be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_727286a8-3e15-4b49-acd6-a38d2e07a7fe" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_0ae2032d-9a54-4bf5-a06f-25b2d36334be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_e540cdea-ea71-4fae-96e0-624f8264552a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_727286a8-3e15-4b49-acd6-a38d2e07a7fe" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_e540cdea-ea71-4fae-96e0-624f8264552a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_e9240885-7170-423d-97e7-87c87c9194cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_727286a8-3e15-4b49-acd6-a38d2e07a7fe" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_e9240885-7170-423d-97e7-87c87c9194cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ce384a94-e441-4f8e-b302-e03da0e7e42a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_727286a8-3e15-4b49-acd6-a38d2e07a7fe" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ce384a94-e441-4f8e-b302-e03da0e7e42a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_d52082aa-ab9b-4a0e-a657-11d30b3fd88b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_727286a8-3e15-4b49-acd6-a38d2e07a7fe" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_d52082aa-ab9b-4a0e-a657-11d30b3fd88b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_026ae972-077f-4a49-a612-a6aa0a09d003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_727286a8-3e15-4b49-acd6-a38d2e07a7fe" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_026ae972-077f-4a49-a612-a6aa0a09d003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_429ce067-3ef3-4ee7-842c-5a1642bef55a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_727286a8-3e15-4b49-acd6-a38d2e07a7fe" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_429ce067-3ef3-4ee7-842c-5a1642bef55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b62efb18-4eaa-430f-85b8-925674b00de1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_727286a8-3e15-4b49-acd6-a38d2e07a7fe" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b62efb18-4eaa-430f-85b8-925674b00de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_0bc17797-ae98-4ff4-833e-ad56a6d0f63d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_121bc8bf-a229-44bd-b1e2-094bcc2c8983" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_0bc17797-ae98-4ff4-833e-ad56a6d0f63d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e8a97126-2f6b-479d-b337-2bd3110e81bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_0bc17797-ae98-4ff4-833e-ad56a6d0f63d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e8a97126-2f6b-479d-b337-2bd3110e81bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_efec1db3-13c8-4426-b194-7e95658da9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_0bc17797-ae98-4ff4-833e-ad56a6d0f63d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_efec1db3-13c8-4426-b194-7e95658da9b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_054ec008-1066-4233-822d-e692ae37ead8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_0bc17797-ae98-4ff4-833e-ad56a6d0f63d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_054ec008-1066-4233-822d-e692ae37ead8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5a692564-0e17-4118-8949-418582666c73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_121bc8bf-a229-44bd-b1e2-094bcc2c8983" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5a692564-0e17-4118-8949-418582666c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_37c2f100-24a5-4ac7-b2d8-c39acdb9e04b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_121bc8bf-a229-44bd-b1e2-094bcc2c8983" xlink:to="loc_us-gaap_RestrictedCashCurrent_37c2f100-24a5-4ac7-b2d8-c39acdb9e04b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_a7d2e720-6ebf-4991-a53c-e7e9b01f81f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_121bc8bf-a229-44bd-b1e2-094bcc2c8983" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_a7d2e720-6ebf-4991-a53c-e7e9b01f81f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_b9353541-3682-4e04-bc52-484f2722a3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_121bc8bf-a229-44bd-b1e2-094bcc2c8983" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_b9353541-3682-4e04-bc52-484f2722a3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b575951f-0d6d-4612-bd00-aeb9cc3f8887" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_121bc8bf-a229-44bd-b1e2-094bcc2c8983" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b575951f-0d6d-4612-bd00-aeb9cc3f8887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentation" xlink:type="simple" xlink:href="mo-20210930.xsd#BackgroundandBasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8a5e5caa-0379-46b1-81c7-82283a64dde0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_66a4c9f9-59af-42b0-a1db-a85a637416ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8a5e5caa-0379-46b1-81c7-82283a64dde0" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_66a4c9f9-59af-42b0-a1db-a85a637416ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationPolicies" xlink:type="simple" xlink:href="mo-20210930.xsd#BackgroundandBasisofPresentationPolicies"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7ee50218-7024-4208-8cb0-56c57021ecc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_1e2f65b6-1215-47ad-b711-1062c0e732c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7ee50218-7024-4208-8cb0-56c57021ecc2" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_1e2f65b6-1215-47ad-b711-1062c0e732c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_49254db2-0e51-4354-9358-c32a1efc13ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7ee50218-7024-4208-8cb0-56c57021ecc2" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_49254db2-0e51-4354-9358-c32a1efc13ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3c14e076-c229-4425-aa06-d71d2599f216" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7ee50218-7024-4208-8cb0-56c57021ecc2" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3c14e076-c229-4425-aa06-d71d2599f216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CashDiscountsPolicyTextBlock_077e051e-f0a7-446c-aaba-fb6a57ff5859" xlink:href="mo-20210930.xsd#mo_CashDiscountsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7ee50218-7024-4208-8cb0-56c57021ecc2" xlink:to="loc_mo_CashDiscountsPolicyTextBlock_077e051e-f0a7-446c-aaba-fb6a57ff5859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_2e66b850-ac3b-4b90-a162-353054cff227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7ee50218-7024-4208-8cb0-56c57021ecc2" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_2e66b850-ac3b-4b90-a162-353054cff227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalCostsPolicy_09892bab-78e6-4ddf-8953-32804fecd939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EnvironmentalCostsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7ee50218-7024-4208-8cb0-56c57021ecc2" xlink:to="loc_us-gaap_EnvironmentalCostsPolicy_09892bab-78e6-4ddf-8953-32804fecd939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationTables" xlink:type="simple" xlink:href="mo-20210930.xsd#BackgroundandBasisofPresentationTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7400f008-a1f6-49a3-a58d-04f1a9fbecfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_89632004-32ed-48c3-81da-2799be40d707" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7400f008-a1f6-49a3-a58d-04f1a9fbecfb" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_89632004-32ed-48c3-81da-2799be40d707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#BackgroundandBasisofPresentationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a608f14b-6309-448f-ac69-aa4cb1baae85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_d6f159ec-6216-47b7-8a26-cfc65e00c3f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a608f14b-6309-448f-ac69-aa4cb1baae85" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_d6f159ec-6216-47b7-8a26-cfc65e00c3f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_220e78b1-2677-4502-8b7e-a9c29afef675" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_d6f159ec-6216-47b7-8a26-cfc65e00c3f0" xlink:to="loc_srt_OwnershipAxis_220e78b1-2677-4502-8b7e-a9c29afef675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_f527d43c-f6eb-4fa7-aeba-804253bdda3f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_220e78b1-2677-4502-8b7e-a9c29afef675" xlink:to="loc_srt_OwnershipDomain_f527d43c-f6eb-4fa7-aeba-804253bdda3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HelixInnovationsLLCMember_8af49b99-1f9a-4b6b-9042-9166258d9065" xlink:href="mo-20210930.xsd#mo_HelixInnovationsLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_f527d43c-f6eb-4fa7-aeba-804253bdda3f" xlink:to="loc_mo_HelixInnovationsLLCMember_8af49b99-1f9a-4b6b-9042-9166258d9065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_fb39038e-1d3d-4565-9c18-80e18d81537b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_d6f159ec-6216-47b7-8a26-cfc65e00c3f0" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_fb39038e-1d3d-4565-9c18-80e18d81537b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_5aaa2b2f-0a25-4ec0-ba79-05624a4fc8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_fb39038e-1d3d-4565-9c18-80e18d81537b" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_5aaa2b2f-0a25-4ec0-ba79-05624a4fc8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_July2019ShareRepurchaseProgramMember_4f560f62-a2f2-4702-b4a6-8f5328c8f9d0" xlink:href="mo-20210930.xsd#mo_July2019ShareRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_5aaa2b2f-0a25-4ec0-ba79-05624a4fc8e6" xlink:to="loc_mo_July2019ShareRepurchaseProgramMember_4f560f62-a2f2-4702-b4a6-8f5328c8f9d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_January2021ShareRepurchaseProgramMember_a00f9dd3-a32f-45d7-858e-98dc18ee9979" xlink:href="mo-20210930.xsd#mo_January2021ShareRepurchaseProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_5aaa2b2f-0a25-4ec0-ba79-05624a4fc8e6" xlink:to="loc_mo_January2021ShareRepurchaseProgramMember_a00f9dd3-a32f-45d7-858e-98dc18ee9979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_97cb1f9c-2730-42cc-ab89-6421eea474ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_d6f159ec-6216-47b7-8a26-cfc65e00c3f0" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_97cb1f9c-2730-42cc-ab89-6421eea474ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_cfb6e950-34a3-46bb-97c1-08cf6457428e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_97cb1f9c-2730-42cc-ab89-6421eea474ef" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_cfb6e950-34a3-46bb-97c1-08cf6457428e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d89da509-e86c-459f-b669-ca8d66107db5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_cfb6e950-34a3-46bb-97c1-08cf6457428e" xlink:to="loc_us-gaap_SubsequentEventMember_d89da509-e86c-459f-b669-ca8d66107db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_d6f159ec-6216-47b7-8a26-cfc65e00c3f0" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_4c5c7582-894a-4a1d-b61f-3a2377f4a65f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_4c5c7582-894a-4a1d-b61f-3a2377f4a65f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NoncontrollingInterestRemainingInterestPurchasedByParent_0b52f924-c974-4818-a1a8-19c9b4335d6d" xlink:href="mo-20210930.xsd#mo_NoncontrollingInterestRemainingInterestPurchasedByParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:to="loc_mo_NoncontrollingInterestRemainingInterestPurchasedByParent_0b52f924-c974-4818-a1a8-19c9b4335d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_f1e3f565-1618-4a21-a213-3a8fc906e52c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:to="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_f1e3f565-1618-4a21-a213-3a8fc906e52c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStockDividendIncreasePercentage_e463d01f-5e32-4e66-aaad-e63a9eddcdc5" xlink:href="mo-20210930.xsd#mo_CommonStockDividendIncreasePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:to="loc_mo_CommonStockDividendIncreasePercentage_e463d01f-5e32-4e66-aaad-e63a9eddcdc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_1ff344b5-8a09-404a-b7b6-a67024665a51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_1ff344b5-8a09-404a-b7b6-a67024665a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStockDividendRateAnnualPerShare_4c384652-581b-419c-b074-6ffec4c22067" xlink:href="mo-20210930.xsd#mo_CommonStockDividendRateAnnualPerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:to="loc_mo_CommonStockDividendRateAnnualPerShare_4c384652-581b-419c-b074-6ffec4c22067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_8d1fff13-0bfe-46a0-a35c-4aca7e39e16d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_8d1fff13-0bfe-46a0-a35c-4aca7e39e16d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount_0700b317-2b73-45f2-8f7d-5ead00b0b700" xlink:href="mo-20210930.xsd#mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:to="loc_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount_0700b317-2b73-45f2-8f7d-5ead00b0b700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_1bebefd1-3441-49aa-8f88-cd9f22b47050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_1bebefd1-3441-49aa-8f88-cd9f22b47050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_6034101d-700e-4be5-84e2-b61e1bc8612a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_6034101d-700e-4be5-84e2-b61e1bc8612a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_StockRepurchaseProgramIncreaseAuthorizedAmount_ece58050-b9a7-4f24-bf41-cabea0d9967d" xlink:href="mo-20210930.xsd#mo_StockRepurchaseProgramIncreaseAuthorizedAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9fac2f75-5b2c-4f99-9895-f7f790c0c08e" xlink:to="loc_mo_StockRepurchaseProgramIncreaseAuthorizedAmount_ece58050-b9a7-4f24-bf41-cabea0d9967d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#BackgroundandBasisofPresentationShareRepurchaseTableDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d089fcbe-2f08-4e16-9c82-b8b858db76a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_e5b50307-2a00-4b28-9af8-8e959d2bfd7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d089fcbe-2f08-4e16-9c82-b8b858db76a2" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_e5b50307-2a00-4b28-9af8-8e959d2bfd7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_f25a676f-a474-4191-b27a-7df9638fa6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_e5b50307-2a00-4b28-9af8-8e959d2bfd7f" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_f25a676f-a474-4191-b27a-7df9638fa6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_6577aa09-32b7-4d54-87b3-b4d3a1328b41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_f25a676f-a474-4191-b27a-7df9638fa6c9" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_6577aa09-32b7-4d54-87b3-b4d3a1328b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_January2021ShareRepurchaseProgramMember_09c610db-f08f-45ff-9300-3d959e12f379" xlink:href="mo-20210930.xsd#mo_January2021ShareRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_6577aa09-32b7-4d54-87b3-b4d3a1328b41" xlink:to="loc_mo_January2021ShareRepurchaseProgramMember_09c610db-f08f-45ff-9300-3d959e12f379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ee44fb1b-fb24-40b0-bed0-f8c93821f699" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_e5b50307-2a00-4b28-9af8-8e959d2bfd7f" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ee44fb1b-fb24-40b0-bed0-f8c93821f699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_dd8a683c-4c90-4560-a317-6cafe356ce39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ee44fb1b-fb24-40b0-bed0-f8c93821f699" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_dd8a683c-4c90-4560-a317-6cafe356ce39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_0a2eca23-745d-4cbc-9333-5c078ea0cd07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ee44fb1b-fb24-40b0-bed0-f8c93821f699" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_0a2eca23-745d-4cbc-9333-5c078ea0cd07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_f36d52a4-665c-4127-9934-f17332de2865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ee44fb1b-fb24-40b0-bed0-f8c93821f699" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_f36d52a4-665c-4127-9934-f17332de2865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/RevenuesfromContractswithCustomers" xlink:type="simple" xlink:href="mo-20210930.xsd#RevenuesfromContractswithCustomers"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/RevenuesfromContractswithCustomers" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_dd5510c8-6c14-4ba1-9b7b-a6e4355e7ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_5b86366a-9f27-42ee-a723-6287e751cd10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_dd5510c8-6c14-4ba1-9b7b-a6e4355e7ccf" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_5b86366a-9f27-42ee-a723-6287e751cd10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#RevenuesfromContractswithCustomersNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_66e5c764-2eb7-4fed-b682-dc34ef399bea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_4f7c937a-a43e-482f-9291-d235a412d4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_66e5c764-2eb7-4fed-b682-dc34ef399bea" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_4f7c937a-a43e-482f-9291-d235a412d4a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_ea58c2ed-1690-49af-b540-d6cc78539b05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_4f7c937a-a43e-482f-9291-d235a412d4a9" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_ea58c2ed-1690-49af-b540-d6cc78539b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_cc472085-beb9-487d-8ef6-eb273363c304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_ea58c2ed-1690-49af-b540-d6cc78539b05" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_cc472085-beb9-487d-8ef6-eb273363c304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_57c02cfb-bca8-4ce0-9216-9af66776b1c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_cc472085-beb9-487d-8ef6-eb273363c304" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_57c02cfb-bca8-4ce0-9216-9af66776b1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cf994d57-d51a-49c6-ba38-793bdbc9bce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_4f7c937a-a43e-482f-9291-d235a412d4a9" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cf994d57-d51a-49c6-ba38-793bdbc9bce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_165cce3e-8a43-4abd-8cba-632934242dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cf994d57-d51a-49c6-ba38-793bdbc9bce7" xlink:to="loc_us-gaap_ContractWithCustomerLiability_165cce3e-8a43-4abd-8cba-632934242dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_c618d85c-9f98-4fd5-a8a9-42aed672bbd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfTiming"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cf994d57-d51a-49c6-ba38-793bdbc9bce7" xlink:to="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_c618d85c-9f98-4fd5-a8a9-42aed672bbd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ReceivablesNetCurrentIncludingAssetsHeldForSale_4499c44d-9c49-4830-8672-769a4090c971" xlink:href="mo-20210930.xsd#mo_ReceivablesNetCurrentIncludingAssetsHeldForSale"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cf994d57-d51a-49c6-ba38-793bdbc9bce7" xlink:to="loc_mo_ReceivablesNetCurrentIncludingAssetsHeldForSale_4499c44d-9c49-4830-8672-769a4090c971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_736d020e-391c-4863-8d32-f6db7705e6a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cf994d57-d51a-49c6-ba38-793bdbc9bce7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_736d020e-391c-4863-8d32-f6db7705e6a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_9b8d7555-a8d3-4fc2-a36c-1c203d0865e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cf994d57-d51a-49c6-ba38-793bdbc9bce7" xlink:to="loc_us-gaap_ReceivablesNetCurrent_9b8d7555-a8d3-4fc2-a36c-1c203d0865e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_983eb87f-6be5-44e5-9cdc-7e8aa4ab6d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cf994d57-d51a-49c6-ba38-793bdbc9bce7" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_983eb87f-6be5-44e5-9cdc-7e8aa4ab6d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/RevenuefromContractwithCustomerPolicies" xlink:type="simple" xlink:href="mo-20210930.xsd#RevenuefromContractwithCustomerPolicies"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/RevenuefromContractwithCustomerPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_639829a7-f364-4d60-b9bf-beaea965fd4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_5a3a0741-3b18-45ee-8ae5-ad89204d035b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_639829a7-f364-4d60-b9bf-beaea965fd4a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_5a3a0741-3b18-45ee-8ae5-ad89204d035b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/AssetsHeldforSale" xlink:type="simple" xlink:href="mo-20210930.xsd#AssetsHeldforSale"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/AssetsHeldforSale" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_6c119ecc-7677-4a19-b5b9-7072519b4086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_c06c56aa-b1c1-4f6d-b602-001cbc2af709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_6c119ecc-7677-4a19-b5b9-7072519b4086" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_c06c56aa-b1c1-4f6d-b602-001cbc2af709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/AssetsHeldforSaleTables" xlink:type="simple" xlink:href="mo-20210930.xsd#AssetsHeldforSaleTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/AssetsHeldforSaleTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_6511c345-916c-4330-ab54-745e092678f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_ce952ec6-bcc1-4207-8fbf-b219186a28d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_6511c345-916c-4330-ab54-745e092678f2" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_ce952ec6-bcc1-4207-8fbf-b219186a28d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#AssetsHeldforSaleNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_013f1e1d-4b5c-4e43-8a9e-86723561ebee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_aed127bc-402e-4028-b684-5169d1049043" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_013f1e1d-4b5c-4e43-8a9e-86723561ebee" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_aed127bc-402e-4028-b684-5169d1049043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c97a7442-48ba-4fa2-b8bb-72f4c4415b69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_aed127bc-402e-4028-b684-5169d1049043" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c97a7442-48ba-4fa2-b8bb-72f4c4415b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d99d3968-b907-4474-9bc7-3ded533e2b43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c97a7442-48ba-4fa2-b8bb-72f4c4415b69" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d99d3968-b907-4474-9bc7-3ded533e2b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SteMichelleTransactionsMember_a711b2f2-1762-44e9-a3b0-f4cebd760dac" xlink:href="mo-20210930.xsd#mo_SteMichelleTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d99d3968-b907-4474-9bc7-3ded533e2b43" xlink:to="loc_mo_SteMichelleTransactionsMember_a711b2f2-1762-44e9-a3b0-f4cebd760dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SteMichelleTransactionMember_10d10528-92d5-4baa-ae50-48d6f08e203a" xlink:href="mo-20210930.xsd#mo_SteMichelleTransactionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d99d3968-b907-4474-9bc7-3ded533e2b43" xlink:to="loc_mo_SteMichelleTransactionMember_10d10528-92d5-4baa-ae50-48d6f08e203a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_f42a1433-5529-4ad8-a0ce-4c9f595924f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_aed127bc-402e-4028-b684-5169d1049043" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_f42a1433-5529-4ad8-a0ce-4c9f595924f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e2c839a5-75b7-454f-86b6-7e95d9ce6382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_f42a1433-5529-4ad8-a0ce-4c9f595924f6" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e2c839a5-75b7-454f-86b6-7e95d9ce6382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_78a269d8-1ebb-444a-8109-f3b2b89e8527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_e2c839a5-75b7-454f-86b6-7e95d9ce6382" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_78a269d8-1ebb-444a-8109-f3b2b89e8527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_db3d3f7a-3200-44f3-870c-ab1868241853" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_aed127bc-402e-4028-b684-5169d1049043" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_db3d3f7a-3200-44f3-870c-ab1868241853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_25b82337-442d-4508-bc82-8be962b268d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_db3d3f7a-3200-44f3-870c-ab1868241853" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_25b82337-442d-4508-bc82-8be962b268d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SteMichelleTransactionsMember_49b24401-91a6-467d-9c06-7459042321c2" xlink:href="mo-20210930.xsd#mo_SteMichelleTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_25b82337-442d-4508-bc82-8be962b268d5" xlink:to="loc_mo_SteMichelleTransactionsMember_49b24401-91a6-467d-9c06-7459042321c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SteMichelleTransactionMember_07d5c7b5-2068-4189-9e14-89c6bbed1457" xlink:href="mo-20210930.xsd#mo_SteMichelleTransactionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_25b82337-442d-4508-bc82-8be962b268d5" xlink:to="loc_mo_SteMichelleTransactionMember_07d5c7b5-2068-4189-9e14-89c6bbed1457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_8d89dbbc-da73-48bb-9611-707cc85d7a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_aed127bc-402e-4028-b684-5169d1049043" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_8d89dbbc-da73-48bb-9611-707cc85d7a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e52ebe95-4016-4679-91f4-f888bfd69b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8d89dbbc-da73-48bb-9611-707cc85d7a1e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e52ebe95-4016-4679-91f4-f888bfd69b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_55724be9-6967-47a0-9678-f3e8f0936cde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_e52ebe95-4016-4679-91f4-f888bfd69b5d" xlink:to="loc_us-gaap_SubsequentEventMember_55724be9-6967-47a0-9678-f3e8f0936cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ab23d828-6bb5-4d37-b73b-4fb4c36eb959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_aed127bc-402e-4028-b684-5169d1049043" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ab23d828-6bb5-4d37-b73b-4fb4c36eb959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9d8f66c5-6277-4a67-8c5e-89d64f665984" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ab23d828-6bb5-4d37-b73b-4fb4c36eb959" xlink:to="loc_us-gaap_SegmentDomain_9d8f66c5-6277-4a67-8c5e-89d64f665984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineSegmentMember_4658df3a-3a19-4854-b5f0-637922b757e5" xlink:href="mo-20210930.xsd#mo_WineSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9d8f66c5-6277-4a67-8c5e-89d64f665984" xlink:to="loc_mo_WineSegmentMember_4658df3a-3a19-4854-b5f0-637922b757e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_813e1059-3931-4bee-a849-80f053e3da94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_aed127bc-402e-4028-b684-5169d1049043" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_813e1059-3931-4bee-a849-80f053e3da94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_53c59d25-3f71-44a7-81e3-6eba51fcf6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_813e1059-3931-4bee-a849-80f053e3da94" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_53c59d25-3f71-44a7-81e3-6eba51fcf6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarketingAdministrationAndResearchCostsMember_95a73736-35e4-4a4c-b2f8-1e99868d097a" xlink:href="mo-20210930.xsd#mo_MarketingAdministrationAndResearchCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_53c59d25-3f71-44a7-81e3-6eba51fcf6d3" xlink:to="loc_mo_MarketingAdministrationAndResearchCostsMember_95a73736-35e4-4a4c-b2f8-1e99868d097a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a13ca168-430c-4d31-8b0c-13bafeb857c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_aed127bc-402e-4028-b684-5169d1049043" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a13ca168-430c-4d31-8b0c-13bafeb857c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_ea617b4c-7a2b-47c3-b696-ee8e4c311556" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a13ca168-430c-4d31-8b0c-13bafeb857c4" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_ea617b4c-7a2b-47c3-b696-ee8e4c311556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_1118f9fd-5781-418f-9ddc-0c841a3ee56b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a13ca168-430c-4d31-8b0c-13bafeb857c4" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_1118f9fd-5781-418f-9ddc-0c841a3ee56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts_6b8d48c7-4f3f-4439-b492-8a61b226d98d" xlink:href="mo-20210930.xsd#mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a13ca168-430c-4d31-8b0c-13bafeb857c4" xlink:to="loc_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts_6b8d48c7-4f3f-4439-b492-8a61b226d98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts_eef90762-2c67-4611-8224-5c670dadb5e1" xlink:href="mo-20210930.xsd#mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a13ca168-430c-4d31-8b0c-13bafeb857c4" xlink:to="loc_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts_eef90762-2c67-4611-8224-5c670dadb5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_4e9a77dc-433a-43d7-beab-5ad995df1e97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a13ca168-430c-4d31-8b0c-13bafeb857c4" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_4e9a77dc-433a-43d7-beab-5ad995df1e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_4cd18997-5e3d-4f7c-b876-eb47dd8a7e48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6ff82903-0042-4367-bd0c-3c0e8256a38a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_4cd18997-5e3d-4f7c-b876-eb47dd8a7e48" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6ff82903-0042-4367-bd0c-3c0e8256a38a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_35b474e3-0917-4696-9775-696e4c7d90a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6ff82903-0042-4367-bd0c-3c0e8256a38a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_35b474e3-0917-4696-9775-696e4c7d90a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c8620948-f52b-4181-9510-fcfd27905b25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_35b474e3-0917-4696-9775-696e4c7d90a4" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c8620948-f52b-4181-9510-fcfd27905b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SteMichelleTransactionsMember_bc483a45-6bac-41c7-8d47-864b44364d7d" xlink:href="mo-20210930.xsd#mo_SteMichelleTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c8620948-f52b-4181-9510-fcfd27905b25" xlink:to="loc_mo_SteMichelleTransactionsMember_bc483a45-6bac-41c7-8d47-864b44364d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_1f799b03-afaf-4779-9fc8-bb25c31ec21d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6ff82903-0042-4367-bd0c-3c0e8256a38a" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_1f799b03-afaf-4779-9fc8-bb25c31ec21d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_553b8385-9060-4a14-87b5-e840acb818ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1f799b03-afaf-4779-9fc8-bb25c31ec21d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_553b8385-9060-4a14-87b5-e840acb818ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_c0a7bb59-4304-4df3-a451-9d580948ae4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_553b8385-9060-4a14-87b5-e840acb818ad" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_c0a7bb59-4304-4df3-a451-9d580948ae4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_975bb01a-61b5-4456-984b-e15dad97cd88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6ff82903-0042-4367-bd0c-3c0e8256a38a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_975bb01a-61b5-4456-984b-e15dad97cd88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bae6a33d-71b5-45d5-b2a2-a58437597e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_975bb01a-61b5-4456-984b-e15dad97cd88" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bae6a33d-71b5-45d5-b2a2-a58437597e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_baafed3c-1b56-4c23-9262-06573c7b1ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bae6a33d-71b5-45d5-b2a2-a58437597e3d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_baafed3c-1b56-4c23-9262-06573c7b1ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_0a970775-379d-4df4-8ab3-0012e5113fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bae6a33d-71b5-45d5-b2a2-a58437597e3d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_0a970775-379d-4df4-8ab3-0012e5113fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_e7888b49-e53b-48ac-bf9b-0dbc5e0cd7ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bae6a33d-71b5-45d5-b2a2-a58437597e3d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_e7888b49-e53b-48ac-bf9b-0dbc5e0cd7ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_54d065a6-c2fa-4f01-a0a9-4f36b1249ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bae6a33d-71b5-45d5-b2a2-a58437597e3d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_54d065a6-c2fa-4f01-a0a9-4f36b1249ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_21918bab-ad7f-4f89-92cc-7eb5c4597557" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bae6a33d-71b5-45d5-b2a2-a58437597e3d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_21918bab-ad7f-4f89-92cc-7eb5c4597557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_55e400ce-8319-4c71-8268-c5f9273283cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bae6a33d-71b5-45d5-b2a2-a58437597e3d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_55e400ce-8319-4c71-8268-c5f9273283cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross_f8f771ea-9ec5-4e04-9d72-e6041ab46fae" xlink:href="mo-20210930.xsd#mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bae6a33d-71b5-45d5-b2a2-a58437597e3d" xlink:to="loc_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross_f8f771ea-9ec5-4e04-9d72-e6041ab46fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve_81d1775f-7355-43a7-8b88-1d66010e5b25" xlink:href="mo-20210930.xsd#mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bae6a33d-71b5-45d5-b2a2-a58437597e3d" xlink:to="loc_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve_81d1775f-7355-43a7-8b88-1d66010e5b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_89db3df4-6f53-4e26-a3b8-7d22938d318c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bae6a33d-71b5-45d5-b2a2-a58437597e3d" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_89db3df4-6f53-4e26-a3b8-7d22938d318c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_43a965ec-4559-4da0-9adc-0bbf6aa5225e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_975bb01a-61b5-4456-984b-e15dad97cd88" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_43a965ec-4559-4da0-9adc-0bbf6aa5225e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_4ecb1c14-0e07-49a8-87cb-c3ca0e1506e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_43a965ec-4559-4da0-9adc-0bbf6aa5225e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_4ecb1c14-0e07-49a8-87cb-c3ca0e1506e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_79ef9404-4ccb-4e69-9866-978aa6e66619" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_43a965ec-4559-4da0-9adc-0bbf6aa5225e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_79ef9404-4ccb-4e69-9866-978aa6e66619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationCurrent_0b619a0e-0e35-43c0-a571-a8406d5c7140" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_43a965ec-4559-4da0-9adc-0bbf6aa5225e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationCurrent_0b619a0e-0e35-43c0-a571-a8406d5c7140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_0ea78b15-88c7-4793-88db-060a46faa66a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_43a965ec-4559-4da0-9adc-0bbf6aa5225e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_0ea78b15-88c7-4793-88db-060a46faa66a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_44d46e0d-690b-439c-92b0-eeee6da21775" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_43a965ec-4559-4da0-9adc-0bbf6aa5225e" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_44d46e0d-690b-439c-92b0-eeee6da21775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_c2f2762a-7c88-424f-bc3a-93ef9fd94047" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_975bb01a-61b5-4456-984b-e15dad97cd88" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_c2f2762a-7c88-424f-bc3a-93ef9fd94047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecurities" xlink:type="simple" xlink:href="mo-20210930.xsd#InvestmentsinEquitySecurities"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_43e27bbf-8c9a-4eb2-bc7e-c0897a0ea185" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTextBlock_4ac7f57f-b2db-4afa-800f-29fca83d85e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_43e27bbf-8c9a-4eb2-bc7e-c0897a0ea185" xlink:to="loc_us-gaap_InvestmentTextBlock_4ac7f57f-b2db-4afa-800f-29fca83d85e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesTables" xlink:type="simple" xlink:href="mo-20210930.xsd#InvestmentsinEquitySecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_3e6eddb6-7788-4af0-b0d3-3c4b0fbfcc14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTableTextBlock_c9de8ff8-c232-4372-a1fe-1927a91540f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_3e6eddb6-7788-4af0-b0d3-3c4b0fbfcc14" xlink:to="loc_us-gaap_InvestmentTableTextBlock_c9de8ff8-c232-4372-a1fe-1927a91540f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_2bcd30f6-0553-4f59-9191-93f96d68d93f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_3e6eddb6-7788-4af0-b0d3-3c4b0fbfcc14" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_2bcd30f6-0553-4f59-9191-93f96d68d93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_0d66c420-32d9-4883-ac55-f90bb49e0525" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_3e6eddb6-7788-4af0-b0d3-3c4b0fbfcc14" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_0d66c420-32d9-4883-ac55-f90bb49e0525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_3f480c6c-fc1d-40da-9a84-d271e05a1cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_a5ec62f8-090c-41fb-90b1-0189bfa1fec4" xlink:href="mo-20210930.xsd#mo_InvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_3f480c6c-fc1d-40da-9a84-d271e05a1cf6" xlink:to="loc_mo_InvestmentsTable_a5ec62f8-090c-41fb-90b1-0189bfa1fec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_96997db7-5434-464b-969c-3861ee994535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_a5ec62f8-090c-41fb-90b1-0189bfa1fec4" xlink:to="loc_us-gaap_FinancialInstrumentAxis_96997db7-5434-464b-969c-3861ee994535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2b995ea6-2ddf-4d43-adc5-0d133b6e5e24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_96997db7-5434-464b-969c-3861ee994535" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2b995ea6-2ddf-4d43-adc5-0d133b6e5e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_28c68789-26bf-410d-8f31-efd8db905a30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2b995ea6-2ddf-4d43-adc5-0d133b6e5e24" xlink:to="loc_us-gaap_CommonStockMember_28c68789-26bf-410d-8f31-efd8db905a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_44ab6406-dcdf-4b6b-819c-ca8f217580be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_a5ec62f8-090c-41fb-90b1-0189bfa1fec4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_44ab6406-dcdf-4b6b-819c-ca8f217580be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3893af27-ed23-4665-801d-56d97a00fe86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_44ab6406-dcdf-4b6b-819c-ca8f217580be" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3893af27-ed23-4665-801d-56d97a00fe86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_68093dcd-ba5b-466b-934a-a47fa3b3fa1d" xlink:href="mo-20210930.xsd#mo_EquityContractWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3893af27-ed23-4665-801d-56d97a00fe86" xlink:to="loc_mo_EquityContractWarrantMember_68093dcd-ba5b-466b-934a-a47fa3b3fa1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_76e94f36-f8db-464e-ab81-45f812f16496" xlink:href="mo-20210930.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3893af27-ed23-4665-801d-56d97a00fe86" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_76e94f36-f8db-464e-ab81-45f812f16496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f5a134a5-0080-4516-b7c3-28885030a204" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_a5ec62f8-090c-41fb-90b1-0189bfa1fec4" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f5a134a5-0080-4516-b7c3-28885030a204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a2092297-da2e-42df-9104-654942e4aacb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f5a134a5-0080-4516-b7c3-28885030a204" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a2092297-da2e-42df-9104-654942e4aacb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_d93507d7-92f3-4c5e-87b4-b36b2cc8dbab" xlink:href="mo-20210930.xsd#mo_ABInBevMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a2092297-da2e-42df-9104-654942e4aacb" xlink:to="loc_mo_ABInBevMember_d93507d7-92f3-4c5e-87b4-b36b2cc8dbab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_403287f2-2720-43c6-b514-0e1bf11a9539" xlink:href="mo-20210930.xsd#mo_JUULMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a2092297-da2e-42df-9104-654942e4aacb" xlink:to="loc_mo_JUULMember_403287f2-2720-43c6-b514-0e1bf11a9539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_41e1b926-1bb6-485d-99ef-b1fb8bec3a59" xlink:href="mo-20210930.xsd#mo_CronosGroupInc.Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a2092297-da2e-42df-9104-654942e4aacb" xlink:to="loc_mo_CronosGroupInc.Member_41e1b926-1bb6-485d-99ef-b1fb8bec3a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_eb559e1c-ff3d-4cf8-9314-9ecfb1b34b52" xlink:href="mo-20210930.xsd#mo_InvestmentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_a5ec62f8-090c-41fb-90b1-0189bfa1fec4" xlink:to="loc_mo_InvestmentsLineItems_eb559e1c-ff3d-4cf8-9314-9ecfb1b34b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_ab22b25c-6230-46f2-922e-aaf1389fe9de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_eb559e1c-ff3d-4cf8-9314-9ecfb1b34b52" xlink:to="loc_us-gaap_EquityMethodInvestments_ab22b25c-6230-46f2-922e-aaf1389fe9de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityInvestmentFairValueOption_f69efb34-6474-4ca8-871a-20dcf9fc3f1f" xlink:href="mo-20210930.xsd#mo_EquityInvestmentFairValueOption"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_eb559e1c-ff3d-4cf8-9314-9ecfb1b34b52" xlink:to="loc_mo_EquityInvestmentFairValueOption_f69efb34-6474-4ca8-871a-20dcf9fc3f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_2beb2bea-2146-4bc6-84c6-c61a7fa9399b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_eb559e1c-ff3d-4cf8-9314-9ecfb1b34b52" xlink:to="loc_us-gaap_Investments_2beb2bea-2146-4bc6-84c6-c61a7fa9399b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_47229f50-337f-4f04-a05b-34f84973df7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_eb559e1c-ff3d-4cf8-9314-9ecfb1b34b52" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_47229f50-337f-4f04-a05b-34f84973df7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_aa52b4a0-2094-42d7-b49f-e96c72bf19fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_bd6aa09a-3889-45ae-a25d-942da1eb739a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_aa52b4a0-2094-42d7-b49f-e96c72bf19fd" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_bd6aa09a-3889-45ae-a25d-942da1eb739a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b80e33f1-9d50-41f5-a98e-89c85f33f7d1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_bd6aa09a-3889-45ae-a25d-942da1eb739a" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b80e33f1-9d50-41f5-a98e-89c85f33f7d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_c533190a-791b-4b86-9087-16053f024e99" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b80e33f1-9d50-41f5-a98e-89c85f33f7d1" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_c533190a-791b-4b86-9087-16053f024e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_ed596870-705a-4ad3-8a7c-1472846e97a9" xlink:href="mo-20210930.xsd#mo_ABInBevMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_c533190a-791b-4b86-9087-16053f024e99" xlink:to="loc_mo_ABInBevMember_ed596870-705a-4ad3-8a7c-1472846e97a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_b2c1116a-1767-44ac-8810-71f220af9ddb" xlink:href="mo-20210930.xsd#mo_CronosGroupInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_c533190a-791b-4b86-9087-16053f024e99" xlink:to="loc_mo_CronosGroupInc.Member_b2c1116a-1767-44ac-8810-71f220af9ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_3763673d-12c6-4e4c-9c53-b5f2ba198c73" xlink:href="mo-20210930.xsd#mo_JUULMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_c533190a-791b-4b86-9087-16053f024e99" xlink:to="loc_mo_JUULMember_3763673d-12c6-4e4c-9c53-b5f2ba198c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a30d86bb-d483-4693-80f6-90e14e391964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_bd6aa09a-3889-45ae-a25d-942da1eb739a" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a30d86bb-d483-4693-80f6-90e14e391964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_4bd952ce-8f3e-473d-9c1c-ad9bc681bb20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a30d86bb-d483-4693-80f6-90e14e391964" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_4bd952ce-8f3e-473d-9c1c-ad9bc681bb20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestmentsFairValueOption_7fc97eec-08bb-413c-8431-608e8786a18f" xlink:href="mo-20210930.xsd#mo_IncomeLossFromEquityInvestmentsFairValueOption"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a30d86bb-d483-4693-80f6-90e14e391964" xlink:to="loc_mo_IncomeLossFromEquityInvestmentsFairValueOption_7fc97eec-08bb-413c-8431-608e8786a18f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_8bbaa270-1ec3-4a4d-8475-cc999a2e077f" xlink:href="mo-20210930.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a30d86bb-d483-4693-80f6-90e14e391964" xlink:to="loc_mo_IncomeLossFromEquityInvestments_8bbaa270-1ec3-4a4d-8475-cc999a2e077f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentImpairment_5ec97257-ef7e-4646-b0ff-cd1aa42bbc43" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentImpairment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a30d86bb-d483-4693-80f6-90e14e391964" xlink:to="loc_mo_EquityMethodInvestmentImpairment_5ec97257-ef7e-4646-b0ff-cd1aa42bbc43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_742ac88c-66bd-4901-a00d-7ceacce4f9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1b021b59-66ae-4d82-a829-fcc1741b037e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_742ac88c-66bd-4901-a00d-7ceacce4f9b6" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1b021b59-66ae-4d82-a829-fcc1741b037e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fcd01b19-5e4b-4174-a563-ff0acca6e385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1b021b59-66ae-4d82-a829-fcc1741b037e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fcd01b19-5e4b-4174-a563-ff0acca6e385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f3b60c8-9974-46ed-939c-da108ade0668" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fcd01b19-5e4b-4174-a563-ff0acca6e385" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f3b60c8-9974-46ed-939c-da108ade0668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d8187a23-0052-42cd-b505-7cef27beb277" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f3b60c8-9974-46ed-939c-da108ade0668" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d8187a23-0052-42cd-b505-7cef27beb277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_88c20301-f575-433c-a77b-7ddb3506e5f6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1b021b59-66ae-4d82-a829-fcc1741b037e" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_88c20301-f575-433c-a77b-7ddb3506e5f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_7ce5c70d-5da0-4536-b4e4-0c68d19a9403" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_88c20301-f575-433c-a77b-7ddb3506e5f6" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_7ce5c70d-5da0-4536-b4e4-0c68d19a9403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_603a4b96-2b88-47cd-89ab-cb00b88664a3" xlink:href="mo-20210930.xsd#mo_ABInBevMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_7ce5c70d-5da0-4536-b4e4-0c68d19a9403" xlink:to="loc_mo_ABInBevMember_603a4b96-2b88-47cd-89ab-cb00b88664a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_894040ef-9e01-4e5f-bf09-5c78930ddcfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1b021b59-66ae-4d82-a829-fcc1741b037e" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_894040ef-9e01-4e5f-bf09-5c78930ddcfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_fddab318-282f-4781-918e-0a058f65ccf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_894040ef-9e01-4e5f-bf09-5c78930ddcfd" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_fddab318-282f-4781-918e-0a058f65ccf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_2449a74e-f4a4-452c-a7e8-5bf9e9f92d05" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedRestricted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_894040ef-9e01-4e5f-bf09-5c78930ddcfd" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_2449a74e-f4a4-452c-a7e8-5bf9e9f92d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_47b1ae2a-d02c-444a-bac9-de9a9b3756bf" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedCommon"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_894040ef-9e01-4e5f-bf09-5c78930ddcfd" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_47b1ae2a-d02c-444a-bac9-de9a9b3756bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RestrictedSharesLockupPeriod_b9bb6c81-4ee9-4769-92d0-9a657efe6655" xlink:href="mo-20210930.xsd#mo_RestrictedSharesLockupPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_894040ef-9e01-4e5f-bf09-5c78930ddcfd" xlink:to="loc_mo_RestrictedSharesLockupPeriod_b9bb6c81-4ee9-4769-92d0-9a657efe6655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_98643c03-a2d1-42d9-8b3f-1f97a9705bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_894040ef-9e01-4e5f-bf09-5c78930ddcfd" xlink:to="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_98643c03-a2d1-42d9-8b3f-1f97a9705bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_f53ffeb2-b18e-468d-a48b-d06e2a8456f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_894040ef-9e01-4e5f-bf09-5c78930ddcfd" xlink:to="loc_us-gaap_EquityMethodInvestments_f53ffeb2-b18e-468d-a48b-d06e2a8456f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_e5c9610d-05ee-4d5a-b75b-d57367ccedb3" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_894040ef-9e01-4e5f-bf09-5c78930ddcfd" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_e5c9610d-05ee-4d5a-b75b-d57367ccedb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentImpairment_bfdf3b75-bb92-4064-9d95-04f5c4a61114" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentImpairment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_894040ef-9e01-4e5f-bf09-5c78930ddcfd" xlink:to="loc_mo_EquityMethodInvestmentImpairment_bfdf3b75-bb92-4064-9d95-04f5c4a61114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentReductionInSharePricePercentage_e6f25a29-a9d1-4a3a-8380-7b6fa7e06978" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentReductionInSharePricePercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_894040ef-9e01-4e5f-bf09-5c78930ddcfd" xlink:to="loc_mo_EquityMethodInvestmentReductionInSharePricePercentage_e6f25a29-a9d1-4a3a-8380-7b6fa7e06978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_f636fce8-8d54-4f8f-9e55-f0da818ad9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_894040ef-9e01-4e5f-bf09-5c78930ddcfd" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_f636fce8-8d54-4f8f-9e55-f0da818ad9b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_96a606dc-a087-415d-b9b3-023883b4545d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_abfc9dea-a5b8-4482-9884-641a239af337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_96a606dc-a087-415d-b9b3-023883b4545d" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_abfc9dea-a5b8-4482-9884-641a239af337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c98c528c-a68f-4eb9-8fac-9062cad26897" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_abfc9dea-a5b8-4482-9884-641a239af337" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c98c528c-a68f-4eb9-8fac-9062cad26897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3b715ff5-fdc9-4df3-be53-849720b6e27b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c98c528c-a68f-4eb9-8fac-9062cad26897" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3b715ff5-fdc9-4df3-be53-849720b6e27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_a9756dde-655e-43ba-a829-1c5b138e1f38" xlink:href="mo-20210930.xsd#mo_JUULMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_3b715ff5-fdc9-4df3-be53-849720b6e27b" xlink:to="loc_mo_JUULMember_a9756dde-655e-43ba-a829-1c5b138e1f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_da3375e4-fd36-46a2-8fbf-7ba8c4e567b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_abfc9dea-a5b8-4482-9884-641a239af337" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_da3375e4-fd36-46a2-8fbf-7ba8c4e567b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_b70dea20-8832-4a56-a71b-a5fa644faa89" xlink:href="mo-20210930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_da3375e4-fd36-46a2-8fbf-7ba8c4e567b4" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_b70dea20-8832-4a56-a71b-a5fa644faa89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityInvestmentsFairValueOptionVotingShares_a5af2c37-974b-4bf9-a296-0415e420d515" xlink:href="mo-20210930.xsd#mo_EquityInvestmentsFairValueOptionVotingShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_da3375e4-fd36-46a2-8fbf-7ba8c4e567b4" xlink:to="loc_mo_EquityInvestmentsFairValueOptionVotingShares_a5af2c37-974b-4bf9-a296-0415e420d515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_b3ca2316-ae0a-49a5-93a4-c24803dbf4bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_da3375e4-fd36-46a2-8fbf-7ba8c4e567b4" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_b3ca2316-ae0a-49a5-93a4-c24803dbf4bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_e6e3ae66-eaae-4fe2-a2aa-c933693c1c29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_da3375e4-fd36-46a2-8fbf-7ba8c4e567b4" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_e6e3ae66-eaae-4fe2-a2aa-c933693c1c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_1f8267c1-828b-4603-ba8d-f240aeb04e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_da3375e4-fd36-46a2-8fbf-7ba8c4e567b4" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_1f8267c1-828b-4603-ba8d-f240aeb04e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestmentsFairValueOption_167c87f9-bf31-4183-b5f8-ffe70aaf8315" xlink:href="mo-20210930.xsd#mo_IncomeLossFromEquityInvestmentsFairValueOption"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_da3375e4-fd36-46a2-8fbf-7ba8c4e567b4" xlink:to="loc_mo_IncomeLossFromEquityInvestmentsFairValueOption_167c87f9-bf31-4183-b5f8-ffe70aaf8315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details" xlink:type="simple" xlink:href="mo-20210930.xsd#InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_9ac31c08-071e-48a8-8836-c6727bf0ddf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_aa4248c6-2a2f-4556-a8e7-4ff6afee8eec" xlink:href="mo-20210930.xsd#mo_InvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_9ac31c08-071e-48a8-8836-c6727bf0ddf4" xlink:to="loc_mo_InvestmentsTable_aa4248c6-2a2f-4556-a8e7-4ff6afee8eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_92c8eb3a-31c7-4025-ae4f-601abfe164f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_aa4248c6-2a2f-4556-a8e7-4ff6afee8eec" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_92c8eb3a-31c7-4025-ae4f-601abfe164f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_141227c1-fa39-45da-aa70-f09f2186e548" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_92c8eb3a-31c7-4025-ae4f-601abfe164f4" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_141227c1-fa39-45da-aa70-f09f2186e548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentsFairValueOptionMember_ae37fad3-526f-4078-871d-5902bb9d584c" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentsFairValueOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_141227c1-fa39-45da-aa70-f09f2186e548" xlink:to="loc_mo_EquityMethodInvestmentsFairValueOptionMember_ae37fad3-526f-4078-871d-5902bb9d584c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bfe092ae-95b9-4561-9d0a-2b197d2217eb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_aa4248c6-2a2f-4556-a8e7-4ff6afee8eec" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bfe092ae-95b9-4561-9d0a-2b197d2217eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_0e636f93-3b2c-4089-b1b1-da1a6fcf1efc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bfe092ae-95b9-4561-9d0a-2b197d2217eb" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_0e636f93-3b2c-4089-b1b1-da1a6fcf1efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_540a44bc-8124-478c-89b3-b2ceb0d6e6e1" xlink:href="mo-20210930.xsd#mo_JUULMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_0e636f93-3b2c-4089-b1b1-da1a6fcf1efc" xlink:to="loc_mo_JUULMember_540a44bc-8124-478c-89b3-b2ceb0d6e6e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_9a19a767-00e0-482d-a87d-ce2d442f076e" xlink:href="mo-20210930.xsd#mo_InvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_aa4248c6-2a2f-4556-a8e7-4ff6afee8eec" xlink:to="loc_mo_InvestmentsLineItems_9a19a767-00e0-482d-a87d-ce2d442f076e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4a0916c2-17ad-467d-9e8f-e57eb8a5322a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_9a19a767-00e0-482d-a87d-ce2d442f076e" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4a0916c2-17ad-467d-9e8f-e57eb8a5322a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_37375182-47ae-47e5-8251-f1eeff5792d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4a0916c2-17ad-467d-9e8f-e57eb8a5322a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_37375182-47ae-47e5-8251-f1eeff5792d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_483b3973-862f-4149-b8e0-7043b7544406" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4a0916c2-17ad-467d-9e8f-e57eb8a5322a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_483b3973-862f-4149-b8e0-7043b7544406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_15e47065-a170-4ec2-8e04-60b26c1986ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4a0916c2-17ad-467d-9e8f-e57eb8a5322a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_15e47065-a170-4ec2-8e04-60b26c1986ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_92cc2343-8ec3-4b29-8348-339cfd200703" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_0afa9f8a-6c5b-43cb-9ade-0779dde987c8" xlink:href="mo-20210930.xsd#mo_InvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_92cc2343-8ec3-4b29-8348-339cfd200703" xlink:to="loc_mo_InvestmentsTable_0afa9f8a-6c5b-43cb-9ade-0779dde987c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fe6f8865-537e-45e0-ac30-02c90a0c1ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_0afa9f8a-6c5b-43cb-9ade-0779dde987c8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fe6f8865-537e-45e0-ac30-02c90a0c1ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7bcb9621-a15a-45b8-ac8c-4c99321b4d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fe6f8865-537e-45e0-ac30-02c90a0c1ee6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7bcb9621-a15a-45b8-ac8c-4c99321b4d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1194c23e-808b-4278-881a-454949223603" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7bcb9621-a15a-45b8-ac8c-4c99321b4d5b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1194c23e-808b-4278-881a-454949223603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_7a806d44-79b3-4fec-8c42-1482ae3bee32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_0afa9f8a-6c5b-43cb-9ade-0779dde987c8" xlink:to="loc_us-gaap_FinancialInstrumentAxis_7a806d44-79b3-4fec-8c42-1482ae3bee32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8742cdfe-233a-4a34-aeee-d616183863ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7a806d44-79b3-4fec-8c42-1482ae3bee32" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8742cdfe-233a-4a34-aeee-d616183863ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_1ccead25-d9d6-4caf-9fc7-74dc7871e0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8742cdfe-233a-4a34-aeee-d616183863ea" xlink:to="loc_us-gaap_CommonStockMember_1ccead25-d9d6-4caf-9fc7-74dc7871e0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8b8a119e-de08-44b7-9651-482a44d8be8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_0afa9f8a-6c5b-43cb-9ade-0779dde987c8" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8b8a119e-de08-44b7-9651-482a44d8be8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_22054e86-a951-4e34-9229-0eabd185bdd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8b8a119e-de08-44b7-9651-482a44d8be8a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_22054e86-a951-4e34-9229-0eabd185bdd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_1283f1f5-2300-4909-9395-a33ec1950e38" xlink:href="mo-20210930.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_22054e86-a951-4e34-9229-0eabd185bdd7" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_1283f1f5-2300-4909-9395-a33ec1950e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_a0e057d8-572e-412b-987b-ae5d9b76520d" xlink:href="mo-20210930.xsd#mo_EquityContractWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_22054e86-a951-4e34-9229-0eabd185bdd7" xlink:to="loc_mo_EquityContractWarrantMember_a0e057d8-572e-412b-987b-ae5d9b76520d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember_b02772c3-6f75-4999-8bf8-1d8e63db9afd" xlink:href="mo-20210930.xsd#mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_22054e86-a951-4e34-9229-0eabd185bdd7" xlink:to="loc_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember_b02772c3-6f75-4999-8bf8-1d8e63db9afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_74f32a1c-bfdf-4cf0-949f-d3ab91f59ee0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_0afa9f8a-6c5b-43cb-9ade-0779dde987c8" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_74f32a1c-bfdf-4cf0-949f-d3ab91f59ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_bfbc15bc-93bf-4f6f-b4a6-dbef016fc831" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_74f32a1c-bfdf-4cf0-949f-d3ab91f59ee0" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_bfbc15bc-93bf-4f6f-b4a6-dbef016fc831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_043befd2-29df-424c-93d3-73f87937d23a" xlink:href="mo-20210930.xsd#mo_CronosGroupInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_bfbc15bc-93bf-4f6f-b4a6-dbef016fc831" xlink:to="loc_mo_CronosGroupInc.Member_043befd2-29df-424c-93d3-73f87937d23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_0ad973f2-3820-4107-a890-2a793e8d12bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_0afa9f8a-6c5b-43cb-9ade-0779dde987c8" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_0ad973f2-3820-4107-a890-2a793e8d12bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3d2efd2a-84a9-451c-a50e-e75f65aca29c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_0ad973f2-3820-4107-a890-2a793e8d12bd" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3d2efd2a-84a9-451c-a50e-e75f65aca29c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_3aeb7d9c-d3d9-42c6-a72f-45384e236b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3d2efd2a-84a9-451c-a50e-e75f65aca29c" xlink:to="loc_us-gaap_SubsequentEventMember_3aeb7d9c-d3d9-42c6-a72f-45384e236b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_07b80d9b-f618-4f9d-9fb4-dc92f77580d0" xlink:href="mo-20210930.xsd#mo_InvestmentsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_0afa9f8a-6c5b-43cb-9ade-0779dde987c8" xlink:to="loc_mo_InvestmentsLineItems_07b80d9b-f618-4f9d-9fb4-dc92f77580d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_09ae85a1-17ee-47a9-ba55-6c6c1ee0a04f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_07b80d9b-f618-4f9d-9fb4-dc92f77580d0" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_09ae85a1-17ee-47a9-ba55-6c6c1ee0a04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_6a415588-095b-4411-8d68-5069a31969b5" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedCommon"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_07b80d9b-f618-4f9d-9fb4-dc92f77580d0" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_6a415588-095b-4411-8d68-5069a31969b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentPricePerShareIfExercised_a8661c2b-49b2-48be-818b-53ab026d4b2f" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentPricePerShareIfExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_07b80d9b-f618-4f9d-9fb4-dc92f77580d0" xlink:to="loc_mo_EquityMethodInvestmentPricePerShareIfExercised_a8661c2b-49b2-48be-818b-53ab026d4b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_795fde3c-a0bb-4a34-824f-181e78e78cb3" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_07b80d9b-f618-4f9d-9fb4-dc92f77580d0" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_795fde3c-a0bb-4a34-824f-181e78e78cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_bccaf364-36a8-4868-8b75-6b2690649581" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_07b80d9b-f618-4f9d-9fb4-dc92f77580d0" xlink:to="loc_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_bccaf364-36a8-4868-8b75-6b2690649581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentAggregateExercisePrice_195c7fe8-425f-4e6c-a51a-810a21612382" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentAggregateExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_07b80d9b-f618-4f9d-9fb4-dc92f77580d0" xlink:to="loc_mo_EquityMethodInvestmentAggregateExercisePrice_195c7fe8-425f-4e6c-a51a-810a21612382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage_42e53e2a-7939-4496-9ef1-14cd8900f653" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_07b80d9b-f618-4f9d-9fb4-dc92f77580d0" xlink:to="loc_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage_42e53e2a-7939-4496-9ef1-14cd8900f653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_da7baf8a-aee2-4160-886e-d5fda77e347e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_07b80d9b-f618-4f9d-9fb4-dc92f77580d0" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_da7baf8a-aee2-4160-886e-d5fda77e347e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_59c24dd5-9985-4d41-829f-2bcb9223dc21" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_07b80d9b-f618-4f9d-9fb4-dc92f77580d0" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_59c24dd5-9985-4d41-829f-2bcb9223dc21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstruments" xlink:type="simple" xlink:href="mo-20210930.xsd#FinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e8148a64-4cd3-4444-b5dd-28f7a97b4c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_207acb09-e957-4b08-b6f6-d8e45712566e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e8148a64-4cd3-4444-b5dd-28f7a97b4c5e" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_207acb09-e957-4b08-b6f6-d8e45712566e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsTables" xlink:type="simple" xlink:href="mo-20210930.xsd#FinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d4446a7a-1d5b-4b79-995a-5ee296afbf39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_a13edf8b-9365-4578-add8-c3ba0dbb9b24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d4446a7a-1d5b-4b79-995a-5ee296afbf39" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_a13edf8b-9365-4578-add8-c3ba0dbb9b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_37018503-86d9-4d36-a9de-f9c532c55b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d4446a7a-1d5b-4b79-995a-5ee296afbf39" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_37018503-86d9-4d36-a9de-f9c532c55b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_c0d178a7-8898-45bf-8fbd-678e98df95cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d4446a7a-1d5b-4b79-995a-5ee296afbf39" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_c0d178a7-8898-45bf-8fbd-678e98df95cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_b2043a71-244e-4c4c-ae9f-05869dddb5f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d4446a7a-1d5b-4b79-995a-5ee296afbf39" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_b2043a71-244e-4c4c-ae9f-05869dddb5f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_4ddbd4d8-af97-44c2-ab23-070ab4794a25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d4446a7a-1d5b-4b79-995a-5ee296afbf39" xlink:to="loc_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_4ddbd4d8-af97-44c2-ab23-070ab4794a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsAggregateNotionalAmountsAggregateFairValuesandCarryingValuesDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#FinancialInstrumentsAggregateNotionalAmountsAggregateFairValuesandCarryingValuesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsAggregateNotionalAmountsAggregateFairValuesandCarryingValuesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_00e0e4bc-efbb-40f1-aacc-236100862876" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_3dc4abe4-a374-4e89-84e6-a4491c06a2b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_00e0e4bc-efbb-40f1-aacc-236100862876" xlink:to="loc_us-gaap_DerivativeTable_3dc4abe4-a374-4e89-84e6-a4491c06a2b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_30ae8e54-78ff-4806-8aee-22493490be2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3dc4abe4-a374-4e89-84e6-a4491c06a2b0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_30ae8e54-78ff-4806-8aee-22493490be2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_29eb1d03-fcf5-4e3b-8e28-85f60f2b9879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_30ae8e54-78ff-4806-8aee-22493490be2e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_29eb1d03-fcf5-4e3b-8e28-85f60f2b9879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_2a8d6981-6bd8-49ee-9582-f864ece97d18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_29eb1d03-fcf5-4e3b-8e28-85f60f2b9879" xlink:to="loc_us-gaap_ForeignExchangeContractMember_2a8d6981-6bd8-49ee-9582-f864ece97d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_56c4fb3b-98e0-4b49-9e39-093800384183" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3dc4abe4-a374-4e89-84e6-a4491c06a2b0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_56c4fb3b-98e0-4b49-9e39-093800384183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_73b2c5d2-c6ed-4d01-af58-b895d4fe7acf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_56c4fb3b-98e0-4b49-9e39-093800384183" xlink:to="loc_us-gaap_HedgingRelationshipDomain_73b2c5d2-c6ed-4d01-af58-b895d4fe7acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_ca21cf1c-aafe-4a5a-a4c3-a208e6706a25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_73b2c5d2-c6ed-4d01-af58-b895d4fe7acf" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_ca21cf1c-aafe-4a5a-a4c3-a208e6706a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b411ebe3-0832-4fd6-9fa6-24a862264a60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3dc4abe4-a374-4e89-84e6-a4491c06a2b0" xlink:to="loc_us-gaap_DebtInstrumentAxis_b411ebe3-0832-4fd6-9fa6-24a862264a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8f35c9f9-8b35-44f9-9548-f973617fa107" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b411ebe3-0832-4fd6-9fa6-24a862264a60" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8f35c9f9-8b35-44f9-9548-f973617fa107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtMember_9b1bb34e-ffe5-4b75-b9e0-b92472401f1c" xlink:href="mo-20210930.xsd#mo_ForeignCurrencyDenominatedDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f35c9f9-8b35-44f9-9548-f973617fa107" xlink:to="loc_mo_ForeignCurrencyDenominatedDebtMember_9b1bb34e-ffe5-4b75-b9e0-b92472401f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_378b813f-d698-454e-a7ba-9d5ccf19b65b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3dc4abe4-a374-4e89-84e6-a4491c06a2b0" xlink:to="loc_us-gaap_DerivativeLineItems_378b813f-d698-454e-a7ba-9d5ccf19b65b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_4d0d6124-ccf9-4c56-a07c-b472463867e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_378b813f-d698-454e-a7ba-9d5ccf19b65b" xlink:to="loc_us-gaap_DerivativeNotionalAmount_4d0d6124-ccf9-4c56-a07c-b472463867e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_8201de99-b986-4237-8e64-7ca0685e0c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_378b813f-d698-454e-a7ba-9d5ccf19b65b" xlink:to="loc_us-gaap_LongTermDebt_8201de99-b986-4237-8e64-7ca0685e0c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_cb26c3ca-f6ea-4f5b-b0d9-5961bbc5dac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_378b813f-d698-454e-a7ba-9d5ccf19b65b" xlink:to="loc_us-gaap_DebtInstrumentFairValue_cb26c3ca-f6ea-4f5b-b0d9-5961bbc5dac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#FinancialInstrumentsAggregateFairValueandCarryingValueDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cbfe6938-bd0a-482a-bfaf-5d99f3334a87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_0dad997b-c7e4-4131-b672-61ff68f99063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cbfe6938-bd0a-482a-bfaf-5d99f3334a87" xlink:to="loc_us-gaap_LongTermDebt_0dad997b-c7e4-4131-b672-61ff68f99063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_58855b0c-b9e8-498d-a126-20650b7a5b27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cbfe6938-bd0a-482a-bfaf-5d99f3334a87" xlink:to="loc_us-gaap_LongTermDebtFairValue_58855b0c-b9e8-498d-a126-20650b7a5b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6f5b2cdd-0c9b-44a0-a3ca-1a8e8aebd5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_0ffeca72-c83e-44b6-ab5c-51b5f977ff8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6f5b2cdd-0c9b-44a0-a3ca-1a8e8aebd5e1" xlink:to="loc_us-gaap_DerivativeTable_0ffeca72-c83e-44b6-ab5c-51b5f977ff8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_189825f7-8716-495b-aa51-871a4369f7fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0ffeca72-c83e-44b6-ab5c-51b5f977ff8b" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_189825f7-8716-495b-aa51-871a4369f7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_8d68b3d0-59bb-4079-8359-97d0d2856a55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_189825f7-8716-495b-aa51-871a4369f7fb" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_8d68b3d0-59bb-4079-8359-97d0d2856a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_44c49fae-6dc9-4f14-a683-c53373493b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_8d68b3d0-59bb-4079-8359-97d0d2856a55" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_44c49fae-6dc9-4f14-a683-c53373493b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_e8b7d4bb-f0d3-43d6-a14c-1d7521681241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_8d68b3d0-59bb-4079-8359-97d0d2856a55" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_e8b7d4bb-f0d3-43d6-a14c-1d7521681241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_265821ca-bccd-4a1b-ba48-01453f0f9122" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_8d68b3d0-59bb-4079-8359-97d0d2856a55" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_265821ca-bccd-4a1b-ba48-01453f0f9122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_ea74a8f1-33a0-4843-b70a-0934f26dc900" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_8d68b3d0-59bb-4079-8359-97d0d2856a55" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_ea74a8f1-33a0-4843-b70a-0934f26dc900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_9faf584d-e4f0-4087-a5fa-1ef256946597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_8d68b3d0-59bb-4079-8359-97d0d2856a55" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_9faf584d-e4f0-4087-a5fa-1ef256946597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MeasurementInputWeightedAverageExpectedTermMember_a57e89f2-ce04-4298-bf51-630746ba9ff8" xlink:href="mo-20210930.xsd#mo_MeasurementInputWeightedAverageExpectedTermMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_8d68b3d0-59bb-4079-8359-97d0d2856a55" xlink:to="loc_mo_MeasurementInputWeightedAverageExpectedTermMember_a57e89f2-ce04-4298-bf51-630746ba9ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ee9a5343-7c16-4f93-b1ed-39cff609a3d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0ffeca72-c83e-44b6-ab5c-51b5f977ff8b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ee9a5343-7c16-4f93-b1ed-39cff609a3d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3dbf07f6-5dad-4b88-839a-b270599349c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ee9a5343-7c16-4f93-b1ed-39cff609a3d7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3dbf07f6-5dad-4b88-839a-b270599349c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_91b53942-a2a2-40b7-9dd3-4c4fbdf7b08c" xlink:href="mo-20210930.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3dbf07f6-5dad-4b88-839a-b270599349c1" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_91b53942-a2a2-40b7-9dd3-4c4fbdf7b08c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_9f8b5386-06cb-4824-a1a4-121664be9fcc" xlink:href="mo-20210930.xsd#mo_EquityContractWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3dbf07f6-5dad-4b88-839a-b270599349c1" xlink:to="loc_mo_EquityContractWarrantMember_9f8b5386-06cb-4824-a1a4-121664be9fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_208d7dd2-cbbc-4210-a182-acb32cad8bed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0ffeca72-c83e-44b6-ab5c-51b5f977ff8b" xlink:to="loc_srt_RangeAxis_208d7dd2-cbbc-4210-a182-acb32cad8bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_99e6a053-571f-405c-9c67-0c935af05428" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_208d7dd2-cbbc-4210-a182-acb32cad8bed" xlink:to="loc_srt_RangeMember_99e6a053-571f-405c-9c67-0c935af05428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_fed4319f-cff2-4988-9336-f8be1cbde9a7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_99e6a053-571f-405c-9c67-0c935af05428" xlink:to="loc_srt_MinimumMember_fed4319f-cff2-4988-9336-f8be1cbde9a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bd0bf37a-6c10-4987-a070-050403decdf4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_99e6a053-571f-405c-9c67-0c935af05428" xlink:to="loc_srt_MaximumMember_bd0bf37a-6c10-4987-a070-050403decdf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_ba0506db-2d80-4c0f-93d4-c20667e7a0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0ffeca72-c83e-44b6-ab5c-51b5f977ff8b" xlink:to="loc_us-gaap_DerivativeLineItems_ba0506db-2d80-4c0f-93d4-c20667e7a0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetMeasurementInput_3810d7f2-1301-4c82-b32b-28701d20f0da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ba0506db-2d80-4c0f-93d4-c20667e7a0d5" xlink:to="loc_us-gaap_DerivativeAssetMeasurementInput_3810d7f2-1301-4c82-b32b-28701d20f0da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ef09b76c-539f-46c7-ac1a-2d4dc2220aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_445c8114-1f5c-40e8-a12e-ac66cb27168f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ef09b76c-539f-46c7-ac1a-2d4dc2220aa9" xlink:to="loc_us-gaap_DerivativeTable_445c8114-1f5c-40e8-a12e-ac66cb27168f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9ecc2314-5c99-4de4-a39a-fcd81291861e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_445c8114-1f5c-40e8-a12e-ac66cb27168f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9ecc2314-5c99-4de4-a39a-fcd81291861e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fc884e11-e617-4668-8174-edd16de102a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9ecc2314-5c99-4de4-a39a-fcd81291861e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fc884e11-e617-4668-8174-edd16de102a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_969c207d-30fb-4495-a2b7-b0c49d99189a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fc884e11-e617-4668-8174-edd16de102a9" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_969c207d-30fb-4495-a2b7-b0c49d99189a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_af47906a-2341-4c48-8984-e74e2686e2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_445c8114-1f5c-40e8-a12e-ac66cb27168f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_af47906a-2341-4c48-8984-e74e2686e2dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3dc7d1d1-7f78-4892-91e9-39b1cc2fab35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_af47906a-2341-4c48-8984-e74e2686e2dc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3dc7d1d1-7f78-4892-91e9-39b1cc2fab35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityContractMember_c0679410-5b83-4b5e-a88e-dce0d5e449ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3dc7d1d1-7f78-4892-91e9-39b1cc2fab35" xlink:to="loc_us-gaap_EquityContractMember_c0679410-5b83-4b5e-a88e-dce0d5e449ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_5893e6af-8f05-4314-86d2-10e4e98915fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_445c8114-1f5c-40e8-a12e-ac66cb27168f" xlink:to="loc_us-gaap_DerivativeLineItems_5893e6af-8f05-4314-86d2-10e4e98915fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_b293a688-f01c-4397-b649-6d688d8dbd59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5893e6af-8f05-4314-86d2-10e4e98915fa" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_b293a688-f01c-4397-b649-6d688d8dbd59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_2be9b660-e34a-4f81-bdbf-39a947019757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_b293a688-f01c-4397-b649-6d688d8dbd59" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_2be9b660-e34a-4f81-bdbf-39a947019757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_3aff3b57-7e9a-4bf0-b38f-36b694ae1d04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_b293a688-f01c-4397-b649-6d688d8dbd59" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_3aff3b57-7e9a-4bf0-b38f-36b694ae1d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_a3b7732a-5eb6-48c1-9de4-bc41ddede7d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_b293a688-f01c-4397-b649-6d688d8dbd59" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_a3b7732a-5eb6-48c1-9de4-bc41ddede7d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7099225c-81ab-427d-afcb-edf83c792f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d127c4bf-6297-45e5-a3e5-0ec0322764fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7099225c-81ab-427d-afcb-edf83c792f7b" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d127c4bf-6297-45e5-a3e5-0ec0322764fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_09b55c22-a2d0-451e-9bf0-ac58f72d9817" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d127c4bf-6297-45e5-a3e5-0ec0322764fd" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_09b55c22-a2d0-451e-9bf0-ac58f72d9817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_eba4ef40-fa6c-4290-8ae1-6002ee6c73e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_09b55c22-a2d0-451e-9bf0-ac58f72d9817" xlink:to="loc_us-gaap_HedgingRelationshipDomain_eba4ef40-fa6c-4290-8ae1-6002ee6c73e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_62b8d1e6-128c-4f19-a027-cec45b4b8b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_eba4ef40-fa6c-4290-8ae1-6002ee6c73e9" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_62b8d1e6-128c-4f19-a027-cec45b4b8b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4a94f37b-603b-479c-baee-ae1dbccbee74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d127c4bf-6297-45e5-a3e5-0ec0322764fd" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4a94f37b-603b-479c-baee-ae1dbccbee74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6f26f0b0-54a9-45a8-92fa-a92d51e6a5af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4a94f37b-603b-479c-baee-ae1dbccbee74" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6f26f0b0-54a9-45a8-92fa-a92d51e6a5af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_22fa410e-1197-48ae-82ca-2b248a3fa3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6f26f0b0-54a9-45a8-92fa-a92d51e6a5af" xlink:to="loc_us-gaap_ForeignExchangeContractMember_22fa410e-1197-48ae-82ca-2b248a3fa3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityContractMember_c82d06ed-2192-4e24-95e8-9c555477b1ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6f26f0b0-54a9-45a8-92fa-a92d51e6a5af" xlink:to="loc_us-gaap_EquityContractMember_c82d06ed-2192-4e24-95e8-9c555477b1ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_e75efe8d-6a95-4901-89d8-9e833f386999" xlink:href="mo-20210930.xsd#mo_EquityContractWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityContractMember_c82d06ed-2192-4e24-95e8-9c555477b1ea" xlink:to="loc_mo_EquityContractWarrantMember_e75efe8d-6a95-4901-89d8-9e833f386999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_34eae739-dca5-413e-bce5-11f7cffaedb3" xlink:href="mo-20210930.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityContractMember_c82d06ed-2192-4e24-95e8-9c555477b1ea" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_34eae739-dca5-413e-bce5-11f7cffaedb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_09d87299-4baf-4c94-a79d-c324d8dd34f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d127c4bf-6297-45e5-a3e5-0ec0322764fd" xlink:to="loc_us-gaap_HedgingDesignationAxis_09d87299-4baf-4c94-a79d-c324d8dd34f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_68e8e776-e70e-434b-a6c4-f2ef23c8829f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_09d87299-4baf-4c94-a79d-c324d8dd34f5" xlink:to="loc_us-gaap_HedgingDesignationDomain_68e8e776-e70e-434b-a6c4-f2ef23c8829f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_369723b8-aa1f-4466-a698-3401e4e9098e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_68e8e776-e70e-434b-a6c4-f2ef23c8829f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_369723b8-aa1f-4466-a698-3401e4e9098e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_d87c1276-3189-46a9-adfb-9ffec85cff6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_68e8e776-e70e-434b-a6c4-f2ef23c8829f" xlink:to="loc_us-gaap_NondesignatedMember_d87c1276-3189-46a9-adfb-9ffec85cff6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_60b7093a-8e87-4b3a-bff9-13f448c8f77b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d127c4bf-6297-45e5-a3e5-0ec0322764fd" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_60b7093a-8e87-4b3a-bff9-13f448c8f77b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1945f429-883b-402d-bde5-14907337b113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_60b7093a-8e87-4b3a-bff9-13f448c8f77b" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1945f429-883b-402d-bde5-14907337b113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_cf75b7ce-a081-4886-9f78-ea8649c2512f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1945f429-883b-402d-bde5-14907337b113" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_cf75b7ce-a081-4886-9f78-ea8649c2512f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_36c1ab29-b428-45d0-afcd-4df1d854070c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1945f429-883b-402d-bde5-14907337b113" xlink:to="loc_us-gaap_OtherAssetsMember_36c1ab29-b428-45d0-afcd-4df1d854070c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherAccruedLiabilitiesMember_0838e66b-8104-4200-9b22-381c3d21650a" xlink:href="mo-20210930.xsd#mo_OtherAccruedLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1945f429-883b-402d-bde5-14907337b113" xlink:to="loc_mo_OtherAccruedLiabilitiesMember_0838e66b-8104-4200-9b22-381c3d21650a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_e1e698f1-ff9a-4818-a44c-c13c489b8d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1945f429-883b-402d-bde5-14907337b113" xlink:to="loc_us-gaap_OtherLiabilitiesMember_e1e698f1-ff9a-4818-a44c-c13c489b8d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsInEquitySecuritiesMember_e99d1a98-a0d7-48bd-a198-f6fc1ce1e9ca" xlink:href="mo-20210930.xsd#mo_InvestmentsInEquitySecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1945f429-883b-402d-bde5-14907337b113" xlink:to="loc_mo_InvestmentsInEquitySecuritiesMember_e99d1a98-a0d7-48bd-a198-f6fc1ce1e9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_e63fb47d-c9dc-4d4d-a22f-395e216682c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d127c4bf-6297-45e5-a3e5-0ec0322764fd" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_e63fb47d-c9dc-4d4d-a22f-395e216682c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0da22170-2952-418e-8092-1425ef3e4b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e63fb47d-c9dc-4d4d-a22f-395e216682c0" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0da22170-2952-418e-8092-1425ef3e4b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_83ba0d72-5292-4010-934a-db766b8d9726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e63fb47d-c9dc-4d4d-a22f-395e216682c0" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_83ba0d72-5292-4010-934a-db766b8d9726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#FinancialInstrumentsPretaxUnrealizedGainsLossesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7420e758-180a-438d-a194-5147f03e193f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_0e94a736-2801-44f7-9ee9-a54147ac6762" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7420e758-180a-438d-a194-5147f03e193f" xlink:to="loc_us-gaap_DerivativeTable_0e94a736-2801-44f7-9ee9-a54147ac6762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5b034d34-14fc-4579-b1e6-8129ac5175e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0e94a736-2801-44f7-9ee9-a54147ac6762" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5b034d34-14fc-4579-b1e6-8129ac5175e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_68fa8c86-a076-4645-a7c6-02ed6949a2af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5b034d34-14fc-4579-b1e6-8129ac5175e0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_68fa8c86-a076-4645-a7c6-02ed6949a2af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_69dc3bae-faeb-4ad9-ae5e-5f9e5b03aa65" xlink:href="mo-20210930.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_68fa8c86-a076-4645-a7c6-02ed6949a2af" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_69dc3bae-faeb-4ad9-ae5e-5f9e5b03aa65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_c8cac1bb-f5c7-459b-9fa4-b35bc20e026d" xlink:href="mo-20210930.xsd#mo_EquityContractWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_68fa8c86-a076-4645-a7c6-02ed6949a2af" xlink:to="loc_mo_EquityContractWarrantMember_c8cac1bb-f5c7-459b-9fa4-b35bc20e026d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_3ffceb95-4c04-46c2-a739-62e075d9e8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0e94a736-2801-44f7-9ee9-a54147ac6762" xlink:to="loc_us-gaap_DerivativeLineItems_3ffceb95-4c04-46c2-a739-62e075d9e8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_354f2df2-9e76-4603-b84c-bc6242fa5907" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3ffceb95-4c04-46c2-a739-62e075d9e8a0" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_354f2df2-9e76-4603-b84c-bc6242fa5907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_bd50057a-d74d-4018-ad4c-cabcf5e68069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1b6f32d6-d527-409a-aca5-6c2b0ae611c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_bd50057a-d74d-4018-ad4c-cabcf5e68069" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1b6f32d6-d527-409a-aca5-6c2b0ae611c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_d980062f-5ccd-49f4-afc6-c9ac46c5d543" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1b6f32d6-d527-409a-aca5-6c2b0ae611c2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_d980062f-5ccd-49f4-afc6-c9ac46c5d543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3fac800f-ba8b-44fe-8db7-1a73d3d5911d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d980062f-5ccd-49f4-afc6-c9ac46c5d543" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3fac800f-ba8b-44fe-8db7-1a73d3d5911d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_ea3482fa-3043-4d56-bcdc-30ea1c114a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3fac800f-ba8b-44fe-8db7-1a73d3d5911d" xlink:to="loc_us-gaap_ForeignExchangeContractMember_ea3482fa-3043-4d56-bcdc-30ea1c114a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtMember_e4e13d55-827c-451c-9f3b-c59cdb4ddeb7" xlink:href="mo-20210930.xsd#mo_ForeignCurrencyDenominatedDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3fac800f-ba8b-44fe-8db7-1a73d3d5911d" xlink:to="loc_mo_ForeignCurrencyDenominatedDebtMember_e4e13d55-827c-451c-9f3b-c59cdb4ddeb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_57c39543-4123-454b-a896-bc116492db42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1b6f32d6-d527-409a-aca5-6c2b0ae611c2" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_57c39543-4123-454b-a896-bc116492db42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c909e012-8a1e-4c57-82b0-5050562a65b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_57c39543-4123-454b-a896-bc116492db42" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c909e012-8a1e-4c57-82b0-5050562a65b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_c1c8d60a-3e6d-4a77-bfac-74bc8ba64879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c909e012-8a1e-4c57-82b0-5050562a65b4" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_c1c8d60a-3e6d-4a77-bfac-74bc8ba64879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_f7873af7-0aad-4b09-b90c-31b726d650fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1b6f32d6-d527-409a-aca5-6c2b0ae611c2" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_f7873af7-0aad-4b09-b90c-31b726d650fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_6d2b4384-41fb-467a-ad4f-8848e2c37189" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_f7873af7-0aad-4b09-b90c-31b726d650fd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_6d2b4384-41fb-467a-ad4f-8848e2c37189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_ec06edfd-c10c-4c45-9ec6-51a21fb180d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_f7873af7-0aad-4b09-b90c-31b726d650fd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_ec06edfd-c10c-4c45-9ec6-51a21fb180d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlans" xlink:type="simple" xlink:href="mo-20210930.xsd#BenefitPlans"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BenefitPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_896ad6b0-7ac6-468e-837c-bf6cf1541c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_602e65d5-87d4-4abe-a6ee-a2b68acdeb21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_896ad6b0-7ac6-468e-837c-bf6cf1541c9c" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_602e65d5-87d4-4abe-a6ee-a2b68acdeb21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansTables" xlink:type="simple" xlink:href="mo-20210930.xsd#BenefitPlansTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BenefitPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c7b24351-737e-4c38-a2c3-778f603c1405" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_7db887b0-638a-48b0-8029-0c926b5f4c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c7b24351-737e-4c38-a2c3-778f603c1405" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_7db887b0-638a-48b0-8029-0c926b5f4c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8ec63896-9415-41c5-8e83-92952ee8256e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f6f47e47-8ecc-46ba-be5c-4a7b8f4f8b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8ec63896-9415-41c5-8e83-92952ee8256e" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f6f47e47-8ecc-46ba-be5c-4a7b8f4f8b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_c0ab9a3c-f5e8-4f2d-82d4-78a51f59af58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f6f47e47-8ecc-46ba-be5c-4a7b8f4f8b9c" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_c0ab9a3c-f5e8-4f2d-82d4-78a51f59af58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_acaa5819-e2be-4fd6-a376-dc615471422e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c0ab9a3c-f5e8-4f2d-82d4-78a51f59af58" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_acaa5819-e2be-4fd6-a376-dc615471422e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_ff6eb56a-9d95-4d80-93ad-5f419b463c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_acaa5819-e2be-4fd6-a376-dc615471422e" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_ff6eb56a-9d95-4d80-93ad-5f419b463c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_d5a9665c-9177-4134-ba19-4ab8037a53bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_acaa5819-e2be-4fd6-a376-dc615471422e" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_d5a9665c-9177-4134-ba19-4ab8037a53bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d4146963-ead1-4e03-a54a-bbbd1f5a7e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f6f47e47-8ecc-46ba-be5c-4a7b8f4f8b9c" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d4146963-ead1-4e03-a54a-bbbd1f5a7e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_35b666a8-196a-4f2c-9245-9f7604da7e35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d4146963-ead1-4e03-a54a-bbbd1f5a7e4a" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_35b666a8-196a-4f2c-9245-9f7604da7e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_fb078433-9de5-4471-b398-654cc0820d85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d4146963-ead1-4e03-a54a-bbbd1f5a7e4a" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_fb078433-9de5-4471-b398-654cc0820d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_99e26f4d-0a68-4e93-a5fa-44cf6652c5fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d4146963-ead1-4e03-a54a-bbbd1f5a7e4a" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_99e26f4d-0a68-4e93-a5fa-44cf6652c5fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_01c119f1-4fee-464c-b63b-1a3463693818" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d4146963-ead1-4e03-a54a-bbbd1f5a7e4a" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_01c119f1-4fee-464c-b63b-1a3463693818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_8931260f-7b06-4050-ae74-9554ddeda220" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_01c119f1-4fee-464c-b63b-1a3463693818" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_8931260f-7b06-4050-ae74-9554ddeda220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_279891b8-d1a1-4507-9e7c-4b310c0670c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_01c119f1-4fee-464c-b63b-1a3463693818" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_279891b8-d1a1-4507-9e7c-4b310c0670c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3c3547b0-56f4-4083-9d2c-ab8fcbfe73f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d4146963-ead1-4e03-a54a-bbbd1f5a7e4a" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3c3547b0-56f4-4083-9d2c-ab8fcbfe73f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansNarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#BenefitPlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BenefitPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_12d45719-cf78-4b35-9365-a30739f35759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3709025f-88e5-462c-93c2-e186bfd3bfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_12d45719-cf78-4b35-9365-a30739f35759" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3709025f-88e5-462c-93c2-e186bfd3bfd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_de339186-4f2b-413d-82f7-dbd10d5f4aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3709025f-88e5-462c-93c2-e186bfd3bfd4" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_de339186-4f2b-413d-82f7-dbd10d5f4aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_4ca1766c-f1c0-4899-ab2f-48fcc5375716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_de339186-4f2b-413d-82f7-dbd10d5f4aaf" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_4ca1766c-f1c0-4899-ab2f-48fcc5375716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_9ae65500-3a17-461e-aa4a-411c970f950b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_4ca1766c-f1c0-4899-ab2f-48fcc5375716" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_9ae65500-3a17-461e-aa4a-411c970f950b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_09e41336-908d-45f8-af3d-856c7ce9ddb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_4ca1766c-f1c0-4899-ab2f-48fcc5375716" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_09e41336-908d-45f8-af3d-856c7ce9ddb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2e2a93de-c73b-4eff-9962-04194235780a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3709025f-88e5-462c-93c2-e186bfd3bfd4" xlink:to="loc_srt_RangeAxis_2e2a93de-c73b-4eff-9962-04194235780a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dd8c6b74-ebbc-4d01-bab4-1e9207493f54" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2e2a93de-c73b-4eff-9962-04194235780a" xlink:to="loc_srt_RangeMember_dd8c6b74-ebbc-4d01-bab4-1e9207493f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_82b83f5b-c547-4622-a43a-d3f69d962d3b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_dd8c6b74-ebbc-4d01-bab4-1e9207493f54" xlink:to="loc_srt_MaximumMember_82b83f5b-c547-4622-a43a-d3f69d962d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6a943a44-5326-4d9d-8862-76395fe710d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3709025f-88e5-462c-93c2-e186bfd3bfd4" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6a943a44-5326-4d9d-8862-76395fe710d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_7415046d-4dba-47ee-9e23-e2d21feca407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6a943a44-5326-4d9d-8862-76395fe710d2" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_7415046d-4dba-47ee-9e23-e2d21feca407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_008efa91-4fd7-47ad-a62a-7d6222d48808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6a943a44-5326-4d9d-8862-76395fe710d2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_008efa91-4fd7-47ad-a62a-7d6222d48808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_96b06a1a-8ff8-48a0-b346-b92f3c43f556" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6a943a44-5326-4d9d-8862-76395fe710d2" xlink:to="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_96b06a1a-8ff8-48a0-b346-b92f3c43f556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/EarningsLossesperShare" xlink:type="simple" xlink:href="mo-20210930.xsd#EarningsLossesperShare"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/EarningsLossesperShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_43f75473-3593-48dc-bca9-98ebf39bcabf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_d7adb4eb-c960-4c45-a4bc-3cf522c2ffee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_43f75473-3593-48dc-bca9-98ebf39bcabf" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_d7adb4eb-c960-4c45-a4bc-3cf522c2ffee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/EarningsLossesperShareTables" xlink:type="simple" xlink:href="mo-20210930.xsd#EarningsLossesperShareTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/EarningsLossesperShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2cd40799-7482-429e-b527-83c715664e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_4131de7a-5397-4519-ac80-304dca454e41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2cd40799-7482-429e-b527-83c715664e9a" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_4131de7a-5397-4519-ac80-304dca454e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/EarningsLossesperShareBasicandDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#EarningsLossesperShareBasicandDilutedEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/EarningsLossesperShareBasicandDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_49e61990-e276-41e5-a642-9a35737ecc40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8105748d-842a-4cbf-8191-f4dd7191d555" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_49e61990-e276-41e5-a642-9a35737ecc40" xlink:to="loc_us-gaap_NetIncomeLoss_8105748d-842a-4cbf-8191-f4dd7191d555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_b9376376-a2c5-43cc-8546-b002deb02cf7" xlink:href="mo-20210930.xsd#mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_49e61990-e276-41e5-a642-9a35737ecc40" xlink:to="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_b9376376-a2c5-43cc-8546-b002deb02cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_ab79680d-a7e2-4249-bb63-e558bea95323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_49e61990-e276-41e5-a642-9a35737ecc40" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_ab79680d-a7e2-4249-bb63-e558bea95323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_10fc7b80-6d83-4c4f-a395-b558abf56396" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_49e61990-e276-41e5-a642-9a35737ecc40" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_10fc7b80-6d83-4c4f-a395-b558abf56396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_34c4432d-85d5-4aac-9ff8-9501ee7d659a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_49e61990-e276-41e5-a642-9a35737ecc40" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_34c4432d-85d5-4aac-9ff8-9501ee7d659a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_08c280df-93e4-4919-a510-a17cdb2574e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_49e61990-e276-41e5-a642-9a35737ecc40" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_08c280df-93e4-4919-a510-a17cdb2574e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e7edd89f-e41f-4dab-9e41-b2f6515cfee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_49e61990-e276-41e5-a642-9a35737ecc40" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e7edd89f-e41f-4dab-9e41-b2f6515cfee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLosses" xlink:type="simple" xlink:href="mo-20210930.xsd#OtherComprehensiveEarningsLosses"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLosses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_03e766be-28a7-477a-a8ac-0a1ab13965c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_c045c040-83da-4156-9605-f6b926771926" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_03e766be-28a7-477a-a8ac-0a1ab13965c6" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_c045c040-83da-4156-9605-f6b926771926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesTables" xlink:type="simple" xlink:href="mo-20210930.xsd#OtherComprehensiveEarningsLossesTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_846f20ea-f5c4-4740-88de-b494ded1b48e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_0a7391eb-c173-4702-8973-27d03ed279a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_846f20ea-f5c4-4740-88de-b494ded1b48e" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_0a7391eb-c173-4702-8973-27d03ed279a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_a90d04f8-e3cb-49bd-8bed-ae430e959105" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_846f20ea-f5c4-4740-88de-b494ded1b48e" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_a90d04f8-e3cb-49bd-8bed-ae430e959105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_78b83f14-b789-4cc7-beae-b2021294abc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a263a9f4-72f6-4019-8ad2-0085e8e92aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_78b83f14-b789-4cc7-beae-b2021294abc2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a263a9f4-72f6-4019-8ad2-0085e8e92aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_cd9ca4d7-568f-4f38-9dbb-6eec55f78d36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a263a9f4-72f6-4019-8ad2-0085e8e92aa0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_cd9ca4d7-568f-4f38-9dbb-6eec55f78d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d78cb71d-3c5a-4e29-b345-676f23c98606" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cd9ca4d7-568f-4f38-9dbb-6eec55f78d36" xlink:to="loc_us-gaap_EquityComponentDomain_d78cb71d-3c5a-4e29-b345-676f23c98606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_33d712f5-a9c6-424f-89ac-061698a2b068" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d78cb71d-3c5a-4e29-b345-676f23c98606" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_33d712f5-a9c6-424f-89ac-061698a2b068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_df20c61c-5491-464c-b6ef-f9ce60703366" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_33d712f5-a9c6-424f-89ac-061698a2b068" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_df20c61c-5491-464c-b6ef-f9ce60703366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_19b2d833-468f-4b6b-a17c-e13ea778066d" xlink:href="mo-20210930.xsd#mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_33d712f5-a9c6-424f-89ac-061698a2b068" xlink:to="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_19b2d833-468f-4b6b-a17c-e13ea778066d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_f020ebc8-bf02-4b12-864a-84ac8102ab6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_33d712f5-a9c6-424f-89ac-061698a2b068" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_f020ebc8-bf02-4b12-864a-84ac8102ab6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a444221b-7f81-482f-ab95-34f90aba2592" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a263a9f4-72f6-4019-8ad2-0085e8e92aa0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a444221b-7f81-482f-ab95-34f90aba2592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0eb894bc-c697-4da0-afd0-fe4b5e20093c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a444221b-7f81-482f-ab95-34f90aba2592" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0eb894bc-c697-4da0-afd0-fe4b5e20093c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5109d6c8-d734-4449-8070-ab6be2468146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0eb894bc-c697-4da0-afd0-fe4b5e20093c" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5109d6c8-d734-4449-8070-ab6be2468146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_486f9821-ef42-40eb-b36a-cb9fd74de20f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0eb894bc-c697-4da0-afd0-fe4b5e20093c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_486f9821-ef42-40eb-b36a-cb9fd74de20f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_a2e3ddd5-07e3-48dc-b11b-f5b0bf24eb25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0eb894bc-c697-4da0-afd0-fe4b5e20093c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_a2e3ddd5-07e3-48dc-b11b-f5b0bf24eb25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_bf9e1eee-f83e-4ed0-89d2-dd4b9bc52563" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0eb894bc-c697-4da0-afd0-fe4b5e20093c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_bf9e1eee-f83e-4ed0-89d2-dd4b9bc52563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_64c1d7a5-b894-4d9a-ae80-f06cff991ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0eb894bc-c697-4da0-afd0-fe4b5e20093c" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_64c1d7a5-b894-4d9a-ae80-f06cff991ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_c4a4583e-becd-406e-a82f-f724876650d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0eb894bc-c697-4da0-afd0-fe4b5e20093c" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_c4a4583e-becd-406e-a82f-f724876650d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e9420724-c113-4361-a6a3-49aacdfb670e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0eb894bc-c697-4da0-afd0-fe4b5e20093c" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e9420724-c113-4361-a6a3-49aacdfb670e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9794fa44-e1f1-419a-bf97-bcb4e4207d19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0eb894bc-c697-4da0-afd0-fe4b5e20093c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9794fa44-e1f1-419a-bf97-bcb4e4207d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ab8b9be8-dc48-415f-b981-68978e05cef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0eb894bc-c697-4da0-afd0-fe4b5e20093c" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ab8b9be8-dc48-415f-b981-68978e05cef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#OtherComprehensiveEarningsLossesReclassificationsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_cebfb134-7cae-4666-bf88-191b74305258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_c1fe3717-51fe-4acb-9dfb-7347f14d7729" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_cebfb134-7cae-4666-bf88-191b74305258" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_c1fe3717-51fe-4acb-9dfb-7347f14d7729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_610d70b2-f27c-4b18-9497-2a3e70ef370d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_c1fe3717-51fe-4acb-9dfb-7347f14d7729" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_610d70b2-f27c-4b18-9497-2a3e70ef370d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7a1ddb40-9dc4-4569-a726-253013437e19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_610d70b2-f27c-4b18-9497-2a3e70ef370d" xlink:to="loc_us-gaap_EquityComponentDomain_7a1ddb40-9dc4-4569-a726-253013437e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f67ee744-ab70-458a-9a32-0f36c4d3c027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7a1ddb40-9dc4-4569-a726-253013437e19" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f67ee744-ab70-458a-9a32-0f36c4d3c027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_4c0393b4-7a66-474f-8c99-e5750aaf084e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f67ee744-ab70-458a-9a32-0f36c4d3c027" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_4c0393b4-7a66-474f-8c99-e5750aaf084e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_5863802e-81ab-41c1-8fc3-934656a2a461" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f67ee744-ab70-458a-9a32-0f36c4d3c027" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_5863802e-81ab-41c1-8fc3-934656a2a461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_27327f9f-f0ab-4849-9d63-26ba45c0aa73" xlink:href="mo-20210930.xsd#mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f67ee744-ab70-458a-9a32-0f36c4d3c027" xlink:to="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_27327f9f-f0ab-4849-9d63-26ba45c0aa73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_b11f6832-9248-4a06-b750-6ce58f58ac61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f67ee744-ab70-458a-9a32-0f36c4d3c027" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_b11f6832-9248-4a06-b750-6ce58f58ac61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_9c9c7a7a-4164-48da-9165-aced70e4db56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_c1fe3717-51fe-4acb-9dfb-7347f14d7729" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_9c9c7a7a-4164-48da-9165-aced70e4db56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_1e50b097-af7d-45c3-8f99-a13cdcc8517a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_9c9c7a7a-4164-48da-9165-aced70e4db56" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_1e50b097-af7d-45c3-8f99-a13cdcc8517a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_3c25830b-2e5a-4675-b270-b9a2fa4ef3b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_1e50b097-af7d-45c3-8f99-a13cdcc8517a" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_3c25830b-2e5a-4675-b270-b9a2fa4ef3b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_20b21350-6a32-45e4-8102-17e1a4ed754c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_c1fe3717-51fe-4acb-9dfb-7347f14d7729" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_20b21350-6a32-45e4-8102-17e1a4ed754c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_b75c45b2-235d-4c4e-bd8e-b5ec32e5334d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_20b21350-6a32-45e4-8102-17e1a4ed754c" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_b75c45b2-235d-4c4e-bd8e-b5ec32e5334d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_85e42601-3293-4f2b-a9c6-0698f169e4bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_20b21350-6a32-45e4-8102-17e1a4ed754c" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_85e42601-3293-4f2b-a9c6-0698f169e4bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_03a7002b-bc09-48b9-9073-8c072da529bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_20b21350-6a32-45e4-8102-17e1a4ed754c" xlink:to="loc_us-gaap_ProfitLoss_03a7002b-bc09-48b9-9073-8c072da529bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReporting" xlink:type="simple" xlink:href="mo-20210930.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_6dc2545d-b7ad-4f70-943b-c7c3521c321a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_0d972e72-03ff-44a1-bd97-66c397fcce53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6dc2545d-b7ad-4f70-943b-c7c3521c321a" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_0d972e72-03ff-44a1-bd97-66c397fcce53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="mo-20210930.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_2274c3bc-637a-4324-b2ac-838fa7b890be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_715b2a8c-ddec-4456-bfad-26222f92bca5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_2274c3bc-637a-4324-b2ac-838fa7b890be" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_715b2a8c-ddec-4456-bfad-26222f92bca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock_11bc8131-d4ba-4295-9b8d-c41d93927f0b" xlink:href="mo-20210930.xsd#mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_2274c3bc-637a-4324-b2ac-838fa7b890be" xlink:to="loc_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock_11bc8131-d4ba-4295-9b8d-c41d93927f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock_ce7f36d2-5792-4ebe-b5ec-2648899b52d3" xlink:href="mo-20210930.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_2274c3bc-637a-4324-b2ac-838fa7b890be" xlink:to="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock_ce7f36d2-5792-4ebe-b5ec-2648899b52d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#SegmentReportingSegmentDataScheduleDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b2c20d5a-7eef-424a-a78d-723376d9a36c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_48b0384d-fbd2-479d-823b-d60d4dfb89eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b2c20d5a-7eef-424a-a78d-723376d9a36c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_48b0384d-fbd2-479d-823b-d60d4dfb89eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_3174b10d-6e9a-410f-a68b-f9cd09f37a85" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_48b0384d-fbd2-479d-823b-d60d4dfb89eb" xlink:to="loc_srt_ConsolidationItemsAxis_3174b10d-6e9a-410f-a68b-f9cd09f37a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_489240ee-0dd7-4a33-a823-f05f4b9c1030" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_3174b10d-6e9a-410f-a68b-f9cd09f37a85" xlink:to="loc_srt_ConsolidationItemsDomain_489240ee-0dd7-4a33-a823-f05f4b9c1030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_193d6144-5fa3-448c-807e-ac3d68106e57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_489240ee-0dd7-4a33-a823-f05f4b9c1030" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_193d6144-5fa3-448c-807e-ac3d68106e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_72ca46f8-8be9-4554-a64b-86d3a239eea1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_489240ee-0dd7-4a33-a823-f05f4b9c1030" xlink:to="loc_us-gaap_CorporateNonSegmentMember_72ca46f8-8be9-4554-a64b-86d3a239eea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c0d74fd0-4a9a-47db-a709-320af3686be9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_48b0384d-fbd2-479d-823b-d60d4dfb89eb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c0d74fd0-4a9a-47db-a709-320af3686be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_14c1ce0e-1d3f-4ce8-b3ed-d651b901660c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c0d74fd0-4a9a-47db-a709-320af3686be9" xlink:to="loc_us-gaap_SegmentDomain_14c1ce0e-1d3f-4ce8-b3ed-d651b901660c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_eb8ed13f-7717-4667-ba6e-3857aaf9b13e" xlink:href="mo-20210930.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_14c1ce0e-1d3f-4ce8-b3ed-d651b901660c" xlink:to="loc_mo_SmokeableProductsSegmentMember_eb8ed13f-7717-4667-ba6e-3857aaf9b13e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember_217284c1-efc1-4fa0-9151-9c7754b0c5d9" xlink:href="mo-20210930.xsd#mo_OralTobaccoSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_14c1ce0e-1d3f-4ce8-b3ed-d651b901660c" xlink:to="loc_mo_OralTobaccoSegmentMember_217284c1-efc1-4fa0-9151-9c7754b0c5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineSegmentMember_ffa53fe0-3499-41fe-a77b-418f3a794689" xlink:href="mo-20210930.xsd#mo_WineSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_14c1ce0e-1d3f-4ce8-b3ed-d651b901660c" xlink:to="loc_mo_WineSegmentMember_ffa53fe0-3499-41fe-a77b-418f3a794689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_40af2bc9-2129-4a71-92ee-29c17d1b12f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_14c1ce0e-1d3f-4ce8-b3ed-d651b901660c" xlink:to="loc_us-gaap_AllOtherSegmentsMember_40af2bc9-2129-4a71-92ee-29c17d1b12f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_48b0384d-fbd2-479d-823b-d60d4dfb89eb" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6c75b465-c90f-476b-9003-6a8f6369e2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6c75b465-c90f-476b-9003-6a8f6369e2ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles_ff0b08ec-cc4a-4868-839b-ebf96f36b78c" xlink:href="mo-20210930.xsd#mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:to="loc_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles_ff0b08ec-cc4a-4868-839b-ebf96f36b78c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_80e3e34e-ac47-4490-8ca3-ad3a37195b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_80e3e34e-ac47-4490-8ca3-ad3a37195b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_91945b87-3313-4124-84cd-ff2398a9bd39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_91945b87-3313-4124-84cd-ff2398a9bd39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a6ac7cf9-d431-4779-9959-c549d4ddf718" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:to="loc_us-gaap_OperatingIncomeLoss_a6ac7cf9-d431-4779-9959-c549d4ddf718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_a4794b4e-55c7-46f4-b8ef-17d0249e7b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_a4794b4e-55c7-46f4-b8ef-17d0249e7b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_42c3790c-0d65-4120-bed3-801b4ad87ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_42c3790c-0d65-4120-bed3-801b4ad87ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_d0250e4e-a8d4-4e18-a1a4-bdf5d1b32824" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_d0250e4e-a8d4-4e18-a1a4-bdf5d1b32824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_b43dc144-6a1a-4968-bd9a-f6f2bacbadf5" xlink:href="mo-20210930.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:to="loc_mo_IncomeLossFromEquityInvestments_b43dc144-6a1a-4968-bd9a-f6f2bacbadf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_3e958591-1f50-4376-8b30-880a22d7809e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_3e958591-1f50-4376-8b30-880a22d7809e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6ae85386-e6d3-452e-8b6e-59410d680424" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6ae85386-e6d3-452e-8b6e-59410d680424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a360e7ca-fd39-49c7-b6be-51e4f6e81f44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e26459c3-a263-4718-9ee5-5181e26486eb" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a360e7ca-fd39-49c7-b6be-51e4f6e81f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_afcb97bd-67d9-4ac6-84de-84a69322d390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_846bc5c3-687e-4aef-8047-c0c03a8a02cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_afcb97bd-67d9-4ac6-84de-84a69322d390" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_846bc5c3-687e-4aef-8047-c0c03a8a02cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_1bde0c53-3e35-4b7b-8979-c9363843d8da" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_846bc5c3-687e-4aef-8047-c0c03a8a02cb" xlink:to="loc_srt_LitigationCaseAxis_1bde0c53-3e35-4b7b-8979-c9363843d8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_a04c1d4b-064d-45b0-9923-e1b5541af6ae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_1bde0c53-3e35-4b7b-8979-c9363843d8da" xlink:to="loc_srt_LitigationCaseTypeDomain_a04c1d4b-064d-45b0-9923-e1b5541af6ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember_f37efd5d-2c18-485e-85a0-12f12f216a88" xlink:href="mo-20210930.xsd#mo_NonParticipatingManufacturerArbitrationPanelDecisionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_a04c1d4b-064d-45b0-9923-e1b5541af6ae" xlink:to="loc_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember_f37efd5d-2c18-485e-85a0-12f12f216a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_be11c5cf-e186-4ff5-8e82-c61d8731a708" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_846bc5c3-687e-4aef-8047-c0c03a8a02cb" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_be11c5cf-e186-4ff5-8e82-c61d8731a708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ce6e874f-dad9-4efb-a152-02794f9df8c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_be11c5cf-e186-4ff5-8e82-c61d8731a708" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ce6e874f-dad9-4efb-a152-02794f9df8c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossMember_e546da35-2202-4a1c-bea4-7a8d30d0c9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ce6e874f-dad9-4efb-a152-02794f9df8c2" xlink:to="loc_us-gaap_OperatingIncomeLossMember_e546da35-2202-4a1c-bea4-7a8d30d0c9c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InterestAndOtherDebtExpenseNetMember_b019bdd8-d04a-4451-977d-bcd3728098c4" xlink:href="mo-20210930.xsd#mo_InterestAndOtherDebtExpenseNetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ce6e874f-dad9-4efb-a152-02794f9df8c2" xlink:to="loc_mo_InterestAndOtherDebtExpenseNetMember_b019bdd8-d04a-4451-977d-bcd3728098c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_57eb9492-d386-41ef-8de1-b4e50073215c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_846bc5c3-687e-4aef-8047-c0c03a8a02cb" xlink:to="loc_us-gaap_NatureOfExpenseAxis_57eb9492-d386-41ef-8de1-b4e50073215c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_2fa7eb25-7ea6-4231-b097-13672c6082c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NatureOfExpenseAxis_57eb9492-d386-41ef-8de1-b4e50073215c" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_2fa7eb25-7ea6-4231-b097-13672c6082c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NpmAdjustmentToCostOfSalesMember_cdc52f9a-46d6-473d-839e-c178ab57c512" xlink:href="mo-20210930.xsd#mo_NpmAdjustmentToCostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_2fa7eb25-7ea6-4231-b097-13672c6082c9" xlink:to="loc_mo_NpmAdjustmentToCostOfSalesMember_cdc52f9a-46d6-473d-839e-c178ab57c512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_895f8cf6-5725-49a6-bb80-f7dc4ddacbc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_846bc5c3-687e-4aef-8047-c0c03a8a02cb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_895f8cf6-5725-49a6-bb80-f7dc4ddacbc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c7fcf5ec-e783-4a41-acde-3094d3e86e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_895f8cf6-5725-49a6-bb80-f7dc4ddacbc2" xlink:to="loc_us-gaap_SegmentDomain_c7fcf5ec-e783-4a41-acde-3094d3e86e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_6c0d0bb9-a2a2-4c8b-80e7-4d711c0f8bb8" xlink:href="mo-20210930.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c7fcf5ec-e783-4a41-acde-3094d3e86e9d" xlink:to="loc_mo_SmokeableProductsSegmentMember_6c0d0bb9-a2a2-4c8b-80e7-4d711c0f8bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_506cff7d-92a1-4409-b875-1e5db13e0979" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_846bc5c3-687e-4aef-8047-c0c03a8a02cb" xlink:to="loc_dei_LegalEntityAxis_506cff7d-92a1-4409-b875-1e5db13e0979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_68c4513b-4441-4db9-b99a-b154636f5c76" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_506cff7d-92a1-4409-b875-1e5db13e0979" xlink:to="loc_dei_EntityDomain_68c4513b-4441-4db9-b99a-b154636f5c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_c6440f37-ebac-403a-b32a-4d370eb0216c" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_68c4513b-4441-4db9-b99a-b154636f5c76" xlink:to="loc_mo_PhilipMorrisUSAMember_c6440f37-ebac-403a-b32a-4d370eb0216c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_eef8a4e4-2c93-43bd-a35c-4c8176cfd6e1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_846bc5c3-687e-4aef-8047-c0c03a8a02cb" xlink:to="loc_srt_ConsolidationItemsAxis_eef8a4e4-2c93-43bd-a35c-4c8176cfd6e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3c499ce5-fa3e-469d-ba09-22de5d69bd65" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_eef8a4e4-2c93-43bd-a35c-4c8176cfd6e1" xlink:to="loc_srt_ConsolidationItemsDomain_3c499ce5-fa3e-469d-ba09-22de5d69bd65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_58c0ca2c-6605-46dc-9016-ab6dfd73f041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_3c499ce5-fa3e-469d-ba09-22de5d69bd65" xlink:to="loc_us-gaap_OperatingSegmentsMember_58c0ca2c-6605-46dc-9016-ab6dfd73f041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_328c0cbb-e576-4904-8072-36180f011e86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_3c499ce5-fa3e-469d-ba09-22de5d69bd65" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_328c0cbb-e576-4904-8072-36180f011e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_d0175c11-6cce-4f0d-9ad2-abdd5faca36b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_846bc5c3-687e-4aef-8047-c0c03a8a02cb" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_d0175c11-6cce-4f0d-9ad2-abdd5faca36b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_9117fc8a-e0e6-4049-8c9a-1a72ecb6e5d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d0175c11-6cce-4f0d-9ad2-abdd5faca36b" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_9117fc8a-e0e6-4049-8c9a-1a72ecb6e5d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_54cb6929-bdf7-4857-a35a-bfbf4d969d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ce1e009a-b1fb-4176-89be-17e79c032ea3" xlink:href="mo-20210930.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_54cb6929-bdf7-4857-a35a-bfbf4d969d4f" xlink:to="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ce1e009a-b1fb-4176-89be-17e79c032ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b18a46b3-e4e3-44ec-a44b-f05e2c275b76" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ce1e009a-b1fb-4176-89be-17e79c032ea3" xlink:to="loc_dei_LegalEntityAxis_b18a46b3-e4e3-44ec-a44b-f05e2c275b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ad7d98a7-4bc3-40f2-824f-b57909623d76" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_b18a46b3-e4e3-44ec-a44b-f05e2c275b76" xlink:to="loc_dei_EntityDomain_ad7d98a7-4bc3-40f2-824f-b57909623d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_248f85e6-7aea-4dd3-a0ab-a6d7b813e3da" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_ad7d98a7-4bc3-40f2-824f-b57909623d76" xlink:to="loc_mo_PhilipMorrisUSAMember_248f85e6-7aea-4dd3-a0ab-a6d7b813e3da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_aeda89f1-9fce-4e6e-902f-cb7dbad641df" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ce1e009a-b1fb-4176-89be-17e79c032ea3" xlink:to="loc_srt_LitigationCaseAxis_aeda89f1-9fce-4e6e-902f-cb7dbad641df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_48c247c6-5c25-4489-acdc-0b3c1c9660ce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_aeda89f1-9fce-4e6e-902f-cb7dbad641df" xlink:to="loc_srt_LitigationCaseTypeDomain_48c247c6-5c25-4489-acdc-0b3c1c9660ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthLitigationCasesMember_ec81e235-357d-4b63-8f80-c7ced6c0cce8" xlink:href="mo-20210930.xsd#mo_TobaccoandHealthLitigationCasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_48c247c6-5c25-4489-acdc-0b3c1c9660ce" xlink:to="loc_mo_TobaccoandHealthLitigationCasesMember_ec81e235-357d-4b63-8f80-c7ced6c0cce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_1efb1bf7-72fe-40eb-941c-f2f359a86065" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ce1e009a-b1fb-4176-89be-17e79c032ea3" xlink:to="loc_srt_ConsolidationItemsAxis_1efb1bf7-72fe-40eb-941c-f2f359a86065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_40f47a4b-32f4-4d8d-95d6-629718f0d502" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_1efb1bf7-72fe-40eb-941c-f2f359a86065" xlink:to="loc_srt_ConsolidationItemsDomain_40f47a4b-32f4-4d8d-95d6-629718f0d502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_2a03fa5d-60c1-4302-8fdb-f8b0c61fb7df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_40f47a4b-32f4-4d8d-95d6-629718f0d502" xlink:to="loc_us-gaap_OperatingSegmentsMember_2a03fa5d-60c1-4302-8fdb-f8b0c61fb7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_c075ab95-b7d3-47ac-9270-2d46441640bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_40f47a4b-32f4-4d8d-95d6-629718f0d502" xlink:to="loc_us-gaap_CorporateNonSegmentMember_c075ab95-b7d3-47ac-9270-2d46441640bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_171cd108-0bdd-4653-9d55-9a208e4e41a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_40f47a4b-32f4-4d8d-95d6-629718f0d502" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_171cd108-0bdd-4653-9d55-9a208e4e41a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6c7f45f9-a12e-4fa9-8af1-f94390b573a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ce1e009a-b1fb-4176-89be-17e79c032ea3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6c7f45f9-a12e-4fa9-8af1-f94390b573a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2c84f674-ba8e-4368-979f-4035bd4801d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6c7f45f9-a12e-4fa9-8af1-f94390b573a0" xlink:to="loc_us-gaap_SegmentDomain_2c84f674-ba8e-4368-979f-4035bd4801d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_2cda2532-82fd-4111-92c5-939eee47b7b8" xlink:href="mo-20210930.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2c84f674-ba8e-4368-979f-4035bd4801d9" xlink:to="loc_mo_SmokeableProductsSegmentMember_2cda2532-82fd-4111-92c5-939eee47b7b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_bf6c86c8-7a28-4bf9-bf07-03fb03665722" xlink:href="mo-20210930.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ce1e009a-b1fb-4176-89be-17e79c032ea3" xlink:to="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_bf6c86c8-7a28-4bf9-bf07-03fb03665722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_3b572ffc-61f7-45fd-a782-4d89ebc71793" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_bf6c86c8-7a28-4bf9-bf07-03fb03665722" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_3b572ffc-61f7-45fd-a782-4d89ebc71793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#SegmentReportingNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SegmentReportingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_69be0e58-054b-434c-9711-a8e13c56be72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d4b07cff-10f7-4f0d-a8b9-2b561e378447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_69be0e58-054b-434c-9711-a8e13c56be72" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d4b07cff-10f7-4f0d-a8b9-2b561e378447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_b24e8ff6-a660-4d23-ba6d-d2da66ae87d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d4b07cff-10f7-4f0d-a8b9-2b561e378447" xlink:to="loc_us-gaap_RestructuringPlanAxis_b24e8ff6-a660-4d23-ba6d-d2da66ae87d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_89991efe-1c24-4e97-9860-ae1f72dd4b00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_b24e8ff6-a660-4d23-ba6d-d2da66ae87d7" xlink:to="loc_us-gaap_RestructuringPlanDomain_89991efe-1c24-4e97-9860-ae1f72dd4b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineBusinessStrategicResetMember_dea0aec3-d4b1-4986-bff4-d60ddbda8153" xlink:href="mo-20210930.xsd#mo_WineBusinessStrategicResetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_89991efe-1c24-4e97-9860-ae1f72dd4b00" xlink:to="loc_mo_WineBusinessStrategicResetMember_dea0aec3-d4b1-4986-bff4-d60ddbda8153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_399db37a-da3a-455d-aa5e-4fd842c15138" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d4b07cff-10f7-4f0d-a8b9-2b561e378447" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_399db37a-da3a-455d-aa5e-4fd842c15138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_f3d52e1d-f553-428b-bfa9-3835b62319f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_399db37a-da3a-455d-aa5e-4fd842c15138" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_f3d52e1d-f553-428b-bfa9-3835b62319f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InventoryDisposalCostsandOtherMember_b72555ab-4ba4-42bc-9d93-aca48f06074c" xlink:href="mo-20210930.xsd#mo_InventoryDisposalCostsandOtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_f3d52e1d-f553-428b-bfa9-3835b62319f9" xlink:to="loc_mo_InventoryDisposalCostsandOtherMember_b72555ab-4ba4-42bc-9d93-aca48f06074c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InventoryWriteOffMember_d9ff67bb-9638-4a08-a305-41c80e020200" xlink:href="mo-20210930.xsd#mo_InventoryWriteOffMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_f3d52e1d-f553-428b-bfa9-3835b62319f9" xlink:to="loc_mo_InventoryWriteOffMember_d9ff67bb-9638-4a08-a305-41c80e020200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentMember_14b1ef7a-9970-4276-a8a7-83d821e262bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseCommitmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_f3d52e1d-f553-428b-bfa9-3835b62319f9" xlink:to="loc_us-gaap_PurchaseCommitmentMember_14b1ef7a-9970-4276-a8a7-83d821e262bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9fd4157b-228a-479b-b72e-953074a86764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d4b07cff-10f7-4f0d-a8b9-2b561e378447" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9fd4157b-228a-479b-b72e-953074a86764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d5b83406-1ad2-437f-ac22-51ba1cd40ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9fd4157b-228a-479b-b72e-953074a86764" xlink:to="loc_us-gaap_SegmentDomain_d5b83406-1ad2-437f-ac22-51ba1cd40ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember_a7c94484-d5fc-4c44-9088-b63c4b33de1e" xlink:href="mo-20210930.xsd#mo_OralTobaccoSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d5b83406-1ad2-437f-ac22-51ba1cd40ea7" xlink:to="loc_mo_OralTobaccoSegmentMember_a7c94484-d5fc-4c44-9088-b63c4b33de1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_e2558053-1e3d-4c50-ab77-b5472787b9de" xlink:href="mo-20210930.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d5b83406-1ad2-437f-ac22-51ba1cd40ea7" xlink:to="loc_mo_SmokeableProductsSegmentMember_e2558053-1e3d-4c50-ab77-b5472787b9de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineSegmentMember_95e69473-8b89-462c-ac53-a45e36ea03f3" xlink:href="mo-20210930.xsd#mo_WineSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d5b83406-1ad2-437f-ac22-51ba1cd40ea7" xlink:to="loc_mo_WineSegmentMember_95e69473-8b89-462c-ac53-a45e36ea03f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_589af2e8-fbad-4d02-a261-6b53cfcae039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d4b07cff-10f7-4f0d-a8b9-2b561e378447" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_589af2e8-fbad-4d02-a261-6b53cfcae039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_29bc20c7-10e4-4496-a741-dfda7d8cc2a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_589af2e8-fbad-4d02-a261-6b53cfcae039" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_29bc20c7-10e4-4496-a741-dfda7d8cc2a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_COVID19Member_bb9fbb51-4287-4377-a5cb-6efd2923f324" xlink:href="mo-20210930.xsd#mo_COVID19Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_29bc20c7-10e4-4496-a741-dfda7d8cc2a1" xlink:to="loc_mo_COVID19Member_bb9fbb51-4287-4377-a5cb-6efd2923f324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d04a50bd-a23b-4f41-8fef-3dbe3c59063d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d4b07cff-10f7-4f0d-a8b9-2b561e378447" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d04a50bd-a23b-4f41-8fef-3dbe3c59063d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b35f1dd1-d9ae-47f9-9da3-d26d4f44526b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d04a50bd-a23b-4f41-8fef-3dbe3c59063d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b35f1dd1-d9ae-47f9-9da3-d26d4f44526b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_7478773e-397a-4a8b-9cb8-affe7b6566fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_b35f1dd1-d9ae-47f9-9da3-d26d4f44526b" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_7478773e-397a-4a8b-9cb8-affe7b6566fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5636acb5-153f-4fd8-ac3c-71951b293036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d4b07cff-10f7-4f0d-a8b9-2b561e378447" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5636acb5-153f-4fd8-ac3c-71951b293036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_db654491-c47d-4b8f-96c9-efbfcd3d415a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5636acb5-153f-4fd8-ac3c-71951b293036" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_db654491-c47d-4b8f-96c9-efbfcd3d415a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SteMichelleTransactionMember_268a48c7-c9b3-4dfd-bfc3-938f3cdb099d" xlink:href="mo-20210930.xsd#mo_SteMichelleTransactionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_db654491-c47d-4b8f-96c9-efbfcd3d415a" xlink:to="loc_mo_SteMichelleTransactionMember_268a48c7-c9b3-4dfd-bfc3-938f3cdb099d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_889c84c1-45e5-40b0-812e-bb68292730a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d4b07cff-10f7-4f0d-a8b9-2b561e378447" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_889c84c1-45e5-40b0-812e-bb68292730a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c5690152-26e7-45de-8f5a-454c32b803ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_889c84c1-45e5-40b0-812e-bb68292730a7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c5690152-26e7-45de-8f5a-454c32b803ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarketingAdministrationAndResearchCostsMember_98f62c92-6550-45a5-99d7-708e3f25b105" xlink:href="mo-20210930.xsd#mo_MarketingAdministrationAndResearchCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c5690152-26e7-45de-8f5a-454c32b803ea" xlink:to="loc_mo_MarketingAdministrationAndResearchCostsMember_98f62c92-6550-45a5-99d7-708e3f25b105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_8c723e2c-9706-457c-bfdf-b688e26f1f08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d4b07cff-10f7-4f0d-a8b9-2b561e378447" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_8c723e2c-9706-457c-bfdf-b688e26f1f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_54ee3bda-313a-48b4-8dcd-f9f9558ea996" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c723e2c-9706-457c-bfdf-b688e26f1f08" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_54ee3bda-313a-48b4-8dcd-f9f9558ea996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts_c10f3701-369e-4b7b-9e5a-3dd28f993c88" xlink:href="mo-20210930.xsd#mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c723e2c-9706-457c-bfdf-b688e26f1f08" xlink:to="loc_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts_c10f3701-369e-4b7b-9e5a-3dd28f993c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts_781b6fab-8b5b-44e9-923d-14367fe02a91" xlink:href="mo-20210930.xsd#mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c723e2c-9706-457c-bfdf-b688e26f1f08" xlink:to="loc_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts_781b6fab-8b5b-44e9-923d-14367fe02a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_cb15a621-58ba-42b5-998d-32ad868d8ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c723e2c-9706-457c-bfdf-b688e26f1f08" xlink:to="loc_us-gaap_RestructuringCharges_cb15a621-58ba-42b5-998d-32ad868d8ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_4b079bb4-af98-46bb-bf4b-eee1d52696de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c723e2c-9706-457c-bfdf-b688e26f1f08" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_4b079bb4-af98-46bb-bf4b-eee1d52696de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/Debt" xlink:type="simple" xlink:href="mo-20210930.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_daf89a0c-280c-412c-aea2-9daf0bf4d4c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_da5c37d3-29d3-4157-ae91-f179a750ee85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_daf89a0c-280c-412c-aea2-9daf0bf4d4c4" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_da5c37d3-29d3-4157-ae91-f179a750ee85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/DebtTables" xlink:type="simple" xlink:href="mo-20210930.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6174ded2-9626-4f42-bf21-d2d2ee4b50cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_812d6a6d-5ee4-44de-a741-315e9b0174fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6174ded2-9626-4f42-bf21-d2d2ee4b50cc" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_812d6a6d-5ee4-44de-a741-315e9b0174fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#DebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_14780a28-78de-4b31-adac-a8c34a9ec869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a9620b17-3ff1-471d-b849-b4e551baf235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_14780a28-78de-4b31-adac-a8c34a9ec869" xlink:to="loc_us-gaap_DebtInstrumentTable_a9620b17-3ff1-471d-b849-b4e551baf235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_4c4ab7be-f79b-42e2-a967-8532c1e4d222" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a9620b17-3ff1-471d-b849-b4e551baf235" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_4c4ab7be-f79b-42e2-a967-8532c1e4d222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fed7dace-01bd-4e5f-87ad-8633a97afeb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_4c4ab7be-f79b-42e2-a967-8532c1e4d222" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fed7dace-01bd-4e5f-87ad-8633a97afeb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_2c861a53-bf9a-41af-b097-4286c5e968e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fed7dace-01bd-4e5f-87ad-8633a97afeb9" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_2c861a53-bf9a-41af-b097-4286c5e968e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_9ec5f406-07f2-4b28-88e2-9a0346f401a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a9620b17-3ff1-471d-b849-b4e551baf235" xlink:to="loc_us-gaap_VariableRateAxis_9ec5f406-07f2-4b28-88e2-9a0346f401a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_6695bd11-5c40-44c0-af91-92ca3baa4c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_9ec5f406-07f2-4b28-88e2-9a0346f401a1" xlink:to="loc_us-gaap_VariableRateDomain_6695bd11-5c40-44c0-af91-92ca3baa4c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_5ac9a13c-0b6e-435b-ba24-ef98c774faa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_6695bd11-5c40-44c0-af91-92ca3baa4c46" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_5ac9a13c-0b6e-435b-ba24-ef98c774faa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_853adb2f-172d-4776-959e-27fb72aa5cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a9620b17-3ff1-471d-b849-b4e551baf235" xlink:to="loc_us-gaap_CreditFacilityAxis_853adb2f-172d-4776-959e-27fb72aa5cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f7f547f6-97e1-49e7-bf67-bd553f5b0c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_853adb2f-172d-4776-959e-27fb72aa5cc1" xlink:to="loc_us-gaap_CreditFacilityDomain_f7f547f6-97e1-49e7-bf67-bd553f5b0c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_56665061-e2da-48fd-b4c7-6fcbb311d00f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f7f547f6-97e1-49e7-bf67-bd553f5b0c2f" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_56665061-e2da-48fd-b4c7-6fcbb311d00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5120bb37-d679-4f9e-8d87-9ca6d4042114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a9620b17-3ff1-471d-b849-b4e551baf235" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5120bb37-d679-4f9e-8d87-9ca6d4042114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_465a60af-ebf2-4e82-9050-2d48ccede1be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5120bb37-d679-4f9e-8d87-9ca6d4042114" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_465a60af-ebf2-4e82-9050-2d48ccede1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_03c118d6-c1a5-4037-8b7d-9a06031c6539" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_465a60af-ebf2-4e82-9050-2d48ccede1be" xlink:to="loc_us-gaap_LineOfCreditMember_03c118d6-c1a5-4037-8b7d-9a06031c6539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_86ae3818-cf74-4b7f-b43d-dec20154eb92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_465a60af-ebf2-4e82-9050-2d48ccede1be" xlink:to="loc_us-gaap_SeniorNotesMember_86ae3818-cf74-4b7f-b43d-dec20154eb92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c97b003b-2610-4f86-a37a-3d84e4bdfd30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a9620b17-3ff1-471d-b849-b4e551baf235" xlink:to="loc_us-gaap_DebtInstrumentAxis_c97b003b-2610-4f86-a37a-3d84e4bdfd30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ad390ebc-d6a0-46c6-8294-ca97eca80b01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c97b003b-2610-4f86-a37a-3d84e4bdfd30" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ad390ebc-d6a0-46c6-8294-ca97eca80b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RevolvingCreditFacilityDueAugust2024Member_014dd6cc-b9ea-446e-abd9-e1f5d99b20b6" xlink:href="mo-20210930.xsd#mo_RevolvingCreditFacilityDueAugust2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ad390ebc-d6a0-46c6-8294-ca97eca80b01" xlink:to="loc_mo_RevolvingCreditFacilityDueAugust2024Member_014dd6cc-b9ea-446e-abd9-e1f5d99b20b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesMember_b07620d9-248b-4410-886d-5d87388140f6" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ad390ebc-d6a0-46c6-8294-ca97eca80b01" xlink:to="loc_mo_USDDenominatedNotesMember_b07620d9-248b-4410-886d-5d87388140f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesDue2032Member_b0093bc3-907e-4429-9ecd-81f58cb8c7a6" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotesDue2032Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ad390ebc-d6a0-46c6-8294-ca97eca80b01" xlink:to="loc_mo_USDDenominatedNotesDue2032Member_b0093bc3-907e-4429-9ecd-81f58cb8c7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesDue2041Member_3a97c7c0-8a70-4040-8fd7-7d9a45afc1db" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotesDue2041Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ad390ebc-d6a0-46c6-8294-ca97eca80b01" xlink:to="loc_mo_USDDenominatedNotesDue2041Member_3a97c7c0-8a70-4040-8fd7-7d9a45afc1db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesDue2051Member_87e2e830-c5fc-45dc-b924-94c30227857e" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotesDue2051Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ad390ebc-d6a0-46c6-8294-ca97eca80b01" xlink:to="loc_mo_USDDenominatedNotesDue2051Member_87e2e830-c5fc-45dc-b924-94c30227857e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesDue2061Member_76b74dd7-c466-40e9-995b-8c89d1ff0320" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotesDue2061Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ad390ebc-d6a0-46c6-8294-ca97eca80b01" xlink:to="loc_mo_USDDenominatedNotesDue2061Member_76b74dd7-c466-40e9-995b-8c89d1ff0320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes3490PercentDue2022Member_620bf90d-9cc7-4888-9e7b-7fb4bf08c4c7" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotes3490PercentDue2022Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ad390ebc-d6a0-46c6-8294-ca97eca80b01" xlink:to="loc_mo_USDDenominatedNotes3490PercentDue2022Member_620bf90d-9cc7-4888-9e7b-7fb4bf08c4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a9620b17-3ff1-471d-b849-b4e551baf235" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_827b4dba-bfec-472b-a0b3-061f606d71ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_ShortTermBorrowings_827b4dba-bfec-472b-a0b3-061f606d71ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_90486ede-6074-4878-8c82-e6469828c1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_90486ede-6074-4878-8c82-e6469828c1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_9250404f-7bc2-4444-b172-6bedd065a257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_DebtInstrumentTerm_9250404f-7bc2-4444-b172-6bedd065a257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentExtensionTerm_8937f46b-e612-402c-9c59-bf0e1246d5db" xlink:href="mo-20210930.xsd#mo_DebtInstrumentExtensionTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_mo_DebtInstrumentExtensionTerm_8937f46b-e612-402c-9c59-bf0e1246d5db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_611adfb2-0efa-4157-83e1-70c00df5a05b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_611adfb2-0efa-4157-83e1-70c00df5a05b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_5e1806c1-82ea-4ae5-a011-551f60b606fd" xlink:href="mo-20210930.xsd#mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_5e1806c1-82ea-4ae5-a011-551f60b606fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_bb3109f3-0805-4afc-8067-63ebf76a2dc7" xlink:href="mo-20210930.xsd#mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_bb3109f3-0805-4afc-8067-63ebf76a2dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_83ca4831-6e5f-4b63-9b44-54eb51bc264e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_83ca4831-6e5f-4b63-9b44-54eb51bc264e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e3f9d908-6134-48de-93be-2ff456ae81a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_LongTermDebt_e3f9d908-6134-48de-93be-2ff456ae81a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfUnsecuredDebt_1a9f0828-5a35-4489-8fdc-abafab0e7f44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfUnsecuredDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_RepaymentsOfUnsecuredDebt_1a9f0828-5a35-4489-8fdc-abafab0e7f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_dcc35ae5-7d01-4ceb-a5e7-45ae178c6f85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_dcc35ae5-7d01-4ceb-a5e7-45ae178c6f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_b9e1e39e-a658-49ea-9eb5-9211e92c20c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_b9e1e39e-a658-49ea-9eb5-9211e92c20c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_529c4af8-d620-4bbe-a925-0fa3e1602735" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_529c4af8-d620-4bbe-a925-0fa3e1602735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_536289ae-c023-4da3-9bde-7bb174651efc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_536289ae-c023-4da3-9bde-7bb174651efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_07437ceb-8ac6-4987-b377-f21c57122076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_07437ceb-8ac6-4987-b377-f21c57122076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_c75fc5d3-b11d-4fd9-b93e-c195b4f70c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_c75fc5d3-b11d-4fd9-b93e-c195b4f70c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_e76cb5b1-b9aa-479d-a2e1-6ae6206cf15c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d75ffc04-024a-47dc-9e9c-cf9fcf633da9" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_e76cb5b1-b9aa-479d-a2e1-6ae6206cf15c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/DebtTenderOffersDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#DebtTenderOffersDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/DebtTenderOffersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d4259cbe-5421-4b87-8b10-1ce649738645" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_94f51414-84bf-416f-a277-78307ae9bd84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d4259cbe-5421-4b87-8b10-1ce649738645" xlink:to="loc_us-gaap_DebtInstrumentTable_94f51414-84bf-416f-a277-78307ae9bd84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_18e39b19-34e8-49bf-a509-c7f3e1de4545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_94f51414-84bf-416f-a277-78307ae9bd84" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_18e39b19-34e8-49bf-a509-c7f3e1de4545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_538c54be-8474-45c7-b50b-99885becfb8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_18e39b19-34e8-49bf-a509-c7f3e1de4545" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_538c54be-8474-45c7-b50b-99885becfb8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_81b32488-49bf-4754-8dd1-c64692f4e3c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_538c54be-8474-45c7-b50b-99885becfb8e" xlink:to="loc_us-gaap_SeniorNotesMember_81b32488-49bf-4754-8dd1-c64692f4e3c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_44811bf0-bf4d-42e0-a6e5-d6fcc5a32e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_94f51414-84bf-416f-a277-78307ae9bd84" xlink:to="loc_us-gaap_DebtInstrumentAxis_44811bf0-bf4d-42e0-a6e5-d6fcc5a32e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d4745393-7ce8-4bb1-a462-5425bb77110f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_44811bf0-bf4d-42e0-a6e5-d6fcc5a32e36" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d4745393-7ce8-4bb1-a462-5425bb77110f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes2850PercentDue2022Member_04f89ff9-93f8-47be-b492-b1965f998dbd" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotes2850PercentDue2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4745393-7ce8-4bb1-a462-5425bb77110f" xlink:to="loc_mo_USDDenominatedNotes2850PercentDue2022Member_04f89ff9-93f8-47be-b492-b1965f998dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes2950PercentDue2023Member_f7e2d178-abf2-4152-bef5-e1b183f7f686" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotes2950PercentDue2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4745393-7ce8-4bb1-a462-5425bb77110f" xlink:to="loc_mo_USDDenominatedNotes2950PercentDue2023Member_f7e2d178-abf2-4152-bef5-e1b183f7f686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes4000PercentDue2024Member_76fe33e8-fbe1-4c87-a351-bf4fccd1b2f3" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotes4000PercentDue2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4745393-7ce8-4bb1-a462-5425bb77110f" xlink:to="loc_mo_USDDenominatedNotes4000PercentDue2024Member_76fe33e8-fbe1-4c87-a351-bf4fccd1b2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes3800PercentDue2024Member_a0281d1f-c0a1-4a77-8f35-fd6b4867d58b" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotes3800PercentDue2024Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4745393-7ce8-4bb1-a462-5425bb77110f" xlink:to="loc_mo_USDDenominatedNotes3800PercentDue2024Member_a0281d1f-c0a1-4a77-8f35-fd6b4867d58b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes4400PercentDue2026Member_ea21af31-fee7-4d9b-96c4-d548dc40ba81" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotes4400PercentDue2026Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4745393-7ce8-4bb1-a462-5425bb77110f" xlink:to="loc_mo_USDDenominatedNotes4400PercentDue2026Member_ea21af31-fee7-4d9b-96c4-d548dc40ba81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes4800PercentDue2029Member_259ab169-8d55-4c77-9285-85340f6565a5" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotes4800PercentDue2029Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4745393-7ce8-4bb1-a462-5425bb77110f" xlink:to="loc_mo_USDDenominatedNotes4800PercentDue2029Member_259ab169-8d55-4c77-9285-85340f6565a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes9950PercentDue2038Member_5b531519-325e-470c-9c39-4d2033425e4a" xlink:href="mo-20210930.xsd#mo_USDDenominatedNotes9950PercentDue2038Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4745393-7ce8-4bb1-a462-5425bb77110f" xlink:to="loc_mo_USDDenominatedNotes9950PercentDue2038Member_5b531519-325e-470c-9c39-4d2033425e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedDebt10200PercentDue2039Member_450fe370-0645-475b-992a-37ae2b1eab44" xlink:href="mo-20210930.xsd#mo_USDDenominatedDebt10200PercentDue2039Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4745393-7ce8-4bb1-a462-5425bb77110f" xlink:to="loc_mo_USDDenominatedDebt10200PercentDue2039Member_450fe370-0645-475b-992a-37ae2b1eab44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedDebt6200PercentDue2059Member_b10db195-48db-43e4-8627-d75f9f78be54" xlink:href="mo-20210930.xsd#mo_USDDenominatedDebt6200PercentDue2059Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4745393-7ce8-4bb1-a462-5425bb77110f" xlink:to="loc_mo_USDDenominatedDebt6200PercentDue2059Member_b10db195-48db-43e4-8627-d75f9f78be54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_596121dc-01b8-43bb-ba46-f1f077e371d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_94f51414-84bf-416f-a277-78307ae9bd84" xlink:to="loc_us-gaap_DebtInstrumentLineItems_596121dc-01b8-43bb-ba46-f1f077e371d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_edef35cb-40d6-498b-96d5-69406a46bd3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_596121dc-01b8-43bb-ba46-f1f077e371d4" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_edef35cb-40d6-498b-96d5-69406a46bd3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_afa9e5cb-5fba-4b1d-b1c1-2e9d150d55e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_596121dc-01b8-43bb-ba46-f1f077e371d4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_afa9e5cb-5fba-4b1d-b1c1-2e9d150d55e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mo-20210930.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f324d360-7134-4097-b5d6-50049c592869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_e7a2787a-7052-4ec1-8f1d-c3404137a1e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f324d360-7134-4097-b5d6-50049c592869" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_e7a2787a-7052-4ec1-8f1d-c3404137a1e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesupdateTables" xlink:type="simple" xlink:href="mo-20210930.xsd#IncomeTaxesupdateTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/IncomeTaxesupdateTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_de91efe3-1e32-4fad-9b79-7fa66924875a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SummaryOfIncomeTaxesTableTextBlock_a617b13a-3f73-4008-9a36-83567b39708c" xlink:href="mo-20210930.xsd#mo_SummaryOfIncomeTaxesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_de91efe3-1e32-4fad-9b79-7fa66924875a" xlink:to="loc_mo_SummaryOfIncomeTaxesTableTextBlock_a617b13a-3f73-4008-9a36-83567b39708c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_cfe894b0-6d0f-41b1-a920-7481219dd85a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_de91efe3-1e32-4fad-9b79-7fa66924875a" xlink:to="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_cfe894b0-6d0f-41b1-a920-7481219dd85a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesSummaryofIncomeTaxesDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#IncomeTaxesSummaryofIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/IncomeTaxesSummaryofIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_67de7bac-987d-42c9-a953-c42475e39e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_572e17dc-f53e-41be-ba9e-fcb56e156dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_67de7bac-987d-42c9-a953-c42475e39e1b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_572e17dc-f53e-41be-ba9e-fcb56e156dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_eb67d1df-ebc2-4a6a-8e0d-7bd2f5bade0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_67de7bac-987d-42c9-a953-c42475e39e1b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_eb67d1df-ebc2-4a6a-8e0d-7bd2f5bade0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c1774e7e-0770-43c6-a7bc-c9cb06e7a8c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_67de7bac-987d-42c9-a953-c42475e39e1b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c1774e7e-0770-43c6-a7bc-c9cb06e7a8c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0f14d207-13d8-493f-bb07-838bc6996dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_276cb6fa-d3ea-419a-ab69-fee877e34f46" xlink:href="mo-20210930.xsd#mo_InvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0f14d207-13d8-493f-bb07-838bc6996dbc" xlink:to="loc_mo_InvestmentsTable_276cb6fa-d3ea-419a-ab69-fee877e34f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_504a3413-ad0d-4633-80e4-f7d8434bf75e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_276cb6fa-d3ea-419a-ab69-fee877e34f46" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_504a3413-ad0d-4633-80e4-f7d8434bf75e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_8b24e247-b477-4b76-b6f1-a61cc61d703e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_504a3413-ad0d-4633-80e4-f7d8434bf75e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_8b24e247-b477-4b76-b6f1-a61cc61d703e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_4eb2703c-7e7f-44a9-b0e9-98cd8c251d98" xlink:href="mo-20210930.xsd#mo_ABInBevMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8b24e247-b477-4b76-b6f1-a61cc61d703e" xlink:to="loc_mo_ABInBevMember_4eb2703c-7e7f-44a9-b0e9-98cd8c251d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_d9a356ea-4162-45ce-9108-16b13db0be97" xlink:href="mo-20210930.xsd#mo_JUULMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8b24e247-b477-4b76-b6f1-a61cc61d703e" xlink:to="loc_mo_JUULMember_d9a356ea-4162-45ce-9108-16b13db0be97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_25e4f917-aa2d-49e3-8859-2478b094c826" xlink:href="mo-20210930.xsd#mo_InvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_276cb6fa-d3ea-419a-ab69-fee877e34f46" xlink:to="loc_mo_InvestmentsLineItems_25e4f917-aa2d-49e3-8859-2478b094c826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentImpairment_0ea64db7-3e0a-499c-b762-4d522d9a816d" xlink:href="mo-20210930.xsd#mo_EquityMethodInvestmentImpairment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_25e4f917-aa2d-49e3-8859-2478b094c826" xlink:to="loc_mo_EquityMethodInvestmentImpairment_0ea64db7-3e0a-499c-b762-4d522d9a816d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_a5b88313-5cf4-4e19-b91f-27d5fcab352c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_25e4f917-aa2d-49e3-8859-2478b094c826" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_a5b88313-5cf4-4e19-b91f-27d5fcab352c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_73240939-a554-4e7b-9f05-c67a3badb9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceRollforwardRollForward_e7cc9a29-bcad-4e9e-9231-b6562df374b8" xlink:href="mo-20210930.xsd#mo_ValuationAllowanceRollforwardRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_73240939-a554-4e7b-9f05-c67a3badb9a4" xlink:to="loc_mo_ValuationAllowanceRollforwardRollForward_e7cc9a29-bcad-4e9e-9231-b6562df374b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_e8a3f9d5-075a-4245-b83b-59c8bef0bd02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ValuationAllowanceRollforwardRollForward_e7cc9a29-bcad-4e9e-9231-b6562df374b8" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_e8a3f9d5-075a-4245-b83b-59c8bef0bd02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount_52cbe505-3102-4ce4-b80c-3658eb67f202" xlink:href="mo-20210930.xsd#mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ValuationAllowanceRollforwardRollForward_e7cc9a29-bcad-4e9e-9231-b6562df374b8" xlink:to="loc_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount_52cbe505-3102-4ce4-b80c-3658eb67f202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount_863fd879-f116-4387-97ea-ec35fc84b9ed" xlink:href="mo-20210930.xsd#mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ValuationAllowanceRollforwardRollForward_e7cc9a29-bcad-4e9e-9231-b6562df374b8" xlink:to="loc_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount_863fd879-f116-4387-97ea-ec35fc84b9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment_faa983a7-ec65-4128-bd89-41df50204708" xlink:href="mo-20210930.xsd#mo_ValuationAllowanceForeignCurrencyTranslationAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ValuationAllowanceRollforwardRollForward_e7cc9a29-bcad-4e9e-9231-b6562df374b8" xlink:to="loc_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment_faa983a7-ec65-4128-bd89-41df50204708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_224feca7-04cc-490b-94b4-00ad58b34856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ValuationAllowanceRollforwardRollForward_e7cc9a29-bcad-4e9e-9231-b6562df374b8" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_224feca7-04cc-490b-94b4-00ad58b34856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/Contingencies" xlink:type="simple" xlink:href="mo-20210930.xsd#Contingencies"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/Contingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7c8b8f92-2565-4704-b92a-16d42b7a89e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_95b7a566-5f1b-44dc-8215-014413785af0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7c8b8f92-2565-4704-b92a-16d42b7a89e2" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_95b7a566-5f1b-44dc-8215-014413785af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesTables" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b3d3931b-9418-43e4-8292-a09cbd91e383" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_7f25d5ec-c02d-47bc-8cab-9aa3c93b3514" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b3d3931b-9418-43e4-8292-a09cbd91e383" xlink:to="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_7f25d5ec-c02d-47bc-8cab-9aa3c93b3514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesGeneralInformationDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesGeneralInformationDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesGeneralInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c89bec5e-19ec-4b98-99bb-b9ae04f3782b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond_c96fb01c-8043-47c2-8aef-f972065aecf9" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c89bec5e-19ec-4b98-99bb-b9ae04f3782b" xlink:to="loc_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond_c96fb01c-8043-47c2-8aef-f972065aecf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b6926bd2-52a8-49e3-b4e5-b51f025a53bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_d5972877-7b97-4be9-a4e5-9d9b3fa01c54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b6926bd2-52a8-49e3-b4e5-b51f025a53bc" xlink:to="loc_us-gaap_LossContingenciesTable_d5972877-7b97-4be9-a4e5-9d9b3fa01c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_fd821da9-2e70-4948-acdd-94a8014b1f04" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d5972877-7b97-4be9-a4e5-9d9b3fa01c54" xlink:to="loc_srt_LitigationCaseAxis_fd821da9-2e70-4948-acdd-94a8014b1f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_1706b05a-9d54-4f54-8f30-bde72357d516" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_fd821da9-2e70-4948-acdd-94a8014b1f04" xlink:to="loc_srt_LitigationCaseTypeDomain_1706b05a-9d54-4f54-8f30-bde72357d516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthJudgmentMember_e6033b26-cc02-47af-8a28-150e6ac00c42" xlink:href="mo-20210930.xsd#mo_TobaccoandHealthJudgmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_1706b05a-9d54-4f54-8f30-bde72357d516" xlink:to="loc_mo_TobaccoandHealthJudgmentMember_e6033b26-cc02-47af-8a28-150e6ac00c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember_531ee8a2-3f84-4b1d-a300-d3f60ea93656" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_1706b05a-9d54-4f54-8f30-bde72357d516" xlink:to="loc_mo_EngleProgenyCasesMember_531ee8a2-3f84-4b1d-a300-d3f60ea93656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_a9e26e5c-2254-4ba1-80ac-b31dc9aa2e24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d5972877-7b97-4be9-a4e5-9d9b3fa01c54" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_a9e26e5c-2254-4ba1-80ac-b31dc9aa2e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_16568566-064e-4f93-901f-1cf639d702d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a9e26e5c-2254-4ba1-80ac-b31dc9aa2e24" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_16568566-064e-4f93-901f-1cf639d702d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_dc7014da-7475-49ca-b6a3-3b6352f08b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_16568566-064e-4f93-901f-1cf639d702d0" xlink:to="loc_us-gaap_AssetsMember_dc7014da-7475-49ca-b6a3-3b6352f08b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_a226bd37-01fa-4284-8341-f8e9d68f4929" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d5972877-7b97-4be9-a4e5-9d9b3fa01c54" xlink:to="loc_us-gaap_LitigationStatusAxis_a226bd37-01fa-4284-8341-f8e9d68f4929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_d6ca7835-c384-44d1-b246-6428bf5e02c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_a226bd37-01fa-4284-8341-f8e9d68f4929" xlink:to="loc_us-gaap_LitigationStatusDomain_d6ca7835-c384-44d1-b246-6428bf5e02c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_c5dbbc44-7b17-4999-bc5a-b72250ba1747" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_d6ca7835-c384-44d1-b246-6428bf5e02c9" xlink:to="loc_us-gaap_PendingLitigationMember_c5dbbc44-7b17-4999-bc5a-b72250ba1747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_277ee8fb-ad6e-49d4-be2d-920ce82a22ed" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d5972877-7b97-4be9-a4e5-9d9b3fa01c54" xlink:to="loc_dei_LegalEntityAxis_277ee8fb-ad6e-49d4-be2d-920ce82a22ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_63100925-b37f-4ba5-b8f2-8f0fc4c710e4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_277ee8fb-ad6e-49d4-be2d-920ce82a22ed" xlink:to="loc_dei_EntityDomain_63100925-b37f-4ba5-b8f2-8f0fc4c710e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_a7964e53-e316-4e84-910b-18c77638e5ca" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_63100925-b37f-4ba5-b8f2-8f0fc4c710e4" xlink:to="loc_mo_PhilipMorrisUSAMember_a7964e53-e316-4e84-910b-18c77638e5ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d3aebb6e-a582-45eb-a847-50e889b2c808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d5972877-7b97-4be9-a4e5-9d9b3fa01c54" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d3aebb6e-a582-45eb-a847-50e889b2c808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_8ef7c930-c208-4afc-b56b-d62b8866ae13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d3aebb6e-a582-45eb-a847-50e889b2c808" xlink:to="loc_us-gaap_LossContingencyNatureDomain_8ef7c930-c208-4afc-b56b-d62b8866ae13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationCasesResultsMember_fa81bfed-39fe-4791-8b27-c8118ec5dd0c" xlink:href="mo-20210930.xsd#mo_LitigationCasesResultsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_8ef7c930-c208-4afc-b56b-d62b8866ae13" xlink:to="loc_mo_LitigationCasesResultsMember_fa81bfed-39fe-4791-8b27-c8118ec5dd0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InterestExpenseRelatedToLitigationMember_9b03e382-0308-4de5-ac1a-8611335cc3c4" xlink:href="mo-20210930.xsd#mo_InterestExpenseRelatedToLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_8ef7c930-c208-4afc-b56b-d62b8866ae13" xlink:to="loc_mo_InterestExpenseRelatedToLitigationMember_9b03e382-0308-4de5-ac1a-8611335cc3c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_112caaea-c49a-4256-96fa-ffba3d737d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d5972877-7b97-4be9-a4e5-9d9b3fa01c54" xlink:to="loc_us-gaap_LossContingenciesLineItems_112caaea-c49a-4256-96fa-ffba3d737d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_2a7e9a40-0076-4e9a-86b4-6e7cf99d34b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_112caaea-c49a-4256-96fa-ffba3d737d7e" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_2a7e9a40-0076-4e9a-86b4-6e7cf99d34b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementInterest_d1e63136-b1dd-4490-84b9-6f0eb17375d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_112caaea-c49a-4256-96fa-ffba3d737d7e" xlink:to="loc_us-gaap_LitigationSettlementInterest_d1e63136-b1dd-4490-84b9-6f0eb17375d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualRollForward_ea0512ab-c833-4821-af92-d636b8be868c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_112caaea-c49a-4256-96fa-ffba3d737d7e" xlink:to="loc_us-gaap_LossContingencyAccrualRollForward_ea0512ab-c833-4821-af92-d636b8be868c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_14ade3a1-b0ef-4d55-98e7-2fba307aa2da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_ea0512ab-c833-4821-af92-d636b8be868c" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_14ade3a1-b0ef-4d55-98e7-2fba307aa2da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_f78a5117-9e21-49be-8931-00fa21a97153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_ea0512ab-c833-4821-af92-d636b8be868c" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_f78a5117-9e21-49be-8931-00fa21a97153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_f2b6ff55-3666-401f-a520-fcf58f7b4723" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_ea0512ab-c833-4821-af92-d636b8be868c" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_f2b6ff55-3666-401f-a520-fcf58f7b4723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_0547bcba-bc12-461f-86d1-4e8eaaa33820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_ea0512ab-c833-4821-af92-d636b8be868c" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_0547bcba-bc12-461f-86d1-4e8eaaa33820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationEscrowDeposit_37f382dd-d3b6-4c29-aa21-5acc9fcf8bbc" xlink:href="mo-20210930.xsd#mo_LitigationEscrowDeposit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_112caaea-c49a-4256-96fa-ffba3d737d7e" xlink:to="loc_mo_LitigationEscrowDeposit_37f382dd-d3b6-4c29-aa21-5acc9fcf8bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesScheduleofPendingCasesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5d26de5f-8d1e-442f-be1e-91a3a3e34160" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_9e008ed4-7caf-4391-bcf7-1c644d5d5111" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5d26de5f-8d1e-442f-be1e-91a3a3e34160" xlink:to="loc_us-gaap_LossContingenciesTable_9e008ed4-7caf-4391-bcf7-1c644d5d5111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_72bba7aa-2ed9-4c10-8e92-e34bf80f58bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_9e008ed4-7caf-4391-bcf7-1c644d5d5111" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_72bba7aa-2ed9-4c10-8e92-e34bf80f58bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_92715f03-7cda-4e71-811d-241172cb0054" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_72bba7aa-2ed9-4c10-8e92-e34bf80f58bc" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_92715f03-7cda-4e71-811d-241172cb0054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_2f49d9e5-1582-4282-a06b-cd3a1b4d9956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_92715f03-7cda-4e71-811d-241172cb0054" xlink:to="loc_us-gaap_SubsequentEventMember_2f49d9e5-1582-4282-a06b-cd3a1b4d9956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_71c31864-ae0a-4e7e-8b6c-a3dfec4f983b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_9e008ed4-7caf-4391-bcf7-1c644d5d5111" xlink:to="loc_srt_LitigationCaseAxis_71c31864-ae0a-4e7e-8b6c-a3dfec4f983b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_69e1a00c-1fc1-4e84-9a82-3e243add7b88" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_71c31864-ae0a-4e7e-8b6c-a3dfec4f983b" xlink:to="loc_srt_LitigationCaseTypeDomain_69e1a00c-1fc1-4e84-9a82-3e243add7b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IndividualSmokingAndHealthCasesMember_97cce8c4-c970-40ac-a1b3-b87f50cfb865" xlink:href="mo-20210930.xsd#mo_IndividualSmokingAndHealthCasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_69e1a00c-1fc1-4e84-9a82-3e243add7b88" xlink:to="loc_mo_IndividualSmokingAndHealthCasesMember_97cce8c4-c970-40ac-a1b3-b87f50cfb865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ETSSmokingandHealthCaseFlightAttendantsMember_859b6bb8-606c-4041-ba2c-7500d25a8ad9" xlink:href="mo-20210930.xsd#mo_ETSSmokingandHealthCaseFlightAttendantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_IndividualSmokingAndHealthCasesMember_97cce8c4-c970-40ac-a1b3-b87f50cfb865" xlink:to="loc_mo_ETSSmokingandHealthCaseFlightAttendantsMember_859b6bb8-606c-4041-ba2c-7500d25a8ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_c37e0651-b5ed-4a57-a29c-97812221125b" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_69e1a00c-1fc1-4e84-9a82-3e243add7b88" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_c37e0651-b5ed-4a57-a29c-97812221125b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EvaporLitigationMember_942a50ef-b412-4881-b099-68e4e66ce818" xlink:href="mo-20210930.xsd#mo_EvaporLitigationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_69e1a00c-1fc1-4e84-9a82-3e243add7b88" xlink:to="loc_mo_EvaporLitigationMember_942a50ef-b412-4881-b099-68e4e66ce818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherTabaccoRelatedCasesMember_b9d7e270-3f79-4be5-9c6a-b9695afce854" xlink:href="mo-20210930.xsd#mo_OtherTabaccoRelatedCasesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_69e1a00c-1fc1-4e84-9a82-3e243add7b88" xlink:to="loc_mo_OtherTabaccoRelatedCasesMember_b9d7e270-3f79-4be5-9c6a-b9695afce854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_2ac35e57-58e5-4955-aef9-ce742738555c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_9e008ed4-7caf-4391-bcf7-1c644d5d5111" xlink:to="loc_us-gaap_LitigationStatusAxis_2ac35e57-58e5-4955-aef9-ce742738555c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_cc86d01d-aebf-45d7-8905-67ab5bef10ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_2ac35e57-58e5-4955-aef9-ce742738555c" xlink:to="loc_us-gaap_LitigationStatusDomain_cc86d01d-aebf-45d7-8905-67ab5bef10ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_db701bdc-21c2-4955-b7b6-eac04aa24463" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_cc86d01d-aebf-45d7-8905-67ab5bef10ea" xlink:to="loc_us-gaap_PendingLitigationMember_db701bdc-21c2-4955-b7b6-eac04aa24463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember_e2b4c9b9-633a-49c8-9b78-fb954eef0796" xlink:href="mo-20210930.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_cc86d01d-aebf-45d7-8905-67ab5bef10ea" xlink:to="loc_mo_PendingIndividualLawsuitsMember_e2b4c9b9-633a-49c8-9b78-fb954eef0796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_4cef902f-18e8-4e5b-b337-b1f4cbe6633a" xlink:href="mo-20210930.xsd#mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_cc86d01d-aebf-45d7-8905-67ab5bef10ea" xlink:to="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_4cef902f-18e8-4e5b-b337-b1f4cbe6633a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ccf10894-7e5b-423f-b109-865b69dad772" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_9e008ed4-7caf-4391-bcf7-1c644d5d5111" xlink:to="loc_srt_StatementGeographicalAxis_ccf10894-7e5b-423f-b109-865b69dad772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_36538957-fd2a-4237-9d57-eff7cb43e886" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_ccf10894-7e5b-423f-b109-865b69dad772" xlink:to="loc_srt_SegmentGeographicalDomain_36538957-fd2a-4237-9d57-eff7cb43e886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IL_b5ae7657-282a-4c5c-b0f4-ac6000b1a84c" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_IL"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_36538957-fd2a-4237-9d57-eff7cb43e886" xlink:to="loc_stpr_IL_b5ae7657-282a-4c5c-b0f4-ac6000b1a84c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NM_c8b90a95-69c9-45c9-b992-18c5ebbeba26" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_NM"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_36538957-fd2a-4237-9d57-eff7cb43e886" xlink:to="loc_stpr_NM_c8b90a95-69c9-45c9-b992-18c5ebbeba26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA_9a51f085-5da2-44e9-9174-e09c1f860151" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MA"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_36538957-fd2a-4237-9d57-eff7cb43e886" xlink:to="loc_stpr_MA_9a51f085-5da2-44e9-9174-e09c1f860151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_caef1c67-4c18-46d7-9c5c-f5abe9d04d99" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_FL"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_36538957-fd2a-4237-9d57-eff7cb43e886" xlink:to="loc_stpr_FL_caef1c67-4c18-46d7-9c5c-f5abe9d04d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_b967d7a5-a5b4-446f-b5b6-bfbaee2266aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_9e008ed4-7caf-4391-bcf7-1c644d5d5111" xlink:to="loc_us-gaap_LossContingenciesLineItems_b967d7a5-a5b4-446f-b5b6-bfbaee2266aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_9832ced3-f685-4d38-a4d8-29246430b82a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b967d7a5-a5b4-446f-b5b6-bfbaee2266aa" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_9832ced3-f685-4d38-a4d8-29246430b82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCases_79ba1e47-bc3b-48f3-b7d6-e407ff1f41b7" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfCases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b967d7a5-a5b4-446f-b5b6-bfbaee2266aa" xlink:to="loc_mo_LossContingencyNumberOfCases_79ba1e47-bc3b-48f3-b7d6-e407ff1f41b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassActionLawsuit_2ef83d98-e8af-450d-afb1-f3376d2bf1e6" xlink:href="mo-20210930.xsd#mo_LossContingencyClassActionLawsuit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b967d7a5-a5b4-446f-b5b6-bfbaee2266aa" xlink:to="loc_mo_LossContingencyClassActionLawsuit_2ef83d98-e8af-450d-afb1-f3376d2bf1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfInactiveCases_8665fe5d-c7f1-464d-a02c-e4531220e6ec" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfInactiveCases"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b967d7a5-a5b4-446f-b5b6-bfbaee2266aa" xlink:to="loc_mo_LossContingencyNumberOfInactiveCases_8665fe5d-c7f1-464d-a02c-e4531220e6ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfInactiveClassActionLawsuits_5ab6e774-47b1-49bd-9135-17af30192a90" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfInactiveClassActionLawsuits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b967d7a5-a5b4-446f-b5b6-bfbaee2266aa" xlink:to="loc_mo_LossContingencyNumberOfInactiveClassActionLawsuits_5ab6e774-47b1-49bd-9135-17af30192a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_47a2a3b0-e997-4cd4-96be-ec947684e3db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_7ab8a735-1d16-4885-a0b5-bf2d8ae4334c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_47a2a3b0-e997-4cd4-96be-ec947684e3db" xlink:to="loc_us-gaap_LossContingenciesTable_7ab8a735-1d16-4885-a0b5-bf2d8ae4334c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_e94cbc5d-1598-4b10-be5d-72b0a12777b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_7ab8a735-1d16-4885-a0b5-bf2d8ae4334c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_e94cbc5d-1598-4b10-be5d-72b0a12777b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c1741265-d3db-4d48-9ae9-1a07b36d468b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e94cbc5d-1598-4b10-be5d-72b0a12777b9" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c1741265-d3db-4d48-9ae9-1a07b36d468b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ec86c8a0-e3a6-47b7-9ed0-a22cd4c1efc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c1741265-d3db-4d48-9ae9-1a07b36d468b" xlink:to="loc_us-gaap_SubsequentEventMember_ec86c8a0-e3a6-47b7-9ed0-a22cd4c1efc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c8198218-c0b2-4b3a-84ab-3ebe49bc5f5b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_7ab8a735-1d16-4885-a0b5-bf2d8ae4334c" xlink:to="loc_dei_LegalEntityAxis_c8198218-c0b2-4b3a-84ab-3ebe49bc5f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8756ea8d-2ddb-4bb0-b35d-4707812b2944" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_c8198218-c0b2-4b3a-84ab-3ebe49bc5f5b" xlink:to="loc_dei_EntityDomain_8756ea8d-2ddb-4bb0-b35d-4707812b2944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_d48d76f6-af74-4289-aadf-2036b0b8b9c0" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_8756ea8d-2ddb-4bb0-b35d-4707812b2944" xlink:to="loc_mo_PhilipMorrisUSAMember_d48d76f6-af74-4289-aadf-2036b0b8b9c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAandAltriaGroupMember_ac2affa7-a766-4323-8932-74776778397c" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAandAltriaGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_8756ea8d-2ddb-4bb0-b35d-4707812b2944" xlink:to="loc_mo_PhilipMorrisUSAandAltriaGroupMember_ac2affa7-a766-4323-8932-74776778397c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_ecd53c42-1c42-41dc-9d9f-3e7091ad1ce0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_7ab8a735-1d16-4885-a0b5-bf2d8ae4334c" xlink:to="loc_srt_LitigationCaseAxis_ecd53c42-1c42-41dc-9d9f-3e7091ad1ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_210c2ea5-bc20-465f-8b82-0aea583dd8e0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_ecd53c42-1c42-41dc-9d9f-3e7091ad1ce0" xlink:to="loc_srt_LitigationCaseTypeDomain_210c2ea5-bc20-465f-8b82-0aea583dd8e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_9238578f-2fa4-4051-9686-222113b2f8e9" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_210c2ea5-bc20-465f-8b82-0aea583dd8e0" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_9238578f-2fa4-4051-9686-222113b2f8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsMember_3edd605f-d33f-4422-acbe-0fbdeb5cec20" xlink:href="mo-20210930.xsd#mo_SmokingAndHealthClassActionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_210c2ea5-bc20-465f-8b82-0aea583dd8e0" xlink:to="loc_mo_SmokingAndHealthClassActionsMember_3edd605f-d33f-4422-acbe-0fbdeb5cec20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember_d879a601-a347-4505-bd77-4d25a6211a4a" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_210c2ea5-bc20-465f-8b82-0aea583dd8e0" xlink:to="loc_mo_EngleProgenyCasesMember_d879a601-a347-4505-bd77-4d25a6211a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenyCasesMember_44472cab-4d52-48da-81d8-311785418091" xlink:href="mo-20210930.xsd#mo_NonEngleProgenyCasesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_210c2ea5-bc20-465f-8b82-0aea583dd8e0" xlink:to="loc_mo_NonEngleProgenyCasesMember_44472cab-4d52-48da-81d8-311785418091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_2038c36c-94c8-475e-9aac-3e6c3a59c6a6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_7ab8a735-1d16-4885-a0b5-bf2d8ae4334c" xlink:to="loc_srt_StatementGeographicalAxis_2038c36c-94c8-475e-9aac-3e6c3a59c6a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_2038c36c-94c8-475e-9aac-3e6c3a59c6a6" xlink:to="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_932eb677-a43f-4171-b1f9-753477cbfe9e" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_country_CA_932eb677-a43f-4171-b1f9-753477cbfe9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AK_8a46f621-8815-45d7-9b0b-a6d956c9809e" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_AK"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_AK_8a46f621-8815-45d7-9b0b-a6d956c9809e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_c29b2233-24af-490d-9991-0dbcd2a5a7d1" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_CA"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_CA_c29b2233-24af-490d-9991-0dbcd2a5a7d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CT_2fb2479b-8c12-43cc-a4f0-36141d9755be" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_CT"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_CT_2fb2479b-8c12-43cc-a4f0-36141d9755be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_6a31e7c5-2143-4e28-a168-de80a9b4cb29" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_FL"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_FL_6a31e7c5-2143-4e28-a168-de80a9b4cb29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_LA_af5343a4-6860-4d77-8330-11d55aa9b11a" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_LA"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_LA_af5343a4-6860-4d77-8330-11d55aa9b11a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA_134d457e-effd-40ee-8a8d-74237d9b6766" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MA"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_MA_134d457e-effd-40ee-8a8d-74237d9b6766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MS_28189467-f34f-42cb-842c-bd0be1e6b3c1" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MS"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_MS_28189467-f34f-42cb-842c-bd0be1e6b3c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MO_777c2ac1-9d65-42f1-b925-e5034d515a40" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MO"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_MO_777c2ac1-9d65-42f1-b925-e5034d515a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NH_cf47b1e6-d6e6-406b-a4a7-88dc26b2b157" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_NH"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_NH_cf47b1e6-d6e6-406b-a4a7-88dc26b2b157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ_9f5a7796-c906-4326-b557-6c90d003dd28" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_NJ"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_NJ_9f5a7796-c906-4326-b557-6c90d003dd28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_4dcc6d2e-249a-4bc2-b064-02aa75578404" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_NY"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_NY_4dcc6d2e-249a-4bc2-b064-02aa75578404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OH_a4738ee9-dcee-4fc0-80bd-770af08c06ed" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_OH"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_OH_a4738ee9-dcee-4fc0-80bd-770af08c06ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_PA_89ffca6a-fffa-40ba-874b-eaf4b1c01c15" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_PA"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_PA_89ffca6a-fffa-40ba-874b-eaf4b1c01c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_RI_0b1ec4f9-ed66-4d69-8fbb-2b30e55624e2" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_RI"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_RI_0b1ec4f9-ed66-4d69-8fbb-2b30e55624e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TN_48258349-8bdf-4ee3-8b74-2ac363e55ecf" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_TN"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_TN_48258349-8bdf-4ee3-8b74-2ac363e55ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WV_1da325e7-e270-4697-94f9-30847b3a1c55" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_WV"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0e9445e3-416a-4c8a-bbb2-0baa7ea5134e" xlink:to="loc_stpr_WV_1da325e7-e270-4697-94f9-30847b3a1c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_980f6691-1bd5-481e-8ed7-903e72eb01f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_7ab8a735-1d16-4885-a0b5-bf2d8ae4334c" xlink:to="loc_us-gaap_LossContingenciesLineItems_980f6691-1bd5-481e-8ed7-903e72eb01f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_c6842b7f-e815-4daf-9a66-f3ff530b78a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_980f6691-1bd5-481e-8ed7-903e72eb01f3" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_c6842b7f-e815-4daf-9a66-f3ff530b78a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofCasesSetforTrial_f8e8835f-9830-4ce6-ab53-8dc7ca5272d4" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberofCasesSetforTrial"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_980f6691-1bd5-481e-8ed7-903e72eb01f3" xlink:to="loc_mo_LossContingencyNumberofCasesSetforTrial_f8e8835f-9830-4ce6-ab53-8dc7ca5272d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecided_2bb4c651-1068-439f-9833-ee3c0f8daf79" xlink:href="mo-20210930.xsd#mo_LossContingencyClaimsDecided"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_980f6691-1bd5-481e-8ed7-903e72eb01f3" xlink:to="loc_mo_LossContingencyClaimsDecided_2bb4c651-1068-439f-9833-ee3c0f8daf79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedFavorableNumber_8244fd8f-8edc-4a7e-bdc8-581ae3986519" xlink:href="mo-20210930.xsd#mo_LossContingencyClaimsDecidedFavorableNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_980f6691-1bd5-481e-8ed7-903e72eb01f3" xlink:to="loc_mo_LossContingencyClaimsDecidedFavorableNumber_8244fd8f-8edc-4a7e-bdc8-581ae3986519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_256b6e70-abf9-4f33-b07a-2a675ca14b9d" xlink:href="mo-20210930.xsd#mo_LossContingencyClaimsDecidedUnfavorableNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_980f6691-1bd5-481e-8ed7-903e72eb01f3" xlink:to="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_256b6e70-abf9-4f33-b07a-2a675ca14b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsResolvedNumber_6052bb46-e076-4811-9987-a123678735d6" xlink:href="mo-20210930.xsd#mo_LossContingencyClaimsResolvedNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_980f6691-1bd5-481e-8ed7-903e72eb01f3" xlink:to="loc_mo_LossContingencyClaimsResolvedNumber_6052bb46-e076-4811-9987-a123678735d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictReversedNumber_0afb98df-5ef5-4e92-920e-c06430d7a628" xlink:href="mo-20210930.xsd#mo_LossContingencyVerdictReversedNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_980f6691-1bd5-481e-8ed7-903e72eb01f3" xlink:to="loc_mo_LossContingencyVerdictReversedNumber_0afb98df-5ef5-4e92-920e-c06430d7a628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesNonEngleProgenyLitigationDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a9b1424f-ee9e-43cf-a700-c0bdbd599730" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_1ed700d3-2ed0-4ad5-96c8-9a5a7b491dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a9b1424f-ee9e-43cf-a700-c0bdbd599730" xlink:to="loc_us-gaap_LossContingenciesTable_1ed700d3-2ed0-4ad5-96c8-9a5a7b491dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_db623ad5-cdec-4695-8a33-20c625ea084b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1ed700d3-2ed0-4ad5-96c8-9a5a7b491dcc" xlink:to="loc_srt_LitigationCaseAxis_db623ad5-cdec-4695-8a33-20c625ea084b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_80b8670c-c4ff-46e5-8e9b-339d302c699c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_db623ad5-cdec-4695-8a33-20c625ea084b" xlink:to="loc_srt_LitigationCaseTypeDomain_80b8670c-c4ff-46e5-8e9b-339d302c699c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_30148588-6250-43c7-bb82-fe54f9b72c4c" xlink:href="mo-20210930.xsd#mo_NonEngleProgenySmokingAndHealthCasePrincipeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_80b8670c-c4ff-46e5-8e9b-339d302c699c" xlink:to="loc_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_30148588-6250-43c7-bb82-fe54f9b72c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_0c62a4b8-741f-4494-9991-a9cf2b2f0168" xlink:href="mo-20210930.xsd#mo_NonEngleProgenySmokingandHealthCaseGreeneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_80b8670c-c4ff-46e5-8e9b-339d302c699c" xlink:to="loc_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_0c62a4b8-741f-4494-9991-a9cf2b2f0168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseLaramieMember_eb48b133-322b-4dec-b0cd-14a71fb01711" xlink:href="mo-20210930.xsd#mo_NonEngleProgenySmokingandHealthCaseLaramieMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_80b8670c-c4ff-46e5-8e9b-339d302c699c" xlink:to="loc_mo_NonEngleProgenySmokingandHealthCaseLaramieMember_eb48b133-322b-4dec-b0cd-14a71fb01711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseGentileMember_b30813f3-1010-43ae-85f1-103987179349" xlink:href="mo-20210930.xsd#mo_NonEngleProgenySmokingandHealthCaseGentileMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_80b8670c-c4ff-46e5-8e9b-339d302c699c" xlink:to="loc_mo_NonEngleProgenySmokingandHealthCaseGentileMember_b30813f3-1010-43ae-85f1-103987179349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_f3efefa6-a022-466c-82ef-d6dfe02e1db0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1ed700d3-2ed0-4ad5-96c8-9a5a7b491dcc" xlink:to="loc_dei_LegalEntityAxis_f3efefa6-a022-466c-82ef-d6dfe02e1db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a1584237-cb30-4b72-95b3-8b6a884e3041" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_f3efefa6-a022-466c-82ef-d6dfe02e1db0" xlink:to="loc_dei_EntityDomain_a1584237-cb30-4b72-95b3-8b6a884e3041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_17aa819e-1e3f-4550-be11-bf74436d0ae9" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a1584237-cb30-4b72-95b3-8b6a884e3041" xlink:to="loc_mo_PhilipMorrisUSAMember_17aa819e-1e3f-4550-be11-bf74436d0ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_29eefeaf-e9c3-47d4-838d-16983575a5ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1ed700d3-2ed0-4ad5-96c8-9a5a7b491dcc" xlink:to="loc_us-gaap_LossContingenciesLineItems_29eefeaf-e9c3-47d4-838d-16983575a5ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_a0b58bb5-ea0e-4d06-9ed7-fc02e88938ad" xlink:href="mo-20210930.xsd#mo_LossContingencyCompensatoryDamagesAwardedValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_29eefeaf-e9c3-47d4-838d-16983575a5ec" xlink:to="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_a0b58bb5-ea0e-4d06-9ed7-fc02e88938ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue_8a5af126-1236-4091-af93-8929a9c95819" xlink:href="mo-20210930.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_29eefeaf-e9c3-47d4-838d-16983575a5ec" xlink:to="loc_mo_LossContingencyPunitiveDamagesAwardedValue_8a5af126-1236-4091-af93-8929a9c95819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_d4bb98d5-c1ca-491a-bfe0-3defaf1ee3dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_29eefeaf-e9c3-47d4-838d-16983575a5ec" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_d4bb98d5-c1ca-491a-bfe0-3defaf1ee3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_4757dae9-9382-49ea-ad8d-2b87b584b298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_29eefeaf-e9c3-47d4-838d-16983575a5ec" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_4757dae9-9382-49ea-ad8d-2b87b584b298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage_4082991a-82d9-413e-8f2a-f42f4c382ec5" xlink:href="mo-20210930.xsd#mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_29eefeaf-e9c3-47d4-838d-16983575a5ec" xlink:to="loc_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage_4082991a-82d9-413e-8f2a-f42f4c382ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e846f42d-37a7-485d-b448-05fb1a7dbc5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_80827a3d-fd5f-43aa-bfab-8501a0fc183e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e846f42d-37a7-485d-b448-05fb1a7dbc5a" xlink:to="loc_us-gaap_LossContingenciesTable_80827a3d-fd5f-43aa-bfab-8501a0fc183e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_8ba10dd5-5717-40c8-a6a1-7c42794c7fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_80827a3d-fd5f-43aa-bfab-8501a0fc183e" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_8ba10dd5-5717-40c8-a6a1-7c42794c7fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_37e0b3d5-9684-428c-a88b-2243d302fc7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8ba10dd5-5717-40c8-a6a1-7c42794c7fc7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_37e0b3d5-9684-428c-a88b-2243d302fc7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e6b776de-172e-44a6-a59e-bd9573884cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_37e0b3d5-9684-428c-a88b-2243d302fc7c" xlink:to="loc_us-gaap_SubsequentEventMember_e6b776de-172e-44a6-a59e-bd9573884cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_22e7d3fa-d7b8-43fa-b7b4-b359b1a1825d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_80827a3d-fd5f-43aa-bfab-8501a0fc183e" xlink:to="loc_srt_LitigationCaseAxis_22e7d3fa-d7b8-43fa-b7b4-b359b1a1825d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_828753a4-5937-4d33-9485-104b16597927" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_22e7d3fa-d7b8-43fa-b7b4-b359b1a1825d" xlink:to="loc_srt_LitigationCaseTypeDomain_828753a4-5937-4d33-9485-104b16597927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember_113008d1-11d1-40dd-940a-3dfd9ca70c51" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_828753a4-5937-4d33-9485-104b16597927" xlink:to="loc_mo_EngleProgenyCasesMember_113008d1-11d1-40dd-940a-3dfd9ca70c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesStateMember_13c0ea17-f993-431a-912f-f6908eb4f641" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesStateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_EngleProgenyCasesMember_113008d1-11d1-40dd-940a-3dfd9ca70c51" xlink:to="loc_mo_EngleProgenyCasesStateMember_13c0ea17-f993-431a-912f-f6908eb4f641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesFederalMember_83b2a3a3-3868-452c-9298-ba28dae10079" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesFederalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_EngleProgenyCasesMember_113008d1-11d1-40dd-940a-3dfd9ca70c51" xlink:to="loc_mo_EngleProgenyCasesFederalMember_83b2a3a3-3868-452c-9298-ba28dae10079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember_b5532b16-c537-4754-96e8-468501218cb5" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_828753a4-5937-4d33-9485-104b16597927" xlink:to="loc_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember_b5532b16-c537-4754-96e8-468501218cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesReiderandBanksMember_7ab60fd3-c36f-4d73-a2d1-55ecae48c6db" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesReiderandBanksMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_828753a4-5937-4d33-9485-104b16597927" xlink:to="loc_mo_EngleProgenyCasesReiderandBanksMember_7ab60fd3-c36f-4d73-a2d1-55ecae48c6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesWeingartandHancockMember_8b8abdcf-2bec-4c71-957c-e58f7048c325" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesWeingartandHancockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_828753a4-5937-4d33-9485-104b16597927" xlink:to="loc_mo_EngleProgenyCasesWeingartandHancockMember_8b8abdcf-2bec-4c71-957c-e58f7048c325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesPollariMember_f160369d-c172-445f-a1f1-f16564a2d0fb" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesPollariMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_828753a4-5937-4d33-9485-104b16597927" xlink:to="loc_mo_EngleProgenyCasesPollariMember_f160369d-c172-445f-a1f1-f16564a2d0fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_e56027f8-e902-4f5d-829a-e970e3659ebe" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesGlogerRintoulandDuignamMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_828753a4-5937-4d33-9485-104b16597927" xlink:to="loc_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_e56027f8-e902-4f5d-829a-e970e3659ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesFreemanMember_ed3bb2d8-7b3d-4ac6-9e7e-60d1d3801dde" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesFreemanMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_828753a4-5937-4d33-9485-104b16597927" xlink:to="loc_mo_EngleProgenyCasesFreemanMember_ed3bb2d8-7b3d-4ac6-9e7e-60d1d3801dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_1cce1991-b1dc-4bdb-85bf-b5c69ade0475" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_80827a3d-fd5f-43aa-bfab-8501a0fc183e" xlink:to="loc_dei_LegalEntityAxis_1cce1991-b1dc-4bdb-85bf-b5c69ade0475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_02a0981b-6518-4808-b04b-5cb5a484010a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1cce1991-b1dc-4bdb-85bf-b5c69ade0475" xlink:to="loc_dei_EntityDomain_02a0981b-6518-4808-b04b-5cb5a484010a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_02914997-9b71-4f7b-9e9a-b99da6be7191" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_02a0981b-6518-4808-b04b-5cb5a484010a" xlink:to="loc_mo_PhilipMorrisUSAMember_02914997-9b71-4f7b-9e9a-b99da6be7191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_80827a3d-fd5f-43aa-bfab-8501a0fc183e" xlink:to="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue_0dae4df4-9575-42e7-aeec-6b4466ae6e4a" xlink:href="mo-20210930.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_mo_LossContingencyPunitiveDamagesAwardedValue_0dae4df4-9575-42e7-aeec-6b4466ae6e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_c7b22675-b945-4848-bb40-177706189e7f" xlink:href="mo-20210930.xsd#mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_c7b22675-b945-4848-bb40-177706189e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_7303dedc-0c4a-4dbd-99e0-a4c0491e4298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_7303dedc-0c4a-4dbd-99e0-a4c0491e4298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_dbfbb90f-df1c-4097-b2d6-e7d0783f30ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_dbfbb90f-df1c-4097-b2d6-e7d0783f30ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecided_beff213a-fb8d-43c8-b00d-ded6c860e8ae" xlink:href="mo-20210930.xsd#mo_LossContingencyClaimsDecided"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_mo_LossContingencyClaimsDecided_beff213a-fb8d-43c8-b00d-ded6c860e8ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_fb4e2260-9908-4683-a0f9-2561492a7ee5" xlink:href="mo-20210930.xsd#mo_LossContingencyClaimsDecidedUnfavorableNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_fb4e2260-9908-4683-a0f9-2561492a7ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyUnfavorableVerdictsPendingReversed_72aa19c3-009a-4198-9130-5cb767f2a6a9" xlink:href="mo-20210930.xsd#mo_LossContingencyUnfavorableVerdictsPendingReversed"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_mo_LossContingencyUnfavorableVerdictsPendingReversed_72aa19c3-009a-4198-9130-5cb767f2a6a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedFavorableNumber_997b894b-8962-48e8-8b72-06f47095f60b" xlink:href="mo-20210930.xsd#mo_LossContingencyClaimsDecidedFavorableNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_mo_LossContingencyClaimsDecidedFavorableNumber_997b894b-8962-48e8-8b72-06f47095f60b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictReversedNumber_b32427f3-9534-4d15-838e-0f11e283231c" xlink:href="mo-20210930.xsd#mo_LossContingencyVerdictReversedNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_mo_LossContingencyVerdictReversedNumber_b32427f3-9534-4d15-838e-0f11e283231c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyZeroDamagesVerdicts_57d70c0f-1285-459b-b36a-f3fab0c11045" xlink:href="mo-20210930.xsd#mo_LossContingencyZeroDamagesVerdicts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_mo_LossContingencyZeroDamagesVerdicts_57d70c0f-1285-459b-b36a-f3fab0c11045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_56d52c69-dd4c-400b-a9ae-71dbc3259a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_56d52c69-dd4c-400b-a9ae-71dbc3259a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyZeroDamagesVerdictModified_6b5598d8-1f91-4669-9549-8f6ceaf3a3e4" xlink:href="mo-20210930.xsd#mo_LossContingencyZeroDamagesVerdictModified"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_mo_LossContingencyZeroDamagesVerdictModified_6b5598d8-1f91-4669-9549-8f6ceaf3a3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ProvisionRecordedNumberOfCases_27512f54-a880-46c4-b906-afa34b748e08" xlink:href="mo-20210930.xsd#mo_ProvisionRecordedNumberOfCases"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d63bdc28-2884-4e7f-b34e-274230c2350e" xlink:to="loc_mo_ProvisionRecordedNumberOfCases_27512f54-a880-46c4-b906-afa34b748e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_df438cac-1f86-470e-ab30-c2d2eb8c4841" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_b0eafcd2-fadb-413d-bbec-7ae549d2c0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_df438cac-1f86-470e-ab30-c2d2eb8c4841" xlink:to="loc_us-gaap_LossContingenciesTable_b0eafcd2-fadb-413d-bbec-7ae549d2c0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_d9a006ea-5627-4d78-b687-e44ef5791a3a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b0eafcd2-fadb-413d-bbec-7ae549d2c0f6" xlink:to="loc_srt_LitigationCaseAxis_d9a006ea-5627-4d78-b687-e44ef5791a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_d9a006ea-5627-4d78-b687-e44ef5791a3a" xlink:to="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesLippMember_e2f75e8a-78e4-46cf-a003-cca6b817d1f1" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesLippMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesLippMember_e2f75e8a-78e4-46cf-a003-cca6b817d1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGarciaMember_df562140-7be2-4444-bfb4-bdac5a8af53b" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesGarciaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesGarciaMember_df562140-7be2-4444-bfb4-bdac5a8af53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesDuignanMember_5104be37-c735-44b4-bb8b-3f6ba1f69379" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesDuignanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesDuignanMember_5104be37-c735-44b4-bb8b-3f6ba1f69379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesCuddiheeMember_1970f5f4-4d81-4c29-a94d-62047dff0bbf" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesCuddiheeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesCuddiheeMember_1970f5f4-4d81-4c29-a94d-62047dff0bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesRintoulMember_e4092066-a62a-4e95-8a26-d0ea2480f374" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesRintoulMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesRintoulMember_e4092066-a62a-4e95-8a26-d0ea2480f374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGlogerMember_052598a7-fb1e-4fb9-8110-3656e70c662f" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesGlogerMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesGlogerMember_052598a7-fb1e-4fb9-8110-3656e70c662f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMcCallMember_a87bfed7-18fe-41b7-bdd8-5a99c4e59f42" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesMcCallMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesMcCallMember_a87bfed7-18fe-41b7-bdd8-5a99c4e59f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesNeffMember_6dc65d2c-91ab-47e1-ad9c-86e3c401a7ca" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesNeffMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesNeffMember_6dc65d2c-91ab-47e1-ad9c-86e3c401a7ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMahfuzMember_e027328f-a1ae-4894-8c71-9c12a85edd71" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesMahfuzMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesMahfuzMember_e027328f-a1ae-4894-8c71-9c12a85edd71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesHollimanMember_8eb0fb9c-2aae-4238-87e0-d8feb2e3cfcc" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesHollimanMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesHollimanMember_8eb0fb9c-2aae-4238-87e0-d8feb2e3cfcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesChadwellMember_962d6ece-a326-4668-bfb4-3abd901bcf9f" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesChadwellMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesChadwellMember_962d6ece-a326-4668-bfb4-3abd901bcf9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesKaplanMember_f826e25f-0e38-4740-ba50-00da09a27b7f" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesKaplanMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesKaplanMember_f826e25f-0e38-4740-ba50-00da09a27b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesR.DouglasMember_3e04023f-0938-4da4-8ea9-014ee0e0313e" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesR.DouglasMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesR.DouglasMember_3e04023f-0938-4da4-8ea9-014ee0e0313e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesSommersMember_d3c13510-166a-4ffc-99ae-c11f19dfa6d1" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesSommersMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesSommersMember_d3c13510-166a-4ffc-99ae-c11f19dfa6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesCooperMember_c4cb32b1-cde9-4ffe-9ca9-a37de053b332" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesCooperMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesCooperMember_c4cb32b1-cde9-4ffe-9ca9-a37de053b332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesD.BrownMember_347503db-630a-493f-aad8-0296203f259b" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesD.BrownMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesD.BrownMember_347503db-630a-493f-aad8-0296203f259b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesBergerMember_803e9101-3072-4818-a560-618859294e56" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesBergerMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesBergerMember_803e9101-3072-4818-a560-618859294e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesSantoroMember_fc9db265-56d6-472a-a189-a4805e7acf85" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesSantoroMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesSantoroMember_fc9db265-56d6-472a-a189-a4805e7acf85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesNaugleGoreMBrownJordanTheisAndLandiMember_c89eca3e-1430-47d0-b1b0-16d9d1f7f962" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesNaugleGoreMBrownJordanTheisAndLandiMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesNaugleGoreMBrownJordanTheisAndLandiMember_c89eca3e-1430-47d0-b1b0-16d9d1f7f962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesNaugleMember_1049b7b1-9060-48b7-b88d-b53237d018d7" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesNaugleMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesNaugleMember_1049b7b1-9060-48b7-b88d-b53237d018d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGoreMember_363d8a30-e48e-4b9e-b1b0-2f51e6e32179" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesGoreMember"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesGoreMember_363d8a30-e48e-4b9e-b1b0-2f51e6e32179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesM.BrownMember_3d6bb322-e1fe-4b99-9b94-cab1f2e712ce" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesM.BrownMember"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesM.BrownMember_3d6bb322-e1fe-4b99-9b94-cab1f2e712ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesJordanMember_2adac8ed-fbe9-40fa-8e26-9c72daf97cfa" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesJordanMember"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesJordanMember_2adac8ed-fbe9-40fa-8e26-9c72daf97cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesTheisMember_19223226-5e4b-496e-b189-c32da93aa889" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesTheisMember"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesTheisMember_19223226-5e4b-496e-b189-c32da93aa889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesLandiMember_ecf967cd-62ea-4411-b89f-b825763d964a" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesLandiMember"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesLandiMember_ecf967cd-62ea-4411-b89f-b825763d964a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesRJReynoldsMember_276ac9b2-4870-4f7b-a1ed-916870f4eaf8" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesRJReynoldsMember"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf157fdb-082a-43e7-897b-2129d6d95e32" xlink:to="loc_mo_EngleProgenyCasesRJReynoldsMember_276ac9b2-4870-4f7b-a1ed-916870f4eaf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_ab1c644f-e788-476f-b45e-a89055145f87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b0eafcd2-fadb-413d-bbec-7ae549d2c0f6" xlink:to="loc_us-gaap_LitigationStatusAxis_ab1c644f-e788-476f-b45e-a89055145f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_b8428b74-15ec-4741-95aa-1e91b7728898" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_ab1c644f-e788-476f-b45e-a89055145f87" xlink:to="loc_us-gaap_LitigationStatusDomain_b8428b74-15ec-4741-95aa-1e91b7728898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_31368484-2bea-47a7-869a-6b5f4b0b7f94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_b8428b74-15ec-4741-95aa-1e91b7728898" xlink:to="loc_us-gaap_PendingLitigationMember_31368484-2bea-47a7-869a-6b5f4b0b7f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_857f2250-5696-4163-bd63-6d73acccda09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_b8428b74-15ec-4741-95aa-1e91b7728898" xlink:to="loc_us-gaap_SettledLitigationMember_857f2250-5696-4163-bd63-6d73acccda09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_d34178d0-f213-4104-bd48-3d4aba31704d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b0eafcd2-fadb-413d-bbec-7ae549d2c0f6" xlink:to="loc_dei_LegalEntityAxis_d34178d0-f213-4104-bd48-3d4aba31704d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a6ceceb5-019f-4a25-93dc-dd0998a7fb9a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_d34178d0-f213-4104-bd48-3d4aba31704d" xlink:to="loc_dei_EntityDomain_a6ceceb5-019f-4a25-93dc-dd0998a7fb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_c27a4c91-a440-4ac8-bb4e-5f7831129740" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a6ceceb5-019f-4a25-93dc-dd0998a7fb9a" xlink:to="loc_mo_PhilipMorrisUSAMember_c27a4c91-a440-4ac8-bb4e-5f7831129740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_628f7272-1693-4e51-a35d-2afd2fbe211f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b0eafcd2-fadb-413d-bbec-7ae549d2c0f6" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_628f7272-1693-4e51-a35d-2afd2fbe211f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_86dd8111-3ac9-434b-bd7e-24a8b12e7156" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_628f7272-1693-4e51-a35d-2afd2fbe211f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_86dd8111-3ac9-434b-bd7e-24a8b12e7156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_bc7f946d-e303-4a93-abf1-960b5e06e51a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_86dd8111-3ac9-434b-bd7e-24a8b12e7156" xlink:to="loc_us-gaap_SubsequentEventMember_bc7f946d-e303-4a93-abf1-960b5e06e51a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c10c7e64-2959-46b0-ab53-d60f96e17403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b0eafcd2-fadb-413d-bbec-7ae549d2c0f6" xlink:to="loc_us-gaap_LossContingenciesLineItems_c10c7e64-2959-46b0-ab53-d60f96e17403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo_a829c85a-649a-485a-9fd4-4af6b477747d" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c10c7e64-2959-46b0-ab53-d60f96e17403" xlink:to="loc_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo_a829c85a-649a-485a-9fd4-4af6b477747d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_9f755107-063b-4d32-97ce-f1a8f688dbd9" xlink:href="mo-20210930.xsd#mo_LossContingencyCompensatoryDamagesAwardedValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c10c7e64-2959-46b0-ab53-d60f96e17403" xlink:to="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_9f755107-063b-4d32-97ce-f1a8f688dbd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue_52c5af01-fd55-44b9-a911-5786994cd8a1" xlink:href="mo-20210930.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c10c7e64-2959-46b0-ab53-d60f96e17403" xlink:to="loc_mo_LossContingencyPunitiveDamagesAwardedValue_52c5af01-fd55-44b9-a911-5786994cd8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_f53cf924-d5c2-4662-9da4-6296f7284797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c10c7e64-2959-46b0-ab53-d60f96e17403" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_f53cf924-d5c2-4662-9da4-6296f7284797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_bf8af5d5-08e1-41d5-aa4e-6453a63b05f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c10c7e64-2959-46b0-ab53-d60f96e17403" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_bf8af5d5-08e1-41d5-aa4e-6453a63b05f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_667f1923-e496-4be5-ac00-3fdb8fd33f53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c10c7e64-2959-46b0-ab53-d60f96e17403" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_667f1923-e496-4be5-ac00-3fdb8fd33f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesFloridaBondStatuteDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_cef07060-9117-447a-8f34-622100365758" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_55fa7fae-64bd-475e-8ec7-0d8b6cb6cc1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_cef07060-9117-447a-8f34-622100365758" xlink:to="loc_us-gaap_LossContingenciesTable_55fa7fae-64bd-475e-8ec7-0d8b6cb6cc1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_fa37241a-dc56-4e1a-8411-0ad55f467141" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_55fa7fae-64bd-475e-8ec7-0d8b6cb6cc1d" xlink:to="loc_srt_StatementGeographicalAxis_fa37241a-dc56-4e1a-8411-0ad55f467141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8de8a097-6d2f-437e-849f-b742225c9b18" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_fa37241a-dc56-4e1a-8411-0ad55f467141" xlink:to="loc_srt_SegmentGeographicalDomain_8de8a097-6d2f-437e-849f-b742225c9b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_dd4f8284-aa0e-4308-a9ed-7a9ae12d3c57" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_FL"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8de8a097-6d2f-437e-849f-b742225c9b18" xlink:to="loc_stpr_FL_dd4f8284-aa0e-4308-a9ed-7a9ae12d3c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_7502628f-a095-4f8b-8267-2d08e617d023" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_55fa7fae-64bd-475e-8ec7-0d8b6cb6cc1d" xlink:to="loc_srt_LitigationCaseAxis_7502628f-a095-4f8b-8267-2d08e617d023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_94719271-5f3c-4121-b547-e0a8f29f1fe7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_7502628f-a095-4f8b-8267-2d08e617d023" xlink:to="loc_srt_LitigationCaseTypeDomain_94719271-5f3c-4121-b547-e0a8f29f1fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesStateMember_23aa80f9-1f29-40b2-8ef5-e8275970bc6e" xlink:href="mo-20210930.xsd#mo_EngleProgenyCasesStateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_94719271-5f3c-4121-b547-e0a8f29f1fe7" xlink:to="loc_mo_EngleProgenyCasesStateMember_23aa80f9-1f29-40b2-8ef5-e8275970bc6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ec293dfc-b4cd-4dc6-8ca0-e6acabafb4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_55fa7fae-64bd-475e-8ec7-0d8b6cb6cc1d" xlink:to="loc_us-gaap_LossContingenciesLineItems_ec293dfc-b4cd-4dc6-8ca0-e6acabafb4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MaximumBondForAllDefendants_e268aaf7-8534-47d8-996a-bcd8b1780a7e" xlink:href="mo-20210930.xsd#mo_MaximumBondForAllDefendants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ec293dfc-b4cd-4dc6-8ca0-e6acabafb4f1" xlink:to="loc_mo_MaximumBondForAllDefendants_e268aaf7-8534-47d8-996a-bcd8b1780a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesOtherSmokingandHealthClassActionsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_41a197a5-f2d6-4448-9162-966329134091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_954d3b4e-9ac0-44f4-8df3-e26c4f3fb8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_41a197a5-f2d6-4448-9162-966329134091" xlink:to="loc_us-gaap_LossContingenciesTable_954d3b4e-9ac0-44f4-8df3-e26c4f3fb8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a86e77b5-786d-4324-97bb-4198c64f9e8b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_954d3b4e-9ac0-44f4-8df3-e26c4f3fb8f6" xlink:to="loc_srt_StatementGeographicalAxis_a86e77b5-786d-4324-97bb-4198c64f9e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_a86e77b5-786d-4324-97bb-4198c64f9e8b" xlink:to="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AR_b052de5c-762b-43fc-b32f-7c0422d0a27a" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_AR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_AR_b052de5c-762b-43fc-b32f-7c0422d0a27a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_73b146e8-9ffc-4a34-b4c1-79ae6e1e9bdf" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_CA"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_CA_73b146e8-9ffc-4a34-b4c1-79ae6e1e9bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DE_2878c2b1-fcce-416d-bf4f-b0e87ec4ccab" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_DE"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_DE_2878c2b1-fcce-416d-bf4f-b0e87ec4ccab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DC_48b8710a-9f2b-4880-b5d6-625ed06367fd" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_DC"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_DC_48b8710a-9f2b-4880-b5d6-625ed06367fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_7a0134ac-c705-4f13-8b1a-4890e32d52e3" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_FL"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_FL_7a0134ac-c705-4f13-8b1a-4890e32d52e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IL_61131b94-83b8-48d6-91d4-f04a04b3135d" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_IL"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_IL_61131b94-83b8-48d6-91d4-f04a04b3135d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IA_91bec151-deba-4a64-8971-70d5716ba970" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_IA"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_IA_91bec151-deba-4a64-8971-70d5716ba970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_KS_17b230fd-9e69-465c-a8c6-b2572ec097b5" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_KS"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_KS_17b230fd-9e69-465c-a8c6-b2572ec097b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_LA_9bc24e4b-230e-4fad-853c-840e0a51a380" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_LA"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_LA_9bc24e4b-230e-4fad-853c-840e0a51a380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MD_da9ad02c-545f-4485-a4e1-b21cbd646195" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MD"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_MD_da9ad02c-545f-4485-a4e1-b21cbd646195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MI_811b7d50-58f8-4fc5-b825-c2498b113b35" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MI"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_MI_811b7d50-58f8-4fc5-b825-c2498b113b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MN_a730c63b-dd20-4547-9dda-411577a84e20" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MN"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_MN_a730c63b-dd20-4547-9dda-411577a84e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NV_3b658d89-28f3-4fee-954f-3ec3b588e0b9" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_NV"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_NV_3b658d89-28f3-4fee-954f-3ec3b588e0b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ_8d6b1f6d-e1e8-4101-ba72-03babaf7a2af" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_NJ"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_NJ_8d6b1f6d-e1e8-4101-ba72-03babaf7a2af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_eb0abe00-8731-4a50-8d9e-9affd7f2ea9f" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_NY"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_NY_eb0abe00-8731-4a50-8d9e-9affd7f2ea9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OH_f809755b-30db-4717-ab51-ceabe3fd6822" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_OH"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_OH_f809755b-30db-4717-ab51-ceabe3fd6822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OK_2bc3b729-4371-4eb3-a58d-133e9e239112" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_OK"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_OK_2bc3b729-4371-4eb3-a58d-133e9e239112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OR_32c31469-5a94-4c15-87ab-d402694180d4" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_OR"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_OR_32c31469-5a94-4c15-87ab-d402694180d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_PA_2d3729cb-8bc9-4169-9605-bffceee59285" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_PA"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_PA_2d3729cb-8bc9-4169-9605-bffceee59285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_PR_a9f1abee-d3af-4b8b-b552-83cf5f5a9345" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_PR"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_country_PR_a9f1abee-d3af-4b8b-b552-83cf5f5a9345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_SC_127ba1be-f93c-4089-af43-713229df7e9c" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_SC"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_SC_127ba1be-f93c-4089-af43-713229df7e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_ea528225-86e7-4e9d-b673-5221f99b39d8" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_TX"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_TX_ea528225-86e7-4e9d-b673-5221f99b39d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WI_21d20026-033e-4c5b-99cf-f1c84004cc19" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_WI"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_stpr_WI_21d20026-033e-4c5b-99cf-f1c84004cc19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_14b6f60a-a290-443d-9fa0-77561b7ab213" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_country_CA_14b6f60a-a290-443d-9fa0-77561b7ab213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_BritishColumbiaSaskatchewanMember_8a0ade4c-b03b-4e5f-a013-52aec4184bc6" xlink:href="mo-20210930.xsd#mo_BritishColumbiaSaskatchewanMember"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a666335b-3612-4e10-bed9-13ae56ad7771" xlink:to="loc_mo_BritishColumbiaSaskatchewanMember_8a0ade4c-b03b-4e5f-a013-52aec4184bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c2fd9f97-c22c-40bb-890d-6c6560ec4b16" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_954d3b4e-9ac0-44f4-8df3-e26c4f3fb8f6" xlink:to="loc_dei_LegalEntityAxis_c2fd9f97-c22c-40bb-890d-6c6560ec4b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_01543eba-562c-43a1-8c03-eb1f5e202ef9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_c2fd9f97-c22c-40bb-890d-6c6560ec4b16" xlink:to="loc_dei_EntityDomain_01543eba-562c-43a1-8c03-eb1f5e202ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_a9381b32-eef3-4de1-9fb8-6fec0df64b5b" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_01543eba-562c-43a1-8c03-eb1f5e202ef9" xlink:to="loc_mo_PhilipMorrisUSAMember_a9381b32-eef3-4de1-9fb8-6fec0df64b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAandAltriaGroupMember_e78dfe01-6e26-4455-bc06-c1418cc09250" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAandAltriaGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_01543eba-562c-43a1-8c03-eb1f5e202ef9" xlink:to="loc_mo_PhilipMorrisUSAandAltriaGroupMember_e78dfe01-6e26-4455-bc06-c1418cc09250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CanadianTobaccoManufacturersMember_1cd6bcb3-9f99-4333-83d7-0947cd31e391" xlink:href="mo-20210930.xsd#mo_CanadianTobaccoManufacturersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_01543eba-562c-43a1-8c03-eb1f5e202ef9" xlink:to="loc_mo_CanadianTobaccoManufacturersMember_1cd6bcb3-9f99-4333-83d7-0947cd31e391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AltriaGroupMember_67494553-d246-4c29-937a-f7daf3510676" xlink:href="mo-20210930.xsd#mo_AltriaGroupMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_01543eba-562c-43a1-8c03-eb1f5e202ef9" xlink:to="loc_mo_AltriaGroupMember_67494553-d246-4c29-937a-f7daf3510676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_8b84a230-d179-4193-b95a-6bc1683d526b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_954d3b4e-9ac0-44f4-8df3-e26c4f3fb8f6" xlink:to="loc_srt_LitigationCaseAxis_8b84a230-d179-4193-b95a-6bc1683d526b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7cfa08a5-316b-4ead-bd62-c1494cf3ec65" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_8b84a230-d179-4193-b95a-6bc1683d526b" xlink:to="loc_srt_LitigationCaseTypeDomain_7cfa08a5-316b-4ead-bd62-c1494cf3ec65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsMember_49fc184e-3d66-445d-80f6-ea3236b84e4a" xlink:href="mo-20210930.xsd#mo_SmokingAndHealthClassActionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cfa08a5-316b-4ead-bd62-c1494cf3ec65" xlink:to="loc_mo_SmokingAndHealthClassActionsMember_49fc184e-3d66-445d-80f6-ea3236b84e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_56833547-12c0-4dda-ae06-21bac709f4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_954d3b4e-9ac0-44f4-8df3-e26c4f3fb8f6" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_56833547-12c0-4dda-ae06-21bac709f4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_16ed109a-a764-4c6a-9e46-744a42e78025" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_56833547-12c0-4dda-ae06-21bac709f4e9" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_16ed109a-a764-4c6a-9e46-744a42e78025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e33752c7-fdb0-4a52-93b2-267d448d118b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_16ed109a-a764-4c6a-9e46-744a42e78025" xlink:to="loc_us-gaap_SubsequentEventMember_e33752c7-fdb0-4a52-93b2-267d448d118b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_a8ee4d5e-6b78-469d-8185-b3bb347ac0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_954d3b4e-9ac0-44f4-8df3-e26c4f3fb8f6" xlink:to="loc_us-gaap_LossContingenciesLineItems_a8ee4d5e-6b78-469d-8185-b3bb347ac0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassNotCertifiedNumber_d7e844c7-9f5e-46c0-b106-280ad09a736b" xlink:href="mo-20210930.xsd#mo_LossContingencyClassNotCertifiedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a8ee4d5e-6b78-469d-8185-b3bb347ac0c4" xlink:to="loc_mo_LossContingencyClassNotCertifiedNumber_d7e844c7-9f5e-46c0-b106-280ad09a736b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_0b115b35-790f-4b30-833f-ec989e770c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a8ee4d5e-6b78-469d-8185-b3bb347ac0c4" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_0b115b35-790f-4b30-833f-ec989e770c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofManufacturers_2ee12b3c-145f-4260-a9c7-22b2040a4eb3" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberofManufacturers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a8ee4d5e-6b78-469d-8185-b3bb347ac0c4" xlink:to="loc_mo_LossContingencyNumberofManufacturers_2ee12b3c-145f-4260-a9c7-22b2040a4eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictsUpheld_001ef8ff-4728-498a-bac6-b9f5b9becde5" xlink:href="mo-20210930.xsd#mo_LossContingencyVerdictsUpheld"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a8ee4d5e-6b78-469d-8185-b3bb347ac0c4" xlink:to="loc_mo_LossContingencyVerdictsUpheld_001ef8ff-4728-498a-bac6-b9f5b9becde5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AmountAwardedtoOtherParty_3d03b503-6407-436c-a2ab-a73fc45f8056" xlink:href="mo-20210930.xsd#mo_AmountAwardedtoOtherParty"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a8ee4d5e-6b78-469d-8185-b3bb347ac0c4" xlink:to="loc_mo_AmountAwardedtoOtherParty_3d03b503-6407-436c-a2ab-a73fc45f8056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesHealthCareCostRecoveryLitigationDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c8d3d14b-05d3-48c7-863e-60ade2898e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_99e4a3d3-43ee-4ce8-9be6-aec45ee67fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c8d3d14b-05d3-48c7-863e-60ade2898e9f" xlink:to="loc_us-gaap_LossContingenciesTable_99e4a3d3-43ee-4ce8-9be6-aec45ee67fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_898362c4-a809-4d9a-81eb-aef337eeb197" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_99e4a3d3-43ee-4ce8-9be6-aec45ee67fe0" xlink:to="loc_dei_LegalEntityAxis_898362c4-a809-4d9a-81eb-aef337eeb197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c23dc1cb-b685-4406-8166-8ee265e4d0c3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_898362c4-a809-4d9a-81eb-aef337eeb197" xlink:to="loc_dei_EntityDomain_c23dc1cb-b685-4406-8166-8ee265e4d0c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CanadianTobaccoManufacturersMember_78dd0c81-c124-4780-a8bc-000caf754ac3" xlink:href="mo-20210930.xsd#mo_CanadianTobaccoManufacturersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_c23dc1cb-b685-4406-8166-8ee265e4d0c3" xlink:to="loc_mo_CanadianTobaccoManufacturersMember_78dd0c81-c124-4780-a8bc-000caf754ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_d14488ef-304f-4ef7-83d7-82f18d5c9a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_99e4a3d3-43ee-4ce8-9be6-aec45ee67fe0" xlink:to="loc_us-gaap_LitigationStatusAxis_d14488ef-304f-4ef7-83d7-82f18d5c9a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_effe74aa-97ea-460e-a930-ae268fd0d389" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_d14488ef-304f-4ef7-83d7-82f18d5c9a4e" xlink:to="loc_us-gaap_LitigationStatusDomain_effe74aa-97ea-460e-a930-ae268fd0d389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ThreatenedLitigationMember_cc233d80-d873-4345-8939-a46b1a2f505a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ThreatenedLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_effe74aa-97ea-460e-a930-ae268fd0d389" xlink:to="loc_us-gaap_ThreatenedLitigationMember_cc233d80-d873-4345-8939-a46b1a2f505a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_768e97fe-d0e1-4281-9bb6-cc5169c4ec02" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_99e4a3d3-43ee-4ce8-9be6-aec45ee67fe0" xlink:to="loc_srt_StatementGeographicalAxis_768e97fe-d0e1-4281-9bb6-cc5169c4ec02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_cce5be4b-fc64-4f2a-a05a-ee877d031c6f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_768e97fe-d0e1-4281-9bb6-cc5169c4ec02" xlink:to="loc_srt_SegmentGeographicalDomain_cce5be4b-fc64-4f2a-a05a-ee877d031c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_d4c49157-e4e3-4993-a449-f7346da252c3" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cce5be4b-fc64-4f2a-a05a-ee877d031c6f" xlink:to="loc_country_CA_d4c49157-e4e3-4993-a449-f7346da252c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_8d467970-b3cb-4d16-bff1-922f6d2dc64a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_99e4a3d3-43ee-4ce8-9be6-aec45ee67fe0" xlink:to="loc_srt_LitigationCaseAxis_8d467970-b3cb-4d16-bff1-922f6d2dc64a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_78822751-c15d-4cc3-b64d-bda78249bd7f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_8d467970-b3cb-4d16-bff1-922f6d2dc64a" xlink:to="loc_srt_LitigationCaseTypeDomain_78822751-c15d-4cc3-b64d-bda78249bd7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_b7188c5d-723d-4c14-a710-e8d4dc36af9f" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_78822751-c15d-4cc3-b64d-bda78249bd7f" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_b7188c5d-723d-4c14-a710-e8d4dc36af9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsMember_13e4371b-7c10-4f73-af52-28dfe20225f8" xlink:href="mo-20210930.xsd#mo_SmokingAndHealthClassActionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_78822751-c15d-4cc3-b64d-bda78249bd7f" xlink:to="loc_mo_SmokingAndHealthClassActionsMember_13e4371b-7c10-4f73-af52-28dfe20225f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_9958f2cf-c769-41f4-9cbd-6bcd4d727b09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_99e4a3d3-43ee-4ce8-9be6-aec45ee67fe0" xlink:to="loc_us-gaap_LossContingenciesLineItems_9958f2cf-c769-41f4-9cbd-6bcd4d727b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_09d8c480-cf65-4533-8534-2585d33809f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9958f2cf-c769-41f4-9cbd-6bcd4d727b09" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_09d8c480-cf65-4533-8534-2585d33809f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofManufacturers_d930fa06-b1fe-458a-a885-cf1b7483b2f5" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberofManufacturers"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9958f2cf-c769-41f4-9cbd-6bcd4d727b09" xlink:to="loc_mo_LossContingencyNumberofManufacturers_d930fa06-b1fe-458a-a885-cf1b7483b2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigation_8b2f3a92-2c7b-4d6b-9422-e41321be3723" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberofStateswithSettledLitigation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9958f2cf-c769-41f4-9cbd-6bcd4d727b09" xlink:to="loc_mo_LossContingencyNumberofStateswithSettledLitigation_8b2f3a92-2c7b-4d6b-9422-e41321be3723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAnnualPaymentAmount_dab75431-efce-48ad-b9b0-e1dd2738dc00" xlink:href="mo-20210930.xsd#mo_LitigationSettlementAnnualPaymentAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9958f2cf-c769-41f4-9cbd-6bcd4d727b09" xlink:to="loc_mo_LitigationSettlementAnnualPaymentAmount_dab75431-efce-48ad-b9b0-e1dd2738dc00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_73e7625b-49dc-4542-82e6-a9ee96c850af" xlink:href="mo-20210930.xsd#mo_LitigationSettlementAnnualLegalFeesPayableMaximum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9958f2cf-c769-41f4-9cbd-6bcd4d727b09" xlink:to="loc_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_73e7625b-49dc-4542-82e6-a9ee96c850af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_8e9de2d8-90b4-4c9d-abdf-d68887fe1174" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9958f2cf-c769-41f4-9cbd-6bcd4d727b09" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_8e9de2d8-90b4-4c9d-abdf-d68887fe1174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesNPMAdjustmentDisputesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_25962e20-dd23-4147-9a13-1b447f8ef86b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_2ab54e45-f6e5-4b65-b2d4-f2b910dcaf29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_25962e20-dd23-4147-9a13-1b447f8ef86b" xlink:to="loc_us-gaap_LossContingenciesTable_2ab54e45-f6e5-4b65-b2d4-f2b910dcaf29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d68b2efa-a92e-4172-8af8-723b74aa47a5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2ab54e45-f6e5-4b65-b2d4-f2b910dcaf29" xlink:to="loc_srt_StatementGeographicalAxis_d68b2efa-a92e-4172-8af8-723b74aa47a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3121253d-9e29-4dbf-b0cf-08c6198f7937" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_d68b2efa-a92e-4172-8af8-723b74aa47a5" xlink:to="loc_srt_SegmentGeographicalDomain_3121253d-9e29-4dbf-b0cf-08c6198f7937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_7ca85ee2-0db4-4083-b6fd-47e0ec540650" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_NY"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3121253d-9e29-4dbf-b0cf-08c6198f7937" xlink:to="loc_stpr_NY_7ca85ee2-0db4-4083-b6fd-47e0ec540650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MT_4597f340-d001-4df6-a146-9b6fe86aeffd" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MT"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3121253d-9e29-4dbf-b0cf-08c6198f7937" xlink:to="loc_stpr_MT_4597f340-d001-4df6-a146-9b6fe86aeffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_68b95236-dfeb-4bb8-ac8c-39e1f07284d7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2ab54e45-f6e5-4b65-b2d4-f2b910dcaf29" xlink:to="loc_dei_LegalEntityAxis_68b95236-dfeb-4bb8-ac8c-39e1f07284d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9879bb41-e35f-4971-94e1-a91515098167" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_68b95236-dfeb-4bb8-ac8c-39e1f07284d7" xlink:to="loc_dei_EntityDomain_9879bb41-e35f-4971-94e1-a91515098167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_60720c06-65e7-4a5f-81c5-3057f693c625" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_9879bb41-e35f-4971-94e1-a91515098167" xlink:to="loc_mo_PhilipMorrisUSAMember_60720c06-65e7-4a5f-81c5-3057f693c625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_0d8d5b4f-a64d-4bda-bbda-3a14f395c06d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2ab54e45-f6e5-4b65-b2d4-f2b910dcaf29" xlink:to="loc_srt_LitigationCaseAxis_0d8d5b4f-a64d-4bda-bbda-3a14f395c06d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_11df2369-cdda-436a-91be-523ebd7e923d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_0d8d5b4f-a64d-4bda-bbda-3a14f395c06d" xlink:to="loc_srt_LitigationCaseTypeDomain_11df2369-cdda-436a-91be-523ebd7e923d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_11df2369-cdda-436a-91be-523ebd7e923d" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_9642b7ac-f3ec-414c-ac2f-a2fbb2b72eab" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_9642b7ac-f3ec-414c-ac2f-a2fbb2b72eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_7e93a069-82b3-4979-b6f1-99193c71da76" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_7e93a069-82b3-4979-b6f1-99193c71da76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_947a85f8-966d-4549-a503-cb8420ac7f54" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_947a85f8-966d-4549-a503-cb8420ac7f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_dba01c3d-1809-4780-baae-fdcd9f6d90ff" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_dba01c3d-1809-4780-baae-fdcd9f6d90ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_b92811cb-9bad-4500-98b5-4b9605200cad" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_b92811cb-9bad-4500-98b5-4b9605200cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_d49bd932-24c3-4508-b0c4-a626615a8833" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_d49bd932-24c3-4508-b0c4-a626615a8833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_c0cf662d-b56d-4f86-959d-18fedcbc1fc5" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_c0cf662d-b56d-4f86-959d-18fedcbc1fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_2c902dad-7bd9-4eaf-8c8d-c0be06e0d2e3" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_2c902dad-7bd9-4eaf-8c8d-c0be06e0d2e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_d6d49442-ca13-4f3a-832b-6c1338dcc1ac" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_d6d49442-ca13-4f3a-832b-6c1338dcc1ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_ebce2ac3-882b-436c-abd6-582845294573" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_ebce2ac3-882b-436c-abd6-582845294573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_63dc7288-4a24-454d-8d8c-54e557b06c17" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_63dc7288-4a24-454d-8d8c-54e557b06c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_6ee29c26-80a8-4105-b386-5a74e882a84f" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_6ee29c26-80a8-4105-b386-5a74e882a84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_266aefac-5e9e-465c-afb9-4404535baa33" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_266aefac-5e9e-465c-afb9-4404535baa33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_12ca49e7-20f2-406f-8960-85207dc7c3b2" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_12ca49e7-20f2-406f-8960-85207dc7c3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_83c49271-132a-45a9-aec5-3f1e2cc806d5" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_83c49271-132a-45a9-aec5-3f1e2cc806d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_d21381bb-1639-4f36-83dc-d4de41fe60e1" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_d21381bb-1639-4f36-83dc-d4de41fe60e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember_ba332393-6f8c-422e-9cb8-73f49114fb70" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember_ba332393-6f8c-422e-9cb8-73f49114fb70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member_2998063f-6261-4d2f-9539-942d95b77385" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActionsTransitionYears20042020Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member_2998063f-6261-4d2f-9539-942d95b77385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember_c0dacca5-8463-4084-a3b0-92b37a39cf52" xlink:href="mo-20210930.xsd#mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_18c7e8fb-4b0b-4181-ad76-a8926b7e9de3" xlink:to="loc_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember_c0dacca5-8463-4084-a3b0-92b37a39cf52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_30608a65-46c2-44db-a286-9deaa3d9f16f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2ab54e45-f6e5-4b65-b2d4-f2b910dcaf29" xlink:to="loc_us-gaap_LitigationStatusAxis_30608a65-46c2-44db-a286-9deaa3d9f16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_9a18ce78-4110-4651-b20e-40e537d7c606" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_30608a65-46c2-44db-a286-9deaa3d9f16f" xlink:to="loc_us-gaap_LitigationStatusDomain_9a18ce78-4110-4651-b20e-40e537d7c606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_3159a5ad-c9d9-4f39-a571-634c4a4cfe9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_9a18ce78-4110-4651-b20e-40e537d7c606" xlink:to="loc_us-gaap_SettledLitigationMember_3159a5ad-c9d9-4f39-a571-634c4a4cfe9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_ad1b2efe-9f43-49b7-ac5b-3e21e419fe25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_9a18ce78-4110-4651-b20e-40e537d7c606" xlink:to="loc_us-gaap_PendingLitigationMember_ad1b2efe-9f43-49b7-ac5b-3e21e419fe25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ArbitrationPeriodAxis_4077fa45-bdf4-450f-8fa2-762e8c887c4f" xlink:href="mo-20210930.xsd#mo_ArbitrationPeriodAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2ab54e45-f6e5-4b65-b2d4-f2b910dcaf29" xlink:to="loc_mo_ArbitrationPeriodAxis_4077fa45-bdf4-450f-8fa2-762e8c887c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ArbitrationPeriodDomain_4fb7df8c-391e-4942-8014-9c37712cea17" xlink:href="mo-20210930.xsd#mo_ArbitrationPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ArbitrationPeriodAxis_4077fa45-bdf4-450f-8fa2-762e8c887c4f" xlink:to="loc_mo_ArbitrationPeriodDomain_4fb7df8c-391e-4942-8014-9c37712cea17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PeriodOneMember_f9bdd316-79c1-4539-864a-8afb663c4042" xlink:href="mo-20210930.xsd#mo_PeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ArbitrationPeriodDomain_4fb7df8c-391e-4942-8014-9c37712cea17" xlink:to="loc_mo_PeriodOneMember_f9bdd316-79c1-4539-864a-8afb663c4042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PeriodTwoMember_512056a7-ee76-45e2-9141-30a5d638dfb4" xlink:href="mo-20210930.xsd#mo_PeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ArbitrationPeriodDomain_4fb7df8c-391e-4942-8014-9c37712cea17" xlink:to="loc_mo_PeriodTwoMember_512056a7-ee76-45e2-9141-30a5d638dfb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2b329aef-c539-47ad-ad78-a545b67545ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2ab54e45-f6e5-4b65-b2d4-f2b910dcaf29" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2b329aef-c539-47ad-ad78-a545b67545ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2ed7b6ad-4042-49b9-81b7-37846af49da5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2b329aef-c539-47ad-ad78-a545b67545ec" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2ed7b6ad-4042-49b9-81b7-37846af49da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_19e7fb05-33d9-4762-bc9a-7f8f37ec816d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2ed7b6ad-4042-49b9-81b7-37846af49da5" xlink:to="loc_us-gaap_CostOfSalesMember_19e7fb05-33d9-4762-bc9a-7f8f37ec816d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2ab54e45-f6e5-4b65-b2d4-f2b910dcaf29" xlink:to="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementEstimateofPossibleGain_088e58c2-0b01-4632-a837-4c14f34fa12e" xlink:href="mo-20210930.xsd#mo_LitigationSettlementEstimateofPossibleGain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_mo_LitigationSettlementEstimateofPossibleGain_088e58c2-0b01-4632-a837-4c14f34fa12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_3a5c361f-18ae-4a79-a474-d190590f7ca6" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_3a5c361f-18ae-4a79-a474-d190590f7ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_6bc1497f-943e-4739-945e-a119b43c9b8d" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_6bc1497f-943e-4739-945e-a119b43c9b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_89e95247-0ab2-4677-93b6-eacd7c60eb02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_89e95247-0ab2-4677-93b6-eacd7c60eb02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty_a34b39d4-4f8b-414e-a0ae-ee1dd7dd4fd4" xlink:href="mo-20210930.xsd#mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty_a34b39d4-4f8b-414e-a0ae-ee1dd7dd4fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_50af5aa5-2f89-4db5-8dc7-a56cc766b4a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_50af5aa5-2f89-4db5-8dc7-a56cc766b4a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotSettled_aef18c85-3da4-4063-b959-984d6c1e3f21" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfStatesNotSettled"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_mo_LossContingencyNumberOfStatesNotSettled_aef18c85-3da4-4063-b959-984d6c1e3f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesWithConcludedHearings_85e6be36-d81e-413c-bfc5-9b6286e80948" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfStatesWithConcludedHearings"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_mo_LossContingencyNumberOfStatesWithConcludedHearings_85e6be36-d81e-413c-bfc5-9b6286e80948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues_a52aa95a-711d-4bde-9dcb-d88b0cf4fa79" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues_a52aa95a-711d-4bde-9dcb-d88b0cf4fa79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues_7ca3b4ba-d3d8-4a67-9c47-f27de1919371" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues_7ca3b4ba-d3d8-4a67-9c47-f27de1919371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyReductionToCostOfSales_1a84bf4f-81e0-431f-afc5-a6de539c6d80" xlink:href="mo-20210930.xsd#mo_LossContingencyReductionToCostOfSales"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_mo_LossContingencyReductionToCostOfSales_1a84bf4f-81e0-431f-afc5-a6de539c6d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_a2c335c8-8f50-47ef-a72f-589d2054a879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_a2c335c8-8f50-47ef-a72f-589d2054a879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod_38d39b6a-36a8-4741-8d77-26e22afcf5af" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d2f40feb-73c2-49c3-9c5c-f36bd99d9fb6" xlink:to="loc_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod_38d39b6a-36a8-4741-8d77-26e22afcf5af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5e967ac4-cb06-4f1d-a2ac-c55f8c73b753" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_efce0d71-5c3f-4484-a454-ae2b4072de7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5e967ac4-cb06-4f1d-a2ac-c55f8c73b753" xlink:to="loc_us-gaap_LossContingenciesTable_efce0d71-5c3f-4484-a454-ae2b4072de7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_f53db878-5aed-49e8-9793-c2fe20179af7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_efce0d71-5c3f-4484-a454-ae2b4072de7e" xlink:to="loc_dei_LegalEntityAxis_f53db878-5aed-49e8-9793-c2fe20179af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ff2f0219-50b0-4358-a442-be1f2cd4e576" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_f53db878-5aed-49e8-9793-c2fe20179af7" xlink:to="loc_dei_EntityDomain_ff2f0219-50b0-4358-a442-be1f2cd4e576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_0c0ec754-e413-4332-b692-56083fdfc222" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_ff2f0219-50b0-4358-a442-be1f2cd4e576" xlink:to="loc_mo_PhilipMorrisUSAMember_0c0ec754-e413-4332-b692-56083fdfc222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_2cd1fd0c-0aae-402d-80d6-85e6f333d35a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_efce0d71-5c3f-4484-a454-ae2b4072de7e" xlink:to="loc_srt_LitigationCaseAxis_2cd1fd0c-0aae-402d-80d6-85e6f333d35a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_2aefdc4b-054e-4448-9af6-da5f49feda4e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_2cd1fd0c-0aae-402d-80d6-85e6f333d35a" xlink:to="loc_srt_LitigationCaseTypeDomain_2aefdc4b-054e-4448-9af6-da5f49feda4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherDisputesUndertheStateSettlementAgreementsMember_5ff2a3b8-81a8-43d6-b4b1-437ff91bec52" xlink:href="mo-20210930.xsd#mo_OtherDisputesUndertheStateSettlementAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_2aefdc4b-054e-4448-9af6-da5f49feda4e" xlink:to="loc_mo_OtherDisputesUndertheStateSettlementAgreementsMember_5ff2a3b8-81a8-43d6-b4b1-437ff91bec52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_912caf8d-d49f-47cf-a05c-5d0b41550dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_efce0d71-5c3f-4484-a454-ae2b4072de7e" xlink:to="loc_us-gaap_LossContingenciesLineItems_912caf8d-d49f-47cf-a05c-5d0b41550dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_697f7e33-c1e1-4762-a63e-4e5d60f91037" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_912caf8d-d49f-47cf-a05c-5d0b41550dc9" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_697f7e33-c1e1-4762-a63e-4e5d60f91037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesFederalGovernmentsLawsuitDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_51554f99-4891-4fe9-88b7-17eb25a28141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_6e74f327-9d4c-41b6-a2a0-0577417c50b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_51554f99-4891-4fe9-88b7-17eb25a28141" xlink:to="loc_us-gaap_LossContingenciesTable_6e74f327-9d4c-41b6-a2a0-0577417c50b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_302e70c6-fb0c-498c-b0aa-29b28075993c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6e74f327-9d4c-41b6-a2a0-0577417c50b5" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_302e70c6-fb0c-498c-b0aa-29b28075993c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_e74710ea-9d92-493f-9c76-55d1b650bbdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_302e70c6-fb0c-498c-b0aa-29b28075993c" xlink:to="loc_us-gaap_LossContingencyNatureDomain_e74710ea-9d92-493f-9c76-55d1b650bbdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ImplementationofCorrectiveCommunicationsMember_10e98063-a251-46b9-9d09-90dc8afbc789" xlink:href="mo-20210930.xsd#mo_ImplementationofCorrectiveCommunicationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_e74710ea-9d92-493f-9c76-55d1b650bbdc" xlink:to="loc_mo_ImplementationofCorrectiveCommunicationsMember_10e98063-a251-46b9-9d09-90dc8afbc789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_5b6b1dc7-33e2-4da8-831a-afe16cea3e5c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6e74f327-9d4c-41b6-a2a0-0577417c50b5" xlink:to="loc_srt_LitigationCaseAxis_5b6b1dc7-33e2-4da8-831a-afe16cea3e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_914bfc05-e77d-48b6-8a91-3e7704919fc5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_5b6b1dc7-33e2-4da8-831a-afe16cea3e5c" xlink:to="loc_srt_LitigationCaseTypeDomain_914bfc05-e77d-48b6-8a91-3e7704919fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalGovernmentsLawsuitMember_35970922-7857-406e-aa68-c993673dd145" xlink:href="mo-20210930.xsd#mo_FederalGovernmentsLawsuitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_914bfc05-e77d-48b6-8a91-3e7704919fc5" xlink:to="loc_mo_FederalGovernmentsLawsuitMember_35970922-7857-406e-aa68-c993673dd145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b2b4f4d1-51a7-4e18-9a8d-dc781bd5f0b3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6e74f327-9d4c-41b6-a2a0-0577417c50b5" xlink:to="loc_dei_LegalEntityAxis_b2b4f4d1-51a7-4e18-9a8d-dc781bd5f0b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_12ffe043-9eca-4feb-bccd-547e5cca731b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_b2b4f4d1-51a7-4e18-9a8d-dc781bd5f0b3" xlink:to="loc_dei_EntityDomain_12ffe043-9eca-4feb-bccd-547e5cca731b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_ed6d454d-8d51-4a48-b3da-32a6bce02555" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_12ffe043-9eca-4feb-bccd-547e5cca731b" xlink:to="loc_mo_PhilipMorrisUSAMember_ed6d454d-8d51-4a48-b3da-32a6bce02555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AltriaGroupMember_7d4ecff8-ff2c-4038-be14-4e2e17bba84c" xlink:href="mo-20210930.xsd#mo_AltriaGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_12ffe043-9eca-4feb-bccd-547e5cca731b" xlink:to="loc_mo_AltriaGroupMember_7d4ecff8-ff2c-4038-be14-4e2e17bba84c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_bc16a862-c5f0-469c-9480-976e884f3cef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6e74f327-9d4c-41b6-a2a0-0577417c50b5" xlink:to="loc_us-gaap_LossContingenciesLineItems_bc16a862-c5f0-469c-9480-976e884f3cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalTradeCommissionDisclosurePeriod_08033c3a-3ed0-47ac-a9df-2fe4d37b1513" xlink:href="mo-20210930.xsd#mo_FederalTradeCommissionDisclosurePeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_bc16a862-c5f0-469c-9480-976e884f3cef" xlink:to="loc_mo_FederalTradeCommissionDisclosurePeriod_08033c3a-3ed0-47ac-a9df-2fe4d37b1513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_7aef2868-b268-4647-b03c-003747000596" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_bc16a862-c5f0-469c-9480-976e884f3cef" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_7aef2868-b268-4647-b03c-003747000596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesEvaporProductLitigationandIQOSLitigationDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3c0f699d-0710-458d-9afb-b1879094f0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_4ce82723-66fa-4534-aba9-03cd1c27dfa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3c0f699d-0710-458d-9afb-b1879094f0b6" xlink:to="loc_us-gaap_LossContingenciesTable_4ce82723-66fa-4534-aba9-03cd1c27dfa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_8905bf5c-eee6-4809-9247-100bbc8fbfbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_4ce82723-66fa-4534-aba9-03cd1c27dfa8" xlink:to="loc_us-gaap_LitigationStatusAxis_8905bf5c-eee6-4809-9247-100bbc8fbfbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_739dc935-dbf7-4ff1-b00a-d64403f5f180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_8905bf5c-eee6-4809-9247-100bbc8fbfbf" xlink:to="loc_us-gaap_LitigationStatusDomain_739dc935-dbf7-4ff1-b00a-d64403f5f180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ClassActionLawsuitMember_573fb75d-6394-4b33-a482-45e5e544cda1" xlink:href="mo-20210930.xsd#mo_ClassActionLawsuitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_739dc935-dbf7-4ff1-b00a-d64403f5f180" xlink:to="loc_mo_ClassActionLawsuitMember_573fb75d-6394-4b33-a482-45e5e544cda1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember_5bf0256d-05b3-486f-af5b-433e60f8802f" xlink:href="mo-20210930.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_739dc935-dbf7-4ff1-b00a-d64403f5f180" xlink:to="loc_mo_PendingIndividualLawsuitsMember_5bf0256d-05b3-486f-af5b-433e60f8802f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingLawsuitFiledBySchoolDistrictMember_998c09e5-ceb6-4f74-95a4-d3311dba5d79" xlink:href="mo-20210930.xsd#mo_PendingLawsuitFiledBySchoolDistrictMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_739dc935-dbf7-4ff1-b00a-d64403f5f180" xlink:to="loc_mo_PendingLawsuitFiledBySchoolDistrictMember_998c09e5-ceb6-4f74-95a4-d3311dba5d79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_b31294ad-93fb-4812-a015-28eff05a10ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_739dc935-dbf7-4ff1-b00a-d64403f5f180" xlink:to="loc_us-gaap_SettledLitigationMember_b31294ad-93fb-4812-a015-28eff05a10ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1754a22e-2167-4153-beec-85cae2e5aeb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_4ce82723-66fa-4534-aba9-03cd1c27dfa8" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1754a22e-2167-4153-beec-85cae2e5aeb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_260e6e0a-b94a-4fe7-8d3f-cbe3f2eff846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1754a22e-2167-4153-beec-85cae2e5aeb0" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_260e6e0a-b94a-4fe7-8d3f-cbe3f2eff846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_632747f5-da1c-4ddf-a28b-e15a0b58b610" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_260e6e0a-b94a-4fe7-8d3f-cbe3f2eff846" xlink:to="loc_us-gaap_SubsequentEventMember_632747f5-da1c-4ddf-a28b-e15a0b58b610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_6e520aae-c628-412b-b358-45fcf094c8a0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_4ce82723-66fa-4534-aba9-03cd1c27dfa8" xlink:to="loc_srt_LitigationCaseAxis_6e520aae-c628-412b-b358-45fcf094c8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_fbabf2fa-4785-4499-ab4d-8036eb667e80" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_6e520aae-c628-412b-b358-45fcf094c8a0" xlink:to="loc_srt_LitigationCaseTypeDomain_fbabf2fa-4785-4499-ab4d-8036eb667e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EvaporLitigationMember_3bf10c08-4461-453e-9234-df84a1966f47" xlink:href="mo-20210930.xsd#mo_EvaporLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_fbabf2fa-4785-4499-ab4d-8036eb667e80" xlink:to="loc_mo_EvaporLitigationMember_3bf10c08-4461-453e-9234-df84a1966f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IQOSMember_8b679928-fa53-4b51-8c86-87b51a9b97b8" xlink:href="mo-20210930.xsd#mo_IQOSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_fbabf2fa-4785-4499-ab4d-8036eb667e80" xlink:to="loc_mo_IQOSMember_8b679928-fa53-4b51-8c86-87b51a9b97b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_b82e93e2-c2de-4711-805e-e5e8fa00efc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_4ce82723-66fa-4534-aba9-03cd1c27dfa8" xlink:to="loc_us-gaap_LossContingenciesLineItems_b82e93e2-c2de-4711-805e-e5e8fa00efc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_6fcba97b-e775-4842-8cab-dd2c7ba48c72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b82e93e2-c2de-4711-805e-e5e8fa00efc6" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_6fcba97b-e775-4842-8cab-dd2c7ba48c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber_1bad2a14-6327-4255-9ec4-697479acd179" xlink:href="mo-20210930.xsd#mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b82e93e2-c2de-4711-805e-e5e8fa00efc6" xlink:to="loc_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber_1bad2a14-6327-4255-9ec4-697479acd179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_10de25d5-ad06-4f35-a24b-70cbf3f9947f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b82e93e2-c2de-4711-805e-e5e8fa00efc6" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_10de25d5-ad06-4f35-a24b-70cbf3f9947f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCasesWithCourtDatesSet_35f79f18-0e85-4627-9e11-e8d9bdaa03e4" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfCasesWithCourtDatesSet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b82e93e2-c2de-4711-805e-e5e8fa00efc6" xlink:to="loc_mo_LossContingencyNumberOfCasesWithCourtDatesSet_35f79f18-0e85-4627-9e11-e8d9bdaa03e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NumberOfThirdPartyLawsuits_e558f55f-fa78-45fa-bd87-7d0952ed94dd" xlink:href="mo-20210930.xsd#mo_NumberOfThirdPartyLawsuits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b82e93e2-c2de-4711-805e-e5e8fa00efc6" xlink:to="loc_mo_NumberOfThirdPartyLawsuits_e558f55f-fa78-45fa-bd87-7d0952ed94dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsSettledNumber_b7d82714-4489-466c-bf09-8a862cf74231" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyClaimsSettledNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b82e93e2-c2de-4711-805e-e5e8fa00efc6" xlink:to="loc_us-gaap_LossContingencyClaimsSettledNumber_b7d82714-4489-466c-bf09-8a862cf74231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_0bac835c-7004-43c5-8fa4-e30446fcbf29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b82e93e2-c2de-4711-805e-e5e8fa00efc6" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_0bac835c-7004-43c5-8fa4-e30446fcbf29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyDamagesRecoverableValue_727d4221-d8b8-4118-bb9d-7414645f3e4e" xlink:href="mo-20210930.xsd#mo_LossContingencyDamagesRecoverableValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b82e93e2-c2de-4711-805e-e5e8fa00efc6" xlink:to="loc_mo_LossContingencyDamagesRecoverableValue_727d4221-d8b8-4118-bb9d-7414645f3e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_cf4e8a5a-587a-420b-9a5c-261f39509095" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_3333aa94-a03d-457b-a366-387c5c54beaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_cf4e8a5a-587a-420b-9a5c-261f39509095" xlink:to="loc_us-gaap_LossContingenciesTable_3333aa94-a03d-457b-a366-387c5c54beaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_a0fa34ed-f714-480b-8d05-4876317adc16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3333aa94-a03d-457b-a366-387c5c54beaa" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_a0fa34ed-f714-480b-8d05-4876317adc16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_78068c3a-0573-41b3-9aba-a651d83ae540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a0fa34ed-f714-480b-8d05-4876317adc16" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_78068c3a-0573-41b3-9aba-a651d83ae540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_25a592fb-108d-4744-9513-2e01886cb862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_78068c3a-0573-41b3-9aba-a651d83ae540" xlink:to="loc_us-gaap_SubsequentEventMember_25a592fb-108d-4744-9513-2e01886cb862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_edd1647d-edeb-4870-9754-8d485b613ab3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3333aa94-a03d-457b-a366-387c5c54beaa" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_edd1647d-edeb-4870-9754-8d485b613ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_153aa7bd-f038-45ca-bab1-d10332ef2bdf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_edd1647d-edeb-4870-9754-8d485b613ab3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_153aa7bd-f038-45ca-bab1-d10332ef2bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_1d7395c7-49b5-4da1-9631-7cf4e4311bc2" xlink:href="mo-20210930.xsd#mo_JUULMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_153aa7bd-f038-45ca-bab1-d10332ef2bdf" xlink:to="loc_mo_JUULMember_1d7395c7-49b5-4da1-9631-7cf4e4311bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_8fd42053-e7be-4aef-a834-605f7ca4b232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3333aa94-a03d-457b-a366-387c5c54beaa" xlink:to="loc_us-gaap_LossContingenciesLineItems_8fd42053-e7be-4aef-a834-605f7ca4b232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_48813b83-a8e0-4b52-8ba3-ada0732851b2" xlink:href="mo-20210930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8fd42053-e7be-4aef-a834-605f7ca4b232" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_48813b83-a8e0-4b52-8ba3-ada0732851b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassActionLawsuit_5c9a4b30-64d1-4bd3-aaaa-48d6da72dd2e" xlink:href="mo-20210930.xsd#mo_LossContingencyClassActionLawsuit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8fd42053-e7be-4aef-a834-605f7ca4b232" xlink:to="loc_mo_LossContingencyClassActionLawsuit_5c9a4b30-64d1-4bd3-aaaa-48d6da72dd2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfComplaints_73a47f6e-295a-4e18-a5c6-7234365553a6" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfComplaints"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8fd42053-e7be-4aef-a834-605f7ca4b232" xlink:to="loc_mo_LossContingencyNumberOfComplaints_73a47f6e-295a-4e18-a5c6-7234365553a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_f651ec17-6626-4cf6-b4b0-3e247e74d16a" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8fd42053-e7be-4aef-a834-605f7ca4b232" xlink:to="loc_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_f651ec17-6626-4cf6-b4b0-3e247e74d16a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_d6e73e7b-41dd-408d-9507-8386878aeec5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8fd42053-e7be-4aef-a834-605f7ca4b232" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_d6e73e7b-41dd-408d-9507-8386878aeec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfPendingCasesConsolidated_2064ebd9-2e37-48c8-8256-f3a2ca4ed443" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfPendingCasesConsolidated"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8fd42053-e7be-4aef-a834-605f7ca4b232" xlink:to="loc_mo_LossContingencyNumberOfPendingCasesConsolidated_2064ebd9-2e37-48c8-8256-f3a2ca4ed443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits_7b2b51ce-d2dd-4ffe-bcba-f2b4a85ee9bb" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8fd42053-e7be-4aef-a834-605f7ca4b232" xlink:to="loc_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits_7b2b51ce-d2dd-4ffe-bcba-f2b4a85ee9bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfConsolidatedDerivativeLawsuits_caee3232-c5f2-4f24-b716-ec38c77001ea" xlink:href="mo-20210930.xsd#mo_LossContingencyNumberOfConsolidatedDerivativeLawsuits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8fd42053-e7be-4aef-a834-605f7ca4b232" xlink:to="loc_mo_LossContingencyNumberOfConsolidatedDerivativeLawsuits_caee3232-c5f2-4f24-b716-ec38c77001ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesLightsUltraLightsCasesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7ddec0fe-2816-41a6-8dbb-711225a47255" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_5ca101a9-4349-4616-a3f4-fa65b451e3be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7ddec0fe-2816-41a6-8dbb-711225a47255" xlink:to="loc_us-gaap_LossContingenciesTable_5ca101a9-4349-4616-a3f4-fa65b451e3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_53a319ad-87b6-46c5-a29f-a8efef045434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5ca101a9-4349-4616-a3f4-fa65b451e3be" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_53a319ad-87b6-46c5-a29f-a8efef045434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a29bc6d1-c7c0-42d5-8460-8d36dfe66651" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_53a319ad-87b6-46c5-a29f-a8efef045434" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a29bc6d1-c7c0-42d5-8460-8d36dfe66651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_83540f7a-32d3-442e-9b17-5fe1e244ab5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a29bc6d1-c7c0-42d5-8460-8d36dfe66651" xlink:to="loc_us-gaap_SubsequentEventMember_83540f7a-32d3-442e-9b17-5fe1e244ab5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_2d8ccbb4-7696-441a-9c81-c1be8c747ced" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5ca101a9-4349-4616-a3f4-fa65b451e3be" xlink:to="loc_srt_LitigationCaseAxis_2d8ccbb4-7696-441a-9c81-c1be8c747ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_71034b3d-3151-4408-8004-28b9a85e8b06" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_2d8ccbb4-7696-441a-9c81-c1be8c747ced" xlink:to="loc_srt_LitigationCaseTypeDomain_71034b3d-3151-4408-8004-28b9a85e8b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LightsMember_381c39cd-3f56-48d7-bd1c-327b60d7aa5e" xlink:href="mo-20210930.xsd#mo_LightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_71034b3d-3151-4408-8004-28b9a85e8b06" xlink:to="loc_mo_LightsMember_381c39cd-3f56-48d7-bd1c-327b60d7aa5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsMember_42d7cc3f-9bb9-4bed-a480-62c9a5297ff0" xlink:href="mo-20210930.xsd#mo_SmokingAndHealthClassActionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_71034b3d-3151-4408-8004-28b9a85e8b06" xlink:to="loc_mo_SmokingAndHealthClassActionsMember_42d7cc3f-9bb9-4bed-a480-62c9a5297ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USTLitigationMember_ff5bac63-282a-47d4-89c4-f7e00335916a" xlink:href="mo-20210930.xsd#mo_USTLitigationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_71034b3d-3151-4408-8004-28b9a85e8b06" xlink:to="loc_mo_USTLitigationMember_ff5bac63-282a-47d4-89c4-f7e00335916a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a338e49b-05ce-4245-8110-4396b1e0bae5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5ca101a9-4349-4616-a3f4-fa65b451e3be" xlink:to="loc_dei_LegalEntityAxis_a338e49b-05ce-4245-8110-4396b1e0bae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_88ebb2bd-5cd0-4663-b1da-0e2f0a8dfb10" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_a338e49b-05ce-4245-8110-4396b1e0bae5" xlink:to="loc_dei_EntityDomain_88ebb2bd-5cd0-4663-b1da-0e2f0a8dfb10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_f6906f9d-d9bd-4d43-9481-6e294480be7f" xlink:href="mo-20210930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_88ebb2bd-5cd0-4663-b1da-0e2f0a8dfb10" xlink:to="loc_mo_PhilipMorrisUSAMember_f6906f9d-d9bd-4d43-9481-6e294480be7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c0330409-1363-4c08-965e-307669c21f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5ca101a9-4349-4616-a3f4-fa65b451e3be" xlink:to="loc_us-gaap_LossContingenciesLineItems_c0330409-1363-4c08-965e-307669c21f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyStateCourtsNumber_c837f544-909b-4944-8689-f3b6f313f92e" xlink:href="mo-20210930.xsd#mo_LossContingencyStateCourtsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c0330409-1363-4c08-965e-307669c21f1f" xlink:to="loc_mo_LossContingencyStateCourtsNumber_c837f544-909b-4944-8689-f3b6f313f92e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsNotCertifiedNumber_c63c8816-dee6-43ea-babe-816a01801835" xlink:href="mo-20210930.xsd#mo_LossContingencyClaimsNotCertifiedNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c0330409-1363-4c08-965e-307669c21f1f" xlink:to="loc_mo_LossContingencyClaimsNotCertifiedNumber_c63c8816-dee6-43ea-babe-816a01801835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_276dcdb2-1ad5-467e-90dc-88d65ee8a8a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c0330409-1363-4c08-965e-307669c21f1f" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_276dcdb2-1ad5-467e-90dc-88d65ee8a8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesUSTLitigationsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_17e209f2-8aa7-499a-aad4-d81ef85e9832" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_d160e90a-ce20-4c46-bd3f-c05669d8f000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_17e209f2-8aa7-499a-aad4-d81ef85e9832" xlink:to="loc_us-gaap_LossContingenciesTable_d160e90a-ce20-4c46-bd3f-c05669d8f000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_3f6875ea-8662-4080-a66d-4ee210b907be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d160e90a-ce20-4c46-bd3f-c05669d8f000" xlink:to="loc_us-gaap_LitigationStatusAxis_3f6875ea-8662-4080-a66d-4ee210b907be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_f3bec1f8-ef8e-4372-8fd8-16a4d545863e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_3f6875ea-8662-4080-a66d-4ee210b907be" xlink:to="loc_us-gaap_LitigationStatusDomain_f3bec1f8-ef8e-4372-8fd8-16a4d545863e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember_571c1a20-3866-480d-9296-2a0865dee073" xlink:href="mo-20210930.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_f3bec1f8-ef8e-4372-8fd8-16a4d545863e" xlink:to="loc_mo_PendingIndividualLawsuitsMember_571c1a20-3866-480d-9296-2a0865dee073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_277d9feb-b936-4c1f-82af-f8441f54e212" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d160e90a-ce20-4c46-bd3f-c05669d8f000" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_277d9feb-b936-4c1f-82af-f8441f54e212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_bc616a08-cf1b-4830-87d3-fa9cb00e32f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_277d9feb-b936-4c1f-82af-f8441f54e212" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_bc616a08-cf1b-4830-87d3-fa9cb00e32f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_aa1e14d7-9351-45a5-aabe-7bce4f2029ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_bc616a08-cf1b-4830-87d3-fa9cb00e32f0" xlink:to="loc_us-gaap_SubsequentEventMember_aa1e14d7-9351-45a5-aabe-7bce4f2029ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_a192e4dc-ede8-4c51-a240-976fe4a31144" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d160e90a-ce20-4c46-bd3f-c05669d8f000" xlink:to="loc_srt_LitigationCaseAxis_a192e4dc-ede8-4c51-a240-976fe4a31144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_24b11bc2-1ca1-4181-9e18-295e1bb073fb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_a192e4dc-ede8-4c51-a240-976fe4a31144" xlink:to="loc_srt_LitigationCaseTypeDomain_24b11bc2-1ca1-4181-9e18-295e1bb073fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USTLitigationMember_da9e128c-5cca-4ca3-a6bc-80008e530d8d" xlink:href="mo-20210930.xsd#mo_USTLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_24b11bc2-1ca1-4181-9e18-295e1bb073fb" xlink:to="loc_mo_USTLitigationMember_da9e128c-5cca-4ca3-a6bc-80008e530d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_dfa44b12-e229-4eb1-8764-e6d259009dba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d160e90a-ce20-4c46-bd3f-c05669d8f000" xlink:to="loc_us-gaap_LossContingenciesLineItems_dfa44b12-e229-4eb1-8764-e6d259009dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_87e8905a-afc5-4a7e-a387-16747ae4ff32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_dfa44b12-e229-4eb1-8764-e6d259009dba" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_87e8905a-afc5-4a7e-a387-16747ae4ff32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails" xlink:type="simple" xlink:href="mo-20210930.xsd#ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6de8665f-d825-4eaa-9f5e-d51b100a09f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_3460661e-d315-4df5-a615-c4c7a28a4637" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6de8665f-d825-4eaa-9f5e-d51b100a09f5" xlink:to="loc_us-gaap_LossContingenciesTable_3460661e-d315-4df5-a615-c4c7a28a4637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fc831220-ada8-42b7-ba4d-bfb438ad9ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3460661e-d315-4df5-a615-c4c7a28a4637" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fc831220-ada8-42b7-ba4d-bfb438ad9ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_76aa53f6-d9c8-4167-85ab-c8a4250ad29b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fc831220-ada8-42b7-ba4d-bfb438ad9ce8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_76aa53f6-d9c8-4167-85ab-c8a4250ad29b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_35b90949-4705-45d9-b513-e807355cc601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_76aa53f6-d9c8-4167-85ab-c8a4250ad29b" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_35b90949-4705-45d9-b513-e807355cc601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_dde63912-abec-4ca6-8d77-0f923ba2c991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3460661e-d315-4df5-a615-c4c7a28a4637" xlink:to="loc_us-gaap_DebtInstrumentAxis_dde63912-abec-4ca6-8d77-0f923ba2c991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1e58580e-74b0-484d-b279-03e2571e41aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_dde63912-abec-4ca6-8d77-0f923ba2c991" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1e58580e-74b0-484d-b279-03e2571e41aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CreditAgreementMember_8490b0a4-1dff-459d-9c13-b981bc7d95fc" xlink:href="mo-20210930.xsd#mo_CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e58580e-74b0-484d-b279-03e2571e41aa" xlink:to="loc_mo_CreditAgreementMember_8490b0a4-1dff-459d-9c13-b981bc7d95fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_4d3cf179-e71e-419b-b427-6a503249a74f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3460661e-d315-4df5-a615-c4c7a28a4637" xlink:to="loc_us-gaap_CreditFacilityAxis_4d3cf179-e71e-419b-b427-6a503249a74f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0e7b574b-09b8-4b27-aeb6-06659e805a10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_4d3cf179-e71e-419b-b427-6a503249a74f" xlink:to="loc_us-gaap_CreditFacilityDomain_0e7b574b-09b8-4b27-aeb6-06659e805a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_ca2d5834-c9ad-43ab-8fb7-fd74a32b8445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_0e7b574b-09b8-4b27-aeb6-06659e805a10" xlink:to="loc_us-gaap_LetterOfCreditMember_ca2d5834-c9ad-43ab-8fb7-fd74a32b8445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_35643434-57a2-4366-ab1f-5649491d2ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3460661e-d315-4df5-a615-c4c7a28a4637" xlink:to="loc_us-gaap_LossContingenciesLineItems_35643434-57a2-4366-ab1f-5649491d2ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_81d46857-a3f4-4cb2-9286-87b3d7b4e057" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_35643434-57a2-4366-ab1f-5649491d2ec9" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_81d46857-a3f4-4cb2-9286-87b3d7b4e057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_e2d9bd91-30af-40f3-9fa0-ad74c58763db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_35643434-57a2-4366-ab1f-5649491d2ec9" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_e2d9bd91-30af-40f3-9fa0-ad74c58763db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted" xlink:type="simple" xlink:href="mo-20210930.xsd#NewAccountingGuidanceNotYetAdopted"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_a2cab53e-c7b6-45b0-9148-5c4a0c220063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_7136d248-cd48-4b06-8d82-43d1b22297db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_a2cab53e-c7b6-45b0-9148-5c4a0c220063" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_7136d248-cd48-4b06-8d82-43d1b22297db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/NewAccountingGuidanceNotYetAdoptedTables" xlink:type="simple" xlink:href="mo-20210930.xsd#NewAccountingGuidanceNotYetAdoptedTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/NewAccountingGuidanceNotYetAdoptedTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_eee22167-2fd3-46b9-881f-4fa2483aa8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_73072c6f-f3e4-4a39-beb0-5d7d3ee987ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_eee22167-2fd3-46b9-881f-4fa2483aa8ed" xlink:to="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_73072c6f-f3e4-4a39-beb0-5d7d3ee987ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>mo-20210930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mo="http://www.altria.com/20210930"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2021"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mo-20210930.xsd" xlink:type="simple"/>
    <context id="i083f183560914b169a2b47229664ba43_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i45fa0eb8e2f44df1a1178d965055b18b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock0.3313ParValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5f72e3af91ab46a8894e0b9546b1c4b4_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock1.000NotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i637e2b2941ef4dd592b5c3c4d55bfa25_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock1.700NotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1bf469c5379b4f2d88bdd9ee3efeecc8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock2.200NotesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia576c3905ea64c98b404cc8e4f72a7d9_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock3.125NotesDue2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iea6b6e16a27d4008b94c6c65b72d6673_I20211021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2021-10-21</instant>
        </period>
    </context>
    <context id="i503473da7ed148e2805b9efd533f401c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0b7b05662cb744f89da910b211c223dc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0784260d7eb94408af38c2b30275095c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibe5793331b9d44488c81b7f716d22cbb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i44e385b4040e4ead83a85c0957688fd6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i48d419bfc78f4132b045cf4fa761d902_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3dbc9fb0ec734480b6f0af9d1b9ac7b9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2fa834a6c7dd41229d83b9ffbdd1b664_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaa3df180bbc24f8c80034b0bb74a30e9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i53aea5f1004341c7abdb570f2d2eb5b4_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i13776c8fb39a40d9af4989bb9862e205_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibd9b7b88141b400786601f5cd3fec33a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5ca1deaa032a4cdd9c95cc8ea4e8b898_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib6f34d72cb7945e9bf68e87fc2c12f53_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic487ab98208d404887e95b93923fab79_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8693290ed18e4d7f87c0282e3f727528_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i007a6b02e9c44466879605af235d8517_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic6448179dc624c73a14533ac4f8492a2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic8c26c7de7b3445bb7421e82ca7564b4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5fd83e66c1ff4909a7a501481a11f766_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib231dbdd7b5c42a4892838893be458cb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0c17c5569ff54cf28521a8e8625991d8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i715d5e9f7cbe440b8d3c2b5ed4aeae4e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i433dda944a934320af202e2f484eaa1c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8a16f34256ad48b49ed8a50852fea048_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i954fc4945ffa4f8e8cdfabbaf3f7cb6f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9bf636ab56ad4d7cb37b9d77019eed37_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0e8e3bf6dc224a4aa974a22b40a91d8a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5cb0ffd7d3ff4483920746a3ef17c36d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6f1f1cd9567d4e048bfb64a6d6ee6bd0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8407362350ee44c99f4b71eae2816e16_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibf1005329da74407b072e55e84c44f7f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i87c1b1fef9414aef84749896871324f1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic81e63acf60f4e9c8c9e8e24c19afd4b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i337dce81edc54d6b886012952b0b9ade_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6b2a0f8b0eb84d6e98048c9c107d0d60_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5f4f34969f60495f8314b93ba8b0dce5_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iaeb4c19649a6480d80da77904d536dee_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3b11e531794f48868e8b9e32c403e904_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9137713c9da54ea7a9359074d78d444d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iffa730c0799046999cf2e97fed548bb6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifcdf82bc9a97456f9411c9f42374d3f6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0ea0515263584ea09063bbf40ec274b1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i610ba96937d54033839c8aaabcec01b3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i86447877e5b642e4a75424d1e386ce93_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3df7c108f2c5403c96f58e273f0dc0d1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if06993d5e1db4a3f9eda4a58697e58a1_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib37636bce9b94aaeb1cbaece44b60523_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i811d953ad6844425a1abf068a0bef5ea_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icb6a68caffdb4a49a42f353a7047b68a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idfa6672fba3e4b2380d43bce7cac51b6_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i04acd635c03342bf90bc79dd81caef6b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id142ac3234994ef79d1ee5f1de4d371d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i83adb27c0e2746b595871ff0b3f2b7d8_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i65d2cfacd8464cd8a25b7d8f01804516_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ib54bea9ab2a541ef9a1b1495988aba10_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i4b48e147a93c4d159841fd5c68e5adba_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i967d1f95af3f41eda51eed3bfc8a12af_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i3d98dc6b3b424d3cb692eff540ce05d9_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9284f3c4288b4cd2b2c41662e054c3d2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iece3d64b93d440e3863844f51f91d57b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idba80b960aa444f9afc7b3189ec8d63e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9870fc1d39c94d9f81e1e50ced847ae2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie227d61fadaa4ad894b027826871e831_D20201201-20210429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mo:HelixInnovationsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2021-04-29</endDate>
        </period>
    </context>
    <context id="i33693bcc9b6d47e48094cbb1bb3c5f74_D20201201-20210429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2021-04-29</endDate>
        </period>
    </context>
    <context id="i96dcc4ff54674f288ddfdd67f37a96ab_D20210801-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="i96ddae8ac4da494d95d13e4d56d378cc_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia7921863f9b84211b6ab722289417409_I20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:July2019ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-31</instant>
        </period>
    </context>
    <context id="i58b4cc5497fa437d9019b1914e39936e_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:July2019ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="ie1160db7af33456abd28f3ff1afe8c43_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:July2019ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if027f1be3b8b4d97b39ef8c617dc8946_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="i210e56c06a7e4442963844e819875e34_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id4244523c3094b0a9521b3089395bca7_I20211028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-28</instant>
        </period>
    </context>
    <context id="i0c8666d14400451b9e82c0e7c854ebe9_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i66dae12b306e4c15a45bf2cedaae9792_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ica91e72247354acf9f03bbc39e5c5f66_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4d91b3c8886d4970bfefc99ee9bd77ec_I20211001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mo:SteMichelleTransactionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-01</instant>
        </period>
    </context>
    <context id="i800ea809d24a4ae99423280ab9ed1ce7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mo:SteMichelleTransactionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9321155464464f6abb0579cd48d53de2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mo:SteMichelleTransactionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:MarketingAdministrationAndResearchCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2ae5a856a040414ea2c55c9313370362_D20211001-20211001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mo:SteMichelleTransactionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-10-01</endDate>
        </period>
    </context>
    <context id="i11c3f27b7191493b8194d2564e1cbc32_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mo:SteMichelleTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib20e8844a92447d0a46d19d86ed0f7f5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mo:SteMichelleTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib6f738f3284745ba87d4ead6955d877d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8023b74faf63413a92633caf766ceda1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i72200b393daa452fb6e8b503937f1675_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia53e50acb7e34afea6df1a5247e0b9d6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia3134917de914447a308c3c06a9e6332_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib5afb831a7af4995b73bda6b83b376f7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie2d67aef385b4488b0e8489bde6ec505_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4c1ec10071a549c494de909a6803c0bc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id27af0c56a0e4f2c91692075789f16f1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i55353e2d6bb3468a8bb902e7ef81616b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia7f2b6c32d774ec2b7a6087a9251d893_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie01a2991fc0c45cda4ae5f730f069b9b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ife49fc973ca746f092aa4d83bca9d740_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i142e3b708e7c4513964bfdef3821842c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic62d4fc827d0412695035c4816dc2a17_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6b92cf433a64434db9bce40cc2385d5e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7f91523b32934656837eccb431840056_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i16da5adef0b64404a908cb9d15134fb8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if3a641fc878c4afe85e1c9467ee9853c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if07c963ba7314996a07680309ec4ce52_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2a7ceafc35c8455aa006544f31dada24_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iff7bce46de9948cfbbc1a3790debcee8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0d7c9a004f294d309f5a0ddbff7f9c62_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i26492b9b36f34d359befa59e3e1f285d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i32e2dbe44f974df484f948ed2b86c221_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id3b7793faa454c9499956ae3df8ea507_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7b95bdcd547049af892afbaf8e444f3e_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i134145e8cb494481a64026d08e24f670_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">mo:EquityMethodInvestmentsFairValueOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5fe43b6fc76f4ce480f73470bdcc7717_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">mo:EquityMethodInvestmentsFairValueOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i050fe6a531654ecd9ffb665ff8b70dce_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">mo:EquityMethodInvestmentsFairValueOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia1881e260a3842d1bcc033077fcf431f_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="ia17ccdc17eaa43c2895a3756a03e1e51_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="ia8e68dd2bdba4a9fb2cab39cdf6ff65a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i413418f0ee6d4970991e224cb3ef2b61_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4c45d9f454c845349a17b5b89122518e_D20211025-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-25</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="i90625c50de644d79a497ab347321af26_D20211025-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-25</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="ia2c7ce11a66f40d7b866ad7f5cf8a0d7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantAndEquityContractPreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i30a456d16ad04abf8d2bbed9680d3088_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibcf3cacc08db49a29687505d3387266b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i87169f0e47aa46f581a3b1a6a073d849_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic10cda982ea5415199ad34d94e8b02ba_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9f7d03ea00174970b1ec83dc2dac1886_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia4d49e3b18b5423e972b0489f00c3c44_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i97d4b0a3f973401ab8af04812ad88ab8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i299ff36535794f3da00e849d49232f7e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i58618b2d87444fa1b1e248c65a98ccf7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ife62efd21d3c4274a6d99ee48062bd72_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i27b16784136a4ee1b08eab8d661c0473_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibe8f6ff98f9b4b6ba0315bd2c6c328fe_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5f3288737dff4923b723710d770b6bfe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2d742841c5fe465985b241c6d5f4484c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if695dc35dec34537808c09ca053c1768_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie51acd28a242489eb93cb384c8145b12_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic441be4c36e54182a0d7529d2ecc38b4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i14ff2002b85248c2a717760fa5447b57_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8230deeac7a042d782c7c2a1edc62727_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i95ddf40ef20a463983f2f6637bdadb3a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia4bf3c8921284849a8922aa21c6d0fba_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibb4ecc1e346d4864b399340e003690e1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i729af67cdbe44560b187bc2a5355d961_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia84fe1dcb00d4c42946248812c92de20_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6074d0f496474bc6b259bb2df8d5b30c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5ebb29f66c07461aa96dfc8433fac067_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mo:MeasurementInputWeightedAverageExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i55362d8be9514c0cabf140dc7d6239f6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mo:MeasurementInputWeightedAverageExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i48b89d0bd67646b288c756c93a850879_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mo:MeasurementInputWeightedAverageExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i57543deaa7a640628f92b751104d9900_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mo:MeasurementInputWeightedAverageExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie7a53ae7739f46c7b604110d4483c929_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic67976b0907f4b868fa3d035e132418d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i18d875d64a0945bd8350d34786e8fc87_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i28afb29902db4901b31c391429b1b607_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia80bd4793ddf4b2d915e5f5ea7d8ca62_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EquityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i64ff63b34a204467b3064abd7fcc4a64_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EquityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i888b21f50f1241039283cfc1fe265126_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EquityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2cdb57e3b67e4af08c71b8743251e9dc_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EquityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ice62522e8f3e4793835443a9d9fd2cda_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EquityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if2be07afbaf94c6fb3d9eeb024386d1a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4a791d31299e4494b797ffdc1cac8f2b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7bd27afbf2ce487ea8421adf4864eba8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mo:OtherAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i23b6cc53678a4c949419f35fd13251a6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mo:OtherAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibd824826dc2c4942a04c7d39edd256d5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib813ea19505f4d82aac201b8d7cb1729_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i420bac3921ce42bea9dfcd0aa2d91620_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if2d4c37137a7441c8d333d4e72463e40_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i448255743e3c41a4859a9556d275d76c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iddb651cf441648dbb1dff101d6d3d546_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia565cea6862d417c97c684e3d00ae39e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mo:InvestmentsInEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0bbe0c1517c44ab49c07a8fd54a1eb3c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mo:InvestmentsInEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1e277a3e43d44130afbf73dc7dde1b91_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mo:InvestmentsInEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iddd36608a5eb4e55a57cc46e949da550_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mo:InvestmentsInEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i48f32e9fb6254c8587a74bd98c7ba505_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EquityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id8922561835d4c67b1663239e270549b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EquityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idaabb1ac00dc4de9afa2e9b2a864fa5b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ifd5a3b6fb7e34bca9dea72a0c14da288_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7c367050085a48a69fa712c3eceab7c0_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i60d37aaec4d1491e9ffbbf008424f75a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i20b1e637093c48f4969fae7d410a2693_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i16161f66e87a41ab993f192e9c451cf6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7b30b55ee2ef446882c7477d8328c504_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i84041ff1f2d1478e9462865044b54b4d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ideb6d765d89e4b91aa1a4fbb97d5de55_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7def76adb3ad4f72a02323fce73fbe1a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2b22d5f204d248aab1e00daf3b0d8153_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib358f1bbb75b41f3aaca506bf354a2c0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie4ee47e867c246b8be587254b4a9a6cc_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i157a11cd19544cd68917916131342ac2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3eaa97db709e43d0b68539ebfc1f7fcd_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i801ea70096974921a9cc6afb7fabddb3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1f6f91cba83e4cafb448b38e704724c2_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i75d11c60a1504c2a8018692b2fdb8592_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i95c1f586ef4041dd8c67ab4c79e3718a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibe0426ef79dd4e1b93e9f3b19953e12f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i641562cd01894f84aa15b3d08486a81e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i285fd763c7cb4c95a6689072055b09d4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i92dcd11d5d934931ab51a35b59f2acd1_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8cc174939f1e414593012b716f47f230_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i65e5f978b5c84e8aa707cac5eb7382f1_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia30f1b1250de433dabcb2cbe9baabacf_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib46d19a7eb014c0d80e8454b5ba93ecc_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1bb0ce68c3494d79abc790fd0561a2c9_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8a9748c0c5a34059bb965420acaa9a71_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id4b4f1114be54cf39186a491bbc07db4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5da59f9184554221a714ef4fa85eeff2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3a5e492ac0384dd28bb0ad0497562294_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i32402401a0f844239e2c32d640969c41_D20210531-20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-31</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="ia2ad51d5efd34c6890d17e0c82b226b7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3f3fa8b9977e4b429a89b213dd45435e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibb1b7837d3fd4f8097b3317e18a83bbf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4320d8cfd0aa4682ac4fd8e97489f333_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib94d886e09a149778fc4b762edca1bc7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic3b0235cbe654245a5397a036c1d3132_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie628688809594c33a0f517053cd1c98f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7c08359b25be43c9b6378dcc5e5e3f52_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id6cd59bba4c64d728580eef19f7136ca_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia60bc9c826684e3dbf0b2a03a36b0a67_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4f37b78605b24016b376248d47913825_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i64f0bf43c52c463298e2f9f2570fe3e3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifbbd3f4ab1454dcfa39e110e53cca664_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibfb335bd0af94b69b6dbeda93b2431f4_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ieb267062b0c74a0a89cf1006daf242da_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaadcf1874ca04724982a8928b2ba0492_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4ad5ab3a5d744eae96a566cd3203adfa_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iaa91dd46f82a4982882dee9eb8e7ef08_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie55982b4b8094afd8cbd3644050918a9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i70e46b26b4fc462a81bca6b1ee77e04c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia1b552df277f47bdac453b74353a2434_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ieedc417e26a742608b043deb27b97448_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib1b03165fb2c4b76807e0ccc90d962b2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib5bf1a00e1e4420f9e82ccdfbc6a5434_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id14c8ad0e1114859a5ef9774b11273ab_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ib3dac29830b94be0b1b1d5af479d71b6_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i529da0d49b1b4fcda97c6cf43be5a0e6_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ibc3428a068464ada9a25e4ce62287f36_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if9501d5a448d4b8fb83b9f4658086140_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1663f22cd4af448bb0eabf4a88a2c65f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i903649a4650d4581b810b87a8e7abece_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iba009efde806409683cbc9e86246b4df_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id1f84a88e08b4b88ac5ad7e5696842ef_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i386a65106eed4b8480296af72f76b88a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia911d34c10624a4caad11aaf671e57a2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i00054ad5017c49e886588f8692292ab7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i148aed2cafc8405f9c753e10684af7ce_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0c117e78f8df4689addea5ed534be7cc_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i90237e5e67d24c74afa25e85687a853f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic4234136b96446cc9cf8cb134f4533f0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6cdea01ef93f447c96c7b2a20036eb30_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i09764927c7ec46e49e7775b99fd97136_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i129971b2b9ec49abbe1afc97cb429284_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia80f603ac4c848f78a7bcaf6c95cb8a5_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibaa55d29a7cf455ca4bf8fe55b94e9c0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3d50e83d51e04a2c81a2fb7b3d33bd41_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if41a4137b96044f2853f90bee854a5a1_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie0c26c7c96cd4d82a4534ab1f5e26951_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7e957d6659b146e1a8a2c22448c05e52_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie3658d6662464166bd1a7d63193f62b6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6c60e64bda5e406c906f14c501403dcf_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifb73dd7e78c54dc0bb94170fd12ab8ab_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i88fcf49918a84402902b9a4fd578a532_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8e951f6b74194f1ea5354f9049777599_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic3e0ae69ae05491a91e3fdb908e909db_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1a2569691b65440c9038155bd4cf097b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8712c39f1b4b407d8d3f616cd0f6d0b2_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaf557385c26346d78697ab7216ad25aa_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2cc47fbf28e740b583be5f01ebc5de9b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7773a1a4d8454a6f8b93d93dbf471801_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib7294329e59b4737858f1c36f4d117a6_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaecb6abc654940949c584c7bce9fa618_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idf8f1c9e35d64a1f98b39384820c20cc_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i82c1570001674d4a844a4bfcb4e16ca8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i867ac19dbb4643b59a94aeeec8a58fa8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i41fcc7aaf3534c59ace9f381d20aac6a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie45eb514d8c24379a2d84b6fdadc5908_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i348527fc0572499b8b09c70427059222_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idda2d39340b64a38b25c3fbb87815b91_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id08e4c2d3cad43fea50a182ef5e4bd72_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i45eb44ceb75d4820b3468fcd56c069bb_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic06d55ed183d403ea8fab3081dabed8d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib87ad1bdee774676a43d32c69faf494a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib8113c4d3abd42a8a3d5dc65de3551ea_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i23d680315a484e78bb04a83054b0bd2c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5750ad1593bf4f39a28a67676e4be777_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i901cc99ae1b84fcaa334b79a557b2716_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i92ece1efc67e4955b20f6106bfa5b1bc_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibbc3e1fdad35440a8019431504912e54_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NpmAdjustmentToCostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iab4ebcb1e91f46c4be02c3ade89e7bd6_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NpmAdjustmentToCostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8a6c36dc62614c039382474701d62704_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:InterestAndOtherDebtExpenseNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NpmAdjustmentToCostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia0bdf868958f46d39d41b03294b42969_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:InterestAndOtherDebtExpenseNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NpmAdjustmentToCostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8b0b695b39e941948146139c5236ab09_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NpmAdjustmentToCostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i01fb7d5238cf4de6af35e1b8ee70534b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NpmAdjustmentToCostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia0da5bdcd164423ab6c5e7d2d4619255_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i71a6552e683a45df8a80deb0ff141acc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib8c00af2fa2a47a08ce2e121cec7fa1a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id86681b1496e4200ac6e85e6642cca96_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i44c555d22e7b40b0b20993dec5333004_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i13dbf73b19844cd8895f0cadcf052f90_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5717ce456bae4169a32dfcce88700f00_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7e76683652f2470896a6eb26e4f4b7a2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9e46fc85802e4a6291b8902ec7c022dc_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic3e6860a06dc45078a5772ad589b6723_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i17fc09b753d24ddfb9c43ac782832373_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6059c690166441149c61f26c7db17255_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if433ba93efde45f38a5688307f77c9c4_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i876dc6b8472b4c2ea0c3ae119b771d02_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i74d52c13d1e44d56853af2d044689b8c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib11d64a866fe4276882eac217af0ec5f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0e1577fefc474a9b9a5a1b492deccd82_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mo:COVID19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i986e7568db0547edb5f58a6f3d032e05_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mo:COVID19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i509fd5cc79b84947a1ddc23a201ceee8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mo:COVID19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if08ac6b396064588b67bc488b59ea368_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mo:COVID19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie4f93cb048684f5f81d4c6d87a4b0f83_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mo:COVID19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i637d3a2f463a43b4ba0c2c56616e75d5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mo:COVID19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iaf975d8c2d674ea3839f3277f75cf4f1_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mo:InventoryDisposalCostsandOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mo:WineBusinessStrategicResetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i99a5d17aefbc4d5ca90136899d314788_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mo:InventoryWriteOffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mo:WineBusinessStrategicResetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i57818fd795f445829d1bf3dd90269c34_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:PurchaseCommitmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mo:WineBusinessStrategicResetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0f700f27ee5b4dc0b6b7ca55099ab015_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8782aa269d064a7f878a2d5f0a778720_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4d9e692ae91a4176bbb8ab4a42237fa6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic42084bb2e9740b8b51ae3feeb2862d5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i634fff1d9b644e8cb5c918e89bad5ae8_D20200301-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib0080cbb283042c7ad61da99c612ad5a_D20210501-20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="i2620d02ad1494d46ab52a4c075ab2c6b_I20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="i857205f0e0394b73ad424ddb571fbf8c_I20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesDue2032Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="idb779f48ef584729a5fa769c008b9ac8_I20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesDue2041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="i72bc00d2c5e94db1be910ff08d7edb62_I20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesDue2051Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="idd06b0461cd94297b50a5616b6cabc08_I20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesDue2061Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="ifc8423e2c5df46eea5b83d3f181cc413_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="ic85fd5bdf74f4f0091c93c498eb3cc11_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2224c863f13e437d85f29be315d3c712_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes2850PercentDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i808f87bc995d47d5a86a27d0ee9f22b4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes2950PercentDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2502deb2ffd14f39bc40df7e2d62056e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes4000PercentDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie52346405ce94721b9a8f4e6ccd91ef6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes3800PercentDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="icab982db20034341aa05031441a073b1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes4400PercentDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5d76ccb7e1a5434bb17c22937296a8ae_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes4800PercentDue2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iffbca0a488934ac8a34f87b93f39560e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes9950PercentDue2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i61833c0644204fbfbcc52b66fce61e91_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedDebt10200PercentDue2039Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i347f7da5d0054edbad9c6e2ea4a0651c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedDebt6200PercentDue2059Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic1fd6ffda965426487b95b70a8b31910_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes3490PercentDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i20e14cfe0c0d46339af63110c7811e34_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes3490PercentDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ice0b95503da241eb84089a6759b1e50f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i926660aafc7244e495754a8afa4f6531_D20041001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2004-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9a75c3716f9f44f8b0a633a8086be1e4_D20041001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2004-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3400b8bfff76440f9313bb4f3fb62ca3_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ica387b7fecba4bfebc8ddf8f17f04ad8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ied52ab66233a43c196b987b68bd00b86_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic5ef8014d73d4900afc3092294d2ca38_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6b3cc5d6b74f41e9aed08f62d1656e61_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic2529fcd54b74ef2a31abcd12138bb42_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia6645d5f78024731bf63efa024c27f2f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if53282b7834348a9a6ada854639fdbd1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3ea29768db1440de8cdfdba1d0ddb39f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i663ff20a0cf640f8ae7953fdba19634a_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="ia5ed554a97e64e58a2f7dff3f260635e_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="i35aefdfd25a54a77a106cbf1a1685ab5_I20191028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-28</instant>
        </period>
    </context>
    <context id="i20886114cad04457981190cedb862851_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="ibf6d7d9ce89842c7976f502120165e8c_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="i2704bd9b49ac4bdc8fb4f82a270c44ef_I20191028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-28</instant>
        </period>
    </context>
    <context id="i2d4206f6a0024fed8cfaa7a66fcf85d9_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="i71b573459eca4bea97af58bf49c87201_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="icaf8b745a94b42ccad21473588116847_I20191028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-28</instant>
        </period>
    </context>
    <context id="i12bdefb971104deda60ea7c60dd43501_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherTabaccoRelatedCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="ib3dbb26207114dcbb85df4982dbc5033_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherTabaccoRelatedCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="i2b166612ac8e4f99b7ad03601c8126b7_I20191028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherTabaccoRelatedCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-28</instant>
        </period>
    </context>
    <context id="i1b18278bbd184abca4253784cfde6900_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="i223b3b59e9644a15b7fe55e88c315de3_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="if18a359a02814e81ac2e7da57ce8914e_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="ic2722814648844259fc7fba910bcb8f0_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="i11bb0f709f4840c9a6ba836ea86e439b_D20211025-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:ETSSmokingandHealthCaseFlightAttendantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-25</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="i7e914a4a2b8344169accefce0c454834_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingIndividualLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="iaeab395fb605402fb5a6b9c5bdc4a711_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingLawsuitsFiledByStateOrLocalGovernmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="i4d5084fb63864e7d87b275079786c20d_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:ClassActionLawsuitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="i656d506fcc8a4b9ab2659e2676677a0a_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="ibd987a82f3714a11b7e8c291d69672a9_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="ia9e0a1f532ea4ebf81ee548bc37ef0cc_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAandAltriaGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="i61b4bd1b44014f77ba98ffaddac70a1c_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAandAltriaGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="i90226fb36aa64d6bacef37bf4db3884b_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="i90fcd7f5574440a5ab359cb20e1a04c8_D19990101-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="idce33acf337c4fe9a1645ddb2e019e7f_D19990101-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:AK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="id289701c573b45cca1a140d0c73c998a_D19990101-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="i8d46d835a2d24d1ebd56341154a639d8_D19990101-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CT</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="i6f2e6b71ad0c495aa1c5d1de5f3d1b7f_D19990101-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="ie3500d94f16d4d48be23dbcd39c4724d_D19990101-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:LA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="i68a963409b744c62ada96bbe606437d0_D19990101-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="i5a74a591f616416a8beecae26d6b025a_D19990101-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MS</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="i080e23384aca46ac97b6d8534dd6870f_D19990101-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MO</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="if89eceae6818421ab7e71078e8640a23_D19990101-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="ia3434a001edb4107b89f9f106fa2815e_D19990101-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="i8dbfceaeded0450399ee40b258518a3e_D19990101-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="i5569874aeca64116b11922db9cb7839b_D19990101-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="ib231c8aea8fd44718baa2914cd6cba3f_D19990101-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:PA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="i552ef3865e7d48829a38177ee62b4979_D19990101-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:RI</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="id38fc93aeda6476b9dac24a91fd1cf6d_D19990101-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="ia00a1362eff94111880c5d8063950c56_D19990101-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WV</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="i052ec416024f4823bef90cd01d8b4153_I20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingAndHealthCasePrincipeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-29</instant>
        </period>
    </context>
    <context id="i517f019e7c1743319a6e9441dc360c47_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGreeneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ib96d34ed4ae34693801830017a4f6049_I20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGreeneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="i7ea87da7184343c09f4ee1578cc648ee_I20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGreeneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="ifa32d699351d4292af9042e00b380590_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseLaramieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="id38820dc93e04812843942939c4e6352_D20210901-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseLaramieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9edffb5157944c1b92f53a2aa6e6ff0a_I20171031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGentileMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-31</instant>
        </period>
    </context>
    <context id="i7e21fbb1029544a7bf549cf560acc7df_I20171031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGentileMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-31</instant>
        </period>
    </context>
    <context id="i5287e7b9447640e785f900c6e40cbb09_I20000731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2000-07-31</instant>
        </period>
    </context>
    <context id="i3a5d377b4b3f458eba4a9e7b517b8e16_I20000731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2000-07-31</instant>
        </period>
    </context>
    <context id="i9a03e98802a847ef9e56a147ecdc0b02_D20060701-20060731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2006-07-01</startDate>
            <endDate>2006-07-31</endDate>
        </period>
    </context>
    <context id="id970cacb82804a6dafd9bb28ce0e0227_I20080131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2008-01-31</instant>
        </period>
    </context>
    <context id="i781149ad13854355a035d0bcc92ce4e5_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="i0285dbb248214e6b82f1b1e1fca99520_D20211025-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-25</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="if243dafacad643ca8a92639963f3f04f_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesFederalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="i85fafeeb94a94367a935be26dbab3f38_D20211025-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-25</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="i1eb0635e87454a0fa2b2eec4909179e5_D20211025-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-25</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="ibfc1fdbaa928482089e8a85cb409cd50_D20211025-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesPearsonDCohenCollarChaconMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-25</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="ie96b5489b60e4b18b201d51a8582e17d_D20211025-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesReiderandBanksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-25</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="ie0be9670c3294c5380d9907c287d1387_D20211025-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesWeingartandHancockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-25</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="icc49a3c9173544c3ba44b82aea64b761_D20211025-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesPollariMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-25</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="if13eaf2626b1498396e84993151f34c0_D20211025-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGlogerRintoulandDuignamMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-25</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="ifda6adf0b2d84253922e03c7982666d4_D20211025-20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesFreemanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-25</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <context id="iec72a8c6101f4a219bd73a2c63d2d869_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="i73ae2282abd0496a96c1fcd57396db0e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesLippMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i194fa22064b649108a6b18c631884f77_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesLippMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i17b84f6260d04ad6961ed01a6a4643ab_I20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGarciaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="i44c6aea7f36842009497759eedcaee54_I20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesDuignanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-29</instant>
        </period>
    </context>
    <context id="iecc7b1e7a5514f8d981e71849df19766_I20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesDuignanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-29</instant>
        </period>
    </context>
    <context id="i98691888015f4b7f97a8a5c022078de5_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCuddiheeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="if0f67b4fed23474aa26757b30fb8314b_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCuddiheeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="i6b6b72d00f4a4457b91e1936a8656c3b_I20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesRintoulMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="id11f7d76781a495487c1eed6818fc118_I20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesRintoulMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="i1ef26206b34a4ca08fa1661b761ff4d0_I20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGlogerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="i17f63ef63bb548338c974ec35dd2a170_I20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGlogerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="i019a0fe5dd374adeb0d5245d94a4dfb5_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMcCallMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ief9b76c5f9e7421797d6551c8f48d8b6_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMcCallMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i6fc0d1aced7b4e3090804c6395b59378_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesNeffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ia1103462b7784169b773bbbc0efd59f8_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesNeffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="iefe17f299cc745aea480c5200a6d62fe_I20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMahfuzMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-28</instant>
        </period>
    </context>
    <context id="i4cd3514504b94f14b23eac85e141bf5c_I20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMahfuzMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-28</instant>
        </period>
    </context>
    <context id="ic644f159146c4bce8ae598030b7521b2_I20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesHollimanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-28</instant>
        </period>
    </context>
    <context id="iffaa0265108c43ac903736f8d4f7d960_I20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesHollimanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-28</instant>
        </period>
    </context>
    <context id="i934ff2e5139b4f9b96a1effc5fb356ce_I20180930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesChadwellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="ia0494654648d4e449182d0811815a094_I20180930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesChadwellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="i2aad4919d9504ddfb45b65695fb63cfe_I20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesKaplanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-31</instant>
        </period>
    </context>
    <context id="i1eed45c1dca24b51910ffb82b58ab797_I20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesKaplanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-31</instant>
        </period>
    </context>
    <context id="i507aeabef70b43509c6b3bb411894994_I20171130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesR.DouglasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-30</instant>
        </period>
    </context>
    <context id="i44733c669e7348d3b2b001c64d98bc3c_I20171130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesR.DouglasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-30</instant>
        </period>
    </context>
    <context id="ib164100fedd24083b3c0a5073943dffd_I20170430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSommersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-04-30</instant>
        </period>
    </context>
    <context id="idd484e32de2d4223bdc64a37b20f3802_I20170430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSommersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-04-30</instant>
        </period>
    </context>
    <context id="i3e2d19c2ad0043a29926ac4f687526be_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSommersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icd834bc282ff4ab6bfccb6bf6f85c412_I20150930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCooperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-09-30</instant>
        </period>
    </context>
    <context id="i7978ed075eb24ecab8ef0c666e380e86_I20150930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCooperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-09-30</instant>
        </period>
    </context>
    <context id="i7c9bd9d9e7904a7c88f369cfecb8bcff_I20150131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesD.BrownMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-01-31</instant>
        </period>
    </context>
    <context id="if28ca12f29db4c178b382557c7195523_I20150131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesD.BrownMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-01-31</instant>
        </period>
    </context>
    <context id="ie8dcabc9bf25458b893acc42347fba65_D20181001-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesBergerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ic5b096cd3d6d4418807bf4da87541ffb_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesBergerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i149fa1186f594219bfa987dbdd8108f6_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSantoroMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i56daa4d75b794bf798d94d227d29e58d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSantoroMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8b7112204f034a1d857b3dec087a6b72_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesNaugleGoreMBrownJordanTheisAndLandiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9786b102ec154400a94c47410abdf0d2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesNaugleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1a270cd854f546eaa7d120809442f7ea_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGoreMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0c3f1a744f0843eb886c976a94595df2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesM.BrownMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2ea5715a75a04415a4cc1a94df208c7b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesJordanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ice47fff653d74495b39ba1566ff6ab1b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesTheisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie4bc3e6b7f3141d8ad1df8728d140283_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesLandiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifb6a94b0655c424dbf083fa25f9e6807_D20210401-20210429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesM.BrownMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-29</endDate>
        </period>
    </context>
    <context id="i2cdf509335c8425e86145370f35dab92_D20210501-20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesTheisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="ie6ca88fb103d422eba56dd92aabfb961_D20210701-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesLandiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="i0f8871aa42a34c93b07bdabe159afc9d_D20210701-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesRJReynoldsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="i91285291d0224d41a9f6b6f098c51c67_I20090630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2009-06-30</instant>
        </period>
    </context>
    <context id="i5e74537c0b4c4859a3f2089a42ce56ae_D19960501-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic64ffeb5c74f4dfb969778dccaadc1bf_D19960501-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:AR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id40a29a6291543d78c372cbf264db1d9_D19960501-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i555c1554720a424d98f50f13e51eeb80_D19960501-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i53e4eebb4a714524b636f0534865d23e_D19960501-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:DC</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i898cd371a7b3471d989e10fd1301c6c6_D19960501-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4a99e02ce83d418b860435133fff2496_D19960501-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib09e7e21f8824054b044c6461611053c_D19960501-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icefa681020fe4e1cb4c5b70752a2483d_D19960501-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:KS</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iddd4591b90d04ff19b36afa6fd9b9e7a_D19960501-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:LA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i58f52856b1ef4eaeb4ce8c5360ba8d3c_D19960501-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia8cca8977ddf4dceb3cd11ee8f5468f3_D19960501-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MI</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3e80e20cf6794e25b4bcef5d2425a2c0_D19960501-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i01b20b669936475f993e104a31de5013_D19960501-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NV</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i83fd76d8eb1c479c890d6dbefa8006e5_D19960501-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie80c16c4c2d34cf7b117c4db4d715bd7_D19960501-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3950ec60b64d43e79a255e2090017c76_D19960501-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5ef55ce7cdbf4a49ab62450c92339999_D19960501-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0af01f3e38964466aabcb29ac90c169f_D19960501-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i12033c228a91450cb06602a444123772_D19960501-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:PA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3e9ec11b5d7f4c02a0471f53510291d4_D19960501-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i438bd25e9e5b4fa5b786198ed333fea2_D19960501-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:SC</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i15af965191ab4b03be2934d3ca487181_D19960501-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaf606e5861bc4311aab5a4deb0ea2a7e_D19960501-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WI</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i39795ebd6cb34fd9b722c425c1d7f1b5_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mo:BritishColumbiaSaskatchewanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAandAltriaGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="i4618babb55a643e08513e3f263b04127_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:CanadianTobaccoManufacturersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i275c1685fc084d30907f39c9ca35ef66_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:AltriaGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i78204298c1714c59b1565b14ec68a768_D20190301-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:CanadianTobaccoManufacturersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i4afafb6cc22d4bfc8634ef389a32cb14_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:ThreatenedLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if3b522f7309f4c28bb7cdb2e6f309062_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:CanadianTobaccoManufacturersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i94453f2294bb47798d15011e7260b27b_D19981101-19981130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1998-11-01</startDate>
            <endDate>1998-11-30</endDate>
        </period>
    </context>
    <context id="i9116d2cabdcb49b38d8d90ace75f12d8_I19981130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>1998-11-30</instant>
        </period>
    </context>
    <context id="i53eb33b5a5a54692bf19b84768b69b6f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0748deafef534cbdb4febc2a98913d94_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic2672eb1f4624a6b91e6bd2e2ad0726e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ica606fb15fa64e31a1db6c7bbbc4c3a8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9664ef4ada2b462a8ed748d49c2d084c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i906990683f674cd28e47cbcc0f1c3ce6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2005NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9ee9df31ad2b4e4ba1a5db1f61706b48_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2006NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia38de3fc206c47ab8cac6dffc4614a4d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2007NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i641a64c3fd2249f69b0e9e1f3f788718_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2008NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2774e5040f8c4961ae53d545a9f37afe_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2009NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0f745bd8bca441319b8ed301cc2bc4cc_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2010NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id7e7f831dff6421d8eb531fa106546e6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2011NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5ed22e918d4f48e8b808961d921a33f4_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2012NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id9721043231044bc9aeae35bc61c92e2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2013NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i315da09d5b6b446fb033c07698d6d7a5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2014NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i65cffff74cb04e8ea2ecc68c77d2b4db_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2015NPMAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4720a28bdb104979ab2247511d0da7e2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i65954542804549b295903e71ce88b5d9_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2017NPMAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id2c3b4aebf6646d9972246c1621e7c8a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2018NPMAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i21f876e2b3cf44cdb355f679e4503b4c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2019NPMAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifebf0c01e22141d8beb01098ae7c84fd_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2020NPMAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0c5082287da0495e8408464c2a0a26c2_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i96af53950024460b8a4b3ff962001c7b_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i33c7acc23f4a44fe8c2a26183ccd5df2_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i4d3472b2a91245dea8ecb3a70a055bbc_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1ead92d842db4635b29251f1f090ed5f_D20150101-20151231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsTransitionYears20042020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-01-01</startDate>
            <endDate>2015-12-31</endDate>
        </period>
    </context>
    <context id="i5f1a36b47df14a2887897a88255928c0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MT</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i308a1982e0b2451ba03e43963d30bf8a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia16faf9bb3364629910ff901aa086762_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie82ddd3ae8a04ec1904fa44df200d11f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icb250f9fcdf1428aa03ed81b876ddfae_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20052007NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic8c655e105f449fd919701efabc22bc1_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20052007NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mo:ArbitrationPeriodAxis">mo:PeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9eb956b79e6c4406aa88f5877ca274ab_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20052007NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mo:ArbitrationPeriodAxis">mo:PeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i52787a392f8143ad96b8a01791362efb_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherDisputesUndertheStateSettlementAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i37765c8db4d14257a1db295453135743_D20060801-20060831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2006-08-01</startDate>
            <endDate>2006-08-31</endDate>
        </period>
    </context>
    <context id="iac111175a4b94767b66b855e1ae095ae_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i95495989d64f46e4884394df5ac52ea3_D20140101-20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-01-01</startDate>
            <endDate>2014-12-31</endDate>
        </period>
    </context>
    <context id="i05574f14d9b74110b3542338d268b496_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:AltriaGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i37604da1eb80482781b7544e25e04971_D20140101-20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:AltriaGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-01-01</startDate>
            <endDate>2014-12-31</endDate>
        </period>
    </context>
    <context id="i43eda0d8e1cd4c80b86df99bd8127abd_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingLawsuitFiledBySchoolDistrictMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="i8ac851e84d934c1fae22ee819de18e27_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i34283e5fbf764b508c0c3b5d55b0c2d8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i39fd421e674b4f2885bbdc2d844388dc_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i05447dda5f5a4d59809fb46f46b15f92_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IQOSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i035c8420533b4cbbb71f640ebbdb0bc3_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="i93cb9eb992434b78b7e8af13960914e0_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="if859d02a78924c39895c8fe236aea331_I20201130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="i8b76752f44e74819b436e49281d45ca0_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6840f559dfc14605ad93fc181579892b_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="i199dd80736164b16bc4c33007d8b83f5_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i20c19903e59744cda38126a75fe80854_D20210401-20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="ic61197cb6b06443dbfd08c5b6acfcd30_D20200901-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="i72c3cdb7c38d49a39f60eaafddfc2f55_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:LightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="icdad9497490d4094a88132d419cbfe76_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="ibadad7f290d443d29bbe99b6abd7399f_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:USTLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingIndividualLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="i8b49abf1769f40eb98805158adeb07ff_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i89787fa06a89496fbdd25f2aaa8f0fe7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id021cc782b074325a57d6e0da163d67c_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:LightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="cadPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:CAD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="cad">
        <measure>iso4217:CAD</measure>
    </unit>
    <unit id="year">
        <measure>mo:year</measure>
    </unit>
    <unit id="state">
        <measure>mo:state</measure>
    </unit>
    <unit id="claim">
        <measure>mo:claim</measure>
    </unit>
    <unit id="case">
        <measure>mo:case</measure>
    </unit>
    <unit id="lawsuit">
        <measure>mo:lawsuit</measure>
    </unit>
    <unit id="plantiff">
        <measure>mo:plantiff</measure>
    </unit>
    <unit id="manufacture">
        <measure>mo:manufacture</measure>
    </unit>
    <unit id="ruling">
        <measure>mo:ruling</measure>
    </unit>
    <unit id="complaint">
        <measure>mo:complaint</measure>
    </unit>
    <unit id="shareholder">
        <measure>mo:shareholder</measure>
    </unit>
    <unit id="court">
        <measure>mo:court</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y180L2ZyYWc6MjFmMTBlYzAyOTg3NGFiMWI0YTZlZjIwYjYzNTdkYjYvdGFibGU6YTlkODBhNWZiNWNhNDYyNjg4MzIzZTEwMzU3ZjU2YjAvdGFibGVyYW5nZTphOWQ4MGE1ZmI1Y2E0NjI2ODgzMjNlMTAzNTdmNTZiMF8xLTEtMS0xLTA_590a731b-f56f-4114-866b-766d086fd39b">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y180L2ZyYWc6MjFmMTBlYzAyOTg3NGFiMWI0YTZlZjIwYjYzNTdkYjYvdGFibGU6YTlkODBhNWZiNWNhNDYyNjg4MzIzZTEwMzU3ZjU2YjAvdGFibGVyYW5nZTphOWQ4MGE1ZmI1Y2E0NjI2ODgzMjNlMTAzNTdmNTZiMF8yLTEtMS0xLTA_d48820e2-92a6-4f80-bcf2-6abd99f48a95">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y180L2ZyYWc6MjFmMTBlYzAyOTg3NGFiMWI0YTZlZjIwYjYzNTdkYjYvdGFibGU6YTlkODBhNWZiNWNhNDYyNjg4MzIzZTEwMzU3ZjU2YjAvdGFibGVyYW5nZTphOWQ4MGE1ZmI1Y2E0NjI2ODgzMjNlMTAzNTdmNTZiMF8zLTEtMS0xLTA_bd074e46-138a-4837-8503-1f5e7c8e6516">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y180L2ZyYWc6MjFmMTBlYzAyOTg3NGFiMWI0YTZlZjIwYjYzNTdkYjYvdGFibGU6YTlkODBhNWZiNWNhNDYyNjg4MzIzZTEwMzU3ZjU2YjAvdGFibGVyYW5nZTphOWQ4MGE1ZmI1Y2E0NjI2ODgzMjNlMTAzNTdmNTZiMF80LTEtMS0xLTA_1c475cb2-d44b-4a72-937a-54445d1091c2">0000764180</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y180L2ZyYWc6MjFmMTBlYzAyOTg3NGFiMWI0YTZlZjIwYjYzNTdkYjYvdGFibGU6YTlkODBhNWZiNWNhNDYyNjg4MzIzZTEwMzU3ZjU2YjAvdGFibGVyYW5nZTphOWQ4MGE1ZmI1Y2E0NjI2ODgzMjNlMTAzNTdmNTZiMF81LTEtMS0xLTA_69692a58-f418-4405-98c5-a1f4fcabd80b">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMy9mcmFnOmE5OTcyOGY5Y2NmNjQ4ZDA4OTY3MzY2NDg0Y2RkODUxL3RhYmxlOjM0OTY4ZjRlOTc0NzRhNjc4OGMzYjNlZGE0Y2JjZjE0L3RhYmxlcmFuZ2U6MzQ5NjhmNGU5NzQ3NGE2Nzg4YzNiM2VkYTRjYmNmMTRfMi0xLTEtMS0w_fac722f5-baa7-4b0e-951b-7f56e2c8089c"
      unitRef="usdPerShare">0.3333</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMy9mcmFnOmE5OTcyOGY5Y2NmNjQ4ZDA4OTY3MzY2NDg0Y2RkODUxL3RhYmxlOjM0OTY4ZjRlOTc0NzRhNjc4OGMzYjNlZGE0Y2JjZjE0L3RhYmxlcmFuZ2U6MzQ5NjhmNGU5NzQ3NGE2Nzg4YzNiM2VkYTRjYmNmMTRfMi0yLTEtMS0w_2e093059-de80-445e-b5f1-2f33dfe9b222"
      unitRef="usdPerShare">0.3333</us-gaap:CommonStockParOrStatedValuePerShare>
    <mo:RestrictedSharesLockupPeriod
      contextRef="ife49fc973ca746f092aa4d83bca9d740_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzkwMzI2NjI3OTEyMjM_deac5b80-5cfb-43db-b6ef-127a6fca35e3">P5Y</mo:RestrictedSharesLockupPeriod>
    <mo:LossContingencyNumberOfStatesNotSettledArbitrationPeriod
      contextRef="ic8c655e105f449fd919701efabc22bc1_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM1NjYx_a644eea3-4823-4d15-b961-96400803386e">P3Y</mo:LossContingencyNumberOfStatesNotSettledArbitrationPeriod>
    <mo:LossContingencyNumberOfStatesNotSettledArbitrationPeriod
      contextRef="i9eb956b79e6c4406aa88f5877ca274ab_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM1NzEx_1f0bca57-bdd0-4faf-a0bb-bb958177008c">P1Y</mo:LossContingencyNumberOfStatesNotSettledArbitrationPeriod>
    <mo:LossContingencyStateCourtsNumber
      contextRef="id021cc782b074325a57d6e0da163d67c_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDMvZnJhZzoxMGRjNWMzNTg5OTE0MWY2OTEwNGQyMzUwNjYzOWM4OS90ZXh0cmVnaW9uOjEwZGM1YzM1ODk5MTQxZjY5MTA0ZDIzNTA2NjM5Yzg5XzU_6947b49a-350b-40fd-a482-283aaf25af92"
      unitRef="court">21</mo:LossContingencyStateCourtsNumber>
    <dei:DocumentType
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGV4dHJlZ2lvbjpjYWE5NzIzNzRhOWM0MmJmYjlkODRmNmU5YjJhYTczMV8yMDg4_96aa91a5-a9f4-40e4-a5e4-62ce5a68ba8d">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZmM5NjgzZDUwMjczNDUyOGFlNGVlNDg4ZTI1YmZhNGIvdGFibGVyYW5nZTpmYzk2ODNkNTAyNzM0NTI4YWU0ZWU0ODhlMjViZmE0Yl8wLTAtMS0xLTA_3e5ca9c7-b5e7-4e52-9aa4-ce2fbe733086">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGV4dHJlZ2lvbjpjYWE5NzIzNzRhOWM0MmJmYjlkODRmNmU5YjJhYTczMV8yNzQ4Nzc5MDcxNTU4_a8779482-c7de-436c-b2e0-30ba02ace769">2021-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6N2E5ZTE0MjMyZDUwNDA0ZTg4NmM0YTg1ZDQ0ZGNjMmMvdGFibGVyYW5nZTo3YTllMTQyMzJkNTA0MDRlODg2YzRhODVkNDRkY2MyY18wLTAtMS0xLTA_53aceef9-7a30-43cc-8888-04663422e9df">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGV4dHJlZ2lvbjpjYWE5NzIzNzRhOWM0MmJmYjlkODRmNmU5YjJhYTczMV8yMDg1_668a1747-e062-4bf9-bdb8-07a52fbfe3f2">1-08940</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGV4dHJlZ2lvbjpjYWE5NzIzNzRhOWM0MmJmYjlkODRmNmU5YjJhYTczMV8yMDg5_f2cbdec7-4cc9-49a9-9e98-1dc730865fa9">Altria Group, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWFmYjRmYWM1Y2Q0NDdmMjg3MDIwOTllYzNhMDJmYmIvdGFibGVyYW5nZTplYWZiNGZhYzVjZDQ0N2YyODcwMjA5OWVjM2EwMmZiYl8xLTAtMS0xLTA_5a1dedae-38f9-48fa-a72f-22155daf2a8c">VA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWFmYjRmYWM1Y2Q0NDdmMjg3MDIwOTllYzNhMDJmYmIvdGFibGVyYW5nZTplYWZiNGZhYzVjZDQ0N2YyODcwMjA5OWVjM2EwMmZiYl8xLTMtMS0xLTA_1f813581-a44e-4f22-b453-a5eddb67b5c7">13-3260245</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWFmYjRmYWM1Y2Q0NDdmMjg3MDIwOTllYzNhMDJmYmIvdGFibGVyYW5nZTplYWZiNGZhYzVjZDQ0N2YyODcwMjA5OWVjM2EwMmZiYl80LTAtMS0xLTA_0c0e3fab-b351-4d5d-9fc2-08ea8c624477">6601 West Broad Street,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWFmYjRmYWM1Y2Q0NDdmMjg3MDIwOTllYzNhMDJmYmIvdGFibGVyYW5nZTplYWZiNGZhYzVjZDQ0N2YyODcwMjA5OWVjM2EwMmZiYl80LTEtMS0xLTA_f64654ee-62b7-4652-a103-f0dcd804a0f6">Richmond,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWFmYjRmYWM1Y2Q0NDdmMjg3MDIwOTllYzNhMDJmYmIvdGFibGVyYW5nZTplYWZiNGZhYzVjZDQ0N2YyODcwMjA5OWVjM2EwMmZiYl80LTItMS0xLTA_0650dcec-5f4d-441d-a830-c74dbaac9c1f">VA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWFmYjRmYWM1Y2Q0NDdmMjg3MDIwOTllYzNhMDJmYmIvdGFibGVyYW5nZTplYWZiNGZhYzVjZDQ0N2YyODcwMjA5OWVjM2EwMmZiYl80LTMtMS0xLTA_454fce4d-0106-450d-bd8f-74ac04a35026">23230</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGV4dHJlZ2lvbjpjYWE5NzIzNzRhOWM0MmJmYjlkODRmNmU5YjJhYTczMV8yMDg2_941a5958-acda-4552-b116-b362e013cff0">804</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGV4dHJlZ2lvbjpjYWE5NzIzNzRhOWM0MmJmYjlkODRmNmU5YjJhYTczMV8yMDgx_f729b3ff-ef14-4de9-b1f7-fd60300a3117">274-2200</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i45fa0eb8e2f44df1a1178d965055b18b_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl8xLTAtMS0xLTA_b25fa8f9-c11c-404d-9cd2-19ee03ecfa96">Common Stock, $0.33 1/3 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i45fa0eb8e2f44df1a1178d965055b18b_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl8xLTEtMS0xLTA_fd51a1b7-c1ec-435b-8bf3-b6a5a1c05eac">MO</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i45fa0eb8e2f44df1a1178d965055b18b_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl8xLTItMS0xLTA_a0c0ae8d-b8ab-4428-85a9-9a0352db5d01">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i5f72e3af91ab46a8894e0b9546b1c4b4_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl8yLTAtMS0xLTA_d8160d2c-8d2a-4cf6-b1f6-2044d25634a2">1.000% Notes due 2023</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i5f72e3af91ab46a8894e0b9546b1c4b4_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl8yLTEtMS0xLTA_aac23a3c-59db-4660-94a4-3fbeae8c86b6">MO23A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i5f72e3af91ab46a8894e0b9546b1c4b4_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl8yLTItMS0xLTA_975723f8-b373-47c1-b8f3-01c77adb0406">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i637e2b2941ef4dd592b5c3c4d55bfa25_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl8zLTAtMS0xLTA_a0370fda-00eb-49f1-93e0-b85ecee120bd">1.700% Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i637e2b2941ef4dd592b5c3c4d55bfa25_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl8zLTEtMS0xLTA_7577d81f-7256-4ec0-8941-0d73dec33773">MO25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i637e2b2941ef4dd592b5c3c4d55bfa25_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl8zLTItMS0xLTA_85cdc9ef-2c46-45cf-b3cb-3c4deb074d8b">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i1bf469c5379b4f2d88bdd9ee3efeecc8_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl80LTAtMS0xLTA_92f40670-6bb1-4599-9449-4d111cd52051">2.200% Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i1bf469c5379b4f2d88bdd9ee3efeecc8_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl80LTEtMS0xLTA_57283a7a-42bb-4daf-a9fa-13cf5f965a20">MO27</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i1bf469c5379b4f2d88bdd9ee3efeecc8_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl80LTItMS0xLTA_f42f8c56-fb7b-4f57-acdb-fbb7779d60ba">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ia576c3905ea64c98b404cc8e4f72a7d9_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl81LTAtMS0xLTA_5addb28e-1653-4762-be73-443bdde4e9f5">3.125% Notes due 2031</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ia576c3905ea64c98b404cc8e4f72a7d9_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl81LTEtMS0xLTA_3ae3fff1-be29-467d-8ef8-1252f7a7910b">MO31</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ia576c3905ea64c98b404cc8e4f72a7d9_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6ZWZlY2RmNjAwYzcxNDNlMWIxYTk2Y2RiMGU2ZWQwYmYvdGFibGVyYW5nZTplZmVjZGY2MDBjNzE0M2UxYjFhOTZjZGIwZTZlZDBiZl81LTItMS0xLTA_40a40154-f260-418c-ab50-2531e40c4567">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGV4dHJlZ2lvbjpjYWE5NzIzNzRhOWM0MmJmYjlkODRmNmU5YjJhYTczMV8yMDgy_446cd166-f85d-4db0-ad6c-89077542e7c6">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGV4dHJlZ2lvbjpjYWE5NzIzNzRhOWM0MmJmYjlkODRmNmU5YjJhYTczMV8yMDgz_7d893983-7c9e-440b-bcab-f94e182afd25">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6NTE0NTNmN2JkYjU3NDVmZDhkYmU3ZGE3MGExYTBkOGQvdGFibGVyYW5nZTo1MTQ1M2Y3YmRiNTc0NWZkOGRiZTdkYTcwYTFhMGQ4ZF8wLTAtMS0xLTA_98c72b49-ff22-4655-b109-8be61087bb83">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6NTE0NTNmN2JkYjU3NDVmZDhkYmU3ZGE3MGExYTBkOGQvdGFibGVyYW5nZTo1MTQ1M2Y3YmRiNTc0NWZkOGRiZTdkYTcwYTFhMGQ4ZF8yLTYtMS0xLTA_5a0f5bd8-18e3-4cda-9909-5f0401ec287f">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGFibGU6NTE0NTNmN2JkYjU3NDVmZDhkYmU3ZGE3MGExYTBkOGQvdGFibGVyYW5nZTo1MTQ1M2Y3YmRiNTc0NWZkOGRiZTdkYTcwYTFhMGQ4ZF8zLTYtMS0xLTA_36401ff1-c370-4c96-b375-4e4330843a7e">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGV4dHJlZ2lvbjpjYWE5NzIzNzRhOWM0MmJmYjlkODRmNmU5YjJhYTczMV8yMDg3_734ceed0-831b-4beb-81e8-3965323751a1">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="iea6b6e16a27d4008b94c6c65b72d6673_I20211021"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xL2ZyYWc6Y2FhOTcyMzc0YTljNDJiZmI5ZDg0ZjZlOWIyYWE3MzEvdGV4dHJlZ2lvbjpjYWE5NzIzNzRhOWM0MmJmYjlkODRmNmU5YjJhYTczMV8yNzQ4Nzc5MDcxNzI5_8247cf70-3718-4a75-820c-5fe397e0d283"
      unitRef="shares">1836988822</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMi0yLTEtMS0w_b3925cf1-7288-4656-8e5e-ed8341940cf3"
      unitRef="usd">2957000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMi00LTEtMS0w_ead053f5-08d5-4aa6-b67c-74c1c34fb878"
      unitRef="usd">4945000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMy0yLTEtMS0w_ae491670-29eb-47c6-9b3f-8c03b64043ac"
      unitRef="usd">36000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMy00LTEtMS0w_40175702-e81f-40e7-8dff-94ae24bed899"
      unitRef="usd">137000000</us-gaap:ReceivablesNetCurrent>
    <mo:InventoryRawMaterialsPlantMaterialNetofReserves
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfNS0yLTEtMS0w_68165030-ed14-4078-9877-42e8c7464a3a"
      unitRef="usd">644000000</mo:InventoryRawMaterialsPlantMaterialNetofReserves>
    <mo:InventoryRawMaterialsPlantMaterialNetofReserves
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfNS00LTEtMS0w_c9e80244-e16d-41a2-852e-0fb162488c4b"
      unitRef="usd">844000000</mo:InventoryRawMaterialsPlantMaterialNetofReserves>
    <mo:OtherInventoryRawMaterialsNetofReserves
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfNi0yLTEtMS0w_88791573-4f9d-4517-b5f1-bc2a136ff11a"
      unitRef="usd">159000000</mo:OtherInventoryRawMaterialsNetofReserves>
    <mo:OtherInventoryRawMaterialsNetofReserves
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfNi00LTEtMS0w_f2508475-73d3-4115-89b2-5788136c4ad7"
      unitRef="usd">200000000</mo:OtherInventoryRawMaterialsNetofReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfNy0yLTEtMS0w_7980a32f-90db-4b2a-a8c2-80b1c3d941f8"
      unitRef="usd">30000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfNy00LTEtMS0w_02b06d16-69c5-4f89-b6bf-52e9ff99847b"
      unitRef="usd">502000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfOC0yLTEtMS0w_88384d29-5177-4b8f-8551-717af8c23f68"
      unitRef="usd">300000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfOC00LTEtMS0w_c764833f-9169-4114-bdac-9975c75c7615"
      unitRef="usd">420000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfOS0yLTEtMS0w_f7970a99-492a-4d81-9f39-28bd427ed527"
      unitRef="usd">1133000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfOS00LTEtMS0w_d05b21b4-7575-4ee9-9594-bb45a2160a4c"
      unitRef="usd">1966000000</us-gaap:InventoryNet>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTItMi0xLTEtMzA5NA_3ceb1b71-a4c7-42a5-8c4b-5fb8d367884a"
      unitRef="usd">1490000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTItNC0xLTEtMzEwMQ_d6ff4362-debe-4d60-8abf-ff877ad32c54"
      unitRef="usd">0</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTMtMi0xLTEtMTA4MTE_383632a5-a756-4a7f-bffa-baa22f6dc855"
      unitRef="usd">404000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTMtNC0xLTEtMTA4MzU_b380f149-d55c-4b33-952f-6b46c2f31bd9"
      unitRef="usd">69000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTItMi0xLTEtMA_3fe6ab54-0eea-4214-af16-a069af40efa0"
      unitRef="usd">6020000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTItNC0xLTEtMA_8be7b242-5665-411c-8eb9-d830faccc882"
      unitRef="usd">7117000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTMtMi0xLTEtMA_ab3931bf-e7e2-4f02-ae9a-20c1af67a169"
      unitRef="usd">4418000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTMtNC0xLTEtMA_4f23d399-ec9c-4036-b67d-0b21f3d62e50"
      unitRef="usd">5150000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTQtMi0xLTEtMA_cedea25c-9221-4a72-83fe-acc08695d078"
      unitRef="usd">2900000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTQtNC0xLTEtMA_d556cf51-bccc-42d4-91ab-43140c761016"
      unitRef="usd">3138000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTUtMi0xLTEtMA_ab05a8ab-4c3f-4746-8e80-c2809c13ec07"
      unitRef="usd">1518000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTUtNC0xLTEtMA_22d45e5f-f874-4d40-bae5-ad30ccde4d14"
      unitRef="usd">2012000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTYtMi0xLTEtMA_3672e313-96e7-4431-96cd-b64663714b43"
      unitRef="usd">5177000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTYtNC0xLTEtMA_9cc27abd-33f6-4b9c-9847-f2db5d93ef3a"
      unitRef="usd">5177000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTctMi0xLTEtMA_01472b53-f57f-4617-94dd-a3e32418811f"
      unitRef="usd">12326000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTctNC0xLTEtMA_70ed52d4-e24c-4dc7-885b-bcd1e80cbdb4"
      unitRef="usd">12615000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjdkM2VlZmIxNGZhNjQ4MjNiM2UyNGMyNDg4YThhOTEzXzM4_9e40f0bd-af09-4b96-a9ca-a4de6f3667ad"
      unitRef="usd">1740000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjdkM2VlZmIxNGZhNjQ4MjNiM2UyNGMyNDg4YThhOTEzXzQ1_1013e5b4-9aa0-42b5-8cb8-774baf675082"
      unitRef="usd">1868000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:Investments
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTgtMi0xLTEtMA_bf0e1c79-77ec-47b0-aa87-db72cbaf0c31"
      unitRef="usd">13874000000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMTgtNC0xLTEtMA_13cce1b5-69a9-4619-85a5-fb295b0cac05"
      unitRef="usd">19529000000</us-gaap:Investments>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMjAtMi0xLTEtMA_3f65b438-79f6-45fb-a332-b6ecb7515285"
      unitRef="usd">649000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMjAtNC0xLTEtMA_83f169fd-2a62-4632-870d-dbb63034361a"
      unitRef="usd">964000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMjEtMi0xLTEtMA_f102a95f-6cfa-4443-a560-9fac93dec1fc"
      unitRef="usd">39564000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjY3MWEyYmY4MTU5YzQ5N2JiYWJmMjA2NDUwNTg1NGRiL3RhYmxlcmFuZ2U6NjcxYTJiZjgxNTljNDk3YmJhYmYyMDY0NTA1ODU0ZGJfMjEtNC0xLTEtMA_23aa3564-e9c2-4e4a-bd35-e0f866fb06ff"
      unitRef="usd">47414000000</us-gaap:Assets>
    <us-gaap:LongTermDebtCurrent
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMy0yLTEtMS0w_1313c593-f540-444a-ab1d-936fd6d60101"
      unitRef="usd">1105000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMy00LTEtMS0w_8d7717a5-be5c-4767-94fc-3cd4a4308028"
      unitRef="usd">1500000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfNC0yLTEtMS0w_885e8fd2-6f3b-4faf-84bf-005cb43fed69"
      unitRef="usd">266000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfNC00LTEtMS0w_f9eadbff-8787-4d24-a453-d31bd83a31c0"
      unitRef="usd">380000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedMarketingCostsCurrent
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfNi0yLTEtMS0w_017cb363-6c83-46cf-9987-9ff33b1149cf"
      unitRef="usd">680000000</us-gaap:AccruedMarketingCostsCurrent>
    <us-gaap:AccruedMarketingCostsCurrent
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfNi00LTEtMS0w_3e824ab3-46d0-4759-9b6d-a4ab5a19d4a4"
      unitRef="usd">523000000</us-gaap:AccruedMarketingCostsCurrent>
    <mo:AccruedSettlementLiabilityCurrent
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfOS0yLTEtMS0w_0f31f277-01b8-4598-b99b-82220b8a2993"
      unitRef="usd">2996000000</mo:AccruedSettlementLiabilityCurrent>
    <mo:AccruedSettlementLiabilityCurrent
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfOS00LTEtMS0w_fc57e11a-bbf5-4c16-a6a2-092c8a05422b"
      unitRef="usd">3564000000</mo:AccruedSettlementLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTAtMi0xLTEtMA_d66755ab-3972-478e-a567-92c2c976dc06"
      unitRef="usd">1109000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTAtNC0xLTEtMA_ce79c00b-0f1c-46d0-a3a3-fae6e17841b7"
      unitRef="usd">1494000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTItMi0xLTEtMA_c2768128-07f9-4763-9709-2e624061b06e"
      unitRef="usd">1661000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTItNC0xLTEtMA_ee802bd4-1ce8-422f-9c79-877aa63709de"
      unitRef="usd">1602000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTMtMi0xLTEtMzExMg_9de928ff-e76c-44a8-9103-53f370778651"
      unitRef="usd">295000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTMtNC0xLTEtMzExNw_884c4a0d-c49b-430a-9379-b5fb70404982"
      unitRef="usd">0</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTMtMi0xLTEtMA_1d7dd156-d331-4478-bbbe-fbc4d752b9cd"
      unitRef="usd">8112000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTMtNC0xLTEtMA_17c99142-f20b-4a00-89c8-4ee544fd25c8"
      unitRef="usd">9063000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTQtMi0xLTEtMA_9b5ae7f8-a3a7-4197-b5e3-082a9bdb2300"
      unitRef="usd">27022000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTQtNC0xLTEtMA_c2356510-8213-44b6-8e76-a942815eb1e7"
      unitRef="usd">27971000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTUtMi0xLTEtMA_51545fbf-f85a-4f9f-a862-b5248fb73bf1"
      unitRef="usd">3557000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTUtNC0xLTEtMA_7ecde68f-ae42-4bf5-b145-c554f3254206"
      unitRef="usd">4532000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTYtMi0xLTEtMA_7ca96f0f-9c6a-43cb-9917-968e153adefa"
      unitRef="usd">280000000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTYtNC0xLTEtMA_f0c0b180-57c1-4eb5-8091-95081e6794b9"
      unitRef="usd">551000000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTctMi0xLTEtMA_9bfc20db-cc42-417c-a615-bd20658460c3"
      unitRef="usd">1512000000</us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent>
    <us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTctNC0xLTEtMA_ad43b7b0-be8f-46d7-9578-a5497fb7c39a"
      unitRef="usd">1951000000</us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTgtMi0xLTEtMA_54ab344e-f584-4fad-9c45-51ed23648e88"
      unitRef="usd">307000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTgtNC0xLTEtMA_76907112-542e-40aa-ad05-38aa5817cf4a"
      unitRef="usd">381000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTktMi0xLTEtMA_3d7808e4-cba5-46bf-a59b-fda5ddbe2003"
      unitRef="usd">40790000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMTktNC0xLTEtMA_74579203-ec46-4fd5-b5b1-d7971b55a982"
      unitRef="usd">44449000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjAtMi0xLTEtMA_57d6ff06-5d13-4e94-aa01-b7c48f45d0e6"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjAtNC0xLTEtMA_b0b83a90-227b-4a29-9d61-45a9e8b2cc5b"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjEtMi0xLTEtMA_f780172b-ef84-4444-80e3-e553ffc4c065"
      unitRef="usd">39000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjEtNC0xLTEtMA_55cb9e8c-685c-4664-9e7f-399eed26660e"
      unitRef="usd">40000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommonStockSharesIssued
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOjI3ODAxNTIwMjdiNzQ2NWNiZDU0NWFjZWVhZDJkYjcwXzUw_15e8a503-8625-40e0-ba01-62f78920f2ec"
      unitRef="shares">2805961317</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOjI3ODAxNTIwMjdiNzQ2NWNiZDU0NWFjZWVhZDJkYjcwXzUw_38a977f0-aadb-4203-8e3e-fd73f74c14f2"
      unitRef="shares">2805961317</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjMtMi0xLTEtMA_1be9f7d3-4cf8-4e31-85bb-72f68e807176"
      unitRef="usd">935000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjMtNC0xLTEtMA_d3dbf824-1775-4c65-8617-c8dc9b4534c9"
      unitRef="usd">935000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjQtMi0xLTEtMA_574a73b0-5387-4767-9775-804abb79a62e"
      unitRef="usd">5846000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjQtNC0xLTEtMA_6be716d0-1602-4a9b-a492-f2f6712fa262"
      unitRef="usd">5910000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjUtMi0xLTEtMA_9d21af08-20a1-48c9-b104-91bfe289c4ac"
      unitRef="usd">30685000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjUtNC0xLTEtMA_91e9c684-e493-41de-bf41-4301e0c2bbe9"
      unitRef="usd">34679000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjYtMi0xLTEtMA_0921820e-375e-4fe6-883e-d0ef9f758c7f"
      unitRef="usd">-3430000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjYtNC0xLTEtMA_0525410f-48f6-40ab-a574-de95a405f51c"
      unitRef="usd">-4341000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmRjNGZiZGNmYTQ2ZDQ4YzViZWM3Y2I3OGU2Yjk0YTYyXzMy_9a659a35-8eac-4b46-8e90-14dc4b3155df"
      unitRef="shares">967321022</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmRjNGZiZGNmYTQ2ZDQ4YzViZWM3Y2I3OGU2Yjk0YTYyXzY0_8f5ac817-feda-4dac-8a26-c35d654e032b"
      unitRef="shares">947542152</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjctMi0xLTEtMA_70000d5d-21b1-4fa3-9dc1-155d721ae82e"
      unitRef="usd">35303000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjctNC0xLTEtMA_35389638-0329-46ab-8b9c-4bc65fa7e786"
      unitRef="usd">34344000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjgtMi0xLTEtMA_90ae2ed1-5a69-4341-955e-355dab70ef5d"
      unitRef="usd">-1267000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjgtNC0xLTEtMA_96263690-f657-48ee-a44f-c0de05871f35"
      unitRef="usd">2839000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjktMi0xLTEtMA_db5f5086-9347-4af3-b679-5a05b95ecd14"
      unitRef="usd">2000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMjktNC0xLTEtMA_f5a112c0-e105-4e8c-aa3c-c66c6af29f2e"
      unitRef="usd">86000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMzAtMi0xLTEtMA_1744a9f2-bd2b-4513-8ff7-b1f4562af871"
      unitRef="usd">-1265000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMzAtNC0xLTEtMA_a8e5d276-07e3-4c5f-98b6-9affbdc07b32"
      unitRef="usd">2925000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMzEtMi0xLTEtMA_5c4e35ad-efd3-4beb-89c8-b4fa476c2a9d"
      unitRef="usd">39564000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMC9mcmFnOmI0YzE0YTVmMTBkOTQ5MGNhMzA1N2Q4ZDU4ODM1MTBlL3RhYmxlOjEyZjhjYjdkMTU1YTRjYjdhY2JmNTJmM2U2YzJiYTE4L3RhYmxlcmFuZ2U6MTJmOGNiN2QxNTVhNGNiN2FjYmY1MmYzZTZjMmJhMThfMzEtNC0xLTEtMA_1ef20625-4c1b-41ae-8775-c605771e9185"
      unitRef="usd">47414000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMi0yLTEtMS0w_ac78efc5-e1a0-48e7-ac13-03d0908d2ea5"
      unitRef="usd">19758000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMi00LTEtMS0w_ca21b028-e933-4107-8646-bcaeb6e0fb4d"
      unitRef="usd">19849000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMi02LTEtMS0w_0eae1368-1812-42f1-bba2-a5c342f5766d"
      unitRef="usd">6786000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMi04LTEtMS0w_69d1cc19-3e7b-44ff-a67f-d0790be964c7"
      unitRef="usd">7123000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMy0yLTEtMS0w_efc5db53-5b5b-4169-b574-38fc9e2c8520"
      unitRef="usd">5348000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMy00LTEtMS0w_5c9d76ce-22c3-4839-ad59-5e3502fbc19d"
      unitRef="usd">5909000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMy02LTEtMS0w_a69c0b34-a04f-4ead-96ea-572cd916193a"
      unitRef="usd">1858000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMy04LTEtMS0w_4ca21f10-697c-4e88-be69-c599fb3759e4"
      unitRef="usd">1961000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfNC0yLTEtMS0w_5e4f634e-fb3d-454e-a1e2-5300960d3e2f"
      unitRef="usd">3733000000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfNC00LTEtMS0w_e0e04f75-6250-4804-88fd-2a538889631a"
      unitRef="usd">4063000000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfNC02LTEtMS0w_2dda625b-c2cb-491e-a8a2-8be48d68b9db"
      unitRef="usd">1255000000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfNC04LTEtMS0w_f1cbf7d6-3db3-4e3c-860f-b237a3f38f6f"
      unitRef="usd">1445000000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:GrossProfit
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfNS0yLTEtMS0w_2c5034a2-8cbe-41fa-a1c5-07e96e250b0d"
      unitRef="usd">10677000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfNS00LTEtMS0w_dbbec6ae-1843-4670-b1a7-74c394ea4295"
      unitRef="usd">9877000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfNS02LTEtMS0w_992857ad-c8c9-4874-90fa-56a3ff04fee9"
      unitRef="usd">3673000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfNS04LTEtMS0w_a3b0438a-11f2-4a04-b27f-f17a487a67a2"
      unitRef="usd">3717000000</us-gaap:GrossProfit>
    <mo:MarketingAdministrationandResearchCosts
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfNi0yLTEtMS0w_3db6ec1b-707c-4bb1-9016-5c8d64040644"
      unitRef="usd">1850000000</mo:MarketingAdministrationandResearchCosts>
    <mo:MarketingAdministrationandResearchCosts
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfNi00LTEtMS0w_72f1fa97-d354-48a5-9941-89d6423e3f96"
      unitRef="usd">1585000000</mo:MarketingAdministrationandResearchCosts>
    <mo:MarketingAdministrationandResearchCosts
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfNi02LTEtMS0w_6e4582db-96e3-4e86-8b7a-d0ce9c0a4d73"
      unitRef="usd">722000000</mo:MarketingAdministrationandResearchCosts>
    <mo:MarketingAdministrationandResearchCosts
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfNi04LTEtMS0w_b9ec322d-5012-4d13-8cc8-c5c649b2bcb4"
      unitRef="usd">557000000</mo:MarketingAdministrationandResearchCosts>
    <us-gaap:OperatingIncomeLoss
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfOC0yLTEtMS0w_3cae308f-d4a0-4770-bd1d-827f0ed620d8"
      unitRef="usd">8827000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfOC00LTEtMS0w_9f92c5cc-9ffb-4df9-90b4-a379d5923d91"
      unitRef="usd">8292000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfOC02LTEtMS0w_2f4f6147-5564-443d-b465-ef09ac8d2bd2"
      unitRef="usd">2951000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfOC04LTEtMS0w_c6e10aa1-25a6-4a83-850f-03a9a69da016"
      unitRef="usd">3160000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfOS0yLTEtMS0w_e555f8d6-f71b-471a-a9a5-dc08ff8aef81"
      unitRef="usd">-869000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfOS00LTEtMS0w_ec05b7e4-5d09-4971-80b4-7310bdacbbcf"
      unitRef="usd">-893000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfOS02LTEtMS0w_678cbf04-af0f-4f62-9c55-11409d1aa189"
      unitRef="usd">-266000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfOS04LTEtMS0w_d938773d-d316-4b2e-9036-43563165b613"
      unitRef="usd">-310000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTAtMi0xLTEtMA_ce78fd5d-a89f-4718-ab63-1426ddd6634b"
      unitRef="usd">-649000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTAtNC0xLTEtMA_2f5c9e81-4463-4b42-b90d-db449c7da1a7"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTAtNi0xLTEtMA_36ba1b00-daf4-4eaa-8de0-1d0514f942ec"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTAtOC0xLTEtMA_74adc56f-1d7a-4c44-b268-a31aef07ccab"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTEtMi0xLTEtMA_416da791-497c-46d0-a18a-ac2b46b4690c"
      unitRef="usd">-152000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTEtNC0xLTEtMA_4629ead1-b522-4d9e-afde-9cf558e2ab62"
      unitRef="usd">-58000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTEtNi0xLTEtMA_a50085ac-e4e3-4493-8b75-1e3204bdac64"
      unitRef="usd">-63000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTEtOC0xLTEtMA_d0cb54a2-1386-47e8-bf27-7e32222a24b8"
      unitRef="usd">-3000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTItMi0xLTEtMA_72e21590-3d5c-4029-9952-552af710f959"
      unitRef="usd">-5789000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTItNC0xLTEtMA_3b8b2f44-23f6-4db9-b78f-d79b618375d4"
      unitRef="usd">-306000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTItNi0xLTEtMA_1d47c25d-aa9e-441f-af30-31f9685f8919"
      unitRef="usd">-5915000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTItOC0xLTEtMA_9a67a6e9-d17b-4147-a8f9-026d919aead1"
      unitRef="usd">-472000000</mo:IncomeLossFromEquityInvestments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTMtMi0xLTEtMA_cde40c38-1b07-4d09-8d75-52a177e397b4"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTMtNC0xLTEtMA_9baff033-2513-42d1-a97e-ee2254aa3bbe"
      unitRef="usd">2600000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTMtNi0xLTEtMA_623557cd-f273-4eb7-b2f2-2fa2ac984619"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTMtOC0xLTEtMA_d3b8babd-4722-4187-9a4d-6cb8eaedf2fb"
      unitRef="usd">2600000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTQtMi0xLTEtMA_57c72893-93ed-4e4a-acd9-007b27994880"
      unitRef="usd">-128000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTQtNC0xLTEtMA_fab442dc-20d5-4898-a662-689b27f497b2"
      unitRef="usd">-202000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTQtNi0xLTEtMA_8b3afaea-9e45-4e2c-b9ef-5755de0da0c0"
      unitRef="usd">-135000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTQtOC0xLTEtMA_c9632bd4-f06d-4565-862a-9cf353893c6d"
      unitRef="usd">-105000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTYtMi0xLTEtMA_074ad156-5090-49f7-8342-dd0895d65a9d"
      unitRef="usd">1544000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTYtNC0xLTEtMA_f1e49282-da8b-430a-b084-d4f2ebccc94d"
      unitRef="usd">4349000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTYtNi0xLTEtMA_a67896e2-e7f9-4336-8e7c-640a3a659a21"
      unitRef="usd">-3302000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTYtOC0xLTEtMA_ca2633cb-287c-400a-9251-b9e614119470"
      unitRef="usd">-324000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTctMi0xLTEtMA_34ce4104-ca53-4968-a0dd-7120b40423e6"
      unitRef="usd">693000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTctNC0xLTEtMA_14cb1b30-aa27-4a61-8f2b-a772ae57c815"
      unitRef="usd">1817000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTctNi0xLTEtMA_3752c2ee-c992-4910-8ca6-fcda3e5ca0c9"
      unitRef="usd">-582000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTctOC0xLTEtMA_ead4e7f4-36db-48ad-90f2-339ddc28a22e"
      unitRef="usd">632000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTgtMi0xLTEtMA_c344639e-424f-4fa9-a1d4-e876f221f5bd"
      unitRef="usd">851000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTgtNC0xLTEtMA_80b57013-8813-4066-9a15-dd5959a8a805"
      unitRef="usd">2532000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTgtNi0xLTEtMA_bcacd4c7-1c5f-4b36-a430-9c4bccd19bc6"
      unitRef="usd">-2720000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTgtOC0xLTEtMA_2db02dda-14b3-41e1-b479-89f4cd35273d"
      unitRef="usd">-956000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTktMi0xLTEtMA_01c5b5b6-0dda-48db-9202-313a75f6aa15"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTktNC0xLTEtMA_97714597-3d91-4ead-9dc0-01f7e71ce528"
      unitRef="usd">-11000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTktNi0xLTEtMA_bb51fe09-36ac-465f-bc2a-33ecde754794"
      unitRef="usd">2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMTktOC0xLTEtMA_34cb588f-0893-488f-9d38-835c8c1db0e5"
      unitRef="usd">-4000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMjAtMi0xLTEtMA_38f362dc-e15c-436e-8124-580f3e4689d7"
      unitRef="usd">851000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMjAtNC0xLTEtMA_e46bb0ee-4b94-4add-8be8-e3219fa44f95"
      unitRef="usd">2543000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMjAtNi0xLTEtMA_7dcd2cd7-96fa-4a40-9a1c-bc547979e282"
      unitRef="usd">-2722000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMjAtOC0xLTEtMA_052fe737-90fc-4f22-b119-7102dce6a1bb"
      unitRef="usd">-952000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMjItMi0xLTEtMA_3ad84ac3-7eac-4b03-a48f-890953550101"
      unitRef="usdPerShare">0.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMjItNC0xLTEtMA_b825c939-f8ba-4a3e-95d7-04b616fae195"
      unitRef="usdPerShare">1.37</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMjItNi0xLTEtMA_ec896b15-6191-4b75-a4f3-dcab4186faed"
      unitRef="usdPerShare">-1.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMjItOC0xLTEtMA_a7e8d095-60f2-4f8d-b1c1-29e82f21b993"
      unitRef="usdPerShare">-0.51</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMjMtMi0xLTEtMA_5a7caacf-380b-4b46-88b7-bd76d8628bdb"
      unitRef="usdPerShare">0.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMjMtNC0xLTEtMA_c4dca33c-f319-4d07-ad36-b4f527966187"
      unitRef="usdPerShare">1.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMjMtNi0xLTEtMA_b2e00d38-646e-477d-9046-6879ca5a6fa9"
      unitRef="usdPerShare">-1.48</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNi9mcmFnOjRmMzg5ZDJkZmRiMjQ4NWQ5YzY0NGVmNDc3YTIxZmM0L3RhYmxlOjhiNzI2YTIzMmY0MTQ2ZjI5ODkzZjMyYjYxN2JkZmMyL3RhYmxlcmFuZ2U6OGI3MjZhMjMyZjQxNDZmMjk4OTNmMzJiNjE3YmRmYzJfMjMtOC0xLTEtMA_55d70f77-a821-453d-a52b-53a207719c2a"
      unitRef="usdPerShare">-0.51</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ProfitLoss
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfMi0yLTEtMS0w_771cb154-a4d5-4310-b9f7-4be61026d4f6"
      unitRef="usd">851000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfMi00LTEtMS0w_8415f675-2b3f-4360-b66f-a913282804da"
      unitRef="usd">2532000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfMi02LTEtMS0w_5dce92b3-f91d-436d-af22-6c65e3f1a16a"
      unitRef="usd">-2720000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfMi04LTEtMS0w_345393f2-df85-4c50-a1ba-34ee22d9bf6c"
      unitRef="usd">-956000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNC0yLTEtMS0w_a2fe7e2f-0221-41ae-a452-3dbfb247d0b0"
      unitRef="usd">-383000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNC00LTEtMS0w_25c5b9aa-3ca9-4848-9818-32abca9e89d4"
      unitRef="usd">-27000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNC02LTEtMS0w_339668e8-ba64-4f53-bb8b-9fd83bbe7226"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNC04LTEtMS0w_c7e8e822-3f45-4195-8776-1c3fa9bfc077"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OciEquityMethodInvestmentAfterTax
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNS0yLTEtMS0w_30588ac8-c1cb-42b2-b771-feb272152bf5"
      unitRef="usd">495000000</us-gaap:OciEquityMethodInvestmentAfterTax>
    <us-gaap:OciEquityMethodInvestmentAfterTax
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNS00LTEtMS0w_ad415e10-0dea-47ba-81f8-5ecb103c70a7"
      unitRef="usd">-928000000</us-gaap:OciEquityMethodInvestmentAfterTax>
    <us-gaap:OciEquityMethodInvestmentAfterTax
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNS02LTEtMS0w_9689b52a-6168-4322-9cd8-19639ae477ec"
      unitRef="usd">161000000</us-gaap:OciEquityMethodInvestmentAfterTax>
    <us-gaap:OciEquityMethodInvestmentAfterTax
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNS04LTEtMS0w_de0ada17-3bd9-401c-ad49-0028873cec41"
      unitRef="usd">-15000000</us-gaap:OciEquityMethodInvestmentAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNi0yLTEtMS0w_e36309e8-e882-4156-8f5c-26bd7172e2e8"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNi00LTEtMS0w_1d5d60ac-9627-451f-9ade-3ae1854f3d6f"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNi02LTEtMS0w_f22ff8a1-b540-496f-b81d-ef8e21a4890a"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNi04LTEtMS0w_d40bab72-7849-4afd-a014-1053617d81ef"
      unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNy0yLTEtMS0w_048388cd-9348-47f9-9cf6-36013364bf82"
      unitRef="usd">911000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNy00LTEtMS0w_79715a2a-f5b4-4f8b-87e5-e5626289603d"
      unitRef="usd">-917000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNy02LTEtMS0w_bc215c24-0921-492c-813f-69043435ca23"
      unitRef="usd">172000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfNy04LTEtMS0w_316b2a5f-a049-45da-9f8b-aff6072eb07e"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfOS0yLTEtMS0w_c7a3e2ed-9cae-41c2-919b-6ecd1f0bcfc3"
      unitRef="usd">1762000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfOS00LTEtMS0w_854289c5-9d27-4475-834b-b9924cd6e6c9"
      unitRef="usd">1615000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfOS02LTEtMS0w_768ca6cc-2391-4cbb-882c-61193ca4b945"
      unitRef="usd">-2548000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfOS04LTEtMS0w_1e924c98-b3a6-4d33-ac5b-0ef8c09e014f"
      unitRef="usd">-963000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfMTAtMi0xLTEtMA_c8de2a2c-0f9d-445f-926c-2f24b5abf136"
      unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfMTAtNC0xLTEtMA_9a0d15e9-5bd4-40cc-a1e7-610a23b891d1"
      unitRef="usd">-11000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfMTAtNi0xLTEtMA_d6943aca-0c39-4ce4-8f65-c74016a69eb7"
      unitRef="usd">2000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfMTAtOC0xLTEtMA_764e4f4e-9389-4075-9195-aed8c4dacb0c"
      unitRef="usd">-4000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfMTEtMi0xLTEtMA_37d20655-ebe9-46c0-b357-17c570af7ef8"
      unitRef="usd">1762000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfMTEtNC0xLTEtMA_4dea7290-cfd9-4132-b149-b9efde4592ed"
      unitRef="usd">1626000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfMTEtNi0xLTEtMA_531a1fbf-e3d2-44f2-9834-5f10b5f62ba5"
      unitRef="usd">-2550000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xOS9mcmFnOmNmYmRmNjNlOWFmNzQwNmRiMmY3NWEzMTdjZmI0NzIyL3RhYmxlOmFmYjg3MGM3N2MyMTQ2ZTQ4YjQ0NWM1YWFkZGU2NmEwL3RhYmxlcmFuZ2U6YWZiODcwYzc3YzIxNDZlNDhiNDQ1YzVhYWRkZTY2YTBfMTEtOC0xLTEtMA_60245580-69ab-43ce-b36e-07327235c0c1"
      unitRef="usd">-959000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibe5793331b9d44488c81b7f716d22cbb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMi0yLTEtMS0w_dbc1f0ec-38a7-4bbc-8bc3-48849d297e43"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i44e385b4040e4ead83a85c0957688fd6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMi00LTEtMS0w_fd5a8be3-0b5c-4932-9319-17664cf7a818"
      unitRef="usd">5910000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i48d419bfc78f4132b045cf4fa761d902_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMi02LTEtMS0w_44b5b960-5976-4217-b953-49adecfc6915"
      unitRef="usd">34679000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3dbc9fb0ec734480b6f0af9d1b9ac7b9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMi04LTEtMS0w_96213114-fa8a-4f6a-a2e0-4004e8bb8204"
      unitRef="usd">-4341000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2fa834a6c7dd41229d83b9ffbdd1b664_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMi0xMC0xLTEtMA_2d104714-8558-495c-a2d8-ec16cf7ab650"
      unitRef="usd">-34344000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaa3df180bbc24f8c80034b0bb74a30e9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMi0xMi0xLTEtMA_3d01a196-d5d9-4da3-928d-06206bcee8fb"
      unitRef="usd">86000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMi0xNC0xLTEtMA_389a2397-04c8-43d1-ba45-bd48ed017560"
      unitRef="usd">2925000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i53aea5f1004341c7abdb570f2d2eb5b4_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMy02LTEtMS0w_800dee3e-6c08-48a8-94d5-7442ad98a88e"
      unitRef="usd">851000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i13776c8fb39a40d9af4989bb9862e205_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMy0xMi0xLTEtMA_e60fc491-328c-4c42-ba33-ec78cf50126b"
      unitRef="usd">-4000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMy0xNC0xLTEtMA_6d928a65-3130-4032-8eb4-26155a95136d"
      unitRef="usd">847000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibd9b7b88141b400786601f5cd3fec33a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfNC04LTEtMS0w_c3eb0343-2290-4590-82bc-1202f0422843"
      unitRef="usd">911000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfNC0xNC0xLTEtMA_aa0aa7fb-c655-475b-80e2-17011aea907d"
      unitRef="usd">911000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i5ca1deaa032a4cdd9c95cc8ea4e8b898_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfNS00LTEtMS0w_569196ee-6a5e-4eab-a5d4-4cdc01054da3"
      unitRef="usd">13000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="ib6f34d72cb7945e9bf68e87fc2c12f53_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfNS0xMC0xLTEtMA_33c91c40-c0e4-427b-97ce-f1cedf06a0cb"
      unitRef="usd">13000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfNS0xNC0xLTEtMA_8677b951-eae4-48e1-a20c-978a20eaefaf"
      unitRef="usd">26000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfNi0wLTEtMS0wL3RleHRyZWdpb246MTBlNzJhYWQ1ODZjNGI5NDgwYTYzM2I4MTQ3NjJmZDRfMjc0ODc3OTA2OTQ4Mw_bbb36c31-88d2-48b8-b585-562be22678fa"
      unitRef="usdPerShare">2.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i53aea5f1004341c7abdb570f2d2eb5b4_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfNi02LTEtMS0w_21f6b03b-a2f6-4c03-83ec-7ee45d7de8a1"
      unitRef="usd">4845000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfNi0xNC0xLTEtMA_dd869e5d-d86c-4e88-990b-713f229dc1fb"
      unitRef="usd">4845000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ib6f34d72cb7945e9bf68e87fc2c12f53_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfNy0xMC0xLTEtMA_b60c0781-0979-4827-b77f-9ca8fdcddc14"
      unitRef="usd">972000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfNy0xNC0xLTEtMA_4b653530-d375-4972-bb5b-0cdc21daab04"
      unitRef="usd">972000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockholdersEquityOther
      contextRef="i5ca1deaa032a4cdd9c95cc8ea4e8b898_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfOC00LTEtMS0w_b1200d39-2bbc-446d-af4c-b59a2cb1072e"
      unitRef="usd">77000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i13776c8fb39a40d9af4989bb9862e205_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfOC0xMi0xLTEtMA_cb2717aa-46fe-493e-b582-bd2353400bd8"
      unitRef="usd">80000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfOC0xNC0xLTEtMA_4025fc2c-2256-4c1c-ba8b-25d2714d062e"
      unitRef="usd">157000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic487ab98208d404887e95b93923fab79_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMTAtMi0xLTEtMA_16027baf-5af8-478f-98dd-8f152a95e1a6"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8693290ed18e4d7f87c0282e3f727528_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMTAtNC0xLTEtMA_71c67a12-9b6b-487f-99e3-4db33ccabec6"
      unitRef="usd">5846000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i007a6b02e9c44466879605af235d8517_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMTAtNi0xLTEtMA_0f442185-72ec-4265-9f2b-24fa54f78b70"
      unitRef="usd">30685000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic6448179dc624c73a14533ac4f8492a2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMTAtOC0xLTEtMA_f753caa1-f6a2-4114-8549-baac88f83932"
      unitRef="usd">-3430000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic8c26c7de7b3445bb7421e82ca7564b4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMTAtMTAtMS0xLTA_1942656b-8df3-42f7-8589-f3fd8361d253"
      unitRef="usd">-35303000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5fd83e66c1ff4909a7a501481a11f766_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMTAtMTItMS0xLTA_25357d8c-df83-4a6b-8d8b-ac61b55b8b2d"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMTAtMTQtMS0xLTA_65558933-a183-4e00-9a21-f55b7852e5d2"
      unitRef="usd">-1265000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib231dbdd7b5c42a4892838893be458cb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMi0yLTEtMS0w_7ed3a8e1-6023-45e3-bd3a-6ee9d6b1ece2"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0c17c5569ff54cf28521a8e8625991d8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMi00LTEtMS0w_ae3ebed3-90c3-4bdc-b995-e9f8cc645b78"
      unitRef="usd">5970000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i715d5e9f7cbe440b8d3c2b5ed4aeae4e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMi02LTEtMS0w_4488fabb-f46b-4a80-8016-20a39d6eb071"
      unitRef="usd">36539000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i433dda944a934320af202e2f484eaa1c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMi04LTEtMS0w_1b40da41-ce32-4883-8a8a-c5f9fb4952d8"
      unitRef="usd">-2864000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8a16f34256ad48b49ed8a50852fea048_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMi0xMC0xLTEtMA_12b84008-0cdc-453c-96ac-a1e12bd617da"
      unitRef="usd">-34358000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i954fc4945ffa4f8e8cdfabbaf3f7cb6f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMi0xMi0xLTEtMA_e31d6790-0503-4c92-a1ee-9ac1a579a6cb"
      unitRef="usd">97000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9bf636ab56ad4d7cb37b9d77019eed37_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMi0xNC0xLTEtMA_ef551cab-98ba-41c7-ba12-dcebdb645e42"
      unitRef="usd">6319000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i0e8e3bf6dc224a4aa974a22b40a91d8a_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMy02LTEtMS0w_cfd1eecd-b66e-4023-878c-717aa000efe8"
      unitRef="usd">2543000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i5cb0ffd7d3ff4483920746a3ef17c36d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMy0xMi0xLTEtMA_565cff0f-4a2a-4943-9896-5eb2823df608"
      unitRef="usd">-13000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMy0xNC0xLTEtMA_7bcd41f6-88a5-47e4-a622-337fa0cd6df4"
      unitRef="usd">2530000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6f1f1cd9567d4e048bfb64a6d6ee6bd0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfNC04LTEtMS0w_536de7a6-124f-4283-8f28-82d6f0fc2c5d"
      unitRef="usd">-917000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfNC0xNC0xLTEtMA_a55a0bb2-7645-4ca2-820d-f0daec6d5a1d"
      unitRef="usd">-917000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i8407362350ee44c99f4b71eae2816e16_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfNS00LTEtMS0w_df000f7b-7e87-48ed-9b5c-dd4fa3583b22"
      unitRef="usd">3000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="ibf1005329da74407b072e55e84c44f7f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfNS0xMC0xLTEtMA_a8e5d496-c9be-48f8-b48e-746679f41016"
      unitRef="usd">14000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfNS0xNC0xLTEtMA_37ee7ea6-7994-48bd-8977-d7bf01cec57d"
      unitRef="usd">17000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfNi0wLTEtMS0wL3RleHRyZWdpb246YTBiMzQ5Zjc0ZDhiNDI3NmFhNDhhNWM2Y2EyYTNjN2RfMjc0ODc3OTA2OTQ4Mg_3749665f-a07e-4563-bb2e-77e09292c19b"
      unitRef="usdPerShare">2.54</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i0e8e3bf6dc224a4aa974a22b40a91d8a_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfNi02LTEtMS0w_d6f36aa3-2b60-4767-896e-70741263e99f"
      unitRef="usd">4726000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfNi0xNC0xLTEtMA_b9514623-ffd2-4373-a4db-09ccb34d53bb"
      unitRef="usd">4726000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityOther
      contextRef="i5cb0ffd7d3ff4483920746a3ef17c36d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfOS0xMi0xLTEtMA_ee7f961d-49ed-44d5-93d2-b13639b04171"
      unitRef="usd">-9000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfOS0xNC0xLTEtMA_b9224981-32d0-4019-9906-ec55e10a080c"
      unitRef="usd">-9000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i87c1b1fef9414aef84749896871324f1_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMTAtMi0xLTEtMA_49bd45e1-ab42-4a8d-bb53-eb9f366009e0"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic81e63acf60f4e9c8c9e8e24c19afd4b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMTAtNC0xLTEtMA_daa6cd4a-aa34-40d0-b926-63267e3562bd"
      unitRef="usd">5973000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i337dce81edc54d6b886012952b0b9ade_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMTAtNi0xLTEtMA_8f85158c-d7de-46c9-b0e1-4a44608f4e7a"
      unitRef="usd">34356000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6b2a0f8b0eb84d6e98048c9c107d0d60_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMTAtOC0xLTEtMA_51eeb9b2-7b6d-4430-8def-469a2f07ce81"
      unitRef="usd">-3781000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5f4f34969f60495f8314b93ba8b0dce5_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMTAtMTAtMS0xLTA_826b59b9-3761-458f-94e2-9d54197301f6"
      unitRef="usd">-34344000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaeb4c19649a6480d80da77904d536dee_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMTAtMTItMS0xLTA_55d00b26-59a3-4b8f-b12b-5278cba73231"
      unitRef="usd">93000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3b11e531794f48868e8b9e32c403e904_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMTAtMTQtMS0xLTA_ce04d473-0c70-4779-87da-9f69aba5a321"
      unitRef="usd">3232000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RleHRyZWdpb246NWU1N2I2YTdkOGRhNGRiMmFkODU2YTZjNmQ1ZDM4MDdfMzI1_9792b5d7-e167-42a2-8c57-e042a1e953a2"
      unitRef="usd">4000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RleHRyZWdpb246NWU1N2I2YTdkOGRhNGRiMmFkODU2YTZjNmQ1ZDM4MDdfMzMy_9e40e23a-308f-498b-b12b-44ce8007ef73"
      unitRef="usd">2000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9137713c9da54ea7a9359074d78d444d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMi0yLTEtMS0w_02099726-2fb5-44af-82f5-393ceb82b91b"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iffa730c0799046999cf2e97fed548bb6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMi00LTEtMS0w_b9ddc80b-a9ee-44bb-b3ab-b1803826b03f"
      unitRef="usd">5840000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifcdf82bc9a97456f9411c9f42374d3f6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMi02LTEtMS0w_bd2ef235-12b6-4adb-908e-acb8064dab7d"
      unitRef="usd">35065000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0ea0515263584ea09063bbf40ec274b1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMi04LTEtMS0w_a0e74227-c4c5-4bd1-80b3-fd4747a397c8"
      unitRef="usd">-3602000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i610ba96937d54033839c8aaabcec01b3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMi0xMC0xLTEtMA_28631a5a-7eaf-4208-abdb-69a02e77523b"
      unitRef="usd">-34981000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i86447877e5b642e4a75424d1e386ce93_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMi0xMi0xLTEtMA_14e559e9-ec24-4a82-b0ae-a71b46ed865a"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3df7c108f2c5403c96f58e273f0dc0d1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMi0xNC0xLTEtMA_bd619966-7695-4167-a8fd-e1356ce50427"
      unitRef="usd">3259000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="if06993d5e1db4a3f9eda4a58697e58a1_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMy02LTEtMS0w_69b19076-2d5c-4d98-ad1d-f41bbaa4b111"
      unitRef="usd">-2722000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ib37636bce9b94aaeb1cbaece44b60523_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMy0xMi0xLTEtMA_478e1bc5-b708-41bf-ae0f-dfcc7133747a"
      unitRef="usd">0</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMy0xNC0xLTEtMA_7a2b4fe7-191b-47fb-b8e9-4985f46e58f0"
      unitRef="usd">-2722000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i811d953ad6844425a1abf068a0bef5ea_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfNC04LTEtMS0w_96d542a5-30af-45ca-ba98-aaf27e11d973"
      unitRef="usd">172000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfNC0xNC0xLTEtMA_75c093cd-c16e-469b-9f9d-63827fb6b4f3"
      unitRef="usd">172000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="icb6a68caffdb4a49a42f353a7047b68a_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfNS00LTEtMS0w_1c6d2781-e6c8-4447-804e-ba3dbf0ba4c3"
      unitRef="usd">6000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="idfa6672fba3e4b2380d43bce7cac51b6_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfNS0xMC0xLTEtMA_5050b2f8-52dc-4655-884f-dec243822ab6"
      unitRef="usd">0</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfNS0xNC0xLTEtMA_22dbfd18-aff8-49cd-aa5f-75e091e93953"
      unitRef="usd">6000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfNi0wLTEtMS0wL3RleHRyZWdpb246MTg5ZDZkNzUwMDg2NGQ5MTg5ZjgwNTdmZTUxNWIyNmNfMjc0ODc3OTA2OTQ4Mg_eb91678b-c5ec-46d5-ac36-d1f47f0f80d9"
      unitRef="usdPerShare">0.90</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="if06993d5e1db4a3f9eda4a58697e58a1_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfNi02LTEtMS0w_289c4bbd-fce9-4666-b243-36f4ded62437"
      unitRef="usd">1658000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfNi0xNC0xLTEtMA_bb45a8be-01ad-47b5-91f0-a713db6ddddf"
      unitRef="usd">1658000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="idfa6672fba3e4b2380d43bce7cac51b6_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfNy0xMC0xLTEtMA_86a3eeeb-f9a8-4090-a7d3-ae7c494c2938"
      unitRef="usd">322000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfNy0xNC0xLTEtMA_e4df6a39-2927-43ec-a9e2-72e8e15eb4c5"
      unitRef="usd">322000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic487ab98208d404887e95b93923fab79_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfOS0yLTEtMS0w_ab24a533-0275-4355-b3a7-b20d687933b8"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8693290ed18e4d7f87c0282e3f727528_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfOS00LTEtMS0w_fffccbf5-7563-4ea7-95e3-e786ac6f4c3d"
      unitRef="usd">5846000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i007a6b02e9c44466879605af235d8517_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfOS02LTEtMS0w_8ff6461e-b9f4-4037-8819-c5449c5821c6"
      unitRef="usd">30685000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic6448179dc624c73a14533ac4f8492a2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfOS04LTEtMS0w_944e59e9-381c-4d7a-9c6c-6ce62378f075"
      unitRef="usd">-3430000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic8c26c7de7b3445bb7421e82ca7564b4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfOS0xMC0xLTEtMA_2addefc5-f862-4983-a4be-87f7e3e41277"
      unitRef="usd">-35303000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5fd83e66c1ff4909a7a501481a11f766_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfOS0xMi0xLTEtMA_b0e12402-b6bf-4586-9282-167c57538868"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfOS0xNC0xLTEtMA_18956863-9394-4822-b9c7-05dbeddede43"
      unitRef="usd">-1265000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i04acd635c03342bf90bc79dd81caef6b_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMi0yLTEtMS0w_1cb820e6-a23c-43f7-a9c6-d82731f77f94"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id142ac3234994ef79d1ee5f1de4d371d_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMi00LTEtMS0w_6cd3163d-b375-4504-ad1c-1bfae38ba777"
      unitRef="usd">5964000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i83adb27c0e2746b595871ff0b3f2b7d8_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMi02LTEtMS0w_b23e7051-003e-491e-b7c8-5aa3a7b01280"
      unitRef="usd">36908000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i65d2cfacd8464cd8a25b7d8f01804516_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMi04LTEtMS0w_1b7188bd-265b-4ea1-89ee-0581539bc53b"
      unitRef="usd">-3774000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib54bea9ab2a541ef9a1b1495988aba10_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMi0xMC0xLTEtMA_6fc07e1c-f6a5-4a43-b8e1-66bb110c31b5"
      unitRef="usd">-34345000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4b48e147a93c4d159841fd5c68e5adba_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMi0xMi0xLTEtMA_72e0266c-a0dc-4dbf-ba32-fb76593ffe10"
      unitRef="usd">98000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i967d1f95af3f41eda51eed3bfc8a12af_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMi0xNC0xLTEtMA_3e4ac13f-c3c7-4d20-ba85-140dc18b64d5"
      unitRef="usd">5786000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i3d98dc6b3b424d3cb692eff540ce05d9_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMy02LTEtMS0w_f78d8c97-44f4-4870-b445-718b17513598"
      unitRef="usd">-952000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i9284f3c4288b4cd2b2c41662e054c3d2_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMy0xMi0xLTEtMA_e299ff39-6891-4862-b4c3-befa6e4d3fde"
      unitRef="usd">-5000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMy0xNC0xLTEtMA_78df59c3-809f-49aa-9b5c-a0fa6132b6b1"
      unitRef="usd">-957000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iece3d64b93d440e3863844f51f91d57b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfNC04LTEtMS0w_e8b55e7e-1148-49d1-92e0-9019fab2c7bf"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfNC0xNC0xLTEtMA_68c2b893-6d4b-453f-89a5-03609dc1f77f"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="idba80b960aa444f9afc7b3189ec8d63e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfNS00LTEtMS0w_270d645d-0cca-4d77-8517-fc3c3e9de371"
      unitRef="usd">9000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i9870fc1d39c94d9f81e1e50ced847ae2_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfNS0xMC0xLTEtMA_b376419c-264d-4238-9255-7a712f92da69"
      unitRef="usd">1000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfNS0xNC0xLTEtMA_b809a789-8827-4f17-9bdd-b25b02df4b6c"
      unitRef="usd">10000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfNi0wLTEtMS0wL3RleHRyZWdpb246NTM5MGZiY2YyOThkNGQ0ZWIzMzE5ODcxMmIyNzliZWZfMjc0ODc3OTA2OTQ5NQ_0e56eeab-6c7e-4f81-aa7a-828286d2356f"
      unitRef="usdPerShare">0.86</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i3d98dc6b3b424d3cb692eff540ce05d9_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfNi02LTEtMS0w_f948b0d6-69c3-4923-8ec3-37870ee77698"
      unitRef="usd">1600000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfNi0xNC0xLTEtMA_965aac6e-72c1-4481-be39-b3f91cd594c9"
      unitRef="usd">1600000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i87c1b1fef9414aef84749896871324f1_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfOS0yLTEtMS0w_1a302e93-c3ff-445d-92c0-d4565834c8a8"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic81e63acf60f4e9c8c9e8e24c19afd4b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfOS00LTEtMS0w_b0d7257b-c4b5-4c7b-aedb-bf9079b062db"
      unitRef="usd">5973000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i337dce81edc54d6b886012952b0b9ade_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfOS02LTEtMS0w_da0ae987-831a-4614-b965-5cadb25feecb"
      unitRef="usd">34356000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6b2a0f8b0eb84d6e98048c9c107d0d60_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfOS04LTEtMS0w_7e974c93-c590-44f1-85fd-2420b0ecf033"
      unitRef="usd">-3781000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5f4f34969f60495f8314b93ba8b0dce5_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfOS0xMC0xLTEtMA_9b47dacc-e746-4af3-869c-21527d1f85fe"
      unitRef="usd">-34344000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaeb4c19649a6480d80da77904d536dee_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfOS0xMi0xLTEtMA_a557d41a-fada-41d6-a23c-e27dd579992a"
      unitRef="usd">93000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3b11e531794f48868e8b9e32c403e904_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfOS0xNC0xLTEtMA_5fffdb1f-0194-4d1e-8db2-8a6cd131dd08"
      unitRef="usd">3232000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RleHRyZWdpb246MmEyMDFjMzQ1ZGJjNGI3ZmE5MWVkOTA3MDdiNTRlOTRfMzUw_f4a38c9e-0fa2-40ed-af0e-14431f6a7499"
      unitRef="usd">2000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RleHRyZWdpb246MmEyMDFjMzQ1ZGJjNGI3ZmE5MWVkOTA3MDdiNTRlOTRfMjc0ODc3OTA3MDc0NA_ecd687b2-bdd4-45b7-af58-9cfadca2b51d"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMi0yLTEtMS0w_d7146f06-6e7f-4d1b-8a1b-df9902d49254"
      unitRef="usd">851000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMi00LTEtMS0w_65ad409d-44f7-4d62-a8b6-ad40e3a7e8dd"
      unitRef="usd">2532000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfNC0yLTEtMS0w_984d5a8c-b5c3-46ad-b637-15e7e0626cb7"
      unitRef="usd">190000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfNC00LTEtMS0w_cfa135dd-d8f1-49cf-9643-b909b032c32b"
      unitRef="usd">192000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfNS0yLTEtMS0w_06fb0a8a-ff15-43bc-a541-32b5de18a41f"
      unitRef="usd">-1180000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfNS00LTEtMS0w_d43c9bd2-f148-4fc1-bdd2-13184a8f6a5f"
      unitRef="usd">-111000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfNi0yLTEtMS0w_b3918efa-ba78-4f98-b08b-bb1dd5b53c69"
      unitRef="usd">-5789000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfNi00LTEtMS0w_2ebbddbc-242a-4b99-9b94-f50f98940467"
      unitRef="usd">-306000000</mo:IncomeLossFromEquityInvestments>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfNy0yLTEtMS0w_dff39cb4-b988-4aa8-ba3c-327b885ca271"
      unitRef="usd">119000000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfNy00LTEtMS0w_489dbc03-2997-45c9-b275-4e3711948d94"
      unitRef="usd">108000000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfOS0yLTEtMS0w_687b7d82-9cc2-4717-8483-3ac60d5b3a7e"
      unitRef="usd">-128000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfOS00LTEtMS0w_c4498872-1490-4b25-bfa4-c55014d958d9"
      unitRef="usd">-202000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTAtMi0xLTEtMTM4MTE_7cf8430a-911d-4da5-a7d4-682a0d71cdb0"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTAtMi0xLTEtMTM4MTE_92da0c18-f8ac-4099-b1b8-427a925d27a7"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTAtNC0xLTEtOTgz_aa7a6a57-d2fe-4b49-936c-a26405cffc5e"
      unitRef="usd">2600000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTItMi0xLTEtMA_761cac2a-0eb9-4aa6-9532-36498209d6fa"
      unitRef="usd">-649000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTItNC0xLTEtMA_ddc0024a-a72c-4d90-bb39-bd64ea7cb621"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTQtMi0xLTEtMA_c9bc1cab-9b90-497c-9943-616f633a3627"
      unitRef="usd">7000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTQtNC0xLTEtMA_6e5be5fe-d082-4dad-915f-1dfd6ffe2e03"
      unitRef="usd">-1000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTUtMi0xLTEtMA_1a46d545-bd78-4ada-a99d-b30b6fb0a70f"
      unitRef="usd">-118000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTUtNC0xLTEtMA_c346ab08-a6fb-45be-931b-72987654eefd"
      unitRef="usd">-136000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTYtMi0xLTEtMA_627c4a8d-7684-4031-b292-2af16980f9d0"
      unitRef="usd">3000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTYtNC0xLTEtMA_0480bfdc-24b4-417c-b43e-8ac0897ae1ee"
      unitRef="usd">24000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTctMi0xLTEtMA_2fd98c22-9c0e-401c-82a9-73f09cdf1c4a"
      unitRef="usd">-200000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTctNC0xLTEtMA_c47ed5a9-624e-4c39-a949-8388bf833c88"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTgtMi0xLTEtMA_132cc766-ac7f-441f-ad4a-4a98b2f42382"
      unitRef="usd">104000000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTgtNC0xLTEtMA_3e78207b-2326-42e7-89e8-efb27a0604e5"
      unitRef="usd">504000000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet>
    <mo:IncreaseDecreaseInSettlementPayable
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTktMi0xLTEtMA_70cacccd-24c5-45e7-86d7-143e35433655"
      unitRef="usd">-568000000</mo:IncreaseDecreaseInSettlementPayable>
    <mo:IncreaseDecreaseInSettlementPayable
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMTktNC0xLTEtMA_ffb53b99-8737-4ef4-9af9-82df355c7769"
      unitRef="usd">-140000000</mo:IncreaseDecreaseInSettlementPayable>
    <us-gaap:PensionAndOtherPostretirementBenefitContributions
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjAtMi0xLTEtMA_925a71e5-bfcd-4d34-bfbc-c45523261391"
      unitRef="usd">23000000</us-gaap:PensionAndOtherPostretirementBenefitContributions>
    <us-gaap:PensionAndOtherPostretirementBenefitContributions
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjAtNC0xLTEtMA_330f4e49-e886-43f4-a6c1-24189dfa6165"
      unitRef="usd">16000000</us-gaap:PensionAndOtherPostretirementBenefitContributions>
    <us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjEtMi0xLTEtMA_bc56abd0-88b6-4213-a37c-ca54494ea2dd"
      unitRef="usd">-127000000</us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash>
    <us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjEtNC0xLTEtMA_0c0e6682-e432-468c-8e75-f99063baa0e1"
      unitRef="usd">-35000000</us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjItMi0xLTEtMA_2fc96a21-b96e-484d-ab85-979d3fdfa3e8"
      unitRef="usd">104000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjItNC0xLTEtMA_9bfb5284-a421-42b3-b286-66b16e575028"
      unitRef="usd">549000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjMtMi0xLTEtMA_b448e8ba-87f7-49c9-afa2-bb8a33f9361c"
      unitRef="usd">5742000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjMtNC0xLTEtMA_9c11e16c-1beb-4692-9789-96e3058b7e2f"
      unitRef="usd">5844000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjUtMi0xLTEtMA_585d82dd-76a5-4d74-9dfd-e6ad0056b01c"
      unitRef="usd">102000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjUtNC0xLTEtMA_6e9ff6a5-3a17-4e2f-b8f6-871ca6050e39"
      unitRef="usd">162000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjktMi0xLTEtMA_68bd0cfa-8b10-4ea6-93ae-17073fa261ac"
      unitRef="usd">-60000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjktNC0xLTEtMA_168fbbd2-ee1f-4114-8f6c-8932751b4feb"
      unitRef="usd">-55000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMzAtMi0xLTEtMA_75c1800f-6a08-45b8-942e-e9ce0bb22de1"
      unitRef="usd">-42000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMzAtNC0xLTEtMA_47d730fb-0e99-4329-8d18-fe40b2b13252"
      unitRef="usd">-107000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMi0yLTEtMS0w_a15f1802-f471-448c-8384-02226405ef58"
      unitRef="usd">0</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMi00LTEtMS0w_a1623f17-91f7-4242-b533-85b1444bc2d0"
      unitRef="usd">3000000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMy0yLTEtMS0w_1dd4a30b-dcfa-455a-a87e-e1a9c7b9cfac"
      unitRef="usd">0</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMy00LTEtMS0w_42b35a7a-6b79-456d-86bc-62cce394f831"
      unitRef="usd">3000000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfNC0yLTEtMS0w_379ed8e2-fc59-4c24-9878-cf602286290b"
      unitRef="usd">5472000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfNC00LTEtMS0w_c9febc6e-27e5-4ca3-a634-2aa00cfce5c1"
      unitRef="usd">1993000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfNS0yLTEtMS0w_a5bc7478-7edd-4efb-a1fc-1e5a45715b5b"
      unitRef="usd">6542000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfNS00LTEtMS0w_14352ccd-5a8f-4c64-8b8a-54f525879f3f"
      unitRef="usd">1000000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfNi0yLTEtMS0w_f768a012-df4b-4302-921c-13e5e97a9240"
      unitRef="usd">972000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfNi00LTEtMS0w_bdfc8521-0140-46be-8658-459c7804afc2"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfNy0yLTEtMS0w_081add56-0677-4aaf-b0cb-3cf7b305bda8"
      unitRef="usd">4787000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfNy00LTEtMS0w_b004ed9b-b52d-484b-851f-12f2ef931522"
      unitRef="usd">4690000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMTAtMi0xLTEtMA_b5fe2099-1f88-4b04-82c7-6dec15880a1a"
      unitRef="usd">623000000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMTAtNC0xLTEtMA_e78e6a70-cb8c-4669-a0e0-475684fb520a"
      unitRef="usd">0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMTEtMi0xLTEtMA_955397fe-3f36-4923-a52f-a88cba79f17e"
      unitRef="usd">-216000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMTEtNC0xLTEtMA_4a1d99a3-034b-404a-95ff-ac92b4bfd5ef"
      unitRef="usd">-16000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMTItMi0xLTEtMA_301d666e-126f-4fb7-b05f-2cba6a811b28"
      unitRef="usd">-7668000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMTItNC0xLTEtMA_e37d808e-4ce0-4de4-b72e-088ab54982be"
      unitRef="usd">-3713000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMTQtMi0xLTEtMA_932d5894-c2eb-407b-baf5-c60cf8de7317"
      unitRef="usd">-1968000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMTQtNC0xLTEtMA_ae507599-1787-43fb-86ae-d2543506ef35"
      unitRef="usd">2024000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMTUtMi0xLTEtMA_4d45006f-d58a-457c-b964-022719622bf4"
      unitRef="usd">5006000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9bf636ab56ad4d7cb37b9d77019eed37_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMTUtNC0xLTEtMA_bb66c604-d5d9-4452-9340-74e50ed6872e"
      unitRef="usd">2160000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMTYtMi0xLTEtMA_5e6d196f-cc1d-4a83-a4ba-000c6b08cb1a"
      unitRef="usd">3038000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3b11e531794f48868e8b9e32c403e904_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMTYtNC0xLTEtMA_f94c320a-0c08-4e5f-9c53-5db404b32fa5"
      unitRef="usd">4184000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjAtMi0xLTEtMA_4a02cd8b-7b05-4e2d-911e-a6caa4d44542"
      unitRef="usd">2957000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjAtNC0xLTEtMA_663e4661-1316-492c-943b-e987908a5e04"
      unitRef="usd">4945000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjEtMi0xLTEtMA_d74cfa78-d346-4336-bc60-534c20b3ac98"
      unitRef="usd">0</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjEtNC0xLTEtMA_e6f646b8-5f2a-45f9-af1e-7b395ab83a46"
      unitRef="usd">1000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjMtMi0xLTEtMTQxMTg_49279f22-b894-4fd8-9feb-815fc4242613"
      unitRef="usd">45000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjMtNC0xLTEtMTQxMzg_969296e8-ad90-4de3-a528-19eb8d7cd4f8"
      unitRef="usd">60000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjItMi0xLTEtMA_426d9aea-ecde-453e-bb32-ce817786fe90"
      unitRef="usd">36000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjItNC0xLTEtMA_bbf1361c-cd98-4785-bdd8-db7d1ceeb089"
      unitRef="usd">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjMtMi0xLTEtMA_ac434255-3402-46f3-a7b0-dc2dfea210b1"
      unitRef="usd">3038000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjMtNC0xLTEtMA_4e27126c-979a-4273-9e46-3d1cce7db2f5"
      unitRef="usd">5006000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfNTk2OA_58bf489e-79bc-49ca-b862-29b1c428b9ef">Background and Basis of Presentation&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;When used in these notes, the term &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Altria,&#x201d; refers to Altria Group, Inc. and its subsidiaries, unless the context requires otherwise.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Background: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2021, Altria&#x2019;s wholly owned subsidiaries included Philip Morris USA Inc. (&#x201c;PM USA&#x201d;), which is engaged in the manufacture and sale of cigarettes in the United States; John Middleton Co. (&#x201c;Middleton&#x201d;), which is engaged in the manufacture and sale of machine-made large cigars and pipe tobacco and is a wholly owned subsidiary of PM USA; UST LLC (&#x201c;UST&#x201d;), which through its wholly owned subsidiaries, including U.S. Smokeless Tobacco Company LLC (&#x201c;USSTC&#x201d;) and Ste. Michelle Wine Estates Ltd. (&#x201c;Ste. Michelle&#x201d;), is engaged in the manufacture and sale of moist smokeless tobacco products (&#x201c;MST&#x201d;), snus products and wine; Helix Innovations LLC (&#x201c;Helix&#x201d;), which operates in the United States and Canada, and Helix Innovations GmbH and its subsidiaries (&#x201c;Helix ROW&#x201d;), which operate internationally in the rest-of-world, are engaged in the manufacture and sale of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;on! &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;oral nicotine pouches; and Philip Morris Capital Corporation (&#x201c;PMCC&#x201d;), which maintains a portfolio of finance assets, substantially all of which are leveraged leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 8, 2021, UST entered into a share purchase agreement pursuant to which it agreed to sell its subsidiary, International Wine &amp;amp; Spirits Ltd. (&#x201c;IWS&#x201d;), which includes Ste. Michelle.  The sale was completed on October 1, 2021.  At September 30, 2021, the assets and liabilities associated with the pending sale of IWS were classified as assets held for sale on Altria&#x2019;s condensed consolidated balance sheet.  For further discussion, see Note 3. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets Held for Sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Altria owns 100% of the global &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;on!&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; business as a result of transactions in December 2020 and April 2021 to purchase the remaining 20% interest in (i) Helix ROW and (ii) Helix, respectively&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;  The total purchase price of the December 2020 and April 2021 transactions was approximately $250 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other Altria wholly owned subsidiaries included Altria Group Distribution Company, which provides sales and distribution services to certain Altria operating subsidiaries, and Altria Client Services LLC, which provides various support services in areas such as legal, regulatory, consumer engagement, finance, human resources and external affairs to Altria and its subsidiaries.  Altria&#x2019;s access to the operating cash flows of its wholly owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans by its subsidiaries.  At September&#160;30, 2021, Altria&#x2019;s significant wholly owned subsidiaries were not limited by contractual obligations in their ability to pay cash dividends or make other distributions with respect to their equity interests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2021, Altria&#x2019;s investments in equity securities consisted of Anheuser-Busch InBev SA/NV (&#x201c;ABI&#x201d;), Cronos Group Inc. (&#x201c;Cronos&#x201d;) and JUUL Labs, Inc. (&#x201c;JUUL&#x201d;).  Altria accounts for its investments in ABI and Cronos under the equity method of accounting using a one-quarter lag.  Altria accounts for its equity investment in JUUL under the fair value option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For further discussion of Altria&#x2019;s investments in equity securities, see Note 4. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Equity Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-right:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Dividends and Share Repurchases: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2021, Altria&#x2019;s Board of Directors (the &#x201c;Board of Directors&#x201d; or &#x201c;Board&#x201d;) approved a 4.7% increase in the quarterly dividend rate to $0.90 per share of Altria common stock versus the previous rate of $0.86 per share.  The current annualized dividend rate is $3.60.  Future dividend payments remain subject to the discretion of the Board.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-right:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2019, the Board of Directors authorized a $1.0 billion share repurchase program.  In April 2020, the Board rescinded the $500 million remaining in this program as part of Altria&#x2019;s efforts to enhance its liquidity position in response to the COVID-19 pandemic.  Altria did not repurchase any shares in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, the Board authorized a new $2.0 billion share repurchase program, of which  $1,028 million was remaining at September 30, 2021.  In October 2021, the Board authorized a $1.5 billion expansion of this program to $3.5 billion.  The timing of share repurchases under this program depends upon marketplace conditions and other factors, and the program remains subject to the discretion of the Board.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Altria&#x2019;s share repurchase activity for the nine and three months ended September&#160;30, 2021 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total number of shares repurchased&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate cost of shares repurchased&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;972&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;322&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share of shares repurchased&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;48.17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;48.35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Basis of Presentation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The interim condensed consolidated financial statements of Altria are unaudited.  It is the opinion of Altria&#x2019;s management that all adjustments necessary for a fair statement of the interim results presented have been reflected in the interim condensed consolidated financial statements.  All such adjustments were of a normal recurring nature.  Net revenues and net earnings for any interim period are not necessarily indicative of results that may be expected for the entire year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain immaterial prior year amounts have been reclassified to conform with the current year&#x2019;s presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These statements should be read in conjunction with Altria&#x2019;s audited consolidated financial statements and related notes, which appear in Altria&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2020 (the &#x201c;2020 Form 10-K&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2021, Altria adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU No. 2019-12&#x201d;).  This guidance removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes.  The adoption of ASU No. 2019-12 did not have a material impact on Altria&#x2019;s condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, on January 1, 2021, Altria adopted ASU No. 2020-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815):&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Clarifying the Interactions between Topic 321, Topic 323, and Topic 815&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU No. 2020-01&#x201d;).  This guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities.  The adoption of ASU No. 2020-01 did not have a material impact on Altria&#x2019;s condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a description of issued accounting guidance applicable to, but not yet adopted by, Altria, see Note 13. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New Accounting Guidance Not Yet Adopted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
      contextRef="ie227d61fadaa4ad894b027826871e831_D20201201-20210429"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMTMzMg_225dc2ad-8f92-4ba7-826c-1445a0b0f2d7"
      unitRef="number">1</us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions>
    <mo:NoncontrollingInterestRemainingInterestPurchasedByParent
      contextRef="ie227d61fadaa4ad894b027826871e831_D20201201-20210429"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMTQ0OA_75584995-2e82-419e-8c22-8fcadd484594"
      unitRef="number">0.20</mo:NoncontrollingInterestRemainingInterestPurchasedByParent>
    <us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries
      contextRef="i33693bcc9b6d47e48094cbb1bb3c5f74_D20201201-20210429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMTYwMA_3b8763fb-aa59-4fcf-a707-7d0c63cd8d77"
      unitRef="usd">250000000</us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfNTk1NA_699fc204-96bc-466b-b816-ae31a18dca70">Altria accounts for its investments in ABI and Cronos under the equity method of accounting using a one-quarter lag.  Altria accounts for its equity investment in JUUL under the fair value option.</us-gaap:InvestmentPolicyTextBlock>
    <mo:CommonStockDividendIncreasePercentage
      contextRef="i96dcc4ff54674f288ddfdd67f37a96ab_D20210801-20210831"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMjc0ODc3OTA3OTE3MA_08db400c-2cd5-47ec-b850-81014cf81ced"
      unitRef="number">0.047</mo:CommonStockDividendIncreasePercentage>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i96dcc4ff54674f288ddfdd67f37a96ab_D20210801-20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMjc0ODc3OTA3OTE3Nw_707fafa9-9b3a-4348-84c1-a5cd49c7c746"
      unitRef="usdPerShare">0.90</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i96ddae8ac4da494d95d13e4d56d378cc_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMjc0ODc3OTA3OTE4NQ_222b2dc3-c042-4b4e-bd09-929cb398cb88"
      unitRef="usdPerShare">0.86</us-gaap:CommonStockDividendsPerShareDeclared>
    <mo:CommonStockDividendRateAnnualPerShare
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMjc0ODc3OTA3OTE5Mw_a3cbf72c-737e-4d74-bc3e-44e3b0d315e6"
      unitRef="usdPerShare">3.60</mo:CommonStockDividendRateAnnualPerShare>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ia7921863f9b84211b6ab722289417409_I20190731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMzIyOQ_17b58755-ae31-4947-a8ba-aa797a911905"
      unitRef="usd">1000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <mo:StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount
      contextRef="i58b4cc5497fa437d9019b1914e39936e_I20200430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMzI5OA_2531b70b-bd95-47e9-be40-d2d2c2bea1d0"
      unitRef="usd">500000000</mo:StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ie1160db7af33456abd28f3ff1afe8c43_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMzQzOQ_7d8b77b8-393f-4a21-b1df-5bf3a3a22560"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="if027f1be3b8b4d97b39ef8c617dc8946_I20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMzUxOA_32674f34-6b5c-4222-8ba5-620477049a1d"
      unitRef="usd">2000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i210e56c06a7e4442963844e819875e34_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMzU2Ng_186544bd-bd47-41a6-bbc1-1f78186a9f49"
      unitRef="usd">1028000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <mo:StockRepurchaseProgramIncreaseAuthorizedAmount
      contextRef="id4244523c3094b0a9521b3089395bca7_I20211028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMjc0ODc3OTA3OTU1Mg_dfd38650-6bd1-4db6-9d7f-d5fa9f538e6b"
      unitRef="usd">1500000000</mo:StockRepurchaseProgramIncreaseAuthorizedAmount>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="id4244523c3094b0a9521b3089395bca7_I20211028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfMjc0ODc3OTA3OTU5Mw_2454ad04-1584-4e15-a39e-299cc6b88179"
      unitRef="usd">3500000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfNTk3NQ_2e45b067-a2eb-4829-b353-eaa51df361b7">&lt;div style="padding-right:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Altria&#x2019;s share repurchase activity for the nine and three months ended September&#160;30, 2021 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total number of shares repurchased&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate cost of shares repurchased&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;972&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;322&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share of shares repurchased&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;48.17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;48.35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i0c8666d14400451b9e82c0e7c854ebe9_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RhYmxlOmFiZGVkMTg5N2Y5NTRmNjg5OWI1NDkwOTg1OWE4YzdkL3RhYmxlcmFuZ2U6YWJkZWQxODk3Zjk1NGY2ODk5YjU0OTA5ODU5YThjN2RfMS0xLTEtMS0w_2a0d90d5-7500-41ae-bc04-4e5cd8bdb951"
      unitRef="shares">20200000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i66dae12b306e4c15a45bf2cedaae9792_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RhYmxlOmFiZGVkMTg5N2Y5NTRmNjg5OWI1NDkwOTg1OWE4YzdkL3RhYmxlcmFuZ2U6YWJkZWQxODk3Zjk1NGY2ODk5YjU0OTA5ODU5YThjN2RfMS0zLTEtMS0w_779f1517-6849-427a-8c18-ad0b13e57f79"
      unitRef="shares">6700000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i0c8666d14400451b9e82c0e7c854ebe9_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RhYmxlOmFiZGVkMTg5N2Y5NTRmNjg5OWI1NDkwOTg1OWE4YzdkL3RhYmxlcmFuZ2U6YWJkZWQxODk3Zjk1NGY2ODk5YjU0OTA5ODU5YThjN2RfMi0xLTEtMS0w_2a984507-b135-4339-bdec-832d0fc15d4d"
      unitRef="usd">972000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i66dae12b306e4c15a45bf2cedaae9792_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RhYmxlOmFiZGVkMTg5N2Y5NTRmNjg5OWI1NDkwOTg1OWE4YzdkL3RhYmxlcmFuZ2U6YWJkZWQxODk3Zjk1NGY2ODk5YjU0OTA5ODU5YThjN2RfMi0zLTEtMS0w_c07d9c84-927a-4c01-817e-50cad85a8f20"
      unitRef="usd">322000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i0c8666d14400451b9e82c0e7c854ebe9_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RhYmxlOmFiZGVkMTg5N2Y5NTRmNjg5OWI1NDkwOTg1OWE4YzdkL3RhYmxlcmFuZ2U6YWJkZWQxODk3Zjk1NGY2ODk5YjU0OTA5ODU5YThjN2RfMy0xLTEtMS0w_b72bc1ad-f078-4166-ae31-1991722afb1f"
      unitRef="usdPerShare">48.17</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i66dae12b306e4c15a45bf2cedaae9792_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RhYmxlOmFiZGVkMTg5N2Y5NTRmNjg5OWI1NDkwOTg1OWE4YzdkL3RhYmxlcmFuZ2U6YWJkZWQxODk3Zjk1NGY2ODk5YjU0OTA5ODU5YThjN2RfMy0zLTEtMS0w_822d89c5-5419-4f7f-994f-5f78f890d8af"
      unitRef="usdPerShare">48.35</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfNTk3NA_668e55f3-09c8-4071-9a51-4cf75400bfe7">The interim condensed consolidated financial statements of Altria are unaudited.  It is the opinion of Altria&#x2019;s management that all adjustments necessary for a fair statement of the interim results presented have been reflected in the interim condensed consolidated financial statements.  All such adjustments were of a normal recurring nature.  Net revenues and net earnings for any interim period are not necessarily indicative of results that may be expected for the entire year.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNC9mcmFnOmZmYmY0NTNlZWY4YTRlMWI4OTFkM2ExNTVmYjFlNjY5L3RleHRyZWdpb246ZmZiZjQ1M2VlZjhhNGUxYjg5MWQzYTE1NWZiMWU2NjlfNTk2NQ_5d64768f-5b6b-427a-96e3-5310da8b79c4">&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2021, Altria adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU No. 2019-12&#x201d;).  This guidance removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes.  The adoption of ASU No. 2019-12 did not have a material impact on Altria&#x2019;s condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, on January 1, 2021, Altria adopted ASU No. 2020-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815):&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Clarifying the Interactions between Topic 321, Topic 323, and Topic 815&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU No. 2020-01&#x201d;).  This guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities.  The adoption of ASU No. 2020-01 did not have a material impact on Altria&#x2019;s condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a description of issued accounting guidance applicable to, but not yet adopted by, Altria, see Note 13. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New Accounting Guidance Not Yet Adopted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.232%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Standards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effective Date for Public Entity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect on Financial Statements &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ASU 2020-06 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Accounting for Convertible Instruments and Contracts in an Entity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;s Own Equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#x2019;s own equity.&#160; Key provisions of the guidance include reducing the number of accounting models, simplifying the earnings per share calculations and expanding the disclosures related to convertible instruments.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021.  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Altria&#x2019;s adoption of this guidance is not expected to have a material impact on its consolidated financial statements and related  disclosures. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNy9mcmFnOmFlYmRlMzk4MGM1ZDQ0ODRhNDBmNDY4NjMyZDU5OWExL3RleHRyZWdpb246YWViZGUzOTgwYzVkNDQ4NGE0MGY0Njg2MzJkNTk5YTFfMzkxOQ_583c152f-29b8-4281-8aa9-ffb7fd413c57">Revenues from Contracts with Customers&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria disaggregates net revenues based on product type.  For further discussion, see Note 9. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, a majority of Altria&#x2019;s businesses offered cash discounts to customers for prompt payment and calculated cash discounts as a percentage of the list price based on historical experience and agreed-upon payment terms.  Beginning in the first quarter of 2021 for USSTC and the third quarter of 2021 for PM USA, cash discounts were calculated as a flat rate per unit, based on agreed-upon payment terms.  Altria&#x2019;s businesses record receivables net of the cash discounts on Altria&#x2019;s condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria&#x2019;s businesses that receive payments in advance of product shipment record such payments as deferred revenue.  These payments are included in other accrued liabilities on Altria&#x2019;s condensed consolidated balance sheets until control of such products is obtained by the customer.  Deferred revenue was $260 million and $301 million at September&#160;30, 2021 and December&#160;31, 2020, respectively.  When cash is received in advance of product shipment, Altria&#x2019;s businesses satisfy their performance obligations within three days of receiving payment.  At September&#160;30, 2021 and December&#160;31, 2020, there were no differences between amounts recorded as deferred revenue and amounts subsequently recognized as revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Receivables were $144 million (including $108 million in assets held for sale) and $137 million at September&#160;30, 2021 and December&#160;31, 2020, respectively.  At September&#160;30, 2021 and December&#160;31, 2020, there were no expected differences between amounts recorded and subsequently received, and Altria&#x2019;s businesses did not record an allowance for doubtful accounts against these receivables.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria&#x2019;s businesses record an allowance for returned goods, which is included in other accrued liabilities on Altria&#x2019;s condensed consolidated balance sheets.  While all of Altria&#x2019;s tobacco operating companies sell tobacco products with dates relative to freshness as printed on product packaging, it is USSTC&#x2019;s policy to accept authorized sales returns from its customers for products that have passed such dates due to the limited shelf life of USSTC&#x2019;s MST and snus products.  Altria&#x2019;s businesses record estimated sales returns, which are based principally on historical volume and return rates, as a reduction to revenues.  Actual sales returns will differ from estimated sales returns to the extent actual results differ from estimated assumptions.  Altria&#x2019;s businesses reflect differences between actual and estimated sales returns in the period in which the actual amounts become known.  These differences, if any, have not had a material impact on Altria&#x2019;s condensed consolidated financial statements.  All returned goods are destroyed upon return and not included in inventory.  Consequently, Altria&#x2019;s businesses do not record an asset for their right to recover goods from customers upon return.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales incentives include variable payments related to goods sold by Altria&#x2019;s businesses.  Altria&#x2019;s businesses include estimates of variable consideration as a reduction to revenues upon shipment of goods to customers.  The sales incentives that require significant estimates and judgments are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Price promotion payments- &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria&#x2019;s businesses make price promotion payments, substantially all of which are made to their retail partners, to incent the promotion of certain product offerings in select geographic areas.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Wholesale and retail participation payments-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Altria&#x2019;s businesses make payments to their wholesale and retail partners to incent merchandising and sharing of sales data in accordance with each business&#x2019;s trade agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These estimates primarily include estimated wholesale to retail sales volume and historical acceptance rates.  Actual payments will differ from estimated payments to the extent actual results differ from estimated assumptions.  Differences between actual and estimated payments are reflected in the period such information becomes available.  These differences, if any, have not had a material impact on Altria&#x2019;s condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <mo:CashDiscountsPolicyTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNy9mcmFnOmFlYmRlMzk4MGM1ZDQ0ODRhNDBmNDY4NjMyZDU5OWExL3RleHRyZWdpb246YWViZGUzOTgwYzVkNDQ4NGE0MGY0Njg2MzJkNTk5YTFfMzkyMA_ad01b287-52aa-44ce-8506-e450bf0ff6bc">In 2020, a majority of Altria&#x2019;s businesses offered cash discounts to customers for prompt payment and calculated cash discounts as a percentage of the list price based on historical experience and agreed-upon payment terms.  Beginning in the first quarter of 2021 for USSTC and the third quarter of 2021 for PM USA, cash discounts were calculated as a flat rate per unit, based on agreed-upon payment terms.  Altria&#x2019;s businesses record receivables net of the cash discounts on Altria&#x2019;s condensed consolidated balance sheets.</mo:CashDiscountsPolicyTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNy9mcmFnOmFlYmRlMzk4MGM1ZDQ0ODRhNDBmNDY4NjMyZDU5OWExL3RleHRyZWdpb246YWViZGUzOTgwYzVkNDQ4NGE0MGY0Njg2MzJkNTk5YTFfOTMy_c77188ac-27d8-460d-b0ea-d3f5075e491e"
      unitRef="usd">260000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNy9mcmFnOmFlYmRlMzk4MGM1ZDQ0ODRhNDBmNDY4NjMyZDU5OWExL3RleHRyZWdpb246YWViZGUzOTgwYzVkNDQ4NGE0MGY0Njg2MzJkNTk5YTFfOTM5_5f258860-920c-4ee9-b645-b5c5fbe87809"
      unitRef="usd">301000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:RevenuePerformanceObligationDescriptionOfTiming
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNy9mcmFnOmFlYmRlMzk4MGM1ZDQ0ODRhNDBmNDY4NjMyZDU5OWExL3RleHRyZWdpb246YWViZGUzOTgwYzVkNDQ4NGE0MGY0Njg2MzJkNTk5YTFfMTA5MA_ec7a9961-33fb-42d4-bfc4-b9d7546aff0a">three days</us-gaap:RevenuePerformanceObligationDescriptionOfTiming>
    <mo:ReceivablesNetCurrentIncludingAssetsHeldForSale
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNy9mcmFnOmFlYmRlMzk4MGM1ZDQ0ODRhNDBmNDY4NjMyZDU5OWExL3RleHRyZWdpb246YWViZGUzOTgwYzVkNDQ4NGE0MGY0Njg2MzJkNTk5YTFfMTI2Ng_4dcf3d16-e7a9-4f0f-bb0e-99f7b5b07d56"
      unitRef="usd">144000000</mo:ReceivablesNetCurrentIncludingAssetsHeldForSale>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="ica91e72247354acf9f03bbc39e5c5f66_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNy9mcmFnOmFlYmRlMzk4MGM1ZDQ0ODRhNDBmNDY4NjMyZDU5OWExL3RleHRyZWdpb246YWViZGUzOTgwYzVkNDQ4NGE0MGY0Njg2MzJkNTk5YTFfMjc0ODc3OTA3NDAyOQ_6cb30840-84ca-4b60-b61a-ea241aa223f5"
      unitRef="usd">108000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNy9mcmFnOmFlYmRlMzk4MGM1ZDQ0ODRhNDBmNDY4NjMyZDU5OWExL3RleHRyZWdpb246YWViZGUzOTgwYzVkNDQ4NGE0MGY0Njg2MzJkNTk5YTFfMTI3Mw_1df1001d-bbd1-4b70-b401-9bb2442f3ebf"
      unitRef="usd">137000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNy9mcmFnOmFlYmRlMzk4MGM1ZDQ0ODRhNDBmNDY4NjMyZDU5OWExL3RleHRyZWdpb246YWViZGUzOTgwYzVkNDQ4NGE0MGY0Njg2MzJkNTk5YTFfMjc0ODc3OTA3NDM2Ng_1a5471c0-c01f-4c78-866d-970dc5dee9a7"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables>
    <us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNy9mcmFnOmFlYmRlMzk4MGM1ZDQ0ODRhNDBmNDY4NjMyZDU5OWExL3RleHRyZWdpb246YWViZGUzOTgwYzVkNDQ4NGE0MGY0Njg2MzJkNTk5YTFfMjc0ODc3OTA3NDM2Ng_68699ec7-af71-4f9e-965a-c2beea6db716"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18zNy9mcmFnOmFlYmRlMzk4MGM1ZDQ0ODRhNDBmNDY4NjMyZDU5OWExL3RleHRyZWdpb246YWViZGUzOTgwYzVkNDQ4NGE0MGY0Njg2MzJkNTk5YTFfMjE5OTAyMzI2MDQ4Nw_3654c7b5-964e-42a8-a759-8286d3e3d244">Altria&#x2019;s businesses record an allowance for returned goods, which is included in other accrued liabilities on Altria&#x2019;s condensed consolidated balance sheets.  While all of Altria&#x2019;s tobacco operating companies sell tobacco products with dates relative to freshness as printed on product packaging, it is USSTC&#x2019;s policy to accept authorized sales returns from its customers for products that have passed such dates due to the limited shelf life of USSTC&#x2019;s MST and snus products.  Altria&#x2019;s businesses record estimated sales returns, which are based principally on historical volume and return rates, as a reduction to revenues.  Actual sales returns will differ from estimated sales returns to the extent actual results differ from estimated assumptions.  Altria&#x2019;s businesses reflect differences between actual and estimated sales returns in the period in which the actual amounts become known.  These differences, if any, have not had a material impact on Altria&#x2019;s condensed consolidated financial statements.  All returned goods are destroyed upon return and not included in inventory.  Consequently, Altria&#x2019;s businesses do not record an asset for their right to recover goods from customers upon return.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGV4dHJlZ2lvbjoxYzgwNjM1NjdiMmY0NmM0YTNhZmEzNzAxMWI3NGJhZF8yMTk5MDIzMjU5NDk3_db87d8b9-b41c-44d6-91ff-2dbdabcbcd10">Assets Held for Sale&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 8, 2021, UST entered into a share purchase agreement pursuant to which it agreed to sell its subsidiary, IWS, which includes Ste. Michelle, to an entity controlled by investment funds managed by Sycamore Partners Management, L.P. in an all-cash transaction with a purchase price of approximately $1.2 billion and the assumption of certain liabilities of IWS and its subsidiaries (the &#x201c;Ste. Michelle Transaction&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2021, the assets and liabilities associated with the Ste. Michelle Transaction were classified as assets held for sale and were measured at their fair value less costs to sell, resulting in a pre-tax charge of $41 million.  A reserve (as shown below), representing the adjustment to record the assets and liabilities at their fair value less costs to sell, was included as a component of assets held for sale in Altria&#x2019;s condensed consolidated balance sheets at September&#160;30, 2021.  Altria recorded an additional pre-tax charge of $10 million for disposition-related costs related to the Ste. Michelle Transaction.  The total pre-tax charges of $51 million were included in the wine segment and recorded in marketing, administration and research costs in Altria&#x2019;s condensed consolidated statements of earnings (losses) for the nine and three months ended September 30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 1, 2021, UST completed the sale of IWS and received approximately $1.2 billion in net cash proceeds.  Altria expects to record additional adjustments related to the Ste. Michelle Transaction in the fourth quarter of 2021 and does not expect these adjustments to be material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The major classes of assets and liabilities of IWS classified as held for sale at September 30, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net of accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued pension costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets and liabilities held for sale, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i4d91b3c8886d4970bfefc99ee9bd77ec_I20211001"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGV4dHJlZ2lvbjoxYzgwNjM1NjdiMmY0NmM0YTNhZmEzNzAxMWI3NGJhZF8yNzQ4Nzc5MDczMzkx_e1502bdc-b0b9-43c5-a7a8-9fd23abc23bd"
      unitRef="usd">1200000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i800ea809d24a4ae99423280ab9ed1ce7_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGV4dHJlZ2lvbjoxYzgwNjM1NjdiMmY0NmM0YTNhZmEzNzAxMWI3NGJhZF8yNzQ4Nzc5MDczNDA3_7692919f-3674-4f48-a108-6be93ca7c214"
      unitRef="usd">41000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <mo:DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts
      contextRef="i800ea809d24a4ae99423280ab9ed1ce7_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGV4dHJlZ2lvbjoxYzgwNjM1NjdiMmY0NmM0YTNhZmEzNzAxMWI3NGJhZF8yNzQ4Nzc5MDc0OTEy_207dd39d-5bfa-4702-8b18-1b1c3c3254e6"
      unitRef="usd">10000000</mo:DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts>
    <mo:DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts
      contextRef="i9321155464464f6abb0579cd48d53de2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGV4dHJlZ2lvbjoxYzgwNjM1NjdiMmY0NmM0YTNhZmEzNzAxMWI3NGJhZF8yNzQ4Nzc5MDc0ODk3_19f899e6-a34a-40a6-8bb9-08fa173e4b1c"
      unitRef="usd">51000000</mo:DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i2ae5a856a040414ea2c55c9313370362_D20211001-20211001"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGV4dHJlZ2lvbjoxYzgwNjM1NjdiMmY0NmM0YTNhZmEzNzAxMWI3NGJhZF8yNzQ4Nzc5MDczNDIz_f76c6f25-4f3b-4180-a833-37eb98a676b4"
      unitRef="usd">1200000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGV4dHJlZ2lvbjoxYzgwNjM1NjdiMmY0NmM0YTNhZmEzNzAxMWI3NGJhZF8yMTk5MDIzMjU5NTAx_ae064e29-8fa9-4abc-93a4-3fea17e30096">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The major classes of assets and liabilities of IWS classified as held for sale at September 30, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net of accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued pension costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets and liabilities held for sale, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl8yLTItMS0xLTEyODEw_abbce3af-4f64-45e0-bd85-0974f0d35cf9"
      unitRef="usd">36000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl8zLTItMS0xLTU5NDY_aea5f779-aa99-475a-83de-b58e5bb51818"
      unitRef="usd">108000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl80LTItMS0xLTEyODEw_521ce51e-a476-4b5e-b601-80703df92993"
      unitRef="usd">715000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent
      contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl81LTItMS0xLTEyODEw_c891ea0a-ab35-48a5-b623-71dee127dc49"
      unitRef="usd">407000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent
      contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl82LTItMS0xLTEyODEw_2c54666d-1781-44c8-8847-fa46f6176cd7"
      unitRef="usd">236000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets
      contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl83LTItMS0xLTEyODEw_a1b65c1c-e0c8-411d-8fa4-eea3f57f9790"
      unitRef="usd">29000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets>
    <mo:DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross
      contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl84LTItMS0xLTEyODEw_701b4e1b-9f12-48c9-99b7-973bf44d87cd"
      unitRef="usd">1531000000</mo:DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross>
    <mo:DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve
      contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl85LTItMS0xLTEyODEw_c1a88dfb-fcde-4d24-8873-13362b59e156"
      unitRef="usd">41000000</mo:DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl8xMC0yLTEtMS0xMjgxMA_7186c651-5295-4e9e-9c99-a862f8c31e39"
      unitRef="usd">1490000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent
      contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl8xMy0yLTEtMS0xMjgxMA_684a43ad-ac7b-444b-a4bb-b075bfeb2453"
      unitRef="usd">114000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent
      contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl8xNC0yLTEtMS0xMjgxMA_baaa70d7-466f-4dcc-92d8-abb47793786e"
      unitRef="usd">83000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationCurrent
      contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl8xNS0yLTEtMS0xMjgxMA_0da2ae1f-e82e-4727-a5e0-717b31729c5d"
      unitRef="usd">49000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities
      contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl8xNi0yLTEtMS0xMjgxMA_2d1904e3-a164-4f35-bd7a-f8520b4fd321"
      unitRef="usd">49000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i11c3f27b7191493b8194d2564e1cbc32_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl8xNy0yLTEtMS0xMjgxMA_0885d7f5-d3ae-40ff-b0a9-6e6bc5fe61fd"
      unitRef="usd">295000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ib20e8844a92447d0a46d19d86ed0f7f5_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xNDMyL2ZyYWc6MWM4MDYzNTY3YjJmNDZjNGEzYWZhMzcwMTFiNzRiYWQvdGFibGU6MTYzNWIyNGY0OTdlNDBhNTk4ZmU4NTg2MDE1ZDRhZGIvdGFibGVyYW5nZToxNjM1YjI0ZjQ5N2U0MGE1OThmZTg1ODYwMTVkNGFkYl8xOS0yLTEtMS0xMjgxMA_e36d8702-9871-4087-a4c5-9a8bdbf8d37f"
      unitRef="usd">1195000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:InvestmentTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzU1OQ_4aa6b21a-e2a9-4acd-90a1-b3aa5fa076b2">Investments in Equity Securities&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amount of Altria&#x2019;s investments consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JUUL&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,705&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;932&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,874&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Atria&#x2019;s investment in Cronos at September 30, 2021 consisted of Altria&#x2019;s equity method investment in Cronos ($897 million), the Cronos warrant ($32 million) and the Fixed-price Preemptive Rights ($3 million), (collectively, &#x201c;Investment in Cronos&#x201d;).  The Investment in Cronos at December 31, 2020 consisted of Altria&#x2019;s equity method investment in Cronos ($1,010 million), the Cronos warrant ($139 million) and the Fixed-price Preemptive Rights ($24 million).  See below for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income (losses) from equity investments accounted for under the equity method of accounting and fair value option consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.952%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.184%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,644)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(6,036)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(418)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;21&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (losses) from investments under equity method of accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(6,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JUUL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (losses) from equity investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,915)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;For the nine and three months ended September 30, 2021, Altria recorded a non-cash, pre-tax impairment charge of $6,157 million related to its equity investment in ABI. See below for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investment in ABI&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2021, Altria had an approximate 10% ownership interest in ABI, consisting of 185 million restricted shares of ABI (the &#x201c;Restricted Shares&#x201d;) and 12 million ordinary shares of ABI.  The Restricted Shares:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt"&gt;are unlisted and not admitted to trading on any stock exchange;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt"&gt;are convertible by Altria into ordinary shares of ABI on a one-for-one basis;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt"&gt;rank equally with ordinary shares of ABI with regards to dividends and voting rights; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt"&gt;have director nomination rights with respect to ABI.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restricted Shares were subject to a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzkwMzI2NjI3OTEyMjM_deac5b80-5cfb-43db-b6ef-127a6fca35e3"&gt;five&lt;/span&gt;-year lock-up period that ended October 10, 2021.  As of this filing, Altria has not elected to convert its Restricted Shares into ordinary shares of ABI.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria accounts for its investment in ABI under the equity method of accounting because Altria has the ability to exercise significant influence over the operating and financial policies of ABI, including having active representation on ABI&#x2019;s board of directors and certain ABI board committees.  Through this representation, Altria participates in ABI policy making processes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria reports its share of ABI&#x2019;s results using a one-quarter lag because ABI&#x2019;s results are not available in time for Altria to record them in the concurrent period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of Altria&#x2019;s equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI&#x2019;s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy.  Altria can convert its Restricted Shares to ordinary shares at its discretion.  Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2019, the fair value of Altria&#x2019;s equity investment in ABI declined below its carrying value and has not recovered.   At December&#160;31, 2020, the fair value of Altria&#x2019;s equity investment in ABI was $13.8 billion (carrying value of $16.7 billion), which was less than its carrying value by approximately 17%. In preparing its financial statements for the period ended December&#160;31, 2020, Altria evaluated the factors related to the fair value decline, including the impact on the fair value of ABI&#x2019;s shares during the COVID-19 pandemic, which has negatively impacted ABI&#x2019;s business.  Altria evaluated the duration and magnitude of the fair value decline, ABI&#x2019;s financial condition and near-term prospects and Altria&#x2019;s intent and ability to hold its &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;investment in ABI until recovery.  Altria concluded that the decline in fair value of its investment in ABI at December 31, 2020 below its carrying value was temporary and, therefore, no impairment was recorded at that time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following the consideration of the same factors, Altria, in preparing its financial statements for the period ended September&#160;30, 2021, concluded that the decline in fair value of its investment in ABI at September&#160;30, 2021 was other than temporary. As a result, Altria recorded a non-cash, pre-tax impairment charge of $6.2 billion for the nine and three months ended September&#160;30, 2021, which was recorded to income (losses) from equity investments in its condensed consolidated statements of earnings (losses).  This impairment charge reflects the difference between the fair value of Altria&#x2019;s investment in ABI using ABI&#x2019;s share price at September&#160;30, 2021 and the carrying value of Altria&#x2019;s equity investment in ABI at September&#160;30, 2021.  Altria continues to have confidence in ABI&#x2019;s (i) long-term strategies, (ii) premium global brands, (iii) experienced management team and (iv) capability to successfully navigate its near-term challenges. Altria further expects that the impacts related to the COVID-19 pandemic that have negatively impacted ABI&#x2019;s global business are transitory, but now also anticipates that the full recovery to carrying value will take longer than previously expected. This is evidenced by the resumption of declines in fair value during the third quarter of 2021, following positive share price momentum during the first half of 2021.  At September&#160;30, 2021, prior to recording the impairment charge, the fair value of Altria&#x2019;s investment in ABI was below the carrying value by approximately 35%, which represents an additional 18% reduction in ABI&#x2019;s share price since December&#160;31, 2020.  After recording the impairment charge, the fair value and carrying value of Altria&#x2019;s equity investment in ABI at September&#160;30, 2021 were $11.2 billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2021, the carrying value of Altria&#x2019;s equity investment in ABI exceeded its share of ABI&#x2019;s net assets attributable to equity holders of ABI by approximately $5.1 billion.  Substantially all of this difference is comprised of goodwill and other indefinite-lived intangible assets (consisting primarily of trademarks).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investment in JUUL&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2018, Altria made an investment in JUUL and received a 35% economic interest in JUUL through non-voting shares, which were convertible at Altria&#x2019;s election into voting shares (&#x201c;Share Conversion&#x201d;), and a security convertible into additional non-voting or voting shares, as applicable, upon settlement or exercise of certain JUUL convertible securities (the &#x201c;JUUL Transaction&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria received a broad preemptive right to purchase JUUL shares, exercisable each quarter upon dilution, to maintain its ownership percentage and is subject to a standstill restriction under which it may not acquire additional JUUL shares above its 35% interest.  Furthermore, Altria agreed not to sell or transfer any of its JUUL shares until December 20, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2020, the U.S. Federal Trade Commission (&#x201c;FTC&#x201d;) issued an administrative complaint challenging Altria&#x2019;s investment in JUUL.  For further discussion, see Note 12. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies -&#160;Antitrust Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2020, Altria exercised its rights to convert its non-voting JUUL shares into voting shares.  Altria does not currently intend to exercise its additional governance rights obtained upon Share Conversion, including the right to elect directors to JUUL&#x2019;s board or to vote its JUUL shares other than as a passive investor, pending the outcome of the FTC administrative complaint.  At September&#160;30, 2021, Altria had a 35% ownership interest in JUUL, consisting of 42 million voting shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following Share Conversion in the fourth quarter of 2020, Altria elected to account for its equity method investment in JUUL under the fair value option.  Under this option, Altria&#x2019;s condensed consolidated statements of earnings (losses) include any cash dividends received from its investment in JUUL and any changes in the estimated fair value of its investment, which is calculated quarterly.  Altria believes the fair value option provides quarterly transparency to investors as to the fair market value of Altria&#x2019;s investment in JUUL, given the changes and volatility in the e-vapor category since Altria&#x2019;s initial investment, as well as the lack of publicly available information regarding JUUL&#x2019;s business or a market-derived valuation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the beginning and ending balance of Altria&#x2019;s investment in JUUL, which is classified in Level 3 of the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Investment &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) included in income (losses) from equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,705&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended September 30, 2021, Altria recorded a non-cash, pre-tax unrealized gain of $100 million, as a result of changes in the estimated fair value of its investment in JUUL.  At September 30, 2021, the estimated fair value of Altria&#x2019;s JUUL investment was $1.7 billion, unchanged from its December 31, 2020 estimated fair value.  There were no material &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;changes to the significant assumptions used in the valuations, as described below, during the nine and three months ended September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to Share Conversion, Altria accounted for its investment in JUUL as an investment in an equity security.  Since the JUUL shares do not have a readily determinable fair value, Altria elected to measure its investment in JUUL at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.  There were no upward or downward adjustments to the carrying value of Altria&#x2019;s investment in JUUL resulting from observable price changes in orderly transactions since the JUUL Transaction through the date of Share Conversion.  In addition, prior to Share Conversion, Altria reviewed its investment in JUUL for impairment by performing a qualitative assessment of impairment indicators on a quarterly basis in connection with the preparation of its financial statements.  If this qualitative assessment indicated that Altria&#x2019;s investment in JUUL may be impaired, a quantitative assessment was performed.  If the quantitative assessment indicated the estimated fair value of the investment was less than its carrying value, the investment was written down to its fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2020, JUUL announced a strategic update, which included its plans for a significant global workforce reduction, its evaluation of its resource allocation and the possibility of exiting various international markets.  As part of the preparation of Altria&#x2019;s financial statements for the period ended September 30, 2020, Altria performed a qualitative assessment of impairment indicators for its investment in JUUL and determined that JUUL&#x2019;s strategic update was an indicator of impairment at September 30, 2020, given the significant deterioration in JUUL&#x2019;s business prospects.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Given the existence of this impairment indicator, Altria performed a quantitative valuation of its investment in JUUL during the third quarter of 2020 and recorded a non-cash, pre-tax charge of $2.6 billion for the nine and three months ended September 30, 2020, reported as impairment of JUUL equity securities in its condensed consolidated statements of earnings (losses).  The impairment charge was driven by Altria&#x2019;s projections of lower JUUL revenues over time due to lower pricing assumptions and delays in JUUL achieving previously forecasted operating margin performance.  These drivers were the result of (i) JUUL&#x2019;s revised international expansion plans and (ii) the evolving U.S. e-vapor category and associated competitive dynamics.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria uses an income approach to estimate the fair value of its investment in JUUL.  The income approach reflects the discounting of future cash flows for the U.S. and international markets at a rate of return that incorporates the risk-free rate for the use of those funds, the expected rate of inflation and the risks associated with realizing future cash flows.  Future cash flows were based on a range of scenarios that consider various potential regulatory and market outcomes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining the estimated fair value of its investment in JUUL, as of September&#160;30, 2021 and December&#160;31, 2020, Altria made various judgments, estimates and assumptions, the most significant of which were sales volume, operating margins, discount rates and perpetual growth rates.  All significant inputs used in the valuation are classified in Level 3 of the fair value hierarchy.  Additionally, in determining these significant assumptions, Altria made judgments regarding the (i) likelihood and extent of various potential regulatory actions and the continued adverse public perception impacting the e-vapor category and specifically JUUL, (ii) risk created by the number and types of legal cases pending against JUUL and (iii) expectations for the future state of the e-vapor category, including competitive dynamics.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investment in Cronos&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2021, Altria had a 41.9% ownership interest in Cronos, consisting of 156.6&#160;million shares, which Altria accounts for under the equity method of accounting.  Altria&#x2019;s ownership percentage decreased from 43.5% at December 31, 2020 due to the issuance of additional shares by Cronos.  Altria reports its share of Cronos&#x2019;s results using a one-quarter lag because Cronos&#x2019;s results are not available in time for Altria to record them in the concurrent period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of its Investment in Cronos, at September&#160;30, 2021, Altria owned:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;anti-dilution protections to purchase Cronos common shares, exercisable each quarter upon dilution, to maintain its ownership percentage.  Certain of the anti-dilution protections provide Altria the ability to purchase additional Cronos common shares at a per share exercise price of Canadian dollar (&#x201c;CAD&#x201d;) $16.25 upon the occurrence of specified events (&#x201c;Fixed-price Preemptive Rights&#x201d;).  Based on Altria&#x2019;s assumptions as of September 30, 2021, Altria estimates the Fixed-price Preemptive Rights allows Altria to purchase up to an additional approximately 14 million common shares of Cronos; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;a warrant providing Altria the ability to purchase an additional approximate 10% of common shares of Cronos (approximately 83 million common shares at September 30, 2021) at a per share exercise price of CAD $19.00, which expires on March 8, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If exercised in full, the exercise prices for the warrant and Fixed-price Preemptive Rights are approximately CAD $1.6 billion and CAD $0.2 billion, respectively (approximately USD $1.3 billion and $0.2 billion, respectively, based on the CAD to USD exchange rate on October 25, 2021).  At September 30, 2021, upon full exercise of the Fixed-price Preemptive Rights, to the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;extent such rights become available, and the warrant, Altria would own approximately 53% of the outstanding common shares of Cronos.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a discussion of derivatives related to the Investment in Cronos, including Altria&#x2019;s accounting for changes in the fair value of these derivatives, see Note 5. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of Altria&#x2019;s equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos&#x2019;s common shares and was classified in Level 1 of the fair value hierarchy.  In September 2021, the fair value of Altria&#x2019;s equity method investment in Cronos declined below its carrying value.  At September&#160;30, 2021, the fair value of Altria&#x2019;s equity method investment in Cronos was less than its carrying value by $14&#160;million or approximately 2%.  The fair value of Altria&#x2019;s equity method investment in Cronos exceeded its carrying value by $77 million or approximately 8% at December&#160;31, 2020.  Based on Altria&#x2019;s evaluation of the duration and magnitude of the fair value decline at September 30, 2021, Altria concluded that the decline in fair value of its equity method investment in Cronos below its carrying value is temporary and, therefore, no impairment was recorded.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentTextBlock>
    <us-gaap:InvestmentTableTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzU1NA_918e02bf-2a22-4a9c-908c-055367c0afa5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amount of Altria&#x2019;s investments consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JUUL&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,705&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;932&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,874&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Atria&#x2019;s investment in Cronos at September 30, 2021 consisted of Altria&#x2019;s equity method investment in Cronos ($897 million), the Cronos warrant ($32 million) and the Fixed-price Preemptive Rights ($3 million), (collectively, &#x201c;Investment in Cronos&#x201d;).  The Investment in Cronos at December 31, 2020 consisted of Altria&#x2019;s equity method investment in Cronos ($1,010 million), the Cronos warrant ($139 million) and the Fixed-price Preemptive Rights ($24 million).  See below for further discussion.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentTableTextBlock>
    <us-gaap:EquityMethodInvestments
      contextRef="ib6f738f3284745ba87d4ead6955d877d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOjRlMmZhMjUxOWU0NDRjY2I5ZDBkYjJkODkyYTBlMDFhL3RhYmxlcmFuZ2U6NGUyZmEyNTE5ZTQ0NGNjYjlkMGRiMmQ4OTJhMGUwMWFfMS0yLTEtMS0w_ee0e5ac5-96dd-46d7-a101-fdaab639dcb2"
      unitRef="usd">11237000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i8023b74faf63413a92633caf766ceda1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOjRlMmZhMjUxOWU0NDRjY2I5ZDBkYjJkODkyYTBlMDFhL3RhYmxlcmFuZ2U6NGUyZmEyNTE5ZTQ0NGNjYjlkMGRiMmQ4OTJhMGUwMWFfMS00LTEtMS0w_0ce394a7-7dbc-4232-b6a6-43671b78e3cb"
      unitRef="usd">16651000000</us-gaap:EquityMethodInvestments>
    <mo:EquityInvestmentFairValueOption
      contextRef="i72200b393daa452fb6e8b503937f1675_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOjRlMmZhMjUxOWU0NDRjY2I5ZDBkYjJkODkyYTBlMDFhL3RhYmxlcmFuZ2U6NGUyZmEyNTE5ZTQ0NGNjYjlkMGRiMmQ4OTJhMGUwMWFfMi0yLTEtMS0w_fbaca8f5-1bc3-4fca-a41f-d2b63c1c3369"
      unitRef="usd">1705000000</mo:EquityInvestmentFairValueOption>
    <mo:EquityInvestmentFairValueOption
      contextRef="ia53e50acb7e34afea6df1a5247e0b9d6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOjRlMmZhMjUxOWU0NDRjY2I5ZDBkYjJkODkyYTBlMDFhL3RhYmxlcmFuZ2U6NGUyZmEyNTE5ZTQ0NGNjYjlkMGRiMmQ4OTJhMGUwMWFfMi00LTEtMS0w_c22f2d42-c072-42d6-8074-2d59a02d26bb"
      unitRef="usd">1705000000</mo:EquityInvestmentFairValueOption>
    <us-gaap:EquityMethodInvestments
      contextRef="ia3134917de914447a308c3c06a9e6332_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOjRlMmZhMjUxOWU0NDRjY2I5ZDBkYjJkODkyYTBlMDFhL3RhYmxlcmFuZ2U6NGUyZmEyNTE5ZTQ0NGNjYjlkMGRiMmQ4OTJhMGUwMWFfMy0yLTEtMS0w_6d2db296-6eb2-47c9-b2fe-d6d90f3c23f7"
      unitRef="usd">932000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ib5afb831a7af4995b73bda6b83b376f7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOjRlMmZhMjUxOWU0NDRjY2I5ZDBkYjJkODkyYTBlMDFhL3RhYmxlcmFuZ2U6NGUyZmEyNTE5ZTQ0NGNjYjlkMGRiMmQ4OTJhMGUwMWFfMy00LTEtMS0w_3b7b3779-2433-4f8f-8a42-d0ac5d4ad321"
      unitRef="usd">1173000000</us-gaap:EquityMethodInvestments>
    <us-gaap:Investments
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOjRlMmZhMjUxOWU0NDRjY2I5ZDBkYjJkODkyYTBlMDFhL3RhYmxlcmFuZ2U6NGUyZmEyNTE5ZTQ0NGNjYjlkMGRiMmQ4OTJhMGUwMWFfNC0yLTEtMS0w_9c7c59b9-b0b3-4bb1-b729-f0fdc3e32ca1"
      unitRef="usd">13874000000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOjRlMmZhMjUxOWU0NDRjY2I5ZDBkYjJkODkyYTBlMDFhL3RhYmxlcmFuZ2U6NGUyZmEyNTE5ZTQ0NGNjYjlkMGRiMmQ4OTJhMGUwMWFfNC00LTEtMS0w_d5ef1d4c-36c0-48a8-b17d-5cb2f9501f09"
      unitRef="usd">19529000000</us-gaap:Investments>
    <us-gaap:EquityMethodInvestments
      contextRef="ie2d67aef385b4488b0e8489bde6ec505_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMTg5_0c266e1d-fbe0-4101-b5a9-495632844521"
      unitRef="usd">897000000</us-gaap:EquityMethodInvestments>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i4c1ec10071a549c494de909a6803c0bc_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMjE0_66f552bc-8fdb-40cc-a1c2-08fb85fc96b8"
      unitRef="usd">32000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="id27af0c56a0e4f2c91692075789f16f1_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMjU3_e7fec709-60cd-4c9d-89cb-def60575a9d0"
      unitRef="usd">3000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:EquityMethodInvestments
      contextRef="i55353e2d6bb3468a8bb902e7ef81616b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfNDAz_4db853a4-feb1-41b1-b63e-747f7e7af605"
      unitRef="usd">1010000000</us-gaap:EquityMethodInvestments>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ia7f2b6c32d774ec2b7a6087a9251d893_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfNDI4_f03e1bd5-008a-4873-a263-6efd568b3f3a"
      unitRef="usd">139000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ie01a2991fc0c45cda4ae5f730f069b9b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfNDcx_9a36291c-04f0-4f21-923d-4f59a8cb3152"
      unitRef="usd">24000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzU1Mw_290e3727-29ab-4742-973e-aef3a98cce1f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income (losses) from equity investments accounted for under the equity method of accounting and fair value option consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.952%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.184%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,644)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(6,036)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(418)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;21&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (losses) from investments under equity method of accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(6,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JUUL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (losses) from equity investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,915)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;For the nine and three months ended September 30, 2021, Altria recorded a non-cash, pre-tax impairment charge of $6,157 million related to its equity investment in ABI. See below for further discussion.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ife49fc973ca746f092aa4d83bca9d740_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfMi0xLTEtMS0w_fd5b639f-fb50-482b-b439-86c2311bd160"
      unitRef="usd">-5644000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i142e3b708e7c4513964bfdef3821842c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfMi0zLTEtMS0w_a3361718-78b6-4fbd-a2d2-56c5015a2c06"
      unitRef="usd">-306000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic62d4fc827d0412695035c4816dc2a17_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfMi01LTEtMS0w_ef4136d5-0274-4506-b639-d12e8072b9e0"
      unitRef="usd">-6036000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i6b92cf433a64434db9bce40cc2385d5e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfMi03LTEtMS0w_9a17e577-d4b7-498e-ba0f-7cfb720e95a9"
      unitRef="usd">-418000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i7f91523b32934656837eccb431840056_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfMy0xLTEtMS0w_c337c316-5111-47b0-a216-e22b375dd452"
      unitRef="usd">-145000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i16da5adef0b64404a908cb9d15134fb8_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfMy0zLTEtMS0w_126b6a3c-b5f9-4860-ac63-7ac560be9d3c"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if3a641fc878c4afe85e1c9467ee9853c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfMy01LTEtMS0w_63c1d1ba-2798-4bea-93c1-d5dc3323412a"
      unitRef="usd">21000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if3a641fc878c4afe85e1c9467ee9853c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfMy01LTEtMS0w_f35816df-b515-4b7b-b548-32599e8bbb2d"
      unitRef="usd">21000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if07c963ba7314996a07680309ec4ce52_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfMy03LTEtMS0w_62d20a20-1901-4c7d-9e59-825f8a0a619b"
      unitRef="usd">-54000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfNC0xLTEtMS0w_3b3ff5cc-478c-4dfa-896b-bdcbeade9bf0"
      unitRef="usd">-5789000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfNC0zLTEtMS0w_ab89b3fa-2fd9-4bd2-804c-740bd49a3005"
      unitRef="usd">-306000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfNC01LTEtMS0w_a64ccf31-d7f6-4902-911d-ed812b11a3c5"
      unitRef="usd">-6015000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfNC03LTEtMS0w_5083ec23-0eac-49d0-a27e-ab4b68ae9e25"
      unitRef="usd">-472000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <mo:IncomeLossFromEquityInvestmentsFairValueOption
      contextRef="i2a7ceafc35c8455aa006544f31dada24_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfNS0xLTEtMS0w_16c357c5-b4ab-4c98-9bb3-5b9ce1ab92fb"
      unitRef="usd">0</mo:IncomeLossFromEquityInvestmentsFairValueOption>
    <mo:IncomeLossFromEquityInvestmentsFairValueOption
      contextRef="iff7bce46de9948cfbbc1a3790debcee8_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfNS0zLTEtMS0w_393f375f-73c8-4021-bddf-cdd8b2b7bf0a"
      unitRef="usd">0</mo:IncomeLossFromEquityInvestmentsFairValueOption>
    <mo:IncomeLossFromEquityInvestmentsFairValueOption
      contextRef="i0d7c9a004f294d309f5a0ddbff7f9c62_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfNS01LTEtMS0w_937ff4b1-ce28-49ae-9da1-7c36e47d71fa"
      unitRef="usd">100000000</mo:IncomeLossFromEquityInvestmentsFairValueOption>
    <mo:IncomeLossFromEquityInvestmentsFairValueOption
      contextRef="i26492b9b36f34d359befa59e3e1f285d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfNS03LTEtMS0w_c6e7b96f-f563-4570-ab75-950d650b6da3"
      unitRef="usd">0</mo:IncomeLossFromEquityInvestmentsFairValueOption>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfNi0xLTEtMS0w_d45752fd-e53b-44f0-9f82-5019cb69eea0"
      unitRef="usd">-5789000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfNi0zLTEtMS0w_68d0be54-a6c5-4e27-8088-bfd5ae346549"
      unitRef="usd">-306000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfNi01LTEtMS0w_6993e694-c297-4cdd-a40c-62248f76ff88"
      unitRef="usd">-5915000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RhYmxlOmEyNDEzYmQ2M2VhMDQ5N2Q5MzdjYWZmZGViMTU1ZDQ0L3RhYmxlcmFuZ2U6YTI0MTNiZDYzZWEwNDk3ZDkzN2NhZmZkZWIxNTVkNDRfNi03LTEtMS0w_3804f3aa-8217-4720-87e1-7f74f10273d8"
      unitRef="usd">-472000000</mo:IncomeLossFromEquityInvestments>
    <mo:EquityMethodInvestmentImpairment
      contextRef="ife49fc973ca746f092aa4d83bca9d740_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzI5ODUzNDkwMDI3Ng_6a37dd71-d6cf-4ce5-884a-7d2cc643850c"
      unitRef="usd">6157000000</mo:EquityMethodInvestmentImpairment>
    <mo:EquityMethodInvestmentImpairment
      contextRef="ic62d4fc827d0412695035c4816dc2a17_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzI5ODUzNDkwMDI3Ng_9903f87f-2c6c-44ff-9939-bcc8ccad5ace"
      unitRef="usd">6157000000</mo:EquityMethodInvestmentImpairment>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ib6f738f3284745ba87d4ead6955d877d_I20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfNjkz_6b508091-5219-4fcc-a5df-eea075ddc372"
      unitRef="number">0.10</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <mo:EquityMethodInvestmentNumberofSharesOwnedRestricted
      contextRef="ib6f738f3284745ba87d4ead6955d877d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfNzM3_58b8ba5d-048e-4b5c-9070-4955c118854b"
      unitRef="shares">185000000</mo:EquityMethodInvestmentNumberofSharesOwnedRestricted>
    <mo:EquityMethodInvestmentNumberofSharesOwnedCommon
      contextRef="ib6f738f3284745ba87d4ead6955d877d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfNzk1_f466b0b5-83fb-41c2-b6d3-9ba25bd35bfe"
      unitRef="shares">12000000</mo:EquityMethodInvestmentNumberofSharesOwnedCommon>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzU2Ng_bb3b631b-a1a2-4a93-aaa9-be03138f53f6">&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria accounts for its investment in ABI under the equity method of accounting because Altria has the ability to exercise significant influence over the operating and financial policies of ABI, including having active representation on ABI&#x2019;s board of directors and certain ABI board committees.  Through this representation, Altria participates in ABI policy making processes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria reports its share of ABI&#x2019;s results using a one-quarter lag because ABI&#x2019;s results are not available in time for Altria to record them in the concurrent period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of Altria&#x2019;s equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI&#x2019;s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy.  Altria can convert its Restricted Shares to ordinary shares at its discretion.  Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2019, the fair value of Altria&#x2019;s equity investment in ABI declined below its carrying value and has not recovered.   At December&#160;31, 2020, the fair value of Altria&#x2019;s equity investment in ABI was $13.8 billion (carrying value of $16.7 billion), which was less than its carrying value by approximately 17%. In preparing its financial statements for the period ended December&#160;31, 2020, Altria evaluated the factors related to the fair value decline, including the impact on the fair value of ABI&#x2019;s shares during the COVID-19 pandemic, which has negatively impacted ABI&#x2019;s business.  Altria evaluated the duration and magnitude of the fair value decline, ABI&#x2019;s financial condition and near-term prospects and Altria&#x2019;s intent and ability to hold its &lt;/span&gt;&lt;/div&gt;investment in ABI until recovery.  Altria concluded that the decline in fair value of its investment in ABI at December 31, 2020 below its carrying value was temporary and, therefore, no impairment was recorded at that time.Following the consideration of the same factors, Altria, in preparing its financial statements for the period ended September&#160;30, 2021, concluded that the decline in fair value of its investment in ABI at September&#160;30, 2021 was other than temporary. As a result, Altria recorded a non-cash, pre-tax impairment charge of $6.2 billion for the nine and three months ended September&#160;30, 2021, which was recorded to income (losses) from equity investments in its condensed consolidated statements of earnings (losses).  This impairment charge reflects the difference between the fair value of Altria&#x2019;s investment in ABI using ABI&#x2019;s share price at September&#160;30, 2021 and the carrying value of Altria&#x2019;s equity investment in ABI at September&#160;30, 2021.  Altria continues to have confidence in ABI&#x2019;s (i) long-term strategies, (ii) premium global brands, (iii) experienced management team and (iv) capability to successfully navigate its near-term challenges. Altria further expects that the impacts related to the COVID-19 pandemic that have negatively impacted ABI&#x2019;s global business are transitory, but now also anticipates that the full recovery to carrying value will take longer than previously expected. This is evidenced by the resumption of declines in fair value during the third quarter of 2021, following positive share price momentum during the first half of 2021.  At September&#160;30, 2021, prior to recording the impairment charge, the fair value of Altria&#x2019;s investment in ABI was below the carrying value by approximately 35%, which represents an additional 18% reduction in ABI&#x2019;s share price since December&#160;31, 2020.  The fair value of Altria&#x2019;s equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos&#x2019;s common shares and was classified in Level 1 of the fair value hierarchy.  In September 2021, the fair value of Altria&#x2019;s equity method investment in Cronos declined below its carrying value.</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="i32e2dbe44f974df484f948ed2b86c221_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfNzY5NjU4MTQxMTk0NA_2d7851c7-9b06-4905-8a64-b0be382cb742"
      unitRef="usd">13800000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <us-gaap:EquityMethodInvestments
      contextRef="i8023b74faf63413a92633caf766ceda1_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfNzY5NjU4MTQxMTk2Nw_d443dc89-adf7-4af2-b24a-c5a5cdf2b8e8"
      unitRef="usd">16700000000</us-gaap:EquityMethodInvestments>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage
      contextRef="id3b7793faa454c9499956ae3df8ea507_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfNzY5NjU4MTQxMjAyOA_822c7fbf-4ab0-4470-ab65-8d933e35a5ef"
      unitRef="number">-0.17</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage>
    <mo:EquityMethodInvestmentImpairment
      contextRef="id3b7793faa454c9499956ae3df8ea507_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzI5ODUzNDkwMDIyMQ_7445f01c-5d8d-4a56-90fb-6b8ad7de4315"
      unitRef="usd">0</mo:EquityMethodInvestmentImpairment>
    <mo:EquityMethodInvestmentImpairment
      contextRef="ife49fc973ca746f092aa4d83bca9d740_D20210101-20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzI5ODUzNDkwMDIzMA_61e782a2-9f07-4ec6-b309-f9cf56611226"
      unitRef="usd">6200000000</mo:EquityMethodInvestmentImpairment>
    <mo:EquityMethodInvestmentImpairment
      contextRef="ic62d4fc827d0412695035c4816dc2a17_D20210701-20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzI5ODUzNDkwMDIzMA_95df2bdb-1871-4e44-a2ff-9d57e0ce87a6"
      unitRef="usd">6200000000</mo:EquityMethodInvestmentImpairment>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage
      contextRef="ife49fc973ca746f092aa4d83bca9d740_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfNzY5NjU4MTQxMDA5MA_0186c66c-46e0-41cc-a39c-1b07ad647b30"
      unitRef="number">-0.35</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage>
    <mo:EquityMethodInvestmentReductionInSharePricePercentage
      contextRef="ib6f738f3284745ba87d4ead6955d877d_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzI5ODUzNDkwMDI1MQ_d8bb450e-d1f5-469f-9aaf-8641bd8daeb9"
      unitRef="number">0.18</mo:EquityMethodInvestmentReductionInSharePricePercentage>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMjY2Ng_e5de8afb-9a1f-402c-8352-9add88f37ac9"
      unitRef="usd">11200000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <us-gaap:EquityMethodInvestments
      contextRef="ib6f738f3284745ba87d4ead6955d877d_I20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMjY2Ng_f5ede66c-013d-464b-bd88-f087eab807f9"
      unitRef="usd">11200000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
      contextRef="ib6f738f3284745ba87d4ead6955d877d_I20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzI5ODUzNDkwMDI1Nw_06a2a3ec-4c71-42a6-a608-1a4c25a6a60f"
      unitRef="usd">5100000000</us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage
      contextRef="i7b95bdcd547049af892afbaf8e444f3e_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RleHRyZWdpb246ZWQyNmE4YTUyYjU3NDE5OWJiMjg1Mzc0MzlhMzBhYTBfOTI_78908f0b-807a-4260-8e46-e0f67291d8f9"
      unitRef="number">0.35</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage
      contextRef="i7b95bdcd547049af892afbaf8e444f3e_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RleHRyZWdpb246ZWQyNmE4YTUyYjU3NDE5OWJiMjg1Mzc0MzlhMzBhYTBfNjYz_dc3b3f22-02dd-4464-b368-7db787187748"
      unitRef="number">0.35</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage
      contextRef="i72200b393daa452fb6e8b503937f1675_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RleHRyZWdpb246ZWQyNmE4YTUyYjU3NDE5OWJiMjg1Mzc0MzlhMzBhYTBfMTM5Mg_4b887ff9-f9b8-4bb0-9675-06abe39b2fa5"
      unitRef="number">0.35</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage>
    <mo:EquityInvestmentsFairValueOptionVotingShares
      contextRef="i72200b393daa452fb6e8b503937f1675_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RleHRyZWdpb246ZWQyNmE4YTUyYjU3NDE5OWJiMjg1Mzc0MzlhMzBhYTBfMTQzNw_9c2267eb-2acf-4e66-8f1b-2b495a9f0964"
      unitRef="shares">42000000</mo:EquityInvestmentsFairValueOptionVotingShares>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RleHRyZWdpb246ZWQyNmE4YTUyYjU3NDE5OWJiMjg1Mzc0MzlhMzBhYTBfMjE5OTAyMzI2NzQ3OA_e43d1331-0671-4416-a75b-57cc04f4dea3">&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the beginning and ending balance of Altria&#x2019;s investment in JUUL, which is classified in Level 3 of the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Investment &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) included in income (losses) from equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,705&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i134145e8cb494481a64026d08e24f670_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RhYmxlOjU5NGIxMGNkMTVkMDQ4ODI5M2Y3M2YxYmFjODAwMDlhL3RhYmxlcmFuZ2U6NTk0YjEwY2QxNWQwNDg4MjkzZjczZjFiYWM4MDAwOWFfMi0yLTEtMS00OTY3OA_0ebfa021-cfcc-4834-a6c8-654f7139cf10"
      unitRef="usd">1705000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i5fe43b6fc76f4ce480f73470bdcc7717_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RhYmxlOjU5NGIxMGNkMTVkMDQ4ODI5M2Y3M2YxYmFjODAwMDlhL3RhYmxlcmFuZ2U6NTk0YjEwY2QxNWQwNDg4MjkzZjczZjFiYWM4MDAwOWFfMy0yLTEtMS00OTY3Mg_1073114d-068a-43c4-99c5-e180c1f6d0c8"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i050fe6a531654ecd9ffb665ff8b70dce_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RhYmxlOjU5NGIxMGNkMTVkMDQ4ODI5M2Y3M2YxYmFjODAwMDlhL3RhYmxlcmFuZ2U6NTk0YjEwY2QxNWQwNDg4MjkzZjczZjFiYWM4MDAwOWFfNC0yLTEtMS01MDk5NQ_22285a07-3a54-4919-ba8c-94b5a7419780"
      unitRef="usd">1705000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <mo:IncomeLossFromEquityInvestmentsFairValueOption
      contextRef="i0d7c9a004f294d309f5a0ddbff7f9c62_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RleHRyZWdpb246ZWQyNmE4YTUyYjU3NDE5OWJiMjg1Mzc0MzlhMzBhYTBfMTQ4NDM0MDY5ODU5NDc_339d62f5-4d1f-468e-8d69-4bbb5608b3b3"
      unitRef="usd">100000000</mo:IncomeLossFromEquityInvestmentsFairValueOption>
    <mo:EquityInvestmentFairValueOption
      contextRef="i72200b393daa452fb6e8b503937f1675_I20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RleHRyZWdpb246ZWQyNmE4YTUyYjU3NDE5OWJiMjg1Mzc0MzlhMzBhYTBfMzI5ODUzNDg5NjEzMg_e4b32d69-c033-4e77-be3a-22c2e07f55df"
      unitRef="usd">1700000000</mo:EquityInvestmentFairValueOption>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount
      contextRef="ia1881e260a3842d1bcc033077fcf431f_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RleHRyZWdpb246ZWQyNmE4YTUyYjU3NDE5OWJiMjg1Mzc0MzlhMzBhYTBfMTg4Mw_db9140ed-38da-4524-96a3-c6b7b58b2782"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount
      contextRef="ia17ccdc17eaa43c2895a3756a03e1e51_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RleHRyZWdpb246ZWQyNmE4YTUyYjU3NDE5OWJiMjg1Mzc0MzlhMzBhYTBfMTg4Mw_e20fabc3-27e9-4646-8018-f8a4e1d38ae5"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i26492b9b36f34d359befa59e3e1f285d_D20200701-20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RleHRyZWdpb246ZWQyNmE4YTUyYjU3NDE5OWJiMjg1Mzc0MzlhMzBhYTBfMjc0ODc3OTA3NzI2Ng_464fc599-469c-425b-b9e2-013ca4b080d0"
      unitRef="usd">2600000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="iff7bce46de9948cfbbc1a3790debcee8_D20200101-20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181NS9mcmFnOmVkMjZhOGE1MmI1NzQxOTliYjI4NTM3NDM5YTMwYWEwL3RleHRyZWdpb246ZWQyNmE4YTUyYjU3NDE5OWJiMjg1Mzc0MzlhMzBhYTBfMjc0ODc3OTA3NzI2Ng_4ff90847-68aa-454c-a680-9db96bd4a9d3"
      unitRef="usd">2600000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ia3134917de914447a308c3c06a9e6332_I20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfNDY_08d5d906-3699-4b47-a55c-295d9b2144b0"
      unitRef="number">0.419</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <mo:EquityMethodInvestmentNumberofSharesOwnedCommon
      contextRef="ia3134917de914447a308c3c06a9e6332_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfOTM_894980f1-02ec-4a0f-9765-c5f6ad8e9cbc"
      unitRef="shares">156600000</mo:EquityMethodInvestmentNumberofSharesOwnedCommon>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ib5afb831a7af4995b73bda6b83b376f7_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMjE1_ae309607-d6b0-411b-a960-cfd1dcd4f6e5"
      unitRef="number">0.435</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <mo:EquityMethodInvestmentPricePerShareIfExercised
      contextRef="id27af0c56a0e4f2c91692075789f16f1_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfODMx_c280a85d-af13-4dae-a471-2e2b039fedb5"
      unitRef="cadPerShare">16.25</mo:EquityMethodInvestmentPricePerShareIfExercised>
    <mo:EquityMethodInvestmentNumberofSharesEligibleForPurchase
      contextRef="id27af0c56a0e4f2c91692075789f16f1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMTA3Mg_31738973-b174-4c10-b57e-706114c35cf2"
      unitRef="shares">14000000</mo:EquityMethodInvestmentNumberofSharesEligibleForPurchase>
    <mo:EquityMethodInvestmentPercentageofSharesEligibleForPurchase
      contextRef="i4c1ec10071a549c494de909a6803c0bc_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMTE4MQ_8bd4b6b4-c1ab-4d71-8833-75a9ed83b631"
      unitRef="number">0.10</mo:EquityMethodInvestmentPercentageofSharesEligibleForPurchase>
    <mo:EquityMethodInvestmentNumberofSharesEligibleForPurchase
      contextRef="i4c1ec10071a549c494de909a6803c0bc_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMTIyNg_1d71990e-d224-4405-a923-16e77eec1571"
      unitRef="shares">83000000</mo:EquityMethodInvestmentNumberofSharesEligibleForPurchase>
    <mo:EquityMethodInvestmentPricePerShareIfExercised
      contextRef="i4c1ec10071a549c494de909a6803c0bc_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMTI5OA_8fadf37e-03df-455e-9e71-2f01ff5a7184"
      unitRef="cadPerShare">19.00</mo:EquityMethodInvestmentPricePerShareIfExercised>
    <mo:EquityMethodInvestmentAggregateExercisePrice
      contextRef="ia8e68dd2bdba4a9fb2cab39cdf6ff65a_D20210101-20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMTQ0OQ_4d66deda-7d12-4dac-8f2e-be9318a810a1"
      unitRef="cad">1600000000</mo:EquityMethodInvestmentAggregateExercisePrice>
    <mo:EquityMethodInvestmentAggregateExercisePrice
      contextRef="i413418f0ee6d4970991e224cb3ef2b61_D20210101-20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMTQ2MA_12f6d63f-8112-4498-a683-39ee27533bb2"
      unitRef="cad">200000000</mo:EquityMethodInvestmentAggregateExercisePrice>
    <mo:EquityMethodInvestmentAggregateExercisePrice
      contextRef="i4c45d9f454c845349a17b5b89122518e_D20211025-20211025"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMTQ5Nw_10e24711-d565-42d4-a7a2-cec55d1a2cd6"
      unitRef="usd">1300000000</mo:EquityMethodInvestmentAggregateExercisePrice>
    <mo:EquityMethodInvestmentAggregateExercisePrice
      contextRef="i90625c50de644d79a497ab347321af26_D20211025-20211025"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMTUwNA_705adff1-a465-4c1b-aadf-25a072fcbcfa"
      unitRef="usd">200000000</mo:EquityMethodInvestmentAggregateExercisePrice>
    <mo:EquityMethodInvestmentWarrantExercisedOwnershipPercentage
      contextRef="ia2c7ce11a66f40d7b866ad7f5cf8a0d7_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMTc0Nw_6386f993-e827-4a6f-85d5-d1ed317969c1"
      unitRef="number">0.53</mo:EquityMethodInvestmentWarrantExercisedOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMzc5MzMxNTExNjE3Mjg_8169507c-212b-41e5-bda6-65de62c82ddf"
      unitRef="usd">14000000</us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage
      contextRef="i7f91523b32934656837eccb431840056_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMjM4MQ_11e0efa3-58f2-4a75-b93d-94ff7a2e8c8d"
      unitRef="number">0.02</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage>
    <us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMzc5MzMxNTExNjE3NDY_fc159456-7527-4156-958a-e765c92faff1"
      unitRef="usd">77000000</us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage
      contextRef="i30a456d16ad04abf8d2bbed9680d3088_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181OC9mcmFnOmU5NzcxNDFlNGNiNDQ0MTdiZDU3NjAxNjZmY2I5MDQ0L3RleHRyZWdpb246ZTk3NzE0MWU0Y2I0NDQxN2JkNTc2MDE2NmZjYjkwNDRfMjM4OA_bd678119-6a2e-474f-b4b6-a6a31dfe994e"
      unitRef="number">0.08</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfNjE4NA_b97f96b0-c614-44ae-a23b-a99ab86f82db">Financial Instruments&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria enters into derivative financial instruments to mitigate the potential impact of certain market risks, including foreign currency exchange rate risk.  Altria uses various types of derivative financial instruments, including forward contracts, options and swaps.  Altria does not enter into or hold derivative financial instruments for trading or speculative purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria&#x2019;s investment in ABI, whose functional currency is the Euro, exposes Altria to foreign currency exchange risk on the carrying value of its investment.  To manage this risk, Altria designates certain foreign exchange contracts, including cross-currency swap contracts and forward contracts (collectively, &#x201c;foreign currency contracts&#x201d;), and Euro denominated unsecured long-term notes (&#x201c;foreign currency denominated debt&#x201d;) as net investment hedges of Altria&#x2019;s investment in ABI.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, all outstanding foreign currency contracts matured.  When Altria has foreign currency contracts in effect, counterparties are domestic and international financial institutions.  Under these contracts, Altria is exposed to potential losses due to non-performance by these counterparties.  Altria manages its credit risk by entering into transactions with counterparties with investment grade credit ratings, limiting the amount of exposure Altria has with each counterparty and monitoring the financial condition of each counterparty.  The counterparty agreements contain provisions that require Altria to maintain an investment grade credit rating.  In the event Altria&#x2019;s credit rating falls below investment grade, counterparties to Altria&#x2019;s foreign currency contracts can require Altria to post collateral.  No collateral was received or posted related to derivative assets and liabilities at December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides (i) the aggregate notional amounts of foreign currency contracts and (ii) the aggregate carrying value and fair value of foreign currency denominated debt:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (notional amounts)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,905&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,288&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria&#x2019;s estimates of the fair values of its foreign currency contracts are determined using valuation models with significant inputs that are readily available in public markets, or can be derived from observable market transactions, and therefore are classified in Level 2 of the fair value hierarchy.  An adjustment for credit risk and non-performance risk is included in the fair values of foreign currency contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the aggregate carrying value and fair value of Altria&#x2019;s total long-term debt:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;28,127&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;31,037&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria&#x2019;s estimate of the fair value of its total long-term debt is based on observable market information derived from a third-party pricing source and is classified in Level 2 of the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Fixed-price Preemptive Rights and Cronos warrant, which are further discussed in Note 4. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Equity Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, are derivative financial instruments, which are required to be recorded at fair value.  The fair values of the Fixed-price Preemptive Rights and Cronos warrant are estimated using Black-Scholes option-pricing models, adjusted for observable inputs (which are classified in Level 1 of the fair value hierarchy), including share price, and unobservable inputs, including &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;probability factors and weighting of expected life, volatility levels and risk-free interest rates (which are classified in Level 3 of the fair value hierarchy) based on the following assumptions at:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.448%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fixed-price Preemptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cronos Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;C$7.15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$8.84&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;C$7.15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$8.84&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.81 year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.05 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.43 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.18 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;67.32%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.68%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;67.32%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.68%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.24%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.13%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.39%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.21%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Based on the closing market price for Cronos common stock on the Toronto Stock Exchange on the date indicated.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Based on the weighted-average expected life of the Fixed-price Preemptive Rights (with a range from approximately 0.25 year to 4.00 years at September&#160;30, 2021 and 0.25 year to 5 years at December&#160;31, 2020) and the March 8, 2023 expiration date of the Cronos warrant.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Based on a blend of historical volatility of the underlying equity security and implied volatility from traded options on the underlying equity security at September&#160;30, 2021.  Based on a blend of historical volatility levels of the underlying equity security and peer companies at December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Based on the implied yield currently available on Canadian Treasury zero coupon issues (with a range from approximately 0.12% to 0.89% at September&#160;30, 2021 and 0.06% to 0.39% at December&#160;31, 2020) weighted for the remaining expected life of the Fixed-price Preemptive Rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Based on the implied yield currently available on Canadian Treasury zero coupon issues and the expected life of the Cronos warrant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Based on Cronos&#x2019;s expected dividend payments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the beginning and ending balance of the Fixed-price Preemptive Rights and Cronos warrant, which are classified in Level 3 of the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax earnings (losses) recognized in net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax earnings (losses) recognized in net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria elects to record the gross assets and liabilities of derivative financial instruments executed with the same counterparty on its condensed consolidated balance sheets.  The fair values of Altria&#x2019;s derivative financial instruments on a gross basis included on the condensed consolidated balance sheets were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="30" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cronos warrant&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fixed-price Preemptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria records in its condensed consolidated statements of earnings (losses) any changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant as gains or losses on Cronos-related financial instruments in the periods in which the changes occur.  For the nine and three months ended September&#160;30, 2021 and 2020, Altria recorded non-cash, pre-tax unrealized gains (losses), representing the changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant, as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.278%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed-price Preemptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Investment Hedging&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The pre-tax effects of Altria&#x2019;s net investment hedges on accumulated other comprehensive losses and the condensed consolidated statements of earnings (losses) were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Recognized in Accumulated Other Comprehensive Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Recognized in &lt;br/&gt;Net Earnings (Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Recognized in Accumulated Other Comprehensive Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Recognized in &lt;br/&gt;Net Earnings (Losses)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;118&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;286&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;118&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the fair value of the foreign currency contracts and in the carrying value of the foreign currency denominated debt due to changes in the Euro to USD exchange rate were recognized in accumulated other comprehensive losses related to ABI.  Gains on the foreign currency contracts arising from components excluded from effectiveness testing were recognized in interest and other debt expense, net in the condensed consolidated statements of earnings (losses) based on an amortization approach.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfNjE3MA_31c8b71f-5e73-4931-8bf2-829b096c9d63">&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides (i) the aggregate notional amounts of foreign currency contracts and (ii) the aggregate carrying value and fair value of foreign currency denominated debt:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (notional amounts)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,905&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,288&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;For the nine and three months ended September&#160;30, 2021 and 2020, Altria recorded non-cash, pre-tax unrealized gains (losses), representing the changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant, as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.278%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed-price Preemptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The pre-tax effects of Altria&#x2019;s net investment hedges on accumulated other comprehensive losses and the condensed consolidated statements of earnings (losses) were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Recognized in Accumulated Other Comprehensive Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Recognized in &lt;br/&gt;Net Earnings (Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Recognized in Accumulated Other Comprehensive Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Recognized in &lt;br/&gt;Net Earnings (Losses)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;118&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;286&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;118&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ibcf3cacc08db49a29687505d3387266b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjBjZTdjMTNjYzFjZjQyNDVhYWY0ODc4YTkzMDUyYWRhL3RhYmxlcmFuZ2U6MGNlN2MxM2NjMWNmNDI0NWFhZjQ4NzhhOTMwNTJhZGFfMS0xLTEtMS0w_e83e1f82-aec8-4d63-9c05-1a88e3327a15"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i87169f0e47aa46f581a3b1a6a073d849_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjBjZTdjMTNjYzFjZjQyNDVhYWY0ODc4YTkzMDUyYWRhL3RhYmxlcmFuZ2U6MGNlN2MxM2NjMWNmNDI0NWFhZjQ4NzhhOTMwNTJhZGFfMS0zLTEtMS0w_c4e36033-9a63-4b84-9083-73287a718abc"
      unitRef="usd">1066000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="ic10cda982ea5415199ad34d94e8b02ba_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjBjZTdjMTNjYzFjZjQyNDVhYWY0ODc4YTkzMDUyYWRhL3RhYmxlcmFuZ2U6MGNlN2MxM2NjMWNmNDI0NWFhZjQ4NzhhOTMwNTJhZGFfMy0xLTEtMS0w_5af4e374-3d97-40a0-b8f2-d45032ca3078"
      unitRef="usd">4905000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9f7d03ea00174970b1ec83dc2dac1886_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjBjZTdjMTNjYzFjZjQyNDVhYWY0ODc4YTkzMDUyYWRhL3RhYmxlcmFuZ2U6MGNlN2MxM2NjMWNmNDI0NWFhZjQ4NzhhOTMwNTJhZGFfMy0zLTEtMS0w_fd3ae30c-227e-4c1a-b8a5-a1ff2c1fb502"
      unitRef="usd">5171000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ic10cda982ea5415199ad34d94e8b02ba_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjBjZTdjMTNjYzFjZjQyNDVhYWY0ODc4YTkzMDUyYWRhL3RhYmxlcmFuZ2U6MGNlN2MxM2NjMWNmNDI0NWFhZjQ4NzhhOTMwNTJhZGFfNC0xLTEtMS0w_56fbdb53-ebb2-4103-b68f-0b9598489402"
      unitRef="usd">5288000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i9f7d03ea00174970b1ec83dc2dac1886_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjBjZTdjMTNjYzFjZjQyNDVhYWY0ODc4YTkzMDUyYWRhL3RhYmxlcmFuZ2U6MGNlN2MxM2NjMWNmNDI0NWFhZjQ4NzhhOTMwNTJhZGFfNC0zLTEtMS0w_e6aa1801-62b7-48eb-89b1-5760ce84afa0"
      unitRef="usd">5687000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfNjE3MQ_863d94b3-b289-48e4-8454-7e4ce4899e95">&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the aggregate carrying value and fair value of Altria&#x2019;s total long-term debt:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;28,127&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;31,037&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmY0OThlZTM4MDI4MjRjYWFiOTVjZDI0MzI1ZGNiOTNjL3RhYmxlcmFuZ2U6ZjQ5OGVlMzgwMjgyNGNhYWI5NWNkMjQzMjVkY2I5M2NfMS0xLTEtMS0w_a98aae77-c3ef-4afd-9149-524585a5d893"
      unitRef="usd">28127000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmY0OThlZTM4MDI4MjRjYWFiOTVjZDI0MzI1ZGNiOTNjL3RhYmxlcmFuZ2U6ZjQ5OGVlMzgwMjgyNGNhYWI5NWNkMjQzMjVkY2I5M2NfMS0zLTEtMS0w_db15a5a4-1d43-4a8d-81ff-7b774efeded2"
      unitRef="usd">29471000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtFairValue
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmY0OThlZTM4MDI4MjRjYWFiOTVjZDI0MzI1ZGNiOTNjL3RhYmxlcmFuZ2U6ZjQ5OGVlMzgwMjgyNGNhYWI5NWNkMjQzMjVkY2I5M2NfMi0xLTEtMS0w_7af65a5f-b33f-4cd6-85f0-4e06545cc819"
      unitRef="usd">31037000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmY0OThlZTM4MDI4MjRjYWFiOTVjZDI0MzI1ZGNiOTNjL3RhYmxlcmFuZ2U6ZjQ5OGVlMzgwMjgyNGNhYWI5NWNkMjQzMjVkY2I5M2NfMi0zLTEtMS0w_3cc294c9-d349-4eca-bccb-037c166bc795"
      unitRef="usd">34682000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfNjE4MA_61f53d79-91be-426a-9f54-3d41ea61632e">The fair values of the Fixed-price Preemptive Rights and Cronos warrant are estimated using Black-Scholes option-pricing models, adjusted for observable inputs (which are classified in Level 1 of the fair value hierarchy), including share price, and unobservable inputs, including &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;probability factors and weighting of expected life, volatility levels and risk-free interest rates (which are classified in Level 3 of the fair value hierarchy) based on the following assumptions at:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.448%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fixed-price Preemptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cronos Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;C$7.15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$8.84&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;C$7.15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$8.84&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.81 year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.05 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.43 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.18 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;67.32%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.68%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;67.32%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.68%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.24%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.13%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.39%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.21%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Based on the closing market price for Cronos common stock on the Toronto Stock Exchange on the date indicated.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Based on the weighted-average expected life of the Fixed-price Preemptive Rights (with a range from approximately 0.25 year to 4.00 years at September&#160;30, 2021 and 0.25 year to 5 years at December&#160;31, 2020) and the March 8, 2023 expiration date of the Cronos warrant.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Based on a blend of historical volatility of the underlying equity security and implied volatility from traded options on the underlying equity security at September&#160;30, 2021.  Based on a blend of historical volatility levels of the underlying equity security and peer companies at December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Based on the implied yield currently available on Canadian Treasury zero coupon issues (with a range from approximately 0.12% to 0.89% at September&#160;30, 2021 and 0.06% to 0.39% at December&#160;31, 2020) weighted for the remaining expected life of the Fixed-price Preemptive Rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Based on the implied yield currently available on Canadian Treasury zero coupon issues and the expected life of the Cronos warrant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Based on Cronos&#x2019;s expected dividend payments.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="ia4d49e3b18b5423e972b0489f00c3c44_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfMi0yLTEtMS0w_efecde8a-d961-493c-990b-48ac25a3af65"
      unitRef="cadPerShare">7.15</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i97d4b0a3f973401ab8af04812ad88ab8_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfMi00LTEtMS0w_f9307483-e578-4e3d-8baf-4c60bed4599a"
      unitRef="cadPerShare">8.84</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i299ff36535794f3da00e849d49232f7e_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfMi02LTEtMS0w_247a4985-0027-4353-8480-b0f7b7888bb1"
      unitRef="cadPerShare">7.15</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i58618b2d87444fa1b1e248c65a98ccf7_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfMi04LTEtMS0w_b5b8574d-b630-4333-b39b-971e93662c9c"
      unitRef="cadPerShare">8.84</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="ife62efd21d3c4274a6d99ee48062bd72_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfMy0yLTEtMS0w_29554be8-0b61-42ec-9f08-723b43bbc4f4"
      unitRef="year">0.81</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i27b16784136a4ee1b08eab8d661c0473_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfMy00LTEtMS0w_5feb2e5a-8c9b-4fbf-a835-cc0564d7a045"
      unitRef="year">1.05</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="ibe8f6ff98f9b4b6ba0315bd2c6c328fe_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfMy02LTEtMS0w_93fafb7c-ca34-4402-8da3-b3d3aed0e8b4"
      unitRef="year">1.43</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i5f3288737dff4923b723710d770b6bfe_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfMy04LTEtMS0w_0c53accd-3a48-4ee3-b33a-1e7198f05b46"
      unitRef="year">2.18</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i2d742841c5fe465985b241c6d5f4484c_I20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfNC0yLTEtMS0w_efb6afb0-95a7-4732-a39a-36346908e415"
      unitRef="number">0.6732</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="if695dc35dec34537808c09ca053c1768_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfNC00LTEtMS0w_c6cf7460-4e3d-4bf6-949a-2c821ed9e88e"
      unitRef="number">0.8068</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="ie51acd28a242489eb93cb384c8145b12_I20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfNC02LTEtMS0w_f43a8e48-44ef-4e8e-9ed1-cc2bb6dc37b4"
      unitRef="number">0.6732</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="ic441be4c36e54182a0d7529d2ecc38b4_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfNC04LTEtMS0w_1a312c41-8b27-4313-8e60-8f74519b2af3"
      unitRef="number">0.8068</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i14ff2002b85248c2a717760fa5447b57_I20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfNS0yLTEtMS0w_2456379b-ba19-48c9-8a0a-03075080cca0"
      unitRef="number">0.0024</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i8230deeac7a042d782c7c2a1edc62727_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfNS00LTEtMS0w_e8eff803-d751-4b6b-a8b8-441482e4e93f"
      unitRef="number">0.0013</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i95ddf40ef20a463983f2f6637bdadb3a_I20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfNS02LTEtMS0w_9db206ab-00bd-4225-82fa-3f85f480cdfa"
      unitRef="number">0.0039</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="ia4bf3c8921284849a8922aa21c6d0fba_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfNS04LTEtMS0w_9afce585-336e-40d4-9a3e-20a3a2c038db"
      unitRef="number">0.0021</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="ibb4ecc1e346d4864b399340e003690e1_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfNi0yLTEtMS0w_30b31c4c-5ed8-4b91-a733-8037cc28a779"
      unitRef="number">0</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i729af67cdbe44560b187bc2a5355d961_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfNi00LTEtMS0w_087349bb-818c-4ccd-83d1-4ab50920ca88"
      unitRef="number">0</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="ia84fe1dcb00d4c42946248812c92de20_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfNi02LTEtMS0w_e2ad6762-3dfa-4d11-9b0e-98e68c3f621d"
      unitRef="number">0</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i6074d0f496474bc6b259bb2df8d5b30c_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjMwMjU2MjU5MzkyNzQ5YzM4YjgwYWEyYTBmMGVjZTRiL3RhYmxlcmFuZ2U6MzAyNTYyNTkzOTI3NDljMzhiODBhYTJhMGYwZWNlNGJfNi04LTEtMS0w_7e8932f4-a5f0-49fb-b8fa-898f0e9a81fd"
      unitRef="number">0</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i5ebb29f66c07461aa96dfc8433fac067_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfMzY1MQ_f170b0eb-cb9e-4c46-9a76-863b46008168"
      unitRef="year">0.25</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i55362d8be9514c0cabf140dc7d6239f6_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfMzY2Mg_82bff19d-f0fb-4a34-8303-e1a0b9080d46"
      unitRef="year">4.00</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i48b89d0bd67646b288c756c93a850879_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfMzY4MQ_9e880125-c4eb-4e8f-ad74-f69d3a104a4a"
      unitRef="year">0.25</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i57543deaa7a640628f92b751104d9900_I20201231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfMzY5Mg_524a2907-c142-493e-92a3-6ccac01409f8"
      unitRef="year">5</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="ie7a53ae7739f46c7b604110d4483c929_I20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfNDE2Nw_88ebafa5-6cff-4f29-875c-165ca11cf9e0"
      unitRef="year">0.0012</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="ic67976b0907f4b868fa3d035e132418d_I20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfNDE3Mw_4bf25eca-a17e-4dc8-a8da-a5d8144495fa"
      unitRef="year">0.0089</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i18d875d64a0945bd8350d34786e8fc87_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfNDE4Ng_c844bcf1-613e-4eb0-8c8e-6c0fbbd61242"
      unitRef="year">0.0006</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i28afb29902db4901b31c391429b1b607_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfNDE5Mg_ed338a72-32dd-4ec2-b602-c22d52ce4c79"
      unitRef="year">0.0039</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfNjE4MQ_f24bc7ea-33e9-4e0a-b790-53905e65d93e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the beginning and ending balance of the Fixed-price Preemptive Rights and Cronos warrant, which are classified in Level 3 of the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax earnings (losses) recognized in net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax earnings (losses) recognized in net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="ia80bd4793ddf4b2d915e5f5ea7d8ca62_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjBiYmJhMDcyMjFmMzQ3MGRiY2VhNjVkZTdhY2FhYWEyL3RhYmxlcmFuZ2U6MGJiYmEwNzIyMWYzNDcwZGJjZWE2NWRlN2FjYWFhYTJfMS0xLTEtMS0w_880ece5a-f36a-49ab-afb6-0d8ab4ee6884"
      unitRef="usd">303000000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i64ff63b34a204467b3064abd7fcc4a64_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjBiYmJhMDcyMjFmMzQ3MGRiY2VhNjVkZTdhY2FhYWEyL3RhYmxlcmFuZ2U6MGJiYmEwNzIyMWYzNDcwZGJjZWE2NWRlN2FjYWFhYTJfMy0xLTEtMS0w_7b72c382-dd09-47fa-90c1-de348ee97fa0"
      unitRef="usd">-140000000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i888b21f50f1241039283cfc1fe265126_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjBiYmJhMDcyMjFmMzQ3MGRiY2VhNjVkZTdhY2FhYWEyL3RhYmxlcmFuZ2U6MGJiYmEwNzIyMWYzNDcwZGJjZWE2NWRlN2FjYWFhYTJfNC0xLTEtMS0w_b6b5a8a1-e2db-4af3-93db-759f9b0ade24"
      unitRef="usd">163000000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i2cdb57e3b67e4af08c71b8743251e9dc_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjBiYmJhMDcyMjFmMzQ3MGRiY2VhNjVkZTdhY2FhYWEyL3RhYmxlcmFuZ2U6MGJiYmEwNzIyMWYzNDcwZGJjZWE2NWRlN2FjYWFhYTJfNS0xLTEtMS0w_3929bb99-b870-4ae4-bd02-1503d44cd9ea"
      unitRef="usd">-128000000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="ice62522e8f3e4793835443a9d9fd2cda_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjBiYmJhMDcyMjFmMzQ3MGRiY2VhNjVkZTdhY2FhYWEyL3RhYmxlcmFuZ2U6MGJiYmEwNzIyMWYzNDcwZGJjZWE2NWRlN2FjYWFhYTJfNi0xLTEtMS0w_c16d1cdb-7230-4f62-b9f6-d7986e248d92"
      unitRef="usd">35000000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RleHRyZWdpb246NGY3MTkwNTlmMTYxNDFlMzgwMDJlOGY5MDExOTM3YTJfNjE2OA_7052b53b-463c-44d5-bec5-989dc88eb782">The fair values of Altria&#x2019;s derivative financial instruments on a gross basis included on the condensed consolidated balance sheets were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="30" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cronos warrant&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fixed-price Preemptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if2be07afbaf94c6fb3d9eeb024386d1a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfMy0zLTEtMS0w_961b2f5a-b2c4-4201-81fc-d770745d86cd"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i4a791d31299e4494b797ffdc1cac8f2b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfMy01LTEtMS0w_38c83c50-806a-42d8-acf0-52dc1d92abb2"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i7bd27afbf2ce487ea8421adf4864eba8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfMy04LTEtMS0w_b71ec57d-7cc6-49db-b731-c7fa0b0a40c3"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i23b6cc53678a4c949419f35fd13251a6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfMy0xMC0xLTEtMA_7126fd7b-94f3-43f3-ba24-de343438e632"
      unitRef="usd">87000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ibd824826dc2c4942a04c7d39edd256d5_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfNC0zLTEtMS0w_156833f7-52c3-4654-8e7e-c48f53f80245"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ib813ea19505f4d82aac201b8d7cb1729_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfNC01LTEtMS0w_510f6873-7b68-41ed-ab23-4f0ba6678c05"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i420bac3921ce42bea9dfcd0aa2d91620_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfNC04LTEtMS0w_dc77d82f-637f-4386-ad16-73f0753ecfc8"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="if2d4c37137a7441c8d333d4e72463e40_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfNC0xMC0xLTEtMA_59e8b5ef-5148-4acf-b312-a796526080f0"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i448255743e3c41a4859a9556d275d76c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfNi0zLTEtMS0w_ad195c73-698c-4f8b-b40d-db91aea7c23c"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iddb651cf441648dbb1dff101d6d3d546_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfNi01LTEtMS0w_4632361d-fe4a-4afc-b3c9-61148e21b073"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i448255743e3c41a4859a9556d275d76c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfNi04LTEtMS0w_8a338544-7005-4037-bcbc-da396d1e3747"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="iddb651cf441648dbb1dff101d6d3d546_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfNi0xMC0xLTEtMA_04f6111e-feab-4f29-9dc3-545457c45351"
      unitRef="usd">87000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ia565cea6862d417c97c684e3d00ae39e_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfOS0zLTEtMS0w_f1dc930c-953e-43fc-a76a-e9b2275a11ab"
      unitRef="usd">32000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i0bbe0c1517c44ab49c07a8fd54a1eb3c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfOS01LTEtMS0w_cbaf95ca-dd5a-4789-89d2-9de84585528a"
      unitRef="usd">139000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i1e277a3e43d44130afbf73dc7dde1b91_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfMTAtMy0xLTEtMA_1eb61d93-86ce-4584-8bb2-5dd5abd528a1"
      unitRef="usd">3000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iddd36608a5eb4e55a57cc46e949da550_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfMTAtNS0xLTEtMA_ab02982f-5a3a-44ee-b1ae-6117bc3485d2"
      unitRef="usd">24000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i48f32e9fb6254c8587a74bd98c7ba505_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfMTEtMy0xLTEtMA_e62c9bd5-6167-494a-8bd2-daff1b5f9327"
      unitRef="usd">35000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="id8922561835d4c67b1663239e270549b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfMTEtNS0xLTEtMA_609018c4-1b33-41b8-8c93-4982d2cc747f"
      unitRef="usd">163000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="idaabb1ac00dc4de9afa2e9b2a864fa5b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfMTMtMy0xLTEtMA_5230eaa8-d2ba-45cb-9d02-f0f482f4a9a6"
      unitRef="usd">35000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ifd5a3b6fb7e34bca9dea72a0c14da288_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfMTMtNS0xLTEtMA_c9d8eec3-d2d1-4110-9efd-6709d2f34422"
      unitRef="usd">163000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="idaabb1ac00dc4de9afa2e9b2a864fa5b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfMTMtOC0xLTEtMA_7b6398b4-8091-4f6e-adc0-d7035b74313b"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ifd5a3b6fb7e34bca9dea72a0c14da288_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmRiMjYzN2IwYzkxOTQ4NDJiNGM5MjVlMjFkYTgxNTUwL3RhYmxlcmFuZ2U6ZGIyNjM3YjBjOTE5NDg0MmI0YzkyNWUyMWRhODE1NTBfMTMtMTAtMS0xLTA_411a015d-3dde-42e0-b022-8c95b1c06f11"
      unitRef="usd">87000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i7c367050085a48a69fa712c3eceab7c0_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmM2OTk0N2RhYjk0YTQwM2U5MzEyYTIwZGJhYzFjNjVhL3RhYmxlcmFuZ2U6YzY5OTQ3ZGFiOTRhNDAzZTkzMTJhMjBkYmFjMWM2NWFfMi0xLTEtMS0w_e9b795fc-c033-4a5c-a890-0bb276fcc21c"
      unitRef="usd">-21000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i60d37aaec4d1491e9ffbbf008424f75a_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmM2OTk0N2RhYjk0YTQwM2U5MzEyYTIwZGJhYzFjNjVhL3RhYmxlcmFuZ2U6YzY5OTQ3ZGFiOTRhNDAzZTkzMTJhMjBkYmFjMWM2NWFfMi0zLTEtMS0w_aaba65a4-e4a5-47ea-a7bf-ff610dc05854"
      unitRef="usd">-54000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i20b1e637093c48f4969fae7d410a2693_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmM2OTk0N2RhYjk0YTQwM2U5MzEyYTIwZGJhYzFjNjVhL3RhYmxlcmFuZ2U6YzY5OTQ3ZGFiOTRhNDAzZTkzMTJhMjBkYmFjMWM2NWFfMi01LTEtMS0w_6b343191-4238-4612-b805-0614c6fb3c99"
      unitRef="usd">-17000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i16161f66e87a41ab993f192e9c451cf6_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmM2OTk0N2RhYjk0YTQwM2U5MzEyYTIwZGJhYzFjNjVhL3RhYmxlcmFuZ2U6YzY5OTQ3ZGFiOTRhNDAzZTkzMTJhMjBkYmFjMWM2NWFfMi03LTEtMS0w_c0b3c5c6-0c2c-4c5b-b59a-585cebd5d60f"
      unitRef="usd">-25000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i7b30b55ee2ef446882c7477d8328c504_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmM2OTk0N2RhYjk0YTQwM2U5MzEyYTIwZGJhYzFjNjVhL3RhYmxlcmFuZ2U6YzY5OTQ3ZGFiOTRhNDAzZTkzMTJhMjBkYmFjMWM2NWFfMy0xLTEtMS0w_83418c22-50da-4891-a32e-b119322412cd"
      unitRef="usd">-107000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i84041ff1f2d1478e9462865044b54b4d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmM2OTk0N2RhYjk0YTQwM2U5MzEyYTIwZGJhYzFjNjVhL3RhYmxlcmFuZ2U6YzY5OTQ3ZGFiOTRhNDAzZTkzMTJhMjBkYmFjMWM2NWFfMy0zLTEtMS0w_5b5a8beb-f06f-4558-804e-7d6008346ddb"
      unitRef="usd">-148000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ideb6d765d89e4b91aa1a4fbb97d5de55_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmM2OTk0N2RhYjk0YTQwM2U5MzEyYTIwZGJhYzFjNjVhL3RhYmxlcmFuZ2U6YzY5OTQ3ZGFiOTRhNDAzZTkzMTJhMjBkYmFjMWM2NWFfMy01LTEtMS0w_e14339be-f1e7-43b7-a0fc-c77c9ad5141b"
      unitRef="usd">-118000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i7def76adb3ad4f72a02323fce73fbe1a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmM2OTk0N2RhYjk0YTQwM2U5MzEyYTIwZGJhYzFjNjVhL3RhYmxlcmFuZ2U6YzY5OTQ3ZGFiOTRhNDAzZTkzMTJhMjBkYmFjMWM2NWFfMy03LTEtMS0w_f5680ffe-ba7c-47bd-9358-b17337994d39"
      unitRef="usd">-80000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmM2OTk0N2RhYjk0YTQwM2U5MzEyYTIwZGJhYzFjNjVhL3RhYmxlcmFuZ2U6YzY5OTQ3ZGFiOTRhNDAzZTkzMTJhMjBkYmFjMWM2NWFfNC0xLTEtMS0w_b05a0baf-66b9-4a29-b2f2-05604b2874da"
      unitRef="usd">-128000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmM2OTk0N2RhYjk0YTQwM2U5MzEyYTIwZGJhYzFjNjVhL3RhYmxlcmFuZ2U6YzY5OTQ3ZGFiOTRhNDAzZTkzMTJhMjBkYmFjMWM2NWFfNC0zLTEtMS0w_8fc4f7f3-9a3a-46b6-8a17-f753e6c208ec"
      unitRef="usd">-202000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmM2OTk0N2RhYjk0YTQwM2U5MzEyYTIwZGJhYzFjNjVhL3RhYmxlcmFuZ2U6YzY5OTQ3ZGFiOTRhNDAzZTkzMTJhMjBkYmFjMWM2NWFfNC01LTEtMS0w_7aab1e40-110a-438e-a5ac-4896ca1ef8da"
      unitRef="usd">-135000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOmM2OTk0N2RhYjk0YTQwM2U5MzEyYTIwZGJhYzFjNjVhL3RhYmxlcmFuZ2U6YzY5OTQ3ZGFiOTRhNDAzZTkzMTJhMjBkYmFjMWM2NWFfNC03LTEtMS0w_ca04483f-ee62-4973-aaa1-5d10bc28ac7b"
      unitRef="usd">-105000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i2b22d5f204d248aab1e00daf3b0d8153_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfMy0yLTEtMS0w_4c4bea0d-71ee-4193-b7f5-c46013600d9d"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ib358f1bbb75b41f3aaca506bf354a2c0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfMy00LTEtMS0w_7a3fea05-548d-46a3-845d-182108cfd53b"
      unitRef="usd">-28000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i2b22d5f204d248aab1e00daf3b0d8153_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfMy02LTEtMS0w_59310655-e790-4f66-9c18-b77afc86adf9"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="ib358f1bbb75b41f3aaca506bf354a2c0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfMy04LTEtMS0w_be209ef8-1e10-4552-ac05-e450735e698c"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ie4ee47e867c246b8be587254b4a9a6cc_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfMy0xMC0xLTEtMA_c01ad271-06e0-4697-9f4b-e88b1a6972a6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i157a11cd19544cd68917916131342ac2_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfMy0xMi0xLTEtMA_09eeabc1-21f1-4d9a-b6f6-087457924c80"
      unitRef="usd">-66000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="ie4ee47e867c246b8be587254b4a9a6cc_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfMy0xNC0xLTEtMA_c55b4900-18a2-4079-8954-0281ba83d53c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i157a11cd19544cd68917916131342ac2_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfMy0xNi0xLTEtMA_340c7903-b75e-47f9-9fb1-ec6a75715020"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i3eaa97db709e43d0b68539ebfc1f7fcd_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNC0yLTEtMS0w_f4ebc078-cdae-4e61-b740-44ed4475ce56"
      unitRef="usd">270000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i801ea70096974921a9cc6afb7fabddb3_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNC00LTEtMS0w_c05531e3-f67b-4ff4-851f-5b65d5002ee4"
      unitRef="usd">-215000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i3eaa97db709e43d0b68539ebfc1f7fcd_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNC02LTEtMS0w_b2c255d4-2831-4e2d-9dce-0d8bda57dc43"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i801ea70096974921a9cc6afb7fabddb3_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNC04LTEtMS0w_a3af6e0a-6f4b-4161-a3f7-9de42c26a9a9"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i1f6f91cba83e4cafb448b38e704724c2_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNC0xMC0xLTEtMA_18658f8e-da2c-4764-ad0a-255a81b586ae"
      unitRef="usd">118000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i75d11c60a1504c2a8018692b2fdb8592_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNC0xMi0xLTEtMA_9ba1cb88-3fdd-403d-8172-5bd9387ec5a9"
      unitRef="usd">-206000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i1f6f91cba83e4cafb448b38e704724c2_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNC0xNC0xLTEtMA_cadd9db1-42fa-420e-a69d-95afbf5ab7c0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i75d11c60a1504c2a8018692b2fdb8592_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNC0xNi0xLTEtMA_d517bef6-fc37-4cb1-9e02-b3ab13adccd2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i95c1f586ef4041dd8c67ab4c79e3718a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNS0yLTEtMS0w_55d063a1-584c-4110-90dd-9ca938f31b7b"
      unitRef="usd">286000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ibe0426ef79dd4e1b93e9f3b19953e12f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNS00LTEtMS0w_06de61de-64c5-4fa7-8a10-7daed3683490"
      unitRef="usd">-243000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i95c1f586ef4041dd8c67ab4c79e3718a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNS02LTEtMS0w_468d4a5b-866d-4936-947c-44cc8012f3ab"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="ibe0426ef79dd4e1b93e9f3b19953e12f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNS04LTEtMS0w_5da920c5-bd25-472f-a4c5-4cccefd75630"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i641562cd01894f84aa15b3d08486a81e_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNS0xMC0xLTEtMA_0f6b6489-7b51-496e-8608-964b2aefcf81"
      unitRef="usd">118000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i285fd763c7cb4c95a6689072055b09d4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNS0xMi0xLTEtMA_d277f97d-a1c4-4881-adb6-3227c6664e6e"
      unitRef="usd">-272000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i641562cd01894f84aa15b3d08486a81e_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNS0xNC0xLTEtMA_b9c6034c-02c8-4521-b107-5bbfd1a92b7b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i285fd763c7cb4c95a6689072055b09d4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182MS9mcmFnOjRmNzE5MDU5ZjE2MTQxZTM4MDAyZThmOTAxMTkzN2EyL3RhYmxlOjljYTQ4Nzc1NmFmMTRjOTY4NWMyYzgwZTU3ZGRlMDY5L3RhYmxlcmFuZ2U6OWNhNDg3NzU2YWYxNGM5Njg1YzJjODBlNTdkZGUwNjlfNS0xNi0xLTEtMA_4ff3a2fd-5b94-46f4-9b8b-8f8ab6901047"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RleHRyZWdpb246Y2Q0NDc3ZDE2ZDE5NGE3Y2JhNjFjMTQxNDhlOTFiOTZfMTY3OA_1debc8c6-0e47-47dc-92a8-9cf574599166">Benefit Plans&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Components of Net Periodic Benefit (Income) Cost&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net periodic benefit (income) cost consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;139&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;46&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(393)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;99&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost (credit)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(income) cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Employer Contributions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria makes contributions to the pension plans to the extent that the contributions are tax deductible and pays benefits that relate to plans for salaried employees that cannot be funded under Internal Revenue Service regulations.  Altria made employer contributions of $23 million to its pension plans and did not make any contributions to its postretirement plans during the nine months ended September 30, 2021.  Currently, Altria anticipates making additional employer contributions to its pension plans of up to approximately $5 million and no  additional contributions to its postretirement plans for the remainder of 2021. However, the foregoing estimates of 2021 contributions to the pension and postretirement plans are subject to change as a result of changes in tax and other benefit laws, changes in interest rates, as well as asset performance significantly above or below the assumed long-term rate of return for each respective plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2021, Altria announced several amendments to its salaried retiree healthcare plans, primarily changing its post-age 65 coverage to a private medicare marketplace.  These amendments triggered a plan remeasurement as of May 31, 2021 and resulted in Altria recording a reduction of $432 million to its accrued postretirement health care costs liability and a corresponding reduction to its accumulated other comprehensive losses on its condensed consolidated balance sheet.  Ongoing amortization has been adjusted to reflect these changes as of June 1, 2021 and is reflected in the amounts shown above.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RleHRyZWdpb246Y2Q0NDc3ZDE2ZDE5NGE3Y2JhNjFjMTQxNDhlOTFiOTZfMTY4Mw_03d28615-1254-46be-83b8-5a92601f64e7">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net periodic benefit (income) cost consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;139&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;46&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(393)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;99&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost (credit)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(income) cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i92dcd11d5d934931ab51a35b59f2acd1_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMy0xLTEtMS0w_6098ce8a-1d68-4ef1-b2d0-880e6933519f"
      unitRef="usd">51000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i8cc174939f1e414593012b716f47f230_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMy0zLTEtMS0w_b1d68765-b7da-403a-8f43-918063e98a35"
      unitRef="usd">55000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i65e5f978b5c84e8aa707cac5eb7382f1_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMy01LTEtMS0w_09934d2d-c389-4b86-ad79-e54f93f35545"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ia30f1b1250de433dabcb2cbe9baabacf_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMy03LTEtMS0w_4c95da18-43aa-463c-b9b7-6b7df239b781"
      unitRef="usd">13000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ib46d19a7eb014c0d80e8454b5ba93ecc_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMy05LTEtMS0w_4c758c81-7da0-4aa5-8cb2-93920b2abd4a"
      unitRef="usd">17000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i1bb0ce68c3494d79abc790fd0561a2c9_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMy0xMS0xLTEtMA_c33f6619-7aa6-47ad-b733-dde54b9ca53b"
      unitRef="usd">18000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i8a9748c0c5a34059bb965420acaa9a71_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMy0xMy0xLTEtMA_46abc41a-c53f-4365-bef2-6e6cc2677109"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="id4b4f1114be54cf39186a491bbc07db4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMy0xNS0xLTEtMA_e6ad9857-d73e-4056-8f80-9c46d6434ac6"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i92dcd11d5d934931ab51a35b59f2acd1_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNC0xLTEtMS0w_17c36b5a-cf04-4669-9d08-9435bd7a7ce0"
      unitRef="usd">139000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i8cc174939f1e414593012b716f47f230_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNC0zLTEtMS0w_0508b030-fef5-41d8-96b5-37a429a27799"
      unitRef="usd">188000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i65e5f978b5c84e8aa707cac5eb7382f1_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNC01LTEtMS0w_e143b6cd-eec6-464c-affb-aec63e649f41"
      unitRef="usd">29000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ia30f1b1250de433dabcb2cbe9baabacf_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNC03LTEtMS0w_d6ff2b6e-74c2-45eb-96cb-223dff6326f2"
      unitRef="usd">44000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ib46d19a7eb014c0d80e8454b5ba93ecc_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNC05LTEtMS0w_7b496da2-20f4-4ab8-88f2-bcdf392b8813"
      unitRef="usd">46000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i1bb0ce68c3494d79abc790fd0561a2c9_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNC0xMS0xLTEtMA_72b80244-5deb-42b7-8f1f-c92688025c59"
      unitRef="usd">62000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i8a9748c0c5a34059bb965420acaa9a71_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNC0xMy0xLTEtMA_996125ea-d550-4cf7-98fc-de18318fd4c1"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="id4b4f1114be54cf39186a491bbc07db4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNC0xNS0xLTEtMA_4b012f8b-257f-4333-bde3-e33db5edabf0"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i92dcd11d5d934931ab51a35b59f2acd1_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNS0xLTEtMS0w_9244cd77-7e60-475c-8c38-bb164dc0a5fa"
      unitRef="usd">393000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i8cc174939f1e414593012b716f47f230_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNS0zLTEtMS0w_4b2a54a2-b5d2-4239-8c37-28f927df6a60"
      unitRef="usd">376000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i65e5f978b5c84e8aa707cac5eb7382f1_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNS01LTEtMS0w_e8514fc8-372d-49f0-9cfc-0ed6d0530825"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ia30f1b1250de433dabcb2cbe9baabacf_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNS03LTEtMS0w_8b3fc6cc-a39d-4f4c-9168-06a8204f12b2"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ib46d19a7eb014c0d80e8454b5ba93ecc_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNS05LTEtMS0w_b38b5927-8631-4ad5-be64-14919796bcc1"
      unitRef="usd">131000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i1bb0ce68c3494d79abc790fd0561a2c9_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNS0xMS0xLTEtMA_9fcb221b-3d01-4105-a6e6-05e5215971fd"
      unitRef="usd">125000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i8a9748c0c5a34059bb965420acaa9a71_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNS0xMy0xLTEtMA_06280ee3-ddd3-4375-b31a-61d4c43020f1"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="id4b4f1114be54cf39186a491bbc07db4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNS0xNS0xLTEtMA_995d4f85-e3eb-4266-bb06-d610f30dfeaa"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i92dcd11d5d934931ab51a35b59f2acd1_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNy0xLTEtMS0w_3206eb18-2027-4cbb-a3b8-acca4bdca951"
      unitRef="usd">-99000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i8cc174939f1e414593012b716f47f230_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNy0zLTEtMS0w_37e697c5-5f95-4fd5-825d-3b0fc1a0c59f"
      unitRef="usd">-108000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i65e5f978b5c84e8aa707cac5eb7382f1_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNy01LTEtMS0w_7ba999e1-0e0a-4956-9bbd-dc82c348e9ef"
      unitRef="usd">-16000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ia30f1b1250de433dabcb2cbe9baabacf_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNy03LTEtMS0w_d5add744-a0c9-433e-a42b-fe24a443846b"
      unitRef="usd">-7000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ib46d19a7eb014c0d80e8454b5ba93ecc_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNy05LTEtMS0w_66d1dbe3-c6c8-495f-8885-f40a1c4a448d"
      unitRef="usd">-33000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i1bb0ce68c3494d79abc790fd0561a2c9_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNy0xMS0xLTEtMA_1b6245eb-c2d2-4bd1-a2c0-bbd395358112"
      unitRef="usd">-55000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i8a9748c0c5a34059bb965420acaa9a71_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNy0xMy0xLTEtMA_2797922f-9a91-46d1-aa23-35b14ca4cf8d"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="id4b4f1114be54cf39186a491bbc07db4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfNy0xNS0xLTEtMA_82aae319-cf6b-4da3-a858-e08f2c7458f3"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i92dcd11d5d934931ab51a35b59f2acd1_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfOC0xLTEtMS0w_158f4a9d-ea22-435c-9662-ba9caca07b5e"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i8cc174939f1e414593012b716f47f230_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfOC0zLTEtMS0w_910d3bb2-1f40-43a7-ba1e-16edb7f8a29a"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i65e5f978b5c84e8aa707cac5eb7382f1_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfOC01LTEtMS0w_02c5f87c-d498-465f-9240-9fb2f01def2b"
      unitRef="usd">-35000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ia30f1b1250de433dabcb2cbe9baabacf_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfOC03LTEtMS0w_5072a529-5d1f-467f-add3-0e2054f7fd02"
      unitRef="usd">-22000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ib46d19a7eb014c0d80e8454b5ba93ecc_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfOC05LTEtMS0w_cd71ed21-5b83-40f4-981c-2f12cc1d2022"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i1bb0ce68c3494d79abc790fd0561a2c9_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfOC0xMS0xLTEtMA_359550d1-ac22-4214-9a5f-6d8aba5be145"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i8a9748c0c5a34059bb965420acaa9a71_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfOC0xMy0xLTEtMA_48b3dd90-4827-4cb7-955e-b38a662f9b54"
      unitRef="usd">-20000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="id4b4f1114be54cf39186a491bbc07db4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfOC0xNS0xLTEtMA_b95f1ca5-b3bb-4a16-b9ff-54d807cfad74"
      unitRef="usd">-7000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i92dcd11d5d934931ab51a35b59f2acd1_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMTAtMS0xLTEtMA_734f88ed-df22-4339-a4f4-1d8896e922df"
      unitRef="usd">-101000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i8cc174939f1e414593012b716f47f230_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMTAtMy0xLTEtMA_0413cdc0-311d-4d07-a68a-4d7501555d64"
      unitRef="usd">-21000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i65e5f978b5c84e8aa707cac5eb7382f1_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMTAtNS0xLTEtMA_2d64084f-355f-4e63-a888-70a6a8bf1820"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ia30f1b1250de433dabcb2cbe9baabacf_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMTAtNy0xLTEtMA_ad18707d-eb8f-4cd3-90e5-84f0c2dd2123"
      unitRef="usd">31000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ib46d19a7eb014c0d80e8454b5ba93ecc_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMTAtOS0xLTEtMA_52813db1-7a1e-4399-b85b-19dd15dc9c68"
      unitRef="usd">-34000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i1bb0ce68c3494d79abc790fd0561a2c9_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMTAtMTEtMS0xLTA_1ce6f7b4-078e-4aa1-9dd1-7de99ad8b5fa"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i8a9748c0c5a34059bb965420acaa9a71_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMTAtMTMtMS0xLTA_15b2c9c7-fcf8-4751-906d-69944dbdef41"
      unitRef="usd">-7000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="id4b4f1114be54cf39186a491bbc07db4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RhYmxlOjc0MTk4ZjI2MWI3ZDRlOThiZjA4MmE5NWE1YTczZWM2L3RhYmxlcmFuZ2U6NzQxOThmMjYxYjdkNGU5OGJmMDgyYTk1YTVhNzNlYzZfMTAtMTUtMS0xLTA_5a417344-aa29-48f6-a7a1-f84b01a9d378"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i92dcd11d5d934931ab51a35b59f2acd1_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RleHRyZWdpb246Y2Q0NDc3ZDE2ZDE5NGE3Y2JhNjFjMTQxNDhlOTFiOTZfNDMx_f5b90941-fcb9-4c3c-887a-65e003b85e59"
      unitRef="usd">23000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i65e5f978b5c84e8aa707cac5eb7382f1_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RleHRyZWdpb246Y2Q0NDc3ZDE2ZDE5NGE3Y2JhNjFjMTQxNDhlOTFiOTZfNDYz_5e6931ba-d6b2-4b9c-9749-e59055c8ef40"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear
      contextRef="i5da59f9184554221a714ef4fa85eeff2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RleHRyZWdpb246Y2Q0NDc3ZDE2ZDE5NGE3Y2JhNjFjMTQxNDhlOTFiOTZfNjY4_dfb16285-9c10-4077-b45f-5d19073b8b94"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear
      contextRef="i3a5e492ac0384dd28bb0ad0497562294_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RleHRyZWdpb246Y2Q0NDc3ZDE2ZDE5NGE3Y2JhNjFjMTQxNDhlOTFiOTZfMjc0ODc3OTA3MTM2MQ_af3fceec-8e0e-455b-824d-174c4fe6f9ba"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear>
    <us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations
      contextRef="i32402401a0f844239e2c32d640969c41_D20210531-20210531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y182Ny9mcmFnOmNkNDQ3N2QxNmQxOTRhN2NiYTYxYzE0MTQ4ZTkxYjk2L3RleHRyZWdpb246Y2Q0NDc3ZDE2ZDE5NGE3Y2JhNjFjMTQxNDhlOTFiOTZfMTMzMA_c6796350-2f61-4b12-8b51-580723bdcdfd"
      unitRef="usd">-432000000</us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RleHRyZWdpb246Yjk3ZDU0ZGVkMTYwNDU5ODlmODk3NTk3MmI1NzM1MzNfMTE2_0da84f5c-a612-4a32-926a-3ac0f9238f1e">Earnings (Losses) per Share&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted earnings (losses) per share (&#x201c;EPS&#x201d;) were calculated using the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.952%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (losses) attributable to Altria&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;851&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,722)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(952)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Distributed and undistributed earnings attributable to share-based awards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (losses) for basic and diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;843&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,724)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares for basic EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,849&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,842&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus: contingently issuable performance stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares for diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,849&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,842&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RleHRyZWdpb246Yjk3ZDU0ZGVkMTYwNDU5ODlmODk3NTk3MmI1NzM1MzNfMTMy_ae67ce13-33e9-4755-ae5f-8432a7e255c6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted earnings (losses) per share (&#x201c;EPS&#x201d;) were calculated using the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.952%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (losses) attributable to Altria&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;851&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,722)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(952)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Distributed and undistributed earnings attributable to share-based awards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (losses) for basic and diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;843&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,724)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares for basic EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,849&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,842&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus: contingently issuable performance stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares for diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,849&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,842&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfMi0yLTEtMS0w_2d29d92f-47c1-43e1-abb6-41a3fa1f1f7a"
      unitRef="usd">851000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfMi00LTEtMS0w_ce67cd9f-95e1-405f-9a84-4967d8c5b58b"
      unitRef="usd">2543000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfMi02LTEtMS0w_7fdbb055-a9ba-4e7d-ac7b-e88fa65c717a"
      unitRef="usd">-2722000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfMi04LTEtMS0w_ac355825-d652-426d-916c-184bdf4b4eca"
      unitRef="usd">-952000000</us-gaap:NetIncomeLoss>
    <mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfMy0yLTEtMS0w_c9c8c39d-8126-4a27-a1da-cb11787439e2"
      unitRef="usd">8000000</mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted>
    <mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfMy00LTEtMS0w_3271436e-12e9-4643-8a31-b1953d42c76a"
      unitRef="usd">6000000</mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted>
    <mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfMy02LTEtMS0w_97f69e87-58c6-4b75-93e6-e9e2853e4674"
      unitRef="usd">2000000</mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted>
    <mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfMy04LTEtMS0w_e1141cd7-6ff7-444e-a689-78d361f36f6a"
      unitRef="usd">1000000</mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNC0yLTEtMS0w_7d8b6d63-8f0a-4ebd-ad6a-915f0c7105ef"
      unitRef="usd">843000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNC0yLTEtMS0w_a0c8c40a-fbec-43f7-a9fb-8bd9bd6e6f3e"
      unitRef="usd">843000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNC00LTEtMS0w_08de98b8-6380-4126-847e-289a33e08cf6"
      unitRef="usd">2537000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNC00LTEtMS0w_fce68ec1-1882-4e8f-94e3-93b41d638c60"
      unitRef="usd">2537000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNC02LTEtMS0w_4a154170-e462-4f47-994a-55e3356306f0"
      unitRef="usd">-2724000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNC02LTEtMS0w_4b168712-d962-4092-bf78-a7758a880e3e"
      unitRef="usd">-2724000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNC04LTEtMS0w_affdfcb2-2dfa-46b6-afac-a81ad4d0d261"
      unitRef="usd">-953000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNC04LTEtMS0w_f7caaef6-698b-4ac7-83fd-cbd40bef645d"
      unitRef="usd">-953000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNi0yLTEtMS0w_bef9acb7-7fcf-4af8-a96f-c5959082f924"
      unitRef="shares">1849000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNi00LTEtMS0w_7975b9af-e48d-4b07-b4ee-97daa055254d"
      unitRef="shares">1858000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNi02LTEtMS0w_bfde6240-5301-4ae8-8cb8-81719b10e9be"
      unitRef="shares">1842000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNi04LTEtMS0w_357fe358-3da1-4b5f-aa64-104ca4fa37c4"
      unitRef="shares">1858000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNy0yLTEtMS0w_b17a7455-2150-47a0-8da0-3bb4dffe37c6"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable>
    <us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNy00LTEtMS0w_06c27f38-0322-45ac-a9d1-32627dbdbcd5"
      unitRef="shares">1000000</us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable>
    <us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNy02LTEtMS0w_79c5e2d5-e1e4-4951-a44b-2c259d152027"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable>
    <us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfNy04LTEtMS0w_7861040f-e104-4418-9143-6c32288c6581"
      unitRef="shares">1000000</us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfOC0yLTEtMS0w_1d5760f6-7f27-4580-be4b-15cde16f2d3d"
      unitRef="shares">1849000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfOC00LTEtMS0w_373fb84a-7d8e-4d74-84c2-6a39c36e824c"
      unitRef="shares">1859000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfOC02LTEtMS0w_c0b98b09-4f06-4007-a0eb-19d5500dec7e"
      unitRef="shares">1842000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183MC9mcmFnOmI5N2Q1NGRlZDE2MDQ1OTg5Zjg5NzU5NzJiNTczNTMzL3RhYmxlOjg4NzQ4NzAyYjVjZDQwNGU4OTUyZDViNWZkY2YyZmRjL3RhYmxlcmFuZ2U6ODg3NDg3MDJiNWNkNDA0ZTg5NTJkNWI1ZmRjZjJmZGNfOC04LTEtMS0w_8c0358f1-c495-4173-8293-98b7b1d09104"
      unitRef="shares">1859000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RleHRyZWdpb246NjIxYTZiY2Q3ZWE0NDg4NGIwOTVjZGFlYmQ2ZThhN2RfMjMx_0ea2d43e-c919-4878-8315-d5ce9a5ec7b2">Other Comprehensive Earnings/Losses&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth the changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,420)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,938)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;432&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;685&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,152&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;314&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;534&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;883&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;92&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;69&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;28&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;383&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;495&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;911&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,037)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;50&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,043)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,604)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,602)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;215&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;221&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;167&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;164&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;161&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;172&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,037)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;50&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(693)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,023)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(928)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(917)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,774)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Reflects the remeasurement impact of salaried retiree healthcare plan amendments.  For further discussion, see Note 6. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Benefit Plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Primarily reflects Altria&#x2019;s share of ABI&#x2019;s currency translation adjustments and the impact of Altria&#x2019;s designated net investment hedges.  For further discussion of designated net investment hedges, see Note 5. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings (losses):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit Plans: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;124&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;39&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;92&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustments and Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Amounts are included in net defined benefit plan costs.  For further information related to defined benefit plans, see Note 6. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Benefit Plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Amounts are included in (income) losses from equity investments.  For further information related to equity investments, see Note 4. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Equity Securities.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RleHRyZWdpb246NjIxYTZiY2Q3ZWE0NDg4NGIwOTVjZGFlYmQ2ZThhN2RfMjI4_ae430878-0533-4024-bbc7-6d7c1fdc815b">&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth the changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,420)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,938)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;432&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;685&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,152&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;314&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;534&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;883&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;92&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;69&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;28&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;383&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;495&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;911&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,037)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;50&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,043)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,604)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,602)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;215&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;221&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;167&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;164&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;161&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;172&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,037)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;50&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(693)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,023)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(928)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(917)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,774)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Reflects the remeasurement impact of salaried retiree healthcare plan amendments.  For further discussion, see Note 6. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Benefit Plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Primarily reflects Altria&#x2019;s share of ABI&#x2019;s currency translation adjustments and the impact of Altria&#x2019;s designated net investment hedges.  For further discussion of designated net investment hedges, see Note 5. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia2ad51d5efd34c6890d17e0c82b226b7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMi0yLTEtMS0w_854ce322-3b10-49cd-8a03-ab3dd195c951"
      unitRef="usd">-2420000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3f3fa8b9977e4b429a89b213dd45435e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMi00LTEtMS0w_7056b00a-733d-47c9-8493-284baff6fc6d"
      unitRef="usd">-1938000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibb1b7837d3fd4f8097b3317e18a83bbf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMi02LTEtMS0w_b008c498-f0b5-4215-9a38-71d0538c06a9"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3dbc9fb0ec734480b6f0af9d1b9ac7b9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMi04LTEtMS0w_c7bb36fd-c883-4d38-8766-5c6a7fbcc10c"
      unitRef="usd">-4341000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i4320d8cfd0aa4682ac4fd8e97489f333_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfNC0yLTEtMS0w_a9425a54-18b7-4c66-91ca-c499fa32706b"
      unitRef="usd">432000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ib94d886e09a149778fc4b762edca1bc7_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfNC00LTEtMS0w_9294b5c3-5b59-4531-86d1-514e0a67f89a"
      unitRef="usd">685000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ic3b0235cbe654245a5397a036c1d3132_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfNC02LTEtMS0w_a00e12b3-2e77-4949-847b-95c87290c731"
      unitRef="usd">35000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ibd9b7b88141b400786601f5cd3fec33a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfNC04LTEtMS0w_b90be383-3024-47ea-b845-b5a671065b2a"
      unitRef="usd">1152000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i4320d8cfd0aa4682ac4fd8e97489f333_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfNS0yLTEtMS0w_1764feb9-7401-4554-b615-a8671f01d2e9"
      unitRef="usd">118000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ib94d886e09a149778fc4b762edca1bc7_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfNS00LTEtMS0w_e2e7a2c8-9f70-4607-9c37-88c71ff8bab7"
      unitRef="usd">151000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ic3b0235cbe654245a5397a036c1d3132_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfNS02LTEtMS0w_a34b8cbb-6ff3-4d86-99f8-5bb6d7be144c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ibd9b7b88141b400786601f5cd3fec33a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfNS04LTEtMS0w_6ee529fa-174b-4632-8ac0-ca0ecf83f29d"
      unitRef="usd">269000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i4320d8cfd0aa4682ac4fd8e97489f333_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfNi0yLTEtMS0w_e1546fe6-44e5-43d8-9aaf-a0663d70c52f"
      unitRef="usd">314000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib94d886e09a149778fc4b762edca1bc7_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfNi00LTEtMS0w_b1181c5d-9e0e-40b7-889e-4b5a1e29cba9"
      unitRef="usd">534000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic3b0235cbe654245a5397a036c1d3132_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfNi02LTEtMS0w_b27a3527-861b-4f06-aaa3-7b4becfa0e35"
      unitRef="usd">35000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ibd9b7b88141b400786601f5cd3fec33a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfNi04LTEtMS0w_354bb924-fc51-40be-bf9c-b080e1122779"
      unitRef="usd">883000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i4320d8cfd0aa4682ac4fd8e97489f333_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfOC0yLTEtMS0w_14a59fc3-12de-421e-828a-172be42ae694"
      unitRef="usd">-92000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ib94d886e09a149778fc4b762edca1bc7_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfOC00LTEtMS0w_d3f39ad7-60f3-44f1-9146-5e4d23beebe9"
      unitRef="usd">49000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ic3b0235cbe654245a5397a036c1d3132_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfOC02LTEtMS0w_d102ed58-f531-4ec3-8d0b-0e6f4d101390"
      unitRef="usd">2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ibd9b7b88141b400786601f5cd3fec33a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfOC04LTEtMS0w_6f4ad506-baf4-41b0-a816-7802d48c7747"
      unitRef="usd">-41000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i4320d8cfd0aa4682ac4fd8e97489f333_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfOS0yLTEtMS0w_17dce605-0e41-498a-a950-d767b6736a40"
      unitRef="usd">-23000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ib94d886e09a149778fc4b762edca1bc7_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfOS00LTEtMS0w_e2e8a90f-1a7b-4d37-9f72-e2906e0bd2fa"
      unitRef="usd">10000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ic3b0235cbe654245a5397a036c1d3132_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfOS02LTEtMS0w_7221f7be-c58f-4f34-8d61-935b49d28e4e"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ibd9b7b88141b400786601f5cd3fec33a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfOS04LTEtMS0w_506a6a8b-bb6d-44b9-b0b4-6401b70b627d"
      unitRef="usd">-13000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4320d8cfd0aa4682ac4fd8e97489f333_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMTAtMi0xLTEtMA_0b4d8dfa-fe17-4c99-b22d-c7e03686b93e"
      unitRef="usd">-69000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib94d886e09a149778fc4b762edca1bc7_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMTAtNC0xLTEtMA_09122b8a-d213-489d-a3ae-2a5c2fec6bde"
      unitRef="usd">39000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic3b0235cbe654245a5397a036c1d3132_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMTAtNi0xLTEtMA_670ccbba-a695-415e-a70e-9099c98c36fa"
      unitRef="usd">2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ibd9b7b88141b400786601f5cd3fec33a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMTAtOC0xLTEtMA_af813e54-7427-43f7-8373-f70e1665b9c7"
      unitRef="usd">-28000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4320d8cfd0aa4682ac4fd8e97489f333_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMTItMi0xLTEtMA_abee255f-a32c-4596-9fda-3a55f3afc4dd"
      unitRef="usd">383000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib94d886e09a149778fc4b762edca1bc7_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMTItNC0xLTEtMA_ca26c7a6-89e3-4252-bb99-72ffd62da1b4"
      unitRef="usd">495000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic3b0235cbe654245a5397a036c1d3132_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMTItNi0xLTEtMA_e0232d52-d116-4d6a-9d1a-e2a0871b5860"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibd9b7b88141b400786601f5cd3fec33a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMTItOC0xLTEtMA_8eb75c55-64b0-4726-bc95-0f24197025e2"
      unitRef="usd">911000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie628688809594c33a0f517053cd1c98f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMTQtMi0xLTEtMA_fd339ba4-eb1a-4caf-b6c7-7119eeb6189e"
      unitRef="usd">-2037000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7c08359b25be43c9b6378dcc5e5e3f52_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMTQtNC0xLTEtMA_5cfac3fa-0d5f-4c4b-b3e2-a90681dc4cba"
      unitRef="usd">-1443000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id6cd59bba4c64d728580eef19f7136ca_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMTQtNi0xLTEtMA_fe346e41-36d4-45f0-8f34-83720c46fe79"
      unitRef="usd">50000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic6448179dc624c73a14533ac4f8492a2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183My9mcmFnOjYyMWE2YmNkN2VhNDQ4ODRiMDk1Y2RhZWJkNmU4YTdkL3RhYmxlOjQxNzZjMzJhM2QwNzRhZjlhYzNmYzIyNDcyZDRiMDE3L3RhYmxlcmFuZ2U6NDE3NmMzMmEzZDA3NGFmOWFjM2ZjMjI0NzJkNGIwMTdfMTQtOC0xLTEtMA_6df875b1-8f49-403d-a9a5-46834a47f5cf"
      unitRef="usd">-3430000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia60bc9c826684e3dbf0b2a03a36b0a67_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMi0yLTEtMS0w_573f0130-b0a3-449e-9ea6-2ad50ae66f57"
      unitRef="usd">-2043000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4f37b78605b24016b376248d47913825_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMi00LTEtMS0w_961a2a96-1ed0-4e04-bf4c-e357cd888f92"
      unitRef="usd">-1604000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i64f0bf43c52c463298e2f9f2570fe3e3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMi02LTEtMS0w_fca62af0-a42d-468a-9112-fea6c8bcb1e5"
      unitRef="usd">45000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0ea0515263584ea09063bbf40ec274b1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMi04LTEtMS0w_aa7c1b14-85aa-43a9-9c93-bfffece3ab11"
      unitRef="usd">-3602000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ifbbd3f4ab1454dcfa39e110e53cca664_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfNC0yLTEtMS0w_93b82407-219c-466d-aadb-c6e028df1154"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ibfb335bd0af94b69b6dbeda93b2431f4_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfNC00LTEtMS0w_22e8b32c-3988-466b-b93c-4163aa1a512c"
      unitRef="usd">215000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ieb267062b0c74a0a89cf1006daf242da_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfNC02LTEtMS0w_3862937f-0f9a-448f-9275-924e1d4baa54"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i811d953ad6844425a1abf068a0bef5ea_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfNC04LTEtMS0w_4061a215-e94b-444d-b47e-d54b1b365d1f"
      unitRef="usd">221000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ifbbd3f4ab1454dcfa39e110e53cca664_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfNS0yLTEtMS0w_316d4b3d-c2bb-40e2-984f-4a47288e96a6"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ibfb335bd0af94b69b6dbeda93b2431f4_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfNS00LTEtMS0w_14e1ef21-faa0-42fc-998e-18d4b6c38717"
      unitRef="usd">48000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ieb267062b0c74a0a89cf1006daf242da_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfNS02LTEtMS0w_a16d47b3-5a4e-4a4b-b664-1d27b9f5b5ac"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i811d953ad6844425a1abf068a0bef5ea_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfNS04LTEtMS0w_75a31e60-c1d2-4347-929f-9f96c079ec55"
      unitRef="usd">57000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ifbbd3f4ab1454dcfa39e110e53cca664_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfNi0yLTEtMS0w_281d46aa-34b9-4f9b-b9e2-fc08f489fab5"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ibfb335bd0af94b69b6dbeda93b2431f4_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfNi00LTEtMS0w_71d9e5d0-f912-4450-9219-4f00a28e0ba1"
      unitRef="usd">167000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ieb267062b0c74a0a89cf1006daf242da_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfNi02LTEtMS0w_d9e4dd65-629a-4edd-9b80-ab3c8f675132"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i811d953ad6844425a1abf068a0bef5ea_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfNi04LTEtMS0w_0b8f5dfc-609b-4112-b037-c18eba9daa00"
      unitRef="usd">164000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ifbbd3f4ab1454dcfa39e110e53cca664_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfOC0yLTEtMS0w_b3eb991d-f35f-426f-a5d8-5b14f692e50f"
      unitRef="usd">-20000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ibfb335bd0af94b69b6dbeda93b2431f4_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfOC00LTEtMS0w_45c750ea-6f2c-4994-9256-16581840ee9b"
      unitRef="usd">7000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ieb267062b0c74a0a89cf1006daf242da_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfOC02LTEtMS0w_981e8e90-868e-4822-b7f3-6cc28ca9a971"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i811d953ad6844425a1abf068a0bef5ea_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfOC04LTEtMS0w_12a2b95d-d5be-4389-a140-2b2ecd63c6a3"
      unitRef="usd">-12000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ifbbd3f4ab1454dcfa39e110e53cca664_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfOS0yLTEtMS0w_57e83fd1-9162-41f0-82d9-a38cb9edcded"
      unitRef="usd">-5000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ibfb335bd0af94b69b6dbeda93b2431f4_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfOS00LTEtMS0w_5fbbf552-1915-4ce0-aa7a-e863aea94177"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ieb267062b0c74a0a89cf1006daf242da_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfOS02LTEtMS0w_c34360d0-49c3-4dc6-9c0d-7cda687e2b56"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i811d953ad6844425a1abf068a0bef5ea_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfOS04LTEtMS0w_ff3f9b7a-e325-4347-9d6f-1524c1fccd9e"
      unitRef="usd">-4000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ifbbd3f4ab1454dcfa39e110e53cca664_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMTAtMi0xLTEtMA_4988ddd3-4187-4c70-834f-72382e3fb51e"
      unitRef="usd">-15000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ibfb335bd0af94b69b6dbeda93b2431f4_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMTAtNC0xLTEtMA_c0122198-1bcb-44ac-b833-cc5268397661"
      unitRef="usd">6000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ieb267062b0c74a0a89cf1006daf242da_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMTAtNi0xLTEtMA_1f4ce9d7-d3ce-4dac-a144-9dc70448259f"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i811d953ad6844425a1abf068a0bef5ea_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMTAtOC0xLTEtMA_b32ab6ce-4d64-411a-9872-25dbf31050fd"
      unitRef="usd">-8000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ifbbd3f4ab1454dcfa39e110e53cca664_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMTItMi0xLTEtMA_01ab8000-fc2e-48d0-b096-0e08e2bceff2"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibfb335bd0af94b69b6dbeda93b2431f4_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMTItNC0xLTEtMA_8ccf29c2-ea41-48a3-8d00-b803c922762e"
      unitRef="usd">161000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ieb267062b0c74a0a89cf1006daf242da_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMTItNi0xLTEtMA_03a32b31-cc4c-49df-9233-101aee537892"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i811d953ad6844425a1abf068a0bef5ea_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMTItOC0xLTEtMA_d25cec60-1c88-42f8-8146-c36f70d6c7a9"
      unitRef="usd">172000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie628688809594c33a0f517053cd1c98f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMTQtMi0xLTEtMA_36e753d9-e5c6-4922-93a2-65f2f1be5dc5"
      unitRef="usd">-2037000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7c08359b25be43c9b6378dcc5e5e3f52_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMTQtNC0xLTEtMA_2cb6ef58-96c4-4fea-8e24-6bc6600003b0"
      unitRef="usd">-1443000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id6cd59bba4c64d728580eef19f7136ca_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMTQtNi0xLTEtMA_5c39ae5a-37c0-45e3-ba66-33cfb00ce7a2"
      unitRef="usd">50000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic6448179dc624c73a14533ac4f8492a2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183Ni9mcmFnOmE0YTg3MTNjYjI5ODRjMjNiYzQzMTM0YTdhZWYxNjQ1L3RhYmxlOjIyMDVmYmM2NzZmNTQ4YWFhNzA5ZTA4M2MxYzI1ZjUwL3RhYmxlcmFuZ2U6MjIwNWZiYzY3NmY1NDhhYWE3MDllMDgzYzFjMjVmNTBfMTQtOC0xLTEtMA_62a961aa-458e-4e35-b233-f6b5cb9daa64"
      unitRef="usd">-3430000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaadcf1874ca04724982a8928b2ba0492_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMi0yLTEtMS0w_00ad2a4c-ed81-4568-b4a3-8ae777a81d90"
      unitRef="usd">-2192000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4ad5ab3a5d744eae96a566cd3203adfa_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMi00LTEtMS0w_afcf6955-e60e-4c43-832f-d3c436807f6a"
      unitRef="usd">-693000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaa91dd46f82a4982882dee9eb8e7ef08_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMi02LTEtMS0w_cd2cd5a9-3093-413a-bfd5-394fac9e25e3"
      unitRef="usd">21000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i433dda944a934320af202e2f484eaa1c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMi04LTEtMS0w_856edb8e-68b8-4bed-8fc8-e28baa836967"
      unitRef="usd">-2864000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ie55982b4b8094afd8cbd3644050918a9_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfNC0yLTEtMS0w_88214d0b-6730-472d-b0ed-6ebf6450f5b1"
      unitRef="usd">-75000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i70e46b26b4fc462a81bca6b1ee77e04c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfNC00LTEtMS0w_81239dcb-b930-4e02-87df-ce91ab85d5ef"
      unitRef="usd">-1211000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ia1b552df277f47bdac453b74353a2434_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfNC02LTEtMS0w_db3513d8-e53e-4049-ac94-7486edb63b56"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i6f1f1cd9567d4e048bfb64a6d6ee6bd0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfNC04LTEtMS0w_e34b3fed-619d-4a5e-acc3-fb57cedcf98b"
      unitRef="usd">-1302000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ie55982b4b8094afd8cbd3644050918a9_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfNS0yLTEtMS0w_2b641c24-e3de-49c0-b7cf-c90f49d530cb"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i70e46b26b4fc462a81bca6b1ee77e04c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfNS00LTEtMS0w_f10d31f2-6e9b-46e7-b855-083366b911cb"
      unitRef="usd">-260000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ia1b552df277f47bdac453b74353a2434_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfNS02LTEtMS0w_d4a63db6-447f-4be9-a58e-58c1e9b488b0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i6f1f1cd9567d4e048bfb64a6d6ee6bd0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfNS04LTEtMS0w_3beba0fb-acc2-4fc9-bd79-2b6d0f0e2b3a"
      unitRef="usd">-279000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie55982b4b8094afd8cbd3644050918a9_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfNi0yLTEtMS0w_b411d22b-bf1e-4b9b-a638-b556e9185f56"
      unitRef="usd">-56000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i70e46b26b4fc462a81bca6b1ee77e04c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfNi00LTEtMS0w_69449d50-e01a-4e98-9863-7b79116d4b86"
      unitRef="usd">-951000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia1b552df277f47bdac453b74353a2434_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfNi02LTEtMS0w_4ddda360-3d79-47e9-9bd1-573232a93c08"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i6f1f1cd9567d4e048bfb64a6d6ee6bd0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfNi04LTEtMS0w_65dfdccd-d456-45d9-a39a-1812522660b6"
      unitRef="usd">-1023000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ie55982b4b8094afd8cbd3644050918a9_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfOC0yLTEtMS0w_b78dc326-76aa-474f-8e97-e283a7a57fe7"
      unitRef="usd">-111000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i70e46b26b4fc462a81bca6b1ee77e04c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfOC00LTEtMS0w_7cbab4a2-8d32-4223-a492-ab9db7c40c22"
      unitRef="usd">-29000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ia1b552df277f47bdac453b74353a2434_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfOC02LTEtMS0w_8b59733a-485e-413d-9b2a-296cf5ccb431"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i6f1f1cd9567d4e048bfb64a6d6ee6bd0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfOC04LTEtMS0w_db707d11-7710-443a-856a-a2574e63128f"
      unitRef="usd">-140000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ie55982b4b8094afd8cbd3644050918a9_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfOS0yLTEtMS0w_65d69c71-74f9-4d80-9b3f-e382edb23294"
      unitRef="usd">-28000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i70e46b26b4fc462a81bca6b1ee77e04c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfOS00LTEtMS0w_0aa7eebc-802f-499c-a133-3116493583d7"
      unitRef="usd">-6000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ia1b552df277f47bdac453b74353a2434_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfOS02LTEtMS0w_9b4057f0-2562-4014-918c-b50b5235d2a4"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i6f1f1cd9567d4e048bfb64a6d6ee6bd0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfOS04LTEtMS0w_fcf0af32-ba0a-4037-a710-0888db0b0c7d"
      unitRef="usd">-34000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie55982b4b8094afd8cbd3644050918a9_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMTAtMi0xLTEtMA_857e7a9e-f31a-4c22-945a-b0ab829cde2e"
      unitRef="usd">-83000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i70e46b26b4fc462a81bca6b1ee77e04c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMTAtNC0xLTEtMA_5ef4c146-c603-4114-bbb0-84a084a51100"
      unitRef="usd">-23000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia1b552df277f47bdac453b74353a2434_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMTAtNi0xLTEtMA_63cdae92-1609-4dbf-84a2-2f5e35d8c4e0"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6f1f1cd9567d4e048bfb64a6d6ee6bd0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMTAtOC0xLTEtMA_a185e205-3c21-4c1c-929f-28f13bfd6578"
      unitRef="usd">-106000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie55982b4b8094afd8cbd3644050918a9_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMTItMi0xLTEtMA_a0033764-00e9-4c6f-ac76-628f0151030d"
      unitRef="usd">27000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i70e46b26b4fc462a81bca6b1ee77e04c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMTItNC0xLTEtMA_290930af-f91b-4d79-b3ed-700f9e15745c"
      unitRef="usd">-928000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia1b552df277f47bdac453b74353a2434_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMTItNi0xLTEtMA_3a2b9655-f203-4681-ac0a-2dbb65d085d6"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6f1f1cd9567d4e048bfb64a6d6ee6bd0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMTItOC0xLTEtMA_3bd26f0a-1aff-4fb8-bc24-83c07f0f8e7d"
      unitRef="usd">-917000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieedc417e26a742608b043deb27b97448_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMTQtMi0xLTEtMA_cae1c2a5-5fc9-49a1-9720-aa0e1d1481a6"
      unitRef="usd">-2165000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib1b03165fb2c4b76807e0ccc90d962b2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMTQtNC0xLTEtMA_d2a5621e-2ff0-4160-b794-4cd0d6ad45b0"
      unitRef="usd">-1621000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib5bf1a00e1e4420f9e82ccdfbc6a5434_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMTQtNi0xLTEtMA_a19f42f1-b1d1-4fe3-8ab6-4f687219c59d"
      unitRef="usd">5000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6b2a0f8b0eb84d6e98048c9c107d0d60_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y183OS9mcmFnOjdmODBhMmNjYmI0NzQzODZiYmY0NDcwMDIxZGIxN2I4L3RhYmxlOjI4YzNjYmQ1ODdlYTQyZjE4YzA0OGIwZTkyOWFjN2QxL3RhYmxlcmFuZ2U6MjhjM2NiZDU4N2VhNDJmMThjMDQ4YjBlOTI5YWM3ZDFfMTQtOC0xLTEtMA_9080dd06-d13b-4f6d-8770-a1fec6a7b514"
      unitRef="usd">-3781000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id14c8ad0e1114859a5ef9774b11273ab_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMi0yLTEtMS0w_e0e110cd-1a85-4553-b42d-ea5a6c7d4ef6"
      unitRef="usd">-2150000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib3dac29830b94be0b1b1d5af479d71b6_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMi00LTEtMS0w_f7188f85-ea94-46fb-b459-806fbaf07556"
      unitRef="usd">-1606000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i529da0d49b1b4fcda97c6cf43be5a0e6_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMi02LTEtMS0w_b03a9a0c-7baa-4d8a-b21e-88c0d83c1de3"
      unitRef="usd">-18000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i65d2cfacd8464cd8a25b7d8f01804516_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMi04LTEtMS0w_00cfd4c0-0a28-4774-a0e3-e1576211a5c7"
      unitRef="usd">-3774000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ibc3428a068464ada9a25e4ce62287f36_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfNC0yLTEtMS0w_80f52eb5-aa71-4b22-9d4c-bff74b3f2482"
      unitRef="usd">-75000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="if9501d5a448d4b8fb83b9f4658086140_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfNC00LTEtMS0w_f7d67fb8-06ac-4d8e-8ddf-82e666f24c11"
      unitRef="usd">-71000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i1663f22cd4af448bb0eabf4a88a2c65f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfNC02LTEtMS0w_9d1ff8f9-35b7-43e2-b116-d71f0fad93d1"
      unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="iece3d64b93d440e3863844f51f91d57b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfNC04LTEtMS0w_2aba3531-09d0-489e-9ddd-597fb3cf43e7"
      unitRef="usd">-123000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ibc3428a068464ada9a25e4ce62287f36_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfNS0yLTEtMS0w_ff89c2ae-0b15-436a-9beb-4ecddda228e1"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="if9501d5a448d4b8fb83b9f4658086140_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfNS00LTEtMS0w_4f959fd7-7973-4eed-bace-4e2047ace68a"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i1663f22cd4af448bb0eabf4a88a2c65f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfNS02LTEtMS0w_d5e908d1-ba6a-4a2d-9b5a-1b1f3d58ad64"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="iece3d64b93d440e3863844f51f91d57b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfNS04LTEtMS0w_95e52d21-8147-4eed-a481-9095eeeae393"
      unitRef="usd">-41000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ibc3428a068464ada9a25e4ce62287f36_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfNi0yLTEtMS0w_e7b27ee2-592f-4392-a0b4-716206626c67"
      unitRef="usd">-56000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if9501d5a448d4b8fb83b9f4658086140_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfNi00LTEtMS0w_3fa9f4ea-dd34-4d67-9f1b-dc16f04882dc"
      unitRef="usd">-49000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i1663f22cd4af448bb0eabf4a88a2c65f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfNi02LTEtMS0w_01e45ae0-1eaf-44ff-9f18-0f67e75f39c6"
      unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iece3d64b93d440e3863844f51f91d57b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfNi04LTEtMS0w_c5b92c59-cf51-4496-ab42-46358210c6a4"
      unitRef="usd">-82000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ibc3428a068464ada9a25e4ce62287f36_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfOC0yLTEtMS0w_329dfa76-4107-4edb-9241-ba3ac9598830"
      unitRef="usd">-55000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="if9501d5a448d4b8fb83b9f4658086140_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfOC00LTEtMS0w_c07819de-ca37-4f66-b16b-4eff57d29504"
      unitRef="usd">-44000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i1663f22cd4af448bb0eabf4a88a2c65f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfOC02LTEtMS0w_9bc81f35-0b60-4714-b29f-6c0b56af4513"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="iece3d64b93d440e3863844f51f91d57b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfOC04LTEtMS0w_d02e8e36-46b1-4738-b086-26a4fdcbf918"
      unitRef="usd">-99000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ibc3428a068464ada9a25e4ce62287f36_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfOS0yLTEtMS0w_689d8ea4-678e-4ea9-b423-29a32004f748"
      unitRef="usd">-14000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="if9501d5a448d4b8fb83b9f4658086140_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfOS00LTEtMS0w_3e43e362-9ed6-4703-9be1-55881b4d72ed"
      unitRef="usd">-10000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i1663f22cd4af448bb0eabf4a88a2c65f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfOS02LTEtMS0w_8d1a32e5-d18a-4172-9851-3f02d51e4944"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="iece3d64b93d440e3863844f51f91d57b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfOS04LTEtMS0w_4f0ddc5b-b930-498f-860e-0ba63c68b3e6"
      unitRef="usd">-24000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ibc3428a068464ada9a25e4ce62287f36_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMTAtMi0xLTEtMA_23650dc3-2a93-4de6-a6f5-a7e64c77bc05"
      unitRef="usd">-41000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if9501d5a448d4b8fb83b9f4658086140_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMTAtNC0xLTEtMA_fdc67248-4b72-4898-9a38-fb4ee4f6e4a3"
      unitRef="usd">-34000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i1663f22cd4af448bb0eabf4a88a2c65f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMTAtNi0xLTEtMA_afd8adc1-6241-47c1-82d4-4083bb5cdf3c"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iece3d64b93d440e3863844f51f91d57b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMTAtOC0xLTEtMA_7ba1b225-639d-4081-82cd-dce1e7300ace"
      unitRef="usd">-75000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibc3428a068464ada9a25e4ce62287f36_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMTItMi0xLTEtMA_dd88d262-5234-4c81-abce-5a4f733bd6d5"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if9501d5a448d4b8fb83b9f4658086140_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMTItNC0xLTEtMA_e2670ed3-3731-4947-9bef-871f43615a31"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1663f22cd4af448bb0eabf4a88a2c65f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMTItNi0xLTEtMA_c5ee4c60-00a6-420f-a581-986cf7a37f7f"
      unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iece3d64b93d440e3863844f51f91d57b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMTItOC0xLTEtMA_40511a77-f2e8-4113-8ae5-4d03e645555a"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieedc417e26a742608b043deb27b97448_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMTQtMi0xLTEtMA_e199f29c-8657-469e-b592-5a892a85608a"
      unitRef="usd">-2165000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib1b03165fb2c4b76807e0ccc90d962b2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMTQtNC0xLTEtMA_8c63d1ee-31ef-4cec-8987-dae109275e98"
      unitRef="usd">-1621000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib5bf1a00e1e4420f9e82ccdfbc6a5434_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMTQtNi0xLTEtMA_4eac24eb-c9c1-4d37-90c0-04422919f789"
      unitRef="usd">5000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6b2a0f8b0eb84d6e98048c9c107d0d60_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184Mi9mcmFnOmVlYzE5ZjY0ZmVkYzQwOGRhMDZjMDFmN2QwNDNjMDZjL3RhYmxlOmFhNjI2NjM5ZDVhMTRlYjI5MTExNzQzZjM4ZjZmN2FlL3RhYmxlcmFuZ2U6YWE2MjY2MzlkNWExNGViMjkxMTE3NDNmMzhmNmY3YWVfMTQtOC0xLTEtMA_083aa4e4-23a3-436d-9780-9766c952871d"
      unitRef="usd">-3781000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RleHRyZWdpb246OTkyYjQ3YjI4OTRlNDNmMDgwMTFlYWZjZDgyYTgwZmRfNDU5_e750f64d-a61d-471d-bd93-0c3311a640d2">&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings (losses):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit Plans: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;124&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;39&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;92&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustments and Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Amounts are included in net defined benefit plan costs.  For further information related to defined benefit plans, see Note 6. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Benefit Plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Amounts are included in (income) losses from equity investments.  For further information related to equity investments, see Note 4. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Equity Securities.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i903649a4650d4581b810b87a8e7abece_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfMy0yLTEtMS0w_dd3a2f23-bb59-4bd0-9470-a2cf102963b7"
      unitRef="usd">124000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="iba009efde806409683cbc9e86246b4df_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfMy00LTEtMS0w_f30512e3-1d5d-4ed5-b8b9-f23915074090"
      unitRef="usd">129000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="id1f84a88e08b4b88ac5ad7e5696842ef_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfMy02LTEtMS0w_37ed227e-8295-42b6-bc41-e73558b1983f"
      unitRef="usd">39000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i386a65106eed4b8480296af72f76b88a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfMy04LTEtMS0w_d942e582-278f-4607-a0b1-99428f104b38"
      unitRef="usd">60000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="ia911d34c10624a4caad11aaf671e57a2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNC0yLTEtMS0w_1bbe657a-06b0-4572-8e7c-2e16983d9836"
      unitRef="usd">-32000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i00054ad5017c49e886588f8692292ab7_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNC00LTEtMS0w_9f64518d-2330-4a99-8fb4-80443b533ade"
      unitRef="usd">-18000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i148aed2cafc8405f9c753e10684af7ce_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNC02LTEtMS0w_73185224-afad-4dec-8ca9-4c7427fb6fcc"
      unitRef="usd">-19000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i0c117e78f8df4689addea5ed534be7cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNC04LTEtMS0w_31272423-48d9-4a00-9736-f4ed2e854185"
      unitRef="usd">-5000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i90237e5e67d24c74afa25e85687a853f_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNS0yLTEtMS0w_c0db3774-4f46-40aa-b379-f19d7fcb754a"
      unitRef="usd">92000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="ic4234136b96446cc9cf8cb134f4533f0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNS00LTEtMS0w_ae04680f-04b2-4194-bff3-218e7a76e8ed"
      unitRef="usd">111000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i6cdea01ef93f447c96c7b2a20036eb30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNS02LTEtMS0w_8af72a3c-26c9-401d-a0eb-4c08b58ede03"
      unitRef="usd">20000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i09764927c7ec46e49e7775b99fd97136_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNS04LTEtMS0w_2995e01c-2b6e-4df0-9d50-b02f7d38e1db"
      unitRef="usd">55000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i129971b2b9ec49abbe1afc97cb429284_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNi0yLTEtMS0w_50e81ecf-83b8-4a85-8828-452dbf6f0e8b"
      unitRef="usd">49000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ia80f603ac4c848f78a7bcaf6c95cb8a5_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNi00LTEtMS0w_8bbe1d32-287d-44a0-a85f-191409e412cf"
      unitRef="usd">-29000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ibaa55d29a7cf455ca4bf8fe55b94e9c0_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNi02LTEtMS0w_93e7e4a8-92f0-4d1a-a86f-e3945eff9a85"
      unitRef="usd">7000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i3d50e83d51e04a2c81a2fb7b3d33bd41_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNi04LTEtMS0w_68095f6f-7efb-4de4-88b0-0b9cb218fac6"
      unitRef="usd">-44000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if41a4137b96044f2853f90bee854a5a1_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNy0yLTEtMS0w_96de2405-ea9e-42f6-aeb5-472a31a6004d"
      unitRef="usd">2000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie0c26c7c96cd4d82a4534ab1f5e26951_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNy00LTEtMS0w_abb467e7-b349-4f66-bd99-ff9ea575f7c8"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i7e957d6659b146e1a8a2c22448c05e52_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNy02LTEtMS0w_61f3115c-89e2-45f9-90f9-774caee71c30"
      unitRef="usd">1000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie3658d6662464166bd1a7d63193f62b6_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfNy04LTEtMS0w_7c32a3fb-7151-4e1b-b800-331c9370bfd0"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ProfitLoss
      contextRef="i6c60e64bda5e406c906f14c501403dcf_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfOC0yLTEtMS0w_c2a20cd7-7a6a-4c93-865e-e31646287ff4"
      unitRef="usd">-41000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ifb73dd7e78c54dc0bb94170fd12ab8ab_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfOC00LTEtMS0w_3221b232-b7cc-41e7-b8f1-4733f44c4609"
      unitRef="usd">-140000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i88fcf49918a84402902b9a4fd578a532_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfOC02LTEtMS0w_79280ef2-efb0-4ee6-bb76-7d760a49efb4"
      unitRef="usd">-12000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8e951f6b74194f1ea5354f9049777599_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184NS9mcmFnOjk5MmI0N2IyODk0ZTQzZjA4MDExZWFmY2Q4MmE4MGZkL3RhYmxlOjc4M2Y5MzhhOTA4NDQ5NDY4OTcxMWZmYWE0NjBmMDgyL3RhYmxlcmFuZ2U6NzgzZjkzOGE5MDg0NDk0Njg5NzExZmZhYTQ2MGYwODJfOC04LTEtMS0w_a81862fd-37ef-4144-94d9-22eca94c5d52"
      unitRef="usd">-99000000</us-gaap:ProfitLoss>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfNDYzNA_05bdd5ac-bd83-4e95-935c-b67b08b2d986">Segment Reporting&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The products of Altria&#x2019;s subsidiaries include smokeable tobacco products, consisting of combustible cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton; oral tobacco products, consisting of MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix; and wine produced and/or distributed by Ste. Michelle.  The products and services of these subsidiaries constitute Altria&#x2019;s reportable segments of smokeable products, oral tobacco products and wine.  The financial services and the innovative tobacco products businesses, which include the heated tobacco business and Helix ROW, are included in all other.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria&#x2019;s chief operating decision maker (the &#x201c;CODM&#x201d;) reviews operating companies income (loss) (&#x201c;OCI&#x201d;) to evaluate the performance of, and allocate resources to, the segments.  OCI for the segments is defined as operating income before general corporate expenses and amortization of intangibles.  Interest and other debt expense, net, along with net periodic benefit income/cost, excluding service cost, and provision (benefit) for income taxes are centrally managed at the corporate level and, accordingly, such items are not presented by segment since they are excluded from the measure of segment profitability reviewed by the CODM.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment data were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17,275&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,975&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,945&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;626&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;494&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;177&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;44&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19,758&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,786&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings (losses) before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;OCI:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,901&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,753&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,269&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;405&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;21&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(255)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,827&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,951&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other debt expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(266)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on early extinguishment of debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(649)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:22.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit income, excluding &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;service cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;152&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;63&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (losses) from equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,915)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment of JUUL equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) on Cronos-related financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (losses) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,544&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The comparability of OCI for the reportable segments was affected by the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Non-Participating Manufacturer (&#x201c;NPM&#x201d;) Adjustment Items:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Pre-tax (income) for NPM adjustment items was recorded to Altria&#x2019;s condensed consolidated statements of earnings (losses) as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.903%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other debt expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;NPM adjustment items result from the resolutions of certain disputes with states and territories related to the NPM adjustment provision under the 1998 Master Settlement Agreement (such dispute resolutions are referred to as &#x201c;NPM Adjustment Items&#x201d; and are more fully described in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Cost Recovery Litigation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in Note 12. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).  The amounts shown in the table above for the smokeable products segment were recorded as reductions to cost of sales, which increased OCI in the smokeable products segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Tobacco and Health and Certain Other Litigation Items:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pre-tax charges related to tobacco and health and certain other litigation items were recorded in Altria&#x2019;s condensed consolidated statements of earnings (losses) as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;70&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;70&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other debt expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;148&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;105&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts shown in the table above for the smokeable products segment and general corporate were recorded in marketing, administration and research costs.  For further discussion, see Note 12. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;COVID-19 Special Items: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net pre-tax charges of $50 million ($41 million in the smokeable products segment and $9 million in the oral tobacco products segment) related to the COVID-19 pandemic were recorded in Altria&#x2019;s condensed consolidated statements of earnings (losses) for the nine months ended September 30, 2020.  The net pre-tax charges, which were directly related to disruptions caused by or efforts to mitigate the impact of the COVID-19 pandemic, were all recorded in costs of sales and included premium pay, personal protective equipment and health screenings, which were partially offset by certain employment tax credits.  The COVID-19 special items do not include the inventory-related implementation costs associated with the wine business strategic reset discussed below.  These implementation costs were due to increased inventory levels, which were further negatively impacted by the COVID-19 pandemic, including economic uncertainty and government restrictions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Implementation, Acquisition and Disposition-Related Costs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Ste. Michelle Transaction:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the nine and three months ended September&#160;30, 2021, pre-tax disposition-related costs of $51 million were recorded in the wine segment, which consisted of a pre-tax charge of $41 million to record the assets and liabilities associated with the Ste. Michelle Transaction at their fair value less costs to sell and  $10 million of other disposition-related costs.  For further discussion, see Note 3. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets Held for Sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Wine Business Strategic Reset&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: During the nine months ended September 30, 2020, Ste. Michelle recorded pre-tax implementation costs of  $395 million associated with a strategic reset initiated in the first quarter of 2020 to maximize Ste. Michelle&#x2019;s profitability and achieve improved long-term cash flow generation.  Substantially all of the charges consisted of the following: (i) write-off of inventory ($292 million) as Ste. Michelle no longer believed that the benefit of the blending and production plans for its inventory outweighed inventory carrying cost given the reduced product volume demand; and (ii) estimated losses on future non-cancelable grape purchase commitments that Ste. Michelle believed no longer had a future economic benefit ($100 million).  These charges were included in cost of sales in Altria&#x2019;s condensed consolidated statements of earnings (losses).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition-Related Costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: For the nine months ended September 30, 2021, Altria recorded pre-tax acquisition-related costs of $37 million in the oral tobacco products segment primarily for the settlement of an arbitration related to the 2019 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;on!&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; transaction.  These costs were included in marketing, administration and research costs in Altria&#x2019;s condensed consolidated statements of earnings (losses).&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfNDY0Ng_49d09b17-794d-40ed-a406-df3484950ec9">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment data were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17,275&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,975&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,945&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;626&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;494&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;177&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;44&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19,758&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,786&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings (losses) before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;OCI:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,901&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,753&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,269&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;405&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;21&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(255)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,827&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,951&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other debt expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(266)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on early extinguishment of debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(649)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:22.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit income, excluding &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;service cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;152&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;63&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (losses) from equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,915)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment of JUUL equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) on Cronos-related financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (losses) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,544&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic3e0ae69ae05491a91e3fdb908e909db_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMy0yLTEtMS0w_72bb635a-1aeb-4bbc-801e-d396e970609a"
      unitRef="usd">17275000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a2569691b65440c9038155bd4cf097b_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMy00LTEtMS0w_cb444576-8d14-46b0-9d13-489d8469b067"
      unitRef="usd">17522000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8712c39f1b4b407d8d3f616cd0f6d0b2_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMy02LTEtMS0w_30c5c4ad-d36e-4026-bd54-7a6b9522e99e"
      unitRef="usd">5975000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf557385c26346d78697ab7216ad25aa_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMy04LTEtMS0w_3437d29b-17eb-4e37-8918-ecb01d072a5d"
      unitRef="usd">6313000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2cc47fbf28e740b583be5f01ebc5de9b_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNC0yLTEtMS0w_c3c0dcf9-b1df-44d6-9d4f-98f3a6b3598b"
      unitRef="usd">1945000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7773a1a4d8454a6f8b93d93dbf471801_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNC00LTEtMS0w_625f23df-943c-4204-b329-a2cfce91373f"
      unitRef="usd">1901000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib7294329e59b4737858f1c36f4d117a6_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNC02LTEtMS0w_9e061f37-60a9-4c79-9255-c784b170ff3a"
      unitRef="usd">626000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaecb6abc654940949c584c7bce9fa618_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNC04LTEtMS0w_4d94b35d-2787-46e4-bcc9-42f8908bc6f3"
      unitRef="usd">640000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idf8f1c9e35d64a1f98b39384820c20cc_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNS0yLTEtMS0w_398d0d71-fcd8-440c-996d-9408c196cf9f"
      unitRef="usd">494000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i82c1570001674d4a844a4bfcb4e16ca8_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNS00LTEtMS0w_df772681-56ad-418d-9ed5-233280459d02"
      unitRef="usd">434000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i867ac19dbb4643b59a94aeeec8a58fa8_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNS02LTEtMS0w_1cec1187-8d61-4be9-894e-6378422f0b98"
      unitRef="usd">177000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i41fcc7aaf3534c59ace9f381d20aac6a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNS04LTEtMS0w_deb425ea-3a97-4b09-a8cc-372aad114e91"
      unitRef="usd">157000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie45eb514d8c24379a2d84b6fdadc5908_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNi0yLTEtMS0w_0f64e4fe-a047-4e74-987a-461e491b8166"
      unitRef="usd">44000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i348527fc0572499b8b09c70427059222_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNi00LTEtMS0w_ae32a59c-c00a-4ab8-a602-2ddd3188f5a9"
      unitRef="usd">-8000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idda2d39340b64a38b25c3fbb87815b91_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNi02LTEtMS0w_5ca0c688-46f1-4aaa-9f74-caa6086c5bd8"
      unitRef="usd">8000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id08e4c2d3cad43fea50a182ef5e4bd72_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNi04LTEtMS0w_1dbab2cd-da68-4698-a907-1cd8b16cc391"
      unitRef="usd">13000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNy0yLTEtMS0w_1586e0b0-aa86-418a-9baf-67bfa24012ee"
      unitRef="usd">19758000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNy00LTEtMS0w_c593609e-3cf3-4852-bdf0-bcdacaa7e8c3"
      unitRef="usd">19849000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNy02LTEtMS0w_4bf2e9e0-ffe0-4e72-8f67-26afad1b8d29"
      unitRef="usd">6786000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfNy04LTEtMS0w_71e4cf70-d894-4e39-8760-745f4bc8fc10"
      unitRef="usd">7123000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="ic3e0ae69ae05491a91e3fdb908e909db_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTAtMi0xLTEtMA_232b7eb0-caba-4b7b-a051-90d5ae400244"
      unitRef="usd">7901000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i1a2569691b65440c9038155bd4cf097b_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTAtNC0xLTEtMA_093e32f3-f698-4ca1-977d-70a613c85755"
      unitRef="usd">7609000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i8712c39f1b4b407d8d3f616cd0f6d0b2_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTAtNi0xLTEtMA_4c91f919-be9a-405c-ad96-c69023530c31"
      unitRef="usd">2753000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="iaf557385c26346d78697ab7216ad25aa_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTAtOC0xLTEtMA_6048d3a2-fc86-4408-9945-07f2993d3da3"
      unitRef="usd">2789000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i2cc47fbf28e740b583be5f01ebc5de9b_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTEtMi0xLTEtMA_68ce09ce-151b-437f-a013-5b6f5d973a6b"
      unitRef="usd">1269000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i7773a1a4d8454a6f8b93d93dbf471801_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTEtNC0xLTEtMA_449473ad-f5ed-4519-a871-8ff9278f1c57"
      unitRef="usd">1297000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="ib7294329e59b4737858f1c36f4d117a6_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTEtNi0xLTEtMA_86bce0a5-5275-433f-a115-ea717ce6f544"
      unitRef="usd">405000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="iaecb6abc654940949c584c7bce9fa618_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTEtOC0xLTEtMA_01f68864-a84f-4719-b8f9-5c6855277969"
      unitRef="usd">436000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="idf8f1c9e35d64a1f98b39384820c20cc_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTItMi0xLTEtMA_69b82b81-de6f-4724-bf84-ec58a2d94676"
      unitRef="usd">21000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i82c1570001674d4a844a4bfcb4e16ca8_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTItNC0xLTEtMA_d2f9f58c-5e21-4a71-9e65-7d338f587baa"
      unitRef="usd">-347000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i867ac19dbb4643b59a94aeeec8a58fa8_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTItNi0xLTEtMA_1241df02-0eed-4003-8cfd-4f804f5baa46"
      unitRef="usd">-24000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i41fcc7aaf3534c59ace9f381d20aac6a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTItOC0xLTEtMA_b453cd59-024c-4e4b-8a58-1d22ea8c3b6a"
      unitRef="usd">19000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="ie45eb514d8c24379a2d84b6fdadc5908_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTMtMi0xLTEtMA_9fd89f26-a6bf-4654-9a99-b19790258721"
      unitRef="usd">-56000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i348527fc0572499b8b09c70427059222_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTMtNC0xLTEtMA_dbe3fef7-3005-44cb-bdc5-42775f7ed0b5"
      unitRef="usd">-63000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="idda2d39340b64a38b25c3fbb87815b91_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTMtNi0xLTEtMA_9e3aab33-b680-498a-a3c8-9d855eababc1"
      unitRef="usd">-30000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="id08e4c2d3cad43fea50a182ef5e4bd72_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTMtOC0xLTEtMA_1f8f44f3-5a30-439e-b0d7-211138e4c485"
      unitRef="usd">-7000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i45eb44ceb75d4820b3468fcd56c069bb_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTQtMi0xLTEtMA_e38c36a4-8f97-48ba-bdee-14c2589af227"
      unitRef="usd">53000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic06d55ed183d403ea8fab3081dabed8d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTQtNC0xLTEtMA_cc93c7eb-4410-4066-ad6b-ac49b9703a88"
      unitRef="usd">54000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib87ad1bdee774676a43d32c69faf494a_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTQtNi0xLTEtMA_b24abb6e-adcc-454e-9433-93c89ecb9a40"
      unitRef="usd">18000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib8113c4d3abd42a8a3d5dc65de3551ea_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTQtOC0xLTEtMA_69e50c2e-e735-4ff0-9332-7a7bde91c029"
      unitRef="usd">17000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i23d680315a484e78bb04a83054b0bd2c_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTUtMi0xLTEtMA_e443b68e-5c60-436d-9f82-63518521b771"
      unitRef="usd">255000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i5750ad1593bf4f39a28a67676e4be777_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTUtNC0xLTEtMA_e19c5b83-60df-4b58-ae6b-60558d365d50"
      unitRef="usd">150000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i901cc99ae1b84fcaa334b79a557b2716_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTUtNi0xLTEtMA_db6bdf87-cfac-4313-bcf6-bb1941aabbac"
      unitRef="usd">135000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i92ece1efc67e4955b20f6106bfa5b1bc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTUtOC0xLTEtMA_e0e41923-3186-4ff3-9896-babe84191eda"
      unitRef="usd">60000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTctMi0xLTEtMA_0f1f91b3-3675-4f8b-923d-b451e159cebd"
      unitRef="usd">8827000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTctNC0xLTEtMA_ac893f23-cfa5-4632-9782-6e7227f2ad04"
      unitRef="usd">8292000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTctNi0xLTEtMA_77a6cbf3-7da4-44dd-9577-802522fcf08a"
      unitRef="usd">2951000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTctOC0xLTEtMA_7c2b7651-47a7-4792-b471-cc33ac4993dc"
      unitRef="usd">3160000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTgtMi0xLTEtMA_65b17fda-3ceb-41d3-b441-cf7c97d75441"
      unitRef="usd">-869000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTgtNC0xLTEtMA_2c4c67db-dd81-4922-896b-8aa30925ec21"
      unitRef="usd">-893000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTgtNi0xLTEtMA_7c36f5bb-9b23-4476-a437-06c9afa4922c"
      unitRef="usd">-266000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTgtOC0xLTEtMA_b18c614c-1423-4832-bbfb-648bb85c0b07"
      unitRef="usd">-310000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTktMi0xLTEtMA_787d5e44-b80e-40be-9749-22ec272d28c0"
      unitRef="usd">-649000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTktNC0xLTEtMA_3ed5c128-04ce-4a88-881b-2f6daa2b6809"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTktNi0xLTEtMA_2fb6d971-6a54-40a1-a441-4a1aff3af07c"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMTktOC0xLTEtMA_b484a550-8fac-4d65-9e11-80ee24f95056"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjAtMi0xLTEtMA_b60e2142-8187-4bfd-bda5-9c3f16169272"
      unitRef="usd">-152000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjAtNC0xLTEtMA_6f4c1592-0a08-47df-9de3-f3ab2dda04b3"
      unitRef="usd">-58000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjAtNi0xLTEtMA_756b01d9-f58c-4f9d-821e-0f82f8f34f37"
      unitRef="usd">-63000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjAtOC0xLTEtMA_cddb9eca-b118-4752-9cdf-28ad11156774"
      unitRef="usd">-3000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjEtMi0xLTEtMA_d6585ae6-b6b0-4019-a138-49aad873433d"
      unitRef="usd">-5789000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjEtNC0xLTEtMA_2c650870-f575-4c19-8662-768c062c4510"
      unitRef="usd">-306000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjEtNi0xLTEtMA_e5a7d081-7886-4437-8069-c4a5d707b017"
      unitRef="usd">-5915000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjEtOC0xLTEtMA_d269cba1-0e4c-4419-b0fd-6de9286fa5c9"
      unitRef="usd">-472000000</mo:IncomeLossFromEquityInvestments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjItMi0xLTEtMTI2ODU_21844dd2-815e-4a3e-a69d-33a113d8933e"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjItNC0xLTEtMTMxMQ_1550427a-9f43-4c8c-b85e-33ab01179b36"
      unitRef="usd">2600000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjItNi0xLTEtMTI2ODU_e1c0796a-4671-4e7c-acce-1a04994ac5cd"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjItOC0xLTEtMTMxNw_64d0d438-d796-4e64-920c-9b9221e83ffb"
      unitRef="usd">2600000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjMtMi0xLTEtMA_f0f254d1-68c3-4d4b-85b8-37cc308317fb"
      unitRef="usd">-128000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjMtNC0xLTEtMA_7c019a27-91cb-4b16-891b-e4f70882a098"
      unitRef="usd">-202000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjMtNi0xLTEtMA_2a6c1774-f36d-480f-b111-5e04e4f16896"
      unitRef="usd">-135000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjMtOC0xLTEtMA_62713641-33b0-49b1-b3c3-4ffbe9518707"
      unitRef="usd">-105000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjQtMi0xLTEtMA_d63eabbe-1b60-4a70-a4e6-ce81bd1d9c7c"
      unitRef="usd">1544000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjQtNC0xLTEtMA_bf258827-f3f2-4998-bd20-38c3fa457ac4"
      unitRef="usd">4349000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjQtNi0xLTEtMA_06c38aae-67b6-46e9-8aa4-1af775691a2f"
      unitRef="usd">-3302000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmE5ZTI5Mjk2NzM4NDQ0OWRiZjdmMDM0ZmM4N2RjMWI1L3RhYmxlcmFuZ2U6YTllMjkyOTY3Mzg0NDQ5ZGJmN2YwMzRmYzg3ZGMxYjVfMjQtOC0xLTEtMA_f0a0bf12-66ed-41e1-8475-cfd854a03933"
      unitRef="usd">-324000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <mo:ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfMjE5OTAyMzI2NDI3MA_c76cd14c-1253-4172-a2f8-22d812dd724f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Non-Participating Manufacturer (&#x201c;NPM&#x201d;) Adjustment Items:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Pre-tax (income) for NPM adjustment items was recorded to Altria&#x2019;s condensed consolidated statements of earnings (losses) as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.903%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other debt expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</mo:ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ibbc3e1fdad35440a8019431504912e54_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmMyYmI1MjA5MjY4MzQwYjZhZmM2MWQ5MzYwNWQ3NzQ3L3RhYmxlcmFuZ2U6YzJiYjUyMDkyNjgzNDBiNmFmYzYxZDkzNjA1ZDc3NDdfMi0yLTEtMS04NTM5_c8f456eb-c173-4da7-b7f1-1edc105e8397"
      unitRef="usd">53000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="iab4ebcb1e91f46c4be02c3ade89e7bd6_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmMyYmI1MjA5MjY4MzQwYjZhZmM2MWQ5MzYwNWQ3NzQ3L3RhYmxlcmFuZ2U6YzJiYjUyMDkyNjgzNDBiNmFmYzYxZDkzNjA1ZDc3NDdfMi00LTEtMS04NTM1_f4ed9fd6-52c9-4ca8-998f-e786d05a7af3"
      unitRef="usd">21000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i8a6c36dc62614c039382474701d62704_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmMyYmI1MjA5MjY4MzQwYjZhZmM2MWQ5MzYwNWQ3NzQ3L3RhYmxlcmFuZ2U6YzJiYjUyMDkyNjgzNDBiNmFmYzYxZDkzNjA1ZDc3NDdfMy0yLTEtMS04NTg3_dbd5045b-f356-426c-8f2e-611d91743183"
      unitRef="usd">23000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ia0bdf868958f46d39d41b03294b42969_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmMyYmI1MjA5MjY4MzQwYjZhZmM2MWQ5MzYwNWQ3NzQ3L3RhYmxlcmFuZ2U6YzJiYjUyMDkyNjgzNDBiNmFmYzYxZDkzNjA1ZDc3NDdfMy00LTEtMS04NjMw_3a5c1d03-b02d-4d37-980d-394e298588bc"
      unitRef="usd">23000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i8b0b695b39e941948146139c5236ab09_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmMyYmI1MjA5MjY4MzQwYjZhZmM2MWQ5MzYwNWQ3NzQ3L3RhYmxlcmFuZ2U6YzJiYjUyMDkyNjgzNDBiNmFmYzYxZDkzNjA1ZDc3NDdfNC0yLTEtMS0xMjYzNw_4268889d-8931-4ae6-b9ec-8fc8290d85a9"
      unitRef="usd">76000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i01fb7d5238cf4de6af35e1b8ee70534b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOmMyYmI1MjA5MjY4MzQwYjZhZmM2MWQ5MzYwNWQ3NzQ3L3RhYmxlcmFuZ2U6YzJiYjUyMDkyNjgzNDBiNmFmYzYxZDkzNjA1ZDc3NDdfNC00LTEtMS0xMjY0OA_ca71714a-049b-4d1e-aed3-b6f85e6b2dd9"
      unitRef="usd">44000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <mo:ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfNDYzMg_fe013eb3-140a-4c47-9d4f-4cf5a444211e">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Tobacco and Health and Certain Other Litigation Items:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pre-tax charges related to tobacco and health and certain other litigation items were recorded in Altria&#x2019;s condensed consolidated statements of earnings (losses) as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;70&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;70&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other debt expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;148&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;105&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</mo:ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ia0da5bdcd164423ab6c5e7d2d4619255_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfMi0yLTEtMS0w_a9ad46e0-b892-4e8c-abbf-d97ea0e6f8e7"
      unitRef="usd">72000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i71a6552e683a45df8a80deb0ff141acc_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfMi00LTEtMS0w_8abdf419-d57f-40a1-a533-b393667f14e2"
      unitRef="usd">73000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ib8c00af2fa2a47a08ce2e121cec7fa1a_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfMi02LTEtMS0w_173f1029-f19c-4c25-9ece-8d05e82261e4"
      unitRef="usd">29000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="id86681b1496e4200ac6e85e6642cca96_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfMi04LTEtMS0w_24d64f29-50fd-4c1f-a013-0b635f9e84be"
      unitRef="usd">34000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i44c555d22e7b40b0b20993dec5333004_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfMy0yLTEtMS01MzUzNw_bf48c05b-5702-45f8-8734-c46bf7e892f6"
      unitRef="usd">70000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i13dbf73b19844cd8895f0cadcf052f90_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfMy00LTEtMS01MzUzNw_feb18ba7-c07e-452d-9e9a-2b3f206ccde9"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i5717ce456bae4169a32dfcce88700f00_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfMy02LTEtMS01MzI2MA_e89c234a-9a9c-45a2-81ee-82172e963805"
      unitRef="usd">70000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i7e76683652f2470896a6eb26e4f4b7a2_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfMy04LTEtMS01MzA5Mg_9296d139-4594-4ffc-ac81-4c6895d7cab1"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i9e46fc85802e4a6291b8902ec7c022dc_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfMy0yLTEtMS0w_6f53f8f4-457e-42f5-9ba2-cb9f383acf1b"
      unitRef="usd">6000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ic3e6860a06dc45078a5772ad589b6723_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfMy00LTEtMS0w_9d1703ce-2523-4902-96f1-afc961c30de3"
      unitRef="usd">3000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i17fc09b753d24ddfb9c43ac782832373_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfMy02LTEtMS0w_e98571c1-2e42-4adf-83c6-33166d3e3743"
      unitRef="usd">6000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i6059c690166441149c61f26c7db17255_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfMy04LTEtMS0w_943e02fc-57b7-43af-9c81-2f0ea560aae5"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="if433ba93efde45f38a5688307f77c9c4_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfNC0yLTEtMS0w_b13edd0e-1fb4-4d87-8c47-4bdeb4ff300b"
      unitRef="usd">148000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i876dc6b8472b4c2ea0c3ae119b771d02_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfNC00LTEtMS0w_17a8797d-325d-42ad-b104-200d144f021b"
      unitRef="usd">76000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i74d52c13d1e44d56853af2d044689b8c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfNC02LTEtMS0w_8ee9a9f1-9a4a-4ffd-ab2f-05b85cff6f2c"
      unitRef="usd">105000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ib11d64a866fe4276882eac217af0ec5f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RhYmxlOjQ2ZjY1ZTNmYjFmMDQyODk5NDNkYjM3ZTEzZjIwZGJlL3RhYmxlcmFuZ2U6NDZmNjVlM2ZiMWYwNDI4OTk0M2RiMzdlMTNmMjBkYmVfNC04LTEtMS0w_6a851f84-a706-4bbd-ac9b-3c2b68ea4938"
      unitRef="usd">34000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i0e1577fefc474a9b9a5a1b492deccd82_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfMjQ2Mw_3f2502c8-cb3f-434d-ad15-8d9f28cfeab4"
      unitRef="usd">50000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i986e7568db0547edb5f58a6f3d032e05_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfMjQ2Mw_f46b4975-dffa-47a6-800c-8702e16a768f"
      unitRef="usd">50000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i509fd5cc79b84947a1ddc23a201ceee8_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfMjQ2Nw_05d10a78-525b-455a-8861-d76da33739f5"
      unitRef="usd">41000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if08ac6b396064588b67bc488b59ea368_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfMjQ2Nw_611b402d-2644-4162-8931-1b9ef1c08a8b"
      unitRef="usd">41000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ie4f93cb048684f5f81d4c6d87a4b0f83_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfMjUwOA_247b0811-64e2-4948-83b2-dfff830902bf"
      unitRef="usd">9000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i637d3a2f463a43b4ba0c2c56616e75d5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfMjUwOA_3beb5bf0-0716-40c1-8cef-d42416f388ff"
      unitRef="usd">9000000</us-gaap:CostOfGoodsAndServicesSold>
    <mo:DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts
      contextRef="i9321155464464f6abb0579cd48d53de2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfMjc0ODc3OTA3OTg3Nw_4f8ea03c-5c52-4ee1-95f7-5667989b2e73"
      unitRef="usd">51000000</mo:DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts>
    <mo:DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts
      contextRef="i9321155464464f6abb0579cd48d53de2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfMjc0ODc3OTA3OTg3Nw_ad7026a9-66a0-4328-a2db-fb38ab78ea7d"
      unitRef="usd">51000000</mo:DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts>
    <mo:DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts
      contextRef="i800ea809d24a4ae99423280ab9ed1ce7_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfNDk0NzgwMjMzNTcyNg_6bdb1251-2609-46b3-8e43-077277d76a84"
      unitRef="usd">41000000</mo:DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts>
    <mo:DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts
      contextRef="i800ea809d24a4ae99423280ab9ed1ce7_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfNDk0NzgwMjMzNTczMg_c62635bf-cb7f-45c2-bc68-6f490b98c003"
      unitRef="usd">10000000</mo:DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts>
    <us-gaap:RestructuringCharges
      contextRef="iaf975d8c2d674ea3839f3277f75cf4f1_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfMzU0NA_fdd14038-064b-4bc4-b1b2-d331e467177f"
      unitRef="usd">395000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i99a5d17aefbc4d5ca90136899d314788_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfMzgwNQ_07728b88-3d49-43f1-a20a-7e057cf8c4c9"
      unitRef="usd">292000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i57818fd795f445829d1bf3dd90269c34_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfNDE0MA_bb5e3891-bf64-4d5f-b7a6-46d158e10af6"
      unitRef="usd">100000000</us-gaap:RestructuringCharges>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i2cc47fbf28e740b583be5f01ebc5de9b_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y184OC9mcmFnOjQ4ZjQ5ZTI0ZGRmMjQ2ODg4MjhjZjUzNjc4MTU0MjA5L3RleHRyZWdpb246NDhmNDllMjRkZGYyNDY4ODgyOGNmNTM2NzgxNTQyMDlfNDM3MQ_5b454d53-0110-499e-8eaf-00b41a315373"
      unitRef="usd">37000000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNTI4OA_6c876eb1-972a-4e82-95b5-4f538aaa66b9">Debt&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Short-term Borrowings and Borrowing Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2021 and December&#160;31, 2020, Altria had no short-term borrowings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 18, 2021, Altria entered into an extension and amendment (the &#x201c;Extension and Amendment&#x201d;) to its $3.0 billion senior unsecured 5-year revolving credit agreement (as amended, the &#x201c;Credit Agreement&#x201d;).  The Extension and Amendment extends the maturity date of the Credit Agreement from August 1, 2023 to August 1, 2024 and amends the Credit Agreement to update certain provisions regarding a successor interest rate to the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;) and make certain other market updates.  All other terms and conditions of the Credit Agreement remain in full force and effect.  The Credit Agreement, which is used for general corporate purposes, includes an additional option, subject to certain conditions, for Altria to extend the expiration date for an additional one-year period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2021, the Credit Agreement had available borrowings up to an aggregate principal amount of $3.0 billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pricing for interest and fees under the Credit Agreement may be modified in the event of a change in the rating of Altria&#x2019;s long-term senior unsecured debt.  Interest rates on borrowings under the Credit Agreement are expected to be based on LIBOR, or a fallback benchmark rate determined based on prevailing market convention, plus a percentage based on the higher of the ratings of Altria&#x2019;s long-term senior unsecured debt from Moody&#x2019;s Investors Service, Inc. (&#x201c;Moody&#x2019;s&#x201d;) and Standard&#160;&amp;amp; Poor&#x2019;s Financial Services LLC (&#x201c;S&amp;amp;P&#x201d;).  The applicable percentage based on Altria&#x2019;s long-term senior unsecured debt ratings&#160;at September&#160;30, 2021 for borrowings under the Credit Agreement was 1.0%.  The Credit Agreement does not include any other rating triggers, or any provisions that could require the posting of collateral.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement includes various covenants, one of which requires Altria to maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization (&#x201c;EBITDA&#x201d;) to Consolidated Interest Expense of not less than 4.0 to 1.0, calculated as of the end of the applicable quarter on a rolling four quarters basis.  At September&#160;30, 2021, the ratio of consolidated EBITDA to Consolidated Interest Expense, calculated in accordance with the Credit Agreement, was 9.8 to 1.0.  At September&#160;30, 2021, Altria was in compliance with its covenants in the Credit Agreement.  The terms &#x201c;Consolidated EBITDA&#x201d; and &#x201c;Consolidated Interest Expense,&#x201d; each as defined in the Credit Agreement, include certain adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, due to the uncertainty at that time in the global capital markets, including the commercial paper markets, resulting from the COVID-19 pandemic, Altria elected to borrow the full $3.0 billion available under the Credit Agreement as a precautionary measure to increase its cash position and preserve financial flexibility.  In June 2020, Altria repaid the full amount outstanding under the Credit Agreement using the net proceeds from the issuance of long-term senior unsecured notes issued in May 2020 and available cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any commercial paper issued by Altria and borrowings under the Credit Agreement are guaranteed by PM&#160;USA.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate carrying value of Altria&#x2019;s total long-term debt at September&#160;30, 2021 and December&#160;31, 2020 was $28.1 billion and $29.5 billion, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, Altria repaid in full senior unsecured notes in the aggregate principal amount of $1.5 billion at maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, Altria issued long-term senior unsecured notes in the aggregate principal amount of $5.5 billion (the &#x201c;Notes&#x201d;).  The net proceeds from the Notes were used (i) to fund the purchase and redemption of certain unsecured notes and payment of related fees and expenses, as described below, and (ii) for other general corporate purposes.  The Notes contain the following terms:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;$1.75 billion at 2.450%, due 2032, interest payable semiannually beginning August 4, 2021;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;$1.50 billion at 3.400%, due 2041, interest payable semiannually beginning August 4, 2021;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;$1.25 billion at 3.700%, due 2051, interest payable semiannually beginning August 4, 2021; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;$1.00 billion at 4.000%, due 2061, interest payable semiannually beginning August 4, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Notes are Altria&#x2019;s senior unsecured obligations and rank equally in right of payment with all of Altria&#x2019;s existing and future senior unsecured indebtedness.  Upon the occurrence of both (i) a change of control of Altria and (ii) the Notes ceasing to be rated investment grade by each of Moody&#x2019;s, S&amp;amp;P and Fitch Ratings, Inc. within a specified time period, Altria will be required to make an offer to purchase the Notes at a price equal to 101% of the aggregate principal amount of such Notes, plus accrued and unpaid interest to the date of repurchase as and to the extent set forth in the terms of the Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The obligations of Altria under the Notes are guaranteed by PM USA.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2021, Altria completed debt tender offers to purchase for cash certain of its long-term senior unsecured notes in an aggregate principal amount of $4,042 million.  Details of the debt tender offers are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Principal Amount of Notes Purchased&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.850% Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;795&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.950% Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;132&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000% Notes due 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;624&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.800% Notes due 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;655&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.400% Notes due 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;430&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.800% Notes due 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,094&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.950% Notes due 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.200% Notes due 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.200% Notes due 2059&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;229&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,042&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2021, Altria also redeemed all of its outstanding 3.490% Notes due 2022 in an aggregate principal amount of $1.0 billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the debt tender offers and redemption, during the first quarter of 2021, Altria recorded pre-tax losses on early extinguishment of debt of $649 million, which included premiums and fees of $623 million and the write-off of related unamortized debt discounts and debt issuance costs of $26 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2021 and December&#160;31, 2020, accrued interest on long-term debt of $206 million and $458 million, respectively, was included in other accrued liabilities on Altria&#x2019;s condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a discussion of the fair value of Altria&#x2019;s long-term debt and the designation of its Euro denominated senior unsecured notes as a net investment hedge of its investment in ABI, see Note 5. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ShortTermBorrowings
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfODg_6e89f641-31b9-46b9-8d76-f6c66633ebc1"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfODg_f5c7315a-cdc9-4315-b87a-b141814f4740"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0f700f27ee5b4dc0b6b7ca55099ab015_I20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMjc0ODc3OTA3NzQyOQ_822a2179-2e1b-480f-b4d0-884a94a85dbb"
      unitRef="usd">3000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentTerm
      contextRef="i8782aa269d064a7f878a2d5f0a778720_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMjE5OTAyMzI2MzY0MA_c92a75d3-9c23-41e7-ad3b-f55e178be964">P5Y</us-gaap:DebtInstrumentTerm>
    <mo:DebtInstrumentExtensionTerm
      contextRef="i8782aa269d064a7f878a2d5f0a778720_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNTI5Mw_9d80b219-6007-4a7a-8e53-89446761570f">P1Y</mo:DebtInstrumentExtensionTerm>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0f700f27ee5b4dc0b6b7ca55099ab015_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNTQ5NzU1ODE0NTk4Nw_49a3ad5b-6333-4277-a65c-f190a0bc66f7"
      unitRef="usd">3000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i4d9e692ae91a4176bbb8ab4a42237fa6_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMTE5MQ_4c950843-bd6b-4d9d-8272-61d15b995e9d"
      unitRef="number">0.010</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <mo:DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum
      contextRef="ic42084bb2e9740b8b51ae3feeb2862d5_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMTU2Mw_ea149248-224f-4aec-8c71-32381bc4e416"
      unitRef="number">4.0</mo:DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum>
    <mo:DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio
      contextRef="ic42084bb2e9740b8b51ae3feeb2862d5_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMTc5MA_fba01e2e-f829-478f-bc9b-efef4a12d88a"
      unitRef="number">9.8</mo:DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i634fff1d9b644e8cb5c918e89bad5ae8_D20200301-20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMjIxMg_a62e9d5a-702f-4c68-9ea4-39935d3744f2"
      unitRef="usd">3000000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:LongTermDebt
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMjc0NQ_a4d014f3-8b68-4c16-860c-a1cfd5b75668"
      unitRef="usd">28100000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMjc1Mg_dbcab7ba-5fee-4954-9087-45c2765d7a3e"
      unitRef="usd">29500000000</us-gaap:LongTermDebt>
    <us-gaap:RepaymentsOfUnsecuredDebt
      contextRef="ib0080cbb283042c7ad61da99c612ad5a_D20210501-20210531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMjg2NQ_5d3c5f49-031b-4c19-b5f9-df4a60c36e5d"
      unitRef="usd">1500000000</us-gaap:RepaymentsOfUnsecuredDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i2620d02ad1494d46ab52a4c075ab2c6b_I20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMjk4Mw_2093457f-5d90-4bb4-9897-3feb20756bd4"
      unitRef="usd">5500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i857205f0e0394b73ad424ddb571fbf8c_I20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMzI2MQ_e820f3c8-d09f-4d42-a1de-6aa7c759da7a"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i857205f0e0394b73ad424ddb571fbf8c_I20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMzI2Nw_89fb41bf-7eb8-4081-9a78-a8031856eced"
      unitRef="number">0.02450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="idb779f48ef584729a5fa769c008b9ac8_I20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMzMzOA_2420a3d2-ba42-4751-bc28-1ea09795bb83"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idb779f48ef584729a5fa769c008b9ac8_I20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMzM0NA_372077c2-3594-4bb3-a5fe-a5903e3aa5c7"
      unitRef="number">0.03400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i72bc00d2c5e94db1be910ff08d7edb62_I20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMzQxNA_7f673136-62fb-4f51-9efb-e2cf2dc43a5d"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i72bc00d2c5e94db1be910ff08d7edb62_I20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMzQyMA_a865f5f8-d292-4750-a208-97f076197217"
      unitRef="number">0.03700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="idd06b0461cd94297b50a5616b6cabc08_I20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMzQ5NA_3343bad2-72ae-422d-b6e5-6dbd69280960"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idd06b0461cd94297b50a5616b6cabc08_I20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfMzUwMA_4897a29c-d826-4100-935e-041b06fde0af"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="ifc8423e2c5df46eea5b83d3f181cc413_D20210201-20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNDAxMw_edf97e65-6a2a-4168-9f4f-b0584586c9ad"
      unitRef="number">1.01</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNTI4Ng_83059b90-df51-4d03-87cc-2d59b5a2653d">&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2021, Altria completed debt tender offers to purchase for cash certain of its long-term senior unsecured notes in an aggregate principal amount of $4,042 million.  Details of the debt tender offers are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Principal Amount of Notes Purchased&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.850% Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;795&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.950% Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;132&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000% Notes due 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;624&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.800% Notes due 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;655&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.400% Notes due 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;430&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.800% Notes due 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,094&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.950% Notes due 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.200% Notes due 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.200% Notes due 2059&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;229&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,042&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="ic85fd5bdf74f4f0091c93c498eb3cc11_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNDQyNQ_e1972a46-56a6-4dc4-aa39-3e0c16c8ebd5"
      unitRef="usd">4042000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2224c863f13e437d85f29be315d3c712_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfMS0wLTEtMS0wL3RleHRyZWdpb246NDRhZGFmOWZjMDNjNDY0ZjhlZWJhZWRlMzBiOTI3NzJfNA_0cc56b75-6d8d-4acd-a02c-7624ec789f6d"
      unitRef="number">0.02850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i2224c863f13e437d85f29be315d3c712_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfMS0xLTEtMS0w_b424dabf-e779-417a-a551-9be375b20ae8"
      unitRef="usd">795000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i808f87bc995d47d5a86a27d0ee9f22b4_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfMi0wLTEtMS0wL3RleHRyZWdpb246NjgyYjJmNjdiZjdiNDUwOWI2ZTU5ZmQzZDJlNTAxYjVfNA_a1657f26-2984-4960-8ae0-681c183182ea"
      unitRef="number">0.02950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i808f87bc995d47d5a86a27d0ee9f22b4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfMi0xLTEtMS0w_a6ea437b-e24c-4bf5-a90d-fbd63bd2a715"
      unitRef="usd">132000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2502deb2ffd14f39bc40df7e2d62056e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfMy0wLTEtMS0wL3RleHRyZWdpb246YjFmMjQ1YTRiZWRkNDhiMGIyOWU3MDRkMjg5MjVkZjdfNA_c604834e-b86d-4d21-a971-3b2caad111f6"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i2502deb2ffd14f39bc40df7e2d62056e_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfMy0xLTEtMS0w_fab747a0-640f-4059-b365-f75336835675"
      unitRef="usd">624000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie52346405ce94721b9a8f4e6ccd91ef6_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfNC0wLTEtMS0wL3RleHRyZWdpb246MDdlZWViZTNjZWY0NDM4MTk0MGQ0NWQyNjBhNzkyNGZfNA_df84b60e-e995-455b-ac41-401b32fc1876"
      unitRef="number">0.03800</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="ie52346405ce94721b9a8f4e6ccd91ef6_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfNC0xLTEtMS0w_0ef13555-f376-4526-b6f7-2d12eda46be1"
      unitRef="usd">655000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icab982db20034341aa05031441a073b1_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfNS0wLTEtMS0wL3RleHRyZWdpb246NGQ5YzUyNjUyMjliNGMwY2E0MzNhNWRmMmVmMTE2MTlfNA_5c81171c-5163-4573-8c58-123e014c9e8b"
      unitRef="number">0.04400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="icab982db20034341aa05031441a073b1_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfNS0xLTEtMS0w_25a3f13e-569a-4484-ae6f-002b9c8778d6"
      unitRef="usd">430000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5d76ccb7e1a5434bb17c22937296a8ae_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfNi0wLTEtMS0wL3RleHRyZWdpb246ZTM1NmNmOTAwZWFlNDZhMWI1Yzc1NzVkMzk0YmQyNjBfNA_7e72a0cc-7e5f-447e-8628-37d54638ff6d"
      unitRef="number">0.04800</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i5d76ccb7e1a5434bb17c22937296a8ae_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfNi0xLTEtMS0w_17c78a9f-ea93-4f85-b573-7696a6295851"
      unitRef="usd">1094000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iffbca0a488934ac8a34f87b93f39560e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfNy0wLTEtMS0wL3RleHRyZWdpb246YzQzOWM4NjBjOWY2NGQ0ZDkxM2RjNjc1N2YwN2ExYzVfNA_1b23df55-26c9-4f6a-b9da-8ffb12c66f84"
      unitRef="number">0.09950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="iffbca0a488934ac8a34f87b93f39560e_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfNy0xLTEtMS0w_f6b8cd42-a5f4-488f-9ca7-76a247b1afdb"
      unitRef="usd">65000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i61833c0644204fbfbcc52b66fce61e91_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfOC0wLTEtMS0wL3RleHRyZWdpb246NGVjYjZlNzA0NWY3NGY0NGFmYTBiZDkxYWY5OGQxZGJfNA_d1bdf8ec-50cb-423b-8967-2c2fb7d2d3e8"
      unitRef="number">0.10200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i61833c0644204fbfbcc52b66fce61e91_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfOC0xLTEtMS0w_3b80f4bb-1aa3-460d-a1f7-97dd946de1cb"
      unitRef="usd">18000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i347f7da5d0054edbad9c6e2ea4a0651c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfOS0wLTEtMS0wL3RleHRyZWdpb246ZDdjZGVkOGRjMGExNDkzMWFiYzA2OWQ3NjY1ZDhiZGFfNA_d03ca73d-defe-48ba-b368-06d3e5770f0b"
      unitRef="number">0.06200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i347f7da5d0054edbad9c6e2ea4a0651c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfOS0xLTEtMS0w_1a2035c5-1b61-48af-af97-3436c2ce10ff"
      unitRef="usd">229000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="ic85fd5bdf74f4f0091c93c498eb3cc11_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RhYmxlOjUyNmJkODc1YTFiZjQyM2VhMTU5YTRiOGFmZjhmY2RkL3RhYmxlcmFuZ2U6NTI2YmQ4NzVhMWJmNDIzZWExNTlhNGI4YWZmOGZjZGRfMTAtMS0xLTEtMA_e1972a46-56a6-4dc4-aa39-3e0c16c8ebd5"
      unitRef="usd">4042000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic1fd6ffda965426487b95b70a8b31910_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNDU2MA_ca1573db-780b-4727-9b5d-f9c69d5b765f"
      unitRef="number">0.03490</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i20e14cfe0c0d46339af63110c7811e34_D20210101-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNDYxNA_4b1c9adb-bcf1-4f94-ab73-3a322a0b5bf8"
      unitRef="usd">1000000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ice0b95503da241eb84089a6759b1e50f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNDc3Mg_4e1f77c4-e6c3-43ca-8fb0-4c204174c75c"
      unitRef="usd">-649000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="ice0b95503da241eb84089a6759b1e50f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNDgxMg_3f62df37-a1ec-473b-a55b-dbbb5b1a004d"
      unitRef="usd">-623000000</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="ice0b95503da241eb84089a6759b1e50f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNDg5OA_d6174176-039c-49a2-b88f-61a6ea3289ff"
      unitRef="usd">26000000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNDk1NA_606e84b7-3354-43b6-b485-96671b95d040"
      unitRef="usd">206000000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185NC9mcmFnOjI1Yjg2YzFmMjQ2ZDQ3ZjY4YjI0YmYzMmVlODhhZTRjL3RleHRyZWdpb246MjViODZjMWYyNDZkNDdmNjhiMjRiZjMyZWU4OGFlNGNfNDk2MQ_51ccebe2-7704-492e-bcd5-75953729ee9e"
      unitRef="usd">458000000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RleHRyZWdpb246M2ViZTg4MDQzNGQ2NDUzYTk2MDIyOWQwYWJhZmJiNDRfMTIwMw_0c17ce46-8321-44da-a1fa-34780b225b90">Income Taxes&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Earnings (losses) before income taxes, provision (benefit) for income taxes and income tax rates consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (losses) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,544&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,349&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,302)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(324)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision (benefit) for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;693&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,817&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;44.9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(195.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria&#x2019;s income tax rates for the nine and three months ended September 30, 2021 and 2020 are not comparable in a meaningful way due to the following significant pre-tax charges and valuation allowances:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;the $6,157 million impairment of Altria&#x2019;s equity investment in ABI during the nine and three months ended September 30, 2021;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;the $2,600 million impairment of Altria&#x2019;s investment in JUUL during the nine and three months ended September 30, 2020 and valuation allowances associated with Altria&#x2019;s investments in JUUL and Altria&#x2019;s Investment in Cronos.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria&#x2019;s income tax rates for the nine and three months ended September 30, 2021 differ from the U.S. federal statutory rate of 21%, due primarily to the state tax treatment of the impairment charge on Altria&#x2019;s equity investment in ABI.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria&#x2019;s income tax rates for the nine and three months ended September 30, 2020 differ from the U.S. federal statutory rate of 21%, due primarily to valuation allowances primarily attributable to deferred tax assets recorded in connection with the impairment of Altria&#x2019;s investment in JUUL, and Altria&#x2019;s Investment in Cronos.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For further information on the impairments of Altria&#x2019;s equity investment in ABI and investment in JUUL, see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Note 4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Equity Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following chart provides a reconciliation of the beginning and ending valuation allowances for the period ended September&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions to valuation allowance charged to income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;264&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions to valuation allowance credited to income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,004&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria determines the realizability of deferred tax assets based on the weight of available evidence, that it is more-likely-than-not that the deferred tax asset will not be realized. In reaching this determination, Altria considers all available positive and negative evidence, including the character of the loss, carryback and carryforward considerations, future reversals of temporary differences and available tax planning strategies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The current changes in valuation allowances were due to deferred tax assets recorded in connection with Altria&#x2019;s Investment in Cronos and changes in the estimated fair value of its investment in JUUL.  The valuation allowance at the end of the period is primarily attributable to deferred tax assets recorded in connection with Altria&#x2019;s investment in JUUL and Investment in Cronos.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <mo:SummaryOfIncomeTaxesTableTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RleHRyZWdpb246M2ViZTg4MDQzNGQ2NDUzYTk2MDIyOWQwYWJhZmJiNDRfMjE5OTAyMzI3NzA4Mg_3f9a4a90-29c5-4ac6-9206-e836e76de121">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Earnings (losses) before income taxes, provision (benefit) for income taxes and income tax rates consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (losses) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,544&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,349&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,302)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(324)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision (benefit) for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;693&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,817&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;44.9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(195.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</mo:SummaryOfIncomeTaxesTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjBiZmYxZmFkMzBjODQwOTE4MWIyODFiN2Y5MGQ1MDU0L3RhYmxlcmFuZ2U6MGJmZjFmYWQzMGM4NDA5MTgxYjI4MWI3ZjkwZDUwNTRfMi0yLTEtMS00OTgwNQ_14729549-bae0-4437-9f55-f1ca207159c1"
      unitRef="usd">1544000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjBiZmYxZmFkMzBjODQwOTE4MWIyODFiN2Y5MGQ1MDU0L3RhYmxlcmFuZ2U6MGJmZjFmYWQzMGM4NDA5MTgxYjI4MWI3ZjkwZDUwNTRfMi00LTEtMS00OTgwNQ_f5893501-75bc-4e2f-8cc1-253074215a5e"
      unitRef="usd">4349000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjBiZmYxZmFkMzBjODQwOTE4MWIyODFiN2Y5MGQ1MDU0L3RhYmxlcmFuZ2U6MGJmZjFmYWQzMGM4NDA5MTgxYjI4MWI3ZjkwZDUwNTRfMi02LTEtMS00OTgwNQ_05e3c760-27af-4548-8120-d18b73b3f01e"
      unitRef="usd">-3302000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjBiZmYxZmFkMzBjODQwOTE4MWIyODFiN2Y5MGQ1MDU0L3RhYmxlcmFuZ2U6MGJmZjFmYWQzMGM4NDA5MTgxYjI4MWI3ZjkwZDUwNTRfMi04LTEtMS00OTgwNQ_3baf5292-fbc1-4016-be27-d481b021929e"
      unitRef="usd">-324000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjBiZmYxZmFkMzBjODQwOTE4MWIyODFiN2Y5MGQ1MDU0L3RhYmxlcmFuZ2U6MGJmZjFmYWQzMGM4NDA5MTgxYjI4MWI3ZjkwZDUwNTRfMy0yLTEtMS00OTgwNQ_d1a4369f-9028-49f4-a75b-b2c99d21d136"
      unitRef="usd">693000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjBiZmYxZmFkMzBjODQwOTE4MWIyODFiN2Y5MGQ1MDU0L3RhYmxlcmFuZ2U6MGJmZjFmYWQzMGM4NDA5MTgxYjI4MWI3ZjkwZDUwNTRfMy00LTEtMS00OTgwNQ_4123e773-356a-4d15-8b2d-4de11690a07f"
      unitRef="usd">1817000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjBiZmYxZmFkMzBjODQwOTE4MWIyODFiN2Y5MGQ1MDU0L3RhYmxlcmFuZ2U6MGJmZjFmYWQzMGM4NDA5MTgxYjI4MWI3ZjkwZDUwNTRfMy02LTEtMS00OTgwNQ_6400eadf-2d6a-4a52-b71f-a7a83951a741"
      unitRef="usd">-582000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjBiZmYxZmFkMzBjODQwOTE4MWIyODFiN2Y5MGQ1MDU0L3RhYmxlcmFuZ2U6MGJmZjFmYWQzMGM4NDA5MTgxYjI4MWI3ZjkwZDUwNTRfMy04LTEtMS00OTgwNQ_8a6e71f3-10fc-4cf0-a915-ec8d25a6c049"
      unitRef="usd">632000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjBiZmYxZmFkMzBjODQwOTE4MWIyODFiN2Y5MGQ1MDU0L3RhYmxlcmFuZ2U6MGJmZjFmYWQzMGM4NDA5MTgxYjI4MWI3ZjkwZDUwNTRfNC0yLTEtMS01MDA1OA_7dbb1270-470f-4f51-a1a4-0bec2ff89495"
      unitRef="number">0.449</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjBiZmYxZmFkMzBjODQwOTE4MWIyODFiN2Y5MGQ1MDU0L3RhYmxlcmFuZ2U6MGJmZjFmYWQzMGM4NDA5MTgxYjI4MWI3ZjkwZDUwNTRfNC00LTEtMS01MDA2NA_36b4e49e-622a-4808-85dc-90d90e2a9115"
      unitRef="number">0.418</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjBiZmYxZmFkMzBjODQwOTE4MWIyODFiN2Y5MGQ1MDU0L3RhYmxlcmFuZ2U6MGJmZjFmYWQzMGM4NDA5MTgxYjI4MWI3ZjkwZDUwNTRfNC02LTEtMS01MDA3Mg_17b74217-4fb1-4e33-8643-cb24b9c0d59c"
      unitRef="number">0.176</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjBiZmYxZmFkMzBjODQwOTE4MWIyODFiN2Y5MGQ1MDU0L3RhYmxlcmFuZ2U6MGJmZjFmYWQzMGM4NDA5MTgxYjI4MWI3ZjkwZDUwNTRfNC04LTEtMS01MDA5MQ_6c04d5ff-bd4d-48c6-b1e0-b0a35d2f1a97"
      unitRef="number">-1.951</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <mo:EquityMethodInvestmentImpairment
      contextRef="ife49fc973ca746f092aa4d83bca9d740_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RleHRyZWdpb246M2ViZTg4MDQzNGQ2NDUzYTk2MDIyOWQwYWJhZmJiNDRfMjc0ODc3OTA5MDU1Mg_43b69887-e836-4433-9d85-30be1704a462"
      unitRef="usd">6157000000</mo:EquityMethodInvestmentImpairment>
    <mo:EquityMethodInvestmentImpairment
      contextRef="ic62d4fc827d0412695035c4816dc2a17_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RleHRyZWdpb246M2ViZTg4MDQzNGQ2NDUzYTk2MDIyOWQwYWJhZmJiNDRfMjc0ODc3OTA5MDU1Mg_a3b5d996-7b94-4612-8e99-24de2166adfc"
      unitRef="usd">6157000000</mo:EquityMethodInvestmentImpairment>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="iff7bce46de9948cfbbc1a3790debcee8_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RleHRyZWdpb246M2ViZTg4MDQzNGQ2NDUzYTk2MDIyOWQwYWJhZmJiNDRfMjc0ODc3OTA5MDU2Mg_47fd4983-27fe-40d1-9652-1ccc27ccb763"
      unitRef="usd">2600000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i26492b9b36f34d359befa59e3e1f285d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RleHRyZWdpb246M2ViZTg4MDQzNGQ2NDUzYTk2MDIyOWQwYWJhZmJiNDRfMjc0ODc3OTA5MDU2Mg_df27a969-3c31-4d60-bbfa-3bbd1cb63fc1"
      unitRef="usd">2600000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:SummaryOfValuationAllowanceTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RleHRyZWdpb246M2ViZTg4MDQzNGQ2NDUzYTk2MDIyOWQwYWJhZmJiNDRfMTIwMg_dad3f485-9472-41fd-8f88-495c6d0034a3">&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following chart provides a reconciliation of the beginning and ending valuation allowances for the period ended September&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions to valuation allowance charged to income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;264&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions to valuation allowance credited to income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,004&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjAyYjc0MjdjZTQxMTQ5MzhhYzllNDc5MWQ2MmM1MGY2L3RhYmxlcmFuZ2U6MDJiNzQyN2NlNDExNDkzOGFjOWU0NzkxZDYyYzUwZjZfMS0yLTEtMS0w_fe526642-f00c-4433-a94b-f4c3b8c1aca5"
      unitRef="usd">2817000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <mo:ValuationAllowanceDeferredTaxAssetIncreaseInAmount
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjAyYjc0MjdjZTQxMTQ5MzhhYzllNDc5MWQ2MmM1MGY2L3RhYmxlcmFuZ2U6MDJiNzQyN2NlNDExNDkzOGFjOWU0NzkxZDYyYzUwZjZfMi0yLTEtMS0w_9a086ff7-723e-465b-b93b-24f5110ca03d"
      unitRef="usd">264000000</mo:ValuationAllowanceDeferredTaxAssetIncreaseInAmount>
    <mo:ValuationAllowanceDeferredTaxAssetDecreaseInAmount
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjAyYjc0MjdjZTQxMTQ5MzhhYzllNDc5MWQ2MmM1MGY2L3RhYmxlcmFuZ2U6MDJiNzQyN2NlNDExNDkzOGFjOWU0NzkxZDYyYzUwZjZfMy0yLTEtMS0w_1b2f14d7-2c04-4d74-96bd-9026cb03c11d"
      unitRef="usd">73000000</mo:ValuationAllowanceDeferredTaxAssetDecreaseInAmount>
    <mo:ValuationAllowanceForeignCurrencyTranslationAdjustment
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjAyYjc0MjdjZTQxMTQ5MzhhYzllNDc5MWQ2MmM1MGY2L3RhYmxlcmFuZ2U6MDJiNzQyN2NlNDExNDkzOGFjOWU0NzkxZDYyYzUwZjZfNC0yLTEtMS0w_5b264c7e-c681-4f28-a5d4-e5c16afab1f8"
      unitRef="usd">-4000000</mo:ValuationAllowanceForeignCurrencyTranslationAdjustment>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y185Ny9mcmFnOjNlYmU4ODA0MzRkNjQ1M2E5NjAyMjlkMGFiYWZiYjQ0L3RhYmxlOjAyYjc0MjdjZTQxMTQ5MzhhYzllNDc5MWQ2MmM1MGY2L3RhYmxlcmFuZ2U6MDJiNzQyN2NlNDExNDkzOGFjOWU0NzkxZDYyYzUwZjZfNS0yLTEtMS0w_25c1dc25-24dc-4577-a24c-b5c1f87e841c"
      unitRef="usd">3004000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:LegalMattersAndContingenciesTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzYyNTk0_7abcdf57-0268-44ca-9d11-8de5bb7eb8b8">Contingencies&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legal proceedings covering a wide range of matters are pending or threatened in various U.S. and foreign jurisdictions against Altria and its subsidiaries, including PM USA and USSTC, as well as their respective indemnitees and Altria&#x2019;s investees.  Various types of claims may be raised in these proceedings, including product liability, unfair trade practices, antitrust, tax, contraband shipments, patent infringement, employment matters, claims alleging violation of the Racketeer Influenced and Corrupt Organizations Act (&#x201c;RICO&#x201d;), claims for contribution and claims of competitors, shareholders or distributors.  Legislative action, such as changes to tort law, also may expand the types of claims and remedies available to plaintiffs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Litigation is subject to uncertainty and it is possible that there could be adverse developments in pending or future cases.  An unfavorable outcome or settlement of pending tobacco-related or other litigation could encourage the commencement of additional litigation.  Damages claimed in some tobacco-related and other litigation are or can be significant and, in certain cases, have ranged in the billions of dollars.  The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome.  In certain cases, plaintiffs claim that defendants&#x2019; liability is joint and several.  In such cases, Altria or its subsidiaries may face the risk that one or more co-defendants decline or otherwise fail to participate in the bonding required for an appeal or to pay their proportionate or jury-allocated share of a judgment.  As a result, Altria or its subsidiaries under certain circumstances may have to pay more than their proportionate share of any bonding- or judgment-related amounts.  Furthermore, in those cases where plaintiffs are successful, Altria or its subsidiaries also may be required to pay interest and attorneys&#x2019; fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although PM USA has historically been able to obtain required bonds or relief from bonding requirements in order to prevent plaintiffs from seeking to collect judgments while adverse verdicts have been appealed, there remains a risk that such relief may not be obtainable in all cases.  This risk has been substantially reduced given that 47 states and Puerto Rico limit the dollar amount of bonds or require no bond at all.  As discussed below, however, tobacco litigation plaintiffs have challenged the constitutionality of Florida&#x2019;s bond cap statute in several cases and plaintiffs may challenge state bond cap statutes in other jurisdictions as well.  Such challenges may include the applicability of state bond caps in federal court.  States, including Florida, also may seek to repeal or alter bond cap statutes through legislation.  Although Altria cannot predict the outcome of such challenges, it is possible that the consolidated results of operations, cash flows or financial position of Altria, or one or more of its subsidiaries, could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome of one or more such challenges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria and its subsidiaries record provisions in the condensed consolidated financial statements for pending litigation when they determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated.  At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, except to the extent discussed elsewhere in this Note 12. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: (i)&#160;management has concluded that it is not probable that a loss has been incurred in any of the pending cases; (ii)&#160;management is unable to estimate the possible loss or range of loss that could result from an unfavorable outcome in any of the pending cases; and (iii)&#160;accordingly, management has not provided any amounts in the condensed consolidated financial statements for unfavorable outcomes, if any.  Litigation defense costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria and its subsidiaries have achieved substantial success in managing litigation.  Nevertheless, litigation is subject to uncertainty and significant challenges remain.  It is possible that the consolidated results of operations, cash flows or financial position of Altria, or one or more of its subsidiaries, could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation.  Altria and each of its subsidiaries named as a defendant believe, and each has been so advised by counsel handling the respective cases, that it has valid defenses to the litigation pending against it, as well as valid bases for appeal of adverse verdicts.  Each of the companies has defended, and will continue to defend, vigorously against litigation challenges.  However, Altria and its subsidiaries may enter into settlement discussions in particular cases if they believe it is in the best interests of Altria to do so.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Judgments Paid and Provisions for Tobacco and Health and Certain Other Litigation Items (Including &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; Progeny Litigation): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After exhausting all appeals in those cases resulting in adverse verdicts associated with tobacco-related litigation, since October 2004, PM USA has paid judgments and settlements (including related costs and fees) totaling approximately $865 million and interest totaling approximately $218 million as of September 30, 2021.  These amounts include payments for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny judgments (and related costs and fees) totaling approximately $410 million and related interest totaling approximately $56 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in Altria&#x2019;s accrued liability for tobacco and health and certain other litigation items, including related interest costs, for the periods specified below are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liability for tobacco and health and certain other  litigation items at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax charges for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tobacco and health and certain other litigation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;99&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related interest costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liability for tobacco and health and certain other  litigation items at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes amounts related to certain other litigation and pre-trial resolution of certain tobacco and health cases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accrued liability for tobacco and health and certain other litigation items, including related interest costs, was included in accrued liabilities on Altria&#x2019;s condensed consolidated balance sheets.  Pre-tax charges for tobacco and health and certain other litigation were included in marketing, administration and research costs on Altria&#x2019;s condensed consolidated statements of earnings (losses).  Pre-tax charges for related interest costs were included in interest and other debt expense, net on Altria&#x2019;s condensed consolidated statements of earnings (losses).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Security for Judgments: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To obtain stays of judgments pending appeal, PM USA has posted various forms of security.  As of September 30, 2021, PM USA has posted appeal bonds totaling approximately $45 million, which have been collateralized with restricted cash that are included in assets on the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Overview of Altria and/or PM USA Tobacco-Related Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Types and Number of U.S. Cases: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Claims related to tobacco products generally fall within the following categories: (i)&#160;smoking and health cases alleging personal injury brought on behalf of individual plaintiffs; (ii)&#160;health care cost recovery cases brought by governmental (both domestic and foreign) plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and/or disgorgement of profits; (iii) e-vapor cases alleging violation of RICO, fraud, failure to warn, design defect, negligence, antitrust and unfair trade practices; and (iv)&#160;other tobacco-related litigation described below.  Plaintiffs&#x2019; theories of recovery and the defenses raised in tobacco-related litigation are discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below lists the number of certain tobacco-related cases pending in the U.S. against PM USA and/or Altria as of October 25, 2021, October 27, 2020 and October 28, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt;text-indent:-9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;October 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;October 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;October 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual Smoking and Health Cases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;179&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Care Cost Recovery Actions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;E-vapor Cases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,951&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Tobacco-Related Cases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes 18 cases filed in Illinois, 17 cases filed in New Mexico, 40 cases filed in Massachusetts and 70 non-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;cases filed in Florida.  Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;case (these &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; progeny cases are discussed below in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smoking and Health Litigation - Engle Class Action&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).  Also does not include 1,471 cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (&#x201c;ETS&#x201d;).  The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Broin&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).  The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages.  Class members were prohibited from filing individual lawsuits after 2000 under the court-approved settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Cost Recovery Litigation - Federal Government&#x2019;s Lawsuit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes 53 class action lawsuits, 2,548 individual lawsuits and 350 &#x201c;third party&#x201d; lawsuits relating to JUUL e-vapor products, which include school districts, state and local government, tribal and healthcare organization lawsuits.  JUUL is an additional named defendant in each of these lawsuits. The 53 class action lawsuits include 28 cases in the Northern District of California (&#x201c;Multidistrict Litigation&#x201d; or &#x201c;MDL&#x201d;) involving plaintiffs whose claims were previously included in other class action complaints but were refiled as separate stand-alone class actions for procedural and other reasons.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms &#x201c;Lights&#x201d; and &#x201c;Ultra Lights&#x201d; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;International Tobacco-Related Cases: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of October 25, 2021, (i) Altria is named as a defendant in three e-vapor class action lawsuits in Canada; (ii) PM USA is a named defendant in 10 health care cost recovery actions in Canada, eight of which also name Altria as a defendant; and (iii) PM USA and Altria are named as defendants in seven smoking and health class actions filed in various Canadian provinces.  See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Guarantees and Other Similar Matters&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below for a discussion of the Distribution Agreement between Altria and Philip Morris International Inc. (&#x201c;PMI&#x201d;) that provides for indemnities for certain liabilities concerning tobacco products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Tobacco-Related Cases Set for Trial: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of October 25, 2021, no &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny or individual smoking and health cases against PM USA are set for trial through December 31, 2021.  Trial dates are subject to change and many of the trials were postponed due to the COVID-19 pandemic; however, the courts are reopening and additional trials may be scheduled for the remainder of 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Trial Results: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since January 1999, excluding the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny cases (separately discussed below), verdicts have been returned in 69 tobacco-related cases in which PM USA was a defendant. Verdicts in favor of PM USA and other defendants were returned in 44 of the 69 cases.  These 44 cases were tried in Alaska (1), California (7), Connecticut (1), Florida (10), Louisiana (1), Massachusetts (4), Mississippi (1), Missouri (4), New Hampshire (1), New Jersey (1), New York (5), Ohio (2), Pennsylvania (1), Rhode Island (1), Tennessee (2) and West Virginia (2).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Of the 25 non-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases in which verdicts were returned in favor of plaintiffs, 20 have reached final resolution, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and two cases (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Gentile &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Principe&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) that were initially returned in favor of plaintiffs were reversed post-trial and remain pending.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smoking and Health Liti&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;gation - Engle Progeny Trial Results&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below for a discussion of verdicts in state and federal &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases involving PM USA as of October 25, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Smoking and Health Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Overview: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Plaintiffs&#x2019; allegations of liability in smoking and health cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, nuisance, breach of express and implied warranties, breach of special duty, conspiracy, concert of action, violations of unfair trade practice laws and consumer protection statutes, and claims under the federal and state anti-racketeering statutes.  Plaintiffs in the smoking and health cases seek various forms of relief, including compensatory and punitive damages, treble/multiple damages and other statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and equitable relief.  Defenses raised in these cases include lack of proximate cause, assumption of the risk, comparative fault and/or contributory negligence, statutes of limitations and preemption by the Federal Cigarette Labeling and Advertising Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Non-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; Progeny Litigation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summarized below are the non-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny smoking and health cases pending during 2021 in which a verdict was returned in favor of plaintiff and against PM USA.  Charts listing certain verdicts for plaintiffs in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny cases can be found in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smoking and Health Litigation - Engle Progeny Trial Results&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Principe&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In February 2020, a jury in a Florida state court returned a verdict in favor of plaintiff and against PM USA, awarding approximately $11 million in compensatory damages.  There was no claim for punitive damages.  PM USA appealed the trial court verdict to the Third District Court of Appeal and, in September 2021, the appellate court reversed the trial court&#x2019;s decision and found in favor of PM USA.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Greene&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In September 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiffs and against PM USA, awarding approximately $10 million in compensatory damages.  In May 2020, the court ruled on plaintiffs&#x2019; remaining claim and trebled the compensatory damages award to approximately $30 million.  In February 2021, the trial court awarded plaintiffs attorneys&#x2019; fees and costs in the amount of approximately $2.3 million.  Also in February 2021, PM USA served its post-trial motions to reverse the judgment or for a new trial. The trial court denied the post-trial motions in June 2021.  In July 2021, PM USA appealed the judgment to the Appeals Court of Massachusetts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Laramie&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In August 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiff and against PM USA, awarding $11 million in compensatory damages and $10 million in punitive damages.  PM USA appealed and, in February 2021, the Massachusetts Supreme Judicial Court asserted jurisdiction over the appeal.  In September 2021, the Massachusetts Supreme Judicial Court affirmed the trial court award of $21 million in compensatory and punitive damages.  PM USA recorded a pre-tax provision of approximately $27.1 million for the judgment, including interest, in the third quarter of 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Gentile&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In October 2017, a jury in a Florida state court returned a verdict in favor of plaintiff and against PM USA, awarding approximately $7.1 million in compensatory damages and allocating 75% of the fault to PM USA.  PM USA appealed.  In September 2019, the Florida Fourth District Court of Appeal reversed the judgment entered by the trial court, granted PM USA judgment on certain claims and remanded for a new trial on the remaining claims.  Plaintiff petitioned the Florida Supreme Court for further review, which the court denied in January 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Federal Government&#x2019;s Lawsuit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Cost Recovery Litigation - Federal Government&#x2019;s Lawsuit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below for a discussion of the verdict and post-trial developments in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States of America&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; health care cost recovery case.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; Class Action: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2000, in the second phase of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; smoking and health class action in Florida, a jury returned a verdict assessing punitive damages totaling approximately $145 billion against various defendants, including $74 billion against PM USA.  Following entry of judgment, PM USA appealed.  In May 2003, the Florida Third District Court of Appeal reversed the judgment entered by the trial court and instructed the trial court to order the decertification of the class.  Plaintiffs petitioned the Florida Supreme Court for further review.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2006, the Florida Supreme Court ordered that the punitive damages award be vacated, that the class approved by the trial court be decertified and that members of the decertified class could file individual actions against defendants within one year of issuance of the mandate.  The court further declared the following Phase I findings are entitled to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;res judicata&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; effect in such individual actions brought within one year of the issuance of the mandate: (i)&#160;that smoking causes various diseases; (ii)&#160;that nicotine in cigarettes is addictive; (iii)&#160;that defendants&#x2019; cigarettes were defective and unreasonably dangerous; (iv)&#160;that defendants concealed or omitted material information not otherwise known or available knowing that the material was false or misleading or failed to disclose a material fact concerning the health effects or addictive nature of smoking; (v)&#160;that defendants agreed to misrepresent information regarding the health effects or addictive nature of cigarettes with the intention of causing the public to rely on this information to their detriment; (vi)&#160;that defendants agreed to conceal or omit information regarding the health effects of cigarettes or their addictive nature with the intention that smokers would rely on the information to their detriment; (vii)&#160;that all defendants sold or supplied cigarettes that were defective; and (viii)&#160;that defendants were negligent.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2006, PM USA and plaintiffs sought rehearing from the Florida Supreme Court on parts of its July 2006 opinion.  In December 2006, the Florida Supreme Court refused to revise its July 2006 ruling, except that it revised the set of Phase I findings entitled to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;res judicata&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; effect by excluding finding (v)&#160;listed above (relating to agreement to misrepresent information), and added the finding that defendants sold or supplied cigarettes that, at the time of sale or supply, did not conform to the representations of fact made by defendants.  In February 2008, the trial court decertified the class.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Pending &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engl&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;e Progeny Cases: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The deadline for filing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases expired in January 2008, at which point a total of approximately 9,300 federal and state claims were pending.  As of October 25, 2021, approximately 1,026 state court cases were pending against PM USA or Altria asserting individual claims by or on behalf of approximately 1,285 state court plaintiffs.&#160; Because of a number of factors, including docketing delays, duplicated filings and overlapping dismissal orders, these numbers are estimates.  While the Federal &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Agreement (discussed below) resolved nearly all &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny cases pending in federal court, as of October 25, 2021, two cases were pending against PM USA in federal court representing the cases excluded from that agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; Progeny Trial Results: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of October 25, 2021, 137 federal and state &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases involving PM USA have resulted in verdicts since the Florida Supreme Court &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; decision.  Seventy-six verdicts were returned in favor of plaintiffs and seven verdicts (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Skolnick&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Calloway&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Oshinsky-Blacker,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;McCoy, Mahfuz, Neff and Frogel&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) that were initially returned in favor of plaintiffs were reversed post-trial or on appeal and remain pending.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fifty-four verdicts were returned in favor of PM USA, of which 44 were state cases.  In addition, there have been a number of mistrials, only some of which have resulted in new trials as of October 25, 2021.  The jury in one case, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Garcia&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, awarded plaintiff compensatory damages and found plaintiff was entitled to punitive damages; however, the court declared a mistrial in the second phase of the trial regarding punitive damages because the jury was unable to determine the amount of the punitive damages. Four verdicts (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pearson, D. Cohen&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collar &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Chacon&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) that were returned in favor of PM USA were subsequently reversed for new trials.  Juries in two cases (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reider &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Banks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;returned zero damages verdicts in favor of PM USA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Juries in two other cases (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Weingart&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Hancock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) returned verdicts against PM USA awarding no damages, but the trial court in each case decided to award plaintiffs damages.  One case, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pollari, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;resulted in a verdict in favor of PM USA following a retrial of an initial verdict returned in favor of plaintiff.  Plaintiff and defendants appealed the verdict and the appellate court affirmed the judgement in favor of the defendants.  Three cases, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Gloger,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Rintoul &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Caprio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Duignan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, resulted in verdicts in favor of plaintiffs following retrial of initial verdicts returned in favor of plaintiffs.  Post-trial appeals are pending in those three cases.  Two cases, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Freeman &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Harris&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, resulted in an appellate reversal of a jury verdict in favor of plaintiff, and a judgment in favor of PM USA.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The charts below list the verdicts and post-trial developments in certain &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases in which verdicts were returned in favor of plaintiffs.  The first chart lists cases that are pending as of October 25, 2021 but where PM USA has determined an unfavorable outcome is not probable and the amount of loss cannot be reasonably estimated.  The second chart lists cases that have concluded within the previous 12 months.  Unless otherwise noted for a particular case, the jury&#x2019;s award for compensatory damages will not be reduced by any finding of plaintiff&#x2019;s comparative fault.  Further, the damages noted reflect adjustments based on post-trial or appellate rulings.  As of October 25, 2021, there are no &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases where PM USA has recorded a provision in its condensed consolidated financial statements because PM USA has not determined for any currently pending case that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;References below to &#x201c;R.J. Reynolds,&#x201d; &#x201c;Lorillard&#x201d; and &#x201c;Liggett Group&#x201d; are to R.J. Reynolds Tobacco Company, Lorillard Tobacco Company and Liggett Group, LLC, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Currently Pending Engle Cases with Verdicts Against PM USA &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(rounded to nearest $ million)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.488%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Plaintiff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Verdict Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Defendant(s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Court&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Compensatory Damages &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Punitive Damages &lt;br/&gt;(PM USA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Appeal Status&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Lipp&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$15 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$28 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Defendant&#x2019;s post-trial motions denied.  Defendant plans to appeal.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Garcia&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;May 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mistrial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by defendant to Third District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Duignan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;February 2020 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pinellas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$12&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by defendants to Second District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cuddihee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;January 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Duval&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by defendant to First District Court of Appeal pending. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Rintoul &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Caprio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;November 2019 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$9&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$74 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by plaintiff and defendants to Fourth District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Gloger&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;November 2019 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$15&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$11 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by defendants to Third District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;McCall&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1&#160;million (&amp;lt;$1&#160;million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;New trial ordered on punitive damages.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Neff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$4&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fourth District Court of Appeal reversed the judgment against defendants and remanded for a new trial. Plaintiff's motion for rehearing was denied.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.488%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Plaintiff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Verdict Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Defendant(s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Court&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Compensatory Damages &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Punitive Damages &lt;br/&gt;(PM USA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Appeal Status&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Mahfuz&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$12&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$10 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fourth District Court of Appeal reversed the judgment against defendants and remanded for a new trial.   Plaintiff's motion for rehearing was denied.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Holliman&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Defendant&#x2019;s appeal to Third District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Chadwell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third District Court of Appeal affirmed the compensatory damages award.  PM USA petitioned Florida Supreme Court for review.  Case stayed pending Florida Supreme Court decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Prentice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Kaplan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Fourth District Court of Appeal affirmed the verdict and  reaffirmed the verdict on rehearing.  Defendants sought review of the decision before the Florida Supreme Court and the court stayed the case pending its decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%"&gt;Sheffield&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;R. Douglas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;November 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Duval&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Awaiting entry of final judgment by the trial court.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Sommers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;April 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$1&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third District Court of Appeal affirmed compensatory damages award and granted new trial on punitive damages.  Florida Supreme Court denied PM USA&#x2019;s petition for review of the Third District Court of Appeal&#x2019;s decision.  PM USA paid approximately $1 million for the compensatory damages award and awaits the new trial on punitive damages.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;  The trial court stayed the new trial on punitive damages pending Florida Supreme Court&#x2019;s decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Sheffield&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cooper (Blackwood)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$5&#160;million &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(&amp;lt;$1&#160;million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fourth District Court of Appeal affirmed judgment and granted a new trial on punitive damages.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;D. Brown&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;January 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal Court - Middle District of Florida&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$8&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$9&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by defendant to U.S. Court of Appeals for the Eleventh Circuit stayed pending Florida Supreme Court decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Prentice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;PM USA&#x2019;s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Plaintiff&#x2019;s verdict following a retrial of an initial verdict in favor of plaintiff.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; PM USA is not a defendant in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Prentice &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;or&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; Sheffield&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Prentice &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; Sheffield &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;are discussed below in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle Progeny Appellate Issues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Plaintiff was granted an award of approximately $3 million in fees, costs and interest that PM USA appealed.  The Florida Third District Court of Appeals affirmed the award and PM USA paid the award amount in March 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:10pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engle Cases Concluded Within Past 12 Months &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(rounded to nearest $ million)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.265%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Plaintiff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Verdict Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Defendant(s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Court&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrual Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payment Amount&lt;br/&gt;(if any)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Berger (Cote)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal Court - Middle District of Florida&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fourth quarter of 2018 and first quarter of 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$29 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;February 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Santoro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA, R.J. Reynolds and Liggett Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Second quarter of 2020 and first quarter of 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$1 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;January 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In six cases in which PM USA paid the judgments more than a year ago, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Naugle,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Gore&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;M. Brown,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Jordan,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Theis &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; Landi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, plaintiffs were awarded approximately $8 million, $2 million, $8 million, $4 million, $1 million and $3 million in fees and costs, respectively.  PM USA has appealed in all of these cases, except &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Theis &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Landi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.  In&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; M. Brown&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, in March 2021 the Florida First District Court of Appeals affirmed the fee award and reversed the pre-judgment interest award and, in April 2021, PM USA paid $8.2 million in satisfaction of the fee award and post-judgment interest. In &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Theis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, PM USA paid $1 million in satisfaction of fees and costs in May 2021 and, in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Landi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, PM USA paid approximately $1.5 million in satisfaction of fees, costs and interest in July 2021 (R.J. Reynolds paid approximately $1.5 million of the approximately $3 million award).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; Progeny Appellate Issues: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Florida appellate courts are considering the following appeals which may have wide application to other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mary Sheffield v. R.J. Reynolds Tobacco Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, an &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny case against R.J. Reynolds only, the Florida Supreme Court has taken jurisdiction to resolve the conflict among Florida&#x2019;s District Courts of Appeal over whether the 1999 amendments to Florida&#x2019;s punitive damages statute (including its caps and bar on multiple punitive damages awards for the same course of conduct) apply in wrongful death cases where the decedent was injured prior to the October 1, 1999 effective date of the amendments but died from his or her injuries after such effective date.  Oral argument was held before the Florida Supreme Court in April 2021; a decision has not yet been issued.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Linda Prentice v. R.J. Reynolds Tobacco Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, an &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny case against R.J. Reynolds only, the Florida First District Court of Appeal in January 2020 reversed a judgment in favor of the plaintiff and remanded for a new trial. The court held that the trial court had erred by failing to instruct the jury that in order to prevail on her claim for conspiracy to commit fraudulent concealment, the plaintiff was required to prove that her decedent relied to his detriment on a statement that concealed or omitted material information about the health risks of smoking.  That holding conflicts with decisions from the Second, Third, and Fourth District Courts of Appeal, which have each held that &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;plaintiffs do not need to prove reliance on a statement, and instead can prevail by proving reliance on the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; defendants&#x2019; concealment of information.  In August 2020, the Florida Supreme Court accepted jurisdiction in the case.  As an alternative ground to approve the First District Court of Appeal&#x2019;s decision in its favor in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Prentice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, R.J. Reynolds has asked the Florida Supreme Court to reconsider its prior decisions giving the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Phase I findings preclusive effect in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases, as described more fully in the section &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Class Action above.  Oral argument was held before the Florida Supreme Court in June 2021; a decision has not yet been issued.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Florida Bond Statute: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2009, Florida amended its existing bond cap statute by adding a $200 million bond cap that applies to all state &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny lawsuits in the aggregate and establishes individual bond caps for individual &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases in amounts that vary depending on the number of judgments in effect at a given time.  Plaintiffs have been unsuccessful in various challenges to the bond cap statute in Florida state court.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No federal court has yet addressed the constitutionality of the bond cap statute or the applicability of the bond cap to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny cases tried in federal court.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, legislation has been presented to the Florida legislature that would repeal the bond cap statute; however to date, no legislation repealing the statute has passed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Smoking and Health Class Actions: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since the dismissal in May 1996 of a purported nationwide class action brought on behalf of allegedly addicted smokers, plaintiffs have filed numerous putative smoking and health class action suits in various state and federal courts.  In general, these cases purport to be brought on behalf of residents of a particular state or states (although a few cases purport to be nationwide in scope) and raise addiction claims and, in many cases, claims of physical injury as well.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Class certification has been denied or reversed by courts in 61 smoking and health class actions involving PM USA in Arkansas (1), California (1), Delaware (1), the District of Columbia (2), Florida (2), Illinois (3), Iowa (1), Kansas (1), Louisiana (1), Maryland (1), Michigan (1), Minnesota (1), Nevada (29), New Jersey (6), New York (2), Ohio (1), Oklahoma (1), Oregon (1), Pennsylvania (1), Puerto Rico (1), South Carolina (1), Texas (1)&#160;and Wisconsin (1).  See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Certain Other Tobacco-Related &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;below for a discussion of &#x201c;Lights&#x201d; and &#x201c;Ultra Lights&#x201d; class action cases and medical monitoring class action cases pending against PM USA.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of October 25, 2021, PM USA and Altria are named as defendants, along with other cigarette manufacturers, in seven class actions filed in the Canadian provinces of Alberta, Manitoba, Nova Scotia, Saskatchewan, British Columbia and Ontario.  In Saskatchewan, British Columbia (two separate cases) and Ontario, plaintiffs seek class certification on behalf of individuals who suffer or have suffered from various diseases, including chronic obstructive pulmonary disease, emphysema, heart disease or cancer, after smoking defendants&#x2019; cigarettes.  In the actions filed in Alberta, Manitoba and Nova Scotia, plaintiffs seek certification of classes of all individuals who smoked defendants&#x2019; cigarettes.  In March 2019, all of these class actions were stayed as a result of three Canadian tobacco manufacturers (none of which is related to Altria or its subsidiaries) seeking protection under Canada&#x2019;s Companies&#x2019; Creditors Arrangement Act (which is similar to Chapter 11 bankruptcy in the U.S.).  The companies entered into these proceedings following a Canadian appellate court upholding two smoking and health class action verdicts against those companies totaling approximately CAD $13 billion.  See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Guarantees and Other Similar Matters&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below for a discussion of the Distribution Agreement between Altria and PMI, which provides for indemnities for certain liabilities concerning tobacco products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Health Care Cost Recovery Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Overview: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the health care cost recovery litigation, governmental entities seek reimbursement of health care cost expenditures allegedly caused by tobacco products and, in some cases, of future expenditures and damages.  Relief sought by some but not all plaintiffs includes punitive damages, multiple damages and other statutory damages and penalties, injunctions prohibiting alleged marketing and sales to minors, disclosure of research, disgorgement of profits, funding of anti-smoking programs, additional disclosure of nicotine yields, and payment of attorney and expert witness fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although there have been some decisions to the contrary, most judicial decisions in the U.S. have dismissed all or most health care cost recovery claims against cigarette manufacturers.  Nine federal circuit courts of appeals and eight state appellate courts, relying primarily on grounds that plaintiffs&#x2019; claims were too remote, have ordered or affirmed dismissals of health care cost recovery actions.  The United States Supreme Court has refused to consider plaintiffs&#x2019; appeals from the cases decided by five federal circuit courts of appeal.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the cases brought in the U.S., health care cost recovery actions have also been brought against tobacco industry participants, including PM USA and Altria, in Canada (10 cases),&#160;and other entities have stated that they are considering filing such actions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since the beginning of 2008, the Canadian Provinces of British Columbia, New Brunswick, Ontario, Newfoundland and Labrador, Quebec, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia have brought health care reimbursement claims against cigarette manufacturers.  PM USA is named as a defendant in the British Columbia and Quebec cases, while both Altria and PM USA are named as defendants in the New Brunswick, Ontario, Newfoundland and Labrador, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia cases.  The Nunavut Territory and Northwest Territory have passed legislation permitting similar claims, but lawsuits based on this legislation have not been filed.  All of these cases have been stayed pending resolution of proceedings in Canada involving three tobacco manufacturers (none of which are affiliated with Altria or its subsidiaries) under the Companies&#x2019; Creditors Arrangement Act discussed above.  See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smoking and Health Litigation - Other Smoking and Health Class Actions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; above for a discussion of these proceedings.  See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Guarantees and Other Similar Matters&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below for a discussion of the Distribution Agreement between Altria and PMI that provides for indemnities for certain liabilities concerning tobacco products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Settlements of Health Care Cost Recovery Litigation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 1998, PM USA and certain other tobacco product manufacturers entered into the 1998 Master Settlement Agreement (the &#x201c;MSA&#x201d;) with 46 states, the District of Columbia and certain U.S. territories to settle asserted and unasserted health care cost recovery and other claims.  PM USA and certain other tobacco product manufacturers had previously entered into agreements to settle similar claims brought by Mississippi, Florida, Texas and Minnesota (together with the MSA, the &#x201c;State Settlement Agreements&#x201d;).  The State Settlement Agreements require that the original participating manufacturers or &#x201c;OPMs&#x201d; (now PM USA, R.J. Reynolds and, with respect to certain brands, ITG Brands, LLC (&#x201c;ITG&#x201d;)) make annual payments of approximately $9.4 billion, subject to adjustments for several factors, including inflation, market share and industry volume.  In addition, the OPMs are required to pay settling plaintiffs&#x2019; attorneys&#x2019; fees, subject to an annual cap of $500 million.  For the three months ended September 30, 2021 and 2020, the aggregate amount recorded in cost of sales with respect to the State Settlement Agreements was approximately $1.1 billion and $1.2 billion, respectively.  For the nine months ended September 30, 2021 and 2020, the aggregate amount recorded in cost of sales with respect to the State Settlement Agreements was approximately $3.2 billion and $3.3 billion, respectively. These amounts include PM USA&#x2019;s estimate of amounts related to NPM Adjustments discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NPM Adjustment Disputes: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The &#x201c;NPM Adjustment&#x201d; is a reduction in MSA payments made by the OPMs and those manufacturers that are subsequent signatories to the MSA (collectively, the &#x201c;participating manufacturers&#x201d; or &#x201c;PMs&#x201d;) that &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;applies if the PMs collectively lose at least a specified level of market share to non-participating manufacturers since 1997, subject to certain conditions and defenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The independent auditor (&#x201c;IA&#x201d;) appointed under the MSA has calculated that PM USA&#x2019;s share of the maximum potential NPM Adjustments for 2004-2020 is (exclusive of interest or earnings):  $388 million for 2004; $181 million for 2005; $154 million for 2006; $185 million for 2007; $250 million for 2008; $211 million for 2009; $218 million for 2010; $166 million for 2011; $214 million for 2012; $224 million for 2013; $258 million for 2014; $313 million for 2015; $292 million for 2016; $302 million for 2017; $325 million for 2018; $444 million for 2019; and $572 million for 2020.  These maximum amounts will be reduced, likely substantially, to reflect the NPM Adjustment settlements discussed below, and potentially for current and future calculation disputes and other developments.  In addition, PM USA&#x2019;s recovery of these amounts, even as reduced, is dependent upon subsequent determinations regarding state-specific defenses and disputes with other PMs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Settlements of NPM Adjustment Disputes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Multi-State Settlement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; By the end of 2018, PM USA entered into a multi-state settlement of NPM Adjustment disputes with a total of 36 MSA states and territories in which PM USA settled the NPM Adjustment disputes through 2022 with 35 of the 36 states, and through 2024 with one state.  Pursuant to the multi-state settlement, PM USA received $1.03 billion and expects to receive approximately $320 million in credits to offset PM USA&#x2019;s MSA payments through 2029.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;New York Settlement.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2015, PM USA entered into a separate NPM Adjustment settlement with New York in which PM USA settled the NPM Adjustment disputes with New York in perpetuity.  PM USA received $373 million pursuant to the New York settlement and expects to receive annual credits applied against the MSA payments due to New York going forward.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Montana Settlement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  In 2020, PM USA entered into a separate NPM Adjustment settlement with Montana in which PM USA settled the NPM Adjustment disputes with Montana through 2030.  This settlement resulted in a payment by PM USA of $4 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Continuing NPM Adjustment Disputes with States That Have Not Settled&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;2004 NPM Adjustment.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  The PMs and the 10 states that have not settled the NPM Adjustment disputes are currently arbitrating NPM Adjustment disputes for 2004 in a multi-state arbitration.  Hearings for 9 of the 10 states have concluded.  In September 2021, the arbitration panels issued decisions finding that two states, Missouri and Washington, were not diligent in their enforcement of their escrow statutes in 2004 and, therefore, are subject to the NPM adjustment for 2004. The arbitration panels further found that the remaining seven states were diligent in their enforcement and, therefore, are not subject to the NPM adjustment for 2004.  The hearing for one remaining state is currently scheduled for February 2022.  Several issues remain to be resolved by the arbitration panels that will affect the final amount of the 2004 NPM adjustment PM USA and other PMs will receive. PM USA recorded $21 million as a reduction to cost of sales in the third quarter of 2021 for its estimate of the minimum amount of the 2004 NPM adjustment it will receive.  PM USA estimates it is entitled to interest of approximately $23 million in connection with the 2004 NPM adjustment, which it recorded as interest income in the third quarter of 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;2005-2007 NPM Adjustments.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  The PMs and the 10 states that have not settled the NPM Adjustment disputes are currently arbitrating NPM Adjustment disputes before a single arbitration panel.  The arbitration encompasses &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM1NjYx_a644eea3-4823-4d15-b961-96400803386e"&gt;three&lt;/span&gt; years, 2005-2007, for nine of the 10 states, and &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM1NzEx_1f0bca57-bdd0-4faf-a0bb-bb958177008c"&gt;one&lt;/span&gt; year, 2005, for one state.  As of October 25, 2021, no decisions have resulted from the arbitration.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Subsequent Years.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No assurance can be given as to when proceedings for 2008 and subsequent years will be scheduled or the precise form those proceedings will take.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Disputes Under the State Settlement Agreements: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The payment obligations of the tobacco product manufacturers that are parties to the State Settlement Agreements, as well as the allocations of any NPM Adjustments and related settlements, have been and may continue to be affected by R.J. Reynolds&#x2019;s acquisition of Lorillard in 2015 and its related sale of certain cigarette brands to ITG (the &#x201c;ITG transferred brands&#x201d;).  PM USA filed motions to enforce the state settlement agreements in Florida, Minnesota, Texas and Mississippi in connection with various positions that R.J. Reynolds and ITG took with regard to the ITG transferred brands.  After various court decisions in each of those states that were favorable to PM USA, those motions to enforce have now been resolved either through settlement or exhaustion of appeals.  Despite these resolutions, PM USA continues to dispute the accuracy of certain submissions made by R.J. Reynolds and ITG concerning the calculation of certain payments relating to the ITG transferred brands and may pursue such claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the State of Mississippi filed a motion in Mississippi state court seeking to enforce the Mississippi State Settlement Agreement against PM USA, R.J. Reynolds and ITG concerning the tax rates used in the annual calculation of the net operating profit adjustment payments starting in 2018. The Mississippi state court held a hearing in October 2021 and has not yet issued a decision.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, PM USA and other PMs reached an agreement with several MSA states to waive the PMs&#x2019; claim under the most favored nation provision of the MSA in connection with a settlement between those MSA states and a non-participating manufacturer, S&amp;amp;M Brands, Inc. (&#x201c;S&amp;amp;M Brands&#x201d;), under which the states released certain claims against S&amp;amp;M Brands in exchange for receiving a portion of the funds S&amp;amp;M Brands deposited into escrow accounts in those states pursuant to the states&#x2019; escrow statutes.  In consideration for waiving its most favored nation claim, PM USA received approximately $32 million from the escrow funds paid to those MSA states under their settlement with S&amp;amp;M Brands.  These funds were received in January 2021 and were recorded in Altria&#x2019;s condensed consolidated statement of earnings for the first quarter of 2021 as a reduction to cost of sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Federal Government&#x2019;s Lawsuit: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 1999, the United States government filed a lawsuit in the U.S. District Court for the District of Columbia against various cigarette manufacturers, including PM USA, and others, including Altria, asserting claims under three federal statutes.  The case ultimately proceeded only under the civil provisions of RICO.  In August 2006, the district court held that certain defendants, including Altria and PM USA, violated RICO and engaged in seven of the eight &#x201c;sub-schemes&#x201d; to defraud that the government had alleged.  Specifically, the court found that:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants falsely denied, distorted and minimized the significant adverse health consequences of smoking;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants hid from the public that cigarette smoking and nicotine are addictive;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants falsely denied that they control the level of nicotine delivered to create and sustain addiction;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants falsely marketed and promoted &#x201c;low tar/light&#x201d; cigarettes as less harmful than full-flavor cigarettes;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants falsely denied that they intentionally marketed to youth;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants publicly and falsely denied that ETS is hazardous to non-smokers; and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants suppressed scientific research.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The court did not impose monetary penalties on defendants, but ordered the following relief: (i)&#160;an injunction against &#x201c;committing any act of racketeering&#x201d; relating to the manufacturing, marketing, promotion, health consequences or sale of cigarettes in the United States; (ii)&#160;an injunction against participating directly or indirectly in the management or control of the Council for Tobacco Research, the Tobacco Institute, or the Center for Indoor Air Research, or any successor or affiliated entities of each; (iii)&#160;an injunction against &#x201c;making, or causing to be made in any way, any material false, misleading, or deceptive statement or representation or engaging in any public relations or marketing endeavor that is disseminated to the United States public and that misrepresents or suppresses information concerning cigarettes;&#x201d; (iv)&#160;an injunction against conveying any express or implied health message or health descriptors on cigarette packaging or in cigarette advertising or promotional material, including &#x201c;lights,&#x201d; &#x201c;ultra lights&#x201d; and &#x201c;low tar,&#x201d; which the court found could cause consumers to believe one cigarette brand is less hazardous than another brand; (v)&#160;the issuance of &#x201c;corrective statements&#x201d; in various media regarding the adverse health effects of smoking, the addictiveness of smoking and nicotine, the lack of any significant health benefit from smoking &#x201c;low tar&#x201d; or &#x201c;light&#x201d; cigarettes, defendants&#x2019; manipulation of cigarette design to ensure optimum nicotine delivery and the adverse health effects of exposure to ETS; (vi)&#160;the disclosure on defendants&#x2019; public document websites and in the Minnesota document repository of all documents produced to the government in the lawsuit or produced in any future court or administrative action concerning smoking and health until the third quarter of 2021, with certain additional requirements as to documents withheld from production under a claim of privilege or confidentiality; (vii)&#160;the disclosure of disaggregated marketing data to the government in the same form and on the same schedule as defendants now follow in disclosing such data to the FTC for a period of 10 years; (viii)&#160;certain restrictions on the sale or transfer by defendants of any cigarette brands, brand names, formulas or cigarette businesses within the U.S.; and (ix)&#160;payment of the government&#x2019;s costs in bringing the action.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following several years of appeals relating to the content of the corrective statements remedy described above, in October 2017, the district court approved the parties&#x2019; proposed consent order implementing corrective statements in newspapers and on television.  The corrective statements began appearing in newspapers and on television in the fourth quarter of 2017.  In April 2018, the parties reached agreement on the implementation details of the corrective statements on websites and onserts.  The corrective statements began appearing on websites in the second quarter of 2018 and the onserts began appearing in the fourth quarter of 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2014 and 2019, Altria and PM USA recorded provisions totaling approximately $36 million for the estimated costs of implementing the corrective communications remedy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The requirements related to corrective statements at point-of-sale remain outstanding.  In May 2014, the district court ordered further briefing on the issue, which was completed in June 2014.  In May 2018, the parties submitted a joint status report and additional briefing on point-of-sale signage to the district court.  In May 2019, the district court ordered a hearing on the point-of-sale signage issue.  The hearing is currently scheduled for June 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2020, the United States government filed a motion with the district court asking for clarification as to whether the court-ordered injunction that applies to cigarettes also applies to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;HeatSticks,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; a heated tobacco product used with the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; electronic device.  In August 2020, Altria and PM USA filed an opposition to the government&#x2019;s motion and, in the alternative, a motion to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;modify the injunction to make clear it does not apply to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;HeatSticks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  Regardless of the district court&#x2019;s decisions on the pending motions, the government has indicated it will not oppose a modification to the injunction that permits PM USA to use the Modified Risk Tobacco Product claim authorized by the United States Food and Drug Administration for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;HeatSticks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;E-vapor Product Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of October 25, 2021, Altria and/or its subsidiaries, including PM USA, were named as defendants in 53 class action lawsuits relating to JUUL e-vapor products.  JUUL is an additional named defendant in each of these lawsuits.  The theories of recovery include violation of RICO, fraud, failure to warn, design defect, negligence and unfair trade practices.  Plaintiffs seek various remedies, including compensatory and punitive damages and an injunction prohibiting product sales.  The 53 class action lawsuits include 28 cases involving plaintiffs whose claims were previously included in other class action complaints but were refiled as separate stand-alone class actions for procedural and other reasons&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria and/or its subsidiaries, including PM USA, also have been named as defendants in other lawsuits involving JUUL e-vapor products, including 2,548 individual lawsuits, 350 &#x201c;third party&#x201d; lawsuits, which include school districts, state and local governments and tribal and healthcare organization lawsuits.  JUUL is an additional named defendant in each of these lawsuits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the individual and class action lawsuits mentioned above were filed in federal court.  In October 2019, the United States Judicial Panel on Multidistrict Litigation ordered the coordination or consolidation of these lawsuits in the U.S. District Court for the Northern District of California for pretrial purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria and its subsidiaries filed motions to dismiss certain claims in the class action and school district cases, including the federal RICO claim.  In October 2020, the U.S. District Court for the Northern District of California granted the motion to dismiss the RICO class action claim without prejudice.  Although it otherwise denied the motion, the court found that plaintiffs had not sufficiently alleged standing or causation with respect to their claim under California law.  The court also granted the motion to dismiss the RICO claim in the cases filed by various school districts, but denied the motion in all other respects.  The court gave plaintiffs the opportunity to amend their complaints to attempt to cure the deficiencies the court identified and plaintiffs filed their amended complaints in November 2020.  In January 2021, Altria and its subsidiaries filed a renewed motion to dismiss the RICO claim, which the court denied in April 2021.  In December 2020, the U.S. District Court for the Northern District of California and the parties selected 20 personal injury plaintiffs to be adjudicated as bellwether cases and in July 2021, the court set dates for the first four of such cases to commence in 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An additional group of cases is pending in California state courts.  In January 2020, the Judicial Council of California determined that this group of cases was appropriate for coordination and assigned the group to the Superior Court of California, Los Angeles County, for pretrial purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;JUUL also is named in a significant number of additional individual and class action lawsuits to which neither Altria nor any of its subsidiaries is currently named.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Three of the &#x201c;third party&#x201d; lawsuits noted above against Altria and/or its subsidiaries and JUUL, as an additional named defendant, were initiated, individually, by the attorneys general of Alaska, Hawaii and Minnesota alleging violations of state consumer protection and other similar laws.  JUUL is also named in other attorneys general lawsuits to which neither Altria nor any of its subsidiaries is currently named.  JUUL settled one such lawsuit by agreeing to (i) pay approximately $40 million and (ii) certain restrictions on its sales and marketing activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;IQOS &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, RAI Strategic Holdings, Inc. and R.J. Reynolds Vapor Co., which are affiliates of R.J. Reynolds, filed a lawsuit against Altria, PM USA, Altria Client Services LLC, PMI and its affiliate, Philip Morris Products S.A., in the United States District Court for the Eastern District of Virginia.  The lawsuit asserts claims of patent infringement based on the sale of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; electronic device and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;HeatSticks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the United States.  Plaintiffs seek various remedies, including preliminary and permanent injunctive relief, treble damages and attorneys&#x2019; fees.  Altria and PMI have been dismissed from the lawsuit.  In June 2020, the remaining defendants filed a motion to dismiss certain of plaintiffs&#x2019; claims and also filed counterclaims against the plaintiffs for infringement of various patents owned by the remaining defendants. The case was stayed in December 2020 due to the COVID-19 pandemic; however, the stay was lifted with respect to defendants&#x2019; counterclaims in February 2021 and a trial is currently scheduled for April 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Also in April 2020, a related action was filed against the same defendants by the same plaintiffs, as well as R.J. Reynolds, with the United States International Trade Commission (&#x201c;ITC&#x201d;).  There, the plaintiffs also allege patent infringement, but the remedies sought include a prohibition on the importation of the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; IQOS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; electronic device, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;HeatSticks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and component parts into the United States and on the sale of any such products previously imported into the United States.  No damages are recoverable in the proceedings before the ITC.  In May 2021, an administrative law judge found that the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; electronic device and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;HeatSticks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; infringe plaintiffs&#x2019; patents and recommended to the ITC a ban on the importation of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; electronic device, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;HeatSticks &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and the infringing components into the United States.  In September 2021, the ITC affirmed the administrative law judge&#x2019;s initial determination and issued a limited exclusion order barring the importation of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;electronic device,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;HeatSticks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and the infringing components into the United States and a cease and desist order barring domestic sales, marketing and distribution of these imported products.  The orders will become effective on November 29, 2021 unless rejected by the Biden Administration prior to that date.  Defendants may appeal the orders to the United States Court of Appeals for the Federal Circuit; however, any ban on importation or on the sale, marketing and distribution of previously imported product is unlikely to be stayed pending the conclusion of the appeal.  Due to this litigation, in October 2021, PM USA announced plans to begin removing the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;electronic device and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; HeatSticks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; from the marketplace as it awaits the outcome of administrative review.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An additional unrelated patent infringement case regarding the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; electronic device was filed in November 2020 in the United States District Court for the Northern District of Georgia against PM USA and Philip Morris Products S.A. seeking damages and equitable relief.  In February 2021, defendants filed a motion to dismiss the lawsuit, which the court granted in July 2021.  In August 2021, plaintiff filed a motion to amend the complaint.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Antitrust Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, the FTC issued an administrative complaint against Altria and JUUL alleging that Altria&#x2019;s 35% investment in JUUL and the associated agreements constitute an unreasonable restraint of trade in violation of Section 1 of the Sherman Antitrust Act of 1890 (&#x201c;Sherman Act&#x201d;) and Section 5 of the Federal Trade Commission Act of 1914, and substantially lessened competition in violation of Section 7 of the Clayton Antitrust Act (&#x201c;Clayton Act&#x201d;).  If the FTC&#x2019;s challenge is successful, the FTC may order a broad range of remedies, including divestiture of Altria&#x2019;s minority investment in JUUL, rescission of the transaction and all associated agreements, a requirement of FTC approval of future agreements related to the development, manufacture, distribution or sale of e-vapor products and prohibition against any officer or director of either Altria or JUUL serving on the other party&#x2019;s board of directors or attending meetings of the other party&#x2019;s board of directors.  The administrative trial was held before an FTC administrative law judge in June 2021.  The post-trial briefing was completed in October 2021.  The administrative law judge&#x2019;s decision is subject to review by the FTC on its own motion or at the request of any party.  The FTC then issues its ruling, which may be appealed to any United States Court of Appeals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Also as of October 25, 2021, 16 putative class action lawsuits have been filed against Altria and JUUL in the United States District Court for the Northern District of California.  The lawsuits initially named, in addition to the two companies, certain senior executives and certain members of the board of directors of both companies as defendants; however, those individuals currently or formerly affiliated with Altria were later dismissed. In November 2020 these lawsuits were consolidated into three complaints (one on behalf of direct purchasers, one on behalf of indirect purchasers and one on behalf of indirect resellers).  The consolidated lawsuits, as amended, cite the FTC administrative complaint and allege that Altria and JUUL violated Sections 1, 2 and/or 3 of the Sherman Act and Section 7 of the Clayton Act and various state antitrust, consumer protection and unjust enrichment laws by restraining trade and/or substantially lessening competition in the U.S. closed-system electronic cigarette market.  Plaintiffs seek various remedies, including treble damages, attorneys&#x2019; fees, a declaration that the agreements between Altria and JUUL are invalid, divestiture of Altria&#x2019;s minority investment in JUUL and rescission of the transaction.  Altria filed a motion to dismiss these lawsuits in January 2021.  In August 2021, the United States District Court for the Northern District of California denied Altria&#x2019;s motion to dismiss except with respect to plaintiffs&#x2019; claims for injunctive and equitable relief.  However, plaintiffs were granted the opportunity to replead such claims by the trial court, which plaintiffs did in September 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2020, Altria exercised its rights to convert its non-voting JUUL shares to voting shares.  However, pending the outcome of the FTC administrative complaint, Altria currently does not intend to exercise its additional governance rights obtained upon the conversion, including the right to elect directors to JUUL&#x2019;s board or to vote its JUUL shares other than as a passive investor.  For further discussion of Altria&#x2019;s rights in the event of share conversion, see Note 4.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Equity Securities - Investment in JUUL&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shareholder Class Action and Shareholder Derivative Lawsuits&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shareholder Class Action:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  In October and December 2019, two purported Altria shareholders filed putative class action lawsuits against Altria, Howard A. Willard III, Altria&#x2019;s former Chairman and Chief Executive Officer, and William F. Gifford, Jr., Altria&#x2019;s former Vice Chairman and Chief Financial Officer and current Chief Executive Officer, in the United States District Court for the Eastern District of New York.  In December 2019, the court consolidated the two lawsuits into a single proceeding.  The consolidated lawsuit was subsequently transferred to the United States District Court for the Eastern District of Virginia.  The lawsuit asserts claims under Sections 10(b) and 20(a) and under Rule 10b-5 of the Exchange Act.  In April 2020, JUUL, its founders and some of its current and former executives were added to the lawsuit.  The claims allege false and misleading statements and omissions relating to Altria&#x2019;s investment in JUUL.  Plaintiffs seek various remedies, including damages and attorneys&#x2019; fees.  In July 2020, the defendants filed motions to dismiss plaintiffs&#x2019; claims, which the district court denied in March 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Federal Shareholder Derivative Lawsuits: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In August 2020, two purported Altria shareholders filed separate derivative lawsuits in the United States District Court for the Northern District of California on behalf of themselves and Altria, against Mr. Willard, Mr. Gifford, JUUL and certain of its executives and officers.  These derivative lawsuits relate to Altria&#x2019;s &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;investment in JUUL, and assert claims of breach of fiduciary duty by the Altria defendants and aiding and abetting in that alleged breach of fiduciary duty by the remaining defendants.  In March 2021, the United States District Court for the Northern District of California granted defendants&#x2019; motion to transfer both lawsuits to the United States District Court for the Eastern District of Virginia.  Three additional federal derivative lawsuits were filed in October 2020, January 2021 and March 2021, respectively, in the United States District Court for the Eastern District of Virginia against Mr. Willard, Mr. Gifford, Mr. Crosthwaite, certain members of Altria&#x2019;s Board of Directors, JUUL, its founders and some of its current and former executives.  These suits assert various claims, including breach of fiduciary duty, unjust enrichment, waste of corporate assets and violations of certain federal securities laws.  The remedies sought in these lawsuits include damages, disgorgement of profits, reformation of Altria&#x2019;s corporate governance and internal procedures, and attorneys&#x2019; fees.  In April 2021, the court consolidated the five cases pending in the Eastern District of Virginia into a single action.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;State Shareholder Derivative Lawsuits:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  Six derivative lawsuits have been filed in Virginia state courts against Mr. Willard, Mr. Gifford, Mr. Crosthwaite (Altria&#x2019;s former Chief Growth Officer and JUUL&#x2019;s current Chief Executive Officer), certain members of Altria&#x2019;s Board of Directors, JUUL, its founders and some of its current and former executives.  The lawsuits were filed in September 2020, May 2021, June 2021, July 2021, August 2021 and August 2021, respectively.  The lawsuits assert various claims, including breach of fiduciary duty, and seek remedies similar to those sought by plaintiffs in the cases pending in federal court in the Eastern District of Virginia.  In July 2021 and September 2021, the court consolidated the first four of these state derivative cases into a single action.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Certain Other Tobacco-Related Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#x201c;Lights/Ultra Lights&#x201d; Cases and Other Smoking and Health Class Actions: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Plaintiffs have sought certification of their cases as class actions, alleging among other things, that the uses of the terms &#x201c;Lights&#x201d; and/or &#x201c;Ultra Lights&#x201d; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment or breach of warranty, and have sought injunctive and equitable relief, including restitution and, in certain cases, punitive damages.  These class actions have been brought against PM USA and, in certain instances, Altria or its other subsidiaries, on behalf of individuals who purchased and consumed various brands of cigarettes.  Defenses raised in these cases include lack of misrepresentation, lack of causation, injury and damages, the statute of limitations, non-liability under state statutory provisions exempting conduct that complies with federal regulatory directives, and the First Amendment. Twenty-one state courts in 23 &#x201c;Lights&#x201d; cases have refused to certify class actions, dismissed class action allegations, reversed prior class certification decisions or have entered judgment in favor of PM USA.  As of October 25, 2021, two &#x201c;Lights/Ultra Lights&#x201d; class actions are pending in U.S. state court.  Neither case is active.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of October 25, 2021, one smoking and health case alleging personal injury or seeking court-supervised programs or ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, is pending in a U.S. state court.  The case is currently inactive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;UST Litigation:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;UST and/or its tobacco subsidiaries have been named in a number of individual tobacco and health lawsuits over time.  Plaintiffs&#x2019; allegations of liability in these cases have been based on various theories of recovery, such as negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of implied warranty, addiction and breach of consumer protection statutes.  Plaintiffs have typically sought various forms of relief, including compensatory and punitive damages, and certain equitable relief, including but not limited to disgorgement.  Defenses raised in these cases include lack of causation, assumption of the risk, comparative fault and/or contributory negligence, and statutes of limitations.  As of October 25, 2021, there is one case pending against USSTC.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Environmental Regulation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria and its subsidiaries (and former subsidiaries) are subject to various federal, state and local laws and regulations concerning the discharge of materials into the environment, or otherwise related to environmental protection, including, in the U.S.: the Clean Air Act, the Clean Water Act, the Resource Conservation and Recovery Act and the Comprehensive Environmental Response, Compensation and Liability Act (commonly known as &#x201c;Superfund&#x201d;), which can impose joint and several liability on each responsible party.  Subsidiaries (and former subsidiaries) of Altria are involved in several matters subjecting them to potential costs of remediation and natural resource damages under Superfund or other laws and regulations.  Altria&#x2019;s subsidiaries expect to continue to make capital and other expenditures in connection with environmental laws and regulations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria provides for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are probable and can be reasonably estimated.  Such accruals are adjusted as new information develops or circumstances change.  Other than those amounts, it is not possible to reasonably estimate the cost of any environmental remediation and compliance efforts that subsidiaries of Altria may undertake in the future.  In the opinion of management, however, compliance with environmental laws and regulations, including the payment of any remediation costs or damages and the making of related expenditures, has not had, and is not expected to have, a material adverse effect on Altria&#x2019;s consolidated results of operations, capital expenditures, financial position or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Guarantees and Other Similar Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, certain subsidiaries of Altria have agreed to indemnify a limited number of third parties in the event of future litigation.  At September&#160;30, 2021, Altria and certain of its subsidiaries (i) had $48 million of unused letters of credit obtained in the ordinary course of business; (ii) were contingently liable for guarantees related to their own performance, including $24 million for surety bonds;  and (iii) had a redeemable noncontrolling interest of $39 million recorded on its condensed consolidated balance sheet.  In addition, from time to time, subsidiaries of Altria issue lines of credit to affiliated entities.  These items have not had, and are not expected to have, a significant impact on Altria&#x2019;s liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of a distribution agreement between Altria and PMI (the &#x201c;Distribution Agreement&#x201d;), entered into as a result of Altria&#x2019;s 2008 spin-off of its former subsidiary PMI, liabilities concerning tobacco products will be allocated based in substantial part on the manufacturer.  PMI will indemnify Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for liabilities related to tobacco products manufactured by PM USA, excluding tobacco products contract manufactured for PMI.  Altria does not have a related liability recorded on its condensed consolidated balance sheet at September&#160;30, 2021 as the fair value of this indemnification is insignificant.  PMI has agreed not to seek indemnification with respect to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; patent litigation discussed above under &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Certain Other Tobacco-Related Litigation - IQOS Litigation, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;excluding the patent infringement case filed with the United States District Court for the Northern District of Georgia.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PM USA has issued guarantees relating to Altria&#x2019;s obligations under its outstanding debt securities, borrowings under its $3.0 billion Credit Agreement and amounts outstanding under its commercial paper program.&lt;/span&gt;&lt;/div&gt;</us-gaap:LegalMattersAndContingenciesTextBlock>
    <mo:LossContingencyNumberofStatesThatCapBondorRequireNoBond
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI0MDk_03b91ae2-d9f6-45ab-a125-3dbdb2d8f3fa"
      unitRef="state">47</mo:LossContingencyNumberofStatesThatCapBondorRequireNoBond>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="i926660aafc7244e495754a8afa4f6531_D20041001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNTkxODY_23450641-4137-4b67-b5b6-8449cb083147"
      unitRef="usd">865000000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:LitigationSettlementInterest
      contextRef="i926660aafc7244e495754a8afa4f6531_D20041001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNTkyMjY_ad591dc7-2ef8-4cd3-883b-af1a6155d2ae"
      unitRef="usd">218000000</us-gaap:LitigationSettlementInterest>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="i9a75c3716f9f44f8b0a633a8086be1e4_D20041001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNTkzNjg_0fcbff62-a5c6-40d7-a6d4-d35b34e2ef97"
      unitRef="usd">410000000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:LitigationSettlementInterest
      contextRef="i9a75c3716f9f44f8b0a633a8086be1e4_D20041001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNTk0MTY_88838f0c-d5e2-492c-86cf-a60865e3c573"
      unitRef="usd">56000000</us-gaap:LitigationSettlementInterest>
    <us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIxOTkwMjMzNDg1NzA_7d4643f6-0366-49fa-83a2-a14c119f60b0">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in Altria&#x2019;s accrued liability for tobacco and health and certain other litigation items, including related interest costs, for the periods specified below are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liability for tobacco and health and certain other  litigation items at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax charges for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tobacco and health and certain other litigation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;99&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related interest costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liability for tobacco and health and certain other  litigation items at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes amounts related to certain other litigation and pre-trial resolution of certain tobacco and health cases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below lists the number of certain tobacco-related cases pending in the U.S. against PM USA and/or Altria as of October 25, 2021, October 27, 2020 and October 28, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt;text-indent:-9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;October 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;October 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;October 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual Smoking and Health Cases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;179&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Care Cost Recovery Actions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;E-vapor Cases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,951&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Tobacco-Related Cases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes 18 cases filed in Illinois, 17 cases filed in New Mexico, 40 cases filed in Massachusetts and 70 non-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;cases filed in Florida.  Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;case (these &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; progeny cases are discussed below in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smoking and Health Litigation - Engle Class Action&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).  Also does not include 1,471 cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (&#x201c;ETS&#x201d;).  The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Broin&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).  The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages.  Class members were prohibited from filing individual lawsuits after 2000 under the court-approved settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Cost Recovery Litigation - Federal Government&#x2019;s Lawsuit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes 53 class action lawsuits, 2,548 individual lawsuits and 350 &#x201c;third party&#x201d; lawsuits relating to JUUL e-vapor products, which include school districts, state and local government, tribal and healthcare organization lawsuits.  JUUL is an additional named defendant in each of these lawsuits. The 53 class action lawsuits include 28 cases in the Northern District of California (&#x201c;Multidistrict Litigation&#x201d; or &#x201c;MDL&#x201d;) involving plaintiffs whose claims were previously included in other class action complaints but were refiled as separate stand-alone class actions for procedural and other reasons.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms &#x201c;Lights&#x201d; and &#x201c;Ultra Lights&#x201d; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Currently Pending Engle Cases with Verdicts Against PM USA &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(rounded to nearest $ million)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.488%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Plaintiff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Verdict Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Defendant(s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Court&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Compensatory Damages &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Punitive Damages &lt;br/&gt;(PM USA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Appeal Status&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Lipp&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$15 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$28 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Defendant&#x2019;s post-trial motions denied.  Defendant plans to appeal.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Garcia&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;May 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mistrial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by defendant to Third District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Duignan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;February 2020 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pinellas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$12&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by defendants to Second District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cuddihee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;January 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Duval&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by defendant to First District Court of Appeal pending. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Rintoul &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Caprio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;November 2019 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$9&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$74 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by plaintiff and defendants to Fourth District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Gloger&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;November 2019 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$15&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$11 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by defendants to Third District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;McCall&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1&#160;million (&amp;lt;$1&#160;million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;New trial ordered on punitive damages.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Neff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$4&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fourth District Court of Appeal reversed the judgment against defendants and remanded for a new trial. Plaintiff's motion for rehearing was denied.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.488%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Plaintiff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Verdict Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Defendant(s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Court&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Compensatory Damages &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Punitive Damages &lt;br/&gt;(PM USA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Appeal Status&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Mahfuz&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$12&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$10 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fourth District Court of Appeal reversed the judgment against defendants and remanded for a new trial.   Plaintiff's motion for rehearing was denied.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Holliman&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Defendant&#x2019;s appeal to Third District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Chadwell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third District Court of Appeal affirmed the compensatory damages award.  PM USA petitioned Florida Supreme Court for review.  Case stayed pending Florida Supreme Court decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Prentice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Kaplan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Fourth District Court of Appeal affirmed the verdict and  reaffirmed the verdict on rehearing.  Defendants sought review of the decision before the Florida Supreme Court and the court stayed the case pending its decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%"&gt;Sheffield&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;R. Douglas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;November 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Duval&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Awaiting entry of final judgment by the trial court.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Sommers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;April 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$1&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third District Court of Appeal affirmed compensatory damages award and granted new trial on punitive damages.  Florida Supreme Court denied PM USA&#x2019;s petition for review of the Third District Court of Appeal&#x2019;s decision.  PM USA paid approximately $1 million for the compensatory damages award and awaits the new trial on punitive damages.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;  The trial court stayed the new trial on punitive damages pending Florida Supreme Court&#x2019;s decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Sheffield&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cooper (Blackwood)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$5&#160;million &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(&amp;lt;$1&#160;million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fourth District Court of Appeal affirmed judgment and granted a new trial on punitive damages.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;D. Brown&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;January 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal Court - Middle District of Florida&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$8&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$9&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by defendant to U.S. Court of Appeals for the Eleventh Circuit stayed pending Florida Supreme Court decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Prentice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;PM USA&#x2019;s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Plaintiff&#x2019;s verdict following a retrial of an initial verdict in favor of plaintiff.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; PM USA is not a defendant in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Prentice &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;or&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; Sheffield&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Prentice &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; Sheffield &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;are discussed below in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle Progeny Appellate Issues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Plaintiff was granted an award of approximately $3 million in fees, costs and interest that PM USA appealed.  The Florida Third District Court of Appeals affirmed the award and PM USA paid the award amount in March 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:10pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engle Cases Concluded Within Past 12 Months &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(rounded to nearest $ million)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.265%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Plaintiff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Verdict Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Defendant(s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Court&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrual Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payment Amount&lt;br/&gt;(if any)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Berger (Cote)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal Court - Middle District of Florida&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fourth quarter of 2018 and first quarter of 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$29 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;February 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Santoro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA, R.J. Reynolds and Liggett Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Second quarter of 2020 and first quarter of 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$1 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;January 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In six cases in which PM USA paid the judgments more than a year ago, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Naugle,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Gore&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;M. Brown,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Jordan,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Theis &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; Landi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, plaintiffs were awarded approximately $8 million, $2 million, $8 million, $4 million, $1 million and $3 million in fees and costs, respectively.  PM USA has appealed in all of these cases, except &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Theis &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Landi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.  In&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; M. Brown&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, in March 2021 the Florida First District Court of Appeals affirmed the fee award and reversed the pre-judgment interest award and, in April 2021, PM USA paid $8.2 million in satisfaction of the fee award and post-judgment interest. In &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Theis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, PM USA paid $1 million in satisfaction of fees and costs in May 2021 and, in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Landi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, PM USA paid approximately $1.5 million in satisfaction of fees, costs and interest in July 2021 (R.J. Reynolds paid approximately $1.5 million of the approximately $3 million award).&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzItMS0xLTEtNTMxODk_8fad86d5-57d6-45c2-8214-c7e8a4a73184"
      unitRef="usd">9000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i9bf636ab56ad4d7cb37b9d77019eed37_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzItMy0xLTEtNTMxODk_8f88470c-d704-489c-bb98-6b87eaa77410"
      unitRef="usd">14000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i3df7c108f2c5403c96f58e273f0dc0d1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzItNS0xLTEtNTMxOTM_6d73b746-eb0f-40f7-bb56-8d65b18951e8"
      unitRef="usd">0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i967d1f95af3f41eda51eed3bfc8a12af_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzItNy0xLTEtNTMxODk_58dec502-09a0-4a23-a0fd-1ff11b7cc3d4"
      unitRef="usd">22000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i3400b8bfff76440f9313bb4f3fb62ca3_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzQtMS0xLTEtNTMxODk_ef29e80f-c040-4d90-b1e1-4991e9c5f3ee"
      unitRef="usd">142000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ica387b7fecba4bfebc8ddf8f17f04ad8_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzQtMy0xLTEtNTMxODk_1af78dff-0d92-4a5b-8d73-e2acf7bffdc8"
      unitRef="usd">73000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ied52ab66233a43c196b987b68bd00b86_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzQtNS0xLTEtNTMxOTM_e2275338-3699-412d-9595-1998ae17210a"
      unitRef="usd">99000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ic5ef8014d73d4900afc3092294d2ca38_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzQtNy0xLTEtNTMxODk_88379e7c-5127-4f27-a647-398b27b1052b"
      unitRef="usd">34000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i6b3cc5d6b74f41e9aed08f62d1656e61_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzUtMS0xLTEtNTMxODk_3df1559a-1bc9-4b55-b6cf-d6a6315d6283"
      unitRef="usd">6000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ic2529fcd54b74ef2a31abcd12138bb42_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzUtMy0xLTEtNTMxODk_f61cce80-bac2-494c-a501-337afcab9d54"
      unitRef="usd">3000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ia6645d5f78024731bf63efa024c27f2f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzUtNS0xLTEtNTMxOTM_6cf09437-f918-4681-9696-f20abd671cb5"
      unitRef="usd">6000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="if53282b7834348a9a6ada854639fdbd1_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzUtNy0xLTEtNTMxODk_bbe30cb4-210c-43da-8aa3-c26b2d775851"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualPayments
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzktMS0xLTEtNTMxODk_6ae6d8ee-3659-464b-9e73-10a2489d1d45"
      unitRef="usd">60000000</us-gaap:LossContingencyAccrualPayments>
    <us-gaap:LossContingencyAccrualPayments
      contextRef="i5ee61a961b254412991dfd59f7bbe2dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzktMy0xLTEtNTMxODk_fc2331f6-6f9d-4ce7-8bab-45d9669f0d12"
      unitRef="usd">81000000</us-gaap:LossContingencyAccrualPayments>
    <us-gaap:LossContingencyAccrualPayments
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzktNS0xLTEtNTMxOTM_26aec93d-b85f-4320-b05f-47c57ce5734a"
      unitRef="usd">8000000</us-gaap:LossContingencyAccrualPayments>
    <us-gaap:LossContingencyAccrualPayments
      contextRef="i0784260d7eb94408af38c2b30275095c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzktNy0xLTEtNTMxODk_1b07673a-f751-46ce-984b-e1507760da55"
      unitRef="usd">47000000</us-gaap:LossContingencyAccrualPayments>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzEwLTEtMS0xLTUzMTkz_56d2f1fa-cd52-40ad-b621-f1400b6e3b85"
      unitRef="usd">97000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i3b11e531794f48868e8b9e32c403e904_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzEwLTMtMS0xLTUzMTkz_81ef5710-a39c-4ddf-8173-5c36ee318108"
      unitRef="usd">9000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzEwLTUtMS0xLTUzMTkz_3fb9b7d6-8c1a-4ab2-a0ab-2f0c006690a6"
      unitRef="usd">97000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i3b11e531794f48868e8b9e32c403e904_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo3ZjQ5YThmZGRkNDI0OTY4Yjc4YzljMGE2ZmY1NThlYi90YWJsZXJhbmdlOjdmNDlhOGZkZGQ0MjQ5NjhiNzhjOWMwYTZmZjU1OGViXzEwLTctMS0xLTUzMTg5_01c135c9-30ef-4634-ba49-2c9fff1b74bc"
      unitRef="usd">9000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <mo:LitigationEscrowDeposit
      contextRef="i3ea29768db1440de8cdfdba1d0ddb39f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNjA0MDQ_cf92ca66-ee45-4415-9e6f-379f600e6910"
      unitRef="usd">45000000</mo:LitigationEscrowDeposit>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i663ff20a0cf640f8ae7953fdba19634a_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTpmYzIzZmUxYmI5YzI0YjQzYThjMWFlYjc2ZTkyZWUxYS90YWJsZXJhbmdlOmZjMjNmZTFiYjljMjRiNDNhOGMxYWViNzZlOTJlZTFhXzEtMS0xLTEtMA_7a93d09d-b5ca-4243-9761-0d21b4c90d3d"
      unitRef="claim">179</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ia5ed554a97e64e58a2f7dff3f260635e_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTpmYzIzZmUxYmI5YzI0YjQzYThjMWFlYjc2ZTkyZWUxYS90YWJsZXJhbmdlOmZjMjNmZTFiYjljMjRiNDNhOGMxYWViNzZlOTJlZTFhXzEtMy0xLTEtMA_96d48a20-2510-4825-931a-1cd8018e8150"
      unitRef="claim">142</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i35aefdfd25a54a77a106cbf1a1685ab5_I20191028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTpmYzIzZmUxYmI5YzI0YjQzYThjMWFlYjc2ZTkyZWUxYS90YWJsZXJhbmdlOmZjMjNmZTFiYjljMjRiNDNhOGMxYWViNzZlOTJlZTFhXzEtNS0xLTEtMA_4f2e3eb0-27e3-4183-9e5b-6e0a85a6fec2"
      unitRef="claim">95</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i20886114cad04457981190cedb862851_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTpmYzIzZmUxYmI5YzI0YjQzYThjMWFlYjc2ZTkyZWUxYS90YWJsZXJhbmdlOmZjMjNmZTFiYjljMjRiNDNhOGMxYWViNzZlOTJlZTFhXzItMS0xLTEtMA_7c401007-b113-46fd-a8f6-5f53414c9a44"
      unitRef="claim">1</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ibf6d7d9ce89842c7976f502120165e8c_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTpmYzIzZmUxYmI5YzI0YjQzYThjMWFlYjc2ZTkyZWUxYS90YWJsZXJhbmdlOmZjMjNmZTFiYjljMjRiNDNhOGMxYWViNzZlOTJlZTFhXzItMy0xLTEtMA_f895406d-84a6-4a48-b7f7-e192f9c126e6"
      unitRef="claim">1</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i2704bd9b49ac4bdc8fb4f82a270c44ef_I20191028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTpmYzIzZmUxYmI5YzI0YjQzYThjMWFlYjc2ZTkyZWUxYS90YWJsZXJhbmdlOmZjMjNmZTFiYjljMjRiNDNhOGMxYWViNzZlOTJlZTFhXzItNS0xLTEtMA_b0dc73b1-d5cc-46d8-9826-6b32a5d86068"
      unitRef="claim">1</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i2d4206f6a0024fed8cfaa7a66fcf85d9_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTpmYzIzZmUxYmI5YzI0YjQzYThjMWFlYjc2ZTkyZWUxYS90YWJsZXJhbmdlOmZjMjNmZTFiYjljMjRiNDNhOGMxYWViNzZlOTJlZTFhXzMtMS0xLTEtMA_ec2f2e04-cd7d-48e6-ab39-f4d5071b557b"
      unitRef="claim">2951</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i71b573459eca4bea97af58bf49c87201_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTpmYzIzZmUxYmI5YzI0YjQzYThjMWFlYjc2ZTkyZWUxYS90YWJsZXJhbmdlOmZjMjNmZTFiYjljMjRiNDNhOGMxYWViNzZlOTJlZTFhXzMtMy0xLTEtMA_84a8e95a-d667-442e-b1ac-413c1a6223fe"
      unitRef="claim">1145</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="icaf8b745a94b42ccad21473588116847_I20191028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTpmYzIzZmUxYmI5YzI0YjQzYThjMWFlYjc2ZTkyZWUxYS90YWJsZXJhbmdlOmZjMjNmZTFiYjljMjRiNDNhOGMxYWViNzZlOTJlZTFhXzMtNS0xLTEtMA_06f91d0b-1056-4cac-99a4-42579bd5349f"
      unitRef="claim">0</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i12bdefb971104deda60ea7c60dd43501_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTpmYzIzZmUxYmI5YzI0YjQzYThjMWFlYjc2ZTkyZWUxYS90YWJsZXJhbmdlOmZjMjNmZTFiYjljMjRiNDNhOGMxYWViNzZlOTJlZTFhXzQtMS0xLTEtMA_dba9f0ae-e5ff-49fc-bbca-99c0223514c4"
      unitRef="claim">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ib3dbb26207114dcbb85df4982dbc5033_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTpmYzIzZmUxYmI5YzI0YjQzYThjMWFlYjc2ZTkyZWUxYS90YWJsZXJhbmdlOmZjMjNmZTFiYjljMjRiNDNhOGMxYWViNzZlOTJlZTFhXzQtMy0xLTEtMA_9b61eab7-c34e-434f-b4f7-5f1f32496ec2"
      unitRef="claim">4</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i2b166612ac8e4f99b7ad03601c8126b7_I20191028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTpmYzIzZmUxYmI5YzI0YjQzYThjMWFlYjc2ZTkyZWUxYS90YWJsZXJhbmdlOmZjMjNmZTFiYjljMjRiNDNhOGMxYWViNzZlOTJlZTFhXzQtNS0xLTEtMA_23819de9-eb9e-4786-8489-964b4b7269d4"
      unitRef="claim">4</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i1b18278bbd184abca4253784cfde6900_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzYwODI_3f1b733c-9d1b-4d41-8949-601880690c28"
      unitRef="claim">18</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i223b3b59e9644a15b7fe55e88c315de3_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzYxMTA_eaed9f6c-084f-4c66-b6eb-770ec50fd81c"
      unitRef="claim">17</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="if18a359a02814e81ac2e7da57ce8914e_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzYxNDA_65741eb2-8a20-4f18-af45-cf1a61f78359"
      unitRef="claim">40</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ic2722814648844259fc7fba910bcb8f0_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzYxNzY_b068119c-348e-4a7d-a78c-f9bc40bda403"
      unitRef="claim">70</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyNumberOfCases
      contextRef="i11bb0f709f4840c9a6ba836ea86e439b_D20211025-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzY1MTU_ce6abc99-38ef-4427-99f0-7238c17e13ce"
      unitRef="case">1471</mo:LossContingencyNumberOfCases>
    <mo:LossContingencyClassActionLawsuit
      contextRef="i2d4206f6a0024fed8cfaa7a66fcf85d9_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzcyMDk_d14fd3fe-2231-4d69-9fbc-3111fe17fbc9"
      unitRef="lawsuit">53</mo:LossContingencyClassActionLawsuit>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i7e914a4a2b8344169accefce0c454834_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzcyMzU_334aff9f-9a4e-4153-bd48-a602ddf4ea2a"
      unitRef="claim">2548</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="iaeab395fb605402fb5a6b9c5bdc4a711_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzcyNjI_fd09b3bf-5ef4-4ce4-8289-8d4d22486689"
      unitRef="claim">350</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyClassActionLawsuit
      contextRef="i2d4206f6a0024fed8cfaa7a66fcf85d9_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzc0OTg_d14fd3fe-2231-4d69-9fbc-3111fe17fbc9"
      unitRef="lawsuit">53</mo:LossContingencyClassActionLawsuit>
    <mo:LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber
      contextRef="i4d5084fb63864e7d87b275079786c20d_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzc1MzE_f63adaac-038f-4711-8c34-8460c3c026be"
      unitRef="claim">28</mo:LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber>
    <mo:LossContingencyNumberOfInactiveCases
      contextRef="i12bdefb971104deda60ea7c60dd43501_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzc4MTM_c467c519-bc73-4e54-b72b-7db98c72d311"
      unitRef="case">1</mo:LossContingencyNumberOfInactiveCases>
    <mo:LossContingencyNumberOfInactiveClassActionLawsuits
      contextRef="i12bdefb971104deda60ea7c60dd43501_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzc5NTM_ddf612b1-b8f8-46e4-9a5b-462ea1ad53cb"
      unitRef="case">2</mo:LossContingencyNumberOfInactiveClassActionLawsuits>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i656d506fcc8a4b9ab2659e2676677a0a_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzgyODQ_4a7f70db-2672-432b-a744-2cce7203459b"
      unitRef="claim">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ibd987a82f3714a11b7e8c291d69672a9_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzgzNjQ_57a9f6aa-150b-460e-bff2-1c31820bfe9b"
      unitRef="claim">10</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ia9e0a1f532ea4ebf81ee548bc37ef0cc_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzg0MTI_07a3d2ad-2959-4ee9-8e0c-34ab6f1e7076"
      unitRef="claim">8</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i61b4bd1b44014f77ba98ffaddac70a1c_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzg1MTI_e0bc12c8-b85f-493c-8b92-3069b5b85c98"
      unitRef="claim">7</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyNumberofCasesSetforTrial
      contextRef="i90226fb36aa64d6bacef37bf4db3884b_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzg4ODE_7d987095-db43-479d-8b7e-ba7a97ae5874"
      unitRef="case">0</mo:LossContingencyNumberofCasesSetforTrial>
    <mo:LossContingencyClaimsDecided
      contextRef="i90fcd7f5574440a5ab359cb20e1a04c8_D19990101-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzkyODk_159facdd-0afd-4510-8951-81f119a450ae"
      unitRef="case">69</mo:LossContingencyClaimsDecided>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i90fcd7f5574440a5ab359cb20e1a04c8_D19990101-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk0MTM_05be57d2-3a3a-439b-9c81-5a5091d9302d"
      unitRef="case">44</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecided
      contextRef="i90fcd7f5574440a5ab359cb20e1a04c8_D19990101-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk0MjM_159facdd-0afd-4510-8951-81f119a450ae"
      unitRef="case">69</mo:LossContingencyClaimsDecided>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i90fcd7f5574440a5ab359cb20e1a04c8_D19990101-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk0NDA_05be57d2-3a3a-439b-9c81-5a5091d9302d"
      unitRef="case">44</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="idce33acf337c4fe9a1645ddb2e019e7f_D19990101-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk0NzE_4c8dbc2d-8e63-4f7b-90ff-af11dd9ad6c4"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="id289701c573b45cca1a140d0c73c998a_D19990101-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk0ODg_22ba26e2-4181-4f70-a9dc-3dea6708d924"
      unitRef="case">7</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i8d46d835a2d24d1ebd56341154a639d8_D19990101-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk1MDY_ac4e25af-9842-4d07-bef6-cd1b3503bbfd"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i6f2e6b71ad0c495aa1c5d1de5f3d1b7f_D19990101-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk1MjA_828ad3ff-6e54-4497-9449-a850e6f4b7a8"
      unitRef="case">10</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ie3500d94f16d4d48be23dbcd39c4724d_D19990101-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk1MzY_dcf8c667-b9dd-47d9-98a0-b18076b850b7"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i68a963409b744c62ada96bbe606437d0_D19990101-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk1NTY_670ce984-8756-4374-97da-04161375e730"
      unitRef="case">4</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i5a74a591f616416a8beecae26d6b025a_D19990101-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk1NzQ_fedec37f-ab06-4234-8aa9-8ecaec3f23a9"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i080e23384aca46ac97b6d8534dd6870f_D19990101-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk1ODk_5e3b239a-8ff2-415c-88e5-26f27445a502"
      unitRef="case">4</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="if89eceae6818421ab7e71078e8640a23_D19990101-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk2MDk_d354be8b-0197-4aa0-9bbe-031363c9ec8c"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ia3434a001edb4107b89f9f106fa2815e_D19990101-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk2MjY_80ad797f-944d-45bd-b4a3-a8e4857559ee"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i8dbfceaeded0450399ee40b258518a3e_D19990101-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk2NDE_af9c1c43-1ad6-46f4-a246-fd82290ff4ee"
      unitRef="case">5</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i5569874aeca64116b11922db9cb7839b_D19990101-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk2NTI_83d5f591-615c-4e18-91b1-c2998b9b27d1"
      unitRef="case">2</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ib231c8aea8fd44718baa2914cd6cba3f_D19990101-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk2NzE_f607ab93-e7ca-4216-80b6-c54ab95252f7"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i552ef3865e7d48829a38177ee62b4979_D19990101-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk2OTA_31b40851-4f85-42b2-ae5e-61ae07e46f06"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="id38fc93aeda6476b9dac24a91fd1cf6d_D19990101-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk3MDY_d2d600be-6fd2-4ee9-a424-dcbf2d179719"
      unitRef="case">2</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ia00a1362eff94111880c5d8063950c56_D19990101-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk3Mjk_d8cafe08-cc63-45f8-8833-ee9935b1427a"
      unitRef="case">2</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedUnfavorableNumber
      contextRef="i90fcd7f5574440a5ab359cb20e1a04c8_D19990101-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk3NDE_08ef4441-8fb5-4ad4-87a4-3062cd5f4a41"
      unitRef="case">25</mo:LossContingencyClaimsDecidedUnfavorableNumber>
    <mo:LossContingencyClaimsResolvedNumber
      contextRef="i90fcd7f5574440a5ab359cb20e1a04c8_D19990101-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk4MjQ_06d4c3a0-b1ad-44ed-871f-4e221dbc661b"
      unitRef="case">20</mo:LossContingencyClaimsResolvedNumber>
    <mo:LossContingencyVerdictReversedNumber
      contextRef="i90fcd7f5574440a5ab359cb20e1a04c8_D19990101-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzk4NjI_c5c48f28-a6e0-4225-bc6b-c53b6a727613"
      unitRef="case">2</mo:LossContingencyVerdictReversedNumber>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i052ec416024f4823bef90cd01d8b4153_I20200229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzEzMzYz_22ff336b-7f89-4096-abcd-3df0322b7130"
      unitRef="usd">11000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i052ec416024f4823bef90cd01d8b4153_I20200229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzEzNDAy_898c8742-bc2e-4f2d-9054-ce9263eb1453"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i517f019e7c1743319a6e9441dc360c47_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzEzNjUw_96ed6e3b-f5f4-40fe-85ce-016f09d937e0"
      unitRef="usd">10000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="ib96d34ed4ae34693801830017a4f6049_I20200531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzEzNzk5_b0c308c7-f611-4be8-9a86-50de289399ae"
      unitRef="usd">30000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i7ea87da7184343c09f4ee1578cc648ee_I20210228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzEzOTE0_9eb8e57e-a7b7-4f39-9cd4-1bf6ce4479a4"
      unitRef="usd">2300000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="ifa32d699351d4292af9042e00b380590_I20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE0Mjg5_9f28d4d9-c75a-4f7c-ad74-bcee2bcc09ec"
      unitRef="usd">11000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="ifa32d699351d4292af9042e00b380590_I20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE0MzIw_1362e064-5b71-4a42-ab4f-7affda1454f1"
      unitRef="usd">10000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="id38820dc93e04812843942939c4e6352_D20210901-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNDE2NzA_b3ae4e1d-5b4b-409b-a813-2675c68a3dda"
      unitRef="usd">21000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="id38820dc93e04812843942939c4e6352_D20210901-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNDE2ODU_639258e4-74ef-4275-a849-1394b50842d9"
      unitRef="usd">27100000</us-gaap:LossContingencyAccrualProvision>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i9edffb5157944c1b92f53a2aa6e6ff0a_I20171031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE0NjEy_9e22e498-b341-4e92-8e75-526b861a71b7"
      unitRef="usd">7100000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedAllocationPercentage
      contextRef="i7e21fbb1029544a7bf549cf560acc7df_I20171031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE0NjU0_cefba787-b6ac-4bcd-8535-1bd32de35942"
      unitRef="number">0.75</mo:LossContingencyCompensatoryDamagesAwardedAllocationPercentage>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i5287e7b9447640e785f900c6e40cbb09_I20000731"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE1NDM3_27d16adb-9471-4fc1-a759-9b5dbe7fc198"
      unitRef="usd">145000000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i3a5d377b4b3f458eba4a9e7b517b8e16_I20000731"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE1NDc4_772df556-6eff-4be7-a937-c646f65dea79"
      unitRef="usd">74000000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants
      contextRef="i9a03e98802a847ef9e56a147ecdc0b02_D20060701-20060731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE2MDQx_4f411703-8d97-4694-be21-61b48a186b6f">P1Y</mo:LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants>
    <mo:LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants
      contextRef="i9a03e98802a847ef9e56a147ecdc0b02_D20060701-20060731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE2MjA5_88ae6915-870e-44da-8c98-f71cbe57091e">P1Y</mo:LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="id970cacb82804a6dafd9bb28ce0e0227_I20080131"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE3OTM3_289d0c2c-e74a-411d-84b0-f29f76d04e1b"
      unitRef="claim">9300</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i781149ad13854355a035d0bcc92ce4e5_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE4MDE1_64f04954-83d3-4033-8cab-71b34f6a5bf5"
      unitRef="claim">1026</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="i0285dbb248214e6b82f1b1e1fca99520_D20211025-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE4MTM1_ea293a7a-616c-4221-a433-e3c3689322e9"
      unitRef="plantiff">1285</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="if243dafacad643ca8a92639963f3f04f_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE4NDQ1_a46b418c-99ed-455d-a68c-fe0d07b830bd"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyClaimsDecided
      contextRef="i85fafeeb94a94367a935be26dbab3f38_D20211025-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE4NjAy_6f38b492-6f70-4af9-8a21-a9d3472c2a4b"
      unitRef="case">137</mo:LossContingencyClaimsDecided>
    <mo:LossContingencyClaimsDecidedUnfavorableNumber
      contextRef="i85fafeeb94a94367a935be26dbab3f38_D20211025-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE4NzM1_2cde145a-67ac-438c-9d24-1b64767e479e"
      unitRef="case">76</mo:LossContingencyClaimsDecidedUnfavorableNumber>
    <mo:LossContingencyUnfavorableVerdictsPendingReversed
      contextRef="i90226fb36aa64d6bacef37bf4db3884b_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE4Nzg4_d41e5750-cbfe-409b-80cc-aa72fe83eb86"
      unitRef="case">7</mo:LossContingencyUnfavorableVerdictsPendingReversed>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i85fafeeb94a94367a935be26dbab3f38_D20211025-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE4OTgx_e334a32b-a844-432d-974e-eb01b4721b56"
      unitRef="case">54</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i1eb0635e87454a0fa2b2eec4909179e5_D20211025-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE5MDM2_4050b6b9-9af1-46d2-9e54-957d8903f7b6"
      unitRef="case">44</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyVerdictReversedNumber
      contextRef="ibfc1fdbaa928482089e8a85cb409cd50_D20211025-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE5NDc4_6144ea19-ed77-4f53-9892-cd08dfbe95ed"
      unitRef="case">4</mo:LossContingencyVerdictReversedNumber>
    <mo:LossContingencyZeroDamagesVerdicts
      contextRef="ie96b5489b60e4b18b201d51a8582e17d_D20211025-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE5NjIx_d8d38cef-fcd5-4f97-af21-51f58a470982"
      unitRef="case">2</mo:LossContingencyZeroDamagesVerdicts>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="ie96b5489b60e4b18b201d51a8582e17d_D20211025-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE5NjU4_e1688240-192a-448a-b693-f527683059de"
      unitRef="usd">0</us-gaap:LossContingencyDamagesAwardedValue>
    <mo:LossContingencyZeroDamagesVerdictModified
      contextRef="ie0be9670c3294c5380d9907c287d1387_D20211025-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE5NzA5_6d8a047f-6db9-41a5-acf7-50ba89dfc163"
      unitRef="case">2</mo:LossContingencyZeroDamagesVerdictModified>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="ie0be9670c3294c5380d9907c287d1387_D20211025-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE5Nzg5_2391ec49-0470-4b6b-bccd-9493592c8e95"
      unitRef="usd">0</us-gaap:LossContingencyDamagesAwardedValue>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="icc49a3c9173544c3ba44b82aea64b761_D20211025-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzE5ODcy_c58c9f8b-a6c2-4d4d-bf46-47b129407793"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="if13eaf2626b1498396e84993151f34c0_D20211025-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIwMTI4_626b7fa5-5b9d-4203-99cc-ed8ba769e4de"
      unitRef="case">3</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="if13eaf2626b1498396e84993151f34c0_D20211025-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIwMzMy_a0d1d270-6bb9-435b-9ef1-8b3611d660bd"
      unitRef="case">3</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ifda6adf0b2d84253922e03c7982666d4_D20211025-20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIwMzQz_a927bee7-27a5-454b-b685-ac070aca9adf"
      unitRef="case">2</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:ProvisionRecordedNumberOfCases
      contextRef="iec72a8c6101f4a219bd73a2c63d2d869_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIxMTg2_6e8c9921-6932-45e4-a89e-83ce5b8fb56f"
      unitRef="case">0</mo:ProvisionRecordedNumberOfCases>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i73ae2282abd0496a96c1fcd57396db0e_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzEtNC0xLTEtMzc1MjgvdGV4dHJlZ2lvbjo0OGFhNTY0MmM5OTg0YjEzOTE2YzUxYjhhYjk5YmIwZl8yNzQ4Nzc5MDY5NDU1_47f69fe8-db5a-45b3-bb89-4ea95bba9547"
      unitRef="usd">15000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i194fa22064b649108a6b18c631884f77_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzEtNS0xLTEtMzc1MzQvdGV4dHJlZ2lvbjplZDllZWJhZDYxOTA0NzNhODgyNGNhNzFhMGY1N2Y4M18yNzQ4Nzc5MDY5NDU1_4d83a315-f77a-4a2b-a542-d2041b805162"
      unitRef="usd">28000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i17b84f6260d04ad6961ed01a6a4643ab_I20210531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzEtNC0xLTEtMC90ZXh0cmVnaW9uOmUwZmY5ZTk1MjkzZjRmZDU4MTc4OTM3NWRjMmNmN2ViXzQ_e3863474-2ed7-438a-9300-3b1cf13b892e"
      unitRef="usd">3000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i44c6aea7f36842009497759eedcaee54_I20200229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzItNC0xLTEtMC90ZXh0cmVnaW9uOjU4NGE4OTFiMDE4YzRjYjRiOTgyZTZhMGQwYjVhYjBhXzQ_ffe73d38-e2b9-49e5-a827-99aaa3d1be9f"
      unitRef="usd">3000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="iecc7b1e7a5514f8d981e71849df19766_I20200229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzItNS0xLTEtMC90ZXh0cmVnaW9uOmM2ODQ0NzMxZTc4ZTQ4NmRiMjAxYjgyYjE2N2I1OGQ3XzQ_eec49789-485b-4d3c-bae1-627186fdfc43"
      unitRef="usd">12000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i98691888015f4b7f97a8a5c022078de5_I20200131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzMtNC0xLTEtMC90ZXh0cmVnaW9uOmJhMzY5ZWI4YTZlYzQ4OTVhMzNkNDU2NDZmM2Y3YjRkXzQ_3a2dd211-8e3c-4a09-97bb-8621114a2698"
      unitRef="usd">3000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="if0f67b4fed23474aa26757b30fb8314b_I20200131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzMtNS0xLTEtMC90ZXh0cmVnaW9uOjM5YjA2OWI5NjJiMDRiMzRhMjM3Mjg3MzdiNDk1NjFjXzQ_3030c0bb-daff-4024-ba0b-4bc87e86613b"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i6b6b72d00f4a4457b91e1936a8656c3b_I20191130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzQtNC0xLTEtMC90ZXh0cmVnaW9uOmUzNDViMTYwNDMzZTQ1MTY4ZGU4OGE2OGM3N2E2ZDM1XzQ_76cfdd0a-ec37-4de7-984c-662d700d0b05"
      unitRef="usd">9000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="id11f7d76781a495487c1eed6818fc118_I20191130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzQtNS0xLTEtMC90ZXh0cmVnaW9uOjk1NDk0NDBhMzNjMzQwZjhiYWRhNmM5NzI1ZjcxNjE4XzQ_c22a1b0c-dc33-4eb1-a22b-2a577bd8b1f2"
      unitRef="usd">74000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i1ef26206b34a4ca08fa1661b761ff4d0_I20191130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzUtNC0xLTEtMC90ZXh0cmVnaW9uOjFiOWUyZjBmNDA3NTRiNWZiNDNlYTBhZDg1NjUyYzZlXzQ_8a77e591-176d-49c2-a4a7-6a011874f62b"
      unitRef="usd">15000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i17f63ef63bb548338c974ec35dd2a170_I20191130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzUtNS0xLTEtMC90ZXh0cmVnaW9uOjQ2MzRhZDYxNDJiNjQ3YWY4NDI3MzZkZWE4YWI1ZTZlXzQ_9fb21b04-942b-4548-9b72-49798ef997b7"
      unitRef="usd">11000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i019a0fe5dd374adeb0d5245d94a4dfb5_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzYtNC0xLTEtMC90ZXh0cmVnaW9uOjkxYjc5YTU2OTQyMzQ3ODhhOTAwYzYyMWRiMzMxNmYyXzU_8c3dc018-8a18-4a6b-b285-f33fda9b5c38"
      unitRef="usd">1000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="ief9b76c5f9e7421797d6551c8f48d8b6_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzYtNC0xLTEtMC90ZXh0cmVnaW9uOjkxYjc5YTU2OTQyMzQ3ODhhOTAwYzYyMWRiMzMxNmYyXzEw_95a1cd6c-2597-461f-abdf-a3b55b1252d7"
      unitRef="usd">1000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="ief9b76c5f9e7421797d6551c8f48d8b6_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzYtNS0xLTEtMC90ZXh0cmVnaW9uOjc3YzQyMjc1YTZkNzRiYTFiNGRhNDAyMWU1ZTI3ZGNhXzQ_548d8357-7633-45ce-98db-5bcf78438116"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i6fc0d1aced7b4e3090804c6395b59378_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzctNC0xLTEtMC90ZXh0cmVnaW9uOmQyMjBhMjBjYjllMzRiZDI5ODYwODZlYmQ0Y2ZjNzgxXzQ_ace5f99e-c5b6-4ffe-9293-fa2b03d1358b"
      unitRef="usd">4000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="ia1103462b7784169b773bbbc0efd59f8_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzctNS0xLTEtMC90ZXh0cmVnaW9uOjVmZTIzZTdlZmM1ZjRkYWNhNWU3YzVmYWExNGZiZDY4XzQ_d44f492a-f3a8-4c5c-adb8-8ede4319838c"
      unitRef="usd">2000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="iefe17f299cc745aea480c5200a6d62fe_I20190228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzgtNC0xLTEtMC90ZXh0cmVnaW9uOmJkOTA4NDc3OGNhNjQ5NWFiNTcyMWM0ZWM5OTUzN2VkXzQ_cd723893-5670-4d52-a18d-ab7b5704ef5a"
      unitRef="usd">12000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i4cd3514504b94f14b23eac85e141bf5c_I20190228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzgtNS0xLTEtMC90ZXh0cmVnaW9uOjExYmFlODE3NmIwZDQzOWZiZmM3ODYyYzRiN2M4Yzc4XzQ_2e192fd3-5a15-4c0d-aeff-55b85cb4c826"
      unitRef="usd">10000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="ic644f159146c4bce8ae598030b7521b2_I20190228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzktNC0xLTEtMC90ZXh0cmVnaW9uOjNjZjg0ODM0MjgyOTQ3NjE5NWU5MTZmMmFlNWJkODVlXzQ_d72296bf-8011-42e5-85ef-4a0827a56307"
      unitRef="usd">3000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="iffaa0265108c43ac903736f8d4f7d960_I20190228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzktNS0xLTEtMC90ZXh0cmVnaW9uOmI5YWM3ZTk3YmZhZDQxN2Y4MTZiMGQzYjk4NWRhYWU3XzQ_261c6434-6b80-4fb0-a2a7-6f2295f34336"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i934ff2e5139b4f9b96a1effc5fb356ce_I20180930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzEwLTQtMS0xLTAvdGV4dHJlZ2lvbjphMTVkZjk4ODU3ZWY0MTY0OThjZmIwM2Q2ODcwNGM5MV80_91e61b1f-b63c-421d-8584-e9821129da6d"
      unitRef="usd">2000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="ia0494654648d4e449182d0811815a094_I20180930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzEwLTUtMS0xLTAvdGV4dHJlZ2lvbjpjZjQxOGU0M2ViNTU0ZTFiYWMyN2Q0ZjY3OTNjZTY0Yl80_613676ee-1ef2-44a5-afd0-8a5baf06bfb8"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i2aad4919d9504ddfb45b65695fb63cfe_I20180731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzExLTQtMS0xLTAvdGV4dHJlZ2lvbjpkNjU3MGYxNjYxYzI0Y2M1YTdmN2Q5YjRmODY0MGU3ZV80_605fafce-1a4c-4cca-a33a-89f2d5f84f4a"
      unitRef="usd">2000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i1eed45c1dca24b51910ffb82b58ab797_I20180731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzExLTUtMS0xLTAvdGV4dHJlZ2lvbjo5YzdlMDNiMzNjMzY0ZWU4YmIzMjIxOGFjZTA3NTY3Y180_828b006c-91c2-406c-92ad-34f3fce7531c"
      unitRef="usd">2000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i507aeabef70b43509c6b3bb411894994_I20171130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzEyLTQtMS0xLTAvdGV4dHJlZ2lvbjo3ZjE1OWU4ZDk2NzI0OThmOWJhMDNkYjk4NDZiYWI0NV81_a8c17c5e-7fe9-41b7-ac14-74d88cff11af"
      unitRef="usd">1000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i44733c669e7348d3b2b001c64d98bc3c_I20171130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzEyLTUtMS0xLTAvdGV4dHJlZ2lvbjo2NDA4YWZmMzFhZDQ0MjJlYmI1NTRmZDAyNzYwMTBkOV80_9b391973-a30e-477b-9dc7-6485fc5037ca"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="ib164100fedd24083b3c0a5073943dffd_I20170430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzEzLTQtMS0xLTAvdGV4dHJlZ2lvbjpkYjA3OGVkMDBlZWU0MDc4YTYyNWZhZGI3OTY2OGRjMV80_2a132710-4797-4ecc-b061-f5e4aa79e61d"
      unitRef="usd">1000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="idd484e32de2d4223bdc64a37b20f3802_I20170430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzEzLTUtMS0xLTAvdGV4dHJlZ2lvbjpmMmNhZTE2NWYwMmY0MzQyODhmMTExOTQxMmU4MTEzMl80_3e471682-5028-48aa-8c72-3f449b12358c"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i3e2d19c2ad0043a29926ac4f687526be_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzEzLTYtMS0xLTAvdGV4dHJlZ2lvbjo1NmRlOTM2ZDg1M2Q0YWZiOWVhMDc5MDBmNjhiOGRhM18yNTA_b7b8c0b9-4e39-4eab-a94e-770c1cf3c116"
      unitRef="usd">1000000</us-gaap:LossContingencyAccrualProvision>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="icd834bc282ff4ab6bfccb6bf6f85c412_I20150930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzE0LTQtMS0xLTAvdGV4dHJlZ2lvbjpmM2U4NGNhNmIxYmU0ZmYxOWJiNjhhMDJhY2IwOTg4Nl80_1314c30d-0d0d-4f5f-89fa-aa3983e39065"
      unitRef="usd">5000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i7978ed075eb24ecab8ef0c666e380e86_I20150930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzE0LTQtMS0xLTAvdGV4dHJlZ2lvbjpmM2U4NGNhNmIxYmU0ZmYxOWJiNjhhMDJhY2IwOTg4Nl8xMA_4224fb2c-3488-45be-9895-a5cae1fdc7f2"
      unitRef="usd">1000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i7978ed075eb24ecab8ef0c666e380e86_I20150930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzE0LTUtMS0xLTAvdGV4dHJlZ2lvbjo5MDVlYmE0NGY5ZjA0ZTJiOTIzM2U1OGMxZWVhNDM0MF80_f391caee-3cd7-4f32-bd14-f251976c4d4f"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i7c9bd9d9e7904a7c88f369cfecb8bcff_I20150131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzE1LTQtMS0xLTAvdGV4dHJlZ2lvbjoxZDdmMmNhNmExNTU0NWE3OWRmNjNhYTg0MDJhZGEwMV80_4fe64f2c-15c2-4dd8-a3ff-1baa26cc68ba"
      unitRef="usd">8000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="if28ca12f29db4c178b382557c7195523_I20150131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5NzYxNGQ0MmQwODg0MzdlYWNkNzZlNDVmYTg2MTM3NC90YWJsZXJhbmdlOjk3NjE0ZDQyZDA4ODQzN2VhY2Q3NmU0NWZhODYxMzc0XzE1LTUtMS0xLTAvdGV4dHJlZ2lvbjo2OTY1OTJkMzQ2MGI0MjI3OWRjMWY2MWJlNDFhZTZkNF80_3c6a0ea0-1620-47da-ba92-49fc20edf08b"
      unitRef="usd">9000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i3e2d19c2ad0043a29926ac4f687526be_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIyMDMy_e91b1683-ed72-40f9-aa9e-1383dde2d9bb"
      unitRef="usd">3000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="ie8dcabc9bf25458b893acc42347fba65_D20181001-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5MjA2NjVjMjhlMTc0MTE3OTg4ZWVjNjc4Y2U1MWVkYi90YWJsZXJhbmdlOjkyMDY2NWMyOGUxNzQxMTc5ODhlZWM2NzhjZTUxZWRiXzEtNS0xLTEtMC90ZXh0cmVnaW9uOjIxMWI0MmY5OWRkMzRkM2Q5ZmI5MGYxYWNlYmZkOGU5XzQ_921248df-6ab5-4389-b737-1f9a1ad21b90"
      unitRef="usd">29000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="ic5b096cd3d6d4418807bf4da87541ffb_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5MjA2NjVjMjhlMTc0MTE3OTg4ZWVjNjc4Y2U1MWVkYi90YWJsZXJhbmdlOjkyMDY2NWMyOGUxNzQxMTc5ODhlZWM2NzhjZTUxZWRiXzEtNS0xLTEtMC90ZXh0cmVnaW9uOjIxMWI0MmY5OWRkMzRkM2Q5ZmI5MGYxYWNlYmZkOGU5XzQ_ce3a13ab-9e61-4738-9d12-8279ed3a3bff"
      unitRef="usd">29000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i149fa1186f594219bfa987dbdd8108f6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5MjA2NjVjMjhlMTc0MTE3OTg4ZWVjNjc4Y2U1MWVkYi90YWJsZXJhbmdlOjkyMDY2NWMyOGUxNzQxMTc5ODhlZWM2NzhjZTUxZWRiXzItNS0xLTEtMC90ZXh0cmVnaW9uOjY0MWIxNmRiM2U1ZTRhZmFiMzYxN2VkOWM5NWU5YTFmXzQ_93065460-c3f9-455c-a721-84ff36365a0c"
      unitRef="usd">1000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i56daa4d75b794bf798d94d227d29e58d_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90YWJsZTo5MjA2NjVjMjhlMTc0MTE3OTg4ZWVjNjc4Y2U1MWVkYi90YWJsZXJhbmdlOjkyMDY2NWMyOGUxNzQxMTc5ODhlZWM2NzhjZTUxZWRiXzItNS0xLTEtMC90ZXh0cmVnaW9uOjY0MWIxNmRiM2U1ZTRhZmFiMzYxN2VkOWM5NWU5YTFmXzQ_f425f063-5e15-4731-a993-8e702009933b"
      unitRef="usd">1000000</us-gaap:LossContingencyDamagesAwardedValue>
    <mo:LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo
      contextRef="i8b7112204f034a1d857b3dec087a6b72_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIyMjg1_d68296ea-a2de-4766-9a6f-d8e214c19588"
      unitRef="case">6</mo:LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i9786b102ec154400a94c47410abdf0d2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIyNDMx_d003bf23-2136-4f54-955f-10744e640e2e"
      unitRef="usd">8000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i1a270cd854f546eaa7d120809442f7ea_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIyNDM1_e5eb8967-06f8-484a-a70f-c48eedfa4acb"
      unitRef="usd">2000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i0c3f1a744f0843eb886c976a94595df2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIyNDM5_59bf2169-99d7-42ce-b267-37f03727b538"
      unitRef="usd">8000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i2ea5715a75a04415a4cc1a94df208c7b_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIyNDQz_26cf4c49-3a30-4c0b-a55c-3ddd1ff65ad8"
      unitRef="usd">4000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="ice47fff653d74495b39ba1566ff6ab1b_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIyNDUw_f0e1d172-ddbd-4f5d-9806-e8fd9b2cf7cc"
      unitRef="usd">1000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="ie4bc3e6b7f3141d8ad1df8728d140283_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNDE2OTY_5d6fb5e3-a597-44ee-98a2-c45ac718bfbf"
      unitRef="usd">3000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="ifb6a94b0655c424dbf083fa25f9e6807_D20210401-20210429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIyNzE2_a01bb02a-4d77-4947-b506-ca221fec6eec"
      unitRef="usd">8200000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="i2cdf509335c8425e86145370f35dab92_D20210501-20210531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzIyODAy_cca1cd97-0b04-469a-90d2-7b05b45cc1b9"
      unitRef="usd">1000000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="ie6ca88fb103d422eba56dd92aabfb961_D20210701-20210731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNDE3MTA_eee7a49f-05c5-44a5-8c87-0c447f6406d4"
      unitRef="usd">1500000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="i0f8871aa42a34c93b07bdabe159afc9d_D20210701-20210731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNDE3NDA_a5bb4334-795e-4c64-8c19-d29f80e81005"
      unitRef="usd">1500000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i0f8871aa42a34c93b07bdabe159afc9d_D20210701-20210731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMyOTg1MzQ5NjQ0OTU_d08269d7-f6fd-4e7f-9d43-078ca440aa14"
      unitRef="usd">3000000</us-gaap:LossContingencyDamagesAwardedValue>
    <mo:MaximumBondForAllDefendants
      contextRef="i91285291d0224d41a9f6b6f098c51c67_I20090630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI1Mjk4_276f17db-9cef-4008-9ac3-c4fdab645201"
      unitRef="usd">200000000</mo:MaximumBondForAllDefendants>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i5e74537c0b4c4859a3f2089a42ce56ae_D19960501-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2NTYz_e6f24122-5c50-46e1-bb40-433889e46ce0"
      unitRef="case">61</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="ic64ffeb5c74f4dfb969778dccaadc1bf_D19960501-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2NjI5_ae1404be-7126-4de8-9a29-442481a7895c"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="id40a29a6291543d78c372cbf264db1d9_D19960501-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2NjQ2_fec3ef40-5285-457e-8e91-6299c7ecd02a"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i555c1554720a424d98f50f13e51eeb80_D19960501-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2NjYx_c9604d6d-e089-4bb5-9676-8ba5d550ec18"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i53e4eebb4a714524b636f0534865d23e_D19960501-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2Njky_1933198e-ae8e-4bb4-8817-f5f08788eeb6"
      unitRef="case">2</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i898cd371a7b3471d989e10fd1301c6c6_D19960501-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2NzA2_499b86aa-3d4c-48fd-88a2-c25395a19a3c"
      unitRef="case">2</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i4a99e02ce83d418b860435133fff2496_D19960501-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2NzIx_159c1e5a-028e-4fe9-a72c-96b5f9a15f9b"
      unitRef="case">3</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="ib09e7e21f8824054b044c6461611053c_D19960501-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2NzMy_c8677192-5beb-49ac-a818-1afd44d809e5"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="icefa681020fe4e1cb4c5b70752a2483d_D19960501-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2NzQ1_60025cad-ac7f-44d2-8f5c-d37417a2c9c7"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="iddd4591b90d04ff19b36afa6fd9b9e7a_D19960501-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2NzYx_8bcb524a-9a5a-40b0-a1ea-57ce1a7692d3"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i58f52856b1ef4eaeb4ce8c5360ba8d3c_D19960501-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2Nzc2_88daf73e-a7a1-4a75-b6b8-5f31f94ad2aa"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="ia8cca8977ddf4dceb3cd11ee8f5468f3_D19960501-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2Nzkx_99f80655-f05e-4b81-a4f2-10ebb56fb8f1"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i3e80e20cf6794e25b4bcef5d2425a2c0_D19960501-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2ODA3_f9300242-d746-4434-9461-e0a2ab57965d"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i01b20b669936475f993e104a31de5013_D19960501-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2ODIw_eb1cfa6c-62ef-4fd6-9412-ee93eb82ecb0"
      unitRef="case">29</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i83fd76d8eb1c479c890d6dbefa8006e5_D19960501-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2ODM3_b6ed2bd4-ec58-4d34-b3f3-7d392a1cbfd7"
      unitRef="case">6</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="ie80c16c4c2d34cf7b117c4db4d715bd7_D19960501-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2ODUy_0d3a2670-be3c-471b-afc2-1ea8ab8ec00c"
      unitRef="case">2</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i3950ec60b64d43e79a255e2090017c76_D19960501-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2ODYz_8aface47-0603-4edb-9fe2-fbd85b540b55"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i5ef55ce7cdbf4a49ab62450c92339999_D19960501-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2ODc4_d0061840-c059-4b4e-9d2c-681a27354634"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i0af01f3e38964466aabcb29ac90c169f_D19960501-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2ODkx_fc3a1041-3dc7-4613-8242-42804f149ff8"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i12033c228a91450cb06602a444123772_D19960501-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2OTEw_2bdd6681-871e-4e8e-b162-d62d87baec84"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i3e9ec11b5d7f4c02a0471f53510291d4_D19960501-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2OTI4_8e65433e-30d0-4a51-b219-ecf62d1f31d8"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i438bd25e9e5b4fa5b786198ed333fea2_D19960501-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2OTQ5_f3d9cbbc-a973-4155-84a8-00099f4e0b41"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i15af965191ab4b03be2934d3ca487181_D19960501-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2OTYx_da8c262c-a91a-4f46-b2b4-1e29af20e6dc"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="iaf606e5861bc4311aab5a4deb0ea2a7e_D19960501-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI2OTgw_f745d2b1-e976-4508-a526-adedc1f9f2c4"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i61b4bd1b44014f77ba98ffaddac70a1c_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3Mjc5_e0bc12c8-b85f-493c-8b92-3069b5b85c98"
      unitRef="claim">7</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i39795ebd6cb34fd9b722c425c1d7f1b5_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDQz_e0f997b3-aadd-4976-8191-846aa6657cad"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyNumberofManufacturers
      contextRef="i4618babb55a643e08513e3f263b04127_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3OTM1_2f6c4c71-ad1d-4125-bd9c-8bab43d03500"
      unitRef="manufacture">3</mo:LossContingencyNumberofManufacturers>
    <mo:LossContingencyNumberofManufacturers
      contextRef="i275c1685fc084d30907f39c9ca35ef66_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3OTcw_ef73232f-5049-40fc-81e7-943230aa324b"
      unitRef="manufacture">0</mo:LossContingencyNumberofManufacturers>
    <mo:LossContingencyVerdictsUpheld
      contextRef="i4618babb55a643e08513e3f263b04127_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI4MjQ3_85acf636-e402-483e-a936-663a3230c396"
      unitRef="ruling">2</mo:LossContingencyVerdictsUpheld>
    <mo:AmountAwardedtoOtherParty
      contextRef="i78204298c1714c59b1565b14ec68a768_D20190301-20190331"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI4MzQy_0d39102e-8ce6-4813-a906-785b70e51671"
      unitRef="cad">13000000000</mo:AmountAwardedtoOtherParty>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i4afafb6cc22d4bfc8634ef389a32cb14_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI5OTA2_8c6003c8-2893-445e-93d6-7a3dc847c286"
      unitRef="claim">10</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyNumberofManufacturers
      contextRef="if3b522f7309f4c28bb7cdb2e6f309062_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMwNzg3_8eacb306-dc09-4ec3-9d7f-ac0f7df479fa"
      unitRef="manufacture">3</mo:LossContingencyNumberofManufacturers>
    <mo:LossContingencyNumberofStateswithSettledLitigation
      contextRef="i94453f2294bb47798d15011e7260b27b_D19981101-19981130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMxNDU1_d39813d1-ee16-48e5-b7d5-a16d4946fd60"
      unitRef="state">46</mo:LossContingencyNumberofStateswithSettledLitigation>
    <mo:LitigationSettlementAnnualPaymentAmount
      contextRef="i94453f2294bb47798d15011e7260b27b_D19981101-19981130"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMyMDU1_6e784d27-c920-4dc0-834d-2e13e0ff838a"
      unitRef="usd">9400000000</mo:LitigationSettlementAnnualPaymentAmount>
    <mo:LitigationSettlementAnnualLegalFeesPayableMaximum
      contextRef="i9116d2cabdcb49b38d8d90ace75f12d8_I19981130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMyMjY3_4f628c77-f538-47bc-9791-5cf2202c5a04"
      unitRef="usd">500000000</mo:LitigationSettlementAnnualLegalFeesPayableMaximum>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i53eb33b5a5a54692bf19b84768b69b6f_D20210701-20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNDMyMDY_477d226b-49d6-4251-b070-468961f48cfb"
      unitRef="usd">1100000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i0748deafef534cbdb4febc2a98913d94_D20200701-20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNDMxNTc_60204804-2442-481e-bed6-047b73563f52"
      unitRef="usd">1200000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="ic2672eb1f4624a6b91e6bd2e2ad0726e_D20210101-20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMyNjI0_627e3965-af10-4500-9f64-0b0931969da7"
      unitRef="usd">3200000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="ica606fb15fa64e31a1db6c7bbbc4c3a8_D20200101-20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNDMxODc_9f22c676-ba0a-414a-87f8-250426bcec92"
      unitRef="usd">3300000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i9664ef4ada2b462a8ed748d49c2d084c_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzMzIx_58d0ab58-466a-4b73-9d27-82007bcfd572"
      unitRef="usd">388000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i906990683f674cd28e47cbcc0f1c3ce6_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzMzM0_52f1df28-100e-478e-a9b8-aab64c805b06"
      unitRef="usd">181000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i9ee9df31ad2b4e4ba1a5db1f61706b48_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzMzQ3_d45ed409-eae9-41e2-8a9f-f51338a248db"
      unitRef="usd">154000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="ia38de3fc206c47ab8cac6dffc4614a4d_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzMzYw_febb8c89-8f1d-42be-8672-9bcb837cc82b"
      unitRef="usd">185000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i641a64c3fd2249f69b0e9e1f3f788718_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzMzcz_552eea22-dc52-4ca5-a15d-0f130452b782"
      unitRef="usd">250000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i2774e5040f8c4961ae53d545a9f37afe_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzMzg2_2a58577a-fe86-4c87-ad2e-a289eb24b5b6"
      unitRef="usd">211000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i0f745bd8bca441319b8ed301cc2bc4cc_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzMzk5_b048d878-a79e-453c-9afb-d002c26afccd"
      unitRef="usd">218000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="id7e7f831dff6421d8eb531fa106546e6_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzNDEy_a9cdc1d2-d6f9-4f44-b237-10d3fb7ea4c7"
      unitRef="usd">166000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i5ed22e918d4f48e8b808961d921a33f4_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzNDI1_3bf376b4-bb17-4a44-814b-d8b3fb2e6d53"
      unitRef="usd">214000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="id9721043231044bc9aeae35bc61c92e2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzNDM4_902ceb41-6e39-4ee1-b107-bfeed5cb35e6"
      unitRef="usd">224000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i315da09d5b6b446fb033c07698d6d7a5_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzNDUx_f0f02146-0ddd-4411-9247-789c57a09b39"
      unitRef="usd">258000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i65cffff74cb04e8ea2ecc68c77d2b4db_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzNDY0_171ee6d0-8cc0-41db-9048-a5389a5afe88"
      unitRef="usd">313000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i4720a28bdb104979ab2247511d0da7e2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzNDc3_38fbed96-bddf-42d1-80f6-02e3274c430c"
      unitRef="usd">292000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i65954542804549b295903e71ce88b5d9_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzNDkw_35cc402f-5e11-44b9-a734-c53d04691974"
      unitRef="usd">302000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="id2c3b4aebf6646d9972246c1621e7c8a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzNTAz_a158c3cf-190f-4323-9bc5-a46fab8df9fe"
      unitRef="usd">325000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i21f876e2b3cf44cdb355f679e4503b4c_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzNTE2_56f5d4e1-5d04-4ec7-a521-5b31b84cddc5"
      unitRef="usd">444000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="ifebf0c01e22141d8beb01098ae7c84fd_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMzNTMz_063e1fe0-c7bf-4b3a-a3e3-d63cf1556a7f"
      unitRef="usd">572000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne
      contextRef="i0c5082287da0495e8408464c2a0a26c2_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM0MDk4_00c4ec69-8efd-4473-ba9e-0bf125dce271"
      unitRef="state">36</mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne>
    <mo:LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation
      contextRef="i96af53950024460b8a4b3ff962001c7b_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM0MTk4_150d08e8-44d3-4bbf-97ab-4aec8836ca78"
      unitRef="state">35</mo:LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation>
    <mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne
      contextRef="i0c5082287da0495e8408464c2a0a26c2_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM0MjA4_104fb0d9-0637-47d5-8f54-6362b0149739"
      unitRef="state">36</mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne>
    <mo:LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation
      contextRef="i33c7acc23f4a44fe8c2a26183ccd5df2_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM0MjQx_50bcae92-5488-4e10-b438-9533a7d27bf0"
      unitRef="state">1</mo:LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation>
    <us-gaap:LitigationSettlementAmountAwardedFromOtherParty
      contextRef="i0c5082287da0495e8408464c2a0a26c2_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM0MzA4_cb574794-aaf7-4e10-a496-665ba1421052"
      unitRef="usd">1030000000.00</us-gaap:LitigationSettlementAmountAwardedFromOtherParty>
    <mo:LitigationSettlementAmountExpectedToBeAwardedFromOtherParty
      contextRef="i4d3472b2a91245dea8ecb3a70a055bbc_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM0MzQ4_c1395f7e-5eef-492c-bc83-3cf30c87233f"
      unitRef="usd">320000000</mo:LitigationSettlementAmountExpectedToBeAwardedFromOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i1ead92d842db4635b29251f1f090ed5f_D20150101-20151231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM0NjA4_8ccc43e6-0b0d-4b8d-9047-ee627009a64f"
      unitRef="usd">373000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i5f1a36b47df14a2887897a88255928c0_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM0OTgw_e7997c07-4262-4cf3-a5d2-80a7b37bfaaf"
      unitRef="usd">4000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mo:LossContingencyNumberOfStatesNotSettled
      contextRef="i308a1982e0b2451ba03e43963d30bf8a_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM1MDky_4836df38-dd25-400c-845a-e94bd5e2c3b9"
      unitRef="state">10</mo:LossContingencyNumberOfStatesNotSettled>
    <mo:LossContingencyNumberOfStatesWithConcludedHearings
      contextRef="i308a1982e0b2451ba03e43963d30bf8a_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM1MjU1_7da925a1-70cb-4233-a343-762c9d35d085"
      unitRef="state">9</mo:LossContingencyNumberOfStatesWithConcludedHearings>
    <mo:LossContingencyNumberOfStatesNotSettled
      contextRef="i308a1982e0b2451ba03e43963d30bf8a_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM1MjY1_b8e5f161-edb9-42cd-afd5-423b90e6af02"
      unitRef="state">10</mo:LossContingencyNumberOfStatesNotSettled>
    <mo:LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues
      contextRef="i308a1982e0b2451ba03e43963d30bf8a_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMyOTg1MzQ5NjQ0ODg_0f332de6-1752-40f9-8cf7-f66359350a9d"
      unitRef="state">2</mo:LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues>
    <mo:LossContingencyNumberOfStatesInComplianceWithEscrowStatues
      contextRef="i308a1982e0b2451ba03e43963d30bf8a_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQ5NDc4MDI0MTgwMjg_d706a46c-a8c4-428a-a5c4-8b9e8f07b072"
      unitRef="state">7</mo:LossContingencyNumberOfStatesInComplianceWithEscrowStatues>
    <mo:LossContingencyReductionToCostOfSales
      contextRef="ia16faf9bb3364629910ff901aa086762_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMyOTg1MzQ5NjgwNTI_da2ddb02-f808-4748-82b7-4d156b7851cd"
      unitRef="usd">21000000</mo:LossContingencyReductionToCostOfSales>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="ie82ddd3ae8a04ec1904fa44df200d11f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMyOTg1MzQ5NjgwNjk_0ffbed8c-462b-48ab-8ca5-3cbd21e58dbc"
      unitRef="usd">23000000</us-gaap:LossContingencyDamagesSoughtValue>
    <mo:LossContingencyNumberOfStatesNotSettled
      contextRef="icb250f9fcdf1428aa03ed81b876ddfae_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM1NDg3_720f17e9-5157-433b-a913-062a2daff373"
      unitRef="state">10</mo:LossContingencyNumberOfStatesNotSettled>
    <mo:LossContingencyNumberOfStatesNotSettled
      contextRef="ic8c655e105f449fd919701efabc22bc1_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM1Njg2_b09ecdc2-c6de-422e-b994-8fd7aec0556f"
      unitRef="state">9</mo:LossContingencyNumberOfStatesNotSettled>
    <mo:LossContingencyNumberOfStatesNotSettled
      contextRef="icb250f9fcdf1428aa03ed81b876ddfae_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM1Njk2_59713fd2-102c-426d-8da1-6c46e5c8a11b"
      unitRef="state">10</mo:LossContingencyNumberOfStatesNotSettled>
    <mo:LossContingencyNumberOfStatesNotSettled
      contextRef="i9eb956b79e6c4406aa88f5877ca274ab_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM1NzMw_b3892aa2-95e5-485d-8555-2fd8ae092bbf"
      unitRef="state">1</mo:LossContingencyNumberOfStatesNotSettled>
    <us-gaap:LitigationSettlementAmountAwardedFromOtherParty
      contextRef="i52787a392f8143ad96b8a01791362efb_D20210101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMyOTg1MzQ5NjgwOTA_8de37841-3e88-4794-9041-e25edb82e595"
      unitRef="usd">32000000</us-gaap:LitigationSettlementAmountAwardedFromOtherParty>
    <mo:FederalTradeCommissionDisclosurePeriod
      contextRef="i37765c8db4d14257a1db295453135743_D20060801-20060831"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQwNzIx_f4b842d5-304c-4571-9795-594f10a9b6f3">P10Y</mo:FederalTradeCommissionDisclosurePeriod>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="iac111175a4b94767b66b855e1ae095ae_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQxNjc2_1ba37c19-3568-4904-988f-b41c5223076e"
      unitRef="usd">36000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i95495989d64f46e4884394df5ac52ea3_D20140101-20141231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQxNjc2_4c9ee1cb-7d0e-4e20-8b52-e8a891c6c4f0"
      unitRef="usd">36000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i05574f14d9b74110b3542338d268b496_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQxNjc2_988333cb-6bb0-4c79-a898-3378ca1aaeb2"
      unitRef="usd">36000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i37604da1eb80482781b7544e25e04971_D20140101-20141231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQxNjc2_c795d270-05c5-41a9-9d06-d4106ba86c0a"
      unitRef="usd">36000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i4d5084fb63864e7d87b275079786c20d_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQzMDk1_5e95cdd6-aa09-4df1-9e23-2c3be1e56996"
      unitRef="claim">53</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i4d5084fb63864e7d87b275079786c20d_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQzNDgx_fef19941-ac4e-4677-8af9-fd07b03ef33f"
      unitRef="claim">53</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber
      contextRef="i4d5084fb63864e7d87b275079786c20d_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQzNTE0_f63adaac-038f-4711-8c34-8460c3c026be"
      unitRef="claim">28</mo:LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i7e914a4a2b8344169accefce0c454834_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQzODUw_aadac51d-f0f9-46e3-856c-3819e4c6bca6"
      unitRef="claim">2548</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i43eda0d8e1cd4c80b86df99bd8127abd_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQzODc0_07c79ceb-78ab-42ec-943e-ca4a2a3eacb4"
      unitRef="claim">350</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="i8ac851e84d934c1fae22ee819de18e27_D20201201-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQ1NDYw_a4d99f15-5973-434b-9f57-292a091769f1"
      unitRef="plantiff">20</us-gaap:LossContingencyNumberOfPlaintiffs>
    <mo:LossContingencyNumberOfCasesWithCourtDatesSet
      contextRef="i0b7b05662cb744f89da910b211c223dc_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQ1NTgw_2e6324ed-6c68-40bb-941f-018a411ad690"
      unitRef="case">4</mo:LossContingencyNumberOfCasesWithCourtDatesSet>
    <mo:NumberOfThirdPartyLawsuits
      contextRef="i34283e5fbf764b508c0c3b5d55b0c2d8_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQ2MDc3_a04c3f31-4fe7-4861-b2d0-c35d42b8029f"
      unitRef="lawsuit">3</mo:NumberOfThirdPartyLawsuits>
    <us-gaap:LossContingencyClaimsSettledNumber
      contextRef="i39fd421e674b4f2885bbdc2d844388dc_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQ2NTA3_5f1ad8d7-138e-4d2e-bd59-72cd5d383292"
      unitRef="claim">1</us-gaap:LossContingencyClaimsSettledNumber>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i39fd421e674b4f2885bbdc2d844388dc_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQ2NTYw_e7781e2e-3133-4177-8971-2e77c6d050c2"
      unitRef="usd">40000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mo:LossContingencyDamagesRecoverableValue
      contextRef="i05447dda5f5a4d59809fb46f46b15f92_D20200401-20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQ4MTIx_1ea1b56e-4562-4293-a31c-3c870b834a63"
      unitRef="usd">0</mo:LossContingencyDamagesRecoverableValue>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage
      contextRef="i035c8420533b4cbbb71f640ebbdb0bc3_I20200430"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzQ5ODIw_d996d4ad-f708-4f63-a8ba-aec34fb9e250"
      unitRef="number">0.35</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage>
    <mo:LossContingencyClassActionLawsuit
      contextRef="i93cb9eb992434b78b7e8af13960914e0_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzUwOTYx_de8e3d0b-8966-4a51-9b95-beb08f8c2932"
      unitRef="lawsuit">16</mo:LossContingencyClassActionLawsuit>
    <mo:LossContingencyNumberOfComplaints
      contextRef="if859d02a78924c39895c8fe236aea331_I20201130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzUxNDMw_f6ba889e-9d29-459e-b6fc-a03bb002aca2"
      unitRef="complaint">3</mo:LossContingencyNumberOfComplaints>
    <mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits
      contextRef="i8b76752f44e74819b436e49281d45ca0_D20191001-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzUyODc2_b2a2146f-4500-4ad7-b042-282782167736"
      unitRef="shareholder">2</mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits>
    <mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits
      contextRef="i8b76752f44e74819b436e49281d45ca0_D20191001-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzUzMjgz_b2a2146f-4500-4ad7-b042-282782167736"
      unitRef="shareholder">2</mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits>
    <mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits
      contextRef="i6840f559dfc14605ad93fc181579892b_D20200801-20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzUzOTc3_e05b161a-b907-47a3-bcd4-481b5e1e5951"
      unitRef="shareholder">2</mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits>
    <mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits
      contextRef="i199dd80736164b16bc4c33007d8b83f5_D20201001-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMyOTg1MzQ5NjgxMDg_e9ec859f-63f1-4d62-abec-6f0ed36f5005"
      unitRef="shareholder">3</mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits>
    <mo:LossContingencyNumberOfPendingCasesConsolidated
      contextRef="i20c19903e59744cda38126a75fe80854_D20210401-20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzU1ODcy_cd334336-65c0-4a6a-a065-4333a66b9823"
      unitRef="claim">5</mo:LossContingencyNumberOfPendingCasesConsolidated>
    <mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits
      contextRef="ic61197cb6b06443dbfd08c5b6acfcd30_D20200901-20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzMyOTg1MzQ5NjgxMjE_fae947c9-ef99-41bc-85dd-fd819c589761"
      unitRef="shareholder">6</mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits>
    <mo:LossContingencyNumberOfConsolidatedDerivativeLawsuits
      contextRef="i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNjI3NzM_000c0dbc-991b-4975-b5e2-64cfa1b81b69"
      unitRef="claim">4</mo:LossContingencyNumberOfConsolidatedDerivativeLawsuits>
    <mo:LossContingencyClaimsNotCertifiedNumber
      contextRef="i72c3cdb7c38d49a39f60eaafddfc2f55_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzU3NTA1_541fd7b2-eb33-41f4-bfbb-9b5bf815343e"
      unitRef="case">23</mo:LossContingencyClaimsNotCertifiedNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i72c3cdb7c38d49a39f60eaafddfc2f55_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzU3NzEw_c381d466-24cb-4125-b5b1-9817c09078c4"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="icdad9497490d4094a88132d419cbfe76_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzU3ODI4_af94c4c0-1ef5-4599-8c02-863a2ee0b8b2"
      unitRef="claim">1</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ibadad7f290d443d29bbe99b6abd7399f_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzU4ODcz_f1752908-a064-4642-b4b7-7d4039ddf3ad"
      unitRef="claim">1</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:EnvironmentalCostsPolicy
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzYyNTk2_3260e495-b01e-46b3-a905-67973f4b18e9">Altria and its subsidiaries (and former subsidiaries) are subject to various federal, state and local laws and regulations concerning the discharge of materials into the environment, or otherwise related to environmental protection, including, in the U.S.: the Clean Air Act, the Clean Water Act, the Resource Conservation and Recovery Act and the Comprehensive Environmental Response, Compensation and Liability Act (commonly known as &#x201c;Superfund&#x201d;), which can impose joint and several liability on each responsible party.  Subsidiaries (and former subsidiaries) of Altria are involved in several matters subjecting them to potential costs of remediation and natural resource damages under Superfund or other laws and regulations.  Altria&#x2019;s subsidiaries expect to continue to make capital and other expenditures in connection with environmental laws and regulations.Altria provides for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are probable and can be reasonably estimated.  Such accruals are adjusted as new information develops or circumstances change.</us-gaap:EnvironmentalCostsPolicy>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i8b49abf1769f40eb98805158adeb07ff_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzYwODU0_ae4c75e8-33bf-4cbc-9b0f-758052dec1b3"
      unitRef="usd">48000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:GuaranteeObligationsMaximumExposure
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzYxMDE5_f8ab490f-94d6-41c0-b7e1-f3e063b4653d"
      unitRef="usd">24000000</us-gaap:GuaranteeObligationsMaximumExposure>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i503473da7ed148e2805b9efd533f401c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzI3NDg3NzkxNDI5NDc_f780172b-ef84-4444-80e3-e553ffc4c065"
      unitRef="usd">39000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i89787fa06a89496fbdd25f2aaa8f0fe7_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzYyNTE0_1cae6826-fc40-43f0-9ad7-324b0c00859a"
      unitRef="usd">3000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDYvZnJhZzo0NWUxMDBlY2RkMDE0NWY1YjgxZjg0ZjQ4ZDkzNzk4Ni90ZXh0cmVnaW9uOjQ1ZTEwMGVjZGQwMTQ1ZjViODFmODRmNDhkOTM3OTg2XzE3Nw_dfeb17b7-1dcb-46ac-ae1a-bcd24fdd8a1a">New Accounting Guidance Not Yet Adopted&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, Altria:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.232%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Standards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effective Date for Public Entity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect on Financial Statements &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ASU 2020-06 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Accounting for Convertible Instruments and Contracts in an Entity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;s Own Equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#x2019;s own equity.&#160; Key provisions of the guidance include reducing the number of accounting models, simplifying the earnings per share calculations and expanding the disclosures related to convertible instruments.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021.  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Altria&#x2019;s adoption of this guidance is not expected to have a material impact on its consolidated financial statements and related  disclosures. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i083f183560914b169a2b47229664ba43_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDYvZnJhZzo0NWUxMDBlY2RkMDE0NWY1YjgxZjg0ZjQ4ZDkzNzk4Ni90ZXh0cmVnaW9uOjQ1ZTEwMGVjZGQwMTQ1ZjViODFmODRmNDhkOTM3OTg2XzE3NQ_0987f967-3941-424c-ad15-470e5b6d2e9f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, Altria:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.232%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Standards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effective Date for Public Entity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect on Financial Statements &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ASU 2020-06 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Accounting for Convertible Instruments and Contracts in an Entity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;s Own Equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#x2019;s own equity.&#160; Key provisions of the guidance include reducing the number of accounting models, simplifying the earnings per share calculations and expanding the disclosures related to convertible instruments.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021.  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Altria&#x2019;s adoption of this guidance is not expected to have a material impact on its consolidated financial statements and related  disclosures. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMy02LTEtMS0w_cfd1eecd-b66e-4023-878c-717aa000efe8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMy02LTEtMS0w_cfd1eecd-b66e-4023-878c-717aa000efe8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMy0xNC0xLTEtMA_7bcd41f6-88a5-47e4-a622-337fa0cd6df4"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMy0xNC0xLTEtMA_7bcd41f6-88a5-47e4-a622-337fa0cd6df4"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMy0xMi0xLTEtMA_565cff0f-4a2a-4943-9896-5eb2823df608"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMy0xMi0xLTEtMA_565cff0f-4a2a-4943-9896-5eb2823df608"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMy0xNC0xLTEtMA_6d928a65-3130-4032-8eb4-26155a95136d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMy0xNC0xLTEtMA_6d928a65-3130-4032-8eb4-26155a95136d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMy0xMi0xLTEtMA_e60fc491-328c-4c42-ba33-ec78cf50126b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMy0xMi0xLTEtMA_e60fc491-328c-4c42-ba33-ec78cf50126b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMy02LTEtMS0w_800dee3e-6c08-48a8-94d5-7442ad98a88e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMy02LTEtMS0w_800dee3e-6c08-48a8-94d5-7442ad98a88e"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RleHRyZWdpb246NWU1N2I2YTdkOGRhNGRiMmFkODU2YTZjNmQ1ZDM4MDdfNzU1_5d6ab827-9b33-4104-8102-5ca28ce47467" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RleHRyZWdpb246NWU1N2I2YTdkOGRhNGRiMmFkODU2YTZjNmQ1ZDM4MDdfNzU1_5d6ab827-9b33-4104-8102-5ca28ce47467" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">Amounts attributable to noncontrolling interests for the nine months ended September 30, 2021 and 2020 exclude net earnings of $4 million and $2 million, respectively, due to the redeemable noncontrolling interest related to Stag&#x2019;s Leap Wine Cellars</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">,</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> which is reported in the mezzanine equity section on the condensed consolidated balance sheets.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMy02LTEtMS0w_cfd1eecd-b66e-4023-878c-717aa000efe8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RleHRyZWdpb246NWU1N2I2YTdkOGRhNGRiMmFkODU2YTZjNmQ1ZDM4MDdfNzU1_5d6ab827-9b33-4104-8102-5ca28ce47467"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMy0xNC0xLTEtMA_7bcd41f6-88a5-47e4-a622-337fa0cd6df4"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RleHRyZWdpb246NWU1N2I2YTdkOGRhNGRiMmFkODU2YTZjNmQ1ZDM4MDdfNzU1_5d6ab827-9b33-4104-8102-5ca28ce47467"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjdkMGViMmVmODBiNTQ4MWZiYzA1ZDRmZGI5MDAzZjQ0L3RhYmxlcmFuZ2U6N2QwZWIyZWY4MGI1NDgxZmJjMDVkNGZkYjkwMDNmNDRfMy0xMi0xLTEtMA_565cff0f-4a2a-4943-9896-5eb2823df608"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RleHRyZWdpb246NWU1N2I2YTdkOGRhNGRiMmFkODU2YTZjNmQ1ZDM4MDdfNzU1_5d6ab827-9b33-4104-8102-5ca28ce47467"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMy0xNC0xLTEtMA_6d928a65-3130-4032-8eb4-26155a95136d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RleHRyZWdpb246NWU1N2I2YTdkOGRhNGRiMmFkODU2YTZjNmQ1ZDM4MDdfNzU1_5d6ab827-9b33-4104-8102-5ca28ce47467"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMy0xMi0xLTEtMA_e60fc491-328c-4c42-ba33-ec78cf50126b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RleHRyZWdpb246NWU1N2I2YTdkOGRhNGRiMmFkODU2YTZjNmQ1ZDM4MDdfNzU1_5d6ab827-9b33-4104-8102-5ca28ce47467"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfMy02LTEtMS0w_800dee3e-6c08-48a8-94d5-7442ad98a88e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RleHRyZWdpb246NWU1N2I2YTdkOGRhNGRiMmFkODU2YTZjNmQ1ZDM4MDdfNzU1_5d6ab827-9b33-4104-8102-5ca28ce47467"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfOC0xMi0xLTEtMA_cb2717aa-46fe-493e-b582-bd2353400bd8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfOC0xMi0xLTEtMA_cb2717aa-46fe-493e-b582-bd2353400bd8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfOC0xNC0xLTEtMA_4025fc2c-2256-4c1c-ba8b-25d2714d062e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfOC0xNC0xLTEtMA_4025fc2c-2256-4c1c-ba8b-25d2714d062e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfOC00LTEtMS0w_b1200d39-2bbc-446d-af4c-b59a2cb1072e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfOC00LTEtMS0w_b1200d39-2bbc-446d-af4c-b59a2cb1072e"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RleHRyZWdpb246NWU1N2I2YTdkOGRhNGRiMmFkODU2YTZjNmQ1ZDM4MDdfNzUz_029f7e53-60c3-4781-8238-1125abf6da16" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RleHRyZWdpb246NWU1N2I2YTdkOGRhNGRiMmFkODU2YTZjNmQ1ZDM4MDdfNzUz_029f7e53-60c3-4781-8238-1125abf6da16" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents the purchase of the remaining noncontrolling interests in Helix.  For additional information, see Note 1. </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Background and Basis of Presentation</xhtml:span>. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfOC0xMi0xLTEtMA_cb2717aa-46fe-493e-b582-bd2353400bd8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RleHRyZWdpb246NWU1N2I2YTdkOGRhNGRiMmFkODU2YTZjNmQ1ZDM4MDdfNzUz_029f7e53-60c3-4781-8238-1125abf6da16"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfOC0xNC0xLTEtMA_4025fc2c-2256-4c1c-ba8b-25d2714d062e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RleHRyZWdpb246NWU1N2I2YTdkOGRhNGRiMmFkODU2YTZjNmQ1ZDM4MDdfNzUz_029f7e53-60c3-4781-8238-1125abf6da16"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RhYmxlOjE3YmM4MDNkYWQ1NzQyNmNhY2E4M2Q3NzMyYzNjOTBhL3RhYmxlcmFuZ2U6MTdiYzgwM2RhZDU3NDI2Y2FjYTgzZDc3MzJjM2M5MGFfOC00LTEtMS0w_b1200d39-2bbc-446d-af4c-b59a2cb1072e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yMi9mcmFnOjVlNTdiNmE3ZDhkYTRkYjJhZDg1NmE2YzZkNWQzODA3L3RleHRyZWdpb246NWU1N2I2YTdkOGRhNGRiMmFkODU2YTZjNmQ1ZDM4MDdfNzUz_029f7e53-60c3-4781-8238-1125abf6da16"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjItMi0xLTEtMA_2fc96a21-b96e-484d-ab85-979d3fdfa3e8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjItMi0xLTEtMA_2fc96a21-b96e-484d-ab85-979d3fdfa3e8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjItNC0xLTEtMA_9bfb5284-a421-42b3-b286-66b16e575028"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjItNC0xLTEtMA_9bfb5284-a421-42b3-b286-66b16e575028"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RleHRyZWdpb246ZjAzZDVmZWVjYWVhNDVjMGFhYWRjZGQ1ZTk1NjUwNjNfMjE5OTAyMzI1NjU0Nw_9e1319d5-e512-426f-a31b-3024b0ef9ab9" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RleHRyZWdpb246ZjAzZDVmZWVjYWVhNDVjMGFhYWRjZGQ1ZTk1NjUwNjNfMjE5OTAyMzI1NjU0Nw_9e1319d5-e512-426f-a31b-3024b0ef9ab9" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">2020 primarily reflects inventory-related amounts associated with the wine business strategic reset.  For further discussion, see Note 9.<xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjItMi0xLTEtMA_2fc96a21-b96e-484d-ab85-979d3fdfa3e8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RleHRyZWdpb246ZjAzZDVmZWVjYWVhNDVjMGFhYWRjZGQ1ZTk1NjUwNjNfMjE5OTAyMzI1NjU0Nw_9e1319d5-e512-426f-a31b-3024b0ef9ab9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOmRkODkxYTQwY2U5ZjQxMTZhNDk3Nzc1Y2VhNzk0NmU2L3RhYmxlcmFuZ2U6ZGQ4OTFhNDBjZTlmNDExNmE0OTc3NzVjZWE3OTQ2ZTZfMjItNC0xLTEtMA_9bfb5284-a421-42b3-b286-66b16e575028"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RleHRyZWdpb246ZjAzZDVmZWVjYWVhNDVjMGFhYWRjZGQ1ZTk1NjUwNjNfMjE5OTAyMzI1NjU0Nw_9e1319d5-e512-426f-a31b-3024b0ef9ab9"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjMtNC0xLTEtMTQxMzg_969296e8-ad90-4de3-a528-19eb8d7cd4f8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjMtNC0xLTEtMTQxMzg_969296e8-ad90-4de3-a528-19eb8d7cd4f8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjEtMi0xLTEtMA_d74cfa78-d346-4336-bc60-534c20b3ac98"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjEtMi0xLTEtMA_d74cfa78-d346-4336-bc60-534c20b3ac98"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjMtMi0xLTEtMTQxMTg_49279f22-b894-4fd8-9feb-815fc4242613"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjMtMi0xLTEtMTQxMTg_49279f22-b894-4fd8-9feb-815fc4242613"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjEtNC0xLTEtMA_e6f646b8-5f2a-45f9-af1e-7b395ab83a46"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjEtNC0xLTEtMA_e6f646b8-5f2a-45f9-af1e-7b395ab83a46"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RleHRyZWdpb246ZjAzZDVmZWVjYWVhNDVjMGFhYWRjZGQ1ZTk1NjUwNjNfMjE5OTAyMzI1NjU3MQ_fc493c6f-a147-49ed-9e73-6edc925006a1" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RleHRyZWdpb246ZjAzZDVmZWVjYWVhNDVjMGFhYWRjZGQ1ZTk1NjUwNjNfMjE5OTAyMzI1NjU3MQ_fc493c6f-a147-49ed-9e73-6edc925006a1" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals.  See Note 12. </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjMtNC0xLTEtMTQxMzg_969296e8-ad90-4de3-a528-19eb8d7cd4f8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RleHRyZWdpb246ZjAzZDVmZWVjYWVhNDVjMGFhYWRjZGQ1ZTk1NjUwNjNfMjE5OTAyMzI1NjU3MQ_fc493c6f-a147-49ed-9e73-6edc925006a1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjEtMi0xLTEtMA_d74cfa78-d346-4336-bc60-534c20b3ac98"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RleHRyZWdpb246ZjAzZDVmZWVjYWVhNDVjMGFhYWRjZGQ1ZTk1NjUwNjNfMjE5OTAyMzI1NjU3MQ_fc493c6f-a147-49ed-9e73-6edc925006a1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjMtMi0xLTEtMTQxMTg_49279f22-b894-4fd8-9feb-815fc4242613"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RleHRyZWdpb246ZjAzZDVmZWVjYWVhNDVjMGFhYWRjZGQ1ZTk1NjUwNjNfMjE5OTAyMzI1NjU3MQ_fc493c6f-a147-49ed-9e73-6edc925006a1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjEtNC0xLTEtMA_e6f646b8-5f2a-45f9-af1e-7b395ab83a46"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RleHRyZWdpb246ZjAzZDVmZWVjYWVhNDVjMGFhYWRjZGQ1ZTk1NjUwNjNfMjE5OTAyMzI1NjU3MQ_fc493c6f-a147-49ed-9e73-6edc925006a1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMy0xNC0xLTEtMA_7a2b4fe7-191b-47fb-b8e9-4985f46e58f0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMy0xNC0xLTEtMA_7a2b4fe7-191b-47fb-b8e9-4985f46e58f0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMy0xMi0xLTEtMA_478e1bc5-b708-41bf-ae0f-dfcc7133747a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMy0xMi0xLTEtMA_478e1bc5-b708-41bf-ae0f-dfcc7133747a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMy02LTEtMS0w_69b19076-2d5c-4d98-ad1d-f41bbaa4b111"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMy02LTEtMS0w_69b19076-2d5c-4d98-ad1d-f41bbaa4b111"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMy0xMi0xLTEtMA_e299ff39-6891-4862-b4c3-befa6e4d3fde"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMy0xMi0xLTEtMA_e299ff39-6891-4862-b4c3-befa6e4d3fde"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMy02LTEtMS0w_f78d8c97-44f4-4870-b445-718b17513598"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMy02LTEtMS0w_f78d8c97-44f4-4870-b445-718b17513598"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMy0xNC0xLTEtMA_78df59c3-809f-49aa-9b5c-a0fa6132b6b1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMy0xNC0xLTEtMA_78df59c3-809f-49aa-9b5c-a0fa6132b6b1"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RleHRyZWdpb246MmEyMDFjMzQ1ZGJjNGI3ZmE5MWVkOTA3MDdiNTRlOTRfNzU2_99cbc242-6050-4e3b-83de-8963c8a2b245" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RleHRyZWdpb246MmEyMDFjMzQ1ZGJjNGI3ZmE5MWVkOTA3MDdiNTRlOTRfNzU2_99cbc242-6050-4e3b-83de-8963c8a2b245" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amounts attributable to noncontrolling interests for the three months ended September 30, 2021 and 2020 exclude net earnings of $2 million and $1 million, respectively, due to the redeemable noncontrolling interest related to Stag&#x2019;s Leap Wine Cellars</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">,</xhtml:span> which is reported in the mezzanine equity section on the condensed consolidated balance sheets.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMy0xNC0xLTEtMA_7a2b4fe7-191b-47fb-b8e9-4985f46e58f0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RleHRyZWdpb246MmEyMDFjMzQ1ZGJjNGI3ZmE5MWVkOTA3MDdiNTRlOTRfNzU2_99cbc242-6050-4e3b-83de-8963c8a2b245"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMy0xMi0xLTEtMA_478e1bc5-b708-41bf-ae0f-dfcc7133747a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RleHRyZWdpb246MmEyMDFjMzQ1ZGJjNGI3ZmE5MWVkOTA3MDdiNTRlOTRfNzU2_99cbc242-6050-4e3b-83de-8963c8a2b245"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjI1NTU4MDI1NTgzNjQyOTRhMzViODU5ZmExMGI1ZGEyL3RhYmxlcmFuZ2U6MjU1NTgwMjU1ODM2NDI5NGEzNWI4NTlmYTEwYjVkYTJfMy02LTEtMS0w_69b19076-2d5c-4d98-ad1d-f41bbaa4b111"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RleHRyZWdpb246MmEyMDFjMzQ1ZGJjNGI3ZmE5MWVkOTA3MDdiNTRlOTRfNzU2_99cbc242-6050-4e3b-83de-8963c8a2b245"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMy0xMi0xLTEtMA_e299ff39-6891-4862-b4c3-befa6e4d3fde"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RleHRyZWdpb246MmEyMDFjMzQ1ZGJjNGI3ZmE5MWVkOTA3MDdiNTRlOTRfNzU2_99cbc242-6050-4e3b-83de-8963c8a2b245"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMy02LTEtMS0w_f78d8c97-44f4-4870-b445-718b17513598"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RleHRyZWdpb246MmEyMDFjMzQ1ZGJjNGI3ZmE5MWVkOTA3MDdiNTRlOTRfNzU2_99cbc242-6050-4e3b-83de-8963c8a2b245"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RhYmxlOjY3NjQ5MzczZDBiNzQ3N2JiNTkxMTNlOWU0NWNlOWY4L3RhYmxlcmFuZ2U6Njc2NDkzNzNkMGI3NDc3YmI1OTExM2U5ZTQ1Y2U5ZjhfMy0xNC0xLTEtMA_78df59c3-809f-49aa-9b5c-a0fa6132b6b1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yNS9mcmFnOjJhMjAxYzM0NWRiYzRiN2ZhOTFlZDkwNzA3YjU0ZTk0L3RleHRyZWdpb246MmEyMDFjMzQ1ZGJjNGI3ZmE5MWVkOTA3MDdiNTRlOTRfNzU2_99cbc242-6050-4e3b-83de-8963c8a2b245"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjItNC0xLTEtMA_bbf1361c-cd98-4785-bdd8-db7d1ceeb089"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjItNC0xLTEtMA_bbf1361c-cd98-4785-bdd8-db7d1ceeb089"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjItMi0xLTEtMA_426d9aea-ecde-453e-bb32-ce817786fe90"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjItMi0xLTEtMA_426d9aea-ecde-453e-bb32-ce817786fe90"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RleHRyZWdpb246ZjAzZDVmZWVjYWVhNDVjMGFhYWRjZGQ1ZTk1NjUwNjNfMjE5OTAyMzI1NjU3Mg_0c8fe14e-af7d-47e8-a204-fc47447c14d4" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RleHRyZWdpb246ZjAzZDVmZWVjYWVhNDVjMGFhYWRjZGQ1ZTk1NjUwNjNfMjE5OTAyMzI1NjU3Mg_0c8fe14e-af7d-47e8-a204-fc47447c14d4" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Cash included in assets held for sale at September 30, 2021 is related to the Ste. Michelle Transaction.  For further discussion, see Note 3. <xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Assets Held for Sale</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjItNC0xLTEtMA_bbf1361c-cd98-4785-bdd8-db7d1ceeb089"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RleHRyZWdpb246ZjAzZDVmZWVjYWVhNDVjMGFhYWRjZGQ1ZTk1NjUwNjNfMjE5OTAyMzI1NjU3Mg_0c8fe14e-af7d-47e8-a204-fc47447c14d4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RhYmxlOjQwMjRlMDJiODk5OTRhOGZiMmNlNTUzZmU0YTEzMzIzL3RhYmxlcmFuZ2U6NDAyNGUwMmI4OTk5NGE4ZmIyY2U1NTNmZTRhMTMzMjNfMjItMi0xLTEtMA_426d9aea-ecde-453e-bb32-ce817786fe90"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18yOC9mcmFnOmYwM2Q1ZmVlY2FlYTQ1YzBhYWFkY2RkNWU5NTY1MDYzL3RleHRyZWdpb246ZjAzZDVmZWVjYWVhNDVjMGFhYWRjZGQ1ZTk1NjUwNjNfMjE5OTAyMzI1NjU3Mg_0c8fe14e-af7d-47e8-a204-fc47447c14d4"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798030421544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Oct. 21, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-08940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Altria Group, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">VA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3260245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6601 West Broad Street,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Richmond,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">VA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">23230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">274-2200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,836,988,822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000764180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock0.3313ParValueMember', window );">Common Stock, $0.33 1/3 par value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.33 1/3 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock1.000NotesDue2023Member', window );">1.000% Notes due 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.000% Notes due 2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MO23A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock1.700NotesDue2025Member', window );">1.700% Notes due 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.700% Notes due 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MO25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock2.200NotesDue2027Member', window );">2.200% Notes due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2.200% Notes due 2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MO27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock3.125NotesDue2031Member', window );">3.125% Notes due 2031 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.125% Notes due 2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MO31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock0.3313ParValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mo_CommonStock0.3313ParValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock1.000NotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mo_CommonStock1.000NotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock1.700NotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mo_CommonStock1.700NotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock2.200NotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mo_CommonStock2.200NotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock3.125NotesDue2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mo_CommonStock3.125NotesDue2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798030360280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,957<span></span>
</td>
<td class="nump">$ 4,945<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventories:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InventoryRawMaterialsPlantMaterialNetofReserves', window );">Leaf tobacco</a></td>
<td class="nump">644<span></span>
</td>
<td class="nump">844<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_OtherInventoryRawMaterialsNetofReserves', window );">Other raw materials</a></td>
<td class="nump">159<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished product</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">420<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">1,133<span></span>
</td>
<td class="nump">1,966<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">1,490<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">404<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">6,020<span></span>
</td>
<td class="nump">7,117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">4,418<span></span>
</td>
<td class="nump">5,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="nump">2,900<span></span>
</td>
<td class="nump">3,138<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,518<span></span>
</td>
<td class="nump">2,012<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">5,177<span></span>
</td>
<td class="nump">5,177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net</a></td>
<td class="nump">12,326<span></span>
</td>
<td class="nump">12,615<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments in equity securities ($1,740 million and $1,868 million at September 30, 2021 and December 31, 2020, respectively, measured at fair value)</a></td>
<td class="nump">13,874<span></span>
</td>
<td class="nump">19,529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">649<span></span>
</td>
<td class="nump">964<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">39,564<span></span>
</td>
<td class="nump">47,414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">1,105<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">266<span></span>
</td>
<td class="nump">380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedMarketingCostsCurrent', window );">Marketing</a></td>
<td class="nump">680<span></span>
</td>
<td class="nump">523<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AccruedSettlementLiabilityCurrent', window );">Settlement charges</a></td>
<td class="nump">2,996<span></span>
</td>
<td class="nump">3,564<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">1,109<span></span>
</td>
<td class="nump">1,494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividends payable</a></td>
<td class="nump">1,661<span></span>
</td>
<td class="nump">1,602<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">295<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">8,112<span></span>
</td>
<td class="nump">9,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">27,022<span></span>
</td>
<td class="nump">27,971<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">3,557<span></span>
</td>
<td class="nump">4,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent', window );">Accrued pension costs</a></td>
<td class="nump">280<span></span>
</td>
<td class="nump">551<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent', window );">Accrued postretirement health care costs</a></td>
<td class="nump">1,512<span></span>
</td>
<td class="nump">1,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">307<span></span>
</td>
<td class="nump">381<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">40,790<span></span>
</td>
<td class="nump">44,449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Contingencies (Note 12)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; (Deficit) Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.33 1/3&#160;per share (2,805,961,317 shares issued)</a></td>
<td class="nump">935<span></span>
</td>
<td class="nump">935<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">5,846<span></span>
</td>
<td class="nump">5,910<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Earnings reinvested in the business</a></td>
<td class="nump">30,685<span></span>
</td>
<td class="nump">34,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive losses</a></td>
<td class="num">(3,430)<span></span>
</td>
<td class="num">(4,341)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Cost of repurchased stock (967,321,022 shares at September 30, 2021 and 947,542,152 shares at December 31, 2020)</a></td>
<td class="num">(35,303)<span></span>
</td>
<td class="num">(34,344)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; (deficit) equity attributable to Altria</a></td>
<td class="num">(1,267)<span></span>
</td>
<td class="nump">2,839<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders&#8217; (deficit) equity</a></td>
<td class="num">(1,265)<span></span>
</td>
<td class="nump">2,925<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders&#8217; (Deficit) Equity</a></td>
<td class="nump">$ 39,564<span></span>
</td>
<td class="nump">$ 47,414<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_AccruedSettlementLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Settlement Liability, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_AccruedSettlementLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_InventoryRawMaterialsPlantMaterialNetofReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of products consisting of plant matter that is not used in the growth of plant goods</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_InventoryRawMaterialsPlantMaterialNetofReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_OtherInventoryRawMaterialsNetofReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Inventory, Raw Materials, Net of Reserves</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_OtherInventoryRawMaterialsNetofReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedMarketingCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services.   Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedMarketingCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit other postretirement plan, classified as noncurrent. Excludes pension plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798028135096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; (Deficit) Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments, fair value disclosure</a></td>
<td class="nump">$ 1,740<span></span>
</td>
<td class="nump">$ 1,868<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (usd per share)</a></td>
<td class="nump">$ 0.3333<span></span>
</td>
<td class="nump">$ 0.3333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">2,805,961,317<span></span>
</td>
<td class="nump">2,805,961,317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Shares repurchased (in shares)</a></td>
<td class="nump">967,321,022<span></span>
</td>
<td class="nump">947,542,152<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798038860088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Earnings (Losses) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 6,786<span></span>
</td>
<td class="nump">$ 7,123<span></span>
</td>
<td class="nump">$ 19,758<span></span>
</td>
<td class="nump">$ 19,849<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">1,858<span></span>
</td>
<td class="nump">1,961<span></span>
</td>
<td class="nump">5,348<span></span>
</td>
<td class="nump">5,909<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCostOfOperatingRevenue', window );">Excise taxes on products</a></td>
<td class="nump">1,255<span></span>
</td>
<td class="nump">1,445<span></span>
</td>
<td class="nump">3,733<span></span>
</td>
<td class="nump">4,063<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">3,673<span></span>
</td>
<td class="nump">3,717<span></span>
</td>
<td class="nump">10,677<span></span>
</td>
<td class="nump">9,877<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_MarketingAdministrationandResearchCosts', window );">Marketing, administration and research costs</a></td>
<td class="nump">722<span></span>
</td>
<td class="nump">557<span></span>
</td>
<td class="nump">1,850<span></span>
</td>
<td class="nump">1,585<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">2,951<span></span>
</td>
<td class="nump">3,160<span></span>
</td>
<td class="nump">8,827<span></span>
</td>
<td class="nump">8,292<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest and other debt expense, net</a></td>
<td class="nump">266<span></span>
</td>
<td class="nump">310<span></span>
</td>
<td class="nump">869<span></span>
</td>
<td class="nump">893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">649<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Net periodic benefit income, excluding service cost</a></td>
<td class="num">(63)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(152)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_IncomeLossFromEquityInvestments', window );">(Income) losses from equity investments</a></td>
<td class="nump">5,915<span></span>
</td>
<td class="nump">472<span></span>
</td>
<td class="nump">5,789<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment of JUUL equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,600<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">(Gain) loss on Cronos-related financial instruments</a></td>
<td class="nump">135<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="nump">202<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) before income taxes</a></td>
<td class="num">(3,302)<span></span>
</td>
<td class="num">(324)<span></span>
</td>
<td class="nump">1,544<span></span>
</td>
<td class="nump">4,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision (benefit) for income taxes</a></td>
<td class="num">(582)<span></span>
</td>
<td class="nump">632<span></span>
</td>
<td class="nump">693<span></span>
</td>
<td class="nump">1,817<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings (losses)</a></td>
<td class="num">(2,720)<span></span>
</td>
<td class="num">(956)<span></span>
</td>
<td class="nump">851<span></span>
</td>
<td class="nump">2,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net (earnings) losses attributable to noncontrolling interests</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (losses) attributable to Altria</a></td>
<td class="num">$ (2,722)<span></span>
</td>
<td class="num">$ (952)<span></span>
</td>
<td class="nump">$ 851<span></span>
</td>
<td class="nump">$ 2,543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Per share data:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings (losses) per share attributable to Altria (in usd per share)</a></td>
<td class="num">$ (1.48)<span></span>
</td>
<td class="num">$ (0.51)<span></span>
</td>
<td class="nump">$ 0.46<span></span>
</td>
<td class="nump">$ 1.37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings (losses) per share attributable to Altria (in usd per share)</a></td>
<td class="num">$ (1.48)<span></span>
</td>
<td class="num">$ (0.51)<span></span>
</td>
<td class="nump">$ 0.46<span></span>
</td>
<td class="nump">$ 1.36<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_IncomeLossFromEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Equity Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_IncomeLossFromEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_MarketingAdministrationandResearchCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as research and development costs and all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. Research and development costs represent the aggregate costs incurred during an accounting period to research and develop new products/technologies when the technological feasibility has not been reached. General and administrative expenses include salaries of nonsales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_MarketingAdministrationandResearchCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostOfOperatingRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other costs incurred during the reporting period related to other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostOfOperatingRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798117042952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Earnings (Losses) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings (losses)</a></td>
<td class="num">$ (2,720)<span></span>
</td>
<td class="num">$ (956)<span></span>
</td>
<td class="nump">$ 851<span></span>
</td>
<td class="nump">$ 2,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive earnings (losses), net of deferred income taxes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Benefit plans</a></td>
<td class="nump">6<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciEquityMethodInvestmentAfterTax', window );">ABI</a></td>
<td class="nump">161<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="nump">495<span></span>
</td>
<td class="num">(928)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustments and other</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="nump">172<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">911<span></span>
</td>
<td class="num">(917)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive earnings (losses)</a></td>
<td class="num">(2,548)<span></span>
</td>
<td class="num">(963)<span></span>
</td>
<td class="nump">1,762<span></span>
</td>
<td class="nump">1,615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive (earnings) losses attributable to noncontrolling interests</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive earnings (losses) attributable to Altria</a></td>
<td class="num">$ (2,550)<span></span>
</td>
<td class="num">$ (959)<span></span>
</td>
<td class="nump">$ 1,762<span></span>
</td>
<td class="nump">$ 1,626<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciEquityMethodInvestmentAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=124268079&amp;loc=d3e32472-111569<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciEquityMethodInvestmentAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798034625016">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' (Deficit) Equity - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Earnings Reinvested in the Business [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive Losses [Member]</div></th>
<th class="th"><div>Cost of Repurchased Stock [Member]</div></th>
<th class="th"><div>Non-controlling Interests [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 6,319<span></span>
</td>
<td class="nump">$ 935<span></span>
</td>
<td class="nump">$ 5,970<span></span>
</td>
<td class="nump">$ 36,539<span></span>
</td>
<td class="num">$ (2,864)<span></span>
</td>
<td class="num">$ (34,358)<span></span>
</td>
<td class="nump">$ 97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings (losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(917)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(917)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet', window );">Stock award activity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,726)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,726)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,232<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">5,973<span></span>
</td>
<td class="nump">34,356<span></span>
</td>
<td class="num">(3,781)<span></span>
</td>
<td class="num">(34,344)<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jun. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,786<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">5,964<span></span>
</td>
<td class="nump">36,908<span></span>
</td>
<td class="num">(3,774)<span></span>
</td>
<td class="num">(34,345)<span></span>
</td>
<td class="nump">98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings (losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(957)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(952)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet', window );">Stock award activity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,232<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">5,973<span></span>
</td>
<td class="nump">34,356<span></span>
</td>
<td class="num">(3,781)<span></span>
</td>
<td class="num">(34,344)<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,925<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">5,910<span></span>
</td>
<td class="nump">34,679<span></span>
</td>
<td class="num">(4,341)<span></span>
</td>
<td class="num">(34,344)<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings (losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet', window );">Stock award activity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,845)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,845)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchases of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(972)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(972)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">(157)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(80)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,265)<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">5,846<span></span>
</td>
<td class="nump">30,685<span></span>
</td>
<td class="num">(3,430)<span></span>
</td>
<td class="num">(35,303)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,259<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">5,840<span></span>
</td>
<td class="nump">35,065<span></span>
</td>
<td class="num">(3,602)<span></span>
</td>
<td class="num">(34,981)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings (losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(2,722)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,722)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet', window );">Stock award activity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,658)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,658)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchases of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(322)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(322)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (1,265)<span></span>
</td>
<td class="nump">$ 935<span></span>
</td>
<td class="nump">$ 5,846<span></span>
</td>
<td class="nump">$ 30,685<span></span>
</td>
<td class="num">$ (3,430)<span></span>
</td>
<td class="num">$ (35,303)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">Amounts attributable to noncontrolling interests for the nine months ended September 30, 2021 and 2020 exclude net earnings of $4 million and $2 million, respectively, due to the redeemable noncontrolling interest related to Stag&#8217;s Leap Wine Cellars</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> which is reported in the mezzanine equity section on the condensed consolidated balance sheets.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amounts attributable to noncontrolling interests for the three months ended September 30, 2021 and 2020 exclude net earnings of $2 million and $1 million, respectively, due to the redeemable noncontrolling interest related to Stag&#8217;s Leap Wine Cellars</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">,</span> which is reported in the mezzanine equity section on the condensed consolidated balance sheets.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents the purchase of the remaining noncontrolling interests in Helix.  For additional information, see Note 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Background and Basis of Presentation</span>.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment To Additional Paid In Capital, Share Based Compensation, Restricted And Deferred Stock Awards and the tax benefits associated with vestings of prior period restricted and deferred stock awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798026767992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared (usd per share)</a></td>
<td class="nump">$ 0.90<span></span>
</td>
<td class="nump">$ 0.86<span></span>
</td>
<td class="nump">$ 2.62<span></span>
</td>
<td class="nump">$ 2.54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net earnings attributable to noncontrolling interests</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798038592552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="4">9 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th" colspan="2">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th" colspan="2">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Provided by (Used in) Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings (losses)</a></td>
<td class="num">$ (2,720)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 851<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 2,532<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings (losses) to operating cash flows:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">190<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">192<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax provision (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,180)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(111)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_IncomeLossFromEquityInvestments', window );">(Income) losses from equity investments</a></td>
<td class="nump">5,915<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,789<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">306<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions', window );">Dividends from ABI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">119<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">108<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">(Gain) loss on Cronos-related financial instruments</a></td>
<td class="nump">135<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">128<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">202<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment of JUUL equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,600<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">649<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Cash effects of changes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">118<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">136<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">24<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(200)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet', window );">Accrued liabilities and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(104)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(504)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_IncreaseDecreaseInSettlementPayable', window );">Accrued settlement charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(568)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(140)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitContributions', window );">Pension plan contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(23)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(16)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash', window );">Pension provisions and postretirement, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(127)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(35)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">104<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">549<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,742<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,844<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Provided by (Used in) Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(102)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(162)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">60<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">55<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(42)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(107)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Provided by (Used in) Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Repayment of short-term borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Long-term debt issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,472<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,993<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Long-term debt repaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(6,542)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchases of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(972)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid on common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,787)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,690)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Premiums and fees related to early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(623)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(216)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(16)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7,668)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,713)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract', window );"><strong>Cash, cash equivalents and restricted cash:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase (decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,968)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,024<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,006<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,160<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Balance at end of period</a></td>
<td class="nump">3,038<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,038<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,184<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">2,957<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,957<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash included in other current assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash included in other assets</a></td>
<td class="nump">45<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">45<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations', window );">Restricted cash included in assets held for sale</a></td>
<td class="nump">36<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">36<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash</a></td>
<td class="nump">$ 3,038<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 3,038<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 4,184<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">2020 primarily reflects inventory-related amounts associated with the wine business strategic reset.  For further discussion, see Note 9.<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals.  See Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Cash included in assets held for sale at September 30, 2021 is related to the Ste. Michelle Transaction.  For further discussion, see Note 3. <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Assets Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_IncomeLossFromEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Equity Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_IncomeLossFromEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_IncreaseDecreaseInSettlementPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change during the period in Settlement payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_IncreaseDecreaseInSettlementPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; attributable to disposal group, including, but not limited to, discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating assets after deduction of noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for pension and other postretirement benefits. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense (reversal of expense) for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798028022616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Background and Basis of Presentation</a></td>
<td class="text">Background and Basis of Presentation<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">When used in these notes, the term </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Altria,&#8221; refers to Altria Group, Inc. and its subsidiaries, unless the context requires otherwise.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Background: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, Altria&#8217;s wholly owned subsidiaries included Philip Morris USA Inc. (&#8220;PM USA&#8221;), which is engaged in the manufacture and sale of cigarettes in the United States; John Middleton Co. (&#8220;Middleton&#8221;), which is engaged in the manufacture and sale of machine-made large cigars and pipe tobacco and is a wholly owned subsidiary of PM USA; UST LLC (&#8220;UST&#8221;), which through its wholly owned subsidiaries, including U.S. Smokeless Tobacco Company LLC (&#8220;USSTC&#8221;) and Ste. Michelle Wine Estates Ltd. (&#8220;Ste. Michelle&#8221;), is engaged in the manufacture and sale of moist smokeless tobacco products (&#8220;MST&#8221;), snus products and wine; Helix Innovations LLC (&#8220;Helix&#8221;), which operates in the United States and Canada, and Helix Innovations GmbH and its subsidiaries (&#8220;Helix ROW&#8221;), which operate internationally in the rest-of-world, are engaged in the manufacture and sale of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on! </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">oral nicotine pouches; and Philip Morris Capital Corporation (&#8220;PMCC&#8221;), which maintains a portfolio of finance assets, substantially all of which are leveraged leases.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 8, 2021, UST entered into a share purchase agreement pursuant to which it agreed to sell its subsidiary, International Wine &amp; Spirits Ltd. (&#8220;IWS&#8221;), which includes Ste. Michelle.  The sale was completed on October 1, 2021.  At September 30, 2021, the assets and liabilities associated with the pending sale of IWS were classified as assets held for sale on Altria&#8217;s condensed consolidated balance sheet.  For further discussion, see Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Altria owns 100% of the global </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> business as a result of transactions in December 2020 and April 2021 to purchase the remaining 20% interest in (i) Helix ROW and (ii) Helix, respectively</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  The total purchase price of the December 2020 and April 2021 transactions was approximately $250 million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Altria wholly owned subsidiaries included Altria Group Distribution Company, which provides sales and distribution services to certain Altria operating subsidiaries, and Altria Client Services LLC, which provides various support services in areas such as legal, regulatory, consumer engagement, finance, human resources and external affairs to Altria and its subsidiaries.  Altria&#8217;s access to the operating cash flows of its wholly owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans by its subsidiaries.  At September&#160;30, 2021, Altria&#8217;s significant wholly owned subsidiaries were not limited by contractual obligations in their ability to pay cash dividends or make other distributions with respect to their equity interests.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, Altria&#8217;s investments in equity securities consisted of Anheuser-Busch InBev SA/NV (&#8220;ABI&#8221;), Cronos Group Inc. (&#8220;Cronos&#8221;) and JUUL Labs, Inc. (&#8220;JUUL&#8221;).  Altria accounts for its investments in ABI and Cronos under the equity method of accounting using a one-quarter lag.  Altria accounts for its equity investment in JUUL under the fair value option.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion of Altria&#8217;s investments in equity securities, see Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;padding-right:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Dividends and Share Repurchases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, Altria&#8217;s Board of Directors (the &#8220;Board of Directors&#8221; or &#8220;Board&#8221;) approved a 4.7% increase in the quarterly dividend rate to $0.90 per share of Altria common stock versus the previous rate of $0.86 per share.  The current annualized dividend rate is $3.60.  Future dividend payments remain subject to the discretion of the Board.</span></div><div style="margin-bottom:5pt;padding-right:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, the Board of Directors authorized a $1.0 billion share repurchase program.  In April 2020, the Board rescinded the $500 million remaining in this program as part of Altria&#8217;s efforts to enhance its liquidity position in response to the COVID-19 pandemic.  Altria did not repurchase any shares in 2020.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Board authorized a new $2.0 billion share repurchase program, of which  $1,028 million was remaining at September 30, 2021.  In October 2021, the Board authorized a $1.5 billion expansion of this program to $3.5 billion.  The timing of share repurchases under this program depends upon marketplace conditions and other factors, and the program remains subject to the discretion of the Board.</span></div><div style="padding-right:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Altria&#8217;s share repurchase activity for the nine and three months ended September&#160;30, 2021 was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.294%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of shares repurchased</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate cost of shares repurchased</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">972</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">322</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share of shares repurchased</span></div></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48.17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48.35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interim condensed consolidated financial statements of Altria are unaudited.  It is the opinion of Altria&#8217;s management that all adjustments necessary for a fair statement of the interim results presented have been reflected in the interim condensed consolidated financial statements.  All such adjustments were of a normal recurring nature.  Net revenues and net earnings for any interim period are not necessarily indicative of results that may be expected for the entire year.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain immaterial prior year amounts have been reclassified to conform with the current year&#8217;s presentation.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These statements should be read in conjunction with Altria&#8217;s audited consolidated financial statements and related notes, which appear in Altria&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020 (the &#8220;2020 Form 10-K&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021, Altria adopted Accounting Standards Update (&#8220;ASU&#8221;) 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU No. 2019-12&#8221;).  This guidance removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes.  The adoption of ASU No. 2019-12 did not have a material impact on Altria&#8217;s condensed consolidated financial statements.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, on January 1, 2021, Altria adopted ASU No. 2020-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Clarifying the Interactions between Topic 321, Topic 323, and Topic 815</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU No. 2020-01&#8221;).  This guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities.  The adoption of ASU No. 2020-01 did not have a material impact on Altria&#8217;s condensed consolidated financial statements.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of issued accounting guidance applicable to, but not yet adopted by, Altria, see Note 13. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Accounting Guidance Not Yet Adopted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798028176488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues from Contracts with Customers<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenues from Contracts with Customers</a></td>
<td class="text">Revenues from Contracts with Customers<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria disaggregates net revenues based on product type.  For further discussion, see Note 9. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, a majority of Altria&#8217;s businesses offered cash discounts to customers for prompt payment and calculated cash discounts as a percentage of the list price based on historical experience and agreed-upon payment terms.  Beginning in the first quarter of 2021 for USSTC and the third quarter of 2021 for PM USA, cash discounts were calculated as a flat rate per unit, based on agreed-upon payment terms.  Altria&#8217;s businesses record receivables net of the cash discounts on Altria&#8217;s condensed consolidated balance sheets.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s businesses that receive payments in advance of product shipment record such payments as deferred revenue.  These payments are included in other accrued liabilities on Altria&#8217;s condensed consolidated balance sheets until control of such products is obtained by the customer.  Deferred revenue was $260 million and $301 million at September&#160;30, 2021 and December&#160;31, 2020, respectively.  When cash is received in advance of product shipment, Altria&#8217;s businesses satisfy their performance obligations within three days of receiving payment.  At September&#160;30, 2021 and December&#160;31, 2020, there were no differences between amounts recorded as deferred revenue and amounts subsequently recognized as revenue.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables were $144 million (including $108 million in assets held for sale) and $137 million at September&#160;30, 2021 and December&#160;31, 2020, respectively.  At September&#160;30, 2021 and December&#160;31, 2020, there were no expected differences between amounts recorded and subsequently received, and Altria&#8217;s businesses did not record an allowance for doubtful accounts against these receivables.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s businesses record an allowance for returned goods, which is included in other accrued liabilities on Altria&#8217;s condensed consolidated balance sheets.  While all of Altria&#8217;s tobacco operating companies sell tobacco products with dates relative to freshness as printed on product packaging, it is USSTC&#8217;s policy to accept authorized sales returns from its customers for products that have passed such dates due to the limited shelf life of USSTC&#8217;s MST and snus products.  Altria&#8217;s businesses record estimated sales returns, which are based principally on historical volume and return rates, as a reduction to revenues.  Actual sales returns will differ from estimated sales returns to the extent actual results differ from estimated assumptions.  Altria&#8217;s businesses reflect differences between actual and estimated sales returns in the period in which the actual amounts become known.  These differences, if any, have not had a material impact on Altria&#8217;s condensed consolidated financial statements.  All returned goods are destroyed upon return and not included in inventory.  Consequently, Altria&#8217;s businesses do not record an asset for their right to recover goods from customers upon return.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales incentives include variable payments related to goods sold by Altria&#8217;s businesses.  Altria&#8217;s businesses include estimates of variable consideration as a reduction to revenues upon shipment of goods to customers.  The sales incentives that require significant estimates and judgments are as follows:</span></div><div style="margin-bottom:5pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Price promotion payments- </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s businesses make price promotion payments, substantially all of which are made to their retail partners, to incent the promotion of certain product offerings in select geographic areas.</span></div><div style="margin-bottom:5pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wholesale and retail participation payments-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Altria&#8217;s businesses make payments to their wholesale and retail partners to incent merchandising and sharing of sales data in accordance with each business&#8217;s trade agreements.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates primarily include estimated wholesale to retail sales volume and historical acceptance rates.  Actual payments will differ from estimated payments to the extent actual results differ from estimated assumptions.  Differences between actual and estimated payments are reflected in the period such information becomes available.  These differences, if any, have not had a material impact on Altria&#8217;s condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798028002728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assets Held for Sale<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Assets Held for Sale</a></td>
<td class="text">Assets Held for Sale<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 8, 2021, UST entered into a share purchase agreement pursuant to which it agreed to sell its subsidiary, IWS, which includes Ste. Michelle, to an entity controlled by investment funds managed by Sycamore Partners Management, L.P. in an all-cash transaction with a purchase price of approximately $1.2 billion and the assumption of certain liabilities of IWS and its subsidiaries (the &#8220;Ste. Michelle Transaction&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, the assets and liabilities associated with the Ste. Michelle Transaction were classified as assets held for sale and were measured at their fair value less costs to sell, resulting in a pre-tax charge of $41 million.  A reserve (as shown below), representing the adjustment to record the assets and liabilities at their fair value less costs to sell, was included as a component of assets held for sale in Altria&#8217;s condensed consolidated balance sheets at September&#160;30, 2021.  Altria recorded an additional pre-tax charge of $10 million for disposition-related costs related to the Ste. Michelle Transaction.  The total pre-tax charges of $51 million were included in the wine segment and recorded in marketing, administration and research costs in Altria&#8217;s condensed consolidated statements of earnings (losses) for the nine and three months ended September 30, 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2021, UST completed the sale of IWS and received approximately $1.2 billion in net cash proceeds.  Altria expects to record additional adjustments related to the Ste. Michelle Transaction in the fourth quarter of 2021 and does not expect these adjustments to be material.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The major classes of assets and liabilities of IWS classified as held for sale at September 30, 2021 were as follows:</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net of accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,531&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,490&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued pension costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets and liabilities held for sale, net</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798037054280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTextBlock', window );">Investments in Equity Securities</a></td>
<td class="text">Investments in Equity Securities<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of Altria&#8217;s investments consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.885%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,651&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,705</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">932</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,874</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,529&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Atria&#8217;s investment in Cronos at September 30, 2021 consisted of Altria&#8217;s equity method investment in Cronos ($897 million), the Cronos warrant ($32 million) and the Fixed-price Preemptive Rights ($3 million), (collectively, &#8220;Investment in Cronos&#8221;).  The Investment in Cronos at December 31, 2020 consisted of Altria&#8217;s equity method investment in Cronos ($1,010 million), the Cronos warrant ($139 million) and the Fixed-price Preemptive Rights ($24 million).  See below for further discussion.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (losses) from equity investments accounted for under the equity method of accounting and fair value option consisted of the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.952%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.184%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,644)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,036)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(418)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (losses) from investments under equity method of accounting</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,789)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,015)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(472)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (losses) from equity investments</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,789)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,915)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(472)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the nine and three months ended September 30, 2021, Altria recorded a non-cash, pre-tax impairment charge of $6,157 million related to its equity investment in ABI. See below for further discussion.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in ABI</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, Altria had an approximate 10% ownership interest in ABI, consisting of 185 million restricted shares of ABI (the &#8220;Restricted Shares&#8221;) and 12 million ordinary shares of ABI.  The Restricted Shares:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">are unlisted and not admitted to trading on any stock exchange;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">are convertible by Altria into ordinary shares of ABI on a one-for-one basis;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">rank equally with ordinary shares of ABI with regards to dividends and voting rights; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">have director nomination rights with respect to ABI.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restricted Shares were subject to a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y181Mi9mcmFnOmEyMmNlMjI5NGFiNDRlYjJiNTg3OGRiMjY3NzY2MjgyL3RleHRyZWdpb246YTIyY2UyMjk0YWI0NGViMmI1ODc4ZGIyNjc3NjYyODJfMzkwMzI2NjI3OTEyMjM_deac5b80-5cfb-43db-b6ef-127a6fca35e3">five</span>-year lock-up period that ended October 10, 2021.  As of this filing, Altria has not elected to convert its Restricted Shares into ordinary shares of ABI.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria accounts for its investment in ABI under the equity method of accounting because Altria has the ability to exercise significant influence over the operating and financial policies of ABI, including having active representation on ABI&#8217;s board of directors and certain ABI board committees.  Through this representation, Altria participates in ABI policy making processes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria reports its share of ABI&#8217;s results using a one-quarter lag because ABI&#8217;s results are not available in time for Altria to record them in the concurrent period.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of Altria&#8217;s equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI&#8217;s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy.  Altria can convert its Restricted Shares to ordinary shares at its discretion.  Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2019, the fair value of Altria&#8217;s equity investment in ABI declined below its carrying value and has not recovered.   At December&#160;31, 2020, the fair value of Altria&#8217;s equity investment in ABI was $13.8 billion (carrying value of $16.7 billion), which was less than its carrying value by approximately 17%. In preparing its financial statements for the period ended December&#160;31, 2020, Altria evaluated the factors related to the fair value decline, including the impact on the fair value of ABI&#8217;s shares during the COVID-19 pandemic, which has negatively impacted ABI&#8217;s business.  Altria evaluated the duration and magnitude of the fair value decline, ABI&#8217;s financial condition and near-term prospects and Altria&#8217;s intent and ability to hold its </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investment in ABI until recovery.  Altria concluded that the decline in fair value of its investment in ABI at December 31, 2020 below its carrying value was temporary and, therefore, no impairment was recorded at that time.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the consideration of the same factors, Altria, in preparing its financial statements for the period ended September&#160;30, 2021, concluded that the decline in fair value of its investment in ABI at September&#160;30, 2021 was other than temporary. As a result, Altria recorded a non-cash, pre-tax impairment charge of $6.2 billion for the nine and three months ended September&#160;30, 2021, which was recorded to income (losses) from equity investments in its condensed consolidated statements of earnings (losses).  This impairment charge reflects the difference between the fair value of Altria&#8217;s investment in ABI using ABI&#8217;s share price at September&#160;30, 2021 and the carrying value of Altria&#8217;s equity investment in ABI at September&#160;30, 2021.  Altria continues to have confidence in ABI&#8217;s (i) long-term strategies, (ii) premium global brands, (iii) experienced management team and (iv) capability to successfully navigate its near-term challenges. Altria further expects that the impacts related to the COVID-19 pandemic that have negatively impacted ABI&#8217;s global business are transitory, but now also anticipates that the full recovery to carrying value will take longer than previously expected. This is evidenced by the resumption of declines in fair value during the third quarter of 2021, following positive share price momentum during the first half of 2021.  At September&#160;30, 2021, prior to recording the impairment charge, the fair value of Altria&#8217;s investment in ABI was below the carrying value by approximately 35%, which represents an additional 18% reduction in ABI&#8217;s share price since December&#160;31, 2020.  After recording the impairment charge, the fair value and carrying value of Altria&#8217;s equity investment in ABI at September&#160;30, 2021 were $11.2 billion.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, the carrying value of Altria&#8217;s equity investment in ABI exceeded its share of ABI&#8217;s net assets attributable to equity holders of ABI by approximately $5.1 billion.  Substantially all of this difference is comprised of goodwill and other indefinite-lived intangible assets (consisting primarily of trademarks).</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in JUUL</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2018, Altria made an investment in JUUL and received a 35% economic interest in JUUL through non-voting shares, which were convertible at Altria&#8217;s election into voting shares (&#8220;Share Conversion&#8221;), and a security convertible into additional non-voting or voting shares, as applicable, upon settlement or exercise of certain JUUL convertible securities (the &#8220;JUUL Transaction&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria received a broad preemptive right to purchase JUUL shares, exercisable each quarter upon dilution, to maintain its ownership percentage and is subject to a standstill restriction under which it may not acquire additional JUUL shares above its 35% interest.  Furthermore, Altria agreed not to sell or transfer any of its JUUL shares until December 20, 2024.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2020, the U.S. Federal Trade Commission (&#8220;FTC&#8221;) issued an administrative complaint challenging Altria&#8217;s investment in JUUL.  For further discussion, see Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies -&#160;Antitrust Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, Altria exercised its rights to convert its non-voting JUUL shares into voting shares.  Altria does not currently intend to exercise its additional governance rights obtained upon Share Conversion, including the right to elect directors to JUUL&#8217;s board or to vote its JUUL shares other than as a passive investor, pending the outcome of the FTC administrative complaint.  At September&#160;30, 2021, Altria had a 35% ownership interest in JUUL, consisting of 42 million voting shares.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following Share Conversion in the fourth quarter of 2020, Altria elected to account for its equity method investment in JUUL under the fair value option.  Under this option, Altria&#8217;s condensed consolidated statements of earnings (losses) include any cash dividends received from its investment in JUUL and any changes in the estimated fair value of its investment, which is calculated quarterly.  Altria believes the fair value option provides quarterly transparency to investors as to the fair market value of Altria&#8217;s investment in JUUL, given the changes and volatility in the e-vapor category since Altria&#8217;s initial investment, as well as the lack of publicly available information regarding JUUL&#8217;s business or a market-derived valuation.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balance of Altria&#8217;s investment in JUUL, which is classified in Level 3 of the fair value hierarchy:</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) included in income (losses) from equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,705</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2021, Altria recorded a non-cash, pre-tax unrealized gain of $100 million, as a result of changes in the estimated fair value of its investment in JUUL.  At September 30, 2021, the estimated fair value of Altria&#8217;s JUUL investment was $1.7 billion, unchanged from its December 31, 2020 estimated fair value.  There were no material </span></div><div style="margin-bottom:10pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">changes to the significant assumptions used in the valuations, as described below, during the nine and three months ended September&#160;30, 2021.</span></div><div style="margin-bottom:10pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to Share Conversion, Altria accounted for its investment in JUUL as an investment in an equity security.  Since the JUUL shares do not have a readily determinable fair value, Altria elected to measure its investment in JUUL at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.  There were no upward or downward adjustments to the carrying value of Altria&#8217;s investment in JUUL resulting from observable price changes in orderly transactions since the JUUL Transaction through the date of Share Conversion.  In addition, prior to Share Conversion, Altria reviewed its investment in JUUL for impairment by performing a qualitative assessment of impairment indicators on a quarterly basis in connection with the preparation of its financial statements.  If this qualitative assessment indicated that Altria&#8217;s investment in JUUL may be impaired, a quantitative assessment was performed.  If the quantitative assessment indicated the estimated fair value of the investment was less than its carrying value, the investment was written down to its fair value.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, JUUL announced a strategic update, which included its plans for a significant global workforce reduction, its evaluation of its resource allocation and the possibility of exiting various international markets.  As part of the preparation of Altria&#8217;s financial statements for the period ended September 30, 2020, Altria performed a qualitative assessment of impairment indicators for its investment in JUUL and determined that JUUL&#8217;s strategic update was an indicator of impairment at September 30, 2020, given the significant deterioration in JUUL&#8217;s business prospects.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the existence of this impairment indicator, Altria performed a quantitative valuation of its investment in JUUL during the third quarter of 2020 and recorded a non-cash, pre-tax charge of $2.6 billion for the nine and three months ended September 30, 2020, reported as impairment of JUUL equity securities in its condensed consolidated statements of earnings (losses).  The impairment charge was driven by Altria&#8217;s projections of lower JUUL revenues over time due to lower pricing assumptions and delays in JUUL achieving previously forecasted operating margin performance.  These drivers were the result of (i) JUUL&#8217;s revised international expansion plans and (ii) the evolving U.S. e-vapor category and associated competitive dynamics.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria uses an income approach to estimate the fair value of its investment in JUUL.  The income approach reflects the discounting of future cash flows for the U.S. and international markets at a rate of return that incorporates the risk-free rate for the use of those funds, the expected rate of inflation and the risks associated with realizing future cash flows.  Future cash flows were based on a range of scenarios that consider various potential regulatory and market outcomes.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the estimated fair value of its investment in JUUL, as of September&#160;30, 2021 and December&#160;31, 2020, Altria made various judgments, estimates and assumptions, the most significant of which were sales volume, operating margins, discount rates and perpetual growth rates.  All significant inputs used in the valuation are classified in Level 3 of the fair value hierarchy.  Additionally, in determining these significant assumptions, Altria made judgments regarding the (i) likelihood and extent of various potential regulatory actions and the continued adverse public perception impacting the e-vapor category and specifically JUUL, (ii) risk created by the number and types of legal cases pending against JUUL and (iii) expectations for the future state of the e-vapor category, including competitive dynamics.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in Cronos</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, Altria had a 41.9% ownership interest in Cronos, consisting of 156.6&#160;million shares, which Altria accounts for under the equity method of accounting.  Altria&#8217;s ownership percentage decreased from 43.5% at December 31, 2020 due to the issuance of additional shares by Cronos.  Altria reports its share of Cronos&#8217;s results using a one-quarter lag because Cronos&#8217;s results are not available in time for Altria to record them in the concurrent period.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of its Investment in Cronos, at September&#160;30, 2021, Altria owned:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">anti-dilution protections to purchase Cronos common shares, exercisable each quarter upon dilution, to maintain its ownership percentage.  Certain of the anti-dilution protections provide Altria the ability to purchase additional Cronos common shares at a per share exercise price of Canadian dollar (&#8220;CAD&#8221;) $16.25 upon the occurrence of specified events (&#8220;Fixed-price Preemptive Rights&#8221;).  Based on Altria&#8217;s assumptions as of September 30, 2021, Altria estimates the Fixed-price Preemptive Rights allows Altria to purchase up to an additional approximately 14 million common shares of Cronos; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">a warrant providing Altria the ability to purchase an additional approximate 10% of common shares of Cronos (approximately 83 million common shares at September 30, 2021) at a per share exercise price of CAD $19.00, which expires on March 8, 2023.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If exercised in full, the exercise prices for the warrant and Fixed-price Preemptive Rights are approximately CAD $1.6 billion and CAD $0.2 billion, respectively (approximately USD $1.3 billion and $0.2 billion, respectively, based on the CAD to USD exchange rate on October 25, 2021).  At September 30, 2021, upon full exercise of the Fixed-price Preemptive Rights, to the </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">extent such rights become available, and the warrant, Altria would own approximately 53% of the outstanding common shares of Cronos.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of derivatives related to the Investment in Cronos, including Altria&#8217;s accounting for changes in the fair value of these derivatives, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of Altria&#8217;s equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos&#8217;s common shares and was classified in Level 1 of the fair value hierarchy.  In September 2021, the fair value of Altria&#8217;s equity method investment in Cronos declined below its carrying value.  At September&#160;30, 2021, the fair value of Altria&#8217;s equity method investment in Cronos was less than its carrying value by $14&#160;million or approximately 2%.  The fair value of Altria&#8217;s equity method investment in Cronos exceeded its carrying value by $77 million or approximately 8% at December&#160;31, 2020.  Based on Altria&#8217;s evaluation of the duration and magnitude of the fair value decline at September 30, 2021, Altria concluded that the decline in fair value of its equity method investment in Cronos below its carrying value is temporary and, therefore, no impairment was recorded.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -URI http://asc.fasb.org/topic&amp;trid=75115024<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 325<br> -URI http://asc.fasb.org/topic&amp;trid=2197064<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI http://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798027973784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Financial Instruments</a></td>
<td class="text">Financial Instruments<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria enters into derivative financial instruments to mitigate the potential impact of certain market risks, including foreign currency exchange rate risk.  Altria uses various types of derivative financial instruments, including forward contracts, options and swaps.  Altria does not enter into or hold derivative financial instruments for trading or speculative purposes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s investment in ABI, whose functional currency is the Euro, exposes Altria to foreign currency exchange risk on the carrying value of its investment.  To manage this risk, Altria designates certain foreign exchange contracts, including cross-currency swap contracts and forward contracts (collectively, &#8220;foreign currency contracts&#8221;), and Euro denominated unsecured long-term notes (&#8220;foreign currency denominated debt&#8221;) as net investment hedges of Altria&#8217;s investment in ABI.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, all outstanding foreign currency contracts matured.  When Altria has foreign currency contracts in effect, counterparties are domestic and international financial institutions.  Under these contracts, Altria is exposed to potential losses due to non-performance by these counterparties.  Altria manages its credit risk by entering into transactions with counterparties with investment grade credit ratings, limiting the amount of exposure Altria has with each counterparty and monitoring the financial condition of each counterparty.  The counterparty agreements contain provisions that require Altria to maintain an investment grade credit rating.  In the event Altria&#8217;s credit rating falls below investment grade, counterparties to Altria&#8217;s foreign currency contracts can require Altria to post collateral.  No collateral was received or posted related to derivative assets and liabilities at December&#160;31, 2020.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides (i) the aggregate notional amounts of foreign currency contracts and (ii) the aggregate carrying value and fair value of foreign currency denominated debt:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts (notional amounts)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,066&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,905</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,288</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,687&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s estimates of the fair values of its foreign currency contracts are determined using valuation models with significant inputs that are readily available in public markets, or can be derived from observable market transactions, and therefore are classified in Level 2 of the fair value hierarchy.  An adjustment for credit risk and non-performance risk is included in the fair values of foreign currency contracts.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the aggregate carrying value and fair value of Altria&#8217;s total long-term debt:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28,127</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31,037</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,682&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s estimate of the fair value of its total long-term debt is based on observable market information derived from a third-party pricing source and is classified in Level 2 of the fair value hierarchy.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Fixed-price Preemptive Rights and Cronos warrant, which are further discussed in Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, are derivative financial instruments, which are required to be recorded at fair value.  The fair values of the Fixed-price Preemptive Rights and Cronos warrant are estimated using Black-Scholes option-pricing models, adjusted for observable inputs (which are classified in Level 1 of the fair value hierarchy), including share price, and unobservable inputs, including </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">probability factors and weighting of expected life, volatility levels and risk-free interest rates (which are classified in Level 3 of the fair value hierarchy) based on the following assumptions at:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.448%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fixed-price Preemptive Rights</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Warrant</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">C$7.15</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$8.84</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">C$7.15</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$8.84</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.81 year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.05 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.43 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.18 years</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67.32%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.68%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67.32%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.68%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.24%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.39%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.21%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Based on the closing market price for Cronos common stock on the Toronto Stock Exchange on the date indicated.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Based on the weighted-average expected life of the Fixed-price Preemptive Rights (with a range from approximately 0.25 year to 4.00 years at September&#160;30, 2021 and 0.25 year to 5 years at December&#160;31, 2020) and the March 8, 2023 expiration date of the Cronos warrant.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Based on a blend of historical volatility of the underlying equity security and implied volatility from traded options on the underlying equity security at September&#160;30, 2021.  Based on a blend of historical volatility levels of the underlying equity security and peer companies at December&#160;31, 2020.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Based on the implied yield currently available on Canadian Treasury zero coupon issues (with a range from approximately 0.12% to 0.89% at September&#160;30, 2021 and 0.06% to 0.39% at December&#160;31, 2020) weighted for the remaining expected life of the Fixed-price Preemptive Rights.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Based on the implied yield currently available on Canadian Treasury zero coupon issues and the expected life of the Cronos warrant.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Based on Cronos&#8217;s expected dividend payments.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balance of the Fixed-price Preemptive Rights and Cronos warrant, which are classified in Level 3 of the fair value hierarchy:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax earnings (losses) recognized in net earnings (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax earnings (losses) recognized in net earnings (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria elects to record the gross assets and liabilities of derivative financial instruments executed with the same counterparty on its condensed consolidated balance sheets.  The fair values of Altria&#8217;s derivative financial instruments on a gross basis included on the condensed consolidated balance sheets were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.209%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></div></td><td colspan="30" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cronos warrant</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed-price Preemptive Rights</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria records in its condensed consolidated statements of earnings (losses) any changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant as gains or losses on Cronos-related financial instruments in the periods in which the changes occur.  For the nine and three months ended September&#160;30, 2021 and 2020, Altria recorded non-cash, pre-tax unrealized gains (losses), representing the changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant, as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.278%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-price Preemptive Rights</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(21)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(107)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(128)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(135)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Investment Hedging</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pre-tax effects of Altria&#8217;s net investment hedges on accumulated other comprehensive losses and the condensed consolidated statements of earnings (losses) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.391%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.826%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in Accumulated Other Comprehensive Losses</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in <br/>Net Earnings (Losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in Accumulated Other Comprehensive Losses</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in <br/>Net Earnings (Losses)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">118</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">286</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(243)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">118</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the fair value of the foreign currency contracts and in the carrying value of the foreign currency denominated debt due to changes in the Euro to USD exchange rate were recognized in accumulated other comprehensive losses related to ABI.  Gains on the foreign currency contracts arising from components excluded from effectiveness testing were recognized in interest and other debt expense, net in the condensed consolidated statements of earnings (losses) based on an amortization approach.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798027833000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Benefit Plans</a></td>
<td class="text">Benefit Plans<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Components of Net Periodic Benefit (Income) Cost</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit (income) cost consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.094%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended <br/>September 30,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">139</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(393)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(376)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(131)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">99</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(income) cost</span></div></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(101)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(34)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employer Contributions</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria makes contributions to the pension plans to the extent that the contributions are tax deductible and pays benefits that relate to plans for salaried employees that cannot be funded under Internal Revenue Service regulations.  Altria made employer contributions of $23 million to its pension plans and did not make any contributions to its postretirement plans during the nine months ended September 30, 2021.  Currently, Altria anticipates making additional employer contributions to its pension plans of up to approximately $5 million and no  additional contributions to its postretirement plans for the remainder of 2021. However, the foregoing estimates of 2021 contributions to the pension and postretirement plans are subject to change as a result of changes in tax and other benefit laws, changes in interest rates, as well as asset performance significantly above or below the assumed long-term rate of return for each respective plan.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, Altria announced several amendments to its salaried retiree healthcare plans, primarily changing its post-age 65 coverage to a private medicare marketplace.  These amendments triggered a plan remeasurement as of May 31, 2021 and resulted in Altria recording a reduction of $432 million to its accrued postretirement health care costs liability and a corresponding reduction to its accumulated other comprehensive losses on its condensed consolidated balance sheet.  Ongoing amortization has been adjusted to reflect these changes as of June 1, 2021 and is reflected in the amounts shown above.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798026751816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Losses) per Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings (Losses) per Share</a></td>
<td class="text">Earnings (Losses) per Share<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings (losses) per share (&#8220;EPS&#8221;) were calculated using the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.952%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses) attributable to Altria</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">851</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,722)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(952)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Distributed and undistributed earnings attributable to share-based awards</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) for basic and diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">843</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,537&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,724)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(953)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares for basic EPS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,849</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,842</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: contingently issuable performance stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares for diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,849</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,859&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,842</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,859&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798026447240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Earnings/Losses<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Other Comprehensive Earnings/Losses</a></td>
<td class="text">Other Comprehensive Earnings/Losses<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.377%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,420)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,938)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,341)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">432</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">685</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,152</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(269)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">314</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">534</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">883</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">92</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">69</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(39)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">383</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">495</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">911</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,037)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,443)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,430)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.377%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,043)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,604)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,602)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">215</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">221</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">167</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">164</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">161</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">172</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,037)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,443)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,430)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.377%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,192)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(693)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,864)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,302)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(951)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,023)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(928)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(917)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,165)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,621)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,781)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.377%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,150)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,606)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,774)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,165)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,621)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,781)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Reflects the remeasurement impact of salaried retiree healthcare plan amendments.  For further discussion, see Note 6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans.</span></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Primarily reflects Altria&#8217;s share of ABI&#8217;s currency translation adjustments and the impact of Altria&#8217;s designated net investment hedges.  For further discussion of designated net investment hedges, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings (losses):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.806%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.037%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Plans: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">124</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">92</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments and Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Amounts are included in net defined benefit plan costs.  For further information related to defined benefit plans, see Note 6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans.</span></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Amounts are included in (income) losses from equity investments.  For further information related to equity investments, see Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798027994888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment Reporting<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The products of Altria&#8217;s subsidiaries include smokeable tobacco products, consisting of combustible cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton; oral tobacco products, consisting of MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix; and wine produced and/or distributed by Ste. Michelle.  The products and services of these subsidiaries constitute Altria&#8217;s reportable segments of smokeable products, oral tobacco products and wine.  The financial services and the innovative tobacco products businesses, which include the heated tobacco business and Helix ROW, are included in all other.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s chief operating decision maker (the &#8220;CODM&#8221;) reviews operating companies income (loss) (&#8220;OCI&#8221;) to evaluate the performance of, and allocate resources to, the segments.  OCI for the segments is defined as operating income before general corporate expenses and amortization of intangibles.  Interest and other debt expense, net, along with net periodic benefit income/cost, excluding service cost, and provision (benefit) for income taxes are centrally managed at the corporate level and, accordingly, such items are not presented by segment since they are excluded from the measure of segment profitability reviewed by the CODM.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,275</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,975</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,945</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">626</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">494</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">177</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,758</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,849&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,786</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,123&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings (losses) before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,901</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,753</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,269</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">405</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(255)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,827</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,951</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(869)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(266)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(649)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit income, excluding </span></div><div style="padding-left:31.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">service cost</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">152</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">63</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (losses) from equity investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,789)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,915)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of JUUL equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on Cronos-related financial instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(135)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) before income taxes</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,544</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,349&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,302)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The comparability of OCI for the reportable segments was affected by the following:</span></div><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Non-Participating Manufacturer (&#8220;NPM&#8221;) Adjustment Items:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Pre-tax (income) for NPM adjustment items was recorded to Altria&#8217;s condensed consolidated statements of earnings (losses) as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.903%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products segment</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(53)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(21)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(44)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NPM adjustment items result from the resolutions of certain disputes with states and territories related to the NPM adjustment provision under the 1998 Master Settlement Agreement (such dispute resolutions are referred to as &#8220;NPM Adjustment Items&#8221; and are more fully described in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).  The amounts shown in the table above for the smokeable products segment were recorded as reductions to cost of sales, which increased OCI in the smokeable products segment.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Tobacco and Health and Certain Other Litigation Items:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax charges related to tobacco and health and certain other litigation items were recorded in Altria&#8217;s condensed consolidated statements of earnings (losses) as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products segment</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">148</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">105</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts shown in the table above for the smokeable products segment and general corporate were recorded in marketing, administration and research costs.  For further discussion, see Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">COVID-19 Special Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net pre-tax charges of $50 million ($41 million in the smokeable products segment and $9 million in the oral tobacco products segment) related to the COVID-19 pandemic were recorded in Altria&#8217;s condensed consolidated statements of earnings (losses) for the nine months ended September 30, 2020.  The net pre-tax charges, which were directly related to disruptions caused by or efforts to mitigate the impact of the COVID-19 pandemic, were all recorded in costs of sales and included premium pay, personal protective equipment and health screenings, which were partially offset by certain employment tax credits.  The COVID-19 special items do not include the inventory-related implementation costs associated with the wine business strategic reset discussed below.  These implementation costs were due to increased inventory levels, which were further negatively impacted by the COVID-19 pandemic, including economic uncertainty and government restrictions.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Implementation, Acquisition and Disposition-Related Costs:</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ste. Michelle Transaction:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine and three months ended September&#160;30, 2021, pre-tax disposition-related costs of $51 million were recorded in the wine segment, which consisted of a pre-tax charge of $41 million to record the assets and liabilities associated with the Ste. Michelle Transaction at their fair value less costs to sell and  $10 million of other disposition-related costs.  For further discussion, see Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wine Business Strategic Reset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: During the nine months ended September 30, 2020, Ste. Michelle recorded pre-tax implementation costs of  $395 million associated with a strategic reset initiated in the first quarter of 2020 to maximize Ste. Michelle&#8217;s profitability and achieve improved long-term cash flow generation.  Substantially all of the charges consisted of the following: (i) write-off of inventory ($292 million) as Ste. Michelle no longer believed that the benefit of the blending and production plans for its inventory outweighed inventory carrying cost given the reduced product volume demand; and (ii) estimated losses on future non-cancelable grape purchase commitments that Ste. Michelle believed no longer had a future economic benefit ($100 million).  These charges were included in cost of sales in Altria&#8217;s condensed consolidated statements of earnings (losses).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-Related Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: For the nine months ended September 30, 2021, Altria recorded pre-tax acquisition-related costs of $37 million in the oral tobacco products segment primarily for the settlement of an arbitration related to the 2019 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> transaction.  These costs were included in marketing, administration and research costs in Altria&#8217;s condensed consolidated statements of earnings (losses).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798025587016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Short-term Borrowings and Borrowing Arrangements</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021 and December&#160;31, 2020, Altria had no short-term borrowings.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 18, 2021, Altria entered into an extension and amendment (the &#8220;Extension and Amendment&#8221;) to its $3.0 billion senior unsecured 5-year revolving credit agreement (as amended, the &#8220;Credit Agreement&#8221;).  The Extension and Amendment extends the maturity date of the Credit Agreement from August 1, 2023 to August 1, 2024 and amends the Credit Agreement to update certain provisions regarding a successor interest rate to the London Interbank Offered Rate (&#8220;LIBOR&#8221;) and make certain other market updates.  All other terms and conditions of the Credit Agreement remain in full force and effect.  The Credit Agreement, which is used for general corporate purposes, includes an additional option, subject to certain conditions, for Altria to extend the expiration date for an additional one-year period.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, the Credit Agreement had available borrowings up to an aggregate principal amount of $3.0 billion.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pricing for interest and fees under the Credit Agreement may be modified in the event of a change in the rating of Altria&#8217;s long-term senior unsecured debt.  Interest rates on borrowings under the Credit Agreement are expected to be based on LIBOR, or a fallback benchmark rate determined based on prevailing market convention, plus a percentage based on the higher of the ratings of Altria&#8217;s long-term senior unsecured debt from Moody&#8217;s Investors Service, Inc. (&#8220;Moody&#8217;s&#8221;) and Standard&#160;&amp; Poor&#8217;s Financial Services LLC (&#8220;S&amp;P&#8221;).  The applicable percentage based on Altria&#8217;s long-term senior unsecured debt ratings&#160;at September&#160;30, 2021 for borrowings under the Credit Agreement was 1.0%.  The Credit Agreement does not include any other rating triggers, or any provisions that could require the posting of collateral.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement includes various covenants, one of which requires Altria to maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization (&#8220;EBITDA&#8221;) to Consolidated Interest Expense of not less than 4.0 to 1.0, calculated as of the end of the applicable quarter on a rolling four quarters basis.  At September&#160;30, 2021, the ratio of consolidated EBITDA to Consolidated Interest Expense, calculated in accordance with the Credit Agreement, was 9.8 to 1.0.  At September&#160;30, 2021, Altria was in compliance with its covenants in the Credit Agreement.  The terms &#8220;Consolidated EBITDA&#8221; and &#8220;Consolidated Interest Expense,&#8221; each as defined in the Credit Agreement, include certain adjustments.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, due to the uncertainty at that time in the global capital markets, including the commercial paper markets, resulting from the COVID-19 pandemic, Altria elected to borrow the full $3.0 billion available under the Credit Agreement as a precautionary measure to increase its cash position and preserve financial flexibility.  In June 2020, Altria repaid the full amount outstanding under the Credit Agreement using the net proceeds from the issuance of long-term senior unsecured notes issued in May 2020 and available cash.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any commercial paper issued by Altria and borrowings under the Credit Agreement are guaranteed by PM&#160;USA.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Debt</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying value of Altria&#8217;s total long-term debt at September&#160;30, 2021 and December&#160;31, 2020 was $28.1 billion and $29.5 billion, respectively.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, Altria repaid in full senior unsecured notes in the aggregate principal amount of $1.5 billion at maturity.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, Altria issued long-term senior unsecured notes in the aggregate principal amount of $5.5 billion (the &#8220;Notes&#8221;).  The net proceeds from the Notes were used (i) to fund the purchase and redemption of certain unsecured notes and payment of related fees and expenses, as described below, and (ii) for other general corporate purposes.  The Notes contain the following terms:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">$1.75 billion at 2.450%, due 2032, interest payable semiannually beginning August 4, 2021;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">$1.50 billion at 3.400%, due 2041, interest payable semiannually beginning August 4, 2021;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">$1.25 billion at 3.700%, due 2051, interest payable semiannually beginning August 4, 2021; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">$1.00 billion at 4.000%, due 2061, interest payable semiannually beginning August 4, 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Notes are Altria&#8217;s senior unsecured obligations and rank equally in right of payment with all of Altria&#8217;s existing and future senior unsecured indebtedness.  Upon the occurrence of both (i) a change of control of Altria and (ii) the Notes ceasing to be rated investment grade by each of Moody&#8217;s, S&amp;P and Fitch Ratings, Inc. within a specified time period, Altria will be required to make an offer to purchase the Notes at a price equal to 101% of the aggregate principal amount of such Notes, plus accrued and unpaid interest to the date of repurchase as and to the extent set forth in the terms of the Notes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The obligations of Altria under the Notes are guaranteed by PM USA.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, Altria completed debt tender offers to purchase for cash certain of its long-term senior unsecured notes in an aggregate principal amount of $4,042 million.  Details of the debt tender offers are as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal Amount of Notes Purchased</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.850% Notes due 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">795</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.950% Notes due 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">132</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000% Notes due 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">624</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.800% Notes due 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">655</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.400% Notes due 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">430</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.800% Notes due 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,094</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.950% Notes due 2038</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.200% Notes due 2039</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.200% Notes due 2059</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">229</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,042</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, Altria also redeemed all of its outstanding 3.490% Notes due 2022 in an aggregate principal amount of $1.0 billion.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the debt tender offers and redemption, during the first quarter of 2021, Altria recorded pre-tax losses on early extinguishment of debt of $649 million, which included premiums and fees of $623 million and the write-off of related unamortized debt discounts and debt issuance costs of $26 million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021 and December&#160;31, 2020, accrued interest on long-term debt of $206 million and $458 million, respectively, was included in other accrued liabilities on Altria&#8217;s condensed consolidated balance sheets.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of the fair value of Altria&#8217;s long-term debt and the designation of its Euro denominated senior unsecured notes as a net investment hedge of its investment in ABI, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798127410296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Earnings (losses) before income taxes, provision (benefit) for income taxes and income tax rates consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,544</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,349</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,302)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision (benefit) for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">693</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,817</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(582)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax rate</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195.1)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s income tax rates for the nine and three months ended September 30, 2021 and 2020 are not comparable in a meaningful way due to the following significant pre-tax charges and valuation allowances:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the $6,157 million impairment of Altria&#8217;s equity investment in ABI during the nine and three months ended September 30, 2021;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the $2,600 million impairment of Altria&#8217;s investment in JUUL during the nine and three months ended September 30, 2020 and valuation allowances associated with Altria&#8217;s investments in JUUL and Altria&#8217;s Investment in Cronos.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s income tax rates for the nine and three months ended September 30, 2021 differ from the U.S. federal statutory rate of 21%, due primarily to the state tax treatment of the impairment charge on Altria&#8217;s equity investment in ABI.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s income tax rates for the nine and three months ended September 30, 2020 differ from the U.S. federal statutory rate of 21%, due primarily to valuation allowances primarily attributable to deferred tax assets recorded in connection with the impairment of Altria&#8217;s investment in JUUL, and Altria&#8217;s Investment in Cronos.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further information on the impairments of Altria&#8217;s equity investment in ABI and investment in JUUL, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following chart provides a reconciliation of the beginning and ending valuation allowances for the period ended September&#160;30, 2021:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.130%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,817&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to valuation allowance charged to income tax expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">264</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions to valuation allowance credited to income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,004</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria determines the realizability of deferred tax assets based on the weight of available evidence, that it is more-likely-than-not that the deferred tax asset will not be realized. In reaching this determination, Altria considers all available positive and negative evidence, including the character of the loss, carryback and carryforward considerations, future reversals of temporary differences and available tax planning strategies.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current changes in valuation allowances were due to deferred tax assets recorded in connection with Altria&#8217;s Investment in Cronos and changes in the estimated fair value of its investment in JUUL.  The valuation allowance at the end of the period is primarily attributable to deferred tax assets recorded in connection with Altria&#8217;s investment in JUUL and Investment in Cronos.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798026798552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">Contingencies</a></td>
<td class="text">Contingencies<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal proceedings covering a wide range of matters are pending or threatened in various U.S. and foreign jurisdictions against Altria and its subsidiaries, including PM USA and USSTC, as well as their respective indemnitees and Altria&#8217;s investees.  Various types of claims may be raised in these proceedings, including product liability, unfair trade practices, antitrust, tax, contraband shipments, patent infringement, employment matters, claims alleging violation of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), claims for contribution and claims of competitors, shareholders or distributors.  Legislative action, such as changes to tort law, also may expand the types of claims and remedies available to plaintiffs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation is subject to uncertainty and it is possible that there could be adverse developments in pending or future cases.  An unfavorable outcome or settlement of pending tobacco-related or other litigation could encourage the commencement of additional litigation.  Damages claimed in some tobacco-related and other litigation are or can be significant and, in certain cases, have ranged in the billions of dollars.  The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome.  In certain cases, plaintiffs claim that defendants&#8217; liability is joint and several.  In such cases, Altria or its subsidiaries may face the risk that one or more co-defendants decline or otherwise fail to participate in the bonding required for an appeal or to pay their proportionate or jury-allocated share of a judgment.  As a result, Altria or its subsidiaries under certain circumstances may have to pay more than their proportionate share of any bonding- or judgment-related amounts.  Furthermore, in those cases where plaintiffs are successful, Altria or its subsidiaries also may be required to pay interest and attorneys&#8217; fees.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although PM USA has historically been able to obtain required bonds or relief from bonding requirements in order to prevent plaintiffs from seeking to collect judgments while adverse verdicts have been appealed, there remains a risk that such relief may not be obtainable in all cases.  This risk has been substantially reduced given that 47 states and Puerto Rico limit the dollar amount of bonds or require no bond at all.  As discussed below, however, tobacco litigation plaintiffs have challenged the constitutionality of Florida&#8217;s bond cap statute in several cases and plaintiffs may challenge state bond cap statutes in other jurisdictions as well.  Such challenges may include the applicability of state bond caps in federal court.  States, including Florida, also may seek to repeal or alter bond cap statutes through legislation.  Although Altria cannot predict the outcome of such challenges, it is possible that the consolidated results of operations, cash flows or financial position of Altria, or one or more of its subsidiaries, could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome of one or more such challenges.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and its subsidiaries record provisions in the condensed consolidated financial statements for pending litigation when they determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated.  At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, except to the extent discussed elsewhere in this Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: (i)&#160;management has concluded that it is not probable that a loss has been incurred in any of the pending cases; (ii)&#160;management is unable to estimate the possible loss or range of loss that could result from an unfavorable outcome in any of the pending cases; and (iii)&#160;accordingly, management has not provided any amounts in the condensed consolidated financial statements for unfavorable outcomes, if any.  Litigation defense costs are expensed as incurred.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and its subsidiaries have achieved substantial success in managing litigation.  Nevertheless, litigation is subject to uncertainty and significant challenges remain.  It is possible that the consolidated results of operations, cash flows or financial position of Altria, or one or more of its subsidiaries, could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation.  Altria and each of its subsidiaries named as a defendant believe, and each has been so advised by counsel handling the respective cases, that it has valid defenses to the litigation pending against it, as well as valid bases for appeal of adverse verdicts.  Each of the companies has defended, and will continue to defend, vigorously against litigation challenges.  However, Altria and its subsidiaries may enter into settlement discussions in particular cases if they believe it is in the best interests of Altria to do so.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Judgments Paid and Provisions for Tobacco and Health and Certain Other Litigation Items (Including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Progeny Litigation): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After exhausting all appeals in those cases resulting in adverse verdicts associated with tobacco-related litigation, since October 2004, PM USA has paid judgments and settlements (including related costs and fees) totaling approximately $865 million and interest totaling approximately $218 million as of September 30, 2021.  These amounts include payments for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny judgments (and related costs and fees) totaling approximately $410 million and related interest totaling approximately $56 million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in Altria&#8217;s accrued liability for tobacco and health and certain other litigation items, including related interest costs, for the periods specified below are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liability for tobacco and health and certain other  litigation items at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax charges for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">142</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">99</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related interest costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liability for tobacco and health and certain other  litigation items at end of period</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">97</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">97</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes amounts related to certain other litigation and pre-trial resolution of certain tobacco and health cases.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accrued liability for tobacco and health and certain other litigation items, including related interest costs, was included in accrued liabilities on Altria&#8217;s condensed consolidated balance sheets.  Pre-tax charges for tobacco and health and certain other litigation were included in marketing, administration and research costs on Altria&#8217;s condensed consolidated statements of earnings (losses).  Pre-tax charges for related interest costs were included in interest and other debt expense, net on Altria&#8217;s condensed consolidated statements of earnings (losses).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Security for Judgments: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To obtain stays of judgments pending appeal, PM USA has posted various forms of security.  As of September 30, 2021, PM USA has posted appeal bonds totaling approximately $45 million, which have been collateralized with restricted cash that are included in assets on the condensed consolidated balance sheets.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Altria and/or PM USA Tobacco-Related Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Types and Number of U.S. Cases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Claims related to tobacco products generally fall within the following categories: (i)&#160;smoking and health cases alleging personal injury brought on behalf of individual plaintiffs; (ii)&#160;health care cost recovery cases brought by governmental (both domestic and foreign) plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and/or disgorgement of profits; (iii) e-vapor cases alleging violation of RICO, fraud, failure to warn, design defect, negligence, antitrust and unfair trade practices; and (iv)&#160;other tobacco-related litigation described below.  Plaintiffs&#8217; theories of recovery and the defenses raised in tobacco-related litigation are discussed below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below lists the number of certain tobacco-related cases pending in the U.S. against PM USA and/or Altria as of October 25, 2021, October 27, 2020 and October 28, 2019:</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">October 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">October 27, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">October 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Smoking and Health Cases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">179</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Cost Recovery Actions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-vapor Cases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,951</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Tobacco-Related Cases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes 18 cases filed in Illinois, 17 cases filed in New Mexico, 40 cases filed in Massachusetts and 70 non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">cases filed in Florida.  Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">case (these </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> progeny cases are discussed below in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Engle Class Action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  Also does not include 1,471 cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (&#8220;ETS&#8221;).  The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Broin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages.  Class members were prohibited from filing individual lawsuits after 2000 under the court-approved settlement.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation - Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> below.</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes 53 class action lawsuits, 2,548 individual lawsuits and 350 &#8220;third party&#8221; lawsuits relating to JUUL e-vapor products, which include school districts, state and local government, tribal and healthcare organization lawsuits.  JUUL is an additional named defendant in each of these lawsuits. The 53 class action lawsuits include 28 cases in the Northern District of California (&#8220;Multidistrict Litigation&#8221; or &#8220;MDL&#8221;) involving plaintiffs whose claims were previously included in other class action complaints but were refiled as separate stand-alone class actions for procedural and other reasons.</span></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms &#8220;Lights&#8221; and &#8220;Ultra Lights&#8221; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">International Tobacco-Related Cases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 25, 2021, (i) Altria is named as a defendant in three e-vapor class action lawsuits in Canada; (ii) PM USA is a named defendant in 10 health care cost recovery actions in Canada, eight of which also name Altria as a defendant; and (iii) PM USA and Altria are named as defendants in seven smoking and health class actions filed in various Canadian provinces.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the Distribution Agreement between Altria and Philip Morris International Inc. (&#8220;PMI&#8221;) that provides for indemnities for certain liabilities concerning tobacco products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tobacco-Related Cases Set for Trial: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 25, 2021, no </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny or individual smoking and health cases against PM USA are set for trial through December 31, 2021.  Trial dates are subject to change and many of the trials were postponed due to the COVID-19 pandemic; however, the courts are reopening and additional trials may be scheduled for the remainder of 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trial Results: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 1999, excluding the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases (separately discussed below), verdicts have been returned in 69 tobacco-related cases in which PM USA was a defendant. Verdicts in favor of PM USA and other defendants were returned in 44 of the 69 cases.  These 44 cases were tried in Alaska (1), California (7), Connecticut (1), Florida (10), Louisiana (1), Massachusetts (4), Mississippi (1), Missouri (4), New Hampshire (1), New Jersey (1), New York (5), Ohio (2), Pennsylvania (1), Rhode Island (1), Tennessee (2) and West Virginia (2).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the 25 non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in which verdicts were returned in favor of plaintiffs, 20 have reached final resolution, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and two cases (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gentile </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Principe</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) that were initially returned in favor of plaintiffs were reversed post-trial and remain pending.</span></div><div style="margin-bottom:5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Liti</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">gation - Engle Progeny Trial Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of verdicts in state and federal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases involving PM USA as of October 25, 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Smoking and Health Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plaintiffs&#8217; allegations of liability in smoking and health cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, nuisance, breach of express and implied warranties, breach of special duty, conspiracy, concert of action, violations of unfair trade practice laws and consumer protection statutes, and claims under the federal and state anti-racketeering statutes.  Plaintiffs in the smoking and health cases seek various forms of relief, including compensatory and punitive damages, treble/multiple damages and other statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and equitable relief.  Defenses raised in these cases include lack of proximate cause, assumption of the risk, comparative fault and/or contributory negligence, statutes of limitations and preemption by the Federal Cigarette Labeling and Advertising Act.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Progeny Litigation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny smoking and health cases pending during 2021 in which a verdict was returned in favor of plaintiff and against PM USA.  Charts listing certain verdicts for plaintiffs in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases can be found in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Engle Progeny Trial Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In February 2020, a jury in a Florida state court returned a verdict in favor of plaintiff and against PM USA, awarding approximately $11 million in compensatory damages.  There was no claim for punitive damages.  PM USA appealed the trial court verdict to the Third District Court of Appeal and, in September 2021, the appellate court reversed the trial court&#8217;s decision and found in favor of PM USA.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Greene</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In September 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiffs and against PM USA, awarding approximately $10 million in compensatory damages.  In May 2020, the court ruled on plaintiffs&#8217; remaining claim and trebled the compensatory damages award to approximately $30 million.  In February 2021, the trial court awarded plaintiffs attorneys&#8217; fees and costs in the amount of approximately $2.3 million.  Also in February 2021, PM USA served its post-trial motions to reverse the judgment or for a new trial. The trial court denied the post-trial motions in June 2021.  In July 2021, PM USA appealed the judgment to the Appeals Court of Massachusetts.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Laramie</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In August 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiff and against PM USA, awarding $11 million in compensatory damages and $10 million in punitive damages.  PM USA appealed and, in February 2021, the Massachusetts Supreme Judicial Court asserted jurisdiction over the appeal.  In September 2021, the Massachusetts Supreme Judicial Court affirmed the trial court award of $21 million in compensatory and punitive damages.  PM USA recorded a pre-tax provision of approximately $27.1 million for the judgment, including interest, in the third quarter of 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gentile</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In October 2017, a jury in a Florida state court returned a verdict in favor of plaintiff and against PM USA, awarding approximately $7.1 million in compensatory damages and allocating 75% of the fault to PM USA.  PM USA appealed.  In September 2019, the Florida Fourth District Court of Appeal reversed the judgment entered by the trial court, granted PM USA judgment on certain claims and remanded for a new trial on the remaining claims.  Plaintiff petitioned the Florida Supreme Court for further review, which the court denied in January 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation - Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the verdict and post-trial developments in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> health care cost recovery case.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Class Action: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2000, in the second phase of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> smoking and health class action in Florida, a jury returned a verdict assessing punitive damages totaling approximately $145 billion against various defendants, including $74 billion against PM USA.  Following entry of judgment, PM USA appealed.  In May 2003, the Florida Third District Court of Appeal reversed the judgment entered by the trial court and instructed the trial court to order the decertification of the class.  Plaintiffs petitioned the Florida Supreme Court for further review.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2006, the Florida Supreme Court ordered that the punitive damages award be vacated, that the class approved by the trial court be decertified and that members of the decertified class could file individual actions against defendants within one year of issuance of the mandate.  The court further declared the following Phase I findings are entitled to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">res judicata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> effect in such individual actions brought within one year of the issuance of the mandate: (i)&#160;that smoking causes various diseases; (ii)&#160;that nicotine in cigarettes is addictive; (iii)&#160;that defendants&#8217; cigarettes were defective and unreasonably dangerous; (iv)&#160;that defendants concealed or omitted material information not otherwise known or available knowing that the material was false or misleading or failed to disclose a material fact concerning the health effects or addictive nature of smoking; (v)&#160;that defendants agreed to misrepresent information regarding the health effects or addictive nature of cigarettes with the intention of causing the public to rely on this information to their detriment; (vi)&#160;that defendants agreed to conceal or omit information regarding the health effects of cigarettes or their addictive nature with the intention that smokers would rely on the information to their detriment; (vii)&#160;that all defendants sold or supplied cigarettes that were defective; and (viii)&#160;that defendants were negligent.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2006, PM USA and plaintiffs sought rehearing from the Florida Supreme Court on parts of its July 2006 opinion.  In December 2006, the Florida Supreme Court refused to revise its July 2006 ruling, except that it revised the set of Phase I findings entitled to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">res judicata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> effect by excluding finding (v)&#160;listed above (relating to agreement to misrepresent information), and added the finding that defendants sold or supplied cigarettes that, at the time of sale or supply, did not conform to the representations of fact made by defendants.  In February 2008, the trial court decertified the class.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pending </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">e Progeny Cases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The deadline for filing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases expired in January 2008, at which point a total of approximately 9,300 federal and state claims were pending.  As of October 25, 2021, approximately 1,026 state court cases were pending against PM USA or Altria asserting individual claims by or on behalf of approximately 1,285 state court plaintiffs.&#160; Because of a number of factors, including docketing delays, duplicated filings and overlapping dismissal orders, these numbers are estimates.  While the Federal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agreement (discussed below) resolved nearly all </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases pending in federal court, as of October 25, 2021, two cases were pending against PM USA in federal court representing the cases excluded from that agreement.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Progeny Trial Results: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 25, 2021, 137 federal and state </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases involving PM USA have resulted in verdicts since the Florida Supreme Court </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decision.  Seventy-six verdicts were returned in favor of plaintiffs and seven verdicts (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skolnick</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Calloway</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oshinsky-Blacker,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">McCoy, Mahfuz, Neff and Frogel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) that were initially returned in favor of plaintiffs were reversed post-trial or on appeal and remain pending.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fifty-four verdicts were returned in favor of PM USA, of which 44 were state cases.  In addition, there have been a number of mistrials, only some of which have resulted in new trials as of October 25, 2021.  The jury in one case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Garcia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, awarded plaintiff compensatory damages and found plaintiff was entitled to punitive damages; however, the court declared a mistrial in the second phase of the trial regarding punitive damages because the jury was unable to determine the amount of the punitive damages. Four verdicts (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearson, D. Cohen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collar </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Chacon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) that were returned in favor of PM USA were subsequently reversed for new trials.  Juries in two cases (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reider </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Banks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">returned zero damages verdicts in favor of PM USA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Juries in two other cases (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Weingart</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hancock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) returned verdicts against PM USA awarding no damages, but the trial court in each case decided to award plaintiffs damages.  One case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pollari, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resulted in a verdict in favor of PM USA following a retrial of an initial verdict returned in favor of plaintiff.  Plaintiff and defendants appealed the verdict and the appellate court affirmed the judgement in favor of the defendants.  Three cases, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gloger,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rintoul </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Caprio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Duignan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, resulted in verdicts in favor of plaintiffs following retrial of initial verdicts returned in favor of plaintiffs.  Post-trial appeals are pending in those three cases.  Two cases, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Freeman </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Harris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, resulted in an appellate reversal of a jury verdict in favor of plaintiff, and a judgment in favor of PM USA.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The charts below list the verdicts and post-trial developments in certain </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in which verdicts were returned in favor of plaintiffs.  The first chart lists cases that are pending as of October 25, 2021 but where PM USA has determined an unfavorable outcome is not probable and the amount of loss cannot be reasonably estimated.  The second chart lists cases that have concluded within the previous 12 months.  Unless otherwise noted for a particular case, the jury&#8217;s award for compensatory damages will not be reduced by any finding of plaintiff&#8217;s comparative fault.  Further, the damages noted reflect adjustments based on post-trial or appellate rulings.  As of October 25, 2021, there are no </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases where PM USA has recorded a provision in its condensed consolidated financial statements because PM USA has not determined for any currently pending case that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">References below to &#8220;R.J. Reynolds,&#8221; &#8220;Lorillard&#8221; and &#8220;Liggett Group&#8221; are to R.J. Reynolds Tobacco Company, Lorillard Tobacco Company and Liggett Group, LLC, respectively.</span></div><div style="margin-bottom:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Currently Pending Engle Cases with Verdicts Against PM USA </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.488%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensatory Damages </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Punitive Damages <br/>(PM USA)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Appeal Status</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Lipp</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$15 million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$28 million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defendant&#8217;s post-trial motions denied.  Defendant plans to appeal.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Garcia</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2021</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mistrial</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendant to Third District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Duignan</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pinellas</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$12&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendants to Second District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cuddihee</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Duval</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendant to First District Court of Appeal pending. </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Rintoul </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Caprio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 2019 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$9&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$74 million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by plaintiff and defendants to Fourth District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Gloger</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 2019 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$15&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$11 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendants to Third District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">McCall</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1&#160;million (&lt;$1&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New trial ordered on punitive damages.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Neff</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$4&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth District Court of Appeal reversed the judgment against defendants and remanded for a new trial. Plaintiff's motion for rehearing was denied.</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.488%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensatory Damages </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Punitive Damages <br/>(PM USA)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Appeal Status</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Mahfuz</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$12&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$10 million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth District Court of Appeal reversed the judgment against defendants and remanded for a new trial.   Plaintiff's motion for rehearing was denied.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Holliman</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defendant&#8217;s appeal to Third District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Chadwell</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third District Court of Appeal affirmed the compensatory damages award.  PM USA petitioned Florida Supreme Court for review.  Case stayed pending Florida Supreme Court decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Prentice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Kaplan</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2018</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Fourth District Court of Appeal affirmed the verdict and  reaffirmed the verdict on rehearing.  Defendants sought review of the decision before the Florida Supreme Court and the court stayed the case pending its decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Sheffield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">R. Douglas</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 2017</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Duval</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Awaiting entry of final judgment by the trial court.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Sommers</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2017</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third District Court of Appeal affirmed compensatory damages award and granted new trial on punitive damages.  Florida Supreme Court denied PM USA&#8217;s petition for review of the Third District Court of Appeal&#8217;s decision.  PM USA paid approximately $1 million for the compensatory damages award and awaits the new trial on punitive damages.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">  The trial court stayed the new trial on punitive damages pending Florida Supreme Court&#8217;s decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Sheffield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cooper (Blackwood)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5&#160;million </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(&lt;$1&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth District Court of Appeal affirmed judgment and granted a new trial on punitive damages.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">D. Brown</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2015</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal Court - Middle District of Florida</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$8&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$9&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendant to U.S. Court of Appeals for the Eleventh Circuit stayed pending Florida Supreme Court decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Prentice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PM USA&#8217;s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Plaintiff&#8217;s verdict following a retrial of an initial verdict in favor of plaintiff.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> PM USA is not a defendant in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Prentice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Sheffield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Prentice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Sheffield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">are discussed below in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle Progeny Appellate Issues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Plaintiff was granted an award of approximately $3 million in fees, costs and interest that PM USA appealed.  The Florida Third District Court of Appeals affirmed the award and PM USA paid the award amount in March 2021.</span></div><div style="margin-bottom:3pt;margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle Cases Concluded Within Past 12 Months </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:14.465%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.437%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.675%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.850%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.346%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.265%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrual Date</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Amount<br/>(if any)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Berger (Cote)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2014</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal Court - Middle District of Florida</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth quarter of 2018 and first quarter of 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$29 million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Santoro</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2017</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA, R.J. Reynolds and Liggett Group</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Second quarter of 2020 and first quarter of 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2021</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In six cases in which PM USA paid the judgments more than a year ago, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Naugle,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Gore</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">M. Brown,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Jordan,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Theis </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Landi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, plaintiffs were awarded approximately $8 million, $2 million, $8 million, $4 million, $1 million and $3 million in fees and costs, respectively.  PM USA has appealed in all of these cases, except </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Theis </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Landi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.  In</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> M. Brown</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, in March 2021 the Florida First District Court of Appeals affirmed the fee award and reversed the pre-judgment interest award and, in April 2021, PM USA paid $8.2 million in satisfaction of the fee award and post-judgment interest. In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Theis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, PM USA paid $1 million in satisfaction of fees and costs in May 2021 and, in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Landi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, PM USA paid approximately $1.5 million in satisfaction of fees, costs and interest in July 2021 (R.J. Reynolds paid approximately $1.5 million of the approximately $3 million award).</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Progeny Appellate Issues: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Florida appellate courts are considering the following appeals which may have wide application to other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases:</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mary Sheffield v. R.J. Reynolds Tobacco Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny case against R.J. Reynolds only, the Florida Supreme Court has taken jurisdiction to resolve the conflict among Florida&#8217;s District Courts of Appeal over whether the 1999 amendments to Florida&#8217;s punitive damages statute (including its caps and bar on multiple punitive damages awards for the same course of conduct) apply in wrongful death cases where the decedent was injured prior to the October 1, 1999 effective date of the amendments but died from his or her injuries after such effective date.  Oral argument was held before the Florida Supreme Court in April 2021; a decision has not yet been issued.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Linda Prentice v. R.J. Reynolds Tobacco Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny case against R.J. Reynolds only, the Florida First District Court of Appeal in January 2020 reversed a judgment in favor of the plaintiff and remanded for a new trial. The court held that the trial court had erred by failing to instruct the jury that in order to prevail on her claim for conspiracy to commit fraudulent concealment, the plaintiff was required to prove that her decedent relied to his detriment on a statement that concealed or omitted material information about the health risks of smoking.  That holding conflicts with decisions from the Second, Third, and Fourth District Courts of Appeal, which have each held that </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">plaintiffs do not need to prove reliance on a statement, and instead can prevail by proving reliance on the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> defendants&#8217; concealment of information.  In August 2020, the Florida Supreme Court accepted jurisdiction in the case.  As an alternative ground to approve the First District Court of Appeal&#8217;s decision in its favor in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prentice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, R.J. Reynolds has asked the Florida Supreme Court to reconsider its prior decisions giving the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Phase I findings preclusive effect in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases, as described more fully in the section </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Class Action above.  Oral argument was held before the Florida Supreme Court in June 2021; a decision has not yet been issued.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Florida Bond Statute: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2009, Florida amended its existing bond cap statute by adding a $200 million bond cap that applies to all state </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny lawsuits in the aggregate and establishes individual bond caps for individual </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in amounts that vary depending on the number of judgments in effect at a given time.  Plaintiffs have been unsuccessful in various challenges to the bond cap statute in Florida state court.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No federal court has yet addressed the constitutionality of the bond cap statute or the applicability of the bond cap to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases tried in federal court.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, legislation has been presented to the Florida legislature that would repeal the bond cap statute; however to date, no legislation repealing the statute has passed.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Smoking and Health Class Actions: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the dismissal in May 1996 of a purported nationwide class action brought on behalf of allegedly addicted smokers, plaintiffs have filed numerous putative smoking and health class action suits in various state and federal courts.  In general, these cases purport to be brought on behalf of residents of a particular state or states (although a few cases purport to be nationwide in scope) and raise addiction claims and, in many cases, claims of physical injury as well.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Class certification has been denied or reversed by courts in 61 smoking and health class actions involving PM USA in Arkansas (1), California (1), Delaware (1), the District of Columbia (2), Florida (2), Illinois (3), Iowa (1), Kansas (1), Louisiana (1), Maryland (1), Michigan (1), Minnesota (1), Nevada (29), New Jersey (6), New York (2), Ohio (1), Oklahoma (1), Oregon (1), Pennsylvania (1), Puerto Rico (1), South Carolina (1), Texas (1)&#160;and Wisconsin (1).  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Other Tobacco-Related </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for a discussion of &#8220;Lights&#8221; and &#8220;Ultra Lights&#8221; class action cases and medical monitoring class action cases pending against PM USA.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 25, 2021, PM USA and Altria are named as defendants, along with other cigarette manufacturers, in seven class actions filed in the Canadian provinces of Alberta, Manitoba, Nova Scotia, Saskatchewan, British Columbia and Ontario.  In Saskatchewan, British Columbia (two separate cases) and Ontario, plaintiffs seek class certification on behalf of individuals who suffer or have suffered from various diseases, including chronic obstructive pulmonary disease, emphysema, heart disease or cancer, after smoking defendants&#8217; cigarettes.  In the actions filed in Alberta, Manitoba and Nova Scotia, plaintiffs seek certification of classes of all individuals who smoked defendants&#8217; cigarettes.  In March 2019, all of these class actions were stayed as a result of three Canadian tobacco manufacturers (none of which is related to Altria or its subsidiaries) seeking protection under Canada&#8217;s Companies&#8217; Creditors Arrangement Act (which is similar to Chapter 11 bankruptcy in the U.S.).  The companies entered into these proceedings following a Canadian appellate court upholding two smoking and health class action verdicts against those companies totaling approximately CAD $13 billion.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the Distribution Agreement between Altria and PMI, which provides for indemnities for certain liabilities concerning tobacco products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Care Cost Recovery Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the health care cost recovery litigation, governmental entities seek reimbursement of health care cost expenditures allegedly caused by tobacco products and, in some cases, of future expenditures and damages.  Relief sought by some but not all plaintiffs includes punitive damages, multiple damages and other statutory damages and penalties, injunctions prohibiting alleged marketing and sales to minors, disclosure of research, disgorgement of profits, funding of anti-smoking programs, additional disclosure of nicotine yields, and payment of attorney and expert witness fees.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although there have been some decisions to the contrary, most judicial decisions in the U.S. have dismissed all or most health care cost recovery claims against cigarette manufacturers.  Nine federal circuit courts of appeals and eight state appellate courts, relying primarily on grounds that plaintiffs&#8217; claims were too remote, have ordered or affirmed dismissals of health care cost recovery actions.  The United States Supreme Court has refused to consider plaintiffs&#8217; appeals from the cases decided by five federal circuit courts of appeal.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the cases brought in the U.S., health care cost recovery actions have also been brought against tobacco industry participants, including PM USA and Altria, in Canada (10 cases),&#160;and other entities have stated that they are considering filing such actions.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the beginning of 2008, the Canadian Provinces of British Columbia, New Brunswick, Ontario, Newfoundland and Labrador, Quebec, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia have brought health care reimbursement claims against cigarette manufacturers.  PM USA is named as a defendant in the British Columbia and Quebec cases, while both Altria and PM USA are named as defendants in the New Brunswick, Ontario, Newfoundland and Labrador, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia cases.  The Nunavut Territory and Northwest Territory have passed legislation permitting similar claims, but lawsuits based on this legislation have not been filed.  All of these cases have been stayed pending resolution of proceedings in Canada involving three tobacco manufacturers (none of which are affiliated with Altria or its subsidiaries) under the Companies&#8217; Creditors Arrangement Act discussed above.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Other Smoking and Health Class Actions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above for a discussion of these proceedings.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the Distribution Agreement between Altria and PMI that provides for indemnities for certain liabilities concerning tobacco products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Settlements of Health Care Cost Recovery Litigation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 1998, PM USA and certain other tobacco product manufacturers entered into the 1998 Master Settlement Agreement (the &#8220;MSA&#8221;) with 46 states, the District of Columbia and certain U.S. territories to settle asserted and unasserted health care cost recovery and other claims.  PM USA and certain other tobacco product manufacturers had previously entered into agreements to settle similar claims brought by Mississippi, Florida, Texas and Minnesota (together with the MSA, the &#8220;State Settlement Agreements&#8221;).  The State Settlement Agreements require that the original participating manufacturers or &#8220;OPMs&#8221; (now PM USA, R.J. Reynolds and, with respect to certain brands, ITG Brands, LLC (&#8220;ITG&#8221;)) make annual payments of approximately $9.4 billion, subject to adjustments for several factors, including inflation, market share and industry volume.  In addition, the OPMs are required to pay settling plaintiffs&#8217; attorneys&#8217; fees, subject to an annual cap of $500 million.  For the three months ended September 30, 2021 and 2020, the aggregate amount recorded in cost of sales with respect to the State Settlement Agreements was approximately $1.1 billion and $1.2 billion, respectively.  For the nine months ended September 30, 2021 and 2020, the aggregate amount recorded in cost of sales with respect to the State Settlement Agreements was approximately $3.2 billion and $3.3 billion, respectively. These amounts include PM USA&#8217;s estimate of amounts related to NPM Adjustments discussed below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NPM Adjustment Disputes: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The &#8220;NPM Adjustment&#8221; is a reduction in MSA payments made by the OPMs and those manufacturers that are subsequent signatories to the MSA (collectively, the &#8220;participating manufacturers&#8221; or &#8220;PMs&#8221;) that </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applies if the PMs collectively lose at least a specified level of market share to non-participating manufacturers since 1997, subject to certain conditions and defenses.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The independent auditor (&#8220;IA&#8221;) appointed under the MSA has calculated that PM USA&#8217;s share of the maximum potential NPM Adjustments for 2004-2020 is (exclusive of interest or earnings):  $388 million for 2004; $181 million for 2005; $154 million for 2006; $185 million for 2007; $250 million for 2008; $211 million for 2009; $218 million for 2010; $166 million for 2011; $214 million for 2012; $224 million for 2013; $258 million for 2014; $313 million for 2015; $292 million for 2016; $302 million for 2017; $325 million for 2018; $444 million for 2019; and $572 million for 2020.  These maximum amounts will be reduced, likely substantially, to reflect the NPM Adjustment settlements discussed below, and potentially for current and future calculation disputes and other developments.  In addition, PM USA&#8217;s recovery of these amounts, even as reduced, is dependent upon subsequent determinations regarding state-specific defenses and disputes with other PMs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Settlements of NPM Adjustment Disputes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Multi-State Settlement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> By the end of 2018, PM USA entered into a multi-state settlement of NPM Adjustment disputes with a total of 36 MSA states and territories in which PM USA settled the NPM Adjustment disputes through 2022 with 35 of the 36 states, and through 2024 with one state.  Pursuant to the multi-state settlement, PM USA received $1.03 billion and expects to receive approximately $320 million in credits to offset PM USA&#8217;s MSA payments through 2029.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">New York Settlement.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2015, PM USA entered into a separate NPM Adjustment settlement with New York in which PM USA settled the NPM Adjustment disputes with New York in perpetuity.  PM USA received $373 million pursuant to the New York settlement and expects to receive annual credits applied against the MSA payments due to New York going forward.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Montana Settlement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In 2020, PM USA entered into a separate NPM Adjustment settlement with Montana in which PM USA settled the NPM Adjustment disputes with Montana through 2030.  This settlement resulted in a payment by PM USA of $4 million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Continuing NPM Adjustment Disputes with States That Have Not Settled</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">2004 NPM Adjustment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The PMs and the 10 states that have not settled the NPM Adjustment disputes are currently arbitrating NPM Adjustment disputes for 2004 in a multi-state arbitration.  Hearings for 9 of the 10 states have concluded.  In September 2021, the arbitration panels issued decisions finding that two states, Missouri and Washington, were not diligent in their enforcement of their escrow statutes in 2004 and, therefore, are subject to the NPM adjustment for 2004. The arbitration panels further found that the remaining seven states were diligent in their enforcement and, therefore, are not subject to the NPM adjustment for 2004.  The hearing for one remaining state is currently scheduled for February 2022.  Several issues remain to be resolved by the arbitration panels that will affect the final amount of the 2004 NPM adjustment PM USA and other PMs will receive. PM USA recorded $21 million as a reduction to cost of sales in the third quarter of 2021 for its estimate of the minimum amount of the 2004 NPM adjustment it will receive.  PM USA estimates it is entitled to interest of approximately $23 million in connection with the 2004 NPM adjustment, which it recorded as interest income in the third quarter of 2021.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">2005-2007 NPM Adjustments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The PMs and the 10 states that have not settled the NPM Adjustment disputes are currently arbitrating NPM Adjustment disputes before a single arbitration panel.  The arbitration encompasses <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM1NjYx_a644eea3-4823-4d15-b961-96400803386e">three</span> years, 2005-2007, for nine of the 10 states, and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NWU1NmZiMTZmOTRkYWU5ZWFjYzYzMWM1NmQ0NjZjL3NlYzoyOTVlNTZmYjE2Zjk0ZGFlOWVhY2M2MzFjNTZkNDY2Y18xMDAvZnJhZzozYWIwN2ZmOWI3YTc0MGJiODY1ZGFlNDhlYzQ4Nzc1Zi90ZXh0cmVnaW9uOjNhYjA3ZmY5YjdhNzQwYmI4NjVkYWU0OGVjNDg3NzVmXzM1NzEx_1f0bca57-bdd0-4faf-a0bb-bb958177008c">one</span> year, 2005, for one state.  As of October 25, 2021, no decisions have resulted from the arbitration.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Subsequent Years.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No assurance can be given as to when proceedings for 2008 and subsequent years will be scheduled or the precise form those proceedings will take.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Disputes Under the State Settlement Agreements: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The payment obligations of the tobacco product manufacturers that are parties to the State Settlement Agreements, as well as the allocations of any NPM Adjustments and related settlements, have been and may continue to be affected by R.J. Reynolds&#8217;s acquisition of Lorillard in 2015 and its related sale of certain cigarette brands to ITG (the &#8220;ITG transferred brands&#8221;).  PM USA filed motions to enforce the state settlement agreements in Florida, Minnesota, Texas and Mississippi in connection with various positions that R.J. Reynolds and ITG took with regard to the ITG transferred brands.  After various court decisions in each of those states that were favorable to PM USA, those motions to enforce have now been resolved either through settlement or exhaustion of appeals.  Despite these resolutions, PM USA continues to dispute the accuracy of certain submissions made by R.J. Reynolds and ITG concerning the calculation of certain payments relating to the ITG transferred brands and may pursue such claims.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the State of Mississippi filed a motion in Mississippi state court seeking to enforce the Mississippi State Settlement Agreement against PM USA, R.J. Reynolds and ITG concerning the tax rates used in the annual calculation of the net operating profit adjustment payments starting in 2018. The Mississippi state court held a hearing in October 2021 and has not yet issued a decision.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, PM USA and other PMs reached an agreement with several MSA states to waive the PMs&#8217; claim under the most favored nation provision of the MSA in connection with a settlement between those MSA states and a non-participating manufacturer, S&amp;M Brands, Inc. (&#8220;S&amp;M Brands&#8221;), under which the states released certain claims against S&amp;M Brands in exchange for receiving a portion of the funds S&amp;M Brands deposited into escrow accounts in those states pursuant to the states&#8217; escrow statutes.  In consideration for waiving its most favored nation claim, PM USA received approximately $32 million from the escrow funds paid to those MSA states under their settlement with S&amp;M Brands.  These funds were received in January 2021 and were recorded in Altria&#8217;s condensed consolidated statement of earnings for the first quarter of 2021 as a reduction to cost of sales.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Federal Government&#8217;s Lawsuit: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 1999, the United States government filed a lawsuit in the U.S. District Court for the District of Columbia against various cigarette manufacturers, including PM USA, and others, including Altria, asserting claims under three federal statutes.  The case ultimately proceeded only under the civil provisions of RICO.  In August 2006, the district court held that certain defendants, including Altria and PM USA, violated RICO and engaged in seven of the eight &#8220;sub-schemes&#8221; to defraud that the government had alleged.  Specifically, the court found that:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely denied, distorted and minimized the significant adverse health consequences of smoking;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants hid from the public that cigarette smoking and nicotine are addictive;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely denied that they control the level of nicotine delivered to create and sustain addiction;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely marketed and promoted &#8220;low tar/light&#8221; cigarettes as less harmful than full-flavor cigarettes;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely denied that they intentionally marketed to youth;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants publicly and falsely denied that ETS is hazardous to non-smokers; and </span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants suppressed scientific research.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The court did not impose monetary penalties on defendants, but ordered the following relief: (i)&#160;an injunction against &#8220;committing any act of racketeering&#8221; relating to the manufacturing, marketing, promotion, health consequences or sale of cigarettes in the United States; (ii)&#160;an injunction against participating directly or indirectly in the management or control of the Council for Tobacco Research, the Tobacco Institute, or the Center for Indoor Air Research, or any successor or affiliated entities of each; (iii)&#160;an injunction against &#8220;making, or causing to be made in any way, any material false, misleading, or deceptive statement or representation or engaging in any public relations or marketing endeavor that is disseminated to the United States public and that misrepresents or suppresses information concerning cigarettes;&#8221; (iv)&#160;an injunction against conveying any express or implied health message or health descriptors on cigarette packaging or in cigarette advertising or promotional material, including &#8220;lights,&#8221; &#8220;ultra lights&#8221; and &#8220;low tar,&#8221; which the court found could cause consumers to believe one cigarette brand is less hazardous than another brand; (v)&#160;the issuance of &#8220;corrective statements&#8221; in various media regarding the adverse health effects of smoking, the addictiveness of smoking and nicotine, the lack of any significant health benefit from smoking &#8220;low tar&#8221; or &#8220;light&#8221; cigarettes, defendants&#8217; manipulation of cigarette design to ensure optimum nicotine delivery and the adverse health effects of exposure to ETS; (vi)&#160;the disclosure on defendants&#8217; public document websites and in the Minnesota document repository of all documents produced to the government in the lawsuit or produced in any future court or administrative action concerning smoking and health until the third quarter of 2021, with certain additional requirements as to documents withheld from production under a claim of privilege or confidentiality; (vii)&#160;the disclosure of disaggregated marketing data to the government in the same form and on the same schedule as defendants now follow in disclosing such data to the FTC for a period of 10 years; (viii)&#160;certain restrictions on the sale or transfer by defendants of any cigarette brands, brand names, formulas or cigarette businesses within the U.S.; and (ix)&#160;payment of the government&#8217;s costs in bringing the action.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following several years of appeals relating to the content of the corrective statements remedy described above, in October 2017, the district court approved the parties&#8217; proposed consent order implementing corrective statements in newspapers and on television.  The corrective statements began appearing in newspapers and on television in the fourth quarter of 2017.  In April 2018, the parties reached agreement on the implementation details of the corrective statements on websites and onserts.  The corrective statements began appearing on websites in the second quarter of 2018 and the onserts began appearing in the fourth quarter of 2018.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014 and 2019, Altria and PM USA recorded provisions totaling approximately $36 million for the estimated costs of implementing the corrective communications remedy.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The requirements related to corrective statements at point-of-sale remain outstanding.  In May 2014, the district court ordered further briefing on the issue, which was completed in June 2014.  In May 2018, the parties submitted a joint status report and additional briefing on point-of-sale signage to the district court.  In May 2019, the district court ordered a hearing on the point-of-sale signage issue.  The hearing is currently scheduled for June 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, the United States government filed a motion with the district court asking for clarification as to whether the court-ordered injunction that applies to cigarettes also applies to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> a heated tobacco product used with the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device.  In August 2020, Altria and PM USA filed an opposition to the government&#8217;s motion and, in the alternative, a motion to </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">modify the injunction to make clear it does not apply to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Regardless of the district court&#8217;s decisions on the pending motions, the government has indicated it will not oppose a modification to the injunction that permits PM USA to use the Modified Risk Tobacco Product claim authorized by the United States Food and Drug Administration for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">E-vapor Product Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 25, 2021, Altria and/or its subsidiaries, including PM USA, were named as defendants in 53 class action lawsuits relating to JUUL e-vapor products.  JUUL is an additional named defendant in each of these lawsuits.  The theories of recovery include violation of RICO, fraud, failure to warn, design defect, negligence and unfair trade practices.  Plaintiffs seek various remedies, including compensatory and punitive damages and an injunction prohibiting product sales.  The 53 class action lawsuits include 28 cases involving plaintiffs whose claims were previously included in other class action complaints but were refiled as separate stand-alone class actions for procedural and other reasons</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and/or its subsidiaries, including PM USA, also have been named as defendants in other lawsuits involving JUUL e-vapor products, including 2,548 individual lawsuits, 350 &#8220;third party&#8221; lawsuits, which include school districts, state and local governments and tribal and healthcare organization lawsuits.  JUUL is an additional named defendant in each of these lawsuits.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the individual and class action lawsuits mentioned above were filed in federal court.  In October 2019, the United States Judicial Panel on Multidistrict Litigation ordered the coordination or consolidation of these lawsuits in the U.S. District Court for the Northern District of California for pretrial purposes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and its subsidiaries filed motions to dismiss certain claims in the class action and school district cases, including the federal RICO claim.  In October 2020, the U.S. District Court for the Northern District of California granted the motion to dismiss the RICO class action claim without prejudice.  Although it otherwise denied the motion, the court found that plaintiffs had not sufficiently alleged standing or causation with respect to their claim under California law.  The court also granted the motion to dismiss the RICO claim in the cases filed by various school districts, but denied the motion in all other respects.  The court gave plaintiffs the opportunity to amend their complaints to attempt to cure the deficiencies the court identified and plaintiffs filed their amended complaints in November 2020.  In January 2021, Altria and its subsidiaries filed a renewed motion to dismiss the RICO claim, which the court denied in April 2021.  In December 2020, the U.S. District Court for the Northern District of California and the parties selected 20 personal injury plaintiffs to be adjudicated as bellwether cases and in July 2021, the court set dates for the first four of such cases to commence in 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An additional group of cases is pending in California state courts.  In January 2020, the Judicial Council of California determined that this group of cases was appropriate for coordination and assigned the group to the Superior Court of California, Los Angeles County, for pretrial purposes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">JUUL also is named in a significant number of additional individual and class action lawsuits to which neither Altria nor any of its subsidiaries is currently named.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three of the &#8220;third party&#8221; lawsuits noted above against Altria and/or its subsidiaries and JUUL, as an additional named defendant, were initiated, individually, by the attorneys general of Alaska, Hawaii and Minnesota alleging violations of state consumer protection and other similar laws.  JUUL is also named in other attorneys general lawsuits to which neither Altria nor any of its subsidiaries is currently named.  JUUL settled one such lawsuit by agreeing to (i) pay approximately $40 million and (ii) certain restrictions on its sales and marketing activities.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, RAI Strategic Holdings, Inc. and R.J. Reynolds Vapor Co., which are affiliates of R.J. Reynolds, filed a lawsuit against Altria, PM USA, Altria Client Services LLC, PMI and its affiliate, Philip Morris Products S.A., in the United States District Court for the Eastern District of Virginia.  The lawsuit asserts claims of patent infringement based on the sale of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the United States.  Plaintiffs seek various remedies, including preliminary and permanent injunctive relief, treble damages and attorneys&#8217; fees.  Altria and PMI have been dismissed from the lawsuit.  In June 2020, the remaining defendants filed a motion to dismiss certain of plaintiffs&#8217; claims and also filed counterclaims against the plaintiffs for infringement of various patents owned by the remaining defendants. The case was stayed in December 2020 due to the COVID-19 pandemic; however, the stay was lifted with respect to defendants&#8217; counterclaims in February 2021 and a trial is currently scheduled for April 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also in April 2020, a related action was filed against the same defendants by the same plaintiffs, as well as R.J. Reynolds, with the United States International Trade Commission (&#8220;ITC&#8221;).  There, the plaintiffs also allege patent infringement, but the remedies sought include a prohibition on the importation of the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and component parts into the United States and on the sale of any such products previously imported into the United States.  No damages are recoverable in the proceedings before the ITC.  In May 2021, an administrative law judge found that the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infringe plaintiffs&#8217; patents and recommended to the ITC a ban on the importation of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the infringing components into the United States.  In September 2021, the ITC affirmed the administrative law judge&#8217;s initial determination and issued a limited exclusion order barring the importation of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">electronic device,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the infringing components into the United States and a cease and desist order barring domestic sales, marketing and distribution of these imported products.  The orders will become effective on November 29, 2021 unless rejected by the Biden Administration prior to that date.  Defendants may appeal the orders to the United States Court of Appeals for the Federal Circuit; however, any ban on importation or on the sale, marketing and distribution of previously imported product is unlikely to be stayed pending the conclusion of the appeal.  Due to this litigation, in October 2021, PM USA announced plans to begin removing the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">electronic device and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> from the marketplace as it awaits the outcome of administrative review.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An additional unrelated patent infringement case regarding the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device was filed in November 2020 in the United States District Court for the Northern District of Georgia against PM USA and Philip Morris Products S.A. seeking damages and equitable relief.  In February 2021, defendants filed a motion to dismiss the lawsuit, which the court granted in July 2021.  In August 2021, plaintiff filed a motion to amend the complaint.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Antitrust Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the FTC issued an administrative complaint against Altria and JUUL alleging that Altria&#8217;s 35% investment in JUUL and the associated agreements constitute an unreasonable restraint of trade in violation of Section 1 of the Sherman Antitrust Act of 1890 (&#8220;Sherman Act&#8221;) and Section 5 of the Federal Trade Commission Act of 1914, and substantially lessened competition in violation of Section 7 of the Clayton Antitrust Act (&#8220;Clayton Act&#8221;).  If the FTC&#8217;s challenge is successful, the FTC may order a broad range of remedies, including divestiture of Altria&#8217;s minority investment in JUUL, rescission of the transaction and all associated agreements, a requirement of FTC approval of future agreements related to the development, manufacture, distribution or sale of e-vapor products and prohibition against any officer or director of either Altria or JUUL serving on the other party&#8217;s board of directors or attending meetings of the other party&#8217;s board of directors.  The administrative trial was held before an FTC administrative law judge in June 2021.  The post-trial briefing was completed in October 2021.  The administrative law judge&#8217;s decision is subject to review by the FTC on its own motion or at the request of any party.  The FTC then issues its ruling, which may be appealed to any United States Court of Appeals.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also as of October 25, 2021, 16 putative class action lawsuits have been filed against Altria and JUUL in the United States District Court for the Northern District of California.  The lawsuits initially named, in addition to the two companies, certain senior executives and certain members of the board of directors of both companies as defendants; however, those individuals currently or formerly affiliated with Altria were later dismissed. In November 2020 these lawsuits were consolidated into three complaints (one on behalf of direct purchasers, one on behalf of indirect purchasers and one on behalf of indirect resellers).  The consolidated lawsuits, as amended, cite the FTC administrative complaint and allege that Altria and JUUL violated Sections 1, 2 and/or 3 of the Sherman Act and Section 7 of the Clayton Act and various state antitrust, consumer protection and unjust enrichment laws by restraining trade and/or substantially lessening competition in the U.S. closed-system electronic cigarette market.  Plaintiffs seek various remedies, including treble damages, attorneys&#8217; fees, a declaration that the agreements between Altria and JUUL are invalid, divestiture of Altria&#8217;s minority investment in JUUL and rescission of the transaction.  Altria filed a motion to dismiss these lawsuits in January 2021.  In August 2021, the United States District Court for the Northern District of California denied Altria&#8217;s motion to dismiss except with respect to plaintiffs&#8217; claims for injunctive and equitable relief.  However, plaintiffs were granted the opportunity to replead such claims by the trial court, which plaintiffs did in September 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, Altria exercised its rights to convert its non-voting JUUL shares to voting shares.  However, pending the outcome of the FTC administrative complaint, Altria currently does not intend to exercise its additional governance rights obtained upon the conversion, including the right to elect directors to JUUL&#8217;s board or to vote its JUUL shares other than as a passive investor.  For further discussion of Altria&#8217;s rights in the event of share conversion, see Note 4.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities - Investment in JUUL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shareholder Class Action and Shareholder Derivative Lawsuits</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholder Class Action:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  In October and December 2019, two purported Altria shareholders filed putative class action lawsuits against Altria, Howard A. Willard III, Altria&#8217;s former Chairman and Chief Executive Officer, and William F. Gifford, Jr., Altria&#8217;s former Vice Chairman and Chief Financial Officer and current Chief Executive Officer, in the United States District Court for the Eastern District of New York.  In December 2019, the court consolidated the two lawsuits into a single proceeding.  The consolidated lawsuit was subsequently transferred to the United States District Court for the Eastern District of Virginia.  The lawsuit asserts claims under Sections 10(b) and 20(a) and under Rule 10b-5 of the Exchange Act.  In April 2020, JUUL, its founders and some of its current and former executives were added to the lawsuit.  The claims allege false and misleading statements and omissions relating to Altria&#8217;s investment in JUUL.  Plaintiffs seek various remedies, including damages and attorneys&#8217; fees.  In July 2020, the defendants filed motions to dismiss plaintiffs&#8217; claims, which the district court denied in March 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal Shareholder Derivative Lawsuits: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In August 2020, two purported Altria shareholders filed separate derivative lawsuits in the United States District Court for the Northern District of California on behalf of themselves and Altria, against Mr. Willard, Mr. Gifford, JUUL and certain of its executives and officers.  These derivative lawsuits relate to Altria&#8217;s </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investment in JUUL, and assert claims of breach of fiduciary duty by the Altria defendants and aiding and abetting in that alleged breach of fiduciary duty by the remaining defendants.  In March 2021, the United States District Court for the Northern District of California granted defendants&#8217; motion to transfer both lawsuits to the United States District Court for the Eastern District of Virginia.  Three additional federal derivative lawsuits were filed in October 2020, January 2021 and March 2021, respectively, in the United States District Court for the Eastern District of Virginia against Mr. Willard, Mr. Gifford, Mr. Crosthwaite, certain members of Altria&#8217;s Board of Directors, JUUL, its founders and some of its current and former executives.  These suits assert various claims, including breach of fiduciary duty, unjust enrichment, waste of corporate assets and violations of certain federal securities laws.  The remedies sought in these lawsuits include damages, disgorgement of profits, reformation of Altria&#8217;s corporate governance and internal procedures, and attorneys&#8217; fees.  In April 2021, the court consolidated the five cases pending in the Eastern District of Virginia into a single action.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State Shareholder Derivative Lawsuits:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Six derivative lawsuits have been filed in Virginia state courts against Mr. Willard, Mr. Gifford, Mr. Crosthwaite (Altria&#8217;s former Chief Growth Officer and JUUL&#8217;s current Chief Executive Officer), certain members of Altria&#8217;s Board of Directors, JUUL, its founders and some of its current and former executives.  The lawsuits were filed in September 2020, May 2021, June 2021, July 2021, August 2021 and August 2021, respectively.  The lawsuits assert various claims, including breach of fiduciary duty, and seek remedies similar to those sought by plaintiffs in the cases pending in federal court in the Eastern District of Virginia.  In July 2021 and September 2021, the court consolidated the first four of these state derivative cases into a single action.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Other Tobacco-Related Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lights/Ultra Lights&#8221; Cases and Other Smoking and Health Class Actions: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plaintiffs have sought certification of their cases as class actions, alleging among other things, that the uses of the terms &#8220;Lights&#8221; and/or &#8220;Ultra Lights&#8221; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment or breach of warranty, and have sought injunctive and equitable relief, including restitution and, in certain cases, punitive damages.  These class actions have been brought against PM USA and, in certain instances, Altria or its other subsidiaries, on behalf of individuals who purchased and consumed various brands of cigarettes.  Defenses raised in these cases include lack of misrepresentation, lack of causation, injury and damages, the statute of limitations, non-liability under state statutory provisions exempting conduct that complies with federal regulatory directives, and the First Amendment. Twenty-one state courts in 23 &#8220;Lights&#8221; cases have refused to certify class actions, dismissed class action allegations, reversed prior class certification decisions or have entered judgment in favor of PM USA.  As of October 25, 2021, two &#8220;Lights/Ultra Lights&#8221; class actions are pending in U.S. state court.  Neither case is active.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 25, 2021, one smoking and health case alleging personal injury or seeking court-supervised programs or ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, is pending in a U.S. state court.  The case is currently inactive.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UST Litigation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UST and/or its tobacco subsidiaries have been named in a number of individual tobacco and health lawsuits over time.  Plaintiffs&#8217; allegations of liability in these cases have been based on various theories of recovery, such as negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of implied warranty, addiction and breach of consumer protection statutes.  Plaintiffs have typically sought various forms of relief, including compensatory and punitive damages, and certain equitable relief, including but not limited to disgorgement.  Defenses raised in these cases include lack of causation, assumption of the risk, comparative fault and/or contributory negligence, and statutes of limitations.  As of October 25, 2021, there is one case pending against USSTC.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental Regulation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and its subsidiaries (and former subsidiaries) are subject to various federal, state and local laws and regulations concerning the discharge of materials into the environment, or otherwise related to environmental protection, including, in the U.S.: the Clean Air Act, the Clean Water Act, the Resource Conservation and Recovery Act and the Comprehensive Environmental Response, Compensation and Liability Act (commonly known as &#8220;Superfund&#8221;), which can impose joint and several liability on each responsible party.  Subsidiaries (and former subsidiaries) of Altria are involved in several matters subjecting them to potential costs of remediation and natural resource damages under Superfund or other laws and regulations.  Altria&#8217;s subsidiaries expect to continue to make capital and other expenditures in connection with environmental laws and regulations.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria provides for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are probable and can be reasonably estimated.  Such accruals are adjusted as new information develops or circumstances change.  Other than those amounts, it is not possible to reasonably estimate the cost of any environmental remediation and compliance efforts that subsidiaries of Altria may undertake in the future.  In the opinion of management, however, compliance with environmental laws and regulations, including the payment of any remediation costs or damages and the making of related expenditures, has not had, and is not expected to have, a material adverse effect on Altria&#8217;s consolidated results of operations, capital expenditures, financial position or cash flows.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees and Other Similar Matters</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, certain subsidiaries of Altria have agreed to indemnify a limited number of third parties in the event of future litigation.  At September&#160;30, 2021, Altria and certain of its subsidiaries (i) had $48 million of unused letters of credit obtained in the ordinary course of business; (ii) were contingently liable for guarantees related to their own performance, including $24 million for surety bonds;  and (iii) had a redeemable noncontrolling interest of $39 million recorded on its condensed consolidated balance sheet.  In addition, from time to time, subsidiaries of Altria issue lines of credit to affiliated entities.  These items have not had, and are not expected to have, a significant impact on Altria&#8217;s liquidity.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of a distribution agreement between Altria and PMI (the &#8220;Distribution Agreement&#8221;), entered into as a result of Altria&#8217;s 2008 spin-off of its former subsidiary PMI, liabilities concerning tobacco products will be allocated based in substantial part on the manufacturer.  PMI will indemnify Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for liabilities related to tobacco products manufactured by PM USA, excluding tobacco products contract manufactured for PMI.  Altria does not have a related liability recorded on its condensed consolidated balance sheet at September&#160;30, 2021 as the fair value of this indemnification is insignificant.  PMI has agreed not to seek indemnification with respect to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patent litigation discussed above under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Other Tobacco-Related Litigation - IQOS Litigation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">excluding the patent infringement case filed with the United States District Court for the Northern District of Georgia.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA has issued guarantees relating to Altria&#8217;s obligations under its outstanding debt securities, borrowings under its $3.0 billion Credit Agreement and amounts outstanding under its commercial paper program.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798026434680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Guidance Not Yet Adopted<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">New Accounting Guidance Not Yet Adopted</a></td>
<td class="text">New Accounting Guidance Not Yet Adopted<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, Altria:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:16.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.232%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Standards</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective Date for Public Entity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect on Financial Statements </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2020-06 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Accounting for Convertible Instruments and Contracts in an Entity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">s Own Equity</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#8217;s own equity.&#160; Key provisions of the guidance include reducing the number of accounting models, simplifying the earnings per share calculations and expanding the disclosures related to convertible instruments.</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021.  </span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Altria&#8217;s adoption of this guidance is not expected to have a material impact on its consolidated financial statements and related  disclosures. </span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (c)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798026649592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background and Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment, Policy</a></td>
<td class="text">Altria accounts for its investments in ABI and Cronos under the equity method of accounting using a one-quarter lag.  Altria accounts for its equity investment in JUUL under the fair value option.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation, Policy</a></td>
<td class="text">The interim condensed consolidated financial statements of Altria are unaudited.  It is the opinion of Altria&#8217;s management that all adjustments necessary for a fair statement of the interim results presented have been reflected in the interim condensed consolidated financial statements.  All such adjustments were of a normal recurring nature.  Net revenues and net earnings for any interim period are not necessarily indicative of results that may be expected for the entire year.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements, Policy</a></td>
<td class="text"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021, Altria adopted Accounting Standards Update (&#8220;ASU&#8221;) 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU No. 2019-12&#8221;).  This guidance removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes.  The adoption of ASU No. 2019-12 did not have a material impact on Altria&#8217;s condensed consolidated financial statements.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, on January 1, 2021, Altria adopted ASU No. 2020-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Clarifying the Interactions between Topic 321, Topic 323, and Topic 815</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU No. 2020-01&#8221;).  This guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities.  The adoption of ASU No. 2020-01 did not have a material impact on Altria&#8217;s condensed consolidated financial statements.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of issued accounting guidance applicable to, but not yet adopted by, Altria, see Note 13. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Accounting Guidance Not Yet Adopted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:16.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.232%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Standards</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective Date for Public Entity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect on Financial Statements </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2020-06 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Accounting for Convertible Instruments and Contracts in an Entity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">s Own Equity</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#8217;s own equity.&#160; Key provisions of the guidance include reducing the number of accounting models, simplifying the earnings per share calculations and expanding the disclosures related to convertible instruments.</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021.  </span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Altria&#8217;s adoption of this guidance is not expected to have a material impact on its consolidated financial statements and related  disclosures. </span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_CashDiscountsPolicyTextBlock', window );">Cash Discounts</a></td>
<td class="text">In 2020, a majority of Altria&#8217;s businesses offered cash discounts to customers for prompt payment and calculated cash discounts as a percentage of the list price based on historical experience and agreed-upon payment terms.  Beginning in the first quarter of 2021 for USSTC and the third quarter of 2021 for PM USA, cash discounts were calculated as a flat rate per unit, based on agreed-upon payment terms.  Altria&#8217;s businesses record receivables net of the cash discounts on Altria&#8217;s condensed consolidated balance sheets.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity Method Investments</a></td>
<td class="text"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria accounts for its investment in ABI under the equity method of accounting because Altria has the ability to exercise significant influence over the operating and financial policies of ABI, including having active representation on ABI&#8217;s board of directors and certain ABI board committees.  Through this representation, Altria participates in ABI policy making processes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria reports its share of ABI&#8217;s results using a one-quarter lag because ABI&#8217;s results are not available in time for Altria to record them in the concurrent period.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of Altria&#8217;s equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI&#8217;s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy.  Altria can convert its Restricted Shares to ordinary shares at its discretion.  Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2019, the fair value of Altria&#8217;s equity investment in ABI declined below its carrying value and has not recovered.   At December&#160;31, 2020, the fair value of Altria&#8217;s equity investment in ABI was $13.8 billion (carrying value of $16.7 billion), which was less than its carrying value by approximately 17%. In preparing its financial statements for the period ended December&#160;31, 2020, Altria evaluated the factors related to the fair value decline, including the impact on the fair value of ABI&#8217;s shares during the COVID-19 pandemic, which has negatively impacted ABI&#8217;s business.  Altria evaluated the duration and magnitude of the fair value decline, ABI&#8217;s financial condition and near-term prospects and Altria&#8217;s intent and ability to hold its </span></div>investment in ABI until recovery.  Altria concluded that the decline in fair value of its investment in ABI at December 31, 2020 below its carrying value was temporary and, therefore, no impairment was recorded at that time.Following the consideration of the same factors, Altria, in preparing its financial statements for the period ended September&#160;30, 2021, concluded that the decline in fair value of its investment in ABI at September&#160;30, 2021 was other than temporary. As a result, Altria recorded a non-cash, pre-tax impairment charge of $6.2 billion for the nine and three months ended September&#160;30, 2021, which was recorded to income (losses) from equity investments in its condensed consolidated statements of earnings (losses).  This impairment charge reflects the difference between the fair value of Altria&#8217;s investment in ABI using ABI&#8217;s share price at September&#160;30, 2021 and the carrying value of Altria&#8217;s equity investment in ABI at September&#160;30, 2021.  Altria continues to have confidence in ABI&#8217;s (i) long-term strategies, (ii) premium global brands, (iii) experienced management team and (iv) capability to successfully navigate its near-term challenges. Altria further expects that the impacts related to the COVID-19 pandemic that have negatively impacted ABI&#8217;s global business are transitory, but now also anticipates that the full recovery to carrying value will take longer than previously expected. This is evidenced by the resumption of declines in fair value during the third quarter of 2021, following positive share price momentum during the first half of 2021.  At September&#160;30, 2021, prior to recording the impairment charge, the fair value of Altria&#8217;s investment in ABI was below the carrying value by approximately 35%, which represents an additional 18% reduction in ABI&#8217;s share price since December&#160;31, 2020.  The fair value of Altria&#8217;s equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos&#8217;s common shares and was classified in Level 1 of the fair value hierarchy.  In September 2021, the fair value of Altria&#8217;s equity method investment in Cronos declined below its carrying value.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EnvironmentalCostsPolicy', window );">Environmental Regulation</a></td>
<td class="text">Altria and its subsidiaries (and former subsidiaries) are subject to various federal, state and local laws and regulations concerning the discharge of materials into the environment, or otherwise related to environmental protection, including, in the U.S.: the Clean Air Act, the Clean Water Act, the Resource Conservation and Recovery Act and the Comprehensive Environmental Response, Compensation and Liability Act (commonly known as &#8220;Superfund&#8221;), which can impose joint and several liability on each responsible party.  Subsidiaries (and former subsidiaries) of Altria are involved in several matters subjecting them to potential costs of remediation and natural resource damages under Superfund or other laws and regulations.  Altria&#8217;s subsidiaries expect to continue to make capital and other expenditures in connection with environmental laws and regulations.Altria provides for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are probable and can be reasonably estimated.  Such accruals are adjusted as new information develops or circumstances change.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_CashDiscountsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Discounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_CashDiscountsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EnvironmentalCostsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for obligations that resulted from improper or other-than normal operation of a long-lived asset in the past. This accounting policy may address (1) whether the related remediation costs are expensed or capitalized, (2) whether the obligation is measured on a discounted basis, (3) the event, situation, or set of circumstances that generally triggers recognition of loss contingencies arising from the entity's environmental remediation-related obligations, and (4) the timing of recognition of any recoveries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=2175709<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 55<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=6571209&amp;loc=d3e13669-110860<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13185-110859<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13231-110859<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EnvironmentalCostsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798026794856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from Contract with Customer (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue from Contract with Customer</a></td>
<td class="text">Altria&#8217;s businesses record an allowance for returned goods, which is included in other accrued liabilities on Altria&#8217;s condensed consolidated balance sheets.  While all of Altria&#8217;s tobacco operating companies sell tobacco products with dates relative to freshness as printed on product packaging, it is USSTC&#8217;s policy to accept authorized sales returns from its customers for products that have passed such dates due to the limited shelf life of USSTC&#8217;s MST and snus products.  Altria&#8217;s businesses record estimated sales returns, which are based principally on historical volume and return rates, as a reduction to revenues.  Actual sales returns will differ from estimated sales returns to the extent actual results differ from estimated assumptions.  Altria&#8217;s businesses reflect differences between actual and estimated sales returns in the period in which the actual amounts become known.  These differences, if any, have not had a material impact on Altria&#8217;s condensed consolidated financial statements.  All returned goods are destroyed upon return and not included in inventory.  Consequently, Altria&#8217;s businesses do not record an asset for their right to recover goods from customers upon return.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798027818088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background and Basis of Presentation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Schedule of Share Repurchase Activity</a></td>
<td class="text"><div style="padding-right:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Altria&#8217;s share repurchase activity for the nine and three months ended September&#160;30, 2021 was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.294%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of shares repurchased</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate cost of shares repurchased</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">972</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">322</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share of shares repurchased</span></div></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48.17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48.35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798028610680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assets Held for Sale (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Disposal Groups, Including Discontinued Operations</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The major classes of assets and liabilities of IWS classified as held for sale at September 30, 2021 were as follows:</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net of accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,531&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,490&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued pension costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets and liabilities held for sale, net</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798124330632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTableTextBlock', window );">Investment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of Altria&#8217;s investments consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.885%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,651&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,705</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">932</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,874</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,529&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Atria&#8217;s investment in Cronos at September 30, 2021 consisted of Altria&#8217;s equity method investment in Cronos ($897 million), the Cronos warrant ($32 million) and the Fixed-price Preemptive Rights ($3 million), (collectively, &#8220;Investment in Cronos&#8221;).  The Investment in Cronos at December 31, 2020 consisted of Altria&#8217;s equity method investment in Cronos ($1,010 million), the Cronos warrant ($139 million) and the Fixed-price Preemptive Rights ($24 million).  See below for further discussion.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Equity Method Investments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (losses) from equity investments accounted for under the equity method of accounting and fair value option consisted of the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.952%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.184%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,644)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,036)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(418)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (losses) from investments under equity method of accounting</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,789)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,015)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(472)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (losses) from equity investments</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,789)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,915)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(472)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the nine and three months ended September 30, 2021, Altria recorded a non-cash, pre-tax impairment charge of $6,157 million related to its equity investment in ABI. See below for further discussion.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balance of Altria&#8217;s investment in JUUL, which is classified in Level 3 of the fair value hierarchy:</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) included in income (losses) from equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,705</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 325<br> -URI http://asc.fasb.org/topic&amp;trid=2197064<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -URI http://asc.fasb.org/topic&amp;trid=75115024<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI http://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798022997800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Pre-tax Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses</a></td>
<td class="text"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides (i) the aggregate notional amounts of foreign currency contracts and (ii) the aggregate carrying value and fair value of foreign currency denominated debt:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts (notional amounts)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,066&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,905</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,288</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,687&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>For the nine and three months ended September&#160;30, 2021 and 2020, Altria recorded non-cash, pre-tax unrealized gains (losses), representing the changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant, as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.278%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-price Preemptive Rights</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(21)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(107)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(128)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(135)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pre-tax effects of Altria&#8217;s net investment hedges on accumulated other comprehensive losses and the condensed consolidated statements of earnings (losses) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.391%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.826%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in Accumulated Other Comprehensive Losses</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in <br/>Net Earnings (Losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in Accumulated Other Comprehensive Losses</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in <br/>Net Earnings (Losses)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">118</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">286</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(243)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">118</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the aggregate carrying value and fair value of Altria&#8217;s total long-term debt:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28,127</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31,037</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,682&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value Measurement Inputs and Valuation Techniques</a></td>
<td class="text">The fair values of the Fixed-price Preemptive Rights and Cronos warrant are estimated using Black-Scholes option-pricing models, adjusted for observable inputs (which are classified in Level 1 of the fair value hierarchy), including share price, and unobservable inputs, including <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">probability factors and weighting of expected life, volatility levels and risk-free interest rates (which are classified in Level 3 of the fair value hierarchy) based on the following assumptions at:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.448%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fixed-price Preemptive Rights</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Warrant</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">C$7.15</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$8.84</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">C$7.15</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$8.84</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.81 year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.05 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.43 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.18 years</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67.32%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.68%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67.32%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.68%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.24%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.39%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.21%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Based on the closing market price for Cronos common stock on the Toronto Stock Exchange on the date indicated.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Based on the weighted-average expected life of the Fixed-price Preemptive Rights (with a range from approximately 0.25 year to 4.00 years at September&#160;30, 2021 and 0.25 year to 5 years at December&#160;31, 2020) and the March 8, 2023 expiration date of the Cronos warrant.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Based on a blend of historical volatility of the underlying equity security and implied volatility from traded options on the underlying equity security at September&#160;30, 2021.  Based on a blend of historical volatility levels of the underlying equity security and peer companies at December&#160;31, 2020.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Based on the implied yield currently available on Canadian Treasury zero coupon issues (with a range from approximately 0.12% to 0.89% at September&#160;30, 2021 and 0.06% to 0.39% at December&#160;31, 2020) weighted for the remaining expected life of the Fixed-price Preemptive Rights.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Based on the implied yield currently available on Canadian Treasury zero coupon issues and the expected life of the Cronos warrant.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Based on Cronos&#8217;s expected dividend payments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock', window );">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balance of the Fixed-price Preemptive Rights and Cronos warrant, which are classified in Level 3 of the fair value hierarchy:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax earnings (losses) recognized in net earnings (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax earnings (losses) recognized in net earnings (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of Derivative Liabilities at Fair Value</a></td>
<td class="text">The fair values of Altria&#8217;s derivative financial instruments on a gross basis included on the condensed consolidated balance sheets were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.209%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></div></td><td colspan="30" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cronos warrant</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed-price Preemptive Rights</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for net investment hedges of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798027818088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of Net Periodic Benefit (Income) Cost</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit (income) cost consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.094%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended <br/>September 30,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">139</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(393)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(376)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(131)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">99</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(income) cost</span></div></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(101)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(34)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798028610680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Losses) per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings (losses) per share (&#8220;EPS&#8221;) were calculated using the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.952%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses) attributable to Altria</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">851</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,722)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(952)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Distributed and undistributed earnings attributable to share-based awards</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) for basic and diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">843</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,537&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,724)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(953)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares for basic EPS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,849</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,842</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: contingently issuable performance stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares for diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,849</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,859&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,842</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,859&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798128606328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Earnings/Losses (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.377%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,420)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,938)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,341)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">432</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">685</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,152</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(269)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">314</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">534</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">883</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">92</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">69</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(39)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">383</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">495</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">911</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,037)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,443)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,430)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.377%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,043)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,604)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,602)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">215</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">221</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">167</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">164</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">161</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">172</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,037)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,443)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,430)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.377%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,192)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(693)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,864)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,302)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(951)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,023)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(928)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(917)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,165)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,621)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,781)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.377%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,150)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,606)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,774)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,165)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,621)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,781)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Reflects the remeasurement impact of salaried retiree healthcare plan amendments.  For further discussion, see Note 6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans.</span></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Primarily reflects Altria&#8217;s share of ABI&#8217;s currency translation adjustments and the impact of Altria&#8217;s designated net investment hedges.  For further discussion of designated net investment hedges, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock', window );">Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings (losses):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.806%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.037%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Plans: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">124</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">92</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments and Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Amounts are included in net defined benefit plan costs.  For further information related to defined benefit plans, see Note 6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans.</span></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Amounts are included in (income) losses from equity investments.  For further information related to equity investments, see Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798028157912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,275</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,975</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,945</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">626</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">494</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">177</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,758</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,849&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,786</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,123&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings (losses) before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,901</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,753</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,269</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">405</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(255)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,827</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,951</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(869)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(266)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(649)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit income, excluding </span></div><div style="padding-left:31.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">service cost</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">152</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">63</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (losses) from equity investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,789)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,915)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of JUUL equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on Cronos-related financial instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(135)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) before income taxes</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,544</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,349&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,302)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock', window );">Schedule of Non-Participating Manufacturer Adjustment Items</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Non-Participating Manufacturer (&#8220;NPM&#8221;) Adjustment Items:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Pre-tax (income) for NPM adjustment items was recorded to Altria&#8217;s condensed consolidated statements of earnings (losses) as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.903%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products segment</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(53)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(21)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(44)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock', window );">Schedule of Tobacco and Health and Certain Other Litigation Items</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Tobacco and Health and Certain Other Litigation Items:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax charges related to tobacco and health and certain other litigation items were recorded in Altria&#8217;s condensed consolidated statements of earnings (losses) as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products segment</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">148</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">105</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Non-Participating Manufacturer Adjustment Items</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798026447240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt Instruments</a></td>
<td class="text"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, Altria completed debt tender offers to purchase for cash certain of its long-term senior unsecured notes in an aggregate principal amount of $4,042 million.  Details of the debt tender offers are as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal Amount of Notes Purchased</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.850% Notes due 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">795</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.950% Notes due 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">132</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000% Notes due 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">624</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.800% Notes due 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">655</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.400% Notes due 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">430</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.800% Notes due 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,094</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.950% Notes due 2038</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.200% Notes due 2039</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.200% Notes due 2059</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">229</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,042</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798026443448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes update (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_SummaryOfIncomeTaxesTableTextBlock', window );">Summary of Income Taxes</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Earnings (losses) before income taxes, provision (benefit) for income taxes and income tax rates consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,544</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,349</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,302)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision (benefit) for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">693</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,817</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(582)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax rate</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195.1)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Summary of Valuation Allowance</a></td>
<td class="text"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following chart provides a reconciliation of the beginning and ending valuation allowances for the period ended September&#160;30, 2021:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.130%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,817&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to valuation allowance charged to income tax expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">264</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions to valuation allowance credited to income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,004</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_SummaryOfIncomeTaxesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary of Income Taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_SummaryOfIncomeTaxesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798027827560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock', window );">Schedule of Contingencies</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in Altria&#8217;s accrued liability for tobacco and health and certain other litigation items, including related interest costs, for the periods specified below are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liability for tobacco and health and certain other  litigation items at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax charges for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">142</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">99</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related interest costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liability for tobacco and health and certain other  litigation items at end of period</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">97</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">97</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes amounts related to certain other litigation and pre-trial resolution of certain tobacco and health cases.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below lists the number of certain tobacco-related cases pending in the U.S. against PM USA and/or Altria as of October 25, 2021, October 27, 2020 and October 28, 2019:</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">October 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">October 27, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">October 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Smoking and Health Cases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">179</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Cost Recovery Actions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-vapor Cases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,951</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Tobacco-Related Cases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes 18 cases filed in Illinois, 17 cases filed in New Mexico, 40 cases filed in Massachusetts and 70 non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">cases filed in Florida.  Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">case (these </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> progeny cases are discussed below in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Engle Class Action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  Also does not include 1,471 cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (&#8220;ETS&#8221;).  The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Broin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages.  Class members were prohibited from filing individual lawsuits after 2000 under the court-approved settlement.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation - Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> below.</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes 53 class action lawsuits, 2,548 individual lawsuits and 350 &#8220;third party&#8221; lawsuits relating to JUUL e-vapor products, which include school districts, state and local government, tribal and healthcare organization lawsuits.  JUUL is an additional named defendant in each of these lawsuits. The 53 class action lawsuits include 28 cases in the Northern District of California (&#8220;Multidistrict Litigation&#8221; or &#8220;MDL&#8221;) involving plaintiffs whose claims were previously included in other class action complaints but were refiled as separate stand-alone class actions for procedural and other reasons.</span></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms &#8220;Lights&#8221; and &#8220;Ultra Lights&#8221; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.</span></div><div style="margin-bottom:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Currently Pending Engle Cases with Verdicts Against PM USA </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.488%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensatory Damages </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Punitive Damages <br/>(PM USA)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Appeal Status</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Lipp</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$15 million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$28 million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defendant&#8217;s post-trial motions denied.  Defendant plans to appeal.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Garcia</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2021</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mistrial</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendant to Third District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Duignan</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pinellas</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$12&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendants to Second District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cuddihee</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Duval</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendant to First District Court of Appeal pending. </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Rintoul </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Caprio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 2019 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$9&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$74 million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by plaintiff and defendants to Fourth District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Gloger</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 2019 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$15&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$11 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendants to Third District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">McCall</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1&#160;million (&lt;$1&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New trial ordered on punitive damages.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Neff</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$4&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth District Court of Appeal reversed the judgment against defendants and remanded for a new trial. Plaintiff's motion for rehearing was denied.</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.488%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensatory Damages </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Punitive Damages <br/>(PM USA)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Appeal Status</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Mahfuz</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$12&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$10 million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth District Court of Appeal reversed the judgment against defendants and remanded for a new trial.   Plaintiff's motion for rehearing was denied.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Holliman</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defendant&#8217;s appeal to Third District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Chadwell</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third District Court of Appeal affirmed the compensatory damages award.  PM USA petitioned Florida Supreme Court for review.  Case stayed pending Florida Supreme Court decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Prentice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Kaplan</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2018</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Fourth District Court of Appeal affirmed the verdict and  reaffirmed the verdict on rehearing.  Defendants sought review of the decision before the Florida Supreme Court and the court stayed the case pending its decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Sheffield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">R. Douglas</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 2017</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Duval</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Awaiting entry of final judgment by the trial court.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Sommers</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2017</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third District Court of Appeal affirmed compensatory damages award and granted new trial on punitive damages.  Florida Supreme Court denied PM USA&#8217;s petition for review of the Third District Court of Appeal&#8217;s decision.  PM USA paid approximately $1 million for the compensatory damages award and awaits the new trial on punitive damages.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">  The trial court stayed the new trial on punitive damages pending Florida Supreme Court&#8217;s decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Sheffield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cooper (Blackwood)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5&#160;million </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(&lt;$1&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth District Court of Appeal affirmed judgment and granted a new trial on punitive damages.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">D. Brown</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2015</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal Court - Middle District of Florida</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$8&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$9&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendant to U.S. Court of Appeals for the Eleventh Circuit stayed pending Florida Supreme Court decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Prentice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PM USA&#8217;s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Plaintiff&#8217;s verdict following a retrial of an initial verdict in favor of plaintiff.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> PM USA is not a defendant in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Prentice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Sheffield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Prentice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Sheffield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">are discussed below in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle Progeny Appellate Issues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Plaintiff was granted an award of approximately $3 million in fees, costs and interest that PM USA appealed.  The Florida Third District Court of Appeals affirmed the award and PM USA paid the award amount in March 2021.</span></div><div style="margin-bottom:3pt;margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle Cases Concluded Within Past 12 Months </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:14.465%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.437%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.675%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.850%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.346%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.265%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrual Date</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Amount<br/>(if any)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Berger (Cote)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2014</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal Court - Middle District of Florida</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth quarter of 2018 and first quarter of 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$29 million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Santoro</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2017</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA, R.J. Reynolds and Liggett Group</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Second quarter of 2020 and first quarter of 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2021</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In six cases in which PM USA paid the judgments more than a year ago, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Naugle,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Gore</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">M. Brown,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Jordan,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Theis </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Landi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, plaintiffs were awarded approximately $8 million, $2 million, $8 million, $4 million, $1 million and $3 million in fees and costs, respectively.  PM USA has appealed in all of these cases, except </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Theis </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Landi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.  In</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> M. Brown</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, in March 2021 the Florida First District Court of Appeals affirmed the fee award and reversed the pre-judgment interest award and, in April 2021, PM USA paid $8.2 million in satisfaction of the fee award and post-judgment interest. In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Theis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, PM USA paid $1 million in satisfaction of fees and costs in May 2021 and, in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Landi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, PM USA paid approximately $1.5 million in satisfaction of fees, costs and interest in July 2021 (R.J. Reynolds paid approximately $1.5 million of the approximately $3 million award).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14472-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14453-108349<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14394-108349<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12053-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798026664648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Guidance Not Yet Adopted (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Recent Accounting Guidance Not Yet Adopted</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, Altria:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:16.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.232%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Standards</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective Date for Public Entity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect on Financial Statements </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2020-06 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Accounting for Convertible Instruments and Contracts in an Entity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">s Own Equity</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#8217;s own equity.&#160; Key provisions of the guidance include reducing the number of accounting models, simplifying the earnings per share calculations and expanding the disclosures related to convertible instruments.</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021.  </span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Altria&#8217;s adoption of this guidance is not expected to have a material impact on its consolidated financial statements and related  disclosures. </span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e765-108305<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e725-108305<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798038355464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background and Basis of Presentation (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">5 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Apr. 29, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Oct. 28, 2021</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries', window );">Payments to acquire additional interest in subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_CommonStockDividendIncreasePercentage', window );">Common stock, dividend increase, percentage</a></td>
<td class="nump">4.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared (usd per share)</a></td>
<td class="nump">$ 0.90<span></span>
</td>
<td class="nump">$ 0.90<span></span>
</td>
<td class="nump">$ 0.86<span></span>
</td>
<td class="nump">$ 0.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.62<span></span>
</td>
<td class="nump">$ 2.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_CommonStockDividendRateAnnualPerShare', window );">Common stock, dividend rate, annual (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mo_July2019ShareRepurchaseProgramMember', window );">July 2019 Share Repurchase Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Planned share repurchase program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount', window );">Stock repurchase program, rescinded authorized repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mo_January2021ShareRepurchaseProgramMember', window );">January 2021 Share Repurchase Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Planned share repurchase program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining authorized repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,028,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,028,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mo_January2021ShareRepurchaseProgramMember', window );">January 2021 Share Repurchase Program [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Planned share repurchase program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_StockRepurchaseProgramIncreaseAuthorizedAmount', window );">Stock repurchase program, increase authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=mo_HelixInnovationsLLCMember', window );">Helix Innovations LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions', window );">Subsidiary ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_NoncontrollingInterestRemainingInterestPurchasedByParent', window );">Noncontrolling interest, remaining interest purchased by parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_CommonStockDividendIncreasePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Dividend Increase, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_CommonStockDividendIncreasePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_CommonStockDividendRateAnnualPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Dividend Rate, Annual, Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_CommonStockDividendRateAnnualPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_NoncontrollingInterestRemainingInterestPurchasedByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Remaining Interest Purchased By Parent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_NoncontrollingInterestRemainingInterestPurchasedByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_StockRepurchaseProgramIncreaseAuthorizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Program, Increase Authorized Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_StockRepurchaseProgramIncreaseAuthorizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Program, Rescinded Authorized Repurchase Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of noncontrolling interest during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of subsidiary's or equity method investee's stock owned by parent immediately after all stock transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mo_July2019ShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mo_July2019ShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mo_January2021ShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mo_January2021ShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mo_HelixInnovationsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mo_HelixInnovationsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798032818632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background and Basis of Presentation (Share Repurchase Table) (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Aggregate cost of shares repurchased</a></td>
<td class="nump">$ 322<span></span>
</td>
<td class="nump">$ 972<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mo_January2021ShareRepurchaseProgramMember', window );">January 2021 Share Repurchase Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Total number of shares repurchased (shares)</a></td>
<td class="nump">6.7<span></span>
</td>
<td class="nump">20.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Aggregate cost of shares repurchased</a></td>
<td class="nump">$ 322<span></span>
</td>
<td class="nump">$ 972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price per share of shares repurchased (usd per share)</a></td>
<td class="nump">$ 48.35<span></span>
</td>
<td class="nump">$ 48.17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mo_January2021ShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mo_January2021ShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798038859384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues from Contracts with Customers (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">$ 260,000,000<span></span>
</td>
<td class="nump">$ 301,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuePerformanceObligationDescriptionOfTiming', window );">Expected period for satisfaction of performance obligation</a></td>
<td class="text">three days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ReceivablesNetCurrentIncludingAssetsHeldForSale', window );">Receivables, Net Current, Including Assets Held For Sale</a></td>
<td class="nump">$ 144,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables</a></td>
<td class="nump">36,000,000<span></span>
</td>
<td class="nump">137,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables', window );">Allowance for doubtful accounts, receivables</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale, Not Discontinued Operations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Disposal group, including discontinued operation, accounts, notes and loans receivable, net</a></td>
<td class="nump">$ 108,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ReceivablesNetCurrentIncludingAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Receivables, Net Current, Including Assets Held For Sale</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ReceivablesNetCurrentIncludingAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuePerformanceObligationDescriptionOfTiming">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of timing for satisfying performance obligation in contract with customer. Includes, but is not limited to, as services are rendered, and upon shipment, delivery or completion of service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuePerformanceObligationDescriptionOfTiming</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798029753752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assets Held for Sale (Narrative) (Details) - Disposal Group, Held-for-sale, Not Discontinued Operations [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 01, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Ste. Michelle Transaction [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Disposal group, including discontinued operation, consideration</a></td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mo_SteMichelleTransactionMember', window );">Ste. Michelle Transaction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Pre-tax charge for adjustment to record the assets and liabilities at fair value less costs to sell</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts', window );">Disposal group disposition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts', window );">Disposal group, total pre-tax charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mo_SteMichelleTransactionMember', window );">Ste. Michelle Transaction [Member] | Wine Segment [Member] | Marketing Administration And Research Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts', window );">Disposal group, total pre-tax charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mo_SteMichelleTransactionMember', window );">Ste. Michelle Transaction [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestiture of businesses</a></td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operations, Disposition Related Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operations, Marketing, Administration And Research Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mo_SteMichelleTransactionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mo_SteMichelleTransactionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mo_SteMichelleTransactionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mo_SteMichelleTransactionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=mo_MarketingAdministrationAndResearchCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=mo_MarketingAdministrationAndResearchCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798038591848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assets Held for Sale (Summary of Major Classes of Assets and Liabilities Classified as Held for Sale) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Assets held for sale</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">$ 1,490<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities held for sale</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">295<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale, Not Discontinued Operations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Assets held for sale</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Receivables</a></td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mo_SteMichelleTransactionsMember', window );">Ste. Michelle Transaction [Member] | Disposal Group, Held-for-sale, Not Discontinued Operations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Assets held for sale</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Receivables</a></td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent', window );">Inventories</a></td>
<td class="nump">715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent', window );">Property, plant and equipment, net of accumulated depreciation</a></td>
<td class="nump">407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent', window );">Other intangible assets, net</a></td>
<td class="nump">236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets', window );">Other assets</a></td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross', window );">Total assets</a></td>
<td class="nump">1,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve', window );">Reserve</a></td>
<td class="num">(41)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">1,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities held for sale</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationCurrent', window );">Accrued pension costs</a></td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities', window );">Other liabilities</a></td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Assets and liabilities held for sale, net</a></td>
<td class="nump">$ 1,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Assets, Current, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Assets, Current, Reserve</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as defined benefit plan benefit obligations attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mo_SteMichelleTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mo_SteMichelleTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798038995992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments in Equity Securities (Summary of Investments) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">$ 13,874<span></span>
</td>
<td class="nump">$ 19,529<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember', window );">ABI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity securities</a></td>
<td class="nump">11,237<span></span>
</td>
<td class="nump">16,651<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember', window );">JUUL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityInvestmentFairValueOption', window );">JUUL</a></td>
<td class="nump">1,705<span></span>
</td>
<td class="nump">1,705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member', window );">Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity securities</a></td>
<td class="nump">932<span></span>
</td>
<td class="nump">1,173<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember', window );">Equity Contract, Warrant [Member] | Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value, gross asset</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">139<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember', window );">Equity Contract, Preemptive Rights [Member] | Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value, gross asset</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity securities</a></td>
<td class="nump">$ 897<span></span>
</td>
<td class="nump">$ 1,010<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityInvestmentFairValueOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Investment, Fair Value Option</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityInvestmentFairValueOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_InvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Investments [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_InvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798034942312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities (Earnings in Equity Securities) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Income (losses) from investments under equity method of accounting</a></td>
<td class="num">$ (6,015,000,000)<span></span>
</td>
<td class="num">$ (472,000,000)<span></span>
</td>
<td class="num">$ (5,789,000,000)<span></span>
</td>
<td class="num">$ (306,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_IncomeLossFromEquityInvestments', window );">Income (losses) from equity investments</a></td>
<td class="num">(5,915,000,000)<span></span>
</td>
<td class="num">(472,000,000)<span></span>
</td>
<td class="num">(5,789,000,000)<span></span>
</td>
<td class="num">(306,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember', window );">ABI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Income (losses) from investments under equity method of accounting</a></td>
<td class="num">(6,036,000,000)<span></span>
</td>
<td class="num">(418,000,000)<span></span>
</td>
<td class="num">(5,644,000,000)<span></span>
</td>
<td class="num">(306,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentImpairment', window );">Equity method investment, impairment</a></td>
<td class="nump">6,157,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,157,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member', window );">Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Income (losses) from investments under equity method of accounting</a></td>
<td class="nump">21,000,000<span></span>
</td>
<td class="num">(54,000,000)<span></span>
</td>
<td class="num">(145,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember', window );">JUUL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_IncomeLossFromEquityInvestmentsFairValueOption', window );">JUUL</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Impairment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_IncomeLossFromEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Equity Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_IncomeLossFromEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_IncomeLossFromEquityInvestmentsFairValueOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Equity Investments, Fair Value Option</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_IncomeLossFromEquityInvestmentsFairValueOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798039423352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities (Investment in ABI Narrative) (Details) - USD ($)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure', window );">Fair value of equity investment</a></td>
<td class="nump">$ 11,200,000,000<span></span>
</td>
<td class="nump">$ 11,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity', window );">Equity method investment, difference between carrying amount and underlying equity</a></td>
<td class="nump">$ 14,000,000<span></span>
</td>
<td class="nump">$ 14,000,000<span></span>
</td>
<td class="nump">$ 77,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember', window );">ABI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted', window );">Number of restricted shares owned (in shares)</a></td>
<td class="nump">185<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentNumberofSharesOwnedCommon', window );">Number of ordinary shares owned (in shares)</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_RestrictedSharesLockupPeriod', window );">Restricted shares, lock-up period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity securities</a></td>
<td class="nump">$ 11,237,000,000<span></span>
</td>
<td class="nump">$ 11,237,000,000<span></span>
</td>
<td class="nump">$ 16,651,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage', window );">Difference between carrying amount and fair value, percentage (approximately)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentImpairment', window );">Equity method investment, impairment</a></td>
<td class="nump">$ 6,157,000,000<span></span>
</td>
<td class="nump">$ 6,157,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentReductionInSharePricePercentage', window );">Equity method investment, reduction in share price, percentage</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity', window );">Equity method investment, difference between carrying amount and underlying equity</a></td>
<td class="nump">$ 5,100,000,000<span></span>
</td>
<td class="nump">$ 5,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | ABI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure', window );">Fair value of equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,800,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Impairment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentNumberofSharesOwnedCommon">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Number of Shares Owned, Common</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentNumberofSharesOwnedCommon</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Number of Shares Owned, Restricted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentNumberofSharesOwnedRestricted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentReductionInSharePricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Reduction In Share Price, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentReductionInSharePricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_RestrictedSharesLockupPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restricted Shares, Lock-up Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_RestrictedSharesLockupPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investments accounted under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125513658&amp;loc=d3e32014-111567<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798035025016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities (Investment in JUUL Narrative) (Details) - USD ($)<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount', window );">Equity securities without readily determinable fair value, downward price adjustment, cumulative amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment of JUUL equity securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,600,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember', window );">JUUL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage', window );">Equity securities, ownership percentage</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityInvestmentsFairValueOptionVotingShares', window );">Equity investments, fair value option, voting shares (in shares)</a></td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount', window );">Equity securities without readily determinable fair value, upward price adjustment, cumulative amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment of JUUL equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_IncomeLossFromEquityInvestmentsFairValueOption', window );">Income (loss) from equity investments, fair value option</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityInvestmentsFairValueOptionVotingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Investments, Fair Value Option, Voting Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityInvestmentsFairValueOptionVotingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_IncomeLossFromEquityInvestmentsFairValueOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Equity Investments, Fair Value Option</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_IncomeLossFromEquityInvestmentsFairValueOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative loss from downward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798023183400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities (JUUL Investment Classified as Level 3) (Details) - Equity Method Investments, Fair Value Option [Member] - JUUL [Member]<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Balance at beginning of period</a></td>
<td class="nump">$ 1,705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Unrealized gains (losses) included in income (losses) from equity investments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Balance at end of period</a></td>
<td class="nump">$ 1,705<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=mo_EquityMethodInvestmentsFairValueOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=mo_EquityMethodInvestmentsFairValueOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798034232728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities (Investment in Cronos Narrative) (Details)<br> $ / shares in Units, shares in Thousands, $ in Millions, $ in Billions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 25, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity', window );">Equity method investment, difference between carrying amount and underlying equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member', window );">Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43.50%<span></span>
</td>
<td class="nump">41.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentNumberofSharesOwnedCommon', window );">Number of ordinary shares owned (approximately) (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage', window );">Equity method investment, difference between carrying amount and fair value, percentage (approximately)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember', window );">Equity Contract, Preemptive Rights [Member] | Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentPricePerShareIfExercised', window );">Equity method investment, shares purchased, (CAD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase', window );">Equity method investment, number of shares eligible for purchase (approximately) (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentAggregateExercisePrice', window );">Equity method investment, aggregate exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember', window );">Equity Contract, Preemptive Rights [Member] | Cronos [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentAggregateExercisePrice', window );">Equity method investment, aggregate exercise price</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember', window );">Equity Contract, Warrant [Member] | Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentPricePerShareIfExercised', window );">Equity method investment, shares purchased, (CAD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase', window );">Equity method investment, number of shares eligible for purchase (approximately) (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase', window );">Equity method investment, percentage of shares eligible for purchase (approximately)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentAggregateExercisePrice', window );">Equity method investment, aggregate exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember', window );">Equity Contract, Warrant [Member] | Cronos [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentAggregateExercisePrice', window );">Equity method investment, aggregate exercise price</a></td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember', window );">Equity Contract, Warrant And Equity Contract, Preemptive Rights [Member] | Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage', window );">Equity method investment, warrant exercised, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentAggregateExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Aggregate Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentAggregateExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Number of Shares Eligible For Purchase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentNumberofSharesOwnedCommon">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Number of Shares Owned, Common</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentNumberofSharesOwnedCommon</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Percentage of Shares Eligible For Purchase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentPricePerShareIfExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Price Per Share If Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentPricePerShareIfExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Warrant Exercised, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_InvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Investments [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_InvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798038738984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Aggregate Notional Amounts, Aggregate Fair Values and Carrying Values) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying value</a></td>
<td class="nump">$ 28,127<span></span>
</td>
<td class="nump">$ 29,471<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mo_ForeignCurrencyDenominatedDebtMember', window );">Foreign Currency Denominated Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying value</a></td>
<td class="nump">4,905<span></span>
</td>
<td class="nump">5,171<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value</a></td>
<td class="nump">5,288<span></span>
</td>
<td class="nump">5,687<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Currency Contract [Member] | Net Investment Hedging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Foreign currency contracts (notional amounts)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,066<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_ForeignCurrencyDenominatedDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_ForeignCurrencyDenominatedDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798039077144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Aggregate Fair Value and Carrying Value) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying value</a></td>
<td class="nump">$ 28,127<span></span>
</td>
<td class="nump">$ 29,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value</a></td>
<td class="nump">$ 31,037<span></span>
</td>
<td class="nump">$ 34,682<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798034622968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Fair Value Using Black-Scholes Option-Pricing Model) (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>year </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>year </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Share price [Member] | Fixed-price Preemptive Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input | $ / shares</a></td>
<td class="nump">7.15<span></span>
</td>
<td class="nump">8.84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Share price [Member] | Cronos Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input | $ / shares</a></td>
<td class="nump">7.15<span></span>
</td>
<td class="nump">8.84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Expected Life [Member] | Fixed-price Preemptive Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">0.81<span></span>
</td>
<td class="nump">1.05<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Expected Life [Member] | Cronos Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">1.43<span></span>
</td>
<td class="nump">2.18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected Volatility [Member] | Fixed-price Preemptive Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">0.6732<span></span>
</td>
<td class="nump">0.8068<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected Volatility [Member] | Cronos Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">0.6732<span></span>
</td>
<td class="nump">0.8068<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk Free Interest Rate [Member] | Fixed-price Preemptive Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">0.0024<span></span>
</td>
<td class="nump">0.0013<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk Free Interest Rate [Member] | Fixed-price Preemptive Rights [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">0.0012<span></span>
</td>
<td class="nump">0.0006<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk Free Interest Rate [Member] | Fixed-price Preemptive Rights [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">0.0089<span></span>
</td>
<td class="nump">0.0039<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk Free Interest Rate [Member] | Cronos Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">0.0039<span></span>
</td>
<td class="nump">0.0021<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Expected Dividend Yield [Member] | Fixed-price Preemptive Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Expected Dividend Yield [Member] | Cronos Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=mo_MeasurementInputWeightedAverageExpectedTermMember', window );">Weighted Average Expected Term [Member] | Fixed-price Preemptive Rights [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">0.25<span></span>
</td>
<td class="nump">0.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=mo_MeasurementInputWeightedAverageExpectedTermMember', window );">Weighted Average Expected Term [Member] | Fixed-price Preemptive Rights [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">4.00<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=mo_MeasurementInputWeightedAverageExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=mo_MeasurementInputWeightedAverageExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798026653736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Beginning and Ending Balances of Fixed-price Preemptive Rights and Warrants) (Details) - Fair Value, Inputs, Level 3 [Member] - Equity Contract [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward', window );"><strong>Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Balance at begging of period</a></td>
<td class="nump">$ 163<span></span>
</td>
<td class="nump">$ 303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings', window );">Pre-tax earnings (losses) recognized in net earnings (losses)</a></td>
<td class="num">(128)<span></span>
</td>
<td class="num">(140)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Balance at end of period</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 163<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EquityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EquityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798029971592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Fair Value Derivative Financial Instruments) (Details) - Net Investment Hedging [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value of Assets</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair Value of Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Foreign currency contracts [Member] | Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value of Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair Value of Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Foreign currency contracts [Member] | Designated as Hedging Instrument [Member] | Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value of Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Foreign currency contracts [Member] | Designated as Hedging Instrument [Member] | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value of Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Foreign currency contracts [Member] | Designated as Hedging Instrument [Member] | Other Accrued Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair Value of Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Foreign currency contracts [Member] | Designated as Hedging Instrument [Member] | Other Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair Value of Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Equity Contract [Member] | Not Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value of Assets</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">163<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Cronos Warrant [Member] | Not Designated as Hedging Instrument [Member] | Investments In Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value of Assets</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">139<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Fixed-price Preemptive Rights [Member] | Not Designated as Hedging Instrument [Member] | Investments In Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value of Assets</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mo_OtherAccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mo_OtherAccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EquityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EquityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mo_InvestmentsInEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mo_InvestmentsInEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798033930984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Pre-tax Unrealized Gains (Losses)) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Unrealized gain (loss) on derivatives</a></td>
<td class="num">$ (135)<span></span>
</td>
<td class="num">$ (105)<span></span>
</td>
<td class="num">$ (128)<span></span>
</td>
<td class="num">$ (202)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember', window );">Fixed-price Preemptive Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Unrealized gain (loss) on derivatives</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember', window );">Cronos Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Unrealized gain (loss) on derivatives</a></td>
<td class="num">$ (118)<span></span>
</td>
<td class="num">$ (80)<span></span>
</td>
<td class="num">$ (107)<span></span>
</td>
<td class="num">$ (148)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798039176312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details) - Net Investment Hedging [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Gain (Loss) Recognized in Accumulated Other Comprehensive Losses</a></td>
<td class="nump">$ 118<span></span>
</td>
<td class="num">$ (272)<span></span>
</td>
<td class="nump">$ 286<span></span>
</td>
<td class="num">$ (243)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax', window );">Gain (Loss) Recognized in Net Earnings (Losses)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Gain (Loss) Recognized in Accumulated Other Comprehensive Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(66)<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax', window );">Gain (Loss) Recognized in Net Earnings (Losses)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_ForeignCurrencyDenominatedDebtMember', window );">Foreign currency denominated debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Gain (Loss) Recognized in Accumulated Other Comprehensive Losses</a></td>
<td class="nump">118<span></span>
</td>
<td class="num">(206)<span></span>
</td>
<td class="nump">270<span></span>
</td>
<td class="num">(215)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax', window );">Gain (Loss) Recognized in Net Earnings (Losses)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_ForeignCurrencyDenominatedDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_ForeignCurrencyDenominatedDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798029900824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Schedule Of Components Of Net Periodic Benefit Cost (Income)) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="nump">188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(131)<span></span>
</td>
<td class="num">(125)<span></span>
</td>
<td class="num">(393)<span></span>
</td>
<td class="num">(376)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Net loss</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">108<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Prior service cost (credit)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit (income) cost</a></td>
<td class="num">(34)<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Net loss</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Prior service cost (credit)</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit (income) cost</a></td>
<td class="num">$ (7)<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798034360472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Defined benefit plan, plan assets, contributions by employer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear', window );">Anticipated additional employer contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Defined benefit plan, plan assets, contributions by employer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations', window );">Decrease in accrued postretirement health care cost liability</a></td>
<td class="nump">$ 432,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear', window );">Anticipated additional employer contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for pension and other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798038419032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Losses) per Share (Basic and Diluted Earnings Per Share) (Details) - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (losses) attributable to Altria</a></td>
<td class="num">$ (2,722)<span></span>
</td>
<td class="num">$ (952)<span></span>
</td>
<td class="nump">$ 851<span></span>
</td>
<td class="nump">$ 2,543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted', window );">Less: Distributed and undistributed earnings attributable to share-based awards</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Earnings (losses) for basic EPS</a></td>
<td class="num">(2,724)<span></span>
</td>
<td class="num">(953)<span></span>
</td>
<td class="nump">843<span></span>
</td>
<td class="nump">2,537<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Earnings (losses) for diluted EPS</a></td>
<td class="num">$ (2,724)<span></span>
</td>
<td class="num">$ (953)<span></span>
</td>
<td class="nump">$ 843<span></span>
</td>
<td class="nump">$ 2,537<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares for basic EPS (in shares)</a></td>
<td class="nump">1,842,000<span></span>
</td>
<td class="nump">1,858,000<span></span>
</td>
<td class="nump">1,849,000<span></span>
</td>
<td class="nump">1,858,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable', window );">Plus: contingently issuable performance stock units (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares for diluted EPS (in shares)</a></td>
<td class="nump">1,842,000<span></span>
</td>
<td class="nump">1,859,000<span></span>
</td>
<td class="nump">1,849,000<span></span>
</td>
<td class="nump">1,859,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Participating Securities, Distributed and Undistributed Earnings (Loss), Basic and Diluted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shares issuable for little or no cash consideration upon the satisfaction of certain conditions (contingently issuable shares) are considered outstanding common shares and included in the computation of basic Earnings Per Share as of the date that all necessary conditions have been satisfied (in essence, when issuance of the shares is no longer contingent). Outstanding common shares that are contingently returnable (that is, subject to recall) are treated in the same manner as contingently issuable shares. Contingently issuable shares include shares that (a) will be issued in the future upon the satisfaction of specified conditions, (b) have been placed in escrow and all or part must be returned if specified conditions are not met, or (c) have been issued but the holder must return all or part if specified conditions are not met. The number of contingently issuable shares is determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798039275352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 3,259<span></span>
</td>
<td class="nump">$ 5,786<span></span>
</td>
<td class="nump">$ 2,925<span></span>
</td>
<td class="nump">$ 6,319<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="nump">172<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">911<span></span>
</td>
<td class="num">(917)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(1,265)<span></span>
</td>
<td class="nump">3,232<span></span>
</td>
<td class="num">(1,265)<span></span>
</td>
<td class="nump">3,232<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Losses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(3,602)<span></span>
</td>
<td class="num">(3,774)<span></span>
</td>
<td class="num">(4,341)<span></span>
</td>
<td class="num">(2,864)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (losses) before reclassifications</a></td>
<td class="nump">221<span></span>
</td>
<td class="num">(123)<span></span>
</td>
<td class="nump">1,152<span></span>
</td>
<td class="num">(1,302)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Deferred income taxes</a></td>
<td class="num">(57)<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="num">(269)<span></span>
</td>
<td class="nump">279<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</a></td>
<td class="nump">164<span></span>
</td>
<td class="num">(82)<span></span>
</td>
<td class="nump">883<span></span>
</td>
<td class="num">(1,023)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified to net earnings (losses)</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Deferred income taxes</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to net earnings (losses), net of deferred income taxes</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="nump">172<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">911<span></span>
</td>
<td class="num">(917)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(3,430)<span></span>
</td>
<td class="num">(3,781)<span></span>
</td>
<td class="num">(3,430)<span></span>
</td>
<td class="num">(3,781)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Benefit Plans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(2,043)<span></span>
</td>
<td class="num">(2,150)<span></span>
</td>
<td class="num">(2,420)<span></span>
</td>
<td class="num">(2,192)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (losses) before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="nump">432<span></span>
</td>
<td class="num">(75)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Deferred income taxes</a></td>
<td class="num">(9)<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="num">(118)<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
<td class="nump">314<span></span>
</td>
<td class="num">(56)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified to net earnings (losses)</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Deferred income taxes</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to net earnings (losses), net of deferred income taxes</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="nump">6<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(2,037)<span></span>
</td>
<td class="num">(2,165)<span></span>
</td>
<td class="num">(2,037)<span></span>
</td>
<td class="num">(2,165)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember', window );">ABI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(1,604)<span></span>
</td>
<td class="num">(1,606)<span></span>
</td>
<td class="num">(1,938)<span></span>
</td>
<td class="num">(693)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (losses) before reclassifications</a></td>
<td class="nump">215<span></span>
</td>
<td class="num">(71)<span></span>
</td>
<td class="nump">685<span></span>
</td>
<td class="num">(1,211)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Deferred income taxes</a></td>
<td class="num">(48)<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="num">(151)<span></span>
</td>
<td class="nump">260<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</a></td>
<td class="nump">167<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="nump">534<span></span>
</td>
<td class="num">(951)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified to net earnings (losses)</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Deferred income taxes</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to net earnings (losses), net of deferred income taxes</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="nump">161<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="nump">495<span></span>
</td>
<td class="num">(928)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(1,443)<span></span>
</td>
<td class="num">(1,621)<span></span>
</td>
<td class="num">(1,443)<span></span>
</td>
<td class="num">(1,621)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Currency Translation Adjustments and Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">45<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (losses) before reclassifications</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Deferred income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified to net earnings (losses)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Deferred income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to net earnings (losses), net of deferred income taxes</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798037086136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Earnings/Losses (Reclassifications) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Net periodic benefit income, excluding service cost</a></td>
<td class="num">$ (63)<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
<td class="num">$ (152)<span></span>
</td>
<td class="num">$ (58)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">(Income) losses from equity investments</a></td>
<td class="nump">6,015<span></span>
</td>
<td class="nump">472<span></span>
</td>
<td class="nump">5,789<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings (losses)</a></td>
<td class="nump">2,720<span></span>
</td>
<td class="nump">956<span></span>
</td>
<td class="num">(851)<span></span>
</td>
<td class="num">(2,532)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings (losses)</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Benefit Plans [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Net periodic benefit income, excluding service cost</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember', window );">Net loss [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Net periodic benefit income, excluding service cost</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember', window );">Prior service cost/credit [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Net periodic benefit income, excluding service cost</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember', window );">ABI [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">(Income) losses from equity investments</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Currency Translation Adjustments and Other [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">(Income) losses from equity investments</a></td>
<td class="num">$ (1)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798038909480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Segment Data Schedule) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 6,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,123<span></span>
</td>
<td class="nump">$ 19,758<span></span>
</td>
<td class="nump">$ 19,849<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">2,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,160<span></span>
</td>
<td class="nump">8,827<span></span>
</td>
<td class="nump">8,292<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest and other debt expense, net</a></td>
<td class="num">(266)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(310)<span></span>
</td>
<td class="num">(869)<span></span>
</td>
<td class="num">(893)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">$ (649)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(649)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Net periodic benefit income, excluding service cost</a></td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_IncomeLossFromEquityInvestments', window );">Income (losses) from equity investments</a></td>
<td class="num">(5,915)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(472)<span></span>
</td>
<td class="num">(5,789)<span></span>
</td>
<td class="num">(306)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment of JUUL equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,600)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,600)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain (loss) on Cronos-related financial instruments</a></td>
<td class="num">(135)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(105)<span></span>
</td>
<td class="num">(128)<span></span>
</td>
<td class="num">(202)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) before income taxes</a></td>
<td class="num">(3,302)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(324)<span></span>
</td>
<td class="nump">1,544<span></span>
</td>
<td class="nump">4,349<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember', window );">Smokeable Products Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">5,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,313<span></span>
</td>
<td class="nump">17,275<span></span>
</td>
<td class="nump">17,522<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles', window );">OCI</a></td>
<td class="nump">2,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,789<span></span>
</td>
<td class="nump">7,901<span></span>
</td>
<td class="nump">7,609<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember', window );">Oral Tobacco Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">640<span></span>
</td>
<td class="nump">1,945<span></span>
</td>
<td class="nump">1,901<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles', window );">OCI</a></td>
<td class="nump">405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">436<span></span>
</td>
<td class="nump">1,269<span></span>
</td>
<td class="nump">1,297<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember', window );">Wine Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157<span></span>
</td>
<td class="nump">494<span></span>
</td>
<td class="nump">434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles', window );">OCI</a></td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="num">(347)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">All Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles', window );">OCI</a></td>
<td class="num">(30)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
<td class="num">(63)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Segment Reconciling Items [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles</a></td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">General corporate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General corporate expenses</a></td>
<td class="num">$ (135)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (60)<span></span>
</td>
<td class="num">$ (255)<span></span>
</td>
<td class="num">$ (150)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_IncomeLossFromEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Equity Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_IncomeLossFromEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Income (Loss) Before General Corporate Expenses and Amortization Of Intangibles</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798034962856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Non-Participating Manufacturer Adjustment Items) (Details) - Non-Participating Manufacturer Arbitration Panel Decision - NPM Adjustment to Cost Of Sales [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Loss (gain) related to litigation settlement</a></td>
<td class="num">$ (44)<span></span>
</td>
<td class="num">$ (76)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_NonParticipatingManufacturerArbitrationPanelDecisionMember', window );">Operating Income (Loss) [Member] | Smokeable Products Segment [Member] | PM USA [Member] | Operating Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Loss (gain) related to litigation settlement</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_NonParticipatingManufacturerArbitrationPanelDecisionMember', window );">Interest and other debt expense, net [Member] | Segment Reconciling Items [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Loss (gain) related to litigation settlement</a></td>
<td class="num">$ (23)<span></span>
</td>
<td class="num">$ (23)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_NonParticipatingManufacturerArbitrationPanelDecisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_NonParticipatingManufacturerArbitrationPanelDecisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=mo_NpmAdjustmentToCostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=mo_NpmAdjustmentToCostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingIncomeLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingIncomeLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=mo_InterestAndOtherDebtExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=mo_InterestAndOtherDebtExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798030256216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Schedule of Tobacco and Health and Certain Other Litigation Items) (Details) - Tobacco and Health Litigation Cases [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems', window );"><strong>Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="nump">$ 105<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">$ 148<span></span>
</td>
<td class="nump">$ 76<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_TobaccoandHealthLitigationCasesMember', window );">Corporate, Non-Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems', window );"><strong>Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_TobaccoandHealthLitigationCasesMember', window );">Segment Reconciling Items [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems', window );"><strong>Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Operating Segments [Member] | Smokeable Products Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems', window );"><strong>Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">$ 72<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_TobaccoandHealthLitigationCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_TobaccoandHealthLitigationCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798038418072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">$ 1,858<span></span>
</td>
<td class="nump">$ 1,961<span></span>
</td>
<td class="nump">$ 5,348<span></span>
</td>
<td class="nump">$ 5,909<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale, Not Discontinued Operations [Member] | Ste. Michelle Transaction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts', window );">Disposal group, total pre-tax charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts', window );">Disposal group disposition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=mo_COVID19Member', window );">COVID-19 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember', window );">Oral Tobacco Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Business combination, acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember', window );">Oral Tobacco Segment [Member] | COVID-19 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember', window );">Smokeable Products Segment [Member] | COVID-19 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember', window );">Wine Segment [Member] | Disposal Group, Held-for-sale, Not Discontinued Operations [Member] | Ste. Michelle Transaction [Member] | Marketing Administration And Research Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts', window );">Disposal group, total pre-tax charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mo_WineBusinessStrategicResetMember', window );">Wine Business Strategic Reset [Member] | Inventory Disposal Costs and Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">395<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mo_WineBusinessStrategicResetMember', window );">Wine Business Strategic Reset [Member] | Inventory Write-Off [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mo_WineBusinessStrategicResetMember', window );">Wine Business Strategic Reset [Member] | Purchase Commitment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operations, Disposition Related Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operations, Marketing, Administration And Research Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mo_SteMichelleTransactionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mo_SteMichelleTransactionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=mo_COVID19Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=mo_COVID19Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=mo_MarketingAdministrationAndResearchCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=mo_MarketingAdministrationAndResearchCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mo_WineBusinessStrategicResetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mo_WineBusinessStrategicResetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=mo_InventoryDisposalCostsandOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=mo_InventoryDisposalCostsandOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=mo_InventoryWriteOffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=mo_InventoryWriteOffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_PurchaseCommitmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_PurchaseCommitmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798033930152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 31, 2021</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,127,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,127,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,471,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Long-term debt repaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,542,000,000<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 649,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">649,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost', window );">Loss on extinguishment of debt, premiums and fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">623,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost', window );">Write-off of amortized debt discounts and issuance costs, debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest on long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">206,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 206,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 458,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Denominated Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfUnsecuredDebt', window );">Repayments of senior unsecured debt</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Denominated Notes Due 2032 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Denominated Notes Due 2041 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Denominated Notes Due 2051 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Denominated Notes Due 2061 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Denominated Notes, 3.490 Percent, Due 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.49%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Long-term debt repaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum', window );">Debt instrument, covenant, consolidated EBITDA to interest expense ratio, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio', window );">Debt instrument, consolidated EBITDA to interest expense ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member] | Line of Credit [Member] | Revolving Credit Facility Due August 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_DebtInstrumentExtensionTerm', window );">Debt instrument, extension term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">London Interbank Offered Rate (LIBOR) [Member] | Revolving Credit Facility [Member] | Line of Credit [Member] | Revolving Credit Facility Due August 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember', window );">Debt Instrument, Redemption, Period One [Member] | Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt instrument, redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Consolidated EBITDA to Interest Expense Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Consolidated EBITDA to Interest Expense Ratio, Minimum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DebtInstrumentExtensionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Extension Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DebtInstrumentExtensionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the difference between the fair value of payments made to legally extinguish a debt and its carrying value at that time. This item excludes the write-off of amounts previously capitalized as debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfUnsecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is not secured by collateral. Excludes repayments of tax exempt unsecured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfUnsecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotesDue2032Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotesDue2032Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotesDue2041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotesDue2041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotesDue2051Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotesDue2051Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotesDue2061Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotesDue2061Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotes3490PercentDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotes3490PercentDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_RevolvingCreditFacilityDueAugust2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_RevolvingCreditFacilityDueAugust2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798037084904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (Tender Offers) (Details) - Senior Notes [Member]<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt instrument, repurchased face amount</a></td>
<td class="nump">$ 4,042<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">2.850%, Notes Due 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt instrument, repurchased face amount</a></td>
<td class="nump">$ 795<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">2.85%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">2.950%, Notes Due 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt instrument, repurchased face amount</a></td>
<td class="nump">$ 132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">2.95%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">4.000%, Notes Due 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt instrument, repurchased face amount</a></td>
<td class="nump">$ 624<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">3.800%, Notes Due 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt instrument, repurchased face amount</a></td>
<td class="nump">$ 655<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">3.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">4.400%, Notes Due 2026 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt instrument, repurchased face amount</a></td>
<td class="nump">$ 430<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">4.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">4.800%, Notes Due 2029 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt instrument, repurchased face amount</a></td>
<td class="nump">$ 1,094<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">4.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">9.950%, Notes Due 2038 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt instrument, repurchased face amount</a></td>
<td class="nump">$ 65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">9.95%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">10.200%, Notes Due 2039 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt instrument, repurchased face amount</a></td>
<td class="nump">$ 18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">10.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">6.200%, Notes Due 2059 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt instrument, repurchased face amount</a></td>
<td class="nump">$ 229<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">6.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchasedFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of the original debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchasedFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotes2850PercentDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotes2850PercentDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotes2950PercentDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotes2950PercentDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotes4000PercentDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotes4000PercentDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotes3800PercentDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotes3800PercentDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotes4400PercentDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotes4400PercentDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotes4800PercentDue2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotes4800PercentDue2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotes9950PercentDue2038Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotes9950PercentDue2038Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDDenominatedDebt10200PercentDue2039Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDDenominatedDebt10200PercentDue2039Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDDenominatedDebt6200PercentDue2059Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDDenominatedDebt6200PercentDue2059Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798028133272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) before income taxes</a></td>
<td class="num">$ (3,302)<span></span>
</td>
<td class="num">$ (324)<span></span>
</td>
<td class="nump">$ 1,544<span></span>
</td>
<td class="nump">$ 4,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision (benefit) for income taxes</a></td>
<td class="num">$ (582)<span></span>
</td>
<td class="nump">$ 632<span></span>
</td>
<td class="nump">$ 693<span></span>
</td>
<td class="nump">$ 1,817<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax rate</a></td>
<td class="nump">17.60%<span></span>
</td>
<td class="num">(195.10%)<span></span>
</td>
<td class="nump">44.90%<span></span>
</td>
<td class="nump">41.80%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798035027640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment of JUUL equity securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,600,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember', window );">ABI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentImpairment', window );">Equity method investment, impairment</a></td>
<td class="nump">$ 6,157,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,157,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember', window );">JUUL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment of JUUL equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Impairment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_InvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Investments [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_InvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798026640664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ValuationAllowanceRollforwardRollForward', window );"><strong>Valuation Allowance Rollforward [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance at beginning of year</a></td>
<td class="nump">$ 2,817<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount', window );">Additions to valuation allowance charged to income tax expense</a></td>
<td class="nump">264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount', window );">Reductions to valuation allowance credited to income tax benefit</a></td>
<td class="num">(73)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment', window );">Foreign currency translation</a></td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance at end of period</a></td>
<td class="nump">$ 3,004<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Valuation Allowance, Deferred Tax Asset, Decrease In Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Valuation Allowance, Deferred Tax Asset, Increase In Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Valuation Allowance, Foreign Currency Translation Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ValuationAllowanceForeignCurrencyTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ValuationAllowanceRollforwardRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Valuation Allowance Rollforward [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ValuationAllowanceRollforwardRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798028137704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (General Information) (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>state</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond', window );">Number of states that cap bond or require no bond</a></td>
<td class="nump">47<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States That Cap Bond or Require No Bond</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798039485400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">204 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualRollForward', window );"><strong>Loss Contingency Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrued liability for tobacco and health litigation items at beginning of period</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualPayments', window );">Payments</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
<td class="num">(60)<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrued liability for tobacco and health litigation items at end of period</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">$ 97<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_InterestExpenseRelatedToLitigationMember', window );">Related Interest Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualRollForward', window );"><strong>Loss Contingency Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualRollForward', window );"><strong>Loss Contingency Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationEscrowDeposit', window );">Security posted for appeal of judgments</a></td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_TobaccoandHealthJudgmentMember', window );">Tobacco and Health Judgment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Judgments paid (approximately)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementInterest', window );">Litigation settlement interest expense (income)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">218<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_TobaccoandHealthJudgmentMember', window );">Tobacco and Health Judgment [Member] | Tobacco and Health and Certain Other Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualRollForward', window );"><strong>Loss Contingency Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="nump">$ 99<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember', window );">Engle Progeny Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Judgments paid (approximately)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">410<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementInterest', window );">Litigation settlement interest expense (income)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LitigationEscrowDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Escrow Deposit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LitigationEscrowDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest expense (income) directly attributable to an award in settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow reducing loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesPaidValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages paid to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesPaidValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_InterestExpenseRelatedToLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_InterestExpenseRelatedToLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_TobaccoandHealthJudgmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_TobaccoandHealthJudgmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_LitigationCasesResultsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_LitigationCasesResultsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798038267880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (Schedule of Pending Cases) (Details)<br></strong></div></th>
<th class="th">
<div>Oct. 25, 2021 </div>
<div>claim </div>
<div>case </div>
<div>lawsuit</div>
</th>
<th class="th">
<div>Oct. 27, 2020 </div>
<div>claim</div>
</th>
<th class="th">
<div>Oct. 28, 2019 </div>
<div>claim</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_IndividualSmokingAndHealthCasesMember', window );">Individual Smoking and Health Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember', window );">Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EvaporLitigationMember', window );">E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,145<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_OtherTabaccoRelatedCasesMember', window );">Other Tabacco-Related Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassActionLawsuit', window );">Loss contingency, class action lawsuit | lawsuit</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Individual Smoking and Health Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Individual Smoking and Health Cases [Member] | Pending Litigation [Member] | Illinois [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Individual Smoking and Health Cases [Member] | Pending Litigation [Member] | New Mexico [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Individual Smoking and Health Cases [Member] | Pending Litigation [Member] | Massachusetts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Individual Smoking and Health Cases [Member] | Pending Litigation [Member] | Florida [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | ETS Smoking and Health Case, Flight Attendants [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfCases', window );">Number of cases | case</a></td>
<td class="nump">1,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">2,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassActionLawsuit', window );">Loss contingency, class action lawsuit | lawsuit</a></td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | E-vapor Litigation [Member] | Pending Individual Lawsuits [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">2,548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | E-vapor Litigation [Member] | Pending Lawsuits Filed By State Or Local Governments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Other Tabacco-Related Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfInactiveCases', window );">Loss contingency, number of inactive cases | case</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfInactiveClassActionLawsuits', window );">Loss contingency, number of inactive class action lawsuits | case</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClassActionLawsuit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Class Action Lawsuit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClassActionLawsuit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfCases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Cases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfCases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfInactiveCases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Inactive Cases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfInactiveCases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfInactiveClassActionLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Inactive Class Action Lawsuits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfInactiveClassActionLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_IndividualSmokingAndHealthCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_IndividualSmokingAndHealthCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EvaporLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EvaporLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_OtherTabaccoRelatedCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_OtherTabaccoRelatedCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NM">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NM</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_FL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_FL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_ETSSmokingandHealthCaseFlightAttendantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_ETSSmokingandHealthCaseFlightAttendantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798033557624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Overview of Altria and/or PM USA Tobacco-Related Litigation Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">274 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 25, 2021 </div>
<div>claim </div>
<div>case</div>
</th>
<th class="th">
<div>Oct. 25, 2021 </div>
<div>case </div>
<div>claim</div>
</th>
<th class="th">
<div>Oct. 27, 2020 </div>
<div>claim</div>
</th>
<th class="th">
<div>Oct. 28, 2019 </div>
<div>claim</div>
</th>
<th class="th">
<div>Jan. 31, 2008 </div>
<div>claim</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember', window );">Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember', window );">Engle Progeny Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Health Care Cost Recovery Actions [Member] | Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Smoking and Health Class Actions and Aggregated Claims Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Health Care Cost Recovery Actions [Member] | Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Engle Progeny Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofCasesSetforTrial', window );">Number of cases set for trial</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecided', window );">Number of verdicts returned</a></td>
<td class="nump">137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedUnfavorableNumber', window );">Number of unfavorable verdicts</a></td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecided', window );">Number of verdicts returned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedUnfavorableNumber', window );">Number of unfavorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsResolvedNumber', window );">Number of claims resolved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyVerdictReversedNumber', window );">Number of verdicts reversed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Alaska [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | California [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Connecticut [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Florida [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Louisiana [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Massachusetts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Mississippi [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Missouri [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | New Hampshire [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | New Jersey [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | New York [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Ohio [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Pennsylvania [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Rhode Island [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Tennessee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | West Virginia [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Philip Morris USA and Altria Group [Member] | Health Care Cost Recovery Actions [Member] | Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Philip Morris USA and Altria Group [Member] | Smoking and Health Class Actions and Aggregated Claims Litigation [Member] | Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsDecided">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Decided</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsDecided</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsDecidedFavorableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Decided Favorable, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsDecidedFavorableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsDecidedUnfavorableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Decided Unfavorable, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsDecidedUnfavorableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsResolvedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Resolved, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsResolvedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofCasesSetforTrial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Cases Set for Trial</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofCasesSetforTrial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyVerdictReversedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Verdict Reversed, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyVerdictReversedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_NonEngleProgenyCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_NonEngleProgenyCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_AK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_AK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_FL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_FL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_LA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_LA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MO">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MO</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NJ">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NJ</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_OH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_OH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_PA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_PA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_RI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_RI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_TN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_TN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_WV">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_WV</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAandAltriaGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAandAltriaGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798032059144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Non-Engle Progeny Litigation) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>May 31, 2020</div></th>
<th class="th"><div>Feb. 29, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Oct. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingAndHealthCasePrincipeMember', window );">Non-Engle Progeny Smoking And Health Case, Principe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseGreeneMember', window );">Non-Engle Progeny Smoking and Health Case, Greene [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseLaramieMember', window );">Non-Engle Progeny Smoking and Health Case, Laramie [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value</a></td>
<td class="nump">$ 21,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="nump">$ 27,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseGentileMember', window );">Non-Engle Progeny Smoking and Health Case, Gentile [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseGentileMember', window );">Non-Engle Progeny Smoking and Health Case, Gentile [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage', window );">Compensatory damages award, allocation percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Compensatory Damages Awarded, Allocation Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyCompensatoryDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Compensatory Damages Awarded, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyCompensatoryDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyPunitiveDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Punitive Damages Awarded, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyPunitiveDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingAndHealthCasePrincipeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_NonEngleProgenySmokingAndHealthCasePrincipeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseGreeneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseGreeneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseLaramieMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseLaramieMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseGentileMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseGentileMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798039093064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 25, 2021 </div>
<div>USD ($) </div>
<div>claim </div>
<div>case </div>
<div>plantiff</div>
</th>
<th class="th"><div>Jul. 31, 2006</div></th>
<th class="th">
<div>Jan. 31, 2008 </div>
<div>claim</div>
</th>
<th class="th">
<div>Jul. 31, 2000 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember', window );">Engle Progeny Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 145,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember', window );">Engle Progeny Cases [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants', window );">Loss contingency, period for decertified class members to file individual actions against defendants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ProvisionRecordedNumberOfCases', window );">Provision recorded, number of cases</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecided', window );">Number of verdicts returned</a></td>
<td class="nump">137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedUnfavorableNumber', window );">Number of unfavorable verdicts</a></td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyUnfavorableVerdictsPendingReversed', window );">Number of claims with unfavorable verdicts pending/reversed</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, State [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">1,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plantiff</a></td>
<td class="nump">1,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, State [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Federal [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyVerdictReversedNumber', window );">Number of verdicts reversed</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Reider and Banks [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyZeroDamagesVerdicts', window );">Zero damages verdicts</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Weingart and Hancock [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyZeroDamagesVerdictModified', window );">Zero damages verdict modified</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Pollari [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Gloger, Rintoul and Duignam [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Freeman [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsDecided">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Decided</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsDecided</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsDecidedFavorableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Decided Favorable, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsDecidedFavorableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsDecidedUnfavorableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Decided Unfavorable, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsDecidedUnfavorableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Period for Decertified Class Members to File Individual Actions Against Defendants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyPunitiveDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Punitive Damages Awarded, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyPunitiveDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyUnfavorableVerdictsPendingReversed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Unfavorable Verdicts Pending/Reversed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyUnfavorableVerdictsPendingReversed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyVerdictReversedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Verdict Reversed, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyVerdictReversedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyZeroDamagesVerdictModified">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Zero Damages Verdict Modified</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyZeroDamagesVerdictModified</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyZeroDamagesVerdicts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Zero Damages Verdicts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyZeroDamagesVerdicts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ProvisionRecordedNumberOfCases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Provision Recorded, Number Of Cases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ProvisionRecordedNumberOfCases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesStateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesStateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesFederalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesFederalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesReiderandBanksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesReiderandBanksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesWeingartandHancockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesWeingartandHancockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesPollariMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesPollariMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesGlogerRintoulandDuignamMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesGlogerRintoulandDuignamMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesFreemanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesFreemanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798019598728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 29, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>case</div>
</th>
<th class="th">
<div>Feb. 29, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 28, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2015 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesLippMember', window );">Engle Progeny Cases, Lipp [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesLippMember', window );">Engle Progeny Cases, Lipp [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesGarciaMember', window );">Engle Progeny Cases, Garcia [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesDuignanMember', window );">Engle Progeny Cases, Duignan [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesDuignanMember', window );">Engle Progeny Cases, Duignan [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesCuddiheeMember', window );">Engle Progeny Cases, Cuddihee [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesCuddiheeMember', window );">Engle Progeny Cases, Cuddihee [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesRintoulMember', window );">Engle Progeny Cases, Rintoul [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesRintoulMember', window );">Engle Progeny Cases, Rintoul [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesGlogerMember', window );">Engle Progeny Cases, Gloger [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesGlogerMember', window );">Engle Progeny Cases, Gloger [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMcCallMember', window );">Engle Progeny Cases, McCall [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMcCallMember', window );">Engle Progeny Cases, McCall [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesNeffMember', window );">Engle Progeny Cases, Neff [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesNeffMember', window );">Engle Progeny Cases, Neff [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMahfuzMember', window );">Engle Progeny Cases, Mahfuz [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMahfuzMember', window );">Engle Progeny Cases, Mahfuz [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesHollimanMember', window );">Engle Progeny Cases, Holliman [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesHollimanMember', window );">Engle Progeny Cases, Holliman [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesChadwellMember', window );">Engle Progeny Cases, Chadwell [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesChadwellMember', window );">Engle Progeny Cases, Chadwell [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesKaplanMember', window );">Engle Progeny Cases, Kaplan [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesKaplanMember', window );">Engle Progeny Cases, Kaplan [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesR.DouglasMember', window );">Engle Progeny Cases, R. Douglas [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesR.DouglasMember', window );">Engle Progeny Cases, R. Douglas [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesSommersMember', window );">Engle Progeny Cases, Sommers [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesSommersMember', window );">Engle Progeny Cases, Sommers [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesCooperMember', window );">Engle Progeny Cases, Cooper [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesCooperMember', window );">Engle Progeny Cases, Cooper [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesD.BrownMember', window );">Engle Progeny Cases, D. Brown [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesD.BrownMember', window );">Engle Progeny Cases, D. Brown [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesBergerMember', window );">Engle Progeny Cases, Berger [Member] | Settled Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesSantoroMember', window );">Engle Progeny Cases, Santoro [Member] | Settled Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesNaugleGoreMBrownJordanTheisAndLandiMember', window );">Engle Progeny Cases, Naugle, Gore, M. Brown, Jordan, Theis and Landi [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo', window );">Loss contingency, number of cases with payments a year or more ago | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesNaugleMember', window );">Engle Progeny Cases, Naugle [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesGoreMember', window );">Engle Progeny Cases, Gore [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesM.BrownMember', window );">Engle Progeny Cases, M. Brown [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Judgments paid (approximately)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesJordanMember', window );">Engle Progeny Cases, Jordan [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesTheisMember', window );">Engle Progeny Cases, Theis [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Judgments paid (approximately)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesLandiMember', window );">Engle Progeny Cases, Landi [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Judgments paid (approximately)</a></td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesRJReynoldsMember', window );">Engle Progeny Cases, R.J. Reynolds [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Judgments paid (approximately)</a></td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyCompensatoryDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Compensatory Damages Awarded, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyCompensatoryDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Cases With Payments A Year Or More Ago</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyPunitiveDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Punitive Damages Awarded, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyPunitiveDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesPaidValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages paid to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesPaidValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesLippMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesLippMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesGarciaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesGarciaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesDuignanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesDuignanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesCuddiheeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesCuddiheeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesRintoulMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesRintoulMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesGlogerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesGlogerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMcCallMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesMcCallMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesNeffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesNeffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMahfuzMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesMahfuzMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesHollimanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesHollimanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesChadwellMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesChadwellMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesKaplanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesKaplanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesR.DouglasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesR.DouglasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesSommersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesSommersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesCooperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesCooperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesD.BrownMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesD.BrownMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesBergerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesBergerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesSantoroMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesSantoroMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesNaugleGoreMBrownJordanTheisAndLandiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesNaugleGoreMBrownJordanTheisAndLandiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesNaugleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesNaugleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesGoreMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesGoreMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesM.BrownMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesM.BrownMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesJordanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesJordanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesTheisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesTheisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesLandiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesLandiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesRJReynoldsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesRJReynoldsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798154486776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (Florida Bond Statute) (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2009 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_FL', window );">Florida [Member] | Engle Progeny Cases, State [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_MaximumBondForAllDefendants', window );">Maximum bond for all defendants</a></td>
<td class="nump">$ 200,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_MaximumBondForAllDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum Bond For All Defendants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_MaximumBondForAllDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_FL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_FL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesStateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesStateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798117657448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Other Smoking and Health Class Actions) (Details) - Smoking and Health Class Actions and Aggregated Claims Litigation [Member]<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">305 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>CAD ($) </div>
<div>manufacture </div>
<div>ruling</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>case </div>
<div>manufacture</div>
</th>
<th class="th">
<div>Oct. 25, 2021 </div>
<div>claim</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_AR', window );">Arkansas [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_CA', window );">California [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_DE', window );">Delaware [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_DC', window );">District of Columbia [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_FL', window );">Florida [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_IL', window );">Illinois [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_IA', window );">Iowa [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_KS', window );">Kansas [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_LA', window );">Louisiana [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_MD', window );">Maryland [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_MI', window );">Michigan [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_MN', window );">Minnesota [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NV', window );">Nevada [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NJ', window );">New Jersey [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NY', window );">New York [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_OH', window );">Ohio [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_OK', window );">Oklahoma [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_OR', window );">Oregon [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_PA', window );">Pennsylvania [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_PR', window );">Puerto Rico [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_SC', window );">South Carolina [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_TX', window );">Texas [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_WI', window );">Wisconsin [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada [Member] | Philip Morris USA and Altria Group [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada [Member] | Canadian Tobacco Manufacturers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofManufacturers', window );">Number of manufacturers | manufacture</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyVerdictsUpheld', window );">Number of verdicts upheld | ruling</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AmountAwardedtoOtherParty', window );">Amount awarded to other party | $</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada [Member] | Altria Group [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofManufacturers', window );">Number of manufacturers | manufacture</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=mo_BritishColumbiaSaskatchewanMember', window );">British Columbia and Saskatchewan [Member] | Philip Morris USA and Altria Group [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_AmountAwardedtoOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount Awarded to Other Party</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_AmountAwardedtoOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClassNotCertifiedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Class Not Certified, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClassNotCertifiedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofManufacturers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Manufacturers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofManufacturers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyVerdictsUpheld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Verdicts Upheld</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyVerdictsUpheld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_AR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_AR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_DC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_DC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_FL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_FL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_IA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_IA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_KS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_KS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_LA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_LA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NV">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NV</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NJ">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NJ</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_OH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_OH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_OK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_OK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_OR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_OR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_PA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_PA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_PR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_PR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_SC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_SC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_TX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_TX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_WI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_WI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAandAltriaGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAandAltriaGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_CanadianTobaccoManufacturersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_CanadianTobaccoManufacturersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_AltriaGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_AltriaGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=mo_BritishColumbiaSaskatchewanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=mo_BritishColumbiaSaskatchewanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798034226280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Health Care Cost Recovery Litigation) (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 30, 1998 </div>
<div>USD ($) </div>
<div>state</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>claim </div>
<div>manufacture</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>claim </div>
<div>manufacture</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 27, 2020 </div>
<div>claim</div>
</th>
<th class="th">
<div>Oct. 28, 2019 </div>
<div>claim</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>manufacture</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember', window );">Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofStateswithSettledLitigation', window );">Number of states with settled litigation | state</a></td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementAnnualPaymentAmount', window );">State settlement agreements annual payments</a></td>
<td class="nump">$ 9,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementAnnualLegalFeesPayableMaximum', window );">State settlement agreements attorney fees annual cap</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000,000<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="nump">$ 3,200,000,000<span></span>
</td>
<td class="nump">$ 3,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_ThreatenedLitigationMember', window );">Threatened Litigation [Member] | Canada [Member] | Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_CanadianTobaccoManufacturersMember', window );">Canadian Tobacco Manufacturers [Member] | Canada [Member] | Smoking and Health Class Actions and Aggregated Claims Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofManufacturers', window );">Number of manufacturers | manufacture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LitigationSettlementAnnualLegalFeesPayableMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Annual Legal Fees Payable, Maximum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LitigationSettlementAnnualLegalFeesPayableMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LitigationSettlementAnnualPaymentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Annual Payment Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LitigationSettlementAnnualPaymentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofManufacturers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Manufacturers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofManufacturers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofStateswithSettledLitigation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States with Settled Litigation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofStateswithSettledLitigation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_ThreatenedLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_ThreatenedLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_CanadianTobaccoManufacturersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_CanadianTobaccoManufacturersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798031557064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (NPM Adjustment Disputes) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>state</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>state</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember', window );">Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement</a></td>
<td class="nump">$ 1,100.0<span></span>
</td>
<td class="nump">$ 1,200.0<span></span>
</td>
<td class="nump">$ 3,200.0<span></span>
</td>
<td class="nump">$ 3,300.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne', window );">Loss contingency, number of states with settled litigation including New York, subsequent expansion | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty', window );">Loss contingency, credits to offset payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,030.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty', window );">Litigation settlement, amount expected to be awarded from other party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">320.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions [Member] | Settled Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation', window );">Loss contingency, number of additional states extended with settled litigation | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation', window );">Loss contingency, number of additional states extended with settled litigation | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 388.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesNotSettled', window );">Loss contingency, number of states not settled | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesWithConcludedHearings', window );">Loss contingency, number of states with concluded hearings | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues', window );">Loss contingency, number of states not in compliance with escrow statues | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues', window );">Loss contingency, number of states in compliance with escrow statues | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Loss contingency, damages sought, value</a></td>
<td class="nump">$ 23.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member] | Pending Litigation [Member] | Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyReductionToCostOfSales', window );">Loss contingency, reduction to cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">218.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">258.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">302.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">325.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">444.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2020 NPM Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 572.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesNotSettled', window );">Loss contingency, number of states not settled | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment | Pending Litigation [Member] | Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesNotSettled', window );">Loss contingency, number of states not settled | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod', window );">Loss contingency, number of states not settled, arbitration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment | Pending Litigation [Member] | Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesNotSettled', window );">Loss contingency, number of states not settled | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod', window );">Loss contingency, number of states not settled, arbitration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NY', window );">New York [Member] | PM USA [Member] | Health Care Cost Recovery Actions, Transition Years 2004-2018 [Member] | Settled Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 373.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_MT', window );">MONTANA | PM USA [Member] | Settled Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Amount Expected To Be Awarded from Other Party</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LitigationSettlementEstimateofPossibleGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Estimate of Possible Gain</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LitigationSettlementEstimateofPossibleGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of States In Compliance With Escrow Statues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of States Not In Compliance With Escrow Statues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfStatesNotSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of States Not Settled</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfStatesNotSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of States Not Settled, Arbitration Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfStatesWithConcludedHearings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of States With Concluded Hearings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfStatesWithConcludedHearings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Additional States Extended with Settled Litigation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States with Settled Litigation, Settlement One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyReductionToCostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Reduction To Cost Of Sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyReductionToCostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded from other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedFromOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ArbitrationPeriodAxis=mo_PeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ArbitrationPeriodAxis=mo_PeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ArbitrationPeriodAxis=mo_PeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ArbitrationPeriodAxis=mo_PeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsTransitionYears20042020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsTransitionYears20042020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798026683912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Other Disputes Under the State Settlement Agreements) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jan. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Other Disputes Under the State Settlement Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty', window );">Amount ordered to be paid from other party</a></td>
<td class="nump">$ 32<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded from other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedFromOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_OtherDisputesUndertheStateSettlementAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_OtherDisputesUndertheStateSettlementAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798035179512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Federal Government's Lawsuit) (Details) - Federal Governments Lawsuit [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2006</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_FederalTradeCommissionDisclosurePeriod', window );">Disclosure period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_ImplementationofCorrectiveCommunicationsMember', window );">Implementation of Corrective Communications [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_ImplementationofCorrectiveCommunicationsMember', window );">Implementation of Corrective Communications [Member] | Altria Group [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_FederalTradeCommissionDisclosurePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Federal Trade Commission, Disclosure Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_FederalTradeCommissionDisclosurePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_FederalGovernmentsLawsuitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_FederalGovernmentsLawsuitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_ImplementationofCorrectiveCommunicationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_ImplementationofCorrectiveCommunicationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_AltriaGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_AltriaGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798038856008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (E-vapor Product Litigation and IQOS Litigation) (Details)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>plantiff </div>
<div>case</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>claim </div>
<div>lawsuit</div>
</th>
<th class="th">
<div>Oct. 25, 2021 </div>
<div>claim</div>
</th>
<th class="th">
<div>Oct. 27, 2020 </div>
<div>claim</div>
</th>
<th class="th">
<div>Oct. 28, 2019 </div>
<div>claim</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfCasesWithCourtDatesSet', window );">Loss contingency, number of cases with set court dates | case</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EvaporLitigationMember', window );">E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,145<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plantiff</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_NumberOfThirdPartyLawsuits', window );">Number of third party lawsuits | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_IQOSMember', window );">IQOS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyDamagesRecoverableValue', window );">Loss contingency, damages recoverable, value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=mo_ClassActionLawsuitMember', window );">Class Action Lawsuit [Member] | Subsequent Event [Member] | E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber', window );">Number of pending claims, consolidated for pre-trial purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember', window );">Pending Individual Lawsuits [Member] | Subsequent Event [Member] | E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=mo_PendingLawsuitFiledBySchoolDistrictMember', window );">Pending Lawsuit Filed By School District [Member] | Subsequent Event [Member] | E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember', window );">Settled Litigation [Member] | E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyClaimsSettledNumber', window );">Loss contingency, claims settled, number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyDamagesRecoverableValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Damages Recoverable, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyDamagesRecoverableValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfCasesWithCourtDatesSet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Cases With Court Dates Set</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfCasesWithCourtDatesSet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Pending Claims, Consolidated For Pre-Trial Purposes, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_NumberOfThirdPartyLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Third Party Lawsuits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_NumberOfThirdPartyLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyClaimsSettledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of claims settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyClaimsSettledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EvaporLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EvaporLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_IQOSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_IQOSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_ClassActionLawsuitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_ClassActionLawsuitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_PendingLawsuitFiledBySchoolDistrictMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_PendingLawsuitFiledBySchoolDistrictMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798030211656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Antitrust Litigation and Shareholder Class Action and Shareholder Derivative Lawsuits) (Details)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>claim</div>
</th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>shareholder</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>claim</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>shareholder</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>shareholder</div>
</th>
<th class="th">
<div>Aug. 31, 2021 </div>
<div>shareholder</div>
</th>
<th class="th">
<div>Oct. 25, 2021 </div>
<div>lawsuit</div>
</th>
<th class="th">
<div>Nov. 30, 2020 </div>
<div>complaint</div>
</th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfComplaints', window );">Loss contingency, number of complaints | complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits', window );">Loss contingency, number of shareholders filing class action lawsuits | shareholder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfPendingCasesConsolidated', window );">Loss contingency, number of pending cases consolidated | claim</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits', window );">Loss contingency, number of shareholders filing derivative lawsuits | shareholder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfConsolidatedDerivativeLawsuits', window );">Loss contingency, number of consolidated derivative lawsuits | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember', window );">JUUL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage', window );">Equity securities, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassActionLawsuit', window );">Loss contingency, class action lawsuit | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClassActionLawsuit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Class Action Lawsuit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClassActionLawsuit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfComplaints">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Complaints</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfComplaints</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfConsolidatedDerivativeLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Consolidated Derivative Lawsuits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfConsolidatedDerivativeLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfPendingCasesConsolidated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Pending Cases Consolidated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfPendingCasesConsolidated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Shareholders Filing Class Action Lawsuits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Shareholders Filing Derivative Lawsuits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798129485080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (Lights/Ultra Lights Cases) (Details) - Subsequent Event [Member]<br></strong></div></th>
<th class="th">
<div>Oct. 25, 2021 </div>
<div>claim </div>
<div>case </div>
<div>court</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Lights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsNotCertifiedNumber', window );">Claims not certified, number | case</a></td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Lights [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyStateCourtsNumber', window );">Number of state courts | court</a></td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Smoking and Health Class Actions and Aggregated Claims Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsNotCertifiedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Not Certified, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsNotCertifiedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyStateCourtsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, State Courts, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyStateCourtsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_LightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_LightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798028135784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (UST Litigations Narrative) (Details)<br></strong></div></th>
<th class="th">
<div>Oct. 25, 2021 </div>
<div>claim</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember', window );">Pending Individual Lawsuits [Member] | Subsequent Event [Member] | UST Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Claims filed, number</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_USTLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_USTLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798023120904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (Guarantees and Other Similar Matters Narrative) (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsMaximumExposure', window );">Contingent liability related to performance surety bonds</a></td>
<td class="nump">$ 24,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit line available under the agreement</a></td>
<td class="nump">48,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member] | Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit line available under the agreement</a></td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12069-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139798026778184">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="2">Value</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted Cash, Current</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RestrictedCashCurrent</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted Cash, Noncurrent</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RestrictedCashNoncurrent</td>
<td class="nump">60,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations</td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals.  See Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Cash included in assets held for sale at September 30, 2021 is related to the Ste. Michelle Transaction.  For further discussion, see Note 3. <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Assets Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; attributable to disposal group, including, but not limited to, discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>100
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M2"!F.)FD,XF2>UZY/Y:H$UYJ8P<OYA-3.B/G0Q59%J!WHNPX2F\0-[03387
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MZ&/+:X4@M3R(=]Y N3X'2S]WI-(#*U(24$LR&2*)&^(PKV&5)*[196R>WGA
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MY*=<2F$<X'+*M;*L,N!:;+9%N.92Y<:$GU=FG5_R;#_,L[+((4^R![+*2E&
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MS])IUR2L;VG'0FPS#?F.KF0C?&/8EA 44BJ'(*0Q80,BG0F!8:T)A2&]"9W
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M]!+$[-;W;91 RFU+9Z#HS4J;E".99NW;S "/'2B5?A@$?3_E0GFC@;N;F]%
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M5]U6F^C.#>"C^W'[=M*NN9_2YBH6S5_Z8NW=<[,6RC()*Y(*6I\I6E.LDL)
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M(852(C(86*+SA$M)I0V/63G,J!A&)\V7ZP$>8^]J^'*(O2DUB?QCF84I@Z,
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M&NNKMMSBP_'-%O?Z^?KZO7@OY[ZWO92>UPL;""6R5)+1A*XZ/' $9D02$RT
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MO"=<_"D]?@FVX)^OYS8$F_/'%4:0<K0 [Q<6+E5?2$'S_S.\^0]02P,$%
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M!>?I 'XOG(O]#1D8OIQ>_ =02P,$%     @ /5%<4_I?/\F?!0  1PT  !D
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MD1M^VX,\M%9GVR#/_'9CNI(_8<HVT-UF*&0U:R2<= O:@]+^DB[T@"B2(.S
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M-=F&?< D+*\]1+T=6MD7E*3'?AQK1Z,(+9!44,NC*1#9^V8(&AY<21W6P$7
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MKRZ.K$_U_YAJQU]_L:J,J0I^N96H%&NZ )^O*]BZ^X<6"-^'\NK?4$L#!!0
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M1"WKAM3I>2W,6LTWE64;@6 5+ 2-&;R$T3"F-ND-!WWJ.TGO,DFZSAH/J?^
MQDS@#3=U--%Q6U;)K#73)'N:P^_=F=,!"MLSG1&?41<Z%_01=B?NPO4SHJ2=
M3CJ>' YMO./J.1+7_N61Z^# M=^%KUY5,#MC]ZA)).O\IH7H4.+>:#!V[7#D
M[>1@KT1%E::T\\0'I16_@!M3^5KH(GA)ERF!6I7>T0YP:\#=A3BY@KAEG6+1
MKN:!Q[C%8PQ_>EEA2[,*U#NOS(;(5M+6\M7,-N*_J#7OP;W^<WQD>L>E 8%;
M"HW.+X<!Z%J-ZX%5I5? C;*DI][,Z0>&VCG0^E8I>QRX!,TO<?X;4$L#!!0
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M0N,$^+YJP)/N 0WT1[=G_P%02P,$%     @ /5%<4S='1SNZ"P  -B   !D
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M'$&/A=5VX,A(KSVD[<;7,A XEBY@@V5L(KSQU+,.K"T(2LUU+O-88V"M$0V
M2@!/;AXD4>.^$& $(IQ36&:]A)DUU&CF4DER0S6K&LR2V8_B[N971,&J:EJ"
M&R'35!C,MV>[1@-7:BY0;ZSDP"<JUDS^F?RFK&C1HC0XZKR]O/ETS;?=MR=P
MU@.1=6,F\+V2>9D;)E.BE1KG3D2KG'YS>57/]D:H!YD6,(;-@A"N=7FLX/*
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M$BV[1VA!,@*V106N SV$E(Q.DHTU06'A3*8)?X"9TA8<H(5"Q%13YP 8^4!
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MXKDS: ]ZR6Y\2])=<;E-0(:' Q@ZZ.^+G;T#* \'B;A8#Y!(T\ZA>"72?N<
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MW0D=*G/520I'?E"A0].@/%6/EGZ@-3!Y,R^QXMD#Q9UK0ES#NF!A*'IKO%2
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M/^NJNYZ\1)5W8US3J>[@DSJ!P;;+#,;9%;X)H49Q +9>9YJ.DO@>LMQ3IXJ
MTKJJ3HG40,!K!]%1A1,O-1I90N$))2L2]R]ZJR Y,@WU@^Q5Y6P5\-VR58.8
MD98O^W>+Y[/[Q:L)'>U]>C^?;M=<#Y#>184M8+,#"GS?5%5^V)59IW?@X-.[
MZ/0[<W34#@G)F-O ^'I,ZTES<G'MX?0%S?D "#W/"]MI$J 0O!]-^L26VV%;
M<N^J[D9\()$?"TI=++,+?(^":_YIX4I:O4?__,:%V-YC)U4Z]?'7!D== N/P
MVPO8^8Y"C/SOMM!"IX&3,93^]=PTXW(KXJ B]^YASAW13=QR/(F.?GOO:'L
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MW]+DF:WET 3684L=IYZ5B 4E7%C:>V$8OF,. <YMQN1T<.R(P-7(^(I6;M8
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M9%[C$W2N"O40JU6WZ,5SV:1 )I'**KJWS=I=VT2N<\8EIY<$[D@7X!YN0Z-
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MY)&\ ;]?&^.V&^^@^]N8_0502P,$%     @ /5%<4VJ_4[ L P  !0<  !D
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M5F3W 88?X1XYDL3/)J3)&97PF93:>.JGZ0CN#"TKXUX'4$NF7$#R(#5M$3<
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M;$?M[L9@'FQ1/(I5Q>\K%JF+C53/.F;,D)<T$?JR%QN3G8_'.HQ92O5(9DQ
MRU*JE!IX5:NQSA2CD1V4)F//<6;CE'+1N[JP=9_5U87,3<(%^ZR(SM.4JM<;
MELC-9<_M514/?!4;K!A?761TQ1Z9^2W[K.!M7$N)>,J$YE(0Q9:7O6OW_";
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M.. L6QQV!F<"[[5RE84WJL3R=_^8-'7"V%'8DCT)>(?-!63)2V )2Y_ R[I
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MNIP$8+M1UVW(U.UXV1GB8=4N2_YW0.L=V+XWK+W?^ ##_\WR+U!+ P04
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MHAF.V@G0]X-2]G)P!OI_!=M_ %!+ P04    "  ]45Q3@$E\JOX,  "3)@
M&0   'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6S-6FM3&SD6_2LJEIJ%*F-L
M8P;(JXI R"0;,E0@LQ^V]H/<+=N:=+<\:C7&\^OWW"NI'V";S.QLU58JIMVM
MQWV<>^Z]:K]:&ONMG"OEQ$.>%>7KG;ESBQ>'AV4R5[DL^V:A"CR9&IM+AZ]V
M=E@NK)(I3\JSP]%@\.-A+G6Q\^85W[NQ;UZ9RF6Z4#=6E%6>2[MZJS*S?+TS
MW(DWONC9W-&-PS>O%G*F;I7[NKBQ^'98KY+J7!6E-H6P:OIZYWSXXNV8QO.
M7[1:EJUK09I,C/E&7SZDKW<&))#*5.)H!8D_]^I"91DM!#%^"VONU%O2Q/9U
M7/V*=8<N$UFJ"Y/]4Z=N_GKG=$>D:BJKS'TQRY]4T.>8UDM,5O*G6/JQQZ,=
MD52E,WF8# ER7?B_\B'8H37A=+!APBA,&+'<?B.6\E(Z^>:5-4MA:316HPM6
ME6=#.%V04VZ=Q5.->>[-A2F<+F:J2+0JQ=Z=G&2JW']UZ+ VC3A,PCIO_3JC
M#>N<B6NL-"_%NR)5:7?^(62J!1M%P=Z.MBYXJQ9]<33HB=%@--RRWE&MZ!&O
M=[11T3S7#G!RI9!%*KJ*7^HRR4Q9627^=3XIG05:_KUEUW&]ZYAW'6_2 D&4
M5ID29MK=<9V%MR]U-U<BF4LL4 I=B//,62U_^-OI:'CR$BHEB:U4*C(M)SK3
M;B40L,*9"1X85GBN9.;F?)DHZQ"OPKBYLICB]$QRC&BG\K*'Y9.L2B$KPBZ3
M#LOJPBFK2B<24SJ,X,4AT$)9;=)2E N5Z*G&R G%N9 PI"PQ+,.W\H6X"N,_
M0ZD.4@3\C$TGD(.<'<?=S:W:.G /XN<ZRR!UN<\8H8]!Z^K\K[.(D YZS711
MD$W@2J^VV!5G^#\<XX,=,7J)J]%(W%AUX.0#N<N2N[#Q"W'W!W?>&^YCZ9$X
M.1)G9^)H++ZL]87X41SA?]S_1JX\QFGZWH\#?)S2U2G^CT_V_VJK*(SJV.,D
M&"5<D!0?&$TP@\Q-1:)%4#FS>0?:?D%F!,@SS"A-5O$#[!8GK9$Z 4&7?4&Q
MXHC* APS398B8!450^CI*@=1*EX"&A4< #0 T[[V;_M"SC >=K^Y%E]OSVG;
M0]C.!R*A'8O^G& YK#\Z]L35:^Z<]#PN2=KZYBG=')Z]>#+QZ;S'<V#75-_K
MM()];G/SC:2EM7_REKA@-1A$)V<,I+/CYAG"\P+H :82<Z_L"K@@ZV+""!/X
MW[N#>[F ?F&A(T19[^P83WK#\7&-MY_9<0';!Q&B8<YX']@<XU\'!L/38..I
MSAC.X@/BN# :O#(\>?SL,Q+[M7K0B>F)\>#QTVM9EC*95Z5R@==/!J(PQ0%(
M8P;W/QI^E1FK4]D7EP:W"^,"U2G\K8U9MHS9AI686%,AQXO)2L NP.)$S64V
MY0#(  VGI].RM8TH':S!ZTQ5JBS63DQE7>1%VH3 E2K"(N@SD1'B=+O10.SA
M>QGO+*Q!$ED%H<B5*;)7598U^T*$-8CXU$17-,]%!OL%WXO]/K!<&I$^MLVP
M-SX9/K7!-*.*!RS@$"N2 KM4BC=-3([X*:4S0%8J<QE(D'BB- 7LH(M?*TN)
M5V:9FJDT(W4JUF EU,/"IV(0A"KNM34%<1JFQ8@G%\$J!,+1X.6[NUN^&K[<
M]Z'_5#*_#<P*SH(M5VRVG-,)QZTL!%99ZWHVD?0F:GS;$\NY3N9B*4EMYP+
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M$F*BZ OO#ODUV%_5J?/+,^" GX<W;>+<RQB_\K.WRE*_LW<! #_BI_&?B/%
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MDPQ"__+U$_)M>FT*3_QVI6'-?Q8PB 'O5][3?B( P]^/Y3=02P,$%     @
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M9@#\_BB$WMT8!]D!^_0_4$L#!!0    ( #U17%-*8X24_P(  +$(   9
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M^N1 VR.4KQK*5_T;Z]76'KCJGB'[,YP#; 5ICF_Q6\@WH/JV=QB\G/O!?WE
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M3'7AK0:D"W]GG&OB&ZA_7/%' AJW@-\OM*;MP%U#F\^.T=]02P,$%     @
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M)?T"4#L'.L^4LEO#7=#\5(;_ %!+ P04    "  ]45Q3+D-H3+L$  !1%0
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M>IZZ?)_PPG"G]\;@*EE)^>J"^W(:A$X0<BR,8Z#VM\4Y<NZ(K(P_/6<P;.F
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MPXU][%"Y!+N^EM)\!.X^#<]G_A=02P,$%     @ /5%<4WUD1=2?!   71H
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M O*'07P9C]#5BY?H!6(<W;$D,6JJGJ_-8BPE/RJ(OUL3)WN(CR&[1F'P"I&
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M.KJ]1/8RR0:*I_;J77"E+W+[N=:O.1 &H->7G*O]P!@HWH>#OU!+ P04
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M)L:OF[PE3#!J7^BKLAY7O]KC5Z^FWT34/=Y$U#W>1!SSN.\]?]V]_^;R!+C
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MD9P?5AQ^%#>"IOG7_8X*0>/\\@A^""P#R/=[2L7E)DM0'4$M_@502P,$%
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MT.;\=DV3$2E(N\#,+X30VXX]Q.M+V_@O4$L#!!0    ( #U17%,@$; &P@,
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M*)!<)PD5;V.(^?:V@SN[A2>V6*ILP1D-5W0!SZ ^K1Z%?G,J+1%+()6,ITC
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M['GK57GKM>:M<:3_Y3E^@.0%1-L9[E>>],^KN PJQP;G1ZU!8[.Q<=0F3<C
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MET C$!E _S[G7.U>,@/5;??H'U!+ P04    "  ]45Q32D'Z>5,&  #R'
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M<X/$N+"K4_@76"\X:>85G#&) FXPY;XG+'8V;;.3@HDR!)^6,&<"#7R=8K%
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M9^>V;70U\JL-J=)/S84B.X/]<F4_DU [ _M\J11M-\Y!\^$U_@U02P,$%
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M(/)G-O(WBB^R7^<G7"D>9Y=SS6 JS #]^8QK#A1OS 2K)V=._P-02P,$%
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M>4$_WW+MCOK"["8VF\&+_P%02P,$%     @ /5%<4SQ)LO3D @  WP@  !D
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MI7B87.K]-P!A"/3[%>?J<&,4Y(=DXW\!4$L#!!0    ( #U17%/D:9+%'@4
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MI6!;YFV(#V8!?U3BD= #7RGQQ2K5$?RXI<&<1C\-X5 >#B7A4$VX&Q['8+^
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MD,91^@TQW1%\G7Q5FW,A>)!LKBCQ:*0&R/,+SL7+COI0EW_)G?P!4$L#!!0
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M)D$]T#2$NP%@,SB\>GJ8)E0(_;=84!M% H!KT%4I-0 T!K;9N*4B>])Q@R*
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M 12C=E/UR'J#4@30C(Z<J7]1JX0(0:P"K C &G6VUZFRV:G=3#VJ9^H&:D5
MSNC(F?IW(B3Z1OF,VF(+"!MUE:G'@,:XW4P]WO-(R+#Y#- 9_T:F/J<I7:!+
MQCD5A3S%;IG-AMJ_.%LNCK _(P8"QUVE\C&@,VY]5U1<S^;C9UL &IOL>@H
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M&70B^0WP^TQ*\WR2O_6IWB.._@=02P,$%     @ /5%<4V:49MP+"@  KTP
M !D   !X;"]W;W)K<VAE971S+W-H965T-S0N>&ULM9Q;;]LZ$L>_"A&<AQ;(
MQJ+N*M( C9,V2>TVM4]W'P[V@;496SBZ>"4Y:1;[X9>2)0\3B[2HB'EP?!%'
MU']&/W$HCLZ?TNSO?$UI@7['49)_/%D7Q>;#:)0OUC0F^5FZH0G[Y2'-8E*P
MC]EJE&\R2I95HS@:F8;ACF(2)B<7Y]5W]]G%>;HMHC"A]QG*MW%,LN=+&J5/
M'T_P2?/%+%RMB_*+T<7YAJSHG!8_-_<9^S3:6UF&,4WR,$U01A\^GGS"'^;8
MLLH6U2;_#.E3SKU'Y;'\2M._RP^WRX\G1MDE&M%%4=H@[-\C'=,H*DVQCORG
MMGJRWVG9D'_?6/]<'3T[FE\DI^,T^E>X+-8?3_P3M*0/9!L5L_3IAM9'Y)3V
M%FF45Z_HJ=[6.$&+;5ZD<=V8]2 .D]U_\KM6@FM@8D$#LVY@OFX@VH-5-["Z
M[L&N&]A=&SAU Z=K [=NX'9MX-4-O-<-'$$#OV[@=]U#4#<(NC; 1N,YHW.3
MO;,[>QLW[L8'_A8V:1R..WL<-R['G7V.&Z?CSE['C=MQ9[_CQO'XP//")HWK
M<6??X\;YN/+^:'?V5J?^%2G(Q7F6/J&LW)[9*]]4_*C:LS,^3$K6S8N,_1JR
M=L7%.$V*,%G19!'2'+V[3E811?=9RKYY1F/&D!S]F84D0C.:,WKDZ!_HGB9+
MU@219(E8\T6T7=+E>_3NBA8DC/+WZ \4)F@:1A%C67X^*E@WRYV-%G67+G==
M,@5=PFC*.K7.T77"#+>TOY:WMXZUOY&W#R3M1TS>O<9FH_&E*35XMXW.D(5/
MD6F8^.?\"KW[XWU+M\9R*U/RW,'(E=S(ITUVALS@F)7K8UW)NAS0YV.R),R*
M45DQQ%:^R*U<T473%^R+K=S(K<SI9M^7YH@6+/I;+-W*+7VFO_8*2X[J[H@V
M)-DK++'R56[E6_K8'!4.Q%8FG;TMLS+MHHM_S,JWSGZ2>?M[YQ-29N6^N[J>
MV,J/#F?D<2NS[KHX8BOSSE$GL/*"?];^&F-59FV!V9:+RBF:A)L-^FM*XU\T
M^S?ZW_ZJ,@F+<$6J87#SJZ0+]KX+=M4%2]"%29KGZ.6U[J\)VP;=%C3.97MP
M]GMPI <Y3F.6?^2D2+-GM"0Q2Q1R1)Y()K@&[:RYE;4R(7F\P,[YZ+&E!^Z^
M!ZY6F<M?I^CG_%,7X;U]ISQ-POO[/?C2P[[?)F&9+G41?6?)X40W_7;1@_W>
M W71OY!L$9*W1S<V8!1G:)(9<R-%/&2$CVMS?(A;[6)C$_I@JLM]M0U7"4D&
MT!N(ABU=>@.RL#VDWK>UN2YZ ]2PG&H#Z*V$%0RPPZXN#P"[L#<46FYK4R^
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MEK/H4T1RV+%:X)-NOD%7S]3S95K8\"9-FSN=1B2K+6K9@9T#R57[98=N'TX
M\>@,(.X <?#="@672X8L38QNB/'9CLT/0JD![<QQY0]E@\:M<H?#=*$5<E6
MRCA8,K@7VO"<D;E6.=D@PQKAB@R6@(P+>Y50=)H>2;..?][RQV?XO]?JAHR'
MU\1UR>?GS9(,/OS#0IWCWG;<VXX#[>0,[='GRPKD%LPO\DZ^JD( 61OMBGDC
M"W=2]CJ4 'W6!>%Q+SP.PN,SPH_:6O+WIKT\NASR@"#M)85)KS"Y6-J*';BL
M)=GZ(W"WCC A?)^!RIE"^[\C: EO Z&_A?O4[7;[)'1_ZH6>=(J_="MF"JXL
M$;!SV.'-1]>FIFWD-D!=A>;9:G2M&(:EN_M@?();WVF-Q\#W8_\W2?\ 4$L#
M!!0    ( #U17%,50"6:X08  $ L   9    >&PO=V]R:W-H965T<R]S:&5E
M=#<V+GAM;+6:76_;-A2&_PIA]*(%MMCZEHLD@).T6[:X"9IVQ5#L@I%HBXA$
MNB1E-T!__$C9\5%CF]8TZ2;1USDD7U&/^4KG=,7%H\P(4>A[D3-Y-LB46KP=
M#F62D0++$[X@3)^9<5%@I7?%?"@7@N"T"BKRH3L:A<,"4S8X/ZV.W8GS4UZJ
MG#)R)Y LBP*+IPN2\]79P!D\'_A(YYDR!X;GIPL\)_=$?5[<";TWW&9):4&8
MI)PA069G@XGS]FI<!517_$7)2M:VD1G* ^>/9N<Z/1N,3(](3A)E4F#];TDN
M29Z;3+H?WS9)!]LV36!]^SG[^VKP>C /6))+GG^AJ<K.!O$ I62&RUQ]Y*O?
MR69 @<F7\%Q6?]%J<^UH@))2*EYL@G4/"LK6__'WC1"U "\^$.!N MP7 >[X
M0("W"?!>!#B' OQ-@%\ILQY*I<,55OC\5/ 5$N9JG<UL5&)6T7KXE)G[?J^$
M/DMUG#J_Y$Q1-B<LH42BU[<J(P+=%_Q1'T28I>AW@G.5H<L<2XDFU<V2;]#K
M*Z(PS?76KT>OKDY,YG-!YEB1U)RDA40W5%%]P-S\KU-2/!#Q#WJ%*$,7-,]-
MW.E0Z0&:;@Z3S6 NUH-Q#PS&05,]G$RB=RPEZ9[X2WN\-PHL&89:VJV^[K.^
M%ZXUY12+$^0YOR!WY(PO)U?H]:LW!6;E3$_X4A!1ZH#YOI[:T]Z3A4X[,FE=
M)]'SOI9S3[8K>[;;1)T@-]AD,[?',G)O.[.\*JE_J(OE@R3?2L(4>K<T?Y_O
MLB6WO\WM5[F] [EON)Y>/T_=KS?Z&G2M2"%M+03;%@)K[S^4IJ^(SY!15R+-
MV=1,\A]HCSYKC=<)@RJAP>WRW#D=+O?T(=SV(;3VX6Z*/M]/FN@6;3-&/>D6
M;UN(K7U>/_F,*Y00H>B,[G\.XQVMP@-BC;<-CZT-3\0C9A)+@,D/U%Q 9P2\
M'/4DH5-CLM.%B)LL#6:<XT+3KKUIG%.]FF 4MQ02\.!X?0D)F'#\3H3T&PL)
M_'#L +DB.5YA05K*"(QPPKYD!&HX42<R1HUE!)PX=IY<4:D$390AL5[;:2JW
MGIE $F?<DZ0N8,0==2'I)DM=4G>_I"[0Q;73Y7W.!4U;JN@"25RW+Q6!(:Y]
MC=%41:^QBH 6UXZ6:[U(99RV_+UQ@2-NT)>,P!#7OM!H*F.X(Z-W0$9 BVM'
MRS5?M9V)P! W[DM"8(9K7WXTE7#<%)$>H,2SH^3/_['N\8 :GM.3B!X@PSNR
M^&@FXB9+$Q%K9L5.DAM>4DDQ:SD9/>"&UY=U\8 9GGWMT53'QH[% Y1X=I1H
MO_N4&\/?3D;@AM>7D_& &UXG7L;;-3.'9 2<>':<3&F2T3EF[63T@1U^7V[&
M!W+XG;@9O[&;\0$HOATH4\H8D5RU?*I]P(??EYGQ:^\\.C$S?F,SXP-0_"-O
M0\@2MUTQ^L .OR\KXP,W_$ZLC+]K9=SQ 16!)[Z=)Q_("OU!A"1/+94$?/A]
M.9@ T!%TXF""70<3[A<R *($=J(8(?_FXK&=C '@(^C+P@1 CJ 3"Q,TMC !
M "6P ^4VH[REA+77J'W9EP"X$71B7X)=^W( C '@)+#CY/8QQQDO6J(Q '0$
M?5F8 * 1=&)A@L86)@26A':6W HRYRT7.R%@(^S+PH2 C+ 3"Q,VMC AD"2T
MD^2.,":?\B5N_?(V!'2$?;F8$- 1=N)BPN;?76H?7HY\>2EUBQQ]I$E+0(9
MD+ O(Q,"/<).C$S8V,B$ )70#I5[7IKOP5AP?:;EM(R (U%?=B8"BD2=V)FH
ML9V) "Z1'2Z?R/>V+WHBP$C4EY6) !]1)U8F:FQE(J!*9*?*%RH3SB1M^6L3
M 4.BOMQ,5/N<VXF;B1I_F(F *=$1IF#VTA)F-*<+-.5"4%GI615^Y$KHWZ/?
M!"\7]:O;E =$@)VH+P,4 VQB^Z*E18E O&N&HOTW(@8>Q4=XM',CJB,4,_2)
M/^!$_X1-:P4GLHG0,2 I[LLBQ4"DV+ZP :&+GP;R ]FK7B[B7=,$'RPVA0BV
M2W[N+] MMM,-^KLD(J6)DJA<9"1/=8\/%OQ<Q+NP.^#P8H!=;(?=I."E?K3,
MA^B4I$@O:7A5X+7 0CWIWKS:VY%USK!.BT.:  WC(QYM9Y;N!8-MO@ 5X]ZJ
M7&IE+D?>Y;2>D[N+K-$!<8%VL7V1=2&HHC*##^0&O/=8/F*59&3UXC5R[Y@>
M T+'?:W7QL#'\9&71?\=T^/=M=O+1W%8*[DLB)A7I:L2)>9Y6U=?;H]NRV,G
M55'H$"Y?U]9.L9A3)E%.9CIT=&(6,&)=KKK>47Q1%7 ^<*5X46UF!*=$F OT
M^1GGZGG'-+ M&C[_%U!+ P04    "  ]45Q38OPC8Q$$  "B#P  &0   'AL
M+W=O<FMS:&5E=',O<VAE970W-RYX;6RU5]MNVS@0_15"V(<$6$2BY)L"VT B
M)XV!I!O$[?:AV =:&MM")-)+TG8#].-+4K)\DUBC2/(0B]2<,X<SU S9WS#^
M*A8 $OW(,RH&SD+*Y;7KBG@!.1%7; E4O9DQGA.IAGSNBB4'DAA0GKF^YW7<
MG*34&?;-W#,?]ME*9BF%9X[$*L\)?[N%C&T&#G:V$R_I?"'UA#OL+\D<)B"_
M+I^Y&KD52Y+F0$7**.(P&S@W^'J,VQI@+/Y-82/VGI%>RI2Q5ST8)P/'TXH@
M@UAJ"J)^UA!!EFDFI>/_DM2I?&K@_O.6_=XL7BUF2@1$+/N6)G(Q<'H.2F!&
M5IE\89L'*!=D!,8L$^8_VI2VGH/BE9 L+\%*09[2XI?\* .Q!_ [#0"_!/A'
M@*#;  A*0'#L 3< 6B6@=:Z'=@EHG^NA4P(Z1P <-@"Z):![+J!7 GK'DMH-
M@+ $A&8[%/DSR1\1289]SC:(:VO%IA_,#C)HE?.4ZLT^D5R]315.#B-&94KG
M0.,4!+IX )+)!8H(!Q0Q(=$+Q&P-_ T]IC*=$[U!+]'%""1),W'9=Z72H)G<
MN/1W6_CS&_QA]*0\+@2ZHPDD-?C(C@]^A[^SXT,+WE6QJP+H;P-XZUL)/[/U
M%0J\OQ$.P][7R0A=_'4I))%0MS8[U026!97O^;BDBC.2JC)$5S-5%E:\CG5T
M/JM7LM;%[4.TW;^+MD]VEG]B>87\;L%B1-5P/)S#T=,<.&SB&-LYG@A7J\$%
M1V-<#G994'VF@:%N-5 W?Y<WIFD(]/T)\BGP_RS.6I6SEG$6-#A[9$*@P\+P
M_5'9H+&$7-@\M"L/;>MR/J^T5L1F*%:-2B#5NA/E#/U$3:'_5!"V#:'NX.LA
M[KOK_03;+ Y4=BJ5G3-5F@]:J-*L<B! R@P2E%4%4<EN^N)O.R>B6IUZ5=U*
M5=>J:J)=E2K4J4,B,N=@G@0BE*Y(AI;DS8SK!!7DG3U!8<LK_^J%]2IAO3\7
M)B7C%-[0#*"2&9-EG<+>B<*V76!8"0RM G<M;$]E79D.3Q1@?"*AJ+TUIGZ]
MZ=VI:=!@>E]C&MAC@+U=P_>L4?BR4(=B"51MX;V ;,N'VLL1H20A^S/O4GWP
MWI$$?U#]P?[.A__.%2@J&0\*S'&.[3:'6G>U']N+OTE(2BCZPJ8DCAEZVO46
M+NRIF^3L5:^+T*1*8T94?+>9TR]NYNI+51M!;8E(KU[4[0Q;V'>=!7]4:\&[
MWH+/;2[Y09Q^(OM9)<*G'20XSN]O3<96DV))[MYY/0<^-Y<]@6*VHK(X$U2S
MU87RQERCCN8C?#W"-?-W^/J^N"[NZ(O;JSJCS%.5]@QFRI5WU54Z>7$A+ :2
M+<UM8<I4R<[-XT)=HH%K _5^QIC<#K2#ZEH^_ 502P,$%     @ /5%<4TX]
M"84J"   ES@  !D   !X;"]W;W)K<VAE971S+W-H965T-S@N>&ULO5O;;MLX
M$/T5PMB'+I#6(JEKD 1(XJ19H&F#IMU%L=@'QF9L;75Q)3II@/WXI63%(ULB
M(RMB7Q);)F>&9\@S%TE'CVGV/5]P+M#/.$KRX]%"B.7A>)Q/%SQF^;MTR1/Y
MRWV:Q4S(K]E\G"\SSF;EI#@:$\MRQS$+D]')47GM)CLY2E<B"A-^DZ%\%<<L
M>SKC4?IX/,*CYPN?P_E"%!?&)T=+-N>W7'Q=WF3RVW@C91;&/,G#-$$9OS\>
MG>+#J\ N)I0C_@SY8U[[C(JEW*7I]^++'[/CD558Q",^%84()O\]\',>184D
M:<>/2NAHH[.86/_\+/VR7+Q<S!W+^7D:_17.Q.)XY(_0C-^S520^IX]7O%J0
M4\B;IE%>_D6/U5AKA*:K7*1Q-5E:$(?)^C_[60%1FT"P8@*I)I"N$V@U@>Y.
M<!43[&J"W56#4TUPNDYPJPEN5Y.\:H+758-?3?!+[Z[=4?IRP@0[.<K21Y05
MHZ6TXD.Y(<K9TH5A4NS=6Y')7T,Y3YR<IXD(DSE/IB'/T9N/-]?H=/:OU"OW
MIT"3,%^N!,]_1V\F7+ PDI]^0V&"KL,HDELO/QH+:40A:CRM%)ZM%1*%0HJN
MI<I%CBZ2&9^US)_HYP<OS;_4S\=$(V LT=M 2)XA/"-:B;=\^0Y1ZP 1B^"O
MMQ/TYK??6^PZ[R[%4DN9[&]++IC@+:(N!C'H4B]EPJ=2"GY)ROO.4K#_PK*N
MNHMR6@W:V@1T<XYH*=96B+WB+!(+=,XRCL[37*#/?)H^\.P)G98DG:._KWE\
MQ[-_-,KLC3*[5$85RCZD>8ZV3^[?'^08](?@<:[3X&PT.-KE? A%.&=E=,FY
M$!$OZ*#ML*_%N*68(DX^G&!L64?CA_K.;QE$=@=-FH-H8]!%RR!:&[2U5G>S
M5E>[5DEY7V]/-_Y!_Z%!G.EMU'N&G.EO-/AZ9Q8:IAL-3P<H6176H_0>E:<H
MET%'KG?MZ1F*P/EA,HU6,SD/?91IR#>9AAS(-.<NYS]617S@/Y=LG<;\AU3G
M\?W:.*?N,[?=8\%F0<&>"YIF?!:*'(E4+NI>+@0MV5.Q9]LBU/N@N1\MJMA%
MV()(:NU_9@X0B]/5&BJ9KDETI8EW'+%'ELGP@^ZS-$:I6$AO+%DFGEH#HM5$
MD*C,K05^;&S;R\&WU6:IK;K#H< $S".&C@4&SL9ZTM8=##:3&TJNBD7/9X3_
M%+Q(&92'17,&*D.V7.@H/ A1 -LF/7@C5U.<[#T]""$$.Z8\"-2-]=S]"SWH
M-CR(%0X$YL?>T XL\A;+1CMY>A>_0;3 OBF_ 8%C/8-?Y"*4A2<O_+24^L*[
MB*.Y++5;^:_)U]3WV\$G0-=$3]>#@]_[2!'@;((-N88 \1+RVFPA2<7F]*B/
MS*12M'5D%&&+ &>3_IQ=3V;DD")UD18N.,ODX%QK:I.? X6E0,]$3\\=@935
M]#2-EU'(DBE?V\[S::&M&+3B>KOMAMU$83?P-GDA]W_9[M?9[#1L]A0V0QP@
M^\:!&8O97!J2IZOY0J9A#RQ:M9ES5DFNLPNA"GN V<DO9G8]N<A?2YG20[<L
MXIWJ$P(!@9@*" 0" MDWI9<9_6K=WY09\[1:75ZLKG53-6,$4<1G"B&"F@D1
M3H_X3"$(4%-!@$(0H/H@L%=\IBT\[ZO KS54]$3?%WRW#_A ZM14ZX4" 5,]
M >\'?I--L6,KP <^I8/W1$KPO3[@ ZM24ZT2"F1']<V2_<!O]C:PKZCK*' A
MU7-A7_#]'N#;0(:V90A\&ZC-UO<D]@*_DK65^SB*_-(&YK/US-<7_* /^$"&
M-C4%?JVIK,]7]P._)?'$"LZW@?EL/?/U!!];?< ',K1=4^ #M=GZA'$_\+T6
M\!4%L0W,9^N9KR_XN _X0(9V8.I>!U";H\_S]@+?:79CL:MH:#O ?,[@W=@2
M?-(#? ?(T#'5A'6 VAQ]GK<?^,TZG6!%MN, \SF#-U)+\&D?\&NWX$SU3QV@
M-D>?Y^T'?K,%2H@*?& ^QTBIC/LT01T@0\=4S>L M3D#-D$K6=O9CH+S76 ^
MUTB%BW<KW$X=!Q?8T#55XKK ;>Z ):[;+'$I5G2)7* ^UTB)BW=+W&[H QVZ
MIFI<%\C-';#&=9LU+@D4?4ZW=MO?2(V+=VO<;N@#'[JFBEP7V,T=L,AU6V[@
M6RKT@?Q<(T4NWBURNSV+ 83HF:IR/6 W;\ JUVM6N90H6@P>D)]GI,K%NU5N
M-_2!$#U39:X'[.8-6.9ZS3+7MA4ICP?DYQDI<\ENF=L-?2!$SU2=Z]4>=AJP
MSJUDU9OZCJ=@'@_(SS-2YUK.V[8&9]^;OAXPI6>J O:!]OP7GET:[*:OWU(>
M*YIR/C"F;Z0Z[N.R\M<L3&?H4\)UV +7^J:*:!^(TW_U7?&N_NM\)]P'RO4'
MN1->67> 6'87BFSMEV7IC%9+]4HI>N(LRW7P F'[1@C[=?OORV.J,QYHW3=%
MZS[0NJ^G]0'W7[.WJ6@K^[7G7U_] &R?_:=7BLO]IT,7(H"OSY6?G[W=VB1]
MMN27K'A<MUS7M^)PE(\<O"VSZE<_VAE L E,Y=@!1(Q 'S&Z/L!^5<G9>KC,
M4U3V 7!^H,^OKS]]_'+Z\;353SWAA5@0F$JB V#TX 5&[PCO926G#N]N^CRN
MO;T4\VQ>OLE6G-=5(M;O1&RN;MZ6.RW?$=NY?H8/SW'+]0D^O&B[?HD/K];O
MR(':]2M[URR;ATF.(GXO3;#>%?E\MGX+;OU%I,ORG:J[5(@T+C\N.)OQK!@@
M?[]/4_'\I5"P>1?QY']02P,$%     @ /5%<4[ ^<T%4 @  , 4  !D   !X
M;"]W;W)K<VAE971S+W-H965T-SDN>&ULG51-;]LP#/TKA-%#"PQUXK3=4#@&
MDF;#.BQ8T"#;H=A!B1E;J#X\B6E:8#]^E)QX*;#DL(M%4GR/CY2E?&O=DZ\1
M"5ZT,GZ8U$3-;9KZ58U:^$O;H.&=M75:$+NN2GWC4)01I%6:]7HWJ1;2)$4>
M8S-7Y'9#2AJ<.? ;K85[':.RVV'23_:!!UG5% )ID3>BPCG2HIDY]M*.I90:
MC9?6@,/U,!GU;\?7(3\F?)>X]0<VA$Z6UCX%Y[X<)KT@"!6N*# (7I[Q#I4*
M1"SCUXXSZ4H&X*&]9_\4>^=>EL+CG54_9$GU,/F00(EKL5'T8+>?<==/%+BR
MRL<O;'>YO016&T]6[\"L0$O3KN)E-X<#0-8_ LAV@"SJ;@M%E1-!HLB=W8(+
MV<P6C-AJ1+,X:<*AS,GQKF0<%7?6D#05FI5$#^??J$8'$^F;#;&_,"6['(,Y
M">(O$BGD,R$850ZCY2_@?((DI&+K#*2!J52*)^[SE%AAJ).N=FK&K9KLB)H^
M3%E/[>$C%R[?XE/NK&LOV[<WSDX2?A'F$@;]=Y#ULOYB/H'SLXL3M(-N:H-(
M>W6$=C:%Q7P$CU/42W0_X3?\S^ Z_ E%5YVBJZAH<$315^L]O#W,QZ^< _>$
MVI^J<-U5N#[9\TC;#<NWCCO#$LC"$J$1LH2ULQIL'$ C'+W^Z]Q;[IO('1Z*
MYV*0Y>GSH9[TX"_6Z*IX5SVL0MGVA^ZBW7,P:F_!W_3V+9D*5TGC0>&:H;W+
M]US>M?>S=<@V\4XL+?$-BV;-3QJZD,#[:VMI[X0"W2-9_ %02P,$%     @
M/5%<4^ +)='L @  *@D  !D   !X;"]W;W)K<VAE971S+W-H965T.# N>&UL
MM59;3]LP%/XK1Q'20-I(TI9R45NIE\&0J%2!V!X0#VYRFEKXDME."])^_&PG
M#86U&2^\M+Z<[_-W+O%Q;RW5DUXB&GCF3.A^L#0FOPA#G2R1$WTL<Q1V9R$5
M)\9.51;J7"%)/8BSL!5%W9 3*H)!SZ_-U* G"\.HP)D"77!.U,L(F5SW@SC8
M+-S2;&G<0CCHY23#.S3W^4S965BSI)2CT%0*4+CH!\/X8A)'#N M?E)<ZZTQ
M.%?F4CZYR77:#R*G"!DFQE$0^[?",3+FF*R.WQ5I4)_I@-OC#?NE=]XZ,R<:
MQY+]HJE9]H.S %)<D(*96[G^@95#)XXOD4S[7UA7ME$ 2:&-Y!78*N!4E/_D
MN0K$%L#R[ :T*D#K/:"[!]"N .WW@,X>0*<"='QD2E=\'";$D$%/R34H9VW9
MW, 'TZ.M^U2XO-\997>IQ9G!6 I#188BH:CA\!)35(3!E5RA$C:_YHN&&[+6
M!35'<#A!0RC31_ -_K6L#>%ABGR.ZM&:W=]-X/#@" Z "IA2QFRR=2\T5KH3
M$":5S%$IL[5'9@Q3*W2IX;M(,=V!'_\'WVH@"&W,ZL"U-H$;M1H9AT5V#.WX
M*[@O;)>@9O@$DPT\/M\!GWP<WFGPIEV70=OSM??PW4BMX6TM/-Q8&[@VR/5C
MPPF=^H2./Z&S3S'5"9.Z4 @Y*BIW)7'43!%'\()$Z08U)[6:DT:J:YXS=$5+
M_.TC%]9YI=!?0G;(>2%HXO?T:S7_@=G4%O2P7FD0TJV%=#\I\*?U":>-KLZ4
M7-'JFF;$8 I& J.&9J7OUFNI]GQ4)7/7,[L.LAJT;:VOMNNTT>2-X+-:\-EG
MY&;(C*($KI0L\H]DZ+R6<_Y)&8JCUTLX^K0<5=2-26JV*46'6TV$H\I\,]:0
MR$*8\EJL5^N&/_1M[MWZV#T$?'-ZI2E?$5.B,FJSQG!A*:/C4_N1JK(QEQ,C
M<]^JYM+8QN>'2_N80>4,[/Y"2K.9N /JY]'@+U!+ P04    "  ]45Q3DUVS
M0*4$  "K$P  &0   'AL+W=O<FMS:&5E=',O<VAE970X,2YX;6RU6-MNVS@0
M_17"Z$,*I)%(6;X$MH'XDFZ 9)NMT>U#L0^T1-M$*5$E*;L!^O%+ZNK8$NL6
MM1\LB>*<.9P9'E(<[;GX*K>$*/ ]8K$<=[9*);>.(X,MB;"\X0F)]9LU%Q%6
M^E%L')D(@L/,*&(.<MV>$V$:=R:CK.U93$8\58S&Y%D F481%B]3POA^W(&=
MLN$CW6R5:7 FHP1OR)*H3\FST$].A1+2B,22\A@(LAYW[N#M>S0T!EF/?RG9
MRX-[8(:RXORK>7@(QQW7,"*,!,I 8'W9D1EAS"!I'M\*T$[ETQ@>WI?H]]G@
M]6!66)(99Y]IJ+;CSJ #0K+&*5,?^?XO4@S(-W@!9S+[!_NBK]L!02H5CPIC
MS2"B<7[%WXM '!B@7HL!*@S0L0%L,? * ^_(P/-:#+J%0??(  Y;#/S"P#_7
MH%<8],XUZ!<&_2Q9>72SU,RQPI.1X'L@3&^-9FZR_&;6.B,T-J6X5$*_I=I.
M368\5C3>D#B@1(*KQ;L=3K@ SX*'::# (U5T@_.BB4/P\,^'Y4';6W U)PI3
M)M^.'*79&$PG*#Q/<\^HQ3,$3]KW5H)%')*PP7YNMQ]:[!T=A2H4J S%%%D!
MYR2X 1Z\!LA%;L*P#LQZ'>@R;^ VLT/=)4)#N3G4I^4<7+UIBM#<CK(D284"
M"Y2 81HQO)<I50V("SOBAT#= .3GB!E4 \;].1C]?&QM&._/P1@8##ALP'B5
M/Z\J92\#]5I '[F4X'4]?WG4?<"#(I'\S^*A6WGH9AZZ-@]!Y>'E&L1IM"("
M\#4PA2+UY%5;(/4*$O!4*!!BI1M_@)8JFN;N_,R=631VD^[(V34P]"N&OI5A
M.7\/YNV7)V(XVL;?J]![%XIPO_+0M_+_^RB>>L4-M;.F*NV?Q ["KE^%+R_#
MTTYN<X '%<'!F02U0M!,(DR"2[EH2O+@A -J(3&L2 S/)*&V5(0@P4*]@$(5
M#)UV@9@/3]AXS62@6R\AKI6.614LN8<':Q&\4'U!5/M OSB'0QSI39?4&ZN
M[XC *T:NP0ZSE.A(OFD2_\)%[^=E!6OQ@IZ5US)=2?(M);$"BYWY+^>M)O%[
MLQK6L@:[EXI[+4S0KDSGS^Q%@?1JQ@Q]V!+A6KQ@S\I@QK >YEV^!7[,9\AA
ME"^0@5KV8/]2&:B5"YXK73_/P*EF^6TR48L6/%>U"L\@6_GEM9F.DC-J5LL0
MZ,\KH+^JWBE!,0-)*A*NV3:R/-4R-&AFB6HQ0W8Q>RZX/>C+CH:IYO!8"NM%
MBP75,HDN)9.HEDEDE\E?*)8"Z54:_&Y;(FI!1'9!+!-1SM1[RG1U3%_ ,MAR
M_9TTIU*72'#A*8QJ$467$E%4BRCZ8R**3D74\UM6*51K*+)KZ)(H9=+0$,3?
M#W&MDNA2*HEJE41VE3S='^0J97;U9NCEGK_Q<^Y4-EM6+52K)K*KYD$L<P:1
MJ>OFC<F\P#K<F'3=_'?$PSDX,HB(V&2G06;@::SR3^:JM3IQNLO.68[:I_!V
MEI\;U3#Y,=83%AL:2\#(6D.Z-WT=%Y&?#.4/BB?9P<2**\6C['9+<$B$Z:#?
MKSE7Y8-Q4)W/3?X'4$L#!!0    ( #U17%-IBKS7_@,   $0   9    >&PO
M=V]R:W-H965T<R]S:&5E=#@R+GAM;+57;6^;.A3^*Q;2I$VJ H:0ERJ)E+>N
M7=.M6M3=#]/]X( 3K &FMDE6:3]^-A"2)N!P>[<O"08_SWG.\?&QSV!'V0\>
M8"S SRB,^= (A$BN39-[ 8X0;]$$Q_++FK(("3ED&Y,G#",_ T6A:5M6QXP0
MB8W1('OWR$8#FHJ0Q/B1 9Y&$6(O$QS2W=" QO[%5[()A'IAC@8)VN E%D_)
M(Y,CLV3Q281C3F@,&%X/C3&\OH=M!<AF?"-XQX^>@7)E1>D/-;CSAX:E%.$0
M>T)1(/FWQ5,<AHI)ZG@N2(W2I@(>/^_9;S+GI3,KQ/&4AO\07P1#HV< 'Z]1
M&HJO='>+"X=<Q>?1D&>_8%?,M0S@I5S0J !+!1&)\W_TLPC$$0#V:P!V ;!/
M +9; W *@-/40KL M)M:< N VQ30*0"=IH!N >B> F -H%< >J< IP;0+P#]
MTRBUZQ;.VJ^<U1A2+G:>='F69"DV0P*-!HSN %/S)9]ZR/(TP\O,(K':4DO!
MY%<B<6(TI;$@\0;''L$<O!_+D6#2,%@0038H3_O8!\L ,1S0T,<,3$/$.1A[
ME1]GF)$M4OL$+-".IT3P#^#]# M$0OYA8 HI6IDVO4+@)!=HUPB$X$%*##B8
MQS[V*_ S/=ZYA+_1XSN7\!\OZ+<U!*9<K7+)[/V236PMXSAA+>!85\"V;.B%
MB$05JJ87.-*-Y( 9A\4/RU<57SW3$B>7U<SU'#/L[=7 OE[-C9[I ;'2+ZAG
M^M@\0A>8;O5,7SS1 K:;,X7YGJA@N=.S?*;;,LZ61Z-$ACJNXOG4/'NL"OA]
M\Z7J:9+9*>N/D_$Y-7P+*DO)ZR+T?2'G@#N!(_ZOQD*[M-#.++1U%KS2PLL5
MB--H)2L578,RCAS\ KJ@WN4VW,R&NJ9L1\[ W%;(<DM9[IME':4;!VLBH1O@
M9447Y46WR"*E6I^:4_=,MUWJSK>F;L8KSSJE9YTW>R9O@G[FC;P%99,X#8F/
M!/;5 M14CTGG3*);+;%;2NS^T>#[AT.M<>AONIJ4R2O0^8Q.M5^]TJ_>_\CU
MHV!7.U2W +/>F=!VM=!^*;2O%?KIZ6D!OC]@)4ZWR:%UN,=8?ZF0P*.[$M2J
MGC_+0+T CKV4R>L1YE> [F*9)P%)9&HS#\="]B&5EQ0]L^.V+.M=535_*_#^
M#<#78;$/8;&U5,MTQ?%S*IT'\ZWZ;;*PAP,"_JT3 AZ."/A?SXBJ<BMW2/WQ
M?0O/CPAXNIW-HXMZA-DFZR65Y306^9E9OBW[U7'6I9V\G\#K*:QX/X/7\[PQ
M.-#GS;&\&6U(S$&(U]*4U>I*H2SO-_.!H$G6)JRHD&U']AC('ATS-4%^7U,J
M]@-EH.SZ1[\!4$L#!!0    ( #U17%/;OW@\J@(  (X'   9    >&PO=V]R
M:W-H965T<R]S:&5E=#@S+GAM;+5574_;,!3]*U:>F,3(1RD4E%8J91-(=*NH
MV![0'MSD-K5P[&+?M$S:C]^U$[(RVHI)XR7QM7W//>?8N4G7VCS8!0"RIU(J
MVP\6B,OS,+39 DINC_02%*W,M2DY4FB*T"X-\-PGE3),HN@D++E0P2#U<Q,S
M2'6%4BB8&&:KLN3FYP5(O>X'<? \<2N*!;J)<) N>0%3P+OEQ% 4MBBY*$%9
MH14S,.\'P_C\(O8)?L<W 6N[,69.RDSK!Q=<Y_T@<HQ 0H8.@M-K!2.0TB$1
MC\<&-&AKNL3-\3/Z9R^>Q,RXA9&6WT6.BW[0"U@.<UY)O-7K*V@$=1U>IJ7U
M3[9N]D8!RRJ+NFR2B4$I5/WF3XT1&PE);T="TB0DGG==R+.\Y,@'J=%K9MQN
M0G,#+]5G$SFAW*E,T="JH#P<C+1"H0I0F0#+#FZ<"!O>232<U0$;D6C[@1U<
M G(A:?213:N9A<<*%+)/*_>\'T,Y _,C#9%(.>@P:PA<U 22'02^9GC$DNXA
M2Z(DSB0794;U,ET9? D6DK)67M+*2SSZ\0[T1L)V>B\0.RUBQR-V=B%J2Y:\
M<.W^AO:P:X32[JMPW%8XWLMYY$RP3&ED&1@4<P'Y(5.54\!^,6?/-IMKT*X'
M==_B:I!TTG"UA4BW)=+=2^1+75+/?4W+J!/DI'I;\>[KXMMKG[2U3_[EX$CW
M9,SNIL.W'.5I6^/TG8ZRUU;HO=%!BQR!^6MMW2&^OM^UD;W71L;;G3QK.9SM
MY3 M]0,)9%SE[ JXQ 6C&T;*A[XO6K\P+ H#!5',67/];@0*FG"=\PV6Q]&?
M?A.]D^GQ1D^+_]?%;9 V#?_;[W"CN[H_U9B;0I!O$N:4$QV=4K*IFW\=H%[Z
MACO32.W;#Q?TPP3C-M#Z7&M\#EP/;W_!@]]02P,$%     @ /5%<4Y^J4IP=
M @  ;00  !D   !X;"]W;W)K<VAE971S+W-H965T.#0N>&UL?53;;MLP#/T5
MP4\M4,2.D^Q2. :6=,,*I%O0K-M#L0?%IFVANK@2'7? /GZ2[!@.L.3%$D6>
MPT.*<M(J_6(J "1O@DNS#"K$^C8,35:!H&:B:I#64R@M*%I3EZ&I-=#<@P0/
MXRAZ%PK*9) F_FRKTT0UR)F$K2:F$8+J/RO@JET&T^!X\,C*"MU!F"8U+6$'
M^%1OM;7"@25G J1A2A(-Q3+X-+U=S5V\#_C)H#6C/7&5[)5Z<<9]O@PB)P@X
M9.@8J%T.L ;.'9&5\=IS!D-*!QSOC^Q??.VVECTUL%;\%\NQ6@8? I)#01N.
MCZK]"GT]"\>7*6[\E[1];!20K#&H1 ^V"@23W4K?^CZ, -./9P!Q#XB][BZ1
M5WE'D::)5BW1+MJRN8TOU:.M.";=I>Q06R^S.$S72B*3)<B,@2%73[L?9,.0
ME=3US)!O5&OJ^G9-KNX *>/F.@G1)G;P,.N3K+HD\9DDWS.<D'AQ0^(HGF:<
M,G'*$5K1@_)X4!Y[TOD9TBW(W"HG]W8YL+RAG&QH:QJ&ACP_@-B#_DW^DEVS
M-_#:@$3R^>"^(]]IM8/G@KC9(&[FQ<W.B-LH8\AI;Y\W-H;<(PAS*<-\R#"_
M6/[:M=&0@G'(;XALG/+_W4S'LO L[H4>TFD2'L:)P]'TN(?X0'7)[-US*"PF
MFKRW8-T-=V>@JOU [17:\?3;ROX/0+L ZR^4PJ/A9G3XPZ3_ %!+ P04
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MIVD,M7.@_8,B&9J%"]#.=YO_ 5!+ P04    "  ]45Q3$CK/)3@#  #R$P
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M@54!ZQV([X\#/>7WB2*H*J8->X)Q)$DP!'K1WZ-QC&0GAH^_/MA3$D5)XD<
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MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0
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M%VU=G_A]-^I*\_+Y/WG/_R?\]!]02P,$%     @ /5%<4U(UQJ.* @  N3(
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MA'HG KT-]38"O0WU-@*]#?4V KT-]38"O0WU-@*];?*QDD!O0[V-0&]#O8U
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MM.=?\24QEK[X_>P\[<8V;\R.U_MS=(=E'CY;'I??\>\S?JG_SCX$I \)Z:.
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M4$L! A0#%     @ /5%<4R,831CO    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ /5%<4YE<G",0!@  G"<
M !,              ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    "  ]45Q3%%Q9J$X&  !@(   &               @($."   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ /5%<4^U'VE(P"   F2(
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M965T-BYX;6Q02P$"% ,4    "  ]45Q34CWZ%=@"  #;!P  &
M    @('=+   >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @
M/5%<4_KI&II<"0  N"@  !@              ("!ZR\  'AL+W=O<FMS:&5E
M=',O<VAE970X+GAM;%!+ 0(4 Q0    ( #U17%,*]'>P:0P  -L@   8
M          " @7TY  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4
M    "  ]45Q3L%N7BW '  !%%0  &0              @($<1@  >&PO=V]R
M:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( #U17%/Z7S_)GP4  $<-
M   9              " @<--  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL
M4$L! A0#%     @ /5%<4X7-IDB4%   &T4  !D              ("!F5,
M 'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    "  ]45Q3%^>H
MHPX,   !)P  &0              @(%D:   >&PO=V]R:W-H965T<R]S:&5E
M=#$S+GAM;%!+ 0(4 Q0    ( #U17%.>/.[UJ04  .L,   9
M  " @:ET  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @
M/5%<4_L#P#,6 P  '@<  !D              ("!B7H  'AL+W=O<FMS:&5E
M=',O<VAE970Q-2YX;6Q02P$"% ,4    "  ]45Q3<HR&OC0&  #&%0  &0
M            @('6?0  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4
M Q0    ( #U17%,W1T<[N@L  #8@   9              " @4&$  !X;"]W
M;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ /5%<4T-=]YSK"@
M!QX  !D              ("!,I   'AL+W=O<FMS:&5E=',O<VAE970Q."YX
M;6Q02P$"% ,4    "  ]45Q37+*Y?:X%  #X#P  &0              @(%4
MFP  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( #U17%.U
M>/(\D2@  +N%   9              " @3FA  !X;"]W;W)K<VAE971S+W-H
M965T,C N>&UL4$L! A0#%     @ /5%<4Q,!G0;- P  I@@  !D
M     ("! <H  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #U17%-R"NM/XP0  /(,   9              "
M@<[D  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ /5%<
M4VBB/1B#"   #!L  !D              ("!Z.D  'AL+W=O<FMS:&5E=',O
M<VAE970R-RYX;6Q02P$"% ,4    "  ]45Q3H4Y*PA$#  "O!@  &0
M        @(&B\@  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0
M   ( #U17%,PE%E$' ,   ('   9              " @>KU  !X;"]W;W)K
M<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ /5%<4QIOP2ME!@  <Q8
M !D              ("!/?D  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q0
M2P$"% ,4    "  ]45Q3&U=.#W$%   +#@  &0              @('9_P
M>&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( #U17%.E41+[
M^@(  'L&   9              " @8$% 0!X;"]W;W)K<VAE971S+W-H965T
M,S(N>&UL4$L! A0#%     @ /5%<4UTZF15H P  (0@  !D
M ("!L@@! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    "  ]
M45Q3@$E\JOX,  "3)@  &0              @(%1# $ >&PO=V]R:W-H965T
M<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( #U17%.<6^>6W@,  (H(   9
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M970S.2YX;6Q02P$"% ,4    "  ]45Q346M^HE($  !B$   &0
M    @('T+0$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    (
M #U17%.IC 9O4 ,   T-   9              " @7TR 0!X;"]W;W)K<VAE
M971S+W-H965T-#$N>&UL4$L! A0#%     @ /5%<4X"UUC&F P  00\  !D
M             ("!!#8! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"
M% ,4    "  ]45Q3HTRU?T<$   \$0  &0              @('A.0$ >&PO
M=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( #U17%,D+,JWS@,
M 'D.   9              " @5\^ 0!X;"]W;W)K<VAE971S+W-H965T-#0N
M>&UL4$L! A0#%     @ /5%<4_\:8(K7 @  8 8  !D              ("!
M9$(! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    "  ]45Q3
M+D-H3+L$  !1%0  &0              @(%R10$ >&PO=V]R:W-H965T<R]S
M:&5E=#0V+GAM;%!+ 0(4 Q0    ( #U17%.K@4CBWP(  #D(   9
M      " @61* 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%
M  @ /5%<4SXT>51. @  2@4  !D              ("!>DT! 'AL+W=O<FMS
M:&5E=',O<VAE970T."YX;6Q02P$"% ,4    "  ]45Q3?61%U)\$  !=&@
M&0              @('_3P$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+
M 0(4 Q0    ( #U17%/5E[+&(0,  )$'   9              " @=54 0!X
M;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ /5%<4Z7@ /'C
M P  KA,  !D              ("!+5@! 'AL+W=O<FMS:&5E=',O<VAE970U
M,2YX;6Q02P$"% ,4    "  ]45Q36)4V/0H#   K"@  &0
M@(%'7 $ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( #U1
M7%,S>YWHG0,  !8.   9              " @8A? 0!X;"]W;W)K<VAE971S
M+W-H965T-3,N>&UL4$L! A0#%     @ /5%<4^E9S+1F!   CA(  !D
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M 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    "  ]45Q3\EM
M>)\$  #Y%@  &0              @($:=P$ >&PO=V]R:W-H965T<R]S:&5E
M=#4X+GAM;%!+ 0(4 Q0    ( #U17%-*0?IY4P8  /(<   9
M  " @?![ 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @
M/5%<4PER8*\J P  A D  !D              ("!>H(! 'AL+W=O<FMS:&5E
M=',O<VAE970V,"YX;6Q02P$"% ,4    "  ]45Q3!Q$&C7P#   9#0  &0
M            @(';A0$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4
M Q0    ( #U17%-C8*Q9M00   T5   9              " @8Z) 0!X;"]W
M;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ /5%<4W4>'P#/!@
M12,  !D              ("!>HX! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX
M;6Q02P$"% ,4    "  ]45Q3_=)(>NP#   8%@  &0              @(&
ME0$ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( #U17%,\
M2;+TY (  -\(   9              " @:.9 0!X;"]W;W)K<VAE971S+W-H
M965T-C4N>&UL4$L! A0#%     @ /5%<4TFI=E3D @  . H  !D
M     ("!OIP! 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #U17%.Y$.[O"0<   HR   9              "
M@2NO 0!X;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @ /5%<
M4RF7>!C3 P  [ \  !D              ("!:[8! 'AL+W=O<FMS:&5E=',O
M<VAE970W,BYX;6Q02P$"% ,4    "  ]45Q3];,ZVWD%  !3'   &0
M        @(%UN@$ >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0
M   ( #U17%-FE&;<"PH  *],   9              " @27  0!X;"]W;W)K
M<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @ /5%<4V:EE2H8 @  600
M !D              ("!9\H! 'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6Q0
M2P$"% ,4    "  ]45Q3%4 EFN$&  ! +   &0              @(&VS $
M>&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    ( #U17%-B_"-C
M$00  *(/   9              " @<[3 0!X;"]W;W)K<VAE971S+W-H965T
M-S<N>&UL4$L! A0#%     @ /5%<4TX]"84J"   ES@  !D
M ("!%M@! 'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q02P$"% ,4    "  ]
M45Q3L#YS050"   P!0  &0              @(%WX $ >&PO=V]R:W-H965T
M<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( #U17%/@"R71[ (  "H)   9
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M970X-"YX;6Q02P$"% ,4    "  ]45Q3499GQ)$"  #?!@  &0
M    @(%K] $ >&PO=V]R:W-H965T<R]S:&5E=#@U+GAM;%!+ 0(4 Q0    (
M #U17%,>O4A/< ,  .L)   9              " @3/W 0!X;"]W;W)K<VAE
M971S+W-H965T.#8N>&UL4$L! A0#%     @ /5%<4Q(ZSR4X P  \A,   T
M             ( !VOH! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  ]45Q3
MEXJ[',     3 @  "P              @ $]_@$ 7W)E;',O+G)E;'-02P$"
M% ,4    "  ]45Q3TI/S5IL&  #3.   #P              @ $F_P$ >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ /5%<4U(UQJ.* @  N3(  !H
M         ( ![@4" 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ /5%<4X/1K $N @  1#$  !,              ( !L @" %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&     %X 7@#)&0  #PL"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>564</ContextCount>
  <ElementCount>429</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>224</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>17</UnitCount>
  <MyReports>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Earnings (Losses)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses</Role>
      <ShortName>Condensed Consolidated Statements of Earnings (Losses)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Earnings (Losses)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsLosses</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Earnings (Losses)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' (Deficit) Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquityParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Background and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BackgroundandBasisofPresentation</Role>
      <ShortName>Background and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2106102 - Disclosure - Revenues from Contracts with Customers</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/RevenuesfromContractswithCustomers</Role>
      <ShortName>Revenues from Contracts with Customers</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2109103 - Disclosure - Assets Held for Sale</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/AssetsHeldforSale</Role>
      <ShortName>Assets Held for Sale</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2113104 - Disclosure - Investments in Equity Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecurities</Role>
      <ShortName>Investments in Equity Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2121105 - Disclosure - Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstruments</Role>
      <ShortName>Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2130106 - Disclosure - Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BenefitPlans</Role>
      <ShortName>Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2134107 - Disclosure - Earnings (Losses) per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/EarningsLossesperShare</Role>
      <ShortName>Earnings (Losses) per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2137108 - Disclosure - Other Comprehensive Earnings/Losses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/OtherComprehensiveEarningsLosses</Role>
      <ShortName>Other Comprehensive Earnings/Losses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2141109 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2147110 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2151111 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2156112 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2176113 - Disclosure - New Accounting Guidance Not Yet Adopted</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted</Role>
      <ShortName>New Accounting Guidance Not Yet Adopted</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Background and Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BackgroundandBasisofPresentationPolicies</Role>
      <ShortName>Background and Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2208202 - Disclosure - Revenue from Contract with Customer (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/RevenuefromContractwithCustomerPolicies</Role>
      <ShortName>Revenue from Contract with Customer (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Background and Basis of Presentation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BackgroundandBasisofPresentationTables</Role>
      <ShortName>Background and Basis of Presentation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/BackgroundandBasisofPresentation</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2310302 - Disclosure - Assets Held for Sale (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/AssetsHeldforSaleTables</Role>
      <ShortName>Assets Held for Sale (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/AssetsHeldforSale</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2314303 - Disclosure - Investments in Equity Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesTables</Role>
      <ShortName>Investments in Equity Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecurities</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2322304 - Disclosure - Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstrumentsTables</Role>
      <ShortName>Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/FinancialInstruments</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2331305 - Disclosure - Benefit Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BenefitPlansTables</Role>
      <ShortName>Benefit Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/BenefitPlans</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2335306 - Disclosure - Earnings (Losses) per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/EarningsLossesperShareTables</Role>
      <ShortName>Earnings (Losses) per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/EarningsLossesperShare</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2338307 - Disclosure - Other Comprehensive Earnings/Losses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/OtherComprehensiveEarningsLossesTables</Role>
      <ShortName>Other Comprehensive Earnings/Losses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/OtherComprehensiveEarningsLosses</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2342308 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/SegmentReporting</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2348309 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/Debt</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2352310 - Disclosure - Income Taxes update (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/IncomeTaxesupdateTables</Role>
      <ShortName>Income Taxes update (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2357311 - Disclosure - Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesTables</Role>
      <ShortName>Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/Contingencies</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2377312 - Disclosure - New Accounting Guidance Not Yet Adopted (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/NewAccountingGuidanceNotYetAdoptedTables</Role>
      <ShortName>New Accounting Guidance Not Yet Adopted (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Background and Basis of Presentation (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails</Role>
      <ShortName>Background and Basis of Presentation (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/BackgroundandBasisofPresentationTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Background and Basis of Presentation (Share Repurchase Table) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails</Role>
      <ShortName>Background and Basis of Presentation (Share Repurchase Table) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/BackgroundandBasisofPresentationTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Revenues from Contracts with Customers (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails</Role>
      <ShortName>Revenues from Contracts with Customers (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/RevenuesfromContractswithCustomers</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2411404 - Disclosure - Assets Held for Sale (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails</Role>
      <ShortName>Assets Held for Sale (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/AssetsHeldforSaleTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2412405 - Disclosure - Assets Held for Sale (Summary of Major Classes of Assets and Liabilities Classified as Held for Sale) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails</Role>
      <ShortName>Assets Held for Sale (Summary of Major Classes of Assets and Liabilities Classified as Held for Sale) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/AssetsHeldforSaleTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2415406 - Disclosure - Investments in Equity Securities (Summary of Investments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails</Role>
      <ShortName>Investments in Equity Securities (Summary of Investments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2416407 - Disclosure - Investments in Equity Securities (Earnings in Equity Securities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails</Role>
      <ShortName>Investments in Equity Securities (Earnings in Equity Securities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2417408 - Disclosure - Investments in Equity Securities (Investment in ABI Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails</Role>
      <ShortName>Investments in Equity Securities (Investment in ABI Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2418409 - Disclosure - Investments in Equity Securities (Investment in JUUL Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails</Role>
      <ShortName>Investments in Equity Securities (Investment in JUUL Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2419410 - Disclosure - Investments in Equity Securities (JUUL Investment Classified as Level 3) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details</Role>
      <ShortName>Investments in Equity Securities (JUUL Investment Classified as Level 3) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2420411 - Disclosure - Investments in Equity Securities (Investment in Cronos Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails</Role>
      <ShortName>Investments in Equity Securities (Investment in Cronos Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2423412 - Disclosure - Financial Instruments (Aggregate Notional Amounts, Aggregate Fair Values and Carrying Values) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstrumentsAggregateNotionalAmountsAggregateFairValuesandCarryingValuesDetails</Role>
      <ShortName>Financial Instruments (Aggregate Notional Amounts, Aggregate Fair Values and Carrying Values) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2424413 - Disclosure - Financial Instruments (Aggregate Fair Value and Carrying Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails</Role>
      <ShortName>Financial Instruments (Aggregate Fair Value and Carrying Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2425414 - Disclosure - Financial Instruments (Fair Value Using Black-Scholes Option-Pricing Model) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails</Role>
      <ShortName>Financial Instruments (Fair Value Using Black-Scholes Option-Pricing Model) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2426415 - Disclosure - Financial Instruments (Beginning and Ending Balances of Fixed-price Preemptive Rights and Warrants) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails</Role>
      <ShortName>Financial Instruments (Beginning and Ending Balances of Fixed-price Preemptive Rights and Warrants) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2427416 - Disclosure - Financial Instruments (Fair Value Derivative Financial Instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails</Role>
      <ShortName>Financial Instruments (Fair Value Derivative Financial Instruments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2428417 - Disclosure - Financial Instruments (Pre-tax Unrealized Gains (Losses)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails</Role>
      <ShortName>Financial Instruments (Pre-tax Unrealized Gains (Losses)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2429418 - Disclosure - Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails</Role>
      <ShortName>Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2432419 - Disclosure - Benefit Plans (Schedule Of Components Of Net Periodic Benefit Cost (Income)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails</Role>
      <ShortName>Benefit Plans (Schedule Of Components Of Net Periodic Benefit Cost (Income)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/BenefitPlansTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2433420 - Disclosure - Benefit Plans (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BenefitPlansNarrativeDetails</Role>
      <ShortName>Benefit Plans (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/BenefitPlansTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2436421 - Disclosure - Earnings (Losses) per Share (Basic and Diluted Earnings Per Share) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/EarningsLossesperShareBasicandDilutedEarningsPerShareDetails</Role>
      <ShortName>Earnings (Losses) per Share (Basic and Diluted Earnings Per Share) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/EarningsLossesperShareTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2439422 - Disclosure - Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails</Role>
      <ShortName>Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/OtherComprehensiveEarningsLossesTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2440423 - Disclosure - Other Comprehensive Earnings/Losses (Reclassifications) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails</Role>
      <ShortName>Other Comprehensive Earnings/Losses (Reclassifications) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/OtherComprehensiveEarningsLossesTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2443424 - Disclosure - Segment Reporting (Segment Data Schedule) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails</Role>
      <ShortName>Segment Reporting (Segment Data Schedule) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/SegmentReportingTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2444425 - Disclosure - Segment Reporting (Non-Participating Manufacturer Adjustment Items) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails</Role>
      <ShortName>Segment Reporting (Non-Participating Manufacturer Adjustment Items) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/SegmentReportingTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2445426 - Disclosure - Segment Reporting (Schedule of Tobacco and Health and Certain Other Litigation Items) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails</Role>
      <ShortName>Segment Reporting (Schedule of Tobacco and Health and Certain Other Litigation Items) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/SegmentReportingTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2446427 - Disclosure - Segment Reporting (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SegmentReportingNarrativeDetails</Role>
      <ShortName>Segment Reporting (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/SegmentReportingTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2449428 - Disclosure - Debt (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/DebtNarrativeDetails</Role>
      <ShortName>Debt (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/DebtTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2450429 - Disclosure - Debt (Tender Offers) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/DebtTenderOffersDetails</Role>
      <ShortName>Debt (Tender Offers) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/DebtTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2453430 - Disclosure - Income Taxes - Summary of Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/IncomeTaxesSummaryofIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Summary of Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2454431 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2455432 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/IncomeTaxesupdateTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2458433 - Disclosure - Contingencies (General Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesGeneralInformationDetails</Role>
      <ShortName>Contingencies (General Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2459434 - Disclosure - Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails</Role>
      <ShortName>Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2460435 - Disclosure - Contingencies (Schedule of Pending Cases) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails</Role>
      <ShortName>Contingencies (Schedule of Pending Cases) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2461436 - Disclosure - Contingencies (Overview of Altria and/or PM USA Tobacco-Related Litigation Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails</Role>
      <ShortName>Contingencies (Overview of Altria and/or PM USA Tobacco-Related Litigation Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2462437 - Disclosure - Contingencies (Non-Engle Progeny Litigation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails</Role>
      <ShortName>Contingencies (Non-Engle Progeny Litigation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2463438 - Disclosure - Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails</Role>
      <ShortName>Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2464439 - Disclosure - Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails</Role>
      <ShortName>Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2465440 - Disclosure - Contingencies (Florida Bond Statute) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails</Role>
      <ShortName>Contingencies (Florida Bond Statute) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2466441 - Disclosure - Contingencies (Other Smoking and Health Class Actions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails</Role>
      <ShortName>Contingencies (Other Smoking and Health Class Actions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2467442 - Disclosure - Contingencies (Health Care Cost Recovery Litigation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails</Role>
      <ShortName>Contingencies (Health Care Cost Recovery Litigation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2468443 - Disclosure - Contingencies (NPM Adjustment Disputes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails</Role>
      <ShortName>Contingencies (NPM Adjustment Disputes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2469444 - Disclosure - Contingencies (Other Disputes Under the State Settlement Agreements) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails</Role>
      <ShortName>Contingencies (Other Disputes Under the State Settlement Agreements) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2470445 - Disclosure - Contingencies (Federal Government's Lawsuit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails</Role>
      <ShortName>Contingencies (Federal Government's Lawsuit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2471446 - Disclosure - Contingencies (E-vapor Product Litigation and IQOS Litigation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails</Role>
      <ShortName>Contingencies (E-vapor Product Litigation and IQOS Litigation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>2472447 - Disclosure - Contingencies (Antitrust Litigation and Shareholder Class Action and Shareholder Derivative Lawsuits) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails</Role>
      <ShortName>Contingencies (Antitrust Litigation and Shareholder Class Action and Shareholder Derivative Lawsuits) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>2473448 - Disclosure - Contingencies (Lights/Ultra Lights Cases) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails</Role>
      <ShortName>Contingencies (Lights/Ultra Lights Cases) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>2474449 - Disclosure - Contingencies (UST Litigations Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails</Role>
      <ShortName>Contingencies (UST Litigations Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>2475450 - Disclosure - Contingencies (Guarantees and Other Similar Matters Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails</Role>
      <ShortName>Contingencies (Guarantees and Other Similar Matters Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="mo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - mo-20210930.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - mo-20210930.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="mo-20210930.htm">mo-20210930.htm</File>
    <File>exhibit311q32021.htm</File>
    <File>exhibit312q32021.htm</File>
    <File>exhibit321q32021.htm</File>
    <File>exhibit322q32021.htm</File>
    <File>exhibit991q32021.htm</File>
    <File>exhibit992q32021.htm</File>
    <File>mo-20210930.xsd</File>
    <File>mo-20210930_cal.xml</File>
    <File>mo-20210930_def.xml</File>
    <File>mo-20210930_lab.xml</File>
    <File>mo-20210930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/stpr/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>106
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mo-20210930.htm": {
   "axisCustom": 1,
   "axisStandard": 37,
   "contextCount": 564,
   "dts": {
    "calculationLink": {
     "local": [
      "mo-20210930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mo-20210930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "mo-20210930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mo-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mo-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "mo-20210930.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 732,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 2,
    "http://www.altria.com/20210930": 4,
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 11
   },
   "keyCustom": 95,
   "keyStandard": 334,
   "memberCustom": 136,
   "memberStandard": 84,
   "nsprefix": "mo",
   "nsuri": "http://www.altria.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.altria.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106102 - Disclosure - Revenues from Contracts with Customers",
     "role": "http://www.altria.com/role/RevenuesfromContractswithCustomers",
     "shortName": "Revenues from Contracts with Customers",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109103 - Disclosure - Assets Held for Sale",
     "role": "http://www.altria.com/role/AssetsHeldforSale",
     "shortName": "Assets Held for Sale",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113104 - Disclosure - Investments in Equity Securities",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecurities",
     "shortName": "Investments in Equity Securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121105 - Disclosure - Financial Instruments",
     "role": "http://www.altria.com/role/FinancialInstruments",
     "shortName": "Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130106 - Disclosure - Benefit Plans",
     "role": "http://www.altria.com/role/BenefitPlans",
     "shortName": "Benefit Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2134107 - Disclosure - Earnings (Losses) per Share",
     "role": "http://www.altria.com/role/EarningsLossesperShare",
     "shortName": "Earnings (Losses) per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137108 - Disclosure - Other Comprehensive Earnings/Losses",
     "role": "http://www.altria.com/role/OtherComprehensiveEarningsLosses",
     "shortName": "Other Comprehensive Earnings/Losses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141109 - Disclosure - Segment Reporting",
     "role": "http://www.altria.com/role/SegmentReporting",
     "shortName": "Segment Reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147110 - Disclosure - Debt",
     "role": "http://www.altria.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2151111 - Disclosure - Income Taxes",
     "role": "http://www.altria.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i503473da7ed148e2805b9efd533f401c_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.altria.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i503473da7ed148e2805b9efd533f401c_I20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mo:InventoryRawMaterialsPlantMaterialNetofReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2156112 - Disclosure - Contingencies",
     "role": "http://www.altria.com/role/Contingencies",
     "shortName": "Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2176113 - Disclosure - New Accounting Guidance Not Yet Adopted",
     "role": "http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted",
     "shortName": "New Accounting Guidance Not Yet Adopted",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Background and Basis of Presentation (Policies)",
     "role": "http://www.altria.com/role/BackgroundandBasisofPresentationPolicies",
     "shortName": "Background and Basis of Presentation (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2208202 - Disclosure - Revenue from Contract with Customer (Policies)",
     "role": "http://www.altria.com/role/RevenuefromContractwithCustomerPolicies",
     "shortName": "Revenue from Contract with Customer (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Background and Basis of Presentation (Tables)",
     "role": "http://www.altria.com/role/BackgroundandBasisofPresentationTables",
     "shortName": "Background and Basis of Presentation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2310302 - Disclosure - Assets Held for Sale (Tables)",
     "role": "http://www.altria.com/role/AssetsHeldforSaleTables",
     "shortName": "Assets Held for Sale (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2314303 - Disclosure - Investments in Equity Securities (Tables)",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesTables",
     "shortName": "Investments in Equity Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322304 - Disclosure - Financial Instruments (Tables)",
     "role": "http://www.altria.com/role/FinancialInstrumentsTables",
     "shortName": "Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331305 - Disclosure - Benefit Plans (Tables)",
     "role": "http://www.altria.com/role/BenefitPlansTables",
     "shortName": "Benefit Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2335306 - Disclosure - Earnings (Losses) per Share (Tables)",
     "role": "http://www.altria.com/role/EarningsLossesperShareTables",
     "shortName": "Earnings (Losses) per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i503473da7ed148e2805b9efd533f401c_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i503473da7ed148e2805b9efd533f401c_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2338307 - Disclosure - Other Comprehensive Earnings/Losses (Tables)",
     "role": "http://www.altria.com/role/OtherComprehensiveEarningsLossesTables",
     "shortName": "Other Comprehensive Earnings/Losses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2342308 - Disclosure - Segment Reporting (Tables)",
     "role": "http://www.altria.com/role/SegmentReportingTables",
     "shortName": "Segment Reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2348309 - Disclosure - Debt (Tables)",
     "role": "http://www.altria.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mo:SummaryOfIncomeTaxesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2352310 - Disclosure - Income Taxes update (Tables)",
     "role": "http://www.altria.com/role/IncomeTaxesupdateTables",
     "shortName": "Income Taxes update (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mo:SummaryOfIncomeTaxesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2357311 - Disclosure - Contingencies (Tables)",
     "role": "http://www.altria.com/role/ContingenciesTables",
     "shortName": "Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2377312 - Disclosure - New Accounting Guidance Not Yet Adopted (Tables)",
     "role": "http://www.altria.com/role/NewAccountingGuidanceNotYetAdoptedTables",
     "shortName": "New Accounting Guidance Not Yet Adopted (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i33693bcc9b6d47e48094cbb1bb3c5f74_D20201201-20210429",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Background and Basis of Presentation (Narrative) (Details)",
     "role": "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
     "shortName": "Background and Basis of Presentation (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i33693bcc9b6d47e48094cbb1bb3c5f74_D20201201-20210429",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockValueAcquiredCostMethod",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Background and Basis of Presentation (Share Repurchase Table) (Details)",
     "role": "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails",
     "shortName": "Background and Basis of Presentation (Share Repurchase Table) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i66dae12b306e4c15a45bf2cedaae9792_D20210701-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockValueAcquiredCostMethod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i503473da7ed148e2805b9efd533f401c_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Revenues from Contracts with Customers (Narrative) (Details)",
     "role": "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails",
     "shortName": "Revenues from Contracts with Customers (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i503473da7ed148e2805b9efd533f401c_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i4d91b3c8886d4970bfefc99ee9bd77ec_I20211001",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411404 - Disclosure - Assets Held for Sale (Narrative) (Details)",
     "role": "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails",
     "shortName": "Assets Held for Sale (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i4d91b3c8886d4970bfefc99ee9bd77ec_I20211001",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Earnings (Losses)",
     "role": "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses",
     "shortName": "Condensed Consolidated Statements of Earnings (Losses)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherCostOfOperatingRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i503473da7ed148e2805b9efd533f401c_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412405 - Disclosure - Assets Held for Sale (Summary of Major Classes of Assets and Liabilities Classified as Held for Sale) (Details)",
     "role": "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails",
     "shortName": "Assets Held for Sale (Summary of Major Classes of Assets and Liabilities Classified as Held for Sale) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i11c3f27b7191493b8194d2564e1cbc32_I20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i503473da7ed148e2805b9efd533f401c_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Investments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415406 - Disclosure - Investments in Equity Securities (Summary of Investments) (Details)",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails",
     "shortName": "Investments in Equity Securities (Summary of Investments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i72200b393daa452fb6e8b503937f1675_I20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mo:EquityInvestmentFairValueOption",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416407 - Disclosure - Investments in Equity Securities (Earnings in Equity Securities) (Details)",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
     "shortName": "Investments in Equity Securities (Earnings in Equity Securities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "ic62d4fc827d0412695035c4816dc2a17_D20210701-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i503473da7ed148e2805b9efd533f401c_I20210930",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417408 - Disclosure - Investments in Equity Securities (Investment in ABI Narrative) (Details)",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
     "shortName": "Investments in Equity Securities (Investment in ABI Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "ife49fc973ca746f092aa4d83bca9d740_D20210101-20210930",
      "decimals": "2",
      "lang": "en-US",
      "name": "mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "ia17ccdc17eaa43c2895a3756a03e1e51_I20201031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418409 - Disclosure - Investments in Equity Securities (Investment in JUUL Narrative) (Details)",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails",
     "shortName": "Investments in Equity Securities (Investment in JUUL Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "ia17ccdc17eaa43c2895a3756a03e1e51_I20201031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i134145e8cb494481a64026d08e24f670_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419410 - Disclosure - Investments in Equity Securities (JUUL Investment Classified as Level 3) (Details)",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details",
     "shortName": "Investments in Equity Securities (JUUL Investment Classified as Level 3) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i134145e8cb494481a64026d08e24f670_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i0b7b05662cb744f89da910b211c223dc_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420411 - Disclosure - Investments in Equity Securities (Investment in Cronos Narrative) (Details)",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
     "shortName": "Investments in Equity Securities (Investment in Cronos Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "ib5afb831a7af4995b73bda6b83b376f7_I20201231",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i503473da7ed148e2805b9efd533f401c_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423412 - Disclosure - Financial Instruments (Aggregate Notional Amounts, Aggregate Fair Values and Carrying Values) (Details)",
     "role": "http://www.altria.com/role/FinancialInstrumentsAggregateNotionalAmountsAggregateFairValuesandCarryingValuesDetails",
     "shortName": "Financial Instruments (Aggregate Notional Amounts, Aggregate Fair Values and Carrying Values) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "ic10cda982ea5415199ad34d94e8b02ba_I20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i503473da7ed148e2805b9efd533f401c_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424413 - Disclosure - Financial Instruments (Aggregate Fair Value and Carrying Value) (Details)",
     "role": "http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails",
     "shortName": "Financial Instruments (Aggregate Fair Value and Carrying Value) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i503473da7ed148e2805b9efd533f401c_I20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "ia4d49e3b18b5423e972b0489f00c3c44_I20210930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425414 - Disclosure - Financial Instruments (Fair Value Using Black-Scholes Option-Pricing Model) (Details)",
     "role": "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails",
     "shortName": "Financial Instruments (Fair Value Using Black-Scholes Option-Pricing Model) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "ia4d49e3b18b5423e972b0489f00c3c44_I20210930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Comprehensive Earnings (Losses)",
     "role": "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsLosses",
     "shortName": "Condensed Consolidated Statements of Comprehensive Earnings (Losses)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i888b21f50f1241039283cfc1fe265126_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426415 - Disclosure - Financial Instruments (Beginning and Ending Balances of Fixed-price Preemptive Rights and Warrants) (Details)",
     "role": "http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails",
     "shortName": "Financial Instruments (Beginning and Ending Balances of Fixed-price Preemptive Rights and Warrants) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "ia80bd4793ddf4b2d915e5f5ea7d8ca62_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "idaabb1ac00dc4de9afa2e9b2a864fa5b_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427416 - Disclosure - Financial Instruments (Fair Value Derivative Financial Instruments) (Details)",
     "role": "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails",
     "shortName": "Financial Instruments (Fair Value Derivative Financial Instruments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "idaabb1ac00dc4de9afa2e9b2a864fa5b_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrealizedGainLossOnDerivatives",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428417 - Disclosure - Financial Instruments (Pre-tax Unrealized Gains (Losses)) (Details)",
     "role": "http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails",
     "shortName": "Financial Instruments (Pre-tax Unrealized Gains (Losses)) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrealizedGainLossOnDerivatives",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i641562cd01894f84aa15b3d08486a81e_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429418 - Disclosure - Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details)",
     "role": "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails",
     "shortName": "Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i641562cd01894f84aa15b3d08486a81e_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "ib46d19a7eb014c0d80e8454b5ba93ecc_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432419 - Disclosure - Benefit Plans (Schedule Of Components Of Net Periodic Benefit Cost (Income)) (Details)",
     "role": "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails",
     "shortName": "Benefit Plans (Schedule Of Components Of Net Periodic Benefit Cost (Income)) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "ib46d19a7eb014c0d80e8454b5ba93ecc_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i92dcd11d5d934931ab51a35b59f2acd1_D20210101-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433420 - Disclosure - Benefit Plans (Narrative) (Details)",
     "role": "http://www.altria.com/role/BenefitPlansNarrativeDetails",
     "shortName": "Benefit Plans (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i92dcd11d5d934931ab51a35b59f2acd1_D20210101-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436421 - Disclosure - Earnings (Losses) per Share (Basic and Diluted Earnings Per Share) (Details)",
     "role": "http://www.altria.com/role/EarningsLossesperShareBasicandDilutedEarningsPerShareDetails",
     "shortName": "Earnings (Losses) per Share (Basic and Diluted Earnings Per Share) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i3df7c108f2c5403c96f58e273f0dc0d1_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439422 - Disclosure - Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details)",
     "role": "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails",
     "shortName": "Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i811d953ad6844425a1abf068a0bef5ea_D20210701-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440423 - Disclosure - Other Comprehensive Earnings/Losses (Reclassifications) (Details)",
     "role": "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails",
     "shortName": "Other Comprehensive Earnings/Losses (Reclassifications) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i88fcf49918a84402902b9a4fd578a532_D20210701-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443424 - Disclosure - Segment Reporting (Segment Data Schedule) (Details)",
     "role": "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails",
     "shortName": "Segment Reporting (Segment Data Schedule) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i8712c39f1b4b407d8d3f616cd0f6d0b2_D20210701-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i9bf636ab56ad4d7cb37b9d77019eed37_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity",
     "role": "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity",
     "shortName": "Condensed Consolidated Statements of Stockholders' (Deficit) Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "ib231dbdd7b5c42a4892838893be458cb_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "mo:ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i01fb7d5238cf4de6af35e1b8ee70534b_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossRelatedToLitigationSettlement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444425 - Disclosure - Segment Reporting (Non-Participating Manufacturer Adjustment Items) (Details)",
     "role": "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
     "shortName": "Segment Reporting (Non-Participating Manufacturer Adjustment Items) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "mo:ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i01fb7d5238cf4de6af35e1b8ee70534b_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossRelatedToLitigationSettlement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i74d52c13d1e44d56853af2d044689b8c_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualProvision",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445426 - Disclosure - Segment Reporting (Schedule of Tobacco and Health and Certain Other Litigation Items) (Details)",
     "role": "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails",
     "shortName": "Segment Reporting (Schedule of Tobacco and Health and Certain Other Litigation Items) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i74d52c13d1e44d56853af2d044689b8c_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualProvision",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446427 - Disclosure - Segment Reporting (Narrative) (Details)",
     "role": "http://www.altria.com/role/SegmentReportingNarrativeDetails",
     "shortName": "Segment Reporting (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CostOfGoodsAndServicesSold",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i986e7568db0547edb5f58a6f3d032e05_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i503473da7ed148e2805b9efd533f401c_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermBorrowings",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449428 - Disclosure - Debt (Narrative) (Details)",
     "role": "http://www.altria.com/role/DebtNarrativeDetails",
     "shortName": "Debt (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ShortTermBorrowings",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i0b7b05662cb744f89da910b211c223dc_I20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShortTermBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "ic85fd5bdf74f4f0091c93c498eb3cc11_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentRepurchasedFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450429 - Disclosure - Debt (Tender Offers) (Details)",
     "role": "http://www.altria.com/role/DebtTenderOffersDetails",
     "shortName": "Debt (Tender Offers) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "ic85fd5bdf74f4f0091c93c498eb3cc11_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentRepurchasedFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mo:SummaryOfIncomeTaxesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453430 - Disclosure - Income Taxes - Summary of Income Taxes (Details)",
     "role": "http://www.altria.com/role/IncomeTaxesSummaryofIncomeTaxesDetails",
     "shortName": "Income Taxes - Summary of Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mo:SummaryOfIncomeTaxesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454431 - Disclosure - Income Taxes - Narrative (Details)",
     "role": "http://www.altria.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i0b7b05662cb744f89da910b211c223dc_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455432 - Disclosure - Income Taxes (Details)",
     "role": "http://www.altria.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i0b7b05662cb744f89da910b211c223dc_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i503473da7ed148e2805b9efd533f401c_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyNumberofStatesThatCapBondorRequireNoBond",
      "reportCount": 1,
      "unique": true,
      "unitRef": "state",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458433 - Disclosure - Contingencies (General Information) (Details)",
     "role": "http://www.altria.com/role/ContingenciesGeneralInformationDetails",
     "shortName": "Contingencies (General Information) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i503473da7ed148e2805b9efd533f401c_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyNumberofStatesThatCapBondorRequireNoBond",
      "reportCount": 1,
      "unique": true,
      "unitRef": "state",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i3df7c108f2c5403c96f58e273f0dc0d1_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459434 - Disclosure - Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details)",
     "role": "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
     "shortName": "Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i3df7c108f2c5403c96f58e273f0dc0d1_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical)",
     "role": "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquityParenthetical",
     "shortName": "Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "link:footnote",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "ia5ed554a97e64e58a2f7dff3f260635e_I20201027",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460435 - Disclosure - Contingencies (Schedule of Pending Cases) (Details)",
     "role": "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
     "shortName": "Contingencies (Schedule of Pending Cases) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "ia5ed554a97e64e58a2f7dff3f260635e_I20201027",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "ibf6d7d9ce89842c7976f502120165e8c_I20201027",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461436 - Disclosure - Contingencies (Overview of Altria and/or PM USA Tobacco-Related Litigation Narrative) (Details)",
     "role": "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
     "shortName": "Contingencies (Overview of Altria and/or PM USA Tobacco-Related Litigation Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i90fcd7f5574440a5ab359cb20e1a04c8_D19990101-20211025",
      "decimals": "INF",
      "lang": "en-US",
      "name": "mo:LossContingencyClaimsDecided",
      "reportCount": 1,
      "unique": true,
      "unitRef": "case",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i052ec416024f4823bef90cd01d8b4153_I20200229",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyCompensatoryDamagesAwardedValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462437 - Disclosure - Contingencies (Non-Engle Progeny Litigation) (Details)",
     "role": "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
     "shortName": "Contingencies (Non-Engle Progeny Litigation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i052ec416024f4823bef90cd01d8b4153_I20200229",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyCompensatoryDamagesAwardedValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i5287e7b9447640e785f900c6e40cbb09_I20000731",
      "decimals": "-9",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyPunitiveDamagesAwardedValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463438 - Disclosure - Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)",
     "role": "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
     "shortName": "Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i5287e7b9447640e785f900c6e40cbb09_I20000731",
      "decimals": "-9",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyPunitiveDamagesAwardedValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i73ae2282abd0496a96c1fcd57396db0e_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyCompensatoryDamagesAwardedValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2464439 - Disclosure - Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details)",
     "role": "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
     "shortName": "Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i73ae2282abd0496a96c1fcd57396db0e_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyCompensatoryDamagesAwardedValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i91285291d0224d41a9f6b6f098c51c67_I20090630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:MaximumBondForAllDefendants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2465440 - Disclosure - Contingencies (Florida Bond Statute) (Details)",
     "role": "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
     "shortName": "Contingencies (Florida Bond Statute) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i91285291d0224d41a9f6b6f098c51c67_I20090630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:MaximumBondForAllDefendants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "icdad9497490d4094a88132d419cbfe76_I20211025",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466441 - Disclosure - Contingencies (Other Smoking and Health Class Actions) (Details)",
     "role": "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
     "shortName": "Contingencies (Other Smoking and Health Class Actions) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i5e74537c0b4c4859a3f2089a42ce56ae_D19960501-20210930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "mo:LossContingencyClassNotCertifiedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "case",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "ibf6d7d9ce89842c7976f502120165e8c_I20201027",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467442 - Disclosure - Contingencies (Health Care Cost Recovery Litigation) (Details)",
     "role": "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
     "shortName": "Contingencies (Health Care Cost Recovery Litigation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i94453f2294bb47798d15011e7260b27b_D19981101-19981130",
      "decimals": "INF",
      "lang": "en-US",
      "name": "mo:LossContingencyNumberofStateswithSettledLitigation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "state",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i53eb33b5a5a54692bf19b84768b69b6f_D20210701-20210930",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationSettlementAmountAwardedToOtherParty",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468443 - Disclosure - Contingencies (NPM Adjustment Disputes) (Details)",
     "role": "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
     "shortName": "Contingencies (NPM Adjustment Disputes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i0c5082287da0495e8408464c2a0a26c2_D20180101-20181231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne",
      "reportCount": 1,
      "unique": true,
      "unitRef": "state",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i52787a392f8143ad96b8a01791362efb_D20210101-20210131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationSettlementAmountAwardedFromOtherParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2469444 - Disclosure - Contingencies (Other Disputes Under the State Settlement Agreements) (Details)",
     "role": "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
     "shortName": "Contingencies (Other Disputes Under the State Settlement Agreements) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i52787a392f8143ad96b8a01791362efb_D20210101-20210131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationSettlementAmountAwardedFromOtherParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i87c434bf861c4058b94849e22ee0fe19_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i37765c8db4d14257a1db295453135743_D20060801-20060831",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mo:FederalTradeCommissionDisclosurePeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2470445 - Disclosure - Contingencies (Federal Government's Lawsuit) (Details)",
     "role": "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
     "shortName": "Contingencies (Federal Government's Lawsuit) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i37765c8db4d14257a1db295453135743_D20060801-20060831",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mo:FederalTradeCommissionDisclosurePeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i0b7b05662cb744f89da910b211c223dc_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyNumberOfCasesWithCourtDatesSet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "case",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2471446 - Disclosure - Contingencies (E-vapor Product Litigation and IQOS Litigation) (Details)",
     "role": "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
     "shortName": "Contingencies (E-vapor Product Litigation and IQOS Litigation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i0b7b05662cb744f89da910b211c223dc_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyNumberOfCasesWithCourtDatesSet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "case",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "if859d02a78924c39895c8fe236aea331_I20201130",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyNumberOfComplaints",
      "reportCount": 1,
      "unique": true,
      "unitRef": "complaint",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2472447 - Disclosure - Contingencies (Antitrust Litigation and Shareholder Class Action and Shareholder Derivative Lawsuits) (Details)",
     "role": "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
     "shortName": "Contingencies (Antitrust Litigation and Shareholder Class Action and Shareholder Derivative Lawsuits) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "if859d02a78924c39895c8fe236aea331_I20201130",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyNumberOfComplaints",
      "reportCount": 1,
      "unique": true,
      "unitRef": "complaint",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i72c3cdb7c38d49a39f60eaafddfc2f55_I20211025",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyClaimsNotCertifiedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "case",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2473448 - Disclosure - Contingencies (Lights/Ultra Lights Cases) (Details)",
     "role": "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
     "shortName": "Contingencies (Lights/Ultra Lights Cases) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i72c3cdb7c38d49a39f60eaafddfc2f55_I20211025",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyClaimsNotCertifiedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "case",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "ibadad7f290d443d29bbe99b6abd7399f_I20211025",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2474449 - Disclosure - Contingencies (UST Litigations Narrative) (Details)",
     "role": "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails",
     "shortName": "Contingencies (UST Litigations Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "ibadad7f290d443d29bbe99b6abd7399f_I20211025",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i503473da7ed148e2805b9efd533f401c_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GuaranteeObligationsMaximumExposure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2475450 - Disclosure - Contingencies (Guarantees and Other Similar Matters Narrative) (Details)",
     "role": "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
     "shortName": "Contingencies (Guarantees and Other Similar Matters Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i503473da7ed148e2805b9efd533f401c_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GuaranteeObligationsMaximumExposure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Background and Basis of Presentation",
     "role": "http://www.altria.com/role/BackgroundandBasisofPresentation",
     "shortName": "Background and Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i083f183560914b169a2b47229664ba43_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i0b7b05662cb744f89da910b211c223dc_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - mo-20210930.htm",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - mo-20210930.htm",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20210930.htm",
      "contextRef": "i0b7b05662cb744f89da910b211c223dc_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 224,
   "tag": {
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA",
        "terseLabel": "Canada [Member]"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_PR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PUERTO RICO",
        "terseLabel": "Puerto Rico [Member]"
       }
      }
     },
     "localname": "PR",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "mo_ABInBevMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AB InBev [Member]",
        "label": "AB InBev [Member]",
        "terseLabel": "ABI [Member]"
       }
      }
     },
     "localname": "ABInBevMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_AccruedSettlementLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Settlement Liability, Current",
        "label": "Accrued Settlement Liability, Current",
        "terseLabel": "Settlement charges"
       }
      }
     },
     "localname": "AccruedSettlementLiabilityCurrent",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Equity Method Investments Attributable To Parent [Member]",
        "label": "Accumulated Equity Method Investments Attributable To Parent [Member]",
        "terseLabel": "ABI [Member]"
       }
      }
     },
     "localname": "AccumulatedEquityMethodInvestmentsAttributableToParentMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment To Additional Paid In Capital, Share Based Compensation, Restricted And Deferred Stock Awards and the tax benefits associated with vestings of prior period restricted and deferred stock awards",
        "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition and Income Tax Effect, Net",
        "terseLabel": "Stock award activity"
       }
      }
     },
     "localname": "AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_AltriaGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Altria Group",
        "label": "Altria Group [Member]",
        "terseLabel": "Altria Group [Member]"
       }
      }
     },
     "localname": "AltriaGroupMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_AmountAwardedtoOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount Awarded to Other Party",
        "label": "Amount Awarded to Other Party",
        "terseLabel": "Amount awarded to other party"
       }
      }
     },
     "localname": "AmountAwardedtoOtherParty",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_ArbitrationPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arbitration Period",
        "label": "Arbitration Period [Axis]",
        "terseLabel": "Arbitration Period [Axis]"
       }
      }
     },
     "localname": "ArbitrationPeriodAxis",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_ArbitrationPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arbitration Period [Domain]",
        "label": "Arbitration Period [Domain]",
        "terseLabel": "Arbitration Period [Domain]"
       }
      }
     },
     "localname": "ArbitrationPeriodDomain",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_BritishColumbiaSaskatchewanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "British Columbia, Saskatchewan [Member]",
        "label": "British Columbia, Saskatchewan [Member]",
        "terseLabel": "British Columbia and Saskatchewan [Member]"
       }
      }
     },
     "localname": "BritishColumbiaSaskatchewanMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_COVID19Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COVID-19 [Member]",
        "label": "COVID-19 [Member]",
        "terseLabel": "COVID-19 [Member]"
       }
      }
     },
     "localname": "COVID19Member",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CanadianTobaccoManufacturersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Canadian Tobacco Manufacturers [Member]",
        "label": "Canadian Tobacco Manufacturers [Member]",
        "terseLabel": "Canadian Tobacco Manufacturers [Member]"
       }
      }
     },
     "localname": "CanadianTobaccoManufacturersMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CashDiscountsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Discounts",
        "label": "Cash Discounts [Policy Text Block]",
        "terseLabel": "Cash Discounts"
       }
      }
     },
     "localname": "CashDiscountsPolicyTextBlock",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mo_ClassActionLawsuitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Action Lawsuit [Member]",
        "label": "Class Action Lawsuit [Member]",
        "terseLabel": "Class Action Lawsuit [Member]"
       }
      }
     },
     "localname": "ClassActionLawsuitMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CommonStock0.3313ParValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, 0.33 1/3 Par Value [Member]",
        "label": "Common Stock, 0.33 1/3 Par Value [Member]",
        "terseLabel": "Common Stock, $0.33 1/3 par value [Member]"
       }
      }
     },
     "localname": "CommonStock0.3313ParValueMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CommonStock1.000NotesDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, 1.000% Notes Due 2023 [Member]",
        "label": "Common Stock, 1.000% Notes Due 2023 [Member]",
        "terseLabel": "1.000% Notes due 2023 [Member]"
       }
      }
     },
     "localname": "CommonStock1.000NotesDue2023Member",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CommonStock1.700NotesDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, 1.700% Notes Due 2025 [Member]",
        "label": "Common Stock, 1.700% Notes Due 2025 [Member]",
        "terseLabel": "1.700% Notes due 2025 [Member]"
       }
      }
     },
     "localname": "CommonStock1.700NotesDue2025Member",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CommonStock2.200NotesDue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, 2.200% Notes Due 2027 [Member]",
        "label": "Common Stock, 2.200% Notes Due 2027 [Member]",
        "terseLabel": "2.200% Notes due 2027 [Member]"
       }
      }
     },
     "localname": "CommonStock2.200NotesDue2027Member",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CommonStock3.125NotesDue2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, 3.125% Notes Due 2031 [Member]",
        "label": "Common Stock, 3.125% Notes Due 2031 [Member]",
        "terseLabel": "3.125% Notes due 2031 [Member]"
       }
      }
     },
     "localname": "CommonStock3.125NotesDue2031Member",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CommonStockDividendIncreasePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Dividend Increase, Percentage",
        "label": "Common Stock, Dividend Increase, Percentage",
        "terseLabel": "Common stock, dividend increase, percentage"
       }
      }
     },
     "localname": "CommonStockDividendIncreasePercentage",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_CommonStockDividendRateAnnualPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Dividend Rate, Annual, Per Share",
        "label": "Common Stock, Dividend Rate, Annual, Per Share",
        "terseLabel": "Common stock, dividend rate, annual (in usd per share)"
       }
      }
     },
     "localname": "CommonStockDividendRateAnnualPerShare",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mo_CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Agreement [Member]",
        "label": "Credit Agreement [Member]",
        "terseLabel": "Credit Agreement [Member]"
       }
      }
     },
     "localname": "CreditAgreementMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CronosGroupInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cronos Group Inc. [Member]",
        "label": "Cronos Group Inc. [Member]",
        "verboseLabel": "Cronos [Member]"
       }
      }
     },
     "localname": "CronosGroupInc.Member",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Consolidated EBITDA to Interest Expense Ratio",
        "label": "Debt Instrument, Consolidated EBITDA to Interest Expense Ratio",
        "terseLabel": "Debt instrument, consolidated EBITDA to interest expense ratio"
       }
      }
     },
     "localname": "DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Consolidated EBITDA to Interest Expense Ratio, Minimum",
        "label": "Debt Instrument, Covenant, Consolidated EBITDA to Interest Expense Ratio, Minimum",
        "terseLabel": "Debt instrument, covenant, consolidated EBITDA to interest expense ratio, minimum"
       }
      }
     },
     "localname": "DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "mo_DebtInstrumentExtensionTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Extension Term",
        "label": "Debt Instrument, Extension Term",
        "terseLabel": "Debt instrument, extension term"
       }
      }
     },
     "localname": "DebtInstrumentExtensionTerm",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Assets, Current, Gross",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current, Gross",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Assets, Current, Reserve",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current, Reserve",
        "negatedTerseLabel": "Reserve"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAssetsCurrentReserve",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operations, Disposition Related Costs",
        "label": "Disposal Group, Including Discontinued Operations, Disposition Related Costs",
        "terseLabel": "Disposal group disposition related costs"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operations, Marketing, Administration And Research Costs",
        "label": "Disposal Group, Including Discontinued Operations, Marketing, Administration And Research Costs",
        "terseLabel": "Disposal group, total pre-tax charges"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_ETSSmokingandHealthCaseFlightAttendantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ETS Smoking and Health Case, Flight Attendants [Member]",
        "label": "ETS Smoking and Health Case, Flight Attendants [Member]",
        "terseLabel": "ETS Smoking and Health Case, Flight Attendants [Member]"
       }
      }
     },
     "localname": "ETSSmokingandHealthCaseFlightAttendantsMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesBergerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Berger [Member]",
        "label": "Engle Progeny Cases, Berger [Member]",
        "terseLabel": "Engle Progeny Cases, Berger [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesBergerMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesChadwellMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Chadwell [Member] [Member]",
        "label": "Engle Progeny Cases, Chadwell [Member]",
        "terseLabel": "Engle Progeny Cases, Chadwell [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesChadwellMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesCooperMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Cooper [Member]",
        "label": "Engle Progeny Cases, Cooper [Member]",
        "terseLabel": "Engle Progeny Cases, Cooper [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesCooperMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesCuddiheeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Cuddihee",
        "label": "Engle Progeny Cases, Cuddihee [Member]",
        "terseLabel": "Engle Progeny Cases, Cuddihee [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesCuddiheeMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesD.BrownMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, D. Brown [Member]",
        "label": "Engle Progeny Cases, D. Brown [Member]",
        "terseLabel": "Engle Progeny Cases, D. Brown [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesD.BrownMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesDuignanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Duignan [Member]",
        "label": "Engle Progeny Cases, Duignan [Member]",
        "terseLabel": "Engle Progeny Cases, Duignan [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesDuignanMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesFederalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Federal [Member]",
        "label": "Engle Progeny Cases, Federal [Member]",
        "terseLabel": "Engle Progeny Cases, Federal [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesFederalMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesFreemanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Freeman [Member]",
        "label": "Engle Progeny Cases, Freeman [Member]",
        "terseLabel": "Engle Progeny Cases, Freeman [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesFreemanMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesGarciaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Garcia",
        "label": "Engle Progeny Cases, Garcia [Member]",
        "terseLabel": "Engle Progeny Cases, Garcia [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesGarciaMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesGlogerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Gloger [Member]",
        "label": "Engle Progeny Cases, Gloger [Member]",
        "terseLabel": "Engle Progeny Cases, Gloger [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesGlogerMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesGlogerRintoulandDuignamMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]",
        "label": "Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]",
        "terseLabel": "Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesGlogerRintoulandDuignamMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesGoreMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Gore [Member]",
        "label": "Engle Progeny Cases, Gore [Member]",
        "terseLabel": "Engle Progeny Cases, Gore [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesGoreMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesHollimanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Holliman [Member]",
        "label": "Engle Progeny Cases, Holliman [Member]",
        "terseLabel": "Engle Progeny Cases, Holliman [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesHollimanMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesJordanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Jordan [Member]",
        "label": "Engle Progeny Cases, Jordan [Member]",
        "terseLabel": "Engle Progeny Cases, Jordan [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesJordanMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesKaplanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Kaplan [Member]",
        "label": "Engle Progeny Cases, Kaplan [Member]",
        "terseLabel": "Engle Progeny Cases, Kaplan [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesKaplanMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesLandiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Landi [Member]",
        "label": "Engle Progeny Cases, Landi [Member]",
        "terseLabel": "Engle Progeny Cases, Landi [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesLandiMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesLippMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Lipp",
        "label": "Engle Progeny Cases, Lipp [Member]",
        "terseLabel": "Engle Progeny Cases, Lipp [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesLippMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesM.BrownMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, M. Brown [Member]",
        "label": "Engle Progeny Cases, M. Brown [Member]",
        "terseLabel": "Engle Progeny Cases, M. Brown [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesM.BrownMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesMahfuzMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Mahfuz [Member]",
        "label": "Engle Progeny Cases, Mahfuz [Member]",
        "terseLabel": "Engle Progeny Cases, Mahfuz [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesMahfuzMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesMcCallMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, McCall [Member]",
        "label": "Engle Progeny Cases, McCall [Member]",
        "terseLabel": "Engle Progeny Cases, McCall [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesMcCallMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases [Member]",
        "label": "Engle Progeny Cases [Member]",
        "terseLabel": "Engle Progeny Cases [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesNaugleGoreMBrownJordanTheisAndLandiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Naugle, Gore, M. Brown, Jordan, Theis, and Landi",
        "label": "Engle Progeny Cases, Naugle, Gore, M. Brown, Jordan, Theis, and Landi [Member]",
        "terseLabel": "Engle Progeny Cases, Naugle, Gore, M. Brown, Jordan, Theis and Landi [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesNaugleGoreMBrownJordanTheisAndLandiMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesNaugleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Naugle [Member]",
        "label": "Engle Progeny Cases, Naugle [Member]",
        "terseLabel": "Engle Progeny Cases, Naugle [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesNaugleMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesNeffMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Neff [Member]",
        "label": "Engle Progeny Cases, Neff [Member]",
        "terseLabel": "Engle Progeny Cases, Neff [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesNeffMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member] [Member]",
        "label": "Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member] [Member]",
        "terseLabel": "Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesPearsonDCohenCollarChaconMemberMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesPollariMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Pollari [Member]",
        "label": "Engle Progeny Cases, Pollari [Member]",
        "terseLabel": "Engle Progeny Cases, Pollari [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesPollariMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesR.DouglasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, R. Douglas [Member]",
        "label": "Engle Progeny Cases, R. Douglas [Member]",
        "terseLabel": "Engle Progeny Cases, R. Douglas [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesR.DouglasMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesRJReynoldsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, R.J. Reynolds",
        "label": "Engle Progeny Cases, R.J. Reynolds [Member]",
        "terseLabel": "Engle Progeny Cases, R.J. Reynolds [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesRJReynoldsMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesReiderandBanksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Reider and Banks [Member]",
        "label": "Engle Progeny Cases, Reider and Banks [Member]",
        "terseLabel": "Engle Progeny Cases, Reider and Banks [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesReiderandBanksMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesRintoulMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Rintoul",
        "label": "Engle Progeny Cases, Rintoul [Member]",
        "terseLabel": "Engle Progeny Cases, Rintoul [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesRintoulMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesSantoroMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Santoro [Member]",
        "label": "Engle Progeny Cases, Santoro [Member]",
        "terseLabel": "Engle Progeny Cases, Santoro [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesSantoroMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesSommersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Sommers [Member]",
        "label": "Engle Progeny Cases, Sommers [Member]",
        "terseLabel": "Engle Progeny Cases, Sommers [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesSommersMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesStateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, State [Member]",
        "label": "Engle Progeny Cases, State [Member]",
        "terseLabel": "Engle Progeny Cases, State [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesStateMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesTheisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Theis [Member]",
        "label": "Engle Progeny Cases, Theis [Member]",
        "terseLabel": "Engle Progeny Cases, Theis [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesTheisMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesWeingartandHancockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Weingart and Hancock [Member]",
        "label": "Engle Progeny Cases, Weingart and Hancock [Member]",
        "terseLabel": "Engle Progeny Cases, Weingart and Hancock [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesWeingartandHancockMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EquityContractPreemptiveRIghtsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Contract, Preemptive RIghts [Member]",
        "label": "Equity Contract, Preemptive RIghts [Member]",
        "terseLabel": "Fixed-price Preemptive Rights [Member]",
        "verboseLabel": "Equity Contract, Preemptive Rights [Member]"
       }
      }
     },
     "localname": "EquityContractPreemptiveRIghtsMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails",
      "http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Contract, Warrant And Equity Contract, Preemptive Rights",
        "label": "Equity Contract, Warrant And Equity Contract, Preemptive Rights [Member]",
        "terseLabel": "Equity Contract, Warrant And Equity Contract, Preemptive Rights [Member]"
       }
      }
     },
     "localname": "EquityContractWarrantAndEquityContractPreemptiveRightsMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EquityContractWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Contract, Warrant [Member]",
        "label": "Equity Contract, Warrant [Member]",
        "terseLabel": "Equity Contract, Warrant [Member]",
        "verboseLabel": "Cronos Warrant [Member]"
       }
      }
     },
     "localname": "EquityContractWarrantMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails",
      "http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EquityInvestmentFairValueOption": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Investment, Fair Value Option",
        "label": "Equity Investment, Fair Value Option",
        "terseLabel": "JUUL"
       }
      }
     },
     "localname": "EquityInvestmentFairValueOption",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_EquityInvestmentsFairValueOptionVotingShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Investments, Fair Value Option, Voting Shares",
        "label": "Equity Investments, Fair Value Option, Voting Shares",
        "terseLabel": "Equity investments, fair value option, voting shares (in shares)"
       }
      }
     },
     "localname": "EquityInvestmentsFairValueOptionVotingShares",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mo_EquityMethodInvestmentAggregateExercisePrice": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Aggregate Exercise Price",
        "label": "Equity Method Investment, Aggregate Exercise Price",
        "terseLabel": "Equity method investment, aggregate exercise price"
       }
      }
     },
     "localname": "EquityMethodInvestmentAggregateExercisePrice",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage",
        "label": "Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage",
        "negatedTerseLabel": "Difference between carrying amount and fair value, percentage (approximately)",
        "terseLabel": "Equity method investment, difference between carrying amount and fair value, percentage (approximately)"
       }
      }
     },
     "localname": "EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_EquityMethodInvestmentImpairment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Impairment",
        "label": "Equity Method Investment, Impairment",
        "terseLabel": "Equity method investment, impairment"
       }
      }
     },
     "localname": "EquityMethodInvestmentImpairment",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Number of Shares Eligible For Purchase",
        "label": "Equity Method Investment, Number of Shares Eligible For Purchase",
        "terseLabel": "Equity method investment, number of shares eligible for purchase (approximately) (in shares)"
       }
      }
     },
     "localname": "EquityMethodInvestmentNumberofSharesEligibleForPurchase",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mo_EquityMethodInvestmentNumberofSharesOwnedCommon": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Number of Shares Owned, Common",
        "label": "Equity Method Investment, Number of Shares Owned, Common",
        "terseLabel": "Number of ordinary shares owned (in shares)",
        "verboseLabel": "Number of ordinary shares owned (approximately) (in shares)"
       }
      }
     },
     "localname": "EquityMethodInvestmentNumberofSharesOwnedCommon",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mo_EquityMethodInvestmentNumberofSharesOwnedRestricted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Number of Shares Owned, Restricted",
        "label": "Equity Method Investment, Number of Shares Owned, Restricted",
        "terseLabel": "Number of restricted shares owned (in shares)"
       }
      }
     },
     "localname": "EquityMethodInvestmentNumberofSharesOwnedRestricted",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Percentage of Shares Eligible For Purchase",
        "label": "Equity Method Investment, Percentage of Shares Eligible For Purchase",
        "terseLabel": "Equity method investment, percentage of shares eligible for purchase (approximately)"
       }
      }
     },
     "localname": "EquityMethodInvestmentPercentageofSharesEligibleForPurchase",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_EquityMethodInvestmentPricePerShareIfExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Price Per Share If Exercised",
        "label": "Equity Method Investment, Price Per Share If Exercised",
        "terseLabel": "Equity method investment, shares purchased, (CAD per share)"
       }
      }
     },
     "localname": "EquityMethodInvestmentPricePerShareIfExercised",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mo_EquityMethodInvestmentReductionInSharePricePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Reduction In Share Price, Percentage",
        "label": "Equity Method Investment, Reduction In Share Price, Percentage",
        "terseLabel": "Equity method investment, reduction in share price, percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentReductionInSharePricePercentage",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Warrant Exercised, Ownership Percentage",
        "label": "Equity Method Investment, Warrant Exercised, Ownership Percentage",
        "terseLabel": "Equity method investment, warrant exercised, ownership percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentWarrantExercisedOwnershipPercentage",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_EquityMethodInvestmentsFairValueOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investments, Fair Value Option",
        "label": "Equity Method Investments, Fair Value Option [Member]",
        "terseLabel": "Equity Method Investments, Fair Value Option [Member]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsFairValueOptionMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Ownership Percentage",
        "label": "Equity Securities Without Readily Determinable Fair Value, Ownership Percentage",
        "terseLabel": "Equity securities, ownership percentage"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_EvaporLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "E-vapor Litigation [Member]",
        "label": "E-vapor Litigation [Member]",
        "terseLabel": "E-vapor Litigation [Member]"
       }
      }
     },
     "localname": "EvaporLitigationMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_FederalGovernmentsLawsuitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal Government's Lawsuit [Member]",
        "label": "Federal Governments Lawsuit [Member]",
        "terseLabel": "Federal Governments Lawsuit [Member]"
       }
      }
     },
     "localname": "FederalGovernmentsLawsuitMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_FederalTradeCommissionDisclosurePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal Trade Commission, Disclosure Period",
        "label": "Federal Trade Commission, Disclosure Period",
        "terseLabel": "Disclosure period"
       }
      }
     },
     "localname": "FederalTradeCommissionDisclosurePeriod",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mo_ForeignCurrencyDenominatedDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Currency Denominated Debt [Member]",
        "label": "Foreign Currency Denominated Debt [Member]",
        "terseLabel": "Foreign Currency Denominated Debt [Member]",
        "verboseLabel": "Foreign currency denominated debt [Member]"
       }
      }
     },
     "localname": "ForeignCurrencyDenominatedDebtMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsAggregateNotionalAmountsAggregateFairValuesandCarryingValuesDetails",
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2004NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment",
        "label": "Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions20052007NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2005NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2006NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2007NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2008NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2009NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2010NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2011NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2012NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2013NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2014NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]",
        "label": "Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2015NPMAdjustmentsMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]",
        "label": "Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member] [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]",
        "label": "Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2017NPMAdjustmentsMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]",
        "label": "Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2018NPMAdjustmentsMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]",
        "label": "Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2019NPMAdjustmentsMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2020 NPM Adjustments",
        "label": "Health Care Cost Recovery Actions, 2020 NPM Adjustments [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2020 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2020NPMAdjustmentsMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions [Member]",
        "label": "Health Care Cost Recovery Actions [Member]",
        "terseLabel": "Health Care Cost Recovery Actions [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActionsMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActionsTransitionYears20042020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, Transition Years 2004-2020 [Member]",
        "label": "Health Care Cost Recovery Actions, Transition Years 2004-2020 [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, Transition Years 2004-2018 [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActionsTransitionYears20042020Member",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HelixInnovationsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Helix Innovations LLC [Member]",
        "label": "Helix Innovations LLC [Member]",
        "terseLabel": "Helix Innovations LLC [Member]"
       }
      }
     },
     "localname": "HelixInnovationsLLCMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_IQOSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IQOS",
        "label": "IQOS [Member]",
        "terseLabel": "IQOS"
       }
      }
     },
     "localname": "IQOSMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_ImplementationofCorrectiveCommunicationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Implementation of Corrective Communications [Member]",
        "label": "Implementation of Corrective Communications [Member]",
        "terseLabel": "Implementation of Corrective Communications [Member]"
       }
      }
     },
     "localname": "ImplementationofCorrectiveCommunicationsMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_IncomeLossFromEquityInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income (Loss) from Equity Investments",
        "label": "Income (Loss) from Equity Investments",
        "negatedTerseLabel": "(Income) losses from equity investments",
        "terseLabel": "Income (losses) from equity investments",
        "totalLabel": "Income (losses) from equity investments"
       }
      }
     },
     "localname": "IncomeLossFromEquityInvestments",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_IncomeLossFromEquityInvestmentsFairValueOption": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails": {
       "order": 2.0,
       "parentTag": "mo_IncomeLossFromEquityInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income (Loss) from Equity Investments, Fair Value Option",
        "label": "Income (Loss) from Equity Investments, Fair Value Option",
        "terseLabel": "JUUL",
        "verboseLabel": "Income (loss) from equity investments, fair value option"
       }
      }
     },
     "localname": "IncomeLossFromEquityInvestmentsFairValueOption",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_IncreaseDecreaseInSettlementPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change during the period in Settlement payable.",
        "label": "Increase (Decrease) In Settlement Payable",
        "terseLabel": "Accrued settlement charges"
       }
      }
     },
     "localname": "IncreaseDecreaseInSettlementPayable",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_IndividualSmokingAndHealthCasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individual Smoking and Health Cases [Member]",
        "label": "Individual Smoking And Health Cases [Member]",
        "terseLabel": "Individual Smoking and Health Cases [Member]"
       }
      }
     },
     "localname": "IndividualSmokingAndHealthCasesMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_InterestAndOtherDebtExpenseNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest And Other Debt Expense, Net [Member]",
        "label": "Interest And Other Debt Expense, Net [Member]",
        "terseLabel": "Interest and other debt expense, net [Member]"
       }
      }
     },
     "localname": "InterestAndOtherDebtExpenseNetMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_InterestExpenseRelatedToLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Expense Related To Litigation [Member]",
        "label": "Interest Expense Related To Litigation [Member]",
        "terseLabel": "Related Interest Costs [Member]"
       }
      }
     },
     "localname": "InterestExpenseRelatedToLitigationMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_InventoryDisposalCostsandOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory Disposal Costs and Other [Member]",
        "label": "Inventory Disposal Costs and Other [Member]",
        "terseLabel": "Inventory Disposal Costs and Other [Member]"
       }
      }
     },
     "localname": "InventoryDisposalCostsandOtherMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_InventoryRawMaterialsPlantMaterialNetofReserves": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of products consisting of plant matter that is not used in the growth of plant goods",
        "label": "Inventory, Raw Materials, Plant Material, Net of Reserves",
        "terseLabel": "Leaf tobacco"
       }
      }
     },
     "localname": "InventoryRawMaterialsPlantMaterialNetofReserves",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_InventoryWriteOffMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory Write-Off [Member]",
        "label": "Inventory Write-Off [Member]",
        "terseLabel": "Inventory Write-Off [Member]"
       }
      }
     },
     "localname": "InventoryWriteOffMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_InvestmentsInEquitySecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments In Equity Securities [Member]",
        "label": "Investments In Equity Securities [Member]",
        "terseLabel": "Investments In Equity Securities [Member]"
       }
      }
     },
     "localname": "InvestmentsInEquitySecuritiesMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_InvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Investments [Table]",
        "label": "Investments [Line Items]",
        "terseLabel": "Investments [Line Items]"
       }
      }
     },
     "localname": "InvestmentsLineItems",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_InvestmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments [Table]",
        "label": "Investments [Table]",
        "terseLabel": "Investments [Table]"
       }
      }
     },
     "localname": "InvestmentsTable",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_JUULMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "JUUL [Member]",
        "label": "JUUL [Member]",
        "terseLabel": "JUUL [Member]"
       }
      }
     },
     "localname": "JUULMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_January2021ShareRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "January 2021 Share Repurchase Program",
        "label": "January 2021 Share Repurchase Program [Member]",
        "terseLabel": "January 2021 Share Repurchase Program [Member]"
       }
      }
     },
     "localname": "January2021ShareRepurchaseProgramMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_July2019ShareRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "July 2019 Share Repurchase Program [Member]",
        "label": "July 2019 Share Repurchase Program [Member]",
        "terseLabel": "July 2019 Share Repurchase Program [Member]"
       }
      }
     },
     "localname": "July2019ShareRepurchaseProgramMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_LightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lights [Member]",
        "label": "Lights [Member]",
        "terseLabel": "Lights [Member]"
       }
      }
     },
     "localname": "LightsMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_LitigationCasesResultsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Cases Results [Member]",
        "label": "Litigation Cases Results [Member]",
        "terseLabel": "Tobacco and Health and Certain Other Litigation [Member]"
       }
      }
     },
     "localname": "LitigationCasesResultsMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_LitigationEscrowDeposit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Escrow Deposit",
        "label": "Litigation Escrow Deposit",
        "terseLabel": "Security posted for appeal of judgments"
       }
      }
     },
     "localname": "LitigationEscrowDeposit",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Amount Expected To Be Awarded from Other Party",
        "label": "Litigation Settlement, Amount Expected To Be Awarded from Other Party",
        "terseLabel": "Litigation settlement, amount expected to be awarded from other party"
       }
      }
     },
     "localname": "LitigationSettlementAmountExpectedToBeAwardedFromOtherParty",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LitigationSettlementAnnualLegalFeesPayableMaximum": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Annual Legal Fees Payable, Maximum",
        "label": "Litigation Settlement, Annual Legal Fees Payable, Maximum",
        "terseLabel": "State settlement agreements attorney fees annual cap"
       }
      }
     },
     "localname": "LitigationSettlementAnnualLegalFeesPayableMaximum",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LitigationSettlementAnnualPaymentAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Annual Payment Amount",
        "label": "Litigation Settlement, Annual Payment Amount",
        "terseLabel": "State settlement agreements annual payments"
       }
      }
     },
     "localname": "LitigationSettlementAnnualPaymentAmount",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LitigationSettlementEstimateofPossibleGain": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Estimate of Possible Gain",
        "label": "Litigation Settlement, Estimate of Possible Gain",
        "terseLabel": "Estimate of possible gain"
       }
      }
     },
     "localname": "LitigationSettlementEstimateofPossibleGain",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LossContingencyClaimsDecided": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Claims Decided",
        "label": "Loss Contingency, Claims Decided",
        "terseLabel": "Number of verdicts returned"
       }
      }
     },
     "localname": "LossContingencyClaimsDecided",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyClaimsDecidedFavorableNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Claims Decided Favorable, Number",
        "label": "Loss Contingency, Claims Decided Favorable, Number",
        "terseLabel": "Number of favorable verdicts"
       }
      }
     },
     "localname": "LossContingencyClaimsDecidedFavorableNumber",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyClaimsDecidedUnfavorableNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Claims Decided Unfavorable, Number",
        "label": "Loss Contingency, Claims Decided Unfavorable, Number",
        "terseLabel": "Number of unfavorable verdicts"
       }
      }
     },
     "localname": "LossContingencyClaimsDecidedUnfavorableNumber",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyClaimsNotCertifiedNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Claims Not Certified, Number",
        "label": "Loss Contingency, Claims Not Certified, Number",
        "terseLabel": "Claims not certified, number"
       }
      }
     },
     "localname": "LossContingencyClaimsNotCertifiedNumber",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyClaimsResolvedNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Claims Resolved, Number",
        "label": "Loss Contingency, Claims Resolved, Number",
        "terseLabel": "Number of claims resolved"
       }
      }
     },
     "localname": "LossContingencyClaimsResolvedNumber",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyClassActionLawsuit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Class Action Lawsuit",
        "label": "Loss Contingency, Class Action Lawsuit",
        "terseLabel": "Loss contingency, class action lawsuit"
       }
      }
     },
     "localname": "LossContingencyClassActionLawsuit",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyClassNotCertifiedNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Class Not Certified, Number",
        "label": "Loss Contingency, Class Not Certified, Number",
        "terseLabel": "Class not certified"
       }
      }
     },
     "localname": "LossContingencyClassNotCertifiedNumber",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Compensatory Damages Awarded, Allocation Percentage",
        "label": "Loss Contingency, Compensatory Damages Awarded, Allocation Percentage",
        "terseLabel": "Compensatory damages award, allocation percentage"
       }
      }
     },
     "localname": "LossContingencyCompensatoryDamagesAwardedAllocationPercentage",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_LossContingencyCompensatoryDamagesAwardedValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Compensatory Damages Awarded, Value",
        "label": "Loss Contingency, Compensatory Damages Awarded, Value",
        "terseLabel": "Compensatory damages awarded"
       }
      }
     },
     "localname": "LossContingencyCompensatoryDamagesAwardedValue",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LossContingencyDamagesRecoverableValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Damages Recoverable, Value",
        "label": "Loss Contingency, Damages Recoverable, Value",
        "terseLabel": "Loss contingency, damages recoverable, value"
       }
      }
     },
     "localname": "LossContingencyDamagesRecoverableValue",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LossContingencyNumberOfCases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Cases",
        "label": "Loss Contingency, Number Of Cases",
        "verboseLabel": "Number of cases"
       }
      }
     },
     "localname": "LossContingencyNumberOfCases",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfCasesWithCourtDatesSet": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Cases With Court Dates Set",
        "label": "Loss Contingency, Number of Cases With Court Dates Set",
        "terseLabel": "Loss contingency, number of cases with set court dates"
       }
      }
     },
     "localname": "LossContingencyNumberOfCasesWithCourtDatesSet",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Cases With Payments A Year Or More Ago",
        "label": "Loss Contingency, Number Of Cases With Payments A Year Or More Ago",
        "terseLabel": "Loss contingency, number of cases with payments a year or more ago"
       }
      }
     },
     "localname": "LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfComplaints": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Complaints",
        "label": "Loss Contingency, Number Of Complaints",
        "terseLabel": "Loss contingency, number of complaints"
       }
      }
     },
     "localname": "LossContingencyNumberOfComplaints",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfConsolidatedDerivativeLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Consolidated Derivative Lawsuits",
        "label": "Loss Contingency, Number Of Consolidated Derivative Lawsuits",
        "terseLabel": "Loss contingency, number of consolidated derivative lawsuits"
       }
      }
     },
     "localname": "LossContingencyNumberOfConsolidatedDerivativeLawsuits",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfInactiveCases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Inactive Cases",
        "label": "Loss Contingency, Number Of Inactive Cases",
        "terseLabel": "Loss contingency, number of inactive cases"
       }
      }
     },
     "localname": "LossContingencyNumberOfInactiveCases",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfInactiveClassActionLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Inactive Class Action Lawsuits",
        "label": "Loss Contingency, Number Of Inactive Class Action Lawsuits",
        "terseLabel": "Loss contingency, number of inactive class action lawsuits"
       }
      }
     },
     "localname": "LossContingencyNumberOfInactiveClassActionLawsuits",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfPendingCasesConsolidated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Pending Cases Consolidated",
        "label": "Loss Contingency, Number Of Pending Cases Consolidated",
        "terseLabel": "Loss contingency, number of pending cases consolidated"
       }
      }
     },
     "localname": "LossContingencyNumberOfPendingCasesConsolidated",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Shareholders Filing Class Action Lawsuits",
        "label": "Loss Contingency, Number Of Shareholders Filing Class Action Lawsuits",
        "terseLabel": "Loss contingency, number of shareholders filing class action lawsuits"
       }
      }
     },
     "localname": "LossContingencyNumberOfShareholdersFilingClassActionLawsuits",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Shareholders Filing Derivative Lawsuits",
        "label": "Loss Contingency, Number Of Shareholders Filing Derivative Lawsuits",
        "terseLabel": "Loss contingency, number of shareholders filing derivative lawsuits"
       }
      }
     },
     "localname": "LossContingencyNumberOfShareholdersFilingDerivativeLawsuits",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of States In Compliance With Escrow Statues",
        "label": "Loss Contingency, Number Of States In Compliance With Escrow Statues",
        "terseLabel": "Loss contingency, number of states in compliance with escrow statues"
       }
      }
     },
     "localname": "LossContingencyNumberOfStatesInComplianceWithEscrowStatues",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of States Not In Compliance With Escrow Statues",
        "label": "Loss Contingency, Number Of States Not In Compliance With Escrow Statues",
        "terseLabel": "Loss contingency, number of states not in compliance with escrow statues"
       }
      }
     },
     "localname": "LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfStatesNotSettled": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of States Not Settled",
        "label": "Loss Contingency, Number Of States Not Settled",
        "terseLabel": "Loss contingency, number of states not settled"
       }
      }
     },
     "localname": "LossContingencyNumberOfStatesNotSettled",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of States Not Settled, Arbitration Period",
        "label": "Loss Contingency, Number Of States Not Settled, Arbitration Period",
        "terseLabel": "Loss contingency, number of states not settled, arbitration period"
       }
      }
     },
     "localname": "LossContingencyNumberOfStatesNotSettledArbitrationPeriod",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mo_LossContingencyNumberOfStatesWithConcludedHearings": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of States With Concluded Hearings",
        "label": "Loss Contingency, Number Of States With Concluded Hearings",
        "terseLabel": "Loss contingency, number of states with concluded hearings"
       }
      }
     },
     "localname": "LossContingencyNumberOfStatesWithConcludedHearings",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Additional States Extended with Settled Litigation",
        "label": "Loss Contingency, Number of Additional States Extended with Settled Litigation",
        "terseLabel": "Loss contingency, number of additional states extended with settled litigation"
       }
      }
     },
     "localname": "LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofCasesSetforTrial": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Cases Set for Trial",
        "label": "Loss Contingency, Number of Cases Set for Trial",
        "terseLabel": "Number of cases set for trial"
       }
      }
     },
     "localname": "LossContingencyNumberofCasesSetforTrial",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofManufacturers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Manufacturers",
        "label": "Loss Contingency, Number of Manufacturers",
        "terseLabel": "Number of manufacturers"
       }
      }
     },
     "localname": "LossContingencyNumberofManufacturers",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of States That Cap Bond or Require No Bond",
        "label": "Loss Contingency, Number of States That Cap Bond or Require No Bond",
        "terseLabel": "Number of states that cap bond or require no bond"
       }
      }
     },
     "localname": "LossContingencyNumberofStatesThatCapBondorRequireNoBond",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGeneralInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofStateswithSettledLitigation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of States with Settled Litigation",
        "label": "Loss Contingency, Number of States with Settled Litigation",
        "terseLabel": "Number of states with settled litigation"
       }
      }
     },
     "localname": "LossContingencyNumberofStateswithSettledLitigation",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of States with Settled Litigation, Settlement One",
        "label": "Loss Contingency, Number of States with Settled Litigation, Settlement One",
        "terseLabel": "Loss contingency, number of states with settled litigation including New York, subsequent expansion"
       }
      }
     },
     "localname": "LossContingencyNumberofStateswithSettledLitigationSettlementOne",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Pending Claims, Consolidated For Pre-Trial Purposes, Number",
        "label": "Loss Contingency, Pending Claims, Consolidated For Pre-Trial Purposes, Number",
        "terseLabel": "Number of pending claims, consolidated for pre-trial purposes"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Period for Decertified Class Members to File Individual Actions Against Defendants",
        "label": "Loss Contingency, Period for Decertified Class Members to File Individual Actions Against Defendants",
        "terseLabel": "Loss contingency, period for decertified class members to file individual actions against defendants"
       }
      }
     },
     "localname": "LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mo_LossContingencyPunitiveDamagesAwardedValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Punitive Damages Awarded, Value",
        "label": "Loss Contingency, Punitive Damages Awarded, Value",
        "terseLabel": "Punitive damages awarded"
       }
      }
     },
     "localname": "LossContingencyPunitiveDamagesAwardedValue",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LossContingencyReductionToCostOfSales": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Reduction To Cost Of Sales",
        "label": "Loss Contingency, Reduction To Cost Of Sales",
        "terseLabel": "Loss contingency, reduction to cost of sales"
       }
      }
     },
     "localname": "LossContingencyReductionToCostOfSales",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LossContingencyStateCourtsNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, State Courts, Number",
        "label": "Loss Contingency, State Courts, Number",
        "terseLabel": "Number of state courts"
       }
      }
     },
     "localname": "LossContingencyStateCourtsNumber",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyUnfavorableVerdictsPendingReversed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Unfavorable Verdicts Pending/Reversed",
        "label": "Loss Contingency, Unfavorable Verdicts Pending/Reversed",
        "terseLabel": "Number of claims with unfavorable verdicts pending/reversed"
       }
      }
     },
     "localname": "LossContingencyUnfavorableVerdictsPendingReversed",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyVerdictReversedNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Verdict Reversed, Number",
        "label": "Loss Contingency, Verdict Reversed, Number",
        "terseLabel": "Number of verdicts reversed"
       }
      }
     },
     "localname": "LossContingencyVerdictReversedNumber",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyVerdictsUpheld": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Verdicts Upheld",
        "label": "Loss Contingency, Verdicts Upheld",
        "terseLabel": "Number of verdicts upheld"
       }
      }
     },
     "localname": "LossContingencyVerdictsUpheld",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyZeroDamagesVerdictModified": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Zero Damages Verdict Modified",
        "label": "Loss Contingency, Zero Damages Verdict Modified",
        "terseLabel": "Zero damages verdict modified"
       }
      }
     },
     "localname": "LossContingencyZeroDamagesVerdictModified",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyZeroDamagesVerdicts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Zero Damages Verdicts",
        "label": "Loss Contingency, Zero Damages Verdicts",
        "terseLabel": "Zero damages verdicts"
       }
      }
     },
     "localname": "LossContingencyZeroDamagesVerdicts",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_MarketingAdministrationAndResearchCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketing Administration And Research Costs [Member]",
        "label": "Marketing Administration And Research Costs [Member]",
        "terseLabel": "Marketing Administration And Research Costs [Member]"
       }
      }
     },
     "localname": "MarketingAdministrationAndResearchCostsMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_MarketingAdministrationandResearchCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as research and development costs and all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. Research and development costs represent the aggregate costs incurred during an accounting period to research and develop new products/technologies when the technological feasibility has not been reached. General and administrative expenses include salaries of nonsales personnel, rent, utilities, communication, etc.",
        "label": "Marketing, Administration and Research Costs",
        "terseLabel": "Marketing, administration and research costs"
       }
      }
     },
     "localname": "MarketingAdministrationandResearchCosts",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_MaximumBondForAllDefendants": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum Bond For All Defendants",
        "label": "Maximum Bond For All Defendants",
        "terseLabel": "Maximum bond for all defendants"
       }
      }
     },
     "localname": "MaximumBondForAllDefendants",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_MeasurementInputWeightedAverageExpectedTermMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Weighted Average Expected Term [Member]",
        "label": "Measurement Input, Weighted Average Expected Term [Member]",
        "terseLabel": "Weighted Average Expected Term [Member]"
       }
      }
     },
     "localname": "MeasurementInputWeightedAverageExpectedTermMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NonEngleProgenyCasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non Engle Progeny Cases [Member]",
        "label": "Non Engle Progeny Cases [Member]",
        "terseLabel": "Non Engle Progeny Cases [Member]"
       }
      }
     },
     "localname": "NonEngleProgenyCasesMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NonEngleProgenySmokingAndHealthCasePrincipeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Engle Progeny Smoking And Health Case, Principe",
        "label": "Non-Engle Progeny Smoking And Health Case, Principe [Member]",
        "terseLabel": "Non-Engle Progeny Smoking And Health Case, Principe [Member]"
       }
      }
     },
     "localname": "NonEngleProgenySmokingAndHealthCasePrincipeMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NonEngleProgenySmokingandHealthCaseGentileMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Engle Progeny Smoking and Health Case, Gentile",
        "label": "Non-Engle Progeny Smoking and Health Case, Gentile [Member]",
        "terseLabel": "Non-Engle Progeny Smoking and Health Case, Gentile [Member]"
       }
      }
     },
     "localname": "NonEngleProgenySmokingandHealthCaseGentileMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NonEngleProgenySmokingandHealthCaseGreeneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Engle Progeny Smoking and Health Case, Greene [Member]",
        "label": "Non-Engle Progeny Smoking and Health Case, Greene [Member]",
        "terseLabel": "Non-Engle Progeny Smoking and Health Case, Greene [Member]"
       }
      }
     },
     "localname": "NonEngleProgenySmokingandHealthCaseGreeneMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NonEngleProgenySmokingandHealthCaseLaramieMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Engle Progeny Smoking and Health Case, Laramie [Member] [Member]",
        "label": "Non-Engle Progeny Smoking and Health Case, Laramie [Member]",
        "terseLabel": "Non-Engle Progeny Smoking and Health Case, Laramie [Member]"
       }
      }
     },
     "localname": "NonEngleProgenySmokingandHealthCaseLaramieMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NonParticipatingManufacturerArbitrationPanelDecisionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Participating Manufacturer Arbitration Panel Decision [Member]",
        "label": "Non-Participating Manufacturer Arbitration Panel Decision [Member]",
        "terseLabel": "Non-Participating Manufacturer Arbitration Panel Decision"
       }
      }
     },
     "localname": "NonParticipatingManufacturerArbitrationPanelDecisionMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NoncontrollingInterestRemainingInterestPurchasedByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Remaining Interest Purchased By Parent",
        "label": "Noncontrolling Interest, Remaining Interest Purchased By Parent",
        "terseLabel": "Noncontrolling interest, remaining interest purchased by parent"
       }
      }
     },
     "localname": "NoncontrollingInterestRemainingInterestPurchasedByParent",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_NpmAdjustmentToCostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NPM Adjustment to Cost Of Sales [Member]",
        "label": "NPM Adjustment to Cost Of Sales [Member]",
        "terseLabel": "NPM Adjustment to Cost Of Sales [Member]"
       }
      }
     },
     "localname": "NpmAdjustmentToCostOfSalesMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NumberOfThirdPartyLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Third Party Lawsuits",
        "label": "Number Of Third Party Lawsuits",
        "terseLabel": "Number of third party lawsuits"
       }
      }
     },
     "localname": "NumberOfThirdPartyLawsuits",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Income (Loss) Before General Corporate Expenses and Amortization Of Intangibles",
        "label": "Operating Income (Loss) Before General Corporate Expenses and Amortization Of Intangibles",
        "terseLabel": "OCI"
       }
      }
     },
     "localname": "OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_OralTobaccoSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oral Tobacco Segment [Member]",
        "label": "Oral Tobacco Segment [Member]",
        "terseLabel": "Oral Tobacco Segment [Member]",
        "verboseLabel": "Oral Tobacco Segment [Member]"
       }
      }
     },
     "localname": "OralTobaccoSegmentMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_OtherAccruedLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Accrued Liabilities [Member]",
        "label": "Other Accrued Liabilities [Member]",
        "terseLabel": "Other Accrued Liabilities [Member]"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_OtherDisputesUndertheStateSettlementAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Disputes Under the State Settlement Agreements [Member]",
        "label": "Other Disputes Under the State Settlement Agreements [Member]",
        "terseLabel": "Other Disputes Under the State Settlement Agreements [Member]"
       }
      }
     },
     "localname": "OtherDisputesUndertheStateSettlementAgreementsMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_OtherInventoryRawMaterialsNetofReserves": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Inventory, Raw Materials, Net of Reserves",
        "label": "Other Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Other raw materials"
       }
      }
     },
     "localname": "OtherInventoryRawMaterialsNetofReserves",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_OtherTabaccoRelatedCasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Tabacco-Related Cases [Member]",
        "label": "Other Tabacco-Related Cases [Member]",
        "terseLabel": "Other Tabacco-Related Cases [Member]"
       }
      }
     },
     "localname": "OtherTabaccoRelatedCasesMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/EarningsLossesperShareBasicandDilutedEarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Participating Securities, Distributed and Undistributed Earnings (Loss), Basic and Diluted",
        "label": "Participating Securities, Distributed and Undistributed Earnings (Loss), Basic and Diluted",
        "negatedLabel": "Less: Distributed and undistributed earnings attributable to share-based awards"
       }
      }
     },
     "localname": "ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/EarningsLossesperShareBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_PendingIndividualLawsuitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pending Individual Lawsuits [Member]",
        "label": "Pending Individual Lawsuits [Member]",
        "terseLabel": "Pending Individual Lawsuits [Member]"
       }
      }
     },
     "localname": "PendingIndividualLawsuitsMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PendingLawsuitFiledBySchoolDistrictMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pending Lawsuit Filed By School District [Member]",
        "label": "Pending Lawsuit Filed By School District [Member]",
        "terseLabel": "Pending Lawsuit Filed By School District [Member]"
       }
      }
     },
     "localname": "PendingLawsuitFiledBySchoolDistrictMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pending Lawsuits Filed By State Or Local Governments [Member]",
        "label": "Pending Lawsuits Filed By State Or Local Governments [Member]",
        "terseLabel": "Pending Lawsuits Filed By State Or Local Governments [Member]"
       }
      }
     },
     "localname": "PendingLawsuitsFiledByStateOrLocalGovernmentsMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PeriodOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period One",
        "label": "Period One [Member]",
        "terseLabel": "Period One"
       }
      }
     },
     "localname": "PeriodOneMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PeriodTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period Two",
        "label": "Period Two [Member]",
        "terseLabel": "Period Two"
       }
      }
     },
     "localname": "PeriodTwoMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PhilipMorrisUSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Philip Morris USA [Member]",
        "label": "Philip Morris USA [Member]",
        "terseLabel": "PM USA [Member]"
       }
      }
     },
     "localname": "PhilipMorrisUSAMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PhilipMorrisUSAandAltriaGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Philip Morris USA and Altria Group [Member]",
        "label": "Philip Morris USA and Altria Group [Member]",
        "terseLabel": "Philip Morris USA and Altria Group [Member]"
       }
      }
     },
     "localname": "PhilipMorrisUSAandAltriaGroupMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_ProvisionRecordedNumberOfCases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provision Recorded, Number Of Cases",
        "label": "Provision Recorded, Number Of Cases",
        "terseLabel": "Provision recorded, number of cases"
       }
      }
     },
     "localname": "ProvisionRecordedNumberOfCases",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_ReceivablesNetCurrentIncludingAssetsHeldForSale": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receivables, Net Current, Including Assets Held For Sale",
        "label": "Receivables, Net Current, Including Assets Held For Sale",
        "terseLabel": "Receivables, Net Current, Including Assets Held For Sale"
       }
      }
     },
     "localname": "ReceivablesNetCurrentIncludingAssetsHeldForSale",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_RestrictedSharesLockupPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Shares, Lock-up Period",
        "label": "Restricted Shares, Lock-up Period",
        "terseLabel": "Restricted shares, lock-up period"
       }
      }
     },
     "localname": "RestrictedSharesLockupPeriod",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mo_RevolvingCreditFacilityDueAugust2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility Due August 2024 [Member]",
        "label": "Revolving Credit Facility Due August 2024 [Member]",
        "terseLabel": "Revolving Credit Facility Due August 2024 [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityDueAugust2024Member",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Non-Participating Manufacturer Adjustment Items",
        "label": "Schedule of Non-Participating Manufacturer Adjustment Items [Table Text Block]",
        "terseLabel": "Schedule of Non-Participating Manufacturer Adjustment Items"
       }
      }
     },
     "localname": "ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]",
        "label": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]",
        "terseLabel": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]"
       }
      }
     },
     "localname": "ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]",
        "label": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]",
        "terseLabel": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]"
       }
      }
     },
     "localname": "ScheduleofPretaxTobaccoandHealthLitigationChargesTable",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Table Text Block] for Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]",
        "label": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Table Text Block]",
        "terseLabel": "Schedule of Tobacco and Health and Certain Other Litigation Items"
       }
      }
     },
     "localname": "ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mo_SmokeableProductsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Smokeable Products Segment [Member]",
        "label": "Smokeable Products Segment [Member]",
        "terseLabel": "Smokeable Products Segment [Member]"
       }
      }
     },
     "localname": "SmokeableProductsSegmentMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_SmokingAndHealthClassActionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Smoking and Health Class Actions and Aggregated Claims Litigation [Member]",
        "label": "Smoking And Health Class Actions [Member]",
        "terseLabel": "Smoking and Health Class Actions and Aggregated Claims Litigation [Member]"
       }
      }
     },
     "localname": "SmokingAndHealthClassActionsMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_SteMichelleTransactionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ste. Michelle Transaction",
        "label": "Ste. Michelle Transaction [Member]",
        "terseLabel": "Ste. Michelle Transaction [Member]"
       }
      }
     },
     "localname": "SteMichelleTransactionMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_SteMichelleTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ste. Michelle Transactions",
        "label": "Ste. Michelle Transactions [Member]",
        "terseLabel": "Ste. Michelle Transaction [Member]"
       }
      }
     },
     "localname": "SteMichelleTransactionsMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails",
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_StockRepurchaseProgramIncreaseAuthorizedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Repurchase Program, Increase Authorized Amount",
        "label": "Stock Repurchase Program, Increase Authorized Amount",
        "terseLabel": "Stock repurchase program, increase authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramIncreaseAuthorizedAmount",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Repurchase Program, Rescinded Authorized Repurchase Amount",
        "label": "Stock Repurchase Program, Rescinded Authorized Repurchase Amount",
        "terseLabel": "Stock repurchase program, rescinded authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_SummaryOfIncomeTaxesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of Income Taxes",
        "label": "Summary of Income Taxes [Table Text Block]",
        "terseLabel": "Summary of Income Taxes"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxesTableTextBlock",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesupdateTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mo_TobaccoandHealthJudgmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tobacco and Health Judgment [Member]",
        "label": "Tobacco and Health Judgment [Member]",
        "terseLabel": "Tobacco and Health Judgment [Member]"
       }
      }
     },
     "localname": "TobaccoandHealthJudgmentMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_TobaccoandHealthLitigationCasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tobacco and Health Litigation Cases [Member]",
        "label": "Tobacco and Health Litigation Cases [Member]",
        "terseLabel": "Tobacco and Health Litigation Cases [Member]"
       }
      }
     },
     "localname": "TobaccoandHealthLitigationCasesMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDDenominatedDebt10200PercentDue2039Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Denominated Debt, 10.200 Percent, Due 2039",
        "label": "USD Denominated Debt, 10.200 Percent, Due 2039 [Member]",
        "terseLabel": "10.200%, Notes Due 2039 [Member]"
       }
      }
     },
     "localname": "USDDenominatedDebt10200PercentDue2039Member",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/DebtTenderOffersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDDenominatedDebt6200PercentDue2059Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Denominated Debt, 6.200 Percent, Due 2059",
        "label": "USD Denominated Debt, 6.200 Percent, Due 2059 [Member]",
        "terseLabel": "6.200%, Notes Due 2059 [Member]"
       }
      }
     },
     "localname": "USDDenominatedDebt6200PercentDue2059Member",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/DebtTenderOffersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDDenominatedNotes2850PercentDue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Denominated Notes, 2.850 Percent, Due 2022",
        "label": "USD Denominated Notes, 2.850 Percent, Due 2022 [Member]",
        "terseLabel": "2.850%, Notes Due 2022 [Member]"
       }
      }
     },
     "localname": "USDDenominatedNotes2850PercentDue2022Member",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/DebtTenderOffersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDDenominatedNotes2950PercentDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Denominated Notes, 2.950 Percent, Due 2023",
        "label": "USD Denominated Notes, 2.950 Percent, Due 2023 [Member]",
        "terseLabel": "2.950%, Notes Due 2023 [Member]"
       }
      }
     },
     "localname": "USDDenominatedNotes2950PercentDue2023Member",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/DebtTenderOffersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDDenominatedNotes3490PercentDue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Denominated Notes, 3.490 Percent, Due 2022",
        "label": "USD Denominated Notes, 3.490 Percent, Due 2022 [Member]",
        "terseLabel": "USD Denominated Notes, 3.490 Percent, Due 2022 [Member]"
       }
      }
     },
     "localname": "USDDenominatedNotes3490PercentDue2022Member",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDDenominatedNotes3800PercentDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Denominated Notes, 3.800 Percent, Due 2024",
        "label": "USD Denominated Notes, 3.800 Percent, Due 2024 [Member]",
        "terseLabel": "3.800%, Notes Due 2024 [Member]"
       }
      }
     },
     "localname": "USDDenominatedNotes3800PercentDue2024Member",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/DebtTenderOffersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDDenominatedNotes4000PercentDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Denominated Notes, 4.000 Percent, Due 2024",
        "label": "USD Denominated Notes, 4.000 Percent, Due 2024 [Member]",
        "terseLabel": "4.000%, Notes Due 2024 [Member]"
       }
      }
     },
     "localname": "USDDenominatedNotes4000PercentDue2024Member",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/DebtTenderOffersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDDenominatedNotes4400PercentDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Denominated Notes, 4.400 Percent, Due 2026",
        "label": "USD Denominated Notes, 4.400 Percent, Due 2026 [Member]",
        "terseLabel": "4.400%, Notes Due 2026 [Member]"
       }
      }
     },
     "localname": "USDDenominatedNotes4400PercentDue2026Member",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/DebtTenderOffersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDDenominatedNotes4800PercentDue2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Denominated Notes, 4.800 Percent, Due 2029",
        "label": "USD Denominated Notes, 4.800 Percent, Due 2029 [Member]",
        "terseLabel": "4.800%, Notes Due 2029 [Member]"
       }
      }
     },
     "localname": "USDDenominatedNotes4800PercentDue2029Member",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/DebtTenderOffersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDDenominatedNotes9950PercentDue2038Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Denominated Notes, 9.950 Percent, Due 2038",
        "label": "USD Denominated Notes, 9.950 Percent, Due 2038 [Member]",
        "terseLabel": "9.950%, Notes Due 2038 [Member]"
       }
      }
     },
     "localname": "USDDenominatedNotes9950PercentDue2038Member",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/DebtTenderOffersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDDenominatedNotesDue2032Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Denominated Notes Due 2032",
        "label": "USD Denominated Notes Due 2032 [Member]",
        "terseLabel": "USD Denominated Notes Due 2032 [Member]"
       }
      }
     },
     "localname": "USDDenominatedNotesDue2032Member",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDDenominatedNotesDue2041Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Denominated Notes Due 2041",
        "label": "USD Denominated Notes Due 2041 [Member]",
        "terseLabel": "USD Denominated Notes Due 2041 [Member]"
       }
      }
     },
     "localname": "USDDenominatedNotesDue2041Member",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDDenominatedNotesDue2051Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Denominated Notes Due 2051",
        "label": "USD Denominated Notes Due 2051 [Member]",
        "terseLabel": "USD Denominated Notes Due 2051 [Member]"
       }
      }
     },
     "localname": "USDDenominatedNotesDue2051Member",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDDenominatedNotesDue2061Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Denominated Notes Due 2061",
        "label": "USD Denominated Notes Due 2061 [Member]",
        "terseLabel": "USD Denominated Notes Due 2061 [Member]"
       }
      }
     },
     "localname": "USDDenominatedNotesDue2061Member",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDDenominatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Denominated Notes [Member]",
        "label": "USD Denominated Notes [Member]",
        "terseLabel": "USD Denominated Notes [Member]"
       }
      }
     },
     "localname": "USDDenominatedNotesMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USTLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "UST Litigation [Member]",
        "label": "UST Litigation [Member]",
        "terseLabel": "UST Litigation [Member]"
       }
      }
     },
     "localname": "USTLitigationMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation Allowance, Deferred Tax Asset, Decrease In Amount",
        "label": "Valuation Allowance, Deferred Tax Asset, Decrease In Amount",
        "negatedTerseLabel": "Reductions to valuation allowance credited to income tax benefit"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetDecreaseInAmount",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation Allowance, Deferred Tax Asset, Increase In Amount",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase In Amount",
        "terseLabel": "Additions to valuation allowance charged to income tax expense"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetIncreaseInAmount",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_ValuationAllowanceForeignCurrencyTranslationAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation Allowance, Foreign Currency Translation Adjustment",
        "label": "Valuation Allowance, Foreign Currency Translation Adjustment",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "ValuationAllowanceForeignCurrencyTranslationAdjustment",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_ValuationAllowanceRollforwardRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation Allowance Rollforward [Roll Forward]",
        "label": "Valuation Allowance Rollforward [Roll Forward]",
        "terseLabel": "Valuation Allowance Rollforward [Roll Forward]"
       }
      }
     },
     "localname": "ValuationAllowanceRollforwardRollForward",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_WineBusinessStrategicResetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Wine Business Strategic Reset [Member]",
        "label": "Wine Business Strategic Reset [Member]",
        "terseLabel": "Wine Business Strategic Reset [Member]"
       }
      }
     },
     "localname": "WineBusinessStrategicResetMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_WineSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Wine Segment [Member]",
        "label": "Wine Segment [Member]",
        "terseLabel": "Wine Segment [Member]"
       }
      }
     },
     "localname": "WineSegmentMember",
     "nsuri": "http://www.altria.com/20210930",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r143",
      "r198",
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r218",
      "r222",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r320",
      "r321",
      "r323",
      "r325",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r143",
      "r198",
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r218",
      "r222",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r320",
      "r321",
      "r323",
      "r325",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]",
        "verboseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r331",
      "r371",
      "r495",
      "r500",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r647",
      "r700",
      "r702",
      "r723",
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r331",
      "r371",
      "r495",
      "r500",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r647",
      "r700",
      "r702",
      "r723",
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r331",
      "r371",
      "r439",
      "r495",
      "r500",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r647",
      "r700",
      "r702",
      "r723",
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r331",
      "r371",
      "r439",
      "r495",
      "r500",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r647",
      "r700",
      "r702",
      "r723",
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r226",
      "r227",
      "r404",
      "r407",
      "r701",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r226",
      "r227",
      "r404",
      "r407",
      "r701",
      "r712",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "stpr_AK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ALASKA",
        "terseLabel": "Alaska [Member]"
       }
      }
     },
     "localname": "AK",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_AR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ARKANSAS",
        "terseLabel": "Arkansas [Member]"
       }
      }
     },
     "localname": "AR",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CALIFORNIA",
        "terseLabel": "California [Member]"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_CT": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONNECTICUT",
        "terseLabel": "Connecticut [Member]"
       }
      }
     },
     "localname": "CT",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_DC": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DISTRICT OF COLUMBIA",
        "terseLabel": "District of Columbia [Member]"
       }
      }
     },
     "localname": "DC",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_DE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DELAWARE",
        "terseLabel": "Delaware [Member]"
       }
      }
     },
     "localname": "DE",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_FL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FLORIDA",
        "terseLabel": "Florida [Member]"
       }
      }
     },
     "localname": "FL",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_IA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "IOWA",
        "terseLabel": "Iowa [Member]"
       }
      }
     },
     "localname": "IA",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_IL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ILLINOIS",
        "terseLabel": "Illinois [Member]"
       }
      }
     },
     "localname": "IL",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_KS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "KANSAS",
        "terseLabel": "Kansas [Member]"
       }
      }
     },
     "localname": "KS",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_LA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LOUISIANA",
        "terseLabel": "Louisiana [Member]"
       }
      }
     },
     "localname": "LA",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MASSACHUSETTS",
        "verboseLabel": "Massachusetts [Member]"
       }
      }
     },
     "localname": "MA",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MARYLAND",
        "terseLabel": "Maryland [Member]"
       }
      }
     },
     "localname": "MD",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MI": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MICHIGAN",
        "terseLabel": "Michigan [Member]"
       }
      }
     },
     "localname": "MI",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MINNESOTA",
        "terseLabel": "Minnesota [Member]"
       }
      }
     },
     "localname": "MN",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MO": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MISSOURI",
        "terseLabel": "Missouri [Member]"
       }
      }
     },
     "localname": "MO",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MISSISSIPPI",
        "terseLabel": "Mississippi [Member]"
       }
      }
     },
     "localname": "MS",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MT": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MONTANA",
        "terseLabel": "MONTANA"
       }
      }
     },
     "localname": "MT",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_NH": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW HAMPSHIRE",
        "terseLabel": "New Hampshire [Member]"
       }
      }
     },
     "localname": "NH",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_NJ": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW JERSEY",
        "terseLabel": "New Jersey [Member]"
       }
      }
     },
     "localname": "NJ",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_NM": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW MEXICO",
        "terseLabel": "New Mexico [Member]"
       }
      }
     },
     "localname": "NM",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_NV": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEVADA",
        "terseLabel": "Nevada [Member]"
       }
      }
     },
     "localname": "NV",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_NY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW YORK",
        "terseLabel": "New York [Member]"
       }
      }
     },
     "localname": "NY",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_OH": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OHIO",
        "terseLabel": "Ohio [Member]"
       }
      }
     },
     "localname": "OH",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_OK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OKLAHOMA",
        "terseLabel": "Oklahoma [Member]"
       }
      }
     },
     "localname": "OK",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_OR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OREGON",
        "terseLabel": "Oregon [Member]"
       }
      }
     },
     "localname": "OR",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_PA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PENNSYLVANIA",
        "terseLabel": "Pennsylvania [Member]"
       }
      }
     },
     "localname": "PA",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_RI": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RHODE ISLAND",
        "terseLabel": "Rhode Island [Member]"
       }
      }
     },
     "localname": "RI",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_SC": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SOUTH CAROLINA",
        "terseLabel": "South Carolina [Member]"
       }
      }
     },
     "localname": "SC",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_TN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TENNESSEE",
        "terseLabel": "Tennessee [Member]"
       }
      }
     },
     "localname": "TN",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_TX": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TEXAS",
        "terseLabel": "Texas [Member]"
       }
      }
     },
     "localname": "TX",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_WI": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "WISCONSIN",
        "terseLabel": "Wisconsin [Member]"
       }
      }
     },
     "localname": "WI",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_WV": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "WEST VIRGINIA",
        "terseLabel": "West Virginia [Member]"
       }
      }
     },
     "localname": "WV",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "Accumulated Other Comprehensive Income [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r56",
      "r614"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]",
        "terseLabel": "Accrued liabilities:"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedMarketingCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services.   Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Marketing Costs, Current",
        "terseLabel": "Marketing"
       }
      }
     },
     "localname": "AccruedMarketingCostsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r79",
      "r86",
      "r94",
      "r95",
      "r96",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Benefit Plans [Member]"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember": {
     "auth_ref": [
      "r81",
      "r86",
      "r94",
      "r95",
      "r96",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to prior service cost (credit) component of defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]",
        "terseLabel": "Prior service cost/credit [Member]"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember": {
     "auth_ref": [
      "r78",
      "r86",
      "r94",
      "r95",
      "r96",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]",
        "terseLabel": "Net loss [Member]"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r54",
      "r277"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Less accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r44",
      "r83",
      "r85",
      "r86",
      "r680",
      "r707",
      "r710"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive losses"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r94",
      "r95",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r82",
      "r86",
      "r94",
      "r95",
      "r96",
      "r144",
      "r145",
      "r146",
      "r544",
      "r703",
      "r704",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "verboseLabel": "Accumulated Other Comprehensive Losses [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r76",
      "r86",
      "r94",
      "r95",
      "r96",
      "r544",
      "r600",
      "r601",
      "r602",
      "r603",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Currency Translation Adjustments and Other [Member]"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r502",
      "r503",
      "r504",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net earnings (losses) to operating cash flows:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r194",
      "r211",
      "r212",
      "r213",
      "r214",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "All Other [Member]"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables": {
     "auth_ref": [
      "r231"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet.",
        "label": "Allowance for Doubtful Accounts, Premiums and Other Receivables",
        "terseLabel": "Allowance for doubtful accounts, receivables"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r131",
      "r270",
      "r272"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedLabel": "Amortization of intangibles"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r139",
      "r206",
      "r213",
      "r220",
      "r249",
      "r313",
      "r314",
      "r315",
      "r317",
      "r318",
      "r319",
      "r320",
      "r322",
      "r324",
      "r326",
      "r327",
      "r539",
      "r545",
      "r594",
      "r612",
      "r614",
      "r654",
      "r676"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r22",
      "r23",
      "r71",
      "r139",
      "r249",
      "r313",
      "r314",
      "r315",
      "r317",
      "r318",
      "r319",
      "r320",
      "r322",
      "r324",
      "r326",
      "r327",
      "r539",
      "r545",
      "r594",
      "r612",
      "r614"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets [Member]",
        "terseLabel": "Assets [Member]"
       }
      }
     },
     "localname": "AssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Assets [Abstract]",
        "terseLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r3",
      "r4",
      "r12",
      "r14",
      "r17",
      "r275",
      "r281"
     ],
     "calculation": {
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "terseLabel": "Assets held for sale",
        "totalLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails",
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r558",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation, Policy"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r491",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r491",
      "r496",
      "r532",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r531"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Business combination, acquisition related costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r20",
      "r51",
      "r133"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]",
        "terseLabel": "Cash, cash equivalents and restricted cash:"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r127",
      "r133",
      "r134"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "totalLabel": "Cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations": {
     "auth_ref": [
      "r127",
      "r133",
      "r134"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; attributable to disposal group, including, but not limited to, discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations",
        "terseLabel": "Restricted cash included in assets held for sale"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r127",
      "r598"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Increase (decrease)"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r137",
      "r139",
      "r169",
      "r170",
      "r175",
      "r178",
      "r180",
      "r191",
      "r192",
      "r193",
      "r249",
      "r313",
      "r318",
      "r319",
      "r320",
      "r326",
      "r327",
      "r369",
      "r370",
      "r372",
      "r373",
      "r594",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r381",
      "r382",
      "r383",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r65",
      "r299",
      "r661",
      "r686"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "verboseLabel": "Contingencies (Note 12)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "verboseLabel": "Dividends declared (usd per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquityParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r144",
      "r145",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r40",
      "r614"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, par value $0.33 1/3\u00a0per share (2,805,961,317 shares issued)"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r90",
      "r92",
      "r93",
      "r104",
      "r668",
      "r694"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsLosses": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive earnings (losses) attributable to Altria"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsLosses"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r90",
      "r92",
      "r103",
      "r537",
      "r538",
      "r549",
      "r667",
      "r693"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsLosses": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Comprehensive (earnings) losses attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsLosses"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r90",
      "r92",
      "r102",
      "r536",
      "r549",
      "r666",
      "r692"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsLosses": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive earnings (losses)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsLosses"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r101",
      "r113",
      "r665",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Other Comprehensive Earnings/Losses"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLosses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r385",
      "r386",
      "r405"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r222",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate, Non-Segment [Member]",
        "verboseLabel": "General corporate [Member]"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r108",
      "r648"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Sales [Member]"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r136",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r345",
      "r352",
      "r353",
      "r355",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r33",
      "r34",
      "r35",
      "r138",
      "r143",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r335",
      "r341",
      "r342",
      "r343",
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r357",
      "r358",
      "r359",
      "r360",
      "r609",
      "r655",
      "r656",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/DebtNarrativeDetails",
      "http://www.altria.com/role/DebtTenderOffersDetails",
      "http://www.altria.com/role/FinancialInstrumentsAggregateNotionalAmountsAggregateFairValuesandCarryingValuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt instrument, basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r328",
      "r357",
      "r358",
      "r608",
      "r609",
      "r610"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r343",
      "r357",
      "r358",
      "r593"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsAggregateNotionalAmountsAggregateFairValuesandCarryingValuesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r62",
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument, interest rate, stated percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails",
      "http://www.altria.com/role/DebtTenderOffersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails",
      "http://www.altria.com/role/DebtTenderOffersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r63",
      "r138",
      "r143",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r335",
      "r341",
      "r342",
      "r343",
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r357",
      "r358",
      "r359",
      "r360",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/DebtNarrativeDetails",
      "http://www.altria.com/role/DebtTenderOffersDetails",
      "http://www.altria.com/role/FinancialInstrumentsAggregateNotionalAmountsAggregateFairValuesandCarryingValuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period One [Member]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Debt instrument, redemption price, percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentRepurchasedFaceAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of the original debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchased Face Amount",
        "terseLabel": "Debt instrument, repurchased face amount"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtTenderOffersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r63",
      "r138",
      "r143",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r335",
      "r341",
      "r342",
      "r343",
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r354",
      "r357",
      "r358",
      "r359",
      "r360",
      "r376",
      "r377",
      "r378",
      "r379",
      "r607",
      "r608",
      "r609",
      "r610",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails",
      "http://www.altria.com/role/DebtTenderOffersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt instrument, term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r131",
      "r140",
      "r515",
      "r523",
      "r524",
      "r525"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax provision (benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r507",
      "r508"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r513"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of year"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": {
     "auth_ref": [
      "r36",
      "r415",
      "r416",
      "r438"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.",
        "label": "Liability, Defined Benefit Pension Plan, Noncurrent",
        "terseLabel": "Accrued pension costs"
       }
      }
     },
     "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r417",
      "r455",
      "r479",
      "r485",
      "r486"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedLabel": "Net loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r417",
      "r456",
      "r480",
      "r485",
      "r486"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "verboseLabel": "Prior service cost (credit)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r432",
      "r440",
      "r442",
      "r483",
      "r485",
      "r486"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Defined benefit plan, plan assets, contributions by employer"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear": {
     "auth_ref": [
      "r483",
      "r486"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year",
        "terseLabel": "Anticipated additional employer contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r417",
      "r454",
      "r478",
      "r485",
      "r486"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r417",
      "r421",
      "r453",
      "r477",
      "r485",
      "r486"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r451",
      "r475",
      "r485",
      "r486"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit (income) cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]",
        "terseLabel": "Amortization:"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r419",
      "r452",
      "r476",
      "r485",
      "r486"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "verboseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r131",
      "r201"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetMeasurementInput": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure derivative asset.",
        "label": "Derivative Asset, Measurement Input",
        "terseLabel": "Derivative asset, measurement input"
       }
      }
     },
     "localname": "DerivativeAssetMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsAggregateNotionalAmountsAggregateFairValuesandCarryingValuesDetails",
      "http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails",
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails",
      "http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r72",
      "r73",
      "r74",
      "r561",
      "r629"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Fair Value of Assets",
        "verboseLabel": "Derivative asset, fair value, gross asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r72",
      "r73",
      "r74",
      "r561",
      "r629"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Fair Value of Liabilities"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r560"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "negatedTerseLabel": "(Gain) loss on Cronos-related financial instruments",
        "terseLabel": "Gain (loss) on Cronos-related financial instruments"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r73",
      "r559",
      "r562",
      "r567",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsAggregateNotionalAmountsAggregateFairValuesandCarryingValuesDetails",
      "http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails",
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails",
      "http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r579",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r556",
      "r559",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsAggregateNotionalAmountsAggregateFairValuesandCarryingValuesDetails",
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r556",
      "r559",
      "r567",
      "r572",
      "r573",
      "r576",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsAggregateNotionalAmountsAggregateFairValuesandCarryingValuesDetails",
      "http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails",
      "http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r552",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Foreign currency contracts (notional amounts)"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsAggregateNotionalAmountsAggregateFairValuesandCarryingValuesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r551",
      "r553",
      "r554",
      "r556",
      "r557",
      "r564",
      "r567",
      "r574",
      "r575",
      "r578",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsAggregateNotionalAmountsAggregateFairValuesandCarryingValuesDetails",
      "http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails",
      "http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument [Member]"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails",
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails",
      "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails",
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails",
      "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r14",
      "r273",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Held-for-sale, Not Discontinued Operations [Member]"
       }
      }
     },
     "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails",
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails",
      "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r3",
      "r4",
      "r12",
      "r281"
     ],
     "calculation": {
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails": {
       "order": 4.0,
       "parentTag": "mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "terseLabel": "Receivables",
        "verboseLabel": "Disposal group, including discontinued operation, accounts, notes and loans receivable, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails",
      "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent": {
     "auth_ref": [
      "r3",
      "r4",
      "r12",
      "r275",
      "r281"
     ],
     "calculation": {
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r3",
      "r4",
      "r12",
      "r275",
      "r281"
     ],
     "calculation": {
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": {
     "auth_ref": [
      "r3",
      "r4",
      "r12",
      "r281"
     ],
     "calculation": {
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails": {
       "order": 2.0,
       "parentTag": "mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Disposal group, including discontinued operation, consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent": {
     "auth_ref": [
      "r3",
      "r4",
      "r12",
      "r275",
      "r281"
     ],
     "calculation": {
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails": {
       "order": 3.0,
       "parentTag": "mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets, Current",
        "terseLabel": "Other intangible assets, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent": {
     "auth_ref": [
      "r3",
      "r4",
      "r12",
      "r275",
      "r281"
     ],
     "calculation": {
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails": {
       "order": 6.0,
       "parentTag": "mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory, Current",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets": {
     "auth_ref": [
      "r3",
      "r4",
      "r12",
      "r275",
      "r281"
     ],
     "calculation": {
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails": {
       "order": 1.0,
       "parentTag": "mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets, Current",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities": {
     "auth_ref": [
      "r3",
      "r4",
      "r12",
      "r275",
      "r281"
     ],
     "calculation": {
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities, Current",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationCurrent": {
     "auth_ref": [
      "r4",
      "r12",
      "r281"
     ],
     "calculation": {
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as defined benefit plan benefit obligations attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation, Current",
        "terseLabel": "Accrued pension costs"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent": {
     "auth_ref": [
      "r3",
      "r4",
      "r12",
      "r275",
      "r281"
     ],
     "calculation": {
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails": {
       "order": 5.0,
       "parentTag": "mo_DisposalGroupIncludingDiscontinuedOperationAssetsCurrentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current",
        "terseLabel": "Property, plant and equipment, net of accumulated depreciation"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "auth_ref": [
      "r131",
      "r274",
      "r279"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "terseLabel": "Assets and liabilities held for sale, net"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown": {
     "auth_ref": [
      "r131",
      "r274",
      "r279"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down",
        "terseLabel": "Pre-tax charge for adjustment to record the assets and liabilities at fair value less costs to sell"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r18",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Assets Held for Sale"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSale"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r491",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails",
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r380"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Cash dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrent": {
     "auth_ref": [
      "r26",
      "r60"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Dividends Payable, Current",
        "terseLabel": "Dividends payable"
       }
      }
     },
     "localname": "DividendsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Per share data:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r105",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r165",
      "r169",
      "r178",
      "r179",
      "r180",
      "r184",
      "r185",
      "r582",
      "r583",
      "r669",
      "r695"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic earnings (losses) per share attributable to Altria (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r105",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r169",
      "r178",
      "r179",
      "r180",
      "r184",
      "r185",
      "r582",
      "r583",
      "r669",
      "r695"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted earnings (losses) per share attributable to Altria (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r181",
      "r182",
      "r183",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings (Losses) per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/EarningsLossesperShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesSummaryofIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EnvironmentalCostsPolicy": {
     "auth_ref": [
      "r286",
      "r287",
      "r288",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for obligations that resulted from improper or other-than normal operation of a long-lived asset in the past. This accounting policy may address (1) whether the related remediation costs are expensed or capitalized, (2) whether the obligation is measured on a discounted basis, (3) the event, situation, or set of circumstances that generally triggers recognition of loss contingencies arising from the entity's environmental remediation-related obligations, and (4) the timing of recognition of any recoveries.",
        "label": "Environmental Costs, Policy [Policy Text Block]",
        "terseLabel": "Environmental Regulation"
       }
      }
     },
     "localname": "EnvironmentalCostsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r94",
      "r95",
      "r96",
      "r144",
      "r145",
      "r146",
      "r150",
      "r159",
      "r161",
      "r190",
      "r253",
      "r375",
      "r380",
      "r502",
      "r503",
      "r504",
      "r516",
      "r517",
      "r581",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r605",
      "r703",
      "r704",
      "r705",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityContractMember": {
     "auth_ref": [
      "r73",
      "r440",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to share prices.",
        "label": "Equity Contract [Member]",
        "terseLabel": "Equity Contract [Member]"
       }
      }
     },
     "localname": "EquityContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity": {
     "auth_ref": [
      "r247"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.",
        "label": "Equity Method Investment, Difference Between Carrying Amount and Underlying Equity",
        "terseLabel": "Equity method investment, difference between carrying amount and underlying equity"
       }
      }
     },
     "localname": "EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentDividendsOrDistributions": {
     "auth_ref": [
      "r99",
      "r126",
      "r131",
      "r689"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.",
        "label": "Proceeds from Equity Method Investment, Distribution",
        "terseLabel": "Dividends from ABI"
       }
      }
     },
     "localname": "EquityMethodInvestmentDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Equity method investment, ownership percentage",
        "verboseLabel": "Ownership percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r52",
      "r207",
      "r244"
     ],
     "calculation": {
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "verboseLabel": "Investments in equity securities"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r242"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investments accounted under the equity method.",
        "label": "Equity Method Investments, Fair Value Disclosure",
        "terseLabel": "Fair value of equity investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r52",
      "r126",
      "r246",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount": {
     "auth_ref": [
      "r239"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative loss from downward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount",
        "terseLabel": "Equity securities without readily determinable fair value, downward price adjustment, cumulative amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount": {
     "auth_ref": [
      "r239"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount",
        "negatedTerseLabel": "Impairment of JUUL equity securities",
        "terseLabel": "Impairment of JUUL equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses",
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount": {
     "auth_ref": [
      "r240"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount",
        "terseLabel": "Equity securities without readily determinable fair value, upward price adjustment, cumulative amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r589",
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r585",
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r343",
      "r357",
      "r358",
      "r440",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r485",
      "r586",
      "r619",
      "r620",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r343",
      "r440",
      "r442",
      "r447",
      "r485",
      "r586",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r343",
      "r357",
      "r358",
      "r440",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r485",
      "r586",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": {
     "auth_ref": [
      "r590"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings",
        "terseLabel": "Unrealized gains (losses) included in income (losses) from equity investments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": {
     "auth_ref": [
      "r589"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r343",
      "r357",
      "r358",
      "r440",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r485",
      "r619",
      "r620",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]",
        "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock": {
     "auth_ref": [
      "r589",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings": {
     "auth_ref": [
      "r590",
      "r591"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings",
        "terseLabel": "Pre-tax earnings (losses) recognized in net earnings (losses)"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs": {
     "auth_ref": [
      "r585",
      "r591"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at begging of period"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r558",
      "r564",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r235",
      "r236",
      "r238",
      "r239",
      "r240",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r354",
      "r374",
      "r579",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r73",
      "r440",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign currency contracts [Member]",
        "verboseLabel": "Foreign Currency Contract [Member]"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsAggregateNotionalAmountsAggregateFairValuesandCarryingValuesDetails",
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r299"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "negatedTerseLabel": "Loss (gain) related to litigation settlement"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r131",
      "r361",
      "r362"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.altria.com/role/DebtNarrativeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on early extinguishment of debt",
        "negatedTotalLabel": "Loss on early extinguishment of debt",
        "terseLabel": "Loss on early extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses",
      "http://www.altria.com/role/DebtNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r361",
      "r362"
     ],
     "calculation": {
      "http://www.altria.com/role/DebtNarrativeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_GainsLossesOnExtinguishmentOfDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the difference between the fair value of payments made to legally extinguish a debt and its carrying value at that time. This item excludes the write-off of amounts previously capitalized as debt issuance costs.",
        "label": "Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost",
        "negatedTerseLabel": "Loss on extinguishment of debt, premiums and fees"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r110"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "negatedTerseLabel": "General corporate expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r266",
      "r267",
      "r614",
      "r653"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r106",
      "r139",
      "r206",
      "r212",
      "r216",
      "r219",
      "r222",
      "r249",
      "r313",
      "r314",
      "r315",
      "r318",
      "r319",
      "r320",
      "r322",
      "r324",
      "r326",
      "r327",
      "r594"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsMaximumExposure": {
     "auth_ref": [
      "r311"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.",
        "label": "Guarantor Obligations, Maximum Exposure, Undiscounted",
        "terseLabel": "Contingent liability related to performance surety bonds"
       }
      }
     },
     "localname": "GuaranteeObligationsMaximumExposure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r556",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsAggregateNotionalAmountsAggregateFairValuesandCarryingValuesDetails",
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r98",
      "r206",
      "r212",
      "r216",
      "r219",
      "r222",
      "r652",
      "r663",
      "r671",
      "r697"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Earnings (losses) before income taxes",
        "totalLabel": "Earnings (losses) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses",
      "http://www.altria.com/role/IncomeTaxesSummaryofIncomeTaxesDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r99",
      "r131",
      "r203",
      "r244",
      "r662",
      "r689"
     ],
     "calculation": {
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails": {
       "order": 1.0,
       "parentTag": "mo_IncomeLossFromEquityInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedTerseLabel": "(Income) losses from equity investments",
        "verboseLabel": "Income (losses) from investments under equity method of accounting"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r491",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails",
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails",
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails",
      "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r4",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r13",
      "r15",
      "r16",
      "r17",
      "r283",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails",
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails",
      "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r280",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r141",
      "r511",
      "r512",
      "r514",
      "r521",
      "r526",
      "r528",
      "r529",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r142",
      "r160",
      "r161",
      "r204",
      "r509",
      "r522",
      "r527",
      "r698"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision (benefit) for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses",
      "http://www.altria.com/role/IncomeTaxesSummaryofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "verboseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Cash effects of changes:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating assets after deduction of noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net",
        "negatedLabel": "Accrued liabilities and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations": {
     "auth_ref": [
      "r130"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for pension and other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Increase (Decrease) in Obligation, Pension and Other Postretirement Benefits",
        "negatedTerseLabel": "Decrease in accrued postretirement health care cost liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInPensionAndPostretirementObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r269",
      "r271"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "verboseLabel": "Other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r670"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "negatedTerseLabel": "Interest and other debt expense, net",
        "terseLabel": "Interest and other debt expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r660",
      "r688"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.",
        "label": "Interest Payable",
        "terseLabel": "Accrued interest on long-term debt"
       }
      }
     },
     "localname": "InterestPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterimPeriodCostsNotAllocableDomain": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the type of costs and expenses incurred during an interim period that cannot be readily identified with the activities or benefits of other interim periods and are charged to the interim period in which incurred.",
        "label": "Interim Period, Costs Not Allocable [Domain]",
        "terseLabel": "Interim Period, Costs Not Allocable [Domain]"
       }
      }
     },
     "localname": "InterimPeriodCostsNotAllocableDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r49",
      "r265"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished product"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r21",
      "r69",
      "r614"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Inventory, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Net [Abstract]",
        "verboseLabel": "Inventories:"
       }
      }
     },
     "localname": "InventoryNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r50",
      "r265"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r246",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investment, Policy"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTableTextBlock": {
     "auth_ref": [
      "r237",
      "r241",
      "r251",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment.",
        "label": "Investment [Table Text Block]",
        "terseLabel": "Investment"
       }
      }
     },
     "localname": "InvestmentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTextBlock": {
     "auth_ref": [
      "r237",
      "r241",
      "r251",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investment.",
        "label": "Investment [Text Block]",
        "terseLabel": "Investments in Equity Securities"
       }
      }
     },
     "localname": "InvestmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r687"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "totalLabel": "Investments",
        "verboseLabel": "Investments in equity securities ($1,740 million and $1,868 million at September 30, 2021 and December 31, 2020, respectively, measured at fair value)"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]",
        "terseLabel": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r585"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Investments, fair value disclosure"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.",
        "label": "Legal Matters and Contingencies [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "LegalMattersAndContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/Contingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit [Member]"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r59",
      "r139",
      "r214",
      "r249",
      "r313",
      "r314",
      "r315",
      "r318",
      "r319",
      "r320",
      "r322",
      "r324",
      "r326",
      "r327",
      "r540",
      "r545",
      "r546",
      "r594",
      "r612",
      "r613"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "verboseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r47",
      "r139",
      "r249",
      "r594",
      "r614",
      "r659",
      "r683"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Stockholders\u2019 (Deficit) Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r61",
      "r139",
      "r249",
      "r313",
      "r314",
      "r315",
      "r318",
      "r319",
      "r320",
      "r322",
      "r324",
      "r326",
      "r327",
      "r540",
      "r545",
      "r546",
      "r594",
      "r612",
      "r613",
      "r614"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Liabilities [Abstract]",
        "terseLabel": "Liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r3",
      "r4",
      "r12",
      "r14",
      "r17",
      "r275",
      "r281"
     ],
     "calculation": {
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "terseLabel": "Liabilities held for sale",
        "totalLabel": "Liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleSummaryofMajorClassesofAssetsandLiabilitiesClassifiedasHeldforSaleDetails",
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r57"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Credit line available under the agreement"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit [Member]"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedFromOtherParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded from other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded from Other Party",
        "terseLabel": "Loss contingency, credits to offset payments",
        "verboseLabel": "Amount ordered to be paid from other party"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedFromOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Litigation settlement"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest expense (income) directly attributable to an award in settlement of litigation.",
        "label": "Litigation Settlement Interest",
        "netLabel": "Litigation settlement interest expense (income)"
       }
      }
     },
     "localname": "LitigationSettlementInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR) [Member]"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r35",
      "r342",
      "r356",
      "r357",
      "r358",
      "r656",
      "r678"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Carrying value"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails",
      "http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails",
      "http://www.altria.com/role/FinancialInstrumentsAggregateNotionalAmountsAggregateFairValuesandCarryingValuesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-term Debt, Fair Value",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/DebtNarrativeDetails",
      "http://www.altria.com/role/DebtTenderOffersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r63",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/DebtNarrativeDetails",
      "http://www.altria.com/role/DebtTenderOffersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r305",
      "r307",
      "r309",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r305",
      "r307",
      "r309",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r299"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "periodEndLabel": "Accrued liability for tobacco and health litigation items at end of period",
        "periodStartLabel": "Accrued liability for tobacco and health litigation items at beginning of period"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualPayments": {
     "auth_ref": [
      "r299"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow reducing loss contingency liability.",
        "label": "Loss Contingency Accrual, Payments",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "LossContingencyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualProvision": {
     "auth_ref": [
      "r299"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.",
        "label": "Loss Contingency Accrual, Provision",
        "terseLabel": "Provision related to litigation recorded"
       }
      }
     },
     "localname": "LossContingencyAccrualProvision",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Loss Contingency Accrual [Roll Forward]",
        "terseLabel": "Loss Contingency Accrual [Roll Forward]"
       }
      }
     },
     "localname": "LossContingencyAccrualRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyClaimsSettledNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of claims settled.",
        "label": "Loss Contingency, Claims Settled, Number",
        "terseLabel": "Loss contingency, claims settled, number"
       }
      }
     },
     "localname": "LossContingencyClaimsSettledNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "auth_ref": [
      "r299",
      "r302",
      "r306"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Awarded, Value",
        "terseLabel": "Damages awarded, value"
       }
      }
     },
     "localname": "LossContingencyDamagesAwardedValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesPaidValue": {
     "auth_ref": [
      "r299",
      "r302",
      "r306"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages paid to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Paid, Value",
        "terseLabel": "Judgments paid (approximately)"
       }
      }
     },
     "localname": "LossContingencyDamagesPaidValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r299",
      "r302",
      "r306"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Value",
        "terseLabel": "Loss contingency, damages sought, value"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r305",
      "r307",
      "r309",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyNumberOfPlaintiffs": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Number of Plaintiffs",
        "terseLabel": "Number of plaintiffs"
       }
      }
     },
     "localname": "LossContingencyNumberOfPlaintiffs",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Claims filed, number",
        "verboseLabel": "Number of cases pending"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.",
        "label": "Segment Reconciling Items [Member]",
        "terseLabel": "Segment Reconciling Items [Member]"
       }
      }
     },
     "localname": "MaterialReconcilingItemsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "auth_ref": [
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.",
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "terseLabel": "Expected Dividend Yield [Member]"
       }
      }
     },
     "localname": "MeasurementInputExpectedDividendRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "auth_ref": [
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.",
        "label": "Measurement Input, Expected Term [Member]",
        "terseLabel": "Expected Life [Member]"
       }
      }
     },
     "localname": "MeasurementInputExpectedTermMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "auth_ref": [
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
        "label": "Measurement Input, Price Volatility [Member]",
        "terseLabel": "Expected Volatility [Member]"
       }
      }
     },
     "localname": "MeasurementInputPriceVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "auth_ref": [
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "verboseLabel": "Risk Free Interest Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputSharePriceMember": {
     "auth_ref": [
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using share price of saleable stock.",
        "label": "Measurement Input, Share Price [Member]",
        "terseLabel": "Share price [Member]"
       }
      }
     },
     "localname": "MeasurementInputSharePriceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r68",
      "r139",
      "r249",
      "r313",
      "r318",
      "r319",
      "r320",
      "r326",
      "r327",
      "r594",
      "r658",
      "r682"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NatureOfExpenseAxis": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cost or expense.",
        "label": "Nature of Expense [Axis]",
        "terseLabel": "Nature of Expense [Axis]"
       }
      }
     },
     "localname": "NatureOfExpenseAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Cash Provided by (Used in) Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Cash Provided by (Used in) Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r127",
      "r129",
      "r132"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash Provided by (Used in) Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r17",
      "r88",
      "r91",
      "r96",
      "r100",
      "r132",
      "r139",
      "r149",
      "r154",
      "r155",
      "r156",
      "r157",
      "r160",
      "r161",
      "r176",
      "r206",
      "r212",
      "r216",
      "r219",
      "r222",
      "r249",
      "r313",
      "r314",
      "r315",
      "r318",
      "r319",
      "r320",
      "r322",
      "r324",
      "r326",
      "r327",
      "r583",
      "r594",
      "r664",
      "r690"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.altria.com/role/EarningsLossesperShareBasicandDilutedEarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net earnings (losses) attributable to Altria",
        "verboseLabel": "Net earnings (losses) attributable to Altria"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses",
      "http://www.altria.com/role/EarningsLossesperShareBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r88",
      "r91",
      "r96",
      "r160",
      "r161",
      "r542",
      "r548"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Net (earnings) losses attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r107"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest",
        "terseLabel": "Net earnings attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquityParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r154",
      "r155",
      "r156",
      "r157",
      "r165",
      "r166",
      "r177",
      "r180",
      "r206",
      "r212",
      "r216",
      "r219",
      "r222"
     ],
     "calculation": {
      "http://www.altria.com/role/EarningsLossesperShareBasicandDilutedEarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Earnings (losses) for basic EPS"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/EarningsLossesperShareBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r168",
      "r171",
      "r172",
      "r173",
      "r174",
      "r177",
      "r180"
     ],
     "calculation": {
      "http://www.altria.com/role/EarningsLossesperShareBasicandDilutedEarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "totalLabel": "Earnings (losses) for diluted EPS"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/EarningsLossesperShareBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": {
     "auth_ref": [
      "r366",
      "r542",
      "r543"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.",
        "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest",
        "terseLabel": "Net earnings (losses)"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging [Member]"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsAggregateNotionalAmountsAggregateFairValuesandCarryingValuesDetails",
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent": {
     "auth_ref": [
      "r417"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.",
        "label": "Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component",
        "negatedLabel": "Net periodic benefit income, excluding service cost",
        "terseLabel": "Net periodic benefit income, excluding service cost"
       }
      }
     },
     "localname": "NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r2",
      "r147",
      "r148",
      "r151",
      "r152",
      "r162",
      "r163",
      "r164",
      "r233",
      "r234",
      "r254",
      "r255",
      "r408",
      "r409",
      "r410",
      "r411",
      "r505",
      "r518",
      "r519",
      "r520",
      "r580",
      "r595",
      "r596",
      "r597",
      "r611",
      "r649",
      "r650",
      "r651",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "New Accounting Guidance Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements, Policy"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r380",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-controlling Interests [Member]"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument [Member]"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OciEquityMethodInvestmentAfterTax": {
     "auth_ref": [
      "r243"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsLosses": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI.",
        "label": "OCI, Equity Method Investment, after Tax",
        "terseLabel": "ABI"
       }
      }
     },
     "localname": "OciEquityMethodInvestmentAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsLosses"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r206",
      "r212",
      "r216",
      "r219",
      "r222"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income",
        "verboseLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLossMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing operating income (loss).",
        "label": "Operating Income (Loss) [Member]",
        "terseLabel": "Operating Income (Loss) [Member]"
       }
      }
     },
     "localname": "OperatingIncomeLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments [Member]"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r19",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Background and Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r25",
      "r26",
      "r27",
      "r60"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r70",
      "r614"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r558",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets [Member]"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r86",
      "r94",
      "r95",
      "r599",
      "r601",
      "r605"
     ],
     "calculation": {
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "Other comprehensive earnings (losses) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r86",
      "r94",
      "r95",
      "r97",
      "r599",
      "r601",
      "r605"
     ],
     "calculation": {
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "totalLabel": "Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r84",
      "r94"
     ],
     "calculation": {
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "negatedLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax": {
     "auth_ref": [
      "r77",
      "r83",
      "r566",
      "r569",
      "r577"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax",
        "terseLabel": "Gain (Loss) Recognized in Net Earnings (Losses)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsLosses": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Currency translation adjustments and other"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsLosses"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r568"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Gain (Loss) Recognized in Accumulated Other Comprehensive Losses"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r89",
      "r92",
      "r94",
      "r95",
      "r97",
      "r101",
      "r375",
      "r599",
      "r604",
      "r605",
      "r665",
      "r691"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsLosses": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive earnings (losses), net of deferred income taxes",
        "verboseLabel": "Other comprehensive earnings (losses), net of deferred income taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsLosses",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "verboseLabel": "Other comprehensive earnings (losses), net of deferred income taxes:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsLosses"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r80",
      "r83"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsLosses": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Benefit plans"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsLosses"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCostOfOperatingRevenue": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses": {
       "order": 3.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other costs incurred during the reporting period related to other revenue generating activities.",
        "label": "Other Cost of Operating Revenue",
        "terseLabel": "Excise taxes on products"
       }
      }
     },
     "localname": "OtherCostOfOperatingRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsMember": {
     "auth_ref": [
      "r558",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current assets.",
        "label": "Other Current Assets [Member]",
        "terseLabel": "Other Current Assets [Member]"
       }
      }
     },
     "localname": "OtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r558",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other Liabilities [Member]"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "verboseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r414",
      "r415",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r465",
      "r468",
      "r472",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "verboseLabel": "Postretirement [Member]"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent": {
     "auth_ref": [
      "r36",
      "r415",
      "r416",
      "r438"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit other postretirement plan, classified as noncurrent. Excludes pension plan.",
        "label": "Liability, Other Postretirement Defined Benefit Plan, Noncurrent",
        "terseLabel": "Accrued postretirement health care costs"
       }
      }
     },
     "localname": "OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r115",
      "r118"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchases of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.",
        "label": "Payment for Debt Extinguishment or Debt Prepayment Cost",
        "negatedTerseLabel": "Premiums and fees related to early extinguishment of debt"
       }
      }
     },
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends paid on common stock"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries": {
     "auth_ref": [
      "r116"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of noncontrolling interest during the period.",
        "label": "Payments to Acquire Additional Interest in Subsidiaries",
        "terseLabel": "Payments to acquire additional interest in subsidiaries"
       }
      }
     },
     "localname": "PaymentsToAcquireAdditionalInterestInSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation [Member]"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitContributions": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for pension and other postretirement benefits. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree.",
        "label": "Payment for Pension and Other Postretirement Benefits",
        "negatedLabel": "Pension plan contributions"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitContributions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r439",
      "r441",
      "r447",
      "r464",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r485",
      "r487",
      "r488",
      "r489",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Benefit Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash": {
     "auth_ref": [
      "r131"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense (reversal of expense) for pension and other postretirement benefits.",
        "label": "Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash",
        "terseLabel": "Pension provisions and postretirement, net"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r413",
      "r415",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r465",
      "r468",
      "r472",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r489",
      "r490",
      "r496",
      "r497",
      "r498",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension [Member]",
        "verboseLabel": "Pension [Member]"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from divestiture of businesses"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r119"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "verboseLabel": "Proceeds from issuance of debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Long-term debt issued"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r120",
      "r124"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from Short-term Debt",
        "terseLabel": "Proceeds from short-term borrowings"
       }
      }
     },
     "localname": "ProceedsFromShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r17",
      "r88",
      "r91",
      "r96",
      "r125",
      "r139",
      "r149",
      "r160",
      "r161",
      "r206",
      "r212",
      "r216",
      "r219",
      "r222",
      "r249",
      "r313",
      "r314",
      "r315",
      "r318",
      "r319",
      "r320",
      "r322",
      "r324",
      "r326",
      "r327",
      "r536",
      "r541",
      "r543",
      "r548",
      "r549",
      "r583",
      "r594",
      "r671"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsLosses": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "negatedLabel": "Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings (losses)",
        "terseLabel": "Net earnings (losses)",
        "totalLabel": "Net earnings (losses)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsLosses",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r53",
      "r276"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "verboseLabel": "Property, plant and equipment, at cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r29",
      "r30",
      "r278",
      "r614",
      "r672",
      "r685"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseCommitmentMember": {
     "auth_ref": [
      "r37",
      "r657",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier. Excludes long-term commitments.",
        "label": "Purchase Commitment [Member]",
        "terseLabel": "Purchase Commitment [Member]"
       }
      }
     },
     "localname": "PurchaseCommitmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r41",
      "r48",
      "r614",
      "r684",
      "r711"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Receivables"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": {
     "auth_ref": [
      "r86",
      "r94",
      "r95",
      "r599",
      "r603",
      "r605"
     ],
     "calculation": {
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax",
        "negatedLabel": "Amounts reclassified to net earnings (losses)"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r86",
      "r94",
      "r95",
      "r97",
      "r599",
      "r603",
      "r605"
     ],
     "calculation": {
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTotalLabel": "Amounts reclassified to net earnings (losses), net of deferred income taxes"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodTax": {
     "auth_ref": [
      "r84",
      "r87",
      "r94"
     ],
     "calculation": {
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Reclassification from AOCI, Current Period, Tax",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Member]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r364",
      "r365",
      "r367",
      "r368"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "terseLabel": "Redeemable noncontrolling interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Long-term debt repaid",
        "terseLabel": "Long-term debt repaid"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Repayments of Short-term Debt",
        "negatedLabel": "Repayment of short-term borrowings"
       }
      }
     },
     "localname": "RepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfUnsecuredDebt": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to repay long-term debt that is not secured by collateral. Excludes repayments of tax exempt unsecured debt.",
        "label": "Repayments of Unsecured Debt",
        "terseLabel": "Repayments of senior unsecured debt"
       }
      }
     },
     "localname": "RepaymentsOfUnsecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r20",
      "r28",
      "r134"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted cash included in other current assets"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r24",
      "r31",
      "r134",
      "r713"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash included in other assets"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r131",
      "r290",
      "r295",
      "r296"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r291",
      "r292",
      "r296",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r43",
      "r380",
      "r506",
      "r614",
      "r681",
      "r706",
      "r710"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Earnings reinvested in the business"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r144",
      "r145",
      "r146",
      "r150",
      "r159",
      "r161",
      "r253",
      "r502",
      "r503",
      "r504",
      "r516",
      "r517",
      "r581",
      "r703",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Earnings Reinvested in the Business [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r413",
      "r414",
      "r415",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r465",
      "r468",
      "r472",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r496",
      "r497",
      "r498",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r413",
      "r414",
      "r415",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r465",
      "r468",
      "r472",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r496",
      "r497",
      "r498",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r197",
      "r198",
      "r211",
      "r217",
      "r218",
      "r225",
      "r226",
      "r229",
      "r403",
      "r404",
      "r648"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "verboseLabel": "Net revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarningsLosses",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r135",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue from Contract with Customer"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/RevenuefromContractwithCustomerPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r406",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenues from Contracts with Customers"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/RevenuesfromContractswithCustomers"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuePerformanceObligationDescriptionOfTiming": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of timing for satisfying performance obligation in contract with customer. Includes, but is not limited to, as services are rendered, and upon shipment, delivery or completion of service.",
        "label": "Revenue, Performance Obligation, Description of Timing",
        "terseLabel": "Expected period for satisfaction of performance obligation"
       }
      }
     },
     "localname": "RevenuePerformanceObligationDescriptionOfTiming",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r86",
      "r604",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r63",
      "r143",
      "r357",
      "r359",
      "r376",
      "r377",
      "r378",
      "r379",
      "r607",
      "r608",
      "r610",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt Instruments"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r471",
      "r472",
      "r473",
      "r474",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r559",
      "r567",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Pre-tax Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r4",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r13",
      "r15",
      "r16",
      "r17",
      "r283",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/EarningsLossesperShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r17",
      "r139",
      "r248",
      "r249",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock": {
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r305",
      "r307",
      "r309",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date.",
        "label": "Schedule of Loss Contingencies by Contingency [Table Text Block]",
        "terseLabel": "Schedule of Contingencies"
       }
      }
     },
     "localname": "ScheduleOfLossContingenciesByContingencyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of Net Periodic Benefit (Income) Cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for net investment hedges of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Net Investment Hedges, Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Schedule of Derivative Liabilities at Fair Value"
       }
      }
     },
     "localname": "ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r153",
      "r156",
      "r187",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table Text Block]",
        "terseLabel": "Recent Accounting Guidance Not Yet Adopted"
       }
      }
     },
     "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/NewAccountingGuidanceNotYetAdoptedTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r206",
      "r209",
      "r215",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r206",
      "r209",
      "r215",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "auth_ref": [
      "r381",
      "r382",
      "r383",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table Text Block]",
        "terseLabel": "Schedule of Share Repurchase Activity"
       }
      }
     },
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r194",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r222",
      "r229",
      "r294",
      "r298",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]",
        "verboseLabel": "Reporting Segment [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r194",
      "r195",
      "r196",
      "r206",
      "r210",
      "r216",
      "r220",
      "r221",
      "r222",
      "r223",
      "r225",
      "r228",
      "r229",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes [Member]"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails",
      "http://www.altria.com/role/DebtTenderOffersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SettledLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.",
        "label": "Settled Litigation [Member]",
        "terseLabel": "Settled Litigation [Member]"
       }
      }
     },
     "localname": "SettledLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r32",
      "r614",
      "r655",
      "r677"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-term Debt",
        "terseLabel": "Short-term debt"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r5",
      "r194",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r222",
      "r229",
      "r268",
      "r282",
      "r294",
      "r298",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r38",
      "r39",
      "r40",
      "r137",
      "r139",
      "r169",
      "r170",
      "r175",
      "r178",
      "r180",
      "r191",
      "r192",
      "r193",
      "r249",
      "r313",
      "r318",
      "r319",
      "r320",
      "r326",
      "r327",
      "r369",
      "r370",
      "r372",
      "r373",
      "r375",
      "r594",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r67",
      "r94",
      "r95",
      "r96",
      "r144",
      "r145",
      "r146",
      "r150",
      "r159",
      "r161",
      "r190",
      "r253",
      "r375",
      "r380",
      "r502",
      "r503",
      "r504",
      "r516",
      "r517",
      "r581",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r605",
      "r703",
      "r704",
      "r705",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]",
        "verboseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r190",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "verboseLabel": "Planned share repurchase program"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock repurchase program, remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r40",
      "r45",
      "r46",
      "r139",
      "r232",
      "r249",
      "r594",
      "r614"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total stockholders\u2019 (deficit) equity attributable to Altria"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r95",
      "r139",
      "r144",
      "r145",
      "r146",
      "r150",
      "r159",
      "r249",
      "r253",
      "r380",
      "r502",
      "r503",
      "r504",
      "r516",
      "r517",
      "r534",
      "r535",
      "r547",
      "r581",
      "r594",
      "r599",
      "r600",
      "r605",
      "r704",
      "r705",
      "r738"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 (deficit) equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders\u2019 (Deficit) Equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r606",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails",
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r606",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails",
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r606",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetsHeldforSaleNarrativeDetails",
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of subsidiary's or equity method investee's stock owned by parent immediately after all stock transactions.",
        "label": "Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions",
        "terseLabel": "Subsidiary ownership percentage"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SummaryOfValuationAllowanceTextBlock": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.",
        "label": "Summary of Valuation Allowance [Table Text Block]",
        "terseLabel": "Summary of Valuation Allowance"
       }
      }
     },
     "localname": "SummaryOfValuationAllowanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesupdateTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ThreatenedLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of threatened litigation against the entity.",
        "label": "Threatened Litigation [Member]",
        "terseLabel": "Threatened Litigation [Member]"
       }
      }
     },
     "localname": "ThreatenedLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r235",
      "r236",
      "r238",
      "r239",
      "r240",
      "r354",
      "r374",
      "r579",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "verboseLabel": "Average price per share of shares repurchased (usd per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Shares repurchased (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r66",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Cost of Repurchased Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r40",
      "r375",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Repurchase of common stock (shares)",
        "verboseLabel": "Total number of shares repurchased (shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r66",
      "r381",
      "r384"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Cost of repurchased stock (967,321,022 shares at September 30, 2021 and 947,542,152 shares at December 31, 2020)"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r375",
      "r380",
      "r381"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Repurchases of common stock",
        "terseLabel": "Aggregate cost of shares repurchased"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r291",
      "r292",
      "r296",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "auth_ref": [
      "r131"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "terseLabel": "Unrealized gain (loss) on derivatives"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnusualOrInfrequentItemAxis": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Axis]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Axis]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemDomain": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Domain]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Domain]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r168",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted-average shares for diluted EPS (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/EarningsLossesperShareBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares issuable for little or no cash consideration upon the satisfaction of certain conditions (contingently issuable shares) are considered outstanding common shares and included in the computation of basic Earnings Per Share as of the date that all necessary conditions have been satisfied (in essence, when issuance of the shares is no longer contingent). Outstanding common shares that are contingently returnable (that is, subject to recall) are treated in the same manner as contingently issuable shares. Contingently issuable shares include shares that (a) will be issued in the future upon the satisfaction of specified conditions, (b) have been placed in escrow and all or part must be returned if specified conditions are not met, or (c) have been issued but the holder must return all or part if specified conditions are not met. The number of contingently issuable shares is determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares, Contingently Issuable",
        "terseLabel": "Plus: contingently issuable performance stock units (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesContingentlyIssuable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/EarningsLossesperShareBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r165",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-average shares for basic EPS (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/EarningsLossesperShareBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.altria.com/role/DebtNarrativeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_GainsLossesOnExtinguishmentOfDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.",
        "label": "Write off of Deferred Debt Issuance Cost",
        "terseLabel": "Write-off of amortized debt discounts and issuance costs, debt extinguishment"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 17
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080555-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2646-109256"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e725-108305"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e765-108305"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e639-108305"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "321",
   "URI": "http://asc.fasb.org/topic&trid=75115024"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=125513658&loc=d3e32014-111567"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=124268079&loc=d3e32472-111569"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "http://asc.fasb.org/topic&trid=2196965"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "325",
   "URI": "http://asc.fasb.org/topic&trid=2197064"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2599-110228"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2473-110228"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13185-110859"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13231-110859"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6571209&loc=d3e13669-110860"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "http://asc.fasb.org/subtopic&trid=2175709"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(3)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(17))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r725": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r726": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r727": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r728": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r729": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r730": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r731": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r732": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r733": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r734": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r735": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r736": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r737": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(dd)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>107
<FILENAME>0000764180-21-000127-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000764180-21-000127-xbrl.zip
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M@3M8:5C3=,KN,C/14@QE-2Q]N>#"@ F9@8P//7"5,9Y-69%Y6T@8 7  H@.
M!,Y2> ,P:);P&(HL,RED+&^"W(I )F/I'+=3%$GYG81^EW0Z*!-@#'2IB4M
M'R@0*PO< <0R: Z6"&G99*3B$7,%/A;M)]+*4@D.(%5. \E OC)1?@0#=+F,
MR4#4FX-I1L PQ]!,L,%T>1J^@7H3J-M?#J@E2U0&L$$$+F!2!42#.%3;I7J5
M04I+B4O [U@7 G0"%)<P4048*PR-.2 )G0"=0^L%RDN N4==@R,)8N-5E"@T
M" "T#> O4!>R)^9NQ!)M)FZ&>RN'RGF@\IYQ+ QV@Y75)?BZF3$KUKX P9^
MNJ\+TYV=P_3- P"\V3MJ-0^/78G:DG%A8#,),&!I]]U;0L<5XU82#@%7:J E
MXH5) /] *S?"%BB60ES'V([O0KE8&U= .XSXUN@ R-R:6 HH=FP?\"<D #J
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MQ67XANM'<-UZ.;@&%LL4D4,@G".EC*!&<6PV"^TRC3'8>2Z!?T<J%Z@3T;@
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M5@+M\9"F ?[4B>17!EFQ0Y MXGI PS*JZ(BF(,F^925TMXCFQ&MT%.6&L+-
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M3]F.@N<;T./K%5]R#0W?]OZ,> ]K1BA%.2S!8HQCG[0Q]&Y,5<&KP3U2$:K
MU+_.ROLL5L%X'DXGTV 83F=GF,7SQ?OA60CA[.E0]$[@O;VP QL6XZ"DZ35:
M;OWI$!PN8#B:G8?CT=,4<"=;QSV&V03"-V-8#.>OAF?CA37[^73\ 89!:&9\
MU_6_'NU[:M4]X:M07JNL>E]]PYKW;M@TA4BF*8M,QX$UURO0*P;O"J*0CMC
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MDB5$Q]*#>X&MXD(H)=*>?:="%H5(2O50Y2M7"9MG?;%17;$,_P102P,$%
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M7]18X.H%/CI:)IG 3/SL@6,HO<EM@P "$W0THULBLQ.E%R)I!0_9"K2>!*+
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M$"1LXD3,>4'&J<V\@<M^@RPS5L@HB1R"*V))?^J9+.; <<B!=<^#>-D<^!1
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M*?C'KTY4WF8AMON3<XC?[A^I'^[74[]]</OAX=.7_YH<:%RX_\/#R?[+I_Y
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MO?_L_#;Y@T/+GC?O+W'RR=GKLXM\<^%!??*Y06AHA#2ST<#(S:*U*7.)P81
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M8?/=!<:V->!<O:Y;)TK4HH](*Q-B!<8G*IR27D.$?;HZE#8FGR2+UZ? U3E
M0"P)T#D"@UT]X0:*;T<?H#=?&APJF=8XL=>L$K(OSB2(Z*6I6/9Q$R756^*&
M-H]M;+;9RB7$Q" :YZE1!(P<12*QV3YL-S_YNYGZ?C#)1^>#$4V9:F_N2,EJ
MMN2R[>NNMA#HC4S^;@1<ZO56P;O"F#0?3F22DQ D0P5HJ6T?N%<Y^;NI]3B6
M;)-6P )*RY!ZR57,R7H'S9Y4.VX!DE>W/F)]4R!6HL?:HFD@I>9:5/<ZJ+9@
M8Z"M@68SZR/6!9/WB:LH5EP#<*2<H[&N!$>&"K)L#4Q7O#YB7?A$<FA:IMY_
M1_&1DE5^UE*M26PXFJW!9].3O^N#+#1H'DHLZOJ@A):]!2J>4%%46PM; ]E5
MKH]8%S@HU$-0A((1LF']!U,J!CAHDB[;X^\VLCYB;5&)K)7@;2K00$-2EDQ%
MO*M@O"A85X?2IIY Z8L)K*^:K 003%A\*"8!I]Q7 O-ID4(</4^OL*PQK@>:
MUC!Y4TTJRL182JG-24E-.$ FBEL#S8;*&M<%4^66'=72Q]=#WP;+VEH:.*]6
MY-OVP'3598UKPL<(FF"#BS[T"6]3% JB!D:J2T!V:_#9M+)='V31&D(5MIHS
M!N@MFKWF]8A(5:JQY+<&LBLM:UP3.#D"I)R2!(K@!# %<,!6?(Y5RO: LYFR
MQC6AY+DE3=YS<[6;4"VQA2PN^::YH>$K]'H;B\M&-9/G()8)T+<BC( AQZ+4
MS6@WT$-I] 'ZXV585]_AB7R*/FH@*%0 -<NVE5"J % TP?GM0W53:Y^O'MML
M+9?@D6/6U-,%M$AJQ1D-20N"VX?MYJ>_-P)TI8@Q5VRMNV8H"*YY!3X92!3S
M-@*]J;7/5P\N-XPQN4;H!<CY;!B\.NQ4L09+<?O O>*USQMHJPA86?/GJKD8
M.&K%4$V%.=N*TN+9'.OX)?\53G^O2>6R!8?5.P^E@#1%Q8J$9EF ?;*\-=!L
M:/I[74FSJAIRJ1I-P2!2*"$GVYHAWQREDZ5,6P'354]_KVO$*;"K3;U<A@CZ
M;W2AP]*,/D4(-FX-/IL>)%P?9!2 ! N2P]"W("EHR4())6<DM&9K(+O2Z>\U
M@0,$62STZ<3:]]PK&6SC4&.6H)X0MP:<S4Q_KPFE$A/;5D)?NJ0FQ!AL7QM#
MK6:T#MO5H;2I)^"Y9*Z1//4Q;*^):7'2EQN;*B:<[HARM0W#1Q^@/R[7O?IV
MYL5E:.IX7,ZDT=R1JV!C= HI5,]N^U#=U!J9J\=6JGB.O="- 4R?=/(9H 7U
M8Y9#HNW#=O.#A!L!6E5"-E2B000%N&"KB;S-16KFZ&4+@=[4&ID->.B<3*N6
M?:D%N+1LQ4K0H*L)6$+90@]]Q6MDK@32\QV.IB>[&Y^]?W&+H5?ZY]D)/G\'
M,N<21]N0U?R1<P$R+F77E]Q(]B>SM\:ZLU%D<&5H!%G,ES?N_S*5^>+%Y-7Y
MUG3_E,/)F[O3Z>SU:F?OQ;U[MRZ=#=9]_I Q[+FR!@/W/A9/M1:*#$D@FP*5
MR!+Y&EJ"#> WBN=6(M<*/0.)"9H*6.;&'%/SFDO'\YWE\]ESRX/H7_#Q%$7^
M_.>6/VAV\&7/C5$R5F"$'E("6R_ (;)/N=;3YP9GSVT8.>W'SPT^_[G%]01B
M3,59U="M4 9G+2G'DG-.':Y-8,I)FPR3!MS,I.]@]U TRM07N) '\]GS.1Z=
M^]M_'1^^[3_ATX==<C,3#</KV<>AY[$U0$D-P2<N>G*RQ8+X4GP\6TT" U9)
M0T6I*R!8SV"26!L-4\+F/00U)':Y^=8L-LD5_$<+OP?=(6A8</WU%> 7FNE\
M@9]LJCZ;)?&DILA%,]$B+==H$U?UE6=5_G:\D.+T&.=O^Z_8@!&N6KJO9]<H
M:R3$:B*JZ@25E:OQ(<E64\X@?@PM<0<.U)I6GC$X@.!\]:8G=UB"L^1-+KX$
MJIC.]YC.UQ2HS[^/8UK(_Q[W(8C7^J_';U_)Q;&'CPZX9(+T+;CS&@AB:HXQ
ML@4P?0Z>2F]L;235'$!(1K5;_>!,^N/,X^HWU%!H46S?G#<*5!L0 C57A1&E
M:%8RICK!P<.[@1I?+%8TDX3D V!MI1E/5%4VA1K:&+J?WYXL7LT6>/C#?';\
MZM8A+A9ZPKH:M;OH7B\<^$\YY#:;ZTLYF"WUH_Y4)M-CX?NO^O[L?<QO)!%:
M=:Y&Y)ISCJRIIZ$FK98B4HA3DGH6H<U@->]WQXO)5!:+F_5_CR>+R7OHU"H?
M+65_HG=U>"B/YSA=8.T?KRLF;XP\(U8-9BVMDXT1S*;PJN>IE +.NVQ0Y0/;
M*FE$JF'X'#J9?3Z? ?L.#W%:Y=$+D>7-*;^?S^QW<3CK,S^+[]Y>N-N%GN+P
MF"?3YY^^TR\SUU$*H^+5J88 $?2?%I'(A%0J0^;@6=R.P>OT@N?</0T5CTY^
MY'OB/=&W3]^\+F;S5W_(O=F'V.K5]W'^L^B]/;_)1Y/I9+$\N3W]D0]E(:@B
M^-9LL=S*37H=2L <(AHP8$'0U1!J\=;[9'P\M>(NGO:&KJ*&;\5;8U";%V4?
M6<X%6?;[EG/AT"_9WMI6WURBU">XBJ=L"[ +$<1632!'L _=SF#^T&#&D@.3
M,Y)SWSO' 20V")%MX1R%34MM3'NM[UBY"59N7HE0;,GGIEDP) B$N6\N@!Q+
M")Q3XN'ZTUY!]TBOR,>'<K^=U%?NR_+%C.].7\MB^;[J\L-W10[P2,Z1OOG=
MW>EW\GHD_B8;YRE!PQ8]6*]N)WI?L>\7V8?&3SN-#[%T8#1@F?7M?.><,>2+
M[T6JP36*DBD8?2,U&U/8<LOZUX\_WAN)66'P$@Q62N(!FV#D9C$X2&*H<-QR
ML[ITI-9G4Z@9,A2;6%3]J^1";W+UO9ZCB+K" :O_M2!U:SZ;SA8K+:-2YF\C
M,2\*V"A[BPD;E!(H>6*,^E;OU]72EIO758*V/DL3QS&A-)\# >3>^S]#+L02
MI08SX.AUEB]\/YEJ@C#!P[OZ%.;'_=M_M9_+]A%EC?/ U4JU"J!&3"A]ZTMU
MSJ9@S$8=,]7A$^6V_MB^WJ:OESQCRL/)XN=S8,[6;DV7<\T$G^!<<\(O'NZ_
MQI1AIY' U#[\+=!<+3;VC0I#RD65<;/#I<P&0+LL&C^8BQR]ZH<_O/O\Q65,
MLUP*=T+PJM8U.!%YB!DS43%.DK1LHSWK-C9$,;&+2U>;*J3F*%;O."60ZBAA
M-#EA<<%R/NU$/6BB[.+256M>8]&58ELU%4+M':$EM.1-[Q9-9<"^91>7-LV=
M)E!:+<E73!";*0X16%/<BH43F!%,!0U[C';S4R46G'A*)DM2]V!]B4"->XKL
M; 971[!UZX@@WLA6KC4ZAE:S2VS NEB"\:&"2DNN#FT:P;*#$4&\D:4'D8JK
M#;S'"."!-:Y7 5.K\SEP&$/GH!%!O)'^0:D5&YPG[XKFB"%FGZ16 J]NVI@0
MKTLLOG05/H"8'!D#:A VI.9L (O)E0I;C<_0*%^7F'RU4&\D-K?NL34WRRG7
M/DN;@]A:(":1DH.OUR4V7[E57WV,;B;5$CUA\A9*B:@89.--D0I5PA@:P(T0
MZHW$:H>I"K:J,CM#"(C&Q #0O&5D='!=8O7E%&%L/D"WEKJ^CMP7V^7:B*I%
MGXIAT??EV@3H*\!W(U'9L+IJ-5IHK@"KBVX!#3,I[JW4.(:%^F/!=R.AV$4H
M3G-D'YLFRSX4DH:AB!?;G";,UR447XW]7GW\]4X<D_0>R@FX0=8_( L[RK$Z
M-^"2XO/Y5)S,?\+#8_GN[?F?_]0S]@6$;^_):SF\.+UZ?M#=Z:OCY6)UA!W$
MK-FXZIO94TK%MU[=#)J(E5)"1/'<LF P:00-[8:-VN;[VB4J@;AR@&2@8,O%
M82/];V^>UORJLZ3-6XOL91=&V[PV8[0>+ 3)E:  9(L1C(MLLCAH,9E1N?&;
MBX4L5VO0/IHC_AC!Q?F7[K]:QT+;4;!FC2X\- %/L=44&]3>A[LEK[:N-E]3
MLF-JA[*CS\ ' DPP32(&;V, J5Q:HQA#:YF2X2K#+?K<46R#2[-LSE9<-.@S
M.+94^S:S)J76YW#MZ29DU@POKHT#*=,;,ZRGWM*F6KG:))H0^.IR">A3K_'V
M??<6>W5(7>$3.-_CI"(_D/FJ@>/YS^/):[VM#P\].#[J:\UGYW0ZV_%DLIB!
ML^G&K9NWSZ[TJ<U0?O7]_N9MF<Z.)M-/G?:4&OVN%K]WW@NG^.;BW7]PV*=^
M]:^V=?G,G_)I#F6)F=D1$P*61JXB^5*YQ=9BP!'ID5WQ[I#%"/1\*3<C<M*\
MLA0-,@XJ>>E5XW8$1-N5_(Z+<16":MX^5)8A>"@:+RE0+M:Y8+.<=?QR8>_L
MCZ$Q[MJYML]^(D-LS.7"YQ'\PJ%?TIC21!=J,"P1@%-!]:L:O"%Y9[&Y. *"
M7R.*;8TKWP#3T=54Q5J,L8'A1#E&Y-1";1GU]0C$PY>Y\IM3_DW4)Y^!^A -
M<92BPAN$$-DJ_0P@M:RI$PF7F U[DS\NKAGB\/\(H=[(5!S5YBO6:C*3BD>G
M&*=@ GN?DXNGZYY'[&O.!UEG<YD\G]YY4U_@]+F<>9C+#&>+'W RO3=;++Y[
M^T_AYY/I\X=R>-(1\'QOUO.MU&7YGI>G1X]D*#4G&XNFO) 0(;:0+7K2((8F
M><Y0AC]%N&/09J<+JS65L60G&, &6PJR!RX@F8PC'(,/HN7';1<T?IQ2YM;Q
M?"[3^O9\.%2X?V$D]EU:8N,%-=ZGU88L5FKV7!UCM3D/N(O=<-%98SL*8"BB
M#C=3 .>E)$<&LCID4WV%$>P\N'\RBM^_M:J<^W4*^O$1J^F0!_-)E:W-1B_'
MDA/W/0]]*\F#L4@9FW+%.N2<]=7P+7G'E:OR*ZZ4UGP,/J0"S;.Z?U$QI\[&
M>=?2",HJ-C.<? 5,'8H["3EJU'&<4Z_:1*O"P$&N,:B4JW7(_3=W%+D\+W(^
MB?]6</ZK67Q]IOW]/SV#WR0Z:>PLJZAQ"3!RWQ,0LHF.. VX0>]?1_O.FU=2
M58T^EOG:=NT=<O!:GV=RB6Q,&:R/""*63!;5-QRCK0;2"'JT[=AR=5*')/<Z
MH));(:!(:+P-Q*[V+G^Y[:3.)KDZ%)<2^E8F.?G$K74-3,GY9 VG9)0RIR09
MM$O9D>3RDR9.X#3LU+X (H:2 SE]%3DT@ PCZ%G]YV%:R=&?9GU8^G UF[;]
MH6=]7J7%$KCZP%(]!)^RR=64BB;X:E/<RA&9:TB8-;:2#18KNXP.--<N0L57
M\NI:LH5 =@1YT-C"T)^CZU <2P6P)%!]E* (NEX_%%QA)[7Z3#!\Q[+CR57X
M$PNM.6,<Y=#'[APFFU(T#0- HI"&[T_^/%*=1=^K^[^KSV$NB^5#7%Z+R8$U
MEGPX;U@$:T(#*GISKUQT:(5K=,F-8.1WQYJK]S4J=;F!$74X"-&7[)MK,?I$
MC$Q^%&4>XXI)?X&S0W$Q"-1\S<593:@S%-0_':+KV;1IIS5!@W8Q.[)<F6<A
M M6U5CQ$AAR!?"E>/8TQ/A8C ][XZ<N'QVZOUM-.^;K$H_6YF.0*MICJJDU9
MB(9L3J0R)O@0N,01M"C;L68#!7<9FEBN9 Q#!5<@:N:4K:O%L3@S?%\SML#T
M%S@[%!<330*5*U B)* :R85"Y+AE#N1-';Z+V9'ERCQ+$*5&T8RH*FNB12R1
M6\W@?<-JXJC'8I0H'W_X1/J:/N&;KV6.SV6=]0M]\=?#ODCCY.+]Y?YD.CDZ
MOA:5$6O=%#,ZSB0E6*BF(C4+AFOBZ+PR=<?(+V$DOMDQ\L\R$C+EPH8X*E<T
MG.9<4XBU>,S!Y#2"Q69#9N3U\9%KC-HI@&=!3+TW:G2Y%4<I6&N 2S$CZ) Z
M9$9>'Q^YQAJ!A,&CI*0A&F)-% TH'1D@>TU2RYBC]E7.SEQO#[G&6H282HID
MBDD-*,?<T+/Q0:QWRAS>\7'G'Z^2CTJYG )'0%,@$&<?#'M(.4KNV\"-.6)O
MFH_7QS^NL6HX8R.G6M'U%BS&DK?5%PNND-78O>/CSC]>\0R'YM>0BN_E&N2X
MV""A!<'$N6)<U9C:,F0^?EY#EXM@K8LCZ]@VR%\F4VQ9&U,BM!8]>4!G &(B
M;S2J$J=6*V@Z/((^83O*#+@Y6<Z9G&W!-*N9@O'%:0;;JFWB8K!N%*UG=K2Z
M$@U5F4(23S$)8#.Y)DLY@7?!2N&Z-;TSKR5E-M\1LTITP3E-$+UT::0Y(X#'
MPJ6Q<F_TM:O7DE:7LZ3/D9BTVLZN0(V-/!<1,@Y\CFQ'P)3O\!"G51Z]$%G>
MF]55O\&+^-Q?OI#Y2=^TY6K+HB_NS'O=6S%^]KV=GNZV+/0!? *:LP^$;RY.
MCWW_(T9B0H"I6/;6E2( !2B5U!I76[%FM:_AR[Z=">U,:*-Z.!&['H2:Z]LO
M)L$,SF+?ASF"$.8Q1Z&CV8GUW*QU?BQ\;X+4EUQ.9&=".Q-:8Q,I329K#3ZF
MC*M]J,&6YD-CVY-*','@P\Z$=B:TT2A$G!UD%[FZJO;CT$!-[(LPNQ Y##\*
M[6B\01JO6VY_ELX>2OBA;+V@+<&$!FI'B%6C#65.E6QR(ZATW=G.SG8V$W?
M&<+JB[.:_3@2+-PJ&\0^F1W'OT;OBFSG,ZEQ1>KQ.ECM4()/<PS5)^L3)@!;
M,WOO&20YB%Y@!$7M.P/:&= F(Y"F/2$D\.(K6(0<"I:@.8]+@5,<02?001C0
MCL:;C0/,%(.M36- A,Q$EENSQG)DSP%&, :VH_%H:;S&BM800Q6,.:JNL:F6
M5&,&\6P,BB\CZ/#^1R@=S*9\#M3ERY>CV8WWA%S<G9Z4C3R2>CR_PE'DR^X^
M,;HM&=?G^ V1F&J#&@L $I1J$N:F/A^MD!]!XY*=Q>PLYDH[Z8I+"34YUCP9
MK#=]\CWYWBN#Q5(900^ZG<4,3IP-><'1.K,,]C&:C$$() 0,J5:(4J PAC""
MT::=Z>Q,9S/C3+EY)Z51= %J#KD/V!*77!-A,".88=^(Z8R7N'^I4'\PCKXW
M<0[19A\8:NR[]$7O- %WR00H(RCLW;%UZ&Q=GV]E1"*+U1BNP%*PH;I:<I@C
M- PT?-\ZNG1LC3.8'-!3;)3$ U4L+)@<FFJ!T>41[*PU.O#66+U>?=2(8$P.
M"!EC:9BLJUZJ(*5JMF8UYP9DZ.;74D;#/B&*.E4+Q:IZ;41-P08'+07\J&O
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M0,N &FA(L[H,.6*V,G)E,W#(-R(I7 Z-4_0U577G)6",N9CD3 AD"L/()<7
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M^+@NSX[81KU@T?5%M\52#!H25$SZ;$,@AMKZEIXCT@N#!78SL3Y95WUIEH#
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MGE>Y$$<!:5@[8CP"6!FB-1'&L2B4Y$38,"G3@PM<IN<UL]"/M8"FKQ$YJUI
MSBO*K".*Q,B,%38ZEWZ+J+AC>$Q9O,+-XZ(X_?[QG->G\IG%<, Y5\$CR8,E
M+#AC58@(M+0(8+J"$A42BF^\R@4XIZW7'GPUC9B13JE(A78Q. O.6HP3P%5;
MP1ZU$77YKT'_=+Y10SZ[78%$.8-))-I;YK!4EBK"N702:\X)K: P=RB4PFN?
M'>*"\F#B@($BX8PKJS0USK&T*35:(_)$XUB!7Y^$,[P@987>3AB-.L&_#/3^
M"H.Y;-"YKINQ2FF:IM+-Z5 RFRI/CENDA?/4"\^@1Q62-C)OP.]B.$;[H^-5
MVB6N"X^?!_I==#;XP4Q'@[$2D6N6$L)%HY7TUGL@'15%CA_PZ<?X04@43W8_
MR(,&FNX/^D_%SGP@^U0 H13.F0Y <*B8C>/.A3>&><FMU,Q&J977S!,B/=&!
M*U\" JH ])(,I*S$F!#$(J+,8*]2&@X?'%+2I(0)Q<U%]Z#="^8$WMGH#T(]
M5\$?^@-O>LV#T!ZN]OQ' [I\ 83Q#'/&::E$*CH='.:,(60T<TPRC(SU$7E2
M@HCRP_%16@B\?  9&R*1 _9@D3,1C)$>$Z209HQ$&<R"X25GD@HMCT4+<C1B
M(QD8'<5HL$H)IZ4 DN&:^U@&=BE@V+<^KV#?RP.&!,,EYD9R@\#/YH8YAP$N
M@!6DG+SE9Q<0, _IR;$\J0CF\7&9P&2,47#J@64TMU1;@[D0\)ZQ>-'PD@O9
M"BZ/3\S/K*,!W)U(,0,?R'CLHY)$><P04;0$<"F@/9K&K2HE7*)-4L4BP;EC
MA'D+,H9&0U)F%:'0I S91=0.7A0OB6X!X?)L\F7:*%U^Z%7JVZ?(%^=C6C-!
MN4L5:H(2F'$J4:3<&ZLO]"Z_ $P!4[&_7G/$IX<+GTU,+@AGE(H6(YH6D 9K
MN/!>$V-LM/JB9!R2%W IX#:: O++,YDC.3U<Y&S@@J)2$AO#B*',:6J1M$ K
M 7-MHM.^!'!YT :$#]OAK-?O^,6AF.?'C,9$<:*Q1P0$# -?.@HK(M+*<>Q$
MOD$/Z:+.-Z;9FI".WPC]_8$Y/F@[TQEWWW!T/'C[_N/S4,K.%!75GQ31!\5Z
M8Z;P*3OD@DR:PR'+'%- #33%3C2PA@M<F/!U#6LMKC1(Y>/<@8"=;O^HW=M?
M[?F_@^F,#MYUS'"XZM)Q<UT7GKKF04ID5G$4P6(,ECO)8LH6JH664GGGC/$.
MVU@"T$S#%ZO;+VU$*E ^8'\50X9H(\!\<4:]5(Y*XFPD EQQ[/6"@/+=:@7*
M\H"2<^XPYTP29%),2"OP^%-)98Y#L HM""C7UBM0E@B4-#! GV5&8L8)LX*"
MQN>4*<$]H670?%.!\ET%RO* 4H&/Z:G$1EK*)-AKI0-&T6.:<C0XL2"@?(H/
M6H'RN4')C-8!@2NLJ >46"40HQQ3&F,D3)<!E*4&S4R&W.;]0ZZ4H+1(!QD(
MCDH1ACBS*!5P90(+G.:(7 7*,H#R?C>NE*!T(1JA,"(H@KC$SC+'K422$T,8
ML&<)0#E-M_WO3F6^RP-*[SWC&EN=2IS'B+6EP@!.H]<6.-0L""@_5B&A$H&2
MJ\B)XL+B$%DP 9@R*,>I0-8H7PKS/0THZVL5*,L#2J.<,TI+Z7UDW@5+G<<X
M!)7V;:A(2P#*4H-F-D-N<[% 28-"@2 7A=0L$&Y3[8S(/6&$&^+*$#RO0%EO
M+!8H$;8$62&TIH))'N'?@!$S%/N0DM"4 )33=%OC<V6^RP-*1:.7PJM@L6-2
M.P4>C_ 6?'*%D B\!* L-6AF,^0^+!8HP7H[+!QSQ%/FHK082\>\95YB;KTL
M 2BGZK96Q93E 275' 4'OK9@GM$@M2&<@\C4" $Z936C4P:FW/I[L4#)P:OA
M+DCG;62&:6,%81PY32C5\%.!\D'H^-^B@;Z4H$0F(AQIH$H+QH0PQCI+=*I8
M"&9=EV&1;\646_<O82XE*#%!E#I"E-&I@*^S2 A$#&,,$RHE*0$HI^FV?ZH9
MG1*!D@8=',:6>QF9 S@B)G'DE&.4]E*Q\H/2]4]ZH\'9VW^J'1$EPB6CRGK"
M 9W<LFBXE4I@K8*GE,9@%H4L=ZIUOB4")>8F:I%J/QK++*(V$$V9I\XP);'"
M)0!E@7R=YO]5H)S%]'<4*4P.]&@=HQB#K\,-\\$BH$DCR[ CHM1,-I.Q\&71
MIK^UU#Q8+YRE+"U9DX0X1E+]7!E!;8YS\(+&Y"7%HNGYU<YHT#8;@_[)\6(B
M$Z[^UP#N:GCPKM\YZ=JVV3'#(S."_CA]>BZ_RYS4)W88_G,"=[#^#7XUSX[#
M#TFK;QXP>PZ_D6X8HXSP2R ]*#G!2:\]AG_7]$ZB<:.30;B$=S>8(?R=&O7:
MQQ=GNOCTXN]TJKMUL<#*&FLY-X+1@!3'--!(!+6(83(N0ZV+FA1]"C=M'GN$
MWYF>\6W3:_:M<:Y?OVK_7]:^*X\2N59-1M_,I?Z$%!M$ F4+Q:-#"H0NTDA&
MJIUVAO(0A2@NW.[#PHQ9>\Z(7CAT77+DX*0#=W\7/8X_>3 S2D526D+EL,3,
M<6TQ%]QB%IQ01@J5%SX"J(X+'Q42LQ5%/I>S=@'CZ:HKZ9G5IF FFFB%<X1X
M9J-3@K(0J=*&$@=@+6YMBND*C#0/!@&:IC?KNDHO1[,37)I!>-<?CK:#ZW\+
M@[-GX-D9EKZ(U')"H@3['9DCRMHT74^"B,FBBX)71*D8\3G,^BPKK3#&P24A
MFEG+9"K@E$I<XB")0):DU/98:X53[NGQBV+BKAB$<".6HS(\56[HBT-G$LO1
M& M/G+'>6:8M55YYC8P+DD=,O/JZ6?7BM./L=L<\)?\A#98"M1OX'Q.:V+1+
M5#'0NE9H*^*/65(+RN_%Z*$G)#"=U:(ER90/)H;(*7/66Q:#=<1HI3'UFDTJ
M)\J+RHE5=T[;G6CZ[D2SRRI A"3!XL@$8498C8.PG@1B/ )+&$I0@:&@W?DR
M]5>,0"):S*,1+%!LL <_3EIK'7/4J,GHQ-7H?,3HG+8[9S<ZM8!>C,QX0RP,
M4*."3_3+M",>*>86>'2FZKN-?^JK_O!D..K^>D;ET1[4*RBS ]ZSAO\4C4(R
MYXD*3#KK'(K841?$8L.(5S":$8Q"T#Z"4?' 1H%9@PWW(!T$EDA8IDH HY=?
MP_$KM(J'H+64,#+@FP<:'4'",6FL<L8)'Z-C C/#;I7.+B",GM"_LF*CV< (
M.A,TKJ/1$\)T%-JBH ..-,I4EJ5BHUF@52T\&Q$I6>"(H:@<TP*;P*GGC!L=
MJ32Q# YP\6&D%QY&*$K&K5?6&<8P32'.X%-B94>2ZUT&3ZWP,,)HX6'D99!1
M40QR2#""4[X13G$T&(E4WGVQ/36,*VTTJ^WN((J"QLJSR%105B$%MLUK@@VE
MD94 1L5G([+X;*1EJJ)+"87?S#IM@@F46R>PTR20$L#H"?U+*S::T38+S+U!
MVG,K+&,BVK3#'/I8*R^\-+P$,"H^&STH6%Y*& GN(OQ(YBQB005#@G-".2E3
M/-+;"D8S@-'-8/E"SI'FI<*(LMZ"5=-2&TL(DQQCC[R1BV[5Q%T=7!FW)["2
MYHPSHA#\UI9HKA$-$KN@E.6I*.(BHTD^B"XJ'/U$:Q-'+3/!1B&8\!JD-V'"
M84%PD$Z9Q<:1JG TJW@VCDJ*0"QUD3'G+>4\I?<.C", 6!6(G 5<]>*KI A,
MA!S"@1#,L%<V6 "-5B:Q$8MEF*4M/(X(6GP<(<>1(D1);T!M\Z 84DPP1PR(
M<.%RM0W]/<815I@4<\/C'%8DEL.*834U:N!03&:S U$+$WG*)(P(8P)999BE
M,6J1%J\Z:2O4/'$+Y$X8C3JSW/_XBL%*J9/&.4)3:F$6@P)R(P(KZISG/I:!
MXJ8#S3_02.W>_FPWS5;,^JQ@99XR22PQ&A/&?3 J.$N-1 9Q;FT9_(-7C9J7
M47$X&*^)5XQXRP3EEFC"<<01:10\SS?QI>VS8XKC1:2XQZ*F.3!PAO2R%<P@
MWY>0E/LLJ&^>A2]>M0S@TS,KGQFS\H@-%99)'S$S1"FIM#1*$<XU4:F8VHV]
M5T4<(Z4&S4R&7+TY-^)^T ZRF6E3I S6B@1DP=QC:Q -C&I!/44VEB*L7#)M
M6FU<F^%6$2RBB=I:2@431&N,8M0(&X.4D*(,4[45>I^%VR\:<K/G^MUPR?(?
M^RYO@)NMG9Y[*^Z83EC(D&M0Q'M/35 &L>"P1BP:QGR$SO48ER'C1C5J"L+Y
MSY]@Q%G"4=31)1E-E$F*Q2MLE13>1U.&#3DOA-["SW<A_M -D*7D7Z><X#Q@
MQ"-C.GJ--7!MB,8Z0JS#%8)?&,$IP>[ MD>#_*;_R7OVZEKYGUN]4(V3N><3
ML)H+*W40CC$DC%$J<B6E,T0R4X8%O:]^G#1/^]4XF?=N+B*5-%23J#"CQFMA
M0=ECJ3$5),1;XP07+[#XDS[>&AV$P5I[>'PR"L/=G@\#>"-WX,9QQG2%U?U!
M"*]V92">42A02L&=2N7!05ASF7*#D;1XF6+*):,)1D@@E<,HO2@5C-X'0([I
M;"2&Z.50^6A.AR?M.3,"$AE2TW7E^-"9=*5Q&'XD-\QJ)H6T B@A24X3D.9C
M'PG<_LETG"[T5$-_.'P'SP;V,?1<.PS_.FN8E+]X*UZ]?35.-[O'8TK($="'
M8P:# /;@&UB(;O>DUQ['>^:9^_BQ2"L'-Z4T\M/.G>G9K??B3'.MM!<L,A&8
M4HQJYB,WCI-@<F["[ +0K )T!>BI <VF!S2;&: 1!Y,:,4M%Q1C&R%+."*7*
M$Z$LTZ($#/T,M6E>WY@I)3M3*1#S!@>K$%/@C6 K.6.!\)!V4.(2L',%Y@*"
M^468F='@#?(J8.>94\@JX:/6UBM,I+&^N$4??]*#Z]_,<7\PNP#3G,H>3C^&
M[HRGY5&G<2AMC,_W[4[P?YWMN(-^O[/6'L)8=G, [:Q*+][ H3).<1P42 3*
M'(XF$!*"PMH'K *1X^5BF!1XN=CL /G4@$J^8.K9UU8QHFC@T49H4LN1<LA1
MRSWG%KF\Y$A1P]8OVG%SJ>9#=?2,X" DLRP2I;BU/G4"8U0I7X9E[2^T^+(X
M@_AE]B>"D)7>&QY3/7*N%=+1,A&92%44-)FLVF47%1-8\8#SDQ[<_+2U,W?J
M16SZP@AL1KU&N5.,($[3GG9KK<11,!1@T%MD'<VIM["=!7HE^),.. 3K_P$5
M<U8/HX.^W^Q]"^-)K-OOAM PW:MN_;"[^W&NQ/Q#3SVES!IU-DWT:L(HLU)9
M&92)F&J!-&8!%5=N+W#I;]<'I].T>Z.[*MM>?GAQEJF+VT;%M4?$2 6][:A6
M&D9I#(0*$PRE>#PJGZ,&VT/1_H1B9Y>-.CPP@W#0[X O?5>S7OOXP0T+HT9(
M3B)C03)P$2RC(C!-%/:,.X/&T42,GC&:^/# %4;/'K@2BJ'( 9318280-^!K
MP4N%N01P$CLQ[NK"N#_#E.<CS.N4\XOC0V?2;EAK[Q625&#P;+#(JT=1>"RO
MK**13WQ3=*&FGZ%*]2,\PBGQEL3DC HG$^2@Z1 XA5JFY#N&*DR$D3P&A12_
MR+O++MKM&?3)(T3XM'(.STS..8&QELX*BP0X;-Y&#]XTM\*XZ#R]V#JG+]JM
MF.-43]]N,QJGDCCJO)6.IJ)@!IQ@@8(QT0/A$2"^XHJKG_@L']O[!T]?Z+-X
MZNWFB/%@RQBPC$:>(<V,4I@2S[!V-@8I2MGS3Z@J_=KQ8 T 0D:2X  $2K2U
M06L@4.LEU3H6%P_3AOPWX?>WMC\QG4GP?YXS8KL[S<)/IA0%>FD]@[$12Z%C
M"L%HI1#'7!D?+)(Q%C<,?KD?<!!\>_3>N';G<F[X$I9A- J#K3@^IB31<*6E
MDM$@8108"1&M]X1'8HQ1$8%Y*'Z7?.SW]J'=NVO!WC%0ML.W?N<;D,+-GIO5
M0$T7W836'YSDBX\O2&%\L<NUR,7%PK4XS\G@GA@/?/#@,(2'^W).*@+CFE'"
M#9=>!.0-%M0+Z8IK9.8N-Y]YF_,BF)+V][>#T!DO;CEH']?,P WZG9N02%]9
M[@_V_P#OC_XQ.>*/:-PHB_W^J-<?A:5:'/2[VR$.$T+IYS.[UO_VD6Q_:]'Z
MB3]<_[:WH0^W#C=YX\LN;G3WVO7F7G>KN7W4^K++][Z\/VR=M\[K7^KPV2?4
M.-P[_$@;G=9Y_VRK^;G3@&-;A^MD[_ ([6V\[VQ]^7S0(G52/W]_")\=-=9:
MI(756;VMNZ[[OK=UF+[CVXWN.MU;.SAJI>L<?CC86]N'\Z^3UCE\Y\NG\ZVU
M5?J1;A^TNM\[6X?^J+[QN5WO?NYNK?W5;C0_L?J7O7;K?!7OK6UW]S8V>7UM
M]7SO\!.Z^ Y<ZV2/[(H&^72Z]V7S;.]+B]4W-G%C;?_[7O?#87WM\U%C8P^N
M?71:7VMT&VO;L7Z&OC?>H>\?F^NC^NI7:1VX"U%D2AF>,1E89@0A&:7)<C@O
M?&2UDC;H.FUUZPP>'.[I$VZ<?SJ#)H#KK+,Z^40;Y_6SUGGC<*OYU\&/#5J'
M:[7.]T_K9!NNL4L;:YND1>"9FOOG>VN.UL^A<4F=US?>YPU:;U\V:! H.J9Q
M1HER&7.,9-90F@5@3!<YPD38JD%_U:#7$"J\)LH(GE%,4<80)9D*EF5$8,Z-
MYI@*7]8&?;8A3_+&W$&G7UWT. 3G,RM$@.8D-%. S$QB:0Q8VQ"#*FMS/AL^
MKYI3(>1#H"$3#JF,*:,RS3S/)&/$> U_JU#6YGP^@W2-/WE>X ?%C!EB,J89
MS;32(N/!$D6HCP*II5JGW3O:_KE,R#5".FZI-NJ74QATPM_;T(;^V!(F\OLC
M ,NF/]K:V#YH;&Q#W[P_VEK;A??V#N'^H%\2_'ULG._BK]P+8Q61F;9@?QA&
M+%.@RC/N#)BFP"03<JG6'_@P^)^E%$G_XP<M5HFSYZ:6K7<WQH*S)*?EC(D(
M7*V!9BQ7("@\H9PRA*RON/J7#7I-2X"YX]$1EQ'"!8@S[$"<*0MNBX>69AX)
M4EJV?K8&19?&S^*42XKJC%@+6I<)GYG(H$VY-L19C"0)%5?_FJO/OR*BHPR<
M9@(YX&JI< ;&3F48$VYL%"FX\HJX>NO=I ^Z+4 EM%7W<P<0V6DU/^'6^5\'
MK2_OCUID&]I_ES>:+5Q?:YU?CH3N-K3ST7<X]K1%X)X./WV'>SQHK!W!*'"X
M13X?-,Z/4*.[2WX<"7L;G]A6\ST<^]?A7K,#^F3]._0UVFHZ^.[GP[TOZW2K
M^8GL-?=B_7!S=(U:M(V6$P7N,R,X8\32# 2+R(2P6 0N.2(OR-5E:=!KQH]$
MIX6!MK0Z.2J* ;E8Q3,MM:?11T-#^83@(_OA!KGL'8+H7OO<W?OR^; %UVFL
M?3X$:H;O;A]">^.]YA%N'.Z>-@X;T*;K?*NY>E8_WTSOH<;I5QU287IP40+'
M!( J8F8HMAE%A%EP_[2QNJ*:Z4;&X:?3^N%VI[[VH0TC!%IZ^V!K ^ZSVX#K
M[Y[O=7=1J[E^#JU_?LM%6EL]:VSLGM:[FS!"CGAC8YWM=3?/8(3A1A.>%LY5
M;];/Z^->O#XRO&0N&JDR3QFH&$I%9IU &4A"1Y"EQNFR4LVS-6C]JD&;B<[V
MOS)-I(X$U+72+&/1@R<?@P6?"20C(S!0,*U:]5<PO681@XB"":NR-.>8,1XU
MJ$,<,FFI!E&CJ&&B:M!?P?2R01-,S_>_:J$)&$25&:]1QGR@F0'=D6$=K/+2
M>18KL_A LTCKG[ZFH#UUR1AB)L'7#C[308(@#]YIPA$2!K\BL]C8N?""/AS4
M#U>_PQE1X\LV^(G;[0;9.P!1U]E;.SIMG*_2%@@+:%UT-3Q:M''XB=?/'?3(
M7VWP16F#?&@WFD? M VX)@B1+^G?%KLU/ X= 6%YWCAO'-4W-L$7=>#7;N*M
MYOKW>A*?"1&Y"#VX-96E?.0:W*>T>0MZT)A,6^XR@Z(![B86E/C+\4U9&O3Z
M5!;1.D9P[X72X-(H ;:10?O:  T:6%+A+Q@M>5J#PKAO[H+_G?[=/X?&/4LD
M7C__#(0.]]B%QMG8Q'L;ZV>WHB6'B:CW3]._6VMU:-S-1.+GC2^;K $N#A#_
M:>OP\U&K^>'F5('0%FLD148\H))YG3@<^RPR;*TQS&)<6GP^6W->QR>3*F#K
M>&9EFGO!%L@[H)CYZ)S$E$HF3=6@OVK0ZPQJB&4Q2! 3X! R&2V(X:"!2Q5/
M";FXBJBL#?IL#'HUX"-8).4TJ D6P:-0$@%_,IY)K"R6'%.NRR?5'MD+-Z1:
MO;M^5E][?U@_!UFV\>&P :T*D.;U+Y^/0);1^IJ'GMGNP+VG\"CYJK6S#ERP
M3" .HC=0<,NH#YG2@CH%J"6,OR)Q5@[?Y48T#]QGKTTP67#0;XRGJ2Q+2>:"
MPE(J$8-^06HI2X->XVIK(Z8"N\PE(0&F$,R@]RKS5GKL0K!(Z=*1RXO[@?M?
M4=JKC%G(3)0^+8@#E480R\ _E(Q)AYEGOZ":\3O#_LG A>'XSX-@?+[$TK>_
MK?P;?DUV"FH>N(@6BZB9-T$'XYR@V''AF1#N:WZ!R^\,1V>I*[OM7G80TH+5
MMXP?C_X\;?O1P5N,T/^WE!^W\N_AL>FM_-L._H!OCU^/3W+[5&:P#V<;]8_?
M"CA36I*9F4Y[O_?6A=XHW\*<OG]QN.MW^H.W_T+YSY^QWP-B--UVY^SM_VNV
MNV%8:X33VG:_:WK_[\W0](;9, S:<7S@L'T>WF(%5\G_/!T_@(3S /C"Q0-A
MDIYBM['97%^K[317F^L[-Q_AVLT7Y6YWUM_M;F\V-]=W:JN-M=KZ_[W[>Q5&
M<NW=5KV^N;.SN=5XP4<@4SW"E]6=OS<;&\VMQIO:VO*[Y1I!G.E[;_L'V!P;
MG_;F9)T0X0++2EY[;S"^ZOC-HO38^ZWM>BU)@EZ_USCIPDE<;;(B&1@P9191
M-&)%>9Z> H:G3LI8$J*%8-:,LV3_F$BHUC-I*7M: [[6=_FF@;0B>VFR:OYE
M*/7[1[)WUOKB!- H:#,'5.? ''4.&V"NP-3PO;5]M'>X!]\'L_-EG=;/U[_Y
MC<_,__VALT<ZW^SA,=#H.F^ ^6J<@VG[4D?U[@>X=N=H:VV[V^CN\C0MWFJZ
M\_IG!;INGWW5PAB-#<^,3LH7I57%''X)X@(W0EFC_-(*1MFGG!VO>F%E2LC-
M'#=H*MS\5C>#H]I6+_P^_7V.C.V$BT]M;C@RN-^..1Z&MQ<O_O3MX7''G+UM
M]_*KYE_Z<W(NVQ^-^MVWB>J_A<$HU:J<#*)\/(T_OK("RVAL"49@;T;^XLJ3
MCY?SC_X8^=N?D66&U+V?HF5\[V<_.ZOFRU23J4[[1W['X[N&ADD-_#]+=.GB
M"Q-&>4N.O]?P33))Q/-CVXR;97J@K [:IE/;[;5=WX=:?6=:I+ ?D3)N_5F3
M2^P/NF8$WX:''@8'C]?O6-/I]$>V__TN[OET8@; L)VS[7#<'XQ*24/OVW9C
M5^QUZ[QQF-8B@5(^=.>-M=VS+;A68P.N#W2SU]S$K>[> ;B1D^]\AG/PWE[S
MN-LZ/R);:XVC!JB\1G)5FYL,G@OMP7];:P>=^N%GN/XZ:G74Z<?F:G+<06&O
M?J6!.Z.=S"P/X, '3C)M# -_A40;)*5(B:65__Z7EDS\>2^)31#_=# #G3P_
MY>5 _K2[NMU<W_[8JFVO_[.UW:S]L[N]L[O::-::6S50/DV0-S5,:UO;-<Q_
M\[_7MM[7FG^OUZZ)HDM!M/JNF3[&FK(;390/_#]RSOLYH^)GT1#3V8+W_4%M
M=!!J_[D89[7Q%J=:Z/G@9Z\NKA' 6V]&(>O"*0_2N,^\.<O.@AEDH7<7$XQK
M]*R/$TR4D@<>+T<:YY]8X]SQ^IK[GB*J7XV24C-%,B=3(((*EUD24$:1-8@8
M%Z30(.G#\6B\[8ZB-[74"3^.\=H+:OKI +JU/8U(X?<,J4JV5++E)61+<P"W
MWT[!E-+KE@99YWO-=50_K)\E[=)86T5[S7W6Z-;A'/MX;^T37+MQ6._6?] M
M?0K7Z-2;G^!Z'Y)V0?6U[<[6VCYI)<Y+NVC6X#E)_0SN\89NX10H+$2=29-V
MRU'G,@4_&6)"4$9(T#Y.= M;:-W2W%YM[&SFZN2EA$M1#,&%4AE=#JT+J9+F
M,O[[7UB@/Y__=VW4?ZE+%]YTIYH/[6':[%]+R>UK,$"3%IECQ&J<L"!=;'RM
M4M+NDZ)6^*L0RF#)9!:0(!FSP*+66^!.:3AX?3'02)964MXVS=#T>O":V*+/
MX;\0-A7&Y@ZF[;"?:C&8WBAE+7Y]@.)?(W'6!R<SYEQ:16%TIH-6&?9.I@ "
MCP9\C7'QF5I>?>9-;;/GEHN+K6GCI.O?C1OEB*CU8VUPB82:&=:&Q\&E!"Z^
MUN[5VJ-AS1WD'O14,555LIBJ6.;T?@_DT=[),E'W?_K8L\IE0NG,S\K$LD1R
M]J==EDS/PC^[0 F,M[#T4^U;O",?[WJ.Z>$9Y/HO)^2>Q^\<IE+"QX/^M\1)
M-\-D8VL%O-L?@,-YF7LPO.N?]$:#LW?@5Y?2>$V"YU_>PS6VNRVXAQ:!>UCS
MW?KA/JVO;9YN@9/9.F\<U-? D'5O!<\[K2][[<;&WD$K[=0#9[5!6F=;:^ZT
M?KC*X5X/ZV3]M [/W.JH[S><4(-]\"9D5(&&8BJ:S$@2,T(PY]Y$8I1;6OG<
M3DS<-O/W0A\:4WD<LN^.J/S@<?SZF5!ZHI]3P2L>US\.VZ;YOCG)"#>ND%=B
M]^6Y!VS]<L#BJ##E"F>&L9"Q?!<<XVEG4?#>"FFYD^#YT(P2@0CC3QBR-^#]
M>/N5+RLI#,Q_RPU&K3^H]5,=^]KAR: ]].T\9W$2P.WKQB4_;+!O>NWS_._?
M*\);',+[;7-Y>WEGN;;>/>[TS\(@7X1WDZ%JC?[R0_K\KA%S<<SDVG3L%3VN
MF?53>F2>P_EY4/Q"AFO5^T$8#B?_?(0;P)71^I710M=5)G(HT&AL9BG'&?/<
M9SHZDB$50%\*PI@$HR4$PK4O83BJ_37H&U_;&0U"&+U9%-'YLNA]!R^W!LW^
M::_"[A387;_$;MH9SUD(F2!69O":9 8CFD7DG5>(&13%TLIVVQUT^SU?H77.
MSO\$SKF*VQK\ T>"8JN\_FDPO7G%QX(#>H/+>&0^8PS[S"B*,B>9M\8X[7"<
ME]=?,!7X7/S[3Q^@W=EK'U=!JBGA>N7S,LZB"X!4:&J1,<!N9KV*F63& 0%3
MC@A0,*&$WIKK>_7N[@1^R;4]'@!5MH]-IQ:^!W<R:G]+4S[@ZX1AY=@NDF,+
M+%-+-/,TU[7PBV6N9JW_^U^*8/GGL#8*G7!\T.^%6B\/+KY)\9S.27K"FAD$
M4TM+[RY:Y?GO>0P:']PDOO3VI.?#(!UU@=G?YFB/D@NP"HU06@OTI#E^\E4S
M;+CF*C/.IRQ7H.0MQ@*<4D$"PC0ELUY: 4G_HQ'Y?9[+>3[V@3+^29@M<3S\
M23WS_6N41%L:8Q8B9BE3EH:>B3*+7B"*D*$82S#PDF6$H%LV_J57BNE?V21R
MVR8]KUFX6%L([94C[TWN=\$?9J(.3,]?O!7;0P!D+6U2 /:,:<E';S_XVC#Y
M6;6.&8YJ@WRY[POM_YNNM7= X S:HS:<<+RD)0S@&8Y/!L.3M+9EU*_!$7F(
M%Y/?[.])'J5UEZMN]+:H:UNT7E:</F9I"Z7+7$^W N-!*V;4,B6S7\]/V;*4
MTRUNF=-Z_FM]?F._-%\6Y-9^Z<F;SR^*?B9]Y_&[V1YU\C5BP;B#FDNE/I]K
MW>\L9?E\_)(I>Z<Y,+D6W3GK6GB6>4127O3Y&I-EA#E$PO>Q[:@!RYX>M.&=
M*RJ^O3;__F$\8=;)KL+:L-]I^]K%L\Q@C-_FXBDV7;U$Z_Y,A3(>#0I6!1(9
M\Q$;D$S*:\$1YQ8K^PL5.K&79YC8?)R74H5>1*CV.BT"2O-P];1U[KXWUAJ=
M^I?-[ZWF$8'WV_6-7;+WY=-IJ]NZ%:':ZWX^W-N .UK[Z[!QOH[J9/=[ZS#=
M UQM8_-TK[G724G)]GY81F4)-']:0>4P=AE#S&?:>9)2O09$@XM&B_%> 1@+
M.Z.^.WI3^R^T3&D-_T%KQV90^V8Z)^'G*19^PA*/'2(%I) Y@GS"OF/RK1 ^
M!<*O38-Y#LUM)2 \ ,(IMYFRD696&&ZP0QPH?VFEOO6( &P%WOO!^^/\6+*I
MMZ?&+MA[?6)Q2[N+X[GQ?34E9I!#)BB?665LQAA1F>)I%XA!E!-ON4<8] W
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MIID6068,_#5XY7QF!1."2LPLHWFL7%;EH"NN**\6JKCBD5QQ3?=HYX@TUF=
MXB)C5KLL9>S,(O&6>TU#3-69[N:*\@5Y2JENQCO?VKV1Z>VW;2=,EH2_J?5"
MM>JH_(IG\[)CQ\LMP9%;_S[9]5LQW*,8SEU70P@S22RG6>0R9DQ@F6GF?69H
MH(1AI3".2RN8O*&DJK-<$4EYY5!%)',@DFM22:*4IL^S+!#F,N:=S)3B-K/.
MXZ"0L]ZRG$@$YHNW!FEJB>3;WR[./3E%EHY_2R[7+[5[/O1&;[/QCON7&+HI
ML=QPE,*FPU3Q):WF'IW5AL&=#-JC-ESGM_\JGDRXO.7WICWX;#HG(24%Z?2'
M)X-0C>L'C>O]4?UB7+_3:.__#I#K?NZ9+_IDZ] ?U<GGSEYW\WMC8^^@<?B)
MU0\;[3K9/6MLU,\::_NLU3PXV&JNG__?>9U]U8&AB,"!,A'IY$")S&AG,L-\
M$)$*(8U/TUB2W5Z14P-H=Q*XTI:"AR#NV;(O5H@K&.(^X:\881JX99DV!F4,
MM&VFG%69E,RFQ?0<I<U$^(T2MR=.KQ WJNV$XU'H6O M*7I32Q25XW MN,F[
M.'\7/AN$X7& $WP+G;,WM6XP"0 ^G2,",&K?$C)^O[1M8 "JL%JI'=++<5\-
M\H<.\BN_TT84L),:QF4 N0B$G1FC9.:M!-H&:^& G5<P?:-DJ?.S5&'X5^]W
M5GSQ6+ZXYEYB"DX?!F,NM-$I3J4SQ0W/HB6:6^2,0QSX0K_AY,E)6YXO%%^\
M1,1S3%E<_EF&&>?56\1@8!$3ZC7Z/5=E:7@X Q^NWDP2(\"MHN!)Z307RJ/-
M#*4DLR* _>28$P4,+%BIR[A7TP2+*-<J9I@],US/WT(C%CKZC!A!0)L!*2B)
M//AR5E"@<RJP65K1XK8C5[ZX_V1=ZOAD;_$RO[DXM;3)]NZVV^-D>ZNS2K+W
M^%;[D16?I9ONI-#"]=%_/3+YT1/;IBAFI1Q1P_$0JHS,@XS,^G7Y&3$B1O.8
M"1=-QABCF>$"93H:IRDT.XYN:87J-_P..U,B!3H/._,\.0PK=I\#>EXYNY<C
MQENQ^Z/8_?H&,VH,!>;.@G;@0@1F,NLISP**2HAHD8AQ:87)-PP_V8LH L/F
M[L<?(V,[X6)../\UT]&D?C68R!WVZ47O92>$6J\_@O.-^FD<^] ;AF2,>GG[
MYWF38KMG>JX-?LEP!&_D,RO+MV[_XL8GIV?0NW\>]X?M!)BW@] Q:;[^S].V
M'QU<D,JU;TU @:Z^8BS<P<GH_J]<ZW\'MQ0&S\^->1/2'U8:7/M],+A:>K8?
M,CL(YB@S$>[UK>F<FK/ATA\W'JG;[F77V^_'1[_W 6.<VP..QQGP<']<Y.DM
M#.PP2$?!/9G"W$OM8)#,S[_:1// @<"PB)IY$W0PS@F*'1>>">&^2O"R$PW4
M^K'V+EFN7G*US4M)UFN4</OW7=!ZUB% ?N7\Y;>_VAD-VJ:6EPA[4]OLN>5\
MZ<[.B1VV?=L,VF%X+U\4Y1G>79+?N^OD]Y?I /F%VLY!2"4T?TN(R:N>_?YR
M3_0CM=_]0+^U>Q?+JX8)Z[[?Z9C!\$TM?'<A&=@#,PAY/QV'P>0O>&93_ ?;
M[9D3WQZ5H ^^/O#GN47!W7=]CT"YM%)FL ^&*@DUGGN1N:JZLN2YC',);<?#
M\/;BQ9\74]KM7G[%_$M_3LXU,?_)YOV@XO*.''\\,8=:+RM.DT6<1),G%YX8
MR^7<6/Z@2<>?<;G,!+_W8[2,'_497F;X_HO^_)OW?P_+9<$>=]J??4:6,2/S
MN5DZU6E_,0_P@.Q6CSCTC@#$F!X*%4N]O1)VBJF A6V-6PN ;S3&_/*K%2M8
M=7?;?&P;V^[D>T2>LDBFL,GFRG;V:O798F3PF=28J1VGG)[]7I+/G7YO/P-N
M[-9\L(_;Z/Z+=<)/7AM<.'IZ<"R]D"'Q<DQX?@1\-@&>:X#.Q2J1M'ZV=WAP
MV$K[DIJ[N-7<3J_A.A^ZC>:';IWLDM;YAW:KN<Y^C(_7X?.MC48;SOV]T?Q\
MT,A?PS-U6[C>;9WO-?<.Z]T/!_7F0:R?H;,\-KZ#3K]BBJGC.FW29RC-?9K,
M6.PS347TP@N$4=HL\0:CVUMKRS?U6:"]$F7FP!G-)Q:2 \LQ+5AQX),Y$%UR
MH/)28FEX9D.JV"M%2E0274:=9X91I!!1>4+<.W+[%W;_QV)MDEAU#AYE-*P=
MF[,43JLV2A13QMTJ)I#WVC_C3JN(ZN%$U7AW3:PIQ8.*GF0B4INQ:&*FF(T9
M0MQ91F/PJ9H;$54ZI8H8"J9M*F*8/3%<*9BH@_$V AU()3/F"<L,XS3S%%NO
MJ*'8H:45JA:U1%L9],O@)/A:YRJ,_7:N2;/+?HY9JML"[86Y&QUU,S@*([CM
M2M:61-:FP7S9:^_ZPT4KUOY,-JQ]3=PB+)VE@F;"*9HQX6*F-5@S'2.E%F.F
M75Q:$7?8L$K<5O10+'%;T<.,Z.%*XM*@"#,V,8-'&9-<9]H*#SK76&ZP3J&Z
MI15.:'DD;O&FOF<V25Z\&WZ9^?_"2\^=,!IU\IT.-7=@!ON/7%[S6A*#%7N&
MO-N_,#Y7W7JQ<.JLLD /MT!;.]<%:J0X$BDSA*W*&-<JLUK;3!%"D%6&:$WS
M$M"ZU/'7XDV5+PQ[%'MNN6*/V;/'M1"MXS)@;#)K(\^8PR(SPI ,:>*409P1
M8E-1Y[MR#"S&)'/AM5">O:D*P956_MS,PC6FLFOKQBL*>\0ZF>:-1'U>",FY
ML1G5DH 3KD+*E"(SX##BM!3>(3%>+5BEZJL8I'P2J&*0N3#(M6P<+DCM$+(9
MBMB-8WF&&@JP"B)@J1BV>?%YIDN4TJ]X,:QJM\O=.^S:W]H^]/S3UA&^%G>U
M'&KOLD^KQ41/(.G-ZS+/$2D4)BI#,NJT()IF6B*=D2 (0P);)$(B:2%PF65>
M%>EZY3*OHH[94,<U?1>"0L1ZEF$75,8(B9E.M7B4E,8("BSBQ]2!R(*&N0HO
M@JXY-+6#T/%IQ-2&IMI4450Q],/6KZONVXIKH.C[T'=Y0JK-WJ3H;"H6>)&]
M:>LXC%.(5>3V&'*K7^FB\_7O]?VOP%^:J!BS( 4XL,RH# P3S3B-P&Y2*L'Q
MT@K1I=XN6P7 %ET9Q?;WX+/S,.A7_/*R_'(IGH!?&FF/%W/,(, TTS9C%)E,
M4Q!0ED<K$4/L_V?O2YO:2+)V_TH%,_>&.X+$N2]V7T70QNV7CD%NVW3W:W]Q
MY'+2E T2(PEOO_YFE@2(S49"0$FD9]H&558I*_.<YRQY%I.;C/[??VE*Z-/E
M<9']K%;N\K6UN)R1QVTM)IU?IM,]%M#C8I[*/]<P)&]0T_R!*F2S).J7TX.%
M*6";[TE0(1 A46",).5+:>2< Q2=YT$)ZHP/:QV]3LA%ZW*)U*^YH/%N.C$4
M#&JA,E<PZ,Z4M(1!RAM#.$61XJ2@68R1-EXC#B#2%@8JO%[KF'4L;YR*<"<X
M\+!\7S>O;?=0#-4ET:^F"B&M7,O%N\*W5],ZEG'"@HHZQV4HQ(E1R?8$AK"F
MUKC@*,-XK4/5.J9+K605']=#5XL*="P".J:#NR@34I"D$%'"DGGF)-*@)+*&
M4TT$. *J@0ZC+@8.+)_K:BDUH"V(D @]5'7/]P^@&MFO)>=O!12AXWW=;K9U
MUWZ=LOJZ4&!M-EC[:UHC$D3DGO0112TLXM%$9+6D22VB7$>GF(ND2=T1:ID5
MHA(.]< 5H@(ABX60*<U(@0\@=0(.X!3QG +H"!?("\$CHX+3G#C#UP4K85'W
M7*+M$'K#S(T^EVTI'J)V*D87@"M-(_P&O?3#Z,_Q!OZY;WO3 %8LO/EP[.VT
M*J2\-3+B'-0IDRK$O$/&$(6,U$ $LP&B319>*=)5(*-MBE"!C#N$C"G5)V*/
M'=$8">4)XN $TM@09 36!*0RW)FUCA#%(W3?BD]2> 8PJ@?C<E![8/='>Y7/
MW5+GUX4>BH6W'$ZB)J_YSS/[? X("P(N! ']V1.UZ"D.#GF?C3^B/+*2) LP
M)*M/:"ZQ9TU_D96(6BK^HY52FPJZM!%=IO0K&SC+NXL<Z)@K*B1K3"B-K.!&
M1:<\,S:CB[FYAE5<2S<H+'7C8/"'8B.VQJW4;%O!JYOCU8<SIVFYBC/G@&)2
M?7(3HX",YP() H$RF39,Z[4.PTM]EE9<2*NH"Q5XN"5XF#XIDP8K0B@2G +B
MV%ID Q:(:6N%3K93Y#:W,EH%=]'2YKY=+J+'N6\EYVTE5:/Y\DT*$LZ$A)^F
M%246E,8:./+.BF38N9AL.N-0#%:$X(!BS-8Z'*\KL]3';27;;4G09SF\4 5]
MYD>?:3V,"V4H9@@\E\E,"P(YX0@*RBCBA+!-'0+.USF_6.NWC0BP((]32S2P
MRWGQ65.5XP/T?"[N]*C;'T%%Z"^WZFZ:XQFWHZ]\'=9/>O7^_UL;#8[@/"H\
MZQ\<U*/LDAYN]L*9=2HH,0M*?#Q3$%RH(&/$$HF0,S[ <&0M)L@ISW7D(F"0
MF6@N:"=+1XFSR*Y"B7=$B5/RRF&GF3484:IR6C8UR 1)$$^2"K2CW@MW)24N
M*-ZCU;+A-02 @USFLDH+D&E[T-]/PSY4=2+S 0SG2X=^*$>PK3F5.-W'[IEM
MW)[LXO/_'N5^/78P^)8^W3S(C=8+L,P$+,^G15Q,5CA1U"&(^;PB_4$:0]*+
MA6 Q>NZQ%&L=MM0-+TKHQBH:S04W[APWIA02(7S"=^V1U")WNI <&5 1,6,
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M"F] $\1Y @_N.$7.X*0F.<Z-5\$2JS+;:DKHTQ8UDBCLW#[/1V'G>V+G4ZV
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MD#'EWV!..QHY1Y3%I!4%9Y!3N5R2,DXFP:!$2*8/PQ?CY@O3MH5IVQ#N492
M^^7H4R6 !*X\S;&@U@!*&!Q1LF>33D"BD5I$;4BC!!BRU(VR"YZT5PE8O#^E
M0,;"(6/*-6)R8R,)!@6B'.*Y))'5T2!,94AH8?,!R%HGF84M4@(>0F3']L&A
MK0?'V2]__/77?X[](T/P1X-Z5$-I:=1V]\CUHM?&>/;F9%O_J4=[_:,T"QO2
M FS!" 8'=<^Z??@]D<3?=O\(3JDC@^)FKW=D]S</TA85-_%L6+AS)I4F ,>>
M:40<5LD@P@;IH 02U!*E@!F5:YFO0-!L.9%JKP)UMT5>"_;<)_9,.6.,LS%B
MQA 5A"%. T'6*$"03''!K65I]W-!2(G;E)E<N+]][IBB="P!XY\J'9(R(90/
M*%*5VRTYA1R-%-%HJ?5&<YE]-D7I*+#3;J]-43J6!'NFXV+R$9!U 66[%G&B
M%3*6!R2]TV A1!I=^Y2.!Q$@DU/:QN$QN2K*LT&_UQ^B >S;$80J)N[H^=KN
M5W5O.!H<E6"99? &71$GN)7F_MF.ZL^0]SS#V\O>Z6>EV-.L"/=JVJ63-"M%
MM6'(L*0(<^ Y22<8E&29H\HD[5KCM0ZA%X/XETBS*N=A[=6L;B]3J.#&HG%C
MRAT3K>.<!I\V)0C$M='(2DF1U";A1N0FP4?2C'";CL4*[[;/&5-X]ZYX]U3F
M:\=LM&"1 9YX%ZA'SD!$0@D1  >+?9;YK,3 %-QHJS>EX,8=X<:4-\0;R:@+
M'$4LDZT@I$!:4IOS?9E@R8CP,B3<P!=QH[6A,.UK_+QZ(^>-1EJQ5M;/[:"7
M)CVL'HUSNGZI',3^ ";E:*J1_7JSB*5;ZMLVTVZT3E:UP:\U@^?_;"#GLS21
MNG>4%G?2SZW?&_[6$,UXW&XFF>=?1P.;-J?NV<&W[1$<#+O]7GZ%07]_O^D
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M.MG.7F!DB;.(<4AR*1@7I2]M[%O"=B]'>S!(;S<=<7/!.[I>]6#4A+) A,$
M0E4WA;NKD?T*PQO5*5Y$+=GRC"5ZQD+K^-(-*EK.8+]!#Y)(J0[WTT-NHS[O
MR3-^U!/VN@6;VF<,W:TG_0JUH$'),V&)IYT+_LP?]'N;O=",^K,_' U@5 ^:
M>,;)[O^9-W\S?#P:CO*G71B]C+OV:]$Q9M QNL^F_/,V=SP &A&F.6>'6$"6
M"XI8<-%1K@)V>*W#],5F5LOGGV]10;B5P9HV.)H+UK09:TX]U%1XX8Q-!HRW
M!G'--3*::,2H=>D3T";D1O,K6()V9=C]QJK%(MVLA=U;R.ZG;EG&DKZH02-G
M)4<\"H:<TPZ9&#1+X)X42KG66>IR6@5I5MNY61"FA0ASZB#U"A*^T&2M1"Z2
M\6($TDI)1#R+UKCHL<KUI,1R%W)=5H?-YF_;M^K0_!'"7;)TK4.X-KAIS@&<
MKY__]Z@>?=N!T5X_;/<^PQBJ-G,2>(&J&:'JS92?A25=5UNOD2?>(4X=14XI
M@B(XJB@1U$6QUN'F(E8MD3KT \"ZY7)3*P\6-U>';M'14F!CL;!QZC*Q@1,!
M!",<P"*NG$6:1(T$>$<P\PK;I.$8NH#R<85K6RCB%^ N*;QZJ[QZZN\P4ALG
MJ$622(TX2W:)\4$C8B0S%KA2X),U(I<ZU:& 18M%_.V%<Q786#!LG#HQ F ;
M+%&(N6 0Q\2C)/4-PIAJK9@'S\D-G1@+9-J'%G7R[&@P@)[_5HT&Z2G[31VO
MRI[X\(9-Y:A^=OF5D)3E\G7\P)G[>W^0IMD[WOO=O/7C*6[VPNXI(11?[LU@
M<#I1%)ADV(!&H#5%R>J12$?A$94N**(H4-!K'5;B4 K +)U_I$!-"Z#FU*E"
M@@@26X^,I IQ02(R-@!B%H@6/+(@8S;4VG%L5#B]]3Z5PM\MX.]31TRD-$9M
M"7*"8\2-C,AI$A!$#918K@VV3?7DHDD4?%E\1.N=QIT4?+DK?)GRV'#LK%,4
MI8TVB-L8D,6$(X(%DT0%32#I#_2BJ7)_3'[K382O[<29JAT\>03*XY]PNJ%.
MG$%U+FX]>H((VQ"+[VMPNQE]5Y9*/O.Z@K3M=:<S$<\5<K^3_D^S^/%OD*6^
MU*KKG7K!BJ"81U!\F_)I8:Z9UCX@P[A&7$6#C(\2,8D)8S+;('2M8\@JG BV
MHRY&09_5<Y$5')H/ATX=7LHH(BRU* J7,S&T0UJ!0" DE50;B5G(.'0Q\ZIE
M?=D*#+1 ";E3_UEA_OF8_]0;YCPEPE..L,D9WH9ZI F+2!J<MI$);RE;ZQ!U
ML2I@44(*^K1/";G%(*>"0PO'H:EJ5D0Z:D5$%F>OF0@6F:R)V!@E5A0<5K#6
M:;T*,D]KV,65[RM/+T]_,$]?9,(DPTL0:_AC5W-)IFRY:W6&LK^7:!G'&D;Z
M;?\H+_2?_4%S<C<:#6IWU/1'W.UW^[T\[4%_/[WMA^W<(P>&HZ*5S*"5O)S.
MR_3*,J 0D/$6$">>(D.,0Q)\(!$['WVVCM:57 7[J*1MM#!>X&Y;+13DN5?D
MF>K7(#C5Q@MD0HY"Y$H@S;A#SAC*?9 @O<G((R])_2C<WQ;N7]K& P4'[A4'
M3OVS2FIOI?>(,D,0]\XAK:E'DA##O.6)'D33MX67).]60D";79J%R^^5RT^]
MGP2R5#<:.68EXH$Q9+UP"$/4'AO A,>UCI$7@P:7/\W37.)W.1OWI@_;Q;QG
M/3&/CETQOU1C5TQEIWBE&O6KWAENJ>H)NY0RY<ODLHGU5PCH.PSZ,Z!H0<U%
M=T#9W1SMU/AK@YR;[[T.0&U2AW T(5E)(B)#95*6(N5.6!<)D]D;HBFA3Y?9
M0U,R.E;:0S.[?E:0Y1:0I?OL!%F,Q8$(,$BXP!''R0*S!%2RN["ES.FTQ[GN
MQL78W,+8;6'L5CA?"D/?*T.?J@I!&LZLMPA[9A#WP)&.4B"O.";22@-.K74N
M'N.4K.X6L'(;LBZ+C&X%2[\\E=%*<N"1 S),Y]I82N3368$L!.UYL-YAO];A
M+1+1-TRT'#_L"<EY@-/Q,;/%M*U L,L%%\OF?OK=WB0&YL9+?.U>NHO<T[:U
MVKUI?_&%KDU;I%?;7%GSG_T5:363M'H^[:MB*E LA4#@DEG)I<?(,:$045XH
M;*."J%<GEFBA$NMN4C$*]-]KE_65A/XV.!<+]-\+]$\Y$WD JZC!R,=<Q)<P
MBASA!CD#,0 7AD)H@KGHQ:IR!7X+_!;->YE=P N.ORM /"L0G^K@@A%+HHL(
M6*"(\TB1T8PC$0EV(DKJ[#B:3N"%91H6#'XP&%Q4X-4)@"PP.R/,3CGF):9<
M"(V1--8ASCP@QR0@K!A5E F//5GK&&&6'&0;=_[CQ@E]246_ SOX4/>:[^:+
MK]NG?\9F-+/9&X"JUQ^EYXWZF:E"(G7(HJ'7+(4=I5]BW;,]7]O]-+?T0=.X
M8N/*.H63Q_-\@G#8']9YVYX,(-<1_0Q/O]1AM'=LY4[=-=D??'J+=6D&1Z.K
M;YG:"@_YM.SND:I90GFNW.'4WWFV#390(T#(Z(B,A@<+!JSWDA$O9.!2^O>4
MKAW?M'=2'>#0?DB,,0#["=G<*.>)W?]BOPW7'I\EHT1#QXL^J8)Y?LFN7)@8
M;VUAQJR24+8_:$K(/DF\"8,\*LW)MF8NU=X@RY!__7R+U%IGMSE.ZL?J618_
MO1RA:^_+]TI/?:\7_[Z,).^4=>C/#*UF^N-3N>I% N[#]2K)UXVF(<Z;(S>L
M0VT']?E:HBU\AV<GH/EL&C3?G$!EII<WH[[_M-??3U0W;*)-U=/JT1;$VM>C
M7ZIQ;ZS6OVDR3ZO1'E3==*7:2</WAM7S]/+I9>$PO:R#0<7P>I7MW&8?L[)U
M=4';6W^M\Q+P\K=Z5/>J]-3]! O-5H7^_KX=#-<K^.K3:U6'Z:V&>W8 5=I8
M^TOK7^>OGCT*=2+!UD_U_?7^7'B-!4_6S("T,RWI./C@1,%I%$V?J>MP"$^.
M?W@:ZN'AOOWVI.XU7]K<]'2B&DZT(G$QOZ7YOO'E4VF_@<<2?Q) ,OGFR>6-
MYM(YM7E\C?(-KOF5E_$&F>L:W2#,S'7GCR:K-J2:;SX_OB;8U=]9YMJNN1*\
MP?E\I'7WD]4;FB_+PJH-3?22S-5L:"6O]=2?1-7-VXO@;J70#V(M?O!.5T?\
MJNN\_UB6W<T*_%1I:%9@<][ OADJD+6"('[JOUDP0:S*ZQ=F_^$!SY2_\[PO
M=*EPX%G_X*#?^]4-'G<:X_HZH;W7>/>'M(2;::[9&V;WFV7\T]8!U>,E?68/
MZU'ZO"SJK(OZ?!**WBSC:ZB;5N<0FE_K7O:?-#_^=C1,MPZOE>)?5O@LV7I_
M='"T;X]7M:F[/*;:Z=.ZYI/_-.D 99'G@-=A[DLUH>+#HX'?L\/)@E\7;Q>C
M<K1O;;K]'FH68BI=J_E]>X;"':NZ.+O]T42>7.+S;CX_[_>N9E'?;E <> DT
MOM_LONUY&*Y76^ G#G72.-3Q36K!+# Z9Z;5ON?PF^NM^?6C;V9[]WL*K[G>
M2\\07.- *,,8(\X$SKG67A.GHB(R4.J=>[^=R9-01GZ<VCX-!V/&7^828M]V
MZDG4S<=\3ZB[!\_9NZV]3V_S]WS\8^_=UH?T_.?T[?=TSS^OOK_<VF0G43<?
MG[.W!SM\9ZN;YO2*=+^_^M8]Z*;O><YWZ"O6_;[S[>WW[L>7N[_MG8^ZV4G?
M]?;[AR\[]'7ZCK]8=VN;OJ7IG78_?'^WY=G.]S\^IMF*G1>_QYUZJE1Q<)Y$
M#!XQ;17BSGFDG6<H[2@W@1H%G*UU#+MQN=!9 ?DN$N + A8$G!L!.0>FA>.8
M8^!@@V96"X^-4%+K&.35"#A#0'>!Q_N Q]-ZRC$(JQTPA)WPB!M&D6'$(**D
MY#XJJXE>ZXAU0RY&?A> + #YH %2!TZ,BU[IF)/7'.;"1QZMDB083 M +BU
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M!'TU I::PBV'1WP"CQ88N 21R&"?X-$%CYPQ H&)VGO)<UGAW-35J(M=F0I
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MXE5  TOJ4?"4<LNM-8I;2AW'-H>KV/=;%%.,"2:H^>&2KM@SZ$@)Z9-2U#^
M'&K_4_5H  '@(/]:=*6;ZTK?ILYG?0S)</0!.2D!\1SDIY7V2!%E;2)-B-"<
M.0C.;JHI%=XO"%UVJ>S2,N[2+,=1PCL<8U"!Q<BY9H9BQ:5E$(GR3(9K"-*3
M<ZDB--LC-*<=L$(*'R..**E(%G'#&3+:2"3 44U9B!(GL4DNRLSK'S\5%F^M
MJBP )+%&$D<%YX3F>.X8A(G*.:#A.AQ>5.5EX?HIMZ)R/G 2)=+:"L05<&0E
MI8@Q%2WV08;(&V69W3C:>X'</V]NY V<A^=24%$>W[!A\XRZ%Z W>H),@R[W
MP.I-ZG=:BZFT[XMNQ_6J!SF7.3%NA$%BJZINN+ :V:]3N>&S._?.+>]<*'O)
M%BT'RLZG[EY.D7=QVEAVJ>Q2V:6R2W=C.LI((O'!"*D"!\RUBTYR*X-,&J<+
M>'[3L1%Y9PJ=G.J42<%\&7?MUZ(:SJ :)K7P-');)+,>E)6(4)YL0IHCMR/5
M2-,@DY7HJ1=AK6/(Q8"<F<,1"]\6="V[5'9IJ79I)O?IS9TK10;>F0R<=H]8
M(2QVCB(EN4#<6YH$( XHXF#!RR L:9,4O(>@JI;[19K Q<I^L8-0Y9WY/%UF
MJT0QE7.]E=NE6;+,.%9,4B8P .?>F,B=(F"!:B*!R&O(I;$X.N@_V0P?CX:C
M@\3MPU'_M)YJ+J5:]R9%5-_LV0'D@,*015:25S8/>@W_/:J']0C>P.!S[>'/
M]-K]\!I\_T-O_)1>&$NU),R>QPA^E$1;D6JS2+4W4P5>0DSTEU0/I$ KQ#4$
M9)SP* 0>+1.:.4K7.B4V9LGXOJ!SV:6R2W=?%3*F6P2C)EC%DSQU6%$0 C3W
MG$<5BPQ='1DZG;%M-8C C43>.$A2-&KDDBQ%BDNIDB*5-ERN=<C%LA:%]5O-
M^@6@EV&7[M;Y5@!Z60!ZRG7'%( "*Y$RAB> =@%IHQ0*RD5,/'BA0@+H&R>4
ME["F6^3S9W:X5Z5IUFD>89C9<M_FN*5'__X1 B3F:KAPL4BPW?W]O/M]W'JG
M\3%N'4_R^,NW)G,]X6%<>/CG/%SC+\>.BO2<??B?U^F^<.@HEV]W?ZMWOK\2
M[SYZG.9==[>V6??@][WNUMY>]Y\=^I8^__9VM_NQ2U_'G33FY99G+W<WZ<L\
MUP\)#Y*V)D5$%JNDL G)D',T*6P*L*&&>F+<6H=NB(LJ6W4(@VJ8-_4F&; /
M^KBL'&J672J[=/='SW>; GLB!*<$8Q;A18^=30:>)K,&&9FTEB'J)$9<296T
M6)FD%E9)@Y$,C(EK';ZNJ&S'$73AX(*S99?*+I5=*KMT?^%R16>Y<YUEVO?F
MC"!<4H9B#!1QIABR/#B$C?>.\2"8<ZW26G[B>0OU\'#??LOSA!^S?1E91LX^
MLI!?&=E>\EMXV/!]Y4?/U3KV09^SEM/PLDMEE\HNE5TJNU1VJ>S2[45IW5J%
MN8NEZQM=L+AW9G#OO'QSME<'J&@D"2CWI4*<!X$,"Q0YPB0S#G.2.V#>N Y]
M8=?VLNNM9307=ET,NY[QQE+*C2:(T8 1Q\0@8[!$X(4 @BW6V+>+7><-A)RT
MK!@_[ G9$&?[5ER[HT6;/1F_V7W;\S!<K][ X0@.' PJAM>KS&=S.3@6M79S
M]BBZV6:M= NC&R[-J@@;K3QQ)$(TG' +47/%<VE:K0BC/)+<X>A'@?NEB=']
M51O=W1Q-*8[<N,"3S$'6<9I;IP?DG& (G(E,RK2'@),D8F*Q+8QN+ _NL E<
MP=^"ORW#7Z\)2&9]E#AR,%Y[ QHH]\38&+B[&G]+A[FV@_.4F1"LE3YPBZQE
M/)D)R59(EH-$DE&I@ E)75CKB'6C;EP;HL!S@><"SPN"9\94\) P.GC!@W1:
M2TRH$=1A9VR  L]+#,^GNK..6A"A/0HJ .+2&^1P4J6YY5QBG22S.FX1?S&H
MKN!SP>>"S_=5 MM1BZ-.W.IT F@P&O.D0WN"5<!!XJL!^L1'7I"Z[4C]\E21
M%@3 F5PTU,E\/,8PT@%BPFQC:<0J"^N$U.M*DYM'/Q>,+AA=,/KF.2>11\:-
M-%%B;D34C'!GF+,)MI-V+0I&KP!&-_^]R3B=U&DJG3#.(*9D4J*%CLAPH,@$
MP8E1#),HQ^HTOU@0HJ!T0>F"TG?NZ;#@LM-9<F,EUSBD_UNE#,X)93+ #SP=
M!7Y; ;_;)_ K1,#848F$L0QQE^#7$>J0H$I[9Q6C+(>0%4]SP=^"OVW!7^8(
M <&(,CQRK:4&[0PPZCEFD&"X>)J7&9Q?G8"SAR12N6((>Y6+SBB#M H6)>/(
M6&>%9;1Q8%!&5P&?2_9M&=G>[-OV3;B,7*61A?S*R$)^9>3#'%G(KXPLY%=&
M/LR1A?S*R$)^9>3#'%G(KXPLY%=&/LR1A?S*R$)^9>3#'%G(KXPLY%=&/LR1
MA?S*R$)^9>3#'%G(KXPLY%=&/LR1A?S*R$)^9>3#'%G(KXPLY%=&/LR1#?D]
M;A(GT[^A_MSYM?DKW]OYU0T>=TX2]XXO'C]NDFB'<DIODUG:Y-C5O0"]T1-D
MFH3C?.OQ>'_3[%6QH<7/$E@I_C]/#_O#.F<>/AG OAW5G^%I3A-$;(/DV\\G
M_MDAY">L=1Z1DR(>]=<GL=\?]?HC6,I<T7WXG]??WOT3#AWELID?W:9O=\.G
MER]>[W5?O*YW#G[_]'+KK_39NX]I?N3=U@[?V0JQ^_TO\EX$:9VF"AG'&.($
M<Z0)IDAX2[4'KKA4.8%WO$"O^WES]T:CPR>/'W_Y\F7CJQOL;_0''QY3C-GC
M0;K\^'CLHBGBI_G,#3E,TRG=H)DP-P_Z1[W1L+)3B</5J%_USJ0.5_4D=WB8
MTY6KT1Y4O?3TZB -V1M6D$@]7.RY0"K;"TWSA0J^YCSE=!>,*K"#=/.'8=6/
MU;]G2+'&FD6BF9#8$.Y(KACFN*+42,F=Y:QIK$*.&ZN0&^9:=V&TG9;@ /[3
M'P[/IE6_A@!PD'_NKF2"]=Q,L_-]F[PWRE G@D) I$*<6HJT%^E7G'XF8 2S
M=*USL7!0E>A]/Y- )II9Z.)N>Z(7NIB'+G:^O3? ,5!F$<,Z(FZT&Y<UX=R#
MQEA!5&RM<S%K_I@NUJNTAH?@LQS;_[9>A:,&J#(6#4X6_BK<JAH)F$ JW?%F
M9#\T3?+4TV'U'["'U3\9RY[!_KX=#(\EW^W <_/ )_4HB5S_4\!>ZZS?[FQ^
M^-W5E[W:[U7U,*W=87^0%Z_N-<M] -^_VP;_H2E"40UAS*3]\?6T 4GU&4+6
MO7I-08)FZ=VX.T\UW ,8#3=.U*DI'>,A*%?TEZHJZM7WO[Z_QS1A- B&)/9)
MO5*:($V91H1085V4P1(YQOJZ=P1A,P,T*.Z4\LY1'7E@6EOCC/3$2L4I$WAY
MU+&USFLX3-@$6?W*;'-X-/![B4ZR7C1&M0-;9TWI:F4L,>3_)+KZNE%5OR>]
M++-*)DF[GZZ,95H#G$. JIMIC&Q4K<*WWTZ*GC12_S<[K!NU\,_QNC33OQPG
M[F&[,K=.B+&9V)AC?TJ0G;SFYV[M5!>,R1]:FM<R0P_LX$/=:RK!W (LZFNM
MT1O((GB4GI<$[15R(-:]) ?J1*3#M,-PD!E@8[Y7/B,<",NU<<[*A_%G:]=Z
MV.1%.-U0^3D7\?U+'49[QZ6AIFZ<E.;!I[=8EU[W:'3U+5-5>#QD=E[T=A%\
MK?U29U=C^N\\VX;"J1$@9$P65S0\6#!@O9>,>"$#E]*_IV+M^*:]P>G6? #D
M!F _(1O3"SZQ^U_LM^':X[,TFPCV>-WSHI]?KRM7)<9;6Y4Q!27UOS]HF/5)
M@B<8C*7WK[8U<ZGV!MG\^=?/]T>M=78;Y3@AZ[-L.26&^_6Q[=R**+@FX8UK
M85W\^S)ZO%.^H>>FKRZ=_N9^,OQL]2+)KL/U*AF$&XT >W/DAG6H[:"&X94X
MTY9W>'8"S\^FX?G-"2AG>IDN.3<QFJI'6Q!K7X]^J<9%Z%K_IL<^J]W$,E#M
MC)U6SW_FM+H=]C@_XRN,KWM<T^LQ\*-;69[S6L;E^YG4WHE3H*'1T&\L]_7L
M94S;61VFW1SNV0%4B:+M+_>WE-=[FT=_]>Q14MPAM'ZJ[Z_WYQZ]%I=)D>MJ
MDY<M\M@A?J+H-;46?::WPR$\.?[AZ?&!4MUK9M3<]'2BCT^TPTN< LWWC2^?
M*CX;>*S\3$Y")]\\N;S17#H^V3ISC?(-KOF5E_$&F>L:W2#,S'7GCR:K-J2:
M;SX_OB;8U=]9YMJNN1*\P?E\I'7WD]4;FB_+PJH-3?22S-5L:"6O]=2?A(<L
M49?ZR\L _^"=SA<M/QE*U77>?RS+[F8%?JI&-"NP>>ZP>6Q-+6)%6D80/W6:
M+9@@5N7UEY'9+R?UV]C;Z9+?Y\N!+Q4./.L?'/1[C5+>^!FNL4S7>?>'M(2;
M)T<^S3+^:>N ZO&2/K.'^2"F+.K,B_I\$J'4+.-KJ'N?89C,\^;7\1EX\^-O
M1\-TZW!85GAVLO7^Z."H"<EHEO)E6M/!F&K[!X<#V(/>L/X\7N8<: -ED>>!
MU^&HZL<)%1\?+X>9\'8Q*D?[UJ;;[Z%F(:8.UIO?CX.UKD-PJ[HXN_W11)Y<
MXOYO/K_R". :VMO/.IW\O)5).Q2^R[79W\913L/UZH^C'IR<*EP'ON9?ESG;
M6CWDOE4/I3&5(4PIPKP)5G"PRAHF#%8\*!TXYZ%I3$6P?&"- ;MOC@/>_MC;
M^;CY-3T1=_]Y7;_]_KKNTG=[+W=_WW^W]>E+]_LF>_OQ+_QN]Q,^[3VU3;J[
M?_&=K?SOA^_=CZ_2=[_>V_G^=_UR*\WQX/G7W%?JW8OGW\[WGMKY^%>^YTO^
M]^76#NUNI?=\\?Q[]Y]MWMW=/WB[^_S+VX]_?WJ[^T?<J?&WIF_V&_SE/:;8
M&$4EHM$)Q+F-2-,H$#/,@]/4&>)R5T"QV+93K>K[5Q"P(.#L"!BC50Q[K(S!
M7!IC?*1@5(0@N'9.7HV #[<UWY+ (SZ!1V="\!H[9 U @D?GD&,VIQAHS')#
M:\SB6D>L:XX+0!: +  Y#9 ^Q*1 >&.-XB)'$1+B3>24)361Q0*0RPN0]!0@
M X5(F4"$.HFX#0X9K %9[S26/%BGPEJ'B74LBPI9$/(!(.2C67*/P6)!!)5,
MZ&1%8Y/0T+G(,7BJN"-70^0PO6;ZJ6!EZ[&2GV"EQ: XI0IY[I.M[0)!2;5D
M* :NN++,**]SDV>)+Z:K_E)0LJ#D T5)2;"S1AJFDFF-&=/,>&VM=1X\)HX5
ME%Q^E/RZ\PQ_;9!R\SW5DA$K+%)@(^(4:V1=4BREL9B"4H(REW"2KYO_S]Z[
M-C>1+.O"?T6O]SXG9B)<INX76.$(#P86ZXQMP&8(^$+4U6Z0)2^UA#&__JWJ
MUJ7E&Y:O+;MF[P7&:G575V4^^6165J9$&2@S4#YJH%P )R6G5$@A/#.<8D^U
M8!13ASR1W'IU"4YF!&P# A93!$34,Z:\ M$/H-&KEA@8J*-7+9"AW#O)F3ZO
MJ$EVJ#,"/F4$)"X(BZ ,V":F:!4/3'HL2(#.0G>)/YT)8MOA<7M&$(WC2"G.
M@> J.M*I()B6P0&/"(N6CD&*17*D,5-+ 9$+9S:%ZK]KYR]=5@'A+C5YNUFF
M[X]NE8#YYYV<ZKQ*M25X_6I+G48MRW%)@45,W:GEN_@@SF(B<*X)>T XO^CH
M@L0(OWB8P[R7')Y84-GNE ME <D"D@7D(@%9)'88(%>*..:1,U23H+S35#/)
M5723I4;CZJ[BDNJNUPDBSI7S_"T]'"Q+A<^EX(HGC>UIK@Q24'" ';. .B6!
M=LB!0)$Q6E.#$(J.]*K -]ERR0"0+406D"P@64"614 68!"&"$ZXL5X91;7V
M!EFCO?64&@X9)E=@$$WB$(J?WH%??M#/G*%-G*$9?J=">F0L T9 "2)5"$![
M&( +U@I$2,K6:(#,*=Z042>CSLT=%RDL)=0$R9&ED,D(/I(JC[&/DNB1RH[+
M8P2A1I!;I#XDP0N %#* BF" D5ZE%@<L4!Z]UP!;Y;I<]WSN#:+8IXY!WU\U
M_ZO!<55^(,Y%H_3 V?CW:M6])M6;],$/!E4_A*2 G:'^>;K<ZW4V5&\$M><L
MT7) [=)Y .<KPWWLN&<!R0*2!20+2!:0.XLA2(1<ZE#FN*248J:1-@%RJ:'Q
M@7E]!3(_3],K9C%7TVC&VB.%WPE[^F<FWPN0[TB\9P<U%'>,8LT @2D!F5D-
MC$Y;!SI@X=-:IIYB2)PEWADM,EID<Y(%) M(%I"'Y!LW#QYFOG'7?&,NV,=L
M7 0;A11Q#RA7!JB@'.!$8A$,-S1DQO&@";,M#S562>D=?:P'KI,DX\>9!DIY
MF^;16N*\C]=:2VP-UUQ:'4+*/Z1*4QP((UI *@R75_?\#_O/-]RW43FL>J@-
M^[,*W:DX=]$;E^7>30VJ4J*Z2]8ZFNJJO]^'U%&Y+(9^UP]^%-:_BZ_==Q^\
M[>_WZKOT7&W0HQU_%8*WPVC5LT%?Q*#O-LJ&(<L=3HV'/;<24$H%D)!Z8#1Q
M)D"CJ8WFG"^Q,<^0DVU2%I L(%E ED5 %B M+FC.!0[17'EJ,)'046*L%U9;
MA@R_<<IC)C.M)S/-@BP,,FAPD(!A9P'EC $I:4@Y9)@2B;$V/.=#9DC*-BL+
MR-*'O+-M:K]M:D3.,8X>M4,2Z! -%%76 :U9 ()YJ)!71+'L:N<4W8O6XJ4N
M#SIQF$4<ARL3('1URL']W\N@)VIUI?ZW"T%OMU^?WG:K.QE6L?W-R1@G#]\<
M#W4*'C"#Q^_!HX#'DRA=O$_7__O#R9=/[LA@RK?V]MF7S?@^OSX>;VWNX^TW
M[UGUNV_[Q]M[[O#+WL>?\9XGVX?;8>N;A3N;ENSL;>"=O?=T:_^K-PIQ(0VP
MS">2[!C0EG#@4* BP!"=*+6R#M?4V4X!G2,_Z)1I46]25>1);XXO'97,V1-9
M0+* M$A [KFJR )G\J:FOT$'$F_);L-BEG]6%@1+9:DQ#@2;3M1QSD%D  00
M'JCSCL>?Q<HZ6N5,WKS <-;@#/%90.Y60!"\XOI4$I*7*>MQUN/E%9![KJ.0
MJ=J]4[6Y:K^&,BV-!Q!I!Z@P#"@48"J&3ISA+OX76D76[CL[^0$ \H,_&@WL
M@2[C'?LAE3B(TA['$,7]6BW)G_0NU]+9N[P-F@4D"T@6D"P@64"R@#P* 5G$
MI;J%]-!YKVEOX'4Y&IQ4[M(_NCOR&_:_HV*0<FO*X98?'O1=]J 6\:!.YO(W
M)8\KY;T!06D)*%3)>7($Z+AD5%&+%4F-1]M22"XK;$;T+"!+%B3+B'[GB-Z(
MB7GJ0@1U!;#" E#B+=!QO8# 7GK$O*&6M0C1?Q,1<T5YU-4G:9S^<AW/5^8K
M%[_RNFFOXZYOM2P_1VMLOO7;E9O"M;XQVU^ZJWO6EZN=77\T](?&#SH$KG82
MV-\\(_'&TWC-CI\W6[>6-00]W\A?MR'H#:>FU<1GD>H,5 IME,10.@JIE,(K
M9A11F 1MA!KW"_TMW<DM0>^=$.WLPI-I/I<VF&I&"(!8L$B'& .&: $,AHY+
MH0@QT<%5A"WQ,9!;MDGWV,LY W\&_I8!O^2*8 6]0S*Z4B)$!QABB3T)(B((
MEA<#?VX4W7*K,*O"$[U7:TU@0#!. /71("CF"?!"<FUYH):XE76V*NDR'P_,
M=B';A6P7;LDN0"@T-Q![92FE/'%'#ID.F# G&1+9+BRM79B=_I A<,J1!T8%
M"B@D DB)%+",4F69Q,CRE74"5[G,#D,V#-DP/%;#L,@6F>642B24LQQ3*XA&
ME!&B+0V2*JSQQ9;A.FWXLHEX"!/1Z !"J6?**T D2GW#A0;*<@NX]1P3(0,4
M:7]ME9*SI_D7SCG/")T1.B/TS1%:6LRM<%X80BDS1E",O,161_^?&IH1>OD1
MNIG5AJ,4^V 9")+CU!:5 $V-!U($X8FG" L1,9JM$D@R2&>0SB#]\/$5%IPD
MGG.+0J **BTT@R@2:XU0$)SG#==VHV\Q.Y4)/<(48F"X23WR) <*2PP0%Y8)
M1J3D<F7]$?2KR<"?@3\#_XW9.8.$"N*T\"[BO<<2,J-\<(R00"&RF9T_ OO0
MR%!&4C$N.0&** JHQ-%2*"L 9,[X2-R=IZFCV2KF9V/LRT7.J^S29Y4@3;(D
MIWF<Z_\R@V?K\RF4O_^PNM?TI>O!QQ?NZJ/2/Y_\\&*2Z5KT*LVLOO3B4 _V
MB]YD)N(\G!Y[]6[UQR^."S<\2+J\!FLB-\Z1'3]Y_/%:]=&II:@_PW2-2GKA
MQW -7>LSO(:(NM8W+QNL6./B>N.Y_#-&+GYF'FN[QHK@&J77$ZW['ZQ<DW19
M)E:L22279*QJ30I^I;O^YN# $A5L.=_WN>2=+CXL)Z[R_M8G#G4_,R"O1%:;
MA*\S['<VNO'?^C9FI&4"<;7IN#V!>"ROGY7]TIA#@T.?YM=+A0-U9;:*>N]>
MM5[5%=[]*4WAK"5*-8VI+PHHZBD==T?)D[KPI+[2@UX<;%E-XP=?]'[X<NA=
M]<^BUQD>^.K'OT9E_&I9YAE>7&RM'1V.NGHRJU53^UIJFYWMJ]^DQO8^3_)U
MX+4<=OIA+,63*H%N(;R]'<K1OKG9[O= -1&-6&/U[TG \2H"]U@G9Z\_'-N3
M9O"V*G,B7E2__V/3A\(6PS\[=4AW$?;VN]#A+1[B?M#SV_\9]?SDZ#:\5BG.
M*\_+-?>*EFLSZ/SYONYFT)+L]IS_THL<HZ#:.DZ8A810;(*"Q@KEG$16^\!-
MM=D#(<_;_ MLXWPFV]_>LZU?]M>7S;^*[5_OR3;^3[&]]_WGUMYV?.;'>*_T
M]V=Z>AMG^YO%VYO??VW_VOZ^]>8MV=ZTY//A6[2S]^KG%H[OM_<>?4Y_?SL(
M6T7C7#6R1F+H.="86$!)$$ KRX&36! 4A B*GG^N^D9[[:W:3,\(F!'P&BVT
M$<7:$DRH4M2'"'[(>Q:0\]01@=S%")AWN5L.C[,#QMPZ@CAQP)!4=H)!"K1#
M%B 3M"?2:)$R4-FJXC0#9 ;(#)#-"@Q$.X.%A1X+R@U33 H4 C0D8".<S "Y
MM  Y.VEK,/$",@0@)!Y0E<[<"BL!TYIH82#"$JZL$[ZJX-G>'1DA,T(^.H1<
M)&62,X=MB)ZTI)S&/S5F"1D#1!)2AOC%$)E3)I<%*V='3I$12$KC .;,I&HU
M"$CE/8!,(D:4L8R8=.14B+-D\KH)DQDE,THN.TH:1HW72ANL&44^*(T,HHHI
M*;71"&:47'Z4;![[Y,%"X:.7';B.3K>F!!CI$>#<&(2@)<BDH_ETE=#;RRS/
M0)F!LHU N0!.4D.CFE"A%;'4H8B/% 7'+)>>15=<YSV9=B/@[.BEP!YBSBW0
MT*7B)"8 HPD&P0C.% G!H^A5J^Q19PC,$-B$0,6%0T$Q'4B(5-%IAKQWQ 0K
M-<(ZY)CC\N)CX^@A\51;1 *PQ(J(CQA&?)0,(!KQ$DG#J6-I6T;(LW5?VPB1
M]]U/^*&Z4&S[8<>/LV [?W2K#,P_.W=2,("M27:%,;TXZI=5IO/S@>_J8?'#
MOTAK#,@:.N=HI=&E3W>(_BOZ<_Y8YT*F[HFTK;KH[$+5URPW%\NKE%?I'L-H
MQ"GI+#?$4$P=L88K'$T;H]!ZR%S= @Y.6L#!2PLUS!.B".N1 ?4/?<JI_RT7
M&GCG_6'Z9R9&-R=&)XW-V""DDU9%1D13V6,I(BVBE $1*1$2#!&F4I,4UI*>
M<5G#,P[G5<JKU$IKJ;"D@5B*I334.FRPI8AS'$UEZBJ"L[5<3FO9#+-ZK%0(
M1 $N%8KVDN-H+RT!Q@?-4QIO<-'5N\D>4];P]FHX%))B#IWP1E$*I0Y$6FQ(
MZC '%;-9PY=4PQN!PDB( U-1I254 5"E-5"&I7V5J.&(8,,-2HQ8M$/'KWO$
M\09QP%,G24&ZOE*VZAY%S_G>\#E0%88\@$)7)[CC7#1.;Y^-(*YV>CX=28[:
M&?P@ZE.GJ-2O,]0_&T>\K]W>]D98>LX2+0>67H_3GB^1][%QF%<IKU)>I;Q*
M]\,>O?7$<6H4<9$\>B(YD90&AH)"C@ES??98F;RY>B4S,AF9Y4[8TS\S)UR
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M25%A1( F(M(7':V9HEY'$Y:*^-_D$'2.I#QN_I)5NSVJW<RFM=!S+C'PE&!
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M6=0:W,<67L;?VXF,+"?^WC@R<F\)%!E_;QM_&Q$0SHFGG". "*K.X5N@*#'
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M+HS.D(9.0<> 8!"F6(P'QL+D%C'KI'%&,91.O*WAQ]-OI54-51;HF)*!YTK
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M&_XK"C_O/-$=03&U+]UW.,+=V+[I&(EV&X\#?R%J!6&!>"0PAE__9M4YVB5
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M5@+9%T0/X!3^W>MZ<,+[N2!L*^>)P94&P+N3_A@&R]?^WQ#?;5_M)R6]3%0
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M.#JX_ _[IQ/_]Y_++Y_#J:-<[NUN7^[13Y=-N-?>YVW<>O_?=O-X&XR1YV#
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M$9@)SS61P5-+5 T U1H KKXV)"-.S,0)D[F^@"J.N, R5YL8% B-&BOJ3 0
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M0>78]\_ 7L:#=DXFE106F(GC]OEQXZ#3=6 .70_>H/H=_#)^S[8P7S5'&4[
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M=T+.[]TV?S"_)(QZY2,A5LK$<5!.2VF#2L(G;>'O-\#=V=F-TS;J<_78PSC
MND!CPF)Y#,A%,@TGPS 4-56(6PE 5P2! HF!$66D\2#!8A:X_&M@,[KG9V60
M=EUH.B\.N?I!@G>E[W8T%#@_>YEF5@Q5+O"HQLC5%G!^J<.HX'8ZV3<L<BHQ
MABFFMYFFZMRT,KKWV'QBL6KCB=\-6WVW3_IGO?,)JOCU*.)Y3SC?B BCDI;&
M@N\?N$Y$"\YP@)-H #&J(.JI9=>Q]UTW#+).![3[(SQY?E)Q2939B-W\GSH*
MEDF "OP<]L]DF9TJ>)H*(8.=R)UB\YH'R W- ],-]#5EX7U?%>Q$I[1X%XJH
M.6P$F[/ ]?KAQ _Q5#=1).2RM66<0(&SPQ>LBH%P':G&PIF8@F ,3"JY7XKF
M^FK'K79*L=1)_!'/+F(\^;-^DZJO],U)*.-%._E'U15^WL3-E1?-J^;WUNY;
MN.9;UCPZV-=$&H&51Y10ASB) N5*5"0%./34:QH*0>-LEGZR]C:;K7M ,)4,
M$90Y1@T#CU5JIJ+WCC.B07L)>6\(=H.4@.(8]BBO05FNFFWF9# A$<=D&1(Z
M40!E"H3#L( ,3TE9&K77X=7KV2#"O^JNRONJJ?C=@QVJB4GNIZ&P4PX$"43:
M*<Z3-L$:@ATEQ%/*@G^0:5%K#?7 &BKWD"1/A.%"(B6R9T#@3T9HB\"I%=[0
M9%,"ST#-89!](.7$L(7;!P).(>;6)1VH<S$8J7%@6$^S*DS+T%HY/8)RVGFS
M[X)4FA"#)&@BQ!5/R'$GD966D9 R!49\]5I?7]$_V5%[39WD)+U1Z0H_[XU:
MK(_M <A0GC4^BS)K"#B_P&$8R\AU]Q4+4^F@+G>HOYB3Q3.=Q+=0GXL@9\;?
M\!BYX;QJ)"V@LA<SH\%&YDD>XU_(2'' 8'.;5LW*F7G]/Z[W[]>S/M#M^C@E
M>;5L [A\!#^*W#0(I/A10X?X<8>*;PT=\3$/%TS'_\9PD#5%]I0* <=6N^\[
MW<QGNB(3Q&ESP*AR],\QG'$X_W!M^%YS]\/W+[MEBL;EE]U#N.^;[\W=KU<M
M^O9R6C^TWL,3[\+YW^T<-W?WBHYI7AU<-+?^ZNR\WX-KOOV^L]MD>[M_)3 <
MO 7Z 5Q9D_M]O"2Y/BF780/$1-88Z[1, &W==,<O2TQQ(S+YJ0)=DESP45K/
MO2(T*  [4U/&%\0=IJ9/3,^>GW6[;[[OY'-Z"Q8(/J>U%UP[:6((,H00.4D!
M&[6:L=Y!%7E.BQ2.M^Y8?&F,KJT]6LO2S %R?3#@]!BUUU?]\:7JL.[DJ+DD
M"M7%>!0LZ[7VP4FC+JB_G$I:Y<^/NK,*N<B@F7_8*7_3<T[=KG!DYBW+1J>?
MV1-&_?_]"WLZU@T6NG"'W*M5EJ5:%0 LA]U.N'EU2J50SY;;PA]SPJXF0<V5
MN:?=_E*,&D\J%@L()M_\L9U+OVK"$U_7%P]WLEVU(KP][W5S@U!YX[&>@VMV
M/E,DU.G,6>;22:J.[,WDGJ*3W/=9*.7RMX>6.\3,*E':(@:2.+CO\'9CLC!&
MA]#K]OMH^&Q9,$8?++(R(TJ-7V!7.J.T;-T%,O.>PR\,6D"J)$I>)WC>DVXF
MYLJQMO.30MT$?^IT3PY0ILO(PAA'#28SEQ[_>HCN;-B;!$CA))Z-[]\A&*?J
M_-RTQ\^1]Z5I+VL(9SN=B?3#XNW((RCR<H-(?3Z,)R,F@_YU7X(UBN B^+/<
M]I[IU'NYWS&S;>7"OY")<\X <\PR#TUJ#0"H10W!S3\-.J'[$[)9/TZ[7Y^E
MDF@8J=R*I6O0_)K9#,>(KFJBD7+!\6<<J;KJ!%6-KQX6H5WIZOS%HOSRTA7]
M-\'Q6XB*IEZ[_&Q,B YZF;=E<,W"4P-OTVD?MX<$*K;X4A79Z&G!1^.+7RY8
MF@K'[E0S%'4!V7>'1(^C)<T49^V!1S#SW3H$,GFY@US+4#1W7O2L*4J#1;_J
M@,RXOY=Q_>C9QGL9)SGRY[QR%<6NR,#R1Z8.W<1GP:/H=(8NPM1E9\0,'F.:
M7'6QM'IXT-G7.,UL0UEYY1DLM@//VNJ._7W@:$10;(5J.G\^,UJ-$EYCUC"S
MK]8JLM.NVE':50GY L=N!H,](E3_Z$'OG7?B3IH+VD?S:C\.R/!VTA!(_CTZ
M4#\Q?F?--_O@$&JG2$(B*H:X801IERC2U#ALI#=!LFE<[+BWV"DI%0V<8VF)
MB4J 8YD\_,B0:?R^BG"H!$Z[N7NRJ)R:#;VT(/<+!5719H.RMVRMZYZKXXKH
M(C/4+3Z<$YR!HZM,0:""/29"#C?"@,5]\V,E43G1UTZ7L++5>PWKK,I\P*(-
M3OOQM\$??@_M_FG'7O[6/BGK5+[T^RPBF!H/6&Y8_7I4J[2)JWJE>C1O?>?Z
MUYOE5U/3#JO?2;:)-5GX:[RY^'?779;(3<[9G2Y[_>\$6WS3>SVLO-5E;QA_
MO)K#BN>/>/TENY15"+G_ZRV&$U_S;E4IX$J]W9WF+R^:EOSL5V.&X65B,>XY
MT_N9#^U^M]B:_#)M?6;.R<,LT<L>E/W33,)V/C%OO<<Z. [(VDBM!!:!,:VH
ME.YV92*+IPF-\':KELLI<O$GSJ?>%4K7PZS_./JR&XZ:NRUXEG?P!!\N6UMP
MG\][F4"<[\'GX7J7>Y__F1EFW7S?ZK1H\WN3MHZ:GUO'K:UMW/K\[A"NP5M7
MAX< O0&:_W4(SYZ:'_'W>ICUQ7[4>:: ILA&KQ$'R(V,QP(1JW5DC"I+1.8Q
M *\P\QB\E$'6CS2I^L'-Q[0=?IG:=OX&OW1M._^ME]"V6A%I$HY<6<ME$II8
MYHB5%BL6-#</4O*R5KD/HW*OABK7\\ADGI9L+&A;[C1'!FN&%*-:Y1YY6P@Q
M-[!<1(BY6DIO:?"<RO^>-T2>CH[<PK>Z<2%NX73]^&O<U36Z:7?'*9K,;(CG
M27?[SXE@V<*MI<NMPERK^ZSAOB?8!VLTC59P(H@Q-C >#(_:8>KL@U2%_Z=[
M<K ;>\=;<,K61F<9HW,YAO.%36!V%$<L&(4XMABY7/,;N,",>LNPTJ]>\PV#
M9SD+GQ_*?P(L?Z,"?N[:XMYPU205,(L68Z(RZX@CX'*RX&FPGF@M'P2NKK7%
MW;7%"**FP#*EMD>4JICI!2QH"RN0)2E13Y(3F+YZ+3:((@\$49\2B-;PN,XW
MD4VQ7"AWE9',NV&.[TXH9OD%6CFU]3Q 3E97HQ*"83? 6H,MH<%:?X[CG5QC
MZP1#T3F*.,$,.:D3PLX(H[DVO-)@5,\V$#PCO',G#?:H<&BY)[H36GH!6NEY
M@*FU5GH0K33"55%:2S0F2%('7IB.#FGC"!)*8A\UM\GBK)6DGNUV6UG-4&#7
MOTOISGCGT'B#Q&P5UM,6]T[W?@UI[V>:N_J#:O'K2JYRC>YHUGLUTF743G;<
M#;%35Z#.&9%8JD+S)7K57.7)F2[UV,":(6&C40;OG31<S=PQF$[4=; 2W\J7
MZB:)\1+;(<%.U0*V</XBO6G^8N8 SR5>I9*T,(R,5?GF>TR7#)=?Y!'M@]ZW
M&2J2&^K9GJRPTYT5MJ:?ND;SP[Z6#)"N _!$M<D*BR/-!4<J<A\!19EHQ"UJ
M+NO3/JY81I6"*U>#N63EY)0R.>N>E4KZ0;?%NG9R73NYKIU\7M6"Z]K)=>WD
M0Z0*7V:YSKHX\DXN^P_AT'IY^8]C\,=W#SO5Y[9Y\^B?H[W/[]IP_Z,OX'<W
MK[;)E_<M^'OK:-I/!W]<[+S_;P5RCPXN6^];X-_G=VU];1Y]N&H>_?=K(2RA
MK<FJ2&NTM5$IY%E,"-SR@,"I,$A0+K2P(FC#7KVF>H/064?]&84/UT61JZME
MUT61=]*R/X0';*UE[ZYE1]'0X CH4LL1"9R!EM4!:9(24DXI'E,FAJ.@9<T&
M?[ T\VI60MXS ;U*)W6=<'Y^./&%)79^E"IKCP%&9?,,+9&0@TU"W >)M$@8
M\8BEX,)[3<RKU^ _8_:L >,ZW_P\E=+S@U5KI71'I33"5\Q[:K@W*##P77GT
M%CGO'0(=Y(F4SBLC0"GQ#:EG*7Y75C'<*=V\:NQ2"Q+0<_*O=?IY7E9I@F9_
M-@/</JF.7C[9$\GB/.2YW0NHXBS*;/PY@-GOGO=\E=]JSV?8OSX]/)/B>KK,
MW@VS-//$Q %-?CUOIIH]FO/BZ;R7$^6#$1W5^Q<.4+YJ0S%&!,.%0:SB'FY\
MS'QOA2[I*>=C;-15$3>Q*HX6OF:4*DQ0+@XY:3/GTTC>-AN/S<,ZM#MO"@75
MFY/PGQ$!53/:3"P6=D[^R:N<.</@ ZWN26_PUS]LO]W_[Z#V8S?ZPY/V_SN/
M_9^]F( WW^Q+D@0+RB!#7$2<2HM,$KDEA9-H)9&,QAG"IZ@<H YEA=5<^V2$
M(EH$9KDR01,W77RP.UM<<N.\N3D:H4CD0"L/2GK^Z(#90Q_]8;>3KUPH/]%
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MN?*X?HPGPWCL8K_!\(OYY7&![=_G,+C[K7Y<;'37LGS9]8,PVG&#]6<#&N\
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MG(0SV'  4^\ 6SWS2&MED1018^:TB,)L;-'93'T-4*Y.GG&0Q2R>E\4^BV\
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M)$<DU0(93S#B6"GDN$@YS9'!"G#0&;ZQ-1L%=H&"&? 6$ YF1>0&S!YFFH=
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MC+*824\"(XP6'*DQCDQ<S1;C2*ACB$8%S,OPO->F'#+":T4-]HJ1C2U68*3
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M)>.1PQI'0BA5"HB2UJR TL,=5%U-@L?2>FG]2;:^HB.Y(XN,K_&E7_6)URI
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M="(/N*-9(J@MF=B%(SY'282%[()-7"8Q.:R]@'YMS 98(;!"X$-R02%B=!;
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M\)?-\ZX2WYP]KKDX6:W<RB15]DQE"R6B)[D0E&!!J@A*A;\-7SN[Z4+W)PV
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M HU>: T$<%,A0)TC^+<EF=FH<_ :-<>U37O9-K!Z1TCM*-%<<>H>3W ";I[
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M*=@2A&GMW3T6*Z#?%="GUGMGF%$\1R)TRDB3 8B%: GG*3@+04;)US;MLD(
M'A54;[#XQ^[HJ.=.RENF[^-P_>9=O]E,P2]CYWOIS!D1?YS=<>B&'[K]L^E?
M-K3-XV7)EU(Y=JG=MG/T>6VSLW5Z'N.&J=/MEV#S%/&7YHPE3F+4._ZT/B].
M2[])$#_:Z'1*'?I\/&P.:KK]R9%J@?3F[?&F\>#*^T?KG5%*G=W!.'74QOWX
MQ7Y[]:;!9]TQCGF88S#.U2'>.._[>GFYG8)1F=Q3E"&%A#1/OW@4MVIKDK=R
M3?[4;8[D?SX["FR.#5-S,(^7OYW)S[<X+]\WLS*A92MSQN.@#,3$&:'S-H7C
M(<YONKA83S?=W>-#?'Z8_%W(5;=_["9JU3>?^<U_^>$OFY?7>D.'N)5)JNR9
MRKB[NV23"T$)%J2*H%3XVYBUN01D!J'5\J6!L9NL"<T@-C-K<6;/C<Z%E!]&
M9&:$5-0RP/>VCGO0G%NEP#L05YZVG:>7;].',E%_I*,!BE?_PW9W%'#!'@_3
M/C[F16\0/CTRV]Q[><8VW\#[CV_D^_W7^/T_#G<^ON%[VQ]@Y^,!MOSGU]W"
M+/?_I#L?MR0RQU[ZGS].WO\5CSP'M;M]<+B[W>OM?/SCT_O?WITTC!,9YMYO
MNX>[^SL<F>67W?TW)SO;O8S7ONYN_4VECU&Z0'PT@@#R>V*%Q#^5]M1X'JU1
M$R4 UVF*6\5#AU$>(R3!\-M@L[;!BR"I!R&*&3VM=1)2^",<_O'P&)'K=/ [
MWT;_LBS,KO0+<C&9EIN?>;Z/DE,-FB$)9@FD%!973]#1&9L"MR*M?5\X'EX5
M:Z1A_R!UCH:#>!P04P:YL]4;#[NN\;?1ST>=T;$?=6/7#1%=SD"X,SH<?$J%
MA"& (E</@V\MK)<Q&75'9<A+:XC3_AC_*M\-W0^(Y.,Q-H2]/LZH": PQ"8Z
M!JDZ\H.3SN\[G3_?;JTWGQVZ<%"Z>^CPD3T<KM,F)O$T1]VCZ>.O;6^G&V,O
MC0?]YYW!T/5N[._.V_W)_?WCT718KFW^S[=O]U].>MLTW^^& 3:%(SHX#@??
M>]'_P2WVR_/FH\_-#<VS)E_Z!7<M9+\X#_ZX[%+X];?CM($O@VWV>OA;Y]RL
M->U.\@(U4XC;W2B=G[GREN/N&)N[.,'#1D*:R1Q-A*9I8SK%TZ&Z<@2_O<)I
MKY#JN7[HXC>_=:E\ _N$RZ<_^*>A'Y=;P56";93M?+WS^0!?]-MB*W<>I-/M
M>G+7V9>;EIN1[/RQ]]?Z):+@>KV)"]$M2-PCB>&%6<&5GW)G<)2&KEF:Q: Q
M*LATZ#XAE_FI#$KY,J?/7^YM[S2_LN<_XVS^TTV?1S-W%N<IUS^57F1-$T>I
MGSL_G=Z^]_+UM[L+'?K']1 $)\..C32<J1\2KHG).L<Q'83RA6$:#8Z'H7'%
M6F^^?K9^<"5@J\6]\MS'G>[HFRK@9KMXVC&?\([4^8#LNRRT,!CBRBQ/2I,<
M6)/I=H<%T+].<!H7:K<_=OT/!6#*<U_C'HX=&T]$LN%],?GQ61/K19_!]^@-
M\+&?N^.#1K\Y.LW%]4U!F73HEZ+BK..MIZFWSM7&F@P&+M]_)O/RT^F]/S>O
M??I&8_<E3>AKP ' E^J=%$1P'\H(C)O!F;YE+_V3>J75]>("-QB61_9.D(P>
M%V$8I\-)2_T!=AA?$1N<0,/I\'90)$(S;2?-]R;=/G.J*X\Z3*ZPCT:Z3^\Y
M:DQ@SG=[A4=.%L^DU7)#65E7,,I+#/),5DX7-#2JT"6-XW,WC@_.['\S=YV*
M'IW>XCRB)$+5M;?,V&W*P*;A(PDM%Q=&9^;GP?"L-T<XW\0/D_M$7,;./G.]
MS^YDM/;+>2!"%)H=P(OO?NT;YGQO;SC17Q%[R@HM,W.,JNQPHAO^R[6F+YV#
M82'M_W6SGJ*1[S2;&LK R\+W$9;^]8O;O&H:K^2$-W*\"YPP&XOJ@DPT08GI
M-"9%RBQ+25LJ47'X9@J_-RT$*4,\[J6]?%$?>3W5AU^<G%[\@343NOOA;["1
M6L\TT;A\"- 4B0.J2,P"#%A)4[ 7-8U'"3MOT.=,QXEN[#J?<=LKNVH>X/[\
M>?3L)L)35/ )VSGE?F=@W%C0\15Z[FB4GIW]\OS,&MOM-QUI;GI^6<&_8$IJ
M9'9R>0IH&W0":J>F]-,GGU[>:"Y=. ^87 .Q ?;ZRW2#W?&:5?9.=WZOLXQM
M*':W9K__2*!F53I[;R,+6MQ#9Z6XV^*Z:63Y?)V]X7CI%K59;ORJO?35*T[2
M)\RJ57Y OYYJ%+M%8][!KQ^,.J_ZA>2^34?(D#W2?4'7YP@!>?)#M(^<:.XQ
MFG/IM<O=XIJ 7U3[L=D>LIJY8H%N4_)HWM/EEB^10A7GB9):2IFHIS-FM(Y9
M76</OLX6##.]W8"T#LUWT[A8I1+JTS,JS=T]')==\ZZV7EM_F-:7E$QOXC)K
M6R/V5[N'OKUT^'0GV;\AE\9MAJYMOL:+!H]<]8IM<1E>. 8DB$1=4M8E*L$R
M9UD2.7I+3;+41C]'J/1L:I#^\2&)@\;V7+YQT<+ZQV1_*LE!BDFY].^O[OC@
MY?$(!RL-OU5NV2J'FZ,4]]V7UO@;W]'..O$W/GQ5OB]W/G[BNU]WBK\QW?OK
MC^[[C_%P9WN'OC_$S_@?'W?^>LTN^AN_VR]VV4_85WS;K\7?&)_]V[\/=_F[
MSSM?_SA\]_6#>/_;SI=W'_^3=V9S[FGNO1+2$>9*.2GO S&4)1*%5<EJJJAU
M:YM,KW-]N6C+"@61M"_ST"JCY:*1&6U&RX4#+)CC4EEEF5<2@ 9+A6%2^@@A
M4ZOGB4.N:-DFM)P&,0</ %(K8B(# LJ7\E:L5#>WT8"RGBK=H*7DET/N*F)5
M?M=.?F<TXT'8S#QXH#J:*+)B*D2:5:1^GAC?BEAM0JQI@+"@009P$0E=*<A'
M><G&*J&DU?$642I9F]8VY;JM]*Z"9:5W\U37RE)J863@2H"*VBBKG=><*1>Y
M=.Z6>3(K6#XV6$Z#;P4(';GUA.FB#">AB;',D!0\99%J[F1<VU3K@HD6L;LE
ME2E=#4OFWE4N\XL<9#SY$D<+LT,> NCL,S=) _72")]DIBSY(&.RU?JW4H"W
M>R[+H@@TAFR)9S$3@*A0GX5,K,D"":*0MA0*9>L65IH=U@)J[:536FOAF(-H
M0()3V7@K(O[G,VAFZ&W+?E1T>6QTF5K+%)>9"P06"R(0X!2(%]P2QT,.R3*A
M16[0A5Y.XUHEO"T2OC!_0-T(%P"W25H/6F@C369!J R1,>W4K<N 5"&^=R&>
M*6^::*D+HHFBSA((VA++I21!&_ EO2HR!=2)N*H$H<+'O=A;4/M6S@<EP0*U
M8(,TN P][B#9*6;FL+=4^'A@^)B:5"!:0#TB$JZ-)J 2<H 0;*GN9RPU.*U9
M('PL+>UOB^JLKH9!Y2_\Y#Z<P>8"L%4HK+0P_XFY\!V;4 H4.)91IQ96&#"<
M!OPOW+H,:06P>P:PMS,F$F%-I%$SDD,TI/AS$&M51)V&FL"L"MFB$H-;TRKS
MG_8=GST9^%@\7RL/3"((4:8T1"A9N!WX'#PDIH(S<QA(*GP\,'Q,;2 Q:\V5
M840J%PDP@\B1HB1<"&XH2!LI1_@0"]>9KR+<7@9@E':X5\12&1>$E]99<"FE
M8)PT^52$JP6D52(\M8"PD )CJ+V8J!@!GRPQ%A)10AO@/%-O37'ZTY4!5/BX
M#P8 +(>@G<M""@B('L7T(0R+G#H7U#P>)Q4^'A@^IA:0F#QPF1P1SFJ$#VJ)
M,R$0H;ESD3%(EB%\R,OP45U*'D02M\Z2&E8WDOLD00ED\I)!-(&#T-;Q:,"K
M'%U$3*.FFD':AF+=&3,(S0H2Y$0<!42QI(%8HQT!Q1)8Y@U3"O68E;:"U%.@
M!YZ?GVX!'P*,Y#H'*C4':[W!C31H"EQ3:3GG=Z_N6''DWG%D:@]Q27 G;2"!
M4D0/YPUQBG+"8XR"&9.ELVN;YA*,7$H]5*5X!3E C+CK"RN >@5.&,]E$-E[
MHPV3WK)J"&F?[$X-(3(X&I0QN.F7PJW..6(S$H'@4(2-"M)'<Y7L5@I0P6,)
M9I!(38* ^!%<!)&3D]0QPU.6"7S4O)I!V@<>4S,(B]YY'B*)3A4$L;CQ6ZH)
M"]%XID(0C1EDX<":%OB!K%JJL*LE<S95V"(.(DLL=GJK\6U;4.62(M!7K%SI
MPI3Q3BG;:WQ 6[>$V=Q#3!J5J*?$.:/*V3CR2>\R4=IGQX$RGA)N"79=RY4F
ME;?=%A[BU*VB\E)#W5<,E1?FXC(EQ9Q5##5X ,:M93%'B>J@]XG'6*.V5@R5
M9W(<22MPLTU$A%PR&TE.?,R4^! =:OHZF2 :5#:P<!7JBHSM1<;*5^^82RF
M )^-8@&H--Z62C>)(Y>A.3%;<RFM&#).[9\XJSS91$G.^ .2YL1DI0E7+KO(
MO(G<EO0@VJQT,%P%Y?:"<J6K=S,B%$]-1:-.",= C<O"!.X%Y5I2*T/-V;1B
MH#RU*VN6(&1-23062LXF2XQ6E&B0&7PP.3"ZMJG7&5]6SJ;[!<9EU*?8D*M@
M=KZ::KURPS[V=30IJYM&/Y^5L9TM ;NTTA77C=2R"A'4]FO[]][^#Q6OO/?R
M]=VD?]YP@]K&TVICF;[L0K=<.I94Z.4&GY2%_5!:QSKFUZ"N>L6VZ$DK4NCE
M</!L[RB5JN.E:'9A=?^+5.]%0_-^2WV\TGLY&!Z5NN3IU9>CU$<:Z/IQZ[#4
MV?[:%-C>RZ_[8]?_T,6E/JK*TVT2WNYOC7>Z]$NC0&W]S07WJ!53$IQW!+SV
MQ%')B*51NH0@PP&*^G15CK85LFFUSZ]OE3%T42M4FS%T1<J_5 Q]9 S=??D-
M0W$*D^!9D%R\&B$XA$^M(]'4*2:"D5K*@J&*+GQ@6G&L<L$G512FXMACX]B4
M"T*P+%MFB4\6N2"5@;AH%0G*4BZDH$&PM4V^KN5E4WKE@C\HAE8N^.BU8BJ&
M/C*&[DVYH** &Z7C)(?BTPS4$&M!$JHSMU9$$9UH,-2TB0LN\P2A]3;2Y960
M^5$R&*U("9F*@X^*@Z]F[8K*A$1M2(1)Y@D(G8FC3!#I59;1ZE)>IM1^X.HR
M#JX0EUQBSJ4*.BM96::"SB.#SHPA#L "SGDD6:9(0+*2:DTS8G*V7)<LW%(W
MH&/;E&RM"GY;"\Y4V7YLV9X2"J,\,@HGB>1:(J$02"@8DR0YS71(R"K*0270
ME2Y45U&EO71B:75H*JH\,JK,F&LHR\H8!<@3(!/DA99XDRV101F)2*.MLB4]
M^^6 GJ>1G+7UQIH[EZ?Y4=(JM:<\3<6U1\6UU^?,+]8;[@U#;5457.- ?#9
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MK<8A.IP2X<1Z?XTBZRND?4"DQ1.DS;'FQ(E!0:B$.+8$6<$8<LPP*17L5Z2
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MR2.AG$* \@F9'-Z@"4<K@+#9*.XMO'&/JGS;A(U54?/OLDK73O:[SVU9MD3
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M_#YPRF%>!]76F\W3[8\?V-;&N\];A_MBZ_"?SV!?LPWU$G/->$1.2W#2 R4
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M=TYSD6YXTJ@:'(S[V9;7W[0B:<2 F *S8"DGT6F.M;%2">-(%#A]2U^ <@W
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MA7/].QK!P0D"@?T1^2)"C"8^>\G%Q<2!*2F#)3Z./K>#Z9P"1;.#*4'+C0G
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M+OW<=DZ/,X<"NP%,)J,'S/'#\_?/6Z\RYWE<S'S5L=71.6(WMNX 5V'D0=#
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M['WYW&I<[;=W=M^WX7CS/U=O1@0:]<T#90T+V 3DA+>(4\Z049(@'"AQW$,
MP\*+5Q#)S"U56YA1/*HYXG.VN@?6),VR.BMB$();HZ+D46A+DPHIL40EEDS$
MLBH)K$ZMK>Z[6]WER.J,#!S&!B,J"$9<4X$,(Q81'S0F.FHB\.VMX=96MT)6
MQX2-*:1 A07;4\H2++U+Q!*IA74B6QTQ8'5Z;77?V^H:X[F.)QI9=&!U*C+$
MB8:Y+@J'9,06QDFFZ.F+5^;F^N.W10(+ZG6R3+P_ O:]6'N=%XL^#E<?-@N)
M/4MF//HM:/_N07[N@)YBK24AW-N .1?*:$(,]C$X+:D69 WHE^7DMJ< O>>
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MW%'T@YR!]$T+*E_<#][I<I0IRF<,%SL K)]V.SE$.RM*:?,/7N]\WMY"Q-1
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MZO#<!Y2FQ)AT2"5M$,=&(NM\0"PDS"AUBN2=9&1&QV)0Z';5M'=6-]B2Z -
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M"1(D"6VYPD;36ZM%5LPU?XRM3!FQ9.^S8B[Y3]LY7FK3T5]72QY+58^1\WT
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ME^#^7][ \^V#P>X5A9:!\\0-M2@QJQ'WPB,;G$8ZAL@9,9II_^+53<:2)U\
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M6V_@O.USN-[5SI?]UOY)G<'YEWM7'UL-6N=[5[Y8?*.1&)H"&* E G&/P?;
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M=;/'*II';S_1Q_SG9F7^DB[F[D!T?,^?$%[GM8]-?-T8]/-^CU,^'Z+1&%[
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MTE3AV ">,&,Q;EGEB13<)*FT)"NT,AG"V.<[$EQ8R^N!3WR_QPC1I%X%U+)
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MM&[U[#] \3ASSY6N9L3/75Q/\<%=@0<PT=#*<!/IUNLM0NV#P^&6'5Y2=WX
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M@%O&LW6FO"<(>=5'"JY+6K3(KVV$:^%9+GLCVRV^FZSL!,W#T<ZXVN0+K.%
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MTO2VX,1^$X$A)Z;<9-[)="RRV,6CQW'2S62*3+VZ1[QZ1R?N]]?'(R_T"T7
M=R_EJSI_N ^CX:]K[ZA/AYD.WL9H&/,P@'E$5O'K(U;H@W^8\)NM8>V3BMV8
MUAL9,MYNCV;ZEJ<P\GSB!+;H>L!EC5NO0P%RPR+ 7W.-HN"NKLS)LD;Y9^ S
M']WK'S*/7N .OP,Q7D]6KJ)#K>%"42^Q31B'PHH6_C[XB+7S"_385]2Z'KJ[
MABMW-6P'IV5KXI=[W?75!?(_SFWR#![?&%5 >-UM7],U;*\Z[Y%X:3'U+.>3
MDL";W%8<.81]G!&FW=<\]^G?NWMW(Q<.)-,&G:RA=[JMN[.YQ[,(3:96;);K
M2*2H/1WL$;[7^$Q=@#CLX9;G=X/]BI:'DVIWTMI2@-JN;(9*F^8ZXU(:SF4I
MI*YRSNU!:__I6IN^?*K>+RRI"C@%AJE@FM"29HFDLDHJ,*9R#GY%+O0>K>W4
M6=1[,7KR^^O7QT_NA3J[46,\6[VMVV:%W ="]S<?>K@GP=0/F4G_ H4?@D1,
MX!-9;@G+"X>[)$G)129IE66\+*D4--\YN'C*,I-]>=)TZ^Y5 ^; U3?''G]<
MO3@^RQ9Y!@XV192EE!A@#YDG@J=%4E:\RBUL,C/72E$KBE@NI:9,$UI)BSZA
MX:EB957H7.H',P-2YP++J]N-02RN'ECCVA3T[T;)R/$?OG=NX0@2K5=H/IHV
M[S%.]&S9J#",/8!M1&)WR(N@OU81!P#;\4^!T%W@#R=G(Q[$",O=#-0Q=^8U
M"O_+V@$(]Z![9L):@WX>*<2AH@T,Y1\"5(M!))>ZQ8C^?/31OQUB4O_A;P8T
M>(O]EK!^,/F'82AA:MA5C_;B[@%:L#6GH%M1#VYS?7>!-YF[JYRJC_?ZI3>>
M'/JBCWR#]7"V0H0YT<?<7Z/;83<K'=$88ZN2$AZ3';;F31,A;SJ,+N%1]'>'
MQSF+IO5+J=%\B/ATKS^,#OKT=P1D:99OO0$1'W>.Z(%M#Z 7#OO<P8\T6)GM
M03^Z=3>@/PY;L0*#P(=GP\;'_J_061=WH*>'G936@[CT2?H)F9MW$1 ELA+^
M?"[.T "Z0)?$-UBX^^/%H'00:\9%>^$KJV "NH#RE !WKB8JLR!&'_TEQ/[U
M(OE;)4V4+2XF#W:XJQ)U^^=34#WFYHZ-&Q-"(Y=U[UNL/$HK"@LW/%6C(U%C
M;@-\"N\LN/GU(735@D>#=.V,98&.]:P'>+V:84(')8UV%(_?5:IUJ1(W-5MC
M3@DS)>A^7")R>5\;&8 ]G9^O<#;">4C0S'S;YL/K/32SD$UT^"2^Y"$L%4M#
MT(A%*QVXUG.B \NYMM)0HS  2N[?MCCK$1@>RS0-%LPXD'FQGM+_P,2(-^DX
M:XW$'\2D!SGU]1,>T:=>!8,?*$O$R:8]4MWHF1_($=N(,!?B*A:FXBN.7RI(
MBG;2"+IVH/HN(..=*>''40V<"LL3?G]/A9Z'\57N=\_\7GF@MX:@5%'Y  6X
MB'P8VH'$=ZT@=E0G L\!3\?M9P-R*;Y;E"'3]=B^/3\V1#E2$MWIS"Z;RVT4
MST-'UE@@T?30D74/UO(%.[+N>X?5;D?O[QOA.HJFU22A\.W(6T;W7OM'L8\C
M.K"@#X/*G3M)N>G@ZFZ,A[I;K[@PF$/U<W*VQO'I*\R2#L,#AWCD^K1NM3-$
M:W,=@"M ;@\#?="X6P^E?/_]7Z1,?\S3&"$:^3=;_;-35Z?^'E7#[/^YPY!B
M)BD7TI*JY!;G!'#&TH(43&@CT\J&,-)M=7T80DITXU@,+[D61X(M?FF?M* "
MUS\+Y4SW(_&N/M^<_]2T;7/I^@TNX"_KJV]X5O$?ER^?_IXNA*&J*@Q+\ES:
MA"JLZ9.I3:H"SB:#+28R!_W!K@>4SA%VQYLUFY7+YB^-=UTPY.FV?X"UJV_E
MB1^!I("F(H*N#P-BU@7]KZ5QMO#)(!ZFN/'@B**KA\X-$HH+D XFTEUHM$AS
M6N5:5 :,=&8RV 7)C=5%G@/-$K6;1I/R3B3:B[F7@Z4>2/39.[ N@&&_9<J$
M9SXK%I8)D!= BJ ARX02E2:R,B2QN4G+7-*RR,%ERNA^RK0.X+4UV![;K#20
MF!-K0&=!>.&\ FW,N2,PN(4+MC?+I4\-8IV(]QON'0']UB_[Q635S\.B/7+A
M$]&V5_#I8^<U?<,4-2I@?@KO]E0M;,524F4R,9;1A,)_$I::/#%%D5N+B?&R
M\$ &^X@+,VZM]AFYVH]%T>BHZZF/(\72>7;=J3$!ERAVH\[#A#.P/9P8@W_/
M]QD$;N+!#&V-L7C%0ND!OAQC0V@"]#648"><AY3:Q)-#7WV?*X?)/U<^A951
MYZ E=WEQRQKH"Q9P=9]2!WORO2[N-93?N@J!R2R1'CQY%W;RJZ/GL^_PVR&$
M^'3\S<?QFT,\,5:7^2+VSDD8=')W]+T@7,ZLNX!-:JR--M9VT/ *5S#O8Y!(
M%.,H<$@_][-/PN!,S"XW*M!?2%".D*Z=K1C'FHR&K"#>*[ZPN\M@<TZVPU7;
MHF =+VFLC+>7-+J_F\Z)#XAY3:2NR=_QQGB!NPX?-1\_=FM=>.&GK<0_P8WA
MUCOW\\95#E#7/?2OM]O[50RAXX^1%C@198^9CJ3E0DU8^OT6YV(%1Z#K]R=6
M0+J/1EP=SAC#.\'!P(7#?KENH^UO;R-@KP\#![>K6<*8QL'!BCC)& B5#1"$
MC[W?KVW[T'X5A#S&F:F_C ;"?M7YJ>^F@<\](S)]KY^CWD\#.PD#'N^_H@LR
M$ODZC ?<]I9V(PR.DP6>4%WQTF:-VL)#"!JY'B$IS,&8#F[T^!MW"@3PBE56
MI*5@G/(2H8*RPF9""&93:ZJO& C@WYQQC+GS9^F"*&%*EI4)6+]I0G.;)ARA
M1_.,RE2!K5)P 1;QP_2Z22R#2>RW>C"+O+$9LDMCBAJH!G.UB)'OC)(+7R&&
M]:!WB>9?X\ ?1V%WS$B!L1"8\M'_R/9O._*'[LAO#<J2M'SP(1+@Q_#)NKGX
MH?P3! +YH%BJP]@G^</9GUR$ LM]K%QN$8[V5=OXH> .Y_3Q2C]QV;WN^6I\
M3;U2]<72=,>PCI_ 4CW[ZDSW1V2Z%)X#O_^T_"/[[>SHZ3/X_0_RQYN3=__[
MYB3]WS>_TO]]>O8>/$GZXAK3_4K^]_C9Y1$PU__^_=?+HV/X_<V_@&%_/G_Y
M]+=S8-BSE\='^<OCD^S_>_\L?W&Y^/_9>]?FMHUD8?BOH++)4W(]%$/P)M'>
M395B.[L^3QQ[(V>WWD];0W HXA@$&%PD:W_]V]USP0 $))(B18":4^?X1"0Q
MF.GNZ?ME-N=3]V)Z<>[.L"QAS+QSQK&+HS?K#^>SV25S63E=9>Q=S"]F\_D%
MZT^&K#>YO.C/+_B0S?B\=]GW>#E=!8DI![WS=[#;2,,$ZG#^/] QKV81:)BS
MAT/LE1&&1W=RZ.RG:V_!9UD /-Z2X&XD^,__(-KFDS&P^<G0/1_VAT"",W=T
M/KSH\=%T/.OSR;Q,4@\&^0ZJXV!:_CP"V_:.=!ERV^ED">RGEWBQK[-KU93D
MG/IO%/6SU0K49";2!CHZX_<>C2YQ(<! 5+&0UX_I?LCG2V)'1WNKVR5.Q_/Q
M<-X;7$X&0_>2L]YT<C%F?6]VP5R0//"<.)R././LUW, <\!6"7^M_N,-6!JK
M@-V_]D,"%CWT9ET>X8 <S*B6FZ-]BJ]E]'8RZ5Z.!AC 36/XOYEZL8SM=BFV
M^V,ZJ_ANW!V[H]JO>UVW_M$'ENU?=-W1Q2&6'4W&^U]VV.T/^ALM^R,!6  9
MT(B$];?O!M_E(?@9:DBO^ZMOCEM%4F5<"C3N6\68/'8=>[+94CAC\2P/R<K3
MM_U@[W)&<FI'>T^9.9A>^0ZSH\B5E8$)Z#GOT7U\?YKG1;=;/M_C.F_$7SCN
M(W=SRKRO-S'V(SJ7F_<\SN?S-Y(]2X8+(''(H^>HP\GO44RL?_D - ,^7^?=
MT>H@$G@S:%Y=_T$]D\Y[X\-X@2;;N[/$QG(ACR3]5@R%H[S #V$">DL^=^&M
M].E2J@1LO4CW1P"J=,4T"IZ)\^E.#4 KF>+UC*%!%^0(:$3E5"N8"17'S3$D
M00,ZB^2IVY1JEN0;1$I>2\SL!R*%G21PND*-H"^SHZB&[;Y8!)>3O5\B>Z]$
M]A0MS*?08_J$6+ K0@W._^.%[B"R7$V?4!6YQ1P;ETE_;)Z49)QX&<UXD'04
M3.[5CSFC*!96X\9J3B +/%WN0&?\MF+Y@$9TK >4'E&(]-0<N[N!++,DFR,T
MD6F[5(.(8Q]]](F"4<1B63U).1'^$A'F1S-!J;[*S2[^?(JEX!2DI%32?+"5
M*VL1C>&/%C]U4JWHJB?35)>. KY,W%4%],W4[#R8+^./>=0Q9T.E$47JCID7
MKUNA,_U(AF>5FS9WWQ:<2U7NW+UX:-W^1A[:O;MD^QNY9#_@T.@^4/Y'70>@
MD?LN'ZY*/29#%MQCG49D3J8#W47DCL@:*IT__TGGS^\.NM'6SFURV]0ZVY_;
MX?VNZ/Y1!64LO&]"\&[+^.R_L3PGT\7E0 C_S%@,=SFX![QC'PRR::)XZ;B]
M\W\Z9S)!17^2YZ3DR2_'#-S*_34K"BZ'"JE6/G*/=]SHRZ<^C+)8?1IS'&>A
M0ZG8)3=;=<#0\+J5=:'8;0]'RZNYSGAC8!'0MO009BS+;'Z,N22/_D6J(:;2
M]'N#'@HAJL%2Q9'W#DTNUP/B?74SV0PSHK"-#!=3JYGXXWP><U4^I0E:O$11
M<YYSXV.RE)?)GAA+T%-1URBLS.[8O<BQRWOST: 44?HDX]1J1(GDJ^6]Z:)+
M.D^"^73Q<IX%H*%'V&EQ"ZP]!ZO<#)$XU7O-7ZXF;"4X0J-)M]3Y66N!1\WT
M\4,QN-SM-BR9)X</\9^?F50</AN=78X*.9DY5I/U5JE_ K _8YKB!V"LJ#8!
MT"L]>$H77A>%XC'-.1K/7=6E3!DE+U7>3LU[8](!1)"(4R/#A&ZNH-!)TRCT
M6NQ1JB[ ?5M(CH*>-'D)0#] 7IOJW9<[Z=U'4K+S'O_7V1*VU C=^O%R/& 0
M![2Y,#M.I$9*Y80T1#WC+ ]92])1A?)*H<PI;LD96=FO\V)Z61HM>URQ4!3Y
M>3@*X0QL\N25ILA/;S\H<GR3/P^?.@(7B?%IR-/< <=2D=0N ^+R%,:O9SZ6
M.<^J7':USZ(P4L_GCJ64?7-P(%)>I:!_M X%7:D@E641E:>R;^$GE,W9/$RN
MU@7TG5*ZYPT/L;,&Z&_P0T[!?<,[N=*I(!J.?[^Z^JP *88X@QZ)VYAR\\W4
M>IDM<1R5&LZ 0[/]E 8FJR.0A@I*I^B&H5&XT?&3190%^")L-"VF=OLSJB^@
M4=TKV+7L$N"'HO6':-R >S5^C/VP$SDF"Z%'=0FU]_;E%<>[MCB^ 7O97W'\
M<=P;&#19_[>*M!HH)*DZ2(P74.GPROEK!JGR?BZK&(="5_)?!_DG\+?WWY#;
M.J*/2%X#W"S%E*II0//F'B,N+.7[4=53J4T RP>UH2,Z]91; S'J[H^05N)"
M.PJU)41M<EB01.9C6(D4>E0SJ!VE+,U76Q-#2HM98A,=T>L_N%<-*_$65C\&
M!(":AZ(F9:2@WV;&YU04#I21*S=2I9GB/$6N9+8Q0#'O@R22RL&*^*\^@@]"
M,+S! " *5F%(S3,JYRC;4:)19_UQI1G5/$K]36TY5TT_RBTWAUJ;;V5?IT":
M'WUOP0.@W2_H^1..P,;O_),<QW6I6G503^=?WVJ]%?[6:FNQ$%7JZFJ6B5'S
M"A\E&1;[8H-?:H:'/$-W'DDXEER:_NQ[='33\%(Y4???L%'G_[#EZHUSO?)C
M_/&OZ:R;NV'^?5WNMR=S!Q*GB Q:Z7TBM/;"&H7?&9&-*,]D<%09O%"WC5G=
MV.\ND:VWZ+OK>P\9""<'4XB&VD>C+]>O71!>(D<"C(9SZC"5YF0B1!S+80D&
MA$>J"%L!F_U&7<< 2]^[W;ZNC%%-MXKM?U4:B)G8 1\#P&K:2QJ%R+5D;'C*
MD3ZHN1C/S16A->$KHGS$L:M#\L@Z->/4UK'A61HTS;-T)68!_X,'HC#W&H]X
M3(:X/^?2H#V^R[>?_O7AW;D[@2N%%<2^U_@=8^Z+WO5*[IK*)P/!^E0O.Y$X
MD:AZ>9H6@-?S)HBFV*4.T!LM54Z6*M8AWX\'UB)J+N(7GH-%*73C@5MA?R94
M@/06;D&+IO8.><=W<T$Y\H#-P,+T$\7;\]&,#V]-KGF34;A+*%U<%7?/,D\T
MXZ.B5]4U4O=L7T:W1DJ(:M=C=.P3,;D%MFIWEM@4TCPG6!4@04!+H?!$(JMV
M);3/\M0U9':S+)85QO@KE; R-V$$.K#:":CIHL-C1(U3S0P7 $0E' K=K<KL
M577FSP\F 1LE>NBHD"J<)Z_T4@6,RXD5LK&"%T<:]]CF72?1K=.= 8F 3;%O
MS0+=^ZIA(UA>PGWSJH+*&$Y30O<6QTX ")&\46R4I:A6BU7NHO@K[5+4<HO>
M\XB^ZQ7WJ.8_".X-'^82FX2;459L+IFO+>&-_<E2HR=(I]#,D;Q4<F:9V3L#
M9*<O(8QM=168/.5LE3//==..N@XD-+!@A8-L:3CL+;FYU""%M>I28#Y?N6"X
M8O2K[K>6)U !+81X(2K:6M:<N/GL^4IFE2;8IC=<<T8"4=(H%:"6*D:2$T6>
M+II?$H-?D9=7Z%B59(Y.S\A!0:@A/\7Q"[?HTC:F<2@FPXWN-074P!%J>HZN
M]\F]0?Z@NJFJ,4TB44%4^:]Q.AJ%N,[G1)U8W7W'#$A&XXOS' 4JQE]*+RWQ
MV"7*=;R'*A68T,'A-]&]ZGI(+E&S>P&=)Z#[@[H#.:VC-,)T23+GESAF3X!]
M)6HYY"P2E@'W$E7[HI>P?H_: EC^<J]S42$O7--5O$UB2K@+2B>99=I-4"U3
ML=L62JYE(1-1]EGQ;WWJH7T5)-$:I7FX?Z_D?4JYMPCA[MR @+E/\C9'@F?E
M01,T4$SQ5%J[@MY6,;_%UNPX?"1+5@*P!K7#N] A$?O(U%+=M5N/"\T;Q1"&
M-5"1Y7QD8#)(QH.@,EZ+78*6Q3?1!-%(D)5:1!3.\W#!Z!XD;([-S7)J@)=<
M@3T2T$LD,07U>Z*4:SW>R(#98R_J/BK]A+PKWT7Y;IP9F<39*I>R2$B 7BS-
MO&5^H-KFE#HHF8I%L0%@!:]I/E,NMUC'HE0UZER@7B98DW*T)CW+NJ$Q7R 7
MTAKB*G^W4[Z[.?70^(&B]E'!L2MEI<F03=Q*42FU "GTH[AX&GF%!7_U$W4N
MV:_D$1[[( 7F@WAS?CYW< @ILMZ(AC)(J'?R/44Q[3$7E*JSFHF/1Q0;#!E.
MN8(%GS6?'$';JIKOCCE$_DPVDUWOI:.*K$,GSPSXA*GW5,%RHRHW/GE>ME+,
MY5IP$V,Z])4T:P3_R0/:U_^XTAXM8B"RC;P8"0?RC,<T+$BS930X1%&JC!G3
M+P/R72,KE!(P)G_0C$:^22=,R1#+6\*GV$J>IAE3#%I;['@LO$.K@'F<PKF^
ML2H%;D4.?EC6']&)! \"C(K,+BW+ITKS),ZM$/59@<%WR,N32&Y*4?@<N+>\
MH-#08E)R%9OBX0 ,\](VGW[+"J6^^NL:"="<B*)3LJ?2 K0>B,,$00F0G%@Z
M^HA54@=J!!QU6\9$@#A0(]LP.0(Y"5+@#=>VGJ'[_GOA![Q<)U6]!3C*2N>/
M)"ER*J';"#<[JBGG^C@!7@HI-N1"A:D;*[F@6H+# R@[.^4Q,45FRFDXB6HU
MI]1KV'.N4:-YO\R"3*I?F!_+P^*H;.2SN@D>[">4C)HR.V+4!\7VMU/3JLV"
MARPVNI9UAHDQ&$VW6REH&XQVO0#(/VJ_BWD6Q"+4[\Z5LE)PLI"!!18DI[:>
MKTADR/U64X5F.WK"Q*%\$-7:&V5R^TLUCY-_2Z58D+ZK J<QO-X/>')>Z9'A
MP('RJ1$UYS=K'>&6W9^S]'R!9K^>>Z_D\2I*F"@'1/>'BCM(H:P<W&)?PG#*
M0B$:B*HI0:GH>,F!30'52HC7[%IQ:8.1: YCGDCYL4I=*$MS,);^-]VH%+C
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MK9E))3'G)(K^UFTXR8(% 0^)5VRGU;P\!^G .D@;L!?K(#WBF.*WID%8W1%
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MHGW$M6@?\2EO'_'Z2#*,@.74-;5PX&/NS#+NK&(?2 1>C20H?QCS519["Y8
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M+:KLKT65_:>\RO[UD408 <NIJ_UWX&/NS#+NK&(?* 1>C10H?QCS519["Y8
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M82/P+!A3"F7L%M1$%1 CFKMC,2>%#]Y:@DD=#;X2XXO7W*O3S ]F@IQ@"S,
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M77OO+E^1)]3HM,TB#&<[U+]M"Y$3S97>_/Q-R1BK(8CNL+?G'N,5=\+6O->
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MHK\@"O1?L$FLVSO_?_IR$=L'&8(5$]SCRREP@X';$?T;34Y,'^CG%4]^@XO
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M$/0:K#,HVAW2U2$W@\)<.QXQ08&!1G.C?3;(H3MB4"3S9-H*IF8 >T+MC"*
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MR].U*05'N@_%>034Q-4825 W@N"E=QNMAJ6[K7)K4ZZV@.[0 O=PP+VTP+7
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MQ#?J"-]/\ADQ9[WNZ(=7%60>1'=P64+CE<JKF2RCKYSZ"ZWB:)9YV(I/"7_
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MZ4<S\A/.AB !'K@3]7JM\^GMA\[3:*ICFJN2^U7)E#7^7XU;5EI*,5(<SZB
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M"E?.<31MK-ONZ13D**[@X:3[45 DB&XBJ](]$V(?U;%SG1SL8>P7'V-[&=(
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M5!M(H=M9S.[@]V9V<PC_RX5W)5Z?QG G=RWXLFBEOXQNQ3M-C=.4Y=J($EO
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M8B [CDP\<L[V0,>GRIQ5H]9;@M9<58_Q*4!Y\5FEF[,,,^;W"LI?H1O<]>_
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M>X$"5MBPFB)DBT1%O%LJKL&>GC37(Z]Z(HO09@4ZZF(7CO.XTRR6J+I_52K
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M+:$B!>:9L#N418!]%[CJ[.ZI BVTGS&NZ7!#2(3/9QL'. D6@@6,[#L*5Y%
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MY84DFZ)E"N'W^&8DHXT1J1]8MPMOB9%$1/J7P!LZ[-U2X-/K1J&C[732#7
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M:>ZLYYT- YSXG0T#G/B=#0.<^)WUA5[_8F*OAB)*O#@BY%P#GQ4O3>Q(3*W
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MWJB_7$W=:.G9#V]<GR9!#UVMGKES<47:-GPYE2GM#LL5F2PNORPOM^E2+FN
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MZ&;[:%<QKI%^.C"Z17V2-6H K5'3?532UJ.S:WCK.'FY@="J+R^?]7;P43>
M0R?-2:7619U*)HY:(C?611WV4:EUL6V?C:/FY<:ZJ"\OU\^ZJ"]VW!<3!2L4
M4>+%D35#&+)"\"R\:V)'8HH8:%,[MJU9&"RL#U\^6!_\67!#*&.V%8>P3 B@
M!4.[<QUAQ7,[MI((!F];D;U8>@1<%L4!?!*1Q^ #_Q$.PL6%WT0LAX-!Z*E8
MNH[Z(0Z%/XW:+.>LKW,W2C\0,K*:[:709[,@F+:L:9C<(M!;%%D+$3IS>*L+
M3T4MA(N[$[XK?$? #:[GQG;X  \@+E?(@Z,Q.%XRP0],!?P5WB,( 2Z+NE8
MJJ?&60S/!V.?BAFLRM2:/! ![0A1UUH,!(>O*H1_JSU&'N*<B._$ U4'P+.L
M7X1C ]O"BPQ>"\42O@^/1.4@<H'O/> (OHD'Q3K >;[P</C(ST'B314]84TB
M%\03C,H&"@H'&!28U8Z24!!6'8S'=N($B&%^4#'8AQCG!2STU[]<]KH75S#2
M&/C'#H$;85O$M#\"')X;3%&&P=!",8,YS&$LD=ZY:H*10G-T:)!P7XQXAF&1
MJ*"-?2]P]J&X<X,DHI=[@H0$+4%*N>HC"B)SVA8("">)(M@@2'F)G\G"AS;F
M#(@:A'+R[@(X3*-LXN4RIH"M+41UTFH80E%N]QN8A+#.K5^2".Z)$'GHS@T#
M']GO0.>S'F<B38*[;1CGF77KSH1> YK%V[C?:5F(?6)=!\!1* ONW7C^&.!6
MYME.Y??7U\<@8+4( R$;A#%,=1K ]T&&K0#:3H43LICIM(<_HJ('=>##&UT$
M  4Q-'G(;D4O(-U]EMXQ380"I@6C\A[(7:9T7K,E@)H"!"M(B-D,A)Y/PA)6
M*W9)J@:S603FRP1%_S2)XO!!O1>?9CW@HM$!XN/!6@!GXX10*_Y[#D.WI_^!
MAV!":("5WKUF)(\B[.Y$7I@.< K>A6B^3.[JB_(UH3^@7BQND:AZF5*0Y)))
M]W^T8 $8HBURO\-RT'84Z[:RYLF)Y@/0B,5F7>7I^:5@*TD3:RW+M23R-%J(
MU=)]&L'FD H.C%(RGS8714>@#-=A'#ZJ#3=^^%358;]]^3+JL%1%;:036X5*
MC$^^E*$OS>R::<?>6NTHEW^ FW,91"Z>PM_ ><G&LVR*X_WCJ\Q3DE$[Z2/V
M)(*!Q.6/K "N'8C%1Y=96IA_SD,UFB5(X?,)4/3;N3V#P;ZQO7O[(7KU4W;;
MPIXU"9B?>^D,9[-GFR%["H$= G:IO$E (H5X%XS)KLQ8+!":L[^_^HO;&P_%
M<#2;=$>S\6!JB[& K3#J=YWA:#H8C9S_O0"Q1+#UL/>OX8.XJ?[VD_WS(94D
MB_75/XM8J^9BWA#0]W9D87STQVJ5XV1M)_^@W@$';G']1+OS4,1[PIZNN#,G
M(=*0;(@,C8')$6[H1U R-XUE6Q_+]J"'RC_:-^TL:^@#)7,56BC5XHC#E<_Q
M1D59UF]W?E0;*YZ[X=3Z,P$S480MM*#4T1NYH]ONH.-48;(N"9,U$G\F\ -;
ME;B;5QX:KSP4<7P*ORC0KIS1N:#Z?/:6(C,9W'?I4?BG\-SOUMP&PS,,P ;&
M !).CWARZH)][4Z26+JN&QXT>1 #/.C"Z78[+?B4##]6@AE**;F2DT-3^1RZ
M#FJ=MPY%\:HP@[6D_^/FYNNU);X+)XDEOZ9]FY9R,C9/!O1%B/^DTS]N<]RQ
MC_9<DE/LX[&* _KG6(SPIC]2V0YP^@3)\.:\>WDP,OSU+^/1H'=UN$V0I4UW
MT!Z,D!COX)#,P=1/<.)&>=,;*7G#2Y?Z1<G" C%#RX9Q3@PA5DO.6*EQ^MP2
M<.TXJF>U9V#'#B*#R0Z/T&GR0Z?=N42%C1%W,+^9T6PO"A[CMHH1]9])].WA
M\$25-.WV#)I^0*_9E#Q&:B>GCBM*CJ@N60^,@U% V0M-V48;O8@V^I\$SH:]
M\5:JJ&)<?'B)^PNZPE/?!?/R8+23Y*T6;2TE(@ZMY2M&EHKXYJ2JIT#1'--&
M/<Z,FS7;M(!:N0W:&:8;M,Y:O$K&4;<]&C8J_&55^$<[=.96KU'A>U?AW:-0
MX0>7#ZV*<5LECCW5\UPT-DT-Y5;>IKELM.^!W+DR(:[&"OB@9[QB!3QL%/!Q
M*IM*^!4,55.]+5D1=5P]UJF T@V6"=:OLLPI5\&%T8%ULJOR!D_#E-5ERAP;
M-J&4%P^E> \6>F!J;@96T ^3FH&R'KN)9#?.F*/6)Q51M(TSYD55\+!1P4]2
MP>_%)$SL\,'J7M9>#1_T9/S_GG_]\C;/S\/=PB%5)&X%;9R1Y5!QI20Q>R5J
M1=G&MJFH;5,MJC3),W446MO8-N[T[Z\>KX+M]L>O"BPBI>,)$Y" ]HPZ:RQ/
M=V</T@#Z^6^3\*>?=_[^8%CT_;4(#Z-UP]G?FG1S:U)<HO)OK.N[X4+)+0S,
M%QC_H["W-/Y/P$$VP=I]8:BSW5 W1A6J&GKO^B!$7+#>Y)1(O-PH9(-_$;)!
M!:?Y:&UU6DM$$)Q6E"P0T>*_B)"HEU$BUJFB76&@/% QH4*7^'3]P>*9(8PB
MVT)W[I2@*T/A!$!!S[55A9U^!SX6!]G7$% %C.\>]X(L&GZTDDEBM5P5 3C(
MZ?']$M+40;C*923>J+]<3=UHZ=D/;UR?R$4/7:TN7P[1E+['EU-@A7:'P15D
M?QGY97FY39=R *U\K=]I]_N]TLM@499>6_?:<;MW67YUW5O77QN/QLU8]S[6
M;GO0N:S)6.M$U^<;ZV"CMS[2<>I1N.N^ ;:=16W.(#.CWEC3:XJ%8J6@\LMM
MAGV0K3O,DVT5S;I^-'LO=>0:C$NL?M\$N'T3HIPH===AIJV0=T-&K5;_M^+Y
MG[D^(GM[6%B^ BF_*P_58^DQX?[9=\VQ4J[34&X7REW/;3\%'=IESB=*N&:S
M-INU IMUZUZRLH_M<32+_5W$5BCNA)^(E>ZP^Z% 80.>RAE-/SS3Y*O2=:BD
M$]UX4*-&=-MNO)?H_KV]4C_.756\P,>^JTJZU_<')\G9SB:]W9[.Y=5;\&Z_
M?5FQ%3\$&7;K--@(TL8\*9EU]^*B,4\:\Z0Q3_:KK887)\G9IVN>]-I56_'#
MFR=;NWUDS]TZ.7?>?:>NFK']?=6YL]%N*)ASY7B^) C6'6S=3ODEI5CNDT]I
MDUWIU2GI=GTDJU.5=]2=2TKV\/ HF*3NBU.RA8]C<79]QVE'C;[(B)'EBYC;
MJ9<;&L=YH&S<-(:_^[+3N&D:-TWCIMEO%*G7.4G.KO/;CW-7-KK.#$GT&EW7
MZ+I&U^TY)-$[2<Y^QK?+ ZIZK23WF&[8\@#\3/-JWMZ\O7G[,;]]5R=9O5QA
M1C'\V6]!M%ISM<UTJV:E[,GVKZ0M4E)<T:V?@7\ 8V=78[W*S+XGD[R2S%X2
MQ>D/+IXDKP[,;7O2*M5;&,(A^?'_/"6C]AAWZ.FIH[/>%JD2U=N@=6:VTU,'
MW7'M[8^CU0AGI!)>YW3"GM(8>>=U"K9>!NMXO JA=5":?%@L/8$(8XQ-ALAE
M" 061-3@XSP4GHU',R>(XE-+@!S6*4Y1X02ANG-'\?KTQ\/C6:*JO*/NK%(B
M2.KD#ZDPE]:=.THLQN-9H"85=!<&>&N OS:IG\<;N"^>]46_1LKA.'(&CG-3
M-=DP9C[U23+V1I;2,=;G#GOM;<VHXZ_/;>1H8YP\-9+?H(<TQDECG.QWUJ=>
ME7)JQDE_V*[:BA_>.&F2JYNW-V]OWGY*R=74NNO@&=:R2]FS&/:C]G"# 5VI
M]((WE%[@WHDK7++S?KN@P=C$C@2^X-7/S]._<MB^?-J8NVL'?=9]76-*<[>Y
M72RX2MMI)2 ,[1I">5?:$"RF\Y.\5/LX752:-TM2URY[[=%+9[$>_I309#2N
MI];E1;MC+9?-AMH^*;P[:'>.:T,UTG:/<*_;)O?5@4$:B;L'1=P#R_MU7N;N
MFD.^KI'I,V0W'>P ^K:@37:-CT4U/8#N<)K;'Y]63O27H!,-VS5,^]^/'*F6
MMMJG.;,?,CTE,?D8=U")\=1M;]N\Z8BY>)\VUS-S\4'LE>JM3;]]N>N1NA$S
M+ZJHZY2<=,0BKE'45=]!I3WWML4,/&(N;A1UW11UKSTL],/\%-L33ZCC+ORA
M!L:.!T64/GQ$_B(IL>]Y;'*R[U4OM#S>8,RO?K9T4@%B!M@%#A[+#H4% W<2
MQA"P(RLL>Z8%EZ*E<'#VWD/+@E5SIW!I\J![:Z_KE+#7^5^J^=,+W[@Q$-[9
M@"+MK)_%8#QYVP"7<W6Q[]UI/)<\;3XE^;23/F)/8*\F<?DC*ZWC7WYK$BE&
MXYS/R?ASKI/^EO:M.)^$POYV;L]@L&]L[]Y^B%[]E-VUL$%- N;G7CK#V>S9
M9LB"<2J<("3<C#<@@47(V_)O=F7&8LU#,?O[J[^XO?%0#$>S27<T&P^FMA@+
MVW%&_:XS'$T'HY'SOQ>O?OZ*4A,WV#5\$)@'-I?]\X$L[%YJ8:_^6<1:I5)^
MF)7RP_U+^70V6\J+W^$7ZR/<-H^L=SY*NQNQC,5B(D*>:+_3LGJ=7A=69+$$
M83JU[MUX;FWZ7*=4'AV.1.L) @)>2?N6=3]WG;GE^HZ73$5&ZEL3U_-@VG%@
M.:!!@H4(X7ZX$T1)!+__,.I8,#P/ 6W.L+/TCZ]!HR0"'YC#]P1(H+F[1-0;
MZPX$ZD+ TXME&-S!PPOW.VDG>>,R=!VPB,IE^PHM#T2\3(Z?08O^Z-(@!DC-
M_R.) 3.#L<- D"S(+O 4T#X.PH<4]F<.LX,Q3MT(*(WO<WWK]R 6UM@ZDTM#
MO[E9&"&""R(R\AMXK>!'E"^1[8D(!K'C4K0LV NQ:WLP\F VBX!IP$HH!"V2
MHP]1-LJ!QG-@@[D;3JT_$W@-O!9&1)M,/04CQ9MN8M&V/@(+"N UZVL(2V,[
M^/KJLT(FVF:P0F^8<@)63/Y8Q E'NT'>!R$MK(_B<\'B4ZP3NZTL#_SU+Y>]
M[L658<3>XYMRA#+H/00*(T6'K<%@!)\.DHAV!%R,MB!75=775S N=M)?&S]X
MN@JL9RJP7ONB<*<^MB.MRF_)C,X""U9-?]#/J*QVB=):+_,WD^;%VB1+22*N
M2>WJ"[LR%7"1$A;+TM9I@/I.7DGZF 3-\XGZE&-[[1&)^F[KLO\$42_I]?/?
M)N%//Z\^YD[__NKQHUQW</EJ6Y$YROKZD'?<V</>EZ_[6.2 E\_U;=^!+6E]
M$7>NN-]""[S '!Z-?M <KNUH;GV&/2.]6#_](8WG3TN!QW385V_1V07"R^CW
M6=4-]6L2XHAQ3\W<$*QXTX:2]G.+_',.SGN9SML*]'QM/5_KWHZL'X:MBT%/
MBR,G8R+ Q<O!0%^</O[]3ML"P\*-]*:DCY1:MR*.^;S"XLV'SY-N!FWP@#]'
MQ7K!"^[AZ525Z]O5\9)O8/E0?4'YUHM#U[;F]M2RK?L@_(94=NPEVH! R!DH
M "!07&K7(>U^%8YYJ=M2J\$OUZ(4!FO?,LDGPG/!2HI@0>'E>A 1+; -MI$;
MTV+-$GA_R; B9I3-^ W'.0G",  Q?HN?"8/D%DPS/*,ZCH@BLL2 ^USF!_4M
M6*=O GG!SAV!<:#/[!K;TAK_54QX[+^Y?R8N3.3AD*X[V&!D7>%2!_=5V@A;
MBNL//O#ID8OK1,[5U7/-B^IR.=WM7#R#E&8IJG:A^+X$X\V-DW 78^JEB7]=
M,&IK!A8I2\Q0T!5'GDTF0HD3.)+<DOO]A^XP/?W!+7 8U/\&200VZ33AS34+
M@P4]NX1#IPLVI_$2XR%^R=!\"4;?5D>"\A;^0:]-Y2CQR R6I%+$WW(?2YOR
M)/;Q3,\UOX\O6B/#&YS;ROW61;>_TV:&,S>R7>%6IA<$GD>J]\V&),?0O$Q%
M.,>"AC=]?4!1./K=RX,MRU__,AX->E>'TZ]9VG0'[<$(B0&'5;9&20# Z9[<
M3+B8\&]I947"=T$6)3XHZ 37W@]B&):+W.#[4FD3/^#"D<B:HF41X_$9?>4S
M$;(]!0^+Q5(W#9!B:.$F"[X^$^7O+7CE5$1.Z$YPUZ+)(,URCC5T\S&_AG'V
MRCA@/SM"3"-6' ;?: 7C1E$",H54BQ? "V(1+M8P$TJ'9LU>;K-WVT.]:*@!
M$L][?-/#V2MRYF!-H"MZ88.E@N<N>/RC_4!;OUG!9U[!) 35&0G:>*"-0;O"
MR +GF]Q"S0(\ZP)(7Q"GFOD@_I:V.]6D1PW4D/\YM8[D?F1^.@")A>WZ:'3"
M,[ ,H&+@.(KK\4_AN=^WV L'(G2!P[ Q>%_,;AD:*G WNX7.3W!D206S-G3%
M.F-G=\MY&R$S;%AD#V929X]FTO_8?F*'#WP4;G)_%2M<Y-(VFMS?)O=W!WFR
MG]S? _DARZ,QAQSREB&EFP#4(''%>V"KYZFUV#2>=*Z$M L"V9H'WI1<T^C!
M]!\PV!B19SQ*O+B5B^NA.B[R9N/$*(X(;T.;[=X'^1XEDPC6RP[19PJ*/7(Q
MD16/9_A<*!SAWBD7.;F\4NV2GB-D$TT8[R3!71FU4A=9>K^V<$D9P=_E;,!0
M 4IA+!-'9PX(YOG!MU#/<>:2)(D<5<1C3(>![XVCC"7]]I</-)1[4((X/2 )
MQZVG@14%&.9$*PG_BW?"8*/T?97P_F_)PM<<T_U":U\-#M8!<4J')KX FY1X
MS'#<H_<S&YT.%@M@$<R*6=K S2HV#?]]H"@2\ Z%<H!O[.42R$,B70:UF?DC
M<MBK>XFK,Y>18Y!)5:*V$3(GO4(7)4G?WH:"H_EGZ/87,';ENWV-FW0U8[Q;
M8"0=*.VA-*.AQ?//4@47(TAB+PB^42 OMXYH?4^ \CZN%%!_8?\';LJ\PP)C
M!Q86PS"P%1\]%,HDUJLBBXYJ&U,KD0HY@6Z>O8S$&_67*\R,].R'-ZY/LZ>'
MKE;/$[G20OH>7TXMK7:'K2V);B6_+"^WZ5*N;)BO#3OM8>>R]'*GW2V]MNZU
M8-D/!_V=7KO^VK!?_M'3&>QHH]<^ G>V10%S10N.BR$-;N9!&+,+ 0V\#4K#
MCY42OVE?RHD3XA/KA:>! 3[6[:.SOC*_<FU]/@;!]$'K1TZA"L((E&YXYSJB
M!3\Y;>L,[^AUKC)WTV_=JQ5@UI>@8_6XBXV3S^>]9R?'4_ [CXW>;_L-N5^0
MW#=DG>X%3K5.0A*F[4_M<&K]U5XLKZS/01!JD9E60$B1&5F__7:M)>8-/?+Y
M2;+R<8I5E5_>[B@.GZ&)>2VH]LLOOS3T.HA4R@ILA<6$&,-U;57_WHV=N7*G
MD1FW!U6Y V&JRC7O]V&I/4://1@/1T'R705;0^W]B\4-,=<J#&<@_=J_P87H
MN6N[U@[DW'I/T25W09$9_&_++)*+4B^4=M!;/N7!P.T+(6(.:^7JYD+Q9^*&
M@JL5T:5]*WP14KI2@BF(^,Q*D&$9!K>AO= OCN=!)/ACE0@'K27D!]]ZF]PF
M46Q)W[XD(KG2*3 !TX)AP:X3?J02V6V@T)0"&PBQ $3YH6]DC:SDB S/'X0=
M(NI#X-T1O649828^0B\54PXO2"L^'TA1YGS;LK" ?9:$,:<G4B"% GZ1$.6Q
ME*J1_ZW_L,I0F)#%02JY&+G2S#5Q)BQ8NDWLT(;EXU=\_FC]<?/V$7I5JTSS
M)EDJH"3/^@?/!@:?'O@^^+,@7% RQT'#E6D51I48;DMJIV3]2-%2ZYU_YX:!
M3_QT6!DOV5^70@.KHW"WIR"F;2"XIQ)'6"CI./!,3RD4$25H9,4^\)/KN$O"
M/@DF8#80*\D@IG\;H(B:))%+T4K6&K( $?A.P(:A^.(LP;I%7<2-=5\NN7"-
M\"B,DPJU91K%Q/:_66@%+3EZ'6'ZG&7?X[:%6S"Q81E@;A&.W0_\<Q 'R.J&
MS)1UW"&/R([Y=75DO%*XF0-SW2??^N3$P01HW%41[S]NOJ:)+2:&@\ZMM9?P
MK^\N2"4!UL(/W79O-=,60=UT1@V6"BHFJ^/RF4&M0R6+[(*ZT,KG)L0!0R9,
M8BX [5VVNWKM\#T_],9IWG06A+>*$&6/V7NJ<LG(C5)%'93L6Y[$3= 3MV!L
MW*+T78:NCU+4 \L-SG6K158@G%0J<!WI]%Y,0I6[G!)+&F>;%/AM0"XS(?_,
ML'O1GH@,8Q<SDE#L:(FC90K=22DSG)M_YK[6L""43)=/TY?UJ)C8!"=G&\:Y
MDLP-=QHY> HEC(I5\1I5[4="0GYD:U(YB^_,A5%@&E! YJ8\18&E&RXQ"9=&
MM0QVPGTZ>'UY#A)3,P82'K,3/8'$*BAK@%71BX&T(16BUD!JA3VQU:#5,> H
M](IPE08BBW-./WXQ2.((HRPXR7Y[,.[\*%D*J]1A@CW\))#]T7VOSW_Y3-/9
M]IB2:=(F8Y(N0\S/^@[DB:@2$,ZC=@AJ%DZE,.[$C>8ZP13IC@,:#<8IED,&
M97!:4(--3_3Z&9+AF.]!>(ES6$!S(R0^3#R,@8GD.N-Q"BDALUKQ)UU4PRBO
M5#0\4J^O/M<;"ZA*S[+<S_R=VFR1L6C3Q!&<FNG#,C$[ZYJ0&&%+E!R)F0^(
MTO1Y,3VW[T!6W(KT"<FH^,5\<F_A@[ 42Y4NC"F])' (X0/U?+K#>.DT/!UL
MST$;N'\-E!,)W0$BEL)-)9A.E5_:C!] @/#Q:$-EZ=*2FT6)/IU^JU5.JPRD
M0&V=5-=4SR>SI:G[#^51X=E](MK=N/!M.P1S*HYQW@<^*A=F$_=:I@LIIVLR
M:?P(;Y;X9$&  J,)I:G/P02?2U&]0"C#"3M$UU42<G&J.LFT4O=3I-"OF8G<
M<'J.U9\/QAVO^> N%1.=JN'4BSGW80"2$IY+"P ,/65N44OM3G1QK?J$,Y-,
MR]AL+PK8E+,\<F:GDT5_YVSF>B[)>CR+QP5E!1FP,_8#N<]^<'U&/]I!V3>+
M8]*2/DOR]4ASVV J+@M$E@KR)SG3E\-.TKR%0_**+"I:U=:F;E7R>;.*-U^7
M/E(6%6#;'?8(V!$+W&9W@GP^L-]2B"G\P829PKL0Q2IR;WUWYCHP<UV/X.<G
MK9U@I3Y>"PVWD 9<]BR+:'BN6AQLK=:('911%6*?/0GNJ@%=N25!/RLHSC^(
M<V]BM(UN4J!/S?*LZ=[_^M;Z(FZQ-]&A941.Q2DT-^\ABX+4RTB/3!1KW61U
M37J$-T6JY"A$AZ[4''CU#]_%+7K#-Y'[U<&S%!WGI'95:*=YC<'#:ED?W>D4
M5*P\9/QQ<_/UFH0 :*K_ 'OA_I=&-D<=0XD2M< #,X5T<"2X,O:JD?[^YO/7
MZ[>KP*(9-:B/53_ @2_KZ>JW1R8@E@(*SS>FV.Y,UY1]Z[+O;E/V78&Q-&7?
M!SQ_:O<\.^.S+>U(")FQ$_E#?RNIM#FFO3&0$I"2352DEM+E)IC&[R%)11:J
MX8'%4L2$_+CXV1(=E.O6\#LH%.X.2,.BN"!]*C5*N^/Q)9Q/(W38%,V@BL'_
M?PK; QI<HTJ\QM7] COX3L!A\S<0]FS=6^<T^[?I['^5!#QH0"HU0BIA&JX=
M["_D\T* TR0,Z8BCV9H=6;)VVHKFN!+DKHO^__:^_#EQ)$WT7U'T]FQ41<@4
MMZ&\TR]<5V_-U-7EJIFW/[T04@+J$A*MPQ3[U[_OR)120F# 8(2MC=EN-XA4
M9G[W'5-X$P=3^@D8.J[OP/T#9+)1#_@B<KA)_Y#V&VD^:>W,R[43K-5F"B\G
M\+2;O$8/.Q$I:5N_=K7("_(9Z3Q,%1L0'I*/8.Y2E-IQZASB)X^LH1A+&K//
MJL8QEE] TO=H E8?-;Z5P@W# 1EGV73AZZ:9(7V ?)W2A1J+(/'T_+J12%O+
MY=KATM,R J;VLO8-"+U56&<OT=^@/-GPGQP>H->JW[@^$8;#P0S-VB#F+)/4
M<H,-LLO).4MW1TW-$-#X.QXM$K<41QL#C@5R&I+TKZD)9%D3#Y[7@,^,I?FF
M^P"YK\4$5\993+P9$H+RMDS:"]Q:8!,>C!3#(! "DB6XBR04H3:](.,8$F*<
M(Y-&$U-D2NTXLJ2YS[9$.=D(!!<G9TK^E]24PW'1U:P$(8418KY_;TG^P2A*
MV/4<J6?)=2_7E)MBRZD:!+FCD,Q$X<57R07?"#*'&*F4F7_B_(Q_HS8C%3PB
M5HE\E@-X#+P4_NFX-A(T"R'L,.-C)HU _(,?L.,9:6Y)!/5GXDR8=*AO/(*:
M'N90-#RP-J*8.@4<X-8T](E_:8P"WY$Y(+C>K]U>,6Q(/KN1$$@T'EXV4 ?%
M_A;R>"#+R'-' 5V2;VYDZ(,? 1^Q"TG:.01;T2'R8^\<S'27!.91P#":"A%7
M BGO&HLRI0$A7J:6N9'.O!)?PEOEYV6 #Y*8ALD$N2DSV'\P6\PF 4&7;V$P
M$+:)(6>Y@@"J9G<HQR:52UOY!,Q<$Z-0$3N^0[)(J8(KMPQF>*5]2PAH/-P&
M!W,#^P"&!:NGL?_T$Y1.A'RS(!24/T-C-FTO* 9BM-DN[.N-LBWFQ@E0,#4.
M)H)L"$*R@KZD=;PI#F'!) /.$ 10C'$*#+XP2Y14:9#E:8Y50KORIF%OX2 2
MG]ZHIDL5VO2:'))\]]PMQ@9DABFG]OS:-2\'E[GT!/BH/]3F510-Z72B'2W9
M:/T-'QE[^ CR3:/0V9>T]O*!3F.QH&&G%D[IR,7A\@Y(^436&E3/89<M@[6X
M#%L66B-1%3*I/#RSHHFL']*K .N4X1;>N*$@]2R7T+7ZM<SN0EZB/Z.2OLB:
MHLD3EM%M7/XM V=>?R5^HX&0!IDT&X 9<P4T+>Z9:Z"-G#2)BL-18IZ-TFP,
M^MD24IU+C44R #D!)O=RETI!^LW<+U5^-(H"^/^HD.D4D,0 O"6S*5L05#]
M-NH.!8H>:OSQ:J+MH/DW%<^VU#A'QT5GL&.\_7*##AG6]O1EE?TX(^4BDUB4
MT0#,.Q2QYK,AL)P%4JJTY2)66@G(ZI# 9>53-$$26;YR4!6DC/CI\J2C=83*
M4BLW# &1KZ,GRV;\1 [.D?&+U1SJ-*-Q_5#I%)64 .6>;Y1R)TT!. YG>/$.
MX6TJ3\>0*3IMB<M@;>#A%-\R]%;SRI9SHW0E1\R)@U-N$8O;N6?9K,ZY6OT
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M:MVD2;)_RV=\26[>S'YBC<"*3^+U/WGX)+%R.7#9+:0M:?^<IL7Y<VLB+D;
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M 4@8$QD)8PSV*:XK35KTR]*IV'G,V\$+HHU*A[5 8]!/>8>I:Q$8D4C HN7
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M.P583UPL(!2SN1<LA8B*MS PFY>=\G,.AIW2$ZXOWWQT--(^,8U@]Z IUEX
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M0:B0@YT89%.V8,T3F$R34Q\Y/QZ<*4"%=W-&]IYZ#OQP0USLKRT038B)1>/
M[JGN)P6!X.0M3K^3=L!*>M!)NV#Q/NS$))N^4SSQ N;\@K5T$; Z1ND]S)",
M+[TW[,YAWO ]Q7@V9W;MB!4G8IO"[\S2U77\?F@/Q )U:/?4K$7KYT6/N())
M^I1=3^5A.=ZM#N^7E7?,2GK&@;*^[02MI"+.,?5>^!FIJMGF5)$:';'0'-F]
M4D1!KH5RRM6-=T*1S00LG@B]/044(]_[ [M?D1>D%U+7%@0%W&+F']N]4BRA
MAOE JP/$K)R:Q<DM+KKN6)Y-UL5XC!UV ^T61[D+Y1MV)Z#P@Z'CQ#/6;R 8
M33%=NC^\(<'86 _$XG-B]TI!B!KQ27O$MA;H4]'1F/3*(H%5Z)?%.[9RMSH5
MM*V4LU,< +KH'G9HU2L$10BAFVG0[96CRBFXQ>&W=**U;EB5X83NI %,>\E:
M6YKT;70C%6>1E>)T8Q_?\:(.)&"*Y(YIM'LP/HCK.6GC,Q*"D@-&:%ZQV0@I
MH8(<L&B,A,<9:>LN*261$&>?F)[,Z"^@6 ^88Y[U84NWW"+C&EZC$V$0<W1@
M]TO!M16.;GF 9+GHRAQ3?F],C3$UL.+=R^Z5$V)*95@L0&9Q;%O/"IU=38A!
MO+\=#,I&A8 MV[C;5<\NNW[IH, ]]_P83.&LT7WZLY:F6XN"6!,>VOU22%G(
M7TZ5NXY2NGGS^ZS5=JK,\BFL26TL*1:Q&CWJE3/*JDYA&=+]!.N.38L)UE&L
MBKC$*O9X4-[Y%%BVC:I6-M]G4Q1,,$N]0<YT88>3\::]-?^"?HC5]HG=+T6M
ME60F[1E/%8*^Y8<5?HMGY[II+'HC[*2Y=DEA\<T*5"UVH9C87;M?BELKB4F)
MWG8R_0%/F'=SA%F->9@@-6:6H(1;MMWKE=-_4Q36 L<63[K.AEP#*]R 88V4
M;:82 [9QNUV=S?3S.8I0YO#2TG(:^,1Z#7A62KJHX%CV%2-@911VFHQ-SBT)
M[A'\Y7ASQ#[?H" >(R>"N:1#]__B)*QS%>&9WD:V 3IBUMMVO^1PKV#]+<ND
M*1*VBI2MG+3%:>^$@J_'=(F0\2-Y1HY#X)C_#0.+IRQM#E.8H(";#]?0@PGO
M_/H2LBY1L;@<V/V2_ZI*4V3^>[""TVYP'T?2D21_+^E*:C_EG=D)4&&U-W+D
M2[&(67QH]TOGYRJ-L-T._7/\'*FQ@[<4FZQ'O?+E) :V9?.I8YD6VHNMT>-!
M^3C @+?1 &7C;J93*B'%>N3$[I>. <G$[U1'](@#%].[\9A78]=D1!6PD!<'
M7;M?MP@X+BM!MIW\2/(&'M&;>CF2'$"HV ]ZO:H;A@S:XN#;.<OQG%6.URL
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M9:EOVS*/W:)3JU)4(+_LV%G]L5 A,>O=3N3":UX_] GD 25_KAG*$>,3B\'
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M'('VW$09%>GLW,YGN3_SD3 _]=V8/94=WN#9,Z;%X2?=3$8OA_O X;EDAKQ
M.K9J3W\:8^EWNR=+OF+Q>)OA:O\<'&YP#JIQF9^#]$K,7?&^C>HB5P!MQ3IF
M-91R&_;]-F:3?[>4I0@_A\3WV&4NMW; VG@V/OKT&S"^)YC*]9>HU =]]J*$
M]CT*V-LZ#D^=E6BV-3":E_4[(,:[G0@L8^<I'A.*TY3R,T+G!%K@B[<Y#D)^
MHAK.6+F"/WB_F*3#=LPW\K!62C9,16?:DM^>D_=FONPY%+N>JO&0?#,C >S7
M]%TZEV=D!FT?(EA_W4^LZCK(!7_#1"Q 4C#S4K*RR@MNTM3AJ*H?JB W;?+I
M*83"[/<_P:8$IP8<GL>XW^T?*?.M%K)UK/L-4]=SHO!I/L6^LEI?A3++LNH#
M1K+U;.[ HH#O8Z8AY 3EL[":4CCZ=$[B"2PPL=C*X<P+[0AX0$'@<!*#":]A
MC<7SY(6"6C:*@3[([LB I$-Z>C@_QP&9>0&S@W)=<=@3LTL.9YY=-Q@Q7PPO
MDA;,X^AWS.(7V!V"O0\'?K:I,[8\8CH3#[8!(O.C3]1'KC@6;Z8E;R5*U(X
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M+&9O2$G,SV:XS'.Z7#T49H_$NN;G"I3Y<676X>/4HRZO%2;-9!>!F/4T5EQ
M[A\?K%MGJQZ%>?95=?=DI;L#_1'7HC _XIHZ8(V*A[5X5,E.EZH+%K[F 0O)
M,V&Z6%HP[A<T)U3U5EA=:_/C6-G)^8;&G[@.]4R "D"S*G4UMRUQ2#\259:I
MPYMG8ME9U"AD<].VD(W,Y7>\2?]A#3+SLZ#LYVZG5YM[M9BF8!U.BVH- W?Y
M^WMF.,]9%N_(FTQEK%P/I_DY*:=TKMR$YME#?M)D(9(:Q7S4T+7UQ*UZ 2W)
MJES_(EN&Q^@EMHO'ARIWT*7/9'<816E"I61AZ"$QOQ*26T2/KY+7X$K-S/>\
M6KI&V(WYCG(5< '+:I W*\XCQ?:AA<R5\H6KGH#MKEU]JQZ%><;#@IKR8$0,
M*^F>^![H5^EC=F*@5KQ2US3L NW#C>2/5&%M9?;XLL"RZS:'_65Y/9 \ *^#
MP;S$K^1/:"5;M&<4J]>BU*Y#*=^R4D5G\EI5N?@9.[7K%DPKPIAGJ^ANZ^4&
M[L>6<!B.:0P=)Y[%W!E1DS  =AZ_3L(Z^4CN$97>QE@/IWD9.&47:\+I&?&!
M1QYZ0.$/%#E3_"I+>U, -#^ZZ@CZ"(>.%X" YB'TO$VCF+P2QG:&YPN2>A4D
M(IS?MY+Y^11 S0M!.1" 9>\A"D',CZBFUMW0=7D&,?*3O*^+-W9JQ>Y&"NEI
M(C>LZL%<)C/,AG))R2R1S8*XU@Y>"M=2QX_R\Q_GT-,7Q#Q[FWM2I JG<?YG
M=PZJ7L"4ZC4EX-;I 9;E">8RXF^>-R\*(473RI-E.9^[P?M2+7M!:H4QZ8W^
M[-$4/<N\!MCP.F77#Y7*5%0T-,\?85QLC9!:>T;(4[?2M[VS%[VE=J$$J"6C
M>D3\'GUVW4J^+<B@S(]+%J?M;[#\4S4N\W-0?0J_FLV11X6A0#E@.^_BR1C5
MW2#3JW&U@.FE.WC)BURZ-_>6H<R/JU#\IO>IV^WFC];*,OQ4(,V/3R9O!YO,
M4JE!9GX6KA7R-JY;EH=1*F=YSN&4JU]FS<V/I-*#/<(A\5\:)/-7P+:KG&VI
M"+GPX2,UX);5+/\=LRP.RE[@^0;;+ZA S7V@'H%Y<95HN7YW@RJS#IGY65CU
M-K-KK22&$2#7\]_/<80IBQ!#'_,[H-K/6JZ/WGR2275=+5GY93&0>?:K7 :$
MYI[LCH ^'O-C5_;6L91&)]MR91*_)E;S@IX6F\D\T*Q&NGN:Y-;?T6OHLO^5
M*;= 02LV0M4ZP4A'D=@DQ22+2T+O*2QL#_GW,9T3%M[2,G.:8#9K(BR=AHZ6
M3D,'&N>H&DCSK"^_)",956U[\V.IB3_>H" >PT!B"MNL;O!R!;AE]NHIIOK7
MHI>!S+.MHD[O"'1">E\=4QXVU*GR6P7]H=L,I[')7,]0L8#=1BJ(*=-JIQ>S
M(I-9._6Y/8MA10TMDM$?"6/"W?@!^>J'[CKHEJ8B,-]YP.S&$7J] =XP:R"\
M!\)1]ND61V2<EIP1I6)HXFEG6+KN7M65[EVM.MC627OIN:<T/:CQ<U$+>,.>
MM J5<[)R:WYPK*VUZE&8YVS-IH)4-S!E^'^;3<E>?=Q>Z[J"!(5YAE_-YLD7
MG H9GQ%*<>+J!0LM#CP'*?B/=+&8'W=EJ26>M\NN(#C\^OHI3ET@+#60)P/P
M0BAZY9M4<;9S00C]Q=Q5R'-$V5O@[(E7F[F0U_! 2S"V0&RT'YW.1>$N4/;&
MZ>/]U^V4O^S#M(3.%,_0KS_]/U!+ P04    "  ]45Q3'VB$Y48C  #Z9P$
M$P   &UO+3(P,C$P.3,P7V-A;"YX;6SE?6MSFS>2[O?Y%3[9K]LQ[I?4S&PY
M=C+KJB1VV9XS^XV%2\/BAB)U2,J)]]>?!BG)DDQ)% F0K[Q5B2Q1%-\'Z ?H
M"[H;?_V//T\GSS[A?#&>3?_V'?^>??<,IVF6Q]./?_ONGQ]^!O?=?_S]+W_Y
MZ_\!^*\?W_WR[-4LG9_B=/GLY1S#$O.S/\;+DV?_RKCX_5F9STZ?_6LV_WW\
M*0#\??5'+V=GG^?CCR?+9X()?ONW\Q^$2L9XS\!B#J!R+N"3#> *5U(:8;/
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MN<;\"L_FF,:K*:+O)[B:_VE^<3J;+\?_LWK]SB&,;!1>*<O %ZU ,>LA9A5
M"X>(GENN2Q=BM1K!-A047R@(3Y.#1Y%W,[:^7\[2[R>S"0EC4:$L/X]8#L4Q
M(R 516O%T(*)3%L(V97LD:9#ZBZ\^QK+OJ-[.3L]G4U7G_M_P^0<1T5&SF4*
M8$7RH%Q&<$X)X"%I$0WC.=LN8[N-9$C;\YX<N+T@]IKT=MMPSN,Z]C!Y&\;Y
M]?1E.!LOP^0:N)'P45GA(JUZI4'9HL&A\, R%U$5;;/I0X:'L3URZWQ*]&@L
MF&:$>8?+,)YB_BG,I^0,+F[LZV6<QLM1*:)8YVG$KN[0,45P.FA@*7%F'>-&
MI2Z$>1C;-H213Y,PC073P]![LSS!.3&8U/\)^63C3_AZ2HX:_D)6*-D7;\J'
M\.>(1Y,"#P9$0 E*<P_>%/K"&&J.DGD5>]MSVP#=ADKJ:5*II\B:\>K#',/B
M?/[YF@85*IOBN*JV8" <9!5&'SE@]+;($IPT?4RRK[%LPPY]**.^,3WVG/EF
M#/AE'.)X0EH2%Z/B,20I- 0;:#Q%2?".G!1,I!:=2@6]["+Z:R :CN?E^7Q>
MG9W@,>KL:64QQ&H3.HB!.<@E)TN+RR@G>@_K LN03/%=)7^;R7O.>#LFSZ8?
M/^#\]!7&Y6^S:;K PC#X8,G5Y9S6DBH^T;X:"A@A2U1>Q(B=I+\1SY"L[68,
MV'_FF[& S#2DQ^>UAB7%>FV0J_"+Y"9*=."R9* 2"O#(+! Z\AASR,'WL8P>
M #8DH[H5+UK*HB5!JH7_(T[IF^7;:H_-IC5"=AW<-1+3!!2K2,>K: @C)[1$
M7$"="HO)!_JI%U\>@7-(AG1#^O225#,VK4S[M[/%<H[+\1QK</46[#OQBE@/
M5V, YHNIUB,YDMPC%&E#L)XG:WD79NV.^9$&^9-@V8$DV)9QF_%$)K/"X$"A
M+:"RIA4@F(&2M:57LN,R]&/4SHPQ3Y$Q^TN@77!HL<#EE>U=I,M)D%(5QE8O
MDFGPJ11@D0D5;4PV8Q<2W("Q[YA>3S_1I\SFGZN=P%%DZV@,CA4:DDT*G-4:
MHE*E1".X-'UT\'440W+==I?X;2[O/,^-V?NFO!HOSF:+,/G'?'9^1A;CY+SF
M2=&K:39=CJ?GF-^<X7PU.Y<#YXBZA")!<_(M5'2>]E^1(485BBZ,DQ_:D>J[
M8!Z2^]>.10>283/.O0R+DQ?37/^IH;Q/84)0%B^6+\-\_ID0K^-Q-GC!HW5@
M,_.@6(@0,LL@@B?4R")G?;)MMH(W)(>Q'9/:2Z:MX75SI$YH&4.T((6O!J#F
MX%PNM&%&].BM\)GU,[CN4;C'=0#;T6'/.6]X8)N0R!@GJ\#%)1298\HA"S!2
MD,G'%(+/VH-1-DO%18BY3PKB1CA#<L[:,6#_F6]&@ANV$LJBA"711)4XV4I>
M0D0>:!_22<NL5?1]EO[=-NGV(SJ=??F8=^&/7\,2Y^,P6:P2Q2Y_HL^?E7>X
MP/DG<IBB0?*8K(3$ZGA=(AG2+$-*0BC!?.9,W9^I_/B'#LGDWEGXEX3N/.=[
MLYSPK7;;C2!OXG(Z"(;<0-)15%>7S+4B$83T4B7&K2CA02YL^; A&<PM.-!C
MCMOO<+64Y'7-'TUXD:)P!4R4Q)F(&IA29'O%(,'K',"3;$UP9)"%/IEL6X ;
MDDV\-UEZ":4]6WX>3\>+$\S_F,WR+6 *G8N1S+/B>2'53YB<D@P$US;0K C9
M*<B]!;@AF<SMV=)(*(WC/".ON)%<,U)B1M.SG8' 9003F'4IBZ*RZQBS:1MK
M55)PG@L#5LBZ5;::H=)XD-D9PY1')?HX (]V_0X;F7R4E#<'DW:9XF9<O;>
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M03F)M 7&4@]W4,D87.R42K G\$%%+([ T.;"/00C=UI6MAAK0F)@2TSUO#%
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M@JS7F'K5L-_1 O3QX]E\W\%BI'5DB!ZA&E1$\")I;/2=D9&S()3TH<_)Q!V
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M-O/:KL5+!85;*45&X>XFYUKHS@,(G[C^],5-@ZS/^@@%ZJB99!9$8+0I1N'
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M5;7QDPIU,K0Y0K#,@Q0L%&D<;:_Z9&1LA77J$61[;CHD\ZQ2A6_;=PP T[6
MZAZ<(^L)'4[70T<XV-8]9HY[H+A*/"%#X%D64 D=1(F9_%SSZ!DWAO618YR
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M\OY>DOW+BW!Y>5[.TTW^:_73S%30K/8&$K577*'7<P4+R!Q1)NV9D7W:!N\
M=NKA0DM>'KO-WJU*!\!;Q=$# '8-&W9"/$[HT)38X4YS "L=0HC=0*/4A>=,
MDZD/",H6#SX'"5F83+"5%J;/=="1W&9'*'%<KQE#1F]O^2M>Y#)?T!_QC_G5
MAJK#FZ75*NNLE0C2VP"*YE[P*3H(I:"-1AM30G\?&@YX^OBF,?7;'*L3;QU"
MHM>S-/^,/\[8PT68)?SP";&FUKS(>4E*N*CO<#&_O%[@Y2_?[KWKY8YJQ9L=
M@)$FI*B!:UF6V3@0DDQ@N=<\"@J"99_:]VG>[]0#M"?H)8^_A;T[Z:[]A'<!
M_B-\7BDN#X$]7?0W'/AQ8L*GZ$O;YO+.CM [A!@!/]-R0QM[#DDMQ;U= 6^2
M!RRQI"SK1>L$(<2Q_7='<'K"[CN&_\:"7%?X^SFM91<7^.<BS"Y#JMA6JE+&
M!>62A>2C!)5+!L(CP4M79,J1>?_@5&;=_>F6$8X<BO9B:-[>O/T#T#?S.QL]
MYWQRJFH,:]2@6&3@JNI<C,8)+ZQDG;)>MH#ZR4*]O?EX["JVDZNL"LX&@.L:
MA6V%]R1BK?W)'.8D!S#1(0S:#C)IXQG7 H3!VCDV([BB:\V(2E)$QR3V"7:.
MX";C0IJ)O&0, 6VCC8$Z7:O4%E>,2%Z T9H1NE#%=+(%RQS*(G3D3.\,/T8-
M.7T\TI"I^01FGD([]!7&J\/U0M<^Y6"-T-W8'NB">E1,R)2<8TH));VCSY;Y
ME!A'RTT\6_O$ W>A],C7LQJJ+%WJN^I,MKJ4Q!0PH6K&;D[@T2=(Q9=4C)0Y
M],G'V@#HX$3M3_/%U9^X^/S+?+&8_XO\G69-8:/*,5 DC8G>440(C*)K9G@Q
MS&3+L8^LU1HP1]C=-&#^4:[V@5;ND4UP[S5_"PE??)Y?SZ[./%/.(,V2M5 0
ME+,.7'("T"CCG7")IS[;EDV(3L,%FMB[QW';/5S51\^\T$PQ5<#&)$#1_T#D
MEM:VB#DSHX/04WA Q7**W(^V<<.4XZK5>0_,KW6IK7'V$I7STA9E(CD?)U2L
MJJLE[6F*8LB%,EGGN#-:W#+ \Z:SH?$ZU-S=A_9+N#R__/!E@2&_G?T]4  6
M*7JD")F?&<Y#+E$ HTTLU/HC<!(YQ:J)L4RA,=.=\C4&(GS>7M*5CX8IY8^\
M^>7\*\Y"_?^KKDN8?_WE]9^O7ES-7\^N<(&7Y/%?R.,K\//Y[T3+Y^O/9QJY
M8X8VV4[4ENF!=MJ!<0Y:UT F4BQ3=I]P-X'RO!WG*(0T3#A<@W\8[K,8)3E#
MH=C757F#4!+0"U@P$F.Q)HC\,.0<X$'#QCXYE^E@\@[)"N\6\X28+W\C\[R^
MO+RNMY!O2WV7,R>K3HGD8%"7FR;-/E)XI!5&S2E:,JK/[G,SIN?M)(UMWN%J
MY,U\]K&&4$LL*(O/GCDP7-;]$.V,O(P(HA2EJ[ B#WV2K>ZB. W&][;K8X[=
MX=*#7\*W9>7[V_(WFH;2]0+S$A@/OC#:Z((.\K;ENROTFB&&$B)#"JK[Z(=L
MA'0:[+>Q^&-7\&UW*JOEJ0;#RS/\_ X7B?XB?,2SG)+4-8"QF?A3"2,$O3S&
M#\BM2Z8X/<%>91O&TW"63IRL.;!J?'+Y'C-^_E(-_FYQGO .SNB1H_0(P6@'
MRE,L[+$VDQ"<HQ>U'JQ/>>- @*?H.&W86.,U#22N?\R&]]9%+7RB^-=!-H)1
M[$-+8O!" RN!=N&&"2O[3#&;$)V&7S2Q]QI'.%AMX2]DD<LW\\M+O'P[^_7?
M]8KW^OSR4X5Z&PUK:82K-12)B9I3%FHT3.&2C9%;933'DKIXQ$YHI^$:;1E8
MXR,'GZ7N1/@+EOD"5WJ-]7<%%[?AU6IO5?,#SIA5TM8ETH5DJN"WA5@+AXO@
M25LN!+-]=C/-7N$G\;DNC*[QS8,E0 9 3&2HI+.$R'FNZ=<>HI?T-7&OHRJ6
M)=/G".5G\:;&'*QQDX/+OE<A_+OPK5XUO+PFE+.:Y/_'?)9N_G"&UJ2H(R=D
M82D_5XM2D8,)2&NS287K/@O= '"GX2BM65CC*8<7CMV_G5[F8 =/0]-:"[(4
MVN-9<N'H%+FP0EWEM8KH%!2O 3-5U[$);OY'V_:I-!3;N,O#Q?D\+W-M%47U
MT5(T7ZJ,I1(H**XW%IR6(G%460@Q[7;[.[9C53T<S/[0O?9^+'3/)GJ(\#8C
M=PC&OA6G U >27*D,<.C'.@ >H[E2@6SS2$AD1PIRJJW5\Z&#(ZFY>!M*!BG
M2,>=TH5VR8\\ 0\:P\KDGO-VAJO:P>0,#YI"].)KXDTH$)FW5=[+)(W>.)PB
MR-D(\-@A< MV1[G/?M1T2(Z^FZ!U(]2-29<J-<ML$:"B<%"[S((/3"I#?\,[
M224^1'(JH<Q!%NZ@P7L7STI*?P"BKF'*8TS'"4H.XVH+\0<8NL.RL0:9,5['
M7%/GDF*@5&*UDS@'+U*0,01:2?N<WDY%_8Y@HC?S8^S;@?$W\UF>SY9G-#',
M_OFV%%Q@KOC>O/[E[?O;M4B'Y .7"5@T"$KJ"#$(!5B\2]:J$D*?,&$0O.F#
MA$-Y?)RDU)B$#@'!2X)T7JMVSB_.K[[=U!9K&7(4!;@5% 99:\!KCR!LB580
MG-0IO> QEE,)"@ZT<H>BBON(5@H! S!U#0S6H3I.:' H8UL=X !S=U@LUF(K
MMFAE"R&R6/LYHZ4="VVE8]9:%AU9$N69N\".$&$*#QACY0[,O\>O\XNOM67K
M/7"KE<D8HYGA@"+35M55!2*5+)B2:I(]SXSU<8&ML*8/"PYG[E$&42NS=P@(
M:DK3U6U*4VT&>2-[QFGIB])"-M:#*N3S+CL+/@63%5."\SZ9S.O0G$I0<+"E
M.[1A>8AII: X %77P& ]KN.$!H?SML,1#C!ZG[WD.G3*Z&!8*("Q;IC1T5Z9
M:08B*Y<29N2Q3RK.E*ZP(T28RA/&V+J'!YS/\&VY6:QN%RDF$^<N&T@\5/TI
M>ET7;:[')89)GHSNU+WK,9;I X(6+#TD_C 3=X@#/N#L?+[X8WZ%*RDH9P)*
MQQVD4O4\HBVTS,E,$V82C->*.M\G#^(1E).@_# #=[]=7,YER=O(F(P@#&<T
MESD#0=H ,CN%*N:2)>M"^6,LIQ+U'6CE'GUT[B&Z(VL[!->$Z2S'5D@_E+FM
MCG"@V;M/!W?PA2P]PY@HP F$SR0#3G@%*=!>. 7'(INB_.S(@N-3><,8:[?5
MX]QP3/'J&E]<?[R^O"*6U"I6X2IGDQ+$6OZFE$$(,7M 7G3V/M)L^> Z<8W.
MQ?#QCIT_LB\]\]ZV;1@'$LB_?7CU"F?SS^>S6BA[-U*)S-(*2""$<I$PD;L[
M9S)HVNA(Y[AB93??&Q___.EM8[FVG_,:3.1N@DGQ'1JQ$ZO$/+-(T(0'CRF#
M(T=S*;ID'^I3#"/UWB@GR>W^=FRK@+<)FN*WT&H:6[*)?"Y8>F6F6-5'L&"S
M#TJ'DO@ &;Q=HYPNQ7O9L>'E[19H>@7-613H)(.D2ZJJT'7A$ J\2I()89VV
M.\21!XQRNA3O9<>VXG6;H)D5-&NBI9C 0E+&D/<A33!>QZJNZC,OA:8BMC?%
MYN0IWLN.;>7DUD"3RK-;58DE2K%:3NI10_$L@T_)@G+.T7)B(]@252S,)35
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M$N5M6^5F>KNGZ"N=:&B8([ !X8N4%M?A@E;EK^<UJ>Q,66US58F@2:LV?\,
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M"5"[8AEAE&*/&6#3<"?&>A.KMDW-?CPQ+>>B\UM@A1LFC<^0N!6@E"X0>.%
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M  9-1&NO_SX0-]3[(T*6K),.PCB&&FEG"T&1Y]&!%:>TS2"-[)2M.34:FU[
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M.-'7?]VSMX?Q:&^:QN!Y=!V,]\>KE\L/'R\OX"IAE?V[:T+WCW7A&5XOP$B
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M(S P7+$4O98<DBOF<%O'D)6?BY&,1KUM"] A<=TV<7,$+I+*3*PIO"M)<P1
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MEW-)BZJLYX)**@AB"N $^1!1C""AC$/B^3A)$A;':6!WZ=A>")M9,\T59*T
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MA@21( @X#:VNHISL:6Y4M!$4O-$9^43QD[YH4E]VL".DT]B:,9 3Q,8^NMB
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M]CI421EUJ(L.?5=32__]?UM&L?49(3->&AOWD?E*RUT!7/UPH,%-XZT&MDJ
MG[9J_ S^VFKB\&)T")!N@]+Z"#)M)-H J$["SX:TU3-UCLA%09:JUUO^G.4Z
MJ0599]]%XXBV8 D+?.G'$ <ZZ7#L)S!5W @CS(2?<.H%F/<("^[HUFA23A_V
MVTBM=GG%RTH)+("HY;4\A^X"W8SM7& X49J>!C?-;6]EW?K5.DS>8X:*VX0^
M'7U.F^3'#("3Q#^&KUG[>QP3UWW^5:S7RRJC[@-YU?&T"\D2'[,0P331F1!3
M#T$LDQ3Z6,HP1DD<<6+HV6'0W=Q,K>T^I=P)"M@3*1Y-:<40Y,NLXAZZD4GE
MG"UTGX.]R*"1V2F(QBX4CL&<R%GBVY, N:B^O_Q1 +XI]+9Y_22: !>0O4'X
MI5;D%R<N$A:(M3I#F+0QE=N#A3X'#@XV;_4S^=X)NCY7C"!!& 6"!5!2G^M=
M< 1)XL4PX0*G#,6,1E9>"BW]S(U]M9AVYEL;@&9FFP-81F96+>'X114Z<'!J
MH+7U-:EAUJ'PL4'6]7B_R?]%G]ULV+HB]@<U[$W2,^%+CF*L2\KXR@(+$@9)
MB@1$D1]+*1,?8:LCL)9^YC;YWX@)M)P]\\FUX6K&"0[0&ID3^@!E30D=,#BE
MA+:^)J6$#H6/*:'K\=X7;)MG'9HB^+>"Y&4=I'++_VM3.U<V86!I1!%*(L4+
ME"&U1Q,>5#\$,!4LH8*)-$16#&'6[=P(H[ZET $I>YG!7NCZ@+SVGK.+NK,<
M#>.+.L<8CW]EMQ48?%@5(GO,P0[RO=PG&=L>B+X[<AC;UP]!UW=\)EU/?=MG
M <>9>S^;MX?7A/TDI&PF#$J0+R*B+)I0%WZEJ82$)1@B+XAPFG*,DK1OX==]
M-W.CJ[-%++6X#@J''H#;>;3D"+*1V6<BM/K74NV'VC4+IIJA-Z@6ZBDHY@5/
M#]Z]6E734_DOE2X]\W1/E\XL%Y_E72%XMC4J8N1%/*:I=J0*U-9/AC"EE$$:
M29Q&//*PD%8^G"==S(T?M815!O]*QIXFVQDDS<RS8?B,3(:VT-B[7;9J[];/
M\K2;:1TK6]4\\:1L?W*X*72W6KWLJGG'7NJ)4!E#4>2IV4YY"(FOC*'$3V5
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M;QR<KK(CB#GI\CP>S,?K^H@]]3,(CE+?5K>%9/E0K+YG.HOYP@\3R4BL5O<
M(8@H8I#JU5UB+ 5'1")N%#9MV-_<]A$[P4 AZ@/A]0HL]R&@A6 K\SSCIJ";
MD;1#*$=FW..$UZ"15>=E:*1UQYF&L#@EP*X^)V4S0P".J<GTM;Z9KYG>TF2R
M*0KX>;.N/%R[3M^KVG.*@73.0Q]2)!*((A$K$N(2AHS&(<(A#<QR-[@09FX,
M=:P+6&W6C0>XR256GSJ!@\;2C-NF&J&1B6_<P>F11GLXJH[3:0\0:.*TVL.A
M.TVO[:#-?G2L:)T)P4N=R$ G_]2;U<]2E[)9^)[O"18KGDU"#%&**$Q](F"(
M R(I#5,>^W9.%^V=S<^_8BMKG;(C:Z35<Y8K>>UX\@+(9BSH!KB1.>XM8O<'
MB+V[A)@U>76#X92:+G0W*?%TJWU,*P9O]$A4TN2V?)>5+ZN2+.]6Y;HD><U1
MVSPE(F">Q E,0GU<&(0QQ'Z$H)1I)&F *).!<9Z2[O[F9HGM9 9;H4$E=>77
M6*_R/3)K&.#>Z8_@&LV1&>5J0%ID*'$+Z&0)2H8#:Y>?Q!RF"^E)#!J9+CN)
MN49ODI-8O&9'SN7ZI5C<?5NDW(L)CCA,J9#*;.,))$&BEK783R(_)C(4G@GY
M-NW-C5SO5GDNV#IC&]L RRU EUFRA]ICW\A__O3I_=VW^[L_OPV?C$?JG;&4
M2L%^>5Q]_X=^LK:2]$_5;*QFXK:%26;:D;C;F73\ZYZ1SR^B(.NJC-'6OW/+
M_Q0E4BC;A=.00^3I.12S 'HXPBSQ&,'(J/!P9T]SFUT[0=_Z-O<-96X%V&S;
MXP2VD6=G;\3L8Y&[T' ;<=S:V[1QQ5U*GT0/=[[0CRRV"_9OQ6KS<O?FN*8Z
MSL0XY2P6"":^]K#S.(:IP-K#C@8\2ED0J<8L**.CO[D1Q\Z.K.0%;P7N=;C<
M!;@9A3B$<60B&82@-9D8XN*44KKZG)18# $XIA?3URQM]V*]T*[ 1?F4O51?
MMQ?06(J8P="+!40QCR%&80)CYG/)0Z2K?1E9\<<MSXTX=L)9D<0I8!U6_1 8
MQK8@3!$P-_+;M+TTG=5+!U-9_>MX&I^V.LT6H$V9W6:@]0&[2<A%MGC7G+\\
M;-T#WY&U6(3"]QC'#++$#_1D%) D2,*01&F4A-(+B9'W?&L/<YN46R%!+25X
MKS,6*CG-)F<[D)<GJ1-XQEZE;9$QGK2=VE_8JZMWZ[FK?MCOU-M;G&3B=BJT
MG<#=#_:\V]1WI6I=;D[7SJ84JBJ49'2C%_!R0042/$ $$N9)B'" U417/R6A
M4 LR3[">Z+EXU)>R9F:\M0Q&WWI:?^N'DHQXKU>K %YTBBUV**OE+:CU<)B9
M^.- /-&=*7FMV$2N"K#%>7\&WY+LS.%5:E_HW-ZP6DLQ[<5K7Y!.[F-[-^3$
MI5?M5K+GLBYJP>LPQ(6BN1!A7T*.? \B3A%,D9] &2B;)V$B#KA1@C/S+N=F
MZE0NJ6PO\@U@E=!-&21^ _)*[D&.O>>@-R,WMX".S&;'[KTWH):W*9##MP'+
MH_GX7H!G3#??<]U>T]/W @P=SKZ7WK2OTG:N[4^K]9THUIG,=C.!>S'E*$(P
ME*QR%Q&ZCGD"HRBD6#+)D]C47<2PR[F14#--\M4:L*VD=L1C ?=EXAD'Q&L1
MCY(:W.T1[:"?WA^P<04T]\A.5>W,#<)69<WLP&HO86;8SF3ERNST.BQ-9OGF
M@(3@+?F/?A5JIR*._94/$K5A&L5)D," 1]IGF.F<X#R%@H44D50$+*:+]6I-
MEF;VY !9K#A^)]&(Q[QGDK0)4N1J,$OP4YVN[6= *Z5T.-E;K=1J4&<7XT**
M0L>A9O5U\YK\;9OF;<@ FUFM$PW;V ?SW2G?FN$ZT6:<9' .8'6?E;RG/--G
M)Q\&W-DLY0.;[,?/7]5:7QT9-+E!JIP@M0^"'THJ/0)C1B*(4((A\4,/!C1(
M21S&41);%9%I[6F&]G.=M*;)5=/#W: =53/*<X+5R(1F!Y,U/75"X)1\VGN;
ME%HZE3XFCNX7[*\MWRN;</WZ13QFY;H@^?J3^@@64FV?TR BD&*AMM7,2R!A
MDL)0)"GW*?.8;Q0LV];!W$B@EA'LA01:2O,KR[,@=M]8#H5FY#EOB8K5=>4E
MU7O=5IYM<+++RDOJ'-Y57GRNWYI^GZL9(LIU;4/H0M-YJ5.#+-0D#0+DQ5!(
MQB"2G$,:\0#RF"'!4H]J/Z#F'O";^<K>UE^/V\=ODT14U>)6=V-UMFL=A0E$
M+7BU.;);[EL!EUA$:>H'D 0!@8AZ$F+J>]"/.$DBYD51ZMO84(.0GC1H;3*(
MS0PJ%\"-S*T[S+:[PD;*.A>X.\.J"PJG=E5K9Y.:55TJ'UM5G<_W"::Z7:1"
M,$YTC3L2*!LJ\C"DJ0@@)6D2)5X0>(*;!U/=SFW2WY%EIK:J>49ZQ5+=&L52
M66D]]@[H]N/]A\]?/MW?N@JENKTP"<U"J6ZG#*6Z/9Y Q[_N:[\T<8W_7!7_
MNL^KR/,F6_X7H?.4B7(1J3V'B+D'HP I4R; &)(0Z\@J% 522NJ'1M=\%GW.
M;;YI24&6@Y=:5MOUM!MCTZ75*7*CK[*-M#=@BU\C\>Z4=2NURR77&"+'JV]W
MOQ,OQ,9 G*[)YJ_V6)[O;Q="8)I*B6 8J2T2$AQ!XOLI) EC 8GB.*)&[DM-
M>W.CB_O5CUX+\[W1PFRG[]B3_/,_72W)]X.7Y/LIE^3[\TOR?=\E^7FU>"#%
M.F/92Q4'^57G#JWJ_;W3YQ7:MU!PM<G[,^?[?[]O+B*KVPM29DP]\"Y;;JKJ
M,X0H=)B D9\F:D?,:!V*A-7"S9 7,D&8F5.T:]%ZG%:,/&,_*H+[W^! FVH[
MO3G49W_I2];U[ZJ,P>M57;)&;2U*_=H/4G!# \'YB%\FCZN,XE3NV =Z@;UB
M-R=#^D8Y\'YWC]_<"U<J5@\V2EYI)(T]DZXVHA/Y+UUA9&U\G4:!O]4CRFUO
M4_E-C8+1@7?5..U;+]Z_"[)</]VII4#G!OHBV.J[*%YO6>5"H"!+/CW\<<O_
M:U.7$VKR:01I&O(TYI Q*B'R$@EQ&E/(?811BD62,J-SJI[]S\UPKG4 6HDJ
ML178J@$:/6Z U@0H5<!>%_MD8KW&JG-U'7L$1EY$9PV^\8(X]B!,M.Z--1@V
MB]L0*%O7L%Z-3K54#='X8$4:U$Q/Y[(-+3.>D>+U<W%:P$Z(NSHG<?9=/ CU
MB:KO]U'L@^^E(O?;Y?);0?*2U&(NN$ I"I@' QD3702>PC3&:J7". T"GS+.
MK8Y]G4LXM\5KKV!5SK1.#?&RT\72K<WY>)H=,5]UE$9>X X'J #GJG,*<0/V
M&H*]BF"?[(-H)8'2$ARJZ= ;;ZP1<.O%YUS*:;W_Q@+YQ&MPM(ZL-RC_3O*-
MDD,/:%7$](MX43/KB93BH5@]%N2Y,;72"/F<1"F,J P@2A(.,28!3%%,TQ!)
MCZ61X9[$L,NY,7DC-M!RUQ5ZP5YRT(AN;_B:#D#G1F,$6$>FWBLC:KQ[& '9
MB38,1@@[V1988M2Z$S!M9RKCWU*O WO?]DUKZGZ?/RZKMD3^>J>:+7]3;V>D
M^;I#(DB02 9%$E"( D] ["G#G?,($9$@7UGQAH1]L:.YT70E+&BD!96X-Z 6
MV)Y*+D/<2<G.@!N9B"?$S)ATG6$W$=5>P- )P1KAT4JKE]^>BDR-=#B@4+/G
M)PN,UB&SH1\'D>='VM&-0>2E&.((IQ +S#Q)(LDC89=4K)\@\[LM?W>56.91
MPYC_FT4P7PA@OG;D\HR"EO\[Q"N[#54>'J4\I,#Q:7%C??:=,_52)=YO),NU
M\$J-Y88+?I]O;V(7 1/*@O49]*(J@R-39!MZH2);03 1*$*>D0U[737F9B$_
M% (J<CZ3KT+7/7[,L_]7D7B5H^+DF>E*W0_X;LP6A/E_#2,O*!H 4"%0^U[O
M00 5"FI9V>+P,]@B 58YV&%1.="HY>40#E#C =X"HFUA]4TU"]46%OV9;8%Q
MMSY==V"=KF]74F72]?&ZPW6\OEY9FH'K<R5G:2S?6_&^B;_7OZJ1^=<BC"66
M*$ZAU#$]*(HHI!PCF$8))2'SO8CT6WC=R#>W%?602&L-;>GRB"U[KK*.1M]R
M^9Q^3"=<%YT,)_CK6_4WK2RHM'68J&6D<1AG&7,DXW76)[< MRX\CKOIN:)D
M.5&MDN5]7JZ+Z@"URI\4I#%+$(ZA$%) Y/L<DM2/8"322.@"&BPTJI[1T<_L
M&'XK)MC+V2LS51NNAIP['*VQN;,'4/:4=QD&M]35TM>T%'19X1,JZ7C<^JKQ
MSZ_OWHE\]:S:70O^:;46Y;N-"+S(W[J'".+YB 10<*X,1E\GJZ,\A<I.#(DG
M)"'<]+:QJZ^Y48.2%QP(#"J)@1(9:)GM[\\ZL>Z\=G2)X,AT,3EXQO>/+D&<
MZ KR,IA.;B%-46F]B.QL8*J[2%--#JXCC5_I9W+=K9Z?5WF50?!=]CWC(N?E
M@R@JYY%W^DQ?68.+," RHI)#&5.BB#;R(8W\%#(F9>)1'_NA6'P7!5V96F F
MW=I\[(>=CWC;N!45\$9&\-.FY-JUN@Z]M3RI-@+?S$AS#>C(%%R+6V<1U0&4
MC<0WVM&Y]AE3OVW$=F?"V8#DU)XSZGA2X\X&BF-+S^K=?K3T17P7^49\4')7
M]8P(6_\S6S_=;<KUZED4[__69YEJ=ZJWK>K_N+Z1ER+$<9C&4(9"[1)%@"$F
M?@ IIAY/1$C3,+1CJ1Y2S(^T]"5+42MBZ1G19Q#,V&ID8$<FKT9ZH&<5V,H/
M?F0Z2J[1X ;L= !;)=SZ0PR T"FU]9%C4J8; -0Q\0UIRMGV%VUW%=23OH?B
M!+)(>HKO? [5[I?!B HLPR# ,C J\&S0UW^G[2]RN(-#@[>_?1"\XO9W%/ &
M;W_[@#B#[2\:=_M[C(KU]A?-9?M[K(G!]O?DE>&1#'^P.[)<-M^L5-9DS 6"
MG(D$(@\+B%,:P#@@@H61)#@QK2AWL:.Y,>M9C_):8 =>^6\@[N149\"-3*@3
M8M8_DJ$O=M>,9##%<%!(PSE@S$,:WKQ]M9"&<SI<"FDX^[PU@U9>P;L4G5_(
MCS\41Q<96>H,G:M]2EDLA>0R"6 01(I+D:[.*405R!#'S,,>HZ9AO(9=SHU5
M:R_Z@OP SUMYC0G!%.5..AT!NY&)M8;M('NO$AKLI#;/W=L74F.V'0':B7C7
M%<0V%&R)5BL9F[8S%2U;ZG5 T+9O6E/U;4&S=5%]2P^JX16O_#](B!@CE,,4
M40$1B6-(, ^AIY"F8<!I'">&Q'RV@[G1\(&0H);2RIVF%<=.ZAV,SLA$.Q8P
MQ@0Z&*")Z/(4*">,>%']5OX[_]94;'=1Y@-NN_R<-9.=N7RZSUDA=(J#7=Z:
MA1_QR%,[>"@\3S%;*B5,911"&24\\44<,1H:,IM1AW-CNN9^M:SO5WDCMXZ2
MK02_L<X&9HQ\)Q<ZQ_,J5]7@?@?EPUA0&K.G<T@G8E,7T-K0K!5.K;1KULI4
M-&RETP$MV[UG3=-'A>;_S"7YOBJT__A_B()G;%T^J![57_6=FN)#OO"2.*2,
M,9AR7:?0"W6Z@\2#D9>F@4>D](V-4>O.YT;?GS;Z9$9OO-B29,]E?;F\V>L!
MOC>**"*O-/E'T:ABS$'V(]1)[:/B/C+-:]G!@? ZPF8/]U9^T"CPCR_CPVU,
M_Z/"/M%2X!I^FV6A-WZM2X1]BU,M%[UU/5@Z^K<QL#3<ARS/RB?!?UNM^%'9
M,JY6"8Y) BG#VD65^# -(A]*SZ<B)E'L8Z,Z3A9]SFW1V$JJ:\/Q#;.NM=H-
M\N4%8"3H1N;]@Z//'8"5P%.4ANM&:)S2<!?ZO4YIN&X@6DO#&;PZU'JMS;'/
MLKH[6T@L?8(C F5 =$579:,2B1 ,!)<LB+%$4IKYF7;T9#-+)O(EW=NE6L"^
MQL];/&W-RMX836Y!-G!]EO6%MANX^IJ%O6&[F@5H"M\ 6^\L**9FW=N7KV3!
MG=6@W5@[_[A3@JQ<8M5GL7Y'UJ+\*M8+$D1>C(,()D2M2TAJ9RKFZW*;*454
M!M3CN-_6_G+'<[/0JD^<'7[B^5M"K??Y.@L2TWH KA5Q0ANG@S*(=@=!?2T>
M7C5$ OY9N>I7"%?R Z7 2"@[8>M!:%^;OONA[HK36Z'K1?*GK<V!]5MU-%P&
MVM^W7A?J8A+Z<ROO\[K*Q+X.WC9)>$AI0"2!(?:U_1Q)F&**8.BE"0M($@EF
MZ@YFT-W<UH #D<%]OJW]LI?:WF/4!/-.LG>,Y 2;]NE!-.9RQV!.Q.##0;4A
M;0N,6JG:I(VI"-I"GP-:MGG+LL!]L5XHPB]7RXQ7'\[]6CR7[U;/),L702((
M#E$ $4T)1 'U(2%A H,X" 4)8^X+(X/\4B=S(]XW<H)*4/!7+:HA35R$]#+#
MN@)J9%[MA9'QK#<!X=)YIWK_X*Q3_>OXG/-B!Y,0@8F*V^EO]&R_&Y.:26YI
M6<6H+F@<)*D@*62A/K%,=&2\9 Q*B?PT###V VIS.?*V^;E-]&;A^FLKGV6R
MM"/LS.X\^B,R\HPV!\/Z%N.\SDXO+(ZZF/1NXKQZQ]<0+4\-S*C[Z^ONQ]\S
M4:B&GEX_BN]*7^U5BQ"/J$<$C"-)(>(,0>W)#6/D$X13M7_B1ALHNV[G-LWW
M"5/!3EA <@X^W?Y'ORR)9NB;$8)[3$<FBB%P]D\?:X3..%EA+W=]G62O1G"T
MYG U>]M!R;>E^KEH-L4^BY#:,*0P"F0*D<Y'@;F,(&-,^ %#24))[Y)O!QW-
MC7[.E]ZJ!'91ONP0XL[#&V? C6V,3(?9@))O/;&[:LDW0PR'U7X[ XQ%[;?#
MMZ]7^^V,#A=KOYU[OI]QU^36UI](E4+[FVJF.3L()?4C7^W/J(@P1"FM J1#
MJ+@S#(7:I,6^58'[]J[FQJ('DC9)[+6LEN<R!@B;&6UN<!N91/M"9FVD=:/A
MU#"[T-VDQEBWVL<&F,$;PXVN#X40SR1OEK>8I8G/D(0XBKF.W,60(+T9#!'7
MI2()P[ROU?6FI[D1QMGEKY'8@0WQ%F5[PZLW=M>PO,:"K;_MU1N^:QI?QC .
MLK[.0F-N?KU]_6KVUUDM+AE@YU]P[J_V0%ZK2[C;_Q2D^%S\L2K$[>-J(:*4
M1R%5#,L"J0_.!:1IPF&8R#"6C.$T-$VQV$^"N=&OH0?;2Z,,(.!5J:-&"3SK
M(K'D<>7,SZIER#HY>_R!&)G+.QUE:T^KK1[@%FA-P.<":%W [?ACX,SI;?A8
M7-O[;?B8N/2$NXQG;Y>XEF;GXAMW66L+)[F.AMS7A/\DUGL/D=\%?Q3;:H[G
MJR[?YE42[I0(2:,X@)(2M6PA+X)I['F0)6KQ0E'LL]0J&,Z]B'-;UP[KQ'YY
M4Y#XEBD"V2RKY*[GBJ%_K$H4NRLYWW/(S0XXKCN0(Z^+G:7JZXB^O9*@TO)-
MD>";MG+VU5789 7MAXW%9,7N>XHYZ7'.># ?'P.-V-/@VC[;K,;($UPM"C!"
M(=+Y-ZN#9@R]*(@Q2YCP4ZN#YI,>YL;KAQEF+,\YVE$TX]I!V(Q,E7:P#*FS
M<^Z\PA$SG?9RK0HZYX\SNA_L-ZW_@Q293K;P1=DDM3^0,N=$$C$8QA%1LUHD
MD'@^AWX0!F$D E](WV96'W<PMTF]E0]H 7NY^IQ :#:EAP S\HRVPL1Z0K<I
M[G0^GW0RZ71N4_%X-K<^UV\R?Q6/VB3X(EY6A=YWOLM*MESIZZ1]:71&@HAC
M'$'!B3Z*U-[Z'%-( H\S/XZE$$:9L2SZG-N4;T0&.YGMYKL)RF84X!B[D5GA
M!#:PEQ?\-4IE> N G+*'2;^3$HH%$,<<8_-JST.G%Z%3LN:/^RW*@A 1\L!+
MH"^EA(B$!&*,$:0A$0@'H0PE7ZQ7:[(T/#4Z[<.*5G8]C7ADL!519T95,EH>
MXYP!41)$?!8@Z"4B@ @E#!*6J']Z?L((4S#BU*X(X4 8ITD,XQY(PP.M8>",
M?2*U0^7-.93#,Z1V]=T> IWI9]I3G'9%3XYA+CQJ?6_\:94?7DE_?5[]2[5,
M<OZ[(,OUD[X9^*T0(A?-T4 4(.SY800#$OL044XAYES"-$XX133!V#COM&77
M<[/8E/CPK;M$HT%UDEKK4%V-W8!:#7LW%-O!Z;P:'A'RD9EFAF@;7P*/B/I$
MM[\CH&]SZ]L3P-;K7MOVIKKG[:GGP05OWQ;Z&=G?BLHQ]+4Z^FM. 76-;&4E
M!KX?H11!DM 8HL!/(0G5CCY(TS3!7L "DMKLZ%M[FMNJ4$L%"O&B6GPBNBKR
M3UD.RNK7[8:1);QFMJ,3T$;F]:V,VQSYM9@WH!;4G2'9B853<[*]MTF-RDZE
MCTW+[A=Z)4PZ*?KTH+Z!]?9?;TN2)2E'A$H,)1$<(B$#B&4<0YHBM<6,4C_V
M33T2+;N>&Y5\%$2"]8H2QLP=VFSA[C091P1Q9&IIK_E6B;_[1?\R>[9@6^57
M&@GTJ2J?D*)XK0S$Y]5&@4U*C?#Z20!*U(-,J"51B#H!I/Y+D]*[\KTML[(Z
M4]"_KD;JF:R5UNIML@99"?+5&FS*VGM)M_A8K'XH^W/W^*-.E.PLAU./<;B8
MS\FFO2ES._70\RC/4Y\6^AF>VL%$'QN+,GO,:W\2?<E)<1JEA(<P# 31H4($
M:GM3%\7R$YQX/")6]TCGNYG;.M%("0[$['5GW *JF:TY'*J15X,>*%D;F9=!
M<&IAMG0UJ7EY6=UCV[+CZ;Z5,^J*3N]$_=_[V@WE:;54;91U[IHOJ^7RPZKX
M00J^D*D0R \"B&*90,11 K%(!?2XSS'V$D8B85=%PZK_N5''5GSPTU:!G_6B
M>JC#OVWS)/ZE]0"-(I;48CM,9IPS(OBCFZ;.<>]1HZ,7>H[K==C),''MCEX
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M3 D*(8J". Q1JD_/K:S$2[W-C0_WP@(M+<QRT,C;,YKR,M:&=I\K!,>V] :
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M0C;^YPYSZW7@X#9Q7EMGTV;%ZU#Y).5=U_,]BWMKG_+;LA3K[06'X@84I3R
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MN]S3W,RY2EK0B%MGH+X!?_P"*I'M]Z(=,'?:=^[ &YE=IL7-V+1SA]]$=MU
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MPD)("==UI&7,TD"F5)K&\?:586[+BM8#L+TB-R"O5-%Q#66E#,A7:U#6ZMP
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M\?"P;68IL&((<VA^8! KD=JJ#A3&+$T8%B*CQ"D)O7V:J0F?DE10TUH=NV?
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M'I6!D-0&8*Q4F9@ (X9L,R:J(8UC#6,9"Z9S\U_NU+/$:;:I28Z2S'\%):%
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MHG@"<<0E9 1+F#%&<X0B)HB3E=\]U=2V];;!UYK-?1V&+7BZ;>XP* V\S[<
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M2!@24&0T5Z0@,4N)2QZO_=1.0F2 ;%X3-%.W$WUJ:0?L!;Q9575.J'&+MQP
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M:.J[RIKX5A-[M&_W;H%[GAAD%8,DCC3N!&DU&&<YU$HQ35(A22JLRMEX GQ
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MU[.<R;ID^B1*,L&42B 63$",A8*LP"G,9,053CDATJE!N4?:QB9R#ED#6][
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M7[[-QY\^+W\03/#[/YW_LU#)&.\96,P!5,X%?+(!7.%*2B-L%OA_?_KGP&+
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M(1UM1I(G'.@?Q1-#Q]VK;%MU-T"<2U+T:+D.(KAX=3FOLEM?%59\DT(N%Z.
MT>AZK9R=]+6 44&(14+1KFAI3,BQBQ3Z]M5WP\EY)4$[D/,@\/)F2I\6TG+\
M%5^'9=BP-6(A%^-K&A=K 1,F!)=]!FYC< &=I;BIDRN7;:OOAI?S2H5V(.=!
MX*5>/L]?A25^FLV_C8026I&'!#&I#$J3H70Z,>":B21R0,F[N%NYL^AN!6+G
ME04]7*J# ,6'BS"9O+Q<D#06BY% S7)!#H5545AO"-/&0R''NB3&>$A=V(X[
MB^X&BO/*=QXNU4& XJ<+G'^BD_'?Y[/?EY]?S2Z^A.FWD0^N1,P(R:9J\ 0G
M1]L4D,8'SQU:IKMP1+8NOAM(SBO1>;R4!P&6#Y]Q,KFB'GUA)5L%R#PGJ L)
M@1'RR7T*"F.)B><N#,BM-7>#QKED/8^4Z2 0<>L!SH?/),3%V\ME;?]2@_81
MIV#=Z%0?]40)BCPHB!XM"!.CRQ9]D,<E/IZG83?$G$M^M&.9]XR@%Q<XS;5V
M]N=)^#32DAM!1$ (GF+X5#@$$1F@<\5G*R4[,I:YL]QNN#B77.GADAQ(<?K/
MXT4*D_\7P_QG^LYBY(ST##,#3V:OLN A>.9!9\=\2);<+'44&!Y9>#=8G$OR
MM OI#@H@ZT<8:R:L*-8C9I*"2Z"BE>"X].1!,9U0$!OE./?CT:5W \FY)%2[
MD? PG!%B8QXF;Z89__B?^&U46^UE),MG+1(#"17$X"P8ZP1%Z9F)W$6(>V_9
MW>!Q9GG4(R3;=XW&.H=W8P.OWG!Y':.2R4)1)8)2(0#]EPITD,96Y$=Q7$^Y
MQU;>#2#GDCCM1+Z=8>1??GP@5&+Q;X=VAR2\3Q>8Z8O%;#+.M07HRS"IW2TI
M;,/EXB[]N[6-?/8S.^DGN1_E1S::?-!F[&WY>3REQ<9THLS6S^*NNQKZE-%&
M$\C=\ X43P(\*@I81$ZR&)43?\HJ=]#&[PGJCFU"]V*Q(.%>\ZIT<-I9 2+5
MEU\\DU-N@JPMUI(3TBGY9 WRX;S>I6,@S>>Z0L7]/G1'"/U@P_,5YW'65>?"
ML/C\8IKK7S_]Y^7X:YB0L!8OEJ_"?/Z-@OI5*[51*)Z\=AF!2\-!">_!F\)
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MF-YFZV;3Y#IE@QB!0@<S'<ZZSGFCJ$<4X[B("2-K4_^_'YW]EC,V@%PK'0T
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M$E]<U&J.$47$)NK(ZL0TK#V%+.V?>KEE@M1"%F5\FW3J(=3VF]!OCL;F"AS
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MV<+.%2L'M0.FT-G)G"-(^KOZ4B0(R2,(E:ST(J+ 9L,\NV2D[VY4IPLW^T3
ML#? 3NQZIT0ASJ#(S&B_:P[1<$\\"U=L?2[9J'KC2,+[;GDU"(!WKN'AA(=/
M<#V2B3D34JU:K@_DO*$SB@4/=9PX,9H]+\T&,3Y&5-]C<P:!Q[TT<T9-SF]?
M0-WN=K<9HK9I<-_]9=OC:YWBJFU'3KN_:'O84/"F1 4ES\@2:.9XO?/@$%PM
M3F+**B&,#[G-UM^)O./[H&\6^5@M^B@A=PP-!Z=J)\0DR14Q])51PA2C7(FI
MS2R'NW0,YG*M(UP\;$1^L-0'$)1?4[\9,W[UHG;QXH_Q8F2$S98[!=G79[4^
M:F*&&1":W-O"-$^-<JA/DC401!V@[\>@<[3P!W&-=8^+U[.+,)Z./+<Q6!?!
M.CK*E>&"V!!IY2Q8AW5R29N8>"LY \'.\0K?^H[T&-D/P!B]NNG]_"M>1)R/
MHK#:I8 4/V<$%76!J(4#Q[+TRAFF?)LL^ -2>JZ:/%Z]C_?9/D#6 P#+(V.S
M-\PXI35YRAR2LX[VDE 0.)WM9)&ME(7^;=O4>CQ)5L^EDYV#J#L=# !0]\==
M;[C@A46OHJ=0M/J&0ECPHKY^9LK41WO!IC8E>=OIZ3<UVSV$.I#Z +"SP]3I
M#6-9YJ0%28@;2X>\T!:<XP5$)FEE:;AW;4ZTG4GL-S?:P$@UT<T@/.X[ PLV
M3+ 2.=)Q#=Q%5>>RLE6G&R#!8>)9F^S:A/U;B.DWK=D]E(Z5]P LU?8T_Q4O
M,MEH;($L;+T5KN\=BLB0=)3!&V,QM^ES_115_?86[1Y$G6E@ &BZ#FA_H3-\
MU21C5(P+%JT&0R2#RD[7=A@(P5MC74J(HLV5X$-:!E(UW6&BZ# Q#P H]TM2
MWDP?IF/?TX[X>3;_/<SSR"A.NTH*$*$P4$&1_Z=$ 5:"XQB%+[;-?*X]"1U(
M/NE 7#SL3]),20/ 8$<SOWTJ(24*:UFRAFP_$^"UH"WM@]&V/C<L;7J2G7 $
M?,L>>NT@UF;&^S[Z/ACE7U:%>[2?Y\ON.UX\RS91B7A1__F(#"C^9BXF#86S
MZN_0'TZAI<C(V)"U2#ZV2:=URT?O\W=.AOT>]3\ 2[]3K6KF!954#&@?(T7[
MJ,'QR" I[D5 [V1L<S'56:EQRQ9\)T-JY[KJ-3-S,1O=5.HOEK.[&?+Q589\
MU64@AE7YS$7M!;=2[7LDR2[&2]STN%Y7<[_'-/LT'6_&F-STD"L%TW(U4D"7
M)%AMQ\3J6 J? OC(&&0F%#?&21GO.21;6D:?FNK>)Q(U!_C0H3  ._UZ_'6<
M<9H7MVXC7X7%YY'S(D46"X2B:;]SN9JW6D :+0PZP>B'36SS8Q3U/B3I9/:X
M$YT,IQ+X3LIVU3_[12)YS>MVJUFW^@AQ)+UP9 T5A%2OOC%SH'"Y5K4:97GV
MBL4V><]=J.M]MM+)H->YKH8#PX="6_D]HZR8U^1!@Q.I@,K!0C1, DF029EB
M0M'&"7V$H-XG,?68'=A?(\?B:U!I+1=7AARLQ3HF0SEP2/\L62;.6'2NM,FX
MGC"MU;(GXMFEM?;0]Y%IK9^FMY$^D <7[U:*_8S+<0J34[Z^N+MPKT\QGI#!
M2=]EA"BEC4Q#T-*#*EE =-6UC$%Z=(D,<*M3\ 3O,FXYTM?.]76G04P3^BN/
M4D*IT4<HK!;+&<[(P3$UZ>P<^HRI52?U7:@;R"U79QAZHABV&PT-HCKHB>[>
M[Y]+^!8FG+2!02+!$;,A0LA6 ;/),NT+.M4F #^"Z(%<]S=#Z:GT>:Z=3,/B
M\\^3V>]-^I9>?_9)NI1NYZ3[(_EZH9N7<(+'Y&J21PC"IXH9(D<!%'#'E$1R
MWC6NWME"50>&L'[FN_FLVO;\\MM?2/AOIM<CGE^D)5G].G[M6@[:FN3J+N&>
MU3JLB. ="V!"8MX'%[EITX=F?UH'<S@?AZ8MUJZET@9Q0M]JQRHDUZY(!M))
M\BYR[9Y?DH'@!"HOBR59-@'<4-K@MM;WXYUP]Q'] "Y-;ETJU8.?3OLTGN =
MY^#C;%]1*ADL1MJ:A=M .]77;L!:@HU*UQX,UF$;?Z\%-_TZ@B<&<N]P&,"6
M>(VT<AJO5$Q?3W#3/^_%14V(_=?J^R.M&.WS6%\3U=<=-M-AI%R$J%$'K:1-
MIDV"<Q?J^K6]_6/HP2C2CA4Z")"NEWUL"F IRCF.$AQR!8JE^H:$#B0=T!JT
M47+6)@/T#&']6M,!0K,[-0Y[%+UUCLX?J4';0MZ[]1$<0Y*792[[8G+@]XH^
M&XVB;U;G-AAP=:R-X=Q[;^_U?)UD?3M_/5ZL$UEU".^(<W+&,2M('!FHDA3X
MH#4QF8K1.M-&:M.@:3\Z^RU>&PQJ3Z#D09S;SXU%%UH7%32#(#QMS6P]>%$[
MEGNCDBS1:6R3-.MF2GVSLK7! ;5;50[-RG[ =#E?">NO8]J*E\OW&/)X\NTU
MTF:X&$_K]<#/83Q?55:]N?A"7Z[>CM7;A.GT,DS(N[Z<+D<N91^$TH#.KYZ0
M28A5&CEY.F6$";)IQZ:.V.BW;&YPT.\/(@,PX76W;\:\O9W^]$<5[^5X\7F=
MMGZ-D;QVY8U6+H,MV="9)&4=P>[ UIZC)B;O39L'3L^2UF]%WN!PW*TJAV/"
M'U:074MP\U#@Y@Z9>3J'A %G0VU30C%!<%(!I\-+,^N9$&WNIG:GL=]JO,&!
MMI%R!W&']9 WDCB22T5'R6+D?5!"!4&[CQ62FBLD-0I=M17%V)P-;<T38?46
M64-[ ]T-&IX%W:&*&429\T-V:J@YI?^(=NFH2"60VU2[I92:=?-0WZ5"\J(@
M9[0Y?9O[JR?)&MI[XQ/A[%#%#!1G+U*J3N_B7?BVZN1BBD\JU2>H 2THJTEL
M/F5($6,0PJ'F;>*C9TD;VJOA$^'M& 4-(#K9RM#\\M85 UZSE@IJ)I(%XTM]
MG5([NS#/@-EB%7*>@SM57YQ'B1S:T][3H; #I0W4IUN]C:JUI:LY=<L7%'\M
M%R^F^9=QB./)RE->O3\V23 >,RA._"FN,D29):14O.!*Z]QHF/>A% _M7>^)
ML-I G;T>WNO[L_M/L'"YG*QJ$Z\VH@LA*<-)B())4$8K\$Q'X(G%9'TNDNUT
MH_G<0D-[LMLIJAK(>@"'\"XCE%_5POKK:ZR4:$,XG8 <BIH0D!1!U8?(!4O&
M'(W%5A6;^Y*Z$QS]WTTVIJVJ!Q'$[,+B8E.X\A[)=5B$R=NR^48]%VK#!UM(
MF"P5R))7-UHRB$5Q4#'[(',@O[I-05(7U.^6XF'_ 'TK1 S IJ\XW2+0JX<*
MUV\71E*G&.KII%UMGB-4 &>< ^M<M-Q9+76;L&IG$G?#\]]/A6@;W0XB^MJ]
M@'P4LG/*E0Q.:HHL#6',:Z5 ^X :T<8DVPSHVIW&?G-2)R[&;Z2Z 4P*?H2S
M=;G7(X+,-=]A!52)@0J&@1>E@,S1>::<Y:5-GG1_6@?S=/@D;^BZ4MH@K"7%
MFYMC:=,LBKBE[;;\]FX2IDOR=VKERY?526"Y3LE("V9U%X&!@=/:04C:1^LD
MFES:.+0[TSC(-WB=X>6^3]I&=<,IZKAB\.?9G%A+B'E5W+WR7;8(=<1SRD%E
M\H6<K^T;N8%@I0''9*C=I[5I-+ME3T('^<"N-4I;*'$X4-U=J"/AE'7*>."B
M.%!2!O#&&) &49J0F7-M$E^[TSA(I[,50!NI;KA.Y\_C::#X<ZL@K;""O'<'
M$CE%>U'YVBB2MJ!T62"SP98V)G1_6OL%Z:F=SJZ4-@RG\]9!\.'S;+XD0WRQ
MJCY-IC@1HP)>T)#UER0Y9@NP+&RQ-A-O;5K)/DK2(%W*SM#PL*U#!XH90.[R
M/7[9^!UORUU&6$#!I,CUT90B\10-@9D"0D>1I9%2Q386[E&2!ND.MD)8-XH9
MQBW1K<WR9K&X)'GAV_++;/KIFB?4BJ6, 3#4>70E(#D,R, (1=O)**U%F\3X
M\[0-TL<[A5WK0%4#,W!W^?!"D1^JP7++:DT";2B+%IQ-]'^>>Y7:/&]XC*)^
MZ]EZ-&\'JV4X8>VMX)TXNYRGSV%!&^=6P\]10NE4\ I0U:O,XA"B9 *0R1P8
M6E2M3-RSM/5;G79J$]>MJH9QPE[OI6UC-499"^9$"!"BCQ3U,X0Z4PXXSY)%
M6;)S;5XM/$U7O^5K/<&N Q4-#7)DMN^^D*QC-!8C)DQ ;RF:MQ3_J%"EM9Y@
M' (+S&?266O4;2>MW[>N_0&O T4-Z,B]Y:K>LNFK?/D668Z4\ F9L23#(D%A
M]2F42* #-TI$++I1[<V>A/;[IK7'>*-K)0X@^-A=FJ-H!);(7;UT#* D*^!T
M=."%-E9%QC*>]+;C4&0VJ^\],3(;J6X MQV5K1?37/^J%]]?PZ3NNO7DO_L5
M]]>B9#%Q:[V%.@637.*BP$F)]9&E"2:S8F1N L]#J.TWDFYVX]%<<0.PF)6Y
M>PR^Q]K5*Y'SL!' W6\\*XKKL44__4&QWO03OB?]K&=9CM %;[DP((J)M=M=
M?7DD+8B8)><,'6FK&:Q/QV>_=S/M<;MEHPP41 .Q_P=+9T0T)YYC'5272"^*
MV([<*[#HM=$NAU8CVH\BN]^KH_/: 'NI^,B1;716SI<#0#73"A-C#C@SIF:=
M)3@A,J"I<[^EQ9#;%+BW1W6SJZDS0_4^*NYT$&'7GOH+"DSF\V]T%JW:YXUT
M,#724,"POI;B%(@X3Z&.XDX[88Q)MDV>;2?R^KU;.+$O?HQJ!E%P='?[O%H_
MVQ])FT3AC(%0@>+HD"Q$D1TDZ2F>CAY9HREM6\GI]]J@&:*.%_T PK>[3-QT
M?A@%FP5:P< @B4=YS^MHN@1(3D5DO#A>VABIQRCJ]P[@1"@Z4 $# -)19_WK
M\>++;!$F_SZ?77ZYCMSHNW5DX7AZB7GS4JX^NH]>:JD5 <<X 8HV%,2DZ2NG
MBK!"!(EM>LF<C,5^;Q2:'L'#@\BY[YU1U%9[S6O%JLEU_JR F.D "AA]2K(X
MY]I4%K</A9K=30P3XWNILK/$5*?36%^&]+=/M$6G.4SSR[ 8+V;EW:U/ODO]
M+C-8G_W$#B:O[D=U1_-6W\X_A>EF9M7-Q-=U+X[;B[\MFSNL,+D9!GL-5A<T
MZA0",&D)K"9R<)R<3@J5G0Q&Y=SH-.R$_*,[>1Q#1#T\)K/%Y1P_DDI?3FI9
MCS%!)5]\?6Y/7I>(M/EXCA <A8;2*FY2HX8?'7/2[PW"Z;']H ](G\@8YJ3L
MYZS<.Y)1JF4#G=OHZT\^@:W>SL6@;+;%VO>3.[!,*((2<^ 2X4F;I.E;',G+
M&)Z1Z<IFWTR"6JGJV\T6(R>K&!T-D =6QSX%<KPLYS4!+!)#*T4CN3Q*TO=@
M1?=!V\,.H5WH:@ AULI0O"V;CM 4.:[YN<^5\D*K',G71\U!R=J<4NJ:O1.!
M8TE<EC:=0':CK]];T?[AV$"+ \#F;_C[+8[FLRE]F=92V\Z?3%PALP;2.D 5
M&D)@!K+E66COB[@_@+.STL/]*.WWOK-_O#;5;+]#8FOJ8I5]N[QFYH8-9BTR
MS1$*"Y;8,(G8B %*-$';4K33_FF/\ID5^BT8[ ]870I^ )9O^X#0#5<C@<9$
M5V<N)AE!15\C+B- :LFT2J4(T2:Q^219_=Z/]V_3NM/9$  X_3HFLUPY")/5
MXYH-'\P[+V*(8%WM"I%S >>U!"D<4P53]M*WP=XC%/5[B3X V'6AJ?/,RWQ<
MSR;K/"OS\=;,L[8YF6T<#"LCHQ@KM=8L\%*;P 0)0;L,A" >?(F82IN"F4%D
M9#ZDSY@O)_BV?*S%?Y?S;ZLWKB^_O9J$Q>+&NW#>2-H3BO869E N27 \!Q#6
M^XB*9<O:',@[$OA=9&OV0.)]&]E"C^=I,G\+\UH+\!5?XS*,)PV,YX,53F!&
MG^9J4 8U&.8*5Q&,9'X]1C(DXRD:42GR& (Z_?T:U-5^N[<+5V?@*)O"M<<$
MAB)Y4#9:<$%0O%^2T<A8DJ51\=)C)'T/1G,?M#VHV.A$5SW&,HOY<O3V]RE]
MSN?QEQ=_C!<C(1A:%SD(8RTH\KG!18L0?!(^%"S&[K3YZ)-O 8S^=1]<#Y;N
M^=U:-ZJ<=2'7H0#B]>PBC*>CHH7-2B8H!F-M E8?=,0 %",)+6/.0>YTL;$?
M)-:+]P.*(]6W#00'R++?).U_X&3\QYOI=/9U71CYRR^O?L6+B/.1"T7YZ#WP
MX@.H:")X(A\\-T:0O^F9T4\[2$]]_  T?HBN9AT+;@ )K@^?260W;;/>S6>?
MYN%BM1U*E)Y)A\"SI"A &PT^U0<O#+G+CFMIV\2\C]/4\ZO/3H^/CC4P6"QM
M-IH.(8@H"K @--27>Q"#]<"T$2JHDARVN9-\BJI^W9&N-+\3H Y00[]GT_^X
MG'P3C/OM[&RLK2K:L&($!%$$;3PZLJ,*!ES14KCDBL_LV6-JEY6&B)1#5#IK
M)]^>X1*FEV'^K>KV28X"8T1TEA!D'0BC,YEJ[>JHKDP;#-%[^_S5\XZ+]3P=
MJ@5H&DAY""?795S@?UZ24'_Z2G]\I/]L98:]39'\N 2BCJQ4(B4(T7DP2G#$
MH*S"-N5>CQ#4<W^ -OY/![(?)H0V6RV5:-!K!E*%.M Z4D1@$VG=I6*4MDHT
M&L[T*$D]'V9=*/QY$!T@_>'!:&-.L_,Y:.8!79WRHWV!:(R'%%PVAC.;8YML
M^59R!@>?0U3]-( .D/L P+,NO=EFIG\93_'-$B]HEY601+$:=!3$4O&>#F6O
MH=AB/4OTOXVLT0[$]5NUU^9XZUHG X!9W2OC/"8_\.W\8;47XJO+B\O)ZA[R
M'<Y35>$GO,FT%B+DQ63R<1ZFBY#6[[%5TLEJ)VHSE0 J\$S[C!>004AK"T4<
MNIV?U2DK_=K&SL&VQ4KVI_E^ \S:>F,V7=('T@\_O9G2AQ+/[[$>/;>^\6X3
M#^67W]ZM=#9B48OBA8+DK0+E>*W=" ZX3SXJ*74V]SJM;HDX#UV]WQ"T%1Y/
MI8X!&-L'LVY?Y#RN^@N3*Q[?3*_W9>U>7#C*4C.&W-06QH$,'_V_I"WE2O+,
MH!9M6J#N36J_X6QK8]E6<SV_[KB9='$U_>*J0^"-Y1^A,C(SLN8:96VS8@R$
M$&J'/AD\YIQR>OX2<:>E^O4<&YJY[@4] )NVA:G:9G*547R-:4)_Y1$O12H5
M-;G:M6:'D7L0;23&3*T.-T8'W:9__B[4]?O(H[7EZEP_O;9"W+Z+:KOG%]/I
M99A<<4:^J'3*: ':\0B*'((ZZ5.!J5VA51*"&7N(N7JX5+^/-4YKKHX4] #,
MU8J=A_>TEQ3YS,?_A?G%17UKQT<NTYXH=%ZS6!"4"0R"U'4J=PH6I4=^W]'O
M*HK=C<!^.R0VCTT;:*EON[6=I_>X2.-:R7W#W,WOK-D<,<M8E+SVK+<2E"X4
M81>;R4$(F7["(OW\65MV\/+]-BAL:-].HY !V+P[8EM9[<4FBJ&3/V+$DLD,
MK:8I^A"(%><@95^$B,HRW:9&_0FB^FT7V-JV=:6- 0#KL1VTR=L\OH/XR#"I
M..,9:*N0Y8Y(OJ="41.&6#LR&MYHX.KA-.^6#F;GBLL3*;/?7,=V)J^B\/L.
MQ@@3:D=[#J*O+1:*4! +[<Q$'QI8]M[8Y].]^ZVY&\K.[M:AK>S/\^'BO:JK
MU?UDLS>,3RUV@N>,._,ZJ)>-F3E?4D00A=4)@MR 3XX,FXM.NQRM"=]Q\[['
M+]%11\TD(P<X,$8&7SCPH3APZ+7/(I9LV]SQ?M<O&_=!V^XO&_?1U1!\RB<*
MZ84.QIH"M7ZLIIHX1&$#V%R\D:X$D]KT:3GR$4L/;R#W4OH>CUCVT,!@L;2I
M,#/:VE#3W9*B>%!9*W V2H@JR\"E<%&UN9,XST<L^VA^GT<L^ZCA/%XE,)\,
M9SD"6?%:+U\*D)/&0&;:>\A%D2=^E=#/4Y:]%+O_JX1]I#P 4[1+7(6H5(F<
M6(JU91:+%/M@9E!<\M()7HQOU(>LHW+.'EYK'G/0=:V3 <#LJ>1BSBX8)REB
M3Y[5=XCULH1;,"D4E-HD;-3F[MA4;Z_)CKT L$>J=Q]M#&+ZX!UF5A,4KWBI
M'?K6M:,C%@2F("18I3.Q%A-992E!)V8=!I9RHZYANU W_/K)SL#6A7Z&9LZN
MV'E!J Z?L')U7850I,E:! 7&U.M?+BQX+Q44;J44&86[W^*B!>Z>H'#XY9&=
M8:\K/75H]3I-Z[['KSB]Q$45\ZM:MAS2<O'[>/GYU>5B.;L@\.^?O=WA,SM(
MTNY+>4>YV,VR/]]:]:^W%KW)?V6M.4N.SD!."(R!@X\V0C"HI-9H4VJ35=R1
MP./GKSZYS$W/1AV=D<8$\(4VB!*($"P9;2.<1:MYRKS-I?RN%/;KMK7 T\-1
MK0UT-<QKJN>MPO$=-@]8XR3V[B1=-G?%JS&HDS4*!-:,2<'Z?LH)R$DJ+++V
M:VU3$W$B^_=F2IK!ZXN/EV$2I@D_?$9<OICFFQ<5-Q/9%B^_W9D%NWAF&.PZ
M)Z"*)9?%!@A*(B@G"GCA.60A=2"?(ZO0)M ]$8/G87WW0?/#453#0\H PJ$[
M'*Z\^7$9I[7F:Y(>@W:IMGGFIN84ZNS"J!6#;%*R3DL?69LHZ!G"^@7L(,$T
M:Z?980/UJK]#4E8PIRG&C)Z$93,X+ 8P"HH$C4R2J5-#=0A7<)T"87>0':"5
MH<'L/W"2RVQ._\3?9LOM&W5S=Z1M8B*5"#$%!RHAHYU:JRU",<9:$WFC0H(#
M"1XL) ^!S5.@;*3# 4"U_2%TD\E+Q7N5M86L>2 ;D0S$(!U8+V..R<>$;9+P
M)V2RWUS^.;@40T7< #;CMKCEEW&(X\EX^6W$C4X)2=Z.I XJQ%PG5P4P4GBI
MA!*YT>GP)%G?NP]]()@>O';N2K,#@.DFTGZ'<SH3+ZK W\;)^-/ZY,5%FH^_
MK(M*/XXO2*ZC9&H_89W %T]'8LD:@@MT((N V5@1X_T&NMWFCW8E]'NWW=U
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M)<[PH"4%C#Y0>A@*1.9M;0TTB<([X_ 4CO%) GL&WB'(& 2]P]34 ?K^,U"
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MU6CB;0H<]_KL<<M,8!II_36;I=3.>$4R""E;(;5-FG<*^ ^ R-PM*\?0ZJ,
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M3+:Q>)^D"L=(NOQA8BW=:\/UO]O@.4@9+6#K6T0S7UV=Y_MM;!>)9_)TI8'
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M\>8%V,$::!M@;MOR@A>.5VXG'[#N'\; NU!=8&^8%I6'*1T,L&TCSY.C-R_
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M5 '*P,"+("U*'XL^V!5X=/1N>/NY7@3&445;)$K?6BA)9IC#RHEI(CDU*@5
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M'2=VH_BA3QJ0!*V=REIW)3G-OR^XTCJR;GO.[CF[E%/;XUE=YAP2^ B"Q ?
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MVE'RRG(U%- BV. 1C!()(K)Q5$Y6':V([/_-LFWUD%>F^0]B-,#'G<)>KT^
MVCG0P6>;K4F$@SJM_ [SRL;@9F!>V1AM=. >/D7R0E%1&RI0UZYN8,F$(MJ=
MM'=:>BQ9'HP,UVUVV2A=#Z13CA%\G_C9<)6#<*&5+1#6ZU9 0_/:2@CHK"Q!
M(UES,$)NSW3*40H?3*<<(_W^8'0;O%<6;50U@12AM+Z_+;5!:E D9 @N)SYQ
M_Y]..4K5@^B48^1^9,;<23ZC<GU.;^JW_V&?]-<?Z.IL6;Z_^$27:R_@X7>)
M?L0/-TN/2I'.^ )4J*4^^%94PQI>?R;8Y*3&9\L<CF/5[3/2SF*4N^]^!U79
MD:'YU#PVM<DL2\\GMONMFIBQ&2%AXM.Y%%HKJBJ504')0>![?BS'H_<=#@O+
M611SW*NU?[Q[]WI3R+QX/K!D#R8FVZH:2XCL/H!O1QRCI4QY>R>\WYYW/$1,
MJ9SEOI+JP#-ZYKHPU,)'5JN!?"(P2!4P: -.V.HSFJ3T(0A<W?>NV^>8-I'X
MCTP87Z^I$\K7J\75XB:0OKR^^HFP+,Y__8;X)1\6%TU6W^%BM;XM?O/+!;_Y
M;/'Q+:URT^%[.C4A2)V"YFF2:%Q:!2$A?UE0>*V"E6F[C9EF+)U=!^P(BN4Q
M-=155.AAO8Q3FR.+2PMPK1BS286GP7]XGR^NH%>EJ-$!H8>OZ<RSWAM(T\JU
M*XQ\Y@(M/WQ<4\DN3[U&XZLC4-'B3:UNM-F!5]IH9RT["VXL1AZ^IK--;6J,
M["G7+C%R)VYU^=WB_(8 >V\E7)Y69R5EZ<$YY<#DNFYC+$"3,IX\KP^'N\)G
MT BZ9>]-BZSIM=&=8_XHG;\X\IHE"$86=CS;95JTPD/0P04?D&A8\YUC95@<
M@Q6X"_)F4DF7EFTSJ4:(O4OG/U7"&4HE@B+-A]N0 P1E'52-BN5&Q9CMA;A'
MOK1;#N"T]FL2F7>)IH>6^2'-X]0GE:S,!$6U-5,K0<H)H:ID,%BBF-)TV^3#
M 71+]YM[E]Q3%UTB[N[Z>61^F2VP9K&U8N>*YZ<,)"\=4-8A>R^$I)U=LN=?
MW2TK<&HO?S+YOP"2X.O%^[.KRW?\*WCS<6W#IZ'[/?_LJ8E[(V9R% J>+X6R
M8'.D L/%2'002DK@I53*\G%2W>\8]151\&Q&*21&,-JTG "6 .IJH**SR?"Q
M1B<Z@*/_$BEX8W SD((W1AL='"2?(@99C5I&+*U6!4O&Y98D&9OQYW%682Q/
M[W=/P1NEZX$4O#&"[Q,_M\%2'G7*KDC(/@LPJE@(QHE6;<V52LXY.T_VV NC
MX(U2^& *WACI]P>C3?T<;8VHOO4R+!J,400Q20^VDB1E#"8[4UG>ET3!&Z7J
M012\,7+OJFC=>D&I$G).R8!WD1<4[^H0<V#QR$1\C# ^4QF"FJ^I,?TN.]4$
MXNT*''=9JU)HDW1A3;:>J48$""V54844VT5&2&)0@L'74]%PE%:'5#0<(^(C
MWQ6M3[2;6GQ!9ATS#[O:UGJE>$A%9K:$O#N+XA'M@,#_G2?VHN5=5;/<7T['
M5>_)A^6_V1KR:?#OA.=79W>B?YO)\)[I<]:5=[G$UC%1:7U1!#B5(UH5?:UB
MJ]*WOZ?#&H<[0F%BF1X7(.].?GY0DK-6FS [S8)0K0!D,1!BYOW2$[]<VS@D
M./_(@X_#YI@# OM*[8@Z;YVZ7]-[//]VW:[[)A%*ZT F)A V$SO1AIUHV=K]
MZ>B2))&0GKM!O*3\Q_?+3W_B1]\X!/QAC8<U%AYY86>TGMV]Q'V%>60<?'NW
M8WL(E))*!6QNS8X=(SG)@B!(58&AU/1L!?WM(+C[MN,X!GNK:SF![(YK[]^R
M9!8??UBN5HO+=R>O-K;+1>%J+-"*=X$I1K=&QQ(<J6A:8B3=+]/W6+>HQQY]
M/$7OKJ#EA-+JX'KIF0!GYHU)&!%!:I:(:66XH[,$6GCG8E:RRD.49^R^LO$^
M=]T3B;\K2D%KC47K@H ;=E<.VE?;TE4%VU+#ZP"""Q&J3JYJJ6L<SQE_\);.
MXB [*O))HL!^4NT*(+?,O^757VEUM:B+SS7<V$'.H<4;R[J[JZ9U%AGQGNM0
MR,#_M!V+DZ=>UMEEY-1PF43&W>U/CW)'E7<EEZ1 8FG51CWQBB@90B@L-PH8
M[G>_[8O.>XP4A5U -I-*)BR8/A]AZ8LS_>6/N%JM^5G3,):V/'QJRM*8N1R%
MLR0]*1&K@H#8\H$C F(Q4(*D&BS%,%,";0^<I2*=H"@0,@N!5Z9QD-9=V(3E
ME5E"%6*F'O OGK,T!C<#.4MCM-'#;GFO/^WZ$D-7%[SE?3XXIUINA0!TCL^F
M1&R14A1^+A;<(Z/IS$O?0<M/UX?=3>0=PF;3YHD/KEG6 +QZB%U%SRNKE@#L
M*9IBC0U.'P8X/9"4]M?S%N#L(/0CWQ;>.'[?\_^?%N4:SS=L]=N;,.MEEL@+
M2K-T6@6U E%%!PI%<):/'\)OSWS:\I*^,+&+"A_TEI]$GAT8E:=8?<K[$BLE
M2%&W?%)9(2BL4(,QLEK#*^<@U>-&\6</S4K:9T>:0O!]XN=V?:7LVF5%@%QE
M*S"E!01?-%2,.0E!6MTG)?P^^;.C%#Z8/SM&^OW!Z-:6(DJ2IGB(NH7V+5H^
M*B0"GS*9RNJ/.(@)^77S9T>I>A!_=HS<NZ)(WH2#951D2FZ5[0(O*)X"*M/*
MV[E*!K649E#JQ]?4$7R7G6H"\78%CCM+1IFT+E4',B,#7 ;96E^%5K&%9$KL
MHM5!Q/ROAS\[2JM#^+-C1-P??ZX@#U:%##9G9'&T,F NY<8L$X&L%B5L;RNV
M*W_NL&S:48IZGC\W1FH=.!W/1%Y*1<-R44!*13"4).^IS@"YHFP4(I9TH+80
MK[MF5>QU)S>-^+L#TJ.QMN I1&$1L&8+!CT!ZN!!.F\\LE=5#U)N]$7UBQZ%
M@O'ASS$J>0'5&OYVC2N\N"*ZQ(NR;G9VLOBP.,?5#WC51C%Q.'3TZZ8.D.XW
MWZ.$3!W[5L[9"B4H1APA0JR6H%B9I! H^*NO-F2JC1/.29ZMEJUT=.5#I>-/
MV62/*J!QVA]F2WUQ(=,QN!G::6F$-KK882_>MS*^WU#Z[>:LYJ"E8K\#"_*9
M124/"4V!5)/1 4O,%&9"U,/1=+:+[J#E!\#94^0=PF:3,N00K:X.>+RMF:/S
M$"PFR"P19046%>?)RW]\/,>&SKYZW@*<'83> 71^HD_+\T_-9^1W+ZZ^P[PX
M7_=6N$D?M2F*V(CDOG6;LB5":DU^*/!YV?+QUXEYV(S/#JLO(.VB]^5<2N@
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M4$L! A0#%     @ /5%<4QX"<6PS!   +!$  !0              ( !+1$
M &5X:&EB:70S,C%Q,S(P,C$N:'1M4$L! A0#%     @ /5%<4U7$KL Y!
MO1$  !0              ( !DA4  &5X:&EB:70S,C)Q,S(P,C$N:'1M4$L!
M A0#%     @ /5%<4XVBCM_M%   DM(  !0              ( !_1D  &5X
M:&EB:70Y.3%Q,S(P,C$N:'1M4$L! A0#%     @ /5%<4]I(8!4#!   &!X
M !0              ( !'"\  &5X:&EB:70Y.3)Q,S(P,C$N:'1M4$L! A0#
M%     @ /5%<4]L?<X>5, 0 MB Q  \              ( !43,  &UO+3(P
M,C$P.3,P+FAT;5!+ 0(4 Q0    ( #U17%.!E.V%WR$  (.& 0 /
M      "  1-D! !M;RTR,#(Q,#DS,"YX<V102P$"% ,4    "  ]45Q3'VB$
MY48C  #Z9P$ $P              @ $?A@0 ;6\M,C R,3 Y,S!?8V%L+GAM
M;%!+ 0(4 Q0    ( #U17%-!W*U9SLX  "TV"0 3              "  9:I
M! !M;RTR,#(Q,#DS,%]D968N>&UL4$L! A0#%     @ /5%<4R):K%'060$
M=H . !,              ( !E7@% &UO+3(P,C$P.3,P7VQA8BYX;6Q02P$"
M% ,4    "  ]45Q3-E6+R3C\  #FA L $P              @ &6T@8 ;6\M
F,C R,3 Y,S!?<')E+GAM;%!+!08     #  ,  H#  #_S@<    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
